PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kang, LJ; Yu, ZH; Cai, J; He, R; Lu, JT; Hou, C; Wang, QS; Li, XQ; Zhang, R; Feng, YM				Kang, Li-Juan; Yu, Zi-Han; Cai, Jun; He, Rui; Lu, Jun-Tao; Hou, Chen; Wang, Qing-Shan; Li, Xiao-Qing; Zhang, Rui; Feng, Yu-Mei			Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness	FASEB JOURNAL			English	Article						NCoR1; HDAC3; EMT; chemoresistance	EPITHELIAL-MESENCHYMAL TRANSITION; STEM-CELLS; EXPRESSION; TRANSCRIPTION; PHENOTYPE; SIGNATURE	FOXF2 and FOXQ1, forkhead box transcription factor superfamily members, are encoded by neighboring genes located on human chromosome 6p25.3 and play opposite roles in epithelial-mesenchymal transition (EMT) and metastasis in basal-like breast cancer (BLBC). However, the relationship between FOXF2 and FOXQ1 in cancer remains unknown. Here, we found mutual transcriptional repression between FOXF2 and FOXQ1, and the reciprocal negative feedback loop controlled EMT, aggressiveness, and chemoresistance in BLBC cells. We further demonstrated that FOXF2 recruited nuclear receptor corepressor 1 and histone deacetylase 3 to the FOXQ1 promoter to inhibit its transcription in BLBC cells, but FOXQ1 did not exert such an effect on FOXF2. Our findings reveal novel mechanisms underlying the determination of BLBC aggressiveness and the transrepressive function of FOXF2 in a basal-like cell subtype-specific manner. Therefore, blocking the vicious cycle of the abnormal reciprocal feedback loop between FOXF2 and FOXQ1 to induce cell differentiation and restore tissue homeostasis is a promising strategy for the treatment of aggressive BLBC.Kang, L.-J., Yu, Z.-H., Cai, J., He, R., Lu, J.-T., Hou, C., Wang, Q.-S., Li, X.-Q., Zhang, R., Feng, Y.-M. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.	[Kang, Li-Juan; Yu, Zi-Han; Cai, Jun; He, Rui; Lu, Jun-Tao; Hou, Chen; Wang, Qing-Shan; Li, Xiao-Qing; Zhang, Rui; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Minist Educ,Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Wang, Qing-Shan; Li, Xiao-Qing; Zhang, Rui; Feng, Yu-Mei] Tianjin Med Univ, Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Breast Canc Prevent & Treatment,Minist Ed, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Feng, YM (corresponding author), Tianjin Med Univ, Dept Biochem & Mol Biol, Canc Inst & Hosp, Huan Hu Xi Rd, Tianjin 300060, Peoples R China.	ymfeng@tmu.edu.cn			National Natural Science Foundation of China [81272357, 81472680, 81672894, 81872403]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (81272357, 81472680, 81672894, and 81872403). The authors declare no conflicts of interest.	Benayoun BA, 2011, TRENDS GENET, V27, P224, DOI 10.1016/j.tig.2011.03.003; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Cai J, 2015, CANCER LETT, V367, P129, DOI 10.1016/j.canlet.2015.07.001; Christensen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060051; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Hallett RM, 2012, SCI REP-UK, V2, DOI 10.1038/srep00227; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hupe M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aag2476; Junankar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7548; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Katoh M, 2004, INT J ONCOL, V25, P1495; Katoh M, 2013, CANCER LETT, V328, P198, DOI 10.1016/j.canlet.2012.09.017; Kong PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061591; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez-Iglesias OA, 2016, P NATL ACAD SCI USA, V113, pE328, DOI 10.1073/pnas.1520469113; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nik AM, 2013, GASTROENTEROLOGY, V144, P1001, DOI 10.1053/j.gastro.2013.01.045; Ormestad M, 2006, DEVELOPMENT, V133, P833, DOI 10.1242/dev.02252; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Peng XD, 2015, CANCER BIOL THER, V16, P1099, DOI 10.1080/15384047.2015.1047568; Qiao YY, 2011, CANCER RES, V71, P3076, DOI 10.1158/0008-5472.CAN-10-2787; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Sun BC, 2017, ONCOTARGET, V8, P30502, DOI 10.18632/oncotarget.8461; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tian HP, 2015, J BIOL CHEM, V290, P19173, DOI 10.1074/jbc.M114.636126; Wang QS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0531-1; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Yu ZH, 2017, CANCER LETT, V402, P142, DOI 10.1016/j.canlet.2017.05.020; Zhang HJ, 2011, CANCER RES, V71, P1292, DOI 10.1158/0008-5472.CAN-10-2825	34	13	13	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6564	6573		10.1096/fj.201801916R	http://dx.doi.org/10.1096/fj.201801916R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807702	Bronze			2022-12-26	WOS:000466932600059
J	Shih, JC; Lin, HH; Hsiao, AC; Su, YT; Tsai, S; Chien, CL; Kung, HN				Shih, Jin-Chung; Lin, Hua-Heng; Hsiao, An-Che; Su, Yi-Ting; Tsai, Shawn; Chien, Chung-Liang; Kung, Hsiu-Ni			Unveiling the role of microRNA-7 in linking TGF--Smad-mediated epithelial-mesenchymal transition with negative regulation of trophoblast invasion	FASEB JOURNAL			English	Article						Smad2; microarray; canonical pathway; preeclampsia; placenta accreta	GROWTH-FACTOR-BETA; CELL INVASION; MOLECULAR-MECHANISMS; SIGNALING PATHWAYS; PLACENTA-ACCRETA; UP-REGULATION; E-CADHERIN; ACTIVIN-A; CANCER; SNAIL	Several pregnancy complications result from abnormal trophoblast invasion. The dichotomous effect of TGF- on epithelial-mesenchymal transition (EMT) between trophoblast invasion and cancer progression remains unknown and a critical concern. We attenuated the expression of TGF- type 1 receptor (coding by TGFBR1) with RNA interference in trophoblastic cells and significantly enhanced the trophoblastic invasion. Analysis of microRNA profiles in trophoblasts indicated microRNA-7 as a key molecule linking TGF- with the negative regulation of trophoblast invasion. We then attenuated TGFBR1 and miR-7 transcription by transducing either short hairpin RNA targeting TGFBR1 or anti-miR-7-locked nucleonic acid, and we observed an up-regulation of EMT-related transcription factors (TFs) and their downstream effectors, causing a mesenchymal transition of trophoblasts. Conversely, overexpression of TGFBR1 or miR-7 led to the epithelial transition of trophoblasts. Our results showed that TGF--induced miR-7 expression negatively modulated the TGF--SMAD family member 2-mediated EMT pathway via targeting EMT-related TFs and down-regulating their mesenchymal markers. These findings possibly explain, at least in part, why TGF- exerts an opposite effect on EMT during trophoblast invasion and cancer progression.Shih, J.-C., Lin, H.-H., Hsiao, A.-C., Su, Y.-T., Tsai, S., Chien, C.-L., Kung, H.-N. Unveiling the role of microRNA-7 in linking TGF--Smad-mediated epithelial-mesenchymal transition with negative regulation of trophoblast invasion.	[Shih, Jin-Chung; Hsiao, An-Che; Su, Yi-Ting; Tsai, Shawn; Chien, Chung-Liang; Kung, Hsiu-Ni] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan; [Lin, Hua-Heng] Natl Taiwan Univ, Coll Med, Grad Inst Med Genom & Prote, Taipei, Taiwan; [Shih, Jin-Chung] Natl Taiwan Univ Hosp, Coll Med, Dept Obstet & Gynecol, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Kung, HN (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, 1,Sec 1,Jen Ai Rd, Taipei 10051, Taiwan.	kunghsiuni@gmail.com	SHIH, JIN-CHUNG/AAQ-8651-2021	SHIH, JIN-CHUNG/0000-0002-0296-4327; CHIEN, CHUNG-LIANG/0000-0001-9806-486X; KUNG, HSIU-NI/0000-0001-6979-8346	Ministry of Science and Technology [102-2314-B-002-152, 103-2314-B-002-160, 104-2320-B-002-062, 106-2314-B-002-201]; National Taiwan University Hospital [105-003054, 106-S3468]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Taiwan University Hospital(National Taiwan University)	The authors deeply grieve the death of H.-H.L. (the second author of this research), who passed away from a heart attack while working on this project. This work was supported by funds from the Ministry of Science and Technology (102-2314-B-002-152, 103-2314-B-002-160, 104-2320-B-002-062, 106-2314-B-002-201) and research fund from the National Taiwan University Hospital (NTUH; 105-003054 and 106-S3468). The authors declare no conflicts of interest.	Abou-Kheir W, 2017, PLACENTA, V50, P1, DOI 10.1016/j.placenta.2016.12.007; Arimoto-Ishida E, 2009, ENDOCRINOLOGY, V150, P4306, DOI 10.1210/en.2008-1662; Bainbridge SA, 2005, FREE RADICAL BIO MED, V38, P979, DOI 10.1016/j.freeradbiomed.2004.11.002; Bi YL, 2017, INT J MOL MED, V39, P900, DOI 10.3892/ijmm.2017.2894; Blechschmidt K, 2007, VIRCHOWS ARCH, V450, P195, DOI 10.1007/s00428-006-0343-x; Butz H, 2012, TRENDS PHARMACOL SCI, V33, P382, DOI 10.1016/j.tips.2012.04.003; Caniggia I, 1999, J CLIN INVEST, V103, P1641, DOI 10.1172/JCI6380; Cao MX, 2017, ONCOTARGET, V8, P12472, DOI 10.18632/oncotarget.13957; Chen C, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1278436; Chen CP, 2018, FREE RADICAL BIO MED, V124, P189, DOI 10.1016/j.freeradbiomed.2018.06.006; Chen Y, 2018, J CELL PHYSIOL, V233, P2257, DOI 10.1002/jcp.26098; Cheng JC, 2013, J BIOL CHEM, V288, P33181, DOI 10.1074/jbc.M113.488866; Cheng JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042436; CHOU JY, 1978, P NATL ACAD SCI USA, V75, P1409, DOI 10.1073/pnas.75.3.1409; Chou YT, 2010, CANCER RES, V70, P8822, DOI 10.1158/0008-5472.CAN-10-0638; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Colucci F, 2011, PLACENTA, V32, P539, DOI 10.1016/j.placenta.2011.05.001; Cui W, 1996, CELL, V86, P531, DOI 10.1016/S0092-8674(00)80127-0; Davies JE, 2016, CELL ADHES MIGR, V10, P310, DOI 10.1080/19336918.2016.1170258; Ding XM, 2013, J BIOL CHEM, V288, P10241, DOI 10.1074/jbc.M112.443655; Fu GD, 2013, INT J MOL SCI, V14, P5519, DOI 10.3390/ijms14035519; Fu GD, 2013, HYPERTENSION, V61, P864, DOI 10.1161/HYPERTENSIONAHA.111.203489; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Graham CH, 1997, PLACENTA, V18, P137, DOI 10.1016/S0143-4004(97)90085-0; GRAHAM CH, 1991, J CELL PHYSIOL, V148, P228, DOI 10.1002/jcp.1041480207; Hata A, 2009, CYTOKINE GROWTH F R, V20, P517, DOI 10.1016/j.cytogfr.2009.10.004; Huang JP, 2015, PLACENTA, V36, P1433, DOI 10.1016/j.placenta.2015.10.007; Huang ZY, 2017, ONCOTARGET, V8, P33560, DOI 10.18632/oncotarget.16826; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Kataoka K, 2001, CANCER LETT, V163, P213, DOI 10.1016/S0304-3835(00)00685-6; Khong TY, 2008, J CLIN PATHOL, V61, P1243, DOI 10.1136/jcp.2008.055202; Khoo NKS, 1998, INT J CANCER, V77, P429, DOI 10.1002/(SICI)1097-0215(19980729)77:3<429::AID-IJC20>3.3.CO;2-Q; Kim Sunghwan, 2013, J Lifestyle Med, V3, P80; Kokkinos MI, 2010, PLACENTA, V31, P747, DOI 10.1016/j.placenta.2010.06.017; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li Y, 2015, J CLIN ENDOCR METAB, V100, pE1415, DOI 10.1210/jc.2015-2134; Li Y, 2014, J CLIN ENDOCR METAB, V99, pE2216, DOI 10.1210/jc.2014-2118; Li YZ, 2016, ONCOL REP, V36, P1569, DOI 10.3892/or.2016.4912; Lindsey S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00358; Liu TM, 2015, MOL MED REP, V12, P7403, DOI 10.3892/mmr.2015.4374; Lv ZD, 2013, ONCOL REP, V29, P219, DOI 10.3892/or.2012.2111; Ma L, 2016, ADV CANCER RES, V132, P165, DOI 10.1016/bs.acr.2016.07.004; Martz CA, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa1877; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng B, 2015, J CLIN ENDOCR METAB, V100, pE19, DOI 10.1210/jc.2014-1897; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Pollheimer J, 2005, PLACENTA, V26, pS21, DOI 10.1016/j.placenta.2004.11.013; Quan JJ, 2013, CLIN EXP METASTAS, V30, P659, DOI 10.1007/s10585-013-9570-0; Rama S, 2003, MOL CELL ENDOCRINOL, V206, P123, DOI 10.1016/S0303-7207(03)00202-8; Reiter JL, 2017, PLACENTA, V52, P17, DOI 10.1016/j.placenta.2017.02.010; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Sivadas VP, 2014, TUMOR BIOL, V35, P2857, DOI 10.1007/s13277-013-1481-9; Suzuki HI, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071901; Tang JL, 2016, CANCER LETT, V371, P301, DOI 10.1016/j.canlet.2015.11.043; Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008; Wang H, 2012, ONCOL LETT, V3, P229, DOI 10.3892/ol.2011.448; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang Q, 2009, J HISTOCHEM CYTOCHEM, V57, P605, DOI 10.1369/jhc.2009.953166; Zeng CY, 2016, MOL MED REP, V13, P1297, DOI 10.3892/mmr.2015.4643; Zhang FF, 2016, CANCER LETT, V373, P203, DOI 10.1016/j.canlet.2016.01.037; Zhang HY, 2014, STEM CELLS, V32, P2858, DOI 10.1002/stem.1795; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao MR, 2006, REPRODUCTION, V132, P333, DOI 10.1530/rep.1.01112; Zhao X, 2013, ONCOGENE, V32, P1363, DOI 10.1038/onc.2012.156; Zhou XY, 2016, SCI REP-UK, V6, DOI 10.1038/srep19910	67	20	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6281	6295		10.1096/fj.201801898RR	http://dx.doi.org/10.1096/fj.201801898RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30789794	Bronze			2022-12-26	WOS:000466932600038
J	Fadare, O; Amare, M; Mavrotas, G; Akerele, D; Ogunniyi, A				Fadare, Olusegun; Amare, Mulubrhan; Mavrotas, George; Akerele, Dare; Ogunniyi, Adebayo			Mother's nutrition-related knowledge and child nutrition outcomes: Empirical evidence from Nigeria	PLOS ONE			English	Article							HEALTH; GROWTH; EDUCATION; OBESITY; INPUTS	Background Nutrition outcomes among young children in Nigeria are among the worse globally. Mother's limited knowledge about food choices, feeding, and health care seeking practices contributes significantly to negative nutrition outcomes for children in most developing countries. Much less is known about the relationship between mother's nutrition-related knowledge and child nutritional outcomes in rural Nigeria. This paper investigates therefore: (i) the association of mother's nutrition-related knowledge with nutrition outcomes of young children living in rural Nigeria, where access to education is limited, and (ii) whether mother's education has a complementary effect on such knowledge in producing positive child nutrition outcomes in such settings. Methods Using the Demographic and Health Survey data for Nigeria, we employ both descriptive and regression analyses approaches in analyzing the study's objectives. In particular, we apply ordinary least square (OLS) to investigate the association of mother's nutrition-related knowledge with child HAZ and WHZ while controlling for maternal, child, household and regional characteristics. An index was constructed for mother's nutrition-related knowledge using information on dietary practices, disease treatment and prevention, child immunization, and family planning. Results We found that mother's knowledge is independently and positively associated with HAZ and WHZ scores in young children. Higher levels of mother's education, typically above primary, have a significant, positive association with child HAZ and WHZ scores. We argue that mother's knowledge of health and nutrition may substitute for education in reducing undernutrition in young children among populations with limited access to formal education. However, the present level of mother's education in rural Nigeria appears insufficient to reinforce knowledge in producing better nutrition outcomes for children. Conclusions This study suggests promotion of out-of-school (informal) education, such as adult literacy and numeracy classes where women without formal education can gain health and nutrition knowledge, and practices that could enhance child nutrition outcomes in Nigeria.	[Fadare, Olusegun; Amare, Mulubrhan; Mavrotas, George; Ogunniyi, Adebayo] Int Food Policy Res Inst, Dev Strategy & Governance Div, Washington, DC 20036 USA; [Akerele, Dare] Fed Univ Agr, Abeokuta, Nigeria	CGIAR; International Food Policy Research Institute (IFPRI); University of Agriculture, Abeokuta	Amare, M (corresponding author), Int Food Policy Res Inst, Dev Strategy & Governance Div, Washington, DC 20036 USA.	m.amare@cgiar.org	Fadare, Olusegun/ACC-3706-2022	Fadare, Olusegun/0000-0002-0647-7438; Akerele, Dare/0000-0003-4725-035X	USAID under the Feed the Future Nigeria Agricultural Policy Project	USAID under the Feed the Future Nigeria Agricultural Policy Project	This study benefited from USAID funding under the Feed the Future Nigeria Agricultural Policy Project. We also want to indicate that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya BA, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-80; Akeredolu I. A., 2014, European Journal of Nutrition and Food Safety, V4, P364, DOI 10.9734/EJNFS/2014/7604; Al-Ayed IH, 2010, J FAM COMMUNITY MED, V17, P22, DOI 10.4103/1319-1683.68785; Alderman H, 2017, WORLD DEV, V94, P448, DOI 10.1016/j.worlddev.2017.02.007; Alderson TS, 1999, HEALTH EDUC RES, V14, P717, DOI 10.1093/her/14.6.717; Amare M, 2018, FOOD NUTR BULL, V39, P296, DOI 10.1177/0379572118768568; Appoh LY, 2005, MATERN CHILD NUTR, V1, P100, DOI 10.1111/j.1740-8709.2005.00016.x; Benson T, 2017, 45 IFPRI; Black MM, 1999, J NUTR, V129, p539S, DOI 10.1093/jn/129.2.539S; Block SA, 2007, OXFORD ECON PAP, V59, P330, DOI 10.1093/oep/gpm001; Christiaensen L, 2004, ECON DEV CULT CHANGE, V52, P287, DOI 10.1086/380822; Contento I., 1995, Journal of Nutrition Education, V27, P277; CONTENTO IR, 1993, HEALTH EDUC QUART, V20, P243, DOI 10.1177/109019819302000215; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Onis M, 2007, J NUTR, V137, P144, DOI 10.1093/jn/137.1.144; Debela BL, 2017, APPETITE, V116, P518, DOI 10.1016/j.appet.2017.05.042; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Ekwochi U, 2015, ITAL J PEDIATR, V41, DOI 10.1186/s13052-015-0127-5; Ene-Obong H, 2012, FOOD NUTR BULL, V33, P242, DOI 10.1177/156482651203300404; Fadare O, 2019, PUBLIC HEALTH NUTR, V22, P444, DOI 10.1017/S1368980018003075; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Haddad L, 2015, J NUTR, V145, P663, DOI 10.3945/jn.114.206078; Headey D, 2015, WORLD DEV, V66, P749, DOI 10.1016/j.worlddev.2014.09.022; HORTON S, 1986, J DEV ECON, V23, P161, DOI 10.1016/0304-3878(86)90086-6; Karnawat D., 2015, J MED RES, V1, P90; Kassie B, 2014, J INFECT DIS THER, V2, P1, DOI DOI 10.4172/2332-0877.1000182; Khan MN, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0181-0; Kimenju S.C., 2015, PUBLIC HEALTH NUTR, V18, P3224, DOI [10.1017/S1368980015000919, DOI 10.1017/S1368980015000919]; Kuzma J, 2013, INT BREASTFEED J, V8, DOI 10.1186/1746-4358-8-16; Maiga EW, 2013, AFR EC C; Makoka D., 2013, DHS WORKING PAPERS; Manley J, 2013, WORLD DEV, V48, P133, DOI 10.1016/j.worlddev.2013.03.010; Marias YF., 2014, GUIDELINES ASSESSING; National Population Commission and ICF, 2014, NIG DEM HLTH SURV 20; Olusanya BO, 2011, J HEALTH POPUL NUTR, V29, P639; Osei A, 2010, FOOD NUTR BULL, V31, P483, DOI 10.1177/156482651003100402; Oyekale AS, 2009, SOCIAL SCI, V4, P118; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; ROSENZWEIG MR, 1983, J POLIT ECON, V91, P723, DOI 10.1086/261179; RUEL MT, 1992, AM J EPIDEMIOL, V135, P904, DOI 10.1093/oxfordjournals.aje.a116386; Rutstein S. O., 2004, DHS COMP REPORTS; Sanusi R. A., 2009, PAKISTAN J NUTR, V8, P1506; Singh GCP, 2009, ASIA-PAC J PUBLIC HE, V21, P144, DOI 10.1177/1010539509332063; Srinivasan CS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-581; Stewart CP, 2013, MATERN CHILD NUTR, V9, P27, DOI 10.1111/mcn.12088; Sudfeld CR, 2015, PEDIATRICS, V135, pE1266, DOI 10.1542/peds.2014-3111; UNICEF, 1990, STRAT IMPR NUTR CHIL; Van den Broeck K., 2007, DEP EC DISCUSSION PA, V07-30; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; Vonasek BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150131; Wamani H., 2007, BMC Pediatrics, V7; Webb P, 2004, ECON DEV CULT CHANGE, V52, P801, DOI 10.1086/420901; Webb P, 2003, 21 TUFTS U FOOD POL	53	31	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212775	10.1371/journal.pone.0212775	http://dx.doi.org/10.1371/journal.pone.0212775			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817794	Green Submitted, Green Published, gold			2022-12-26	WOS:000460371500036
J	Pothula, R; Shirley, D; Perera, OP; Klingeman, WE; Oppert, C; Abdelgaffar, HMY; Johnson, BR; Jurat-Fuentes, JL				Pothula, Ratnasri; Shirley, Derek; Perera, O. P.; Klingeman, William E.; Oppert, Cris; Abdelgaffar, Heba M. Y.; Johnson, Brian R.; Jurat-Fuentes, Juan Luis			The digestive system in Zygentoma as an insect model for high cellulase activity	PLOS ONE			English	Article							FIREBRAT; ENZYMES	The digestive system of selected phytophagous insects has been examined as a potential prospecting resource for identification of novel cellulolytic enzymes with potential industrial applications. In contrast to other model species, however, limited detailed information is available that characterizes cellulolytic activity and systems in basal hexapod groups. As part of a screening effort to identify insects with highly active cellulolytic systems, we have for the first time, identified species of Zygentoma that displayed the highest relative cellulase activity levels when compared to all other tested insect groups under the experimental conditions, including model species for cellulolytic systems such as termite and cockroach species in Rhinotermitidae (formerly Isoptera) and Cryptocercidae (formerly Blattodea). The goal of the present study was to provide a morphohistological characterization of cellulose digestion and to identify highly active cellulase enzymes present in digestive fluids of Zygentoma species. Morphohistological characterization supported no relevant differences in the digestive system of firebrat (Thermobia domestica) and the gray silverfish (Ctenolepisma longicaudata). Quantitative and qualitative cellulase assays identified the foregut as the region with the highest levels of cellulase activity in both T. domestica and C. longicaudata. However, T. domestica was found to have higher endoglucanase, xylanase and pectinase activities compared to C. longicaudata. Using nano liquid chromatography coupled to tandem mass spectrometry (nanoLC/MS/MS) and a custom gut transcriptome we identified cellulolytic enzymes from digestive fluids of T. domestica. Among the identified enzymes we report putative endoglucanases matching to insect or arthropod enzymes and glucan endo-1,6-beta-glucosidases matching bacterial enzymes. These findings support combined activities of endogenous and symbiont-derived plant cell wall degrading enzymes in lignocellulose digestion in Zygentoma and advance our understanding of cellulose digestion in a primitive insect group.	[Pothula, Ratnasri; Shirley, Derek; Oppert, Cris; Abdelgaffar, Heba M. Y.; Jurat-Fuentes, Juan Luis] Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA; [Perera, O. P.] USDA ARS, Southern Insect Management Res Unit, Stoneville, MS 38776 USA; [Klingeman, William E.] Univ Tennessee, Dept Plant Sci, Knoxville, TN USA; [Johnson, Brian R.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Oppert, Cris] BASF, Morrisville, NC USA	University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; United States Department of Agriculture (USDA); University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture; University of California System; University of California Davis; BASF	Jurat-Fuentes, JL (corresponding author), Univ Tennessee, Dept Entomol & Plant Pathol, Knoxville, TN 37901 USA.	jurat@utk.edu	Pothula, Ratnasri/AAB-6044-2021	Pothula, Ratnasri/0000-0003-0517-2058; Klingeman, William/0000-0001-6272-0079; Jurat-Fuentes, Juan Luis/0000-0002-8945-1814	Division of Integrative Organismal Systems of the National Science Foundation (NSF) [1456662, 1456678]	Division of Integrative Organismal Systems of the National Science Foundation (NSF)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by grant numbers 1456662 (to JLJ-F) and 1456678 (to BRJ) from the Division of Integrative Organismal Systems of the National Science Foundation (NSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNHART CLYDE STERLING, 1961, ANN ENT SOC AMER, V54, P177; BERGER BG, 1945, J ECON ENTOMOL, V38, P577, DOI 10.1093/jee/38.5.577; Boto L, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2450; Calderon-Cortes N, 2012, ANNU REV ECOL EVOL S, V43, P45, DOI 10.1146/annurev-ecolsys-110411-160312; Cazemier AE, 1997, COMP BIOCHEM PHYS A, V118, P101, DOI 10.1016/S0300-9629(96)00443-4; Cleveland LR, 1924, BIOL BULL-US, V46, P178, DOI 10.2307/1536507; Davison A, 2005, MOL BIOL EVOL, V22, P1273, DOI 10.1093/molbev/msi107; Fischer R, 2013, ADV BIOCHEM ENG BIOT, V136, P51, DOI 10.1007/10_2013_206; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; IRISH J, 1988, Cimbebasia, V10, P15; LASKER R, 1956, J EXP BIOL, V33, P542; Lindsay E., 1940, Proceedings of the Royal Society of Victoria N S, V52, P35; McKenna DD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1088-8; MODDER W. W. D., 1964, CEYLON J SCI BIOL SCI, V5, P1; Oppert C, 2010, COMP BIOCHEM PHYS B, V155, P145, DOI 10.1016/j.cbpb.2009.10.014; Sabbadin F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03142-x; Sahrhage D., 1953, Zeitschrift fuer Wissenschaftliche Zoologie Leipzig, V157, P77; Shelomi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26388; Song JM, 2010, COMP BIOCHEM PHYS B, V155, P403, DOI 10.1016/j.cbpb.2010.01.003; Soumya Chatterjee, 2015, South Asian Journal of Experimental Biology, V5, P271; TERRA WR, 1990, ANNU REV ENTOMOL, V35, P181, DOI 10.1146/annurev.en.35.010190.001145; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; TREVES DS, 1994, J CHEM ECOL, V20, P2003, DOI 10.1007/BF02066239; Watanabe H, 2010, ANNU REV ENTOMOL, V55, P609, DOI 10.1146/annurev-ento-112408-085319; Willis JD, 2010, COMP BIOCHEM PHYS B, V157, P267, DOI 10.1016/j.cbpb.2010.06.012; Willis JD, 2010, INSECT SCI, V17, P184, DOI 10.1111/j.1744-7917.2010.01322.x; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; ZINKLER D, 1987, COMP BIOCHEM PHYS B, V88, P661, DOI 10.1016/0305-0491(87)90360-9	28	15	16	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212505	10.1371/journal.pone.0212505	http://dx.doi.org/10.1371/journal.pone.0212505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817757	gold, Green Submitted, Green Published			2022-12-26	WOS:000460371500025
J	Magill, CR; Eglinton, G; Eglinton, TI				Magill, Clayton R.; Eglinton, Geoffrey; Eglinton, Timothy I.			Isotopic variance among plant lipid homologues correlates with biodiversity patterns of their source communities	PLOS ONE			English	Article							SOUTHERN TROPICAL AFRICA; EARLY HUMAN HABITATS; ECOSYSTEM MULTIFUNCTIONALITY; PHENOTYPIC PLASTICITY; SPECIES COMPOSITION; CO2 CONCENTRATIONS; FUNCTIONAL TYPES; VEGETATION; CLIMATE; DIVERSITY	Plant diversity is important to human welfare worldwide, and this importance is exemplified in subtropical and tropical [(sub) tropical] African savannahs where regional biodiversity enhances the sustaining provision of basic ecosystem services available to millions of residents. Yet, there is a critical lack of knowledge about how savannahs respond to climate change. Here, we report the relationships between savannah vegetation structure, species richness, and bioclimatic variables as recorded by plant biochemical fossils, called biomarkers. Our analyses reveal that the stable carbon isotope composition (delta C-13) of discrete sedimentary plant biomarkers reflects vegetation structure, but the isotopic range among plant biomarkers-which we call LEaf Wax Isotopic Spread (LEWIS)-reflects species richness. Analyses of individual biomarker delta C-13 values and LEWIS for downcore sediments recovered from southeast Africa reveal that the region's species richness mirrored trends in atmospheric carbon dioxide concentration (pCO(2)) throughout the last 25,000 years. This suggests that increasing pCO(2) levels during post-industrialization may prompt future declines in regional biodiversity (1-10 species per unit CO2 p.p.m.v.) through imminent habitat loss or extinction.	[Magill, Clayton R.] Heriot Watt Univ, Lyell Ctr, Edinburgh, Midlothian, Scotland; [Magill, Clayton R.; Eglinton, Timothy I.] Swiss Fed Inst Technol, Inst Geol, Zurich, Switzerland; [Eglinton, Geoffrey] Univ Bristol, Dept Earth Sci, Bristol, Avon, England	Heriot Watt University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bristol	Magill, CR (corresponding author), Heriot Watt Univ, Lyell Ctr, Edinburgh, Midlothian, Scotland.; Magill, CR (corresponding author), Swiss Fed Inst Technol, Inst Geol, Zurich, Switzerland.	C.Magill@hw.ac.uk			H2020 Marie Sklodowska-Curie Actions [FEL-30 12-2]	H2020 Marie Sklodowska-Curie Actions	This work was funded through H2020 Marie Sklodowska-Curie Actions (FEL-30 12-2; http://ec.europa.eu/programmes/horizon2020/en/h2020-section/marie-sklodowskacurie-actions) awarded to C.R.M., but funders played no role in the conception or completion of this work.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Anchukaitis KJ, 2013, CLIM DYNAM, V41, P1291, DOI 10.1007/s00382-012-1483-0; Anderson TM, 2007, J BIOGEOGR, V34, P313, DOI 10.1111/j.1365-2699.2006.01598.x; Araya YN, 2011, NEW PHYTOL, V189, P253, DOI 10.1111/j.1469-8137.2010.03475.x; BELSKY AJ, 1989, J APPL ECOL, V26, P1005, DOI 10.2307/2403708; Birks HJB, 2016, REV PALAEOBOT PALYNO, V228, P1, DOI 10.1016/j.revpalbo.2015.12.011; Breshears DD, 2006, FRONT ECOL ENVIRON, V4, P96, DOI 10.1890/1540-9295(2006)004[0096:TGCTIE]2.0.CO;2; Broennimann O, 2006, GLOBAL CHANGE BIOL, V12, P1079, DOI 10.1111/j.1365-2486.2006.01157.x; Brooks JR, 1997, OECOLOGIA, V110, P301, DOI 10.1007/s004420050163; Burrough SL, 2015, HOLOCENE, V25, P1811, DOI 10.1177/0959683615591355; Busch FA, 2013, PLANT CELL ENVIRON, V36, P200, DOI 10.1111/j.1365-3040.2012.02567.x; Bush RT, 2017, PALAEOGEOGR PALAEOCL, V485, P593, DOI 10.1016/j.palaeo.2017.07.015; Bush RT, 2013, GEOCHIM COSMOCHIM AC, V117, P161, DOI 10.1016/j.gca.2013.04.016; Callaway RM, 2003, ECOLOGY, V84, P1115, DOI 10.1890/0012-9658(2003)084[1115:PPAIAP]2.0.CO;2; Calvo MM, 2015, NEW PHYTOL, V208, P987, DOI 10.1111/nph.13485; Campbell ID, 1999, PALAEOGEOGR PALAEOCL, V149, P245, DOI 10.1016/S0031-0182(98)00204-1; Castaneda IS, 2016, EARTH PLANET SC LETT, V450, P306, DOI 10.1016/j.epsl.2016.06.049; Castaneda IS, 2009, PALAEOGEOGR PALAEOCL, V275, P100, DOI 10.1016/j.palaeo.2009.02.008; Cernusak LA, 2013, NEW PHYTOL, V200, P950, DOI 10.1111/nph.12423; Chen SP, 2005, ECOL RES, V20, P167, DOI 10.1007/s11284-004-0026-5; Colgan MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124078; COWLING RM, 1994, J ARID ENVIRON, V27, P141, DOI 10.1006/jare.1994.1054; Dalerum F, 2012, THEOR ECOL-NETH, V5, P129, DOI 10.1007/s12080-010-0104-y; Daru BH, 2016, J BIOGEOGR, V43, P155, DOI 10.1111/jbi.12619; de Vente J, 2005, EARTH-SCI REV, V71, P95, DOI 10.1016/j.earscirev.2005.02.002; DeBusk GH, 1998, J BIOGEOGR, V25, P479, DOI 10.1046/j.1365-2699.1998.2530479.x; Deryng D, 2016, NAT CLIM CHANGE, V6, P786, DOI [10.1038/NCLIMATE2995, 10.1038/nclimate2995]; Eglinton TI, 2008, EARTH PLANET SC LETT, V275, P1, DOI 10.1016/j.epsl.2008.07.012; Franco AC, 2014, THEOR EXP PLANT PHYS, V26, P19, DOI 10.1007/s40626-014-0002-6; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Goring S, 2013, J ECOL, V101, P1137, DOI 10.1111/1365-2745.12135; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grace J, 2006, J BIOGEOGR, V33, P387, DOI 10.1111/j.1365-2699.2005.01448.x; Hemingway JD, 2016, GEOCHIM COSMOCHIM AC, V184, P20, DOI 10.1016/j.gca.2016.04.003; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Higgins SI, 2012, NATURE, V488, P209, DOI 10.1038/nature11238; Hoffmann WA, 2012, ECOL LETT, V15, P759, DOI 10.1111/j.1461-0248.2012.01789.x; Hooper DU, 2002, BIODIVERSITY AND ECOSYSTEM FUNCTIONING: SYNTHESIS AND PERSPECTIVES, P195; House JI, 2003, J BIOGEOGR, V30, P1763, DOI 10.1046/j.1365-2699.2003.00873.x; Huttich C, 2011, ENVIRON MONIT ASSESS, V176, P531, DOI 10.1007/s10661-010-1602-5; Ivory SJ, 2016, QUATERNARY SCI REV, V148, P101, DOI 10.1016/j.quascirev.2016.07.015; Ivory SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112855; Ivory SJ, 2012, QUATERNARY RES, V77, P77, DOI 10.1016/j.yqres.2011.11.005; Jackson RB, 2002, NATURE, V418, P623, DOI 10.1038/nature00910; Kahmen A, 2005, FUNCT ECOL, V19, P594, DOI 10.1111/j.1365-2435.2005.01001.x; KELLY CK, 1995, J ECOL, V83, P509, DOI 10.2307/2261603; Khon VC, 2014, EARTH PLANET SC LETT, V403, P407, DOI 10.1016/j.epsl.2014.06.043; Kier G, 2005, J BIOGEOGR, V32, P1107, DOI 10.1111/j.1365-2699.2005.01272.x; Kleidon A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014007; Koellner T, 2013, INT J LIFE CYCLE ASS, V18, P1188, DOI 10.1007/s11367-013-0579-z; Krull ES, 2005, GEODERMA, V126, P241, DOI 10.1016/j.geoderma.2004.09.012; Leakey ADB, 2012, PHILOS T R SOC B, V367, P613, DOI 10.1098/rstb.2011.0248; Lloyd J, 2008, TREE PHYSIOL, V28, P451, DOI 10.1093/treephys/28.3.451; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Magill CR, 2016, P NATL ACAD SCI USA, V113, P2874, DOI 10.1073/pnas.1507055113; Magill CR, 2015, ORG GEOCHEM, V88, P29, DOI 10.1016/j.orggeochem.2015.07.009; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1167, DOI 10.1073/pnas.1206276110; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1175, DOI 10.1073/pnas.1209405109; Maguire KC, 2015, ANNU REV ECOL EVOL S, V46, P343, DOI 10.1146/annurev-ecolsys-112414-054441; Mander L, 2014, INT J PLANT SCI, V175, P931, DOI 10.1086/677680; MARGALEF R, 1983, AM NAT, V121, P601, DOI 10.1086/284089; Mitchell N, 2015, AM NAT, V185, P525, DOI 10.1086/680051; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moya-Larano Jordi, 2008, Web Ecology, V8, P35; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; O'Connor TG, 2001, J ECOL, V89, P850, DOI 10.1046/j.0022-0477.2001.00605.x; Odgaard BV, 1999, J BIOGEOGR, V26, P7, DOI 10.1046/j.1365-2699.1999.00280.x; Peterson DW, 2008, PLANT ECOL, V194, P5, DOI 10.1007/s11258-007-9270-4; Polley HW, 2012, GLOBAL CHANGE BIOL, V18, P700, DOI 10.1111/j.1365-2486.2011.02529.x; Rommerskirchen F, 2006, ORG GEOCHEM, V37, P1303, DOI 10.1016/j.orggeochem.2005.12.013; Roscher C, 2013, PERSPECT PLANT ECOL, V15, P139, DOI 10.1016/j.ppees.2013.02.004; Ryan CM, 2014, IEEE T GEOSCI REMOTE, V52, P519, DOI 10.1109/TGRS.2013.2242081; Sadler P.M., 2014, GEOL SOC LOND SPEC P, V404; Sala O.E., 1997, PLANT FUNCTIONAL TYP, P217; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Schefuss E, 2011, NATURE, V480, P509, DOI 10.1038/nature10685; Scheiner SM, 2011, ECOL MONOGR, V81, P195, DOI 10.1890/10-1426.1; Schubert BA, 2015, GEOLOGY, V43, P435, DOI 10.1130/G36467.1; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Shirima DD, 2015, BASIC APPL ECOL, V16, P239, DOI 10.1016/j.baae.2014.11.008; Silvertown J, 2015, J ECOL, V103, P93, DOI 10.1111/1365-2745.12332; Skarpe C, 1996, J VEG SCI, V7, P397, DOI 10.2307/3236283; Soliveres S, 2014, GLOBAL ECOL BIOGEOGR, V23, P1408, DOI 10.1111/geb.12215; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; Timberlake J, 2000, OCCASIONAL PUBLICATI, V9, P1; Tsialtas JT, 2001, FUNCT ECOL, V15, P605, DOI 10.1046/j.0269-8463.2001.00555.x; Valentini R, 2014, BIOGEOSCIENCES, V11, P381, DOI 10.5194/bg-11-381-2014; Vogts A, 2009, ORG GEOCHEM, V40, P1037, DOI 10.1016/j.orggeochem.2009.07.011; Wang YMV, 2013, PALEOCEANOGRAPHY, V28, P619, DOI 10.1002/palo.20053; Wang YMV, 2013, GEOCHIM COSMOCHIM AC, V111, P128, DOI 10.1016/j.gca.2012.10.016; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Whittaker R. J., 2001, DIVERSITY, V28, P453, DOI DOI 10.1046/J.1365-2699.2001.00563.X	94	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212211	10.1371/journal.pone.0212211	http://dx.doi.org/10.1371/journal.pone.0212211			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811453	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400060
J	Chen, LX; Gu, WP; Liu, CX; Wang, WG; Li, N; Chen, Y; Lu, CX; Sun, XM; Han, YY; Kuang, DX; Tong, PF; Dai, JJ				Chen, Linxia; Gu, Wenpeng; Liu, Chenxiu; Wang, Wenguang; Li, Na; Chen, Yang; Lu, Caixia; Sun, Xiaomei; Han, Yuanyuan; Kuang, Dexuan; Tong, Pinfen; Dai, Jiejie			Characteristics of the tree shrew gut virome	PLOS ONE			English	Article							METAGENOMICS; VIRUSES; CLASSIFICATION; INFECTION; ACLAME; MODEL	The tree shrew (Tupaia belangeri) has been proposed as an alternative laboratory animal to primates in biomedical research in recent years. However, characteristics of the tree shrew gut virome remain unclear. In this study, the metagenomic analysis method was used to identify the features of gut virome from fecal samples of this animal. Results showed that 5.80% of sequence reads in the libraries exhibited significant similarity to sequences deposited in the viral reference database (NCBI non-redundant nucleotide databases, viral protein databases and ACLAME database), and these reads were further classified into three major orders: Caudovirales (58.0%), Picornavirales (16.0%), and Herpesvirales (6.0%). Siphoviridae (46.0%), Myoviridae (45.0%), and Podoviridae (8.0%) comprised most Caudovirales. Picornaviridae (99.9%) and Herpesviridae (99.0%) were the primary families of Picornavirales and Herpesvirales, respectively. According to the host types and nucleic acid classifications, all of the related viruses in this study were divided into bacterial phage (61.83%), animal-specific virus (34.50%), plant-specific virus (0.09%), insect-specific virus (0.08%) and other viruses (3.50%). The dsDNA virus accounted for 51.13% of the total, followed by ssRNA (33.51%) and ssDNA virus (15.36%). This study provides an initial understanding of the community structure of the gut virome of tree shrew and a baseline for future tree shrew virus investigation.	[Chen, Linxia; Gu, Wenpeng; Liu, Chenxiu; Wang, Wenguang; Li, Na; Lu, Caixia; Sun, Xiaomei; Han, Yuanyuan; Kuang, Dexuan; Tong, Pinfen; Dai, Jiejie] Chinese Acad Med Sci, Inst Med Biol, Ctr Tree Shrew Germplasm Resources, Kunming, Yunnan, Peoples R China; [Chen, Linxia; Gu, Wenpeng; Liu, Chenxiu; Wang, Wenguang; Li, Na; Lu, Caixia; Sun, Xiaomei; Han, Yuanyuan; Kuang, Dexuan; Tong, Pinfen; Dai, Jiejie] Peking Union Med Coll, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Yunnan Innovat Team Standardizat & Applicat Res T, Kunming, Yunnan, Peoples R China; [Chen, Linxia] Gannan Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Ganzhou, Peoples R China; [Gu, Wenpeng] Yunnan Prov Ctr Dis Control & Prevent, Dept Acute Infect Dis Control & Prevent, Kunming, Yunnan, Peoples R China; [Chen, Yang] Tsinghua Univ, Dept Automat, Ctr Synthet & Syst Biol, MOE Key Lab Bioinformat,TNLIST, Beijing, Peoples R China; [Chen, Yang] Tsinghua Univ, TNLIST Dept Automat, Ctr Synthet & Syst Biol, Bioinformat Div, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Peking Union Medical College; Gannan Medical University; Tsinghua University; Tsinghua University	Dai, JJ (corresponding author), Chinese Acad Med Sci, Inst Med Biol, Ctr Tree Shrew Germplasm Resources, Kunming, Yunnan, Peoples R China.; Dai, JJ (corresponding author), Peking Union Med Coll, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Yunnan Innovat Team Standardizat & Applicat Res T, Kunming, Yunnan, Peoples R China.	djj@imbcams.com.cn	Gu, Wenpeng/U-5367-2017; Wang, WenGuang/AAW-2800-2020		Yunnan Science and Technology Talent and Platform Program [2017HC019]; Yunnan province major science and technology project [2017ZF007]	Yunnan Science and Technology Talent and Platform Program; Yunnan province major science and technology project	This work was supported by Yunnan Science and Technology Talent and Platform Program (2017HC019). Yunnan province major science and technology project (2017ZF007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso PP, 2012, J VIROL, V86, P5039, DOI 10.1128/JVI.07162-11; Belak S, 2013, VET MICROBIOL, V165, P95, DOI 10.1016/j.vetmic.2013.01.022; Calvignac-Spencer S, 2016, ARCH VIROL, V161, P1739, DOI 10.1007/s00705-016-2794-y; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carding SR, 2017, ALIMENT PHARM THER, V46, P800, DOI 10.1111/apt.14280; Caspermeyer J, 2018, MOL BIOL EVOL, V35, P1558, DOI 10.1093/molbev/msy098; Chen H, 2010, J VIROL, V84, P10522, DOI 10.1128/JVI.00450-10; Chinchar VG, 2017, J GEN VIROL, V98, P890, DOI 10.1099/jgv.0.000818; Conceicao-Neto N, 2017, ECOL EVOL, V7, P4135, DOI 10.1002/ece3.2991; Coutinho FH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15955; D'arc M, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0402-9; DARAI G, 1983, J VIROL METHODS, V7, P305, DOI 10.1016/0166-0934(83)90083-6; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Endo H, 2000, J VET MED SCI, V62, P517, DOI 10.1292/jvms.62.517; Fan Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2416; Feng Y, 2017, J GEN VIROL, V98, P2069, DOI 10.1099/jgv.0.000869; Hofer U, 2013, NAT REV MICROBIOL, V11, P595, DOI 10.1038/nrmicro3092; Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084; Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938; Liu W., 2016, ADV MATER, P1, DOI DOI 10.1016/J.PACS.2016.05.001; Lukashev AN, 2017, J GEN VIROL, V98, P955, DOI 10.1099/jgv.0.000760; LVOV SD, 1988, VOP VIRUSOL+, P92; Minot S, 2013, P NATL ACAD SCI USA, V110, P12450, DOI 10.1073/pnas.1300833110; Mokili JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058404; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Romer S, 2018, FRONT NEUROANAT, V12, DOI 10.3389/fnana.2018.00029; Shen Pei-Qing, 2011, Zoological Research, V32, P109, DOI 10.3724/SP.J.1141.2011.01109; Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167; Sullivan MB, 2015, J VIROL, V89, P2459, DOI 10.1128/JVI.03289-14; Tong YH, 2017, ONCOTARGET, V8, P17897, DOI 10.18632/oncotarget.15225; Walker A, 2010, NAT REV MICROBIOL, V8, P841, DOI 10.1038/nrmicro2476; Yang ZF, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-111; Yao YG, 2017, ZOOL RES, V38, P118, DOI 10.24272/j.issn.2095-8137.2017.032; Zhang D, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5152-5	40	4	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212774	10.1371/journal.pone.0212774	http://dx.doi.org/10.1371/journal.pone.0212774			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807598	Green Submitted, Green Published, gold			2022-12-26	WOS:000459712100023
J	Park, SB; Sung, DJ; Kim, B; Kim, S; Han, JK				Park, Seung-Bo; Sung, Dong Jun; Kim, Bokyung; Kim, SoJung; Han, Joung-Kyue			Transcranial Direct Current Stimulation of motor cortex enhances running performance	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; EXERCISE PERFORMANCE; BRAIN-STIMULATION; COGNITIVE CONTROL; MUSCLE AFFERENTS; DC-STIMULATION; PERCEPTION; PAIN; MODULATION; ENDURANCE	Transcranial direct current stimulation (tDCS) is a technique used to modulate neuronal excitability through non-invasive brain stimulation that can enhance exercise performance. We hypothesize that tDCS would improve submaximal running time to exhaustion (TTE) and delay the increase in the rating of perceived exertion (RPE) over time. We also hypothesize that tDCS would not lead to difference in cardiorespiratory responses. We employed a randomized, single-blinded, and counterbalanced design in which 10 trained men participated. After receiving either 20 min of 1.98 mA anodal tDCS applied over the primary motor cortex (M1) or sham-operated control on separate days, participants completed a constant-load test involving running at a speed equivalent to 80% of their own maximum oxygen consumption (VO(2)max). During this constant-load test, RPE, heart rate (HR), VO2, pulmonary ventilation (VE), respiratory exchange ratio (RER), and ventilatory threshold (VT) were continuously monitored. TTE was recorded at the end of the test. TTEs were significantly longer in the tDCS than in the sham conditions (21.18 +/- 7.13 min; 18.44 +/- 6.32 min; p = 0.011). For TTE, no significant differences were found in RPE between conditions at isotime. In addition, no significant differences in HR, VO2, VE, RER, and VT were found during TTE between the two stimulation conditions at any time point. These results indicate that the application of tDCS does not induce a change of the exercise performance-related index; however, it can affect the increase of the exercise duration due to the stimuli in the M1 area.	[Park, Seung-Bo; Kim, Bokyung] Konkuk Univ, Dept Physiol, KU Open Innovat Ctr, Res Inst Med Sci,Sch Med, Chungju, Chungbuk, South Korea; [Sung, Dong Jun] Konkuk Univ, Div Sport & Hlth Sci, Coll Biomed & Hlth Sci, Chungju, Chungbuk, South Korea; [Kim, SoJung] Univ Massachusetts, Dept Phys Therapy & Kinesiol, Coll Hlth Sci, Lowell, MA USA; [Han, Joung-Kyue] Chung Ang Univ, Coll Sport Sci, Anseong, Gyoenggi, South Korea	Konkuk University; Konkuk University Medical Center; Konkuk University; University of Massachusetts System; University of Massachusetts Lowell; Chung Ang University	Han, JK (corresponding author), Chung Ang Univ, Coll Sport Sci, Anseong, Gyoenggi, South Korea.	jkhan@cau.ac.kr		sung, dongjun/0000-0001-6390-454X				Abdelmoula A, 2016, NEUROSCIENCE, V322, P94, DOI 10.1016/j.neuroscience.2016.02.025; Amann M, 2011, J PHYSIOL-LONDON, V589, P5299, DOI 10.1113/jphysiol.2011.213769; Amann M, 2009, J PHYSIOL-LONDON, V587, P271, DOI 10.1113/jphysiol.2008.163303; American College of Sports Medicine, 2017, ACSMS EX TEST PRESCR; Angius L., 2016, P PHYSL SOC, V35, pC03, DOI DOI 10.1016/J.BRS.2017.09.017; Angius L, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00090; Angius L, 2015, EUR J APPL PHYSIOL, V115, P2311, DOI 10.1007/s00421-015-3212-y; Barwood MJ, 2016, BRAIN STIMUL, V9, P842, DOI 10.1016/j.brs.2016.07.006; Boggio PS, 2008, EUR J NEUROL, V15, P1124, DOI 10.1111/j.1468-1331.2008.02270.x; Boggio PS, 2009, J NEUROL NEUROSUR PS, V80, P444, DOI 10.1136/jnnp.2007.141853; Boggio PS, 2008, INT J NEUROPSYCHOPH, V11, P249, DOI 10.1017/S1461145707007833; Boggio PS, 2009, NEUROPSYCHOLOGIA, V47, P212, DOI 10.1016/j.neuropsychologia.2008.07.022; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Morree HM, 2014, J APPL PHYSIOL, V117, P1514, DOI 10.1152/japplphysiol.00898.2013; de Morree HM, 2012, PSYCHOPHYSIOLOGY, V49, P1242, DOI 10.1111/j.1469-8986.2012.01399.x; Edwards DJ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00243; Feeser M, 2014, BRAIN STIMUL, V7, P105, DOI 10.1016/j.brs.2013.08.006; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; George MS, 2010, NEUROPSYCHOPHARMACOL, V35, P301, DOI 10.1038/npp.2009.87; Glass S., 2007, ACSMS METABOLIC CALC, P111; Hopkins WG., NEW VIEW STAT; Jatupaiboon N, 2013, SCI WORLD J, DOI 10.1155/2013/618649; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Liebetanz D, 2002, BRAIN, V125, P2238, DOI 10.1093/brain/awf238; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Mauger AR, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00104; McMorris T, 2018, NEUROSCI BIOBEHAV R, V93, P93, DOI 10.1016/j.neubiorev.2018.03.024; Meinzer M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00253; Montenegro RA, 2011, NEUROSCI LETT, V497, P32, DOI 10.1016/j.neulet.2011.04.019; Nitsche M A, 2012, Front Psychiatry, V3, P58, DOI 10.3389/fpsyt.2012.00058; Nitsche MA, 2003, SUPPL CLIN NEUROPHYS, V56, P255; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Ohuchi H, 1996, PEDIATR CARDIOL, V17, P7, DOI 10.1007/s002469900002; Okano AH, 2017, INT J SPORTS MED, V38, P493, DOI 10.1055/s-0042-121897; Okano AH, 2015, BRIT J SPORT MED, V49, P1213, DOI 10.1136/bjsports-2012-091658; Pena-Gomez C, 2012, BRAIN STIMUL, V5, P252, DOI 10.1016/j.brs.2011.08.006; Polania R, 2012, HUM BRAIN MAPP, V33, P2499, DOI 10.1002/hbm.21380; Reardon S, 2016, NATURE, V531, P283, DOI 10.1038/nature.2016.19534; Rosenkranz K, 2000, NEUROSCI LETT, V296, P61, DOI 10.1016/S0304-3940(00)01621-9; Rosenthal R, 1994, HDB RES SYNTHESIS, P231; Salehinejad MA, 2017, J AFFECT DISORDERS, V210, P241, DOI 10.1016/j.jad.2016.12.036; Tanaka S, 2011, NEUROREHAB NEURAL RE, V25, P565, DOI 10.1177/1545968311402091; Tanaka S, 2009, EXP BRAIN RES, V196, P459, DOI 10.1007/s00221-009-1863-9; Vitor-Costa M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144916; Williams PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081418; Zandieh A, 2013, NEUROMODULATION, V16, P345, DOI 10.1111/ner.12009	48	21	22	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211902	10.1371/journal.pone.0211902	http://dx.doi.org/10.1371/journal.pone.0211902			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794568	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100026
J	Vet, S; Vandervelde, A; Gelens, L				Vet, Stefan; Vandervelde, Alexandra; Gelens, Lendert			Excitable dynamics through toxin-induced mRNA cleavage in bacteria	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTITOXIN SYSTEMS; PROTEIN; NOISE; PERSISTER; MODEL; RATES; LOCI	Toxin-antitoxin ( TA) systems in bacteria and archaea are small genetic elements consisting of the genes coding for an intracellular toxin and an antitoxin that can neutralize this toxin. In various cases, the toxins cleave the mRNA. In this theoretical work we use deterministic and stochastic modeling to explain how toxin-induced cleavage of mRNA in TA systems can lead to excitability, allowing large transient spikes in toxin levels to be triggered. By using a simplified network where secondary complex formation and transcriptional regulation are not included, we show that a two-dimensional, deterministic model captures the origin of such toxin excitations. Moreover, it allows to increase our understanding by examining the dynamics in the phase plane. By systematically comparing the deterministic results with Gillespie simulations we demonstrate that even though the real TA system is intrinsically stochastic, toxin excitations can be accurately described deterministically. A bifurcation analysis of the system shows that the excitable behavior is due to a nearby Hopf bifurcation in the parameter space, where the system becomes oscillatory. The influence of stress is modeled by varying the degradation rate of the antitoxin and the translation rate of the toxin. We find that stress increases the frequency of toxin excitations. The inclusion of secondary complex formation and transcriptional regulation does not fundamentally change the mechanism of toxin excitations. Finally, we show that including growth rate suppression and translational inhibition can lead to longer excitations, and even cause excitations in cases when the system would otherwise be non-excitable. To conclude, the deterministic model used in this work provides a simple and intuitive explanation of toxin excitations in TA systems.	[Vet, Stefan; Gelens, Lendert] VUB, Appl Phys Res Grp, Brussels, Belgium; [Vandervelde, Alexandra; Gelens, Lendert] Katholieke Univ Leuven, Lab Dynam Biol Syst, Leuven, Belgium; [Vet, Stefan] VUB ULB, Interuniv Inst Bioinformat Brussels IB2, Brussels, Belgium; [Vet, Stefan] ULB, Unite Chronobiol Theor, Brussels, Belgium	Vrije Universiteit Brussel; KU Leuven; Universite Libre de Bruxelles	Gelens, L (corresponding author), VUB, Appl Phys Res Grp, Brussels, Belgium.; Gelens, L (corresponding author), Katholieke Univ Leuven, Lab Dynam Biol Syst, Leuven, Belgium.	lendert.gelens@kuleuven.be	Gelens, Lendert/E-6348-2010	Gelens, Lendert/0000-0001-7290-9561; Vet, Stefan/0000-0001-7427-4459	Research Council of the Vrije Universiteit Brussel (SRP31 project); KU Leuven; Interuniversity Institute of Bioinformatics in Brussels (IB2)	Research Council of the Vrije Universiteit Brussel (SRP31 project); KU Leuven(KU Leuven); Interuniversity Institute of Bioinformatics in Brussels (IB2)	This work was financially supported by the Research Council of the Vrije Universiteit Brussel (SRP31 project) and internal funds of KU Leuven (to LG and AV). SV received a one-year fellowship from the Interuniversity Institute of Bioinformatics in Brussels (IB2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENISRAEL A, 1966, J MATH ANAL APPL, V15, P243, DOI 10.1016/0022-247X(66)90115-6; Berglund N, 2006, PROB APPL S; BERNARD P, 1992, J MOL BIOL, V226, P735, DOI 10.1016/0022-2836(92)90629-X; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Cataudella I, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003174; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Culviner PH, 2018, MOL CELL, V70, P868, DOI 10.1016/j.molcel.2018.04.026; Dumortier F, 1996, MEM AM MATH SOC, V121, P1; Feng JC, 2014, P NATL ACAD SCI USA, V111, P544, DOI 10.1073/pnas.1320396110; Gelens L, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003190; Gerdes K, 2012, ANNU REV MICROBIOL, V66, P103, DOI 10.1146/annurev-micro-092611-150159; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Gong CC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169703; Goormaghtigh F, 2018, MBIO, V9, DOI 10.1128/mBio.00640-18; Guisoni N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151086; Harms A, 2018, MOL CELL, V70, P768, DOI 10.1016/j.molcel.2018.01.003; Himeoka Y, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/aaf3e3; Jones E., 2001, SCIPY OPEN SOURCE SC; Kamada K, 2003, MOL CELL, V11, P875, DOI 10.1016/S1097-2765(03)00097-2; KUBITSCHEK HE, 1990, J BACTERIOL, V172, P94, DOI 10.1128/JB.172.1.94-101.1990; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; McKane AJ, 2007, J STAT PHYS, V128, P165, DOI 10.1007/s10955-006-9221-9; Nikolic N, 2019, CURR GENET, V65, P133, DOI 10.1007/s00294-018-0879-8; Nikolic N, 2018, NUCLEIC ACIDS RES, V46, P2918, DOI 10.1093/nar/gky079; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Rue P, 2011, MATH BIOSCI, V231, P90, DOI 10.1016/j.mbs.2011.02.013; Santillan M, 2001, P NATL ACAD SCI USA, V98, P1364, DOI 10.1073/pnas.98.4.1364; Schlosshauer M, 2004, PROTEIN SCI, V13, P1660, DOI 10.1110/ps.03517304; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; Thomas P, 2013, J THEOR BIOL, V335, P222, DOI 10.1016/j.jtbi.2013.06.021; Thomas P, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-39; Thomas P, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3661156; Tian C, 2017, NUCLEIC ACIDS RES, V45, P8180, DOI 10.1093/nar/gkx552; Van Melderen L, 2010, CURR OPIN MICROBIOL, V13, P781, DOI 10.1016/j.mib.2010.10.006; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7; Zorzini V, 2015, NUCLEIC ACIDS RES, V43, P1241, DOI 10.1093/nar/gku1352	45	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212288	10.1371/journal.pone.0212288	http://dx.doi.org/10.1371/journal.pone.0212288			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794601	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100052
J	Wirtz, KW				Wirtz, Kai W.			Physics or biology? Persistent chlorophyll accumulation in a shallow coastal sea explained by pathogens and carnivorous grazing	PLOS ONE			English	Article							SOUTHERN NORTH-SEA; PHYTOPLANKTON SPRING BLOOM; MUSSELS MYTILUS-EDULIS; BIOGEOCHEMICAL MODEL; COMMUNITY STRUCTURE; NUTRIENT GRADIENTS; SEASONAL PATTERNS; MARINE VIRUSES; SHELF-SEA; ZOOPLANKTON	One of the most striking patterns at the land-ocean interface is the massive increase of chlorophyll-a (CHL) from continental shelves towards the coast, a phenomenon that is classically linked to physical features. Here I propose that the coastal-offshore CHL gradient in a shallow sea has biological origins related to phytoplankton mortality that are neglected in state-of-the-art biogeochemical models. I integrate a trait-based ecosystem model into a modular coupling framework that is applied to the southern North Sea (SNS). The coupled model very well reproduces daily, seasonal and inter-annual (2000-2014) dynamics and meso-scale patterns in macronutrients, zooplankton biomass, and CHL as observed in situ and by remote sensors. Numerical experiments reveal that coast-offshore CHL gradients may predominantly arise from a trophic effect as resolved by an increase in carnivorous grazing towards shallow waters. This carnivory gradient reflects higher near-coast abundance of juvenile fish and benthic filter feeders. Furthermore, the temporal evolution of CHL can be much affected by viral infection as a fast-responding loss process at intermediate to high phytoplankton concentrations. Viral control in the model also prevents excessive and unrealistic blooms during late spring. Herbivores as often only ecological factor considered for explaining the spatio-temporal phytoplankton distribution are in this study supplemented by pathogens as well as pelagic and benthic carnivores as powerful agents, which are barely represented in current modeling but can mediate physical drivers of coastal ecosystems.	[Wirtz, Kai W.] Helmholtz Zentrum Geesthacht, Inst Coastal Res, Geesthacht, Germany	Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Wirtz, KW (corresponding author), Helmholtz Zentrum Geesthacht, Inst Coastal Res, Geesthacht, Germany.	kai.wirtz@hzg.de	Wirtz, Kai/GRY-5339-2022		Helmholtz society via the program PACES; German Federal Ministry of Research and Education in the framework project MOSSCO	Helmholtz society via the program PACES; German Federal Ministry of Research and Education in the framework project MOSSCO	The work was supported by the Helmholtz society via the program PACES and by the German Federal Ministry of Research and Education in the framework project MOSSCO.	Albaina A, 2004, MAR ECOL PROG SER, V284, P65, DOI 10.3354/meps284065; Arndt S, 2009, J MARINE SYST, V78, P42, DOI 10.1016/j.jmarsys.2009.02.008; Banas N, 2009, J GEOPHYS RES, V114, P1; Baschek B, 2017, OCEAN SCI, V13, P379, DOI 10.5194/os-13-379-2017; Behrenfeld MJ, 2014, NAT CLIM CHANGE, V4, P880, DOI 10.1038/NCLIMATE2349; Behrenfeld MJ, 2014, ANNU REV MAR SCI, V6, P167, DOI 10.1146/annurev-marine-052913-021325; Benfield MC, 1996, ENVIRON BIOL FISH, V46, P211, DOI 10.1007/BF00005223; Benoit-Bird KJ, 2012, BIOL LETTERS, V8, P813, DOI 10.1098/rsbl.2012.0232; Bialonski S, 2016, J PLANKTON RES, V38, P1077, DOI 10.1093/plankt/fbv122; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; Brandt G, 2010, BIOGEOSCIENCES, V7, P371, DOI 10.5194/bg-7-371-2010; Brown CC, 1978, PRINCIPLES ECOTOXICO, P115; Bruggeman J, 2014, ENVIRON MODELL SOFTW, V61, P249, DOI 10.1016/j.envsoft.2014.04.002; Brussaard CPD, 2004, J EUKARYOT MICROBIOL, V51, P125, DOI 10.1111/j.1550-7408.2004.tb00537.x; Burchard H, 2008, J PHYS OCEANOGR, V38, P566, DOI 10.1175/2007JPO3796.1; Byron CJ, 2014, REV FISH BIOL FISHER, V24, P737, DOI 10.1007/s11160-014-9343-0; Capet A, 2013, BIOGEOSCIENCES, V10, P3943, DOI 10.5194/bg-10-3943-2013; Carstensen J, 2015, ESTUAR COAST SHELF S, V162, P98, DOI 10.1016/j.ecss.2015.05.005; Chavez FP, 2011, ANNU REV MAR SCI, V3, P227, DOI 10.1146/annurev.marine.010908.163917; Chen MR, 2011, CONT SHELF RES, V31, P1075, DOI 10.1016/j.csr.2011.03.011; Ciavatta S, 2016, J GEOPHYS RES-OCEANS, V121, P1824, DOI 10.1002/2015JC011496; Cloern JE, 2014, BIOGEOSCIENCES, V11, P2477, DOI 10.5194/bg-11-2477-2014; Cloern JE, 2010, ESTUAR COAST, V33, P230, DOI 10.1007/s12237-009-9195-3; Compton TJ, 2013, J SEA RES, V82, P103, DOI 10.1016/j.seares.2013.02.002; CYRUS DP, 1987, J EXP MAR BIOL ECOL, V109, P71, DOI 10.1016/0022-0981(87)90186-9; Dahnke K, 2008, LIMNOL OCEANOGR, V53, P1504, DOI 10.4319/lo.2008.53.4.1504; Daewel U, 2015, MAR ECOL PROG SER, V534, P199, DOI 10.3354/meps11367; Davenport J, 2000, MAR ECOL PROG SER, V198, P131, DOI 10.3354/meps198131; de Leeuw G, 2003, ATMOS ENVIRON, V37, pS145, DOI 10.1016/S1352-2310(03)00246-2; De Robertis A, 2003, CAN J FISH AQUAT SCI, V60, P1517, DOI 10.1139/F03-123; Ebenhoh W, 2004, ECOL MODEL, V174, P241, DOI 10.1016/j.ecolmodel.2003.07.011; Eisele A, 2018, LONG TERM CHANGES RE; Ford DA, 2017, BIOGEOSCIENCES, V14, P1419, DOI 10.5194/bg-14-1419-2017; Frenken T, 2016, GLOBAL CHANGE BIOL, V22, P299, DOI 10.1111/gcb.13095; Friedrichs MAM, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003852; Fuhrman JA, 1995, LIMNOL OCEANOGR, V40, P1236, DOI 10.4319/lo.1995.40.7.1236; GLIBERT PM, 1995, MAR ECOL PROG SER, V122, P27, DOI 10.3354/meps122027; Grawe U, 2015, OCEAN MODEL, V92, P56, DOI 10.1016/j.ocemod.2015.05.008; Greve W, 2004, HELGOLAND MAR RES, V58, P274, DOI 10.1007/s10152-004-0191-5; Grosse F, 2016, BIOGEOSCIENCES, V13, P2511, DOI 10.5194/bg-13-2511-2016; Grunwald M, 2010, J SEA RES, V64, P199, DOI 10.1016/j.seares.2010.02.008; Guinder VA, 2010, MAR BIOL, V157, P2703, DOI 10.1007/s00227-010-1530-5; Hantzsche F, 2010, EVALUATION EFFECT FO; Hill C, 2004, COMPUT SCI ENG, V6, P18, DOI 10.1109/MCISE.2004.1255817; Hofmeister R, 2017, GEO-MAR LETT, V37, P179, DOI 10.1007/s00367-016-0469-z; Hydes DJ, 1999, MAR CHEM, V68, P117, DOI 10.1016/S0304-4203(99)00069-9; Irigoien X, 2004, MAR ECOL PROG SER, V267, P85, DOI 10.3354/meps267085; Kerimoglu O, 2017, BIOGEOSCIENCES, V14, P4499, DOI 10.5194/bg-14-4499-2017; KRAUSE M, 1995, PROG OCEANOGR, V35, P81, DOI 10.1016/0079-6611(95)00006-3; Kwiatkowski L, 2014, BIOGEOSCIENCES, V11, P7291, DOI 10.5194/bg-11-7291-2014; Lacroix G, 2007, J MARINE SYST, V64, P66, DOI 10.1016/j.jmarsys.2006.01.010; Le Fouest V, 2006, J MARINE SYST, V60, P30, DOI 10.1016/j.jmarsys.2005.11.008; Lehahn Y, 2014, CURR BIOL, V24, P2041, DOI 10.1016/j.cub.2014.07.046; Lehane C, 2006, ESTUAR COAST SHELF S, V67, P645, DOI 10.1016/j.ecss.2005.12.015; Lemmen C, 2018, WATER-SUI, V10, DOI 10.3390/w10111527; Lemmen C, 2018, GEOSCI MODEL DEV, V11, P915, DOI 10.5194/gmd-11-915-2018; Liu FF, 2014, J MARINE SYST, V129, P303, DOI 10.1016/j.jmarsys.2013.07.007; Loder MGJ, 2012, HELGOLAND MAR RES, V66, P11, DOI 10.1007/s10152-010-0242-z; Los FJ, 2008, J MARINE SYST, V74, P259, DOI 10.1016/j.jmarsys.2008.01.002; Maar M, 2007, MAR ECOL PROG SER, V339, P199, DOI 10.3354/meps339199; Maar M, 2014, PROG OCEANOGR, V124, P78, DOI 10.1016/j.pocean.2014.03.002; Maar M, 2011, ECOL MODEL, V222, P1696, DOI 10.1016/j.ecolmodel.2011.03.006; Maerz J, 2016, BIOGEOSCIENCES, V13, P4863, DOI 10.5194/bg-13-4863-2016; Mateus MD, 2017, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00284; Moller KO, 2012, MAR ECOL PROG SER, V468, P57, DOI 10.3354/meps09984; Mojica KDA, 2016, ISME J, V10, P500, DOI 10.1038/ismej.2015.130; Muller D, 2015, REMOTE SENS ENVIRON, V162, P242, DOI 10.1016/j.rse.2013.11.026; Nasermoaddeli MH, 2018, ESTUAR COAST SHELF S, V211, P62, DOI 10.1016/j.ecss.2017.11.002; Nezlin NP, 2012, J GEOPHYS RES O, P117; Nicolas D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088447; Nielsen TG, 2007, MAR ECOL PROG SER, V339, P185, DOI 10.3354/meps339185; Purkiani K, 2015, J GEOPHYS RES-OCEANS, V120, P225, DOI 10.1002/2014JC010325; Raven, 2007, PHOTOSYNTHESIS PRIMA; Renz J, 2008, J PLANKTON RES, V30, P511, DOI 10.1093/plankt/fbn016; Rhodes CJ, 2008, J MARINE SYST, V74, P216, DOI 10.1016/j.jmarsys.2008.01.005; Ribalet F, 2010, P NATL ACAD SCI USA, V107, P16571, DOI 10.1073/pnas.1005638107; RILEY GA, 1946, J MAR RES, V6, P54; Rolff C, 2008, BIOGEOSCIENCES, V5, P1657, DOI 10.5194/bg-5-1657-2008; Ruardij P, 2005, HARMFUL ALGAE, V4, P941, DOI 10.1016/j.hal.2004.12.011; Salihoglu B, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00339; Slavik K, 2019, HYDROBIOLOGIA, V845, P35, DOI 10.1007/s10750-018-3653-5; SOETAERT K, 1994, J PLANKTON RES, V16, P1277, DOI 10.1093/plankt/16.10.1277; Soetaert K, 1996, GEOCHIM COSMOCHIM AC, V60, P1019, DOI 10.1016/0016-7037(96)00013-0; Staaterman E, 2014, ICES J MAR SCI, V71, P918, DOI 10.1093/icesjms/fst103; Stanev EV, 2009, OCEAN DYNAM, V59, P183, DOI 10.1007/s10236-008-0171-4; SUTTLE CA, 1990, NATURE, V347, P467, DOI 10.1038/347467a0; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tan YH, 2004, CONT SHELF RES, V24, P1949, DOI 10.1016/j.csr.2004.06.018; Thingstad TF, 2000, LIMNOL OCEANOGR, V45, P1320, DOI 10.4319/lo.2000.45.6.1320; Tian T, 2009, J SEA RES, V62, P214, DOI 10.1016/j.seares.2009.04.001; Travers M, 2009, ECOL MODEL, V220, P3089, DOI 10.1016/j.ecolmodel.2009.08.016; van Gennip S, 2016, J GEOPHYS RES-OCEANS, V121, P4149, DOI 10.1002/2016JC011789; van Leeuwen SM, 2013, BIOGEOCHEMISTRY, V113, P137, DOI 10.1007/s10533-012-9704-5; Weitz JS, 2015, ISME J, V9, P1352, DOI 10.1038/ismej.2014.220; Wiltshire KH, 2008, LIMNOL OCEANOGR, V53, P1294, DOI 10.4319/lo.2008.53.4.1294; Wiltshire KH, 2010, ESTUAR COAST, V33, P295, DOI 10.1007/s12237-009-9228-y; Winder M, 2010, PHILOS T R SOC B, V365, P3215, DOI 10.1098/rstb.2010.0125; Wirtz KW, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00131; Wirtz KW, 2013, MAR BIOL, V160, P2319, DOI 10.1007/s00227-012-2163-7; Wirtz KW, 2005, J MARINE SYST, V56, P262, DOI 10.1016/j.jmarsys.2004.11.002; Wirtz KW, 1996, ECOL MODEL, V92, P33, DOI 10.1016/0304-3800(95)00196-4	101	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212143	10.1371/journal.pone.0212143	http://dx.doi.org/10.1371/journal.pone.0212143			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794602	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100041
J	Ferraris, L; Couturier, J; Eckert, C; Delannoy, J; Barbut, F; Butel, MJ; Aires, J				Ferraris, Laurent; Couturier, Jeanne; Eckert, Catherine; Delannoy, Johanne; Barbut, Frederic; Butel, Marie-Jose; Aires, Julio			Carriage and colonization of C-difficile in preterm neonates: A longitudinal prospective study	PLOS ONE			English	Article							INFANTS; INFECTION; TOXIN; EPIDEMIOLOGY; CHILDREN; STRAINS; DISEASE; LOCUS; GUT	Background Premature neonates (PN) present multiple risk factors for high frequencies and high levels of colonization by C. difficile, yet data is missing about this specific pediatric population. Here, we investigated PN C. difficile carriage and colonization dynamics, analyzed the impact of perinatal determinants on colonization, and characterized the isolates. Methods A one year longitudinal monocentric prospective cohort study was performed on 121 PN. C. difficile strains isolated from fecal samples on selective medium were identified and characterized by PCR (tpi housekeeping gene; tcdA and tcdB, and binary toxin genes), capillary gel-based electrophoresis PCR-ribotyping, and Multi-Locus Variable-number tandem repeat Analysis (MLVA). Results Of the 379 samples analyzed, 199 (52%) were C. difficile culture positive with the mean levels of C. difficile colonization decreasing significantly (P = .027) over time. During hospitalization, C. difficile colonization frequency increased up to 61% with 95% of the strains belonging to both non-toxigenic PCR-ribotypes (RTs) FR082 (35%) and 032 (60%). After hospital discharge, if a higher diversity in RTs was observed, RTs FR082 and 032 remained predominant (respectively 40% and 28%). MLVA showed clonal relationship within each FR082 and 032 RTs. Ten toxigenic strains (5%) were isolated, all tcdA(+)/tcdB(+) except for one tcdA(-)/tcdB(+), and all being acquired after hospitalization. At 1 week, the only factors found to be linked with a higher frequency of C. difficile colonization were a higher gestational age (P = 0.006) and a higher birth weight (P = 0.016). Conclusion The dynamics of C. difficile colonization in PN followed a specific pattern. C. difficile colonization rapidly occurred after birth with a low diversity of non-toxigenic RTs. After hospitalization, non-toxigenic RTs diversity increased. Sporadic carriage of toxigenic strains was observed after hospitalization.	[Ferraris, Laurent; Couturier, Jeanne; Delannoy, Johanne; Barbut, Frederic; Butel, Marie-Jose; Aires, Julio] Paris Descartes Univ, Hosp Univ Dept Risks Pregnancy, Sorbonne Paris Cite, EA 4065,Fac Pharm, Paris, France; [Couturier, Jeanne; Barbut, Frederic] CHU St Antoine, French Natl Reference Lab C Difficile, Paris, France; [Eckert, Catherine] GH Est Parisien, AP HP, Dept Bacteriol, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP)	Aires, J (corresponding author), Paris Descartes Univ, Hosp Univ Dept Risks Pregnancy, Sorbonne Paris Cite, EA 4065,Fac Pharm, Paris, France.	julio.aires@parisdescartes.fr	Barbut, frederic/AAF-4952-2021; Eckert, Catherine/O-9808-2017	Eckert, Catherine/0000-0003-2773-7064; Aires, Julio/0000-0002-8090-4565; Delannoy, Johanne/0000-0001-5138-5877	French Research Agency [ANR-07-PNRA-0028]	French Research Agency(French National Research Agency (ANR))	This work was funded by the French Research Agency [grant number ANR-07-PNRA-0028]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adlerberth I, 2014, J CLIN MICROBIOL, V52, P173, DOI 10.1128/JCM.01701-13; [Anonymous], 2016, Nat Rev Dis Primers, V2, P16021, DOI 10.1038/nrdp.2016.21; Azad MB, 2013, CAN MED ASSOC J, V185, P385, DOI 10.1503/cmaj.121189; Belmares J, 2009, CLIN INFECT DIS, V49, P1141, DOI 10.1086/605638; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Bouwknegt M, 2015, NEW ENGL J MED, V372, P2368, DOI 10.1056/NEJMc1505190; Braun V, 1996, GENE, V181, P29, DOI 10.1016/S0378-1119(96)00398-8; Clayton JA, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0603-8; Cotten CM, 2016, CURR OPIN PEDIATR, V28, P141, DOI 10.1097/MOP.0000000000000338; DELMEE M, 1988, EUR J PEDIATR, V147, P36, DOI 10.1007/BF00442608; Deshpande A, 2013, PEDIATR INFECT DIS J, V32, P1138, DOI 10.1097/INF.0b013e3182948518; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Ferraris L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030594; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; KATO H, 1994, J CLIN MICROBIOL, V32, P2067, DOI 10.1128/JCM.32.9.2067-2070.1994; Kuntz JL, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-194; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Lees EA, 2016, EUR J CLIN MICROBIOL, V35, P1047, DOI 10.1007/s10096-016-2639-3; Lemee L, 2004, J CLIN MICROBIOL, V42, P5710, DOI 10.1128/JCM.42.12.5710-5714.2004; MARDH PA, 1982, ACTA PAEDIATR SCAND, V71, P275, DOI 10.1111/j.1651-2227.1982.tb09414.x; Matsuki S, 2005, INT MICROBIOL, V8, P43; Rodriguez-Palacios A, 2013, ANIM HEALTH RES REV, V14, P11, DOI 10.1017/S1466252312000229; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; Rousseau C, 2011, J CLIN MICROBIOL, V49, P858, DOI 10.1128/JCM.01507-10; Stoesser N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182307; TULLUS K, 1989, EUR J CLIN MICROBIOL, V8, P390, DOI 10.1007/BF01964052; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; Zaiss NH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-6	31	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212568	10.1371/journal.pone.0212568	http://dx.doi.org/10.1371/journal.pone.0212568			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785934	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000070
J	Paine, OCC; Leichliter, JN; Avenant, N; Codron, D; Lawrence, A; Sponheimer, M				Paine, Oliver C. C.; Leichliter, Jennifer N.; Avenant, Nico; Codron, Daryl; Lawrence, Austin; Sponheimer, Matt			The ecomorphology of southern African rodent incisors: Potential applications to the hominin fossil record	PLOS ONE			English	Article							SMALL MAMMALS; STERKFONTEIN; EXTANT; MORPHOLOGY; VEGETATION; EVOLUTION; BOVIDS; SITE; DIET	The taxonomic identification of mammalian fauna within fossil assemblages is a well-established component of paleoenvironmental reconstructions. However, many fragmentary specimens recovered from fossil sites are often disregarded as they can be difficult to identify with the precision required for taxonomic methods. For this reason, the large numbers of isolated rodent incisors that are often recovered from hominin fossil bearing sites are generally regarded as offering little interpretive value. Ecomorphological analysis, often referred to as a "taxon-free" method, can potentially circumvent this problem by focusing on the adaptive, rather than the taxonomic significance of rodent incisor morphology. Here, we determine if the morphology of the upper incisors of modern southern African rodents reflects dietary behavior using discriminant function analysis. Our model suggests that a strong ecomorphological signal exists in our modern sample and we apply these results to two samples of isolated incisors from the hominin fossil bearing sites, Sterkfontein and Swartkrans.	[Paine, Oliver C. C.; Sponheimer, Matt] Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA; [Leichliter, Jennifer N.] Johannes Gutenberg Univ Mainz, AG Angew & Analyt Palaontol, Inst Geowissensch, Mainz, Germany; [Avenant, Nico; Codron, Daryl] Natl Museum, Mammol Dept, Bloemfontein, South Africa; [Codron, Daryl] Natl Museum, Florisbad Quaternary Res Dept, Bloemfontein, South Africa; [Lawrence, Austin] Univ Missouri, Dept Integrat Anat, Columbia, MO USA	University of Colorado System; University of Colorado Boulder; Johannes Gutenberg University of Mainz; University of Missouri System; University of Missouri Columbia	Paine, OCC (corresponding author), Univ Colorado, Dept Anthropol, Boulder, CO 80309 USA.	oliver.paine@colorado.edu	Codron, Daryl/B-8867-2008; Sponheimer, Matt/A-6075-2013	Codron, Daryl/0000-0001-5223-9513; Avenant, Nico/0000-0002-5390-9010; Lawrence, Austin/0000-0001-5988-8495; Sponheimer, Matt/0000-0002-8743-1123; Paine, Oliver/0000-0001-7993-6319				Arregoitia LDV, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160957; Avery DM, 2003, PALAEOGEOGR PALAEOCL, V189, P55, DOI 10.1016/S0031-0182(02)00593-X; Avery DM, 2001, J HUM EVOL, V41, P113, DOI 10.1006/jhev.2001.0483; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Brain CK, 1993, SWARTKRANS CAVES CHR, V8, P23; Croft DA, 2011, J MAMMAL, V92, P871, DOI 10.1644/10-MAMM-A-226.1; Damuth John D., 1992, P183; de Lumley MA, 1982, P 1 INT C HUM PAL, P707; de Ruiter DJ, 2008, J HUM EVOL, V55, P1015, DOI 10.1016/j.jhevol.2008.06.003; DEGRAAFF G, 1981, RODENTS SO AFRICA NO; Denys C., 1987, P118; Denys C, 1987, PALAEGEOGR PALAEOCLI, V152, P77; Faurby S, 2015, MOL PHYLOGENET EVOL, V84, P14, DOI 10.1016/j.ympev.2014.11.001; Geraads D, 2013, QUATERNARY RES, V80, P552, DOI 10.1016/j.yqres.2013.08.003; Grine FE., 2000, ENCY HUMAN EVOLUTION, P681; Happold D.C.D., 2013, MAMMALS AFRICA, VIII; Kappelman J, 1997, J HUM EVOL, V32, P229, DOI 10.1006/jhev.1996.0105; KERLEY GIH, 1990, S AFR J WILDL RES, V20, P123; Kovarovic K, 2007, J HUM EVOL, V52, P663, DOI 10.1016/j.jhevol.2007.01.001; Kuman K, 2000, J HUM EVOL, V38, P827, DOI 10.1006/jhev.1999.0392; Leichliter J, 2017, PALAEOGEOGR PALAEOCL, V485, P57, DOI 10.1016/j.palaeo.2017.06.003; Leichliter JN, 2016, J ARCHAEOL SCI-REP, V8, P335, DOI 10.1016/j.jasrep.2016.05.013; Matthews T, 2011, PALAEOGEOGR PALAEOCL, V302, P213, DOI 10.1016/j.palaeo.2011.01.014; MCKEE JK, 1995, AM J PHYS ANTHROPOL, V96, P235, DOI 10.1002/ajpa.1330960303; Monadjem A., 2015, RODENTS SUB SAHARAN; Munkemuller T, 2012, METHODS ECOL EVOL, V3, P743, DOI 10.1111/j.2041-210X.2012.00196.x; Ohazama A, 2010, P NATL ACAD SCI USA, V107, P92, DOI 10.1073/pnas.0907236107; Plummer TW, 2008, J ARCHAEOL SCI, V35, P3016, DOI 10.1016/j.jas.2008.06.015; PLUMMER TW, 1994, J HUM EVOL, V27, P47, DOI 10.1006/jhev.1994.1035; Reed DN, 2007, VERTEBR PALEOBIOL PA, P217, DOI 10.1007/978-1-4020-3098-7_9; Reed DN, 2011, VERTEBR PALEOBIOL PA, P265, DOI 10.1007/978-90-481-9956-3_13; Reed KE, 2008, J HUM EVOL, V54, P743, DOI 10.1016/j.jhevol.2007.08.013; Reed KE, 2013, EARLY HOMININ PALEOECOLOGY, P3, DOI 10.5876/9781607322252:C01; Reed KE, 1998, PALEOBIOLOGY, V24, P384; Ricklefs Robert E., 1994, P13; ROWEROWE DT, 1986, S AFR J WILDL RES, V16, P32; Simpson G.G., 1944, TEMPO MODE EVOLUTION, DOI DOI 10.1073/pnas.1821292116; Skinner J.D., 2005, MAMMALS SO AFRICAN S, DOI DOI 10.1017/CBO9781107340992; Sponheimer M, 1999, J HUM EVOL, V36, P705, DOI 10.1006/jhev.1999.0300; Ungar P.S., 2010, MAMMAL TEETH ORIGIN; VRBA ES, 1985, ENV HOMINIDES PLIO P, P345; Wainwright P.C., 1994, ECOLOGICAL MORPHOLOG; Wake M.H., 1992, Oxford Surveys in Evolutionary Biology, V8, P289; Watson CR, 1987, THESIS	45	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0205476	10.1371/journal.pone.0205476	http://dx.doi.org/10.1371/journal.pone.0205476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785886	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000004
J	Westrupp, EM; D'Esposito, F; Freemantle, J; Mensah, FK; Nicholson, JM				Westrupp, Elizabeth M.; D'Esposito, Fabrizio; Freemantle, Jane; Mensah, Fiona K.; Nicholson, Jan M.			Health outcomes for Australian Aboriginal and Torres Strait Islander children born preterm, low birthweight or small for gestational age: A nationwide cohort study	PLOS ONE			English	Article							ALCOHOL; PROGRESS; DISEASE; WOMEN; RISK; SIZE; CARE	Objective To examine health outcomes in Australian Aboriginal and Torres Strait Islander children experiencing perinatal risk and identify protective factors in the antenatal period. Methods Baby/Child cohorts of the Longitudinal Study of Indigenous Children, born 2001-2008, across four annual surveys (aged 0-8 years, N = 1483). Children with 'mild' and 'moderate-to-high' perinatal risk were compared to children born normal weight at term for maternal rated global health and disability, and body-mass-index measured by the interviewer. Results Almost one third of children had experienced mild (22%) or moderate-to-high perinatal risk (8%). Perinatal risk was associated with lower body-mass-index z-scores (regression coefficients adjusted for pregnancy and environment factors: mild = -0.21, 95% CI = -0.34, -0.07; moderate-to-high = -0.42, 95% CI = -0.63, -0.21). Moderate-to-high perinatal risk was associated with poorer global health, with associations becoming less evident in models adjusted for pregnancy and environment factors; but not evident for disability. A range of protective factors, including cultural-based resilience and smoking cessation, were associated with lower risk of adverse outcomes. Conclusions Perinatal risks are associated with Australian Aboriginal and Torres Strait children experiencing adverse health particularly lower body weight. Cultural-based resilience and smoking cessation may be two modifiable pathways to ameliorating health problems associated with perinatal risk.	[Westrupp, Elizabeth M.; Nicholson, Jan M.] La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia; [Westrupp, Elizabeth M.] Deakin Univ, Sch Psychol, Melbourne, Vic, Australia; [Westrupp, Elizabeth M.; D'Esposito, Fabrizio; Freemantle, Jane; Mensah, Fiona K.] Univ Melbourne, Melbourne, Vic, Australia; [Mensah, Fiona K.; Nicholson, Jan M.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Mensah, Fiona K.] Royal Childrens Hosp, Melbourne, Vic, Australia	La Trobe University; Deakin University; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Westrupp, EM (corresponding author), La Trobe Univ, Judith Lumley Ctr, Melbourne, Vic, Australia.; Westrupp, EM (corresponding author), Deakin Univ, Sch Psychol, Melbourne, Vic, Australia.; Westrupp, EM (corresponding author), Univ Melbourne, Melbourne, Vic, Australia.	elizabeth.westrupp@deakin.edu.au	Mensah, Fiona K/G-3382-2018	Mensah, Fiona K/0000-0002-6951-9949; /0000-0001-6517-6064; Nicholson, Jan/0000-0002-0305-0017	Centre of Research Excellence in Child Language (Australian National Health and Medical Research Council NHMRC) [1023493]; Australian Communities Foundation; NHMRC [1037449, 1111160]; ARC [DP0880637]; Victorian Government's Operational Infrastructure Support Program	Centre of Research Excellence in Child Language (Australian National Health and Medical Research Council NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Communities Foundation; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); ARC(Australian Research Council); Victorian Government's Operational Infrastructure Support Program	EMW was supported by the Centre of Research Excellence in Child Language (Australian National Health and Medical Research Council NHMRC grant 1023493). EMW and JN were supported by the Australian Communities Foundation through the Roberta Holmes Transition to Contemporary Parenthood Program (Coronella sub-fund). FM was supported by an NHMRC Early Career Fellowship 1037449 and Career Development Fellowship 1111160. JF was supported by an ARC Australian Research Fellowship DP0880637. Research at MCRI is supported by the Victorian Government's Operational Infrastructure Support Program. Authors have no other relevant disclosures. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This paper uses unit record data from Footprints in Time, the Longitudinal Study of Indigenous Children. The study is conducted and managed by the Australian Government Department of Social Services (DSS, formerly the Australian Government Department of Families, Housing, Community Services and Indigenous Affairs).	Angus S, 1998, AUST NZ J PUBL HEAL, V22, P636, DOI 10.1111/j.1467-842X.1998.tb01458.x; Australian Government Department of Social Services, 2018, FOOTPR TIM LONG STUD; Australian Institute of Health and Welfare, 2021, ALC OTH DRUG TREATM; Boyle J, 2016, AUST NZ J OBSTET GYN, V56, P223, DOI 10.1111/ajo.12470; Chamberlain C, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0520-9; Coory M, 2000, AUST NZ J PUBL HEAL, V24, P60, DOI 10.1111/j.1467-842X.2000.tb00724.x; Crengle S, 2009, INDIGENOUS CHILDRENS; D'Aprano A, 2016, QUAL HEALTH RES, V26, P613, DOI 10.1177/1049732314562891; Day A, 2013, AUST NZ J PUBL HEAL, V37, P350, DOI 10.1111/1753-6405.12083; de Onis M., 2004, FOOD NUTR B S1, V25, P1; Department of Families Housing Community Services and Indigenous Affairs, 2009, FOOTPR TIM LONG STUD; Department of Health and Aged Care (DoHAC), 2001, MEAS REM ACC REN IND; Dobbins TA, 2012, MED J AUSTRALIA, V197, P291, DOI 10.5694/mja11.11331; Durey A, 2010, AUST NZ J PUBL HEAL, V34, pS87, DOI 10.1111/j.1753-6405.2010.00560.x; Government Australian, 2013, NAT AB TORR STRAIT I; Hoy WE, 1999, KIDNEY INT, V56, P1072, DOI 10.1046/j.1523-1755.1999.00633.x; Hoy WE, 2010, MED J AUSTRALIA, V192, P14, DOI 10.5694/j.1326-5377.2010.tb03394.x; Jenkinson C, 1997, J Health Serv Res Policy, V2, P14; Korda RJ, 2009, AUST NZ J PUBL HEAL, V33, P458, DOI 10.1111/j.1753-6405.2009.00430.x; Lee KSK, 2014, DRUG ALCOHOL REV, V33, P473, DOI 10.1111/dar.12127; Leeder SR, 1998, AUST NZ J PUBL HEAL, V22, P635, DOI 10.1111/j.1467-842X.1998.tb01457.x; Lotz-Sisitka H, 2013, FUNDISA CHANGE IMPLE; Mackerras D, 2000, AUST NZ J PUBL HEAL, V24, P287, DOI 10.1111/j.1467-842X.2000.tb01570.x; McDonald JL, 2012, J PAEDIATR CHILD H, V48, P114, DOI 10.1111/j.1440-1754.2011.02067.x; McNamara BJ, 2012, INT J EPIDEMIOL, V41, P1661, DOI 10.1093/ije/dys190; O'Leary C, 2013, DEV MED CHILD NEUROL, V55, P271, DOI 10.1111/dmcn.12029; O'Leary CM, 2013, BIRTH DEFECTS RES A, V97, P497, DOI 10.1002/bdra.23142; Panaretto K, 2006, AUST NZ J PUBL HEAL, V30, P163, DOI 10.1111/j.1467-842X.2006.tb00111.x; Sayers SM, 2004, DIABETES RES CLIN PR, V65, P151, DOI 10.1016/j.diabres.2003.12.006; Sayers S, 2007, PAEDIATR PERINAT EP, V21, P411, DOI 10.1111/j.1365-3016.2007.00852.x; Sayers S, 2011, AM J HUM BIOL, V23, P417, DOI 10.1002/ajhb.21133; Sayers S, 2009, PAEDIATR PERINAT EP, V23, P548, DOI 10.1111/j.1365-3016.2009.01071.x; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Thomas A, 2010, AUST NZ J PSYCHIAT, V44, P40, DOI 10.3109/00048670903393589; Wake M, 2013, INT J OBESITY, V37, P86, DOI 10.1038/ijo.2012.86; World Health Organization Multicenter Growth Reference Study Group, WHO CHILD GROWTH STA; Wright A, 2018, AUST HEALTH REV, V42, P348, DOI 10.1071/AH16269; Zubrick S., 2004, W AUSTR ABORIGINAL C	38	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212130	10.1371/journal.pone.0212130	http://dx.doi.org/10.1371/journal.pone.0212130			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785929	Green Published, gold			2022-12-26	WOS:000459307000049
J	Kohutova, A; Raska, J; Kruta, M; Seneklova, M; Barta, T; Fojtik, P; Jurakova, T; Walter, CA; Hampl, A; Dvorak, P; Rotrekl, V				Kohutova, Aneta; Raska, Jan; Kruta, Miriama; Seneklova, Monika; Barta, Tomas; Fojtik, Petr; Jurakova, Tereza; Walter, Christi A.; Hampl, Ales; Dvorak, Petr; Rotrekl, Vladimir			Ligase 3-mediated end-joining maintains genome stability of human embryonic stem cells	FASEB JOURNAL			English	Article						base excision repair; PARP1; 53BP1; pluripotent stem cells; alternative DNA end-joining	DOUBLE-STRAND BREAKS; BASE EXCISION-REPAIR; DNA-DAMAGE CLUSTERS; HOMOLOGOUS-RECOMBINATION; IONIZING-RADIATION; POLY(ADP-RIBOSE) POLYMERASE-1; MUTATION FREQUENCY; PATHWAY CHOICE; SOMATIC-CELLS; CHECKPOINT	Maintenance of human embryonic stem cells (hESCs) with stable genome is important for their future use in cell replacement therapy and disease modeling. Our understanding of the mechanisms maintaining genomic stability of hESC and our ability to modulate them is essential in preventing unwanted mutation accumulation during their in vitro cultivation. In this study, we show the DNA damage response mechanism in hESCs is composed of known, yet unlikely components. Clustered oxidative base damage is converted into DNA double-strand breaks (DSBs) by base excision repair (BER) and then quickly repaired by ligase (Lig)3-mediated end-joining (EJ). If there is further induction of clustered oxidative base damage by irradiation, then BER-mediated DSBs become essential in triggering the checkpoint response in hESCs. hESCs limit the mutagenic potential of Lig3-mediated EJ by DNA break end protection involving p53 binding protein 1 (53BP1), which results in fast and error-free microhomology-mediated repair and a low mutant frequency in hESCs. DSBs in hESCs are also repaired via homologous recombination (HR); however, DSB overload, together with massive end protection by 53BP1, triggers competition between error-free HR and mutagenic nonhomologous EJ.-Kohutova, A., Raska, J., Kruta, M., Seneklova, M., Barta, T., Fojtik, P., Jurakova, T., Walter, C. A., Hampl, A., Dvorak, P., Rotrekl, V. Ligase 3-mediated end-joining maintains genome stability of human embryonic stem cells.	[Kohutova, Aneta; Raska, Jan; Kruta, Miriama; Seneklova, Monika; Fojtik, Petr; Jurakova, Tereza; Dvorak, Petr; Rotrekl, Vladimir] Masaryk Univ, Dept Biol, Fac Med, Kamenice 5,Bldg A3, Brno 62500, Czech Republic; [Barta, Tomas; Hampl, Ales] Masaryk Univ, Fac Med, Dept Histol & Embryol, Brno, Czech Republic; [Kohutova, Aneta; Hampl, Ales; Dvorak, Petr; Rotrekl, Vladimir] St Annes Univ Hosp, ICRC, Brno, Czech Republic; [Walter, Christi A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA	Masaryk University Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC); University of Texas System; University of Texas Health San Antonio	Rotrekl, V (corresponding author), Masaryk Univ, Dept Biol, Fac Med, Kamenice 5,Bldg A3, Brno 62500, Czech Republic.	vrotrekl@med.muni.cz	Rotrekl, Vladimir/C-8378-2018; Fojtík, Petr/GLR-7338-2022; Barta, Tomas/B-5076-2010	Rotrekl, Vladimir/0000-0002-1298-0849; Barta, Tomas/0000-0003-0703-066X; Fojtik, Petr/0000-0003-0188-0022	Grant Agency of the Czech Republic (GACR) [P302/12/G157]; National Program of Sustainability II (MEYS CR) [LQ1605]; European Research Center for Life Science, Advanced Materials and Nanotechnology (CEITEC 2020) [LQ1601]; Masaryk University [MUNI/C/0967/2013]	Grant Agency of the Czech Republic (GACR)(Grant Agency of the Czech Republic); National Program of Sustainability II (MEYS CR); European Research Center for Life Science, Advanced Materials and Nanotechnology (CEITEC 2020); Masaryk University	This work was supported by the Grant Agency of the Czech Republic (GACR; Grant P302/12/G157), the National Program of Sustainability II (MEYS CR; LQ1605), and the European Research Center for Life Science, Advanced Materials and Nanotechnology (CEITEC 2020; LQ1601). This work was also supported by the Rector's Program for Student Projects from Masaryk University (MUNI/C/0967/2013). The authors declare no conflicts of interest.	Abdou I, 2015, NUCLEIC ACIDS RES, V43, P875, DOI 10.1093/nar/gku1307; Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ahrabi S, 2016, NUCLEIC ACIDS RES, V44, P5743, DOI 10.1093/nar/gkw326; Alexeyev M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012641; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Asaithamby A, 2009, NUCLEIC ACIDS RES, V37, P3912, DOI 10.1093/nar/gkp237; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bakr A, 2016, ONCOTARGET, V7, P57679, DOI 10.18632/oncotarget.11023; Barta T, 2010, STEM CELLS, V28, P1143, DOI 10.1002/stem.451; Baumann P, 1998, TRENDS BIOCHEM SCI, V23, P247, DOI 10.1016/S0968-0004(98)01232-8; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Bennett PV, 2005, FREE RADICAL BIO MED, V39, P832, DOI 10.1016/j.freeradbiomed.2005.05.008; Bogomazova AN, 2011, AGING-US, V3, P584, DOI 10.18632/aging.100336; Bothmer A, 2010, J EXP MED, V207, P855, DOI 10.1084/jem.20100244; Ceccaldi R, 2015, NATURE, V518, P258, DOI 10.1038/nature14184; Cervantes RB, 2002, P NATL ACAD SCI USA, V99, P3586, DOI 10.1073/pnas.062527199; Chan CY, 2007, NUCLEIC ACIDS RES, V35, P5051, DOI 10.1093/nar/gkm442; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cooper DJ, 2017, STEM CELL RES, V19, P113, DOI 10.1016/j.scr.2016.12.029; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Deng SK, 2014, NAT STRUCT MOL BIOL, V21, P405, DOI 10.1038/nsmb.2786; Desmarais JA, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0279-2; Desmarais JA, 2012, STEM CELLS, V30, P1385, DOI 10.1002/stem.1117; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Ensminger M, 2014, J CELL BIOL, V206, P29, DOI 10.1083/jcb.201312078; Fan JS, 2011, MUTAT RES-FUND MOL M, V713, P8, DOI 10.1016/j.mrfmmm.2011.05.018; Filion TM, 2009, J CELL PHYSIOL, V220, P586, DOI 10.1002/jcp.21735; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Georgakilas AG, 2008, MOL BIOSYST, V4, P30, DOI 10.1039/b713178j; GERMAN J, 2001, CURR PROTOC HUM GENE, pCH8; Grabarz A, 2013, CELL REP, V5, P21, DOI 10.1016/j.celrep.2013.08.034; Gu YS, 1997, P NATL ACAD SCI USA, V94, P8076, DOI 10.1073/pnas.94.15.8076; Gulston M, 2004, NUCLEIC ACIDS RES, V32, P1602, DOI 10.1093/nar/gkh306; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Kent T, 2016, ELIFE, V5, DOI 10.7554/eLife.13740; Kotter A, 2014, MOL ONCOL, V8, P1616, DOI 10.1016/j.molonc.2014.06.008; Kraft D, 2015, LEUKEMIA, V29, P1543, DOI 10.1038/leu.2015.28; Kruta M, 2014, STEM CELLS DEV, V23, P2443, DOI 10.1089/scd.2013.0611; Kruta M, 2013, STEM CELLS, V31, P693, DOI 10.1002/stem.1312; Kuhfittig-Kulle S, 2007, MUTAGENESIS, V22, P217, DOI 10.1093/mutage/gem007; Kunova M, 2013, STEM CELL TRANSL MED, V2, P246, DOI 10.5966/sctm.2012-0081; Li YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039588; Liu PF, 2010, ENVIRON MOL MUTAGEN, V51, P417, DOI 10.1002/em.20576; Lomax ME, 2013, CLIN ONCOL-UK, V25, P578, DOI 10.1016/j.clon.2013.06.007; Luo LZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030541; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Maynard S, 2008, STEM CELLS, V26, P2266, DOI 10.1634/stemcells.2007-1041; Momcilovic O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013410; Momcilovic O, 2009, STEM CELLS, V27, P1822, DOI 10.1002/stem.123; Ochs F, 2016, NAT STRUCT MOL BIOL, V23, P714, DOI 10.1038/nsmb.3251; Sallmyr A, 2008, BLOOD, V112, P1413, DOI 10.1182/blood-2007-07-104257; Serrano L, 2011, STEM CELLS DEV, V20, P363, DOI 10.1089/scd.2010.0159; Sfeir A, 2015, TRENDS BIOCHEM SCI, V40, P701, DOI 10.1016/j.tibs.2015.08.006; Shibata A, 2017, MUTAT RES-FUND MOL M, V803, P51, DOI 10.1016/j.mrfmmm.2017.07.011; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Sutherland BM, 2000, P NATL ACAD SCI USA, V97, P103, DOI 10.1073/pnas.97.1.103; Tavecchio M, 2012, CANCER CHEMOTH PHARM, V69, P155, DOI 10.1007/s00280-011-1662-4; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tichy ED, 2010, STEM CELLS DEV, V19, P1699, DOI 10.1089/scd.2010.0058; Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108; Turinetto V, 2015, NUCLEIC ACIDS RES, V43, P2489, DOI 10.1093/nar/gkv061; Vamvakas S, 1997, CRIT REV TOXICOL, V27, P155, DOI 10.3109/10408449709021617; Vinarsky V, 2013, STEM CELLS DEV, V22, P2964, DOI 10.1089/scd.2013.0057; Wang HL, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0136-8; Weeks LD, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.477; Wyles SP, 2014, INT J MOL SCI, V15, P20948, DOI 10.3390/ijms151120948; Xiong XH, 2015, NUCLEIC ACIDS RES, V43, P1659, DOI 10.1093/nar/gku1406; Yang N, 2006, DNA REPAIR, V5, P43, DOI 10.1016/j.dnarep.2005.07.003; Yang N, 2004, DNA REPAIR, V3, P1323, DOI 10.1016/j.dnarep.2004.04.014; Zhao Y, 2006, CANCER RES, V66, P5354, DOI 10.1158/0008-5472.CAN-05-4275; Zimmermann M, 2013, SCIENCE, V339, P700, DOI 10.1126/science.1231573	76	2	3	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6778	6788		10.1096/fj.201801877RR	http://dx.doi.org/10.1096/fj.201801877RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30807703				2022-12-26	WOS:000476114200009
J	Cheng, DL; Li, T; Smith, G; Yang, J; Hang, C; Miao, ZY; Wu, ZC				Cheng, Dali; Li, Tao; Smith, Gregory; Yang, Jing; Hang, Cheng; Miao, Zhenyue; Wu, Zicheng			Influence of calcium chloride impregnation on the thermal and high-temperature carbonization properties of bamboo fiber	PLOS ONE			English	Article							INORGANIC ADDITIVES; POROUS CARBONS; SURFACE-AREA; CELLULOSE; PYROLYSIS; FTIR; DECOMPOSITION; DEGRADATION; POLYSACCHARIDE; COMBUSTION	In this study, bamboo fiber was pretreated with calcium chloride (CaCl2) solution by using an ultrasonic method, and then heat-treated at 250 degrees C and carbonized at 1000 degrees C. The effect of impregnation with CaCl2 on the thermal and chemical properties and morphology of bamboo fiber was determined using thermogravimetric and differential thermogravimetric analyses, in situ Fourier transform infrared spectroscopy, and scanning electron microscopy. The pore structure of the carbonized bamboo fiber was investigated. The results revealed that bamboo fiber pretreated with 5% CaCl2 (BFCa5) showed a downward shift in the temperature of the maximum rate of weight loss253 degrees C and increase in char residue to 31.89%. BFCa5 was expected to undergo dehydration under the combined effect of oxygen-rich atmosphere and CaCl2 catalysis from 210 degrees C, and cellulose decomposition would be remarkable at 250 degrees C. Pretreatment with 5% CaCl2 promoted the formation of porous structure of the carbonized fiber, which exhibited a typical Type-IV isotherm, with the Brunauer-Emmett-Teller specific surface area of 331.32 m(2)/g an d Barrett-Joyner-Halenda adsorption average pore diameter of 13.6440 nm. Thus, CaCl2 was found to be an effective catalyst for the pyrolysis of bamboo fiber, facilitating the formation of porous carbonized fiber.	[Cheng, Dali; Li, Tao; Yang, Jing] Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China; [Cheng, Dali; Smith, Gregory] Univ British Columbia, Dept Wood Sci, Vancouver, BC, Canada; [Hang, Cheng] Nanjing Univ, State Key Lab Coordinat Chem, Nanjing, Jiangsu, Peoples R China; [Miao, Zhenyue; Wu, Zicheng] Natl Testing Ctr Funt Fiber & Text, Anhui Prod Qual Supervis & Inspect Inst, Hefei, Anhui, Peoples R China	Nanjing Forestry University; University of British Columbia; Nanjing University	Cheng, DL (corresponding author), Nanjing Forestry Univ, Coll Mat Sci & Engn, Nanjing, Jiangsu, Peoples R China.; Cheng, DL (corresponding author), Univ British Columbia, Dept Wood Sci, Vancouver, BC, Canada.	chengdl@njfu.edu.cn			National Natural Science Foundation of China [31700488]; High-level Personnel Fund of Nanjing Forestry University [GXL2014068]; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High-level Personnel Fund of Nanjing Forestry University; Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by National Natural Science Foundation of China (31700488 to DC), High-level Personnel Fund of Nanjing Forestry University (GXL2014068 to DC), Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2001, POLYMER, V42, P2893, DOI 10.1016/S0032-3861(00)00691-1; BACON R, 1964, CARBON, V2, P221, DOI 10.1016/0008-6223(64)90036-3; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; BYRNE GA, 1966, J APPL CHEM, V16, P81, DOI 10.1002/jbt.2570160303; CAEL JJ, 1975, J CHEM PHYS, V62, P1145, DOI 10.1063/1.430558; Calvini P, 2002, RESTAURATOR, V23, P48, DOI 10.1515/REST.2002.48; Chalmers GRL, 2012, INT J COAL GEOL, V103, P120, DOI 10.1016/j.coal.2012.05.006; Cheng WJ, 2010, CARBOHYD POLYM, V81, P707, DOI 10.1016/j.carbpol.2010.03.043; Dobele G, 2003, J ANAL APPL PYROL, V68-9, P197, DOI 10.1016/S0165-2370(03)00063-9; Gregg SJ, 1982, ADSORPTION SURFACE A; Hebel DE, 2014, COMPOS PART B-ENG, V67, P125, DOI 10.1016/j.compositesb.2014.06.032; Helsen L, 2000, J ANAL APPL PYROL, V53, P51, DOI 10.1016/S0165-2370(99)00050-9; Huang MR, 1998, J APPL POLYM SCI, V68, P293, DOI 10.1002/(SICI)1097-4628(19980411)68:2<293::AID-APP11>3.0.CO;2-Z; Jin Myung Kim, 2011, CARBON LETT, V12, P131, DOI DOI 10.5714/CL.2011.12.3.131; Kalliopi KA, 2006, PORE STRUCTURE CEMEN; Kawamoto H, 2003, J WOOD SCI, V49, P469, DOI 10.1007/s10086-002-0487-5; KILZER FJ, 1965, PYRODYNAMIC, V2, P151; KLEEN M, 1995, J ANAL APPL PYROL, V35, P15, DOI 10.1016/0165-2370(95)00893-J; Liu QF, 2004, THERMOCHIM ACTA, V419, P205, DOI 10.1016/j.tca.2003.12.014; Oh SY, 2005, CARBOHYD RES, V340, P2376, DOI 10.1016/j.carres.2005.08.007; Olsson AM, 2004, CARBOHYD RES, V339, P813, DOI 10.1016/j.carres.2004.01.005; Osorio L, 2011, J REINF PLAST COMP, V30, P396, DOI 10.1177/0731684410397683; Patwardhan PR, 2010, BIORESOURCE TECHNOL, V101, P4646, DOI 10.1016/j.biortech.2010.01.112; Ray AK, 2004, J MATER SCI, V39, P1055, DOI 10.1023/B:JMSC.0000012943.27090.8f; Safar M, 2019, APPL ENERG, V235, P346, DOI 10.1016/j.apenergy.2018.10.065; Schwanninger M, 2004, VIB SPECTROSC, V36, P23, DOI 10.1016/j.vibspec.2004.02.003; SEKIGUCHI Y, 1984, J APPL POLYM SCI, V29, P1267, DOI 10.1002/app.1984.070290421; Sevilla M, 2011, ADV FUNCT MATER, V21, P2781, DOI 10.1002/adfm.201100291; Shimada N, 2008, J ANAL APPL PYROL, V81, P80, DOI 10.1016/j.jaap.2007.09.005; Silverstein R.M., 2014, SPECTROMETRIC IDENTI, V8th; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Soares S, 2001, EUR POLYM J, V37, P737, DOI 10.1016/S0014-3057(00)00181-6; Tang W., 2007, J POLYM SCI C, V6, P65, DOI [10.1002/polc.5070060109, DOI 10.1002/POLC.5070060109]; VARHEGYI G, 1988, ENERG FUEL, V2, P267, DOI 10.1021/ef00009a007; VENKATESWARAN R, 1990, J APPL POLYM SCI, V41, P2783, DOI 10.1002/app.1990.070411123; Wongmanerod C, 2001, APPL SURF SCI, V172, P117, DOI 10.1016/S0169-4332(00)00847-3; Yang F, 2014, FUEL, V115, P378, DOI 10.1016/j.fuel.2013.07.040; Zakikhani P, 2014, MATER DESIGN, V63, P820, DOI 10.1016/j.matdes.2014.06.058; Zhang JB, 2013, CARBON, V55, P221, DOI 10.1016/j.carbon.2012.12.030; Zhang LL, 2012, NANO LETT, V12, P1806, DOI 10.1021/nl203903z	40	2	2	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212886	10.1371/journal.pone.0212886	http://dx.doi.org/10.1371/journal.pone.0212886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817796	gold, Green Published, Green Submitted			2022-12-26	WOS:000460371500052
J	Guo, XF; Liu, Y; Kim, JL; Kim, EY; Kim, EQ; Jansen, A; Li, K; Chan, M; Keenan, BT; Conejo-Garcia, J; Lim, DC				Guo, Xiaofeng; Liu, Yan; Kim, Jessica L.; Kim, Emily Y.; Kim, Edison Q.; Jansen, Alexandria; Li, Katherine; Chan, May; Keenan, Brendan T.; Conejo-Garcia, Jose; Lim, Diane C.			Effect of cyclical intermittent hypoxia on Ad5CMVCre induced solitary lung cancer progression and spontaneous metastases in the Kras(G12D+); p53(fl/fl); myristolated p110(fl/fl) ROSA-gfp mouse	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SQUAMOUS-CELL CARCINOMA; TUMOR HYPOXIA; PULMONARY VASOCONSTRICTION; MALIGNANT PROGRESSION; COMPUTED-TOMOGRAPHY; MODEL; P53; ASSOCIATION; RISK	Background Epidemiological data suggests that obstructive sleep apnea (OSA) is associated with increased cancer incidence and mortality. We investigate the effects of cyclical intermittent hypoxia (CIH), akin to the underlying pathophysiology of OSA, on lung cancer progression and metastatic profile in a mouse model. Methods Intrathoracic injection of Ad5CMVCre virus into a genetically engineered mouse (GEM) Kras(G12D+/-); p53(fl/fl); myristolated-p110 alpha(fl/fl) -ROSA-gfp was utilized to induce a solitary lung cancer. Male mice were then exposed to either CIH or Sham for 40-41 days until harvest. To monitor malignant progression, serial micro CT scans with respiratory gating (no contrast) was performed. To detect spontaneous metastases in distant organs, H&E and immunohistochemistry were performed. Results Eighty-eight percent of injected Ad5CMVCre virus was recovered from left lung tissue, indicating reliable and accurate injections. Serial micro CT demonstrated that CIH increases primary lung tumor volume progression compared to Sham on days 33 (p = 0.004) and 40 (p<0.001) post-injection. In addition, CIH increases variability in tumor volume on day 19 (p<0.0001), day 26 (p<0.0001), day 33 (p = 0.025) and day 40 (p = 0.004). Finally, metastases are frequently detected in heart, mediastinal lymph nodes, and right lung using H&E and immunohistochemistry. Conclusions Using a GEM mouse model of metastatic lung cancer, we report that male mice with solitary lung cancer have accelerated malignant progression and increased variability in tumor growth when exposed to cyclical intermittent hypoxia. Our results indicate that cyclical inter-mittent hypoxia is a pathogenic factor in non-small cell lung cancer that promotes the more rapid growth of developing tumors.	[Guo, Xiaofeng; Kim, Jessica L.; Kim, Emily Y.; Kim, Edison Q.; Jansen, Alexandria; Li, Katherine; Chan, May; Keenan, Brendan T.; Lim, Diane C.] Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA; [Liu, Yan] Jilin Univ, Dept Otolaryngol Head & Neck Surg, Hosp 2, Changchun, Jilin, Peoples R China; [Conejo-Garcia, Jose] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL USA; [Lim, Diane C.] Univ Penn, Dept Med, Div Sleep Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Jilin University; H Lee Moffitt Cancer Center & Research Institute; University of Pennsylvania	Lim, DC (corresponding author), Univ Penn, Ctr Sleep & Circadian Neurobiol, Philadelphia, PA 19104 USA.; Lim, DC (corresponding author), Univ Penn, Dept Med, Div Sleep Med, Philadelphia, PA 19104 USA.	limdiane@PennMedicine.upenn.edu	Conejo-Garcia, Jose R/V-1897-2019	Conejo-Garcia, Jose R/0000-0001-6431-4074; Chan, May/0000-0002-7262-3632	Veterans Affairs-VISN4 Competitive Pilot Project Fund [9360-01656]; American Sleep Medicine Foundation- Junior Faculty Research Award [154-JF-16]; National Cancer Institute [2R01CA124515]; NATIONAL CANCER INSTITUTE [R01CA124515, P30CA010815] Funding Source: NIH RePORTER	Veterans Affairs-VISN4 Competitive Pilot Project Fund; American Sleep Medicine Foundation- Junior Faculty Research Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Diane C. Lim-(1) Veterans Affairs-VISN4 Competitive Pilot Project Fund-Grant ID#9360-01656-https://www.pittsburgh.va.gov/Research/docs/funding-source-codes.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (2) American Sleep Medicine Foundation- Junior Faculty Research Award-Grant ID#154-JF-16- https://aasm.org/asmf-accepting-applications-for-junior-faculty-research-award/ - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jose Conejo-Garcia- National Cancer Institute- Grant ID#2R01CA124515-https://www.cancer.gov/ - The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarpour M, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw040; Alberg AJ, 2007, CHEST, V132, p29S, DOI 10.1378/chest.07-1347; Almendros I, 2012, EUR RESPIR J, V39, P215, DOI 10.1183/09031936.00185110; Almendros I, 2014, AM J RESP CRIT CARE, V189, P593, DOI 10.1164/rccm.201310-1830OC; Almendros I, 2012, SLEEP MED, V13, P1254, DOI 10.1016/j.sleep.2012.08.012; Badea CT, 2012, PROC SPIE, V8317, DOI 10.1117/12.912155; Baud MO, 2013, J SLEEP RES, V22, P3, DOI 10.1111/j.1365-2869.2012.01029.x; Brizel DM, 1996, CANCER RES, V56, P941; Brizel DM, 1997, INT J RADIAT ONCOL, V38, P285, DOI 10.1016/S0360-3016(97)00101-6; Byers LA, 2015, CANCER-AM CANCER SOC, V121, P664, DOI 10.1002/cncr.29098; Campos-Rodriguez F, 2013, AM J RESP CRIT CARE, V187, P99, DOI 10.1164/rccm.201209-1671OC; Caswell DR, 2014, CANCER DISCOV, V4, P781, DOI 10.1158/2159-8290.CD-13-0862; Christensen AS, 2013, SLEEP, V36, P1429, DOI 10.5665/sleep.3030; Clark DP, 2014, PHYS MEDICA, V30, P619, DOI 10.1016/j.ejmp.2014.05.011; Cuvier C, 1997, CLIN EXP METASTAS, V15, P19; Dewan NA, 2015, CHEST, V147, P266, DOI 10.1378/chest.14-0500; Drager LF, 2013, J AM COLL CARDIOL, V62, P569, DOI 10.1016/j.jacc.2013.05.045; Drangova M, 2007, INVEST RADIOL, V42, P85, DOI 10.1097/01.rli.0000251572.56139.a3; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Ferone G, 2016, CANCER CELL, V30, P519, DOI 10.1016/j.ccell.2016.09.001; Gazdar AF, 2015, J THORAC ONCOL, V10, P553, DOI 10.1097/JTO.0000000000000459; GOLDENBERGER D, 1995, PCR METH APPL, V4, P368; GRANT JL, 1980, CHEST, V77, P446, DOI 10.1378/chest.77.3.446; Graves EE, 2010, CLIN CANCER RES, V16, P4843, DOI 10.1158/1078-0432.CCR-10-1206; Herter-Sprie GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6870; Hockel M, 1999, CANCER RES, V59, P4525; Hockel M, 1996, CANCER RES, V56, P4509; Hussain A, 2017, OPEN CARDIOVASC MED, V11, P1, DOI 10.2174/1874192401711010001; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kendzerska T, 2014, CAN MED ASSOC J, V186, P985, DOI 10.1503/cmaj.140238; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lim DC, 2017, ANNU REV MED, V68, P99, DOI 10.1146/annurev-med-042915-102623; Lim DC, 2015, J APPL PHYSIOL, V118, P544, DOI 10.1152/japplphysiol.00629.2014; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Lumb AB, 2015, ANESTHESIOLOGY, V122, P932, DOI 10.1097/ALN.0000000000000569; Ma L, 2001, J VIROL METHODS, V93, P181, DOI 10.1016/S0166-0934(01)00257-9; Martinez-Garcia MA, 2014, SLEEP MED, V15, P742, DOI 10.1016/j.sleep.2014.01.020; Meuwissen R, 2005, GENE DEV, V19, P643, DOI 10.1101/gad.1284505; Mitsudomi T, 1997, J THORAC CARDIOV SUR, V114, P354, DOI 10.1016/S0022-5223(97)70180-6; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; MULL RT, 1984, AM J ROENTGENOL, V143, P1101, DOI 10.2214/ajr.143.5.1101; Nakahara R, 2001, THORAX, V56, P302, DOI 10.1136/thorax.56.4.302; Nieto FJ, 2012, AM J RESP CRIT CARE, V186, P190, DOI 10.1164/rccm.201201-0130OC; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Patterson AV, 2007, CLIN CANCER RES, V13, P3922, DOI 10.1158/1078-0432.CCR-07-0478; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Peters KB, 2002, CANCER RES, V62, P5248; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Salgia R, 1998, J CLIN ONCOL, V16, P1207, DOI 10.1200/JCO.1998.16.3.1207; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Shantha GPS, 2015, SLEEP MED, V16, P1289, DOI 10.1016/j.sleep.2015.04.014; Sheen MR, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.65; Sheen MR, 2015, OPEN LIFE SCI, V10, P461, DOI 10.1515/biol-2015-0048; Shin MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046562; Sundfor K, 1998, BRIT J CANCER, V78, P822, DOI 10.1038/bjc.1998.586; Sutherland KD, 2014, P NATL ACAD SCI USA, V111, P4952, DOI 10.1073/pnas.1319963111; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Tarry D, 2017, BJA EDUC, V17, P208, DOI 10.1093/bjaed/mkw076; UyBico SJ, 2010, RADIOGRAPHICS, V30, P1163, DOI 10.1148/rg.305095166; Vijayan VK, 2012, EXPERT REV RESP MED, V6, P557, DOI [10.1586/ers.12.44, 10.1586/ERS.12.44]; Vilaseca A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179444; Walenta S, 2000, CANCER RES, V60, P916; Wang GH, 2013, ANGIOGENESIS, V16, P561, DOI 10.1007/s10456-013-9336-y; Wood SL, 2015, CANCER TREAT REV, V41, P361, DOI 10.1016/j.ctrv.2015.02.008; Yang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075588; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Yuan SH, 2011, J THORAC ONCOL, V6, P71, DOI 10.1097/JTO.0b013e3181f77b40; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zheng S, 2007, ONCOGENE, V26, P6896, DOI 10.1038/sj.onc.1210493	74	7	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212930	10.1371/journal.pone.0212930	http://dx.doi.org/10.1371/journal.pone.0212930			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811514	gold, Green Submitted, Green Published			2022-12-26	WOS:000459806400097
J	Slawinska, A; Dunislawska, A; Plowiec, A; Radomska, M; Lachmanska, J; Siwek, M; Tavaniello, S; Maiorano, G				Slawinska, Anna; Dunislawska, Aleksandra; Plowiec, Arkadiusz; Radomska, Malgorzata; Lachmanska, Jagoda; Siwek, Maria; Tavaniello, Siria; Maiorano, Giuseppe			Modulation of microbial communities and mucosal gene expression in chicken intestines after galactooligosaccharides delivery In Ovo	PLOS ONE			English	Article							GUT MICROBIOTA; GASTROINTESTINAL-TRACT; TIGHT JUNCTIONS; CECAL TONSILS; GOBLET CELLS; SYNBIOTICS; PREBIOTICS; HEALTH; IDENTIFICATION; MORPHOLOGY	Intestinal mucosa is the interface between the microbial content of the gut and the host's milieu. The goal of this study was to modulate chicken intestinal microflora by in ovo stimulation with galactooligosaccharides (GOS) prebiotic and to demonstrate the molecular responses of the host. The animal trial was performed on meat-type chickens (Ross 308). GOS was delivered by in ovo injection performed into the air cell on day 12 of egg incubation. Analysis of microbial communities and mucosal gene expression was performed at slaughter (day 42 post-hatching). Chyme (for DNA isolation) and intestinal mucosa (for RNA isolation) from four distinct intestinal segments (duodenum, jejunum, ileum, and caecum) was sampled. The relative abundance of Bifidobacterium spp. and Lactobacillus spp. in DNA isolated from chyme samples was determined using qPCR. On the host side, the mRNA expression of 13 genes grouped into two panels was analysed with RT-qPCR. Panel (1) included genes related to intestinal innate immune responses (IL-1 beta, IL-10 and IL-12p40, AvBD1 and CATHL2). Panel (2) contained genes involved in intestinal barrier function (MUC6, CLDN1 and TJAP1) and nutrients sensing (FFAR2 and FFAR4, GLUT1, GLUT2 and GLUT5). GOS increased the relative abundance of Bifidobacterium in caecum (from 1.3% to 3.9%). Distinct effects of GOS on gene expression were manifested in jejunum and caecum. Cytokine genes (IL-1 beta, IL-10 and IL-12p40) were up-regulated in the jejunum and caecum of the GOS-treated group. Host defence peptides (AvBD1 and CATHL2) were up-regulated in the caecum of the GOS-treated group. Free fatty acid receptors (FFAR2 and FFAR4) were up-regulated in all three compartments of the intestine (except the duodenum). Glucose transporters were down-regulated in duodenum (GLUT2 and GLUT5) but up-regulated in the hindgut (GLUT1 and GLUT2). In conclusion, GOS delivered in ovo had a bifidogenic effect in adult chickens. It also modulated gene expression related to intestinal immune responses, gut barrier function, and nutrient sensing.	[Slawinska, Anna; Dunislawska, Aleksandra; Plowiec, Arkadiusz; Radomska, Malgorzata; Lachmanska, Jagoda; Siwek, Maria] UTP Univ Sci & Technol, Dept Anim Biotechnol & Genet, Bydgoszcz, Poland; [Slawinska, Anna; Tavaniello, Siria; Maiorano, Giuseppe] Univ Molise, Dept Agr Environm & Food Sci, Campobasso, Italy	Bydgoszcz University of Science & Technology; University of Molise	Slawinska, A (corresponding author), UTP Univ Sci & Technol, Dept Anim Biotechnol & Genet, Bydgoszcz, Poland.; Slawinska, A (corresponding author), Univ Molise, Dept Agr Environm & Food Sci, Campobasso, Italy.	slawinska@utp.edu.pl	Dunisławska, Aleksandra/AAN-5182-2020; tavaniello, siria/AAI-2146-2019; Siwek, Maria/AAG-8929-2019; Maiorano, Giuseppe/AAH-9136-2021; Slawinska, Anna/B-3781-2016	tavaniello, siria/0000-0003-3617-8188; Siwek, Maria/0000-0003-4148-5174; Slawinska, Anna/0000-0002-5706-6145; Dunislawska, Aleksandra/0000-0001-6608-0013	Ministry of Education, Universities and Research (MIUR) in Rome, Italy (OVOBIOTIC) [RBSI14WZCL]; National Science Centre (NSC) in Cracow, Poland [UMO-2013/11/B/NZ9/00783]; Statutory Research of the Department of Animal Biotechnology and Genetics [BS 10/2017]	Ministry of Education, Universities and Research (MIUR) in Rome, Italy (OVOBIOTIC)(Ministry of Education, Universities and Research (MIUR)); National Science Centre (NSC) in Cracow, Poland; Statutory Research of the Department of Animal Biotechnology and Genetics	This study was supported by Ministry of Education, Universities and Research (MIUR) in Rome, Italy (OVOBIOTIC, grant number RBSI14WZCL), AS; and National Science Centre (NSC) in Cracow, Poland (grant number UMO-2013/11/B/NZ9/00783), AS. The study was published with support from the Statutory Research of the Department of Animal Biotechnology and Genetics, BS 10/2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari MR, 2008, CLIN VACCINE IMMUNOL, V15, P1689, DOI 10.1128/CVI.00242-08; Alemka A, 2010, J MED MICROBIOL, V59, P898, DOI 10.1099/jmm.0.019315-0; Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017; [Anonymous], 2013, J IMMUNOL, V190, P1389, DOI [10.4049/jimmunol.1203100, DOI 10.4049/JIMMUNOL.1203100]; Awad WA, 2017, TOXINS, V9, DOI 10.3390/toxins9020060; Azcarate-Peril MA, 2017, APPL ENVIRON MICROB; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barberi C, 2015, IMMUNOL LETT, V168, P337, DOI 10.1016/j.imlet.2015.11.005; Bednarczyk M, 2016, ANIMAL, V10, P1271, DOI 10.1017/S1751731116000173; Bednarczyk M, 2011, B VET I PULAWY, V55, P465; BEFUS AD, 1980, J IMMUNOL, V125, P2626; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bogucka J, 2017, ANN ANIM SCI, V17, P179, DOI 10.1515/aoas-2016-0048; Brisbin JT, 2010, CLIN VACCINE IMMUNOL, V17, P1337, DOI 10.1128/CVI.00143-10; Burns RN, 2010, BIOCHEM BIOPH RES CO, V396, P1030, DOI 10.1016/j.bbrc.2010.05.057; Chen GY, 2017, FREE RADICAL BIO MED, V105, P35, DOI 10.1016/j.freeradbiomed.2016.11.011; Chen JX, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00014; Chistiakov DA, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00781; Christensen Ellen Gerd, 2014, BMC Res Notes, V7, P660, DOI 10.1186/1756-0500-7-660; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; Cuperus T, 2013, DEV COMP IMMUNOL, V41, P352, DOI 10.1016/j.dci.2013.04.019; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Duke G.E., 1986, P269; Dunislawska A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168587; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; Gadde UD, 2017, RES VET SCI, V114, P236, DOI 10.1016/j.rvsc.2017.05.004; Gulewicz K, 2008, INVENTORS MIROSLAW S; Haghighi HR, 2008, VET MICROBIOL, V126, P225, DOI 10.1016/j.vetmic.2007.06.026; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Higgins SE, 2011, POULTRY SCI, V90, P901, DOI 10.3382/ps.2010-00907; Hou T, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040418; Hughes R-A, 2017, FRONT VET SCI, V4, DOI [10.3389/fvets.2017.00004, DOI 10.3389/FVETS.2017.00004]; Hughes RA, 2017, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00192; Jung SJ, 2008, POULTRY SCI, V87, P1694, DOI 10.3382/ps.2007-00489; Kaji R, 2018, J DAIRY SCI; Kawabe H, 2001, J BIOL CHEM, V276, P48350, DOI 10.1074/jbc.M107335200; Kelsall BL, 2008, J PATHOL, V214, P242, DOI 10.1002/path.2286; Khosravi A, 2013, CURR OPIN MICROBIOL, V16, P221, DOI 10.1016/j.mib.2013.03.009; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Kogut MH, 2013, CLIN VACCINE IMMUNOL; Kolodziejski PA, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-017-0227-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopetuso LR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00181; MADARA JL, 1989, J CLIN INVEST, V83, P1089, DOI 10.1172/JCI113987; Madej JP, 2016, POULTRY SCI, V95, P19, DOI 10.3382/ps/pev291; Madej JP, 2015, POULTRY SCI, V94, P1209, DOI 10.3382/ps/pev076; Maiorano G, 2012, POULTRY SCI, V91, P2963, DOI 10.3382/ps.2012-02208; Maiorano G, 2017, POULTRY SCI, V96, P511, DOI 10.3382/ps/pew311; Mangian HF, 2009, JPEN-PARENTER ENTER, V33, P607, DOI 10.1177/0148607109336599; Martin R, 2010, BENEF MICROBES, V1, P367, DOI 10.3920/BM2010.0027; Micciche AC, 2018, FRONT VET SCI, P5; Rodriguez JM, 2015, MICROB ECOL HEALTH D, V26, DOI 10.3402/mehd.v26.26050; Palermo-Neto J, 2013, BRAIN BEHAV IMMUN, V32, pe18; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Penders J, 2005, FEMS MICROBIOL LETT, V243, P141, DOI 10.1016/j.femsle.2004.11.052; Pokusaeva K, 2011, GENES NUTR, V6, P285, DOI 10.1007/s12263-010-0206-6; Pourabedin M, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv122; Pruszynska-Oszmalek E, 2015, POULTRY SCI, V94, P1909, DOI 10.3382/ps/pev162; Rajput IR, 2013, POULTRY SCI, V92, P956, DOI 10.3382/ps.2012-02845; Ranjitkar S, 2016, APPL ENVIRON MICROB, V82, P2399, DOI 10.1128/AEM.02549-15; Ricke SC, 2018, YALE J BIOL MED, V91, P151; Roberfroid M., 2003, PREBIOTICS; Robinson K, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00057; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Rothwell L, 2004, J IMMUNOL, V173, P2675, DOI 10.4049/jimmunol.173.4.2675; Roto SM, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00063; Rychlik I, 2014, VET RES, V45, DOI 10.1186/s13567-014-0119-2; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schokker D, 2011, BMC P; Schokker D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3625-6; Schokker D, 2009, DEV COMP IMMUNOL, V33, P1156, DOI 10.1016/j.dci.2009.06.002; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sevane N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098942; Shao YJ, 2016, INT J BIOL MACROMOL, V85, P573, DOI 10.1016/j.ijbiomac.2016.01.031; Shi N, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-017-0122-9; Simon K, 2016, POULTRY SCI, V95, P1543, DOI 10.3382/ps/pew088; Siwek M, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1738-z; Slawinska A, 2018, POULTRY SCI; Slawinska A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168899; Slawinska A, 2014, AM J VET RES, V75, P997, DOI 10.2460/ajvr.75.11.997; Slawinska A, 2014, FOLIA BIOL-KRAKOW, V62, P277, DOI 10.3409/fb62_3.277; Smirnov A, 2006, POULTRY SCI, V85, P669, DOI 10.1093/ps/85.4.669; Sobolewska A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0193-1; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Sunkara L, 2015, ADV ANIM VET SCI, V3, P9, DOI [10.14737/journal.aavs/2015/3.3s.9.20, DOI 10.14737/JOURNAL.AAVS/2015/3.3S.9.20]; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Svihus B, 2014, J APPL POULTRY RES, V23, P306, DOI 10.3382/japr.2014-00937; Tannock GW, 1999, APPL ENVIRON MICROB, V65, P4264; Tzortzis G, 2005, APPL MICROBIOL BIOT, V68, P412, DOI 10.1007/s00253-005-1919-0; Uni Z, 2005, POULTRY SCI, V84, P764, DOI 10.1093/ps/84.5.764; Varasteh S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138975; Villaluenga CM, 2004, FOLIA BIOL-KRAKOW, V52, P135, DOI 10.3409/1734916044527502; Volf J, 2017, VET RES, V48, DOI 10.1186/s13567-017-0493-7; Walter J, 2000, APPL ENVIRON MICROB, V66, P297, DOI 10.1128/AEM.66.1.297-303.2000; Wei S, 2013, POULTRY SCI, V92, P671, DOI 10.3382/ps.2012-02822; Woting A, 2014, MBIO, V5, DOI 10.1128/mBio.01530-14; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091; YOUNGMAN KR, 1993, GASTROENTEROLOGY, V104, P749, DOI 10.1016/0016-5085(93)91010-F	104	31	33	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212318	10.1371/journal.pone.0212318	http://dx.doi.org/10.1371/journal.pone.0212318			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811518	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400066
J	Felten, R; Perrin, P; Caillard, S; Moulin, B; Javier, RM				Felten, Renaud; Perrin, Peggy; Caillard, Sophie; Moulin, Bruno; Javier, Rose-Marie			Avascular osteonecrosis in kidney transplant recipients: Risk factors in a recent cohort study and evaluation of the role of secondary hyperparathyroidism	PLOS ONE			English	Article							FEMORAL-HEAD; RENAL-TRANSPLANTATION; NONTRAUMATIC OSTEONECROSIS; ASEPTIC NECROSIS; BONE NECROSIS; ASSOCIATION; POPULATION; PREVALENCE; PREDNISONE; FAT	Avascular osteonecrosis (AVN) is a bone complication that indicates poor functional prognosis. Modern immunosuppressive and steroid-sparing drugs have significantly lowered the occurrence of AVN after kidney transplantation (KT). However, recent data on its incidence rates and risk factors are lacking. Using a large, recent cohort, we sought to investigate AVN incidence and risk factors, with a special focus on mineral and bone disorders. We conducted a cohort study in 805 patients who underwent KT between 2004 and 2014. AVN was identified in 32 patients (4%): before KT in 15 (1.8%) and after KT in 18 (2.2%) cases, including one patient with both. In the group with post-KT AVN, the median time intervals from KT to 1) first symptoms and 2) AVN diagnosis were 12 months [1-99] and 20 months [4-100], respectively. Being overweight/obese, having pre-transplant diabetes or hyperparathyroidism at transplantation, developing acute rejection, and receiving higher cumulative corticosteroid doses were associated with AVN occurrence. Multivariate analysis revealed that BMI. 26 kg/m(2) and higher cumulative corticosteroid doses were predictive of AVN. In conclusion, overweight/obesity is a strong risk factor for AVN. Despite a low maintenance dose, the use of corticosteroids-mostly for treatment of acute rejection-remains an independent risk factor.	[Felten, Renaud; Javier, Rose-Marie] Univ Hosp, Dept Rheumatol, Strasbourg, France; [Felten, Renaud; Perrin, Peggy; Caillard, Sophie; Moulin, Bruno; Javier, Rose-Marie] Federat Med Translat FMTS, Strasbourg, France; [Perrin, Peggy; Caillard, Sophie; Moulin, Bruno] Univ Hosp Strasbourg, Dept Nephrol Transplantat, Strasbourg, France	CHU Strasbourg; CHU Strasbourg	Perrin, P (corresponding author), Federat Med Translat FMTS, Strasbourg, France.; Perrin, P (corresponding author), Univ Hosp Strasbourg, Dept Nephrol Transplantat, Strasbourg, France.	peggy.perrin@chru-strasbourg.fr	Caillard, Sophie/AAG-3790-2019; Felten, Renaud/ABC-4204-2020	Felten, Renaud/0000-0002-4951-4032; caillard, sophie/0000-0002-0525-4291; MOULIN, Bruno/0000-0001-6772-7165; Perrin, Peggy/0000-0001-7343-5943				Agarwala S, 2011, J ARTHROPLASTY, V26, P1128, DOI 10.1016/j.arth.2010.11.010; Ajmal M, 2009, ORTHOP CLIN N AM, V40, P235, DOI 10.1016/j.ocl.2009.01.004; ALEXEEVA L, 1994, WHO TECH REP SER, V843, P1; ARLET J, 1972, REV RHUM, V39, P717; Asano Takeshi, 2003, Pharmacogenetics, V13, P675, DOI 10.1097/00008571-200311000-00003; Atallah AM, 2009, RHEUMATOL INT, V30, P75, DOI 10.1007/s00296-009-0918-3; Bredella MA, 2011, OBESITY, V19, P49, DOI 10.1038/oby.2010.106; Celik A, 2006, TRANSPL P, V38, P512, DOI 10.1016/j.transproceed.2005.12.062; CRUESS RL, 1968, J BONE JOINT SURG AM, VA 50, P1577, DOI 10.2106/00004623-196850080-00006; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Ekmekci Y, 2006, NEPHROL DIAL TRANSPL, V21, P3555, DOI 10.1093/ndt/gfl400; Ferrari P, 2002, TRANSPLANTATION, V74, P1147, DOI 10.1097/00007890-200210270-00016; HARRINGTON KD, 1971, J BONE JOINT SURG AM, VA 53, P203, DOI 10.2106/00004623-197153020-00001; Hedri H, 2007, TRANSPL P, V39, P1036, DOI 10.1016/j.transproceed.2007.02.031; Hirata T, 2007, J ORTHOP SCI, V12, P199, DOI 10.1007/s00776-007-1110-9; Hirata T, 2007, J RHEUMATOL, V34, P516; JACOBS B, 1992, NEW YORK STATE J MED, V92, P334; Khwaja K, 2004, AM J TRANSPLANT, V4, P980, DOI 10.1111/j.1600-6143.2004.00443.x; Lai KA, 2005, J BONE JOINT SURG AM, V87A, P2155, DOI 10.2106/JBJS.D.02959; LAUSTEN GS, 1988, ACTA ORTHOP SCAND, V59, P650, DOI 10.3109/17453678809149417; Lopez-Ben R, 2004, CLIN RADIOL, V59, P431, DOI 10.1016/j.crad.2003.11.001; Moya-Angeler J, 2015, WORLD J ORTHOP, V6, P590, DOI 10.5312/wjo.v6.i8.590; NAIKER IP, 1993, S AFR MED J, V83, P646; NEHME D, 1989, NEPHROL DIAL TRANSPL, V4, P123; PATTON PR, 1988, SURGERY, V103, P63; Paydas S, 2011, TRANSPL P, V43, P863, DOI 10.1016/j.transproceed.2011.02.072; Perrin P, 2013, AM J TRANSPLANT, V13, P2653, DOI 10.1111/ajt.12425; PIERIDES AM, 1975, Q J MED, V44, P459; Potluri K, 2010, AM J KIDNEY DIS, V56, P143, DOI 10.1053/j.ajkd.2010.01.017; Pritchett JW, 2001, CLIN ORTHOP RELAT R, P173; RAO DS, 1993, NEW ENGL J MED, V328, P171, DOI 10.1056/NEJM199301213280304; Saito M, 2014, ACTA ORTHOP, V85, P266, DOI 10.3109/17453674.2014.916490; Schachtner T, 2018, NEPHROL DIAL TRANSPL, V33, P2060, DOI 10.1093/ndt/gfy148; Serrano OK, 2017, TRANSPLANTATION, V101, P2590, DOI 10.1097/TP.0000000000001756; Shibatani M, 2008, ACTA ORTHOP, V79, P631, DOI 10.1080/17453670810016641; Sprague SM, 2016, AM J KIDNEY DIS, V67, P559, DOI 10.1053/j.ajkd.2015.06.023; Takao M, 2011, RHEUMATOL INT, V31, P165, DOI 10.1007/s00296-009-1241-8; Tang S, 1999, INT J ARTIF ORGANS, V22, P131, DOI 10.1177/039139889902200304; Tang S, 2000, TRANSPLANT P, V32, P1873, DOI 10.1016/S0041-1345(00)01471-8; TERVONEN O, 1992, RADIOLOGY, V182, P845, DOI 10.1148/radiology.182.3.1535906; Yuan HF, 2016, OSTEOPOROSIS INT, V27, P295, DOI 10.1007/s00198-015-3317-5; Zhao DW, 2015, CHINESE MED J-PEKING, V128, P2843, DOI 10.4103/0366-6999.168017; Zhou L, 2015, SCI REP-UK, V5, DOI 10.1038/srep09397	43	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212931	10.1371/journal.pone.0212931	http://dx.doi.org/10.1371/journal.pone.0212931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794689	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100159
J	Haruma, T; Yamaji, K; Ogawa, K; Masuya, H; Sekine, Y; Kozai, N				Haruma, Toshikatsu; Yamaji, Keiko; Ogawa, Kazuyoshi; Masuya, Hayato; Sekine, Yurina; Kozai, Naofumi			Root-endophytic Chaetomium cupreum chemically enhances aluminium tolerance in Miscanthus sinensis via increasing the aluminium detoxicants, chlorogenic acid and oosporein	PLOS ONE			English	Article							TOXICITY; SIDEROPHORES; GROWTH; FUNGUS; PLANT; RESISTANCE; TRANSPORT; ROLES; PB	Miscanthus sinensis Andersson is a pioneer plant species that grows naturally at mining sites. Miscanthus sinensis can detoxify aluminium (Al) by producing phytosiderophores, such as chlorogenic acid, citric acid, and malic acid, and localizing Al in cell walls. Rootendophytic Chaetomium cupreum, which produces microbial siderophores, enhances Al tolerance in M. sinensis. However, we could not determine whether the siderophores produced by C. cupreum actually enhance Al tolerance in M. sinensis, because the microbial siderophores have not yet been identified in previous research. The purpose of this study was to clarify how C. cupreum chemically increases Al tolerance in M. sinensis under acidic mining site conditions, especially considering siderophores. Using instrumental analyses, the siderophore produced by C. cupreum was identified as oosporein. Comparison of the stability constant between Al and phytosiderophores and oosporein indicated that oosporein could detoxify Al similarly to chlorogenic acid, which shows higher stability constant than citric acid and malic acid. Inoculation test of C. cupreum onto M. sinensis in acidic mine soil showed that C. cupreum promoted seedling growth, and enhanced Al tolerance via inducing chlorogenic-acid production and producing oosporein. These results suggested that C. cupreum could chemically enhance Al tolerance and might promote growth via reducing excessive Al in cell walls, the main site of Al accumulation. In addition, the chemical enhancement of Al tolerance by C. cupreum might be important for M. sinensis to adapt to acidic mining sites.	[Haruma, Toshikatsu; Yamaji, Keiko; Ogawa, Kazuyoshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Masuya, Hayato] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki, Japan; [Sekine, Yurina] Japan Atom Energy Agcy, Mat Sci Res Ctr, Tokai, Ibaraki, Japan; [Kozai, Naofumi] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki, Japan	University of Tsukuba; Forestry & Forest Products Research Institute - Japan; Japan Atomic Energy Agency; Japan Atomic Energy Agency	Yamaji, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	yamaji.keiko.fp@u.tsukuba.ac.jp	Masuya, Hayato/AAN-8998-2021	Sekine, Yurina/0000-0002-8971-2498	Sasakawa Scientific Research Grant of The Japan Science Society [28-530]; JSPS KAKENHI [25292080]	Sasakawa Scientific Research Grant of The Japan Science Society; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	TH received award from the Sasakawa Scientific Research Grant of The Japan Science Society (grant number: 28-530, https://www.jss.or.jp/ikusei/sasakawa/).KY received award from the JSPS KAKENHI (grant number: 25292080, https://www.jsps.go.jp/j-grantsinaid/).The funders played roles in data collection and analysis.	Adams ML, 2002, J CHEM ENG DATA, V47, P289, DOI 10.1021/je010279e; Ahmed E, 2014, MICROB BIOTECHNOL, V7, P196, DOI 10.1111/1751-7915.12117; ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; [Anonymous], 1974, JPN J HUMANIT NAT SC; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Bjerrum J., 1941, METAL AMMINE FORMATI, P123; Braud A, 2009, CHEMOSPHERE, V74, P280, DOI 10.1016/j.chemosphere.2008.09.013; CHENERY EM, 1948, ANN BOT-LONDON, V12, P121, DOI 10.1093/oxfordjournals.aob.a083177; Das A, 2012, PLANT SIGNAL BEHAV, V7, P103, DOI 10.4161/psb.7.1.18472; Day RA Jr, 1982, ACID BASE EQUILIBRIA, P166; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Deng ZJ, 2014, ENVIRON SCI POLLUT R, V21, P2346, DOI 10.1007/s11356-013-2163-2; GADD GM, 1993, NEW PHYTOL, V124, P25, DOI 10.1111/j.1469-8137.1993.tb03796.x; Haruma T, 2018, PLANT SPEC BIOL, V33, P109, DOI 10.1111/1442-1984.12197; He G, 2012, ACTA CRYSTALLOGR E, V68, pO1231, DOI 10.1107/S1600536812012950; HUTCHINSON GE, 1945, SOIL SCI, V60, P29, DOI 10.1097/00010694-194507000-00004; Izumi F, 2007, SOLID STATE PHENOMEN, V130, P15, DOI 10.4028/www.scientific.net/SSP.130.15; Jentschke G, 2000, PHYSIOL PLANTARUM, V109, P107, DOI 10.1034/j.1399-3054.2000.100201.x; KINRAIDE TB, 1991, PLANT SOIL, V134, P167, DOI 10.1007/BF00010729; Kochian LV, 2005, PLANT SOIL, V274, P175, DOI 10.1007/s11104-004-1158-7; Larcher W, 2003, PHYSL PLANT ECOLOGY; Li T, 2011, SCI TOTAL ENVIRON, V409, P1069, DOI 10.1016/j.scitotenv.2010.12.012; Ma JF, 1997, NATURE, V390, P569, DOI 10.1038/37518; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Mao BZ, 2010, AFR J BIOTECHNOL, V9, P5955; Nagaoka T, 2004, Z NATURFORSCH C, V59, P302; Nagata S, 2015, PLANT SPEC BIOL, V30, P116, DOI 10.1111/1442-1984.12039; NAGATA T, 1992, PHYTOCHEMISTRY, V31, P1215, DOI 10.1016/0031-9422(92)80263-E; NEILANDS JB, 1952, J AM CHEM SOC, V74, P4846, DOI 10.1021/ja01139a033; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Rajkumar M, 2012, BIOTECHNOL ADV, V30, P1562, DOI 10.1016/j.biotechadv.2012.04.011; ROBINSON WO, 1945, SOIL SCI, V60, P15, DOI 10.1097/00010694-194507000-00003; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Rogers NJ, 2001, BIOMETALS, V14, P59, DOI 10.1023/A:1016691301330; Schalk IJ, 2011, ENVIRON MICROBIOL, V13, P2844, DOI 10.1111/j.1462-2920.2011.02556.x; SCHINDLER DW, 1988, SCIENCE, V239, P149, DOI 10.1126/science.239.4836.149; Schulz B, 1999, MYCOL RES, V103, P1275, DOI 10.1017/S0953756299008540; Seguel A, 2013, MYCORRHIZA, V23, P167, DOI 10.1007/s00572-013-0479-x; Tabuchi A, 2001, PHYSIOL PLANTARUM, V112, P353, DOI 10.1034/j.1399-3054.2001.1120308.x; TAKEMOTO T, 1978, P JPN ACAD B-PHYS, V54, P469, DOI 10.2183/pjab.54.469; TOMSETT AB, 1988, PLANT CELL ENVIRON, V11, P383, DOI 10.1111/j.1365-3040.1988.tb01362.x; VINING LC, 1962, CAN J MICROBIOL, V8, P931, DOI 10.1139/m62-122; Wang J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20728; Xiao X, 2010, BIORESOURCE TECHNOL, V101, P1668, DOI 10.1016/j.biortech.2009.09.083; Yamaji K, 2012, FOREST PATHOL, V42, P1, DOI 10.1111/j.1439-0329.2010.00709.x; Yamaji K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0169089; YOSHII Y, 1937, BOT MAG, V51, P262, DOI DOI 10.15281/JPLANTRES1887.51.262	47	15	15	6	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212644	10.1371/journal.pone.0212644	http://dx.doi.org/10.1371/journal.pone.0212644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794662	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100102
J	Wang, B; Bian, BT; Wang, CL; Li, CX; Fang, H; Zhang, J; Huang, DJ; Huo, JQ; Liao, WB				Wang, Bo; Bian, Biting; Wang, Chunlei; Li, Changxia; Fang, Hua; Zhang, Jing; Huang, Dengjing; Huo, Jianqiang; Liao, Weibiao			Hydrogen gas promotes the adventitious rooting in cucumber under cadmium stress	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; NITRIC-OXIDE; PLANT TOLERANCE; CELL-DEATH; RESPONSES; TOXICITY; ENZYMES; RICE; SATIVA	Hydrogen gas (H-2) plays an important role in plant development and stress responses. Here, cucumber (Cucumis sativus L.) explants were used to investigate the roles of H2 in adventitious root development under cadmium (Cd) stress and its physiological mechanism. The results showed that hydrogen-rich water (HRW) promoted adventitious rooting under Cd stress and 50% HRW obtained the maximal biological response. Compared with Cd treatment, HRW + Cd treatment significantly reduced the content of malondialdehyde (MDA), hydrogen peroxide (H2O2), superoxide radical (O-2(-)), thiobarbituric acid reactive substances (TBARS), ascorbic acid (AsA) and reduced glutathione (GSH), as well as relative electrical conductivity (REC), lipoxygenase (LOX) activity, AsA/docosahexaenoic acid (DHA) ratio, and GSH/oxidized glutathione (GSSG) ratio, while increasing DHA and GSSG content. HRW + Cd treatment also significantly increased in the activity and related gene expression of ascorbate peroxidase (APX), dehydroascorbate reductase (DHAR), monodehydroascorbate reductase (MDHAR) and glutathione reductase (GR). Additionally, HRW + Cd treatment increased the contents of osmotic adjustment substances, as well as the activities of peroxidase (POD) and polyphenol oxidase (PPO), while significantly decreasing indoleacetic acid oxidase (IAAO) activity. In summary, H-2 could induce adventitious rooting under Cd stress by decreasing the oxidative damage, increasing osmotic adjustment substance content and regulating rooting-related enzyme activity.	[Wang, Bo; Bian, Biting; Wang, Chunlei; Li, Changxia; Fang, Hua; Zhang, Jing; Huang, Dengjing; Huo, Jianqiang; Liao, Weibiao] Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China	Gansu Agricultural University	Liao, WB (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Gansu, Peoples R China.	liaowb@gsau.edu.cn	Liao, Weibiao/AAE-7770-2020		Discipline construction fund project of Gansu Agriculture University [GAU-XKJS-2018-223]; National Natural Science Foundation of China [31860568, 31560563, 31160398]; National Key Research and Development Program [2018YFD1000800]; Research Fund of Higher Education of Gansu, China [2018C-14]; Post-Doctoral Foundation of China [20100470887, 2012T50828]; Natural Science Foundation of Gansu Province, China [1606RJZA073, 1606RJZA077]	Discipline construction fund project of Gansu Agriculture University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Research Fund of Higher Education of Gansu, China; Post-Doctoral Foundation of China(China Postdoctoral Science Foundation); Natural Science Foundation of Gansu Province, China	This work was supported by the Discipline construction fund project of Gansu Agriculture University grant number GAU-XKJS-2018-223 (http://www.gsau.edu.cn/), the National Natural Science Foundation of China grant numbers (31860568, 31560563 and 31160398) (http://www.nsfc.gov.cn/), the National Key Research and Development Program grant number 2018YFD1000800 (http://program.most.gov.cn/), the Research Fund of Higher Education of Gansu, China grant number 2018C-14 (http://www.gsedu.gov.cn/), the Post-Doctoral Foundation of China grant numbers (20100470887 and 2012T50828) (http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx) and the Natural Science Foundation of Gansu Province, China grant numbers (1606RJZA073 and 1606RJZA077) (http://www.gsstc.gov.cn/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad P, 2011, S AFR J BOT, V77, P36, DOI 10.1016/j.sajb.2010.05.003; Anjum NA, 2016, ENVIRON SCI POLLUT R, V23, P19002, DOI 10.1007/s11356-016-7309-6; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUYSSE J, 1993, J EXP BOT, V44, P1627, DOI 10.1093/jxb/44.10.1627; Chen QH, 2017, PLANT GROWTH REGUL, V83, P69, DOI 10.1007/s10725-017-0284-1; Chen Y, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00128; Chew O, 2003, J BIOL CHEM, V278, P46869, DOI 10.1074/jbc.M307525200; Cui WT, 2014, ECOTOX ENVIRON SAFE, V105, P103, DOI 10.1016/j.ecoenv.2014.04.009; Cui WT, 2013, J HAZARD MATER, V260, P715, DOI 10.1016/j.jhazmat.2013.06.032; de Araujo RP, 2017, ECOTOX ENVIRON SAFE, V144, P148, DOI 10.1016/j.ecoenv.2017.06.006; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; EDWARDS EA, 1990, PLANTA, V180, P278, DOI 10.1007/BF00194008; Golding AL, 2010, ENVIRON CHEM LETT, V8, P101, DOI 10.1007/s10311-010-0278-y; Hasanuzzaman M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01061; Hasanuzzaman M, 2012, BIOL TRACE ELEM RES, V149, P248, DOI 10.1007/s12011-012-9419-4; He SY, 2017, PEDOSPHERE, V27, P421, DOI [10.1016/S1002-0160(17)60339-4, 10.1016/s1002-0160(17)60339-4]; Hu HL, 2014, FOOD CHEM, V156, P100, DOI 10.1016/j.foodchem.2014.01.067; Huang CS, 2010, FREE RADICAL RES, V44, P971, DOI 10.3109/10715762.2010.500328; Jabs T, 1996, SCIENCE, V273, P1853, DOI 10.1126/science.273.5283.1853; Jin QJ, 2016, J PLANT GROWTH REGUL, V35, P565, DOI 10.1007/s00344-015-9561-2; Jin QJ, 2013, PLANT CELL ENVIRON, V36, P956, DOI 10.1111/pce.12029; Kovacik J, 2009, J PLANT PHYSIOL, V166, P1460, DOI 10.1016/j.jplph.2009.03.002; Li CX, 2018, FUNCT PLANT BIOL, V45, P783, DOI 10.1071/FP17301; Li Ming, 2000, Forest Research, V13, P493; Liao WB, 2010, J PLANT GROWTH REGUL, V29, P338, DOI 10.1007/s00344-010-9140-5; Lin YT, 2014, J PLANT PHYSIOL, V171, P1, DOI 10.1016/j.jplph.2013.08.009; Lu P, 2008, J INTEGR PLANT BIOL, V50, P393, DOI 10.1111/j.1744-7909.2007.00583.x; Lux A, 2011, J EXP BOT, V62, P21, DOI 10.1093/jxb/erq281; Matsumoto R, 2009, INT J HYDROGEN ENERG, V34, P9576, DOI 10.1016/j.ijhydene.2009.09.052; Meng DK, 2011, J HAZARD MATER, V186, P1823, DOI 10.1016/j.jhazmat.2010.12.062; Moreno JL, 1999, BIOL FERT SOILS, V28, P230, DOI 10.1007/s003740050487; Nahar K, 2016, ECOTOX ENVIRON SAFE, V126, P245, DOI 10.1016/j.ecoenv.2015.12.026; POLLE A, 1990, PLANT PHYSIOL, V94, P312, DOI 10.1104/pp.94.1.312; RENWICK GM, 1964, PLANT PHYSIOL, V39, P303, DOI 10.1104/pp.39.3.303; Rizwan M, 2018, SCI TOTAL ENVIRON, V631-632, P1175, DOI 10.1016/j.scitotenv.2018.03.104; Srivastava RK, 2014, PROTOPLASMA, V251, P1047, DOI 10.1007/s00709-014-0614-3; Su NN, 2014, J AGR FOOD CHEM, V62, P6454, DOI 10.1021/jf5019593; Sung CH, 2010, PLANT BIOTECHNOL REP, V4, P243, DOI 10.1007/s11816-010-0138-z; TORRES V, 1984, ANN NY ACAD SCI, V434, P296, DOI 10.1111/j.1749-6632.1984.tb29849.x; Wu Q, 2015, J PLANT PHYSIOL, V175, P174, DOI 10.1016/j.jplph.2014.09.017; Xie PP, 2015, ECOTOX ENVIRON SAFE, V122, P392, DOI 10.1016/j.ecoenv.2015.09.007; Xu S, 2013, PLANT SOIL, V370, P47, DOI 10.1007/s11104-013-1614-3; Zeng JQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071038; Zhang H, 2003, ACTA BOT SIN, V45, P901; Zhao XQ, 2017, ECOTOX ENVIRON SAFE, V144, P369, DOI 10.1016/j.ecoenv.2017.06.045; Zhu YC, 2016, PLANT SIGNAL BEHAV, V11, P50; Zhu YC, 2017, THEOR EXP PLANT PHYS, V29, P77, DOI 10.1007/s40626-017-0085-y; Zhu YC, 2016, J PLANT PHYSIOL, V195, P50, DOI 10.1016/j.jplph.2016.02.018	49	14	17	5	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0212639	http://dx.doi.org/10.1371/journal.pone.0212639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785953	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000078
J	Wilson, IBH; Schabussova, I				Wilson, Iain B. H.; Schabussova, Irma			Sweet and CRISP(R)y parasite engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Toxoplasma gondii is an intracellular parasite that is highly prevalent within human populations. Its genome encodes a range of enzymes involved in glycan biosynthesis and metabolism. A new study presents a library of CRISPR/Cas9-based glyco-relevant gene knockouts and their examination in glycomic and functional assays. This new resource can pave the way for a better understanding of the role of carbohydrates in infection and immunomodulation by this significant protozoan parasite.	[Wilson, Iain B. H.] Univ Bodenkultur, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria; [Schabussova, Irma] Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Kinderspitalgasse 15, A-1090 Vienna, Austria	Medical University of Vienna	Wilson, IBH (corresponding author), Univ Bodenkultur, Dept Chem, Muthgasse 18, A-1190 Vienna, Austria.; Schabussova, I (corresponding author), Med Univ Vienna, Inst Specif Prophylaxis & Trop Med, Kinderspitalgasse 15, A-1090 Vienna, Austria.	iain.wilson@boku.ac.at; irma.schabussova@meduniwien.ac.at	Wilson, Iain/B-3326-2009	Wilson, Iain/0000-0001-8996-1518; Schabussova, Irma/0000-0002-2109-2640	Austrian Science Fund [P29466, F4612]	Austrian Science Fund(Austrian Science Fund (FWF))	Research in the authors' laboratories is funded by the Austrian Science Fund (FWF Grants P29466 and F4612). The authors declare that they have no conflicts of interest with the contents of this article.	Bandini G, 2019, J BIOL CHEM, V294, P1967, DOI 10.1074/jbc.RA118.005179; Drinic M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15663-4; Gas-Pascual E, 2019, J BIOL CHEM, V294, P1104, DOI 10.1074/jbc.RA118.006072; Khurana S, 2019, J BIOL CHEM, V294, P1541, DOI 10.1074/jbc.RA118.005357; Matricardi PM, 2000, BMJ-BRIT MED J, V320, P412, DOI 10.1136/bmj.320.7232.412; Rahman K, 2017, J BIOL CHEM, V292, P18644, DOI 10.1074/jbc.M117.809301; Wagner A, 2009, INT J PARASITOL, V39, P465, DOI 10.1016/j.ijpara.2008.09.003	7	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 25	2019	294	4					1126	1127		10.1074/jbc.H118.007210	http://dx.doi.org/10.1074/jbc.H118.007210			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HK4GF	30807998	hybrid, Green Published			2022-12-26	WOS:000457879500005
J	Zhang, ZG; Hunter, L; Wu, G; Maidstone, R; Mizoro, Y; Vonslow, R; Fife, M; Hopwood, T; Begley, N; Saer, B; Wang, P; Cunningham, P; Baxter, M; Durrington, H; Blaikley, JF; Hussell, T; Rattray, M; Hogenesch, JB; Gibbs, J; Ray, DW; Loudon, ASI				Zhang, Zhenguang; Hunter, Louise; Wu, Gang; Maidstone, Robert; Mizoro, Yasutaka; Vonslow, Ryan; Fife, Mark; Hopwood, Thomas; Begley, Nicola; Saer, Ben; Wang, Ping; Cunningham, Peter; Baxter, Matthew; Durrington, Hannah; Blaikley, John F.; Hussell, Tracy; Rattray, Magnus; Hogenesch, John B.; Gibbs, Julie; Ray, David W.; Loudon, Andrew S., I			Genome-wide effect of pulmonary airway epithelial cell-specific Bmal1 deletion	FASEB JOURNAL			English	Article						circadian clock; metabolic entrainment; circadian lung function; influenza infection; food entrainment	CIRCADIAN CLOCK; COMPONENT; INFLAMMATION; METABOLISM; RHYTHMS; INJURY; MICE	Pulmonary airway epithelial cells (AECs) form a critical interface between host and environment. We investigated the role of the circadian clock using mice bearing targeted deletion of the circadian gene brain and muscle ARNT-like 1 (Bmal1) in AECs. Pulmonary neutrophil infiltration, biomechanical function, and responses to influenza infection were all disrupted. A circadian time-series RNA sequencing study of laser-captured AECs revealed widespread disruption in genes of the core circadian clock and output pathways regulating cell metabolism (lipids and xenobiotics), extracellular matrix, and chemokine signaling, but strikingly also the gain of a novel rhythmic transcriptome in Bmal1-targeted cells. Many of the rhythmic components were replicated in primary AECs cultured in air-liquid interface, indicating significant cell autonomy for control of pulmonary circadian physiology. Finally, we found that metabolic cues dictate phasing of the pulmonary clock and circadian responses to immunologic challenges. Thus, the local circadian clock in AECs is vital in lung health by coordinating major cell processes such as metabolism and immunity.Zhang, Z. Hunter, L., Wu, G., Maidstone, R., Mizoro, Y., Vonslow, R., Fife, M., Hopwood, T., Begley, N., Saer, B., Wang, P., Cunningham, P., Baxter, M., Durrington, H., Blaikley, J. F., Hussell, T., Rattray, M., Hogenesch, J. B., Gibbs, J., Ray, D. W., Loudon, A. S. I. Genome-wide effect of pulmonary airway epithelial cell-specific Bmal1 deletion.	[Zhang, Zhenguang; Hunter, Louise; Mizoro, Yasutaka; Vonslow, Ryan; Hopwood, Thomas; Begley, Nicola; Saer, Ben; Cunningham, Peter; Baxter, Matthew; Durrington, Hannah; Blaikley, John F.; Gibbs, Julie; Ray, David W.; Loudon, Andrew S., I] Univ Manchester, Fac Biol Hlth & Med, Ctr Biol Timing, Oxford Rd, Manchester M13 9PT, Lancs, England; [Maidstone, Robert; Wang, Ping; Rattray, Magnus] Univ Manchester, Fac Biol Hlth & Med, Div Informat Imaging & Data Sci, Manchester, Lancs, England; [Fife, Mark; Hussell, Tracy] Univ Manchester, Fac Biol Hlth & Med, Manchester Ctr Collaborat Inflammat Res, Manchester, Lancs, England; [Wu, Gang; Hogenesch, John B.] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Wu, Gang] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Ctr Chronobiol, Div Immunobiol, Cincinnati, OH 45229 USA; [Zhang, Zhenguang] Univ Cambridge, MRC Res Ctr, Dept Oncol, Cambridge, England; [Ray, David W.] Univ Oxford, Radcliffe Dept Med, Oxford, England	University of Manchester; University of Manchester; University of Manchester; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Cambridge; University of Oxford	Ray, DW; Loudon, ASI (corresponding author), Univ Manchester, Fac Biol Hlth & Med, Ctr Biol Timing, Oxford Rd, Manchester M13 9PT, Lancs, England.	david.w.ray@manchester.ac.uk; andrew.loudon@manchester.ac.uk	Maidstone, Robert/GOH-0414-2022; Rattray, Magnus/B-4393-2009; Rattray, Magnus/AAE-3297-2021; Wu, Gang/AAC-8206-2022; Durrington, Hannah/B-4564-2016; Hussell, Tracy/O-4630-2014	Maidstone, Robert/0000-0002-3482-3246; Rattray, Magnus/0000-0001-8196-5565; Rattray, Magnus/0000-0001-8196-5565; Wu, Gang/0000-0002-4526-2034; Durrington, Hannah/0000-0002-9990-9446; Baxter, Matthew/0000-0002-3612-2574; Blaikley, John/0000-0001-7651-5682; Loudon, Andrew/0000-0003-3648-445X; Hussell, Tracy/0000-0001-7186-6141; Hunter, Ann Louise/0000-0002-3874-4852; Mizoro, Yasutaka/0000-0002-5081-4884; Gibbs, Julie/0000-0002-4248-2947; Ray, David/0000-0002-4739-6773	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L000954/1, BB/K003097/1]; U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [2R01NS054794]; Wellcome Trust [107849/Z/15/Z]; BBSRC [BB/L000954/1] Funding Source: UKRI; MRC [MR/L006499/1, MR/M008908/1] Funding Source: UKRI; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054794] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Ian Donaldson and Andy Hayes (Bioinformatics and Genomic Technologies Core Facilities, University of Manchester) for providing support with regard to chromatin immunoprecipitation sequencint (ChIP) and RNA-seq analysis and sequencing, Dr. Halina Dobrzynski and Garry Ashton (University of Manchester) for access to LCM machines, Prof. Colin Bingle's group (University of Sheffield, Sheffield, England) in the training of primary AEC ALI culture, Dr. Emma Rawlins (University of Cambridge, Cambridge, United Kingdom) for communications of the Cre virus transfection method, Dr. Christoph Ballestrem, Rachel Lennon, and Patrick Caswell (all from the University of Manchester) for discussions of epithelial cell biology, the Genomics Center for RNA-seq Service, the Histology Laboratory, and Bioimaging Facility, University of Manchester for tissue section studies, and members of the laboratories of A.S.I.L. and D.W.R. for general discussions. The work is supported by Biotechnology and Biological Sciences Research Council (BBSRC) grants awarded to A.S.I.L. and D.W.R. (BB/L000954/1 and BB/K003097/1). D.W.R. and A.S.I.L. are Wellcome Investigators (Wellcome Trust; 107849/Z/15/Z). J.B.H. is supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke (2R01NS054794 to J.B.H. and A.S.I.L.). The authors declare no conflicts of interest.	Akram KM, 2018, MUCOSAL IMMUNOL, V11, P71, DOI [10.1038/mi.2017.45, 10.1038/mi.2017.109]; Anafi RC, 2017, P NATL ACAD SCI USA, V114, P5312, DOI 10.1073/pnas.1619320114; Atger F, 2015, P NATL ACAD SCI USA, V112, pE6579, DOI 10.1073/pnas.1515308112; Balasooriya GI, 2016, DEV CELL, V37, P85, DOI 10.1016/j.devcel.2016.03.001; Bass J, 2016, SCIENCE, V354, P994, DOI 10.1126/science.aah4965; Bayes HK, 2016, SCI REP-UK, V6, DOI 10.1038/srep35838; Betsuyaku T, 2004, MICRON, V35, P229, DOI 10.1016/j.micron.2003.11.015; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Edgar RS, 2016, P NATL ACAD SCI USA, V113, P10085, DOI 10.1073/pnas.1601895113; Ehlers A, 2018, MUCOSAL IMMUNOL, V11, P97, DOI 10.1038/mi.2017.24; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gregory DJ, 2015, AM J PHYSIOL-LUNG C, V309, pL1041, DOI 10.1152/ajplung.00283.2015; Haspel JA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5753; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Ramkisoensing A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00128; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sato S, 2017, CELL, V170, P664, DOI 10.1016/j.cell.2017.07.042; Sukumaran S, 2011, J APPL PHYSIOL, V110, P1732, DOI 10.1152/japplphysiol.00079.2011; Sundar IK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09927; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Yang ZT, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf3006; You Yingjian, 2013, Methods Mol Biol, V945, P123, DOI 10.1007/978-1-62703-125-7_9; Zhang R, 2016, J BIOL RHYTHM, V31, P244, DOI 10.1177/0748730416631895; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	36	29	29	0	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6226	6238		10.1096/fj.201801682R	http://dx.doi.org/10.1096/fj.201801682R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794439	Green Published, hybrid			2022-12-26	WOS:000466932600034
J	Bajpai, P; Koc, E; Sonpavde, G; Singh, R; Singh, KK				Bajpai, Prachi; Koc, Emine; Sonpavde, Guru; Singh, Rajender; Singh, Keshav K.			Mitochondrial localization, import, and mitochondrial function of the androgen receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						androgen receptor; mitochondria; prostate cancer; cell signaling; gene transcription; genomic signaling; mitochondrial localization sequence; nongenomic signaling; oxidative phosphorylation; retrograde signaling; castration-resistant; nuclear receptor	OXIDATIVE-PHOSPHORYLATION SYSTEM; SPLICE VARIANTS; HORMONE-RECEPTORS; SIGNALING PATHWAY; NUCLEAR IMPORT; TARGET GENES; CELL-GROWTH; ACTIVATION; STRESS; PROGRESSION	Nuclear localization of androgen receptor (AR) directs transcriptional regulation of a host of genes, referred to as genomic signaling. Additionally, nonnuclear or nongenomic activities of the AR have long been described, but understanding of these activities remains elusive. Here, we report that AR is imported into and localizes to mitochondria and has a novel role in regulating multiple mitochondrial processes. Employing complementary experimental approaches of AR knockdown in AR-expressing cells and ectopic AR expression in AR-deficient cells, we demonstrate an inverse relationship between AR expression and mitochondrial DNA (mtDNA) content and transcription factor A, mitochondrial (TFAM), a regulator of mtDNA content. We show that AR localizes to mitochondria in prostate tissues and cell lines and is imported into mitochondria in vitro. We also found that AR contains a 36-amino-acid-long mitochondrial localization sequence (MLS) capable of targeting a passenger protein (GFP) to the mitochondria and that deletion of the MLS abolishes the import of AR into the mitochondria. Ectopic AR expression reduced the expression of oxidative phosphorylation (OXPHOS) subunits. Interestingly, AR also controlled translation of mtDNA-encoded genes by regulating expression of multiple nuclear DNA-encoded mitochondrial ribosomal proteins. Consistent with these observations, OXPHOS supercomplexes were destabilized, and OXPHOS enzymatic activities were reduced in AR-expressing cells and restored upon AR knockdown. Moreover, mitochondrial impairment induced AR expression and increased its translocation into mitochondria. We conclude that AR localizes to mitochondria, where it controls multiple mitochondrial functions and mitonuclear communication. Our studies also suggest that mitochondria are novel players in nongenomic activities of AR.	[Bajpai, Prachi; Singh, Rajender; Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Dept Environm Hlth, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Aging, Birmingham, AL 35294 USA; [Singh, Keshav K.] Univ Alabama Birmingham, UAB Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Koc, Emine] Marshall Univ, Joan C Edwards Sch Med, Dept Biomed Sci, Huntington, WV 25701 USA; [Sonpavde, Guru] Dana Farber Canc Inst, Boston, MA 02215 USA; [Singh, Keshav K.] Vet Affairs Med Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Marshall University; Harvard University; Dana-Farber Cancer Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Singh, KK (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Genet, Kaul Genetics Bldg,Suite 620,720 20th St, Birmingham, AL 35294 USA.	kksingh@uab.edu	Singh, Rajender/ABE-3512-2020	Rajender, Singh/0000-0002-4592-6566	National Institutes of Health [R01 CA204430]; Mike Slive Foundation for Prostate Cancer Research; Indo-US Science and Technology Forum (IUSSTF) [2016/120]; NATIONAL CANCER INSTITUTE [R01CA204430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mike Slive Foundation for Prostate Cancer Research; Indo-US Science and Technology Forum (IUSSTF); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Institutes of Health Grant R01 CA204430 and a grant from the Mike Slive Foundation for Prostate Cancer Research. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Indo-US Science and Technology Forum (IUSSTF) Grant 2016/120.	Arciuch VGA, 2012, ANTIOXID REDOX SIGN, V16, P1150, DOI 10.1089/ars.2011.4085; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Ayyasamy V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024792; Bajpai P, 2014, J BIOL CHEM, V289, P29614, DOI 10.1074/jbc.M114.583062; Barbour Jayne Alexandra, 2014, Int J Cell Biol, V2014, P156020, DOI 10.1155/2014/156020; BHAT NK, 1985, BIOCHEMISTRY-US, V24, P8107, DOI 10.1021/bi00348a041; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Biswas G, 1999, EMBO J, V18, P522, DOI 10.1093/emboj/18.3.522; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Caino MC, 2016, CLIN CANCER RES, V22, P540, DOI 10.1158/1078-0432.CCR-15-0460; Carden T, 2017, J BIOL CHEM, V292, P20694, DOI 10.1074/jbc.M117.797001; Carew Jennifer S, 2002, Mol Cancer, V1, P9, DOI 10.1186/1476-4598-1-9; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Chan Siu Chiu, 2014, Adv Pharmacol, V70, P327, DOI 10.1016/B978-0-12-417197-8.00011-0; Chan SC, 2012, J BIOL CHEM, V287, P19736, DOI 10.1074/jbc.M112.352930; Choudhury AR, 2017, SEMIN CANCER BIOL, V47, P125, DOI 10.1016/j.semcancer.2017.05.001; Cutress ML, 2008, J CELL SCI, V121, P957, DOI 10.1242/jcs.022103; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Dudkina NV, 2008, J BIOENERG BIOMEMBR, V40, P419, DOI 10.1007/s10863-008-9167-5; Efstathiou E, 2015, EUR UROL, V67, P53, DOI 10.1016/j.eururo.2014.05.005; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Fernandez-Vizarra E, 2009, BBA-MOL CELL RES, V1793, P200, DOI 10.1016/j.bbamcr.2008.05.028; GASSER SM, 1982, J BIOL CHEM, V257, P3034; Ghezzi D, 2012, ADV EXP MED BIOL, V748, P65, DOI 10.1007/978-1-4614-3573-0_4; Gottlieb B, 2012, HUM MUTAT, V33, P887, DOI 10.1002/humu.22046; Harbauer AB, 2014, CELL METAB, V19, P357, DOI 10.1016/j.cmet.2014.01.010; Higuchi M, 2006, ONCOGENE, V25, P1437, DOI 10.1038/sj.onc.1209190; Higuchi M, 2002, ANTIOXID REDOX SIGN, V4, P945, DOI 10.1089/152308602762197489; Higuchi M, 2007, MITOCHONDRION, V7, P53, DOI 10.1016/j.mito.2006.12.001; Jagla M, 2007, ENDOCRINOLOGY, V148, P4334, DOI 10.1210/en.2007-0446; Jernberg E, 2017, ENDOCR CONNECT, V6, pR146, DOI 10.1530/EC-17-0118; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Kang D, 2007, MITOCHONDRION, V7, P39, DOI 10.1016/j.mito.2006.11.017; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Koc EC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00183; Koochekpour S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074688; Lamb LE, 2011, CANCER RES, V71, P2739, DOI 10.1158/0008-5472.CAN-10-2745; Leung JK, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00002; Levin ER, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.122; Li J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20984; Liao RS, 2013, TRANSL ANDROL UROL, V2, P187, DOI 10.3978/j.issn.2223-4683.2013.09.07; Lorin T, 2015, G3-GENES GENOM GENET, V5, P2275, DOI 10.1534/g3.115.020685; Modica-Napolitano JS, 2007, CURR MOL MED, V7, P121, DOI 10.2174/156652407779940495; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Morrish F, 2006, MITOCHONDRION, V6, P143, DOI 10.1016/j.mito.2006.04.002; Ni L, 2013, MOL CELL BIOL, V33, P4766, DOI 10.1128/MCB.00647-13; Pelicano H, 2006, J CELL BIOL, V175, P913, DOI 10.1083/jcb.200512100; Psarra AMG, 2008, IUBMB LIFE, V60, P210, DOI 10.1002/iub.37; Rimler A, 2002, NEUROENDOCRINOL LETT, V23, P45; Ritch CR, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4405; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scheller K, 2000, EUR J CELL BIOL, V79, P299, DOI 10.1078/S0171-9335(04)70033-3; Sepuri NBV, 2017, HANDB EXP PHARMACOL, V240, P3, DOI 10.1007/164_2016_3; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Singh B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139846; Singh KK, 2017, SEMIN CANCER BIOL, V47, pIV, DOI 10.1016/j.semcancer.2017.10.013; Singh KK, 2009, J HUM GENET, V54, P516, DOI 10.1038/jhg.2009.71; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Xu J, 2016, ASIAN J UROL, V3, P177, DOI 10.1016/j.ajur.2016.08.003; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yang YJ, 2010, J BIOL CHEM, V285, P7417, DOI 10.1074/jbc.M109.053421; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Zarif JC, 2016, CELL SIGNAL, V28, P348, DOI 10.1016/j.cellsig.2016.01.013; Zarif JC, 2015, ONCOTARGET, V6, P6862, DOI 10.18632/oncotarget.3119; Zhou Y, 2015, J MOL ENDOCRINOL, V54, pR15, DOI 10.1530/JME-14-0203	71	39	39	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6621	6634		10.1074/jbc.RA118.006727	http://dx.doi.org/10.1074/jbc.RA118.006727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792308	Green Published, hybrid			2022-12-26	WOS:000468402000035
J	Conteh, AM; Reissaus, CA; Hernandez-Perez, M; Nakshatri, S; Anderson, RM; Mirmira, RG; Tersey, SA; Linnemann, AK				Conteh, Abass M.; Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.			Platelet-type 12-lipoxygenase deletion provokes a compensatory 12/15-lipoxygenase increase that exacerbates oxidative stress in mouse islet cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lipoxygenase pathway; pancreatic islet; diabetes; reactive oxygen species (ROS); oxidative stress	INFLAMMATION; DYSFUNCTION; INHIBITORS; CHEMISTRY; APOPTOSIS; CYTOKINES; PRODUCTS; PROTECTS; MODEL; MICE	In type 1 diabetes, an autoimmune event increases oxidative stress in islet cells, giving rise to cellular dysfunction and apoptosis. Lipoxygenases are enzymes that catalyze the oxygenation of polyunsaturated fatty acids that can form lipid metabolites involved in several biological functions, including oxidative stress. 12-Lipoxygenase and 12/15-lipoxygenase are related but distinct enzymes that are expressed in pancreatic islets, but their relative contributions to oxidative stress in these regions are still being elucidated. In this study, we used mice with global genetic deletion of the genes encoding 12-lipoxygenase (arachidonate 12-lipoxygenase, 12S type [Alox12]) or 12/15-lipoxygenase (Alox15) to compare the influence of each gene deletion on cell function and survival in response to the cell toxin streptozotocin. Alox12(-/-) mice exhibited greater impairment in glucose tolerance following streptozotocin exposure than WT mice, whereas Alox15(-/-) mice were protected against dysglycemia. These changes were accompanied by evidence of islet oxidative stress in Alox12(-/-) mice and reduced oxidative stress in Alox15(-/-) mice, consistent with alterations in the expression of the antioxidant response enzymes in islets from these mice. Additionally, islets from Alox12(-/-) mice displayed a compensatory increase in Alox15 gene expression, and treatment of these mice with the 12/15-lipoxygenase inhibitor ML-351 rescued the dysglycemic phenotype. Collectively, these results indicate that Alox12 loss activates a compensatory increase in Alox15 that sensitizes mouse cells to oxidative stress.	[Conteh, Abass M.; Mirmira, Raghavendra G.; Linnemann, Amelia K.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Conteh, Abass M.; Anderson, Ryan M.; Mirmira, Raghavendra G.; Linnemann, Amelia K.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA; [Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Reissaus, Christopher A.; Hernandez-Perez, Marimar; Nakshatri, Swetha; Anderson, Ryan M.; Mirmira, Raghavendra G.; Tersey, Sarah A.; Linnemann, Amelia K.] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Tersey, SA (corresponding author), 1044 W Walnut St,R4-325, Indianapolis, IN 46202 USA.; Linnemann, AK (corresponding author), 635 Barnhill Dr,MS2031, Indianapolis, IN 46202 USA.	stersey@iu.edu; aklinnem@iu.edu	Mirmira, Raghavendra G/AAD-7592-2020	Mirmira, Raghavendra G/0000-0002-5013-6075; Nakshatri, Swetha/0000-0002-7627-1953; Linnemann, Amelia/0000-0001-7356-4876	NIDDK, National Institutes of Health [R01 DK105588, P30 DK097512, K01 DK102492, R03 DK115990]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK115990, P30DK097512, R01DK105588, K01DK102492, R01DK060581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM077229] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIDDK, National Institutes of Health Grants R01 DK105588 and P30 DK097512 (to R. G. M.) and K01 DK102492 and R03 DK115990 (to A. K. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackermann JA, 2017, BBA-MOL CELL BIOL L, V1862, P371, DOI 10.1016/j.bbalip.2016.07.014; Al Nahdi AMT, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7054272; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bleich D, 1999, J CLIN INVEST, V103, P1431, DOI 10.1172/JCI5241; Cabrera SM, 2013, CLIN EXP IMMUNOL, V172, P375, DOI 10.1111/cei.12068; Delmastro MM, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/593863; Eleazu CO, 2013, J DIABETES METAB DIS, V12, DOI 10.1186/2251-6581-12-60; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Guo YD, 2011, J BIOL CHEM, V286, P33832, DOI 10.1074/jbc.M110.216564; Hernandez-Perez M, 2017, DIABETES, V66, P2875, DOI 10.2337/db17-0215; Hu CY, 2018, MEDCHEMCOMM, V9, P212, DOI 10.1039/c7md00390k; Ikei KN, 2012, J LIPID RES, V53, P2546, DOI 10.1194/jlr.M026385; Johnson EN, 1999, J INVEST DERMATOL, V112, P861, DOI 10.1046/j.1523-1747.1999.00595.x; JOHNSON MB, 1993, DIABETES, V42, P1179, DOI 10.2337/diabetes.42.8.1179; KUBISCH HM, 1994, P NATL ACAD SCI USA, V91, P9956, DOI 10.1073/pnas.91.21.9956; Kuhn H, 2006, PROG LIPID RES, V45, P334, DOI 10.1016/j.plipres.2006.02.003; Kuhn H, 2015, BBA-MOL CELL BIOL L, V1851, P308, DOI 10.1016/j.bbalip.2014.10.002; Lei XY, 2014, ENDOCRINOLOGY, V155, P3352, DOI 10.1210/en.2013-2134; Lenzen S, 2017, BBA-GEN SUBJECTS, V1861, P1929, DOI 10.1016/j.bbagen.2017.05.013; Lismont C, 2017, METHODS MOL BIOL, V1595, P151, DOI 10.1007/978-1-4939-6937-1_14; Lukic M L, 1998, Dev Immunol, V6, P119, DOI 10.1155/1998/92198; Ma K, 2010, J CLIN ENDOCR METAB, V95, P887, DOI 10.1210/jc.2009-1102; Maier B, 2010, J CLIN INVEST, V120, P2156, DOI 10.1172/JCI38924; Marasco MR, 2018, DIABETES, V67, P1576, DOI 10.2337/db17-1280; Mashima R, 2015, REDOX BIOL, V6, P297, DOI 10.1016/j.redox.2015.08.006; McDuffie M, 2008, DIABETES, V57, P199, DOI 10.2337/db07-0830; Miki A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196570; Muller A, 2017, FREE RADICAL BIO MED, V106, P329, DOI 10.1016/j.freeradbiomed.2017.02.044; Neuman JC, 2017, DIABETES, V66, P1572, DOI 10.2337/db16-1362; Newcomer ME, 2015, PROTEIN SCI, V24, P298, DOI 10.1002/pro.2626; Neyestani TR, 2012, EUR J CLIN NUTR, V66, P1054, DOI 10.1038/ejcn.2012.81; Nunemaker CS, 2008, AM J PHYSIOL-ENDOC M, V295, pE1065, DOI 10.1152/ajpendo.90371.2008; Prasad KMR, 2003, BIOCHEM BIOPH RES CO, V308, P427, DOI 10.1016/S0006-291X(03)01418-9; Redondo MJ, 2008, NEW ENGL J MED, V359, P2849, DOI 10.1056/NEJMc0805398; Stull ND, 2012, JOVE-J VIS EXP, DOI 10.3791/4137; Subramanian S., 2000, ENDOTEXT; Tersey SA, 2015, MOL ENDOCRINOL, V29, P791, DOI 10.1210/me.2015-1041; Tersey SA, 2014, MOL CELL BIOL, V34, P3735, DOI 10.1128/MCB.00157-14; Ward DT, 2001, J AM SOC NEPHROL, V12, P779, DOI 10.1681/ASN.V124779; Weaver JR, 2012, MOL CELL ENDOCRINOL, V358, P88, DOI 10.1016/j.mce.2012.03.004; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Yagishita Y, 2014, DIABETES, V63, P605, DOI 10.2337/db13-0909; Zarkovic K, 2017, FREE RADICAL BIO MED, V111, P110, DOI 10.1016/j.freeradbiomed.2016.12.009; Zhang XJ, 2018, NAT MED, V24, P73, DOI 10.1038/nm.4451; Zhou YP, 1998, J CLIN INVEST, V101, P1623, DOI 10.1172/JCI1245	45	14	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6612	6620		10.1074/jbc.RA118.007102	http://dx.doi.org/10.1074/jbc.RA118.007102			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792307	hybrid, Green Published			2022-12-26	WOS:000468402000034
J	Choo, HC; Peiffer, JJ; Lopes-Silva, JP; Mesquita, RNO; Amano, T; Kondo, N; Abbiss, CR				Choo, Hui C.; Peiffer, Jeremiah J.; Lopes-Silva, Joao P.; Mesquita, Ricardo N. O.; Amano, Tatsuro; Kondo, Narihiko; Abbiss, Chris R.			Effect of ice slushy ingestion and cold water immersion on thermoregulatory behavior	PLOS ONE			English	Article							EXERCISE INTENSITY; SKIN TEMPERATURE; BLOOD-VOLUME; HEAT-STRESS; MUSCLE; PERFORMANCE; RESPONSES; EXHAUSTION; REST; TIME	Two studies were conducted to examine the effects of ice slushy ingestion (ICE) and cold water immersion (CWI) on thermoregulatory and sweat responses during constant (study 1) and self-paced (study 2) exercise. In study 1, 11 men cycled at 40-50% of peak aerobic power for 60 min (33.2 +/- 0.3 degrees C, 45.9 +/- 0.5% relative humidity, RH). In study 2, 11 men cycled for 60 min at perceived exertion (RPE) equivalent to 15 (33.9 +/- 0.2 degrees C and 42.5 +/- 3.9% RH). In both studies, each trial was preceded by 30 min of CWI (similar to 22 degrees C), ICE or no cooling (CON). Rectal temperature (T-re), skin temperature (T-sk), thermal sensation, and sweat responses were measured. In study 1, ICE decreased T-re-T-sk gradient versus CON (p = 0.005) during first 5 min of exercise, while CWI increased T-re-T-sk gradient versus CON and ICE for up to 20 min during the exercise (p<0.05). In study 2, thermal sensation was lower in CWI versus CON and ICE for up to 35-40 min during the exercise (p<0.05). ICE reduced thermal sensation versus CON during the first 20 min of exercise (p<0.05). In study 2, CWI improved mean power output (MPO) by similar to 8 W, compared with CON only (p = 0.024). In both studies, CWI (p<0.001) and ICE (p = 0.019) delayed sweating by 1-5 min but did not change the body temperature sweating threshold, compared with CON (both p>0.05). Increased T-re-T-sk gradient by CWI improved MPO while ICE reduced T-re but did not confer any ergogenic effect. Both precooling treatments attenuated the thermal efferent signals until a specific body temperature threshold was reached.	[Choo, Hui C.; Mesquita, Ricardo N. O.; Abbiss, Chris R.] Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sports Sci Res, Joondalup, WA, Australia; [Peiffer, Jeremiah J.] Murdoch Univ, Sch Psychol & Exercise Sci, Murdoch, WA, Australia; [Lopes-Silva, Joao P.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil; [Amano, Tatsuro] Niigata Univ, Fac Educ, Niigata, Niigata, Japan; [Kondo, Narihiko] Kobe Univ, Lab Appl Human Physiol, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan	Edith Cowan University; Murdoch University; Universidade de Sao Paulo; Niigata University; Kobe University	Choo, HC (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Ctr Exercise & Sports Sci Res, Joondalup, WA, Australia.	hchoo0@our.ecu.edu.au	Mesquita, Ricardo/AAU-1170-2020; Silva, João Paulo/L-4396-2017	Mesquita, Ricardo/0000-0002-0327-3253; Silva, João Paulo/0000-0002-2033-365X; Abbiss, Chris/0000-0003-3940-5542; Peiffer, Jeremiah/0000-0002-3331-1177	School of Medical and Health Sciences, Edith Cowan University; International Postgraduate Research Scholarship; Edith Cowan University; CAPES Scholarship [88881.132395/2016-01]	School of Medical and Health Sciences, Edith Cowan University; International Postgraduate Research Scholarship(Australian Government); Edith Cowan University; CAPES Scholarship(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was funded by the School of Medical and Health Sciences, Edith Cowan University. At the time of the study was conducted, HCC and RNOM were supported by the International Postgraduate Research Scholarship and Edith Cowan University. Joao Lopes-Silva (88881.132395/2016-01) was supported by CAPES Scholarship. The other authors have no support or funding to report.	Bongers Coen C W G, 2017, Temperature (Austin), V4, P60, DOI 10.1080/23328940.2016.1277003; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Cheuvront SN, 2009, J APPL PHYSIOL, V107, P69, DOI 10.1152/japplphysiol.00250.2009; Choo H. C., 2016, CLIN PHYSIOL FUNCT I, V38, P46, DOI [10.1111/cpf, DOI 10.1111/CPF]; Choo HC, 2018, EUR J SPORT SCI, V18, P170, DOI 10.1080/17461391.2017.1405077; Choo HC, 2017, J SPORT SCI, V35, P1715, DOI 10.1080/02640414.2016.1235790; COLIN J, 1971, J APPL PHYSIOL, V31, P484, DOI 10.1152/jappl.1971.31.3.484; Cuddy JS, 2014, J THERM BIOL, V43, P7, DOI 10.1016/j.jtherbio.2014.04.002; Flood TR, 2017, EUR J APPL PHYSIOL, V117, P1501, DOI 10.1007/s00421-017-3645-6; Flouris AD, 2009, BRIT J SPORT MED, V43, P199, DOI 10.1136/bjsm.2007.044552; Fujii N, 2015, J PHYSIOL-LONDON, V593, P2515, DOI 10.1113/JP270147; Gagnon D, 2011, J PHYSIOL-LONDON, V589, P6205, DOI 10.1113/jphysiol.2011.219220; Heinonen I, 2011, J APPL PHYSIOL, V111, P818, DOI 10.1152/japplphysiol.00269.2011; Ihsan M, 2013, MED SCI SPORT EXER, V45, P876, DOI 10.1249/MSS.0b013e31827e13a2; Jay O, 2018, SPORTS MED, P1; Kenefick RW, 2012, AM J PHYSIOL-REG I, V302, pR252, DOI 10.1152/ajpregu.00456.2011; KUIPERS H, 1985, INT J SPORTS MED, V6, P197, DOI 10.1055/s-2008-1025839; Lander PJ, 2009, BRIT J SPORT MED, V43, P789, DOI 10.1136/bjsm.2008.056085; Messere A, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.179; Morris NB, 2016, MED SCI SPORT EXER, V48, P114, DOI 10.1249/MSS.0000000000000746; Morris NB, 2014, J APPL PHYSIOL, V116, P1088, DOI 10.1152/japplphysiol.01059.2013; Morrison SA, 2014, J ATHL TRAINING, V49, P632, DOI 10.4085/1062-6050-49.3.27; OLSCHEWSKI H, 1988, J APPL PHYSIOL, V64, P803, DOI 10.1152/jappl.1988.64.2.803; Pearson J, 2011, AM J PHYSIOL-REG I, V300, pR663, DOI 10.1152/ajpregu.00662.2010; Periard JD, 2013, EUR J APPL PHYSIOL, V113, P211, DOI 10.1007/s00421-012-2427-4; Periard JD, 2011, EXP PHYSIOL, V96, P134, DOI 10.1113/expphysiol.2010.054213; Proulx CI, 2006, EUR J APPL PHYSIOL, V96, P434, DOI 10.1007/s00421-005-0063-y; RAMANATHAN NL, 1964, J APPL PHYSIOL, V19, P531, DOI 10.1152/jappl.1964.19.3.531; Sawka MN, 2012, EXP PHYSIOL, V97, P327, DOI [10.1113/expphysiol.2011.061026, 10.1113/expphysiol.2011.061002]; Schlader ZJ, 2011, PHYSIOL BEHAV, V103, P217, DOI 10.1016/j.physbeh.2011.02.002; Schlader ZJ, 2011, EUR J APPL PHYSIOL, V111, P1631, DOI 10.1007/s00421-010-1791-1; Schlader ZJ, 2010, PHYSIOL BEHAV, V99, P269, DOI 10.1016/j.physbeh.2009.12.003; Shibasaki Manabu, 2010, Front Biosci (Schol Ed), V2, P685; Siegel R, 2012, SPORTS MED, V42, P89, DOI 10.2165/11596870-000000000-00000; Siegel R, 2012, J SPORT SCI, V30, P155, DOI 10.1080/02640414.2011.625968; Stanley J, 2014, EUR J APPL PHYSIOL, V114, P147, DOI 10.1007/s00421-013-2755-z; Taylor NAS, 2006, IND HEALTH, V44, P331, DOI 10.2486/indhealth.44.331; Tew GA, 2011, MICROVASC RES, V81, P177, DOI 10.1016/j.mvr.2010.12.001; Tew GA, 2010, EUR J APPL PHYSIOL, V110, P1083, DOI 10.1007/s00421-010-1596-2; Tucker R, 2006, J PHYSIOL-LONDON, V574, P905, DOI 10.1113/jphysiol.2005.101733; Wegmann M, 2012, SPORTS MED, V42, P545, DOI 10.2165/11630550-000000000-00000; Wilson TE, 2002, EUR J APPL PHYSIOL, V88, P67, DOI 10.1007/s00421-002-0696-z; YOUNG AJ, 1987, J APPL PHYSIOL, V63, P1218, DOI 10.1152/jappl.1987.63.3.1218; Zimmermann M, 2017, INT J SPORT NUTR EXE, V27, P220, DOI [10.1123/ijsnem.2016-0028, 10.1123/ijsnem.2015-0215, 10.1123/ijsnem.2016-0215]	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212966	10.1371/journal.pone.0212966	http://dx.doi.org/10.1371/journal.pone.0212966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811512	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400100
J	Samonds, KE; Andrianavalona, TH; Wallett, LA; Zalmout, IS; Ward, DJ				Samonds, Karen E.; Andrianavalona, Tsiory H.; Wallett, Lane A.; Zalmout, Iyad S.; Ward, David J.			A middle - late Eocene neoselachian assemblage from nearshore marine deposits, Mahajanga Basin, northwestern Madagascar	PLOS ONE			English	Article							SELACHIAN FAUNA; SCYLIORHINIDAE; CHONDRICHTHYES; MOROCCO; FISHES; AGE	We report here the first neoselachian fossil fauna from Eocene nearshore marine deposits of the Mahajanga Basin, northwestern Madagascar. The fauna includes seven species of shark: Nebrius blankenhorni, Brachycarcharias koerti, Galeocerdo eaglesomei, two species of Carcharhinus (one of which is described as a new species), Physogaleus, Rhizoprionodon and Sphyrna. Three species of rays were also recovered: Pristis, Myliobatis and an undetermined dasyatid ray. This fauna represents the first Cenozoic neoselachian fossil record from the Eocene of Madagascar and broadens our understanding of their evolutionary and biogeographic history in the southern hemisphere during this time. Although the diversity of the genera and species of the fauna is very low, the age and similarity of genera to those in Congo, west Africa, Arabia, Asia, Europe, and North, Central, and South America suggests that these genera were broadly distributed and diverse within the shallow marine settings of the Tethyan and southern provinces during middle and late Eocene.	[Samonds, Karen E.] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA; [Andrianavalona, Tsiory H.] Univ Antananarivo, Domaine Sci & Technol, Ment Bassins Sedimentaires Evolut Conservat, Antananarivo, Madagascar; [Wallett, Lane A.] Washington State Univ, Coll Vet Med, Dept Integrat Physiol & Neurosci, Pullman, WA 99164 USA; [Zalmout, Iyad S.] Saudi Geol Survey, Dept Paleontol, Jeddah, Saudi Arabia; [Ward, David J.] Nat Hist Museum, Dept Earth Sci, London, England	Northern Illinois University; University Antananarivo; Washington State University; Saudi Geological Survey; Natural History Museum London	Samonds, KE (corresponding author), Northern Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA.	ksamonds@niu.edu	Samonds, Karen/AAL-1766-2021	ZALMOUT, IYAD/0000-0003-1874-801X; Samonds, Karen/0000-0003-3597-9215	National Geographic Research and Exploration Grant [9662-15, 8667-09, 8125-06, 7687-04]	National Geographic Research and Exploration Grant(National Geographic Society)	Funded by National Geographic Research and Exploration Grant (Karen Samonds) Standard Grants (#9662-15, #8667-09, #8125-06, #7687-04); https://www.nationalgeographic.org/topics/exploration/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adnet S, 2007, J ASIAN EARTH SCI, V30, P303, DOI 10.1016/j.jseaes.2006.10.002; Adnet S, 2010, GEOL MAG, V147, P860, DOI 10.1017/S0016756810000348; Andrianavalona TH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129444; Arambourg C., 1952, NOTES ME MOIRES SERV, V92, P1; Besairie H, 1956, CARTOGRAPHER CARTE G; Besairie H, 1972, GEOLOGIE MADAGASCAR; Besairie H, 1969, CARTOGRAPHER CARTE G; CAPPETTA H, 1988, GEOBIOS-LYON, V21, P359, DOI 10.1016/S0016-6995(88)80058-5; Cappetta H., 2012, MESOZOIC CENOZOIC EL; Cappetta H., 2006, ELASMOBRANCHII POSTT; Cappetta Henri, 2005, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V75, P237; Cappetta H, 2016, PALAEONTOGR ABT A, V307, P43; Case G, 2000, MUNCHNER GEOWISS ABH, V39, P7; CASE G R, 1990, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V212, P1; CASE G R, 1981, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V176, P52; Case Gerard R., 1994, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V230, P97; Casier E., 1971, SCI TERRE, V47, P1; Casier E., 1946, MEM MUS HIST NAT BEL, V104, P3; Chandler R., 2015, FOSSILS N CAROLINA N; Cicimurri DJ, 2007, J PALEONTOL, V81, P597, DOI 10.1666/05086.1; CIONE AL, 1994, P GEOLOGIST ASSOC, V105, P1, DOI 10.1016/S0016-7878(08)80134-4; COLLIGNON M., 1927, ANN PALEONTOL, V16, P135; Compagno L.J.V., 1988, SHARKS ORDER CARCHAR; Crottini A, 2012, P NATL ACAD SCI USA, V109, P5358, DOI 10.1073/pnas.1112487109; Dartevelle E., 1943, ANN MUSEE CONGO BE A, V2, P1; Gheerbrant E, 2003, B SOC GEOL FR, V174, P279, DOI 10.2113/174.3.279; Gottfried MD, 2001, CRETACEOUS RES, V22, P491, DOI 10.1006/cres.2001.0269; Gottfried MD, 1998, J VERTEBR PALEONTOL, V18, P275, DOI 10.1080/02724634.1998.10011056; Gottfried MD, 1998, J AFR EARTH SCI, V27, P91; Gottfried MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176553; Human BA, 2006, MOL PHYLOGENET EVOL, V39, P384, DOI 10.1016/j.ympev.2005.09.009; Krause DW, 2006, ANN MO BOT GARD, V93, P178, DOI 10.3417/0026-6493(2006)93[178:LCTVFM]2.0.CO;2; Kriwet J, 2005, J VERTEBR PALEONTOL, V25, P1, DOI 10.1671/0272-4634(2005)025[0001:ATTESF]2.0.CO;2; Kumar K, 2007, CURR SCI INDIA, V93, P553; Landemaine O., 1991, SOC AMICALE GEOLOGUE, V1, P1; Leriche M., 1905, MEMOIRES MUSEE ROYAL, V33, P49; Leriche M., 1902, MEMOIRES MUSEE ROYAL, V22, P1; Long D.J., 1992, Journal of Vertebrate Paleontology, V12, P11; Mollen FH, 2008, GEOL BELG, V11, P123; Mustafa Hakam, 2002, Tertiary Research, V21, P77; Noubhani A, 1997, SYSTEMATIQUE BIOSTRA; Parmley Dennis, 2003, Georgia Journal of Science, V61, P153; Poux C, 2005, SYST BIOL, V54, P719, DOI 10.1080/10635150500234534; Raxworthy C.J., 2003, P934; Reinecke T., 2001, Palaeontos, V1, P1; Reinecke Thomas, 2011, Palaeontos, V20, P1; Samonds KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062086; Samonds KE, 2012, P NATL ACAD SCI USA, V109, P5352, DOI 10.1073/pnas.1113993109; Samonds KE, 2009, J VERTEBR PALEONTOL, V29, P1233, DOI 10.1671/039.029.0417; Siversson M, 2015, ACTA PALAEONTOL POL, V60, P339, DOI 10.4202/app.2012.0137; Stromer E., 1903, Neues Jahrbuch fuer Mineralogie, Vi, P29; Stromer E., 1910, Z DTSCH GEOLOGISCHEN, V62, P478; STROUGO A., 2007, EARTH SCI SERIES, V21, P81; Timmerman J, 1995, CRETACEOUS PALEOGENE; Underwood Charlie J., 2012, Caribbean Journal of Earth Science, V44, P25; Underwood CJ, 2011, P GEOLOGIST ASSOC, V122, P47, DOI 10.1016/j.pgeola.2010.09.004; Voigt M., 2011, FIELD GUIDE SHARKS G; Ward, 1990, ILLUSTRATED GUIDE BR; Ward D.J., 1990, TERTIARY RES, V12, P81; Ward DJ, 1980, TERTIARY RES, V3, P1; Westgate J.W., 1989, Journal of Vertebrate Paleontology, V9, P282; White E. I., 1955, Col Geol Min Res, V5, P319; White EI, 1926, B GEOLOGICAL SURVEY, V10, P7; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 2006, ANNU REV ECOL EVOL S, V37, P405, DOI 10.1146/annurev.ecolsys.37.091305.110239; Zalmout Iyad S., 2012, Museum of Paleontology Papers on Paleontology, V37, P1	66	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211789	10.1371/journal.pone.0211789	http://dx.doi.org/10.1371/journal.pone.0211789			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811516	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400034
J	Feng, LY; Raza, MA; Chen, YK; Bin Khalid, MH; Meraj, TA; Ahsan, F; Fan, YF; Du, JB; Wu, XL; Song, C; Liu, CY; Bawa, G; Zhang, ZW; Yuan, S; Yang, F; Yang, WY				Feng, Lingyang; Raza, Muhammad Ali; Chen, Yuankai; Bin Khalid, Muhammad Hayder; Meraj, Tehseen Ahmad; Ahsan, Faiza; Fan, Yuanfang; Du, Junbo; Wu, Xiaoling; Song, Chun; Liu, Chuanyan; Bawa, George; Zhang, Zhongwei; Yuan, Shu; Yang, Feng; Yang, Wenyu			Narrow-wide row planting pattern improves the light environment and seed yields of intercrop species in relay intercropping system	PLOS ONE			English	Article							PHOTON FLUX-DENSITY; MAIZE; GROWTH; SHADE; WHEAT; PHOTOSYNTHESIS; FIELD; LEAF; PRODUCTIVITY; COMPETITION	Different planting patterns affect the light interception of intercrops under intercropping conditions. Here we revealed that narrow-wide-row relay-intercropping improves the light interception across maize leaves in wide rows (60cm) and narrow rows (40cm), accelerated the biomass production of intercrop-species and compensated the slight maize yield loss by considerably increasing the soybean yield. In a two-year experiment, maize was planted with soybean in different planting patterns (1M1S, 50: 50cm and 2M2S, 40: 60cm) of relay-intercropping, both planting patterns were compared with sole cropping of maize (M) and soybean (S). As compared to M and 1M1S, 2M2S increased the total light interception of maize leaves in wide rows (WR) by 27% and 23%, 20% and 10%, 16% and 9% which in turn significantly enhanced the photosynthetic rate of WR maize leaves by 7% and 5%, 12% and 9%, and 19% and 4%, at tasseling, grain-filling and maturity stage of maize, respectively. Similarly, the light transmittance at soybean canopy increased by 218%, 160% and 172% at V-2, V-5 and R-1 stage in 2M2S compared with 1M1S. The improved light environment at soy-bean canopy in 2M2S considerably enhanced the mean biomass accumulation, and allocation to stem and leaves of soybean by 168%, and 131% and 207%, respectively, while it decreased the mean biomass accumulation, and distribution to stem, leaves and seed of maize by 4%, and 4%, 6% and 5%, respectively than 1M1S. Compared to 1M1S, 2M2S also increased the CR values of soybean (by 157%) but decreased the CR values of maize (by 61%). Overall, under 2M2S, relay-cropped maize and soybean produced 94% and 69% of the sole cropping yield, and the 2M2S achieved LER of 1.7 with net income of 1387.7 US $ha(-1) in 2016 and 1434.4 US $ha(-1) in 2017. Our findings implied that selection of optimum planting pattern (2M2S) may increase the light interception and influence the light distribution between maize and soybean rows under relay-intercropping conditions which will significantly increase the intercrops productivity. Therefore, more attention should be paid to the light environment when considering the sustainability of maize-soybean relay-intercropping via appropriate planting pattern selection.	[Feng, Lingyang; Raza, Muhammad Ali; Chen, Yuankai; Bin Khalid, Muhammad Hayder; Meraj, Tehseen Ahmad; Fan, Yuanfang; Du, Junbo; Wu, Xiaoling; Song, Chun; Liu, Chuanyan; Bawa, George; Yang, Feng; Yang, Wenyu] Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China; [Feng, Lingyang; Raza, Muhammad Ali; Chen, Yuankai; Fan, Yuanfang; Du, Junbo; Wu, Xiaoling; Song, Chun; Liu, Chuanyan; Bawa, George; Yang, Feng; Yang, Wenyu] Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Sichuan, Peoples R China; [Bin Khalid, Muhammad Hayder] Sichuan Agr Univ, Maize Res Inst, Chengdu, Sichuan, Peoples R China; [Ahsan, Faiza; Zhang, Zhongwei; Yuan, Shu] Sichuan Agr Univ, Coll Resources, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Ministry of Agriculture & Rural Affairs; Sichuan Agricultural University; Sichuan Agricultural University	Yang, F; Yang, WY (corresponding author), Sichuan Agr Univ, Coll Agron, Chengdu, Sichuan, Peoples R China.; Yang, F; Yang, WY (corresponding author), Minist Agr, Key Lab Crop Ecophysiol & Farming Syst Southwest, Chengdu, Sichuan, Peoples R China.	f.yang@sicau.edu.cn; mssiyangwy@sicau.edu.cn	feng, lingyang/AGG-7869-2022; Khalid, Muhammad Hayder Bin Khalid/ABF-3145-2020; Bin Khalid, Muhammad Hayder/ABE-6696-2020; Raza, Muhammad Ali/R-8597-2019; Song, Chun/B-8298-2019	Khalid, Muhammad Hayder Bin Khalid/0000-0003-0934-2093; Raza, Muhammad Ali/0000-0003-3817-6848; Song, Chun/0000-0001-9927-2599	National Key Research and Development Program of China [2016YFD0300602, 2016YFD0300209]; National Nature Science Foundation [31571615]; Program on Industrial Technology System of National Soybean [CARS-04-PS19]	National Key Research and Development Program of China; National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Program on Industrial Technology System of National Soybean	This work was funded by the National Key Research and Development Program of China (2016YFD0300602, 2016YFD0300209 to WY), the National Nature Science Foundation (31571615 to WY), and Program on Industrial Technology System of National Soybean (CARS-04-PS19 to WY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banik P, 2000, J AGRON CROP SCI, V185, P9, DOI 10.1046/j.1439-037X.2000.00388.x; Blumenberg M, 2013, BIOGEOSCIENCES, V10, P2725, DOI 10.5194/bg-10-2725-2013; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Chen P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184503; Chirko CP, 1996, FOREST ECOL MANAG, V83, P171, DOI 10.1016/0378-1127(96)03721-8; Fan YF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198159; Feng LY, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01952; FRANCIS CA, 1969, CROP SCI, V9, P537, DOI 10.2135/cropsci1969.0011183X000900050005x; Ghosh PK, 2004, FIELD CROP RES, V88, P227, DOI 10.1016/j.fcr.2004.01.015; Gou F, 2016, EUR J AGRON, V76, P17, DOI 10.1016/j.eja.2016.01.005; Iqbal N, 2019, PLANT PROD SCI, V22, P131, DOI 10.1080/1343943X.2018.1541137; Jiang CD, 2011, PLANT PHYSIOL, V155, P1416, DOI 10.1104/pp.111.172213; Ju XT, 2006, ENVIRON POLLUT, V143, P117, DOI 10.1016/j.envpol.2005.11.005; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kawamura K, 2005, J FOREST RES-JPN, V10, P247, DOI 10.1007/s10310-004-0141-8; KEATING BA, 1993, FIELD CROP RES, V34, P273, DOI 10.1016/0378-4290(93)90118-7; Kurepin LV, 2007, PLANT CELL ENVIRON, V30, P147, DOI 10.1111/j.1365-3040.2006.01612.x; Li FD, 2008, AGROFOREST SYST, V74, P163, DOI 10.1007/s10457-008-9122-9; Li L, 1999, PLANT SOIL, V212, P105, DOI 10.1023/A:1004656205144; Li Rui, 2014, Acta Prataculturae Sinica, V23, P198; Li T, 2014, J PHOTOCH PHOTOBIO B, V137, P31, DOI 10.1016/j.jphotobiol.2014.04.022; Lithourgidis AS, 2011, EUR J AGRON, V34, P287, DOI 10.1016/j.eja.2011.02.007; Liu J, 2016, FOOD CHEM, V207, P107, DOI 10.1016/j.foodchem.2016.03.059; Liu WG, 2016, FIELD CROP RES, V196, P261, DOI 10.1016/j.fcr.2016.07.008; Liu WG, 2015, PLANT PROD SCI, V18, P69, DOI 10.1626/pps.18.69; Liu X, 2018, FIELD CROP RES, V224, P91, DOI 10.1016/j.fcr.2018.05.010; Liu X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169218; Liu X, 2017, FIELD CROP RES, V200, P38, DOI 10.1016/j.fcr.2016.10.003; Marchiori PER, 2014, FIELD CROP RES, V155, P30, DOI 10.1016/j.fcr.2013.09.025; MIDMORE DJ, 1988, FIELD CROP RES, V18, P159, DOI 10.1016/0378-4290(88)90006-8; Monzon JP, 2014, FIELD CROP RES, V162, P48, DOI 10.1016/j.fcr.2014.03.012; Morelli G, 2002, TRENDS PLANT SCI, V7, P399, DOI 10.1016/S1360-1385(02)02314-2; Nagasuga K, 2008, PLANT PROD SCI, V11, P352, DOI 10.1626/pps.11.352; Omoto E, 2012, J PLANT PHYSIOL, V169, P469, DOI 10.1016/j.jplph.2011.11.009; Oseni T. O., 2010, Journal of Agricultural Science (Toronto), V2, P229; Porcel R, 2015, J PLANT PHYSIOL, V185, P75, DOI 10.1016/j.jplph.2015.07.006; Raza MA, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8080149; Raza MA, 2018, FIELD CROP RES, V218, P51, DOI 10.1016/j.fcr.2017.12.024; Ruberti I, 2012, BIOTECHNOL ADV, V30, P1047, DOI 10.1016/j.biotechadv.2011.08.014; Wang ZK, 2015, AGR FOREST METEOROL, V204, P58, DOI 10.1016/j.agrformet.2015.02.004; WARDLAW IF, 1990, NEW PHYTOL, V116, P341, DOI 10.1111/j.1469-8137.1990.tb00524.x; Wittmann C, 2001, BASIC APPL ECOL, V2, P145, DOI 10.1078/1439-1791-00047; WOLFF XY, 1990, J AM SOC HORTIC SCI, V115, P175, DOI 10.21273/JASHS.115.1.175; Wu YS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10026-5; Xue J, 2017, J INTEGR AGR, V16, P85, DOI [10.1016/S2095-3119(16)61394-1, 10.1016/s2095-3119(16)61394-1]; Yang F, 2017, FIELD CROP RES, V203, P16, DOI 10.1016/j.fcr.2016.12.007; Yang Feng, 2015, Acta Agronomica Sinica, V41, P642; Yang F, 2015, AGRON J, V107, P296, DOI 10.2134/agronj14.0263; Yang F, 2014, FIELD CROP RES, V155, P245, DOI 10.1016/j.fcr.2013.08.011; Zhang FS, 2003, PLANT SOIL, V248, P305, DOI 10.1023/A:1022352229863; Zhang YT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129245; Zhang YY, 2012, J ENVIRON SCI, V24, P160, DOI 10.1016/S1001-0742(10)60594-3	52	40	47	9	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212885	10.1371/journal.pone.0212885	http://dx.doi.org/10.1371/journal.pone.0212885			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807607	Green Submitted, Green Published, gold			2022-12-26	WOS:000459712100027
J	Swaminathan, S; Das, A; Assefa, T; Knight, JM; Da Silva, AF; Carvalho, JPS; Hartman, GL; Huang, XQ; Leandro, LF; Cianzio, SR; Bhattacharyya, MK				Swaminathan, Sivakumar; Das, Anindya; Assefa, Teshale; Knight, Joshua M.; Da Silva, Amilton Ferreira; Carvalho, Joao P. S.; Hartman, Glen L.; Huang, Xiaoqiu; Leandro, Leonor F.; Cianzio, Silvia R.; Bhattacharyya, Madan K.			Genome wide association study identifies novel single nucleotide polymorphic loci and candidate genes involved in soybean sudden death syndrome resistance	PLOS ONE			English	Article							F-SP GLYCINES; FUSARIUM-SOLANI; FIELD-RESISTANCE; UNDERLIE RESISTANCE; DISEASE RESISTANCE; SYNDROME PATHOGEN; SP. GLYCINES; VIRGULIFORME; PROTEINS; PHYTOTOXICITY	Fusarium virguliforme is a soil borne root pathogen that causes sudden death syndrome (SDS) in soybean [Glycine max (L.) Merrill]. Once the fungus invades the root xylem tissues, the pathogen secretes toxins that cause chlorosis and necrosis in foliar tissues leading to defoliation, flower and pod drop and eventually death of plants. Resistance to F. virguliforme in soybean is partial and governed by over 80 quantitative trait loci (QTL). We have conducted genome-wide association study (GWAS) for a group of 254 plant introductions lines using a panel of approximately 30,000 SNPs and identified 19 single nucleotide polymorphic loci (SNPL) that are associated with 14 genomic regions encoding foliar SDS and eight SNPL associated with seven genomic regions for root rot resistance. Of the identified 27 SNPL, six SNPL for foliar SDS resistance and two SNPL for root rot resistance co-mapped to previously identified QTL for SDS resistance. This study identified 13 SNPL associated with eight novel genomic regions containing foliar SDS resistance genes and six SNPL with five novel regions for root-rot resistance. This study identified five genes carrying nonsynonymous mutations: (i) three of which mapped to previously identified QTL for foliar SDS resistance and (ii) two mapped to two novel regions containing root rot resistance genes. Of the three genes mapped to QTL for foliar SDS resistance genes, two encode LRR-receptors and third one encodes a novel protein with unknown function. Of the two genes governing root rot resistance, Glyma. 01g222900.1 encodes a soybean-specific LEA protein and Glyma. 10g058700.1 encodes a heparan-alpha-glucosaminide N-acetyltransferase. In the LEA protein, a conserved serine residue was substituted with asparagine; and in the heparanalpha-glucosaminide N-acetyltransferase, a conserved histidine residue was substituted with an arginine residue. Such changes are expected to alter functions of these two proteins regulated through phosphorylation. The five genes with nonsynonymous mutations could be considered candidate SDS resistance genes and should be suitable molecular markers for breeding SDS resistance in soybean. The study also reports desirable plant introduction lines and novel genomic regions for enhancing SDS resistance in soybean.	[Swaminathan, Sivakumar; Assefa, Teshale; Knight, Joshua M.; Da Silva, Amilton Ferreira; Carvalho, Joao P. S.; Cianzio, Silvia R.; Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Das, Anindya; Huang, Xiaoqiu] Iowa State Univ, Dept Comp Sci, Ames, IA USA; [Hartman, Glen L.] Univ Illinois, USDA, Urbana, IL 61801 USA; [Hartman, Glen L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Leandro, Leonor F.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA; [Da Silva, Amilton Ferreira] Univ Fed Sao Joao del Rei, Dept Agr Sci, Sete Lagoas, MG, Brazil; [Carvalho, Joao P. S.] Univ Fed Lavras, Dept Biol, Lavras, MG, Brazil	Iowa State University; Iowa State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Iowa State University; Universidade Federal de Sao Joao del-Rei; Universidade Federal de Lavras	Cianzio, SR; Bhattacharyya, MK (corresponding author), Iowa State Univ, Dept Agron, Ames, IA 50011 USA.	scianzio@iastate.edu; mbhattac@iastate.edu		Swaminathan, Sivakumar/0000-0003-3931-275X; Ferreira da Silva, Amilton/0000-0001-7122-2688	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture [2013-68004-20374]	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture	National Institute of Food and Agriculture (NIFA), United States Department of Agriculture Grant no. 2013-68004-20374 awarded to Madan K. Bhattacharyya, Xiaoqiu Huang, Leonor F. Leandro and Silvia R. Cianzio.; This work was supported by the National Institute of Food and Agriculture (NIFA), United States Department of Agriculture (Grant no. 2013-68004-20374). We thank USDA-ARS-GRIN National Genetic Resources Program for sending us the seeds of soybean lines. We also thank Alexander Luckew, Peter Lundeen, Gregory Gebhart, Vijitha Silva and Sharon Eggenberger for their assistance during the course of the work.	Abdel Majid K.M., 2012, J PLANT GENOME SCI, V1, P18, DOI DOI 10.5147/JPGS.2012.0053; Abdelmajid KM, 2007, REV BIOL BIOTECH, V6, P2, DOI DOI 10.1023/B:PLSO.0000030189.96115.21; Abeysekara NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093667; Achenbach LA, 1996, PLANT DIS, V80, P1228, DOI 10.1094/PD-80-1228; Anderson J, 2015, 3 BIOTECH, V5, P203, DOI 10.1007/s13205-014-0211-3; Aoki T, 2012, MYCOSCIENCE, V53, P167, DOI 10.1007/s10267-011-0150-3; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bradley C, 2014, ESTIMATES SOYBEAN YI; Brar HK, 2011, MOL PLANT MICROBE IN, V24, P1179, DOI 10.1094/MPMI-12-10-0285; Camejo D, 2016, PLANT PHYSIOL BIOCH, V103, P10, DOI 10.1016/j.plaphy.2016.02.035; Chang HX, 2018, THEOR APPL GENET, V131, P757, DOI 10.1007/s00122-018-3063-0; Chang HX, 2016, PHYTOPATHOLOGY, V106, P1139, DOI 10.1094/PHYTO-01-16-0042-FI; Chang SJC, 1996, CROP SCI, V36, P1684, DOI 10.2135/cropsci1996.0011183X003600060044x; Hartman GL, 1997, PLANT DIS, V81, P515, DOI 10.1094/PDIS.1997.81.5.515; Hartman GL, 2004, AUSTRALAS PLANT PATH, V33, P9, DOI 10.1071/AP03072; HARTWIG EE, 1973, CROP SCI, V13, P287, DOI 10.2135/cropsci1973.0011183X001300020047x; Hayden R.W., 2012, J BIOPHARM STAT, V22, P418, DOI [10.1080/10543406.2012.635980, DOI 10.1080/10543406.2012.635980]; Hershman DE, 1990, INFORM B, P37; Hirrel M. C., 1987, P AM SEED TRADE ASS, V16, P95; Hnetkovsky N, 1996, CROP SCI, V36, P393, DOI 10.2135/cropsci1996.0011183X003600020030x; Huang LF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156414; Hughes TJ, 2014, MYCOLOGIA, V106, P686, DOI 10.3852/13-318; Hyten DL, 2007, GENETICS, V175, P1937, DOI 10.1534/genetics.106.069740; Iqbal MJ, 2005, THEOR APPL GENET, V110, P1429, DOI 10.1007/s00122-005-1969-9; Kandel YR, 2015, PLANT DIS, V99, P347, DOI 10.1094/PDIS-06-14-0577-RE; Kassem MA, 2006, THEOR APPL GENET, V113, P1015, DOI 10.1007/s00122-006-0361-8; Kaundal A, 2017, PLANT CELL, V29, P2233, DOI 10.1105/tpc.17.00070; Kazi S, 2007, J PLANT REGIST, V1, P175, DOI 10.3198/jpr2006.07.0481crmp; Kazi S, 2008, THEOR APPL GENET, V116, P967, DOI 10.1007/s00122-008-0728-0; Li B, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.26817; Li S, 1999, PLANT CELL REP, V18, P375, DOI 10.1007/s002990050589; Li S, 2003, PLANT PATHOL, V52, P74, DOI 10.1046/j.1365-3059.2003.00797.x; Li YB, 2016, PLANT PHYSIOL, V170, P2392, DOI 10.1104/pp.15.01930; Lipka AE, 2012, BIOINFORMATICS, V28, P2397, DOI 10.1093/bioinformatics/bts444; Lozovaya VV, 2006, PLANT DIS, V90, P77, DOI 10.1094/PD-90-0077; Luckew AS, 2017, THEOR APPL GENET, V130, P2139, DOI 10.1007/s00122-017-2947-8; Luckew AS, 2012, CROP SCI, V52, P2215, DOI 10.2135/cropsci2011.09.0500; Malvick DK, 2008, CAN J PLANT PATHOL, V30, P467, DOI 10.1080/07060660809507544; Mbofung GYC, 2012, CAN J PLANT PATHOL, V34, P83, DOI 10.1080/07060661.2012.664564; Mueller DS, 2002, PLANT DIS, V86, P741, DOI 10.1094/PDIS.2002.86.7.741; Mueller DS, 2003, PLANT DIS, V87, P827, DOI 10.1094/PDIS.2003.87.7.827; Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3; Navi S.S., 2008, PLANT HLTH PROGR, DOI 10.1094/PHP-2008-0222-01-RS; Neto ALD, 2007, MOL BREEDING, V20, P53, DOI 10.1007/s11032-006-9072-8; Ng A, 2011, AUTOPHAGY, V7, P1082, DOI 10.4161/auto.7.9.16464; Njiti VN, 2006, CAN J PLANT SCI, V86, P83, DOI 10.4141/P05-046; Njiti VN, 2002, THEOR APPL GENET, V104, P294, DOI 10.1007/s001220100682; Njiti VN, 1997, CROP SCI, V37, P132, DOI 10.2135/cropsci1997.0011183X003700010023x; Njiti VN, 2001, CROP SCI, V41, P1726, DOI 10.2135/cropsci2001.1726; O'Donnell K, 2010, PHYTOPATHOLOGY, V100, P58, DOI 10.1094/PHYTO-100-1-0058; Park CJ, 2015, PLANT PATHOLOGY J, V31, P323, DOI 10.5423/PPJ.RW.08.2015.0150; Powell JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17454-3; Prabhu RR, 1999, CROP SCI, V39, P982, DOI 10.2135/cropsci1999.0011183X003900040005x; Pudake RN, 2013, CURR GENET, V59, P107, DOI 10.1007/s00294-013-0392-z; Robertson A, 2010, INTEGRATED CROP MANA; Roy KW, 1997, PLANT DIS, V81, P1100, DOI 10.1094/PDIS.1997.81.10.1100; Ruan L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10090; RUPE JC, 1993, J PROD AGRIC, V6, P218, DOI 10.2134/jpa1993.0218; Sanogo S, 2000, PHYTOPATHOLOGY, V90, P57, DOI 10.1094/PHYTO.2000.90.1.57; Scherm H, 1998, PLANT DIS, V82, P1152, DOI 10.1094/PDIS.1998.82.10.1152; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Seifi HS, 2013, MOL PLANT MICROBE IN, V26, P475, DOI 10.1094/MPMI-07-12-0176-CR; Sharfman M, 2014, PLANT PHYSIOL, V164, P819, DOI 10.1104/pp.113.230136; Sharma M, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01218; SINGH NK, 2013, PLOS ONE, V0008; Singh S, 2005, PROTEIN SCI, V14, P2601, DOI 10.1110/ps.051579205; Song QJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054985; Srivastava SK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081832; STEPHENS PA, 1993, CROP SCI, V33, P929, DOI 10.2135/cropsci1993.0011183X003300050010x; Swaminathan S, 2018, THEOR APPL GENET, V131, P1047, DOI 10.1007/s00122-018-3057-y; Swaminathan S, 2016, THEOR APPL GENET, V129, P495, DOI 10.1007/s00122-015-2643-5; Thoenes P, 2015, COMPETITIVE COMMERCI, P1; Wang HH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-428; Wen ZX, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-809; Yuan JZ, 2012, J PLANT GENOME SCI, V1, P10, DOI DOI 10.5147/pggb.v1i1.147; Zhang JP, 2015, PLANT J, V84, P1124, DOI 10.1111/tpj.13069; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546	77	5	5	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212071	10.1371/journal.pone.0212071	http://dx.doi.org/10.1371/journal.pone.0212071			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807585	Green Submitted, Green Published, gold			2022-12-26	WOS:000459712100012
J	Lee, SH; Son, HF; Kim, KJ				Lee, Seul Hoo; Son, Hyeoncheol Francis; Kim, Kyung-Jin			Structural insights into the inhibition properties of archaeon citrate synthase from Metallosphaera sedula	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; CARBON FIXATION; COENZYME; COMPLEX; SITE; OXALOACETATE; ADAPTATIONS; REFINEMENT; MECHANISM; ENZYME	Metallosphaera sedula is a thermoacidophilic archaeon and has an incomplete TCA/glyoxylate cycle that is used for production of biosynthetic precursors of essential metabolites. Citrate synthase from M. sedula (MsCS) is an enzyme involved in the first step of the incomplete TCA/glyoxylate cycle by converting oxaloacetate and acetyl-CoA into citrate and coenzyme A. To elucidate the inhibition properties of MsCS, we determined its crystal structure at 1.7 A resolution. Like other Type-I CS, MsCS functions as a dimer and each monomer consists of two distinct domains, a large domain and a small domain. The oxaloacetate binding site locates at the cleft between the two domains, and the active site was more closed upon binding of the oxaloacetate substrate than binding of the citrate product. Interestingly, the inhibition kinetic analysis showed that, unlike other Type-I CSs, MsCS is noncompetitively inhibited by NADH. Finally, amino acids and structural comparison of MsCS with other Type-II CSs, which were reported to be non-competitively inhibited by NADH, revealed that MsCS has quite unique NADH binding mode for non-competitive inhibition.	[Lee, Seul Hoo; Son, Hyeoncheol Francis; Kim, Kyung-Jin] Kyungpook Natl Univ, KNU Inst Microorganisms, KNU Creat BioRes Grp, Sch Life Sci, Daegu, South Korea	Kyungpook National University	Kim, KJ (corresponding author), Kyungpook Natl Univ, KNU Inst Microorganisms, KNU Creat BioRes Grp, Sch Life Sci, Daegu, South Korea.	kkim@knu.ac.kr			National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2016M3D3A1A01913269]; National Research Foundation of Korea (NRF) [NRF-2014M1A2A2033626]; NRF-2015-Global PhD Fellowship Program of the Korean Government [2015H1A2A1034233]	National Research Foundation of Korea (NRF) - Ministry of Science and ICT; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); NRF-2015-Global PhD Fellowship Program of the Korean Government	This work was supported by the C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2016M3D3A1A01913269), and also supported by a National Research Foundation of Korea (NRF) grant (NRF-2014M1A2A2033626). H-F Son was supported by the NRF2015-Global PhD Fellowship Program of the Korean Government (2015H1A2A1034233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the C1 Gas Refinery Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2016M3D3A1A01913269), and also supported by a National Research Foundation of Korea (NRF) grant (NRF-2014M1A2A2033626). H-F Son was supported by the NRF-2015-Global PhD Fellowship Program of the Korean Government (2015H1A2A1034233).	Aleksandrov A, 2014, J PHYS CHEM B, V118, P4505, DOI 10.1021/jp412346g; ALTER GM, 1990, BIOCHEMISTRY-US, V29, P7557, DOI 10.1021/bi00485a003; Auernik KS, 2008, CURR OPIN BIOTECH, V19, P445, DOI 10.1016/j.copbio.2008.08.001; Auernik KS, 2010, APPL ENVIRON MICROB, V76, P931, DOI 10.1128/AEM.01336-09; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAYER E, 1981, EUR J BIOCHEM, V120, P155, DOI 10.1111/j.1432-1033.1981.tb05683.x; Bell GS, 2002, EUR J BIOCHEM, V269, P6250, DOI 10.1046/j.1432-1033.2002.03344.x; Berg IA, 2010, NAT REV MICROBIOL, V8, P447, DOI 10.1038/nrmicro2365; Boutz DR, 2007, J MOL BIOL, V368, P1332, DOI 10.1016/j.jmb.2007.02.078; Chruszcz M, 2008, PROTEIN SCI, V17, P623, DOI 10.1110/ps.073360508; Chuakrut S, 2003, J BACTERIOL, V185, P938, DOI 10.1128/JB.185.3.938-947.2003; DANSON MJ, 1977, BIOCHIM BIOPHYS ACTA, V485, P452, DOI 10.1016/0005-2744(77)90181-4; Estelmann S, 2011, J BACTERIOL, V193, P1191, DOI 10.1128/JB.01155-10; Evans CT, 1996, BIOCHEMISTRY-US, V35, P10661, DOI 10.1021/bi960336e; Francois JA, 2006, BIOCHEMISTRY-US, V45, P13487, DOI 10.1021/bi061083k; HARFORD S, 1975, BIOCHEM J, V151, P455, DOI 10.1042/bj1510455; Hawkins AB, 2014, APPL ENVIRON MICROB, V80, P2536, DOI 10.1128/AEM.04146-13; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; HOSTALEK Z, 1969, FOLIA MICROBIOL, V14, P121, DOI 10.1007/BF02892880; JANGAARD NO, 1968, BIOCHIM BIOPHYS ACTA, V151, P225, DOI 10.1016/0005-2744(68)90177-0; Kanamori E, 2015, BIOPHYS PHYSICOBIOL, V12, P47, DOI 10.2142/biophysico.12.0_47; KARPUSAS M, 1990, BIOCHEMISTRY-US, V29, P2213, DOI 10.1021/bi00461a002; Krebs H, 1979, Nurs Mirror, V149, P30; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LOHLEINWERHAHN G, 1988, BIOL CHEM H-S, V369, P109, DOI 10.1515/bchm3.1988.369.1.109; Maurus R, 2003, BIOCHEMISTRY-US, V42, P5555, DOI 10.1021/bi020622s; Murphy JR, 2015, ACTA CRYSTALLOGR F, V71, P1292, DOI 10.1107/S2053230X15015939; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nguyen NT, 2001, BIOCHEMISTRY-US, V40, P13177, DOI 10.1021/bi010408o; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REMINGTON S, 1982, J MOL BIOL, V158, P111, DOI 10.1016/0022-2836(82)90452-1; REMINGTON SJ, 1992, CURR TOP CELL REGUL, V33, P209; Russell RJM, 1997, BIOCHEMISTRY-US, V36, P9983, DOI 10.1021/bi9705321; Russell RJM, 1998, STRUCTURE, V6, P351, DOI 10.1016/S0969-2126(98)00037-9; RUSSELL RJM, 1994, STRUCTURE, V2, P1157, DOI 10.1016/S0969-2126(94)00118-9; Selwood T, 2012, ARCH BIOCHEM BIOPHYS, V519, P131, DOI 10.1016/j.abb.2011.11.020; SMITH CM, 1971, FEBS LETT, V18, P35, DOI 10.1016/0014-5793(71)80400-3; Sussman JL, 1998, SCIENCE, V282, P1993; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; WIEGAND G, 1984, J MOL BIOL, V174, P205, DOI 10.1016/0022-2836(84)90373-5; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97	41	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212807	10.1371/journal.pone.0212807	http://dx.doi.org/10.1371/journal.pone.0212807			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794680	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100142
J	Lopez-Sanmartin, M; Catanese, G; Grau, A; Valencia, JM; Garcia-March, JR; Navas, JI				Lopez-Sanmartin, Monserrat; Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose; Rafa Garcia-March, Jose; Ignacio Navas, Jose			Real-Time PCR based test for the early diagnosis of Haplosporidium pinnae affecting fan mussel Pinna nobilis	PLOS ONE			English	Article							COEFFICIENT; AGREEMENT	Noble pen shell or fan mussel, Pinna nobilis Linnaeus (1758), protected since 1992, was incorporated into the Spanish Catalogue of Threatened Species (Category: Vulnerable, Royal Decree 139/2011). The status is presently in the process of being catalogued as critically endangered, pending approval by Spanish Government (https://www.mapama.gob.es/es/biodiversidad/participacion-publica/Borrador_OM_situacion_critica. aspx). The International Union for the Conservation of Nature (IUCN) alerted the countries of the Mediterranean basin to the "emergent situation" due to serious mortality events suffered by the fan mussel, putting it in serious risk of extinction. Thus, emergency actions have been implemented by Spanish authorities in which several research institutes from all over the country are involved. The parasite, Haplosporidium pinnae, was recently characterized by histology, TEM, SEM and molecular biology techniques and it was considered responsible for the mass mortality of P. nobilis in the Mediterranean Sea. In this context, the aim of this study has been to develop species-specific quantitative PCR (qPCR) protocol carrying out a fast, specific and effective molecular diagnose of H. pinnae. In this sense, the detection limit for qPCR was equal to 30 copies of SSU rDNA / ng of DNA using plasmid alone and when 100ng DNA of non-infected oyster were added. The qPCR assay revealed that 94% of the 32 analysed mantle tissues of fan mussel were infected by H. pinnae, showing a high sensitivity and specificity for its detection (100% if we don't consider negative and too much degraded samples). This technique will allow us to make quicker follow-ups of the disease, allowing us to get a better understanding of its evolution in order to help in the rescue of P. nobilis populations	[Lopez-Sanmartin, Monserrat; Ignacio Navas, Jose] IFAPA Agua Pino, Cartaya, Huelva, Spain; [Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose] LIMIA Govern Illes Balears, Port Dandratx, Mallorca, Spain; [Catanese, Gaetano; Grau, Amalia; Maria Valencia, Jose] INAGEA INIA CAIB UIB Ctra, Edifici Guillem Colom Casasnoves, Palma de Mallorca, Illes Balears, Spain; [Rafa Garcia-March, Jose] UCV, IMEDMAR, Calpe, Spain	Universidad Catolica de Valencia San Vicente Martir	Lopez-Sanmartin, M (corresponding author), IFAPA Agua Pino, Cartaya, Huelva, Spain.	monserratls@yahoo.es	Navas, José Ignacio/D-9086-2012; Garcia‑March, Jose R./T-4120-2018; CATANESE, GAETANO/A-7510-2009	Navas, José Ignacio/0000-0002-2774-7978; Garcia‑March, Jose R./0000-0003-1646-5331; CATANESE, GAETANO/0000-0001-6219-4494; Lopez-Sanmartin, Monserrat/0000-0001-9077-7515; Valencia, Jose/0000-0002-1912-1975; Grau, Amalia/0000-0002-6461-6985	project MAPAMA within LIFE IPE INTERMARES [28-5310, LIFE15 IPE ES 012]; PHENOFISH Project; State Plan for Scientific and Technical Research and Innovation 2013-2016, MINECO [PTA2015-14709-I]; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, INIA CCAA [DOC INIA 8-2013]; Prince Albert II of Monaco Foundation [BF/HEM 15-1662];  [IFAPA-UCV 014/2018]	project MAPAMA within LIFE IPE INTERMARES; PHENOFISH Project; State Plan for Scientific and Technical Research and Innovation 2013-2016, MINECO; Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, INIA CCAA; Prince Albert II of Monaco Foundation; 	This research has been funded by the project MAPAMA ref. 28-5310 within LIFE IPE INTERMARES(LIFE15 IPE ES 012) and the agreement IFAPA-UCV 014/2018 and co-funded by PHENOFISH Project. M. Lopez-Sanmartin contract is co-financed by the State Plan for Scientific and Technical Research and Innovation 2013-2016, MINECO, ref. PTA2015-14709-I. Ministerio de Economia, Industria y Competitividad, Gobierno de Espana, INIA CCAA (DOC INIA 8-2013), Dr Gaetano Catanese. Garcia-March was supported by the project BF/HEM 15-1662 -The study, protection and possible breeding of penshell (Pinna nobilis) in the Boka Kotorska bay (Montenegro) of the Prince Albert II of Monaco Foundation. We thank to M. Vila, R. Leon and I. Giraldez of the Chemistry Department of the University of Huelva (Spain).	Audemard C, 2004, APPL ENVIRON MICROB, V70, P6611, DOI 10.1128/AEM.70.11.6611-6618.2004; Berthe FCJ, 1999, BULL EUR ASSN FISH P, V19, P277; Catanese G, 2018, J INVERTEBR PATHOL, V157, P9, DOI 10.1016/j.jip.2018.07.006; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Darriba S, 2017, J INVERTEBR PATHOL, V148, P14, DOI 10.1016/j.jip.2017.05.006; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; FLEISS JL, 1973, EDUC PSYCHOL MEAS, V33, P613, DOI 10.1177/001316447303300309; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Kralik P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00108; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Mauri I, 2011, FISH SHELLFISH IMMUN, V30, P1310, DOI 10.1016/j.fsi.2011.03.013; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramilo A, 2013, DIS AQUAT ORGAN, V104, P149, DOI 10.3354/dao02597; Sanna D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067372; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Vazquez-Luis M, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00220; Wilbur AE, 2012, DIS AQUAT ORGAN, V102, P107, DOI 10.3354/dao02540; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997	19	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212028	10.1371/journal.pone.0212028	http://dx.doi.org/10.1371/journal.pone.0212028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794588	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100033
J	Skoglund, C; Lagging, M; Castedal, M				Skoglund, Catarina; Lagging, Martin; Castedal, Maria			No need to discontinue hepatitis C virus therapy at the time of liver transplantation	PLOS ONE			English	Article							INFECTION; INTERFERON; SOFOSBUVIR; RECURRENCE; RIBAVIRIN; HCV; SURVIVAL	Objectives Direct antiviral agents (DAA) has dramatically improved the therapy outcome of hepatitis C-virus (HCV) infection, both on the waiting-list and post liver transplantation (LT). DAA are generally well-tolerated in patients with mild to moderate liver and kidney failure, but some DAAs are contraindicated in patients with severe dysfunction of these organs. Today there are few studies of peri-LT DAA use and treatment is commonly discontinued at the time of LT. We report here our experience of DAA therapy given continuously in the perioperative LT period in a real-life setting in Sweden. Material In total 10 patients with HCV-cirrhosis, with or without hepatocellular carcinoma, and a median age of 60.5 years (range, 52-65) were treated with DAAs on the waiting list for LT, and continued in the early postoperative period without any interruption, on the basis of not having reached a full treatment course at the time of LT. Sofosbuvir and a NS5A inhibitor with or without ribavirin, or sofosbuvir and ribavirin only, were given. The distribution of genotypes was genotype 1 and 3, in 4 and 6 patients, respectively. Six of the 10 patients had previously been treated with IFN-based therapy. Results There were no adverse events leading to premature DAA discontinuation. All recipients achieved a sustained viral response 12 weeks after end-of-treatment (SVR12). At the time of LT the median MELD-score was 16.5 (range 7-21), CTP-score 9.0 (range 5-10), creatinine 82.5 mu mol/L (range 56-135, reference 60-105), bilirubin 33 mu mol/L (range 16-79, reference 5-25) and PK-INR 1.5 (range 1.1-1.8). The median duration of DAA therapy was 60 days (range 18-132) pre-LT, 54 days post-LT (range 8-111 days) and in total 15.5 weeks (range 12-30 weeks). Conclusion Interferon-free DAA therapy of HCV-infection given in the immediate pre- and post-operative LT period is safe, well-tolerated and yields high SVR rates.	[Skoglund, Catarina; Castedal, Maria] Sahlgrens Univ Hosp, Transplant Inst, Dept Surg, Gothenburg, Sweden; [Skoglund, Catarina; Castedal, Maria] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Lagging, Martin] Sahlgrens Univ Hosp, Dept Infect Dis Virol, Gothenburg, Sweden; [Lagging, Martin] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg	Castedal, M (corresponding author), Sahlgrens Univ Hosp, Transplant Inst, Dept Surg, Gothenburg, Sweden.; Castedal, M (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden.	maria.castedal@vgregion.se	; Lagging, Martin/D-7734-2015	Castedal, Maria/0000-0002-4782-2752; Skoglund, Catarina/0000-0002-0138-2026; Lagging, Martin/0000-0002-7995-3626				Ackefors M, 2015, INFECT DIS-NOR, V47, P209, DOI 10.3109/00365548.2014.984322; Adam R, 2012, J HEPATOL, V57, P675, DOI 10.1016/j.jhep.2012.04.015; Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002; Bernuth S, 2017, DRUG DES DEV THER, V11, P2131, DOI 10.2147/DDDT.S139837; Charlton M, 2015, GASTROENTEROLOGY, V148, P108, DOI 10.1053/j.gastro.2014.10.001; Chen TY, 2016, CURR OPIN ORGAN TRAN, V21, P111, DOI 10.1097/MOT.0000000000000288; Choudhary NS, 2017, J CLIN EXP HEPATOL, V7, P358, DOI 10.1016/j.jceh.2017.10.003; Crespo G, 2018, J HEPATOL, V69, P11, DOI 10.1016/j.jhep.2018.02.012; Curry MP, 2015, GASTROENTEROLOGY, V148, P100, DOI 10.1053/j.gastro.2014.09.023; Forman LM, 2002, GASTROENTEROLOGY, V122, P889, DOI 10.1053/gast.2002.32418; Hobson EV, 2012, PERITON DIALYSIS INT, V32, P590, DOI 10.3747/pdi.2012.00152; Kwo PY, 2015, CURR OPIN ORGAN TRAN, V20, P235, DOI 10.1097/MOT.0000000000000198; Kwo PY, 2014, NEW ENGL J MED, V371, P2375, DOI 10.1056/NEJMoa1408921; Lagging M, 2016, INFECT DIS-NOR, V48, P251, DOI 10.3109/23744235.2015.1113438; Lionetti R, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13165; Maria C, 2017, SCAND J GASTROENTERO, V52, P585, DOI 10.1080/00365521.2017.1283439; Melum E, 2007, J HEPATOL, V47, P777, DOI 10.1016/j.jhep.2007.06.013; Mutimer D, 2017, DIGEST DIS, V35, P347, DOI 10.1159/000456586; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Roche B, 2018, LIVER INT, V38, P139, DOI 10.1111/liv.13659; Terrault NA, 2006, LIVER TRANSPLANT, V12, P1192, DOI 10.1002/lt.20865	21	3	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211437	10.1371/journal.pone.0211437	http://dx.doi.org/10.1371/journal.pone.0211437			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794555	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100016
J	Vicente, CSL; Nemchinov, LG; Mota, M; Eisenback, JD; Kamo, K; Vieira, P				Vicente, Claudia S. L.; Nemchinov, Lev G.; Mota, Manuel; Eisenback, Jonathan D.; Kamo, Kathryn; Vieira, Paulo			Identification and characterization of the first pectin methylesterase gene discovered in the root lesion nematode Pratylenchus penetrans	PLOS ONE			English	Article							PLANT-CELL WALLS; RICE WEEVIL; EXPRESSION; SEQUENCE; ENZYMES; PARASITISM; ALIGNMENT; ESTERASE; PROTEIN; TOMATO	Similar to other plant-parasitic nematodes, root lesion nematodes possess an array of enzymes that are involved in the degradation of the plant cell wall. Here we report the identification of a gene encoding a cell wall-degrading enzyme, pectin methylesterase PME (EC 3.1.1.11), in the root lesion nematode Pratylenchus penetrans. Both genomic and coding sequences of the gene were cloned for this species, that included the presence of four introns which eliminated a possible contamination from bacteria. Expression of the Pp-pme gene was localized in the esophageal glands of P. penetrans as determined by in situ hybridization. Temporal expression of Pp-pme in planta was validated at early time points of infection. The possible function and activity of the gene were assessed by transient expression of Pp-pme in plants of Nicotiana benthamiana plants via a Potato virus X-based vector. To our knowledge, this is the first report on identification and characterization of a PME gene within the phylum Nematoda.	[Vicente, Claudia S. L.] Univ Evora, Inst Invest & Formacao Avancada, ICAAM, Polo Mitra, Evora, Portugal; [Nemchinov, Lev G.; Vieira, Paulo] ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD 20705 USA; [Mota, Manuel] Univ Evora, Polo Mitra, Dept Biol, Evora, Portugal; [Mota, Manuel] Univ Evora, Polo Mitra, ICAAM, Evora, Portugal; [Eisenback, Jonathan D.; Vieira, Paulo] Virginia Tech, Sch Plant Environm Sci, Blacksburg, VA 24061 USA; [Kamo, Kathryn] USDA, Floral & Nursery Plants Res Unit, US Natl Arboretum, Beltsville, MD 20705 USA	University of Evora; United States Department of Agriculture (USDA); University of Evora; University of Evora; Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA)	Vieira, P (corresponding author), ARS, Mol Plant Pathol Lab, USDA, Beltsville, MD 20705 USA.; Vieira, P (corresponding author), Virginia Tech, Sch Plant Environm Sci, Blacksburg, VA 24061 USA.	pvieira@vt.edu	Vieira, Paulo/I-7173-2019; Vicente, Cláudia SL/X-5058-2019; Mota, Manuel/G-6031-2019	Vieira, Paulo/0000-0001-5627-2628; Vicente, Cláudia SL/0000-0002-3865-5358; Mota, Manuel/0000-0002-4145-5031	FCT (Foundation for Science and Technology) [SFRH/BPD/116030/2016]; national project [PTDC/AGR-PRO/2589/2014 - PratyTech]; National Funds through FCT [UID/AGR/00115/2013]	FCT (Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); national project; National Funds through FCT(Portuguese Foundation for Science and Technology)	This work was supported by the FCT (Foundation for Science and Technology) postdoctoral fellowship SFRH/BPD/116030/2016 (to CSLV); the national project PTDC/AGR-PRO/2589/2014 - PratyTech (to MM), Biotechnology approaches towards control of the root lesion nematode Pratylenchus penetrans and by National Funds through FCT under the Project UID/AGR/00115/2013 (to CSLV and MM).	Agamennone V, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiv128; Antony B, 2017, INSECT MOL BIOL, V26, P469, DOI 10.1111/imb.12314; Barsnes H, 2018, J PROTEOME RES, V17, P2552, DOI 10.1021/acs.jproteome.8b00175; Bellincampi D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00228; Bethke G, 2014, PLANT PHYSIOL, V164, P1093, DOI 10.1104/pp.113.227637; Brown AMV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34955; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castillo P, 2007, NEMATOL MONOGR PERSP, V6, P1; CHAPMAN S, 1992, PLANT J, V2, P549; Chen MH, 2003, PLANT J, V35, P386, DOI 10.1046/j.1365-313X.2003.01818.x; Church M.J., 2008, MICROB ECOL OCEAN, P335, DOI DOI 10.1002/9780470281840.CH10; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Czarnetzki AB, 2004, FEMS MICROBIOL ECOL, V49, P217, DOI 10.1016/j.femsec.2004.03.007; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; de Boer JM, 1998, J NEMATOL, V30, P309; Denver DR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005713; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elhadyl A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177145; Evangelista DE, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/ieu168; Faddeeva-Vakhrusheva A, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3852-x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Haegeman A, 2011, MPMI, V8, P879; Haegeman A, 2009, MOL PLANT PATHOL, V10, P389, DOI [10.1111/J.1364-3703.2009.00539.X, 10.1111/j.1364-3703.2009.00539.x]; Jones MGK, 2014, ANN APPL BIOL, V164, P163, DOI 10.1111/aab.12105; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Katoh K, 2017, MAFFT ONLINE SERVICE; Keegstra K, 2010, PLANT PHYSIOL, V154, P483, DOI 10.1104/pp.110.161240; Keeling CI, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r27; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kikuchi T, 2017, ANNU REV PHYTOPATHOL, V55, P333, DOI 10.1146/annurev-phyto-080516-035434; Kirsch R, 2016, INSECT BIOCHEM MOLEC, V71, P72, DOI 10.1016/j.ibmb.2016.02.007; L'Enfant M, 2015, INT J BIOL MACROMOL, V81, P681, DOI 10.1016/j.ijbiomac.2015.08.066; Li PQ, 2011, J BASIC MICROB, V51, P61, DOI 10.1002/jobm.201000317; Lionetti V, 2012, J PLANT PHYSIOL, V169, P1623, DOI 10.1016/j.jplph.2012.05.006; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Pauchet Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015635; Pelloux J, 2007, TRENDS PLANT SCI, V12, P267, DOI 10.1016/j.tplants.2007.04.001; Perez-Riverol Y, 2016, MOL CELL PROTEOMICS, V15, P305, DOI 10.1074/mcp.O115.050229; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pilling J, 2004, PLANTA, V219, P32, DOI 10.1007/s00425-004-1204-y; Protsenko MA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P1053, DOI 10.1134/S0006297908100015; Quist CW, 2015, ANNU REV PHYTOPATHOL, V53, P289, DOI 10.1146/annurev-phyto-080614-120057; Schulz S, 2013, BIOGEOSCIENCES, V10, P3983, DOI 10.5194/bg-10-3983-2013; Senechal F, 2014, J EXP BOT, V65, P5125, DOI 10.1093/jxb/eru272; Shen ZC, 1999, INSECT BIOCHEM MOLEC, V29, P209, DOI 10.1016/S0965-1748(98)00127-1; Shevchik VE, 1997, MOL MICROBIOL, V24, P1285, DOI 10.1046/j.1365-2958.1997.4331800.x; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Sorensen I, 2010, PLANT PHYSIOL, V153, P366, DOI 10.1104/pp.110.154427; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; Teller DC, 2014, ACTA CRYSTALLOGR F, V70, P1480, DOI 10.1107/S2053230X14020433; TIEMAN DM, 1994, PLANT PHYSIOL, V106, P429, DOI 10.1104/pp.106.2.429; Valette-Collet O, 2003, MOL PLANT MICROBE IN, V16, P360, DOI 10.1094/MPMI.2003.16.4.360; Vanholme B, 2009, NEMATOLOGY, V11, P739, DOI 10.1163/156854109X404599; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; Vieira P, 2017, PLANT PATHOL, V66, P1214, DOI 10.1111/ppa.12664; Vieira P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144674; Vieira P, 2018, MOL PLANT PATHOL, V19, P1887, DOI 10.1111/mpp.12666; Vieira P, 2011, J EXP BOT, V62, P1241, DOI 10.1093/jxb/erq352; Voragen AGJ, 2009, STRUCT CHEM, V20, P263, DOI 10.1007/s11224-009-9442-z; Wen FS, 1999, PLANT CELL, V11, P1129, DOI 10.1105/tpc.11.6.1129; Wietholter N, 2003, MOL PLANT MICROBE IN, V16, P945, DOI 10.1094/MPMI.2003.16.10.945; Wolinska A, 2017, APPL SOIL ECOL, V119, P128, DOI 10.1016/j.apsoil.2017.06.009; Yang JX, 2016, BMC BIOL, V14, DOI 10.1186/s12915-015-0223-4	65	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212540	10.1371/journal.pone.0212540	http://dx.doi.org/10.1371/journal.pone.0212540			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794636	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100083
J	Castellon, RIA; Vargas, EC; Chavarria, REC; Vargas, GAR				Acevedo Castellon, Roger Ivan; Carranza Vargas, Esteban; Cortes Chavarria, Ritzi Elena; Rodriguez Vargas, Gabriel Andres			Rapid assessment of avoidable blindness and diabetic retinopathy in individuals aged 50 years or older in Costa Rica	PLOS ONE			English	Article							VISUAL IMPAIRMENT	In the present study, we examined the causes and the prevalence of avoidable blindness and visual impairment, as well as the prevalence of diabetic retinopathy in individuals aged >= 50 years in Costa Rica, in order to provide baseline data for the initial planning and monitoring of ongoing blindness intervention programs. The assessment was based on the standardized methodology of the Rapid Assessment of Avoidable Blindness and Diabetic Retinopathy, a population-based survey for blindness and visual impairment. From 3,255 eligible subjects, 76.6% were examined. The adjusted prevalence of bilateral blindness [presenting visual acuity (VA) in the better eye of less than 3/60] was 1.7% (95% confidence interval, 1.2%-2.2%), with avoidable causes (treatable and preventable) accounting for 68.8% of cases. The main causes of blindness were cataract (52.1%), glaucoma (6.3%), and diabetic retinopathy (6.3%); these data were similar to those for other neighboring countries. Cataract surgical coverage (CSC) in the survey area was estimated as 88.9% for individuals with blindness (VA, <3/60), 76.6% for those with a VA of <6/60, and 60.3% for those with a VA of <6/18. The most common barriers against cataract surgery in individuals with a best-corrected VA of <= 6/60 included "need not felt" (48.8%) and "fear" (14.6%). Among individuals with a past history of cataract surgery, only 57.1% showed a "good" or "very good" outcome (VA, >= 6/18). Finally, 23.5% individuals with known or newly diagnosed diabetes showed retinopathy and/or maculopathy, with 6.2% exhibiting sight-threatening diabetic retinopathy (proliferative retinopathy, referable maculopathy, or both). Our findings indicate the need to overcome barriers against surgery for cataract, which is the main cause of avoidable blindness, to increase CSC, and to improve surgical outcomes. Moreover, improved methods for diabetic retinopathy screening can ensure prompt identification of patients with a risk of blindness. Glaucoma screening is also necessary for areas with a high prevalence.	[Acevedo Castellon, Roger Ivan; Carranza Vargas, Esteban; Cortes Chavarria, Ritzi Elena; Rodriguez Vargas, Gabriel Andres] Mexico Hosp, Caja Costarricense Seguro Social, Surg Dept, Ophthalmol Serv, San Jose, Costa Rica		Castellon, RIA (corresponding author), Mexico Hosp, Caja Costarricense Seguro Social, Surg Dept, Ophthalmol Serv, San Jose, Costa Rica.	rogerivanac@gmail.com	Castellón, Róger Iván Acevedo/N-8508-2019; Castellón, Róger Iván Acevedo/N-4003-2017; Rodriguez-Vargas, Gabriel/L-9570-2017	Castellón, Róger Iván Acevedo/0000-0002-6935-0178; Castellón, Róger Iván Acevedo/0000-0002-6935-0178; Rodriguez-Vargas, Gabriel/0000-0002-6282-2742	Caja Costarricense de Seguro Social; Panamerican Health Organization	Caja Costarricense de Seguro Social; Panamerican Health Organization	The authors received funding from Caja Costarricense de Seguro Social (http://www.ccss.sa.cr) and Panamerican Health Organization (http://www.paho.org/cor/).	Alvarado D, 2014, REV PANAM SALUD PUBL, V36, P300; American Diabetes Association, 2002, DIABETES CARE, V25, ps90s93, DOI [10.2337/diacare.25.2007.S90, DOI 10.2337/DIACARE.25.2007.S90]; Barcelo A, 2009, SURVERY DIABETES HYP; Silva JC, 2015, REV PANAM SALUD PUBL, V37, P21; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Kuper Hannah, 2006, Community Eye Health, V19, P68; Limburg H, 2013, COMMUNITY EYE HLTH J; Limburg H, 2008, BRIT J OPHTHALMOL, V92, P315, DOI 10.1136/bjo.2007.125906; Lopez M, 2014, REV PANAM SALUD PUBL, V36, P355; Resnikoff S, 2012, BRIT J OPHTHALMOL, V96, P783, DOI 10.1136/bjophthalmol-2011-301378; Vision 20/20, 2015, VISION 20 20 B TRIME; WHO, 2013, PREV BLINDN VIS IMP; Williams GA, 2004, OPHTHALMOLOGY, V111, P1055, DOI 10.1016/j.ophtha.2004.02.004; World Health Organization, 2014, PROGR PREV BLINDN VI; Zachariah Sonia, 2015, Community Eye Health, V28, P72	15	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212660	10.1371/journal.pone.0212660	http://dx.doi.org/10.1371/journal.pone.0212660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789973	Green Published, gold			2022-12-26	WOS:000459330800048
J	Mahmoud, SS; ElAbrak, ES; Aly, MA; Ali, EM				Mahmoud, Sherif S.; ElAbrak, Eman S.; Aly, Mervat A.; Ali, Eman M.			Oculohypotensive effects of various acetozolamide nanopreparations for topical treatment of animal model-induced glaucoma and their impact on optic nerve	PLOS ONE			English	Article							RAMAN-SPECTROSCOPY; OXIDATIVE STRESS; ANTIBACTERIAL; POMEGRANATE; PROPOLIS; DELIVERY; LIPIDS; PLANTS	Acetozolamide-ACZ, carbonic anhydrase inhibitor-is still the most effective systemic drug for glaucoma treatment. Due to its limited ocular bioavailability, topical formulations are not available yet. This study introduces within the framework of nanotechnology three nanopreparations of acetozolamide for topical application, one of them is liposomal phospholipid vehicle and the other two preparations are propolis and Punica granatum (pomegranate). The hypotensive effect of these different nanopreparations in lowering the increased intraocular pressure that was induced in experimental rabbits is monitored for 130 hrs. Structural characteristics of the optic nerve dissected from all involved groups were studied by Fourier transfrom infrared spectroscopy. The obtained results indicate the impact of the topically applied acetozolamide nanopreparations in lowering the intraocular pressure to its normotensive control value. On the other hand, the optic nerve characteristics were found to be dependent on the way acetozolamide introduced. Glaucoma affects structural components that contain OH group and increases beta-turns of the protein secondary structure while, reducing the content of both alpha-helix and Turns. In the same context, liposomal-acetozolamide and propolis nanopreparations protecting the optic nerve protein secondary structure from these changes associated with glaucoma.	[Mahmoud, Sherif S.; ElAbrak, Eman S.; Aly, Mervat A.; Ali, Eman M.] Res Inst Ophthalmol, Biophys & Laser Sci Unit, Giza, Egypt	Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Research Institute of Ophthalmology (RIO)	Mahmoud, SS (corresponding author), Res Inst Ophthalmol, Biophys & Laser Sci Unit, Giza, Egypt.	sherif.siddick@rio.sci.eg	aly, eman mohamed/AAC-1891-2019; Mahmoud, Sherif Siddick/AAJ-7442-2020	aly, eman mohamed/0000-0003-0815-3063; Mahmoud, Sherif Siddick/0000-0002-6826-6011				Adhami VM, 2007, MOL BIOTECHNOL, V37, P52, DOI 10.1007/s12033-007-0047-8; ALVARADO J, 1981, INVEST OPHTH VIS SCI, V21, P714; Beattie JR, 2004, LIPIDS, V39, P407, DOI 10.1007/s11745-004-1245-z; BORCHMAN D, 1991, INVEST OPHTH VIS SCI, V32, P2404; Borchman D, 1996, EXP EYE RES, V62, P191, DOI 10.1006/exer.1996.0023; DeSouza NJ, 1993, J ETHNOPHARMACOL, V83, P167, DOI [10.1016/0378-8741(93)90013-U, DOI 10.1016/0378-8741(93)90013-U]; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flammer J, 1999, J GLAUCOMA, V8, P212; Gautam R, 2007, J ETHNOPHARMACOL, V110, P200, DOI 10.1016/j.jep.2006.12.031; GOLDBERG I, 2000, GLAUCOMA 21 CENTURY, P1; Granero GE, 2008, J PHARM SCI-US, V97, P3691, DOI 10.1002/jps.21282; Guillard E, 2011, ANAL BIOANAL CHEM, V399, P1201, DOI 10.1007/s00216-010-4389-x; Hegazi AG, 2001, Z NATURFORSCH C, V56, P82; Iomdina EN, 2015, FRONT BIOSCI-LANDMRK, V20, P892, DOI 10.2741/4343; Izzotti A, 2006, MUTAT RES-REV MUTAT, V612, P105, DOI 10.1016/j.mrrev.2005.11.001; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Kyei S, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0027-1; Li HL, 2016, AAPS PHARMSCITECH, V17, P710, DOI 10.1208/s12249-015-0382-1; Mahmoud SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196827; Melena J, 1997, METHOD FIND EXP CLIN, V19, P553; Melendez PA, 2006, PHYTOMEDICINE, V13, P272, DOI 10.1016/j.phymed.2004.11.009; Natarajan JV, 2012, INT J NANOMED, V7, DOI 10.2147/IJN.S25468; Plumb GW, 2002, REDOX REP, V7, P41, DOI 10.1179/135100002125000172; Rhee DJ, 2001, SURV OPHTHALMOL, V46, P43, DOI 10.1016/S0039-6257(01)00233-8; Souleman AM., 2016, EGYPTIAN PHARM J, V15, P143, DOI 10.4103/1687-4315.197582; Tfayli A, 2012, EUR J DERMATOL, V22, P36, DOI 10.1684/ejd.2011.1507; Tilahun ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027203; Tylkowski B, 2010, J MEMBRANE SCI, V348, P124, DOI 10.1016/j.memsci.2009.10.049; Yano I, 1998, EUR J CLIN PHARMACOL, V54, P63, DOI 10.1007/s002280050422; Yu SH, 2015, INT J PHARMACEUT, V480, P128, DOI 10.1016/j.ijpharm.2015.01.032	30	3	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212588	10.1371/journal.pone.0212588	http://dx.doi.org/10.1371/journal.pone.0212588			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789966	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800044
J	Langer, MC; McPhee, BW; Marsola, JCD; Roberto-da-Silva, L; Cabreira, SF				Langer, Max Cardoso; McPhee, Blair Wayne; de Almeida Marsola, Julio Cesar; Roberto-da-Silva, Lucio; Cabreira, Sergio Furtado			Anatomy of the dinosaur Pampadromaeus barberenai (Saurischia-Sauropodomorpha) from the Late Triassic Santa Maria Formation of southern Brazil	PLOS ONE			English	Article							GRANDE-DO-SUL; EARLY EVOLUTION; ECOLOGICAL OPPORTUNITY; PHYLOGENETIC-RELATIONSHIPS; CATURRITA FORMATION; THEROPOD DINOSAUR; BASAL DINOSAUR; ORIGIN; ARGENTINA; SKELETON	Sauropodomorphs are the most abundant and diverse Glade of Triassic dinosaurs, but the taxonomy of their earliest (Carnian) representatives is still poorly understood. One such taxon is Pampadromaeus barberenai, represented by a nearly complete disarticulated skeleton recovered from the upper part of the Santa Maria Formation of Rio Grande do Sul, Brazil. Here, the osteology of Pam. barberenai is fully described for the first time. Detailed comparisons with other Carnian sauropodomorphs reveal a unique anatomy, corroborating its status as a valid species. Potential autapomorphies of Pam. barberenai can be seen in the articulation of the sacral zygapophyses, the length of the pectoral epipodium, the shape of the distal articulation of the femur and the proximal articulation of metatarsal 1. A novel phylogenetic study shows that relationships among the Carnian sauropodomorphs are poorly constrained, possibly because they belong to a "zone of variability", where homoplasy abounds. Yet, there is some evidence that Pam. barberenai may nest within Saturnaliidae, along with Saturnalia tupiniquim and Chromogisaurus novasi, which represents the sister group to the larger sauropodomorphs, i.e. Bagualosauria.	[Langer, Max Cardoso; McPhee, Blair Wayne; de Almeida Marsola, Julio Cesar] Univ Sao Paulo, FFCLRP, Lab Paleontol, Ribeirao Preto, SP, Brazil; [Roberto-da-Silva, Lucio; Cabreira, Sergio Furtado] Univ Luterana Brasil, Museu Ciencias Nat, Canoas, RS, Brazil	Universidade de Sao Paulo; Universidade Luterana do Brasil	Langer, MC (corresponding author), Univ Sao Paulo, FFCLRP, Lab Paleontol, Ribeirao Preto, SP, Brazil.	mclanger@ffclrp.usp.br	de A. Marsola, Júlio C./H-6513-2014; Langer, Max/Y-1753-2019; Langer, Max/F-7483-2012	de A. Marsola, Júlio C./0000-0001-5290-7884; Langer, Max/0000-0003-1009-4605	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/03825-3, 2013/23114-1]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by: MCL, 2014/03825-3, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, http://www.fapesp.br/; JCAM, 2013/23114-1, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, http://www.fapesp.br/.	Alcober O, 2010, ZOOKEYS, V63, P1; Apaldetti C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026964; Baron MG, 2017, NATURE, V543, P501, DOI 10.1038/nature21700; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Benson RBJ, 2018, ANNU REV ECOL EVOL S, V49, P379, DOI 10.1146/annurev-ecolsys-110617-062231; Benson RBJ, 2018, PALAEONTOLOGY, V61, P13, DOI 10.1111/pala.12329; Benton MJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0569; Bever GS, 2015, NATURE, V525, P239, DOI 10.1038/nature14900; Bever GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023393; Bever GS, 2011, EVOL DEV, V13, P269, DOI 10.1111/j.1525-142X.2011.00478.x; Bittencourt JD, 2009, ZOOTAXA, P1; Bittencourt JS, 2015, J SYST PALAEONTOL, V13, P189, DOI 10.1080/14772019.2013.878758; Bonaparte JF., 1980, MEMOIRES SOC GEOLOGI, V139, P19; Boulenger GA., 1881, B ACAD ROYALE BELGIQ, V3, P600; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BREMER K, 1994, CLADISTICS, V10, P295, DOI 10.1006/clad.1994.1019; Bristowe Anthea, 2004, Palaeontologia Africana, V40, P31; Bronzati M, PALAEONTOL, V61, P289; Bronzati M, 2017, ZOOL J LINN SOC-LOND, DOI [10.1093/zoolinnean/zlx099, DOI 10.1093/ZOOLINNEAN/ZLX099]; Bronzati M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11737-5; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Cabreira SF, 2011, NATURWISSENSCHAFTEN, V98, P1035, DOI 10.1007/s00114-011-0858-0; Cabreira SF, 2016, CURR BIOL, V26, P3090, DOI 10.1016/j.cub.2016.09.040; Chapelle KEJ, 2018, PEERJ, V6, pe422; Cooper M. R, 1981, NATURAL SCI, V6, P689; CURRIE PJ, 1993, CAN J EARTH SCI, V30, P2037, DOI 10.1139/e93-179; Eddy DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017932; Ezcurra MD, 2010, J SYST PALAEONTOL, V8, P371, DOI 10.1080/14772019.2010.484650; Fabri M, 2018, PHYLONYMS COMPANION; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galton PM, 2004, DINOSAURIA, 2ND EDITION, P232; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Griffin CT, 2016, J VERTEBR PALEONTOL, V36, DOI 10.1080/02724634.2016.1111224; Hall B.K., 2015, BONES CARTILAGE DEV; Harris J.D., 1998, B NEW MEXICO MUSEUM, V13, P1; Horn BLD, 2014, J S AM EARTH SCI, V55, P123, DOI 10.1016/j.jsames.2014.07.007; Huene F.von., 1932, MONOGRAPHIEN GEOLOGI, V1, P1; Hughes M, 2013, P NATL ACAD SCI USA, V110, P13875, DOI 10.1073/pnas.1302642110; Irmis RB, 2010, EARTH ENV SCI T R SO, V101, P397, DOI 10.1017/S1755691011020068; Jarman P.J., 1979, SERENGETI DYNAMICS E, P130, DOI DOI 10.1086/284321; Langer MC, 2007, SPEC PAP PALAEONTOL, P113; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Langer MC, 2018, GONDWANA RES, V57, P133, DOI 10.1016/j.gr.2018.01.005; Langer MC, 2017, NATURE, V551, pE1, DOI 10.1038/nature24011; Langer MC, 2014, PALAEONTOLOGY, V57, P469, DOI 10.1111/pala.12108; Langer MC, 2013, GEOL SOC SPEC PUBL, V379, P353, DOI 10.1144/SP379.16; Langer MC, 2010, EARTH ENV SCI T R SO, V101, P301, DOI 10.1017/S175569101102007X; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; Langer Max C., 2007, Bulletin of the New Mexico Museum of Natural History and Science, V41, P201; Langer MC, 2004, DINOSAURIA, 2ND EDITION, P25; Langer Max Cardoso, 2003, Paleobios, V23, P1; Langer MC, 1999, CR ACAD SCI II A, V329, P511, DOI 10.1016/S1251-8050(00)80025-7; Losos JB, 1997, BIOL J LINN SOC, V61, P459, DOI 10.1006/bijl.1997.0137; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Marsh OC., 1877, AM J SCI, V3, P514, DOI DOI 10.2475/AJS.S3-14.84.514; Martinez RN, 2017, AMEGHINIANA, V54, P488, DOI 10.5710/AMGH.09.04.2017.3065; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P70, DOI 10.1080/02724634.2013.819009; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P10, DOI 10.1080/02724634.2013.818546; Martinez RN, 2012, J VERTEBR PALEONTOL, V32, P51, DOI 10.1080/02724634.2013.819361; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Maxwell EE, 2011, J MORPHOL, V272, P1170, DOI 10.1002/jmor.10972; McPhee BW, 2015, SCI REP-UK, V5, DOI 10.1038/srep13224; McPhee BW, 2014, ZOOL J LINN SOC-LOND, V171, P151, DOI 10.1111/zoj12127; Meyer H, 1837, N JB MIN GEOL PALAON, V816; Muller RT, 2019, HIST BIOL, V31, P794, DOI 10.1080/08912963.2017.1395421; Muller RT, 2016, HIST BIOL, V28, P656, DOI 10.1080/08912963.2015.1004329; Muller RT, 2018, ZOOL J LINN SOC-LOND, DOI [10.1093/zoolinnean/zlx099, DOI 10.1093/ZOOLINNEAN/ZLX099]; Nesbitt SJ, B AM MUS NAT HIST, V352, P1; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Novas FE, 2010, EARTH ENV SCI T R SO, V101, P333, DOI 10.1017/S1755691011020093; Novas Fernando E., 1993, Journal of Vertebrate Paleontology, V13, P400; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; Otero A, 2013, J VERTEBR PALEONTOL, V33, P1138, DOI 10.1080/02724634.2013.769444; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Neto VDP, 2016, PALAEOGEOGR PALAEOCL, V453, P30, DOI 10.1016/j.palaeo.2016.03.026; Piechowski R, 2014, J VERTEBR PALEONTOL, V34, P1383, DOI 10.1080/02724634.2014.873045; Pol D, 2009, CLADISTICS, V25, P515, DOI 10.1111/j.1096-0031.2009.00258.x; Porro LB, 2015, PEERJ, V3, DOI 10.7717/peerj.1494; Pretto FA, 2018, ZOOL J LINN SOC-LOND, DOI [10.1093/zoolinnean/zlx099, DOI 10.1093/ZOOLINNEAN/ZLX099]; Pretto FA, 2016, REV BRAS PALEONTOLOG, V19, P407, DOI 10.4072/rbp.2016.3.06; Prieto-Marquez A, 2011, AM MUS NOVIT, P1; RAATH M A, 1969, Arnoldia (Rhodesia), V4, P1; Rauhut OWM, 2003, SPEC PAP PALAEONTOL, P1; Riedl R., 1978, ORDER LIVING ORGANIS; Salgado Leonardo, 1997, Ameghiniana, V34, P3; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 2005, TAXONSEARCH DATABASE; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; Sereno PC, 2012, J VERTEBR PALEONTOL, V32, P83, DOI 10.1080/02724634.2013.820113; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Smith ND, 2007, ACTA PALAEONTOL POL, V52, P657; Stroud JT, 2016, ANNU REV ECOL EVOL S, V47, P507, DOI 10.1146/annurev-ecolsys-121415-032254; Sues HD, 2011, P ROY SOC B-BIOL SCI, V278, P3459, DOI 10.1098/rspb.2011.0410; THULBORN R A, 1970, Palaeontology (Oxford), V13, P414; UPCHURCH P, 1997, ENCY DINOSAURS, P658; Whitlock JA, 2013, INT J ORAL SCI, V5, P66, DOI 10.1038/ijos.2013.36; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Yates Adam M., 2007, Historical Biology, V19, P93, DOI 10.1080/08912960600866953; Yates AM, 2007, SPEC PAP PALAEONTOL, P9; Yates Adam M., 2005, Palaeontologia Africana, V41, P105; Yates AM, 2010, PALAEONTOLOGY, V53, P739, DOI 10.1111/j.1475-4983.2010.00952.x; Yates AM, 2010, P ROY SOC B-BIOL SCI, V277, P787, DOI 10.1098/rspb.2009.1440; Yates AM, 2012, COMPLETE DINOSAUR, P425; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zerfass H, 2003, SEDIMENT GEOL, V161, P85, DOI 10.1016/S0037-0738(02)00397-4	114	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212543	10.1371/journal.pone.0212543	http://dx.doi.org/10.1371/journal.pone.0212543			64	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785940	gold, Green Published, Green Submitted			2022-12-26	WOS:000459307000069
J	Pfaehler, E; Zwanenburg, A; de Jong, JR; Boellaard, R				Pfaehler, Elisabeth; Zwanenburg, Alex; de Jong, Johan R.; Boellaard, Ronald			RaCaT: An open source and easy to use radiomics calculator tool	PLOS ONE			English	Article							TEXTURAL FEATURES	Purpose The widely known field 'Radiomics' aims to provide an extensive image based phenotyping of e.g. tumors using a wide variety of feature values extracted from medical images. Therefore, it is of utmost importance that feature values calculated by different institutes follow the same feature definitions. For this purpose, the imaging biomarker standardization initiative (IBSI) provides detailed mathematical feature descriptions, as well as (mathematical) test phantoms and corresponding reference feature values. We present here an easy to use radiomic feature calculator, RaCaT, which provides the calculation of a large number of radiomic features for all kind of medical images which are in compliance with the standard. Methods The calculator is implemented in C++ and comes as a standalone executable. Therefore, it can be easily integrated in any programming language, but can also be called from the command line. No programming skills are required to use the calculator. The software architecture is highly modularized so that it is easily extendible. The user can also download the source code, adapt it if needed and build the calculator from source. The calculated feature values are compliant with the ones provided by the IBSI standard. Source code, example files for the software configuration, and documentation can be found online on GitHub (https://gthub.com/ellipfaehlerUMCG/RaCat). Results The comparison with the standard values shows that all calculated features as well as image preprocessing steps, comply with the IBSI standard. The performance is also demonstrated on clinical examples. Conclusions The authors successfully implemented an easy to use Radiomics calculator that can be called from any programming language or from the command line. Image preprocessing and feature settings and calculations can be adjusted by the user.	[Pfaehler, Elisabeth; de Jong, Johan R.; Boellaard, Ronald] Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands; [Zwanenburg, Alex] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Fac Med, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany; [Zwanenburg, Alex] Tech Univ Dresden, Helmholtz Zentrum Dresden Rossendorf, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Zwanenburg, Alex] Germany German Canc Res Ctr DKFZ, Partner Site Dresden, Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Zwanenburg, Alex] Tech Univ Dresden, Fac Med, Dresden, Germany; [Zwanenburg, Alex] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany; [Zwanenburg, Alex] HZDR, Helmholtz Assoc, Dresden, Germany; [Zwanenburg, Alex] German Canc Consortium DKTK, Partner Site Dresden, Heidelberg, Germany; [Zwanenburg, Alex] German Canc Res Ctr, Heidelberg, Germany; [Boellaard, Ronald] Amsterdam Univ Med Ctr, Locat VUMC, Dept Radiol & Nucl Med, Amsterdam, Netherlands	University of Groningen; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Technische Universitat Dresden; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Helmholtz Association; Helmholtz-Zentrum Dresden-Rossendorf (HZDR); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ)	Pfaehler, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, Groningen, Netherlands.	e.a.g.pfaehler@umcg.nl	Zwanenburg, Alex/AAF-6476-2020	Zwanenburg, Alex/0000-0002-0342-9545; Pfaehler, Elisabeth/0000-0002-6160-3011	Netherlands Organisation for Scientific Research (NWO) [14929]; Netherlands Organisation for Health Research and Development [10-10400-98-14002]; Dutch Cancer Society, POINTING project [10034]	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Cancer Society, POINTING project	EP, JdJ, and RB are part of the research program STRaTeGy with project number 14929, which is (partly) financed by the Netherlands Organisation for Scientific Research (NWO). RB is financially supported by the Netherlands Organisation for Health Research and Development [grant 10-10400-98-14002] and by the Dutch Cancer Society, POINTING project, grant 10034.	AMADASUN M, 1989, IEEE T SYST MAN CYB, V19, P1264, DOI 10.1109/21.44046; Avanzo M, 2017, PHYS MEDICA, V38, P122, DOI 10.1016/j.ejmp.2017.05.071; CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F; Coroller TP, 2015, RADIOTHER ONCOL, V114, P345, DOI 10.1016/j.radonc.2015.02.015; Data TA, 2016, RADIOMICS IMAGES ARE, P278; Davatzikos C, 2018, J MED IMAGING, V5, DOI 10.1117/1.JMI.5.1.011018; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2017, EUR J NUCL MED MOL I, V44, P151, DOI 10.1007/s00259-016-3427-0; Johnson, 2015, ITK SOFTWARE GUIDE I; Leijenaar R., 2015, EUR J CANCER, V48, P441, DOI DOI 10.1016/J.EJCA.2011.11.036.RADI0MICS; Nioche C, 2018, CANCER RES, V78, P4786, DOI 10.1158/0008-5472.CAN-18-0125; Parekh V, 2017, EXPERT REV PRECIS ME, V1, P1, DOI [10.1080/23808993.2016, DOI 10.1080/23808993.2016.1164013.RADIOMICS]; Parmar C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11044; SHANMUGAN KS, 1981, IEEE T GEOSCI REMOTE, V19, P153, DOI 10.1109/TGRS.1981.350344; SUN CJ, 1983, COMPUT VISION GRAPH, V23, P341, DOI 10.1016/0734-189X(83)90032-4; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Thibault G, 2014, IEEE T BIO-MED ENG, V61, P630, DOI 10.1109/TBME.2013.2284600; Traverso A, RADIOMICS ONTOLOGY; Vallieres M, 2015, PHYS MED BIOL, V60, P5471, DOI 10.1088/0031-9155/60/14/5471; Zhang Lifei, 2015, Med Phys, V42, P1341, DOI 10.1118/1.4908210; Zwanenburg A, 2017, RADIOTHER ONCOL, V123, pS914, DOI 10.1016/S0167-8140(17)32209-0; Zwanenburg A., 2016, RADIOLOGY, DOI DOI 10.1148/RADIOL.2020191145	22	37	37	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212223	10.1371/journal.pone.0212223	http://dx.doi.org/10.1371/journal.pone.0212223			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785937	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000052
J	Baio, FHR; Antuniassi, UR; Castilho, BR; Teodoro, PE; da Silva, EE				Rojo Baio, Fabio Henrique; Antuniassi, Ulisses Rocha; Castilho, Bruno Rodeguer; Teodoro, Paulo Eduardo; da Silva, Eder Eujacio			Factors affecting aerial spray drift in the Brazilian Cerrado	PLOS ONE			English	Article								Pesticides aerial application may results in the drift to neighboring areas if some application technology is not well executed. This phenomenon should be minimized to reduce environmental risks and agricultural production costs. This work aimed to investigate the interaction of environmental conditions, surrounding distance, and application conditions influencing spray drift in aerial applications. Sampling data from aerial sprays were collected during three agricultural years (from 2012 to 2014) in fields cultivated with sorghum, millet, soybean, corn, and cotton. The following variables were evaluated: application swath width, application rate, distance from the applied field, wind speed, relative humidity, and temperature. The estimated Pearson's correlations and path analysis identified that application rate and distance from the applied field and application were the variables that most influenced drift. Equations relating spray drift in function of distance from the applied field and application rate were adjusted in function of the variable, and a response surface model was constructed to estimate drift. The major pesticide class sprayed with aircraft in the Brazilian Cerrado was insecticide, followed by fungicide. This scenario shows the potential hazard risk of spray drift over the environment. The concentration of the drift deposits decreased as surrounding distance and application rate were increased. A mathematical equation of drift prediction was established, where the variables that contributed most to drift deposits were surrounding distance and wind speed. Thus, it is very important to monitor and respect the wind speed limits during the aerial spraying, mainly when there is any risk potential associated with pesticide exposure over the downwind direction.	[Rojo Baio, Fabio Henrique; Castilho, Bruno Rodeguer; Teodoro, Paulo Eduardo; da Silva, Eder Eujacio] UFMS Chapadao Do Sul Campus, Chapadao Do Sul, MS, Brazil; [Antuniassi, Ulisses Rocha] Unesp FCA, Botucatu, SP, Brazil	Universidade Estadual Paulista	Baio, FHR (corresponding author), UFMS Chapadao Do Sul Campus, Chapadao Do Sul, MS, Brazil.	fabiobaio@ufms.br	SILVA, EDER EUJACIO/J-6094-2018; Baio, Fábio H.R./A-3432-2017; Baio, Fábio Henrique Rojo/M-6201-2019	Baio, Fábio H.R./0000-0002-9522-0342; Baio, Fábio Henrique Rojo/0000-0002-9522-0342; TEODORO, PAULO/0000-0002-8236-542X	CNPq	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	All authors thanks to CNPq, for the financial support, and the company Teonar Agricola de Chapadao do Sul/MS, for the technical support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; To CNPq, for the financial support, and the company Teonar Agricola de Chapadao do Sul/MS, for the technical support.	Al Heidary M, 2014, CROP PROT, V63, P120, DOI 10.1016/j.cropro.2014.05.006; Alves GS, 2014, PLANTA DANINHA, V32, P861, DOI 10.1590/S0100-83582014000400021; American Society of Agricultural and Biological Engineers (ASABE), 2009, S5721 ASABE, P1; Antuniassi U. R., 2014, Aspects of Applied Biology, P279; Antuniassi UR, 2015, OUTLOOKS PEST MANAGE, V26, P12, DOI [10.1564/v26_feb_04, DOI 10.1564/V26_FEB_04, DOI 10.1564/V26_]; Arvidsson T, 2011, PEST MANAG SCI, V67, P586, DOI 10.1002/ps.2114; Bhering LL, 2017, CROP BREED APPL BIOT, V17, P187, DOI 10.1590/1984-70332017v17n2s29; Bueno MR, 2017, BIOSYST ENG, V154, P35, DOI 10.1016/j.biosystemseng.2016.10.017; Cardoso M.R.D., 2015, ACTA GEOGR FICA, V8, P40, DOI DOI 10.5654/ACTA.V8I16.1384; da Cunha JPAR, 2017, ENG AGR-JABOTICABAL, V37, P493, DOI [10.1590/1809-4430-Eng.Agric.v37n3p493-501/2017, 10.1590/1809-4430-eng.agric.v37n3p493-501/2017]; de Cerqueira DTR, 2012, APPL ENG AGRIC, V28, P825; Donkersley P, 2011, CROP PROT, V30, P931, DOI 10.1016/j.cropro.2011.03.020; Embraer, 2018, AER IP; Ferguson JC, 2015, CROP PROT, V76, P1, DOI 10.1016/j.cropro.2015.06.008; Gil E, 2014, CROP PROT, V56, P58, DOI 10.1016/j.cropro.2013.10.018; Gregorio E, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16040499; Gregorio E, 2014, ATMOS ENVIRON, V82, P83, DOI 10.1016/j.atmosenv.2013.09.028; Hilz E, 2013, CROP PROT, V44, P75, DOI 10.1016/j.cropro.2012.10.020; Jiao LZ, 2016, COMPUT ELECTRON AGR, V121, P135, DOI 10.1016/j.compag.2015.12.006; Kim KH, 2017, SCI TOTAL ENVIRON, V575, P525, DOI 10.1016/j.scitotenv.2016.09.009; Micronair, 2018, MICR AU5000 AT; MONTGOMERY D. C., 2001, INTRO LINEAR REGRESS; Nuyttens D, 2017, BIOSYST ENG, V154, P14, DOI 10.1016/j.biosystemseng.2016.09.013; PCIL, 2018, COR PCILBASE; Baio FHR, 2018, AGRON J, V110, P1254, DOI 10.2134/agronj2017.12.0718; Salcedo R, 2017, BIOSYST ENG, V154, P76, DOI 10.1016/j.biosystemseng.2016.09.001; SALYANI M, 1992, T ASAE, V35, P1113, DOI 10.13031/2013.28708; SatLoc, 2018, LITESTAR; Sigma-Aldrich, 2018, TWEEN 80; Teodoro PE., 2014, J AGRON, V13, P23, DOI [10.3923/ja.2014.23.28, DOI 10.3923/JA.2014.23.28]; Trimble, 2018, PROD COMP MATR; Turner, 2018, TRIL LAB FLUOR; Vieira BC, 2018, APPL ENG AGRIC, V34, P507, DOI 10.13031/aea.12587; YATES WE, 1978, WEED SCI, V26, P597, DOI 10.1017/S0043174500064638; Zhang B, 2018, BIOSYST ENG, V166, P184, DOI 10.1016/j.biosystemseng.2017.11.017	35	5	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212289	10.1371/journal.pone.0212289	http://dx.doi.org/10.1371/journal.pone.0212289			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779797	Green Submitted, gold, Green Published			2022-12-26	WOS:000459062900039
J	Kudriaeva, A; Kuzina, ES; Zubenko, O; Smirnov, IV; Belogurov, A				Kudriaeva, Anna; Kuzina, Ekaterina S.; Zubenko, Oleg; Smirnov, Ivan, V; Belogurov, Alexey, Jr.			Charge-mediated proteasome targeting	FASEB JOURNAL			English	Article						ubiquitin-independent degradation; myelin basic protein; direct proteasomal signal; proteasome recognition; PA28; 11S; REG regulatory subunit	MYELIN BASIC-PROTEIN; ORNITHINE-DECARBOXYLASE; MULTIPLE-SCLEROSIS; DISTINCT MECHANISMS; 20S PROTEASOMES; PA28 ALPHA; DEGRADATION; CELL; RECOGNITION; PHOSPHORYLATION	A majority of thousands of intracellular mammalian proteins are recognized by proteasome only being conjugated with ubiquitin (Ub), representing a universal degradation signal operated by the ubiquitination system. Ub-independent proteasome targeting is rationalized by the existence of 2 types of direct proteasome signals (DPSs), specific amino acid sequences or post-translational modifications, which are recognized by proteasome regulatory subunits. Historically, the first type was shown to exist in ornithine decarboxylase, whereas acetylation of core histones recently was reported as a second type of DPS. Here we declare a third type, representing charge-mediated DPS. This discovered DPS may be classified as a monopartite composition- but not sequence-dependent element of similar to 70 angstrom in length enriched in basic and flexible amino acids. This type of degradation signal, which may be provided by cationic chemicals, is most efficiently engaged by proteasomes capped with regulator (REG)alpha or REG gamma in an ATP-independent manner. Taken together, our findings suggest a novel modality of proteasome-substrate interrelation bypassing ubiquitination.-Kudriaeva, A., Kuzina, E. S., Zubenko, O., Smirnov, I. V., Belogurov, A. Charge-mediated proteasome targeting.	[Kudriaeva, Anna; Kuzina, Ekaterina S.; Zubenko, Oleg; Smirnov, Ivan, V; Belogurov, Alexey, Jr.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Smirnov, Ivan, V] Kazan Fed Univ, Kazan, Russia; [Belogurov, Alexey, Jr.] Lomonosov Moscow State Univ, Dept Fundamental Med, Moscow, Russia; [Kuzina, Ekaterina S.] Yale Univ, Sch Med, New Haven, CT USA	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Kazan Federal University; Lomonosov Moscow State University; Yale University	Belogurov, A (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia.	belogurov@ibch.ru	Belogurov, Alexey/L-5859-2017; Smirnov, Ivan/N-5635-2017	Belogurov, Alexey/0000-0002-2033-9621; Smirnov, Ivan/0000-0002-0384-6568; Kuzina, Ekaterina/0000-0002-5468-0262	Russian Scientific Foundation Project [14-14-00585];  [CPi 2445.2013.4]	Russian Scientific Foundation Project(Russian Science Foundation (RSF)); 	The authors thank Prof. Aaron Ciechanover (Technion-Israel Institute of Technology, Haifa, Israel) for many fruitful discussions, critical reading of the manuscript, and providing reagents and plasmids. The authors also thank Dr. Nikolai Bovin (Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry) and Dr. Alexey Khomutov (Engelhardt Institute of Molecular Biology, Moscow, Russia) for providing reagents; and Dr. Dmitry Staroverov (Shemyakin Ovchinnikov Institute of Bioorganic Chemistry) for assistance in flow cytometry. This study was performed in the framework of the Russian Scientific Foundation Project 14-14-00585 (Molecular mechanism and physiological significance of the ubiquitin-independent proteasomal degradation of the proteins), and personally supported by Presidential Fellowship C Pi 2445.2013.4 (to A.B. Jr.). The authors declare no conflicts of interest.	Ahmed MAM, 2010, BIOPHYS J, V99, P1247, DOI 10.1016/j.bpj.2010.06.022; Beenukumar RR, 2015, MICROB CELL, V2, P197, DOI 10.15698/mic2015.06.206; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov A, 2015, FASEB J, V29, P1901, DOI 10.1096/fj.14-259333; Belogurov A, 2014, J BIOL CHEM, V289, P17758, DOI 10.1074/jbc.M113.544247; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Boggs Joan M, 2014, BMC Res Notes, V7, P387, DOI 10.1186/1756-0500-7-387; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Ciechanover A, 2015, NAT REV MOL CELL BIO, V16, P322, DOI 10.1038/nrm3982; D'Souza CA, 2006, NEUROCHEM RES, V31, P1045, DOI 10.1007/s11064-006-9116-9; Eom JW, 1996, PLANT SCI, V115, P17, DOI 10.1016/0168-9452(96)04332-4; Fabre B, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145497; Fishbain S, 2015, NAT STRUCT MOL BIOL, V22, P214, DOI 10.1038/nsmb.2958; Forsthoefel AM, 2004, BIOCHEMISTRY-US, V43, P1972, DOI 10.1021/bi035894p; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Groettrup M, 1996, NATURE, V381, P166, DOI 10.1038/381166a0; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Johnston SC, 1997, PROTEIN SCI, V6, P2469; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Komorek J, 2010, J VIROL, V84, P2719, DOI 10.1128/JVI.02119-09; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Kuzina ES, 2013, DOKL BIOCHEM BIOPHYS, V453, P300, DOI 10.1134/S1607672913060070; Kuzina E, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/926394; LAMENSA JWE, 1993, J NEUROCHEM, V61, P987, DOI 10.1111/j.1471-4159.1993.tb03612.x; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Medveczky P, 2006, FEBS LETT, V580, P545, DOI 10.1016/j.febslet.2005.12.067; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Myers N, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800076; Nathan JA, 2013, CELL, V152, P1184, DOI 10.1016/j.cell.2013.01.037; Ottens AK, 2008, J NEUROCHEM, V104, P1404, DOI 10.1111/j.1471-4159.2007.05086.x; Pedraza L, 1997, NEURON, V18, P579, DOI 10.1016/S0896-6273(00)80299-8; Petrauskas V, 2015, J PHYS CHEM B, V119, P12164, DOI 10.1021/acs.jpcb.5b05767; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Pritzker LB, 2000, BIOCHEMISTRY-US, V39, P5374, DOI 10.1021/bi9925569; Qian MX, 2013, CELL, V153, P1012, DOI 10.1016/j.cell.2013.04.032; Raule M, 2014, BBA-MOL CELL RES, V1843, P1942, DOI 10.1016/j.bbamcr.2014.05.005; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; Sakata E, 2012, P NATL ACAD SCI USA, V109, P1479, DOI 10.1073/pnas.1119394109; Schrader J, 2016, SCIENCE, V353, P594, DOI 10.1126/science.aaf8993; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Smith GST, 2013, J NEUROSCI RES, V91, P349, DOI 10.1002/jnr.23166; Stapulionis R, 2008, J IMMUNOL, V180, P3946, DOI 10.4049/jimmunol.180.6.3946; Steinman L, 1996, CELL, V85, P299, DOI 10.1016/S0092-8674(00)81107-1; Stepanenko A A, 2012, Tsitol Genet, V46, P36; Tekaia F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-307; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Vassall KA, 2015, J MOL BIOL, V427, P1977, DOI 10.1016/j.jmb.2015.03.011; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; Wood DD, 1996, ANN NEUROL, V40, P18, DOI 10.1002/ana.410400106; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yang XP, 2011, NAT METHODS, V8, P659, DOI [10.1038/NMETH.1638, 10.1038/nmeth.1638]; Yu HQ, 2016, J BIOL CHEM, V291, P14526, DOI 10.1074/jbc.M116.727578; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; Zienowicz A, 2015, BIOCHEM BIOPH RES CO, V461, P136, DOI 10.1016/j.bbrc.2015.03.181	67	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6852	6866		10.1096/fj.201802237R	http://dx.doi.org/10.1096/fj.201802237R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811957				2022-12-26	WOS:000476114200015
J	Bousseau, S; Marchand, M; Soleti, R; Vergori, L; Hilairet, G; Recoquillon, S; Le Mao, M; Gueguen, N; Khiati, S; Clarion, L; Bakalara, N; Martinez, MC; Germain, S; Lenaers, G; Andriantsitohaina, R				Bousseau, Simon; Marchand, Marion; Soleti, Raffaella; Vergori, Luisa; Hilairet, Gregory; Recoquillon, Sylvain; Le Mao, Morgane; Gueguen, Naig; Khiati, Salim; Clarion, Ludovic; Bakalara, Norbert; Martinez, M. Carmen; Germain, Stephane; Lenaers, Guy; Andriantsitohaina, Ramaroson			Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization	FASEB JOURNAL			English	Article						angiogenesis; cancer growth; pharmacotherapy; endothelial metabolism; glycosylation	ANGIOGENESIS; RECEPTOR; PROLIFERATION; METABOLISM; PFKFB3; GLYCOSYLATION; GALECTIN-1; MIGRATION; OXIDASE; CANCER	Angiogenesis is a complex process leading to the growth of new blood vessels from existing vasculature, triggered by local proangiogenic factors such as VEGF. An excess of angiogenesis is a recurrent feature of various pathologic conditions such as tumor growth. Phostines are a family of synthetic glycomimetic compounds that exhibit anticancer properties, and the lead compound 3-hydroxy-4,5-bis-benzyloxy-6-benzyloxymethyl-2-phenyl2-oxo-25-[1,2]oxaphosphinane (PST 3.1a) shows antiglioblastoma properties both in vitro and in vivo. In the present study, we assessed the effect of PST 3.1a on angiogenesis and endothelial metabolism. In vitro, PST 3.1a (10 mu M) inhibited all steps that regulate angiogenesis, including migration, proliferation, adhesion, and tube formation. In vivo, PST 3.1a reduced intersegmental vessel formation and vascularization of the subintestinal plexus in zebrafish embryos and also altered pathologic angiogenesis and glioblastoma progression in vivo. Mechanistically, PST 3.1a altered interaction of VEGF receptor 2 and glycosylation-regulating protein galectin-1, a key component regulating angiogenesis associated with tumor resistance. Thus, these data show that use of PST 3.1a is an innovative approach to target angiogenesis.Bousseau, S., Marchand, M., Soleti, R., Vergori, L., Hilairet, G., Recoquillon, S., Le Mao, M., Gueguen, N., Khiati, S., Clarion, L., Bakalara, N., Martinez, M. C., Germain, S., Lenaers, G., Andriantsitohaina, R. Phostine 3.1a as a pharmacological compound with antiangiogenic properties against diseases with excess vascularization.	[Bousseau, Simon; Soleti, Raffaella; Vergori, Luisa; Hilairet, Gregory; Recoquillon, Sylvain; Martinez, M. Carmen; Andriantsitohaina, Ramaroson] Univ Angers, INSERM Unite Mixte Rech UMR 1063, Stress Oxydant & Pathol Metabol, Inst MitoVasc, Angers, France; [Bousseau, Simon; Le Mao, Morgane; Gueguen, Naig; Khiati, Salim; Lenaers, Guy] Univ Angers, Inst MitoVasc, INSERM Unite 1083, MitoLab,Ctr Natl Rech CNRS UMR 6015, Angers, France; [Marchand, Marion; Germain, Stephane] Paris Sci & Lettres PSL Res Univ, CIRB, Coll France, CNRS,INSERM, Paris, France; [Clarion, Ludovic] Phostin SAS Societe Act Simplifiee, Montpellier, France; [Bakalara, Norbert] Inst Neurosci Montpellier, INSERM Unite 1051, Montpellier, France	Universite d'Angers; Universite d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite de Montpellier	Andriantsitohaina, R (corresponding author), Univ Angers, INSERM UMR 1063, Stress Oxydant & Pathol Metabol, Inst Biol Sante, 4 Rue Larrey, F-49933 Angers, France.	ramaroson.andriantsitohaina@univ-angers.fr	soleti, raffaella/AAC-1678-2021; Lenaers, guy/X-4727-2019; SOLETI, RAFFAELLA/ABB-5455-2020; Naig, Gueguen/K-2699-2015; Germain, Stephane/E-2301-2016	SOLETI, RAFFAELLA/0000-0002-0271-0490; Naig, Gueguen/0000-0002-3094-8121; Germain, Stephane/0000-0001-5992-1275; marchand, marion/0000-0001-7247-5003; andriantsitohaina, ramaroson/0000-0002-4770-3585; Bousseau, Simon/0000-0002-8678-3725; Martinez, M Carmen/0000-0003-3897-7397	French Ministry of Education and Research (Universite d'Angers); INSERM; Region Pays de la Loire; Angers Loire Metropole; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	French Ministry of Education and Research (Universite d'Angers); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Pays de la Loire(Region Pays de la Loire); Angers Loire Metropole(Region Pays de la Loire); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	The authors thank the Service Commun d'Animalerie Hospitalo-Universitaire (SCAHU) staff (Universite d'Angers) for taking care of mice, Dr. Christine Rampon and Matthieu Boukaissi [Center for Interdisciplinary Research in Biology (CIRB), Centre National de la Recherche (CNRS) Unite Mixte de Recherche (UMR) 7241, College de France] for the access to the zebrafish facilities, the staff of Plateforme d'Analyse Cellulaire et Moleculaire for the quantitative PCR experiments, and Dr. Zahra Hassani (Phost'in SAS) for experiment advice. S.B. is a recipient of a doctoral fellowship from French Ministry of Education and Research (Universite d'Angers). This work was supported by INSERM, Region Pays de la Loire, Angers Loire Metropole, Universite d'Angers, and the Centre Hospitalier Universitaire d'Angers. S.G., G.L., and R.A. are colast authors. The authors declare no conflicts of interest.	Valdes-Rives SA, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7403747; Arbab AS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122732; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bignon M, 2011, BLOOD, V118, P3979, DOI 10.1182/blood-2010-10-313296; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Chandler KB, 2017, J PROTEOME RES, V16, P677, DOI 10.1021/acs.jproteome.6b00738; Clarion L, 2014, J MED CHEM, V57, P8293, DOI 10.1021/jm500522y; Clarion L, 2012, J MED CHEM, V55, P2196, DOI 10.1021/jm201428a; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; De Bock K, 2013, CELL METAB, V18, P634, DOI 10.1016/j.cmet.2013.08.001; Dimova I, 2014, J BUON, V19, P15; Duluc L, 2013, INT J BIOCHEM CELL B, V45, P783, DOI 10.1016/j.biocel.2013.01.007; Eelen G, 2018, PHYSIOL REV, V98, P3, DOI 10.1152/physrev.00001.2017; Elola MT, 2015, BIOCHEM J, V469, P1, DOI 10.1042/BJ20150461; Griffioen AW, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.01; Harjes U, 2016, CRIT REV ONCOL HEMAT, V97, P15, DOI 10.1016/j.critrevonc.2015.10.011; Hassani Z, 2017, MOL CANCER RES, V15, P1376, DOI 10.1158/1541-7786.MCR-17-0120; Ito K, 2012, CANCER METAST REV, V31, P763, DOI 10.1007/s10555-012-9388-2; Ito K, 2011, ANGIOGENESIS, V14, P293, DOI 10.1007/s10456-011-9213-5; Le QT, 2005, J CLIN ONCOL, V23, P8932, DOI 10.1200/JCO.2005.02.0206; Li B, 2016, MOL MED REP, V13, P469, DOI 10.3892/mmr.2015.4492; Liu Y, 2015, INT J ADV COMPUT SC, V6, P1; Markowska AI, 2011, J BIOL CHEM, V286, P29913, DOI 10.1074/jbc.M111.226423; McIntyre A, 2015, EMBO MOL MED, V7, P368, DOI 10.15252/emmm.201404271; Mendez-Huergo SP, 2017, CURR OPIN IMMUNOL, V45, P8, DOI 10.1016/j.coi.2016.12.003; Merchan JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013699; Potente M, 2017, ANNU REV PHYSIOL, V79, P43, DOI 10.1146/annurev-physiol-021115-105134; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Stanley P, 2014, CELL, V156, P625, DOI 10.1016/j.cell.2014.01.059; Stapor P, 2014, J CELL SCI, V127, P4331, DOI 10.1242/jcs.153908; Treps L, 2016, PHARMACOL REV, V68, P872, DOI 10.1124/pr.116.012492; Yalcin A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.292; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816	35	3	3	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5864	5875		10.1096/fj.201801450RRR	http://dx.doi.org/10.1096/fj.201801450RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817178	Bronze, Green Submitted			2022-12-26	WOS:000466932600006
J	Kapellos, TS; Taylor, L; Feuerborn, A; Valaris, S; Hussain, MT; Rainger, GE; Greaves, DR; Iqbal, AJ				Kapellos, Theodore S.; Taylor, Lewis; Feuerborn, Alexander; Valaris, Sophia; Hussain, Mohammed T.; Rainger, G. E.; Greaves, David R.; Iqbal, Asif J.			Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment	FASEB JOURNAL			English	Article						innate immunity; leukocyte trafficking; adhesion	CB2 RECEPTOR; ACTIVATION; CELLS; 2-ARACHIDONOYLGLYCEROL; INHIBITION; EXPRESSION; MIGRATION; RESPONSES; ADHESION; ENDOCANNABINOIDS	Cannabinoid receptor (CB)(2) is an immune cell-localized GPCR that has been hypothesized to regulate the magnitude of inflammatory responses. However, there is currently no consensus as to the mechanism by which CB2 mediates its anti-inflammatory effects in vivo. To address this question, we employed a murine dorsal air pouch model with wild-type and CB2-/- 8-12-wk-old female and male C57BL/6 mice and found that acute neutrophil and lymphocyte antigen 6 complex, locus C-hi monocyte recruitment in response to Zymosan was significantly enhanced in CB2-/- mice. Additionally, levels of matrix metalloproteinase 9 and the chemokines C-C motif chemokine ligand (CCL)2, CCL4, and C-X-C motif chemokine ligand 10 in CB2-/- pouch exudates were elevated at earlier time points. Importantly, using mixed bone marrow chimeras, we revealed that the proinflammatory phenotype in CB2-/- mice is neutrophil-intrinsic rather than stromal cell-dependent. Indeed, neutrophils isolated from CB2-/- mice exhibited an enhanced migration-related transcriptional profile and increased adhesive phenotype, and treatment of human neutrophils with a CB2 agonist blocked their endothelial transmigration. Overall, we have demonstrated that CB2 plays a nonredundant role during acute neutrophil mobilization to sites of inflammation and, as such, it could represent a therapeutic target for the development of novel anti-inflammatory compounds to treat inflammatory human diseases.Kapellos, T. S., Taylor, L., Feuerborn, A., Valaris, S., Hussain, M. T., Rainger, G. E., Greaves, D. R., Iqbal, A. J. Cannabinoid receptor 2 deficiency exacerbates inflammation and neutrophil recruitment.	[Kapellos, Theodore S.; Taylor, Lewis; Feuerborn, Alexander; Valaris, Sophia; Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Hussain, Mohammed T.; Rainger, G. E.; Iqbal, Asif J.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England	University of Oxford; University of Birmingham	Greaves, DR; Iqbal, AJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England.; Iqbal, AJ (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England.	david.greaves@path.ox.ac.uk; a.j.iqbal@bham.ac.uk		Iqbal, Asif/0000-0002-3224-3651	British Heart Foundation (BHF) Programme Grant [RG/15/10/31485]; BHF Studentship Award [FS/12/69/30008]; Edward P. Abraham Trust [RF 231]; BHF Centre of Research Excellence [RE/13/1/30181]; University of Birmingham Fellowship	British Heart Foundation (BHF) Programme Grant; BHF Studentship Award; Edward P. Abraham Trust; BHF Centre of Research Excellence; University of Birmingham Fellowship	The authors thank Angela Curran (Biomedical Sciences Unit, Oxford, United Kingdom) for excellent technical assistance. This work was supported by a British Heart Foundation (BHF) Programme Grant (RG/15/10/31485), and a BHF Studentship Award (FS/12/69/30008 to L.T.). T.S.K. received funding from the Edward P. Abraham Trust (RF 231). A.J.I. acknowledges support from the BHF Centre of Research Excellence (RE/13/1/30181). A.J.I. is supported by a University of Birmingham Fellowship. T.S.K. and L.T. share first authorship. D.R.G. and A.J.I. share senior authorship. The authors declare no conflicts of interest.	Adhikary S, 2012, BLOOD, V120, P3741, DOI 10.1182/blood-2012-06-435362; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; Batkai S, 2007, FASEB J, V21, P1788, DOI 10.1096/fj.06-7451com; Batkai S, 2012, BRIT J PHARMACOL, V165, P2450, DOI 10.1111/j.1476-5381.2011.01410.x; Chen DJ, 2017, ACTA PHARMACOL SIN, V38, P312, DOI 10.1038/aps.2016.149; Chiurchiu V, 2015, IMMUNOLOGY, V144, P352, DOI 10.1111/imm.12441; Comelli F, 2007, BRIT J PHARMACOL, V152, P787, DOI 10.1038/sj.bjp.0707425; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; Coopman K, 2007, INT IMMUNOPHARMACOL, V7, P360, DOI 10.1016/j.intimp.2006.11.008; Costola-De-Souza C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077706; Csoka B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006409; DAWSON J, 1991, INT J TISSUE REACT, V13, P171; Defer N, 2009, FASEB J, V23, P2120, DOI 10.1096/fj.09-129478; Di Filippo C, 2004, J LEUKOCYTE BIOL, V75, P453, DOI 10.1189/jlb.0703303; Duerr GD, 2015, LIFE SCI, V138, P8, DOI 10.1016/j.lfs.2014.11.005; Engel MA, 2010, J PHYSIOL PHARMACOL, V61, P89; Gasperi V, 2014, INT J BIOCHEM CELL B, V51, P79, DOI 10.1016/j.biocel.2014.03.028; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gokoh M, 2005, FEBS LETT, V579, P6473, DOI 10.1016/j.febslet.2005.10.030; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Gui H, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/741303; Halade GV, 2013, PHARMACOL THERAPEUT, V139, P32, DOI 10.1016/j.pharmthera.2013.03.009; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Kapellos TS, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4315412; Kurihara R, 2006, J BIOL CHEM, V281, P12908, DOI 10.1074/jbc.M510871200; Laprairie RB, 2012, BRIT J PHARMACOL, V167, P1583, DOI 10.1111/j.1476-5381.2012.02175.x; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Mackie K, 2008, J NEUROENDOCRINOL, V20, P10, DOI 10.1111/j.1365-2826.2008.01671.x; Maresz K, 2007, NAT MED, V13, P492, DOI 10.1038/nm1561; MARTIN SW, 1994, J PHARMACOL TOX MET, V32, P139, DOI 10.1016/1056-8719(94)90067-1; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McHugh D, 2008, MOL PHARMACOL, V73, P441, DOI 10.1124/mol.107.041863; Miller AM, 2008, BRIT J PHARMACOL, V153, P299, DOI 10.1038/sj.bjp.0707523; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Netherland CD, 2010, ATHEROSCLEROSIS, V213, P102, DOI 10.1016/j.atherosclerosis.2010.07.060; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Oka S, 2004, J LEUKOCYTE BIOL, V76, P1002, DOI 10.1189/jlb.0404252; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Palazuelos J, 2008, J BIOL CHEM, V283, P13320, DOI 10.1074/jbc.M707960200; Persidsky Y, 2015, J NEUROIMMUNE PHARM, V10, P302, DOI 10.1007/s11481-015-9591-3; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406; Raborn ES, 2014, LIFE SCI, V104, P15, DOI 10.1016/j.lfs.2014.04.008; Ramirez SH, 2012, J NEUROSCI, V32, P4004, DOI 10.1523/JNEUROSCI.4628-11.2012; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Sadik CD, 2011, TRENDS IMMUNOL, V32, P452, DOI 10.1016/j.it.2011.06.008; Sardinha J, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/978678; Sexton M, 2013, INFLAMMOPHARMACOLOGY, V21, P253, DOI 10.1007/s10787-012-0133-9; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Taylor L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10682; Tschop J, 2009, J IMMUNOL, V183, P499, DOI 10.4049/jimmunol.0900203; Turcotte C, 2016, CELL MOL LIFE SCI, V73, P4449, DOI 10.1007/s00018-016-2300-4; Turcotte C, 2015, J LEUKOCYTE BIOL, V97, P1049, DOI 10.1189/jlb.3RU0115-021R; Wang H, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw677; Wen J, 2015, NEUROPHARMACOLOGY, V99, P196, DOI 10.1016/j.neuropharm.2015.07.010; Witkamp R, 2016, EUR J PHARMACOL, V785, P96, DOI 10.1016/j.ejphar.2015.08.051; Zarruk JG, 2012, STROKE, V43, P211, DOI 10.1161/STROKEAHA.111.631044; Zhang M, 2009, MICROVASC RES, V78, P86, DOI 10.1016/j.mvr.2009.03.005; Zhao Y, 2010, J CARDIOVASC PHARM, V55, P292, DOI 10.1097/FJC.0b013e3181d2644d	64	33	33	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6154	6167		10.1096/fj.201802524R	http://dx.doi.org/10.1096/fj.201802524R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30799631	Green Published, hybrid			2022-12-26	WOS:000466932600029
J	Mazzone, A; Gibbons, SJ; Eisenman, ST; Strege, PR; Zheng, TH; D'Amato, M; Ordog, T; Fernandez-Zapico, ME; Farrugia, G				Mazzone, Amelia; Gibbons, Simon J.; Eisenman, Seth T.; Strege, Peter R.; Zheng, Tenghao; D'Amato, Mauro; Ordog, Tamas; Fernandez-Zapico, Martin E.; Farrugia, Gianrico			Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins	FASEB JOURNAL			English	Article						ion channels; gastrointestinal tract; calcium-activated chloride currents; TMEM16A; SNP	CA2+-ACTIVATED CL-CHANNEL; INTERSTITIAL-CELLS; CHLORIDE CHANNELS; TMEM16A; HEDGEHOG; CANCER; INHIBITION; IDENTIFICATION; PROLIFERATION; MARKER	The Ca2+-activated Cl- channel, anoctamin 1 (Ano1, also known as transmembrane protein 16A) contributes to intestinal pacemaking, fluid secretion, cellular excitability, and tissue development. The human ANO1 promoter contains binding sites for the glioma-associated oncogene (Gli) proteins. We investigated regulation of ANO1 transcription by Gli. ANO1 promoter activity was determined using a luciferase reporter system. Binding and functional effects of Glis on ANO1 transcription and expression were demonstrated by chromatin immunoprecipitation, small interfering RNA knockdown, PCR, immunolabeling, and recordings of Ca2+-activated Cl- currents in human embryonic kidney 293 (HEK293) cells. Results from previous genome-wide association studies were used to test ANO1 promoter polymorphisms for association with disease. Gli1 and Gli2 bound to the promoter and repressed ANO1 transcription. Repression depended on Gli binding to a site close to the ANO1 transcriptional start site. Mutation of this site prevented Gli binding and transcriptional repression. Knockdown of Gli expression and inhibition of Gli activity increased expression of ANO1 RNA and Ca2+-activated Cl- currents in HEK293 cells. A single-nucleotide polymorphism prevented Gli binding and showed association with irritable bowel syndrome. We conclude that Gli1 and Gli2 repress ANO1 by a novel mechanism that is independent of Gli cleavage and that has a role in gastrointestinal function.Mazzone, A., Gibbons, S. J., Eisenman, S. T., Strege, P. R., Zheng, T., D'Amato, M., Ordog, T., Fernandez-Zapico, M. E., Farrugia, G. Direct repression of anoctamin 1 (ANO1) gene transcription by Gli proteins.	[Mazzone, Amelia; Gibbons, Simon J.; Eisenman, Seth T.; Strege, Peter R.; Ordog, Tamas; Farrugia, Gianrico] Mayo Clin, Enter NeuroSci, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55905 USA; [Zheng, Tenghao; D'Amato, Mauro] Karolinska Inst, Dept Med Solna, Stockholm, Sweden; [Zheng, Tenghao; D'Amato, Mauro] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [D'Amato, Mauro] Biodonostia Hlth Res Inst, San Sebastian, Spain; [D'Amato, Mauro] Basque Sci Fdn, Ikerbasque, San Sebastian, Spain	Mayo Clinic; Mayo Clinic; Karolinska Institutet; Karolinska Institutet; Instituto de Investigacion Sanitaria Biodonostia; Basque Foundation for Science	Gibbons, SJ; Farrugia, G (corresponding author), Mayo Clin, Div Gastroenterol & Hepatol, Enter NeuroSci Program, 200 First St SW, Rochester, MN 55905 USA.	gibbons.simon@mayo.edu; farrugia.gianrico@mayo.edu	D'Amato, Mauro/F-2450-2010; D'Amato, Mauro/B-5050-2019	D'Amato, Mauro/0000-0003-2743-5197; D'Amato, Mauro/0000-0003-2743-5197; Strege, Peter/0000-0003-4571-2207; MAZZONE, Amelia/0000-0001-6236-6962; Zheng, Tenghao/0000-0003-1587-7481	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK57061, DK84567]; Swedish Research Council (VR) Project [2017-02403]; Health Department of the Basque Government [2015111133]; Spanish Ministry of Economy and Competitiveness [Instituto de Salud Carlos III (ISCIII) Grant Fondo de Investigacion en Salud (FIS)] [PI17/00308]; NATIONAL CANCER INSTITUTE [R01CA136526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567, R01DK057061] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Research Council (VR) Project(Swedish Research Council); Health Department of the Basque Government; Spanish Ministry of Economy and Competitiveness [Instituto de Salud Carlos III (ISCIII) Grant Fondo de Investigacion en Salud (FIS)]; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Kristy Zodrow (Enteric NeuroSciences, Mayo Clinic) for assistance in manuscript preparation. This work is supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK57061 (to G.F. and S.J.G.) and DK84567 (to G.F., S.J.G.), the Swedish Research Council (VR) Project 2017-02403 (to M.D.A.), the Health Department of the Basque Government (Grant 2015111133 to M.D.A.), and the Spanish Ministry of Economy and Competitiveness [Instituto de Salud Carlos III (ISCIII) Grant Fondo de Investigacion en Salud (FIS) PI17/00308 to M.D.A.]. The authors declare no conflicts of interest.	Agyeman A, 2014, ONCOTARGET, V5, P4492, DOI 10.18632/oncotarget.2046; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Amjad A, 2015, J GEN PHYSIOL, V145, P285, DOI 10.1085/jgp.201411348; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Beyder A, 2016, AM J PHYSIOL-GASTR L, V311, pG581, DOI 10.1152/ajpgi.00237.2016; Beyder A, 2014, GASTROENTEROLOGY, V146, P1659, DOI 10.1053/j.gastro.2014.02.054; Bijos DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106190; Bonfiglio F, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13358; Bonfiglio F, 2018, GASTROENTEROLOGY, V155, P168, DOI 10.1053/j.gastro.2018.03.064; Buchholz B, 2014, KIDNEY INT, V85, P1058, DOI 10.1038/ki.2013.418; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Chen GC, 2011, BIOCHEM BIOPH RES CO, V404, P809, DOI 10.1016/j.bbrc.2010.12.065; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Danielsson J, 2015, ANESTHESIOLOGY, V123, P569, DOI 10.1097/ALN.0000000000000769; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Dutta AK, 2011, J BIOL CHEM, V286, P766, DOI 10.1074/jbc.M110.164970; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Espinosa I, 2008, AM J SURG PATHOL, V32, P210, DOI 10.1097/PAS.0b013e3181238cec; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Henstrom M, 2017, GUT, V66, P1725, DOI 10.1136/gutjnl-2016-313346; Holtmann GJ, 2016, LANCET GASTROENTEROL, V1, P133, DOI 10.1016/S2468-1253(16)30023-1; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jankipersadsing SA, 2017, GUT, V66, P756, DOI 10.1136/gutjnl-2016-312398; Kasai K, 2008, CANCER RES, V68, P7723, DOI 10.1158/0008-5472.CAN-07-6661; Kashyap MK, 2009, CANCER BIOL THER, V8, P36, DOI 10.4161/cbt.8.1.7090; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Malysz J, 2017, AM J PHYSIOL-GASTR L, V312, pG228, DOI 10.1152/ajpgi.00363.2016; Manoury B, 2010, J PHYSIOL-LONDON, V588, P2305, DOI 10.1113/jphysiol.2010.189506; Mao J, 2010, DEVELOPMENT, V137, P1721, DOI 10.1242/dev.044586; Mazzone A, 2015, FASEB J, V29, P152, DOI 10.1096/fj.14-258541; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; Mazzone A, 2011, J BIOL CHEM, V286, P13393, DOI 10.1074/jbc.M110.196089; McDermott A, 2005, DEVELOPMENT, V132, P345, DOI 10.1242/dev.01537; Mercer AJ, 2011, J NEUROPHYSIOL, V105, P321, DOI 10.1152/jn.00332.2010; Mimeault M, 2010, PHARMACOL REV, V62, P497, DOI 10.1124/pr.109.002329; Namkung W, 2010, FASEB J, V24, P4178, DOI 10.1096/fj.10-160648; O'Driscoll KE, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-35; Ousingsawat J, 2011, PFLUG ARCH EUR J PHY, V461, P579, DOI 10.1007/s00424-011-0947-0; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Romanenko VG, 2010, J BIOL CHEM, V285, P12990, DOI 10.1074/jbc.M109.068544; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sancho M, 2012, AM J PHYSIOL-RENAL, V302, pF390, DOI 10.1152/ajprenal.00344.2011; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Singh RD, 2014, J PHYSIOL-LONDON, V592, P4051, DOI 10.1113/jphysiol.2014.277152; Sondo E, 2014, BBA-BIOMEMBRANES, V1838, P89, DOI 10.1016/j.bbamem.2013.08.010; Stanich JE, 2011, AM J PHYSIOL-GASTR L, V301, pG1044, DOI 10.1152/ajpgi.00196.2011; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Strege PR, 2017, AM J PHYSIOL-GASTR L, V312, pG572, DOI 10.1152/ajpgi.00429.2016; Strege PR, 2015, AM J PHYSIOL-GASTR L, V309, pG743, DOI 10.1152/ajpgi.00074.2015; Sung TS, 2018, J PHYSIOL-LONDON, V596, P1549, DOI 10.1113/JP275478; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Ubby I, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-75; Veit G, 2012, MOL BIOL CELL, V23, P4188, DOI 10.1091/mbc.E12-06-0424; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wang BX, 2015, J MOL CELL CARDIOL, V82, P22, DOI 10.1016/j.yjmcc.2015.02.020; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8	64	11	11	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6632	6642		10.1096/fj.201802373R	http://dx.doi.org/10.1096/fj.201802373R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802137	Green Published			2022-12-26	WOS:000466932600065
J	Babinchak, WM; Haider, R; Dumm, BK; Sarkar, P; Surewicz, K; Choi, JK; Surewicz, WK				Babinchak, W. Michael; Haider, Raza; Dumm, Benjamin K.; Sarkar, Prottusha; Surewicz, Krystyna; Choi, Jin-Kyu; Surewicz, Witold K.			The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						TAR DNA-binding protein 43 (TDP-43) (TARDBP); amyloid; protein aggregation; intrinsically disordered protein; amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease); neurodegeneration; fibrillation; liquid-liquid phase separation	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; C-TERMINAL FRAGMENTS; AMYLOID FIBRILS; ALS; DISEASE; INCLUSIONS; PEPTIDE; MECHANISMS	Pathological aggregation of the transactive response DNA-binding protein of 43 kDa (TDP-43) is associated with several neurodegenerative disorders, including ALS, frontotemporal dementia, chronic traumatic encephalopathy, and Alzheimer's disease. TDP-43 aggregation appears to be largely driven by its low-complexity domain (LCD), which also has a high propensity to undergo liquid-liquid phase separation (LLPS). However, the mechanism of TDP-43 LCD pathological aggregation and, most importantly, the relationship between the aggregation process and LLPS remains largely unknown. Here, we show that amyloid formation by the LCD is controlled by electrostatic repulsion. We also demonstrate that the liquid droplet environment strongly accelerates LCD fibrillation and that its aggregation under LLPS conditions involves several distinct events, culminating in rapid assembly of fibrillar aggregates that emanate from within mature liquid droplets. These combined results strongly suggest that LLPS may play a major role in pathological TDP-43 aggregation, contributing to pathogenesis in neurodegenerative diseases.	[Babinchak, W. Michael; Haider, Raza; Dumm, Benjamin K.; Sarkar, Prottusha; Surewicz, Krystyna; Choi, Jin-Kyu; Surewicz, Witold K.] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Surewicz, WK (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	witold.surewicz@case.edu		Dumm, Benjamin/0000-0001-8824-7160; Babinchak, William/0000-0002-8299-287X	National Institutes of Health [F30 AG059350, T32 NS077888, T32 GM 007250, P01 AI106705, R01 NS103848, RF1 AG061797]; National Institutes of Health Office of Research Infrastructure Programs [S10 OD024996]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI106705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS077888, R01NS103848] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RF1AG061797, F30AG059350] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Office of Research Infrastructure Programs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants F30 AG059350 (to W. M. B.), T32 NS077888, T32 GM 007250, P01 AI106705 (to W. K. S.), R01 NS103848 (to W. K. S.), and RF1 AG061797 (to W. K. S.). Microscopy work was supported by National Institutes of Health Office of Research Infrastructure Programs Grant S10 OD024996. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afroz T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00062-0; Aguzzi A, 2016, TRENDS CELL BIOL, V26, P547, DOI 10.1016/j.tcb.2016.03.004; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Anderson EN, 2018, HUM MOL GENET, V27, P1366, DOI 10.1093/hmg/ddy047; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bigio EH, 2013, ACTA NEUROPATHOL, V125, P463, DOI 10.1007/s00401-013-1089-6; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; Chang XL, 2016, MOL NEUROBIOL, V53, P3349, DOI 10.1007/s12035-015-9264-5; Chen AKH, 2010, J AM CHEM SOC, V132, P1186, DOI 10.1021/ja9066207; Chen YJ, 2019, J BIOL CHEM, V294, P3696, DOI 10.1074/jbc.RA118.006351; Choi KJ, 2018, BIOCHEMISTRY-US, V57, P6822, DOI 10.1021/acs.biochem.8b01051; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Elbaum-Garfinkle S, 2015, DEV CELL, V35, P531, DOI 10.1016/j.devcel.2015.11.014; Fatima M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0226-y; Francis DJ, 2012, APPL MAGN RESON, V43, P405, DOI 10.1007/s00723-012-0369-y; Guenther EL, 2018, NAT STRUCT MOL BIOL, V25, P463, DOI 10.1038/s41594-018-0064-2; Guo M, 2005, FEBS LETT, V579, P3574, DOI 10.1016/j.febslet.2005.05.036; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Jiang LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23928; Jiang LL, 2013, J BIOL CHEM, V288, P19614, DOI 10.1074/jbc.M113.463828; Johnson BS, 2009, J BIOL CHEM, V284, P20329, DOI 10.1074/jbc.M109.010264; Josephs KA, 2016, ACTA NEUROPATHOL, V131, P571, DOI 10.1007/s00401-016-1537-1; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Li HR, 2018, J BIOL CHEM, V293, P6090, DOI 10.1074/jbc.AC117.001037; Li HR, 2018, BBA-PROTEINS PROTEOM, V1866, P214, DOI 10.1016/j.bbapap.2017.10.001; Li Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7183; Lim LZ, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002338; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Liu GCH, 2013, CHEM COMMUN, V49, P11212, DOI 10.1039/c3cc46762g; Liu-Yesucevitz L, 2014, J NEUROSCI, V34, P4167, DOI 10.1523/JNEUROSCI.2350-13.2014; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McGurk L, 2018, BIOCHEMISTRY-US, V57, P6923, DOI 10.1021/acs.biochem.8b00910; McGurk L, 2018, MOL CELL, V71, P703, DOI 10.1016/j.molcel.2018.07.002; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Mompean M, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002447; Mompean M, 2016, FEBS J, V283, P1242, DOI 10.1111/febs.13651; Mompean M, 2014, ARCH BIOCHEM BIOPHYS, V545, P53, DOI 10.1016/j.abb.2014.01.007; Nelson PT, 2016, J NEUROPATH EXP NEUR, V75, P482, DOI 10.1093/jnen/nlw033; Neumann M, 2007, ARCH NEUROL-CHICAGO, V64, P1388, DOI 10.1001/archneur.64.10.1388; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nonaka T, 2009, HUM MOL GENET, V18, P3353, DOI 10.1093/hmg/ddp275; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Prasad A, 2018, BIOCHIMIE, V150, P76, DOI 10.1016/j.biochi.2018.05.003; Robinson JL, 2013, ACTA NEUROPATHOL, V125, P121, DOI 10.1007/s00401-012-1055-8; Saini A, 2011, CHEMBIOCHEM, V12, P2495, DOI 10.1002/cbic.201100427; Sekiguchi T, 2014, J NEUROL NEUROSUR PS, V85, P85, DOI 10.1136/jnnp-2013-305617; Shimonaka S, 2016, J BIOL CHEM, V291, P8896, DOI 10.1074/jbc.M115.713552; Smethurst P, 2015, NEUROPATH APPL NEURO, V41, P578, DOI 10.1111/nan.12206; St George-Hyslop P, 2018, BRAIN RES, V1693, P11, DOI 10.1016/j.brainres.2018.04.036; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Stoll S, 2007, BIOL MAGN RESON, V27, P299; Stsiapura VI, 2008, J PHYS CHEM B, V112, P15893, DOI 10.1021/jp805822c; Sun YL, 2017, BIOCHEMISTRY-US, V56, P809, DOI 10.1021/acs.biochem.6b01088; Wang AL, 2018, EMBO J, V37, DOI 10.15252/embj.201797452; Wang L, 2018, BIOCHEM BIOPH RES CO, V499, P189, DOI 10.1016/j.bbrc.2018.03.121; Wegmann S, 2018, EMBO J, V37, DOI 10.15252/embj.201798049; Wiesner D, 2018, EXP NEUROL, V299, P15, DOI 10.1016/j.expneurol.2017.09.011; Williams TL, 2015, ACS CHEM NEUROSCI, V6, P1972, DOI 10.1021/acschemneuro.5b00229; Yang CX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015878; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhu L, 2014, HUM MOL GENET, V23, P6863, DOI 10.1093/hmg/ddu409; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	68	122	122	10	61	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6306	6317		10.1074/jbc.RA118.007222	http://dx.doi.org/10.1074/jbc.RA118.007222			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814253	Green Published, hybrid			2022-12-26	WOS:000468402000009
J	Golob-Urbanc, A; Rajcevic, U; Strmsek, Z; Jerala, R				Golob-Urbanc, Anja; Rajcevic, Uros; Strmsek, Ziga; Jerala, Roman			Design of split superantigen fusion proteins for cancer immunotherapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer therapy; T cell; antibody engineering; protein chimera; protein engineering; protein splicing; cancer immunotherapy; split protein; superantigen; T cell activation	STAPHYLOCOCCAL-ENTEROTOXIN-A; NAPTUMOMAB ESTAFENATOX; ANTIBODY; THERAPY; AGENTS; SITES; LINE	Several antibody-targeting cancer immunotherapies have been developed based on T cell activation at the target cells. One of the most potent activators of T cells are bacterial superantigens, which bind to major histocompatibility complex class II on antigen-presenting cells and activate T cells through T cell receptor. Strong T cell activation is also one of the main weaknesses of this strategy as it may lead to systemic T cell activation. To overcome the limitation of conventional antibody-superantigen fusion proteins, we have split a superantigen into two fragments, individually inactive, until both fragments came into close proximity and reassembled into a biologically active form capable of activating T cell response. A screening method based on fusion between SEA and coiled-coil heterodimers was developed that enabled detection of functional split SEA designs. The split SEA design that demonstrated efficacy in fusion with coiled-coil dimer forming polypeptides was fused to a single chain antibody specific for tumor antigen CD20. This design selectively activated T cells by split SEA-scFv fusion binding to target cells.	[Golob-Urbanc, Anja; Strmsek, Ziga; Jerala, Roman] Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia; [Golob-Urbanc, Anja; Strmsek, Ziga] Univ Ljubljana, Grad Sch Biomed, Ljubljana 1000, Slovenia; [Rajcevic, Uros] Blood Transfus Ctr Slovenia, Dept Res & Dev, Slajmerjeva 6, Ljubljana 1000, Slovenia	National Institute of Chemistry - Slovenia; University of Ljubljana	Jerala, R (corresponding author), Natl Inst Chem, Dept Synthet Biol & Immunol, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251	Slovenian Research Agency [P4-0176]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Grant P4-0176 (to R. J.) and for the Ph.D. study (to A. G.). The authors declare that they have no conflicts of interest with the contents of this article.	ABRAHMSEN L, 1995, EMBO J, V14, P2978, DOI 10.1002/j.1460-2075.1995.tb07300.x; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Baker MD, 2004, INT J MED MICROBIOL, V293, P529, DOI 10.1078/1438-4221-00298; Bracha-Drori K, 2004, PLANT J, V40, P419, DOI 10.1111/j.1365-313X.2004.02206.x; Brodin TN, 1998, ADV DRUG DELIVER REV, V31, P131, DOI 10.1016/S0169-409X(97)00097-5; Chen Y, 2009, PROTEIN SCI, V18, P399, DOI 10.1002/pro.42; Croset A, 2012, J BIOTECHNOL, V161, P336, DOI 10.1016/j.jbiotec.2012.06.038; DOHLSTEN M, 1991, P NATL ACAD SCI USA, V88, P9287, DOI 10.1073/pnas.88.20.9287; DOHLSTEN M, 1994, P NATL ACAD SCI USA, V91, P8945, DOI 10.1073/pnas.91.19.8945; DOHLSTEN M, 1995, CANCER IMMUNOL IMMUN, V41, P162, DOI 10.1007/s002620050214; DOHLSTEN M, 1993, INT J CANCER, V54, P482, DOI 10.1002/ijc.2910540321; Drobnak I, 2017, J AM CHEM SOC, V139, P8229, DOI 10.1021/jacs.7b01690; Erlandsson E, 2003, J MOL BIOL, V333, P893, DOI 10.1016/j.jmb.2003.09.009; Forsberg G, 2001, BRIT J CANCER, V85, P129, DOI 10.1054/bjoc.2001.1891; Forsberg G, 2010, J IMMUNOTHER, V33, P492, DOI 10.1097/CJI.0b013e3181d75820; Fraser J, 2000, MOL MED TODAY, V6, P125, DOI 10.1016/S1357-4310(99)01657-3; Giantonio BJ, 1997, J CLIN ONCOL, V15, P1994, DOI 10.1200/JCO.1997.15.5.1994; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; Gradisar H, 2013, NAT CHEM BIOL, V9, P362, DOI 10.1038/nchembio.1248; Hansen H., 2006, U. S. Patent, Patent No. [7,151,164, 7151164]; Hawkins RE, 2016, CLIN CANCER RES, V22, P3172, DOI 10.1158/1078-0432.CCR-15-0580; HEDLUND G, 1990, CELL IMMUNOL, V129, P426, DOI 10.1016/0008-8749(90)90218-G; Kang Ju-Seop, 2009, Korean Journal of Internal Medicine, V24, P1, DOI 10.3904/kjim.2009.24.1.1; Kent KP, 2008, J AM CHEM SOC, V130, P9664, DOI 10.1021/ja803782x; Kondo N, 2010, J BIOL CHEM, V285, P14681, DOI 10.1074/jbc.M109.067090; Litton MJ, 1997, AM J PATHOL, V150, P1607; Paulmurugan R, 2007, ANAL CHEM, V79, P2346, DOI 10.1021/ac062053q; Polyak MJ, 2008, J BIOL CHEM, V283, P18545, DOI 10.1074/jbc.M800784200; Proft T, 2003, CLIN EXP IMMUNOL, V133, P299, DOI 10.1046/j.1365-2249.2003.02203.x; Rosendahl A, 2000, METH MOL B, V145, P241; Santos DD, 2007, EXP HEMATOL, V35, P1366, DOI 10.1016/j.exphem.2007.05.022; SCHAD EM, 1995, EMBO J, V14, P3292, DOI 10.1002/j.1460-2075.1995.tb07336.x; Shaw DM, 2007, BRIT J CANCER, V96, P567, DOI 10.1038/sj.bjc.6603567; Shekhawat SS, 2011, CURR OPIN CHEM BIOL, V15, P789, DOI 10.1016/j.cbpa.2011.10.014; Smith MR, 2003, ONCOGENE, V22, P7359, DOI 10.1038/sj.onc.1206939; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989	38	6	6	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6294	6305		10.1074/jbc.RA118.006742	http://dx.doi.org/10.1074/jbc.RA118.006742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30782846	Green Published, hybrid			2022-12-26	WOS:000468402000008
J	Chang, RF; Lee, CC; Lo, CM				Chang, Ruey-Feng; Lee, Chung-Chien; Lo, Chung-Ming			Quantitative diagnosis of rotator cuff tears based on sonographic pattern recognition	PLOS ONE			English	Article							ARTHROSCOPIC FINDINGS; SHOULDER ULTRASOUND; ULTRASONOGRAPHY; CLASSIFICATION; ACCURACY; PERFORMANCE; MANAGEMENT; LESIONS; IMAGES; PAIN	The lifetime prevalence of shoulder pain is nearly 70% and is mostly attributable to subacromial disorders. A rotator cuff tear is the most severe form of subacromial disorders, and most occur in the supraspinatus. For clinical examination, shoulder ultrasound is recommended to detect supraspinatus tears. In this study, a computer-aided tear classification (CTC) system was developed to identify supraspinatus tears in ultrasound examinations and reduce inter-operator variability. The observed cases included 89 ultrasound images of supraspinatus tendinopathy and 102 of supraspinatus tear from 136 patients. For each case, intensity and texture features were extracted from the entire lesion and combined in a binary logistic regression classifier for lesion classification. The proposed CTC system achieved an accuracy rate of 92% (176/191) and an area under receiver operating characteristic curve (Az) of 0.9694. Based on its diagnostic performance, the CTC system has promise for clinical use.	[Chang, Ruey-Feng; Lee, Chung-Chien] Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan; [Chang, Ruey-Feng] Natl Taiwan Univ, Dept Comp Sci & Informat Engn, Taipei, Taiwan; [Lee, Chung-Chien] New Taipei City Hosp, Dept Orthoped Surg, New Taipei, Taiwan; [Lee, Chung-Chien] Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan; [Lo, Chung-Ming] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Lo, Chung-Ming] Natl Chengchi Univ, Grad Inst Lib Informat & Archival Studies, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; National Chengchi University	Lee, CC (corresponding author), Natl Taiwan Univ, Grad Inst Biomed Elect & Bioinformat, Taipei, Taiwan.; Lee, CC (corresponding author), New Taipei City Hosp, Dept Orthoped Surg, New Taipei, Taiwan.; Lee, CC (corresponding author), Natl Taiwan Univ Hosp, Dept Orthoped Surg, Taipei, Taiwan.; Lo, CM (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan.; Lo, CM (corresponding author), Natl Chengchi Univ, Grad Inst Lib Informat & Archival Studies, Taipei, Taiwan.	leecc@ntu.edu.tw; buddylo@tmu.edu.tw		Lo, Chung-Ming/0000-0001-5068-6002	Ministry of Science and Technology [MOST 107-2221-E-004-013]; New Taipei City Hospital of Taiwan, the Republic of China [NTCH104-001]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); New Taipei City Hospital of Taiwan, the Republic of China	The authors would like to thank the Ministry of Science and Technology (MOST 107-2221-E-004-013), New Taipei City Hospital (NTCH104-001) of Taiwan, the Republic of China, for financially supporting this research.	Alasaarela E, 1998, ANN RHEUM DIS, V57, P357, DOI 10.1136/ard.57.6.357; Allen G M, 2001, Eur J Ultrasound, V14, P3, DOI 10.1016/S0929-8266(01)00140-9; [Anonymous], EVIDENCE BASED SPORT; Baek HJ, 2012, RADIOLOGY, V264, P834, DOI 10.1148/radiol.12112120; Beggs I, 2011, SHOULDER ULTRASOUND; Bigliani LU, 1997, J BONE JOINT SURG AM, V79A, P1854, DOI 10.2106/00004623-199712000-00012; BRENNEKE SL, 1992, AM J SPORT MED, V20, P287, DOI 10.1177/036354659202000309; de Jesus JO, 2009, AM J ROENTGENOL, V192, P1701, DOI 10.2214/AJR.08.1241; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Flores WG, 2015, PATTERN RECOGN, V48, P1125, DOI 10.1016/j.patcog.2014.06.006; GROENEVELD RA, 1984, STATISTICIAN, V33, P391, DOI 10.2307/2987742; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hidalgo-Lozano A, 2010, EXP BRAIN RES, V202, P915, DOI 10.1007/s00221-010-2196-4; Horng MH, 2009, J MED BIOL ENG, V29, P242; Kayser R, 2005, ULTRASCHALL MED, V26, P291, DOI 10.1055/s-2005-858525; Le Corroller T, 2008, SKELETAL RADIOL, V37, P979, DOI 10.1007/s00256-008-0539-z; Lo CM, 2015, COMPUT METH PROG BIO, V122, P354, DOI 10.1016/j.cmpb.2015.09.004; Lo CM, 2015, ULTRASOUND MED BIOL, V41, P2039, DOI 10.1016/j.ultrasmedbio.2015.03.003; Lo CM, 2014, ULTRASONIC IMAGING, V36, P151, DOI 10.1177/0161734613520599; Luime JJ, 2004, SCAND J RHEUMATOL, V33, P73, DOI 10.1080/03009740310004667; Martin-Hervas C, 2001, J SHOULDER ELB SURG, V10, P410, DOI 10.1067/mse.2001.116515; Matta TTd, 2017, CLIN PHYSL FUNCTIONA; Middleton WD, 2004, AM J ROENTGENOL, V183, P1465, DOI 10.2214/ajr.183.5.1831465; Miller D, 2008, INT J CLIN PRACT, V62, P750, DOI 10.1111/j.1742-1241.2007.01682.x; Milosavljevic J, 2005, ACTA RADIOL, V46, P858, DOI 10.1080/02841850500270506; Mitchell C, 2005, BMJ-BRIT MED J, V331, P1124, DOI 10.1136/bmj.331.7525.1124; Moosmayer S, 2007, J CLIN ULTRASOUND, V35, P20, DOI 10.1002/jcu.20286; Mou WY, 2015, BIOMEDICAL PHYS ENG, V1; Murphy RJ, 2013, J BONE JOINT SURG AM, V95A, P266, DOI 10.2106/JBJS.K.00706; Naqvi GA, 2009, INT J SHOULDER SURG, V3, P94, DOI 10.4103/0973-6042.63218; O'Connor PJ, 2005, J CLIN ULTRASOUND, V33, P53, DOI 10.1002/jcu.20088; Park HB, 2005, J BONE JOINT SURG AM, V87A, P1446, DOI 10.2106/JBJS.D.02335; Petranova T, 2012, MED ULTRASON, V14, P133; Read JW, 1998, J SHOULDER ELB SURG, V7, P264, DOI 10.1016/S1058-2746(98)90055-6; Roberts C S, 2001, Am J Orthop (Belle Mead NJ), V30, P159; Rutten MJCM, 2006, RADIOGRAPHICS, V26, P589, DOI 10.1148/rg.262045719; Singh S, 2011, RADIOLOGY, V258, P73, DOI 10.1148/radiol.10081308; Smith TO, 2011, CLIN RADIOL, V66, P1036, DOI 10.1016/j.crad.2011.05.007; Takagishi K, 1996, SKELETAL RADIOL, V25, P221, DOI 10.1007/s002560050068; Teefey SA, 2004, J BONE JOINT SURG AM, V86A, P708, DOI 10.2106/00004623-200404000-00007; Teefey SA, 2000, J BONE JOINT SURG AM, V82A, P498, DOI 10.2106/00004623-200004000-00005; VANHOLSBEECK MT, 1995, RADIOLOGY, V197, P443, DOI 10.1148/radiology.197.2.7480690; Vlychou M, 2009, ACTA RADIOL, V50, P101, DOI 10.1080/02841850802600764; Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006	44	8	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212741	10.1371/journal.pone.0212741	http://dx.doi.org/10.1371/journal.pone.0212741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817804	Green Published, Green Submitted, gold			2022-12-26	WOS:000460371500033
J	DeNegre, AA; Mbah, MLN; Myers, K; Fefferman, NH				DeNegre, Ashley A.; Mbah, Martial L. Ndeffo; Myers, Kellen; Fefferman, Nina H.			Emergence of antibiotic resistance in immunocompromised host populations: A case study of emerging antibiotic resistant tuberculosis in AIDS patients	PLOS ONE			English	Article							INFECTION; EVOLUTION; WORLDWIDE; DYNAMICS	Objective The evolution of antibiotic resistance is far outpacing the development of new antibiotics, causing global public health concern about infections that will increasingly be unresponsive to antimicrobials. This risk of emerging antibiotic resistance may be meaningfully altered in highly AIDS-immunocompromised populations. Such populations fundamentally alter the bacterial evolutionary landscape in two ways, which we seek to model and analyze. First, widespread, population-level immunoincompetence creates a novel host environment with disrupted selective pressures. Second, within AIDS-prevalent populations, the recommendation that antibiotics be taken to treat and prevent opportunistic infection raises the risk of selection for drug-resistant pathogens. Design To determine the impact of HIV/AIDS on the emergence of antibiotic resistance-specifically in the developing world where high prevalence and economic challenges complicate disease management. Methods We present an SEIR epidemiological model of bacterial infection, and parametrize it to capture HIV/AIDS-attributable emergence of resistance under conditions of both high and low HIV/AIDS prevalence. Results We demonstrate that HIV/AIDS-immunocompromised hosts can be responsible for a disproportionately greater contribution to emergence of resistance than would be expected based on population-wide HIV/AIDS prevalence alone. Conclusions As such, the AIDS-immunocompromised have the potential become wellsprings of novel, resistant, opportunistic pathogen strains that can propagate into the broader global community. We discuss how public health policies for HIV/AIDS management can shape the evolutionary environment for opportunistic bacterial infections.	[DeNegre, Ashley A.; Fefferman, Nina H.] Rutgers State Univ, Command Control & Interoperabil Ctr Adv Data Anal, New Brunswick, NJ 08903 USA; [DeNegre, Ashley A.; Fefferman, Nina H.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Mbah, Martial L. Ndeffo] Yale Sch Publ Hlth, New Haven, CT USA; [Myers, Kellen; Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Yale University; University of Tennessee System; University of Tennessee Knoxville	Fefferman, NH (corresponding author), Rutgers State Univ, Command Control & Interoperabil Ctr Adv Data Anal, New Brunswick, NJ 08903 USA.; Fefferman, NH (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.; Fefferman, NH (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	nina.h.fefferman@gmail.com	Fefferman, Nina/AAQ-7378-2021	Fefferman, Nina/0000-0003-0233-1404; Ndeffo Mbah, Martial/0000-0003-4158-7613				[Anonymous], 1926, P EDINBURGH MATH SOC, V1, P98, DOI 10.1017/S0013091500034428; Billington OJ, 1999, ANTIMICROB AGENTS CH, V43, P1866, DOI 10.1128/AAC.43.8.1866; Blower SM, 2004, NAT MED, V10, P1111, DOI 10.1038/nm1102; Bratzler DW, 2004, CLIN INFECT DIS, V38, P1706, DOI 10.1086/421095; CIA, CENTR INT AG WORLD F; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Connor BA, 2015, CLIN INFECT DIS; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; Galvani AP, 2003, TRENDS ECOL EVOL, V18, P132, DOI 10.1016/S0169-5347(02)00050-2; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Laxminarayan R, 2002, J HEALTH ECON, V21, P709, DOI 10.1016/S0167-6296(02)00034-6; Laxminarayan R, 2012, CHALLENGES DRUG RESI, V10; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Levin SA, 1999, P NATL ACAD SCI USA, V96, P800, DOI 10.1073/pnas.96.3.800; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 2007, PLOS MED, V4, P111, DOI 10.1371/journal.pmed.0040015; Maiden MCJ, 1998, CLIN INFECT DIS, V27, pS12, DOI 10.1086/514917; Martinez JL, 2002, CLIN MICROBIOL REV, V15, P647, DOI 10.1128/CMR.15.4.647-679.2002; Masur H, 2002, ANN INTERN MED, V137, P435, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00002; MEYER CN, 1994, SCAND J INFECT DIS, V26, P635, DOI 10.3109/00365549409008630; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Morgan D, 2002, AIDS, V16, P597, DOI 10.1097/00002030-200203080-00011; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Okeke IN, 1999, EMERG INFECT DIS, V5, P18, DOI 10.3201/eid0501.990103; Selgelid MJ, 2007, BIOETHICS, V21, P218, DOI 10.1111/j.1467-8519.2006.00542.x; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Sullivan JC, 2013, CLIN INFECT DIS, V57, P221, DOI 10.1093/cid/cit226; Trostle J, 1996, SOC SCI MED, V42, P1117, DOI 10.1016/0277-9536(95)00384-3; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536	32	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212969	10.1371/journal.pone.0212969	http://dx.doi.org/10.1371/journal.pone.0212969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817798	Green Published, Green Submitted, gold			2022-12-26	WOS:000460371500062
J	Dylewski, J; Dobrinskikh, E; Lewis, L; Tonsawan, P; Miyazaki, M; Jat, PS; Blaine, J				Dylewski, James; Dobrinskikh, Evgenia; Lewis, Linda; Tonsawan, Pantipa; Miyazaki, Makoto; Jat, Parmjit S.; Blaine, Judith			Differential trafficking of albumin and IgG facilitated by the neonatal Fc receptor in podocytes in vitro and in vivo	PLOS ONE			English	Article							GLOMERULAR-FILTRATION; DEGRADATION; PROTEINURIA; HOMEOSTASIS; NEPHRITIS; TRANSPORT; REVEALS; PASSAGE; CELLS; GENE	Proteinuria is strongly associated with kidney disease progression but the mechanisms underlying podocyte handling of serum proteins such as albumin and IgG remain to be elucidated. We have previously shown that albumin and IgG are transcytosed by podocytes in vitro. In other epithelial cells, the neonatal Fc receptor (FcRn) is required to salvage albumin and IgG from the degradative pathway thereby allowing these proteins to be transcytosed or recycled. Here we directly examine the role of FcRn in albumin and IgG trafficking in podocytes by studying handling of these proteins in FcRn knockout (KO) podocytes in vitro and in a podocyte-specific FcRn knockout mice in vivo. In vitro, we find that knockout of FcRn leads to IgG accumulation in podocytes but does not alter albumin trafficking. Similarly, in vivo, podocyte-specific knockout of FcRn does not result in albumin accumulation in podocytes in vivo as measured by mean albumin fluorescence intensity whereas these mice demonstrate significant intraglomerular accumulation of IgG over time. In addition we find that podocyte-specific FcRn KO mice demonstrate mesangial expansion as they age and activation of mesangial cells as demonstrated by increased expression of a-smooth muscle actin. Taken together, these results suggest that trafficking pathways for albumin and IgG differ in podocytes and that sustained disruption of trafficking of plasma proteins alters glomerular structure.	[Dylewski, James; Lewis, Linda; Miyazaki, Makoto; Blaine, Judith] Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA; [Dylewski, James] Denver Hlth Med Ctr, Div Nephrol, Denver, CO USA; [Dobrinskikh, Evgenia] Univ Colorado Denver, Div Pulm, Aurora, CO USA; [Tonsawan, Pantipa] Khon Kaen Univ, Dept Med, Div Nephrol, Khon Kaen, Thailand; [Jat, Parmjit S.] UCL, MRC Prion Unit, Inst Prion Dis, London, England	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Denver Health Medical Center; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Khon Kaen University; University of London; University College London	Blaine, J (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Aurora, CO 80045 USA.	Judith.blaine@ucdenver.edu		Dylewski, James/0000-0002-8158-8605	Norman Coplon Satellite Healthcare; NIH [R01DK104264]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL132318, R01HL117062, R01HL133545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104264, R01DK096030, T32DK007135] Funding Source: NIH RePORTER	Norman Coplon Satellite Healthcare; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by a Norman Coplon Satellite Healthcare grant (https://www.satellitehealth.com/about-us/satellite-research/coplon-grants-overview/) and NIH R01DK104264 (https://www.niddk.nih.gov/research-funding/current-opportunities/pa-18-484) to JB. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abbate M, 2002, AM J PATHOL, V161, P2179, DOI 10.1016/S0002-9440(10)64495-1; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Carson JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099771; Castrop H, 2017, ACTA PHYSIOL, V219, P544, DOI 10.1111/apha.12760; Chaudhury C, 2003, J EXP MED, V197, P315, DOI 10.1084/jem.20021829; Cui SY, 1996, AM J PHYSIOL-RENAL, V271, pF900, DOI 10.1152/ajprenal.1996.271.4.F900; Dickinson BL, 2016, CLIN IMMUNOL, V169, P89, DOI 10.1016/j.clim.2016.06.011; Dobrinskikh E, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12510; Dobrinskikh E, 2014, AM J PHYSIOL-RENAL, V306, pF941, DOI 10.1152/ajprenal.00532.2013; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; FARQUHAR MG, 1960, J BIOPHYS BIOCHEM CY, V7, P297, DOI 10.1083/jcb.7.2.297; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Gianesello L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13789-z; Hemmelgarn BR, 2010, JAMA-J AM MED ASSOC, V303, P423, DOI 10.1001/jama.2010.39; JAT PS, 1989, MOL CELL BIOL, V9, P1672, DOI 10.1128/MCB.9.4.1672; JOHNSON RJ, 1991, J CLIN INVEST, V87, P847, DOI 10.1172/JCI115089; KERJASCHKI D, 1987, J EXP MED, V166, P109, DOI 10.1084/jem.166.1.109; Kim JH, 2006, AM J PHYSIOL-GASTR L, V290, pG352, DOI 10.1152/ajpgi.00286.2005; Kinugasa S, 2011, KIDNEY INT, V80, P1328, DOI 10.1038/ki.2011.282; Kinugasa S, 2010, MED MOL MORPHOL, V43, P218, DOI 10.1007/s00795-010-0500-9; Kuo TT, 2010, J CLIN IMMUNOL, V30, P777, DOI 10.1007/s10875-010-9468-4; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Masuda M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88646; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Morigi M, 2005, AM J PATHOL, V166, P1309, DOI 10.1016/S0002-9440(10)62350-4; Okamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054817; Peti-Peterdi J, 2009, AM J PHYSIOL-RENAL, V296, pF1255, DOI 10.1152/ajprenal.00144.2009; Roopenian DC, 2003, J IMMUNOL, V170, P3528, DOI 10.4049/jimmunol.170.7.3528; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Sandoval RM, 2012, J AM SOC NEPHROL, V23, P447, DOI 10.1681/ASN.2011070666; Schiessl IM, 2016, J AM SOC NEPHROL, V27, P731, DOI 10.1681/ASN.2014111125; Schiessl IM, 2013, AM J PHYSIOL-RENAL, V305, pF1189, DOI 10.1152/ajprenal.00377.2013; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Tenten V, 2013, J AM SOC NEPHROL, V24, P1966, DOI 10.1681/ASN.2013010018; Tojo A, 2008, MED MOL MORPHOL, V41, P92, DOI 10.1007/s00795-008-0397-8; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394	39	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0209732	10.1371/journal.pone.0209732	http://dx.doi.org/10.1371/journal.pone.0209732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811433	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400005
J	Frantzis, A; Leaper, R; Alexiadou, P; Prospathopoulos, A; Lekkas, D				Frantzis, Alexandros; Leaper, Russell; Alexiadou, Paraskevi; Prospathopoulos, Aristides; Lekkas, Dimitrios			Shipping routes through core habitat of endangered sperm whales along the Hellenic Trench, Greece: Can we reduce collision risks?	PLOS ONE			English	Article							PHYSETER-MACROCEPHALUS; SEA; ECHOLOCATION	The Mediterranean sperm whale population is listed as 'Endangered". The Hellenic Trench is the core habitat of the eastern Mediterranean sperm whale sub-population that numbers two to three hundred individuals. Major shipping routes running on or very close to the 1000 m depth contour along the Hellenic Trench are causing an unsustainable number of ship-strikes with sperm whales reviewed in this paper. Sperm whale sighting and density data were combined with specific information on the vessel traffic in the area (e.g., types of vessels, traffic patterns, speed and traffic density), in order to estimate the risk of a whale/ship interaction. Routing options to significantly reduce ship strike risk by a small offshore shift in shipping routes were identified. The overall collision risk for sperm whales in the study area would be reduced by around 70%, while a maximum of 11 nautical miles would be added to major routes and only around 5 nautical miles for the majority of ships. No negative impacts were associated with re-routing by shipping away from sperm whale habitat and there would be additional shipping safety and environmental benefits. A significant contribution to the overall conservation status of the marine Natura2000 sites in the area and very important population units of threatened species such as Cuvier's beaked whales, monk seals and loggerhead turtles would be achieved, by the reduction of shipping noise and reduced risk of any oil spills reaching the coasts, which are also important touristic destinations in Greece.	[Frantzis, Alexandros; Alexiadou, Paraskevi] Pelagos Cetacean Res Inst, Vouliagmeni, Greece; [Leaper, Russell] Int Fund Anim Welf, London, England; [Prospathopoulos, Aristides] Inst Oceanog, Hellen Ctr Marine Res, Anavyssos, Greece; [Lekkas, Dimitrios] MarineTraff Operat SA, Athens, Greece	Hellenic Centre for Marine Research	Frantzis, A (corresponding author), Pelagos Cetacean Res Inst, Vouliagmeni, Greece.	afrantzis@otenet.gr	Prospathopoulos, Aristides M./G-9216-2011	Prospathopoulos, Aristides M./0000-0002-3150-6966; Alexiadou, Paraskevi/0000-0003-0275-2540; Frantzis, Alexandros/0000-0001-7117-062X	International Fund for Animal Welfare (IFAW); OceanCare (Switzerland); Green Institute, Greece (Prasino Institouto)	International Fund for Animal Welfare (IFAW); OceanCare (Switzerland); Green Institute, Greece (Prasino Institouto)	Some funders provided support in the form of salaries for authors according to the following lines. No funder had any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section. International Fund for Animal Welfare, https://www.ifaw.org, provided salaries for AF, RL, and running costs for a server collecting AIS data. MarineTraffic Operations SA provided salary for DL. OceanCare, Switzerland, https://www.oceancare.org/en/startpage/, provided running costs and equipment purchase for sperm whale surveys of Pelagos Cetacean Research Institute (sic) (Green Institute), Greece, http://www.greeninstitute.gr/, provided salary for PA and running costs and equipment purchase for sperm whale surveys of Pelagos Cetacean Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We deeply thank the International Fund for Animal Welfare (IFAW) for their support of this study and of our conservation efforts regarding the mitigation of ship strikes. We are grateful to Sigrid Luber, Silvia Frey and OceanCare (Switzerland) for their continuous support of the sperm whale research and conservation efforts of the Pelagos Cetacean Research Institute since 2008 and their support of various phases of this project. We are also grateful to Olga Kikou and the Green Institute, Greece (Prasino Institouto; http://www.greeninstitute.gr) for their support of the initial phases of this project. We wish to thank Dr. Manos N. Anagnostou for clarifications concerning PAL data. MarineTraffic (https://www.marinetraffic.com) have kindly provided all the AIS data used for this study. Logging data during the sperm whale surveys were collected using the software Logger 2000 developed by the IFAW to promote benign and non-invasive research. Bathymetric data for all plots were from the GEBCO_2014 Grid, version 20150318, www.gebco.net.	Agardy T, 2007, SCI WORKSH; Andre M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45517; Anonymous, 2017, Journal of Cetacean Research and Management, V18, P1; [Anonymous], NATL STRATEGY ACTION; Boisseau O, 2017, CETACEAN POPUL UNPUB; Canadas A, 2018, ECOL INDIC, V85, P128, DOI 10.1016/j.ecolind.2017.10.021; Canadas A., 2012, IUCN RED LIST THREAT; Caruso F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144503; Conn PB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00004.1; Fais A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150660; Frantzis A., 2003, Journal of Cetacean Research and Management, V5, P219; Frantzis A, 1998, NATURE, V392, P29, DOI 10.1038/32068; Frantzis A., 2014, IWC SCI COMM BLED SL; Frantzis A, 2015, IWC SCI COMM SAN DIE; Frantzis A., 2015, FINS, V6, P10; Frantzis A., 2009, CETACEANS GREECE PRE; Frantzis A, 2014, AQUAT CONSERV, V24, P83, DOI 10.1002/aqc.2435; International Maritime Organization, 2017, ROUT MEAS OTH TRAFF; International Maritime Organization, 2009, GUID DOC MIN RISK SH; International Maritime Organization, 2018, FURTH INF REL IMP UN, P1; International Maritime Organization, 2013, EST NEW ROUT MEAS PA; International Maritime Organization, 2016, ID PROT SPEC AR PSSA; International Union for the Conservation of Nature-Marine Mammal Protected Areas Task Force, 2017, 1 IMMA REG WORKH MED; International Whaling Commission, 2016, J CETACEAN RES MAN S, V17, P293; International Whaling Commission, 2016, J CETACEAN RES MAN S, V17, P16; Leaper R, 2011, IWC SCI COMM TROMS N; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Lewis Tim, 2018, Journal of Cetacean Research and Management, V18, P103; Madsen PT, 2002, BEHAV ECOL SOCIOBIOL, V53, P31, DOI 10.1007/s00265-002-0548-1; Margaritoulis D, 2015, 35 ANN S SEA TURTL B, P127; Miller L.A, 2004, ECS NEWSLETTER, V42, P14; Nanayakkara Ranil P., 2017, Journal of Marine Biology, P6235398; Neilson JL, 2012, J MAR SCI, V2012, DOI [10.1155/2012/106282, DOI 10.1155/2012/106282]; Notarbartolo di Sciara G., 2006, STATUS DISTRIBUTION, P45; Nystuen JA, 2015, J ATMOS OCEAN TECH, V32, P334, DOI 10.1175/JTECH-D-13-00264.1; Ozturk A., 2013, J BLACK SEA MEDITERR, V19, p169?177; Panigada S, 2006, MAR POLLUT BULL, V52, P1287, DOI 10.1016/j.marpolbul.2006.03.014; Podesta M, 2016, ADV MAR BIOL, V75, P37; Redfern JV, 2013, CONSERV BIOL, V27, P292, DOI 10.1111/cobi.12029; Rendell L, 2016, ADV MAR BIOL, V75, P37, DOI 10.1016/bs.amb.2016.08.001; Shimada T, 2017, OCEAN COAST MANAGE, V142, P163, DOI 10.1016/j.ocecoaman.2017.03.028; Silber GK, 2012, MAR POLICY, V36, P1221, DOI 10.1016/j.marpol.2012.03.008; Vaes T, 2013, EUR SCI TECHN RES SE; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Williams R., 2011, CONSERV LETT, V2011, P1, DOI [DOI 10.1111/J.1755-263X.2010.00151.X, 10.1111/j.1755-263X.2010.00151.x]	46	15	19	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212016	10.1371/journal.pone.0212016	http://dx.doi.org/10.1371/journal.pone.0212016			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811429	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400045
J	Lopez-Garnier, S; Sheen, P; Zimic, M				Lopez-Garnier, Santiago; Sheen, Patricia; Zimic, Mirko			Automatic diagnostics of tuberculosis using convolutional neural networks analysis of MODS digital images	PLOS ONE			English	Article							CHEST RADIOGRAPHS; CLASSIFICATION; CANCER	Tuberculosis is an infectious disease that causes ill health and death in millions of people each year worldwide. Timely diagnosis and treatment is key to full patient recovery. The Microscopic Observed Drug Susceptibility (MODS) is a test to diagnose TB infection and drug susceptibility directly from a sputum sample in 7-10 days with a low cost and high sensitivity and specificity, based on the visual recognition of specific growth cording patterns of M. Tuberculosis in a broth culture. Despite its advantages, MODS is still limited in remote, low resource settings, because it requires permanent and trained technical staff for the image-based diagnostics. Hence, it is important to develop alternative solutions, based on reliable automated analysis and interpretation of MODS cultures. In this study, we trained and evaluated a convolutional neural network (CNN) for automatic interpretation of MODS cultures digital images. The CNN was trained on a dataset of 12,510 MODS positive and negative images obtained from three different laboratories, where it achieved 96.63 +/- 0.35% accuracy, and a sensitivity and specificity ranging from 91% to 99%, when validated across held-out laboratory datasets. The model's learned features resemble visual cues used by expert diagnosticians to interpret MODS cultures, suggesting that our model may have the ability to generalize and scale. It performed robustly when validated across held-out laboratory datasets and can be improved upon with data from new laboratories. This CNN can assist laboratory personnel, in low resource settings, and is a step towards facilitating automated diagnostics access to critical areas in developing countries.	[Lopez-Garnier, Santiago; Sheen, Patricia; Zimic, Mirko] Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Unidad Bioinformat, Lab Enfermedades Infecciosas,Lab Invest & Desarro, Lima, Peru; [Lopez-Garnier, Santiago] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA	Universidad Peruana Cayetano Heredia; Harvard University	Zimic, M (corresponding author), Univ Peruana Cayetano Heredia, Fac Ciencias & Filosofia, Unidad Bioinformat, Lab Enfermedades Infecciosas,Lab Invest & Desarro, Lima, Peru.	mirko.zimic@upch.pe			Wellcome Trust [099805/Z/12/Z]; Google Latin American Research Award 2016; Wellcome Trust Intermediate Fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); Google Latin American Research Award 2016(Google Incorporated); Wellcome Trust Intermediate Fellowship(Wellcome Trust)	This study was funded by The Wellcome Trust 099805/Z/12/Z, https://wellcome.ac.uk (PS) and by the Google Latin American Research Award 2016 https://research.google.com (MZ). PS was funded by a Wellcome Trust Intermediate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Zaher AM, 2016, EXPERT SYST APPL, V46, P139, DOI 10.1016/j.eswa.2015.10.015; Alva A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082809; Bansal A, 2017, IEEE INT CONF COMP V, P2545, DOI 10.1109/ICCVW.2017.299; Cao Y, 2016, 2016 IEEE FIRST INTERNATIONAL CONFERENCE ON CONNECTED HEALTH: APPLICATIONS, SYSTEMS AND ENGINEERING TECHNOLOGIES (CHASE), P274, DOI 10.1109/CHASE.2016.18; Caviedes L, 2000, J CLIN MICROBIOL, V38, P1203, DOI 10.1128/JCM.38.3.1203-1208.2000; Chen XY, 2015, IEEE ENG MED BIO, P715, DOI 10.1109/EMBC.2015.7318462; Chollet F, 2016, THE KERAS BLOG; Ciresan D, 2012, PROC CVPR IEEE, P3642, DOI 10.1109/CVPR.2012.6248110; COMSTOCK GW, 1982, AM REV RESPIR DIS, V125, P8; Drory A, 2018, RESISTANCE NEURAL NE; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; He KM, 2015, IEEE I CONF COMP VIS, P1026, DOI 10.1109/ICCV.2015.123; Hinton GE, 2012, 12070580 ARXIV, P1; Hwang S, 2016, NOVEL APPROACH TUBER, DOI [10.1117/12.2216198, DOI 10.1117/12.2216198]; Ioffe S., 2015, INT C MACH LEARN APP, P448; Jaeger S, 2014, IEEE T MED IMAGING, V33, P233, DOI 10.1109/TMI.2013.2284099; Jaeger S, 2013, QUANT IMAG MED SURG, V3, P89, DOI 10.3978/j.issn.2223-4292.2013.04.03; Jarrett K, 2009, IEEE I CONF COMP VIS, P2146, DOI 10.1109/ICCV.2009.5459469; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Lakhani P, 2017, RADIOLOGY, V284, P574, DOI 10.1148/radiol.2017162326; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Lee H., 2009, P ANN INT C MACH LEA, P609; Liu C, 2017, IEEE IMAGE PROC, P2314; Lopes UK, 2017, COMPUT BIOL MED, V89, P135, DOI 10.1016/j.compbiomed.2017.08.001; Melendez J, 2018, INT J TUBERC LUNG D, V22, P567, DOI 10.5588/ijtld.17.0492; Melendez J, 2016, SCI REP-UK, V6, DOI 10.1038/srep25265; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Pinto N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000579; Razavian N., 2015, CORR; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Simonyan Karen, ICLR 2015; Szegedy C, 2015, PROC CVPR IEEE, P1, DOI 10.1109/CVPR.2015.7298594; Theano Development Team, 2016, ARXIV E PRINTS; van der Werf MJ, 2012, EUR RESPIR J, V39, P1511, DOI 10.1183/09031936.00125711; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization, 2012, GLOB TUB REP 2012, V258; World Health Organization, 2011, NONC CULT DRUG SUSC; Xie WY, 2016, NEUROCOMPUTING, V173, P930, DOI 10.1016/j.neucom.2015.08.048; Xu T, 2013, EURASIP J IMAGE VIDE, DOI 10.1186/1687-5281-2013-3; Yosinski J., 2015, COMPUTER VISION PATT, V2015, P12; Yuan J, 2017, ROBUST DEEP FACE REC, P593, DOI [10.1007/978-3-319-70096-0_61, DOI 10.1007/978-3-319-70096-0_61]; Zeiler MD, 2014, LECT NOTES COMPUT SC, V8689, P818, DOI 10.1007/978-3-319-10590-1_53; Zhang M, 2011, AM J RESP CRIT CARE, V183, P1254, DOI 10.1164/rccm.201012-1949OC; Zhang WL, 2015, NEUROIMAGE, V108, P214, DOI 10.1016/j.neuroimage.2014.12.061	45	23	23	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212094	10.1371/journal.pone.0212094	http://dx.doi.org/10.1371/journal.pone.0212094			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811445	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400053
J	Goudarzi, M; Boquet-Pujadas, A; Olivo-Marin, JC; Raz, E				Goudarzi, Mohammad; Boquet-Pujadas, Aleix; Olivo-Marin, Jean-Christophe; Raz, Erez			Fluid dynamics during bleb formation in migrating cells in vivo	PLOS ONE			English	Article							MEMBRANE; MOTILITY; PRESSURE; BEHAVIOR; MODES	Blebs are cellular protrusions observed in migrating cells and in cells undergoing spreading, cytokinesis, and apoptosis. Here we investigate the flow of cytoplasm during bleb formation and the concurrent changes in cell volume using zebrafish primordial germ cells (PGCs) as an in vivo model. We show that bleb inflation occurs concomitantly with cytoplasmic inflow into it and that during this process the total cell volume does not change. We thus show that bleb formation in primordial germ cells results primarily from redistribution of material within the cell rather than being driven by flow of water from an external source.	[Goudarzi, Mohammad; Raz, Erez] ZMBE, Inst Cell Biol, Munster, Germany; [Boquet-Pujadas, Aleix; Olivo-Marin, Jean-Christophe] Inst Pasteur, Bioimage Anal Unit, Paris, France; [Boquet-Pujadas, Aleix; Olivo-Marin, Jean-Christophe] CNRS, UMR3691, Paris, France; [Goudarzi, Mohammad] Inst Sci & Technol Austria IST, Campus 1, Klosterneuburg, Austria	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institute of Science & Technology - Austria	Raz, E (corresponding author), ZMBE, Inst Cell Biol, Munster, Germany.	erez.raz@uni-muenster.de			European Research Council (ERC, CellMig); Deutsche Forschungsgemeinschaft (DFG); IZKF Muenster; Cells in Motion cluster of excellence [EXC 1003-CIM]; European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant [665807]; Institut Carnot Pasteur Microbes Sante [ANR 16 CARN 0023-01]; ANR [ANR-10-INBS-04-FranceBioImaging, ANR-10-LABX-62-IBEID]	European Research Council (ERC, CellMig); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); IZKF Muenster; Cells in Motion cluster of excellence; European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant; Institut Carnot Pasteur Microbes Sante; ANR(French National Research Agency (ANR))	This work was supported by the European Research Council (ERC, CellMig), the Deutsche Forschungsgemeinschaft (DFG), and the IZKF Muenster to E.R., and the Cells in Motion cluster of excellence (EXC 1003-CIM) to E.R. A.B.P. is part of the Pasteur - Paris University (PPU) International PhD Program. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 665807, and from the Institut Carnot Pasteur Microbes & Sante (ANR 16 CARN 0023-01). A.B.P is also affiliated with Sorbonne Universite (UPMC, Paris 6) and EDITE. The BIA unit is partially funded by the ANR grants ANR-10-INBS-04-FranceBioImaging and ANR-10-LABX-62-IBEID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the European Research Council (ERC, CellMig), the Deutsche Forschungsgemeinschaft (DFG), and the IZKF Muenster to E.R., and the Cells in Motion cluster of excellence (EXC 1003-CIM) to E.R. A.B.P. is part of the Pasteur-Paris University (PPU) International PhD Program. This project has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Skodowska-Curie grant agreement No 665807, and from the Institut Carnot Pasteur Microbes & Sante (ANR 16 CARN 0023-01).; A.B.P is also affiliated with Sorbonne Universite (UPMC, Paris 6) and EDITE. The BIA unit is partially funded by the ANR grants ANR-10-INBS-04-FranceBioImaging and ANR-10-LABX-62-IBEID.	Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Blaser H, 2006, DEV CELL, V11, P613, DOI 10.1016/j.devcel.2006.09.023; Boquet-Pujadas A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09240-y; Charras GT, 2008, J MICROSC-OXFORD, V231, P466, DOI 10.1111/j.1365-2818.2008.02059.x; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2008, BIOPHYS J, V94, P1836, DOI 10.1529/biophysj.107.113605; Diz-Munoz A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0294-x; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Gebala V, 2016, NAT CELL BIOL, V18, P443, DOI 10.1038/ncb3320; Goudarzi M, 2012, DEV CELL, V23, P210, DOI 10.1016/j.devcel.2012.05.007; Goudarzi M, 2017, DEV CELL, V43, P577, DOI 10.1016/j.devcel.2017.10.030; Koprunner M, 2001, GENE DEV, V15, P2877; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Logue JS, 2015, ELIFE, V4, DOI 10.7554/eLife.08314; Paksa A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11288; Petrie RJ, 2012, J CELL BIOL, V197, P439, DOI 10.1083/jcb.201201124; Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7; Reig G, 2014, DEVELOPMENT, V141, P1999, DOI 10.1242/dev.101451; Scarpa E, 2016, J CELL BIOL, V212, P143, DOI 10.1083/jcb.201508047; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stainier DYR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007000; Taloni A, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.208101; Tarbashevich K, 2015, CURR BIOL, V25, P1096, DOI 10.1016/j.cub.2015.02.071; Tinevez JY, 2009, P NATL ACAD SCI USA, V106, P18581, DOI 10.1073/pnas.0903353106; Yanai M, 1996, CELL MOTIL CYTOSKEL, V33, P22; Zatulovskiy E, 2014, J CELL BIOL, V204, P1027, DOI 10.1083/jcb.201306147; Zhang YY, 2018, CELL RES, V28, P9, DOI 10.1038/cr.2017.133	30	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212699	10.1371/journal.pone.0212699	http://dx.doi.org/10.1371/journal.pone.0212699			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807602	Green Published, Green Submitted, gold			2022-12-26	WOS:000459712100022
J	Wang, SP; Zhang, Q; Zhang, YL; Sun, J; Chen, JJ; Sun, XQ				Wang, Shangping; Zhang, Qian; Zhang, Yaling; Sun, Jin; Chen, Juanjuan; Sun, Xiaoqing			Improving the proof of "Privacy-preserving attribute-keyword based data publish-subscribe service on cloud platforms"	PLOS ONE			English	Article								Most recently, Kan Yang et al. proposed an attribute-keyword based encryption scheme for data publish-subscribe service(AKPS), which is highly useful for cloud storage scenario. Unfortunately, we discover that there is a flaw in the security proof of indistinguishability of the tag and trapdoor against chosen keyword attack under the Bilinear Diffie-Hellman (BDH) assumption. As the security proof is a key component for a cryptographic scheme, based on the Decisional Diffie-Hellman (DDH) assumption, we improve the security proof method and give a new security proof of the AKPS scheme for indistinguishability of the tag and trapdoor in our proposal, which is more rigorous than the original one. Furthermore, we also demonstrate that the AKPS scheme is secure against data Replayable Chosen Ciphertext Attack (RCCA).	[Wang, Shangping; Zhang, Qian; Sun, Jin; Chen, Juanjuan; Sun, Xiaoqing] Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China; [Zhang, Yaling] Xian Univ Technol, Sch Comp Sci & Engn, Xian, Shaanxi, Peoples R China	Xi'an University of Technology; Xi'an University of Technology	Zhang, Q (corresponding author), Xian Univ Technol, Sch Sci, Xian, Shaanxi, Peoples R China.	qianz95119@126.com		Zhang, Qian/0000-0001-9557-483X; Wang, Shangping/0000-0002-8964-5328	National Natural Science Foundation of China [61572019]; Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China [2016JZ001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China	This research is supported by the National Natural Science Foundation of China (No. 61572019 http://www.nsfc.gov.cn), the Key Project of Research Foundation of Natural Science Foundation of Shaanxi Province of China (NO. 2016JZ001. http://www.sninfo.gov.cn/).	Attrapadung N, 2009, DUAL POLICY ATTRIBUT, P168; Canetti R, 2003, RELAXING CHOSEN CIPH, P565; ELGAMAL T, 1985, IEEE T INFORM THEORY, V31, P469, DOI 10.1109/TIT.1985.1057074; Escala A, 2013, ALGEBRAIC FRAMEWORK; Goyal V, 2006, P 13 ACM C COMP COMM, P89, DOI DOI 10.1145/1180405.1180418; Green M., 2011, P 20 USENIX C SEC BE, P34; Hassan MM, 2015, CLUSTER COMPUT, V18, P1539, DOI 10.1007/s10586-015-0476-2; Hindersah H, 2016, 2016 6 INT C SYST EN; Li D, 2017, EFFICIENT CCA2 SECUR; Nabeel M, 2013, PRIVACY PRESERVING C; Nasim R, 2014, 2014 INTERNATIONAL CONFERENCE ON CLOUD AND AUTONOMIC COMPUTING (ICCAC 2014), P187, DOI 10.1109/ICCAC.2014.15; Wang ZW, 2016, SECUR COMMUN NETW, V9, P2387, DOI 10.1002/sec.1507; Waters B., 2011, CIPHERTEXT POLICY AT; Waters B, 2009, DUAL SYSTEM ENCRYPTI, P619; Waters B, 2011, LECT NOTES COMPUT SC, V6571, P53, DOI 10.1007/978-3-642-19379-8_4; Yang K, 2017, INFORM SCIENCES, V387, P116, DOI 10.1016/j.ins.2016.09.020; Zuo C, 2018, FUTURE GENER COMP SY, V78, P730, DOI 10.1016/j.future.2016.10.028	17	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212761	10.1371/journal.pone.0212761	http://dx.doi.org/10.1371/journal.pone.0212761			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802275	Green Published, gold			2022-12-26	WOS:000459710700020
J	Addad, F; Mahdhaoui, A; Gouider, J; Boughzela, E; Kamoun, S; Boujnah, MR; Haouala, H; Gamra, H; Maatouk, F; Ben Khalfallah, A; Kachboura, S; Baccar, H; Ben Halima, N; Guesmi, A; Sayahi, K; Sdiri, W; Neji, A; Bouakez, A; Milouchi, S; Battikh, K; Jullieres, Y; Danchin, N; Monsuez, JJ; Mulak, G; Hagege, A; Bataille, V; Chettaoui, R; Mourali, MS				Addad, Faouzi; Mahdhaoui, Abdallah; Gouider, Jeridi; Boughzela, Essia; Kamoun, Samir; Boujnah, Mohamed Rachid; Haouala, Habib; Gamra, Habib; Maatouk, Faouzi; Ben Khalfallah, Ali; Kachboura, Salem; Baccar, Hedi; Ben Halima, Nejeh; Guesmi, Ali; Sayahi, Khaled; Sdiri, Wissem; Neji, Ali; Bouakez, Ahmed; Milouchi, Sami; Battikh, Kais; Jullieres, Yves; Danchin, Nicolas; Monsuez, Jean Jacques; Mulak, Genevieve; Hagege, Albert; Bataille, Vincent; Chettaoui, Rafik; Mourali, Mohamed Sami		FAST-MI Tunisia Investigators	Management of patients with acute ST-elevation myocardial infarction: Results of the FAST-MI Tunisia Registry	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; HEART-DISEASE MORTALITY; FRENCH REGISTRY; TRENDS; SURVIVAL; ASSOCIATION; STRATEGY; OUTCOMES	Background The FAST-MI Tunisia registry was set up by the Tunisian Society of Cardiology and Cardiovascular Surgery to assess the demographic and clinical characteristics, management and hospital outcome of patients with ST-elevation myocardial infarction (STEMI). Methods Data for 459 consecutive patients (mean age 60.8 years; 88.5% male) with STEMI, treated in 16 public hospitals (representing 72.2% of public hospitals in Tunisia treating STEMI patients), were collected prospectively. The most common risk factors were smoking (63.6%), hypertension (39.7%), diabetes (32%) and dyslipidaemia (18.2%). Results Among the 459 patients, 61.8% received reperfusion therapy: 30% with primary percutaneous coronary intervention (PPCI) and 31.8% with intravenous fibrinolysis (IF) (28.6% with pre-hospital thrombolysis). The median time from symptom onset to thrombolysis was 185 min and to PPCI was 358 min. In-hospital mortality was 5.3%. Compared with those managed at regional hospitals, patients managed at interventional university hospitals (n = 357) were more likely to receive reperfusion therapy (52.9% vs. 34.1%; p<0.001), with less IF (28.6% vs. 43.1%; p = 0.002) but more PPCI (37.8% vs. 3.9%; p<0.0001). However, in-hospital mortality in the two types of hospitals was similar (5.3% vs. 5.1%; p = 0.866). Conclusions Data from the FAST-MI Tunisia registry show that a pharmaco-invasive strategy of management for STEMI should be promoted in non-interventional regional hospitals.	[Addad, Faouzi; Kachboura, Salem] CHU Abderrahmen Mami, Cardiol Dept, Ariana, Tunisia; [Mahdhaoui, Abdallah; Gouider, Jeridi] CHU Farhat Hached, Sousse, Tunisia; [Boughzela, Essia] CHU Sahloul, Sousse, Tunisia; [Kamoun, Samir] CHU Hedi Chaker, Sfax, Tunisia; [Boujnah, Mohamed Rachid] CHU Mongi Slim, Marsa, Tunisia; [Haouala, Habib] Hop Militaire Principal Instruct Tunis, Tunis, Tunisia; [Gamra, Habib] Cardio A CHU Fattouma Bourguiba, Monastir, Tunisia; [Maatouk, Faouzi] Cardio B CHU Fattouma Bourguiba, Monastir, Tunisia; [Ben Khalfallah, Ali] Hop Menzel Bourguiba, Menzel Bourguiba, Tunisia; [Baccar, Hedi] Hop Charles Nicolles, Tunis, Tunisia; [Ben Halima, Nejeh] Hop Reg Ibn El Jazzar, Kairouan, Tunisia; [Guesmi, Ali] Hop Reg Mohamed Ben Sassi, Gabes, Tunisia; [Sayahi, Khaled] Hop Reg MHamed Bourguiba, Kef, Tunisia; [Sdiri, Wissem] Hop Reg Habib Bougatfa, Bizerte, Tunisia; [Neji, Ali] Hop Reg Ben Guerdene, Medenine, Tunisia; [Bouakez, Ahmed] Hop Reg Jendouba, Jendouba, Tunisia; [Milouchi, Sami] Hop Reg Medenine, Medenine, Tunisia; [Battikh, Kais] Clin Djerba, Djerba, Tunisia; [Jullieres, Yves] CHU Nancy, Dept Cardiol, Nancy, France; [Danchin, Nicolas; Hagege, Albert] Hop Europeen Georges Pompidou, AP HP, Paris, France; [Monsuez, Jean Jacques] Hop Univ Paris Seine St Denis, Hop R Muret, AP HP, Sevran, France; [Mulak, Genevieve] Soc Francaise Cardiol, Paris, France; [Bataille, Vincent] CHU Toulouse 3, Serv Aide Med Urgente, Toulouse, France; [Chettaoui, Rafik] Clin Tunis, Tunis, Tunisia; [Mourali, Mohamed Sami] CHU La Rabta, Tunis, Tunisia	Universite de Tunis-El-Manar; Hopital Abderrahmene Mami; Universite de Sousse; Hopital Farhat Hached; Universite de Sousse; Hopital Sahloul; Universite de Sfax; Hopital Hedi Chaker; Universite de Tunis-El-Manar; Hopital Charles Nicolle; CHU de Nancy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rene-Muret - APHP; CHU de Toulouse; Universite de Tunis-El-Manar; Hopital La Rabta	Addad, F (corresponding author), CHU Abderrahmen Mami, Cardiol Dept, Ariana, Tunisia.	secretaire.stcccv@gmail.com	Danchin, Nicolas/AAN-8291-2020	Bataille, Vincent/0000-0002-5780-2333				Addad F, 2015, Ann Cardiol Angeiol (Paris), V64, P439, DOI 10.1016/j.ancard.2015.09.064; Addad F, 2010, ANN CARDIOL ANGEIOL, V59, P183, DOI 10.1016/j.ancard.2010.07.006; Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092; Danchin N, 2008, CIRCULATION, V118, P268, DOI 10.1161/CIRCULATIONAHA.107.762765; Danchin N, 2014, REV ESP CARDIOL, V67, P659, DOI 10.1016/j.rec.2014.04.004; Danchin N, 2014, CIRCULATION, V129, P1629, DOI 10.1161/CIRCULATIONAHA.113.005874; Donataccio MP, 2015, INT J CARDIOL, V201, P265, DOI 10.1016/j.ijcard.2015.08.065; Hanssen M, 2012, HEART, V98, P699, DOI 10.1136/heartjnl-2012-301700; Jernberg T, 2011, JAMA-J AM MED ASSOC, V305, P1677, DOI 10.1001/jama.2011.522; Kostis WJ, 2010, CIRC-CARDIOVASC QUAL, V3, P581, DOI 10.1161/CIRCOUTCOMES.110.957803; Loirat M, 2013, ANN CARDIOL ANGEIOL, V62, P287, DOI 10.1016/j.ancard.2013.08.008; Montalescot G, 2001, NEW ENGL J MED, V344, P1895, DOI 10.1056/NEJM200106213442503; Moustaghfir A, 2012, ARCH CARDIOVASC DIS, V105, P566, DOI 10.1016/j.acvd.2012.07.002; Nichols M, 2013, EUR HEART J, V34, P3017, DOI 10.1093/eurheartj/eht159; Puymirat E, 2012, JAMA-J AM MED ASSOC, V308, P998, DOI 10.1001/2012.jama.11348; Rogers WJ, 2008, AM HEART J, V156, P1026, DOI 10.1016/j.ahj.2008.07.030; Rosamond WD, 2012, CIRCULATION, V125, P1848, DOI 10.1161/CIRCULATIONAHA.111.047480; Saidi O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063202; Schmidt Morten, 2012, BMJ, V344, pe356, DOI 10.1136/bmj.e356; Sinnaeve P, 2003, AM HEART J, V146, P27, DOI 10.1016/S0002-8703(03)00117-0; Sinnaeve PR, 2014, CIRCULATION, V130, P1139, DOI 10.1161/CIRCULATIONAHA.114.009570; Sozmen K, 2015, INT J PUBLIC HEALTH, V60, pS3, DOI 10.1007/s00038-014-0610-6; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207979	10.1371/journal.pone.0207979	http://dx.doi.org/10.1371/journal.pone.0207979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794566	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100006
J	Hong, YY; Luo, YY; Yi, JL; He, L; Dai, LY; Yi, TY				Hong, Yanyun; Luo, Yongyang; Yi, Jianglan; He, Ling; Dai, Liangying; Yi, Tuyong			Screening nested-PCR primer for 'Candidatus Liberibacter asiaticus' associated with citrus Huanglongbing and application in Hunan, China	PLOS ONE			English	Article							REAL-TIME PCR; DIAPHORINA-CITRI; DIAGNOSTIC SYSTEM; ORANGE TREE; OMP GENE; BACTERIUM; DNA; IDENTIFICATION; DIVERSITY; GUANGDONG	Citrus Huanglongbing (HLB) is one of the most devastating citrus diseases worldwide. Sensitive and accurate assays are vital for efficient prevention of the spread of HLB-associated "Candidatus Liberibacter spp". "Candidatus Liberibacter spp" that infect Citrus includes "Candidatus Liberibacter asiaticus" (Las), "Candidatus Liberibacter africanus" (Laf) and "Candidatus Liberibacter americanus" (Lam). Of them, Las is the most widespread species. In this study, a set of nested PCR primer pairs were screened to diagnose Las, and the nested PCR method greatly enhanced the sensitivity to detect Las up to 10 times and 100 times compared to qPCR and conventional PCR, respectively. Totally, 1112 samples from 5 different citrus cultivars in 39 different counties and cities were assayed by nested PCR. The results show that 384 samples were HLB-infected; the highest positive detection rate was 79.7% from the lopsided fruit samples, and the lowest positive detection rate was 16.3% from the apical dieback samples. The results indicate that the designed nested PCR primer pairs can detect Las from different symptomatic tissues, different citrus cultivars and different geographic regions. The set of nested PCR primers designed in the present study will provide a very useful supplementation to the current approaches for Las detection.	[Hong, Yanyun; Luo, Yongyang; He, Ling; Dai, Liangying; Yi, Tuyong] Hunan Agr Univ, Coll Plant Protect, Hunan Prov Key Lab Biol & Control Plant Pests, Changsha, Hunan, Peoples R China; [Yi, Jianglan] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing, Peoples R China	Hunan Agricultural University; Beijing University of Chemical Technology	Yi, TY (corresponding author), Hunan Agr Univ, Coll Plant Protect, Hunan Prov Key Lab Biol & Control Plant Pests, Changsha, Hunan, Peoples R China.	yituyong@hotmail.com			National key Research and development project of China "Research and demonstration of prevention and control technology in central China citrus Huanglongbing interdiction belt and low epidemic areas" [2018YFD 0201505]; Hunan province key Research and development project:" Research and application of key technologies for green control of citrus pests and diseases" [2018NK 2012]	National key Research and development project of China "Research and demonstration of prevention and control technology in central China citrus Huanglongbing interdiction belt and low epidemic areas"; Hunan province key Research and development project:" Research and application of key technologies for green control of citrus pests and diseases"	The project was supported by National key Research and development project of China "Research and demonstration of prevention and control technology in central China citrus Huanglongbing interdiction belt and low epidemic areas (2018YFD 0201505) " and Hunan province key Research and development project:" Research and application of key technologies for green control of citrus pests and diseases (2018NK 2012)"Tuyong Yi received the first fund and Yanyun Hong received the second fund.	Aghasadeghi MR, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.7481; Ahmad K, 2009, INT J AGRIC BIOL, V11, P401; Anderson TP, 2003, CLIN MICROBIOL INFEC, V9, P746, DOI 10.1046/j.1469-0691.2003.00601.x; Angel J.E., 2015, AGRON COLOMB, V32, P377; Valdes RA, 2016, CAN J MICROBIOL, V62, P803, DOI 10.1139/cjm-2016-0022; Bassanezi R. B, 2007, PLANT HLTH PROGR, V8, P1, DOI DOI 10.1094/PHP-2007-0906-01-RV; Bassanezi RB, 2009, EUR J PLANT PATHOL, V125, P565, DOI 10.1007/s10658-009-9506-3; Bastianel C, 2005, APPL ENVIRON MICROB, V71, P6473, DOI 10.1128/AEM.71.11.6473-6478.2005; Benyon L, 2008, PHYTOPATHOLOGY, V98, pS21; Bove JM, 2006, J PLANT PATHOL, V88, P7; Chen J, 2010, PHYTOPATHOLOGY, V100, P567, DOI 10.1094/PHYTO-100-6-0567; Coy MR, 2014, J MICROBIOL METH, V102, P15, DOI 10.1016/j.mimet.2014.04.007; da Fonseca AJ, 2016, J MED VIROL, V88, P888, DOI 10.1002/jmv.24413; Deng X, 2008, PLANT DIS, V92, P513, DOI 10.1094/PDIS-92-4-0513; Deng X, 2007, PLANT DIS, V91, P1051, DOI 10.1094/PDIS-91-8-1051C; Ding F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46467; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; GOTTWALD TR, 2008, P INT RES C HUANGL O, P480; Hocquellet A, 1999, MOL CELL PROBE, V13, P373, DOI 10.1006/mcpr.1999.0263; Hong YY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14023-6; Hong YY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01593; Hu WZ, 2011, J PLANT PATHOL, V93, P211; Kamau E, 2011, J CLIN MICROBIOL, V49, P2946, DOI 10.1128/JCM.00276-11; Kogenaru S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-39; Kunta M, 2014, HORTSCIENCE, V49, P65, DOI 10.21273/HORTSCI.49.1.65; LAFLECHE D, 1970, CR ACAD SCI D NAT, V270, P1915; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; Langeroudi A. G., 2013, Iranian Journal of Veterinary Medicine, V7, P207; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Lin H, 2010, J MICROBIOL METH, V81, P17, DOI 10.1016/j.mimet.2010.01.014; Lin H, 2008, MOL CELL PROBE, V22, P30, DOI 10.1016/j.mcp.2007.06.006; Lu LM, 2013, PLANT DIS, V97, P1295, DOI 10.1094/PDIS-11-12-1086-RE; Manjunath KL, 2008, PHYTOPATHOLOGY, V98, P387, DOI 10.1094/PHYTO-98-4-0387; Okuda M, 2005, PLANT DIS, V89, P705, DOI 10.1094/PD-89-0705; Okuda M., 2008, Japanese Journal of Phytopathology, V74, P316, DOI 10.3186/jjphytopath.74.316; Rigano LA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-86; Schneid AD, 2006, BRAZ J MICROBIOL, V37, P350, DOI 10.1590/S1517-83822006000300027; SCHWARZ R. E., 1967, S AFR J AGR SCI, V10, P471; Sechler A, 2009, PHYTOPATHOLOGY, V99, P480, DOI 10.1094/PHYTO-99-5-0480; Song MK, 2009, J MICROBIOL BIOTECHN, V19, P1470, DOI 10.4014/jmb.0905.05012; Tatineni S, 2008, PHYTOPATHOLOGY, V98, P592, DOI 10.1094/PHYTO-98-5-0592; Teixeira DC, 2008, MOL CELL PROBE, V22, P139, DOI 10.1016/j.mcp.2007.12.006; Tomimura K, 2009, PHYTOPATHOLOGY, V99, P1062, DOI 10.1094/PHYTO-99-9-1062; Traversa D, 2008, J CLIN MICROBIOL, V46, P1811, DOI 10.1128/JCM.01612-07; Ukuda-Hosokawa R, 2015, APPL ENVIRON MICROB, V81, P3728, DOI 10.1128/AEM.00707-15; Xie ZhongChen, 2009, Scientia Agricultura Sinica, V42, P3888; [Xu Meirong 许美容], 2014, [植物病理学报, Acta Phytopathologica Sinica], V44, P609; Zhang MQ, 2010, PHYTOPATHOLOGY, V100, P239, DOI 10.1094/PHYTO-100-3-0239; Zhong X, 2018, J INTEGR AGR, V17, P483, DOI 10.1016/S2095-3119(17)61815-X	50	3	4	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212020	10.1371/journal.pone.0212020	http://dx.doi.org/10.1371/journal.pone.0212020			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794562	Green Submitted, gold, Green Published			2022-12-26	WOS:000459709100032
J	Minato, N; Sok, S; Chen, SB; Delaquis, E; Phirun, I; Le, VX; Burra, DD; Newby, JC; Wyckhuys, KAG; de Haan, S				Minato, Nami; Sok, Sophearith; Chen, Songbi; Delaquis, Erik; Phirun, Iv; Vi Xuan Le; Burra, Dharani D.; Newby, Jonathan C.; Wyckhuys, Kris A. G.; de Haan, Stef			Surveillance for Sri Lankan cassava mosaic virus (SLCMV) in Cambodia and Vietnam one year after its initial detection in a single plantation in 2015	PLOS ONE			English	Article							DISEASE; DNA; GEMINIVIRUSES; EPIDEMIOLOGY; SEVERITY; YIELD	Cassava mosaic disease, one of the ten most economically important crop viral diseases in the world, was first reported in Southeast Asia from a single plantation in Cambodia in 2015. To determine the presence and incidence of Sri Lankan cassava mosaic virus (SLCMV) one year after first detection, a total of 6,480 samples from 419 fields were systematically collected from cassava production areas across Cambodia (3,840 samples; 240 fields) and Vietnam (2,640samples; 179 fields) in the 2016 cropping season. Using PCR-based diagnostics, we identified 49 SLCMV-infected plants from nine fields, representing 2% of the total number of fields sampled. Infected fields were geographically restricted to two provinces of Eastern Cambodia, while no infection was detected from any of the other sampled sites in either country. Symptom expression patterns in infected plants suggested that SLCMV may have been transmitted both through infected planting materials, and by Bemisia tabaci, the known whitefly vector of SLCMV. In addition, 14% of virus infected plants did not express typical symptoms of cassava mosaic disease on their leaves, highlighting that molecular-based validation is needed to confirm the presence of SLCMV in the field. None of the owners of the SLCMV-infected fields indicated acquired planting materials from the plantation in Ratanakiri where SLCMV was first reported. The surveillance baseline data generated for both countries is discussed in light of future options to control and manage cassava mosaic disease.	[Minato, Nami; Sok, Sophearith; Delaquis, Erik; Newby, Jonathan C.; de Haan, Stef] CGIAR Res Program Roots Tubers & Bananas, Int Ctr Trop Agr CIAT, Agrobiodivers Res Area, Asia Reg Off, Hanoi, Vietnam; [Chen, Songbi] CATAS, TCGRI, Danzhou, Hainan, Peoples R China; [Phirun, Iv] GDA, Dept Ind Crops, Phnom Penh, Cambodia; [Vi Xuan Le] Vietnam Acad Agr Sci, PPRI, Hanoi, Vietnam; [Burra, Dharani D.] Int Ctr Trop Agr CIAT, Asia Reg Off, Decis & Policy Anal Res Area, Hanoi, Vietnam; [Wyckhuys, Kris A. G.] Int Joint Res Lab Ecol Pest Management, Fuzhou, Fujian, Peoples R China	Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; Chinese Academy of Tropical Agricultural Sciences; Alliance; International Center for Tropical Agriculture - CIAT	de Haan, S (corresponding author), CGIAR Res Program Roots Tubers & Bananas, Int Ctr Trop Agr CIAT, Agrobiodivers Res Area, Asia Reg Off, Hanoi, Vietnam.	s.dehaan@cgiar.org	Delaquis, Erik/AAZ-6071-2021; Wyckhuys, Kris/AAJ-4352-2020	Delaquis, Erik/0000-0002-1427-6572; Wyckhuys, Kris/0000-0003-0922-488X; de Haan, Stef/0000-0001-8690-1886	CGIAR Research Program on Roots, Tubers and Bananas (RTB); Australian Centre for International Agricultural Research (ACIAR) [AGB/2016/032]; JSPS Overseas Research Fellowships	CGIAR Research Program on Roots, Tubers and Bananas (RTB)(CGIAR); Australian Centre for International Agricultural Research (ACIAR)(Australian Ctr Intl Agr Res); JSPS Overseas Research Fellowships	This research was undertaken as part of the CGIAR Research Program on Roots, Tubers and Bananas (RTB). Funding support for this work was provided by Australian Centre for International Agricultural Research (ACIAR) (Project number: AGB/2016/032). NM was supported by JSPS Overseas Research Fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham K, 2010, P 8 REG WORKSH HELD, P233; Adhikary N., 2018, INT J CURR MICROBIOL, V7, P2887, DOI [10.20546/ijcmas.2018.701.344, DOI 10.20546/IJCMAS.2018.701.344]; Anitha J., 2011, J ROOT CROPS, V37, P41; Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007; Boykin L., 2018, F1000RESEARCH, V7, DOI [10.12688/f1000research.15507.1, DOI 10.12688/F1000RESEARCH.15507.1]; Carvajal-Yepes M, 2016, SURVEYING CASSAVA MO; Cramb R, 2017, J PEASANT STUD, V44, P813, DOI 10.1080/03066150.2016.1242482; Delaquis E, 2018, FRONT SUSTAIN FOOD S, V2, DOI 10.3389/fsufs.2018.00073; Duraisamy R, 2013, MOL BIOTECHNOL, V53, P150, DOI 10.1007/s12033-012-9503-1; Dutt N, 2005, ARCH VIROL, V150, P2101, DOI 10.1007/s00705-005-0579-9; Fargette D, 2006, ANNU REV PHYTOPATHOL, V44, P235, DOI 10.1146/annurev.phyto.44.120705.104644; FARGETTE D, 1985, ANN APPL BIOL, V106, P285, DOI 10.1111/j.1744-7348.1985.tb03118.x; FARGETTE D, 1994, PHYTOPATHOLOGY, V84, P91, DOI 10.1094/Phyto-84-91; FAUQUET C, 1990, PLANT DIS, V74, P404, DOI 10.1094/PD-74-0404; General statistics office of Vietnam, 2018, PLANT AR CASS PROV 0; Gotz M, 2016, J ASIA-PAC ENTOMOL, V19, P537, DOI 10.1016/j.aspen.2016.04.017; Campo BVH, 2011, FOOD SECUR, V3, P329, DOI 10.1007/s12571-011-0141-4; Herrera Campo BV, 2014, REPLICATION DATA THR, DOI [10.7910/DVN/27490, DOI 10.7910/DVN/27490]; Howeler R., 2014, SUSTAINABLE SOIL CRO, P1; Graziosi I, 2016, PEST MANAG SCI, V72, P1071, DOI 10.1002/ps.4250; International Institute of Tropical Agriculture (IITA), 2010, CASS DIS SURV SURV 2; Jose A., 2008, J ROOT CROPS, V34, P21; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Legg JP, 2015, ADV VIRUS RES, V91, P85, DOI 10.1016/bs.aivir.2014.10.001; Legg James P., 2010, P233; Legg JP, 2004, PLANT MOL BIOL, V56, P585, DOI 10.1007/s11103-004-1651-7; Marx V, 2015, NAT METHODS, V12, P393, DOI 10.1038/nmeth.3369; Masinde E. A., 2016, African Journal of Agricultural Research, V11, P2064; Ministry of Agriculture Forestry and Fisheries, 2017, MAFF C CAMB 2017; Mittal D, 2008, ARCH VIROL, V153, P2149, DOI 10.1007/s00705-008-0238-z; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Owor B, 2004, ANN APPL BIOL, V145, P331, DOI 10.1111/j.1744-7348.2004.tb00390.x; Patil BL, 2005, ARCH VIROL, V150, P389, DOI 10.1007/s00705-004-0399-3; Rybicki EP, 2015, ARCH VIROL, V160, P17, DOI 10.1007/s00705-014-2295-9; Saunders K, 2002, VIROLOGY, V293, P63, DOI 10.1006/viro.2001.1251; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Snehi SK, 2017, VIROL MYCOL, V6, P547, DOI DOI 10.4172/2161-0517.1000164; Sseruwagi P, 2004, VIRUS RES, V100, P129, DOI 10.1016/j.virusres.2003.12.021; Tembo M, 2017, J PLANT PATHOL, V99, P681; Thresh J. M., 1994, Tropical Science, V34, P26; Thresh JM, 2005, PLANT PATHOL, V54, P587, DOI 10.1111/j.1365-3059.2005.01282.x; Thresh JM, ADV DIS VECTOR RES, V10; Wang G, 2014, VIRUS GENES, V48, P402, DOI 10.1007/s11262-014-1034-3; Wang HL, 2016, PLANT DIS, V100, P1029, DOI 10.1094/PDIS-10-15-1228-PDN	44	24	24	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212780	10.1371/journal.pone.0212780	http://dx.doi.org/10.1371/journal.pone.0212780			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794679	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100135
J	Saito, K; Koido, S; Odamaki, T; Kajihara, M; Kato, K; Horiuchi, S; Adachi, S; Arakawa, H; Yoshida, S; Akasu, T; Ito, Z; Uchiyama, K; Saruta, M; Xiao, JZ; Sato, N; Ohkusa, T				Saito, Keisuke; Koido, Shigeo; Odamaki, Toshitaka; Kajihara, Mikio; Kato, Kumiko; Horiuchi, Sankichi; Adachi, Sei; Arakawa, Hiroshi; Yoshida, Sayumi; Akasu, Takafumi; Ito, Zensho; Uchiyama, Kan; Saruta, Masayuki; Xiao, Jin-zhong; Sato, Nobuhiro; Ohkusa, Toshifumi			Metagenomic analyses of the gut microbiota associated with colorectal adenoma	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; CANCER; CELLS	Recent studies have suggested an association between certain members of the Fusobacterium genus, especially F. nucleatum, and the progression of advanced colorectal carcinoma (CRC). We assessed such an association of the gut microbiota in Japanese patients with colorectal adenoma (CRA) or intramucosal CRC using colonoscopy aspirates. We analyzed samples from 81 Japanese patients, including 47 CRA and 24 intramucosal CRC patients, and 10 healthy subjects. Metagenomic analysis of the V3-V4 region of the 16S ribosomal RNA gene was performed. The linear discriminant analysis (LDA) effect size (LEfSe) method was used to examine microbial dysbiosis, revealing significant differences in bacterial abundances between the healthy controls and CRA or intramucosal CRC patients. In particular, F. varium was statistically more abundant in patients with CRA and intramucosal CRC than in healthy subjects. Here, we present the metagenomic profile of CRA and intramucosal CRC and demonstrate that F. varium is at least partially involved in the pathogenesis of CRA and intramucosal CRC.	[Saito, Keisuke; Koido, Shigeo; Kajihara, Mikio; Horiuchi, Sankichi; Yoshida, Sayumi; Akasu, Takafumi; Ito, Zensho; Uchiyama, Kan; Ohkusa, Toshifumi] Jikei Univ, Kashiwa Hosp, Sch Med, Div Gastroenterol & Hepatol, Chiba, Japan; [Odamaki, Toshitaka; Kato, Kumiko; Xiao, Jin-zhong] Morinaga Milk Ind Co Ltd, Next Generat Sci Inst, Gut Microbiota Dept, Zama, Kanagawa, Japan; [Adachi, Sei; Arakawa, Hiroshi] Jikei Univ, Kashiwa Hosp, Sch Med, Dept Endoscopy, Chiba, Japan; [Saruta, Masayuki] Jikei Univ, Sch Med, Div Gastroenterol & Hepatol, Tokyo, Japan; [Sato, Nobuhiro; Ohkusa, Toshifumi] Juntendo Univ, Grad Sch Med, Dept Microbiota Res, Tokyo, Japan	Jikei University; Morinaga Milk Industry Company, Ltd; Jikei University; Jikei University; Juntendo University	Koido, S (corresponding author), Jikei Univ, Kashiwa Hosp, Sch Med, Div Gastroenterol & Hepatol, Chiba, Japan.	shigeo_koido@jikei.ac.jp	Saruta, Masayuki/ABL-4991-2022; 大草, 敏史/HGD-2376-2022	Saruta, Masayuki/0000-0001-8172-3240; Koido, Shigeo/0000-0003-0397-4348	Morinaga Milk Industry Co., LTD.; Smoking Research Foundation [6]	Morinaga Milk Industry Co., LTD.; Smoking Research Foundation	Employees of Morinaga Milk Industry Co., LTD., Toshitaka Odamaki, Kumiko Kato, and, Jin-zhong Xiao were received salary from the company. The specific roles of these authors are articulated in the 'author contributions' section. Our work was funded by the Smoking Research Foundation (special study, no. 6). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300; Allen-Vercoe E, 2011, GUT MICROBES, V2, P294, DOI 10.4161/gmic.2.5.18603; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Barberan A, 2015, P ROY SOC B-BIOL SCI, V282, P212, DOI 10.1098/rspb.2015.1139; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111; Chen L, 2016, SCI REP-UK, V6, DOI 10.1038/srep23075; de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324; Edge SB., 2010, AJCC CANC STAGING MA, P143; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Hari DM, 2013, J AM COLL SURGEONS, V217, P181, DOI 10.1016/j.jamcollsurg.2013.04.018; Keku TO, 2015, AM J PHYSIOL-GASTR L, V308, pG351, DOI 10.1152/ajpgi.00360.2012; Keren Nirit, 2012, Biosci Microbiota Food Health, V31, P71, DOI 10.12938/bmfh.31.71; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111; Kuczynski J, 2012, CURR PROTOC MICROBIO, V27, p1E; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377; Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727; Odamaki T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18391-x; Oh JK, 2014, ANN GLOB HEALTH, V80, P384, DOI 10.1016/j.aogh.2014.09.013; Ohkusa T, 2009, J MED MICROBIOL, V58, P535, DOI 10.1099/jmm.0.005801-0; Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012; Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sekizuka T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189319; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Wang HF, 2016, SCI REP-UK, V6, DOI 10.1038/srep33440; Yamaoka Y, 2018, J GASTROENTEROL, V53, P517, DOI 10.1007/s00535-017-1382-6; Yang YB, 2016, 7TH INTERNATIONAL SYMPOSIUM ON HIGH-TEMPERATURE METALLURGICAL PROCESSING, P11	32	22	23	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212406	10.1371/journal.pone.0212406	http://dx.doi.org/10.1371/journal.pone.0212406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794590	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100061
J	Walker, S; Wankell, M; Ho, V; White, R; Deo, N; Devine, C; Dewdney, B; Bhathal, P; Govaere, O; Roskams, T; Qiao, L; George, J; Hebbard, L				Walker, Sarah; Wankell, Miriam; Ho, Vikki; White, Rose; Deo, Nikita; Devine, Carol; Dewdney, Brittany; Bhathal, Prithi; Govaere, Olivier; Roskams, Tania; Qiao, Liang; George, Jacob; Hebbard, Lionel			Targeting mTOR and Src restricts hepatocellular carcinoma growth in a novel murine liver cancer model	PLOS ONE			English	Article							COLORECTAL CARCINOGENESIS; INSULIN-RESISTANCE; MAMMALIAN TARGET; TUMOR-FORMATION; ADIPONECTIN; SORAFENIB; RAPAMYCIN; ACTIVATION; EVEROLIMUS; SURVIVAL	Liver cancer is a poor prognosis cancer with limited treatment options. To develop a new therapeutic approach, we derived HCC cells from a known model of murine hepatocellular carcinoma (HCC). We treated adiponectin (APN) knock-out mice with the carcinogen diethylnitrosamine, and the resulting tumors were 7-fold larger than wild-type controls. Tumors were disassociated from both genotypes and their growth characteristics evaluated. A52 cells from APN KO mice had the most robust growth in vitro and in vivo, and presented with pathology similar to the parental tumor. All primary tumors and cell lines exhibited activity of the mammalian target of Rapamycin (mTOR) and Src pathways. Subsequent combinatorial treatment, with the mTOR inhibitor Rapamycin and the Src inhibitor Dasatinib reduced A52 HCC growth 29-fold in vivo. Through protein and histological analyzes we observed activation of these pathways in human HCC, suggesting that targeting both mTOR and Src may be a novel approach for the treatment of HCC.	[Walker, Sarah; Ho, Vikki; White, Rose; Deo, Nikita; Devine, Carol; Qiao, Liang; George, Jacob; Hebbard, Lionel] Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia; [Walker, Sarah; Ho, Vikki; White, Rose; Deo, Nikita; Devine, Carol; Qiao, Liang; George, Jacob; Hebbard, Lionel] Univ Sydney, Westmead, NSW, Australia; [Walker, Sarah] Canberra Hosp, Gastroenterol & Hepatol Unit, Woden, ACT, Australia; [Wankell, Miriam; Dewdney, Brittany; Hebbard, Lionel] James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Dept Mol & Cell Biol, Townsville, Qld, Australia; [Bhathal, Prithi] Univ Melbourne, Melbourne, Vic, Australia; [Govaere, Olivier; Roskams, Tania] KULeuven, Dept Imaging & Pathol, Translat Cell & Tissue Res, Leuven, Belgium; [Govaere, Olivier; Roskams, Tania] Univ Hosp Leuven, Leuven, Belgium; [Govaere, Olivier] Newcastle Univ, Med Sch, Inst Cellular Med, Liver Res Grp, Newcastle Upon Tyne, Tyne & Wear, England	University of Sydney; Westmead Institute for Medical Research; University of Sydney; Australian National University; Canberra Hospital; James Cook University; University of Melbourne; KU Leuven; KU Leuven; University Hospital Leuven; Newcastle University - UK	Hebbard, L (corresponding author), Westmead Hosp, Westmead Inst Med Res, Storr Liver Ctr, Westmead, NSW, Australia.; Hebbard, L (corresponding author), Univ Sydney, Westmead, NSW, Australia.; Hebbard, L (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Ctr Mol Therapeut, Dept Mol & Cell Biol, Townsville, Qld, Australia.	lionel.hebbard@jcu.edu.au	Hebbard, Lionel/W-4057-2019; Deo, Nikita/J-7688-2019; Govaere, Olivier/R-9372-2019; Hebbard, Lionel/O-1489-2017; Dewdney, Brittany/ABH-1428-2020; Deo, Nikita/V-4547-2019	Govaere, Olivier/0000-0002-4426-6930; Hebbard, Lionel/0000-0002-7094-9065; Dewdney, Brittany/0000-0002-6362-369X; Roskams, Tania/0000-0002-2816-1530; Deo, Nikita/0000-0002-3810-488X	Robert W. Storr Bequest; University of Sydney; National Health and Medical Research Council of Australia (NHMRC) [APP1053206]; NHMRC [1047417, 1006200, 1087297]; Cancer Council NSW [1070076, 1069733]; Cancer Council Queensland Project Grant [1123436]; Belgian Federal Science Policy Office, Interuniversity Attraction Poles program [P7/83-HEPRO]	Robert W. Storr Bequest; University of Sydney(University of Sydney); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council NSW(Cancer Council New South Wales); Cancer Council Queensland Project Grant(Cancer Council Queensland); Belgian Federal Science Policy Office, Interuniversity Attraction Poles program	This work was supported by the Robert W. Storr Bequest to the Sydney Medical Foundation, University of Sydney, National Health and Medical Research Council of Australia (NHMRC) Program grant APP1053206 (https://nhmrc.gov.au/). NHMRC project grants (1047417, LQ; 1006200, 1087297, JG and LH); Cancer Council NSW Project Grants (1070076, LQ; 1069733 (https://www.cancer.org.au/) to LH); Cancer Council Queensland Project Grant (1123436, LH); and the Belgian Federal Science Policy Office, Interuniversity Attraction Poles program-P7/83-HEPRO (TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2009, J GASTROEN HEPATOL, V24, P1669, DOI 10.1111/j.1440-1746.2009.06039.x; Balmer ML, 2010, CLIN SCI, V119, P431, DOI 10.1042/CS20100008; Bertot LC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050774; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Chen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129663; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Denzel MS, 2009, CLIN CANCER RES, V15, P3256, DOI 10.1158/1078-0432.CCR-08-2661; Ertle J, 2011, INT J CANCER, V128, P2436, DOI 10.1002/ijc.25797; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; He GB, 2010, CANCER CELL, V17, P286, DOI 10.1016/j.ccr.2009.12.048; Hebbard L, 2011, ONCOGENE, V30, P301, DOI 10.1038/onc.2010.412; Hebbard L, 2014, BEST PRACT RES CL EN, V28, P59, DOI 10.1016/j.beem.2013.11.005; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Hui JM, 2004, HEPATOLOGY, V40, P46, DOI 10.1002/hep.20280; Ito Y, 2001, J HEPATOL, V35, P68, DOI 10.1016/S0168-8278(01)00077-0; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kamada Y, 2007, J HEPATOL, V47, P556, DOI 10.1016/j.jhep.2007.03.020; Koeberle D, 2016, ANN ONCOL, V27, P856, DOI 10.1093/annonc/mdw054; Kubrusly MS, 2010, HISTOL HISTOPATHOL, V25, P1123, DOI 10.14670/HH-25.1123; Kwong LN, 2014, ONCOGENE, V33, P1, DOI 10.1038/onc.2013.34; Liu TC, 2014, MODERN PATHOL, V27, P420, DOI 10.1038/modpathol.2013.148; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matter MS, 2014, J HEPATOL, V60, P855, DOI 10.1016/j.jhep.2013.11.031; Nishihara T, 2008, WORLD J GASTROENTERO, V14, P6473, DOI 10.3748/wjg.14.6473; Paradis V, 2009, HEPATOLOGY, V49, P851, DOI 10.1002/hep.22734; Patel A, 2016, LIFE SCI, V157, P52, DOI 10.1016/j.lfs.2016.05.036; Ramezani-Moghadam M, 2015, J BIOL CHEM, V290, P5533, DOI 10.1074/jbc.M114.598011; Ray K, 2013, NAT REV GASTRO HEPAT, V10, P621, DOI [10.1038/nrgastro.2013.184, 10.1038/nrgastro.2013.197]; Rebholz H, 2006, FEBS J, V273, P2023, DOI 10.1111/j.1742-4658.2006.05219.x; Saxena NK, 2010, GASTROENTEROLOGY, V139, P1762, DOI 10.1053/j.gastro.2010.07.001; Varkaris A, 2014, CANCER METAST REV, V33, P595, DOI 10.1007/s10555-013-9481-1; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Vojtechova M, 2008, NEOPLASIA, V10, P99, DOI 10.1593/neo.07905; Yang WW, 2011, NATURE, V480, P118, DOI 10.1038/nature10598; Yeo W, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1334-6; Yori JL, 2014, CANCER RES, V74, P4762, DOI 10.1158/0008-5472.CAN-13-3627; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhu AX, 2014, JAMA-J AM MED ASSOC, V312, P57, DOI 10.1001/jama.2014.7189	46	13	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212860	10.1371/journal.pone.0212860	http://dx.doi.org/10.1371/journal.pone.0212860			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794695	gold, Green Published, Green Accepted			2022-12-26	WOS:000459709100152
J	Barwick, AL; Hurn, SE; van Netten, JJ; Reed, LF; Lazzarini, PA				Barwick, Alex L.; Hurn, Sheree E.; van Netten, Jaap J.; Reed, Lloyd F.; Lazzarini, Peter A.			Factors associated with wearing inadequate outdoor footwear in populations at risk of foot ulceration: A cross-sectional study	PLOS ONE			English	Article							DIABETIC-PATIENTS; IWGDF GUIDANCE; ULCERS; PREVENTION; AMPUTATION; PEOPLE; CARE; PAIN	Background Few studies have investigated if people at risk of foot ulceration actually wear the footwear recommended by best practice guidelines to prevent foot ulceration. This study aimed to investigate the prevalence of, and factors associated with, wearing inadequate outdoor footwear in those with diabetes or peripheral neuropathy in an inpatient population. Methods This was a secondary analysis of a multi-site cross-sectional study investigating foot conditions in a large representative inpatient population admitted into hospital for any medical reason on one day. A range of explanatory variables were collected from all participants including sociodemographic, medical and foot condition factors. The outcome variable for this study was the self-reported outdoor footwear type worn most by participants outside the house in the year prior to hospitalisation. The self-reported footwear type was then categorised into adequate and inadequate according to footwear features recommended in guidelines for populations at risk of foot ulceration. Logistic regression identified factors independently associated with inadequate footwear in all inpatient participants, and diabetes and neuropathy subgroups. Results Overall, 47% of a total of 726 inpatients wore inadequate outdoor footwear; 49% of the 171 in the diabetes subgroup and 43% of 159 in the neuropathy subgroup. Wearing inadequate outdoor footwear was independently associated (Odds Ratio (95% Confidence Interval)) with being female in the diabetes (2.7 (1.4-5.2)) and neuropathy subgroups (3.7 (1.8-7.9)) and being female (5.1 (3.7-7.1)), having critical peripheral arterial disease (2.5 (1.1-5.9)) and an amputation (0.3 (0.1-0.7)) in all inpatients (all, p<0.05). Conclusions Almost half of all inpatients at risk of foot ulceration reported wearing outdoor footwear most of the time that did not meet recommendations for prevention. We found women were much more likely to wear inadequate footwear. More work needs to be done to increase the uptake of footwear recommendations in these populations to prevent foot ulceration.	[Barwick, Alex L.] Southern Cross Univ, Sch Hlth & Human Sci, Bilinga, Qld, Australia; [Hurn, Sheree E.; van Netten, Jaap J.; Reed, Lloyd F.; Lazzarini, Peter A.] Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia; [Hurn, Sheree E.; van Netten, Jaap J.; Reed, Lloyd F.; Lazzarini, Peter A.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [van Netten, Jaap J.; Lazzarini, Peter A.] Wound Management Innovat Cooperat Res Ctr, Brisbane, Qld, Australia; [van Netten, Jaap J.] Univ Amsterdam, Amsterdam Movement Sci, Dept Rehabil, Amsterdam, Netherlands; [Reed, Lloyd F.] Footmot Podiatry Brisbane, Brisbane, Qld, Australia; [Lazzarini, Peter A.] Metro North Hosp & Hlth Serv, Allied Hlth Res Collaborat, Brisbane, Qld, Australia	Southern Cross University; Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of Amsterdam; Vrije Universiteit Amsterdam	Lazzarini, PA (corresponding author), Queensland Univ Technol, Sch Clin Sci, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Wound Management Innovat Cooperat Res Ctr, Brisbane, Qld, Australia.; Lazzarini, PA (corresponding author), Metro North Hosp & Hlth Serv, Allied Hlth Res Collaborat, Brisbane, Qld, Australia.	Peter.Lazzarini@health.qld.gov.au	Hurn, Sheree E/AAT-6069-2021; Barwick, Alex/AAN-8955-2021	Lazzarini, Peter/0000-0002-8235-7964; van Netten, Jaap J./0000-0002-6420-6046; Hurn, Sheree/0000-0003-4638-6597; Barwick, Alex/0000-0001-8469-0528	Queensland Health (Queensland Government); Wound Management Innovation Cooperative Research Centre (Australian Government's Cooperative Research Centres Program)	Queensland Health (Queensland Government); Wound Management Innovation Cooperative Research Centre (Australian Government's Cooperative Research Centres Program)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was supported by grant funding from Queensland Health (Queensland Government) and Wound Management Innovation Cooperative Research Centre (Australian Government's Cooperative Research Centres Program).	[Anonymous], 2011, NATL EVIDENCE BASED; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Australian Institute of Health and Welfare, 2013, AUSTR HOSP STAT 2011; Barton CJ, 2009, J FOOT ANKLE RES, V2, DOI 10.1186/1757-1146-2-10; Bergin SM, 2013, J FOOT ANKLE RES, V6, DOI 10.1186/1757-1146-6-6; Boulton AJM, 2012, SEMIN VASC SURG, V25, P61, DOI 10.1053/j.semvascsurg.2012.04.009; Bus SA, 2016, DIABETES-METAB RES, V32, P25, DOI 10.1002/dmrr.2697; Bus SA, 2016, DIABETES-METAB RES, V32, P16, DOI 10.1002/dmrr.2696; Chandalia HB, 2008, INT J DIABETES DEV C, V28, P109, DOI 10.4103/0973-3930.45269; Crawford F, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19570; Dinh T, 2008, WOUNDS, V20, P127; Fan L, 2014, DIABETIC FOOT CANADA, V2, P4; Farndon L, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0149-2; Fernando ME, 2016, CLIN BIOMECH, V37, P98, DOI 10.1016/j.clinbiomech.2016.06.006; Harrison SJ, 2007, INT J CLIN PRACT, V61, P1900, DOI 10.1111/j.1742-1241.2007.01554.x; Hockey J, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.2897; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Isip JDQ, 2016, J ASEAN FEDERATION E, V31, P37, DOI DOI 10.15605/JAFES.031.01.07; Jeffcoate WJ, 2016, LANCET DIABETES ENDO, V4, P781, DOI 10.1016/S2213-8587(16)30012-2; Kaminski MR, 2015, NEPHROL DIAL TRANSPL, V30, P1747, DOI 10.1093/ndt/gfv114; Lazzarini PA, 2016, BURDEN FOOT DIS INPA; Lazzarini PA, 2017, INT WOUND J, V14, P716, DOI 10.1111/iwj.12683; Lazzarini PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010811; Lazzarini PA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008544; Lazzarini PA, 2014, J FOOT ANKLE RES, V7, DOI 10.1186/1757-1146-7-7; McGill M, 2005, INTERN MED J, V35, P451, DOI 10.1111/j.1445-5994.2005.00880.x; Menz HB, 2016, J GERONTOL A-BIOL, V71, P1682, DOI 10.1093/gerona/glw004; Mills JL, 2014, J VASC SURG, V59, P220, DOI 10.1016/j.jvs.2013.08.003; Reiber GE, 2002, J REHABIL RES DEV, V39, P615; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; van Netten JJ, 2016, EUR J VASC ENDOVASC, V51, P248, DOI 10.1016/j.ejvs.2015.10.001; van Netten JJ, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-017-0244-z; van Netten JJ, 2017, PROSTHET ORTHOT INT, V41, P201, DOI 10.1177/0309364616650080; van Netten JJ, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-92; Willrich A, 2005, FOOT ANKLE INT, V26, P128, DOI 10.1177/107110070502600203	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211140	10.1371/journal.pone.0211140	http://dx.doi.org/10.1371/journal.pone.0211140			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789920	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800010
J	Gallivan, M; Oppenheim, B; Madhav, NK				Gallivan, Mark; Oppenheim, Ben; Madhav, Nita K.			Using social media to estimate Zika's impact on tourism: #babymoon, 2014-2017	PLOS ONE			English	Article							VIRUS; TRANSMISSION; EPIDEMIOLOGY; KNOWLEDGE; WOMEN	Zika virus infection during pregnancy can cause microcephaly and other birth defects. We hypothesized that the Latin America Zika epidemic resulted in pregnant women and their partners adopting behavioral changes to limit risk, leading them to forego travel to Zika-affected locations. We evaluated this hypothesis by studying travelers' intent and behavior through Twitter data related to babymoon: a holiday taken by parents-to-be before their baby is born. We found the odds of mentioning representative Zika-affected locations in #babymoon tweets dropped significantly (Odds ratio: 0.29, 95% CI: 0.20-0.40) after the Zika-microcephaly association became well-known. This result was further corroborated through a content analysis of #babymoon tweets mentioning Zika-affected locations, which identified if the Twitter user was physically present in the Zika-affected locations. Conversely, we found a small but statistically insignificant increase in the odds of mentioning Zika-free locations from #babymoon tweets (Odds Ratio: 1.11, 95% CI: 0.97-1.27) after the Zika-microcephaly association became well-known.	[Gallivan, Mark; Oppenheim, Ben; Madhav, Nita K.] Metabiota Inc, San Francisco, CA 94104 USA		Gallivan, M (corresponding author), Metabiota Inc, San Francisco, CA 94104 USA.	mgallivan@metabiota.com	Madhav, Nita K/J-1343-2018	Madhav, Nita/0000-0001-8077-330X				Cervellin G, 2017, J EPIDEMIOL GLOB HEA, V7, P185, DOI 10.1016/j.jegh.2017.06.001; comScore, 2015, COMSCORE REL JUL 201; Curry CL, 2018, J OBSTET GYNAECOL RE, V44, P503, DOI 10.1111/jog.13533; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR; Google, 2018, BABYM GOOGL TRENDS; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295; Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933; Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583; Pan American Health Organization, 2018, ZIK CAS CONG SYNDR A; R CT, 2017, R LANG ENV STAT COMP; Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616; Sloan L, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.3001; Tataryn J, 2018, Can Commun Dis Rep, V44, P18, DOI 10.14745/ccdr.v44i01a05; U. S. Department of Commerce International Trade Administration National Travel and Tourism Office (NTTO), 2017, MONTHL DEP INT DEST; Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5; Whittemore K, 2017, EMERG INFECT DIS, V23, P164, DOI 10.3201/eid2301.161614; WHO, WHO MICR BRAZ; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	23	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212507	10.1371/journal.pone.0212507	http://dx.doi.org/10.1371/journal.pone.0212507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789944	Green Published, gold, Green Submitted			2022-12-26	WOS:000459330800032
J	Kim, JJ; Savas, JN; Miller, MT; Hu, XD; Carromeu, C; Lavallee-Adam, M; Freitas, BCG; Muotri, AR; Yates, JR; Ghosh, A				Kim, Jean J.; Savas, Jeffrey N.; Miller, Meghan T.; Hu, Xindao; Carromeu, Cassiano; Lavallee-Adam, Mathieu; Freitas, Beatriz C. G.; Muotri, Alysson R.; Yates, John R., III; Ghosh, Anirvan			Proteomic analyses reveal misregulation of LIN28 expression and delayed timing of glial differentiation in human iPS cells with MECP2 loss-of-function	PLOS ONE			English	Article							SEVERE MENTAL-RETARDATION; RETT-SYNDROME; STEM-CELLS; QUANTITATIVE PROTEOMICS; DNA METHYLATION; AMINO-ACIDS; MOUSE MODEL; DUPLICATION; NEURONS; GENE	Rett syndrome (RTT) is a pervasive developmental disorder caused by mutations in MECP2. Complete loss of MECP2 function in males causes congenital encephalopathy, neurodevelopmental arrest, and early lethality. Induced pluripotent stem cell (iPSC) lines from male patients harboring mutations in MECP2, along with control lines from their unaffected fathers, give us an opportunity to identify some of the earliest cellular and molecular changes associated with MECP2 loss-of-function (LOF). We differentiated iPSC-derived neural progenitor cells (NPCs) using retinoic acid (RA) and found that astrocyte differentiation is perturbed in iPSC lines derived from two different patients. Using highly stringent quantitative proteomic analyses, we found that LIN28, a gene important for cell fate regulation and developmental timing, is upregulated in mutant NPCs compared to WT controls. Overexpression of LIN28 protein in control NPCs suppressed astrocyte differentiation and reduced neuronal synapse density, whereas downregulation of LIN28 expression in mutant NPCs partially rescued this synaptic deficiency. These results indicate that the pathophysiology of RTT may be caused in part by misregulation of developmental timing in neural progenitors, and the subsequent consequences of this disruption on neuronal and glial differentiation.	[Kim, Jean J.; Hu, Xindao; Ghosh, Anirvan] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Kim, Jean J.; Hu, Xindao; Carromeu, Cassiano; Freitas, Beatriz C. G.; Muotri, Alysson R.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Savas, Jeffrey N.; Lavallee-Adam, Mathieu; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Miller, Meghan T.; Ghosh, Anirvan] F Hoffmann La Roche, Roche Innovat Ctr Basel, pRED, Basel, Switzerland; [Kim, Jean J.] Baylor Coll Med, Dept Mol & Cellular Biol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Savas, Jeffrey N.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ghosh, Anirvan] Biogen, Res & Early Dev, Cambridge, MA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Roche Holding; Baylor College of Medicine; Northwestern University; Feinberg School of Medicine; Biogen	Kim, JJ (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.; Kim, JJ (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Savas, JN (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.; Kim, JJ (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA.; Savas, JN (corresponding author), Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA.	jean.kim@bcm.edu; jeffrey.savas@northwestern.edu	Kim, Jean Jieun/G-5774-2018	Kim, Jean Jieun/0000-0003-4709-262X; Carromeu, Cassiano/0000-0002-7570-2213	California Institute for Regenerative Medicine (CIRM) [TR2-01814, TR4-06747, RB3-05229]; National Institutes of Health (NIH) through NIH Director's New Innovator Award Program [1-DP2-0D006495-01]; NIMH [R01 MH100175-01]; International Rett Syndrome Foundation (IRSF) [2915]; F. Hoffman-La Roche Postdoctoral Fellowship Award [SFP2063]; National Institute on Deafness and Other Communication Disorders [1K99DC013805-01]; Hartwell Foundation; Individual Biomedical Research Award; Fonds de Recherche du Quebec-Nature et Technologies (FRQNT); National Institute of General Medical Sciences [P41 GM103533];  [UOW/R41GM103533];  [MH-2 R01 MH06788011];  [1 R01 MH100175-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100175, R01MH067880] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH) through NIH Director's New Innovator Award Program; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); International Rett Syndrome Foundation (IRSF); F. Hoffman-La Roche Postdoctoral Fellowship Award; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Hartwell Foundation; Individual Biomedical Research Award; Fonds de Recherche du Quebec-Nature et Technologies (FRQNT); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the California Institute for Regenerative Medicine (CIRM) TR2-01814 and TR4-06747 (to A.R.M), and RB3-05229 (to A.G. and J.J.K.). The Muotri lab is supported by National Institutes of Health (NIH) through the NIH Director's New Innovator Award Program (1-DP2-0D006495-01), an R01 MH100175-01 from NIMH and from the International Rett Syndrome Foundation (IRSF grant #2915). J.N.S. was supported by an F. Hoffman-La Roche Postdoctoral Fellowship Award (SFP2063), 1K99DC013805-01 from National Institute on Deafness and Other Communication Disorders, and The Hartwell Foundation, Individual Biomedical Research Award. M.L.-A. was supported by a postdoctoral fellowship from the Fonds de Recherche du Quebec-Nature et Technologies (FRQNT). The Yates' lab is supported by UOW/R41GM103533, MH-2 R01 MH06788011 and 1 R01 MH100175-01, and National Institute of General Medical Sciences P41 GM103533. The funder (F. Hoffmann-La Roche) provided support in the form of salaries for authors (MTM and AG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the ` author contributions' section.	Andoh-Noda T, 2015, MOL BRAIN, V8, DOI 10.1186/s13041-015-0121-2; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2009, NAT NEUROSCI, V12, P311, DOI 10.1038/nn.2275; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brennand K, 2015, MOL PSYCHIATR, V20, P361, DOI 10.1038/mp.2014.22; Brennand KJ, 2011, NATURE, V473, P221, DOI 10.1038/nature09915; Butko MT, 2013, P NATL ACAD SCI USA, V110, pE726, DOI 10.1073/pnas.1300424110; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Chapleau CA, 2009, NEUROBIOL DIS, V35, P219, DOI 10.1016/j.nbd.2009.05.001; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cimadamore F, 2013, P NATL ACAD SCI USA, V110, pE3017, DOI 10.1073/pnas.1220176110; Cox J, 2011, ANNU REV BIOCHEM, V80, P273, DOI 10.1146/annurev-biochem-061308-093216; del Gaudio D, 2006, GENET MED, V8, P784, DOI 10.1097/01.gim.0000250502.28516.3c; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Faigle R, 2008, J NEUROCHEM, V106, P1681, DOI 10.1111/j.1471-4159.2008.05525.x; Friez MJ, 2006, PEDIATRICS, V118, pE1687, DOI 10.1542/peds.2006-0395; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108; Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307; Li Y, 2013, CELL STEM CELL, V13, P446, DOI 10.1016/j.stem.2013.09.001; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Lioy DT, 2011, NATURE, V475, P497, DOI 10.1038/nature10214; MacCoss MJ, 2003, ANAL CHEM, V75, P6912, DOI 10.1021/ac034790h; Maezawa I, 2009, J NEUROSCI, V29, P5051, DOI 10.1523/JNEUROSCI.0324-09.2009; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Namihira M, 2004, FEBS LETT, V572, P184, DOI 10.1016/j.febslet.2004.07.029; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SS, 2012, J PROTEOMICS, V75, P3720, DOI 10.1016/j.jprot.2012.04.035; Patterson M, 2014, STEM CELL REP, V3, P758, DOI 10.1016/j.stemcr.2014.08.015; Patterson M, 2012, CELL RES, V22, P178, DOI 10.1038/cr.2011.133; Pfrieger FW, 1997, SCIENCE, V277, P1684, DOI 10.1126/science.277.5332.1684; Reichow B, 2015, J AUTISM DEV DISORD, V45, P3377, DOI 10.1007/s10803-015-2519-1; Rodrigues DC, 2016, CELL REP, V17, P720, DOI 10.1016/j.celrep.2016.09.049; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Schule B, 2008, CLIN GENET, V74, P116, DOI 10.1111/j.1399-0004.2008.01005.x; Shahbazian MD, 2002, AM J MED GENET, V111, P164, DOI 10.1002/ajmg.10557; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Sztainberg Y, 2015, NATURE, V528, P123, DOI 10.1038/nature16159; Tang X, 2016, P NATL ACAD SCI USA, V113, P751, DOI 10.1073/pnas.1524013113; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vu A., 2009, NUCL CYTOPLASMIC ROL; Wang ITJ, 2013, NEUROBIOL DIS, V58, P3, DOI 10.1016/j.nbd.2013.04.020; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Weaving LS, 2003, AM J MED GENET A, V118A, P103, DOI 10.1002/ajmg.a.10053; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Yasui DH, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-3; Yazdani M, 2012, STEM CELLS, V30, P2128, DOI 10.1002/stem.1180; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	61	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212553	10.1371/journal.pone.0212553	http://dx.doi.org/10.1371/journal.pone.0212553			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789962	gold, Green Published, Green Submitted			2022-12-26	WOS:000459330800037
J	Wang, GL; Jing, Y; Zhou, H; Ding, Y; Wang, J; Qiu, J; Hua, HY; Dong, C				Wang, Guangli; Jing, Yang; Zhou, Hui; Ding, Yi; Wang, Jie; Qiu, Jing; Hua, Haiyong; Dong, Chen			Association between previous schistosome infection and incident hyperuricemia: A prospective cohort study in China	PLOS ONE			English	Article							SERUM URIC-ACID; METABOLIC SYNDROME; RISK-FACTORS; INFLAMMATION; ACTIVATION; PLASMA; REDUCE; LEVEL	Background More than 11 million people were estimated to be infected by Schistosoma japonicum in China before the 1950s. However, seldom studies have been conducted to evaluate the longitudinal effects of previous schistosome infection (PSI). We aimed to investigate the association between PSI and hyperuricemia in China. Methods From February 2013 to October 2013, 3,517 Chinese subjects (908 persons with PSI and 2,609 persons without PSI) were recruited from a prospective cohort study of "135". After two years, 113 and 462 participants had developed hyperuricemia in the persons with and without PSI, respectively. Multivariable logistic models were used to estimate Relative Ratios (RR) and 95% confidence intervals (CIs) for hyperuricemia. Results The PSI participants had a decreased risk of hyperuricemia compared with those without PSI [adjusted RR (95% CI): 0.73 (0.55, 0.97)]. Within the PSI group, higher level of fasting plasma glucose was significantly associated with the reduced incidence of hyperuricemia in PSI population (RR: 0.40, 95% CI: 0.26-0.63). For females, hypertension, increased levels of serum creatinine and triglycerides were the risk factors for incident hyperuricemia in the PSI group. Conclusions Our results suggest that PSI is significantly associated with the lower incidence of hyperuricemia. Moreover, elevated fasting plasma glucose might prevent the onset of hyperuricemia in PSI population.	[Wang, Guangli; Jing, Yang; Wang, Jie; Qiu, Jing; Dong, Chen] Soochow Univ, Jiangsu Key Lab & Translat Med Geriatr Dis, Dept Epidemiol & Stat, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China; [Zhou, Hui; Ding, Yi] Suzhou Ind Pk Ctr Dis Control & Prevent, Suzhou, Jiangsu, Peoples R China; [Hua, Haiyong] Jiangsu Inst Parasit Dis, Wuxi City, Jiangsu, Peoples R China	Soochow University - China	Dong, C (corresponding author), Soochow Univ, Jiangsu Key Lab & Translat Med Geriatr Dis, Dept Epidemiol & Stat, Sch Publ Hlth,Med Coll, Suzhou, Jiangsu, Peoples R China.	cdong@suda.edu.cn			National Natural Science Foundation of China [81502869, 81773507]; Key technologies of prevention and control of major diseases and infectious diseases in Suzhou City [Gwzx201506, Gwzx201605, Gwzx201706]; Jiangsu Provincial Special Program of Medical Science [BL2014020]; 'Prospering the public health with science and education' project for young scientists fund of Suzhou city [KJXW2015063]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key technologies of prevention and control of major diseases and infectious diseases in Suzhou City; Jiangsu Provincial Special Program of Medical Science; 'Prospering the public health with science and education' project for young scientists fund of Suzhou city	This work was supported by the National Natural Science Foundation of China (Grant No. 81502869 and 81773507), Key technologies of prevention and control of major diseases and infectious diseases in Suzhou City (Gwzx201506, Gwzx201605, Gwzx201706), Jiangsu Provincial Special Program of Medical Science (BL2014020), and the 'Prospering the public health with science and education' project for young scientists fund of Suzhou city (KJXW2015063).	Brymora A, 2012, NEPHROL DIAL TRANSPL, V27, P608, DOI 10.1093/ndt/gfr223; Chen LY, 2017, FOOD FUNCT, V8, P1785, DOI [10.1039/C6FO01561A, 10.1039/c6fo01561a]; Chen YH, 2013, J CLIN ENDOCR METAB, V98, pE283, DOI 10.1210/jc.2012-2517; Culleton BF, 1999, ANN INTERN MED, V131, P7, DOI 10.7326/0003-4819-131-1-199907060-00003; Dehghan A, 2008, DIABETES CARE, V31, P361, DOI 10.2337/dc07-1276; Golembiewska E, 2005, ARCH MED RES, V36, P32, DOI 10.1016/j.arcmed.2004.09.003; Hahn K, 2017, J ADV RES, V8, P529, DOI 10.1016/j.jare.2016.09.006; HERMAN JB, 1976, DIABETOLOGIA, V12, P47, DOI 10.1007/BF01221964; La Flamme AC, 2001, J IMMUNOL, V166, P1903, DOI 10.4049/jimmunol.166.3.1903; Lertrattananon D, 2017, J DIABETES RES, V2017, P1; McMullan CJ, 2017, CLIN J AM SOC NEPHRO, V12, P807, DOI 10.2215/CJN.10771016; Nan HR, 2007, DIABETES RES CLIN PR, V76, P68, DOI 10.1016/j.diabres.2006.07.022; Puddu P, 2012, J CARDIOL, V59, P235, DOI 10.1016/j.jjcc.2012.01.013; Qian XY, 2018, GENET TEST MOL BIOMA, V22, P90, DOI 10.1089/gtmb.2017.0141; ROUBENOFF R, 1991, JAMA-J AM MED ASSOC, V266, P3004, DOI 10.1001/jama.266.21.3004; Shen SW, 2015, PARASITE IMMUNOL, V37, P333, DOI 10.1111/pim.12187; Shen SW, 2015, INT J PARASITOL, V45, P289, DOI 10.1016/j.ijpara.2015.01.001; Shen SW, 2014, INT J CARDIOL, V177, P566, DOI 10.1016/j.ijcard.2014.08.128; Shen Xue-hui, 2015, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V27, P457; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Tsai WC, 2009, HEART VESSELS, V24, P371, DOI 10.1007/s00380-008-1127-9; TUOMILEHTO J, 1988, AM J EPIDEMIOL, V127, P321, DOI 10.1093/oxfordjournals.aje.a114807; van der Vlugt LEPM, 2017, INT J PARASITOL, V47, P545, DOI 10.1016/j.ijpara.2017.02.002; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wasilewska A, 2012, ACTA PAEDIATR, V101, P497, DOI 10.1111/j.1651-2227.2011.02582.x; Zaccone P, 2003, EUR J IMMUNOL, V33, P1439, DOI 10.1002/eji.200323910	26	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212702	10.1371/journal.pone.0212702	http://dx.doi.org/10.1371/journal.pone.0212702			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789970	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800050
J	Behrens, I; Basit, S; Lykke, JA; Ranthe, MF; Wohlfahrt, J; Bundgaard, H; Melbye, M; Boyd, HA				Behrens, Ida; Basit, Saima; Lykke, Jacob A.; Ranthe, Mattis F.; Wohlfahrt, Jan; Bundgaard, Henning; Melbye, Mads; Boyd, Heather A.			Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study	PLOS ONE			English	Article							CARDIOLOGY WORKING GROUP; POSITION STATEMENT; EUROPEAN-SOCIETY; PREECLAMPSIA; DIAGNOSIS; RISK; ASSOCIATION; MANAGEMENT; PREDICTORS	Background Peripartum cardiomyopathy (PPCM) is a serious cardiac disorder occurring late in pregnancy or early in the postpartum period. We examined associations between hypertensive disorders of pregnancy (HDP: preeclampsia and gestational hypertension) and PPCM, accounting for other pregnancy-related risk factors for PPCM. Methods Using nationwide Danish register data, we constructed a cohort of all women with >= 1 live birth or stillbirth in Denmark between 1978 and 2012. Using log-linear binomial regression and generalized estimating equations, we estimated risk ratios (RRs) for PPCM associated with HDP of varying severity. Results In a cohort of 1,088,063 women with 2,078,822 eligible pregnancies, 126 women developed PPCM (39 in connection with an HDP-complicated pregnancy). The risks of PPCM were significantly higher in women with HDP-complicated pregnancies than in women with normotensive pregnancies (severe preeclampsia, RR 21.2, 95% confidence interval [CI] 12.0-37.4; moderate preeclampsia, RR 10.2, 95% CI 6.18-16.9; gestational hypertension, RR 5.16, 95% CI 2.11-12.6). The RRs for moderate preeclampsia and gestational hypertension were not significantly different from one another (p = 0.18); the RR for severe preeclampsia was significantly different from the RR for moderate preeclampsia and gestational hypertension combined (p = 0.02). Conclusions Although 70% of PPCM occurred in women with normotensive pregnancies, HDPs were associated with substantial increases in PPCM risk that depended on HDP severity. The heart's capacity to adapt to a normal pregnancy may be exceeded in some women already susceptible to cardiac insult, contributing to PPCM. HDPs, severe preeclampsia in particular, probably represent an additional cardiac stressor during pregnancy.	[Behrens, Ida; Basit, Saima; Ranthe, Mattis F.; Wohlfahrt, Jan; Melbye, Mads; Boyd, Heather A.] Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark; [Lykke, Jacob A.] Copenhagen Univ Hosp, Dept Obstet, Rigshosp, Copenhagen, Denmark; [Bundgaard, Henning] Copenhagen Univ Hosp, Unit Inherited Cardiac Dis, Rigshosp, Copenhagen, Denmark; [Melbye, Mads] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Statens Serum Institut; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Stanford University	Boyd, HA (corresponding author), Statens Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark.	hoy@ssi.dk	Bundgaard, Henning/AAA-4381-2020	Bundgaard, Henning/0000-0002-0563-7049; Lykke, Jacob Alexander/0000-0002-3698-9792; melbye, mads/0000-0001-8264-6785; Boyd, Heather/0000-0001-6849-9985; Ranthe, Mattis Flyvholm/0000-0002-6363-6386	Danish Heart Foundation [R90-A3900]; Danish Council for Independent Research [DFF-4092-00213]	Danish Heart Foundation; Danish Council for Independent Research(Det Frie Forskningsrad (DFF))	This work was supported by the Danish Heart Foundation [grant number R90-A3900 to IB] and the Danish Council for Independent Research [grant number DFF-4092-00213 to HAB]. The funders had no role in study design, data Collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 2016, CIRCULATION, V133, P1397, DOI 10.1161/CIRCULATIONAHA.115.020491; Behrens I, 2016, JAMA-J AM MED ASSOC, V315, P1026, DOI 10.1001/jama.2016.1869; Bello N, 2013, J AM COLL CARDIOL, V62, P1715, DOI 10.1016/j.jacc.2013.08.717; Blauwet LA, 2013, HEART, V99, P308, DOI 10.1136/heartjnl-2012-302760; Blauwet LA, 2011, HEART, V97, P1970, DOI 10.1136/heartjnl-2011-300349; Brown MA, 2018, PREGNANCY HYPERTENS, V13, P291, DOI 10.1016/j.preghy.2018.05.004; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Dyhr L, 2007, DAN MED BULL, V54, P226; Elkayam U, 2005, CIRCULATION, V111, P2050, DOI 10.1161/01.CIR.0000162478.36652.7E; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; England L, 2007, FRONT BIOSCI-LANDMRK, V12, P2471, DOI 10.2741/2248; Ersboll AS, 2016, ACTA OBSTET GYN SCAN, V95, P1205, DOI 10.1111/aogs.13005; Goland S, 2009, J CARD FAIL, V15, P645, DOI 10.1016/j.cardfail.2009.03.008; Gunderson EP, 2011, OBSTET GYNECOL, V118, P583, DOI 10.1097/AOG.0b013e318229e6de; Haghikia A, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0366-9; Hansen AR, 2005, REPORT HLTH ETHNIC M, P36; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Hull E, 1938, SOUTH MED J, V31, P265, DOI [10.1097/00007611-193803000-00010, DOI 10.1097/00007611-193803000-00010]; Kao DP, 2013, JACC-HEART FAIL, V1, P409, DOI 10.1016/j.jchf.2013.04.011; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Klemmensen AK, 2007, AM J EPIDEMIOL, V166, P117, DOI 10.1093/aje/kwm139; Knudsen LB, 1998, DAN MED BULL, V45, P320; Kolte D, 2014, J AM HEART ASSOC, V3, P1, DOI DOI 10.1161/JAHA.113.000590; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; McNamara DM, 2015, J AM COLL CARDIOL, V66, P905, DOI 10.1016/j.jacc.2015.06.1309; Melchiorre K, 2016, HYPERTENSION, V67, P754, DOI 10.1161/HYPERTENSIONAHA.115.06667; Melchiorre K, 2014, CIRCULATION, V130, P703, DOI 10.1161/CIRCULATIONAHA.113.003664; Melchiorre K, 2012, HYPERTENS PREGNANCY, V31, P454, DOI 10.3109/10641955.2012.697951; Mielniczuk LM, 2006, AM J CARDIOL, V97, P1765, DOI 10.1016/j.amjcard.2006.01.039; Patten IS, 2012, NATURE, V485, P333, DOI 10.1038/nature11040; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Sliwa K, 2011, INT J CARDIOL, V147, P202, DOI 10.1016/j.ijcard.2009.08.022; Sliwa K, 2010, EUR J HEART FAIL, V12, P767, DOI 10.1093/eurjhf/hfq120; Sundboll J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012832; Ware JS, 2016, NEW ENGL J MED, V374, P233, DOI 10.1056/NEJMoa1505517	40	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0211857	http://dx.doi.org/10.1371/journal.pone.0211857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785920	gold, Green Submitted, Green Published			2022-12-26	WOS:000459307000042
J	Cardonick, E; Broadrup, R; Xu, PN; Doan, MT; Jiang, HL; Snyder, NW				Cardonick, Elyce; Broadrup, Robert; Xu, Peining; Doan, Mary T.; Jiang, Helen; Snyder, Nathaniel W.			Preliminary results of identification and quantification of paclitaxel and its metabolites in human meconium from newborns with gestational chemotherapeutic exposure	PLOS ONE			English	Article							BREAST-CANCER; PREGNANCY; TAXANES; CARBOPLATIN; DOCETAXEL; OUTCOMES; CHILDREN	Objective Cancer diagnosis during pregnancy occurs in 1 out of 1000 pregnancies with common malignancies including breast and hematological cancers. Fetal exposure to currently utilized agents is poorly described. We directly assessed fetal exposure by screening meconium from 23 newborns whose mothers had undergone treatment for cancer during pregnancy. Study design Meconium was collected from newborns whose mothers were diagnosed with cancer during pregnancy and underwent chemotherapy in the second or third trimester as part of the Cancer and Pregnancy Registry. We conducted screening of 23 meconium samples for chemotherapeutics and known metabolites of chemotherapeutics by liquid chromatography-high resolution mass spectrometry (LC-HRMS). Putative identification of paclitaxel and/or its metabolites was made in 8 screened samples. In positively screened samples, we quantified paclitaxel, 3'-p-hydroxypaclitaxel, and 6 alpha-hydroxypaclitaxel by stable isotope dilution-LC-HRMS. Results Mean (standard deviation) levels of paclitaxel in positively screened samples were 399.9 (248.6) pg/mg in meconium samples from newborn born to mothers that underwent chemotherapy during pregnancy. 3'-p-hydroxypaclitaxel and 6a-hydroxypaclitaxel mean levels were 105.2 (54.6) and 113.4 (48.9) pg/mg meconium, respectively. Conclusion Intact paclitaxel, 3'-p-hydroxypaclitaxel, and 6 alpha-hydroxypaclitaxel were detected in meconium, providing unambiguous confirmation of human fetal exposure. Variability in meconium levels between individuals may indicate a potential for reducing fetal exposure based on timing, dosing, and individual characteristics. This preliminary study may provide an approach for examining the effects of cancer diagnosis during pregnancy on other outcomes by providing a measure of direct fetal exposure.	[Cardonick, Elyce] Rowan Univ, Cooper Med Sch, Camden, NJ 08102 USA; [Broadrup, Robert; Xu, Peining; Doan, Mary T.; Jiang, Helen; Snyder, Nathaniel W.] Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA	Rowan University; Cooper Medical School of Rowan University; Drexel University	Cardonick, E (corresponding author), Rowan Univ, Cooper Med Sch, Camden, NJ 08102 USA.; Snyder, NW (corresponding author), Drexel Univ, AJ Drexel Autism Inst, Philadelphia, PA 19104 USA.	Cardonick-Elyce@CooperHealth.edu; Nws28@drexel.edu		cardonick, elyce/0000-0003-2203-3367; Doan, Mary/0000-0001-6295-4895; Snyder, Nathaniel/0000-0001-5643-8747	National Institute of Health [R21HD087866, K22ES026235, R03CA211820]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD087866] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R03CA211820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K22ES026235] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institute of Health Grants R21HD087866, K22ES026235, and R03CA211820 to NWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander MS, 2003, J CHROMATOGR B, V785, P253, DOI 10.1016/S1570-0232(02)00913-3; Amant F, 2015, NEW ENGL J MED, V373, P1824, DOI 10.1056/NEJMoa1508913; Aviles A, 2001, CLIN LYMPHOMA, V2, P173, DOI 10.3816/CLM.2001.n.023; Berry DL, 1999, J CLIN ONCOL, V17, P855, DOI 10.1200/JCO.1999.17.3.855; Berveiller P, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.10.007; Cardonick E, 2012, ANN ONCOL, V23, P3016, DOI 10.1093/annonc/mds170; Cardonick E, 2004, LANCET ONCOL, V5, P283, DOI 10.1016/S1470-2045(04)01466-4; Cardonick E, 2010, CANCER J, V16, P76, DOI 10.1097/PPO.0b013e3181ce46f9; Cardonick E, 2010, AM J CLIN ONCOL-CANC, V33, P221, DOI 10.1097/COC.0b013e3181a44ca9; Cardonick EH, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.032; Daud ANA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173530; de Graan AJM, 2013, CLIN CANCER RES, V19, P3316, DOI 10.1158/1078-0432.CCR-12-3786; De Santis M, 2000, EUR J CANCER CARE, V9, P235, DOI 10.1046/j.1365-2354.2000.00231.x; Fransson MN, 2011, DRUG METAB DISPOS, V39, P247, DOI 10.1124/dmd.110.035394; Frey AJ, 2017, J STEROID BIOCHEM, V167, P78, DOI 10.1016/j.jsbmb.2016.11.010; Gainford MC, 2006, CLIN ONCOL-UK, V18, P159, DOI 10.1016/j.clon.2005.12.002; Hahn KME, 2006, CANCER, V107, P1219, DOI 10.1002/cncr.22081; Hemauer SJ, 2010, BIOCHEM PHARMACOL, V79, P921, DOI 10.1016/j.bcp.2009.10.026; Himes SK, 2013, ANAL CHEM, V85, P1896, DOI 10.1021/ac303188j; Mendez LE, 2003, OBSTET GYNECOL, V102, P1200, DOI 10.1016/S0029-7844(03)00698-7; Mir O, 2010, ANN ONCOL, V21, P425, DOI 10.1093/annonc/mdp517; MONSARRAT B, 1990, DRUG METAB DISPOS, V18, P895; Monsarrat B, 1998, DRUG METAB DISPOS, V26, P229; Myllynen P, 2007, EXPERT OPIN DRUG MET, V3, P331, DOI 10.1517/17425255.3.3.331; Nieto Y, 2006, CLIN BREAST CANCER, V6, P533, DOI 10.3816/CBC.2006.n.008; Park BY, 2014, ANN EPIDEMIOL, V24, P878, DOI 10.1016/j.annepidem.2014.09.009; Peng SY, 2015, J PROTEOME RES, V14, P1799, DOI 10.1021/pr5011857; Potluri V, 2006, CLIN BREAST CANCER, V7, P167, DOI 10.3816/CBC.2006.n.029; Rouzi AA, 2009, ARCH GYNECOL OBSTET, V280, P823, DOI 10.1007/s00404-009-0992-5; Smit JW, 1999, J CLIN INVEST, V104, P1441, DOI 10.1172/JCI7963; Van Calsteren K, 2010, INT J GYNECOL CANCER, V20, P1456, DOI 10.1111/IGC.0b013e3181fb18c8; Weisz Boaz, 2004, Expert Rev Anticancer Ther, V4, P889, DOI 10.1586/14737140.4.5.889	32	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211821	10.1371/journal.pone.0211821	http://dx.doi.org/10.1371/journal.pone.0211821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785914	gold, Green Submitted, Green Published			2022-12-26	WOS:000459307000040
J	Shevade, VS; Loboda, TV				Shevade, Varada S.; Loboda, Tatiana V.			Oil palm plantations in Peninsular Malaysia: Determinants and constraints on expansion	PLOS ONE			English	Article							AGRICULTURAL LAND; DEFORESTATION; DRIVEN; BORNEO	Agricultural expansion is one of the leading causes of deforestation in the tropics and in Southeast Asia it is predominantly driven by large-scale production for international trade. Peninsular Malaysia has a long history of plantation agriculture and has been a predominantly resource-based economy where expanding plantations like those of oil palm continue to replace natural forests. Habitat loss from deforestation and expanding plantations threatens Malaysian biodiversity. Expanding industrial plantations have also been responsible for drainage and conversions of peatland forests resulting in release of large amounts of carbon dioxide. The demand for palm oil is expected to increase further and result in greater pressures on tropical forests. Given Malaysia's high biophysical suitability for oil palm cultivation, it is important to understand patterns of oil palm expansion to better predict forest areas that are vulnerable to future expansion. We study natural forest conversion to industrial oil palm in Peninsular Malaysia between 1988 and 2012 to identify determinants of recent oil palm expansion using logistic regression and hierarchical partitioning. Using maps of recent conversions and remaining forests, we characterize agro-environmental suitability and accessibility for the past and future conversions. We find that accessibility to previously existing plantations is the strongest determinant of oil palm expansion and is significant throughout the study period. Almost all (> 99%) of the forest loss between 1988 and 2012 that has been converted to industrial oil palm plantations is within 1 km from oil palm plantations that have been established earlier. Although most forest conversions to industrial oil palm have been in areas of high biophysical suitability, there has been an increase in converted area in regions with low oil palm suitability since 2006. We find that reduced suitability does not necessarily restrict conversions to industrial oil palm in the region; however, lack of access to established plantations does.	[Shevade, Varada S.; Loboda, Tatiana V.] Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Shevade, VS (corresponding author), Univ Maryland, Dept Geog Sci, College Pk, MD 20742 USA.	vshevade@terpmail.umd.edu						[Anonymous], 2015, GLOBAL OIL PALM SUIT; Austin K G, 2015, INDONESIA PLOS ONE, V10, DOI [10.1371/journal.pone.0127963, DOI 10.1371/JOURNAL.PONE.0127963]; BROOKFIELD H, 1990, GLOBAL ENVIRON CHANG, V1, P42, DOI 10.1016/0959-3780(90)90006-U; Busch J, 2017, REV ENV ECON POLICY, V11, P3, DOI 10.1093/reep/rew013; Carter C, 2007, EUR J LIPID SCI TECH, V109, P307, DOI 10.1002/ejlt.200600256; Castiblanco C, 2013, ENVIRON SCI POLICY, V27, P172, DOI 10.1016/j.envsci.2013.01.003; Chomitz KM, 2003, AM J AGR ECON, V85, P1016, DOI 10.1111/1467-8276.00504; Clements R, 2010, BIODIVERS CONSERV, V19, P1115, DOI 10.1007/s10531-009-9775-3; Corley RHV, 2009, ENVIRON SCI POLICY, V12, P134, DOI 10.1016/j.envsci.2008.10.011; DeFries RS, 2010, NAT GEOSCI, V3, P178, DOI 10.1038/NGEO756; Department of Statistics Malaysia (DOSM), 2016, SEL AGR IND; Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013; Feintrenie L, 2010, SMALL-SCALE FOR, V9, P379, DOI 10.1007/s11842-010-9122-2; Fick SE, 2016, INT J CLIMATOL; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Gaveau DLA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034013; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gibbs HK, 2010, P NATL ACAD SCI USA, V107, P16732, DOI 10.1073/pnas.0910275107; Guillaume T, 2016, AGR ECOSYST ENVIRON, V232, P110, DOI 10.1016/j.agee.2016.07.002; Gunarso P., 2013, OIL PALM LAND USE CH; Hai Teoh Cheng, 2000, LAND USE OIL PALM IN; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Harris N, 2013, REPORTS SCI PANEL 2; Henders S, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/12/125012; Hosonuma N, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044009; Joppa LN, 2011, P ROY SOC B-BIOL SCI, V278, P1633, DOI 10.1098/rspb.2010.1713; Koh LP, 2008, CONSERV LETT, V1, P60, DOI 10.1111/j.1755-263X.2008.00011.x; Koh LP, 2011, P NATL ACAD SCI USA, V108, P5127, DOI 10.1073/pnas.1018776108; KUMMER DM, 1994, BIOSCIENCE, V44, P323, DOI 10.2307/1312382; Mertens B, 2000, ANN ASSOC AM GEOGR, V90, P467, DOI 10.1111/0004-5608.00205; Meyfroidt P, 2016, GLOBAL ENVIRON CHANG, V37, P1, DOI 10.1016/j.gloenvcha.2016.01.003; Meyfroidt P, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/7/074012; Miettinen J, 2016, GLOB ECOL CONSERV, V6, P67, DOI 10.1016/j.gecco.2016.02.004; Nelson A, 2008, CHRISTIAN TRAVEL PLA; Nelson Andrew, 2011, PLOS ONE, V6, DOI DOI 10.1371/JOURNAL.PONE.0022722; Paterson RRM, 2017, J AGR SCI-CAMBRIDGE, V155, P689, DOI 10.1017/S0021859616000605; Paterson RRM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14457; Peh KSH, 2006, DIVERS DISTRIB, V12, P572, DOI 10.1111/j.1366-9516.2006.00257.x; Petersen R., 2016, MAPPING TREE PLANTAT; Pirker J, 2016, GLOBAL ENVIRON CHANG, V40, P73, DOI 10.1016/j.gloenvcha.2016.06.007; Prishchepov AV, 2013, LAND USE POLICY, V30, P873, DOI 10.1016/j.landusepol.2012.06.011; Raison J, 2015, HIGH CARBON STOCK SC; Ratnayeke S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194217; Rayan DM, 2015, BIOL CONSERV, V184, P18, DOI 10.1016/j.biocon.2014.12.024; Furumo PR, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa5892; Rudel TK, 2009, CONSERV BIOL, V23, P1396, DOI 10.1111/j.1523-1739.2009.01332.x; Sayer J, 2012, GLOB FOOD SECUR-AGR, V1, P114, DOI 10.1016/j.gfs.2012.10.003; Shevade VS, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070747; Stickler C., 2007, UN FRAM CONV CLIM CH; Sumarga E, 2016, REG ENVIRON CHANGE, V16, P1011, DOI 10.1007/s10113-015-0815-0; The World Database on Protected Areas(WDPA), 2014, NON TRADITIONAL REF; Turner EC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001572; Vijay V, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159668; Weinhold D, 2008, GLOBAL ENVIRON CHANG, V18, P54, DOI 10.1016/j.gloenvcha.2007.06.004; Wheeler D, 2013, ECOL ECON, V85, P85, DOI 10.1016/j.ecolecon.2012.11.005; Wicke B, 2011, LAND USE POLICY, V28, P193, DOI 10.1016/j.landusepol.2010.06.001; World Resources Institute (WRI), CARB EM PEAT DRAIN P	58	31	32	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210628	10.1371/journal.pone.0210628	http://dx.doi.org/10.1371/journal.pone.0210628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785883	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000013
J	Charlton, FW; Hover, S; Fuller, J; Hewson, R; Fontana, J; Barr, JN; Mankouri, J				Charlton, Frank W.; Hover, Samantha; Fuller, Jack; Hewson, Roger; Fontana, Juan; Barr, John N.; Mankouri, Jamel			Cellular cholesterol abundance regulates potassium accumulation within endosomes and is an important determinant in bunyavirus entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						virology; potassium channel; potassium transport; cholesterol; endosome; virus entry	VIRUS ENTRY; TRANSPORT INHIBITOR; DENGUE VIRUS; PROTEIN; ENDOCYTOSIS; CLATHRIN; U18666A; CELLS; REPLICATION; TRAFFICKING	The Bunyavirales order of segmented negative-sense RNA viruses includes more than 500 isolates that infect insects, animals, and plants and are often associated with severe and fatal disease in humans. To multiply and cause disease, bunyaviruses must translocate their genomes from outside the cell into the cytosol, achieved by transit through the endocytic network. We have previously shown that the model bunyaviruses Bunyamwera virus (BUNV) and Hazara virus (HAZV) exploit the changing potassium concentration ([K+]) of maturing endosomes to release their genomes at the appropriate endosomal location. K+ was identified as a biochemical cue to activate the viral fusion machinery, promoting fusion between viral and cellular membranes, consequently permitting genome release. In this study, we further define the biochemical prerequisites for BUNV and HAZV entry and their K+ dependence. Using drug-mediated cholesterol extraction along with viral entry and K+ uptake assays, we report three major findings: BUNV and HAZV require cellular cholesterol during endosomal escape; cholesterol depletion from host cells impairs K+ accumulation in maturing endosomes, revealing new insights into endosomal K+ homeostasis; and priming BUNV and HAZV virions with K+ before infection alleviates their cholesterol requirement. Taken together, our findings suggest a model in which cholesterol abundance influences endosomal K+ levels and, consequently, the efficiency of bunyavirus infection. The ability to inhibit bunyaviruses with existing cholesterol-lowering drugs may offer new options for future antiviral interventions for pathogenic bunyaviruses.	[Charlton, Frank W.; Hover, Samantha; Fontana, Juan; Barr, John N.; Mankouri, Jamel] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Fontana, Juan; Barr, John N.; Mankouri, Jamel] Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England; [Fuller, Jack; Hewson, Roger] Publ Hlth England, Natl Infect Serv, Salisbury SP4 0JG, Wilts, England	University of Leeds; University of Leeds; Public Health England	Barr, JN; Mankouri, J (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Barr, JN; Mankouri, J (corresponding author), Univ Leeds, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England.	j.n.barr@leeds.ac.uk; j.mankouri@leeds.ac.uk	; Fontana, Juan/A-9138-2009	Fuller, Jack/0000-0002-8922-5032; Hover, Samantha/0000-0001-9190-5670; Mankouri, Jamel/0000-0002-4325-3687; Fontana, Juan/0000-0002-9084-2927; Charlton, Frank/0000-0003-2892-3555	Wellcome Trust [090932/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The FEI Tecnai G<SUP>2</SUP>-Spirit was funded by the Wellcome Trust (090932/Z/09/Z). We thank Xiaohong Shi (CVR Glasgow) for the kind gift of GFP-BUNV.	Bajimaya S, 2017, VIROLOGY, V510, P234, DOI 10.1016/j.virol.2017.07.024; Cenedella RJ, 2009, LIPIDS, V44, P477, DOI 10.1007/s11745-009-3305-7; Chlanda P, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.50, 10.1038/nmicrobiol.2016.50]; COOPER RA, 1978, J SUPRAMOL STR CELL, V8, P413, DOI 10.1002/jss.400080404; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16; Elliott RM, 1997, MOL MED, V3, P572, DOI 10.1007/BF03401814; FULLER F, 1983, J GEN VIROL, V64, P1705, DOI 10.1099/0022-1317-64-8-1705; Garry Courtney E, 2004, Theor Biol Med Model, V1, P10, DOI 10.1186/1742-4682-1-10; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Hawkins JL, 2008, J PHARMACOL EXP THER, V326, P801, DOI 10.1124/jpet.108.139626; Hollidge BS, 2012, J VIROL, V86, P7988, DOI 10.1128/JVI.00140-12; Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845; Hover S, 2017, J GEN VIROL, V98, P345, DOI 10.1099/jgv.0.000712; Hover S, 2016, J BIOL CHEM, V291, P3411, DOI 10.1074/jbc.M115.692673; Jin M, 2002, VIROLOGY, V294, P60, DOI 10.1006/viro.2001.1303; KIELIAN MC, 1984, J VIROL, V52, P281, DOI 10.1128/JVI.52.1.281-283.1984; Kleinfelter LM, 2015, MBIO, V6, DOI 10.1128/mBio.00801-15; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lee AG, 2018, BIOPHYS J, V115, P522, DOI 10.1016/j.bpj.2018.06.022; Lozach PY, 2010, CELL HOST MICROBE, V7, P488, DOI 10.1016/j.chom.2010.05.007; Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Petersen J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003911; PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615; Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014; Punch EK, 2018, J BIOL CHEM, V293, P9937, DOI 10.1074/jbc.RA118.002494; Shi XH, 2010, J VIROL, V84, P8460, DOI 10.1128/JVI.00902-10; Shi XH, 2009, J GEN VIROL, V90, P2483, DOI 10.1099/vir.0.013540-0; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; SIMONS JF, 1990, J VIROL, V64, P247, DOI 10.1128/JVI.64.1.247-255.1990; Soldan SS, 2005, J NEUROVIROL, V11, P412, DOI 10.1080/13550280591002496; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; Vera-Otarola J, 2012, J VIROL, V86, P2176, DOI 10.1128/JVI.06223-11; VONBONSDORFF CH, 1975, J VIROL, V16, P141, DOI 10.1128/JVI.16.1.141-145.1975; VONBONSDORFF CH, 1975, J VIROL, V16, P1296, DOI 10.1128/JVI.16.5.1296-1307.1975; White JM, 2016, TRAFFIC, V17, P593, DOI 10.1111/tra.12389; Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5; Wolf Y., 2018, INT COMM TAXON VIRUS	41	14	14	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7335	7347		10.1074/jbc.RA119.007618	http://dx.doi.org/10.1074/jbc.RA119.007618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30804209	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000468402900021
J	Sachdeva, M; Duchateau, P; Depil, S; Poirot, L; Valton, J				Sachdeva, Mohit; Duchateau, Philippe; Depil, Stephane; Poirot, Laurent; Valton, Julien			Granulocyte-macrophage colony-stimulating factor inactivation in CAR T-cells prevents monocyte-dependent release of key cytokine release syndrome mediators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; cancer therapy; gene knockout; gene transfer; T-cell; CAR T-cell therapy; cytokine release syndrome (CRS); granulocyte-macrophage colony-stimulating factor (GMCSF); interleukin signaling	TARGETING GM-CSF; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; RECEPTOR; ACTIVATION	Chimeric antigen receptor T-cell (CAR T-cell) therapy has been shown to be clinically effective for managing a variety of hematological cancers. However, CAR T-cell therapy is associated with multiple adverse effects, including neurotoxicity and cytokine release syndrome (CRS). CRS arises from massive cytokine secretion and can be life-threatening, but it is typically managed with an anti-IL-6Ra mAb or glucocorticoid administration. However, these treatments add to a patient's medication burden and address only the CRS symptoms. Therefore, alternative strategies that can prevent CRS and neurotoxicity associated with CAR T-cell treatment are urgently needed. Here, we explored a therapeutic route aimed at preventing CRS rather than limiting its consequences. Using a cytokine-profiling assay, we show that granulocyte-macrophage colony-stimulating factor (GMCSF) is a key CRS-promoting protein. Through a combination of in vitro experiments and gene-editing technology, we further demonstrate that antibody-mediated neutralization or TALEN-mediated genetic inactivation of GMCSF in CAR T-cells drastically decreases available GMCSF and abolishes macrophage-dependent secretion of CRS biomarkers, including monocyte chemoattractant protein 1 (MCP-1), interleukin (IL) 6, and IL-8. Of note, we also found that the genetic inactivation of GMCSF does not impair the antitumor function or proliferative capacity of CAR T-cells in vitro. We conclude that it is possible to prevent CRS by using all-in-one GMCSF-knockout CAR T-cells. This approach may eliminate the need for anti-CRS treatment and may improve the overall safety of CAR T-cell therapies for cancer patients.	[Sachdeva, Mohit; Valton, Julien] Cellectis Inc, 430 East 29th St, New York, NY 10016 USA; [Duchateau, Philippe; Depil, Stephane; Poirot, Laurent] Cellectis, 8 Rue Croix Jarry, F-75013 Paris, France		Sachdeva, M; Valton, J (corresponding author), Cellectis Inc, 430 East 29th St, New York, NY 10016 USA.	mohit.sachdeva@cellectis.com; julien.valton@cellectis.com		Valton, Julien/0000-0003-0826-5401				[Anonymous], 2014, BLOOD, DOI DOI 10.1182/BLOOD.V124.21.2296.2296; Becher B, 2016, IMMUNITY, V45, P963, DOI 10.1016/j.immuni.2016.10.026; Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Burmester GR, 2011, ANN RHEUM DIS, V70, P1542, DOI 10.1136/ard.2010.146225; CHEN BDM, 1988, BLOOD, V71, P997; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; FIEHN C, 1992, Z RHEUMATOL, V51, P121; Fitzgerald JC, 2017, CRIT CARE MED, V45, pE124, DOI 10.1097/CCM.0000000000002053; Frey N, 2017, BEST PRACT RES CL HA, V30, P336, DOI 10.1016/j.beha.2017.09.002; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Gust J, 2017, CANCER DISCOV, V7, P1404, DOI 10.1158/2159-8290.CD-17-0698; Hamilton JA, 2015, EXPERT REV CLIN IMMU, V11, P457, DOI 10.1586/1744666X.2015.1024110; Huizinga TWJ, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1267-3; Jones G, 2010, CLIN MED INSIGHTS-AR, V3, P81, DOI 10.4137/CMAMD.S4864; King IL, 2009, BLOOD, V113, P3190, DOI 10.1182/blood-2008-07-168575; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; Neelapu SS, 2017, NEW ENGL J MED, V377, P2531, DOI 10.1056/NEJMoa1707447; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Papp KA, 2019, BRIT J DERMATOL, V180, P1352, DOI 10.1111/bjd.17195; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Postiglione L, 1998, LIFE SCI, V63, P327, DOI 10.1016/S0024-3205(98)00281-1; Russo RC, 2014, EXPERT REV CLIN IMMU, V10, P593, DOI 10.1586/1744666X.2014.894886; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Sentman ML, 2016, J IMMUNOL, V197, P4674, DOI 10.4049/jimmunol.1600769; Singh N, 2017, CYTOTHERAPY, V19, P867, DOI 10.1016/j.jcyt.2017.04.001; Sterner RM, 2019, BLOOD, V133, P697, DOI 10.1182/blood-2018-10-881722; Tang XY, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013904; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; Valton J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27264-w; Vogel DYS, 2015, EUR J IMMUNOL, V45, P1808, DOI 10.1002/eji.201444960; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; WILLIAMSON DJ, 1988, CLIN EXP IMMUNOL, V72, P67; XU WD, 1989, J CLIN INVEST, V83, P876, DOI 10.1172/JCI113971	39	77	90	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5430	5437		10.1074/jbc.AC119.007558	http://dx.doi.org/10.1074/jbc.AC119.007558			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30804212	hybrid, Green Published			2022-12-26	WOS:000464517500016
J	Gonzalez-Lopez, E; Kawasawa-Imamura, Y; Zhang, LJ; Huang, XM; Koltun, WA; Coates, MD; Vrana, KE				Gonzalez-Lopez, Eugene; Kawasawa-Imamura, Yuka; Zhang, Lijun; Huang, Xuemei; Koltun, Walter A.; Coates, Matthew D.; Vrana, Kent E.			A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C > T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme	PLOS ONE			English	Article							ULCERATIVE-COLITIS; NERVOUS-SYSTEM; 5-HYDROXYTRYPTAMINE; MONOOXYGENASE; PATHOGENESIS; VARIANTS; ASSAY	Inflammatory bowel diseases (IBD) are associated with altered neuronal regulation of the gastrointestinal (GI) tract and release of norepinephrine (NE). As sympathetic innervation of the GI tract modulates motility, blood flow, and immune function, changes in NE signaling may alter the risk of developing IBD. Dopamine beta-hydroxylase (D beta H), the enzyme responsible for NE production, has been suggested to play a critical role in IBD, however the exact mechanism is unknown. We hypothesized that genetic variants of D beta H could increase the risk of IBD. We performed genetic analysis on 45 IBD patients and 74 controls. IBD patients were screened by targeted exome sequencing and compared with NeuroX D beta H single nucleotide polymorphism (SNP) genotyping data of the controls. Serum D beta H protein levels for 15 IBD patients and 13 controls were evaluated using immunoblots and competitive ELISA. Seven SNPs were observed from D beta H targeted exome sequencing in the 45 IBD patients. A single non-synonymous SNP, rs6271 (Arg549Cys), had a significant association with IBD patients; the odds ratio was a 5.6 times higher SNP frequency in IBD patients compared to controls (p = 0.002). We also examined the function and availability of the protein in both the IBD and control patients' sera bearing D beta H Arg549Cys. Both control and IBD subjects bearing the heterozygote allele had statistically lower D beta H protein levels while the intrinsic enzyme activity was higher. This is the first report of a noradrenergic genetic polymorphism (rs6271; Arg549Cys) associated with IBD. This polymorphism is associated with significantly lower levels of circulating D beta H.	[Gonzalez-Lopez, Eugene; Kawasawa-Imamura, Yuka; Huang, Xuemei; Vrana, Kent E.] Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Kawasawa-Imamura, Yuka; Zhang, Lijun] Penn State Univ, Coll Med, Inst Personalized Med, Genome Sci Core Facil, Hershey, PA USA; [Zhang, Lijun] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Neurol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Kinesiol, Hershey, PA USA; [Koltun, Walter A.] Penn State Univ, Dept Surg, Div Colon & Rectal Surg, Hershey, PA USA; [Coates, Matthew D.] Penn State Univ, Hershey Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Vrana, KE (corresponding author), Penn State Coll Med, Dept Pharmacol, Hershey, PA 17033 USA.; Coates, MD (corresponding author), Penn State Univ, Hershey Med Ctr, Dept Med, Div Gastroenterol & Hepatol, Hershey, PA 17033 USA.	mcoates@pennstatehealth.psu.edu; kvrana@pennstatehealth.psu.edu		Vrana, Kent/0000-0003-4902-7733; Gonzalez-Lopez, Eugene/0000-0002-4547-5144	Pennsylvania State University Elliot S. Vesell Professorship endowment; Peter and Marsha Carlino Early Career Professorship in Inflammatory Bowel Disease; Margot E. Walrath Career Development Professorship in Gastroenterology; National Institute of Neurological Disease and Stroke [NS060722, NS082151]; Hershey Medical Center General Clinical Research Center [C06 RR016499, UL1 TR000127]; Penn State College of Medicine Genome Science Core Facility; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002014] Funding Source: NIH RePORTER	Pennsylvania State University Elliot S. Vesell Professorship endowment; Peter and Marsha Carlino Early Career Professorship in Inflammatory Bowel Disease; Margot E. Walrath Career Development Professorship in Gastroenterology; National Institute of Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Hershey Medical Center General Clinical Research Center; Penn State College of Medicine Genome Science Core Facility; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This research was supported by the Pennsylvania State University Elliot S. Vesell Professorship endowment (KEV). This research was supported by the Peter and Marsha Carlino Early Career Professorship in Inflammatory Bowel Disease and the Margot E. Walrath Career Development Professorship in Gastroenterology (MDC). This was also supported in part by the National Institute of Neurological Disease and Stroke (NS060722 and NS082151 to XH), the Hershey Medical Center General Clinical Research Center (C06 RR016499, UL1 TR000127 to XH). All analyses, interpretations, and conclusions are those of the authors and not the research sponsors.; This work was supported by the Penn State College of Medicine Genome Science Core Facility. We express gratitude to all of the participants who volunteered for this study and study personnel who contributed to its success. The authors wish to thank Sarah K. Barrett, August Stuart, Susan Deiling and Leonard Harris for their outstanding technical assistance during the course of this study.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bai A, 2009, CLIN EXP IMMUNOL, V156, P353, DOI 10.1111/j.1365-2249.2009.03894.x; Bonaz BL, 2013, GASTROENTEROLOGY, V144, P36, DOI 10.1053/j.gastro.2012.10.003; Carkaci-Salli N, 2006, J BIOL CHEM, V281, P28105, DOI 10.1074/jbc.M602817200; Coates MD, 2017, ALIMENT PHARM THER, V46, P569, DOI 10.1111/apt.14226; Coates MD, 2004, GASTROENTEROLOGY, V126, P1657, DOI 10.1053/j.gastro.2004.03.013; Collins SM, 1996, GASTROENTEROLOGY, V111, P1683, DOI 10.1016/S0016-5085(96)70034-3; Cubells JF, 2004, PSYCHOPHARMACOLOGY, V174, P463, DOI 10.1007/s00213-004-1840-8; Cubells JF, 2011, HUM GENET, V130, P635, DOI 10.1007/s00439-011-0989-6; Dharmasena SP, 2002, BIOCHEMISTRY-US, V41, P12414, DOI 10.1021/bi0262606; Di Giovangiulio M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00590; Fleiss JL, 2003, STAT METHODS RATES P, Vxxvii; GOLDSTEIN M, 1971, EXPERIENTIA, V27, P632, DOI 10.1007/BF02136929; Kapoor A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026509; Kim CH, 2011, J BIOL CHEM, V286, P9196, DOI 10.1074/jbc.M110.192351; KYOSOLA K, 1977, SCAND J GASTROENTERO, V12, P363; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loftus Edward V Jr, 2016, Gastroenterol Hepatol (N Y), V12, P704; Loftus Edward V Jr, 2011, Gastroenterol Hepatol (N Y), V7, P3; Magro F, 2002, DIGEST DIS SCI, V47, P216, DOI 10.1023/A:1013256629600; MATSUI H, 1981, J NEUROCHEM, V37, P289, DOI 10.1111/j.1471-4159.1981.tb00454.x; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Mustapic M, 2014, HUM MOL GENET, V23, P6375, DOI 10.1093/hmg/ddu332; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; PENTTILA O, 1975, ANN CLIN RES, V7, P447; Punchaichira TJ, 2016, PHARMACOGENET GENOM, V26, P311, DOI 10.1097/FPC.0000000000000214; ROBERTSON D, 1991, HYPERTENSION, V18, P1, DOI 10.1161/01.HYP.18.1.1; Roda G, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.63; RUSH RA, 1980, CRC CR REV CL LAB SC, V12, P241, DOI 10.3109/10408368009108731; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Scanzano A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00171; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Straub RH, 2008, GUT, V57, P911, DOI 10.1136/gut.2007.125401; Straub RH, 2006, GUT, V55, P1640, DOI 10.1136/gut.2006.091322; Taylor CT, 2007, AUTON NEUROSCI-BASIC, V133, P104, DOI 10.1016/j.autneu.2006.11.005; Tong J, 2015, WORLD J BIOL PSYCHIA, V16, P610, DOI 10.3109/15622975.2015.1036771; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; Vendelboe TV, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500980; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; WEINSHILBOUM R, 1971, CIRC RES, V28, P307, DOI 10.1161/01.RES.28.3.307; WIMALASENA K, 1991, ANAL BIOCHEM, V197, P353, DOI 10.1016/0003-2697(91)90404-H; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	42	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0210175	10.1371/journal.pone.0210175	http://dx.doi.org/10.1371/journal.pone.0210175			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817802	gold, Green Published, Green Submitted			2022-12-26	WOS:000460371500005
J	Grant, MKO; Handoko, M; Rozga, M; Brinkmalm, G; Portelius, E; Blennow, K; Ashe, KH; Zahs, KR; Liu, P				Grant, Marianne K. O.; Handoko, Maureen; Rozga, Malgorzata; Brinkmalm, Gunnar; Portelius, Erik; Blennow, Kaj; Ashe, Karen H.; Zahs, Kathleen R.; Liu, Peng			Human cerebrospinal fluid 6E10-immunoreactive protein species contain amyloid precursor protein fragments	PLOS ONE			English	Article							ALZHEIMERS-DISEASE PATIENTS; BETA OLIGOMERS; INHIBITOR DOMAINS; COGNITIVE DECLINE; CSF; BIOMARKERS; TAU; IDENTIFICATION; QUANTITATION; DEMENTIA	In a previous study, we reported that levels of two types of protein species-a type of similar to 55kDa species and a type of similar to 15-kDa species-are elevated in the lumbar cerebrospinal fluid (CSF) of cognitively intact elderly individuals who are at risk for Alzheimer's disease (AD). These species are immunoreactive to the monoclonal antibody 6E10, which is directed against amino acids 6-10 of amyloid-beta (A beta), and their levels correlate with levels of total tau and tau phosphorylated at Thr181. In this study, we investigated the molecular composition of these AD-related proteins using immunoprecipitation (IP)/Western blotting coupled with IP/mass spectrometry. We show that canonical A beta(1-40/42) peptides, together with amyloid-beta precursor protein (APP) fragments located N-terminally of A beta, are present in the similar to 55-kDa, 6E10-immunoreactive species. We demonstrate that APP fragments located N-terminally of A beta, plus the N-terminal region of A beta, are present in the similar to 15-kDa, 6E10-immunoreactive species. These findings add to the catalog of AD-related A beta/APP species found in CSF and should motivate further study to determine whether these species may serve as biomarkers of disease progression.	[Grant, Marianne K. O.; Handoko, Maureen; Ashe, Karen H.; Zahs, Kathleen R.; Liu, Peng] Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA; [Grant, Marianne K. O.; Handoko, Maureen; Ashe, Karen H.; Zahs, Kathleen R.; Liu, Peng] Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA; [Rozga, Malgorzata; Brinkmalm, Gunnar; Portelius, Erik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Molndal, Sweden; [Rozga, Malgorzata; Brinkmalm, Gunnar; Portelius, Erik; Blennow, Kaj] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Ashe, Karen H.] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA; [Ashe, Karen H.] Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Minneapolis, MN USA; [Grant, Marianne K. O.] Univ Minnesota, Dept Expt & Clin Pharmacol, Minneapolis, MN USA; [Handoko, Maureen] Baylor Coll Med, Dept Pediat Neurol, Houston, TX 77030 USA; [Rozga, Malgorzata] Roche Diagnost Gesell Beschrankter Haftung, Penzberg, Germany	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Gothenburg; Sahlgrenska University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine	Zahs, KR; Liu, P (corresponding author), Univ Minnesota, Dept Neurol, Minneapolis, MN 55455 USA.; Zahs, KR; Liu, P (corresponding author), Univ Minnesota, N Bud Grossman Ctr Memory Res & Care, Minneapolis, MN 55455 USA.	zahsx001@umn.edu; liuxx726@umn.edu	Brinkmalm, Gunnar/AAH-3914-2021; Grant, Marianne/AAL-1396-2020	Grant, Marianne/0000-0002-2963-4686	NIH [RC1-AG35870, R01-NS33249]; Swedish Research Council [2017-00915]; Swedish Alzheimer Foundation [AF742881]; Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences; Swedish Brain Foundation [FO2017-0243]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Alzheimer Foundation; Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences; Swedish Brain Foundation	This work is supported by NIH RC1-AG35870 and R01-NS33249 to KHA, The Swedish Research Council (project #2017-00915), The Swedish Alzheimer Foundation (grant #AF742881), The Torsten Soderberg Foundation at the Royal Swedish Academy of Sciences, The Swedish Brain Foundation (project #FO2017-0243). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blennow K, 2003, LANCET NEUROL, V2, P605, DOI 10.1016/S1474-4422(03)00530-1; Blennow K, 2015, TRENDS PHARMACOL SCI, V36, P297, DOI 10.1016/j.tips.2015.03.002; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; Brinkmalm G, 2012, J MASS SPECTROM, V47, P591, DOI 10.1002/jms.2987; Brody DL, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0293-3; Bruggink KA, 2013, ANAL BIOCHEM, V433, P112, DOI 10.1016/j.ab.2012.09.014; Cerasoli E, 2015, FRONT CHEM, V3, DOI 10.3389/fchem.2015.00017; Cuchillo-Ibanez I, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-2; Fukumoto H, 2010, FASEB J, V24, P2716, DOI 10.1096/fj.09-150359; Gao CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015725; Garcia-Ayllon MS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02841-7; Georganopoulou DG, 2005, P NATL ACAD SCI USA, V102, P2273, DOI 10.1073/pnas.0409336102; Handoko M, 2013, JAMA NEUROL, V70, P594, DOI 10.1001/jamaneurol.2013.48; HENRIKSSON T, 1991, J NEUROCHEM, V56, P1037, DOI 10.1111/j.1471-4159.1991.tb02026.x; Holtta M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066381; Jongbloed W, 2015, J ALZHEIMERS DIS, V45, P35, DOI 10.3233/JAD-142136; Kasuga K, 2010, J NEUROL NEUROSUR PS, V81, P608, DOI 10.1136/jnnp.2009.197483; KITAGUCHI N, 1990, BIOCHEM BIOPH RES CO, V166, P1453, DOI 10.1016/0006-291X(90)91030-V; Lewczuk P, 2015, J ALZHEIMERS DIS, V43, P183, DOI 10.3233/JAD-140771; Lopez-Font I, 2017, J ALZHEIMERS DIS, V57, P1281, DOI 10.3233/JAD-161275; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; MOTTER R, 1995, ANN NEUROL, V38, P643, DOI 10.1002/ana.410380413; Olsson B, 2016, LANCET NEUROL, V15, P673, DOI [10.1016/S1474-4422(16)00070-3, 10.1016/s1474-4422(16)00070-3]; Otto M, 2000, NEUROLOGY, V54, P1099, DOI 10.1212/WNL.54.5.1099; PALMERT MR, 1989, P NATL ACAD SCI USA, V86, P6338, DOI 10.1073/pnas.86.16.6338; Pitschke M, 1998, NAT MED, V4, P832, DOI 10.1038/nm0798-832; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2006, NEUROSCI LETT, V409, P215, DOI 10.1016/j.neulet.2006.09.044; Portelius E, 2012, J ALZHEIMERS DIS, V31, P335, DOI 10.3233/JAD-2012-120508; Portelius E, 2010, EXP NEUROL, V223, P351, DOI 10.1016/j.expneurol.2009.06.011; Portelius E, 2009, NEURODEGENER DIS, V6, P87, DOI 10.1159/000203774; PRIOR R, 1991, NEUROSCI LETT, V124, P69, DOI 10.1016/0304-3940(91)90824-D; Sakono M, 2010, FEBS J, V277, P1348, DOI 10.1111/j.1742-4658.2010.07568.x; Sancesario GM, 2012, J ALZHEIMERS DIS, V31, P865, DOI 10.3233/JAD-2012-120211; Santos AN, 2012, J ALZHEIMERS DIS, V29, P171, DOI 10.3233/JAD-2012-111361; Savage MJ, 2014, J NEUROSCI, V34, P2884, DOI 10.1523/JNEUROSCI.1675-13.2014; Schuster J, 2016, J ALZHEIMERS DIS, V53, P53, DOI 10.3233/JAD-151029; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; Sjogren M, 2002, DEMENT GERIATR COGN, V13, P112, DOI 10.1159/000048642; URAKAMI K, 1994, TOHOKU J EXP MED, V174, P199, DOI 10.1620/tjem.174.199; URAKAMI K, 1992, ACTA NEUROL SCAND, V85, P343; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Wiltfang J, 2007, J NEUROCHEM, V101, P1053, DOI 10.1111/j.1471-4159.2006.04404.x; Zetterberg H, 2019, J NEUROSCI METH, V319, P2, DOI 10.1016/j.jneumeth.2018.10.025; Zhang ZT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9762	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212815	10.1371/journal.pone.0212815	http://dx.doi.org/10.1371/journal.pone.0212815			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817799	Green Published, Green Submitted, gold			2022-12-26	WOS:000460371500044
J	Hu, HF; Chang, YP; Lin, CH; Yen, CF				Hu, Huei-Fan; Chang, Yu-Ping; Lin, Chienho; Yen, Cheng-Fang			Quality of life of gay and bisexual men during emerging adulthood in Taiwan: Roles of traditional and cyber harassment victimization	PLOS ONE			English	Article							SEXUAL ORIENTATION; SCHOOL VICTIMIZATION; SOCIAL SUPPORT; HEALTH; MINORITY; STRESS; STIGMA; LGBT; RELIABILITY; DEPRESSION	This study examined factors related to the quality of life (QOL) of gay and bisexual men during emerging adulthood in Taiwan. The factors included traditional harassment (e.g., verbal ridicule, relational exclusion, physical aggression, and theft of belongings), cyber harassment, sex-and gender-related factors (e.g., sexual orientation, age at initial identification of sexual orientation, self-reported level of gender nonconformity, and perceived social acceptance toward homosexuality and bisexuality), and demographic characteristics. In total, 305 Taiwanese gay and bisexual men, aged 20-25 years, were recruited. Their QOL, traditional harassment, and cyber harassment data were collected using the World Health Organization Questionnaire on Quality of Life: Short Form, School Bullying Experience Questionnaire, and Cyberbullying Experiences Questionnaire, respectively. In total, 60.3%, 34.4%, 28.2%, and 29.5% of the participants reported experiencing traditional harassment, cyber harassment, traditional harassment across multiple contexts, and harassment in multiple forms, respectively. Both traditional and cyber harassment were significantly associated with lower QOL. Individuals who experienced traditional harassment across multiple contexts and harassment in multiple forms had lower QOL in nearly all domains than did individuals who had experienced traditional harassment in a single context and harassment of a single form. However, the QOL did not significantly differ between individuals who had experienced traditional harassment in a single context and nonvictims nor between individuals who had experienced harassment of a single form and nonvictims. Lower education level, older age at initial identification of sexual orientation, higher perception of gender nonconformity, and lower perceived social acceptance toward homosexuality and bisexuality were significantly associated with lower QOL. Clinical and public health professionals should consider these factors when developing programs to enhance the QOL of gay and bisexual men.	[Hu, Huei-Fan] Show Chwan Med Care Corp, Tainan Municipal Hosp, Dept Psychiat, Tainan, Taiwan; [Chang, Yu-Ping] SUNY Buffalo, Sch Nursing, Buffalo, NY USA; [Lin, Chienho] Chimei Med Ctr, Dept Psychiat, Tainan, Taiwan; [Yen, Cheng-Fang] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Yen, Cheng-Fang] Kaohsiung Med Univ, Coll Med, Sch Med, Grad Inst Med, Kaohsiung, Taiwan; [Yen, Cheng-Fang] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Psychiat, Kaohsiung, Taiwan	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Lin, CH (corresponding author), Chimei Med Ctr, Dept Psychiat, Tainan, Taiwan.; Yen, CF (corresponding author), Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan.; Yen, CF (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Grad Inst Med, Kaohsiung, Taiwan.; Yen, CF (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Psychiat, Kaohsiung, Taiwan.	alholin@gmail.com; chfaye@cc.kmu.edu.tw	Chang, Yu-Ping/Q-5437-2019	Chang, Yu-Ping/0000-0003-2328-6876	Chi-Mei Medical Center [105CM-KMU-01]; Kaohsiung Medical University Research Foundation [105CM-KMU-01]; Ministry of Science and Technology, Taiwan, R.O.C. [MOST 104-2314-B-037-024-MY3]; Kaohsiung Medical University Hospital [KMUH104-4R60, KMUH105-5R59, KMUH106-6R67]	Chi-Mei Medical Center; Kaohsiung Medical University Research Foundation; Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Hospital	This study was supported by the Chi-Mei Medical Center and Kaohsiung Medical University Research Foundation (grant 105CM-KMU-01), Ministry of Science and Technology, Taiwan, R.O.C. (grant MOST 104-2314-B-037-024-MY3), and Kaohsiung Medical University Hospital (grants KMUH104-4R60, KMUH105-5R59, and KMUH106-6R67). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 2007 NATL SCH CLIMAT; [Anonymous], 2010, 2009 NATL SCH CLIMAT; Arnett JJ, 2000, AM PSYCHOL, V55, P469, DOI 10.1037/0003-066X.55.5.469; Austin SB, 2017, AM J PREV MED, V53, P559, DOI 10.1016/j.amepre.2017.05.007; Birkett M, 2009, J YOUTH ADOLESCENCE, V38, P989, DOI 10.1007/s10964-008-9389-1; Bontempo DE, 2002, J ADOLESCENT HEALTH, V30, P364, DOI 10.1016/S1054-139X(01)00415-3; Calzo JP, 2011, DEV PSYCHOL, V47, P1658, DOI 10.1037/a0025508; Cochran SD, 2007, AM J PUBLIC HEALTH, V97, P2048, DOI 10.2105/AJPH.2006.087254; Earnshaw VA, 2016, PEDIATR CLIN N AM, V63, P999, DOI 10.1016/j.pcl.2016.07.004; Fayers P., 2007, QUALITY LIFE ASSESSM; Fredriksen-Goldsen KI, 2013, GERONTOLOGIST, V53, P664, DOI 10.1093/geront/gns123; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harrison TW, 2003, J SCHOOL HEALTH, V73, P107, DOI 10.1111/j.1746-1561.2003.tb03584.x; Hatzenbuehler ML, 2009, PSYCHOL BULL, V135, P707, DOI 10.1037/a0016441; Herek GM, 2007, J SOC ISSUES, V63, P905, DOI 10.1111/j.1540-4560.2007.00544.x; Hong JS, 2012, EDUC PSYCHOL REV, V24, P271, DOI 10.1007/s10648-012-9194-y; Jager J, 2011, SELF IDENTITY, V10, P417, DOI 10.1080/15298861003771155; Kim HJ, 2017, GERONTOLOGIST, V57, pS30, DOI 10.1093/geront/gnw172; Kosciw J. G., 2016, 2015 NATL SCH CLIMAT; Kowalski R.M., 2012, CYBERBULLYING BULLYI; Kowalski RM, 2007, J ADOLESCENT HEALTH, V41, pS22, DOI 10.1016/j.jadohealth.2007.08.017; Kowalski RM, 2013, J ADOLESCENT HEALTH, V53, pS13, DOI 10.1016/j.jadohealth.2012.09.018; Lin HC, ARCH CLIN PSYCHIAT S; Marshal MP, 2011, J ADOLESCENT HEALTH, V49, P115, DOI 10.1016/j.jadohealth.2011.02.005; Massachusetts Department of Education (MDE), 2005, MASS YOUTH RISK BEH; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Nadal KL, 2011, J LGBT YOUTH, V8, P234, DOI 10.1080/19361653.2011.584204; Pachankis JE, 2015, J CONSULT CLIN PSYCH, V83, P890, DOI 10.1037/ccp0000047; Pachankis JE, 2015, J CONSULT CLIN PSYCH, V83, P875, DOI 10.1037/ccp0000037; Pachankis JE, 2010, J CONSULT CLIN PSYCH, V78, P98, DOI 10.1037/a0017580; Patchin J. W., 2006, YOUTH VIOLENCE JUV J, V4, P148, DOI [10.1177/1541204006286288, DOI 10.1177/1541204006286288]; Patrick DL, 2013, AM J PUBLIC HEALTH, V103, P1255, DOI 10.2105/AJPH.2012.301101; Russell ST, 2016, ANNU REV CLIN PSYCHO, V12, P465, DOI 10.1146/annurev-clinpsy-021815-093153; Stastny P, 1997, QUALITY OF LIFE IN MENTAL DISORDERS, P261; Takizawa R, 2014, AM J PSYCHIAT, V171, P777, DOI 10.1176/appi.ajp.2014.13101401; Thornicroft G., 2006, SHUNNED DISCRIMINATI, DOI 10.1093/med/9780198570981.001.0001; Toomey RB, 2010, DEV PSYCHOL, V46, P1580, DOI 10.1037/a0020705; Traeen B, 2009, J HOMOSEXUAL, V56, P655, DOI 10.1080/00918360903005311; Tucker JS, 2016, J ADOLESCENT HEALTH, V59, P110, DOI 10.1016/j.jadohealth.2016.03.018; Wang CC, 2018, NEUROPSYCH DIS TREAT, V14, P1309, DOI 10.2147/NDT.S164579; Wang P.W., 2018, SUICIDE LIFE THREAT; Yang SJ, 2013, EUR CHILD ADOLES PSY, V22, P309, DOI 10.1007/s00787-012-0374-6; Yao G, 2002, J FORMOS MED ASSOC, V101, P342; Ybarra ML, 2015, CHILD ABUSE NEGLECT, V39, P123, DOI 10.1016/j.chiabu.2014.08.006; Yen CF, 2014, RES DEV DISABIL, V35, P3543, DOI 10.1016/j.ridd.2014.08.035; Yen CF, 2012, KAOHSIUNG J MED SCI, V28, P500, DOI 10.1016/j.kjms.2012.04.008; Zhu YX, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3076-z	48	8	8	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0213015	10.1371/journal.pone.0213015	http://dx.doi.org/10.1371/journal.pone.0213015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30818330	Green Published, Green Submitted, gold			2022-12-26	WOS:000460371500068
J	Hutzler, F; Schuste, S; Marx, C; Hawelka, S				Hutzler, Florian; Schuste, Sarah; Marx, Christina; Hawelka, Stefan			An investigation of parafoveal masks with the incremental boundary paradigm	PLOS ONE			English	Article							SEMANTIC PREVIEW BENEFIT; FOVEAL PROCESSING DIFFICULTY; FIXED-EFFECT FALLACY; EYE-MOVEMENTS; PERCEPTUAL SPAN; INTEGRATING INFORMATION; FIXATION; EXPECTATIONS; ATTENTION; LANGUAGE	Most of what we know about parafoveal preprocessing during reading is based on the boundary paradigm in combination with parafoveal masks as a presumably neutral baseline condition. Recent evidence questions the neutrality of the baseline condition by showing that parafoveal masks inflict preview costs. Using a novel, incremental boundary paradigm we studied the effect of parafoveal masks. Manipulating the salience of parafoveal previews, we found that increasing salience of the masks resulted in increasingly longer fixation times on target words, but also on pretarget words-suggesting preview costs. We conclude that the hidden preview costs of parafoveal masks in the classical boundary paradigm inflate the processing times for the baseline condition and hence lead to an overestimation of the preview benefit. Thus, the present study questions the validity of some of the conclusions drawn on the basis of the classical boundary paradigm.	[Hutzler, Florian; Schuste, Sarah; Marx, Christina; Hawelka, Stefan] Paris Lodron Univ Salzburg, Dept Psychol, Ctr Cognit Neurosci, Salzburg, Austria	Salzburg University	Hutzler, F (corresponding author), Paris Lodron Univ Salzburg, Dept Psychol, Ctr Cognit Neurosci, Salzburg, Austria.	florian.hutzler@sbg.ac.at	Hawelka, Stefan/D-8801-2012; Hutzler, Florian/A-7608-2008	Hutzler, Florian/0000-0001-8195-4911; Hawelka, Stefan/0000-0002-5304-8521	Austrian Science Fund [P-25799]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund grant P-25799 to FH (www.fwf.ac.at).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIIHL D, 1995, J EXP PSYCHOL LEARN, V21, P55, DOI 10.1037/0278-7393.21.1.55; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; Findelsberger E, 2019, ATTEN PERCEPT PSYCHO, V81, P1442, DOI 10.3758/s13414-019-01689-5; Gagl B, 2014, J EXP PSYCHOL LEARN, V40, P588, DOI 10.1037/a0034408; HENDERSON JM, 1990, J EXP PSYCHOL LEARN, V16, P417, DOI 10.1037/0278-7393.16.3.417; Hohenstein S, 2014, J EXP PSYCHOL LEARN, V40, P166, DOI 10.1037/a0033670; Hohenstein S, 2010, J EXP PSYCHOL LEARN, V36, P1150, DOI 10.1037/a0020233; Hutzler F, 2007, BRAIN RES, V1172, P124, DOI 10.1016/j.brainres.2007.07.025; Hutzler F, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00033; INHOFF AW, 1989, J EXP PSYCHOL HUMAN, V15, P544, DOI 10.1037/0096-1523.15.3.544; JACOBS AM, 1995, PERCEPT PSYCHOPHYS, V57, P1101, DOI 10.3758/BF03208367; Johnson RL, 2007, J EXP PSYCHOL HUMAN, V33, P209, DOI 10.1037/0096-1523.33.1.209; JONIDES J, 1984, PSYCHOL BULL, V96, P29, DOI 10.1037/0033-2909.96.1.29; Jordan TR, 2003, J EXP PSYCHOL LEARN, V29, P900, DOI 10.1037/0278-7393.29.5.900; Kirkby JA, 2013, BEHAV RES METHODS, V45, P664, DOI 10.3758/s13428-012-0301-2; Kliegl R, 2013, Q J EXP PSYCHOL, V66, P581, DOI 10.1080/17470218.2012.658073; LIMA SD, 1985, J EXP PSYCHOL HUMAN, V11, P272, DOI 10.1037/0096-1523.11.3.272; Marx C, 2017, SCI REP-UK, V7, DOI 10.1038/srep41602; Marx C, 2015, J COGN PSYCHOL, V27, P549, DOI 10.1080/20445911.2015.1008494; MCCLELLAND JL, 1981, J EXP PSYCHOL HUMAN, V7, P634, DOI 10.1037/0096-1523.7.3.634; MCCLELLAND JL, 1981, J EXP PSYCHOL HUMAN, V7, P652; MCCONKIE GW, 1975, PERCEPT PSYCHOPHYS, V17, P578, DOI 10.3758/BF03203972; McDonald SA, 2006, VIS COGN, V13, P89, DOI 10.1080/13506280500143367; Raaijmakers JGW, 1999, J MEM LANG, V41, P416, DOI 10.1006/jmla.1999.2650; RAYNER K, 1978, J EXP PSYCHOL HUMAN, V4, P529, DOI 10.1037/0096-1523.4.4.529; RAYNER K, 1986, J EXP CHILD PSYCHOL, V41, P211, DOI 10.1016/0022-0965(86)90037-8; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; RAYNER K, 1982, PERCEPT PSYCHOPHYS, V31, P537, DOI 10.3758/BF03204186; RAYNER K, 1981, J EXP PSYCHOL HUMAN, V7, P645, DOI 10.1037/0096-1523.7.3.645; Rayner K, 2009, Q J EXP PSYCHOL, V62, P1457, DOI 10.1080/17470210902816461; Risse S, 2012, J EXP PSYCHOL HUMAN, V38, P1026, DOI 10.1037/a0027735; Shillcock R, 2010, ATTEN PERCEPT PSYCHO, V72, P2184, DOI 10.3758/APP.72.8.2184; Veldre A, 2018, J MEM LANG, V103, P74, DOI 10.1016/j.jml.2018.08.001; Veldre A, 2016, J EXP PSYCHOL HUMAN, V42, P939, DOI 10.1037/xhp0000200; Veldre A, 2015, J EXP PSYCHOL HUMAN, V41, P219, DOI 10.1037/xhp0000017; Warren T, 2011, J EYE MOVEMENT RES, V4; Ziegler JC, 2000, Q J EXP PSYCHOL-A, V53, P671, DOI 10.1080/027249800410508	37	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0203013	10.1371/journal.pone.0203013	http://dx.doi.org/10.1371/journal.pone.0203013			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817789	gold, Green Submitted, Green Published			2022-12-26	WOS:000460371500002
J	Letnes, PA; Hansen, IM; Aas, LMS; Eide, I; Pettersen, R; Tassara, L; Receveur, J; le Floch, S; Guyomarch, J; Camus, L; Bytingsvik, J				Letnes, Paul Anton; Hansen, Ingrid Myrnes; Aas, Lars Martin Sandvik; Eide, Ingvar; Pettersen, Ragnhild; Tassara, Luca; Receveur, Justine; le Floch, Stephane; Guyomarch, Julien; Camus, Lionel; Bytingsvik, Jenny			Underwater hyperspectral classification of deep sea corals exposed to 2-methylnaphthalene	PLOS ONE			English	Article							LOPHELIA-PERTUSA L; HORIZON OIL-SPILL; WATER; REEFS; BIOLOGY	Coral reefs around the world are under threat due to anthropogenic impacts on the environment. It is therefore important to develop methods to monitor the status of the reefs and detect changes in the health condition of the corals at an early stage before severe damage occur. In this work, we evaluate underwater hyperspectral imaging as a method to detect changes in health status of both orange and white color morphs of the coral species Lophelia pertusa. Differing health status was achieved by exposing 60 coral samples to the toxic compound 2-methylnaphthalene in concentrations of 0 mg L-1 to 3.5 mg L-1. A machine learning model was utilized to classify corals according to lethal concentration (LC) levels LC5 (5% mortality) and LC25 (25% mortality), solely based on their reflectance spectra. All coral samples were classified to correct concentration group. This is a first step towards developing a remote sensing technique able to assess environmental impact on deep-water coral habitats over larger areas.	[Letnes, Paul Anton; Hansen, Ingrid Myrnes; Aas, Lars Martin Sandvik] Ecotone AS, Trondheim, Norway; [Eide, Ingvar] Statoil ASA, Res & Technol, Trondheim, Norway; [Pettersen, Ragnhild; Tassara, Luca; Camus, Lionel; Bytingsvik, Jenny] Akvaplan Niva AS, Tromso, Norway; [Receveur, Justine; le Floch, Stephane; Guyomarch, Julien] Ctr Documentat Rech & Expt Pollut Accid Eaux, Brest, France	Equinor; Akvaplan-niva	Letnes, PA (corresponding author), Ecotone AS, Trondheim, Norway.	paul.anton.letnes@gmail.com			Research Council of Norway (RCN); Statoil; ConocoPhillips Skandinavia; Dea Norge; ENI Norge; Lundin Norway; Total EP Norge; Norwegian Deepwater Programme; Ecotone; Akvaplan-niva (RCN project) [235440/E30]; project "Species Sensitivity Distribution for Deep Sea Species and Toxicity of continuous and spiked exposures to crude oil at 1 atm for deep sea species"; American Petroleum Institute (API)	Research Council of Norway (RCN)(Research Council of Norway); Statoil; ConocoPhillips Skandinavia; Dea Norge; ENI Norge; Lundin Norway; Total EP Norge; Norwegian Deepwater Programme; Ecotone; Akvaplan-niva (RCN project)(Akvaplan-niva); project "Species Sensitivity Distribution for Deep Sea Species and Toxicity of continuous and spiked exposures to crude oil at 1 atm for deep sea species"; American Petroleum Institute (API)	This study is part of the joint industry project "New technology and methods for mapping and monitoring of seabed habitats", financed by the Research Council of Norway (RCN), Statoil, ConocoPhillips Skandinavia, Dea Norge, ENI Norge, Lundin Norway, Total E&P Norge, Norwegian Deepwater Programme, Ecotone, and Akvaplan-niva (RCN project number 235440/E30). The exposure experiment received financial support from the project "Species Sensitivity Distribution for Deep Sea Species and Toxicity of continuous and spiked exposures to crude oil at 1 atm for deep sea species", led by Akvaplan-niva and financed by the American Petroleum Institute (API). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ecotone AS, Statoil and Akvaplan-niva AS provided support in the form of salaries for authors PAL, IMH, LMSA, IE, RP, LT, LC and JB but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Albright R, 2016, NATURE, V531, P362, DOI 10.1038/nature17155; Barott K, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008043, 10.1371/journal.pone.0010950]; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Beyer J, 2016, MAR POLLUT BULL, V110, P28, DOI 10.1016/j.marpolbul.2016.06.027; Brooke S, 2013, MAR BIOL, V160, P139, DOI 10.1007/s00227-012-2071-x; Butler JD, 2013, SCI TOTAL ENVIRON, V463, P952, DOI 10.1016/j.scitotenv.2013.06.079; Cairns Stephen D., 1994, SMITHSONIAN CONTRIBU, V557, P1, DOI DOI 10.5479/SI.00810282.557.I; Chennu A, 2013, LIMNOL OCEANOGR-METH, V11, P511, DOI 10.4319/lom.2013.11.511; Costello MJ, 2005, ERLANGEN EARTH C SER, P771, DOI 10.1007/3-540-27673-4_41; Eide I, 2017, INTEGR ENVIRON ASSES, V13, P387, DOI 10.1002/ieam.1840; Elde AC, 2012, MAR DRUGS, V10, P1400, DOI 10.3390/md10061400; Fossa JH, 2002, HYDROBIOLOGIA, V471, P1, DOI 10.1023/A:1016504430684; Freiwald A., 1998, THESIS; Gleason ACR, 2007, P OCEANS 2007 29 SEP, P1, DOI [10.1109/OCEANS.2007.4449394, DOI 10.1109/OCEANS.2007.4449394]; Guyomarch J, P 33 AMOP TECHN SEM, V1; Holden H, 1999, INT J REMOTE SENS, V20, P2545, DOI 10.1080/014311699211921; Johnsen G., 2013, SUBSEA OPTICS IMAGIN, p, DOI DOI 10.1533/9780857093523.3.508; Johnsen G, 2016, IFAC PAPERSONLINE, V49, P476, DOI 10.1016/j.ifacol.2016.10.451; Joyce KE, 2003, LIMNOL OCEANOGR, V48, P489, DOI 10.4319/lo.2003.48.1_part_2.0489; Kohavi R., 1995, P INT JOINT C ARTIFI, P1137, DOI DOI 10.1067/MOD.2000.109031; Kutser T, 2006, ESTUAR COAST SHELF S, V70, P449, DOI 10.1016/j.ecss.2006.06.026; Larsson AI, 2013, MAR POLLUT BULL, V70, P176, DOI 10.1016/j.marpolbul.2013.02.033; Liu G., 2006, P 10 INT CORAL REEF, Vvol. 1793, P1783; Lopez M, 2011, LECT NOTES ARTIF INT, V6678, P132, DOI 10.1007/978-3-642-21219-2_18; Maier C, 2009, BIOGEOSCIENCES, V6, P1671, DOI 10.5194/bg-6-1671-2009; MORTENSEN PB, 1995, SARSIA, V80, P145, DOI 10.1080/00364827.1995.10413586; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Osterloff J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157329; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pope RM, 1997, APPL OPTICS, V36, P8710, DOI 10.1364/AO.36.008710; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Roberts JM, 2006, SCIENCE, V312, P543, DOI 10.1126/science.1119861; Rogers AD, 1999, INT REV HYDROBIOL, V84, P315; SHELTON GAB, 1980, J MAR BIOL ASSOC UK, V60, P517, DOI 10.1017/S0025315400028538; Stogiannidis E, 2015, REV ENVIRON CONTAM T, V234, P49, DOI 10.1007/978-3-319-10638-0_2; Tollefson J, 2016, NATURE, V537, P123, DOI 10.1038/537123a; Turley CM, 2007, CORAL REEFS, V26, P445, DOI 10.1007/s00338-007-0247-5; UPADHYAY RR, 1970, ACTA CHEM SCAND, V24, P3055, DOI 10.3891/acta.chem.scand.24-3055; White HK, 2012, P NATL ACAD SCI USA, V109, P20303, DOI 10.1073/pnas.1118029109; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Wu TF, 2004, J MACH LEARN RES, V5, P975	41	12	12	8	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0209960	10.1371/journal.pone.0209960	http://dx.doi.org/10.1371/journal.pone.0209960			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811426	Green Submitted, gold, Green Published			2022-12-26	WOS:000459806400006
J	Chiou, YJ; Huang, TL				Chiou, Yu-Jie; Huang, Tiao-Lai			Accuracy of brain-derived neurotrophic factor levels for differentiating between Taiwanese patients with major depressive disorder or schizophrenia and healthy controls	PLOS ONE			English	Article							BDNF LEVELS; SERUM CONCENTRATIONS; PLASMA; ASSOCIATIONS; BIOMARKERS; BIPOLAR	Objectives Brain-derived neurotrophic factor (BDNF) has been associated with the psychopathology of both major depressive disorder (MDD) and schizophrenia (SZ). However, studies focusing on the accuracy of BDNF levels to differentiate between these patients and healthy controls (HCs) have been rare. Methods Over a discrete ten-year period, we investigated serum BDNF levels in patients with MDD or SZ and compared them to HCs. Results We found serum BDNF levels in 224 samples with SZ to be lower than those in 390 HCs samples (p = 0.007), but not lower than those in the 273 samples with MDD. Male MDD patients tended to have lower BDNF levels compared to male HCs (p = 0.083). The receiver operating characteristic curve analysis demonstrated that BDNF levels were moderately accurate in differentiating male MDD patients and female patients with SZ from HCs (AUC = 0.652 and 0.623, respectively). The most adequate cut-off points for BDNF level were 5.11 ng/ml (sensitivity = 81.1%, specificity = 48.5%) and 5.88 ng/ml (sensitivity = 74.1%, specificity = 57.4%), respectively. Conclusions Our results support that BDNF demonstrated moderate accuracy in distinguishing male patients with MDD and female patients with SZ from HCs. In the future, greater samples would be required to further confirm these results.	[Chiou, Yu-Jie; Huang, Tiao-Lai] Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Chiou, Yu-Jie; Huang, Tiao-Lai] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University	Huang, TL (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Kaohsiung, Taiwan.	a540520@adm.cgmh.org.tw			 [CMRPG8054];  [CMRPG840521];  [CMRPG860491];  [CMRPG870951];  [CMRPG870952];  [CMRPG8E0351];  [CMRPG8F1061];  [CMRPG8F1461];  [NSC94-2314-B-182A-208];  [NSC96-2314-B-182A-091];  [NSC99-2628-B-182-002];  [MOST103-2314-B182A-012]	; ; ; ; ; ; ; ; ; ; ; 	This work was funded by grant nos. CMRPG8054, CMRPG840521, CMRPG860491, CMRPG870951, CMRPG870952, CMRPG8E0351, CMRPG8F1061, CMRPG8F1461, NSC94-2314-B-182A-208, NSC96-2314-B-182A-091, NSC99-2628-B-182-002 and MOST103-2314-B182A-012 in Taiwan.	BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Buckley PF, 2007, SCHIZOPHR RES, V91, P1, DOI 10.1016/j.schres.2006.12.026; Bus BAA, 2015, MOL PSYCHIATR, V20, P602, DOI 10.1038/mp.2014.83; Bus BAA, 2011, PSYCHONEUROENDOCRINO, V36, P228, DOI 10.1016/j.psyneuen.2010.07.013; Cain SW, 2017, J BIOL RHYTHM, V32, P75, DOI 10.1177/0748730417693124; Cassiman D, 2001, HEPATOLOGY, V33, P148, DOI 10.1053/jhep.2001.20793; Chen CC, 2011, PSYCHIAT RES, V189, P327, DOI 10.1016/j.psychres.2011.01.011; Chen DC, 2009, PSYCHOPHARMACOLOGY, V207, P375, DOI 10.1007/s00213-009-1665-6; Chiou YJ, 2017, WORLD J BIOL PSYCHIA, V18, P382, DOI 10.1080/15622975.2016.1224925; Chiou YJ, 2017, INT J NEUROPSYCHOPH, V20, P213, DOI 10.1093/ijnp/pyw096; CHONG MY, 1989, PSYCHOL MED, V19, P495, DOI 10.1017/S0033291700012526; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Elfving B, 2012, J PSYCHIATR RES, V46, P1118, DOI 10.1016/j.jpsychires.2012.05.003; Fernandes BS, 2015, MOL PSYCHIATR, V20, P1108, DOI 10.1038/mp.2014.117; Fernandes B S, 2014, Mol Psychiatry, V19, P750, DOI 10.1038/mp.2013.172; Fernandes BS, 2009, J PSYCHIATR RES, V43, P1200, DOI 10.1016/j.jpsychires.2009.04.010; First M. B., 1997, STRUCTURED CLIN INTE; Giese M, 2014, MOL PSYCHIATR, V19, P151, DOI 10.1038/mp.2013.10; Halbreich U, 2006, CNS DRUGS, V20, P523, DOI 10.2165/00023210-200620070-00001; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Heitz U, 2019, WORLD J BIOL PSYCHIA, V20, P545, DOI 10.1080/15622975.2018.1462532; Huang TL, 2008, J PSYCHIATR RES, V42, P521, DOI 10.1016/j.jpsychires.2007.05.007; Huang TL, 2006, J PSYCHIATR RES, V40, P664, DOI 10.1016/j.jpsychires.2005.11.004; Huang TL, 2015, ADV CLIN CHEM, V68, P177, DOI 10.1016/bs.acc.2014.11.003; Karege F, 2002, PSYCHIAT RES, V109, P143, DOI 10.1016/S0165-1781(02)00005-7; KAY SR, 1989, BRITISH JOURNAL OF PSYCHIATRY, VOL 155, SUPP NO. 7, P59, DOI 10.1192/S0007125000291514; Kishi T, 2018, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00308; KUHN TS, 1962, SCIENCE, V136, P760, DOI 10.1126/science.136.3518.760; Lee AH, 2011, J CLIN PSYCHOPHARM, V31, P334, DOI 10.1097/JCP.0b013e31821895c1; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Li CY, 2018, INT J MED SCI, V15, P900, DOI 10.7150/ijms.24346; Li ZZ, 2014, BRIT J PSYCHIAT, V205, P29, DOI 10.1192/bjp.bp.113.134064; Man LJ, 2018, PSYCHIAT RES, V263, P1, DOI 10.1016/j.psychres.2018.02.034; Molendijk ML, 2014, MOL PSYCHIATR, V19, P791, DOI 10.1038/mp.2013.105; Molendijk ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048046; Nuernberg GL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.227; Perkins NJ, 2006, AM J EPIDEMIOL, V163, P670, DOI 10.1093/aje/kwj063; Pillai A, 2010, INT J NEUROPSYCHOPH, V13, P535, DOI 10.1017/S1461145709991015; Post RM, 2007, J PSYCHIATR RES, V41, P979, DOI 10.1016/j.jpsychires.2006.09.009; Rizos EN, 2008, PROG NEURO-PSYCHOPH, V32, P1308, DOI 10.1016/j.pnpbp.2008.04.007; Rush AJ, 2007, J CLIN PSYCHIAT, V68, P4; Sotiropoulou M, 2013, LIFE SCI, V92, P305, DOI 10.1016/j.lfs.2013.01.008; Toyooka K, 2002, PSYCHIAT RES, V110, P249, DOI 10.1016/S0165-1781(02)00127-0; Xiu MH, 2009, PROG NEURO-PSYCHOPH, V33, P1508, DOI 10.1016/j.pnpbp.2009.08.011; Youssef MM, 2018, INT J NEUROPSYCHOPH, V21, P528, DOI 10.1093/ijnp/pyy008; Zhang Y, 2018, PSYCHOPHARMACOLOGY, V235, P1191, DOI 10.1007/s00213-018-4835-6	46	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212373	10.1371/journal.pone.0212373	http://dx.doi.org/10.1371/journal.pone.0212373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794585	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100059
J	Hemmatian, Z; Tunuguntla, RH; Noy, A; Rolandi, M				Hemmatian, Zahra; Tunuguntla, Ramya H.; Noy, Aleksandr; Rolandi, Marco			Electronic control of H+ current in a bioprotonic device with carbon nanotube porins	PLOS ONE			English	Article							PROTON; TRANSPORT	Hybrid biotic abiotic devices can be used to interface electronics with biological systems for novel therapies or to increase device functionality beyond silicon. Many strategies exist to merge the electronic and biological worlds, one dominated by electrons and holes as charge carriers, the other by ions. In the biological world, lipid bilayers and ion channels are essential to compartmentalize the cell machinery and regulate ionic fluxes across the cell membrane. Here, we demonstrate a bioelectronic device in which a lipid bilayer supported on H+-conducting Pd/PdHx contacts contains carbon nanotubes porin (CNTP) channels. This bioelectronic device uses CNTPs to control of H+ flow across the lipid bilayer with a voltage applied to the Pd/PdHx contacts. Potential applications of these devices include local pH sensing and control.	[Hemmatian, Zahra; Rolandi, Marco] Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA; [Tunuguntla, Ramya H.; Noy, Aleksandr] Lawrence Livermore Natl Lab, Phys & Life Sci Directorate, Livermore, CA USA; [Noy, Aleksandr] Univ Calif Merced, Sch Nat Sci, Merced, CA USA	University of California System; University of California Santa Cruz; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Merced	Rolandi, M (corresponding author), Univ Calif Santa Cruz, Dept Elect & Comp Engn, Santa Cruz, CA 95064 USA.	mrolandi@ucsc.edu		Noy, Aleksandr/0000-0003-4924-2652	National Science Foundation [DMR-1648815]; Air Force Office of Sponsored Research part of the CyrborgCell program [FA9550-15-1-0273]; U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [SCW0972]; U.S. Department of Energy [DE-AC52-07NA27344]	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Sponsored Research part of the CyrborgCell program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE))	The device work was funded by the National Science Foundation DMR-1648815 and by the Air Force Office of Sponsored Research under award #FA9550-15-1-0273 part of the CyrborgCell program directed by Dr. Patrick Bradshaw to ZH. CNTP synthesis and characterization was supported by the U.S. Department of Energy, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award SCW0972. Work at the Lawrence Livermore National Laboratory was performed under the auspices of the U.S. Department of Energy under Contract DE-AC52-07NA27344.	Ajo-Franklin CM, 2015, ADV MAT; Angione MD, 2012, P NATL ACAD SCI USA, V109, P6429, DOI 10.1073/pnas.1200549109; Busath D, 1981, GRAMICIDIN FORMS MUL; DeCoursey TE, 2015, BIOCHEMISTRY; Deng Y, 2013, SCI REPORTS, V3; Geng J, 2014, NATURE, V514, P612, DOI 10.1038/nature13817; GLASSER L, 1975, CHEM REV, V75, P21, DOI 10.1021/cr60293a002; Hemmatian Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12981; Huang SCJ, 2010, NANO LETT, V10, P1812, DOI 10.1021/nl100499x; Johnson N, 2015, BIOPHYS J, V108, p485A, DOI 10.1016/j.bpj.2014.11.2653; Jonsson A, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500039; Josberger EE, 2014, ADV MATER, V26, P4986, DOI 10.1002/adma.201400320; Kim YJ, 2013, J MATER CHEM B, V1, P3781, DOI 10.1039/c3tb20183j; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Malliaras G, 2015, ADV MATER, V27, P7492, DOI 10.1002/adma.201504783; Misra N, 2009, P NATL ACAD SCI USA, V106, P13780, DOI 10.1073/pnas.0904850106; MITCHELL P, 1967, FED PROC, V26, P1370; Mitraka E, 2015, J MATER CHEM C, V3, P7604, DOI 10.1039/c5tc00753d; Miyake T, 2016, J PHYS-CONDENS MAT, V28, DOI 10.1088/0953-8984/28/2/023001; Miyake T, 2015, APL MATER, V3, DOI 10.1063/1.4900886; MOROWITZ HJ, 1978, AM J PHYSIOL, V235, pR99, DOI 10.1152/ajpregu.1978.235.3.R99; Noy A, 2015, BIOPHYS J, V108, p443A, DOI 10.1016/j.bpj.2014.11.2418; Ordinario DD, 2015, APL MATER, V3, DOI 10.1063/1.4901296; Ordinario DD, 2014, NAT CHEM, V6, P597, DOI [10.1038/NCHEM.1960, 10.1038/nchem.1960]; Owens RM, 2010, MRS BULL, V35, P449, DOI 10.1557/mrs2010.583; Pang C, 2015, ADV MATER, V27, P634, DOI 10.1002/adma.201403807; Rolandi M, 2014, NAT CHEM, V6, P563, DOI 10.1038/nchem.1980; Shen YX, 2014, J MEMBRANE SCI, V454, P359, DOI 10.1016/j.memsci.2013.12.019; Smith SME, 2011, P NATL ACAD SCI USA, V108, P18162, DOI 10.1073/pnas.1115405108; Soto-Rodriguez J, 2016, ADV MATER, V28, P6581, DOI 10.1002/adma.201600222; Stavrinidou E, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501136; Tunuguntla RH, 2016, NAT NANOTECHNOL, V11, P639, DOI [10.1038/nnano.2016.43, 10.1038/NNANO.2016.43]; Tybrandt K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1869; Tybrandt K, 2010, P NATL ACAD SCI USA, V107, P9929, DOI 10.1073/pnas.0913911107; Walz D, 2002, BIOELECTROCHEMISTRY, V55, P89, DOI 10.1016/S1567-5394(01)00162-1; Williamson A, 2015, ADV MATER, V27, P3097; Zhong C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1489	37	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212197	10.1371/journal.pone.0212197	http://dx.doi.org/10.1371/journal.pone.0212197			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794578	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100045
J	Matthews, SM; Eshelman, MA; Berg, AS; Koltun, WA; Yochum, GS				Matthews, Stephen M.; Eshelman, Melanie A.; Berg, Arthur S.; Koltun, Walter A.; Yochum, Gregory S.			The Crohn's disease associated SNP rs6651252 impacts MYC gene expression in human colonic epithelial cells	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; LONG-RANGE INTERACTION; C-MYC; T-CELL; WNT; TARGET; RISK; PATHOGENESIS; ELEMENT; LOCI	Crohn's disease (CD) is a debilitating inflammatory bowel disease (IBD) that arises from chronic inflammation in the gastrointestinal tract. Genome-wide association studies (GWAS) have identified over 200 single nucleotide polymorphisms (SNPs) that are associated with a predisposition for developing IBD. For the majority, the causal variant and target genes affected are unknown. Here, we investigated the CD-associated SNP rs6651252 that maps to a gene desert region on chromosome 8. We demonstrate that rs6651252 resides within a Wnt responsive DNA enhancer element (WRE) and that the disease associated allele augments binding of the TCF7L2 transcription factor to this region. Using CRISPR/Cas9 directed gene editing and epigenetic modulation, we find that the rs6651252 enhancer regulates expression of the c-MYC proto-oncogene (MYC). Furthermore, we found MYC transcript levels are elevated in patient-derived colonic segments harboring the disease-associated allele in comparison to those containing the ancestral allele. These results suggest that Wnt/MYC signaling contributes to CD pathogenesis and that patients harboring the disease-associated allele may benefit from therapies that target MYC or MYC-regulated genes.	[Matthews, Stephen M.; Eshelman, Melanie A.; Yochum, Gregory S.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Matthews, Stephen M.; Eshelman, Melanie A.; Koltun, Walter A.; Yochum, Gregory S.] Penn State Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Hershey, PA 17033 USA; [Berg, Arthur S.] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA.; Yochum, GS (corresponding author), Penn State Univ, Coll Med, Dept Surg, Div Colon & Rectal Surg, Hershey, PA 17033 USA.	gsy3@psu.edu		Matthews, Stephen/0000-0002-8968-225X	Peter and Marshia Carlino fund for Inflammatory Bowel Disease research	Peter and Marshia Carlino fund for Inflammatory Bowel Disease research	This work was supported by the Peter and Marshia Carlino fund for Inflammatory Bowel Disease research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker N, 2014, NAT REV MOL CELL BIO, V15, P19, DOI 10.1038/nrm3721; Bottomly D, 2010, NUCLEIC ACIDS RES, V38, P5735, DOI 10.1093/nar/gkq363; Chia LA, 2010, PROG MOL BIOL TRANSL, V96, P157, DOI 10.1016/S1877-1173(10)96007-9; CICLITIRA PJ, 1987, J PATHOL, V151, P293, DOI 10.1002/path.1711510409; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Ek WE, 2014, ANN GASTROENTEROL, V27, P294; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frey MR, 2016, DIGEST DIS SCI, V61, P327, DOI 10.1007/s10620-015-3947-7; Grisanzio Chiara, 2010, Genes Cancer, V1, P555, DOI 10.1177/1947601910381380; Hartman DJ, 2018, INFLAMM BOWEL DIS, V24, P1780, DOI 10.1093/ibd/izy057; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Komor AC, 2017, CELL, V169, P559, DOI 10.1016/j.cell.2017.04.005; Konsavage WM, 2013, DIGEST DIS SCI, V58, P2858, DOI 10.1007/s10620-013-2686-x; Konsavage WM, 2012, MOL CELL BIOL, V32, P3891, DOI 10.1128/MCB.00548-12; Konsavage WM, 2012, J BIOL CHEM, V287, P11730, DOI 10.1074/jbc.M111.327767; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McGovern DPB, 2015, GASTROENTEROLOGY, V149, P1163, DOI 10.1053/j.gastro.2015.08.001; Meddens CA, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1100-3; Mokry M, 2014, GASTROENTEROLOGY, V146, P1040, DOI 10.1053/j.gastro.2013.12.003; Mokry M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165893; Momozawa Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04365-8; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Raup-Konsavage WM, 2016, DIGEST DIS SCI, V61, P410, DOI 10.1007/s10620-015-3852-0; Rennoll Sherri, 2015, World J Biol Chem, V6, P290, DOI 10.4331/wjbc.v6.i4.290; Rennoll SA, 2016, CANCERS, V8, DOI 10.3390/cancers8050052; Robles AI, 2016, GASTROENTEROLOGY, V150, P931, DOI 10.1053/j.gastro.2015.12.036; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schieffer KM, 2017, AM J PHYSIOL-GASTR L, V313, pG277, DOI 10.1152/ajpgi.00136.2017; Sehgal R, 2012, DIS COLON RECTUM, V55, P115, DOI 10.1097/DCR.0b013e31823ccea8; Sipos F, 2016, WORLD J GASTROENTERO, V22, P7938, DOI 10.3748/wjg.v22.i35.7938; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van Loosdregt J, 2018, J IMMUNOL, V201, P2193, DOI 10.4049/jimmunol.1800633; Wright JB, 2010, MOL CELL BIOL, V30, P1411, DOI 10.1128/MCB.01384-09; Yaeger R, 2016, GASTROENTEROLOGY, V151, P278, DOI 10.1053/j.gastro.2016.04.001; Yamada A, 2016, WORLD J GASTROENTERO, V22, P2195, DOI 10.3748/wjg.v22.i7.2195; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08	56	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212850	10.1371/journal.pone.0212850	http://dx.doi.org/10.1371/journal.pone.0212850			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794691	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100148
J	Siddall, ME; Barkdull, M; Tessler, M; Brugler, MR; Borda, E; Hekkala, E				Siddall, Mark E.; Barkdull, Megan; Tessler, Michael; Brugler, Mercer R.; Borda, Elizabeth; Hekkala, Evon			Ideating iDNA: Lessons and limitations from leeches in legacy collections	PLOS ONE			English	Article							DIGESTIVE-TRACT MICROBIOTA; MEDICINAL LEECH; ENVIRONMENTAL DNA; HIRUDO-ORIENTALIS; CONSERVATION; EVOLUTION; HISTORY; TOOL; TRYPANOSOMES; AMPHIBIANS	Indirect methods for conducting faunal inventories present great promise, and genomic inventories derived from environmental sources (eDNA) are improving. Invertebrate ingested DNA (iDNA) from terrestrial leeches in the family Haemadipsidae has shown potential for surveying vertebrates and biodiversity monitoring in protected areas. Here we present an initial, and critical, evaluation of the limitations and biases of current iDNA protocols for biodiversity monitoring using both standard and NGS barcoding approaches. Key findings include the need for taxon relevant multi-locus markers and reference databases. In particular, the limitations of available reference databases have profound potential to mislead and bias eDNA and iDNA results if not critically interpreted. Nevertheless, there is great potential for recovery of amplifiable DNA from gut contents of invertebrate museum specimens which may reveal both temporal patterns and cryptic diversity in protected areas with increased efficiency. Our analyses of ingested DNA (iDNA) from both freshly stored and previously collected (legacy) samples of terrestrial leeches successfully identified vertebrates from Myanmar, Australia and Madagascar and indicate the potential to characterize microbial communities, pathogen diversity and interactions at low cost.	[Siddall, Mark E.; Tessler, Michael; Brugler, Mercer R.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Barkdull, Megan] New Coll Florida, Sarasota, FL USA; [Brugler, Mercer R.] CUNY, Biol Sci Dept, NYC Coll Technol, Brooklyn, NY 11210 USA; [Borda, Elizabeth] Texas A&M Univ, Dept Sci & Math, San Antonio, TX USA; [Hekkala, Evon] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA	American Museum of Natural History (AMNH); State University System of Florida; New College Florida; City University of New York (CUNY) System; Texas A&M University System; Fordham University	Siddall, ME (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	siddall@amnh.org	Brugler, Mercer R./AAV-3202-2021	Brugler, Mercer R./0000-0003-3676-1226; Hekkala, Evon/0000-0001-9250-3091; Siddall, Mark/0000-0002-3977-7517; Barkdull, Megan/0000-0001-9334-5726; Borda, Elizabeth/0000-0003-1179-163X	National Science Foundation [DBI-1358465]; Gerstner Family Foundation	National Science Foundation(National Science Foundation (NSF)); Gerstner Family Foundation	This research was supported by grant DBI-1358465 from the National Science Foundation. The Gerstner Family Foundation provided partial support to MRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Arengo, 2017, FUTURE NATURAL HIST, P82; Bista I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14087; Bohmann K, 2013, MOL ECOL, V22, P909, DOI 10.1111/mec.12221; Borda E, 2004, LAUTERBORNIA, V52, P25; Borda E, 2010, INVERTEBR SYST, V24, P456, DOI 10.1071/IS10013; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Calvignac-Spencer S, 2013, MOL ECOL, V22, P915, DOI 10.1111/mec.12183; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Cook JA, 2016, BIOSCIENCE, V66, P917, DOI 10.1093/biosci/biw123; Creer S, 2016, METHODS ECOL EVOL, V7, P1008, DOI 10.1111/2041-210X.12574; De Bondi N, 2010, WILDLIFE RES, V37, P456, DOI 10.1071/WR10046; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gariepy TD, 2012, MOL ECOL RESOUR, V12, P646, DOI 10.1111/j.1755-0998.2012.03140.x; Glen AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067940; Graf J, 1999, INFECT IMMUN, V67, P1; Graf J, 2006, TRENDS MICROBIOL, V14, P365, DOI 10.1016/j.tim.2006.06.009; Graf J, 2016, ANNU REV MICROBIOL, V70, P375, DOI 10.1146/annurev-micro-091014-104258; Greenblatt RJ, 2004, VIROLOGY, V321, P101, DOI 10.1016/j.virol.2003.12.026; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gustafsson DR, 2017, ZOOTAXA, V4313, P1, DOI 10.11646/zootaxa.4313.1.1; HAFNER MS, 1990, SYST ZOOL, V39, P192, DOI 10.2307/2992181; Hamilton PB, 2011, TRENDS PARASITOL, V27, P99, DOI 10.1016/j.pt.2010.11.009; Hamilton PB, 2005, INT J PARASITOL, V35, P431, DOI 10.1016/j.ijpara.2004.12.005; Holmes I, 2018, PEERJ, V6, DOI 10.7717/peerj.4662; JAFFE CL, 1984, J IMMUNOL, V133, P440; Johnson PTJ, 2003, CONSERV BIOL, V17, P1724, DOI 10.1111/j.1523-1739.2003.00217.x; Keegan HL, 1968, BLOOD SUCKING ASIAN; Kitano T, 2007, INT J LEGAL MED, V121, P423, DOI 10.1007/s00414-006-0113-y; Kocher A, 2017, MOL ECOL, V26, P6478, DOI 10.1111/mec.14362; Kvist S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028192; Lassen SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-143; Laufer AS, 2008, APPL ENVIRON MICROB, V74, P6151, DOI 10.1128/AEM.00795-08; Levine SM, 2010, AM J CRIT CARE, V19, P471, DOI 10.4037/ajcc2009110; Litwinowicz A, 2014, SURG INFECT, V15, P757, DOI 10.1089/sur.2014.036; Malele I, 2003, INFECT GENET EVOL, V3, P271, DOI 10.1016/S1567-1348(03)00090-X; MARTIN DS, 1992, J PARASITOL, V78, P317, DOI 10.2307/3283481; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; McLean BS, 2016, J MAMMAL, V97, P287, DOI 10.1093/jmammal/gyv178; Moore J. P., 1924, Proceedings of the Academy of Natural Sciences of Philadelphia, V76, P343; Nelson MC, 2012, GUT MICROBES, V3, P322, DOI 10.4161/gmic.20227; Poinar HN, 1998, SCIENCE, V281, P402, DOI 10.1126/science.281.5375.402; Rappole JH, 1985, NOCTURNAL MAMMALS TE; Richardson RL, 1974, MEMOIRS NATL MUSEUM, V35, P97; Schnell IB, 2018, MOL ECOLOGY RESOURCE; Schnell IB, 2015, FRONT ZOOL, V12, DOI 10.1186/s12983-015-0115-z; Schnell IB, 2012, CURR BIOL, V22, pR262, DOI 10.1016/j.cub.2012.02.058; Siddall ME, 2007, APPL ENVIRON MICROB, V73, P655, DOI 10.1128/AEM.01282-06; Siddall ME, 2011, PARASITOLOGY, V138, P1815, DOI 10.1017/S0031182011000539; Siddall ME, 2004, MOL PHYLOGENET EVOL, V30, P178, DOI 10.1016/S1055-7903(03)00184-2; Silveira L, 2003, BIOL CONSERV, V114, P351, DOI 10.1016/S0006-3207(03)00063-6; Silveira L, 2010, ORYX, V44, P104, DOI 10.1017/S0030605309990433; Spellerberg I. F., 2005, MONITORING ECOLOGICA, DOI DOI 10.1017/CBO9780511614699; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Takahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056584; Tessler M, 2018, SYST BIODIVERS, V16, P488, DOI 10.1080/14772000.2018.1433729; Tessler M, 2016, ZOOL SCR, V45, P552, DOI 10.1111/zsc.12165; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Tobler MW, 2008, ANIM CONSERV, V11, P187, DOI 10.1111/j.1469-1795.2008.00181.x; Todd BD, 2010, ECOTOXICOLOGY OF AMPHIBIANS AND REPTILES, SECOND EDITION, P47, DOI 10.1201/EBK1420064162-c3; TUBANGUI MARCOS A., 1932, PHILIPPINE JOUR SCI, V48, P115; Villette P, 2016, J MAMMAL, V97, P32, DOI 10.1093/jmammal/gyv150; Vongsombath C, 2011, ACTA TROP, V119, P178, DOI 10.1016/j.actatropica.2011.05.014; Weiskopf SR, 2018, J APPL ECOL, V55, P2071, DOI 10.1111/1365-2664.13111; Whitaker IS, 2014, PLAST RECONSTR SURG, V133, p408E, DOI 10.1097/01.prs.0000438461.06217.bb; Williams EH, 2006, J VIROL, V80, P4643, DOI 10.1128/JVI.80.9.4643-4644.2006; Wilson JJ, 2016, CONSERV BIOL, V30, P982, DOI 10.1111/cobi.12787; Yoccoz NG, 2001, TRENDS ECOL EVOL, V16, P446, DOI 10.1016/S0169-5347(01)02205-4	70	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212226	10.1371/journal.pone.0212226	http://dx.doi.org/10.1371/journal.pone.0212226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794582	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100047
J	Rezende, RM; Peluzio, MDG; Silva, FD; Della Lucia, EM; Favarato, LSC; Martino, HSD; Natali, AJ				Rezende, Rafael Marins; Gouveia Peluzio, Maria do Carmo; Silva, Franciany de Jesus; Della Lucia, Emanuel Mattos; Campos Favarato, Lukiya Silva; Duarte Martino, Hercia Stampini; Natali, Antonio Jose			Does aerobic exercise associated with tryptophan supplementation attenuates hyperalgesia and inflammation in female rats with experimental fibromyalgia?	PLOS ONE			English	Article							ALPHA-LACTALBUMIN INCREASES; NEUTRAL AMINO-ACIDS; SEROTONERGIC STIMULATION; PROLONGED EXERCISE; PLASMA TRYPTOPHAN; PAIN; CORTISOL; PROTEIN; STRESS; WOMEN	The objective of this study was to verify the effects of aerobic exercise associated with tryptophan (TRP) supplementation on hyperalgesia, as well as on cortisol, IL-6 and TNF concentrations in female rats with experimental fibromyalgia (FM). Female Wistar rats (initial body weight: similar to 350 g; age: 12 months) were randomly divided into 5 groups: CON (Control); F (Fibromyalgia induced); FE (Fibromyalgia induced plus exercise); FES (Fibromyalgia induced plus exercise and TRP supplementation) and FS (Fibromyalgia induced plus TRP supplementation). Fibromyalgia was induced with two injections (20 mu L) of acidic saline (pH 4.0) into the right gastrocnemius muscle with a 3-day interval. Control animals received the same doses of neutral saline (pH 7.4). The exercised animals underwent progressive low intensity aerobic exercise (LIAE) on a treadmill (10-12 m/min, 30-45 min/day, 5 days/week) for three weeks. During this period, the supplemented animals received a TRP supplemented diet (210 g/week), while the others received a control diet. Mechanical hyperalgesia was evaluated weekly and serum cortisol and muscle IL-6 and TNF concentrations were assessed after three weeks of interventions. Experimental FM caused bilateral hind paw hyperalgesia and augmented serum cortisol and muscle IL-6 concentrations. After 3 weeks of interventions, LIAE alone reduced hyperalgesia (151%) and reduced serum cortisol concentrations (72%). Tryptophan supplementation itself diminished hyperalgesia (57%) and reduced serum cortisol concentrations (67%). Adding TRP supplementation to LIAE did not further reduce hyperalgesia significantly (11%), which was followed by an important decrease in muscle IL-6 concentrations (68%), though reduction in serum cortisol pulled back to 45%. Muscle TNF concentrations were not affected. In conclusion, the association of TRP supplementation to LIAE does not potentiate significantly the reduction of bilateral mechanical hyperalgesia promoted by LIAE in female rats with experimental FM, however an important decrease in IL-6 is evident.	[Rezende, Rafael Marins; Gouveia Peluzio, Maria do Carmo; Duarte Martino, Hercia Stampini] Univ Fed Vicosa, Dept Nutr & Hlth, Vicosa, MG, Brazil; [Silva, Franciany de Jesus; Della Lucia, Emanuel Mattos; Natali, Antonio Jose] Univ Fed Vicosa, Dept Phys Educ, Vicosa, MG, Brazil; [Campos Favarato, Lukiya Silva] Univ Fed Vicosa, Dept Vet Med, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Rezende, RM (corresponding author), Univ Fed Vicosa, Dept Nutr & Hlth, Vicosa, MG, Brazil.	faelfisio@yahoo.com.br	NATALI, ANTONIO JOSE/C-1555-2013	NATALI, ANTONIO JOSE/0000-0002-4927-4024	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [PROEX/683/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) [306797/2017-8]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [CDS-APQ-01635-15]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was finnanced in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) (http://www.capes.gov.br/) - Finance Code: PROEX/683/2018 (AJN, MCGP, HSDM); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Brasil (CNPq) (http://www.cnpq.br/) - Grant number: 306797/2017-8 (AJN); and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (http://www.fapemig.br/).Grant number: CDS-APQ-01635-15 (AJN). There was no additional external funding received for this study. All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis MR, 2006, ARTHRIT RHEUM-ARTHR, V55, P57, DOI 10.1002/art.21693; Bote ME, 2012, NEUROIMMUNOMODULAT, V19, P343, DOI 10.1159/000341664; Brosseau L, 2008, PHYS THER, V88, P857, DOI 10.2522/ptj.20070200; Busch AJ, 2011, CURR PAIN HEADACHE R, V15, P358, DOI 10.1007/s11916-011-0214-2; Catley D, 2000, ARTHRIT CARE RES, V13, P51, DOI 10.1002/1529-0131(200002)13:1<51::AID-ART8>3.0.CO;2-Q; Chinn S, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0556-x; COSTILL DL, 1971, J APPL PHYSIOL, V31, P834, DOI 10.1152/jappl.1971.31.6.834; CURZON G, 1974, BRIT J PHARMACOL, V50, P197, DOI 10.1111/j.1476-5381.1974.tb08562.x; Dadabhoy D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2443; DAVIS JM, 1995, INT J SPORT NUTR, V5, pS29, DOI 10.1123/ijsn.5.s1.s29; Dina OA, 2008, NEUROSCIENCE, V152, P521, DOI 10.1016/j.neuroscience.2008.01.006; Dina OA, 2011, EUR J PAIN, V15, P796, DOI 10.1016/j.ejpain.2011.02.005; Dina OA, 2010, J PAIN, V11, P369, DOI 10.1016/j.jpain.2009.08.007; Bote ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074524; Firk C, 2009, CLIN NUTR, V28, P266, DOI 10.1016/j.clnu.2009.03.002; Fischer S, 2016, PSYCHONEUROENDOCRINO, V63, P68, DOI 10.1016/j.psyneuen.2015.09.018; Forrest CM, 2004, FREE RADICAL RES, V38, P1167, DOI 10.1080/10715760400011437; Foster GD, 2003, NEW ENGL J MED, V348, P2082, DOI 10.1056/NEJMoa022207; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; FULLER RW, 1981, NEUROENDOCRINOLOGY, V32, P118, DOI 10.1159/000123142; Gibson EL, 2014, PSYCHOPHARMACOLOGY, V231, P4595, DOI 10.1007/s00213-014-3609-z; Hauser W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3002; Harbeck B, 2013, CLIN EXP RHEUMATOL, V31, pS16; Khasar SG, 2005, PAIN, V116, P79, DOI 10.1016/j.pain.2005.03.040; Lin CCJ, 2012, P NATL ACAD SCI USA, V109, pE76, DOI 10.1073/pnas.1108903108; Lopes KMDC, 2001, THESIS; Macfarlane GJ, 2017, ANN RHEUM DIS, V76, P318, DOI 10.1136/annrheumdis-2016-209724; Markus CR, 2002, AM J CLIN NUTR, V75, P1051, DOI 10.1093/ajcn/75.6.1051; Markus CR, 2000, AM J CLIN NUTR, V71, P1536; Martinov T., 2013, JOVE-J VIS EXP, V19, P51212; Mease P, 2005, J RHEUMATOL, V32, P6; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pietrelli A, 2018, NEUROBIOL LEARN MEM, V155, P528, DOI 10.1016/j.nlm.2018.05.007; Primola-Gomes TN, 2009, J APPL PHYSIOL, V107, P593, DOI 10.1152/japplphysiol.91218.2008; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Riva R, 2010, INT J BEHAV MED, V17, P223, DOI 10.1007/s12529-010-9097-6; Ross Rebecca L, 2010, Open Immunol J, V3, P9; Sanudo B, 2011, J REHABIL MED, V43, P521, DOI 10.2340/16501977-0814; Schmitt JAJ, 2005, J PSYCHOPHARMACOL, V19, P375, DOI 10.1177/0269881105053288; SELTZER S, 1983, J PSYCHIAT RES, V17, P181, DOI 10.1016/0022-3956(82)90020-6; SELTZER S, 1982, PAIN, V13, P385, DOI 10.1016/0304-3959(82)90007-0; Sharma NK, 2010, PHYS THER, V90, P714, DOI 10.2522/ptj.20090168; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Tak LM, 2011, BIOL PSYCHOL, V87, P183, DOI 10.1016/j.biopsycho.2011.02.002; White HD, 2015, INT IMMUNOPHARMACOL, V27, P244, DOI 10.1016/j.intimp.2015.05.020; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; YUNUS MB, 1992, J RHEUMATOL, V19, P90	47	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211824	10.1371/journal.pone.0211824	http://dx.doi.org/10.1371/journal.pone.0211824			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785911	gold, Green Submitted, Green Published			2022-12-26	WOS:000459307000041
J	Rosenberg, YJ; Lewis, GK; Montefiori, DC; LaBranche, CC; Lewis, MG; Urban, LA; Lees, JP; Mao, LJ; Jiang, XM				Rosenberg, Yvonne J.; Lewis, George K.; Montefiori, David C.; LaBranche, Celia C.; Lewis, Mark G.; Urban, Lori A.; Lees, Jonathan P.; Mao, Lingjun; Jiang, Xiaoming			Introduction of the YTE mutation into the non immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques	PLOS ONE			English	Article							BROADLY NEUTRALIZING ANTIBODIES; NEONATAL FC-RECEPTOR; MUCOSAL SHIV CHALLENGE; MONOCLONAL-ANTIBODIES; POTENT NEUTRALIZATION; HALF-LIFE; BINDING; PROTECTION; RECOGNITION; COMBINATION	Recombinant antibodies play increasingly important roles as immunotherapeutic treatments for human cancers as well as inflammatory and infectious diseases and have revolutionized their management. In addition, their therapeutic potential may be enhanced by the introduction of defined mutations in the crystallizable fragment (Fc) domains eg YTE (M252Y/S254T/T256E) and LS (M428UN434S), as a consequence of increased half-lives and prolonged duration of protection. However, the functional properties of any biologic may be compromised by unanticipated immunogenicity in humans, rendering them ineffective. Several potent broadly neutralizing HIV monoclonal antibodies (bnAbs) have been identified that protect against SHIV challenge in macaque models and reduce HIV viremia in HIV-infected individuals. In the present study, the pharmacokinetics and immunogenicity of one or more 5mg/kg subcutaneous (SC) injections in naive macaques of the HIV bnAb PGT121 and its PGT121-YTE mutant, both produced in plants, have been compared towards prolonging efficacy. Induction of anti-drug/anti-idiotypic antibodies (ADA, anti-id) has been monitored using both binding ELISAs and more functional inhibition of virus neutralization (ID50) assays. Timing of the anti-Id responses and their impact on pharmacokinetic profiles (clearance) and efficacy (protection) have also been assessed. The results indicate that ADA induction in naive macaques may result both from injection of the previously non immunogenic PGT121 into pre-primed animals and also by the introduction of the YTE mutation. Binding ADA antibody levels, induced in 7/10 macaques within two weeks of a first or second PGT121-YTE injection, were closely associated with both reduced pharmacokinetic profiles and loss of protection. However no correlation was observed with inhibitory ADA activity. These studies provide insights into both the structural features of bnAb and the immune status of the host which may contribute to the development of ADA in macaques and describe possible YTE-mediated changes in structure/orientation of HIV bnAbs that trigger such responses.	[Rosenberg, Yvonne J.; Urban, Lori A.; Lees, Jonathan P.; Mao, Lingjun; Jiang, Xiaoming] PlantVax Corp, Rockville, MD 20850 USA; [Lewis, George K.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Montefiori, David C.; LaBranche, Celia C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lewis, Mark G.] Bioqual Inc, Rockville, MD USA	University System of Maryland; University of Maryland Baltimore; Duke University; BIOQUAL Inc.	Rosenberg, YJ (corresponding author), PlantVax Corp, Rockville, MD 20850 USA.	yjr@plantvax.com			National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) [R44AI081621]; NIH/NIAID NHP Humoral Immunology Laboratory [HHSN27201100016C]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI124912, R44AI081621] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID NHP Humoral Immunology Laboratory; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	YR received funding from National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIAID) grant #R44AI081621, which provided support in the form of salaries for authors YR, XJ LU, LM and JL but had no additional role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. DM and CL were funded in part by NIH/NIAID NHP Humoral Immunology Laboratory Contract #HHSN27201100016C.	Barnes CO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03632-y; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Datta-Mannan A, 2012, MABS-AUSTIN, V4, P267, DOI 10.4161/mabs.4.2.19364; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Domachowske JB, 2018, PEDIATR INFECT DIS J, V37, P886, DOI [10.1097/inf.0000000000001916, 10.1097/INF.0000000000001916]; FDA Guidance for Industry, 2014, FDA GUID IND IMM ASS; Garces F, 2014, CELL, V159, P69, DOI 10.1016/j.cell.2014.09.009; Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2; Gristick HB, 2016, NAT STRUCT MOL BIOL, V23, P906, DOI 10.1038/nsmb.3291; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018; Klein F, 2012, NATURE, V492, P118, DOI 10.1038/nature11604; Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612; Kuo TT, 2011, MABS-AUSTIN, V3, P422, DOI 10.4161/mabs.3.5.16983; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Majumdar R, 2015, MABS-AUSTIN, V7, P84, DOI 10.4161/19420862.2014.985494; Martinez-Navio JM, 2016, MOL THER, V24, P76, DOI 10.1038/mt.2015.191; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Oganesyan V, 2014, J BIOL CHEM, V289, P7812, DOI 10.1074/jbc.M113.537563; Pejchal R, 2010, P NATL ACAD SCI USA, V107, P11483, DOI 10.1073/pnas.1004600107; R Core Team, 2013, R LANG ENV STAT COMP; Robbie GJ, 2013, ANTIMICROB AGENTS CH, V57, P6147, DOI 10.1128/AAC.01285-13; Rosenberg Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120451; Rosenberg Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058724; Rosenberg YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152760; ROUX KH, 1990, J IMMUNOL, V144, P1387; Scharf L, 2014, CELL REP, V7, P785, DOI 10.1016/j.celrep.2014.04.001; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shankar G, 2014, AAPS J, V16, P658, DOI 10.1208/s12248-014-9599-2; Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746; Shytaj IL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-71; Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111; Stoger E, 2014, ANNU REV PLANT BIOL, V65, P743, DOI 10.1146/annurev-arplant-050213-035850; Tan EM, 2016, J EXP MED, V213, P1937, DOI 10.1084/jem.20160792; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Walters BT, 2016, J BIOL CHEM, V291, P1817, DOI 10.1074/jbc.M115.691568; Wang XH, 2018, PROTEIN CELL, V9, P63, DOI 10.1007/s13238-017-0473-8; Wang YMC, 2016, AAPS J, V18, P395, DOI 10.1208/s12248-015-9857-y; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yu L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00250; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	51	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212649	10.1371/journal.pone.0212649	http://dx.doi.org/10.1371/journal.pone.0212649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785963	gold, Green Submitted, Green Published			2022-12-26	WOS:000459307000080
J	Akbib, S; Stichelmans, J; Stange, G; Ling, ZD; Assefa, Z; Hellemans, KH				Akbib, Sarah; Stichelmans, Jordy; Stange, Geert; Ling, Zhidong; Assefa, Zerihun; Hellemans, Karine H.			Glucocorticoids and checkpoint tyrosine kinase inhibitors stimulate rat pancreatic beta cell proliferation differentially	PLOS ONE			English	Article							MOLECULE GLUCOKINASE ACTIVATOR; IN-VITRO; DYRK1A; DEATH; AMELIORATION; INCREASES; EXPANSION; CAPACITY; SURVIVAL; THERAPY	Cell therapy for diabetes could benefit from the identification of small-molecule compounds that increase the number of functional pancreatic beta cells. Using a newly developed screening assay, we previously identified glucocorticoids as potent stimulators of human and rat beta cell proliferation. We now compare the stimulatory action of these steroid hormones to a selection of checkpoint tyrosine kinase inhibitors that were also found to activate the cell cycle-in beta cells and analyzed their respective effects on DNA-synthesis, beta cell numbers and expression of cell cycle regulators. Our data using glucocorticoids in combination with a receptor antagonist, mifepristone, show that 48h exposure is sufficient to allow beta cells to pass the cell cycle restriction point and to become committed to cell division regardless of sustained glucocorticoid-signaling. To reach the end-point of mitosis another 40h is required. Within 14 days glucocorticoids stimulate up to 75% of the cells to undergo mitosis, which indicates that these steroid hormones act as proliferation competence-inducing factors. In contrast, by correlating thymidine-analogue incorporation to changes in absolute cell numbers, we show that the checkpoint kinase inhibitors, as compared to glucocorticoids, stimulate DNA-synthesis only during a short time-window in a minority of cells, insufficient to give a measurable increase of beta cell numbers. Glucocorticoids, but not the kinase inhibitors, were also found to induce changes in the expression of checkpoint regulators. Our data, using checkpoint kinase-specific inhibitors further point to a role for Chk1 and Cdk1 in G1/S transition and progression of beta cells through the cell cycle upon stimulation with glucocorticoids.	[Akbib, Sarah; Stichelmans, Jordy; Stange, Geert; Ling, Zhidong; Assefa, Zerihun; Hellemans, Karine H.] Vrije Univ Brussel, Diabet Res Cluster, Unit Diabet Pathol & Therapy, Brussels, Belgium; [Ling, Zhidong] Univ Hosp Brussels, Beta Cell Bank, Brussels, Belgium; [Hellemans, Karine H.] Ctr Beta Cell Therapy Diabet, Brussels, Belgium	Vrije Universiteit Brussel; University Hospital Brussels	Hellemans, KH (corresponding author), Vrije Univ Brussel, Diabet Res Cluster, Unit Diabet Pathol & Therapy, Brussels, Belgium.; Hellemans, KH (corresponding author), Ctr Beta Cell Therapy Diabet, Brussels, Belgium.	Karine.Hellemans@vub.be	stange, geert m/C-1092-2009; Hellemans, Karine/B-7573-2013; stichelmans, jordy/HGB-7174-2022	stange, geert m/0000-0003-3148-1372; Hellemans, Karine/0000-0001-9306-4369; Stichelmans, Jordy/0000-0001-5884-321X	Research Foundation Flanders [FWO G0420-09]; Agency for Innovation by Science and Technology in Flanders (IWT) [IWT645]; Wetenschappelijk Fonds Willy Gepts -UZ Brussel (WFWG) [BOR16, BOR14]; European Commission [H2020-681070 BetaCellTherapy]; IWT [IWT121694]; IWT Postdoctoral Innovation Mandate [IWT 120717]; FWO; European Commission; Wetenschappelijk fonds Willy Gepts - UZ Brussel	Research Foundation Flanders(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Wetenschappelijk Fonds Willy Gepts -UZ Brussel (WFWG); European Commission(European CommissionEuropean Commission Joint Research Centre); IWT(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); IWT Postdoctoral Innovation Mandate; FWO(FWO); European Commission(European CommissionEuropean Commission Joint Research Centre); Wetenschappelijk fonds Willy Gepts - UZ Brussel	This study was supported by the Research Foundation Flanders (FWO G0420-09), the Agency for Innovation by Science and Technology in Flanders (IWT; IWT645), Wetenschappelijk Fonds Willy Gepts -UZ Brussel (WFWG; BOR16, BOR14) and the European Commission, (H2020-681070 BetaCellTherapy). S. A. is a recipient of an IWT PhD fellowship (IWT121694); Z.A. was recipient of an IWT Postdoctoral Innovation Mandate (IWT 120717). FWO http://www.fwo.be; IWT - https://www.vlaio.be; European Commission -https://ec.europa.eu/programmes/horizon2020/; Wetenschappelijk fonds Willy Gepts - UZ Brussel -www.uzbrussel.be. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank our collaborators for preparing quality-controlled rat and human beta cells and performing the immunochemical assays and characterizations and D. Pipeleers as director of the Diabetes Research Center and coordinator of the EC H2020 BetaCellTherapy program for supporting this work.	Aarts M, 2012, CANCER DISCOV, V2, P524, DOI 10.1158/2159-8290.CD-11-0320; Abdolazimi Y, 2018, ENDOCRINOLOGY, V159, P3143, DOI 10.1210/en.2018-00083; Agostino Nicole M, 2011, J Oncol Pharm Pract, V17, P197, DOI 10.1177/1078155210378913; Aguayo-Mazzucato C, 2017, CELL METAB; Annes JP, 2012, P NATL ACAD SCI USA, V109, P3915, DOI 10.1073/pnas.1201149109; Assefa Z, 2016, AM J PHYSIOL-ENDOC M, V311, pE698, DOI 10.1152/ajpendo.00070.2016; Assefa Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085174; Beaudry JL, 2012, DIABETES-METAB RES, V28, P560, DOI 10.1002/dmrr.2310; Benthuysen JR, 2016, J CLIN INVEST, V126, P3651, DOI 10.1172/JCI87439; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; Carrassa L, 2012, CELL CYCLE, V11, P2507, DOI 10.4161/cc.20899; Colvin ES, 2013, ENDOCRINOLOGY, V154, P1039, DOI 10.1210/en.2012-1923; Dadon D, 2012, OBES METAB, V14, P101; Del Nagro CJ, 2014, CELL CYCLE, V13, P303, DOI 10.4161/cc.27055; Dirice E, 2016, DIABETES, V65, P1660, DOI 10.2337/db15-1127; Dumortier O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025576; Fiaschi-Taesch NM, 2013, DIABETES, V62, P2450, DOI 10.2337/db12-0777; Fine NHF, 2018, DIABETES, V67, P278, DOI 10.2337/db16-1356; Fransson L, 2013, J ENDOCRINOL, V219, P231, DOI 10.1530/JOE-13-0189; Gesina E, 2006, DIABETOLOGIA, V49, P2939, DOI 10.1007/s00125-006-0449-3; Ghazalli N, 2018, STEM CELLS DEV, V27, P898, DOI 10.1089/scd.2017.0160; Hagerkvist R, 2007, FASEB J, V21, P618, DOI 10.1096/fj.06-6910com; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; Han MS, 2009, DIABETES, V58, P329, DOI 10.2337/db08-0080; Hija A, 2014, DIABETES, V63, P578, DOI 10.2337/db12-1035; Karunakaran U, 2015, CELL SIGNAL, V27, P1066, DOI 10.1016/j.cellsig.2015.01.018; King AJF, 2016, UPSALA J MED SCI, V121, P140, DOI 10.3109/03009734.2016.1151090; Kiyosue A, 2013, DIABETES OBES METAB, V15, P923, DOI 10.1111/dom.12100; Kumar K, 2018, EUR J MED CHEM, V157, P1005, DOI 10.1016/j.ejmech.2018.08.007; Lee YC, 2009, MOL CELL ENDOCRINOL, V297, P18, DOI 10.1016/j.mce.2008.08.033; LING ZD, 1994, ENDOCRINOLOGY, V134, P2614, DOI 10.1210/en.134.6.2614; Ling ZD, 1996, J CLIN INVEST, V98, P2805, DOI 10.1172/JCI119108; Louvet C, 2008, P NATL ACAD SCI USA, V105, P18895, DOI 10.1073/pnas.0810246105; Ma X, 2017, ACTA BIOCH BIOPH SIN, V49, P298; Magnussen GI, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1474-8; Malek R, 2016, EXPERT OPIN INV DRUG, V25, P287, DOI 10.1517/13543784.2016.1142531; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mokhtari D, 2013, DIABETOLOGIA, V56, P1327, DOI 10.1007/s00125-013-2868-2; Nakamura A, 2012, DIABETOLOGIA, V55, P1745, DOI 10.1007/s00125-012-2521-5; Nakamura A, 2009, ENDOCRINOLOGY, V150, P1147, DOI 10.1210/en.2008-1183; Ono K, 2012, INTERNAL MED, V51, P2763, DOI 10.2169/internalmedicine.51.8314; Otto T, 2017, NAT REV CANCER, V17, P93, DOI 10.1038/nrc.2016.138; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P806, DOI 10.1210/endo-117-3-806; Pozzilli P, 2015, NAT REV ENDOCRINOL, V11, P289, DOI 10.1038/nrendo.2015.8; Prada PO, 2013, EXPERT OPIN INV DRUG, V22, P751, DOI 10.1517/13543784.2013.802768; Rachdi L, 2014, CELL CYCLE, V13, P2221, DOI 10.4161/cc.29250; Rafacho A, 2010, ACTA PHYSIOL, V200, P223, DOI 10.1111/j.1748-1716.2010.02146.x; Rafacho A, 2009, AM J PHYSIOL-ENDOC M, V296, pE681, DOI 10.1152/ajpendo.90931.2008; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Ranta F, 2006, DIABETES, V55, P1380, DOI 10.2337/db05-1220; Rieck S, 2012, MOL ENDOCRINOL, V26, P1590, DOI 10.1210/me.2012-1019; Robitaille K, 2016, J BIOL CHEM, V291, P4614, DOI 10.1074/jbc.M115.683912; Rojas J, 2015, J PANCREAS, V16, P11, DOI 10.6092/1590-8577/2893; Saunders D, 2016, J AUTOIMMUN, V71, P59, DOI 10.1016/j.jaut.2016.03.014; Shen WJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9372; Shirakawa J, 2013, DIABETES, V62, P3448, DOI 10.2337/db13-0052; Stange G, 2003, DIABETES MELLIT, V83, P015; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Stolovich-Rain M, 2012, J BIOL CHEM, V287, P27407, DOI 10.1074/jbc.M112.350736; Tamura K, 2015, JPN J CLIN ONCOL, V45, P1097, DOI 10.1093/jjco/hyv131; Tiwari S, 2015, DIABETES, V64, P3485, DOI 10.2337/db14-1885; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Tsuji N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104112; Valtat B, 2011, DIABETOLOGIA, V54, P350, DOI 10.1007/s00125-010-1898-2; VANDEWINKEL M, 1983, BIOCHEM BIOPH RES CO, V114, P835, DOI 10.1016/0006-291X(83)90857-4; Wang P, 2018, CELL METAB; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Zhao Z, 2014, MOL ENDOCRINOL, V28, P1682, DOI 10.1210/me.2014-1120	69	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212210	10.1371/journal.pone.0212210	http://dx.doi.org/10.1371/journal.pone.0212210			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779812	gold, Green Published, Green Submitted			2022-12-26	WOS:000459062900033
J	Wang, YC; Li, X; Liu, W; Li, BJ; Chen, DQ; Hu, FP; Wang, LZ; Liu, XGM; Cui, RJ; Liu, RH				Wang, Yicun; Li, Xin; Liu, Wei; Li, Bingjin; Chen, Dongquan; Hu, Fengping; Wang, Lizhong; Liu, Xiaoguang M.; Cui, Ranji; Liu, Runhua			MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer	ONCOGENE			English	Article							GENOME-WIDE ASSOCIATION; LONG-RANGE INTERACTION; IN-SITU HYBRIDIZATION; PROLYL HYDROXYLASE; NEURONAL APOPTOSIS; C-MYC; PROMOTES; BREAST; EXPRESSION; GENES	The chromosome 8q24.21 locus, which contains the proto-oncogene c-MYC, long non-coding RNA PVT1, and microRNAs (miRs), is the most commonly amplified region in human prostate cancer. A long-range interaction of genetic variants with c-MYC or long non-coding PVT1 at this locus contributes to the genetic risk of prostate cancer. At this locus is a cluster of genes for six miRs (miR-1204, -1205, -1206, -1207-3p, -1207-5p, and -1208), but their functional role remains elusive. Here the copy numbers and expression levels of miRs-1204-1208 were investigated using quantitative PCR for prostate cancer cell lines and primary tumors. The data revealed that copy numbers and expression of miR-1205 were increased in both castration-resistant prostate cancer cell lines and in primary tumors. In castration-resistant prostate cancer specimens, the copy number at the miR-1205 locus correlated with the expression of miR-1205. Furthermore, functional analysis with an miR-1205 mimic, an miR-1205 inhibitor, and CRISPR/Cas9 knockout revealed that, in human prostate cancer cells, miR-1205 promoted cell proliferation and cell cycle progression and inhibited hydrogen peroxide-induced apoptosis. In these cells, miR-1205 downregulated the expression of the Egl-9 family hypoxia inducible factor 3(EGLN3) gene and targeted a site in its 3'-untranslated region to downregulate its transcriptional activity. Thus, by targeting EGLN3, miR-1205 has an oncogenic role and may contribute to the genetic risk of castration-resistant prostate cancer.	[Wang, Yicun; Li, Xin; Liu, Wei; Li, Bingjin; Cui, Ranji] Jilin Univ, Prov Key Lab Mol & Chem Genet, Hosp 2, Changchun, Jilin, Peoples R China; [Wang, Yicun; Li, Xin; Liu, Wei; Hu, Fengping; Wang, Lizhong; Liu, Runhua] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Chen, Dongquan] Univ Alabama Birmingham, Div Prevent Med, Birmingham, AL USA; [Chen, Dongquan; Wang, Lizhong; Liu, Runhua] Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA; [Liu, Xiaoguang M.] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL USA	Jilin University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Cui, RJ (corresponding author), Jilin Univ, Prov Key Lab Mol & Chem Genet, Hosp 2, Changchun, Jilin, Peoples R China.; Liu, RH (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.; Liu, RH (corresponding author), Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL 35294 USA.	cuiranji@jlu.edu.cn; runhua@uab.edu	cui, ranji/AAV-6234-2021	Wang, Yicun/0000-0001-6497-3387; Liu, Xiaoguang (Margaret)/0000-0002-4617-9750	National Institutes of Health/National Cancer Institute [CA118948, CA179282, CA013148]; Department of Defense [BC160808, PC130594, PC140308]; Mike Slive Foundation for Prostate Cancer Research; Natural Science Foundation of China [31571126, 31571342, 81772757]; NATIONAL CANCER INSTITUTE [P30CA013148, U54CA118638, U54CA118948] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Mike Slive Foundation for Prostate Cancer Research; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Donald L Hill for editorial assistance in preparing this manuscript. This work was supported by grants from the National Institutes of Health/National Cancer Institute (CA118948, CA179282, and CA013148 to LW and RL), the Department of Defense (BC160808, PC130594, and PC140308 to LW and RL), the Mike Slive Foundation for Prostate Cancer Research (to LW), and the Natural Science Foundation of China (Nos. 31571126, 31571342, and 81772757 to XL, BL, and RC). Results are based, in part, on data generated by the TCGA Research Network: http://ca ncergenome. nih. gov/.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; [Anonymous], 2018, CANCER DISCOV, V8, pOF15; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Bawa P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122143; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; CHER ML, 1994, GENE CHROMOSOME CANC, V11, P153, DOI 10.1002/gcc.2870110304; Cho SW, 2018, CELL, V173, P1398, DOI 10.1016/j.cell.2018.03.068; Das DK, 2016, EXP CELL RES, V348, P190, DOI 10.1016/j.yexcr.2016.09.021; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fu J, 2013, MOL CELL BIOL, V33, P3050, DOI 10.1128/MCB.00273-13; Gao S, 2017, ONCOTARGET, V8, P41451, DOI 10.18632/oncotarget.17816; Garvalov BK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6577; Gerber SA, 2009, ARTERIOSCL THROM VAS, V29, P1363, DOI 10.1161/ATVBAHA.109.192542; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Henze AT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6582; Hogel H, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0410-5; Hogel H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027112; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kim T, 2014, P NATL ACAD SCI USA, V111, P4173, DOI 10.1073/pnas.1400350111; Lapointe J, 2007, CANCER RES, V67, P8504, DOI 10.1158/0008-5472.CAN-07-0673; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; Liu RH, 2015, CANCER RES, V75, P1714, DOI 10.1158/0008-5472.CAN-14-2109; Liu RH, 2015, CANCER RES, V75, P1703, DOI 10.1158/0008-5472.CAN-14-2108; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Liu XY, 2018, ONCOGENE, V37, P3426, DOI 10.1038/s41388-018-0215-2; Luo WB, 2014, MOL BIOL CELL, V25, P2788, DOI 10.1091/mbc.E14-02-0775; Luo YZ, 2018, J CANCER, V9, P1096, DOI 10.7150/jca.23909; Ma Lijiang, 2014, Curr Protoc Hum Genet, V80, DOI 10.1002/0471142905.hg0721s80; Madden SL, 1996, CANCER RES, V56, P5384; Meyer KB, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002165; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Peng XW, 2015, CANCER BIOL THER, V16, P261, DOI 10.1080/15384047.2014.1001287; Place TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014617; Riquelme E, 2014, J THORAC ONCOL, V9, P998, DOI 10.1097/JTO.0000000000000202; Rodriguez J, 2018, CELL REP, V24, P1316, DOI 10.1016/j.celrep.2018.06.108; Sato H, 2006, INT J UROL, V13, P761, DOI 10.1111/j.1442-2042.2006.01399.x; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Schlisio S, 2009, J CELL MOL MED, V13, P4104, DOI 10.1111/j.1582-4934.2009.00881.x; Shi HL, 2015, ONCOL REP, V33, P1185, DOI 10.3892/or.2014.3695; Shi YX, 2017, MED SCI MONITOR, V23, P2042, DOI 10.12659/MSM.901191; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Tang JM, 2018, ONCOGENE, V37, P4723, DOI 10.1038/s41388-018-0310-4; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; VANDENBERG C, 1995, CLIN CANCER RES, V1, P11; Vergara R, 2012, J EXP BOT, V63, P4123, DOI 10.1093/jxb/ers094; VISAKORPI T, 1995, CANCER RES, V55, P342; Wang LZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6909; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; WEIJERMAN PC, 1994, CANCER RES, V54, P5579; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu GY, 2015, ONCOTARGET, V6, P28882, DOI 10.18632/oncotarget.4921; Yan C, 2017, CANCER SCI, V108, P868, DOI 10.1111/cas.13212; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang GX, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0858-x; Zhang W, 2016, CLIN CANCER RES, V22, P2545, DOI 10.1158/1078-0432.CCR-15-1927; Zhao J, 2018, ONCOGENE, V37, P4094, DOI 10.1038/s41388-018-0250-z	64	28	29	1	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4820	4834		10.1038/s41388-019-0760-3	http://dx.doi.org/10.1038/s41388-019-0760-3			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30808975	Green Accepted			2022-12-26	WOS:000471160500012
J	Zhang, XD; Xie, XT; Heckmann, BL; Saarinen, AM; Gu, HW; Zechner, R; Liu, J				Zhang, Xiaodong; Xie, Xitao; Heckmann, Bradlee L.; Saarinen, Alicia M.; Gu, Haiwei; Zechner, Rudolf; Liu, Jun			Identification of an intrinsic lysophosphatidic acid acyltransferase activity in the lipolytic inhibitor G(0)/G(1) switch gene 2 (G0S2)	FASEB JOURNAL			English	Article						LPA acyltransferase; fatty liver disease; hepatic steatosis; lipolysis; lipogenesis	ADIPOSE TRIGLYCERIDE LIPASE; FATTY LIVER-DISEASE; TRIACYLGLYCEROL LIPASE; MOLECULAR-MECHANISMS; MEDIATED LIPOLYSIS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; LIPID-METABOLISM; X-RECEPTOR; MICE	G(0)/G(1) switch gene 2 (G0S2) is a specific inhibitor of adipose triglyceride lipase (ATGL), the rate-limiting enzyme for intracellular lipolysis. Recent studies show that G0S2 plays a critical role in promoting triacylglycerol (TG) accumulation in the liver, and its encoding gene is a direct target of a major lipogenic transcription factor liver X receptor (LXR). Here we sought to investigate a lipolysis-independent role of G0S2 in hepatic triglyceride synthesis. Knockdown of G0S2 decreased hepatic TG content in mice with ATGL ablation. Conversely, overexpression of G0S2 promoted fatty acid incorporation into TGs and diacylglycerols in both wild-type and ATGL-deficient hepatocytes. Biochemical characterization showed that G0S2 mediates phosphatidic acid synthesis from lysophosphatidic acid (LPA) and acyl-coenzyme A. In response to a high-sucrose lipogenic diet, G0S2 is up-regulated via LXR and required for the increased TG accumulation in liver. Furthermore, deletion of a distinct 4-aa motif necessary for the LPA-specific acyltransferase (LPAAT) activity impaired G0S2's ability to mediate TG synthesis both in vitro and in vivo. These studies identify G0S2 as a dual-function regulator of lipid metabolism as well as a novel mechanism whereby hepatic TG storage is promoted in response to lipogenic stimulation. In addition to its role as a lipolytic inhibitor, G0S2 is capable of directly promoting TG synthesis by acting as a lipid-synthesizing enzyme.Zhang, X., Xie, X., Heckmann, B. L., Saarinen, A. M., Gu, H., Zechner, R., Liu, J. Identification of an intrinsic lysophosphatidic acid acyltransferase activity in the lipolytic inhibitor G(0)/G(1) switch gene 2 (G0S2).	[Zhang, Xiaodong; Saarinen, Alicia M.; Liu, Jun] Mayo Clin, Coll Med & Sci, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Liu, Jun] Mayo Clin, Coll Med & Sci, Div Endocrinol, Rochester, MN 55905 USA; [Xie, Xitao] Arizona State Univ, Dept Chem Engn, Tempe, AZ USA; [Heckmann, Bradlee L.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Gu, Haiwei] Arizona State Univ, Coll Hlth Solut, Ctr Metab & Vasc Biol, Scottsdale, AZ USA; [Zechner, Rudolf] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria	Mayo Clinic; Mayo Clinic; Arizona State University; Arizona State University-Tempe; St Jude Children's Research Hospital; Arizona State University; University of Graz	Liu, J (corresponding author), Mayo Clin, Coll Med & Sci, Guggenheim Bldg 14-05,222 3rd Ave SW, Rochester, MN 55905 USA.	liu.jun@mayo.edu		Heckmann, Bradlee/0000-0002-3271-7183	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK089178, DK109096]; Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK109096] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Mayo Foundation for Medical Education and Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the West Coast Metabolomics Center (University of California-Davis, Davis, CA, USA) for expertise and assistance in lipid profiling. This work was supported by research grants from the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (DK089178 and DK109096 to J.L.), as well as predoctoral funding to B.L.H. from the Mayo Foundation for Medical Education and Research. The authors declare no conflicts of interest.	Agarwal AK, 2002, NAT GENET, V31, P21, DOI 10.1038/ng880; Agarwal AK, 2011, J BIOL CHEM, V286, P37676, DOI 10.1074/jbc.M111.250449; Anthonisen EH, 2010, J BIOL CHEM, V285, P1607, DOI 10.1074/jbc.M109.082685; Barrows BR, 2005, DIABETES, V54, P2668, DOI 10.2337/diabetes.54.9.2668; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Cerk IK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602599; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chen WQ, 2010, HEPATOLOGY, V52, P1134, DOI 10.1002/hep.23812; Chen ZJ, 2000, J BIOL CHEM, V275, P32807, DOI 10.1074/jbc.M004913200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Cortes VA, 2009, CELL METAB, V9, P165, DOI 10.1016/j.cmet.2009.01.002; Eberhardt C, 1997, J BIOL CHEM, V272, P20299, DOI 10.1074/jbc.272.32.20299; El-Assaad W, 2015, DIABETOLOGIA, V58, P149, DOI 10.1007/s00125-014-3429-z; Girousse A, 2012, INT J OBESITY, V36, P581, DOI 10.1038/ijo.2011.113; Green CJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE1, DOI 10.1152/ajpendo.00192.2014; Guo F, 2013, J LIPID RES, V54, P2109, DOI 10.1194/jlr.M035519; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Heckmann BL, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.88735; Hollenback D, 2006, J LIPID RES, V47, P593, DOI 10.1194/jlr.M500435-JLR200; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kato M, 2008, SCAND J GASTROENTERO, V43, P1018, DOI 10.1080/00365520802008140; Kumari M, 2012, CELL METAB, V15, P691, DOI 10.1016/j.cmet.2012.04.008; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Liu J, 2005, J BIOL CHEM, V280, P1432, DOI 10.1074/jbc.M409740200; Lou-Bonafonte JM, 2011, CURR OPIN LIPIDOL, V22, P159, DOI 10.1097/MOL.0b013e3283462288; Ma T, 2014, CANCER BIOL THER, V15, P643, DOI 10.4161/cbt.28251; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; Mashek DG, 2015, HEPATOLOGY, V62, P964, DOI 10.1002/hep.27839; McMahon D, 2014, J LIPID RES, V55, P1750, DOI 10.1194/jlr.M051151; Miyazaki M, 2001, J LIPID RES, V42, P1018; Ong KT, 2011, HEPATOLOGY, V53, P116, DOI 10.1002/hep.24006; Petta S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122082; Reid BN, 2008, J BIOL CHEM, V283, P13087, DOI 10.1074/jbc.M800533200; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Schreiber R, 2015, P NATL ACAD SCI USA, V112, P13850, DOI 10.1073/pnas.1516004112; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Schweitzer GG, 2015, J LIPID RES, V56, P848, DOI 10.1194/jlr.M055962; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Turpin SM, 2011, DIABETOLOGIA, V54, P146, DOI 10.1007/s00125-010-1895-5; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wu JW, 2011, HEPATOLOGY, V54, P122, DOI 10.1002/hep.24338; Yamashita Atsushi, 2014, Biology (Basel), V3, P801, DOI 10.3390/biology3040801; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zhang XD, 2014, DIABETES, V63, P934, DOI 10.2337/db13-1422; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	49	11	11	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6655	6666		10.1096/fj.201802502R	http://dx.doi.org/10.1096/fj.201802502R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802154	Green Published, Bronze			2022-12-26	WOS:000466932600067
J	Chatterjee, BK; Jayaraj, A; Kumar, V; Blagg, B; Davis, RE; Jayaram, B; Deep, S; Chaudhuri, TK				Chatterjee, Bhaskar K.; Jayaraj, Abhilash; Kumar, Vinay; Blagg, Brian; Davis, Rachel E.; Jayaram, B.; Deep, Shashank; Chaudhuri, Tapan K.			Stimulation of heat shock protein 90 chaperone function through binding of a novobiocin analog KU-32	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						molecular chaperone; heat shock protein 90 (Hsp90); molecular dynamics; conformational change; protein-drug interaction; allosteric modulation; chaperone-assisted protein folding; KU-32; novobiocin; neuropathy	MOLECULAR-DYNAMICS; HSP90 INHIBITOR; ATP HYDROLYSIS; COMPUTATIONAL PROTOCOL; CANCER-CELLS; NUCLEOTIDE; AGGREGATION; AFFINITIES; DOCKING; CYCLE	Heat shock protein 90 (Hsp90) is a eukaryotic chaperone responsible for the folding and functional activation of numerous client proteins, many of which are oncoproteins. Thus, Hsp90 inhibition has been intensely pursued, resulting in the development of many potential Hsp90 inhibitors, not all of which are well-characterized. Hsp90 inhibitors not only abrogate its chaperone functions, but also could help us gain insight into the structure-function relationship of this chaperone. Here, using biochemical and cell-based assays along with isothermal titration calorimetry, we investigate KU-32, a derivative of the Hsp90 inhibitor novobiocin (NB), for its ability to modulate Hsp90 chaperone function. Although NB and KU-32 differ only slightly in structure, we found that upon binding, they induce completely opposite conformational changes in Hsp90. We observed that NB and KU-32 both bind to the C-terminal domain of Hsp90, but surprisingly, KU-32 stimulated the chaperone functions of Hsp90 via allosteric modulation of its N-terminal domain, responsible for the chaperone's ATPase activity. In vitro and in silico studies indicated that upon KU-32 binding, Hsp90 undergoes global structural changes leading to the formation of a partially closed intermediate that selectively binds ATP and increases ATPase activity. We also report that KU-32 promotes HeLa cell survival and enhances the refolding of an Hsp90 substrate inside the cell. This discovery explains the effectiveness of KU-32 analogs in the management of neuropathies and may facilitate the design of molecules that promote cell survival by enhancing Hsp90 chaperone function and reducing the load of misfolded proteins in cells.	[Chatterjee, Bhaskar K.; Chaudhuri, Tapan K.] Indian Inst Technol Delhi, Kusuma Sch Biol Sci, Hauz Khas, New Delhi 110016, India; [Jayaraj, Abhilash; Jayaram, B.] Indian Inst Technol Delhi, Supercomp Facil Bioinformat & Computat Biol, Hauz Khas, New Delhi 110016, India; [Kumar, Vinay; Deep, Shashank] Indian Inst Technol Delhi, Dept Chem, Hauz Khas, New Delhi 110016, India; [Blagg, Brian; Davis, Rachel E.] Univ Kansas, Dept Med Chem, Lawrence, KS 66045 USA; [Kumar, Vinay] Indian Inst Technol Delhi, Clensta Int Private Ltd, FITT BBIF Bldg,Hauz Khas, New Delhi 110016, India; [Blagg, Brian; Davis, Rachel E.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46554 USA	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Kansas; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Delhi; University of Notre Dame	Chaudhuri, TK (corresponding author), Indian Inst Technol Delhi, Kusuma Sch Biol Sci, Hauz Khas, New Delhi 110016, India.	tkchaudhuri@bioschool.iitd.ac.in	Chatterjee, Bhaskar Kumar/AAZ-5204-2021; blagg, brian s j/X-7770-2018; Davis, Rachel/P-5448-2017	Chatterjee, Bhaskar Kumar/0000-0003-2626-5763; blagg, brian s j/0000-0002-6200-3480; Jayaram, B/0000-0002-5495-2213; Davis, Rachel/0000-0003-0359-381X	Indian Institute of Technology (Delhi, India); Kusuma Trust	Indian Institute of Technology (Delhi, India); Kusuma Trust	B. K. C. and T. K. C. thank Prof. Johannes Buchner and Dr. William Kaelin Jr. for providing the Hsp90 beta and firefly luciferase plasmids, respectively, and for answering certain queries related to this work. The authors would also like to thank Jon Tally for carefully reading the manuscript and providing valuable suggestions. B. K. C. thanks Harsha Rohira and Ashutosh Pastor for constant support, encouragement, andtechnical advice. B. K. C., A. J., V. K., B. J., S. D., and T. K. C. thank the Indian Institute of Technology (Delhi, India) and Kusuma Trust for their financial support and for providing the infrastructure required to execute this project.	Ahsan A, 2012, NEOPLASIA, V14, P670, DOI 10.1593/neo.12986; Ansar S, 2007, BIOORG MED CHEM LETT, V17, P1984, DOI 10.1016/j.bmcl.2007.01.017; Bagatell R, 2004, MOL CANCER THER, V3, P1021; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cohen SM, 2012, ANN SURG ONCOL, V19, pS483, DOI 10.1245/s10434-011-1971-1; Colombo G, 2008, P NATL ACAD SCI USA, V105, P7976, DOI 10.1073/pnas.0802879105; Cunningham CN, 2008, J BIOL CHEM, V283, P21170, DOI 10.1074/jbc.M800046200; Daturpalli S, 2013, J MOL BIOL, V425, P4614, DOI 10.1016/j.jmb.2013.08.006; Didenko T, 2012, BBA-MOL CELL RES, V1823, P636, DOI 10.1016/j.bbamcr.2011.11.009; Donnelly A, 2008, CURR MED CHEM, V15, P2702, DOI 10.2174/092986708786242895; Eskew JD, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-468; Farmer K, 2012, EXP DIABETES RES, DOI 10.1155/2012/671673; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Frisch M.J., 2016, GAUSSIAN 16 REVISION; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; Hiss DC, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-5; Jain T, 2005, FEBS LETT, V579, P6659, DOI 10.1016/j.febslet.2005.10.031; Jain T, 2007, PROTEINS, V67, P1167, DOI 10.1002/prot.21332; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Krukenberg KA, 2009, J MOL BIOL, V390, P278, DOI 10.1016/j.jmb.2009.04.080; Lee Samuel M, 2012, Commun Integr Biol, V5, P107; Li J, 2012, ACTA BIOCH BIOPH SIN, V44, P300, DOI 10.1093/abbs/gms001; Li PF, 2016, J CHEM INF MODEL, V56, P599, DOI 10.1021/acs.jcim.5b00674; Lotz GP, 2008, J CELL SCI, V121, P717, DOI 10.1242/jcs.015610; Maiti P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/495091; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; Marcu MG, 2000, J BIOL CHEM, V275, P37181, DOI 10.1074/jbc.M003701200; Matts RL, 2011, ACS CHEM BIOL, V6, P800, DOI 10.1021/cb200052x; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Owen BAL, 2002, J BIOL CHEM, V277, P7086, DOI 10.1074/jbc.M111450200; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pratt WB, 2015, ANNU REV PHARMACOL, V55, P353, DOI 10.1146/annurev-pharmtox-010814-124332; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Richter K, 2006, J BIOL CHEM, V281, P11301, DOI 10.1074/jbc.M510142200; Richter K, 2001, J BIOL CHEM, V276, P33689, DOI 10.1074/jbc.M103832200; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Safran M, 2006, P NATL ACAD SCI USA, V103, P105, DOI 10.1073/pnas.0509459103; Shelton SN, 2009, MOL PHARMACOL, V76, P1314, DOI 10.1124/mol.109.058545; Singh T, 2015, MOL BIOSYST, V11, P1041, DOI 10.1039/c5mb00003c; Solarova Z, 2015, INT J ONCOL, V46, P907, DOI 10.3892/ijo.2014.2791; Soti C, 2003, EUR J BIOCHEM, V270, P2421, DOI 10.1046/j.1432-1033.2003.03610.x; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Vital A, 2014, J PERIPHER NERV SYST, V19, P44, DOI 10.1111/jns5.12056; Wang J, 2014, AMBER14 REFERENCE MA; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157; Xu WP, 2005, NAT STRUCT MOL BIOL, V12, P120, DOI 10.1038/nsmb885; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; Yu XM, 2005, J AM CHEM SOC, V127, P12778, DOI 10.1021/ja0535864; Zhang HQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09542; Zhang XY, 2018, ACS CHEM NEUROSCI, V9, P381, DOI 10.1021/acschemneuro.7b00377; Zhao HP, 2012, ACS MED CHEM LETT, V3, P327, DOI 10.1021/ml300018e	56	6	6	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6450	6467		10.1074/jbc.RA118.002502	http://dx.doi.org/10.1074/jbc.RA118.002502			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792306	hybrid, Green Published			2022-12-26	WOS:000468402000022
J	Miao, R; Lung, SC; Li, X; Li, XD; Chye, ML				Miao, Rui; Lung, Shiu-Cheung; Li, Xin; Li, Xiang David; Chye, Mee-Len			Thermodynamic insights into an interaction between ACYL-CoA-BINDING PROTEIN2 and LYSOPHOSPHOLIPASE2 in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						lysophospholipid; thermodynamics; isothermal titration calorimetry (ITC); enzyme mutation; structural model; molecular docking; ankyrin; lipid metabolism; lysophosphatidylcholine; protein-protein interaction	CATALYTIC TRIAD; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; NITRIC-OXIDE; HEAVY-METAL; CADMIUM; GENE; EXPRESSION; TOLERANCE; LIPASE	Lysophospholipids (LPLs) are important lipid-signaling molecules in plants, of which lysophosphatidylcholine (lysoPC) is one of the most well-characterized LPLs, having important roles in plant stress responses. It is broken down by lysophospholipases, but the molecular mechanism involved in lysoPC degradation is unclear. Recombinant Arabidopsis thaliana ACYL-CoA-BINDING PROTEIN2 (AtACBP2) has been reported to bind lysoPC via its acyl-CoA-binding domain and also LYSOPHOSPHOLIPASE 2 (AtLYSOPL2) via its ankyrin repeats in vitro. To investigate the interactions of AtACBP2 with AtLYSOPL2 and lysoPC in more detail, we conducted isothermal titration calorimetry with AtACBP2(70-354), an AtACBP2 derivative consisting of amino acids 70-354, containing both the acyl-CoA-binding domain and ankyrin repeats. We observed that the interactions of AtACBP2(70-354) with AtLYSOPL2 and lysoPC were both endothermic, favored by solvation entropy and opposed by enthalpy, with dissociation constants in the micromolar range. Of note, three AtLYSOPL2 catalytic triad mutant proteins (S147A, D268A, and H298A) bound lysoPC only weakly, with an exothermic burst and dissociation constants in the millimolar range. Furthermore, the binding affinity of lysoPC-premixed AtACBP2(70-354) to AtLYSOPL2 was 10-fold higher than that of AtACBP2(70-354) alone to AtLYSOPL2. We conclude that AtACBP2 may play a role in facilitating a direct interaction between AtLYSOPL2 and lysoPC. Our results suggest that AtACBP2(70-354) probably binds to lysoPC through a hydrophobic interface that enhances a hydrotropic interaction of AtACBP2(70-354) with AtLYSOPL2 and thereby facilitates AtLYSOPL2's lysophospholipase function.	[Miao, Rui; Lung, Shiu-Cheung; Chye, Mee-Len] Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China; [Li, Xin; Li, Xiang David] Univ Hong Kong, Dept Chem, Pokfulam Rd, Hong Kong, Peoples R China; [Chye, Mee-Len] Chinese Univ Hong Kong, State Key Lab Agrobiotechnol, Shatin, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong	Chye, ML (corresponding author), Univ Hong Kong, Sch Biol Sci, Pokfulam Rd, Hong Kong, Peoples R China.	mlchye@hku.hk	Lung, Shiu-Cheung/I-6597-2019; Li, Xin/X-5971-2018; Li, Xin/U-2944-2019; Li, Xiang/ABG-9385-2020; Miao, Rui/AAD-4159-2020	Lung, Shiu-Cheung/0000-0002-6433-4988; Li, Xin/0000-0001-9698-1883; Li, Xin/0000-0001-9698-1883; Li, Xiang/0000-0002-2797-4134; Miao, Rui/0000-0003-0956-6310	Wilson and Amelia Wong Endowment Fund; Research Grants Council of the Hong Kong Special Administrative Region, China [17101818, AoE/M-05/12, AoE/M-403/16]; Innovation Technology Fund of the Innovation Technology Commission	Wilson and Amelia Wong Endowment Fund; Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Innovation Technology Fund of the Innovation Technology Commission	This work was supported by the Wilson and Amelia Wong Endowment Fund, Research Grants Council of the Hong Kong Special Administrative Region, China, Grants 17101818, AoE/M-05/12, and AoE/M-403/16, and Innovation Technology Fund of the Innovation Technology Commission (Funding Support to State Key Laboratory of Agrobiotechnology in Hong Kong). The authors declare that they have no conflicts of interest with the contents of this article.	Abdullah N, 2014, BIOPHYS J, V106, P382, DOI 10.1016/j.bpj.2013.11.4492; ASAOKA Y, 1992, P NATL ACAD SCI USA, V89, P6447, DOI 10.1073/pnas.89.14.6447; Bertrand T, 2010, J MOL BIOL, V396, P663, DOI 10.1016/j.jmb.2009.11.060; Clemens S, 2006, BIOCHIMIE, V88, P1707, DOI 10.1016/j.biochi.2006.07.003; Clemens S, 2016, ANNU REV PLANT BIOL, V67, P489, DOI 10.1146/annurev-arplant-043015-112301; D'Arrigo P, 2010, MOLECULES, V15, P1354, DOI 10.3390/molecules15031354; DalCorso G, 2008, J INTEGR PLANT BIOL, V50, P1268, DOI 10.1111/j.1744-7909.2008.00737.x; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; De Michele R, 2009, PLANT PHYSIOL, V150, P217, DOI 10.1104/pp.108.133397; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Fong YH, 2011, J BIOL CHEM, V286, P43241, DOI 10.1074/jbc.M111.296830; Gao W, 2009, NEW PHYTOL, V181, P89, DOI 10.1111/j.1469-8137.2008.02631.x; Gao W, 2010, PLANT J, V62, P989, DOI 10.1111/j.1365-313X.2010.04209.x; Grechkin A, 1998, PROG LIPID RES, V37, P317, DOI 10.1016/S0163-7827(98)00014-9; Gutierrez-Fernandez J, 2014, J STRUCT BIOL, V187, P215, DOI 10.1016/j.jsb.2014.07.007; Hariharan P, 2015, P NATL ACAD SCI USA, V112, P2407, DOI 10.1073/pnas.1500891112; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hong YW, 2000, P NATL ACAD SCI USA, V97, P8717, DOI 10.1073/pnas.140213697; Hsu KH, 2010, J APPL MICROBIOL, V108, P1712, DOI 10.1111/j.1365-2672.2009.04569.x; Ishiguro S, 2001, PLANT CELL, V13, P2191, DOI 10.1105/tpc.13.10.2191; Karlsson M, 1997, J BIOL CHEM, V272, P27218, DOI 10.1074/jbc.272.43.27218; Kawaguchi M, 2011, J AM CHEM SOC, V133, P12021, DOI 10.1021/ja201028t; Khairnar NP, 2013, J BACTERIOL, V195, P2880, DOI 10.1128/JB.01503-12; Kim RJ, 2016, PLANT J, V85, P758, DOI 10.1111/tpj.13146; Kulik A, 2012, PLANT PHYSIOL, V160, P868, DOI 10.1104/pp.112.194472; Lee LC, 2006, BIOCHEM J, V397, P69, DOI 10.1042/BJ20051645; Li MY, 2011, PLANT CELL, V23, P1107, DOI 10.1105/tpc.110.081240; Lung SC, 2018, NEW PHYTOL, V218, P183, DOI 10.1111/nph.14965; Lung SC, 2017, PLANT PHYSIOL, V174, P1420, DOI 10.1104/pp.17.00412; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Makide K, 2014, J LIPID RES, V55, P1986, DOI 10.1194/jlr.R046920; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; Meier R, 2007, J BIOL CHEM, V282, P31477, DOI 10.1074/jbc.M704942200; Moolenaar WH, 2000, ANN NY ACAD SCI, V905, P1; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murohara T, 1996, CIRC RES, V78, P780, DOI 10.1161/01.RES.78.5.780; Park J, 2012, PLANT J, V69, P278, DOI 10.1111/j.1365-313X.2011.04789.x; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Ryu SB, 2004, TRENDS PLANT SCI, V9, P229, DOI 10.1016/j.tplants.2004.03.004; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sanchez R, 2000, METH MOL B, V143, P97; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Suzuki T, 2016, ANAL SCI, V32, P741, DOI 10.2116/analsci.32.741; Taskinen JP, 2007, PROTEINS, V66, P229, DOI 10.1002/prot.21124; Torkhovskaya TI, 2007, BIOCHEMISTRY-MOSCOW+, V72, P125, DOI 10.1134/S0006297907020010; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Vanholme R, 2013, SCIENCE, V341, P1103, DOI 10.1126/science.1241602; Verbruggen N, 2009, CURR OPIN PLANT BIOL, V12, P364, DOI 10.1016/j.pbi.2009.05.001; Vijayaraj P, 2012, PLANT PHYSIOL, V160, P667, DOI 10.1104/pp.112.202135; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang AJ, 1997, J BIOL CHEM, V272, P22030, DOI 10.1074/jbc.272.35.22030; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; Wang XM, 2004, CURR OPIN PLANT BIOL, V7, P329, DOI 10.1016/j.pbi.2004.03.012; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Wi SJ, 2014, PHYTOCHEMISTRY, V104, P48, DOI 10.1016/j.phytochem.2014.04.009; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Wong CKE, 2009, NEW PHYTOL, V181, P71, DOI 10.1111/j.1469-8137.2008.02638.x; Wuhanqimuge, 2013, FEBS OPEN BIO, V3, P243, DOI 10.1016/j.fob.2013.05.003; Zabela MD, 2002, MOL PLANT MICROBE IN, V15, P808, DOI 10.1094/MPMI.2002.15.8.808; Zhai ZY, 2014, PLANT CELL, V26, P2249, DOI 10.1105/tpc.114.123737	63	15	15	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6214	6226		10.1074/jbc.RA118.006876	http://dx.doi.org/10.1074/jbc.RA118.006876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30782848	Green Published, hybrid			2022-12-26	WOS:000468402000002
J	Gualano, G; Mencarini, P; Musso, M; Mosti, S; Santangelo, L; Murachelli, S; Cannas, A; Di Caro, A; Navarra, A; Goletti, D; Girardi, E; Palmieri, F				Gualano, Gina; Mencarini, Paola; Musso, Maria; Mosti, Silvia; Santangelo, Laura; Murachelli, Silvia; Cannas, Angela; Di Caro, Antonino; Navarra, Assunta; Goletti, Delia; Girardi, Enrico; Palmieri, Fabrizio			Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy	PLOS ONE			English	Article							MDR-TB; THERAPY; REGIMEN	Rationale Treatment of multi-drug resistant Tuberculosis (MDR-TB) is challenging because it mostly relies on drugs with lower efficacy and greater toxicity than those used for drug-susceptible TB. Objectives Aim of the study was to describe the frequency and type of adverse drug reactions in a cohort of MDR-TB patients and their potential impact on treatment outcome. \ Methods We conducted a retrospective study in a cohort of MDR-TB patients enrolled at a tertiary referral hospital in Italy from January 2008 to December 2016. The records of patients were reviewed for epidemiological, clinical, microbiological and adverse drug reactions data. Results Seventy-four MDR-TB patients (mean age 32 years, 58.1% males, 2 XDR, 12 pre-XDR TB) were extracted from the Institute data base and included in the retrospective study cohort in the evaluation period (January 2008-December 2016). Median length of treatment duration was 20 months (IQR 14-24). Treatment outcome was successful in 57 patients (77%; 51 cured, 6 treatment completed); one patient died and one failed (2.7% overall); 15 patients were lost to follow-up (20.3%). Sixty-six (89.2%) presented adverse drug reactions during the whole treatment period. Total number of adverse drug reactions registered was 409. Three hundred forty-six (84.6%) were classified as adverse events (AEs) and 63 (15.4%) were serious AEs (SAEs). One third of the total adverse drug reactions (134/ 409; 32.8%) was of gastrointestinal origin, followed by 47/ 409 (11.5%) ototoxic drug reactions, thirty-five (8.6%) regarded central nervous system and 33 (8.1%) affected the liver. All 63 SAEs required treatment suspension with 61 SAEs out of 63 (96.8%) occurring during the first six months of treatment. Factors associated with unsuccessful treatment outcome were smoking (p = 0.039), alcohol abuse (p = 0.005) and homeless condition (p = 0.044). Neither the number of antitubercular drugs used in different combinations nor the number of AEs showed significant impact on outcome. Patients who completed the treatment experienced a greater number of AEs and SAEs (p < 0.001) if compared to lost to follow-up patients. Conclusions Our data demonstrate that, despite the high frequency of adverse drug reactions and long term therapy, the clinical management of MDR-TB patients in a referral center could reach successful treatment according to WHO target, by implementing active and systematic clinical and laboratory assessment to detect, report and manage suspected and confirmed adverse drug reactions.	[Gualano, Gina; Mencarini, Paola; Musso, Maria; Mosti, Silvia; Palmieri, Fabrizio] Natl Inst Infect Dis L Spallanzani IRCCS, Resp Infect Dis Unit, Rome, Italy; [Santangelo, Laura; Murachelli, Silvia] Natl Inst Infect Dis L Spallanzani IRCCS, Pharm Unit, Rome, Italy; [Cannas, Angela; Di Caro, Antonino] Natl Inst Infect Dis L Spallanzani IRCCS, Microbiol Unit, Rome, Italy; [Navarra, Assunta; Girardi, Enrico] Natl Inst Infect Dis L Spallanzani IRCCS, Clin Epidemiol Unit, Rome, Italy; [Goletti, Delia] Natl Inst Infect Dis L Spallanzani IRCCS, Translat Res Unit, Rome, Italy	IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	Mencarini, P (corresponding author), Natl Inst Infect Dis L Spallanzani IRCCS, Resp Infect Dis Unit, Rome, Italy.	paola.mencarini@inmi.it	gualano, gina/C-3378-2017; goletti, delia/AAM-6577-2020; Di Caro, Antonino/K-6854-2016; Mencarini, Paola/K-5647-2019; Palmieri, Fabrizio/B-5420-2017	gualano, gina/0000-0001-6149-0005; Di Caro, Antonino/0000-0001-6027-3009; Mencarini, Paola/0000-0001-8928-8183; Palmieri, Fabrizio/0000-0001-8184-6291; NAVARRA, ASSUNTA/0000-0002-3662-4312; Goletti, Delia/0000-0001-8360-4376	Italian Ministry of Health, grant Ricerca Corrente IRCCS	Italian Ministry of Health, grant Ricerca Corrente IRCCS	This study was supported by funding from Italian Ministry of Health, grant Ricerca Corrente IRCCS, Research line 4; project no. 4 Tuberculosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2018, LANCET, V392, P821, DOI 10.1016/S0140-6736(18)31644-1; Avong YK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120161; Bastos ML, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00803-2016; Bloss E, 2010, INT J TUBERC LUNG D, V14, P275; Cegielski JP, 2016, CLIN INFECT DIS, V62, P418, DOI 10.1093/cid/civ910; Daley CL, 2018, SEMIN RESP CRIT CARE, V39, P310, DOI 10.1055/s-0038-1661383; Dela AI, 2017, LUNG INDIA, V34, P522, DOI 10.4103/0970-2113.217569; Duraisamy Karthickeyan, 2014, Ann Am Thorac Soc, V11, P712, DOI 10.1513/AnnalsATS.201312-447OC; European Centre for Disease Prevention and Control, 2014, HEALTHC SYST FACT IN; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Halleux CM, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01643-2017; Karo B, 2015, EUROSURVEILLANCE, V20, P18, DOI 10.2807/1560-7917.ES.2015.20.49.30087; Madhav B, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA2708; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Reuter A, 2017, INT J TUBERC LUNG D, V21, P1114, DOI 10.5588/ijtld.17.0468; Shean K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063057; Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912; Suryawanshi SL, 2017, PUBLIC HEALTH ACTION, V7, P116, DOI 10.5588/pha.17.0013; Tiberi S, 2018, LANCET INFECT DIS, V18, pE183, DOI 10.1016/S1473-3099(18)30110-5; Torun T, 2005, INT J TUBERC LUNG D, V9, P1373; Trebucq A, 2018, INT J TUBERC LUNG D, V22, P17, DOI 10.5588/ijtld.17.0498; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; World Health Organization, 2014, DEF REP FRAM TUB 201; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2016, WHOHTMTB201604; World Health Organization, 2017, WHOHTMTB201723; Wu SS, 2016, AM J THER, V23, pE521, DOI 10.1097/01.mjt.0000433951.09030.5a; Yoon HY, 2017, INT J TUBERC LUNG D, V21, P996, DOI 10.5588/ijtld.17.0174; Zhang Y, 2017, MED SCI MONITOR, V23, P2348, DOI 10.12659/MSM.904682	29	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212948	10.1371/journal.pone.0212948	http://dx.doi.org/10.1371/journal.pone.0212948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817779	Green Submitted, Green Published, gold			2022-12-26	WOS:000460371500060
J	Garcia-Ramos, A; Ulloa-Diaz, D; Barboza-Gonzalez, P; Rodriguez-Perea, A; Martinez-Garcia, D; Quidel-Catrilelbun, M; Guede-Rojas, F; Cuevas-Aburto, J; Janicijevic, D; Weakley, J				Garcia-Ramos, Amador; Ulloa-Diaz, David; Barboza-Gonzalez, Paola; Rodriguez-Perea, Angela; Martinez-Garcia, Dario; Quidel-Catrilelbun, Mauricio; Guede-Rojas, Francisco; Cuevas-Aburto, Jesualdo; Janicijevic, Danica; Weakley, Jonathon			Assessment of the load-velocity profile in the free-weight prone bench pull exercise through different velocity variables and regression models	PLOS ONE			English	Article							MOVEMENT VELOCITY; PERFORMANCE; INTENSITY; STRENGTH; PRESS	This aims of this study were (I) to determine the velocity variable and regression model which best fit the load-velocity relationship during the free-weight prone bench pull exercise, (II) to compare the reliability of the velocity attained at each percentage of the one-repetition maximum (1RM) between different velocity variables and regression models, and (III) to compare the within-and between-subject variability of the velocity attained at each %1RM. Eighteen men (14 rowers and four weightlifters) performed an incremental test during the free-weight prone bench pull exercise in two different sessions. General and individual load-velocity relationships were modelled through three velocity variables (mean velocity [MV], mean propulsive velocity [MPV] and peak velocity [PV]) and two regression models (linear and second-order polynomial). The main findings revealed that (I) the general (Pearson's correlation coefficient [r] range = 0.964-0.973) and individual (median r = 0.986 for MV, 0.989 for MPV, and 0.984 for PV) load-velocity relationships were highly linear, (II) the reliability of the velocity attained at each %1RM did not meaningfully differ between the velocity variables (coefficient of variation [ CV] range = 2.55-7.61% for MV, 2.84-7.72% for MPV and 3.50-6.03% for PV) neither between the regression models (CV range = 2.55-7.72% and 2.73-5.25% for the linear and polynomial regressions, respectively), and (III) the within-subject variability of the velocity attained at each % 1RM was lower than the between-subject variability for the light-moderate loads. No meaningful differences between the within-and between-subject CVs were observed for the MV of the 1RM trial (6.02% vs. 6.60%; CVratio = 1.10), while the within-subject CV was lower for PV (6.36% vs. 7.56%; CVratio = 1.19). These results suggest that the individual load-MV relationship should be determined with a linear regression model to obtain the most accurate prescription of the relative load during the free-weight prone bench pull exercise.	[Garcia-Ramos, Amador; Rodriguez-Perea, Angela; Martinez-Garcia, Dario] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Garcia-Ramos, Amador; Ulloa-Diaz, David; Quidel-Catrilelbun, Mauricio; Cuevas-Aburto, Jesualdo] Catholic Univ Most Holy Concepcion, Dept Sports Sci & Phys Conditioning, Fac Educ, CIEDE, Concepcion, Chile; [Barboza-Gonzalez, Paola] Univ Andres Bello, Fac Educ, Concepcion, Chile; [Guede-Rojas, Francisco] Univ Andres Bello, Fac Rehabil Sci, Concepcion, Chile; [Janicijevic, Danica] Univ Belgrade, Res Ctr, Fac Sport & Phys Educ, Belgrade, Serbia; [Weakley, Jonathon] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England	University of Granada; Universidad Catolica de la Santisima Concepcion; Universidad Andres Bello; Universidad Andres Bello; University of Belgrade; Leeds Beckett University	Garcia-Ramos, A (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.; Garcia-Ramos, A (corresponding author), Catholic Univ Most Holy Concepcion, Dept Sports Sci & Phys Conditioning, Fac Educ, CIEDE, Concepcion, Chile.	amagr@ugr.es	Weakley, Jonathon/AAJ-2182-2020; Guede, Francisco/AAD-3561-2019; Ramos, Amador Garcia/S-6982-2016; Janićijević, Danica/AAA-9861-2020; RODRIGUEZ PEREA, ANGELA/B-6638-2019; Garcia, Dario Martinez/Q-2872-2016; Martínez-García, Darío/O-4742-2019	Weakley, Jonathon/0000-0001-7892-4885; Guede, Francisco/0000-0002-1870-1396; Ramos, Amador Garcia/0000-0003-0608-8755; Janićijević, Danica/0000-0001-9925-7751; RODRIGUEZ PEREA, ANGELA/0000-0001-5155-1337; Martínez-García, Darío/0000-0003-0077-6813; Ulloa-Diaz, David/0000-0003-1288-1397				Banyard HG, 2018, INT J SPORT PHYSIOL, V13, P763, DOI 10.1123/ijspp.2017-0610; Conceicao F, 2016, J SPORT SCI, V34, P1099, DOI 10.1080/02640414.2015.1090010; Cormack SJ, 2008, INTJ SPORT PHYSIOL, V3, P131, DOI 10.1123/ijspp.3.2.131; Dong JG, 2016, EXP THER MED, V11, P1531, DOI 10.3892/etm.2016.3104; Fernandes JFT, 2021, J STRENGTH COND RES, V35, P1760, DOI 10.1519/JSC.0000000000002952; Fulton SK, 2009, J SPORT SCI, V27, P535, DOI 10.1080/02640410802641418; Garcia- Ramos A, 2018, INT J SPORTS SCI COA, DOI [10.1177/1747954118791525b, DOI 10.1177/1747954118791525B]; Garcia-Ramos A, 2018, STRENGTH COND J, V40, P54, DOI 10.1519/SSC.0000000000000359; Garcia-Ramos A, 2018, J STRENGTH COND RES, V32, P1273, DOI 10.1519/JSC.0000000000001998; Garcia-Ramos A, 2018, INT J SPORT PHYSIOL, V13, P326, DOI 10.1123/ijspp.2017-0158; Garcia-Ramos A, 2018, INT J SPORT PHYSIOL, V13, P474, DOI 10.1123/ijspp.2017-0374; Gonzalez-Badillo JJ, 2010, INT J SPORTS MED, V31, P347, DOI 10.1055/s-0030-1248333; Gonzalez-Hernandez JM, 2020, J STRENGTH COND RES, V34, P1581, DOI 10.1519/JSC.0000000000002117; Harris NK, 2010, STRENGTH COND J, V32, P66, DOI 10.1519/SSC.0b013e3181eb341b; Helms ER, 2017, J STRENGTH COND RES, V31, P292, DOI 10.1519/JSC.0000000000001517; Hopkins W., NEW VIEW STAT 2000; Jidovtseff B, 2011, J STRENGTH COND RES, V25, P267, DOI 10.1519/JSC.0b013e3181b62c5f; Jovanovic M., 2014, J AUST STRENGTH COND, V22, P58; Loturco I, 2021, J STRENGTH COND RES, V35, P300, DOI 10.1519/JSC.0000000000002543; Pestana-Melero FL, 2018, J APPL BIOMECH, V34, P184, DOI 10.1123/jab.2017-0266; Mann JB, 2015, STRENGTH COND J, V37, P52, DOI 10.1519/SSC.0000000000000177; Peart DJ, 2019, J STRENGTH COND RES, V33, P1167, DOI 10.1519/JSC.0000000000002344; Perez-Castilla A, 2020, J STRENGTH COND RES, V34, P1024, DOI 10.1519/JSC.0000000000002072; Picerno P, 2016, EUR J APPL PHYSIOL, V116, P2035, DOI 10.1007/s00421-016-3457-0; Randell AD, 2011, J STRENGTH COND RES, V25, P87, DOI 10.1519/JSC.0b013e3181fee634; Sanchez-Medina L, 2014, INT J SPORTS MED, V35, P209, DOI 10.1055/s-0033-1351252; Sanchez-Medina L, 2010, INT J SPORTS MED, V31, P123, DOI 10.1055/s-0029-1242815; Sanchez-Medina L, 2011, MED SCI SPORT EXER, V43, P1725, DOI 10.1249/MSS.0b013e318213f880; Weakley JJS, 2019, J STRENGTH COND RES, V33, P2420, DOI 10.1519/JSC.0000000000002133	29	24	24	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212085	10.1371/journal.pone.0212085	http://dx.doi.org/10.1371/journal.pone.0212085			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811432	Green Published, gold, Green Accepted			2022-12-26	WOS:000459806400052
J	Simon, M; Bosset, PO; Rouanne, M; Benhamou, S; Radulescu, C; Molinie, V; Neuzillet, Y; Paoletti, X; Lebret, T				Simon, Marie; Bosset, Pierre-Olivier; Rouanne, Mathieu; Benhamou, Simone; Radulescu, Camelia; Molinie, Vincent; Neuzillet, Yann; Paoletti, Xavier; Lebret, Thierry			Multiple recurrences and risk of disease progression in patients with primary low-grade (TaG1) non-muscle-invasive bladder cancer and with low and intermediate EORTC-risk score	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; FOLLOW-UP; UROTHELIAL CARCINOMA; IMPACT; FGFR3	Aim To assess the prognostic value of multiple recurrences on the risk of progression in a large cohort of TaG1 bladder cancer of low and intermediate risk based on the EORTC score and to evaluate prognostic factors of multiple recurrences. Materials and methods We retrospectively analyzed a French cohort of 470 patients with primary TaG1 bladder cancer diagnosed between 1986 and 2010 and followed until 2012. They were classified at low and intermediate risk using the EORTC risk score. Associations between the number of recurrences and the risk of progression to high grade Ta/T1 bladder cancer and progression to muscle-invasive disease were assessed. The characteristics of recurrences, as occurrence time or localization, and risk of other recurrences were evaluated. Results Out of 470 patients, 251 had recurrence, 34 progressed to high grade Ta/T1 and 17 to muscle-invasive disease, including 4 who had non muscle-invasive progression first. The median follow-up was 7.2 years (interquartile range: 4.2-10.9). In half the progressions, no previous recurrence was observed. No association between the number of recurrences and the risk of progression was detected. Even after 5 years free of event, patients had a 15% risk of recurrence. History of two or more recurrences increased by 4.5 the risk of subsequent recurrence. Time between two recurrences inferior to six months and multifocal localization increased the risk of recurrence. Conclusion Surveillance of patients with TaG1 should be continued beyond 5 years of follow-up. However, cystoscopy exams could be spaced after 5 years. Multiple TaG1 recurrences did not appear to be prognostic for disease progression, but increased significantly the risk of subsequent recurrences. Short time between two recurrences and multifocal localization may serve to adapt monitoring of patients with TaG1 Bladder cancer.	[Simon, Marie; Paoletti, Xavier] Univ Paris Saclay, UVSQ, Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France; [Simon, Marie; Paoletti, Xavier] Univ Paris Saclay, UVSQ, Inst Gustave Roussy, CESP OncoStat,INSERM, Villejuif, France; [Bosset, Pierre-Olivier; Rouanne, Mathieu; Neuzillet, Yann; Lebret, Thierry] Univ Paris Saclay, UVSQ, Hop Foch, Dept Urol, Suresnes, France; [Benhamou, Simone] INSERM, UMR 946, Genet Variat & Human Dis Unit, Paris, France; [Radulescu, Camelia] Univ Paris Saclay, UVSQ, Hop Foch, Dept Pathol, Suresnes, France; [Molinie, Vincent] Univ Hosp Martinique, Dept Pathol, Fort De France, Martinique, France	UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Hospital Foch; UDICE-French Research Universities; Universite Paris Saclay; CHU Martinique	Paoletti, X (corresponding author), Univ Paris Saclay, UVSQ, Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France.; Paoletti, X (corresponding author), Univ Paris Saclay, UVSQ, Inst Gustave Roussy, CESP OncoStat,INSERM, Villejuif, France.	xavier.paoletti@gustaveroussy.fr	Rouanne, Mathieu/AAU-9095-2021; Benhamou, Simone/K-6554-2015; Benhamou, Simone/ABD-2590-2020	Rouanne, Mathieu/0000-0003-2970-4821; RADULESCU, Camelia/0000-0002-3704-8679				Aveyard P, 2002, BJU INT, V90, P228, DOI 10.1046/j.1464-410X.2002.02880.x; Babjuk M., 2018, EUROPEAN ASS UROLOGY; Balan D, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010522; Bosset PO, 2015, UROL ONCOL-SEMIN ORI, V33, DOI 10.1016/j.urolonc.2014.09.001; Dafni U, 2011, CIRC-CARDIOVASC QUAL, V4, P363, DOI 10.1161/CIRCOUTCOMES.110.957951; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fernandez-Gomez J, 2008, EUR UROL, V53, P992, DOI 10.1016/j.eururo.2007.10.006; Giobbie-Hurder Anita, CLIN ONCOL, V31, P2963; Golabesk T, 2017, UROLOGY, V100, P145, DOI 10.1016/j.urology.2016.07.063; Gui-shuang Y, STAT ANAL CLUSTERED; Guy L, 2006, EUR UROL, V50, P516, DOI 10.1016/j.eururo.2006.03.022; Hedegaard J, 2016, CANCER CELL, V30, P27, DOI 10.1016/j.ccell.2016.05.004; Hernandez S, 2006, J CLIN ONCOL, V24, P3664, DOI 10.1200/JCO.2005.05.1771; Hong YM, 2008, UROLOGY, V71, P131, DOI 10.1016/j.urology.2007.08.014; Kamat AM, 2016, LANCET, V388, P2796, DOI 10.1016/S0140-6736(16)30512-8; Knowles MA, 2007, WORLD J UROL, V25, P581, DOI 10.1007/s00345-007-0213-4; Le Goux C, 2013, PROG UROL, V23, P399, DOI 10.1016/j.purol.2013.01.025; Lujan S, 2014, ACTAS UROL ESP; Mongiat-Artus P, 2010, PROG UROL, V20, pS54, DOI 10.1016/S1166-7087(10)70043-9; Rieken M, 2014, EUR UROL, V65, P201, DOI 10.1016/j.eururo.2013.08.034; Roupret M, CCAFU FRENCH NATL GU; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tian YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158891; van Rhijn BWG, 2010, EUR UROL, V58, P433, DOI 10.1016/j.eururo.2010.05.043; van Rhijn BWG, 2009, EUR UROL, V56, P430, DOI 10.1016/j.eururo.2009.06.028; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Vollmer RT, 2016, AM J CLIN PATHOL, V146, P215, DOI [10.1093/AJCP/AQW103, 10.1093/ajcp/aqw103]; Zieger K, 2000, BJU INT, V85, P824, DOI 10.1046/j.1464-410x.2000.00547.x	29	10	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211721	10.1371/journal.pone.0211721	http://dx.doi.org/10.1371/journal.pone.0211721			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811419	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400031
J	Stettz, S; Zaitchik, BF; Ademe, D; Musie, S; Simane, B				Stettz, Stephanie; Zaitchik, Benjamin F.; Ademe, Dereje; Musie, Sintayehu; Simane, Belay			Estimating variability in downwelling surface shortwave radiation in a tropical highland environment	PLOS ONE			English	Article							GLOBAL SOLAR-RADIATION; BUILDING CLIMATE RESILIENCE; BLUE NILE/ABAY HIGHLANDS; PRODUCTS; MODELS; SYSTEM	Surface incoming shortwave (solar) radiation data are an important component of many scientific analyses, but direct measurements are not commonly available. Estimates can be obtained from gridded meteorological analysis or reanalysis systems, such as the Global Data Assimilation Systems (GDAS) and Modern Era Retrospective Reanalysis System (MERRA-2), or calculated using empirical models dependent on meteorological variables such as air temperature. The purpose of this analysis was to compare multiple methods for estimating daily shortwave radiation in a tropical highland environment in Ethiopia. Direct solar radiation outputs of GDAS and MERRA-2, topographically corrected outputs of the two analysis systems, and empirically estimated solar radiation values calculated with the systems' air temperature data were compared to see which produced the most reliable radiation values. GDAS appeared to underestimate the seasonal variability, resulting in low correlation (R-2) with in situ data and large mean bias error (MBE). In comparison, MERRA-2 did not underestimate variability, but produced larger bias than the empirical model estimates. There was an improvement in correlation and reduction in MBE when using the GDAS air temperature predictions in the empirical model, but the opposite was true for MERRA-2. The empirical model using station air temperature data (stationT) produced the highest correlation across all four stations, with best performance at the lower elevation sites. The direct shortwave radiation outputs of MERRA-2 produced comparable correlation values, with larger R-2 at stations at higher elevation. Topography possibly influenced these results, as MERRA-2 performed comparably to stationT at the stations in moderate terrain, but not in steeper terrain. This work can serve as a starting point for analyses in other tropical highland regions, where continuous in situ solar radiation data are rarely available.	[Stettz, Stephanie; Zaitchik, Benjamin F.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Ademe, Dereje; Musie, Sintayehu] Debre Markos Univ, Debre Markos, Amhara, Ethiopia; [Simane, Belay] Addis Ababa Univ, Coll Dev Studies, Addis Ababa, Ethiopia	Johns Hopkins University; Addis Ababa University	Zaitchik, BF (corresponding author), Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA.	zaitchik@jhu.edu	Birhan, Dereje/GRO-6552-2022; Zaitchik, Benjamin/AAB-3298-2020	Zaitchik, Benjamin/0000-0002-0698-0658; Mulugeta, Sintayehu Musie/0000-0001-8510-1983	U.S. National Science Foundation, Directorate for Geosciences [GEO-1211235]	U.S. National Science Foundation, Directorate for Geosciences	Funded by U.S. National Science Foundation, Directorate for Geosciences, Grant GEO-1211235 (BFZ).	Allen RG, 56 FAO, P15; Almorox J, 2011, APPL ENERG, V88, P1703, DOI 10.1016/j.apenergy.2010.11.003; Almorox J, 2008, INTERCIENCIA, V33, P280; Almorox J, 2013, RENEW ENERG, V60, P382, DOI 10.1016/j.renene.2013.05.033; Almorox J, 2011, TURK J PHYS, V35, P53, DOI 10.3906/fiz-0912-20; Boilley A, 2015, RENEW ENERG, V75, P135, DOI 10.1016/j.renene.2014.09.042; BRISTOW KL, 1984, AGR FOREST METEOROL, V31, P159, DOI 10.1016/0168-1923(84)90017-0; DERBER JC, 1991, WEATHER FORECAST, V6, P538, DOI 10.1175/1520-0434(1991)006<0538:TNGOAS>2.0.CO;2; Deressa TT, 2009, J AFR ECON, V18, P529, DOI 10.1093/jae/ejp002; Dingman S., 2002, PHYS HYDROLOGY; Dinku T, 2008, INT J REMOTE SENS, V29, P4097, DOI 10.1080/01431160701772526; Donatelli M, 1998, P 5 EUROPEAN SOC AGR, VII, P133; Gelaro R, 2017, J CLIMATE, V30, P5419, DOI 10.1175/JCLI-D-16-0758.1; Goodin DG, 1999, AGRON J, V91, P845, DOI 10.2134/agronj1999.915845x; HARGREAVES GH, 1982, J IRR DRAIN DIV-ASCE, V108, P225; Hassan MA, 2018, RENEW SUST ENERG REV, V82, P1565, DOI 10.1016/j.rser.2017.07.002; Hassan MA, 2017, APPL ENERG, V203, P897, DOI 10.1016/j.apenergy.2017.06.104; Hirpa FA, 2010, J APPL METEOROL CLIM, V49, P1044, DOI 10.1175/2009JAMC2298.1; Hussain S, 2017, APPL ENERG, V208, P540, DOI 10.1016/j.apenergy.2017.09.100; Quej VH, 2017, J ATMOS SOL-TERR PHY, V155, P62, DOI 10.1016/j.jastp.2017.02.002; Quej VH, 2017, J CLEAN PROD, V141, P75, DOI 10.1016/j.jclepro.2016.09.062; Quej VH, 2016, ENERG CONVERS MANAGE, V110, P448, DOI 10.1016/j.enconman.2015.12.050; Rigollier C, 2004, SOL ENERGY, V77, P159, DOI 10.1016/j.solener.2004.04.017; Romilly TG, 2011, HYDROL EARTH SYST SC, V15, P1505, DOI 10.5194/hess-15-1505-2011; Silva V. J. da, 2016, Australian Journal of Crop Science, V10, P926, DOI 10.21475/ajcs.2016.10.07.p7301; Simane B, 2012, INT J ENV RES PUB HE, V9, P610, DOI 10.3390/ijerph9020610; Vancutsem C, 2010, REMOTE SENS ENVIRON, V114, P449, DOI 10.1016/j.rse.2009.10.002; Zaitchik BF, 2012, INT J ENV RES PUB HE, V9, P435, DOI 10.3390/ijerph9020435; Zhang JY, 2017, RENEW SUST ENERG REV, V70, P314, DOI 10.1016/j.rser.2016.11.124	29	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0211220	10.1371/journal.pone.0211220	http://dx.doi.org/10.1371/journal.pone.0211220			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802255	gold, Green Submitted, Green Published			2022-12-26	WOS:000459710700005
J	Besselink, NJ; Jacobs, JWG; Westgeest, AAA; van der Meijde, P; Welsing, PMJ; Marijnissen, ACA; Lafeber, FPJG; Van Spil, WE				Besselink, N. J.; Jacobs, J. W. G.; Westgeest, A. A. A.; van der Meijde, P.; Welsing, P. M. J.; Marijnissen, A. C. A.; Lafeber, F. P. J. G.; Van Spil, W. E.			Can optical spectral transmission assess ultrasound-detected synovitis in hand osteoarthritis?	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; MUSCULOSKELETAL ULTRASOUND; INFLAMMATION; JOINTS; ULTRASONOGRAPHY; RELIABILITY; SEVERITY; DAMAGE	Objective To determine whether optical spectral transmission (OST) can be used to assess synovitis in hand and wrist joints of patients with hand osteoarthritis (OA). Design Hand and wrist joints of 47 primary hand OA patients with at least one clinically inflamed hand or wrist joint were assessed for synovitis by OST and ultrasound (US). Associations between standardized OST and US synovitis were studied in linear mixed effects models, across all joint types together and individually for wrist, proximal interphalangeal (PIP), and distal interphalangeal (DIP) joints, and were adjusted for OA features that showed associations with US synovitis. Diagnostic performance was determined using receiver operator characteristic (ROC) curves analysis, with US as reference standard. Results Altogether, 6.7% of joints showed US synovitis. Statistically significant associations between OST scores and US synovitis were found for all joints combined (Delta 0.37SD, p<0.001) and PIP joints (Delta 0.81SD, p<0.001), but not for DIP (Delta 0.14SD, p = 0.484) or wrist joints (Delta 0.37SD, p = 0.178). All associations were independent of other OA features, i.e. osteophytes and dorsal vascularity. Analysis of diagnostic performance of OST, revealed an area under the ROC curve (AUC-ROC) of 0.74 for all joints together (p<0.001), 0.69 for PIP joints (p<0.001), 0.54 for DIP joints (p = 0.486), and 0.61 for wrist joints (p = 0.234). Conclusions OST scores and US synovitis are statistically significantly associated, independent of osteophytes and dorsal vascularity. At this stage, OST performs fair in the assessment of synovitis in PIP joints of hand OA patients.	[Besselink, N. J.; Jacobs, J. W. G.; Welsing, P. M. J.; Marijnissen, A. C. A.; Lafeber, F. P. J. G.; Van Spil, W. E.] Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Westgeest, A. A. A.] Maxima Med Ctr, Dept Rheumatol, Eindhoven, Netherlands; [van der Meijde, P.] Noordwest Ziekenhuisgroep, Dept Rheumatol, Alkmaar, Netherlands	Utrecht University; Utrecht University Medical Center; Maxima Medical Center; Medical Center Of Alkmaar	Besselink, NJ (corresponding author), Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	W.E.vanSpil@umcutrecht.nl			Hemics	Hemics	This work was financially supported by Hemics (http://www.hemics.com/), in the form of an unrestricted research grant. Hemics was involved in analysis and interpretation of OST data, but had no role in study design, collection of the data, writing of the manuscript or in the decision to submit the manuscript for publication.	Backhaus M, 2001, ANN RHEUM DIS, V60, P641, DOI 10.1136/ard.60.7.641; Besselink NJ, 2018, RHEUMATOLOGY, V57, P865, DOI 10.1093/rheumatology/kex531; Glimm AM, 2016, ANN RHEUM DIS, V75, P566, DOI 10.1136/annrheumdis-2015-207345; Hall M, 2014, OSTEOARTHR CARTILAGE, V22, P1627, DOI 10.1016/j.joca.2014.05.025; Kortekaas MC, 2013, ANN RHEUM DIS, V72, P930, DOI 10.1136/annrheumdis-2012-201458; Lafeber FPJG, 2016, OXFORD TXB RHEUMATOL, P55; Mancarella L, 2010, OSTEOARTHR CARTILAGE, V18, P1263, DOI 10.1016/j.joca.2010.06.006; Mancarella L, 2017, CURR RHEUMATOL REV, V13, P43, DOI 10.2174/1573397112666160909105903; Mathiessen A, 2016, ANN RHEUM DIS, V75, P825, DOI 10.1136/annrheumdis-2015-207241; Naredo E, 2006, ANN RHEUM DIS, V65, P14, DOI 10.1136/ard.2005.037382; Naredo E, 2013, ANN RHEUM DIS, V72, P1328, DOI 10.1136/annrheumdis-2012-202092; Punzi L, 2010, BEST PRACT RES CL RH, V24, P301, DOI 10.1016/j.berh.2009.12.007; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; Takase-Minegishi K, 2018, RHEUMATOLOGY, V57, P49, DOI 10.1093/rheumatology/kex036; Terslev L, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2016-000427; Tugwell P, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-38; Wakefield RJ, 2007, J RHEUMATOL, V34, P848; Wakefield RJ, 2005, J RHEUMATOL, V32, P2485; Witt M, 2013, ARTHRITIS RHEUM-US, V65, P1694, DOI 10.1002/art.37954; Zhang YQ, 2002, AM J EPIDEMIOL, V156, P1021, DOI 10.1093/aje/kwf141	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0209761	10.1371/journal.pone.0209761	http://dx.doi.org/10.1371/journal.pone.0209761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794572	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100011
J	Masino, AJ; Harris, MC; Forsyth, D; Ostapenko, S; Srinivasan, L; Bonafide, CP; Balamuth, F; Schmatz, M; Grundmeier, RW				Masino, Aaron J.; Harris, Mary Catherine; Forsyth, Daniel; Ostapenko, Svetlana; Srinivasan, Lakshmi; Bonafide, Christopher P.; Balamuth, Fran; Schmatz, Melissa; Grundmeier, Robert W.			Machine learning models for early sepsis recognition in the neonatal intensive care unit using readily available electronic health record data	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; EMPIRICAL ANTIBIOTIC-TREATMENT; CLINICAL-OUTCOMES; VITAL SIGNS; PREDICTION; MORTALITY; BACTEREMIA; DISEASE; CULTURE; BURDEN	Background Rapid antibiotic administration is known to improve sepsis outcomes, however early diagnosis remains challenging due to complex presentation. Our objective was to develop a model using readily available electronic health record (EHR) data capable of recognizing infant sepsis at least 4 hours prior to clinical recognition. Methods and findings We performed a retrospective case control study of infants hospitalized. 48 hours in the Neonatal Intensive Care Unit (NICU) at the Children's Hospital of Philadelphia between September 2014 and November 2017 who received at least one sepsis evaluation before 12 months of age. We considered two evaluation outcomes as cases: culture positive-positive blood culture for a known pathogen (110 evaluations); and clinically positive-negative cultures but antibiotics administered for. 120 hours (265 evaluations). Case data was taken from the 44-hour window ending 4 hours prior to evaluation. We randomly sampled 1,100 44-hour windows of control data from all times. 10 days removed from any evaluation. Model inputs consisted of up to 36 features derived from routine EHR data. Using 10-fold nested cross-validation, 8 machine learning models were trained to classify inputs as sepsis positive or negative. When tasked with discriminating culture positive cases from controls, 6 models achieved a mean area under the receiver operating characteristic (AUC) between 0.80-0.82 with no significant differences between them. Including both culture and clinically positive cases, the same 6 models achieved an AUC between 0.85-0.87, again with no significant differences. Conclusions Machine learning models can identify infants with sepsis in the NICU hours prior to clinical recognition. Learning curves indicate model improvement may be achieved with additional training examples. Additional input features may also improve performance. Further research is warranted to assess potential performance improvements and clinical efficacy in a prospective trial.	[Masino, Aaron J.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Masino, Aaron J.; Forsyth, Daniel; Ostapenko, Svetlana; Grundmeier, Robert W.] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Harris, Mary Catherine; Srinivasan, Lakshmi; Bonafide, Christopher P.; Balamuth, Fran; Grundmeier, Robert W.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Harris, Mary Catherine; Srinivasan, Lakshmi; Schmatz, Melissa] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Bonafide, Christopher P.; Balamuth, Fran; Grundmeier, Robert W.] Childrens Hosp Philadelphia, Ctr Pediat Clin Effectiveness, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Masino, AJ (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.; Masino, AJ (corresponding author), Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA.	masinoa@email.chop.edu		Bonafide, Christopher/0000-0003-2823-5883; Grundmeier, Robert/0000-0002-8290-5588; Harris, Mary Catherine/0000-0001-6287-0026	Institute for Biomedical Informatics at the University of Pennsylvania; Research Institute at Children's Hospital of Philadelphia	Institute for Biomedical Informatics at the University of Pennsylvania; Research Institute at Children's Hospital of Philadelphia	This work was funded by the Institute for Biomedical Informatics at the University of Pennsylvania (http://upibi.org/) and the Research Institute at Children's Hospital of Philadelphia (https://www.research.chop.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamuth F, 2017, ANN EMERG MED, V70, P759, DOI 10.1016/j.annemergmed.2017.03.019; Barber D., 2012, BAYESIAN REASONING M; Batista G.E., 2004, ACM SIGKDD EXPLOR NE, V6, P20, DOI 10.1145/1007730.1007735; Beretta L, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0318-z; Bohanon FJ, 2015, AM J SURG, V210, P661, DOI 10.1016/j.amjsurg.2015.06.002; Calvert JS, 2016, COMPUT BIOL MED, V74, P69, DOI 10.1016/j.compbiomed.2016.05.003; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Coggins SA, 2016, ARCH DIS CHILD-FETAL, V101, pF329, DOI 10.1136/archdischild-2015-309210; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Cohen-Wolkowiez M, 2009, PEDIATR INFECT DIS J, V28, P1052, DOI 10.1097/INF.0b013e3181acf6bd; Connell TG, 2007, PEDIATRICS, V119, P891, DOI 10.1542/peds.2006-0440; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; Desautels T, 2016, JMIR MED INF, V4, P67, DOI 10.2196/medinform.5909; Dong YR, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-222; Fairchild KD, 2017, PEDIATR RES, V81, P315, DOI 10.1038/pr.2016.215; Fairchild KD, 2010, CLIN PERINATOL, V37, P581, DOI 10.1016/j.clp.2010.06.002; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gonsalves WI, 2009, J CLIN MICROBIOL, V47, P3482, DOI 10.1128/JCM.02107-08; Gultepe E, 2014, J AM MED INFORM ASSN, V21, P315, DOI 10.1136/amiajnl-2013-001815; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Henry KE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab3719; Horng S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174708; Kam HJ, 2017, COMPUT BIOL MED, V89, P248, DOI 10.1016/j.compbiomed.2017.08.015; Klingenberg C, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00285; Kraskov A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066138; Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033; KURLAT I, 1989, J CLIN MICROBIOL, V27, P1068, DOI 10.1128/JCM.27.5.1068-1071.1989; Lake DE, 2014, J CLIN MONIT COMPUT, V28, P329, DOI 10.1007/s10877-013-9530-x; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mani S, 2014, J AM MED INFORM ASSN, V21, P326, DOI 10.1136/amiajnl-2013-001854; Mayhew MB, 2017, J BIOMED INFORM; Musil CM, 2002, WESTERN J NURS RES, V24, P815, DOI 10.1177/019394502762477004; Nemati S, 2017, CRIT CARE MED, P1; Odetola FO, 2007, PEDIATRICS, V119, P487, DOI 10.1542/peds.2006-2353; Padula MA, 2014, PEDIATR INFECT DIS J, V33, P1027, DOI 10.1097/INF.0000000000000386; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Qazi SA, 2009, PEDIATR INFECT DIS J, V28, pS1, DOI 10.1097/INF.0b013e31819587a9; ROWLEY AH, 1986, CLIN PEDIATR, V25, P485, DOI 10.1177/000992288602501001; Schelonka RL, 1996, J PEDIATR-US, V129, P275, DOI 10.1016/S0022-3476(96)70254-8; Seymour CW, 2016, JAMA J AM MED ASS; Shashikumar SP, 2017, PHYSIOL MEAS, V38, P2235, DOI 10.1088/1361-6579/aa9772; Shashikumar SP, 2017, J ELECTROCARDIOL, V50, P739, DOI 10.1016/j.jelectrocard.2017.08.013; Squire E, 1980, OBSTET GYNECOL SURV, V35, P448; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Taylor RA, 2016, ACAD EMERG MED, V23, P269, DOI 10.1111/acem.12876; Ting JY, 2016, JAMA PEDIATR, V170, P1181, DOI 10.1001/jamapediatrics.2016.2132; Umscheid CA, 2015, J HOSP MED, V10, P26, DOI 10.1002/jhm.2259; Verstraete EH, 2015, PEDIATRICS, V135, pE1002, DOI 10.1542/peds.2014-3226; Wang HD, 2016, LANCET, V388, P1725, DOI 10.1016/S0140-6736(16)31575-6; Wang HE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048307; Weiss SL, 2014, CRIT CARE MED; Wynn JL, 2016, CURR OPIN PEDIATR, V28, P135, DOI 10.1097/MOP.0000000000000315; Yende S, 2014, TRENDS MOL MED, V20, P234, DOI 10.1016/j.molmed.2014.02.005; Zea-Vera A, 2015, J TROP PEDIATRICS, V61, P1, DOI 10.1093/tropej/fmu079; Zhu J, 2009, STAT INTERFACE, V2, P349	60	59	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212665	10.1371/journal.pone.0212665	http://dx.doi.org/10.1371/journal.pone.0212665			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794638	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100108
J	van Ditzhuijzen, J; Brauer, M; Boeije, H; van Nijnatten, CHCJ				van Ditzhuijzen, Jenneke; Brauer, Marieke; Boeije, Hennie; van Nijnatten, Carolus H. C. J.			Dimensions of decision difficulty in women's decision-making about abortion: A mixed methods longitudinal study	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; PSYCHIATRIC HISTORY; PARTNER SUPPORT; HEALTH SURVEY; HAD	Relatively little is known about the ease or difficulty with which women decide to have an abortion, and most research uses single-item measurements. We used a mixed methods approach to combine data from the Dutch Abortion and Mental Health Study (DAMHS, n = 325) with data from a qualitative study about the decision process with a small subsample (n = 69) of the DAMHS study. We used the findings from the qualitative study to develop the Dimensions of Abortion Decision Difficulty [DADD] scale, and tested this scale among a larger sample of women who took part in the second wave of the cohort study (n = 264). Qualitative analyses revealed six dimensions of decision difficulty. The DADD scale was based on these six dimensions. Results from the DADD scale at follow-up reduced these to four dimensions: (1) unrealistic fears about the abortion and fantasies about the pregnancy; (2) decision conflict; (3) negative abortion attitudes; and (4) general indecisiveness. Decision conflict was the only dimension related to previous mental disorders. The findings suggest that the concept of decision difficulty seems multidimensional, rather than unidimensional. On a clinical level, it could be important to separate the more general fears, attitudes, and indecisiveness from strong decision conflict, because the latter might involve pressure of others, lack of decision ownership, and might be related to previous mental health.	[van Ditzhuijzen, Jenneke; Brauer, Marieke; van Nijnatten, Carolus H. C. J.] Univ Utrecht, Dept Social & Behav Sci, Interdisciplinary Social Sci, Utrecht, Netherlands; [Boeije, Hennie] Univ Utrecht, Dept Social & Behav Sci, Methods & Stat, Utrecht, Netherlands; [Brauer, Marieke] PsyQ Mental Hlth Serv, Purmerend, Netherlands; [Boeije, Hennie] Netherlands Inst Hlth Serv Res NIVEL, Utrecht, Netherlands	Utrecht University; Utrecht University; Netherlands Institute for Health Services Research	van Ditzhuijzen, J (corresponding author), Univ Utrecht, Dept Social & Behav Sci, Interdisciplinary Social Sci, Utrecht, Netherlands.	j.m.vanditzhuijzen@uu.nl	van Ditzhuijzen, Jenneke/R-5942-2019	van Ditzhuijzen, Jenneke/0000-0003-0560-4949	Dutch Ministry of Health, Welfare and Sport, via the Netherlands Organization for Health Research and Development (ZonMw) [127000003, 127000004]	Dutch Ministry of Health, Welfare and Sport, via the Netherlands Organization for Health Research and Development (ZonMw)	This work was supported by the Dutch Ministry of Health, Welfare and Sport, via the Netherlands Organization for Health Research and Development (ZonMw, www.zonmw.nl, grant number 127000003 for the DAMHS Study, and grant number 127000004 for the qualitative study about abortion decision making). The funding source had no role in study design; the collection, analysis and interpretation of data; in the writing of articles; and in the decision to submit for publication.	Allanson S, 1996, J PSYCHOSOM OBST GYN, V17, P158, DOI 10.3109/01674829609025677; Boeije H., 2009, ANAL QUALITATIVE RES; Broen AN, 2006, ACTA OBSTET GYN SCAN, V85, P317, DOI 10.1080/00016340500438116; de Graaf R, 2010, INT J METH PSYCH RES, V19, P125, DOI 10.1002/mpr.317; Fergusson DM, 2009, BRIT J PSYCHIAT, V195, P420, DOI 10.1192/bjp.bp.109.066068; Fielding SL, 2004, QUAL HEALTH RES, V14, P612, DOI 10.1177/1049732304263677; Finer LB, 2006, CONTRACEPTION, V74, P334, DOI 10.1016/j.contraception.2006.04.010; Foster DG, 2012, PERSPECT SEX REPRO H, V44, P117, DOI 10.1363/4411712; HAMARK B, 1995, ACTA OBSTET GYN SCAN, V74, P302, DOI 10.3109/00016349509024454; Haro JM, 2006, INT J METH PSYCH RES, V15, P167, DOI 10.1002/mpr.196; Kapadia F, 2011, WOMEN HEALTH ISS, V21, pS8, DOI 10.1016/j.whi.2011.02.005; Kero A, 2004, SOC SCI MED, V58, P2559, DOI 10.1016/j.socscimed.2003.09.004; Kero A, 2000, J PSYCHOSOM OBST GYN, V21, P81, DOI 10.3109/01674820009075613; Kessler RC, 2007, WORLD PSYCHIATRY, V6, P168; Kroelinger CD, 2000, BIRTH-ISS PERINAT C, V27, P112, DOI 10.1046/j.1523-536x.2000.00112.x; Levels M, 2012, EUR SOCIOL REV, V28, P301, DOI 10.1093/esr/jcq065; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 2009, AM PSYCHOL, V64, P863, DOI 10.1037/a0017497; Ministerie van Volksgezondheid Welzijn en Sport-Inspectie voor de Gezondheidszorg (IGZ): Dutch Ministry of Public Health, JAARR 2015 WET AFBR; Moore AM, 2011, SOC WORK HEALTH CARE, V50, P424, DOI 10.1080/00981389.2011.575538; Moore AM, 2010, SOC SCI MED, V70, P1737, DOI 10.1016/j.socscimed.2010.02.009; QSR International Pty. Ltd, 2006, NVIVO VERS 9; Small ML, 2011, ANNU REV SOCIOL, V37, P57, DOI 10.1146/annurev.soc.012809.102657; Stronks K, 2009, ETHNIC HEALTH, V14, P255, DOI 10.1080/13557850802509206; Tornbom M, 1999, ACTA OBSTET GYN SCAN, V78, P636, DOI 10.1034/j.1600-0412.1999.780713.x; van Ditzhuijzen J, 2017, PERSPECT SEX REPRO H, V49, P123, DOI 10.1363/psrh.12028; van Ditzhuijzen J, 2017, J PSYCHIATR RES, V84, P200, DOI 10.1016/j.jpsychires.2016.10.006; van Ditzhuijzen J, 2015, CONTRACEPTION, V92, P246, DOI 10.1016/j.contraception.2015.05.003; van Ditzhuijzen J, 2013, J PSYCHIATR RES, V47, P1737, DOI 10.1016/j.jpsychires.2013.07.024; Visser M, EVALUATIE WET AFBREK	30	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212611	10.1371/journal.pone.0212611	http://dx.doi.org/10.1371/journal.pone.0212611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794621	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100096
J	Stroud, JL				Stroud, Jacqueline L.			Soil health pilot study in England: Outcomes from an on-farm earthworm survey	PLOS ONE			English	Article							LUMBRICUS-TERRESTRIS; ORGANIC-MATTER; NO-TILL; COMMUNITIES; POPULATIONS; DIVERSITY; ABUNDANCE	Earthworms are primary candidates for national soil health monitoring as they are ecosystem engineers that benefit both food production and ecosystem services associated with soil security. Supporting farmers to monitor soil health could help to achieve the policy aspiration of sustainable soils by 2030 in England; however, little is known about how to overcome participation barriers, appropriate methodologies (practical, cost-effective, usefulness) or training needs. This paper presents the results from a pilot #60minworms study which mobilised farmers to assess over >1300 ha farmland soils in spring 2018. The results interpretation framework is based on the presence of earthworms from each of the three ecological groups at each observation (20 x 20 cm x 20 cm pit) and spatially across a field (10 soil pits). Results showed that most fields have basic earthworm presence and abundance, but 42% fields may be over-worked as indicated by absence/rarity of epigeic and/or anecic earthworms. Tillage had a negative impact (p < 0.05) on earthworm populations and organic matter management did not mitigate tillage impacts. In terms of farmer participation, Twitter and Farmers Weekly magazine were highly effective channels for recruitment. Direct feedback from participants included excellent scores in trust, value and satisfaction of the protocol (e.g. 100% would do the test again) and 57% would use their worm survey results to change their soil management practices. A key training need in terms of earthworm identification skills was reported. The trade-off between data quality, participation rates and fieldwork costs suggests there is potential to streamline the protocol further to #30minworms (5 pits), incurring farmer fieldwork costs of approximately 1.48 pound ha(-1). At national scales, 14 pound million pounds across 4.7 M ha(-1) in fieldwork costs per survey could be saved by farmer participation.	[Stroud, Jacqueline L.] Rothamsted Res, Sustainable Agr Syst Dept, Harpenden, Herts, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Stroud, JL (corresponding author), Rothamsted Res, Sustainable Agr Syst Dept, Harpenden, Herts, England.	Jacqueline.stroud@rothamsted.ac.uk			Natural Environment Research Council [NE/N019253/1]; BBSRC [BBS/E/C/000J0300] Funding Source: UKRI; NERC [NE/N019253/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funded by NE/N019253/1 Natural Environment Research Council (JLS). https://nerc.ukri.org/ The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andriuzzi WS, 2015, PLANT SOIL, V397, P103, DOI 10.1007/s11104-015-2604-4; Bone J, 2012, ENVIRON SCI TECHNOL, V46, P3687, DOI 10.1021/es203880p; Briones MJI, 2017, GLOBAL CHANGE BIOL, V23, P4396, DOI 10.1111/gcb.13744; Cannon RJC, 1999, ANN APPL BIOL, V135, P597, DOI 10.1111/j.1744-7348.1999.tb00892.x; Chan KY, 2001, SOIL TILL RES, V57, P179, DOI 10.1016/S0167-1987(00)00173-2; DEFRA, 2018, AGR FACTS ENGL REG P; Edwards CA, 1996, EARTHWORM BIOL BIOL, P52; Griffiths B, 2018, SOIL BIOL SOIL HLTH; Gruar D, 2003, IBIS, V145, P637, DOI 10.1046/j.1474-919X.2003.00202.x; Jones DT, 2014, NECR145; Kemper WD, 2011, J SOIL WATER CONSERV, V66, p13A, DOI 10.2489/jswc.66.1.13A; Kibblewhite MG, 2008, PHILOS T R SOC B, V363, P685, DOI 10.1098/rstb.2007.2178; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Kladivko EJ, 1997, SOIL BIOL BIOCHEM, V29, P613, DOI 10.1016/S0038-0717(96)00187-3; Knight S., 2012, 502 HGCA; Loveland P, 2003, SOIL TILL RES, V70, P1, DOI 10.1016/S0167-1987(02)00139-3; Martay B, 2018, PEDOBIOLOGIA, V67, P1, DOI 10.1016/j.pedobi.2018.01.002; Ritz K, 2009, ECOL INDIC, V9, P1212, DOI 10.1016/j.ecolind.2009.02.009; Roarty S, 2013, AGR ECOSYST ENVIRON, V170, P45, DOI 10.1016/j.agee.2013.02.011; Rossi JP, 2004, APPL SOIL ECOL, V27, P189, DOI 10.1016/j.apsoil.2004.03.001; Rutgers M, 2016, APPL SOIL ECOL, V97, P98, DOI 10.1016/j.apsoil.2015.08.015; Simonsen J, 2010, APPL SOIL ECOL, V44, P147, DOI 10.1016/j.apsoil.2009.11.005; Singh P, 2015, SCI TOTAL ENVIRON, V518, P337, DOI 10.1016/j.scitotenv.2015.03.027; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Stroud JL, 2016, APPL SOIL ECOL, V108, P72, DOI 10.1016/j.apsoil.2016.08.002; Stroud JL, 2017, SOIL TILL RES, V165, P11, DOI 10.1016/j.still.2016.07.013; Stroud JL, 2016, APPL SOIL ECOL, V105, P31, DOI 10.1016/j.apsoil.2016.03.019; Targetti S, 2016, J ENVIRON MANAGE, V165, P286, DOI 10.1016/j.jenvman.2015.08.044; Targetti S, 2014, ECOL INDIC, V45, P434, DOI 10.1016/j.ecolind.2014.04.050; Townsend TJ, 2016, SOIL USE MANAGE, V32, P106, DOI 10.1111/sum.12241; van Groenigen JW, 2014, SCI REP-UK, V4, DOI 10.1038/srep06365; Whitmore A.P, 2017, 576 AHDB	32	26	28	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0203909	10.1371/journal.pone.0203909	http://dx.doi.org/10.1371/journal.pone.0203909			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785884	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000002
J	Chappell, MA; Seiter, JM; West, HM; Durham, BD; Porter, BE; Price, CL				Chappell, Mark A.; Seiter, Jennifer M.; West, Haley M.; Durham, Brian D.; Porter, Beth E.; Price, Cynthia L.			Building geochemically based quantitative analogies from soil classification systems using different compositional datasets	PLOS ONE			English	Article							SOLID-PHASE CONSIDERATIONS; ENVIRONMENTAL FATE; 1,3,5-TRINITRO-1,3,5-TRICYCLOHEXANE RDX; 2,4,6-TRINITROTOLUENE TNT; MULTIVARIATE-ANALYSIS; IDENTIFICATION; SORPTION; TAXA	Soil heterogeneity is a major contributor to the uncertainty in near-surface biogeochemical modeling. We sought to overcome this limitation by exploring the development of a new classification analogy concept for transcribing the largely qualitative criteria in the pedomorphologically based, soil taxonomic classification systems to quantitative physicochemical descriptions. We collected soil horizons classified under the Alfisols taxonomic Order in the U.S. National Resource Conservation Service (NRCS) soil classification system and quantified their properties via physical and chemical characterizations. Using multivariate statistical modeling modified for compositional data analysis (CoDA), we developed quantitative analogies by partitioning the characterization data up into three different compositions: Water-extracted (WE), Mehlich-III extracted (ME), and particle-size distribution (PSD) compositions. Afterwards, statistical tests were performed to determine the level of discrimination at different taxonomic and location-specific designations. The analogies showed different abilities to discriminate among the samples. Overall, analogies made up from the WE composition more accurately classified the samples than the other compositions, particularly at the Great Group and thermal regime designations. This work points to the potential to quantitatively discriminate taxonomically different soil types characterized by varying compositional datasets.	[Chappell, Mark A.; Seiter, Jennifer M.; West, Haley M.; Durham, Brian D.; Porter, Beth E.; Price, Cynthia L.] US Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA	United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Chappell, MA (corresponding author), US Army, Engn Res & Dev Ctr, Environm Lab, Vicksburg, MS 39180 USA.	mark.a.chappell@usace.army.mil			Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC)	Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC)	The tests described and the resulting data presented herein, unless otherwise noted, were obtained from research funded under the Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The use of trade, product, or firm names in this report is for descriptive purposes only and does not imply endorsement by the U.S. Government. The tests described and the resulting data presented herein, unless otherwise noted, were obtained from research conducted under the Environmental Quality Technology Program of the US Army Corps of Engineers by the U.S. Army Engineer Research and Development Center (ERDC). Permission was granted by the Chief of Engineers to publish this information. The findings of this report are not to be construed as an official Department of the Army position unless so designated by other authorized documents. The authors express gratitude to Dr. Elizabeth Ferguson, Technical Director of the U.S. Army ERDC Environmental Quality Technology Program for support of this research.	Aitchison J, 1999, MATH GEOL, V31, P563, DOI 10.1023/A:1007568008032; Aitchison J, 2002, J R STAT SOC C-APPL, V51, P375, DOI 10.1111/1467-9876.00275; [Anonymous], 2001, MULTIMEDIA ENV MODEL, DOI DOI 10.1201/9781420032543; Ansari AA, 2000, CHEM GEOL, V162, P245, DOI 10.1016/S0009-2541(99)00073-X; Beaudette D., soilDB: soil database interface. R Package Version 2.6.5; Chappell MA, 2014, CHEMOSPHERE, V95, P174, DOI 10.1016/j.chemosphere.2013.08.061; Chappell MA, 2011, ACS SYM SER, V1069, P1; Chappell MA, 2011, MAR POLLUT BULL, V62, P1736, DOI 10.1016/j.marpolbul.2011.05.026; Chappell MA, 2011, APPL GEOCHEM, V26, pS330, DOI 10.1016/j.apgeochem.2011.03.067; Cong J, 2015, SCI REP-UK, V5, DOI [10.1038/srep10007, 10.1038/srep14139]; Cowan CE, 1995, MULTIMEDIA FATE MODE; DEBAKKER H, 1970, GEODERMA, V4, P195, DOI 10.1016/0016-7061(70)90003-0; Evangelou VP., 1998, ENV SOIL WATER CHEM; Fierer N, 2003, SOIL BIOL BIOCHEM, V35, P167, DOI 10.1016/S0038-0717(02)00251-1; FU JM, 1994, GEOCHIM COSMOCHIM AC, V58, P1591, DOI 10.1016/0016-7037(94)90561-4; Hughes P, 2017, GEODERMA REG, V11, P123, DOI 10.1016/j.geodrs.2017.10.004; Hughes P, 2017, GEODERMA, V307, P198, DOI 10.1016/j.geoderma.2017.08.009; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Ballesta RJ, 2010, CENT EUR J GEOSCI, V2, P441, DOI 10.2478/v10085-010-0028-1; Kahle D, 2013, R J, V5, P144; Katseanes CK, 2017, J ENVIRON MANAGE, V203, P383, DOI 10.1016/j.jenvman.2017.08.005; Katseanes CK, 2016, J ENVIRON MANAGE, V182, P101, DOI 10.1016/j.jenvman.2016.07.043; Katseanes CK, 2014, SOIL FERTILITY STATU; Mayo M, 2014, SCI TOTAL ENVIRON, V494, P104, DOI 10.1016/j.scitotenv.2014.06.061; MSS Working Group WRB, 2015, WORLD SOIL RESOURCES; Nachtergaele FO, 2000, GEODERMA, V96, P345, DOI 10.1016/S0016-7061(00)00023-9; NORRIS JM, 1972, J SOIL SCI, V23, P62, DOI 10.1111/j.1365-2389.1972.tb01642.x; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; PawlowskyGlahn V, 2011, COMPOSITIONAL DATA ANALYSIS: THEORY AND APPLICATIONS, P1, DOI 10.1002/9781119976462; Perkey DW, 2017, IDENTIFICATION SEDIM; R Core Team, 2013, R LANG ENV STAT COMP; Ramirez-Guinart O, 2016, GEODERMA, V269, P19, DOI 10.1016/j.geoderma.2016.01.026; Reimann C, 2008, STAT DATA ANAL EXPLA; Singh BK, 2007, APPL SOIL ECOL, V36, P147, DOI 10.1016/j.apsoil.2007.01.004; Sirven JB, 2007, J ANAL ATOM SPECTROM, V22, P1471, DOI 10.1039/b704868h; Suarez MH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111828; Team R. RStudio, 2018, INT DEV R; Templ M., 2011, ROBCOMPOSITIONS R PA, DOI 10.1002/9781119976462.ch25; van den Boogaart G, R PACKAGE VERSION 1; Van den Boogaart KG., 2013, ANAL COMPOSITIONAL D; Venables WN., 2002, MODERN APPL STAT S 4; Wold S., 1977, CHEMOMETRICS THEORY, P243, DOI DOI 10.1021/BK-1977-0052.CH012; ZUMBERGE JE, 1987, GEOCHIM COSMOCHIM AC, V51, P1625, DOI 10.1016/0016-7037(87)90343-7	43	2	2	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212214	10.1371/journal.pone.0212214	http://dx.doi.org/10.1371/journal.pone.0212214			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779791	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900035
J	Koshy, A; Cuesta, M; Boudreau, P; Cermakian, N; Boivin, DB				Koshy, Anna; Cuesta, Marc; Boudreau, Philippe; Cermakian, Nicolas; Boivin, Diane B.			Disruption of central and peripheral circadian clocks in police officers working at night	FASEB JOURNAL			English	Article						night-shift work; oral mucosa cells; PBMCs; urinary 6-sulfatoxymelatonin; salivary cortisol	BLOOD MONONUCLEAR-CELLS; SHIFT WORK; GENE-EXPRESSION; MESSENGER-RNA; RHYTHMS; NURSES; LIGHT; MELATONIN; CORTISOL; CANCER	Working atypical schedules leads to temporal misalignments between a worker's rest-activity cycle and their endogenous circadian system. Several studies have reported disturbed centrally controlled rhythms, but little is known on shift workers' peripheral clocks. Here, we assessed central clock markers, urinary 6-sulfatoxymelatonin and salivary cortisol, and clock gene expression in 2 peripheral clocks, oral mucosa cells and peripheral blood mononuclear cells (PBMCs), in 11 police officers. Before working 7 consecutive nights, officers' centrally controlled rhythms were aligned to a day-oriented schedule. These rhythms were partially realigned to the shifted schedule and dampened after a week working nights. For peripheral clocks at baseline, Period (PER)1-3 and nuclear receptor subfamily 1, group D, member 1 (REV-ERB alpha) in oral mucosa cells had a significant mRNA peak in the afternoon, whereas in PBMCs, higher PER1-3 expression was observed at 10:00 compared with 19:30. After a week working nights, PER1-3 and REV-ERB alpha expression in oral mucosa cells lost rhythmicity, and in PBMCs, the morning/evening difference observed at baseline was lost. To our knowledge, this is the first study to demonstrate the disruption of several peripheral clocks in real shift workers. Molecular circadian disturbances are believed to have important clinical implications for the occurrence of shift work-associated medical disorders.-Koshy, A., Cuesta, M., Boudreau, P., Cermakian, N., Boivin, D. B. Disruption of central and peripheral circadian clocks in police officers working at night.	[Koshy, Anna; Cuesta, Marc; Boudreau, Philippe; Boivin, Diane B.] McGill Univ, Dept Psychiat, Ctr Study & Treatment Circadian Rhythms, Montreal, PQ, Canada; [Koshy, Anna; Cuesta, Marc; Cermakian, Nicolas] McGill Univ, Dept Psychiat, Lab Mol Chronobiol, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada	McGill University; McGill University	Cermakian, N (corresponding author), Douglas Mental Hlth Univ Inst, Lab Mol Chronobiol, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.; Boivin, DB (corresponding author), Douglas Mental Hlth Univ Inst, Ctr Study & Treatment Circadian Rhythms, 6875 LaSalle Blvd, Montreal, PQ H4H 1R3, Canada.	nicolas.cermakian@mcgill.ca; diane.boivin@douglas.mcgill.ca		Boudreau, Philippe/0000-0002-9367-2919	Canadian Institutes of Health Research [MOP-137052, MOP-102724]; Institut de Recherche Robert-Sauve en Sante et en Securite du Travail [2013-0046]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Institut de Recherche Robert-Sauve en Sante et en Securite du Travail	The authors thank the clinical team from the Douglas Mental Health University Institute, which consisted of the physician on call, Dr. Sylvie Rheaume, and nurse, Xing Dai; Dr. Claire-Dominique Walker, who provided hormone assays; Manon Gagnon and Johanne Gauthier, who provided administrative help; the research technicians and trainees of the laboratory, who assisted with this study; and the participating police officers and their municipal department in the Province of Quebec. This study was supported by grants from the Canadian Institutes of Health Research (MOP-137052 and MOP-102724, to D.B.B and N.C.) and the Institut de Recherche Robert-Sauve en Sante et en Securite du Travail (Operating Grant 2013-0046 to D.B.B. and Graduate Fellowship Award to A.K.) D.B.B. provided consultation and medico-legal advices on shift work and sleep/wake related issues. The remaining authors declare no conflicts of interest.	Akashi M, 2010, P NATL ACAD SCI USA, V107, P15643, DOI 10.1073/pnas.1003878107; Alibhai FJ, 2015, CAN J CARDIOL, V31, P860, DOI 10.1016/j.cjca.2015.01.015; Archer SN, 2008, SLEEP, V31, P608, DOI 10.1093/sleep/31.5.608; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Boivin DB, 2003, BLOOD, V102, P4143, DOI 10.1182/blood-2003-03-0779; Boivin DB, 2002, J BIOL RHYTHM, V17, P556, DOI 10.1177/0748730402238238; Boivin DB, 2012, CHRONOBIOL INT, V29, P619, DOI 10.3109/07420528.2012.675257; Boudreau P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070813; Bracci M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050623; Bracci M, 2014, SCAND J WORK ENV HEA, V40, P295, DOI 10.5271/sjweh.3414; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; Cermakian N, 2011, J BIOL RHYTHM, V26, P160, DOI 10.1177/0748730410395732; Cochran WG, 1957, EXPT DESIGNS; Cuesta M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16429-8; Cuesta M, 2016, J IMMUNOL, V196, P2466, DOI 10.4049/jimmunol.1502422; Cuesta M, 2015, FASEB J, V29, P1360, DOI 10.1096/fj.14-265686; Davis S, 2006, CANCER CAUSE CONTROL, V17, P539, DOI 10.1007/s10552-005-9010-9; Emerson KJ, 2009, J COMP PHYSIOL A, V195, P385, DOI 10.1007/s00359-009-0416-9; Fang MZ, 2015, SLEEP MED, V16, P1388, DOI 10.1016/j.sleep.2015.06.011; Filipski E, 2005, JNCI-J NATL CANCER I, V97, P507, DOI 10.1093/jnci/dji083; Fukuoka Y, 2005, J BIOL RHYTHM, V20, P550, DOI 10.1177/0748730405279866; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; James FO, 2004, CHRONOBIOL INT, V21, P961, DOI 10.1081/CBI-200035944; James FO, 2007, CHRONOBIOL INT, V24, P1009, DOI 10.1080/07420520701800736; James FO, 2007, SLEEP, V30, P1427, DOI 10.1093/sleep/30.11.1427; Johnston JD, 2016, ADV NUTR, V7, P399, DOI 10.3945/an.115.010777; Kervezee L, 2018, P NATL ACAD SCI USA, V115, P5540, DOI 10.1073/pnas.1720719115; Kettner NM, 2016, CANCER CELL, V30, P909, DOI 10.1016/j.ccell.2016.10.007; Kiessling S, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0349-7; Kusanagi H, 2008, NEUROSCI RES, V61, P136, DOI 10.1016/j.neures.2008.01.012; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moore RY, 1998, CHRONOBIOL INT, V15, P475, DOI 10.3109/07420529808998703; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Oster H, 2006, GENES BRAIN BEHAV, V5, P73, DOI 10.1111/j.1601-183X.2006.00226.x; Peplonska B, 2012, OCCUP ENVIRON MED, V69, P339, DOI 10.1136/oemed-2011-100273; Pruessner JC, 1997, LIFE SCI, V61, P2539, DOI 10.1016/S0024-3205(97)01008-4; Reszka E, 2013, SCAND J WORK ENV HEA, V39, P187, DOI 10.5271/sjweh.3303; Roenneberg T, 2012, CURR BIOL, V22, P939, DOI 10.1016/j.cub.2012.03.038; Rosenthal N., 1987, SEASONAL PATTERN ASS; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Skene DJ, 2006, ANN CLIN BIOCHEM, V43, P344, DOI 10.1258/000456306778520142; Statistics Canada, 2005, GEN SOCIAL SURVEY; Teboul M, 2005, J MOL MED, V83, P693, DOI 10.1007/s00109-005-0697-6; US Bureau of Labor Statistics/US Census Bureau, 2004, CURR POP SURV CPS S; Vollmers C, 2009, P NATL ACAD SCI USA, V106, P21453, DOI 10.1073/pnas.0909591106; Wehrens SMT, 2017, CURR BIOL, V27, P1768, DOI 10.1016/j.cub.2017.04.059; Weissova K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146200	49	20	20	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6789	6800		10.1096/fj.201801889R	http://dx.doi.org/10.1096/fj.201801889R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811213	Bronze			2022-12-26	WOS:000476114200010
J	Baath, JA; Mazurkewich, S; Poulsen, JCN; Olsson, L; Lo Leggio, L; Larsbrink, J				Baath, Jenny Arnling; Mazurkewich, Scott; Poulsen, Jens-Christian Navarro; Olsson, Lisbeth; Lo Leggio, Leila; Larsbrink, Johan			Structure-function analyses reveal that a glucuronoyl esterase from Teredinibacter turnerae interacts with carbohydrates and aromatic compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein structure; enzyme kinetics; carbohydrate; plant cell wall; enzyme structure; enzyme mechanism; enzyme mutation; biotechnology; carbohydrate esterase; carbohydrate-active enzymes; CE15; glucuronoyl esterase; lignin-carbohydrate complexes; uronic acid	STRUCTURE REFINEMENT; MODEL; DEGRADATION; EXPRESSION	Glucuronoyl esterases (GEs) catalyze the cleavage of ester linkages found between lignin and glucuronic acid moieties on glucuronoxylan in plant biomass. As such, GEs represent promising biochemical tools in industrial processing of these recalcitrant resources. However, details on how GEs interact with their natural substrates are sparse, calling for thorough structure-function studies. Presented here is the structure and biochemical characterization of a GE, TtCE15A, from the bacterium Teredinibacter turnerae, a symbiont of wood-boring shipworms. To gain deeper insight into enzyme-substrate interactions, inhibition studies were performed with both the WT TtCE15A and variants in which we, by using site-directed mutagenesis, substituted residues suggested to have key roles in binding to or interacting with the aromatic and carbohydrate structures of its uronic acid ester substrates. Our results support the hypothesis that two aromatic residues (Phe-174 and Trp-376), conserved in bacterial GEs, interact with aromatic and carbohydrate structures of these substrates in the enzyme active site, respectively. The solved crystal structure of TtCE15A revealed features previously not observed in either fungal or bacterial GEs, with a large inserted N-terminal region neighboring the active site and a differently positioned residue of the catalytic triad. The findings highlight key interactions between GEs and complex lignin-carbohydrate ester substrates and advance our understanding of the substrate specificities of these enzymes in biomass conversion.	[Baath, Jenny Arnling; Mazurkewich, Scott; Olsson, Lisbeth; Larsbrink, Johan] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Wallenberg Wood Sci Ctr, SE-41296 Gothenburg, Sweden; [Poulsen, Jens-Christian Navarro; Lo Leggio, Leila] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	Chalmers University of Technology; University of Copenhagen	Larsbrink, J (corresponding author), Chalmers Univ Technol, Dept Biol & Biol Engn, Div Ind Biotechnol, Kemivagen 10, SE-41296 Gothenburg, Sweden.	johan.larsbrink@chalmers.se	Larsbrink, Johan/A-3053-2013; Lo Leggio, Leila/B-4287-2015	Larsbrink, Johan/0000-0001-8386-2914; Mazurkewich, Scott/0000-0002-9238-0615; Arnling Baath, Jenny/0000-0001-7973-9577; Lo Leggio, Leila/0000-0002-5135-0882	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center; MAX4ESSFUN: Cross Border Science and Society Program [CTH-003]; Novo Nordisk Foundation [NNF17OC0027698]	Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center(Knut & Alice Wallenberg Foundation); MAX4ESSFUN: Cross Border Science and Society Program; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The work performed at Chalmers University of Technology was supported by the Knut and Alice Wallenberg Foundation through the Wallenberg Wood Science Center. The collaborative work between Chalmers University of Technology and Copenhagen University was supported by MAX4ESSFUN: Cross Border Science and Society Program Grant CTH-003 and Novo Nordisk Foundation Grant NNF17OC0027698 (Biotechnology-based Synthesis and Production Research). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aurilia V, 2000, MICROBIOL-SGM, V146, P1391, DOI 10.1099/00221287-146-6-1391; Baath JA, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1213-x; Baath JA, 2016, FEBS LETT, V590, P2611, DOI 10.1002/1873-3468.12290; Biely P, 2015, FEBS LETT, V589, P2334, DOI 10.1016/j.febslet.2015.07.019; Charavgi MD, 2013, ACTA CRYSTALLOGR D, V69, P63, DOI 10.1107/S0907444912042400; d'Errico C, 2016, J BIOTECHNOL, V219, P117, DOI 10.1016/j.jbiotec.2015.12.024; d'Errico C, 2015, BIOTECHNOL BIOENG, V112, P914, DOI 10.1002/bit.25508; De Santi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17677-4; De Santi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159345; Distel DL, 2002, INT J SYST EVOL MICR, V52, P2261, DOI 10.1099/00207713-52-6-2261; Duranova M, 2009, BIOSCI BIOTECH BIOCH, V73, P2483, DOI 10.1271/bbb.90486; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gorrec F, 2009, J APPL CRYSTALLOGR, V42, P1035, DOI 10.1107/S0021889809042022; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Huynh HH, 2016, J GEN APPL MICROBIOL, V62, P217, DOI 10.2323/jgam.2016.03.004; Huttner S, 2017, APPL MICROBIOL BIOT, V101, P5301, DOI 10.1007/s00253-017-8266-9; Huynh H, 2018, APPL MICROBIOL BIOT, V102, P2191, DOI 10.1007/s00253-018-8739-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katsimpouras C, 2014, APPL MICROBIOL BIOT, V98, P5507, DOI 10.1007/s00253-014-5542-9; Lin MI, 2018, APPL MICROBIOL BIOT, V102, P9635, DOI 10.1007/s00253-018-9318-5; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monrad RN, 2018, CRIT REV BIOTECHNOL, V38, P1121, DOI 10.1080/07388551.2018.1468316; Mosbech C, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1075-2; Pokkuluri PR, 2011, PROTEINS, V79, P2588, DOI 10.1002/prot.23088; Spanikova S, 2007, ARCH MICROBIOL, V188, P185, DOI 10.1007/s00203-007-0241-x; Spanikova S, 2006, FEBS LETT, V580, P4597, DOI 10.1016/j.febslet.2006.07.033; Sunner H, 2015, MOLECULES, V20, P17807, DOI 10.3390/molecules201017807; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Topakas E, 2010, APPL MICROBIOL BIOT, V87, P1765, DOI 10.1007/s00253-010-2655-7; Tsai AYL, 2012, PLANT BIOTECHNOL J, V10, P1077, DOI 10.1111/j.1467-7652.2012.00735.x; Vafiadi C, 2009, FEMS MICROBIOL LETT, V296, P178, DOI 10.1111/j.1574-6968.2009.01631.x; Wong D. W., 2012, BIOTECHNOL RES INT, V2012, DOI 10.1155/2012/951267; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085	38	14	14	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6635	6644		10.1074/jbc.RA119.007831	http://dx.doi.org/10.1074/jbc.RA119.007831			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814248	Green Published, hybrid			2022-12-26	WOS:000468402000036
J	Nyasenu, YT; Gbeasor-Komlanvi, FA; Ehlan, A; Issa, SAR; Dossim, S; Kolou, M; Yambiyo, BM; Prince-David, M; Salou, M; Ekouevi, DK; Dagnra, A				Nyasenu, Yawo Tufa; Gbeasor-Komlanvi, Fifonsi Adjidossi; Ehlan, Amivi; Issa, Sabi Abdul-Raouf; Dossim, Sika; Kolou, Malewe; Yambiyo, Brice Martial; Prince-David, Mireille; Salou, Mounerou; Ekouevi, Didier Koumavi; Dagnra, Anoumou			Prevalence and distribution of Human Papillomavirus (HPV) genotypes among HIV infected women in Lome, Togo	PLOS ONE			English	Article							CERVICAL HUMAN-PAPILLOMAVIRUS; CANCER; DIVERSE; AGE	Human papillomavirus (HPV) infection is the most common sexually transmitted disease worldwide, and it particularly affects people living with human immunodeficiency virus (HIV). This study aimed to estimate the prevalence of HPV and to describe HPV genotypes in HIV-1 infected women in Lome, Togo. From September 2014 to September 2015, a cross-sectional study was conducted in two treatment and care centers for people living with HIV: the Centre Hospitalier Universitaire Sylvanus Olympio and the non-profit organization 'Espoir Vie Togo'. Women living with HIV-1, aged 18 years and older, receiving a combination antiretroviral therapy for at least 12 months, and who gave their informed consent to participate in the study were recruited. Cervical swabs were collected using a cytobrush, and cells were stored in a preservative solution. HPV testing was performed using e-BRID equipment. Blood samples were collected for CD4+ count using a flow cytometer and for HIV viral load using polymerase chain reaction. A total of 221 HIV-1 infected women were enrolled. The prevalence of any type and oncogenic HPV was 22.2%, 95% confidence interval (95% CI): [17.1-28.2] and 16.7% (95% CI: 12.3-22.3), respectively. The most prevalent genotypes were: 18 (8.6%), 68 (4.1%), and 62/81 (2.7%). Only 1.3% (3/221) of participants were infected with HPV16. In regression analysis, no factor was associated with HRHPV.	[Nyasenu, Yawo Tufa; Ehlan, Amivi; Issa, Sabi Abdul-Raouf; Dossim, Sika; Kolou, Malewe; Prince-David, Mireille; Salou, Mounerou; Dagnra, Anoumou] Univ Lome, Dept Sci Fondamentales, Lome, Togo; [Gbeasor-Komlanvi, Fifonsi Adjidossi; Ekouevi, Didier Koumavi] Univ Lome, Dept Sante Publ, Lome, Togo; [Gbeasor-Komlanvi, Fifonsi Adjidossi; Ekouevi, Didier Koumavi] Ctr Africain Rech Epidemiol & Sante Publ, Lome, Togo; [Yambiyo, Brice Martial] Inst Pasteur, Serv Epidemiol, Bangui, Cent Afr Republ; [Ekouevi, Didier Koumavi] Univ Bordeaux, ISPED, Bordeaux, France; [Ekouevi, Didier Koumavi] Univ Bordeaux, Ctr Inserm, Bordeaux, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Nyasenu, YT (corresponding author), Univ Lome, Dept Sci Fondamentales, Lome, Togo.	nyasenu@yahoo.fr	EKOUEVI, Didier K/E-7960-2014	GBEASOR-KOMLANVI, Fifonsi Adjidossi/0000-0002-1744-0454; Nyasenu, Tufa/0000-0002-4000-4212	Ministry of Health and Social Protection of Togo	Ministry of Health and Social Protection of Togo	The Ministry of Health and Social Protection of Togo has financed this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amegbor K, 2011, J CANCER EPIDEMIOL, V2011, DOI 10.1155/2011/319872; Ardhaoui M, 2014, REV EPIDEMIOLOGIE SA, V62, pS205, DOI [10.1186/1744-8603-10-46, DOI 10.1186/1744-8603-10-46]; Bouassa RSM, 2017, EXPERT REV ANTI-INFE, V15, P613, DOI 10.1080/14787210.2017.1322902; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Clifford GM, 2006, AIDS, V20, P2337, DOI 10.1097/01.aids.0000253361.63578.14; Cote-Martin A, 2008, J VIROL, V82, P1271, DOI 10.1128/JVI.01405-07; Dagnra AY, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-30; Dhana A, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-46; Djigma FW, 2011, ACTA TROP, V117, P202, DOI 10.1016/j.actatropica.2010.12.007; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Dufit V., 2016, Bulletin Epidemiologique Hebdomadaire, P588; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Firnhaber C, 2009, ACTA CYTOL, V53, P10, DOI 10.1159/000325079; Freire MP, 2014, INT BRAZ J UROL, V40, P67, DOI 10.1590/S1677-5538.IBJU.2014.01.10; Goldie SJ, 1999, ANN INTERN MED, V130, P97, DOI 10.7326/0003-4819-130-2-199901190-00003; Hanisch RA, 2013, J CLIN VIROL, V58, P696, DOI 10.1016/j.jcv.2013.10.012; Hankins C, 1999, CAN MED ASSOC J, V160, P185; Herraez-Hernandez E, 2013, J VIROL METHODS, V193, P9, DOI 10.1016/j.jviromet.2013.04.018; Howley PM, 2007, FIELDS VIROLOGY, V2, P2299; Jaquet A, 2012, BRIT J CANCER, V107, P556, DOI 10.1038/bjc.2012.299; Keita N, 2009, BRIT J CANCER, V101, P202, DOI 10.1038/sj.bjc.6605140; Kjaer SK, 2001, CANCER EPIDEM BIOMAR, V10, P101; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Mansur CP, 2002, MUCOCUTANEOUS MANIFESTATIONS OF VIRAL DISEASES, P247; Ngo-Giang-Huong N, 2019, J ANTIMICROB CHEMOTH, V74, P462, DOI 10.1093/jac/dky443; Ouedraogo CMR, 2011, J GYNECOL OBST BIO R, V40, P633, DOI 10.1016/j.jgyn.2011.05.012; Passmore Jo-Ann S, 2007, J Inflamm (Lond), V4, P8, DOI 10.1186/1476-9255-4-8; Pisani P, 1999, INT J CANCER, V83, P18, DOI 10.1002/(SICI)1097-0215(19990924)83:1&lt;18::AID-IJC5&gt;3.0.CO;2-M; Pretet JL, 2008, INT J CANCER, V122, P428, DOI 10.1002/ijc.23092; Siracusano S, 2014, UROLOGIA J, V81, P200, DOI 10.5301/uro.5000101; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Subramanya D, 2008, POSTGRAD MED, V120, P7, DOI 10.3810/pgm.2008.11.1928; SUN XW, 1995, OBSTET GYNECOL, V85, P680, DOI 10.1016/0029-7844(95)00025-M; Takassi OE, 2018, MED SANTE TROP, V28, P419, DOI 10.1684/mst.2018.0860; Tang N, 2007, J VIROL METHODS, V146, P236, DOI 10.1016/j.jviromet.2007.07.003; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang SQ, 2010, BIOTECHNOL ADV, V28, P770, DOI 10.1016/j.biotechadv.2010.06.004; WHO, WHO BUILDS COUNTR CA; Yugawa T, 2009, REV MED VIROL, V19, P97, DOI 10.1002/rmv.605	40	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212516	10.1371/journal.pone.0212516	http://dx.doi.org/10.1371/journal.pone.0212516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811454	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400075
J	Alcolea, PJ; Alonso, A; Esteban, A; Peris, P; Cortes, A; Castillo, JA; Larraga, V				Alcolea, Pedro J.; Alonso, Ana; Esteban, Adriana; Peris, Paz; Cortes, Alberto; Castillo, Juan A.; Larraga, Vicente			IL12 p35 and p40 subunit genes administered as pPAL plasmid constructs do not improve protection of pPAL-LACK vaccine against canine leishmaniasis	PLOS ONE			English	Article							IMMUNE-RESPONSE; VISCERAL LEISHMANIASIS; INFANTUM; FOCUS; DOGS; DNA; IMMUNIZATION; COINFECTION; IMMUNOLOGY; PARASITE	Leishmania infantum causes zoonotic visceral leishmaniasis (ZVL) in the Mediterranean basin and South America. The parasite has been shown to co-infect HIV patients and an outbreak in central Spain was reported in the last decade. Therfore, ZVL is a public health problem, dogs being the parasite's reservoir. We have developed a DNA vaccine based on the L. infantum activated protein kinase A receptor (LACK) using different plasmid vectors and vaccinia virus strains as vehicles. Recently, we have generated an antibiotic resistance marker-free plasmid vector called pPAL. Homologous pPAL-LACK prime-boost vaccination protects Beagle dogs as well as a heterologous plasmid-virus regime. For both reasons, pPAL improves safety. IL12 was described to trigger Th1 response through IFN-. production in infected dogs, being a good candidate for cytokine therapy in conventional treatmentunresponsive dogs. Herein, we report a complete protection study in dogs through inoculation of genes encoding for the p35 and p40 subunits which compose canine IL12 in combination with the LACK gene. A homologous plasmid-plasmid regime using independent pPAL constructs for each gene was inoculated in a 15-day interval. The infectious challenge using L. infantum promastigotes was successful. The outcome was pPAL-LACK vaccine protection suppression by IL12 administration. The important implications of this finding are discussed in the manuscript.	[Alcolea, Pedro J.; Alonso, Ana; Larraga, Vicente] CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Lab Mol Parasitol, Madrid, Spain; [Esteban, Adriana; Peris, Paz; Cortes, Alberto; Castillo, Juan A.] Univ Zaragoza, Fac Vet, Dept Pathol, Lab Parasitol, Zaragoza, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Zaragoza	Alcolea, PJ (corresponding author), CSIC, Ctr Invest Biol, Dept Cellular & Mol Biol, Lab Mol Parasitol, Madrid, Spain.	pjalcolea@cib.csic.es	Peris, María Paz/AFB-2914-2022; Alcolea Alcolea, Pedro José/O-5654-2016	Alcolea Alcolea, Pedro José/0000-0002-0729-8941; Larraga, Vicente/0000-0003-1260-7400; Peris, Maria Paz/0000-0001-5750-3643; Alonso Ayala, Ana Maria/0000-0002-1228-7331	CZ Veterinaria - Biofabri	CZ Veterinaria - Biofabri	This study was performed with funds received by VL through a contract with CZ Veterinaria - Biofabri (http://www.czveterinaria.com/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge Ricardo Molina and Maribel Jimenez (Centro Nacional de Microbiologia, Virologia e Inmunologia Sanitarias, Instituto de Salud Carlos III) for genotyping and zymodeme determination of the Leishmania infantum isolate used in this study, and Esteban Rodriguez, Eugenia Puentes, and Elena Sotelo (CZ Veterinaria-Biofabri) for their support. This work was funded by a contract with CZ Veterinaria-Biofabri.	ABRANCHES P, 1991, J PARASITOL, V77, P557, DOI 10.2307/3283159; Alcolea PJ, 2016, DOI 10.1016/j.vaccine.2007.11.021, Patent No. [WO2016188973A1 PCT/EP2016/061621;EPO 16725105, 2016188973]; Alcolea PJ, 2018, PLASMID; Alvar J, 1997, CLIN MICROBIOL REV, V10, P298, DOI 10.1128/CMR.10.2.298; Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546; BARRETT TV, 1980, T ROY SOC TROP MED H, V74, P84, DOI 10.1016/0035-9203(80)90016-4; CARVALHO EM, 1995, AM J TROP MED HYG, V53, P273, DOI 10.4269/ajtmh.1995.53.273; Gomes DCD, 2007, VACCINE, V25, P2168, DOI 10.1016/j.vaccine.2006.11.060; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Desjeux P, 1995, Afr Health, V18, P20; Desjeux P, 2001, Med Trop (Mars), V61, P187; Ferrer L, 1989, Enferm Infecc Microbiol Clin, V7, P293; Francino O, 2006, VET PARASITOL, V137, P214, DOI 10.1016/j.vetpar.2006.01.011; Gonzalez-Aseguinolaza G, 1999, EUR J BIOCHEM, V259, P909, DOI 10.1046/j.1432-1327.1999.00122.x; Gonzalo RM, 2001, MICROBES INFECT, V3, P701, DOI 10.1016/S1286-4579(01)01426-5; GRAMICCIA M, 1982, ANN PARASIT HUM COMP, V57, P527, DOI 10.1051/parasite/1982576527; Gurunathan S, 1998, NAT MED, V4, P1409, DOI 10.1038/4000; Gurunathan S, 1997, J EXP MED, V186, P1137, DOI 10.1084/jem.186.7.1137; HANAHAN D, 1983, METHOD ENZYMOL, V100, P333; Hosein S, 2017, PARASITOLOGY, V144, P95, DOI 10.1017/S003118201600055X; Jimenez M, 1997, AIDS, V11, P569, DOI 10.1097/00002030-199705000-00003; Jimenez M, 2014, VET PARASITOL, V202, P296, DOI 10.1016/j.vetpar.2014.03.027; Jimenez M, 2013, PARASITOL RES, V112, P2453, DOI 10.1007/s00436-013-3406-3; Martin-Martin I, 2014, VET PARASITOL, V202, P207, DOI 10.1016/j.vetpar.2014.02.045; Mauricio IL, 2000, PARASITOL TODAY, V16, P188, DOI 10.1016/S0169-4758(00)01637-9; Mauricio IL, 2004, PARASITOLOGY, V128, P263, DOI 10.1017/S0031182003004578; Molina R, 2012, VET PARASITOL, V190, P268, DOI 10.1016/j.vetpar.2012.05.006; Momo Claudia, 2014, Vet Med Int, V2014, P150582, DOI 10.1155/2014/150582; MOODY SF, 1993, ACTA TROP, V53, P185, DOI 10.1016/0001-706X(93)90029-B; Gonzales EP, 2017, PENSAM MARGEN, P1; Poot J, 2006, VACCINE, V24, P2460, DOI 10.1016/j.vaccine.2005.12.039; Ramiro MJ, 2003, VACCINE, V21, P2474, DOI 10.1016/S0264-410X(03)00032-X; Ramos I, 2008, VACCINE, V26, P333, DOI 10.1016/j.vaccine.2007.11.021; Ramos I, 2009, VACCINE, V27, P6695, DOI 10.1016/j.vaccine.2009.08.091; Ribeiro-de-Jesus A, 1998, BRAZ J MED BIOL RES, V31, P143, DOI 10.1590/S0100-879X1998000100020; Roberts MTM, 2005, BRIT MED BULL, V75-76, P115, DOI 10.1093/bmb/ldl003; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; SEMIAOSANTOS SJ, 1995, PARASITOL RES, V81, P235; Strauss-Ayali D, 2005, INT J PARASITOL, V35, P63, DOI 10.1016/j.ijpara.2004.10.015; Tintaya KWQ, 2004, J INFECT DIS, V189, P1035, DOI 10.1086/382049; Tripathi P, 2007, FEMS IMMUNOL MED MIC, V51, P229, DOI 10.1111/j.1574-695X.2007.00311.x; WHO, 2010, WHO TECH REP SER, V949, P1; Wolday D, 2001, MED MICROBIOL IMMUN, V190, P65, DOI 10.1007/s004300100082	43	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212136	10.1371/journal.pone.0212136	http://dx.doi.org/10.1371/journal.pone.0212136			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794597	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100040
J	Brunner, MAT; Rufenacht, S; Bauer, A; Erpel, S; Buchs, N; Braga-Lagache, S; Heller, M; Leeb, T; Jagannathan, V; Wiener, DJ; Welle, MM				Brunner, Magdalena A. T.; Rufenacht, Silvia; Bauer, Anina; Erpel, Susanne; Buchs, Natasha; Braga-Lagache, Sophie; Heller, Manfred; Leeb, Tosso; Jagannathan, Vidhya; Wiener, Dominique J.; Welle, Monika M.			Bald thigh syndrome in sighthounds-Revisiting the cause of a well-known disease	PLOS ONE			English	Article							HAIR FOLLICLE DIFFERENTIATION; ECTODERMAL DYSPLASIAS; CYSTEINE-RICH; STEM-CELLS; MUTATIONS; EXPRESSION; KERATINS; PROTEIN; ALOPECIA; HOXC13	Bald thigh syndrome is a common hair loss disorder in sighthounds. Numerous possible causes, including environmental conditions, trauma, stress, endocrinopathies and genetic components have been proposed, but only endocrinopathies have been ruled out scientifically. The overall goal of our study was to identify the cause of bald thigh syndrome and the pathological changes associated with it. We approached this aim by comparing skin biopsies and hair shafts of affected and control dogs microscopically as well as by applying highthroughput technologies such as genomics, transcriptomics and proteomics. While the histology is rather unspecific in most cases, trichogram analysis and scanning electron microscopy revealed severe structural abnormalities in hair shafts of affected dogs. This finding is supported by the results of the transcriptomic and proteomic profiling where genes and proteins important for differentiation of the inner root sheath and the assembly of a proper hair shaft were downregulated. Transcriptome profiling revealed a downregulation of genes encoding 23 hair shaft keratins and 51 keratin associated proteins, as well as desmosomal cadherins and several actors of the BMP signaling pathway which is important for hair shaft differentiation. The lower expression of keratin 71 and desmocollin 2 on the mRNA level in skin biopsies corresponded with a decreased protein expression in the hair shafts of affected dogs. The genetic analysis revealed a missense variant in the IGFBP5 gene homozygous in all available Greyhounds and other sighthounds. Further research is required to clarify whether the IGFBP5 variant represents a predisposing genetic risk factor. We conclude from our results that structural defects in the hair shafts are the cause for this wellknown disease and these defects are associated with a downregulation of genes and proteins essential for hair shaft formation. Our data add important knowledge to further understand the molecular mechanisms of HF morphogenesis and alopecia in dogs.	[Brunner, Magdalena A. T.; Welle, Monika M.] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland; [Brunner, Magdalena A. T.; Bauer, Anina; Leeb, Tosso; Welle, Monika M.] Univ Bern, DermFocus, Bern, Switzerland; [Rufenacht, Silvia] Tierklin Aarau West, DermaVet, Oberentfelden, Switzerland; [Bauer, Anina; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Inst Genet, Bern, Switzerland; [Erpel, Susanne] Univ Basel, SNI, Nano Imaging Lab, Basel, Switzerland; [Buchs, Natasha; Braga-Lagache, Sophie; Heller, Manfred] Univ Bern, Dept BioMed Res DBMR, Bern, Switzerland; [Wiener, Dominique J.] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA	University of Bern; University of Bern; University of Bern; University of Basel; University of Bern; Texas A&M University System; Texas A&M University College Station	Welle, MM (corresponding author), Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Bern, Switzerland.; Welle, MM (corresponding author), Univ Bern, DermFocus, Bern, Switzerland.	monika.welle@vetsuisse.unibe.ch	Welle, Monika Maria/ABF-6113-2021; Wiener, Dominique Judith/AAN-3313-2021; Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Bauer, Anina/0000-0002-6765-4012; Brunner, Magdalena/0000-0002-0449-0989	Swiss National Science Foundation [CRSII3_ 160738 / 1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a grant from the Swiss National Science Foundation (CRSII3_ 160738 / 1). The funders provided support in the form of the salary for one author (Magdalena Brunner) and consumables, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Silvia Rufenacht, one of the coauthors, owns a private dermatological specialty clinic (Dermavet) and generates her income by seeing patients. She was involved in the planning of the study and collected the biopsy and trichogram samples. Furthermore she evaluated the trichogram samples. She did not receive any payment for this work. The specific roles of all authors are articulated in the 'author contributions' section.	Abitbol M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120668; Adhikari K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10815; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2018, HGNC DAT; Aoki N, 2001, J INVEST DERMATOL, V116, P359, DOI 10.1046/j.1523-1747.2001.01226.x; Bai B, 2015, NUCLEIC ACIDS RES, V43, pD777, DOI 10.1093/nar/gku1174; Balmer P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180359; Basmanav FBU, 2016, AM J HUM GENET, V99, P1292, DOI 10.1016/j.ajhg.2016.10.004; Bauer A, 2019, ANIM GENET, V50, P97, DOI 10.1111/age.12743; Bazzi H, 2009, DIFFERENTIATION, V78, P292, DOI 10.1016/j.diff.2009.06.004; Brunner MAT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186469; Cadieu E, 2009, SCIENCE, V326, P150, DOI 10.1126/science.1177808; Cai J, 2009, DEV BIOL, V326, P420, DOI 10.1016/j.ydbio.2008.11.021; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Deb-Choudhury S, 2018, ADV EXP MED BIOL, V1054, P173, DOI 10.1007/978-981-10-8195-8_12; Duverger O, 2014, SEMIN CELL DEV BIOL, V25, P22, DOI 10.1016/j.semcdb.2013.12.006; Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743; Farooq M, 2011, BRIT J DERMATOL, V165, P425, DOI 10.1111/j.1365-2133.2011.10373.x; Fraser RDB, 2014, J STRUCT BIOL, V188, P213, DOI 10.1016/j.jsb.2014.10.012; Freire-Maia N, 2001, AM J MED GENET, V104, P84, DOI 10.1002/ajmg.1586; Fujimoto A, 2012, J INVEST DERMATOL, V132, P2342, DOI 10.1038/jid.2012.154; Gandolfi B, 2010, MAMM GENOME, V21, P509, DOI 10.1007/s00335-010-9290-6; GARCIA ML, 1978, J SOC COSMET CHEM, V29, P155; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Gross TL, 2005, SKIN DISEASES OF THE DOG AND CAT: CLINICAL AND HISTOPATHOLOGIC DIAGNOSIS, 2ND EDITION, P480; Gross TL., 2008, SKIN DIS DOG CAT CLI; Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6; Harel S, 2012, J INVEST DERMATOL, V132, P2315, DOI 10.1038/jid.2012.291; Harland DP, 2018, ADV EXP MED BIOL, V1054, P109, DOI 10.1007/978-981-10-8195-8_10; Hirano-Ali SA, 2015, PEDIATR DERMATOL, V32, P836, DOI 10.1111/pde.12674; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Itin PH, 2001, J AM ACAD DERMATOL, V44, P891, DOI 10.1067/mjd.2001.114294; Itin PH, 2005, DERMATOLOGY, V211, P63, DOI 10.1159/000085582; Johns SA, 2005, DEV DYNAM, V232, P1062, DOI 10.1002/dvdy.20278; Khan I, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-779; Kizawa K, 2002, BIOCHEM BIOPH RES CO, V299, P857, DOI 10.1016/S0006-291X(02)02744-4; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Koehn H, 2010, J PROTEOME RES, V9, P2920, DOI 10.1021/pr901106m; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Kuramoto T, 2010, J VET MED SCI, V72, P909, DOI 10.1292/jvms.09-0554; Langbein L, 2003, J INVEST DERMATOL, V120, P512, DOI 10.1046/j.1523-1747.2003.12087.x; Langbein L, 1999, J BIOL CHEM, V274, P19874, DOI 10.1074/jbc.274.28.19874; Langbein L, 2001, J BIOL CHEM, V276, P35123, DOI 10.1074/jbc.M103305200; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Langbein L, 2010, J INVEST DERMATOL, V130, P55, DOI 10.1038/jid.2009.192; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Lin ZM, 2012, AM J HUM GENET, V91, P906, DOI 10.1016/j.ajhg.2012.08.029; Lord LK, 2007, J VET INTERN MED, V21, P1243, DOI 10.1892/07-063.1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma L, 2003, DEVELOPMENT, V130, P379, DOI 10.1242/dev.00201; Mallory SB, 2006, ILLUSTRATED DICT DER; Marsh J., 2015, HLTH HAIR, P45; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Muntener T, 2012, VET DERMATOL, V23, P206, DOI 10.1111/j.1365-3164.2012.01049.x; Muntener T, 2011, VET DERMATOL, V22, P383, DOI 10.1111/j.1365-3164.2011.00963.x; Muller Broek A., 2013, VET DERMATOL, V24, P559, DOI [10.1111/vde.12055, DOI 10.1111/VDE.12055]; Peters T, 2003, J INVEST DERMATOL, V121, P674, DOI 10.1046/j.1523-1747.2003.12491.x; PINHEIRO M, 1994, AM J MED GENET, V53, P153, DOI 10.1002/ajmg.1320530207; Poplin R., 2018, BIORXIV, DOI DOI 10.1101/201178; Rakowska A, 2012, MONILETHRIX PSEUDOMO, P145; Velasco MVR, 2009, BRAZ J PHARM SCI, V45, P153, DOI 10.1590/S1984-82502009000100019; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; Rogers MA, 2006, INT REV CYTOL, V251, P209, DOI 10.1016/S0074-7696(06)51006-X; Schlake T, 2005, DEVELOPMENT, V132, P2981, DOI 10.1242/dev.01873; Schlake T, 2005, MECH DEVELOP, V122, P988, DOI 10.1016/j.mod.2005.04.012; Schoning PR, 2000, VET DERMATOL, V11, P49, DOI 10.1046/j.1365-3164.2000.00175.x; Shimomura Y, 2005, J INVEST DERM SYMP P, V10, P230, DOI 10.1111/j.1087-0024.2005.10112.x; Shimomura Y, 2016, J DERMATOL SCI, V84, P232, DOI 10.1016/j.jdermsci.2016.08.006; Shimomura Y, 2010, ANNU REV GENOM HUM G, V11, P109, DOI 10.1146/annurev-genom-021610-131501; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Takizawa T, 1999, J HISTOCHEM CYTOCHEM, V47, P525, DOI 10.1177/002215549904700411; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Tosti A., 2005, DIAGNOSIS TREATMENT, V1st ed; Tumilowicz P, 2018, VET DERMATOL, V29, P332, DOI 10.1111/vde.12656; van Steensel M, 2015, EXP DERMATOL, V24, P222, DOI 10.1111/exd.12624; Wong SY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164993; Yamakoshi T, 2013, BIOCHEM BIOPH RES CO, V432, P66, DOI 10.1016/j.bbrc.2013.01.084; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	81	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212645	10.1371/journal.pone.0212645	http://dx.doi.org/10.1371/journal.pone.0212645			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794648	Green Published, gold			2022-12-26	WOS:000459709100103
J	Duchateau, L; Martin-Aguilar, L; Lleixa, C; Cortese, A; Dols-Icardo, O; Cervera-Carles, L; Pascual-Goni, E; Diaz-Manera, J; Calegari, I; Franciotta, D; Rojas-Garcia, R; Illa, I; Clarimon, J; Querol, L				Duchateau, Lena; Martin-Aguilar, Lorena; Lleixa, Cinta; Cortese, Andrea; Dols-Icardo, Oriol; Cervera-Carles, Laura; Pascual-Goni, Elba; Diaz-Manera, Jordi; Calegari, Ilaria; Franciotta, Diego; Rojas-Garcia, Ricard; Illa, Isabel; Clarimon, Jordi; Querol, Luis			Absence of pathogenic mutations in CD59 in chronic inflammatory demyelinating polyradiculoneuropathy	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; COMPLEMENT; POLYNEUROPATHY; ANTIBODIES	Objective Mutations in CD59 cause CIDP-like polyneuropathy in children with inherited chronic hemolysis. We hypothesized that mutations in CD59 might be found in a subset of sporadic CIDP patients. Methods 35 patients from two centers, fulfilling the EFNS/PNS diagnostic criteria for CIDP were included. CD59 coding region was amplified by PCR and Sanger sequenced. Results One rare variant was detected in a patient which resulted in a synonymous change and predicted to be neutral. Pathogenic variants were absent in our cohort. Interpretation Our pilot study suggests that mutations in CD59 are absent in adult-onset sporadic CIDP.	[Duchateau, Lena; Dols-Icardo, Oriol; Cervera-Carles, Laura; Clarimon, Jordi] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Memory Unit, Barcelona, Spain; [Martin-Aguilar, Lorena; Lleixa, Cinta; Pascual-Goni, Elba; Diaz-Manera, Jordi; Rojas-Garcia, Ricard; Illa, Isabel; Querol, Luis] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, Barcelona, Spain; [Cortese, Andrea; Calegari, Ilaria; Franciotta, Diego] IRCCS Mondino Fdn, Pavia, Italy; [Dols-Icardo, Oriol; Cervera-Carles, Laura; Clarimon, Jordi] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Diaz-Manera, Jordi; Rojas-Garcia, Ricard; Illa, Isabel; Querol, Luis] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain	Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; IRCCS Fondazione Casimiro Mondino; CIBERNED; CIBER - Centro de Investigacion Biomedica en Red; CIBERER	Querol, L (corresponding author), Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Neuromuscular Dis Unit, Barcelona, Spain.; Querol, L (corresponding author), Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain.	lquerol@santpau.cat	ILLA, Isabel/AAD-1816-2019; Franciotta, Diego/K-8262-2016; Cervera-Carles, Laura/AAN-4530-2020; Dols-Icardo, Oriol/AAC-1181-2020; Martín-Aguilar, Lorena/ABC-4295-2020; Franciotta, Diego/ABE-0957-2022	Franciotta, Diego/0000-0002-3014-3913; Cervera-Carles, Laura/0000-0003-2286-200X; Dols-Icardo, Oriol/0000-0003-2656-8748; Martín-Aguilar, Lorena/0000-0002-1553-2224; Franciotta, Diego/0000-0002-3014-3913; Duchateau, Lena/0000-0002-1689-7014	Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain; FEDER [FIS16/00627]; Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2016-2020 of the Departament de Salut of the Generalitat de Catalunya [SLT006/17/00131]	Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain; FEDER(European Commission); Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2016-2020 of the Departament de Salut of the Generalitat de Catalunya	This project was supported by Fondo de Investigaciones Sanitarias (FIS), Instituto de Salud Carlos III, Spain and FEDER under grant FIS16/00627, and a personal grant to LQ SLT006/17/00131 of the Pla Estrategic de Recerca i Innovacioen Salut (PERIS) 2016-2020 of the Departament de Salut of the Generalitat de Catalunya, pricipal investigator LQ.	Ardicli D, 2017, NEUROPEDIATRICS, V48, P477, DOI 10.1055/s-0037-1604483; Blum S, 2014, J PERIPHER NERV SYST, V19, P88, DOI 10.1111/jns5.12074; Brodsky RA, 2008, BLOOD, V111, P1840, DOI 10.1182/blood-2007-06-094136; DALAKAS MC, 1980, ARCH NEUROL-CHICAGO, V37, P637, DOI 10.1001/archneur.1980.00500590061010; Eftimov F, 2018, NEUROMUSCULAR DISORD, V28, P178, DOI 10.1016/j.nmd.2017.10.009; Haliloglu G, 2015, NEUROLOGY, V84, P1220, DOI 10.1212/WNL.0000000000001391; Koike H, 2017, J NEUROL NEUROSUR PS, V88, P465, DOI 10.1136/jnnp-2016-314895; KOSKI CL, 1987, J CLIN INVEST, V80, P1492, DOI 10.1172/JCI113231; Martinez-Martinez L, 2017, J NEUROINFLAMM, V14, P1, DOI [10.1186/s12974-016-0779-0, DOI 10.1186/S12974-016-0779-0]; Mathey EK, 2015, J NEUROL NEUROSUR PS, V86, P973, DOI 10.1136/jnnp-2014-309697; Mead RJ, 2004, LAB INVEST, V84, P21, DOI 10.1038/labinvest.3700015; Mevorach D, 2016, ANN NEUROL, V80, P708, DOI 10.1002/ana.24770; Miyaji K, 2014, J NEUROIMMUNOL, V276, P172, DOI 10.1016/j.jneuroim.2014.08.004; Nevo Y, 2013, BLOOD, V121, P129, DOI 10.1182/blood-2012-07-441857; Parker C, 2018, REV TRANSLATIONAL HE, V106, P3699, DOI [10.1182/blood-2005-04-1717.Supported, DOI 10.1182/BLOOD-2005-04-1717]; Querol L, 2017, NAT REV NEUROL, V13, P533, DOI 10.1038/nrneurol.2017.84; Querol L, 2014, NEUROLOGY, V82, P879, DOI 10.1212/WNL.0000000000000205; Querol L, 2013, ANN NEUROL, V73, P370, DOI 10.1002/ana.23794; Vallat JM, 2017, NEUROMUSCULAR DISORD, V27, P290, DOI 10.1016/j.nmd.2016.10.008; Van den Bergh PYK, 2010, EUR J NEUROL, V17, P356, DOI 10.1111/j.1468-1331.2009.02930.x	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212647	10.1371/journal.pone.0212647	http://dx.doi.org/10.1371/journal.pone.0212647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794663	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100104
J	Kim, HS; Cho, SK; Kim, CS; Park, JS				Kim, Hyung Sun; Cho, Seong Kyung; Kim, Chang Soo; Park, Joon Seong			Big data and analysis of risk factors for gallbladder disease in the young generation of Korea	PLOS ONE			English	Article							GALLSTONE DISEASE; DIETARY PATTERNS; POPULATION; PREVALENCE; SMOKING; OBESITY	Background/Purpose Few studies have examined the risk factors for gallbladder (GB) disease in young adults. This study aimed to evaluate risk factors for GB disease in young adults based on big data in Korea. Methods All participants underwent routine checkup at the Korea Medical Institute from June 2014 to May 2015. After excluding 677 individuals with missing information in records, 724,114 individuals (435,635 men, 288,479 women) were finally included. The definition of abnormal GB finding included stones, sludge, polyps, and adenomyomatosis detected using ultrasonography. All statistical analyses were performed using SAS software version 9.2. Results Overall, 27,130 (17.5%) individuals were diagnosed as having abnormal GB finding in the young age group (N = 154,463, aged 20-39 years). In men, significant differences in low-density lipoprotein (LDL) and cholesterol levels were observed between the abnormal GB finding group and normal GB group (p < 0.05). In women, a significant difference in smoking history was noted between the abnormal GB finding group and normal GB group (p < 0.05). The prevalence rate of GB stones was 1.9% (27,979/154,463) in the young age group. High body mass index (BMI), large thigh circumference, and low high-density lipoprotein (HDL) level in women and low HDL level in men were independent risk factors for the presence of GB stones (p < 0.05). Conclusion In this study, obesity-related factors (BMI, waist size, thigh circumference, and cholesterol, LDL, and HDL levels) correlated with GB disease in the young generation of Korea.	[Kim, Hyung Sun; Park, Joon Seong] Yonsei Univ, Dept Surg, Gangnam Severance Hosp, Pancreatobiliary Canc Clin, Seoul, South Korea; [Cho, Seong Kyung; Kim, Chang Soo] Yonsei Univ, Coll Med, Dept Prevent Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Park, JS (corresponding author), Yonsei Univ, Dept Surg, Gangnam Severance Hosp, Pancreatobiliary Canc Clin, Seoul, South Korea.	JSPARK330@yuhs.ac		Kim, Hyung Sun/0000-0002-9002-3569; a, gokul/0000-0003-2226-4691; Kim, Changsoo/0000-0002-5940-5649; Park, Joon Seong/0000-0001-8048-9990	Korea Medical Institute (KMI)	Korea Medical Institute (KMI)	This thesis was financially supported by Korea Medical Institute (KMI).	Aune D, 2016, EUR J EPIDEMIOL, V31, P643, DOI 10.1007/s10654-016-0124-z; Aune D, 2015, EUR J EPIDEMIOL, V30, P1009, DOI 10.1007/s10654-015-0081-y; Bae Nam-Kyou, 2009, [Journal of Korea Academia-Industrial cooperation Society, 한국산학기술학회논문지], V10, P1091; Banim PJR, 2011, EUR J GASTROEN HEPAT, V23, P733, DOI 10.1097/MEG.0b013e3283477cc9; Cai JS, 2017, SCAND J GASTROENTERO, V52, P34, DOI 10.1080/00365521.2016.1224382; Chen CH, 2006, J GASTROEN HEPATOL, V21, P1737, DOI 10.1111/j.1440-1746.2006.04381.x; Chen YS, 2015, LAB INVEST, V95, P124, DOI 10.1038/labinvest.2014.140; Chilimuri Sridhar, 2017, J Clin Med Res, V9, P117, DOI 10.14740/jocmr2847w; Constantinescu T, 2012, CHIRURGIA-BUCHAREST, V107, P579; CRAIG WY, 1989, BMJ-BRIT MED J, V298, P784, DOI 10.1136/bmj.298.6676.784; Degirmenci B, 2006, WORLD J GASTROENTERO, V12, P5540, DOI 10.3748/wjg.v12.i34.5540; Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), 2002, 3 REP EXP PAN DET EV; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; James PT, 2004, CLIN DERMATOL, V22, P276, DOI 10.1016/j.clindermatol.2004.01.010; Kim CS, 2014, DIABETES METAB J, V38, P35, DOI 10.4093/dmj.2014.38.1.35; Kim Mi-Ok, 2009, Preventive Nutrition and Food Science, V14, P303; Lammert F, 2016, J HEPATOL, V65, P146, DOI 10.1016/j.jhep.2016.03.005; Lammert F, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.24; Larsson SC, 2017, EUR J CANCER, V70, P42, DOI 10.1016/j.ejca.2016.10.012; Leitzmann MF, 1999, NEW ENGL J MED, V341, P777, DOI 10.1056/NEJM199909093411101; Martinez-Gonzalez MA, 2013, REV ENDOCR METAB DIS, V14, P265, DOI 10.1007/s11154-013-9264-6; McConnell TJ, 2017, EUR J CLIN NUTR, V71, P731, DOI 10.1038/ejcn.2016.252; Molina-Molina Emilio, 2018, Eur J Clin Invest, V48, pe12958, DOI 10.1111/eci.12958; NOMURA H, 1988, AM J EPIDEMIOL, V128, P598, DOI 10.1093/oxfordjournals.aje.a115007; Ogden CL, 2016, JAMA-J AM MED ASSOC, V315, P2292, DOI 10.1001/jama.2016.6361; Park Y, 2017, J HEALTH POPUL NUTR, V36, DOI 10.1186/s41043-017-0116-y; Poobalan AS, 2014, HEALTH PSYCHOL BEHAV, V2, P909, DOI 10.1080/21642850.2014.931232; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Portincasa P, 2004, WORLD J GASTROENTERO, V10, P2383; Ramachandran A, 2010, J OBES, V2010, DOI 10.1155/2010/868573; Service NHI, 2015, KON HLTH IND STAT SY; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Sun H, 2009, WORLD J GASTROENTERO, V15, P1886, DOI 10.3748/wjg.15.1886; Tsai CJ, 2008, ANN SURG, V247, P95, DOI 10.1097/SLA.0b013e31815792c2; Unisa S, 2011, HPB, V13, P117, DOI 10.1111/j.1477-2574.2010.00255.x; Van Erpecum KJ, 2011, CLIN RES HEPATOL GAS, V35, P281, DOI 10.1016/j.clinre.2011.01.009; Weerakoon HTW, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-88; Yun-Jin Chung MD, 2007, KOREAN J MED, V72	38	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211480	10.1371/journal.pone.0211480	http://dx.doi.org/10.1371/journal.pone.0211480			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794560	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100018
J	Rajamanikam, A; Hooi, HS; Kudva, M; Samudi, C; Kumar, S				Rajamanikam, Arutchelvan; Hooi, Ho Shiaw; Kudva, Madhav; Samudi, Chandramathi; Kumar, Suresh			A Resistance towards metronidazole in Blastocystis sp.: A pathogenic consequence	PLOS ONE			English	Article							COLORECTAL-CANCER CELLS; CYSTEINE PROTEASES; SUBTYPE 3; HOMINIS; ENTAMOEBA; DIFFERENTIATION; ERADICATION; EXPRESSION; GENOME; FORMS	Blastocsytis sp. is a protozoan parasite that has been linked to common gastrointestinal illnesses. Metronidazole, the first line therapy, was reported to show frequent inefficacy. Previously, Blastocystis sp. isolated from different population showed varying metronidazole resistance. However, the effect of metronidazole treatment on pathogenic potentials of Blastocystis sp. isolated from different populations, which is known to have different gut environment, is unclear. This study investigates the in vitro effect of metronidazole on the pathogenic potentials of Blastocystis sp. isolated from urban and orang asli individuals. Blastocystis sp. ST 3 isolated from symptomatic and asymptomatic individuals were treated with a range of metronidazole concentration. The parasites' growth characteristics, apoptotic rate, specific protease activity and the ability to proliferate cancer cells were analyzed upon treatment with 0.001 mg/l metronidazole. The study demonstrates that Blastocystis sp. isolates showed increase in the parasite numbers especially the amoebic forms (only in urban isolates) after treating with metronidazole at the concentration of 0.001 mg/ml. High number of cells in post-treated isolates coincided with increase of apoptosis. There was a significant increase in cysteine protease of Blastocystis sp. isolates upon treatment despite the initial predominance of serine protease in asymptomatic isolates. Metronidazole resistant Blastocystis sp. also showed significant increase in cancer cell proliferation. Resistance to metronidazole did not show significant different influence on the pathogenicity between Blastocystis sp. isolated from urban and orang asli individual. However, an increase in parasite numbers, higher amoebic forms, cysteine protease and ability to proliferate cancer cells implicates a pathogenic role. The study provides evidence for the first time, the effect of metronidazole towards enhancing pathogenic potentials in Blastocystis sp. when isolated from different gut environment. This necessitates the need for reassessment of metronidazole treatment modalities.	[Rajamanikam, Arutchelvan; Kumar, Suresh] Univ Malaya, Fac Med, Depatment Parasitol, Kuala Lumpur, Malaysia; [Hooi, Ho Shiaw] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia; [Kudva, Madhav] Pantai Hosp, Gastroenterol & Hepatol Specialist Clin, Kuala Lumpur, Malaysia; [Samudi, Chandramathi] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Kumar, S (corresponding author), Univ Malaya, Fac Med, Depatment Parasitol, Kuala Lumpur, Malaysia.	suresh@um.edu.my	samudi@raju, Chandramathi/AAR-1595-2021; Ho, Shiaw-Hooi/B-1606-2017	Ho, Shiaw-Hooi/0000-0003-4992-7627; Rajamanikam, Arutchelvan/0000-0002-3280-1617	Ministry of Higher Education of Malaysia under Fundamental Research Grant Scheme (FRGS) [FP015-2017A]	Ministry of Higher Education of Malaysia under Fundamental Research Grant Scheme (FRGS)	This study was entirely supported by Ministry of Higher Education of Malaysia under Fundamental Research Grant Scheme (FRGS) (FP015-2017A), received by SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andiran N, 2006, J PEDIATR SURG, V41, P1489, DOI 10.1016/j.jpedsurg.2006.04.037; Chan KH, 2012, PARASITOL RES, V110, P2475, DOI 10.1007/s00436-011-2788-3; Chandramathi S, 2010, PARASITOL RES, V106, P941, DOI 10.1007/s00436-010-1764-7; Coyle CM, 2012, CLIN INFECT DIS, V54, P105, DOI 10.1093/cid/cir810; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Denoeud F, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r29; Dhurga DB, 2012, T ROY SOC TROP MED H, V106, P725, DOI 10.1016/j.trstmh.2012.08.005; Dudley R, 2008, FEMS MICROBIOL LETT, V286, P9, DOI 10.1111/j.1574-6968.2008.01249.x; El Deeb HK, 2012, PARASITOL RES, V110, P2167, DOI 10.1007/s00436-011-2743-3; Girish S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0942-y; Graczyk TK, 2005, PARASITOL RES, V98, P38, DOI 10.1007/s00436-005-0003-0; Haresh K, 1999, TROP MED INT HEALTH, V4, P274, DOI 10.1046/j.1365-3156.1999.00398.x; Katsarou-Katsari A, 2008, ACTA DERM-VENEREOL, V88, P80, DOI 10.2340/00015555-0338; Khademvatan S, 2017, PARASITOL INT, V66, P142, DOI 10.1016/j.parint.2017.01.005; Khan NA, 2000, J CLIN MICROBIOL, V38, P2858, DOI 10.1128/JCM.38.8.2858-2861.2000; Kumarasamy V, 2013, PARASITOL RES, V112, P3551, DOI 10.1007/s00436-013-3538-5; Kurt O, 2016, PARASITOL INT, V65, P797, DOI 10.1016/j.parint.2016.01.010; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; Makioka A, 2009, PARASITOL RES, V105, P977, DOI 10.1007/s00436-009-1478-x; MCKERROW JH, 1993, ANNU REV MICROBIOL, V47, P821, DOI 10.1146/annurev.mi.47.100193.004133; Mirza H, 2012, CELL MICROBIOL, V14, P1474, DOI 10.1111/j.1462-5822.2012.01814.x; Moschen AR, 2012, GUT LIVER, V6, P411, DOI 10.5009/gnl.2012.6.4.411; Nigro L, 2003, J TRAVEL MED, V10, P128, DOI 10.2310/7060.2003.31714; Pal D, 2009, ANTIMICROB AGENTS CH, V53, P458, DOI 10.1128/AAC.00909-08; Pasqui A L, 2004, Eur Rev Med Pharmacol Sci, V8, P117; Puthia MK, 2008, EUKARYOT CELL, V7, P435, DOI 10.1128/EC.00371-07; Puthia MK, 2005, PARASITOL RES, V97, P386, DOI 10.1007/s00436-005-1461-0; Ragavan ND, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-404; Rajamanikam A, 2018, PARASITOL RES, V117, P2585, DOI 10.1007/s00436-018-5948-x; Rajamanikam A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-295; Raman K, 2016, PARASITOL RES, V115, P391, DOI 10.1007/s00436-015-4760-0; Roberts T, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-17; Roberts T, 2014, J MED MICROBIOL, V63, P252, DOI 10.1099/jmm.0.065508-0; Scanlan PD, 2014, FEMS MICROBIOL ECOL, V90, P326, DOI 10.1111/1574-6941.12396; Scanlan PD, 2012, TRENDS PARASITOL, V28, P327, DOI 10.1016/j.pt.2012.05.001; Segata N, 2015, CURR BIOL, V25, pR611, DOI 10.1016/j.cub.2015.05.040; Sekar Uma, 2013, Trop Parasitol, V3, P35, DOI 10.4103/2229-5070.113901; Shah Mitanshu, 2012, Case Rep Gastroenterol, V6, P358, DOI 10.1159/000339205; Sio SWS, 2006, PARASITOL RES, V99, P126, DOI 10.1007/s00436-006-0131-1; Stensvold CR, 2008, ANN TROP MED PARASIT, V102, P271, DOI 10.1179/136485908X278847; Stensvold CR, 2010, J CLIN GASTROENTEROL, V44, P85, DOI 10.1097/MCG.0b013e3181bb86ba; Stensvold CR, 2011, AM J TROP MED HYG, V84, P883, DOI 10.4269/ajtmh.2011.11-0005; Tan TC, 2008, PARASITOL RES, V104, P85, DOI 10.1007/s00436-008-1163-5; Tan TC, 2006, PARASITOL RES, V99, P737, DOI 10.1007/s00436-006-0214-z; Tan TC, 2006, PARASITOL RES, V98, P189, DOI 10.1007/s00436-005-0033-7; Tillack M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-170; Tyakht AV, 2014, GUT MICROBES, V5, P351, DOI 10.4161/gmic.28685; Vassalos CM, 2010, AM J CLIN PATHOL, V133, P251, DOI 10.1309/AJCPDOWQSL6E8DMN; Vogelberg C, 2010, PARASITOL INT, V59, P469, DOI 10.1016/j.parint.2010.03.009; Wawrzyniak I, 2012, PARASITOL INT, V61, P437, DOI 10.1016/j.parint.2012.02.007; Weber C, 2006, EUKARYOT CELL, V5, P871, DOI 10.1128/EC.5.5.871-875.2006; Wu ZN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002885; ZIERDT CH, 1976, Z PARASITENKD, V50, P277, DOI 10.1007/BF02462972	53	14	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212542	10.1371/journal.pone.0212542	http://dx.doi.org/10.1371/journal.pone.0212542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794628	gold, Green Published			2022-12-26	WOS:000459709100084
J	Rauf, R; von Matthey, F; Croenlein, M; Zyskowski, M; van Griensven, M; Biberthaler, P; Lefering, R; Huber-Wagner, S; Matthes, G; Trentzsch, H; Bieler, D; Flohe, S; Paffrath, T; Wolfl, C				Rauf, Rauend; von Matthey, Francesca; Croenlein, Moritz; Zyskowski, Michael; van Griensven, Martijn; Biberthaler, Peter; Lefering, Rolf; Huber-Wagner, Stefan; Matthes, Gerritt; Trentzsch, Heiko; Bieler, Dan; Flohe, Sascha; Paffrath, Thomas; Wolfl, Christoph		Section NIS DGU	Changes in the temporal distribution of in-hospital mortality in severely injured patients-An analysis of the TraumaRegister DGU	PLOS ONE			English	Article							MULTIPLE-ORGAN FAILURE; TRAUMA DEATHS; TRIMODAL DISTRIBUTION; RISK-FACTORS; EPIDEMIOLOGY; TIME; POPULATION; FATALITIES; PATTERNS; SCORE	Background The temporal distribution of trauma mortality has been classically described as a trimodal pattern with an immediate, early and late peak. In modern health care systems this time distribution has changed. Methods Data from the TraumaRegister DGU was analysed retrospectively. Between 2002 and 2015, all registered in-hospital deaths with an Injury Severity Score (ISS). 16 were evaluated considering time of death, trauma mechanism, injured body area, age distribution, rates of sepsis and multiple organ failure. Pre-hospital and post-discharge trauma deaths were not considered. Results 78 310 severely injured patients were registered, non-survivors constituted 14 816, representing an in-hospital mortality rate of 18.9%. Mean ISS of non-survivors was 36.0 +/- 16.0, 66.7% were male, mean age was 59.5 +/- 23.5. Within the first hour after admission to hospital, 10.8% of deaths occurred, after 6 hours the percentage increased to 25.5%, after 12 hours 40.0%, after 24 hours 53.2% and within the first 48 hours 61.9%. Mortality showed a constant temporal decrease. Severe head injury (defined by Abbreviated Injury Scale, AISHead. 3) was found in 76.4% of non-survivors. Patients with an isolated head injury showed a more distinct decrease in survival rate, which was accentuated in the first days after admission. The correlation of age and time of death showed a proportional increase with age (55-74a). The rate of sepsis and multiple organ failure among non-survivors was 11.5% and 70.1%, respectively. Conclusion In a modern trauma care system, the mortality distribution of severely injured patients has changed its pattern, where especially the third peak is no longer detectable.	[Rauf, Rauend; von Matthey, Francesca; Croenlein, Moritz; Zyskowski, Michael; van Griensven, Martijn; Biberthaler, Peter; Huber-Wagner, Stefan] Tech Univ Munich, Hosp Rechts Isar, Dept Trauma Surg, Munich, Germany; [Lefering, Rolf] Univ Witten Herdecke, Inst Res Operat Med IFOM, Cologne, Germany	Technical University of Munich; Witten Herdecke University	Rauf, R (corresponding author), Tech Univ Munich, Hosp Rechts Isar, Dept Trauma Surg, Munich, Germany.	Rauend.Rauf@artemed.de	van Griensven, Martijn/F-5808-2012; Trentzsch, Heiko/ABF-3979-2020; Trentzsch, Heiko/I-7679-2014	van Griensven, Martijn/0000-0001-5104-9881; Trentzsch, Heiko/0000-0002-6395-6873; Trentzsch, Heiko/0000-0002-6395-6873				BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; DALY KE, 1992, INJURY, V23, P393, DOI 10.1016/0020-1383(92)90015-K; de Knegt C, 2008, INJURY, V39, P993, DOI 10.1016/j.injury.2008.03.033; Debus F, 2015, DTSCH ARZTEBL INT, V112, P823, DOI 10.3238/arztebl.2015.0823; Demetriades D, 2005, J AM COLL SURGEONS, V201, P343, DOI 10.1016/j.jamcollsurg.2005.05.003; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; *DGU, 2016, NON TRADITIONAL REF; Earl-Royal E, 2016, J SURG RES, V205, P368, DOI 10.1016/j.jss.2016.06.082; ESPOSITO TJ, 1995, J TRAUMA, V39, P955, DOI 10.1097/00005373-199511000-00022; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; FAIST E, 1983, J TRAUMA, V23, P775, DOI 10.1097/00005373-198309000-00002; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Gunst Mark, 2010, Proc (Bayl Univ Med Cent), V23, P349; Harmsen AMK, 2015, INJURY, V46, P602, DOI 10.1016/j.injury.2015.01.008; Kleber C, 2012, WORLD J SURG, V36, P2125, DOI 10.1007/s00268-012-1650-9; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; McGwin G, 2009, J TRAUMA, V66, P526, DOI 10.1097/TA.0b013e3181623321; Meislin H, 1997, J TRAUMA, V43, P433, DOI 10.1097/00005373-199709000-00008; Paffrath T, 2014, INJURY, V45, pS64, DOI 10.1016/j.injury.2014.08.020; Pang JM, 2008, INJURY, V39, P102, DOI 10.1016/j.injury.2007.05.022; Pfeifer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148844; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; REGEL G, 1995, J TRAUMA, V38, P70, DOI 10.1097/00005373-199501000-00020; Ruchholtz S, 2008, DTSCH ARZTEBL INT, V105, P225, DOI 10.3238/arztebl.2008.0225; Ruchholtz S, 2012, EUR J TRAUMA EMERG S, V38, P11, DOI 10.1007/s00068-011-0166-6; SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; SHACKFORD SR, 1993, ARCH SURG-CHICAGO, V128, P571, DOI 10.1001/archsurg.1993.01420170107016; Shen LY, 2006, AM SURGEON, V72, P282; Soreide K, 2007, WORLD J SURG, V31, P2092, DOI 10.1007/s00268-007-9226-9; Stewart RM, 2003, J TRAUMA, V54, P66, DOI 10.1097/00005373-200301000-00009; Trunkey D, 1988, SCI AM, V4, pb22; TRUNKEY DD, 1983, SCI AM, V249, P28, DOI 10.1038/scientificamerican0883-28; Trunkey DD., 1974, J AM COLL EMERG PHYS, V3, P368, DOI 10.1016/S0361-1124(74)80005-5; Valdez C, 2016, J SURG RES, V200, P604, DOI 10.1016/j.jss.2015.08.031; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	39	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212095	10.1371/journal.pone.0212095	http://dx.doi.org/10.1371/journal.pone.0212095			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794579	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100036
J	Shimahara, Y; Sugawara, K; Kojo, KH; Kawai, H; Yoshida, Y; Hasezawa, S; Kutsuna, N				Shimahara, Yuki; Sugawara, Ko; Kojo, Kei H.; Kawai, Hiroki; Yoshida, Yuya; Hasezawa, Seiichiro; Kutsuna, Natsumaro			IMACEL: A cloud-based bioimage analysis platform for morphological analysis and image classification	PLOS ONE			English	Article							HEAT-SHOCK GRANULES; CELL	Automated quantitative image analysis is essential for all fields of life science research. Although several software programs and algorithms have been developed for bioimage processing, an advanced knowledge of image processing techniques and high-performance computing resources are required to use them. Hence, we developed a cloud-based image analysis platform called IMACEL, which comprises morphological analysis and machine learning-based image classification. The unique click-based user interface of IMACEL's morphological analysis platform enables researchers with limited resources to evaluate particles rapidly and quantitatively without prior knowledge of image processing. Because all the image processing and machine learning algorithms are performed on high-performance virtual machines, users can access the same analytical environment from anywhere. A validation study of the morphological analysis and image classification of IMACEL was performed. The results indicate that this platform is an accessible and potentially powerful tool for the quantitative evaluation of bioimages that will lower the barriers to life science research.	[Shimahara, Yuki; Yoshida, Yuya; Hasezawa, Seiichiro; Kutsuna, Natsumaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan; [Shimahara, Yuki; Sugawara, Ko; Kojo, Kei H.; Kawai, Hiroki; Hasezawa, Seiichiro; Kutsuna, Natsumaro] LPixel Inc, Res & Dev Div, Chiyoda Ku, Tokyo, Japan; [Kojo, Kei H.] Sophia Univ, Grad Sch Sci & Technol, Chiyoda Ku, Tokyo, Japan	University of Tokyo; Sophia University	Kutsuna, N (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.; Kutsuna, N (corresponding author), LPixel Inc, Res & Dev Div, Chiyoda Ku, Tokyo, Japan.	kutsuna@edu.k.u-tokyo.ac.jp		Kawai, Hiroki/0000-0002-7129-2384	Japan Society for the Promotion of Science KAKENHI [JP16H06280, 70578559, 16J06044]; LPixel Inc.	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); LPixel Inc.	Funded by Japan Society for the Promotion of Science KAKENHI. URL: https://www.jsps.go.jp/english/e-grants/. Grant Numbers: JP16H06280 (S.H.) 70578559 (N. K.) 16J06044 (K.K.). Source: Research and Development Division, LPixel Inc. Role: The funder, LPixel Inc., provided support in the form of salaries for authors Y.S., K.S., H.K., and N.K., but all of the funder did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are provided in the 'author contributions' section.	Buades A, 2005, PROC CVPR IEEE, P60, DOI 10.1109/cvpr.2005.38; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chessel A, 2017, METHODS, V115, P110, DOI 10.1016/j.ymeth.2016.12.014; COLLIER NC, 1986, J CELL BIOL, V103, P1495, DOI 10.1083/jcb.103.4.1495; Danuser G, 2011, CELL, V147, P973, DOI 10.1016/j.cell.2011.11.001; Eulenberg P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00623-3; Hayashi T, 2007, PLANT CELL PHYSIOL, V48, P1509, DOI 10.1093/pcp/pcm117; Kamatani T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17012-x; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kumagai-Sano F, 2006, NAT PROTOC, V1, P2621, DOI 10.1038/nprot.2006.381; Kutsuna N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2030; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Peng HC, 2016, ADV ANAT EMBRYOL CEL, V219, P263, DOI 10.1007/978-3-319-28549-8_10; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sasaki N, 2018, CANCER SCI, V109, P1135, DOI 10.1111/cas.13533; Settles Burr, 2009, ACTIVE LEARNING LIT; Sommer C, 2013, J CELL SCI, V126, P5529, DOI 10.1242/jcs.123604	19	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212619	10.1371/journal.pone.0212619	http://dx.doi.org/10.1371/journal.pone.0212619			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794647	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100100
J	Srikulnath, K; Azad, B; Singchat, W; Ezaz, T				Srikulnath, Kornsorn; Azad, Bhumika; Singchat, Worapong; Ezaz, Tariq			Distribution and amplification of interstitial telomeric sequences (ITSs) in Australian dragon lizards support frequent chromosome fusions in Iguania	PLOS ONE			English	Article							CENTRAL BEARDED DRAGON; POGONA-VITTICEPS; (TTAGGG)(N) SEQUENCES; KARYOTYPE EVOLUTION; CYTOGENETIC MAP; SEX-CHROMOSOMES; LOCALIZATION; ORIGIN; BIRDS; SQUAMATA	Telomeric sequences are generally located at the ends of chromosomes; however, they can also be found in non-terminal chromosomal regions when they are known as interstitial telomeric sequences (ITSs). Distribution of ITSs across closely related and divergent species elucidates karyotype evolution and speciation as ITSs provide evolutionary evidence for chromosome fusion. In this study, we performed physical mapping of telomeric repeats by fluorescence in situ hybridisation (FISH) in seven Australian dragon lizards thought to represent derived karyotypes of squamate reptiles and a gecko lizard with considerably different karyotypic feature. Telomeric repeats were present at both ends of all chromosomes in all species, while varying numbers of ITSs were also found on microchromosomes and in pericentromeric or centromeric regions on macrochromosomes in five lizard species examined. This suggests that chromosomal rearrangements from ancestral squamate reptiles to Iguania occurred mainly by fusion between ancestral types of acrocentric chromosomes and/or between microchromosomes, leading to appearance of bi-armed macrochromosomes, and in the reduction of microchromosome numbers. These results support the previously proposed hypothesis of karyotype evolution in squamate reptiles. In addition, we observed the presence of telomeric sequences in the similar regions to heterochromatin of the W microchromosome in Pogona barbata and Doporiphora nobbi, while sex chromosomes for the two species contained part of the nucleolar organiser regions (NORs). This likely implies that these ITSs are a part of the satellite DNA and not relics of chromosome fusions. Amplification of telomeric repeats may have involved heterochromatinisation of sex-specific W chromosomes and play a role in the organisation of the nucleolus.	[Srikulnath, Kornsorn; Azad, Bhumika; Ezaz, Tariq] Univ Canberra, Fac Sci & Technol, Inst Appl Ecol, Bruce, ACT, Australia; [Srikulnath, Kornsorn; Singchat, Worapong] Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Bangkok, Thailand; [Azad, Bhumika] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT, Australia; [Azad, Bhumika] Australian Natl Univ, Canberra Hosp, Canberra, ACT, Australia	University of Canberra; Kasetsart University; Australian National University; John Curtin School of Medical Research; Australian National University; Canberra Hospital	Srikulnath, K; Ezaz, T (corresponding author), Univ Canberra, Fac Sci & Technol, Inst Appl Ecol, Bruce, ACT, Australia.; Srikulnath, K (corresponding author), Kasetsart Univ, Fac Sci, Dept Genet, Lab Anim Cytogenet & Comparat Genom ACCG, Bangkok, Thailand.	kornsorn.s@ku.ac.th; Tariq.Ezaz@canberra.edu.au	Srikulnath, Kornsorn/GLU-1326-2022	Srikulnath, Kornsorn/0000-0002-5985-7258; Singchat, Worapong/0000-0002-7083-6159	Australian Research Council Future Fellowship [FT110100733]; Endeavour Research Fellowship [6801_2018]; IAE innovation fund	Australian Research Council Future Fellowship(Australian Research Council); Endeavour Research Fellowship; IAE innovation fund	This work was supported by an Australian Research Council Future Fellowship to TE (FT110100733) and an Endeavour Research Fellowship (6801_2018) to KS and IAE innovation fund to TE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an Australian Research Council Future Fellowship to TE (FT110100733) and an Endeavour Research Fellowship (6801_2018) to KS. BA was supported by research assistance funded by IAE innovation fund awarded to TE. We would also like to thank Arthur Georges, Denis O'Mealey, Mathew Young and Peter Harlow for help with animal sample and Jacqui Richardson and Alistair Zealey for their care of captive animals	Alfoldi J, 2011, NATURE, V477, P587, DOI 10.1038/nature10390; Augstenova B, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010005; Bertolotto CEV, 2001, CARYOLOGIA, V54, P217, DOI 10.1080/00087114.2001.10589229; Bolzan AD, 2017, MUTAT RES-REV MUTAT, V773, P51, DOI 10.1016/j.mrrev.2017.04.002; Deakin JE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2774-3; Ezaz T, 2005, CHROMOSOME RES, V13, P763, DOI 10.1007/s10577-005-1010-9; Ezaz T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-899; Ezaz T, 2009, CHROMOSOME RES, V17, P91, DOI 10.1007/s10577-008-9019-5; Harlow Peter S., 1996, Herpetological Review, V27, P71; Holleley CE, 2015, NATURE, V523, P79, DOI 10.1038/nature14574; Liu WS, 1999, CHROMOSOME RES, V7, P235, DOI 10.1023/A:1009255517764; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; Matsubara K, 2015, J HERED, V106, P753, DOI 10.1093/jhered/esv083; Matsubara K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-604; Matsuda Y, 2005, CHROMOSOME RES, V13, P601, DOI 10.1007/s10577-005-0986-5; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; O'Meally D, 2009, CYTOGENET GENOME RES, V127, P213, DOI 10.1159/000300099; Olmo E, 2008, INTEGR COMP BIOL, V48, P486, DOI 10.1093/icb/icn049; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Quinn AE, 2007, SCIENCE, V316, P411, DOI 10.1126/science.1135925; Rovatsos M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8120382; Rovatsos M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134985; Rovatsos M, 2014, EVOLUTION, V68, P2079, DOI 10.1111/evo.12357; Ruiz-Herrera A, 2008, CYTOGENET GENOME RES, V122, P219, DOI 10.1159/000167807; SCHERTHAN H, 1990, CYTOGENET CELL GENET, V53, P115, DOI 10.1159/000132908; Signorino G., 2005, CHROMOREP REPTILE CH; Singchat W, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5293-6; Srikulnath K, 2009, CYTOGENET GENOME RES, V125, P213, DOI 10.1159/000230005; Srikulnath K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134829; Srikulnath K, 2014, CHROMOSOMA, V123, P563, DOI 10.1007/s00412-014-0467-8; Srikulnath K, 2013, CHROMOSOME RES, V21, P805, DOI 10.1007/s10577-013-9398-0; Srikulnath K, 2011, GENET MOL BIOL, V34, P582, DOI 10.1590/S1415-47572011005000042; Srikulnath K, 2009, CHROMOSOME RES, V17, P975, DOI 10.1007/s10577-009-9101-7; Trifonov VA, 2011, CHROMOSOME RES, V19, P843, DOI 10.1007/s10577-011-9241-4; Uno Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053027; WITTEN GJ, 1983, AUST J ZOOL, V31, P533, DOI 10.1071/ZO9830533; Young MJ, 2013, CHROMOSOME RES, V21, P361, DOI 10.1007/s10577-013-9362-z; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	39	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212683	10.1371/journal.pone.0212683	http://dx.doi.org/10.1371/journal.pone.0212683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794668	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100112
J	Rosa, E; Minard, G; Lindholm, J; Saastamoinen, M				Rosa, Elena; Minard, Guillaume; Lindholm, Johanna; Saastamoinen, Marjo			Moderate plant water stress improves larval development, and impacts immunity and gut microbiota of a specialist herbivore	PLOS ONE			English	Article							INTERGENIC SPACER ANALYSIS; INSECT; BACTERIAL; DROUGHT; CONSEQUENCES; CHEMISTRY; RESPONSES	While host plant drought is generally viewed as a negative phenomenon, its impact on insect herbivores can vary largely depending on the species involved and on the intensity of the drought. Extreme drought killing host plants can clearly reduce herbivore fitness, but the impact of moderate host plant water stress on insect herbivores can vary, and may even be beneficial. The populations of the Finnish Glanville fritillary butterfly (Melitaea cinxia) have faced reduced precipitation in recent years, with impacts even on population dynamics. Whether the negative effects of low precipitation are solely due to extreme desiccation killing the host plant or whether moderate drought reduces plant quality for the larvae remains unknown. We assessed the performance of larvae fed on moderately water-stressed Plantago lanceolata in terms of growth, survival, and immune response, and additionally were interested to assess whether the gut microbial composition of the larvae changed due to modification of the host plant. We found that larvae fed on water-stressed plants had increased growth, with no impact on survival, up-regulated the expression of one candidate immune gene (pelle), and had a more heterogeneous bacterial community and a shifted fungal community in the gut. Most of the measured traits showed considerable variation due to family structure. Our data suggest that in temperate regions moderate host plant water stress can positively shape resource acquisition of this specialized insect herbivore, potentially by increasing nutrient accessibility or concentration. Potentially, the better larval performance may be mediated by a shift of the microbiota on water-stressed plants, calling for further research especially on the understudied gut fungal community.	[Rosa, Elena; Minard, Guillaume; Lindholm, Johanna; Saastamoinen, Marjo] Univ Helsinki, Organismal & Evolutionary Biol Res Programme, Helsinki, Finland; [Rosa, Elena] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Minard, Guillaume] Univ Lyon, Lyon, France; [Minard, Guillaume] Univ Claude Bernard Lyon 1, CNRS UMR 5557, Lab Microbial Ecol, INRA UMR1418, Villeurbanne, France	University of Helsinki; Uppsala University; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Rosa, E (corresponding author), Univ Helsinki, Organismal & Evolutionary Biol Res Programme, Helsinki, Finland.; Rosa, E (corresponding author), Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden.	elena.rosa@ebc.uu.se	; Saastamoinen, Marjo/F-6576-2012	Rosa, Elena/0000-0003-3580-2524; Saastamoinen, Marjo/0000-0001-7009-2527; Minard, Guillaume/0000-0002-2079-8844	European Research Council [637412]	European Research Council(European Research Council (ERC)European Commission)	The study was funded by European Research Council (Independent starting grant no. 637412 'META-STRESS') to MS (https://erc.europa.eu/funding/starting-grants).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ankrah NYD, 2018, ENVIRON MICROBIOL, V20, P2002, DOI 10.1111/1462-2920.14097; ASLING B, 1995, INSECT BIOCHEM MOLEC, V25, P511, DOI 10.1016/0965-1748(94)00091-C; Bordenstein SR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002226; Capo F, 2016, DEV COMP IMMUNOL, V64, P11, DOI 10.1016/j.dci.2016.01.001; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Coon KL, 2017, P NATL ACAD SCI USA, V114, pE5362, DOI 10.1073/pnas.1702983114; Crava CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125991; Dray S., 2017, ADE4 ANAL ECOLOGICAL; Duron O, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-27; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323; Gutbrodt B, 2011, OIKOS, V120, P1732, DOI 10.1111/j.1600-0706.2011.19558.x; Hammer TJ, 2017, P NATL ACAD SCI USA, V114, P9641, DOI 10.1073/pnas.1707186114; Harrington TC., 2005, INSECT FUNGAL ASS EC; Huberty AF, 2004, ECOLOGY, V85, P1383, DOI 10.1890/03-0352; Jamieson MA, 2012, PLANT PHYSIOL, V160, P1719, DOI 10.1104/pp.112.206524; Kahilainen A, 2018, GLOBAL CHANGE BIOL, V24, P4316, DOI 10.1111/gcb.14280; Konrad M, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.1976; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lampert EC, 2015, J CHEM ECOL, V41, P85, DOI 10.1007/s10886-014-0532-z; Leitao-Goncalves R, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000862; Martemyanov VV, 2012, ARTHROPOD-PLANT INTE, V6, P507, DOI 10.1007/s11829-012-9202-7; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970; Mody K, 2009, ECOL ENTOMOL, V34, P133, DOI 10.1111/j.1365-2311.2008.01053.x; Ojanen SP, 2013, ECOL EVOL, V3, P3713, DOI 10.1002/ece3.733; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Otani S, 2016, FRONT ECOL EVOL, V4, DOI [10.3389/fevo.2016.00115, DOI 10.3389/FEVO.2016.00115]; Paludo CR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19583-9; R Core Team, 2021, R LANGUAGE ENV STAT; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ranjard L, 2001, APPL ENVIRON MICROB, V67, P4479, DOI 10.1128/AEM.67.10.4479-4487.2001; Reynolds S., 2009, INSECT INFECT IMMUNI; Ruokolainen L, 2016, OECOLOGIA, V181, P895, DOI 10.1007/s00442-016-3603-8; Salgado AL, 2019, ANIM BEHAV, V150, P27, DOI 10.1016/j.anbehav.2019.01.018; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shikano I, 2017, J CHEM ECOL, V43, P586, DOI 10.1007/s10886-017-0850-z; Siva-Jothy MT, 2002, PHYSIOL ENTOMOL, V27, P206, DOI 10.1046/j.1365-3032.2002.00286.x; Tack AJM, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0173; Tao LL, 2016, J ANIM ECOL, V85, P1246, DOI 10.1111/1365-2656.12558; Vogelweith F, 2015, J INSECT PHYSIOL, V77, P55, DOI 10.1016/j.jinsphys.2015.04.003; Voirol LRP, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00556; WHITE T C R, 1969, Ecology (Washington D C), V50, P905, DOI 10.2307/1933707; Woestmann L, 2017, J EVOLUTION BIOL, V30, P501, DOI 10.1111/jeb.13007; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14	47	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0204292	10.1371/journal.pone.0204292	http://dx.doi.org/10.1371/journal.pone.0204292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785875	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000003
J	Dandge, S; Jeemon, P; Reddy, PS				Dandge, Shailendra; Jeemon, Panniyammakal; Reddy, P. S.			Technology enabled non-physician health workers extending telemedicine to rural homes to control hypertension and diabetes (TETRA): A pre-post demonstration project in Telangana, India	PLOS ONE			English	Article							PREVALENCE; COUNTRIES; STATES	Objectives We aimed to determine the feasibility and effectiveness of an intervention anchored on mHealth and task sharing strategy of involving non-physician health workers (NPHW) on population level detection, treatment and control of hypertension and diabetes in India. Methods Non-physician health workers (NPHWs) equipped with tablet computers that were linked with point-of-care devices for blood pressure (BP) and blood sugar measurements visited households, screened adult individuals for hypertension and diabetes from two randomly selected villages in the Medchal district, Telangana, India. Further, they digitally connected those individuals with hypertension and diabetes to a study physician via Skype, and handed over a printed e-prescription. Medication adherence checks, BP and fasting blood sugar measurements were done once a month and doctor consultations once in three months during follow-up. Results Among 2456 eligible individuals, 1751 and 1686 individuals were screened for hypertension and diabetes, respectively. Prevalence of hypertension was 23.6% (95% CI 21.6%-25.6%) and among them 38.9% were newly detected. Prevalence of diabetes was 11.2% (9.7%-12.7%) and 28.6% of them were newly detected. After 24 months of intervention, control of BP and blood sugar was achieved in 54.0% and 34.1% of individuals with hypertension and diabetes, respectively. Blood pressure control rate improved by 12% (7.9%-16.0%) in known hypertensive individuals over the intervention period. Interpretation This research demonstrates the feasibility and local acceptability of a mHealth intervention strategy anchored on NPHWs guided by physicians for detection, treatment and regular follow-up of individuals with hypertension and diabetes in a community setting in India.	[Dandge, Shailendra] MediCiti Inst Med Sci, Dept Pharmacol, Hyderabad, Telangana, India; [Dandge, Shailendra; Reddy, P. S.] India SHARE INDIA, Soc Hlth Allied Res & Educ, Hyderabad, Telangana, India; [Jeemon, Panniyammakal] Sree Chitra Tirunal Inst Med Sci & Technol, Trivandrum, Kerala, India; [Reddy, P. S.] Univ Pittsburgh, Pittsburgh, PA USA	Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dandge, S (corresponding author), MediCiti Inst Med Sci, Dept Pharmacol, Hyderabad, Telangana, India.; Dandge, S (corresponding author), India SHARE INDIA, Soc Hlth Allied Res & Educ, Hyderabad, Telangana, India.	shailendra962@gmail.com	Dandge, Shailendra/AAZ-1330-2020	Dandge, Shailendra/0000-0002-5037-214X; Jeemon, Panniyammakal/0000-0003-4172-4307	Fogarty non-communicable disease research training program [D43_TW009078]	Fogarty non-communicable disease research training program	This study was supported by an in-country grant as part of the Fogarty non-communicable disease research training program under the grant, D43_TW009078. The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Ajay VS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004343; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; Anjana RM, 2017, LANCET DIABETES ENDO, V5, P585, DOI 10.1016/S2213-8587(17)30174-2; [Anonymous], 2013, SUMM SETT RES PRIOR; Dandona L, 2017, LANCET, V390, P2437, DOI 10.1016/S0140-6736(17)32804-0; National Institute of Medical Statistics, 2007, ICMR IDSP NONC DIS R; O'Donnell MJ, 2016, LANCET, V388, P761, DOI 10.1016/S0140-6736(16)30506-2; Prabhakaran D, CIRCULATION; Tatineni A, 2009, Indian J Public Health, V53, P41; Unnikrishnan R, 2014, DIABETES TECHNOL THE, V16, P596, DOI 10.1089/dia.2014.0018; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	12	5	6	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211551	10.1371/journal.pone.0211551	http://dx.doi.org/10.1371/journal.pone.0211551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779798	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900015
J	Nopparat, J; Nualla-ong, A; Phongdara, A				Nopparat, Jongdee; Nualla-ong, Aekkaraj; Phongdara, Amornrat			Ethanolic extracts of Pluchea indica (L.) leaf pretreatment attenuates cytokine-induced beta-cell apoptosis in multiple low-dose streptozotocin-induced diabetic mice	PLOS ONE			English	Article							ANIMAL-MODELS; TYPE-1; QUERCETIN; RESVERATROL; MECHANISM; INHIBITION; LEAVES; LESS.	Loss of beta-cell mass and function is a fundamental feature of pathogenesis for type 1 and type 2 diabetes. Increasing evidence indicates that apoptosis is one of the main mechanisms of beta-cell death in both types. Ethanolic extracts of Pluchea indica leaf (PILE) have been reported to possess blood glucose lowering actions in vivo. Nevertheless, further study is required to determine the underlying mechanisms. In this report, we have investigated the preventive effects of PILE on multiple low doses of streptozotocin (MLDS)induced beta-cell apoptosis. Mice were pre-treated with PILE at 50 mg/kg (PILE 50) or 100 mg/kg (PILE 100) for 2 weeks before streptozotocin (STZ) stimulation, and the treatment continued for 4 or 8 weeks. Results revealed that PILE 100 mice exhibited improved blood biochemistry, maintained a higher body weight, had decreased hyperglycemia, and restored islet architectures compared to non-treated STZ mice. Significantly, PILE 100 decreased levels of inflammatory response markers interferon-gamma (IFN-gamma), tumor necrosis factor-alpha (TNF alpha), and interlukin1-beta (IL-1 beta), concomitant with the inhibition of caspase-3, caspase-8, capsepase- 9, phosphorylation of signal transducer and activator of transcription 1 (pSTAT1), nuclear factor-kappa B p65 (NF-kappa Bp65), and inducible nitric oxide synthase (iNOS). Additionally, survival and proliferative ability of beta-cells was mediated by up-regulated Bcl-2 and Ki67, respectively. These results provide strong evidence that pretreatment with PILE 100 effectively attenuated STZ-induced diabetes-related symptoms and these effects could be associated with the inhibition of cytokine-induced beta-cell apoptosis.	[Nopparat, Jongdee] Prince Songkla Univ, Fac Sci, Dept Anat, Hat Yai, Songkhla, Thailand; [Nualla-ong, Aekkaraj; Phongdara, Amornrat] Prince Songkla Univ, Fac Sci, Ctr Genom & Bioinformat Res, Hat Yai, Songkhla, Thailand; [Nualla-ong, Aekkaraj] Prince Songkla Univ, Fac Med Technol, Med Technol Serv Ctr, Hat Yai, Songkhla, Thailand; [Phongdara, Amornrat] Prince Songkla Univ, Fac Med Technol, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Nopparat, J (corresponding author), Prince Songkla Univ, Fac Sci, Dept Anat, Hat Yai, Songkhla, Thailand.	Jongdee.n@psu.ac.th	Nualla-ong, Aekkaraj/ABD-6369-2020; Nopparat, Jongdee/AAX-1690-2020	Nopparat, Jongdee/0000-0003-3532-1405; Nualla-ong, Aekkaraj/0000-0003-3480-048X	Thailand Research Fund (TRF) [MRG6080028]; Prince of Songkla University [SCI601252S]; Prince of Songkla University Thailand	Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); Prince of Songkla University; Prince of Songkla University Thailand	This study was supported in part by (1) the Thailand Research Fund (TRF), grant number: MRG6080028, and (2) The budget revenue of Prince of Songkla University, grant number: SCI601252S to JN, and (3) the government budget (or budget revenue) of Prince of Songkla University Thailand to AN and AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amirshahrokhi K, 2008, TOXICOL APPL PHARM, V232, P119, DOI 10.1016/j.taap.2008.06.020; Arnhold T, 2002, TOXICOL SCI, V66, P274, DOI 10.1093/toxsci/66.2.274; Arsiningtyas IS, 2014, NAT PROD RES, V28, P1350, DOI 10.1080/14786419.2014.904306; Biswas R, 2007, PHYTOMEDICINE, V14, P534, DOI 10.1016/j.phymed.2006.11.003; Buapool D, 2013, J ETHNOPHARMACOL, V146, P495, DOI 10.1016/j.jep.2013.01.014; Cho JJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-265; Citro A, 2015, DIABETES, V64, P1329, DOI 10.2337/db14-0443; Furman Brian L, 2015, Curr Protoc Pharmacol, V70, DOI 10.1002/0471141755.ph0547s70; Jeong SM, 2012, NUTR RES PRACT, V6, P201, DOI 10.4162/nrp.2012.6.3.201; Karabatas LM, 2005, PANCREAS, V30, P318, DOI 10.1097/01.mpa.0000161888.02244.7a; Kesari AN, 2006, J ETHNOPHARMACOL, V107, P374, DOI 10.1016/j.jep.2006.03.042; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kongkiatpaiboon S, 2018, REV BRAS FARMACOGN, V28, P145, DOI 10.1016/j.bjp.2018.03.002; Lee JH, 2009, DIABETES, V58, P344, DOI 10.2337/db07-1795; Li YY, 2012, BIO-MED MATER ENG, V22, P97, DOI 10.3233/BME-2012-0694; Meier JJ, 2006, DIABETOLOGIA, V49, P2689, DOI 10.1007/s00125-006-0410-5; Meier JJ, 2006, DIABETES CARE, V29, P1554, DOI 10.2337/dc06-0392; Mohamad S, 2011, J ETHNOPHARMACOL, V133, P1021, DOI 10.1016/j.jep.2010.11.037; Mukhopadhyay P, 2015, RSC ADV, V5, P97547, DOI 10.1039/c5ra18896b; Noridayu A.R., 2011, INT FOOD RES J, V18, P925; Oshaghi EA, 2017, CRIT REV CL LAB SCI, V54, P267, DOI 10.1080/10408363.2017.1343274; Revathy J, 2018, BIOMED PHARMACOTHER, V97, P98, DOI 10.1016/j.biopha.2017.10.102; Roslan J, 2017, BIOMED PHARMACOTHER, V86, P570, DOI 10.1016/j.biopha.2016.12.044; SEN T, 1993, LIFE SCI, V52, P737, DOI 10.1016/0024-3205(93)90236-V; SEN T, 1991, J ETHNOPHARMACOL, V33, P135, DOI 10.1016/0378-8741(91)90172-A; Sen T, 2002, PHYTOTHER RES, V16, P331, DOI 10.1002/ptr.892; Sirichaiwetchakoon K, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/4108787; Sumpter KM, 2011, PEDIATR DIABETES, V12, P656, DOI 10.1111/j.1399-5448.2011.00761.x; Suriyaphan O., 2014, MAHIDOL U J PHARM SC, V41, P1; Szkudelski T, 2011, ANN NY ACAD SCI, V1215, P34, DOI 10.1111/j.1749-6632.2010.05844.x; Thomas HE, 2011, DIABETES-METAB RES, V27, P790, DOI 10.1002/dmrr.1253; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Tomita T, 2017, BOSNIAN J BASIC MED, V17, P183, DOI 10.17305/bjbms.2017.1961; Tomita T, 2016, BOSNIAN J BASIC MED, V16, P162, DOI 10.17305/bjbms.2016.919; van Asseldonk EJP, 2015, CLIN IMMUNOL, V160, P155, DOI 10.1016/j.clim.2015.06.003; Vongsak B, 2018, FOOD BIOSCI, V25, P68, DOI 10.1016/j.fbio.2018.08.006; Widyawati T, 2015, NUTRIENTS, V7, P7764, DOI 10.3390/nu7095365; Widyawati W, 2015, BIRTH-ISS PERINAT C, V42, P337, DOI 10.1111/birt.12181; Wilcox NS, 2016, J AUTOIMMUN, V71, P51, DOI 10.1016/j.jaut.2016.02.001; Yang DK, 2018, BIOMOL THER, V26, P130, DOI 10.4062/biomolther.2017.254; Yazgan UC, 2015, ARCH PHYSIOL BIOCHEM, V121, P157, DOI 10.3109/13813455.2015.1062898; Yu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098044; Zhang YH, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3919627	43	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212133	10.1371/journal.pone.0212133	http://dx.doi.org/10.1371/journal.pone.0212133			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779805	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900029
J	Lind, S; Holdfeldt, A; Martensson, J; Sundqvist, M; Bjorkman, L; Forsman, H; Dahlgren, C				Lind, Simon; Holdfeldt, Andre; Martensson, Jonas; Sundqvist, Martina; Bjorkman, Lena; Forsman, Huamei; Dahlgren, Claes			Functional selective ATP receptor signaling controlled by the free fatty acid receptor 2 through a novel allosteric modulation mechanism	FASEB JOURNAL			English	Article						GPCRs; biased signaling; neutrophil; NADPH oxidase; GPR43	FORMYL PEPTIDE RECEPTORS; RESPIRATORY BURST; HUMAN NEUTROPHILS; FFA2 ANTAGONIST; CYTOSKELETON; ACTIVATION; AGONIST; POTENT; P2Y(2)	A nonactivating allosteric modulator of free fatty acid receptor 2 (FFA2R, also called GPCR 43) turns both propionate (an orthosteric FFA2R agonist) and ATP (an agonist for the purinergic P2Y(2) receptor), into potent activating ligands that trigger an assembly of the superoxide-generating neutrophil NADPH oxidase. The ATP-induced activation requires the participation of FFA2R, and the signaling is biased toward oxidase activation, leaving the ATP-induced rise in intracellular Ca2+ unaffected. No NADPH oxidase activity was induced by ATP when propionate replaced the allosteric modulator. Signaling downstream of propionate-activated FFA2Rs was insensitive to G alpha q inhibition, but the crosstalk activation involving both FFA2R and P2Y(2)R relied on G alpha q signaling. The receptor crosstalk, by which allosterically modulated FFA2Rs communicate with P2Y(2)Rs and generate NADPH oxidase activating signals downstream of G alpha q, represent a novel mechanism by which GPCR activities can be regulated from inside the plasma membrane. Further, the finding that an allosteric FFA2R modulator sensitizes not only the response induced by orthosteric FFA2R agonists, but also the response induced by ATP (P2Y(2)R-specific agonist) and formyl peptide receptor-specific agonists, violates the receptor restriction characteristics normally defining the selectivity of allosteric GPCR modulators.-Lind, S., Holdfeldt, A., Martensson, J., Sundqvist, M., Bjorkman, L., Forsman, H., Dahlgren, C. Functional selective ATP receptor signaling controlled by the free fatty acid receptor 2 through a novel allosteric modulation mechanism.	[Lind, Simon; Holdfeldt, Andre; Martensson, Jonas; Sundqvist, Martina; Bjorkman, Lena; Forsman, Huamei; Dahlgren, Claes] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Martensson, Jonas; Bjorkman, Lena] Sahlgrens Univ Hosp, Rheumatol Unit, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Dahlgren, C (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Guldhedsgatan 10A, S-41346 Gothenburg, Sweden.	claes.dahlgren@microbio.gu.se	Sundqvist, Martina/HCI-9371-2022; Sundqvist, Martina/AAA-8412-2019	Sundqvist, Martina/0000-0002-0859-0792; Lind, Simon/0000-0001-6469-4345	Swedish Medical Research Council [005601, 02448]; King Gustaf V 80-Year Foundation [FAI 2014-0011]; Clas Groschinsky Foundation [MI562]; Wilhelm and Martina Lundgrens Scientific Foundation [2018-2324]; Serena Ehrenstroms Foundation; Torsten and Sara Janssons Scientific Foundation; Radman and Ernst Collianders Foundation; Ake Wibergs Foundation [M15-005]; Swedish government; county councils, Avtalet om Lakarutbildning och Forskning (ALF) agreement [ALFGBG 72510]	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); King Gustaf V 80-Year Foundation; Clas Groschinsky Foundation; Wilhelm and Martina Lundgrens Scientific Foundation; Serena Ehrenstroms Foundation; Torsten and Sara Janssons Scientific Foundation; Radman and Ernst Collianders Foundation; Ake Wibergs Foundation; Swedish government; county councils, Avtalet om Lakarutbildning och Forskning (ALF) agreement	The authors thank the members of the Phagocyte Research Group at the Sahlgrenska Academy, University of Gothenburg for critically discussing the results and the manuscript. The experimental work performed by Linda Bergqvist (University of Gothenburg) is also gratefully acknowledged. This work was supported by the Swedish Medical Research Council (005601 to C.D.; 02448 to H.F.) the King Gustaf V 80-Year Foundation (FAI 2014-0011 to C.D.), the Clas Groschinsky Foundation (MI562 to H.F.), the Wilhelm and Martina Lundgrens Scientific Foundation (2018-2324 to M.S.), the Serena Ehrenstroms and Torsten and Sara Janssons Scientific Foundation (2018 to M.S.), the Radman and Ernst Collianders Foundation (2018 to M.S.), the Ake Wibergs Foundation (M15-005 to H.F.), and the Swedish state under the agreement between the Swedish government and the county councils, Avtalet om Lakarutbildning och Forskning (ALF) agreement (ALFGBG 72510 to C.D.). The authors declare no conflicts of interest.	Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017; ANDERSSON T, 1986, MOL PHARMACOL, V30, P437; Bjorkman L., 2018, J LEUKOC BIOL; Bjorkman L, 2016, MOL CELL BIOL, V36, P2583, DOI 10.1128/MCB.00161-16; Bjornsdottir H, 2016, DATA BRIEF, V6, P386, DOI 10.1016/j.dib.2015.12.003; Bjornsdottir H, 2015, FREE RADICAL BIO MED, V89, P1024, DOI 10.1016/j.freeradbiomed.2015.10.398; Bjornsdottir H, 2013, EXP CELL RES, V319, P761, DOI 10.1016/j.yexcr.2012.12.020; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Bylund J, 2014, METHODS MOL BIOL, V1124, P321, DOI 10.1007/978-1-62703-845-4_21; Bylund J, 2010, FREE RADICAL BIO MED, V49, P1834, DOI 10.1016/j.freeradbiomed.2010.09.016; Changeux JP, 2016, CELL, V166, P1084, DOI 10.1016/j.cell.2016.08.015; Choi M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar7084; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Dagur Pradeep K, 2015, Curr Protoc Cytom, V73, DOI 10.1002/0471142956.cy0501s73; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Due-Hansen ME, 2016, ORG BIOMOL CHEM, V14, P430, DOI 10.1039/c5ob02129d; Erlandson SC, 2018, ANNU REV BIOPHYS, V47, P1, DOI 10.1146/annurev-biophys-070317-032931; Forsman H, 2011, SCAND J IMMUNOL, V74, P227, DOI 10.1111/j.1365-3083.2011.02570.x; Forsman H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060169; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Gabl M, 2015, EXP CELL RES, V336, P242, DOI 10.1016/j.yexcr.2015.07.014; Gabl M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109516; Gao Zhan-Guo, 2013, Drug Discov Today Technol, V10, pe237, DOI 10.1016/j.ddtec.2012.08.004; Gentry PR, 2015, J BIOL CHEM, V290, P19478, DOI 10.1074/jbc.R115.662759; Holdfeldt A, 2017, J LEUKOCYTE BIOL, V102, P871, DOI 10.1189/jlb.2A0317-086RR; Hudson BD, 2013, J BIOL CHEM, V288, P17296, DOI 10.1074/jbc.M113.455337; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Kawakami Toshiaki, 2013, Advances in Biological Regulation, V53, P249, DOI 10.1016/j.jbior.2013.08.001; Kenakin T, 2017, MOL PHARMACOL, V92, P414, DOI 10.1124/mol.117.108787; Laschet C, 2018, BIOCHEM PHARMACOL, V153, P62, DOI 10.1016/j.bcp.2018.02.016; Martensson J, 2018, J LEUKOCYTE BIOL, V104, P1117, DOI 10.1002/JLB.2A0318-130RR; Milligan G, 2017, HANDB EXP PHARMACOL, V236, P17, DOI 10.1007/164_2016_49; Milligan G, 2017, CHEM REV, V117, P67, DOI 10.1021/acs.chemrev.6b00056; Namour F, 2016, BRIT J CLIN PHARMACO, V82, P139, DOI 10.1111/bcp.12900; Onnheim K, 2014, EXP CELL RES, V323, P209, DOI 10.1016/j.yexcr.2014.01.023; Ortiz ZNV, 2018, TRENDS PHARMACOL SCI, V39, P547; Pizzonero M, 2014, J MED CHEM, V57, P10044, DOI 10.1021/jm5012885; Prezeau L, 2010, CURR OPIN PHARMACOL, V10, P6, DOI 10.1016/j.coph.2009.10.009; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Sergeev E, 2016, J BIOL CHEM, V291, P303, DOI 10.1074/jbc.M115.687939; Smith JS, 2018, NAT REV DRUG DISCOV, V17, P243, DOI 10.1038/nrd.2017.229; Sun MM, 2017, J GASTROENTEROL, V52, P1, DOI 10.1007/s00535-016-1242-9; Sundqvist M, 2018, BBA-MOL CELL RES, V1865, P695, DOI 10.1016/j.bbamcr.2018.02.008; Syrovatkina V, 2016, J MOL BIOL, V428, P3850, DOI 10.1016/j.jmb.2016.08.002; van de Geer A, 2018, J CLIN INVEST, V128, P3957, DOI 10.1172/JCI97116; Wang WJ, 2018, TRENDS PHARMACOL SCI, V39, P367, DOI 10.1016/j.tips.2018.01.001; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Welin A, 2015, INFECT IMMUN, V83, P205, DOI 10.1128/IAI.02493-14	50	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6887	6903		10.1096/fj.201802309R	http://dx.doi.org/10.1096/fj.201802309R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30808243	Bronze			2022-12-26	WOS:000476114200018
J	Zhou, L; Liu, Q; Hong, GJ; Song, FM; Zhao, JM; Yuan, JB; Xu, J; Tan, RX; Tickner, J; Gu, Q; Xu, JK				Zhou, Lin; Liu, Qian; Hong, Guoju; Song, Fangming; Zhao, Jinmin; Yuan, Jinbo; Xu, Jun; Tan, Ren Xiang; Tickner, Jennifer; Gu, Qiong; Xu, Jiake			Cumambrin A prevents OVX-induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways	FASEB JOURNAL			English	Article						NF-kappa B; NFATc1; ERK; osteolysis	NF-KAPPA-B; SESQUITERPENE LACTONES; DIFFERENTIATION; EXPRESSION; NFATC1; SUPPRESSION; ACTIVATION; REGULATOR; MEDICINE; SURVIVAL	Being the principal cells responsible for bone resorption and pathologic bone loss, osteoclasts have become the main target for antiresorptive treatment. Cumambrin A is a natural compound isolated from Chrysanthemum indicum L. and belongs to a member of the sesquiterpene lactone family. To date, the therapeutic effect of cumambrin A on osteoporosis and its mechanisms of action are not known. In this study, we found that cumambrin A can significantly inhibit osteoclast formation and bone resorption through the suppression of receptor activator of NF-kappa B ligand (RANKL)-induced NF-kappa B and nuclear factor of activated T-cell activity and ERK phosphorylation. Furthermore, cumambrin A inhibits the expression of osteoclast marker genes including cathepsin K, calcitonin receptor, and V-ATPase d2. Using an in vivo ovariectomized mouse model, we showed that cumambrin A protects against estrogen withdrawal-induced bone loss. Collectively, our results reveal that cumambrin A can suppress osteoclast formation, bone resorption, and RANKL-induced signaling pathways, suggesting that cumambrin A is a potential therapeutic agent for the treatment of osteoporosis.-Zhou, L., Liu, Q., Hong, G., Song, F., Zhao, J., Yuan, J., Xu, J., Tan, R. X., Tickner, J., Gu, Q., Xu, J. Cumambrin A prevents OVX-induced osteoporosis via the inhibition of osteoclastogenesis, bone resorption, and RANKL signaling pathways.	[Zhou, Lin; Liu, Qian; Hong, Guoju; Song, Fangming; Yuan, Jinbo; Tickner, Jennifer; Xu, Jiake] Univ Western Australia, Sch Biomed Sci, M504, Perth, WA 6009, Australia; [Zhou, Lin] Guangzhou Med Univ, Affiliated Hosp 5, Dept Endocrinol, Guangzhou, Guangdong, Peoples R China; [Liu, Qian; Song, Fangming; Zhao, Jinmin] Guangxi Med Univ, Res Ctr Regenerat Med, Nanning, Peoples R China; [Liu, Qian; Song, Fangming; Zhao, Jinmin] Guangxi Med Univ, Guangxi Key Lab Regenerat Med, Nanning, Peoples R China; [Hong, Guoju] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Orthoped Dept, Guangzhou, Guangdong, Peoples R China; [Xu, Jun] Sun Yat Sen Univ, Res Ctr Drug Discovery, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China; [Tan, Ren Xiang; Gu, Qiong] Nanjing Univ, Inst Funct Biomol, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China	University of Western Australia; Guangzhou Medical University; Guangxi Medical University; Guangxi Medical University; Guangzhou University of Chinese Medicine; Sun Yat Sen University; Nanjing University	Xu, JK (corresponding author), Univ Western Australia, Sch Biomed Sci, M504, Perth, WA 6009, Australia.; Gu, Q (corresponding author), Sun Yat Sen Univ, Res Ctr Drug Discovery, Sch Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.	guqiong@sysu.edu.cn; jiake.xu@uwa.edu.au	Hong, Guoju/AFP-4180-2022; Hong, Guoju/AAV-9433-2020; Tickner, Jennifer/H-5965-2014	Zhao, Jinmin/0000-0001-8423-0425; Tickner, Jennifer/0000-0002-5020-0671; Yuan, Jinbo/0000-0002-6240-9333; Gu, Qiong/0000-0001-6011-3697; Zhao, Jinmin/0000-0002-1047-8820; Xu, Jiake/0000-0003-2021-8309	Australian Health and Medical Research Council (NHMRC) [APP1107828, APP1127396, APP1127156]; Arthritis Foundation of Australia; Western Australia Medical and Health Research Infrastructure Fund; Young Innovative Talents Project of Guangdong Province [2017KQNCX167]; Nature Science Foundation of Guangxi [2015GXNSFDA139019]; National Natural Science Foundation of China [81573310]; China Scholarship Council; University of Western Australia Research Collaboration Awards	Australian Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Arthritis Foundation of Australia; Western Australia Medical and Health Research Infrastructure Fund; Young Innovative Talents Project of Guangdong Province; Nature Science Foundation of Guangxi; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); University of Western Australia Research Collaboration Awards	The authors acknowledge the support from Australian Health and Medical Research Council (NHMRC; APP1107828, APP1127396, APP1127156), Arthritis Foundation of Australia (The H.J. and G.J. Mckenzie Grant), Western Australia Medical and Health Research Infrastructure Fund, University of Western Australia Research Collaboration Awards, and Young Innovative Talents Project of Guangdong Province (2017KQNCX167). This study was also funded, in part, by the Nature Science Foundation of Guangxi (2015GXNSFDA139019) and the National Natural Science Foundation of China (81573310). L.Z. is a recipient of a scholarship from the China Scholarship Council. G.H., Q.L., and F.S. are visiting scholars to the University of Western Australia. The authors declare no conflicts of interest.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Blair HC, 2004, HISTOL HISTOPATHOL, V19, P189, DOI 10.14670/HH-19.189; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Brown KD, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2457; Deng SQ, 2017, JMIR RES PROTOC, V6, DOI 10.2196/resprot.7636; Dixit V, 2002, CELL, V111, P615, DOI 10.1016/S0092-8674(02)01166-2; Feng HT, 2009, J BIOL CHEM, V284, P14667, DOI 10.1074/jbc.M901670200; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Jee W. S. S., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P193; Jiang M, 2011, PLANTA MED, V77, P873, DOI 10.1055/s-0030-1270983; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Leibbrandt A., 2011, ENCY CANC, P3165; Leibbrandt A, 2008, ANN NY ACAD SCI, V1143, P123, DOI 10.1196/annals.1443.016; LEWELLEN TK, 1977, J NUCL MED, V18, P929; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mazor RL, 2000, CYTOKINE, V12, P239, DOI 10.1006/cyto.1999.0526; Mercurio F, 1999, ONCOGENE, V18, P6163, DOI 10.1038/sj.onc.1203174; Mercurio F, 1999, CURR OPIN CELL BIOL, V11, P226, DOI 10.1016/S0955-0674(99)80030-1; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Nakamura H, 2003, J BONE MINER RES, V18, P1198, DOI 10.1359/jbmr.2003.18.7.1198; Rungeler P, 1999, BIOORGAN MED CHEM, V7, P2343, DOI 10.1016/S0968-0896(99)00195-9; Schmidt TJ, 1999, CURR ORG CHEM, V3, P577; Soysa Niroshani Surangika, 2012, J Med Dent Sci, V59, P65; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takayanagi Hiroshi, 2009, Rinsho Ketsueki, V50, P447; Tarasov V. A., 1974, CHEM NAT COMPD, V10, P826; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tomoyasu A, 1998, BIOCHEM BIOPH RES CO, V245, P382, DOI 10.1006/bbrc.1998.8443; van der Kraan AGJ, 2013, BIOCHEM J, V451, P235, DOI 10.1042/BJ20121626; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wang T, 2017, CURR DRUG TARGETS, V18, P1051, DOI 10.2174/1389450118666170321105425; Wang T, 2015, INT J MOL SCI, V16, P27470, DOI 10.3390/ijms161126039; Xu JK, 2009, CYTOKINE GROWTH F R, V20, P7, DOI 10.1016/j.cytogfr.2008.11.007; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yip KHM, 2004, J BONE MINER RES, V19, P1905, DOI 10.1359/JBMR.040919; Zhu LL, 2005, BIOCHEM BIOPH RES CO, V326, P131, DOI 10.1016/j.bbrc.2004.10.212; Zhu SP, 2018, BIOL REV, V93, P469, DOI 10.1111/brv.12353; Zou W, 2010, ANN NY ACAD SCI, V1192, P27, DOI 10.1111/j.1749-6632.2009.05245.x	46	10	10	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6726	6735		10.1096/fj.201800883RRR	http://dx.doi.org/10.1096/fj.201800883RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30807230	Bronze			2022-12-26	WOS:000476114200005
J	Tan, YQ; Kwan, HY; Yao, XQ; Leung, LK				Tan, Yan Qin; Kwan, Hiu Yee; Yao, Xiaoqiang; Leung, Lai K.			The activity of transient receptor potential channel C-6 modulates the differentiation of fat cells	FASEB JOURNAL			English	Article						TRPC; adipogenesis; calcium signaling; quercetin	TRPC6 CHANNELS; ADIPOCYTE DIFFERENTIATION; CALCIUM; ADIPOGENESIS; INHIBITION; QUERCETIN; ANTAGONIST; ACTIVATION; OVERWEIGHT; EXERCISE	Previously, the V1-3 isoforms of the transient receptor potential channel (TRP) have been shown to promote or prevent adipocyte differentiation. In the current study, the C isoforms were screened for blocking adipogenesis. The hypothesis that the TRP classic or canonical (TRPC) deters adipocyte differentiation was investigated in 3T3-L1 cells employing the channel-specific activator and antagonist, silencing, and overexpression techniques. Fat accumulation in cells was visualized by Oil Red O staining. Intracellular calcium inflow was estimated by confocal microscopy. A high-fat (HF) feeding study was also performed on C57BL/6J mice to verify the findings in the cell model. Among the 6 C isoforms tested, only TRPC-6 inhibited the differentiation of fat cells. The phytochemical quercetin induced the channel protein expression. Calcium-imaging results also revealed that the flavonoid could trigger calcium inflow. Coadministration of quercetin (1 or 20 mg/kg body weight) in an HF diet prevented TRPC-6 from declining and attenuated phosphorylated (p)-PKB and PI3k, as well as the proliferation of visceral fat cells. The present study illustrated that TRPC-6 activation could perturb adipocyte differentiation. The food flavonoid quercetin was a TRPC-6 inducer and activator and it could prevent adipogenesis in mice.Tan, Y. Q., Kwan, H. Y., Yao, X., Leung, L. K. The activity of transient receptor potential channel C-6 modulates the differentiation of fat cells.	[Tan, Yan Qin; Leung, Lai K.] Chinese Univ Hong Kong, Sch Life Sci, Fac Sci, Hong Kong, Peoples R China; [Yao, Xiaoqiang] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Peoples R China; [Kwan, Hiu Yee] Baptist Univ, Sch Chinese Med, Hong Kong, Peoples R China	Chinese University of Hong Kong; Chinese University of Hong Kong; Hong Kong Baptist University	Leung, LK (corresponding author), Chinese Univ Hong Kong, Food & Nutr Sci Programme, Room 507C MMW Bldg, Hong Kong, Peoples R China.	laikleung@cuhk.edu.hk	Yao, Xiaoqiang/I-5413-2016; Leung, Lai K/E-6314-2011; Tan, Yan Qin/AAF-4352-2021	Yao, Xiaoqiang/0000-0002-0687-8186; Leung, Lai K/0000-0002-7781-3099; Tan, Yan Qin/0000-0001-7769-2023; KWAN, Hiu Yee/0000-0002-6088-7323	Chinese University of Hong Kong [4053256]	Chinese University of Hong Kong(Chinese University of Hong Kong)	The authors are grateful to Prof. Howard Glauert (University of Kentucky, Lexington, KY, USA) for his help in proofreading this manuscript. This study was supported by Chinese University of Hong Kong Direct Grant 4053256. L.K.L. and Y.Q.T. are affiliated with the Food and Nutritional Sciences Programme of The Chinese University of Hong Kong. The authors declare no conflicts of interest.	Allison DB, 2003, EUR J CLIN NUTR, V57, P514, DOI 10.1038/sj.ejcn.1601587; Amiot MJ, 2016, OBES REV, V17, P573, DOI 10.1111/obr.12409; Baudry A, 2006, J CELL SCI, V119, P889, DOI 10.1242/jcs.02792; Benemei S, 2015, CURR OPIN PHARMACOL, V22, P18, DOI 10.1016/j.coph.2015.02.006; Bishnoi M, 2018, OBES REV, V19, P1269, DOI 10.1111/obr.12703; Bishnoi M, 2013, EXPERT REV ENDOCRINO, V8, P173, DOI [10.1586/eem.13.3, 10.1586/eem.13.4]; Bishnoi M, 2013, PHARMACOL REP, V65, P751, DOI 10.1016/S1734-1140(13)71055-7; Che H, 2014, PFLUG ARCH EUR J PHY, V466, P947, DOI 10.1007/s00424-013-1355-4; Cheung SY, 2015, ENDOCRINOLOGY, V156, P2074, DOI 10.1210/en.2014-1831; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2005, PHARMACOL REV, V57, P427, DOI 10.1124/pr.57.4.6; Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66; Dietrich A. G. T., 2014, HDB EXPT PHARM, V222; Ding X, 2010, JNCI-J NATL CANCER I, V102, P1052, DOI 10.1093/jnci/djq217; Doleschal B, 2015, CARDIOVASC RES, V106, P163, DOI 10.1093/cvr/cvv022; Eder P, 2011, CIRC RES, V108, P265, DOI 10.1161/CIRCRESAHA.110.225888; Funakoshi T., 2017, BIOCH BIOPHYS REP, V13, P39; Goudarzi F, 2018, MOL BIOTECHNOL, V60, P279, DOI 10.1007/s12033-018-0071-x; He YH, 2012, MOL CELL BIOCHEM, V361, P321, DOI 10.1007/s11010-011-1118-5; Ilatovskaya DV, 2015, AM J PHYSIOL-RENAL, V309, pF393, DOI 10.1152/ajprenal.00186.2015; Jensen B, 2004, EXP CELL RES, V301, P280, DOI 10.1016/j.yexcr.2004.08.030; Khalilpourfarshbafi M, 2019, EUR J NUTR, V58, P5, DOI 10.1007/s00394-018-1663-8; Kim MA, 2014, LIFE SCI, V101, P64, DOI 10.1016/j.lfs.2014.02.012; Lee SG, 2017, J NUTR BIOCHEM, V42, P62, DOI 10.1016/j.jnutbio.2016.12.018; Maier T, 2015, BRIT J PHARMACOL, V172, P3650, DOI 10.1111/bph.13151; Maki KC, 2009, J NUTR, V139, P264, DOI 10.3945/jn.108.098293; Malczyk M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00707; Miller M. R., 2010, PROBE REPORTS NIH MO; Miller M, 2011, J BIOL CHEM, V286, P33436, DOI 10.1074/jbc.M111.274167; Moseti D, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010124; Nabavi SF, 2015, FOOD CHEM, V179, P305, DOI 10.1016/j.foodchem.2015.02.006; Nagao T, 2005, AM J CLIN NUTR, V81, P122; Neal JW, 2002, J BIOL CHEM, V277, P49776, DOI 10.1074/jbc.M207913200; Nilius B, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-218; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Ntambi JM, 1996, DIFFERENTIATION, V60, P151, DOI 10.1007/s002580050145; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Qiu J, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12501; Ramirez GA, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7070070; Seo MJ, 2015, J NUTR BIOCHEM, V26, P1308, DOI 10.1016/j.jnutbio.2015.06.005; Seo M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030518; Shen B, 2011, J BIOL CHEM, V286, P19439, DOI 10.1074/jbc.M110.210294; Shi H, 2000, PHYSIOL GENOMICS, V3, P75, DOI 10.1152/physiolgenomics.2000.3.2.75; Shi J, 2007, BRIT J PHARMACOL, V152, P122, DOI 10.1038/sj.bjp.0707368; Singh A, 2010, BRIT J PHARMACOL, V160, P1464, DOI 10.1111/j.1476-5381.2010.00786.x; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Thiel G, 2018, INT REV CEL MOL BIO, V335, P167, DOI 10.1016/bs.ircmb.2017.07.010; Urban N, 2017, BRIT J PHARMACOL, V174, P4099, DOI 10.1111/bph.13977; Varnai P, 2009, TRENDS PHARMACOL SCI, V30, P118, DOI 10.1016/j.tips.2008.11.005; Weber EW, 2015, J EXP MED, V212, P1883, DOI 10.1084/jem.20150353; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b; Zhou Y, 2017, SCIENCE, V358, P1332, DOI 10.1126/science.aal4178; Ziegenfuss TN, 2006, J INT SOC SPORT NUTR, V3, DOI 10.1186/1550-2783-3-2-45	53	5	5	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6526	6538		10.1096/fj.201801518RR	http://dx.doi.org/10.1096/fj.201801518RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30785766	Bronze			2022-12-26	WOS:000466932600056
J	Lee, MJ; Cho, S; Cha, J; Kim, S; Kim, ST; Bang, OY; Chung, CS; Lee, KH; Kim, GM				Lee, Mi Ji; Cho, Soohyun; Cha, Jihoon; Kim, Seonwoo; Kim, Sung Tae; Bang, Oh Young; Chung, Chin-Sang; Lee, Kwang Ho; Kim, Gyeong-Moon			Visualization of basilar artery atherosclerotic plaques by conventional T2-weighted magnetic resonance imaging: A case-control study	PLOS ONE			English	Article							INTERNAL CAROTID-ARTERY; HIGH-RESOLUTION MRI; INTRAPLAQUE HEMORRHAGE; OCCLUSIVE DISEASE; ISCHEMIC-STROKE; ANGIOGRAPHY; INFARCTION; STENOSIS	Objective In vivo visualization of intracranial atherosclerotic plaque has been performed only with high-resolution magnetic resonance imaging (HRMR). We investigated whether atherosclerotic plaque of the basilar artery (BA) can be identified in conventional magnetic resonance imaging (MRI). Methods Patients with acute ischemic stroke who had BA stenosis ("symptomatic BAA") were retrospectively recruited using the prospective stroke registry. In the HRMR databank, subjects without BA stenosis were recruited and classified as those with silent plaque ("silent BAA") and without any plaque ("normal controls"). Outer diameter of the BA and T2 plaque sign (an eccentric or complete obscuration of normal flow-void) within the BA were assessed by two blinded raters using conventional T2 MRI. Results Seventy-five patients with symptomatic BAA, 40 with asymptomatic BAA, and 36 normal controls were included in the study. Maximal BA diameter was significantly larger in symptomatic BAA patients with <30%, 30-50%, 50-70%, and >70% stenosis (all p<0.01 in each subgroup) and silent BAA subjects (p=0.018) than controls. T2 plaque signs were present in 46 (61.3%) patients with symptomatic BAA and 6 (14.6%) subjects with asymptomatic BAA, while none in normal controls (p<0.001 and 0.057, respectively). Detection rates were increased with an increase in stenosis degree (25.0% in < 30% stenosis, 57.9% in 30-50% stenosis, 38.5% in 50-70% stenosis, 92.3% in 70-99% stenosis, and 100.0% in occlusion). Conclusions Our data suggest that BA atherosclerosis can be detected by conventional MRI. When the use of HRMR is limited, conventional MR imaging may give additive information to clinicians.	[Lee, Mi Ji; Cho, Soohyun; Bang, Oh Young; Chung, Chin-Sang; Lee, Kwang Ho; Kim, Gyeong-Moon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea; [Cha, Jihoon; Kim, Sung Tae] Sungkyunkwan Univ, Samsung Med Ctr, Dept Radiol, Sch Med, Seoul, South Korea; [Kim, Seonwoo] Samsung Med Ctr, Samsung Biomed Res Inst, Biostat Team, Seoul, South Korea; [Cha, Jihoon] Yonsei Univ, Severance Hosp, Res Inst Radiol Sci, Coll Med,Dept Radiol, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Yonsei University; Yonsei University Health System	Lee, MJ (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurol, Sch Med, Seoul, South Korea.	mirony.lee@gmail.com		Lee, Mi Ji/0000-0003-1364-1969	National Research Foundation of Korea (NRF) - Korean government (MSIP) [2017R1A2B2009086, 2017R1A2B4007254]; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [HI13C1521]	National Research Foundation of Korea (NRF) - Korean government (MSIP); Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This study was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIP) (Nos. 2017R1A2B2009086 to CSC and 2017R1A2B4007254 to MJL) and the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (HI13C1521 to MJL and OYB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXEL L, 1984, AM J ROENTGENOL, V143, P1157, DOI 10.2214/ajr.143.6.1157; Ay H, 2007, STROKE, V38, P2979, DOI 10.1161/STROKEAHA.107.490896; BILLER J, 1988, STROKE, V19, P297, DOI 10.1161/01.STR.19.3.297; Bitar R, 2008, RADIOLOGY, V249, P259, DOI 10.1148/radiol.2491071517; Bodle JD, 2013, STROKE, V44, P287, DOI 10.1161/STROKEAHA.112.664680; BRADLEY WG, 1988, AM J ROENTGENOL, V150, P983, DOI 10.2214/ajr.150.5.983; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Degnan AJ, 2012, AM J NEURORADIOL, V33, P1427, DOI 10.3174/ajnr.A2697; Fayad ZA, 2000, CIRCULATION, V102, P506; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Gorelick PB, 2008, STROKE, V39, P2396, DOI 10.1161/STROKEAHA.107.505776; Kang CK, 2010, J MAGN RESON IMAGING, V32, P544, DOI 10.1002/jmri.22250; Klein IF, 2006, NEUROLOGY, V67, P327, DOI 10.1212/01.wnl.0000225074.47396.71; Lee DK, 2005, STROKE, V36, P2583, DOI 10.1161/01.STR.0000189999.19948.14; Lee WJ, 2015, NEURORADIOLOGY, V57, P1007, DOI 10.1007/s00234-015-1566-9; Li Q, 2015, J STROKE CEREBROVASC, V24, P1591, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.028; Lim SH, 2015, ATHEROSCLEROSIS, V240, P278, DOI 10.1016/j.atherosclerosis.2015.03.029; Ma N, 2010, NEUROLOGY, V75, P253, DOI 10.1212/WNL.0b013e3181e8e714; Mehdiratta M, 2007, ARCH NEUROL-CHICAGO, V64, P1666, DOI 10.1001/archneur.64.11.1666; Momjian-Mayor I, 2005, STROKE, V36, P567, DOI 10.1161/01.STR.0000155727.82242.e1; Pandey S, 2013, RADIOGRAPHICS, V33, pE113, DOI 10.1148/rg.333125148; Ryoo S, 2012, NEUROLOGY; Voetsch B, 2004, ARCH NEUROL-CHICAGO, V61, P496, DOI 10.1001/archneur.61.4.496; Wong KS, 2002, ANN NEUROL, V52, P74, DOI 10.1002/ana.10250; Worthley SG, 2000, CIRCULATION, V101, P586, DOI 10.1161/01.CIR.101.6.586; Xu WH, 2012, ANN NEUROL, V71, P195, DOI 10.1002/ana.22626; Yu JH, 2015, STROKE, V46, P2768, DOI 10.1161/STROKEAHA.115.009412; Yuan C, 2002, J MAGN RESON IMAGING, V15, P62, DOI 10.1002/jmri.10030	28	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212570	10.1371/journal.pone.0212570	http://dx.doi.org/10.1371/journal.pone.0212570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807597	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100019
J	Zhang, LJ; Yang, L; Gu, XX; Chen, PX; Fu, JL; Jiang, HX				Zhang, Li-Juan; Yang, Ling; Gu, Xi-Xi; Chen, Pin-Xian; Fu, Jia-Li; Jiang, Hong-Xia			The first isolation of Clostridium difficile RT078/ST11 from pigs in China	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; TOXIN-A; STRAIN; INFECTION; IDENTIFICATION; CIPROFLOXACIN; EMERGENCE; EPIDEMIC; ANIMALS; HUMANS	We investigated the molecular characteristics and antimicrobial susceptibility of Clostridium difficile isolated from animals in China. We obtained 538 rectal swabs from pigs, chickens and ducks in 5 provinces during 2015 and 2016. C. difficile isolates were characterized by detection of toxin genes, multilocus sequence typing and ribotyping. And antimicrobial susceptibility testing was performed using the agar dilution method. Out of 538 samples, 44 (8.2%) were C. difficile positive with high prevalence in pigs (n = 31). Among these, 39 (88.6%) were toxigenic including 14 (31.8%) that were A(+)B(+)CDT(+) and 13 (29.5%) A(+)B(+). The remaining 12 (27.3%) were A(-)B(+). We identified 7 ST types and 6 PCR ribotypes. The most predominant type was ST11/RT078 with toxin profile A(+)B(+) CDT+ and all were isolated from piglets with diarrhea. ST109 isolates possessed two different toxigenic profiles (A(-)B(-)CDT(-) and A(-)B(+) CDT-) and although it was not the most prevalent sequence type, but it was widely distributed between chickens, ducks and pigs in the 5 provinces. All C. difficile isolates were fully susceptible to vancomycin, metronidazole, fidaxomicin, amoxicillin/clavulanate and meropenem but retained resistance to 4 or 5 of the remaining antibiotics, especially cefotaxime, tetracycline, ciprofloxacin, cefoxitin. The RT078/ST11 isolates were simultaneously resistant to cefotaxime, tetracycline, cefoxitin, ciprofloxacin and imipenem. This is the first report of the molecular epidemiology of C. difficile isolated from food animals in China. We identified the epidemic strain RT078/ST11 as the predominate isolate among the animals we screened in our study.	[Zhang, Li-Juan; Yang, Ling; Gu, Xi-Xi; Chen, Pin-Xian; Fu, Jia-Li; Jiang, Hong-Xia] SCAU, Coll Vet Med, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China; [Zhang, Li-Juan; Yang, Ling; Gu, Xi-Xi; Chen, Pin-Xian; Fu, Jia-Li; Jiang, Hong-Xia] SCAU, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Jiang, HX (corresponding author), SCAU, Coll Vet Med, Natl Risk Assessment Lab Antimicrobial Resistance, Guangzhou, Guangdong, Peoples R China.; Jiang, HX (corresponding author), SCAU, Coll Vet Med, Guangdong Prov Key Lab Vet Pharmaceut Dev & Safet, Guangzhou, Guangdong, Peoples R China.	hxjiang@scau.edu.cn		Jiang, Hong-Xia/0000-0002-8349-2877	National Natural Science Foundation of China [31272602]; Graduate Student Oversea Study Program of South China Agriculture University [2017LHPY029]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Graduate Student Oversea Study Program of South China Agriculture University	This work was supported by the National Natural Science Foundation of China (31272602) (H-XJ) and Graduate Student Oversea Study Program of South China Agriculture University (2017LHPY029) (LY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, METH ANT SUSC TEST A; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Cheng JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18834; Collins DA, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-21; Collins J, 2019, GUT MICROBES, V10, P204, DOI 10.1080/19490976.2018.1491266; Debast SB, 2009, ENVIRON MICROBIOL, V11, P505, DOI 10.1111/j.1462-2920.2008.01790.x; Dridi L, 2002, ANTIMICROB AGENTS CH, V46, P3418, DOI 10.1128/AAC.46.11.3418-3421.2002; Fabrega A, 2009, MICROB BIOTECHNOL, V2, P40, DOI 10.1111/j.1751-7915.2008.00063.x; Gao Qiong, 2015, Yichuan, V37, P458, DOI 10.16288/j.yczz.15-131; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; Goorhuis A, 2008, J CLIN MICROBIOL, V46, P1157, DOI 10.1128/JCM.01536-07; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; He M, 2013, NAT GENET, V45, P109, DOI 10.1038/ng.2478; Huang HH, 2009, INT J ANTIMICROB AG, V33, P339, DOI 10.1016/j.ijantimicag.2008.09.022; Janezic S, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-173; Jin H, 2016, INFECT CONT HOSP EP, V37, P745, DOI 10.1017/ice.2016.58; Kato H, 1998, J CLIN MICROBIOL, V36, P2178, DOI 10.1128/JCM.36.8.2178-2182.1998; Keessen EC, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-14; Knetsch CW, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01384-17; Knetsch CW, 2014, EUROSURVEILLANCE, V19, P30, DOI 10.2807/1560-7917.ES2014.19.45.20954; Knight DR, 2015, CLIN MICROBIOL REV, V28, P721, DOI 10.1128/CMR.00127-14; Krutova M, 2018, INT J MED MICROBIOL, V308, P770, DOI 10.1016/j.ijmm.2018.05.006; Kuijper J, 2006, EMERGENCE CLOSTRIDIU; Lessa FC, 2015, NEW ENGL J MED, V372, P825, DOI [10.1056/NEJMoa1408913, 10.1056/NEJMc1505190]; Mastrantonio P, 2018, UPDATES CLOSTRIDIUM; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Moono P, 2016, FOODBORNE PATHOG DIS, V13, P647, DOI 10.1089/fpd.2016.2181; Norman KN, 2009, ANAEROBE, V15, P256, DOI 10.1016/j.anaerobe.2009.09.006; O'Donoghue C, 2011, CURR OPIN GASTROEN, V27, P38, DOI 10.1097/MOG.0b013e3283411634; Pituch H, 2005, J CLIN MICROBIOL, V43, P472, DOI 10.1128/JCM.43.1.472-475.2005; Rodriguez C, 2016, ADV EXP MED BIOL, V932, P65, DOI 10.1007/5584_2016_27; Shen A, 2012, J INNATE IMMUN, V4, P149, DOI 10.1159/000332946; Spigaglia P, 2002, J CLIN MICROBIOL, V40, P3470, DOI 10.1128/JCM.40.9.3470-3475.2002; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Spigaglia P, 2016, THER ADV INFECT DIS, V3, P23, DOI 10.1177/2049936115622891; Spigaglia P, 2015, ANAEROBE, V31, P42, DOI 10.1016/j.anaerobe.2014.10.003; Stein K, 2017, ANAEROBE, V48, P237, DOI 10.1016/j.anaerobe.2017.10.004; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Suo JJ, 2017, INFECT CONT HOSP EP, V38, P1383, DOI 10.1017/ice.2017.206; Tang CJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37865; Wu YC, 2016, INT J MED MICROBIOL, V306, P115, DOI 10.1016/j.ijmm.2016.02.002; Yan Q, 2013, EPIDEMIOL INFECT, V141, P195, DOI 10.1017/S0950268812000453; Zhang WH, 2017, MICROB DRUG RESIST, V23, P687, DOI 10.1089/mdr.2016.0119	43	12	14	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212965	10.1371/journal.pone.0212965	http://dx.doi.org/10.1371/journal.pone.0212965			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807599	gold, Green Submitted, Green Published			2022-12-26	WOS:000459712100030
J	Portella, AK; Paquet, C; Bischoff, AR; Molle, RD; Faber, A; Moore, S; Arora, N; Levitan, R; Silveira, PP; Dube, L				Portella, Andre Krumel; Paquet, Catherine; Bischoff, Adrianne Rahde; Molle, Roberta Dalle; Faber, Aida; Moore, Spencer; Arora, Narendra; Levitan, Robert; Silveira, Patricia Pelufo; Dube, Laurette			Multi-behavioral obesogenic phenotypes among school-aged boys and girls along the birth weight continuum	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; PHYSICAL-ACTIVITY; MUSCLE STRENGTH; EATING BEHAVIOR; SLEEP DURATION; CARDIORESPIRATORY FITNESS; YOUNG-ADULTS; RISK-FACTORS; CARDIOVASCULAR FITNESS; NONLINEAR RELATIONSHIP	Evidence shows that extremes of birth weight (BW) carry a common increased risk for the development of adiposity and related cardiovascular diseases, but little is known about the role of obesogenic behaviors in this process. Moreover, no one has empirically examined whether the relationship between BW, obesogenic behaviors and BMI along the full low-to-high birthweight continuum reflects the U-shape pattern expected from common risk at both BW extremes. Our objective was to characterize physical activity, screen time, and eating behavior and their relationship to BMI as a function of BW among school-aged boys and girls. In this cross-sectional study, 460 children aged 6 to 12 years (50% boys) from Montreal, Canada provided information on sleeping time, screen time, physical activity levels, eating behavior (emotional, external and restrained eating) and anthropometrics (height, weight, BW) through parent reported questionnaires. BMI was normalized using WHO Standards (zBMI), and BW expressed as ratio using Canadian population standards (BW for gestational age and sex). Analyses were conducted using generalized linear models with linear and quadratic terms for BW, stratified by sex and adjusted for age, ethnicity and household income. In boys, physical activity and screen time showed U-shaped associations with BW, while physical activity had an inverted U-shaped in girls. Emotional and restrained eating had positive linear relations with BW in boys and girls. Sleep time and external eating were not associated with BW. A U-shaped relationship between BW and zBMI was found in boys but no association was found in girls. Only sleep (in boys and girls), and emotional eating (girls only) were related to zBMI and mediation of the BW-zBMI relationship was only supported for emotional eating. In conclusion, BW relates to obesogenic behaviors and BMI in both non-linear and linear ways, and these associations differed by sex.	[Portella, Andre Krumel; Faber, Aida; Dube, Laurette] McGill Univ, Desautels Fac Management, McGill Ctr Convergence Hlth & Econ, Montreal, PQ, Canada; [Portella, Andre Krumel] Univ Fed Ciencias Saude Porto Alegre, PostGrad Program Pediat, Porto Alegre, RS, Brazil; [Paquet, Catherine] Univ South Australia, Sch Hlth Sci, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Bischoff, Adrianne Rahde] Univ Toronto, Div Neonatol, Dept Pediat, Toronto, ON, Canada; [Molle, Roberta Dalle] Univ Fed Rio Grande do Sul, Fac Med, Programa Posgrad Saude Crianca & Adolescente, Porto Alegre, RS, Brazil; [Moore, Spencer] Univ South Carolina, Arnold Sch Publ Hlth, Columbia, SC USA; [Arora, Narendra] INCLEN Trust, New Delhi, India; [Levitan, Robert] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Levitan, Robert] CAMH, Toronto, ON, Canada; [Silveira, Patricia Pelufo] McGill Univ, Dept Psychiat, Fac Med, Montreal, PQ, Canada; [Silveira, Patricia Pelufo] McGill Univ, Sackler Inst Epigenet & Psychobiol, Montreal, PQ, Canada; [Silveira, Patricia Pelufo] Douglas Hosp, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada	McGill University; Universidade Federal de Ciencias da Saude de Porto Alegre; University of South Australia; University of Toronto; Universidade Federal do Rio Grande do Sul; University of South Carolina System; University of South Carolina Columbia; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; McGill University; McGill University; McGill University	Portella, AK (corresponding author), McGill Univ, Desautels Fac Management, McGill Ctr Convergence Hlth & Econ, Montreal, PQ, Canada.; Portella, AK (corresponding author), Univ Fed Ciencias Saude Porto Alegre, PostGrad Program Pediat, Porto Alegre, RS, Brazil.	andre.portella@mcgill.ca	Portella, Andre Krumel/A-9333-2010; Paquet, Catherine/C-3894-2009; Moore, Spencer/AAJ-5022-2020; Silveira, Patricia/F-4897-2014	Portella, Andre Krumel/0000-0003-3390-0016; Paquet, Catherine/0000-0002-6877-7903; Moore, Spencer/0000-0002-1229-9578; Silveira, Patricia/0000-0001-8626-2519; Bischoff, Adrianne R/0000-0001-9218-1301	Canadian Institutes of Health Research (CIHR); CIHR-India [INC 110726]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR-India	This study was supported by Canadian Institutes of Health Research (CIHR); http://www.cihr-irsc.gc.ca/; CIHR-India grant ref no. INC 110726 (LB, SM and NA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abril V, 2013, FOOD NUTR BULL, V34, P388, DOI 10.1177/156482651303400404; Alves MB, 2015, BEHAV BRAIN RES, V287, P73, DOI 10.1016/j.bbr.2015.03.019; Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Anderson SE, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-366; Ayres C, 2012, INT J PEDIAT, V2012, DOI 10.1155/2012/657379; Barbieri MA, 2009, PEDIATR RES, V65, P215, DOI 10.1203/PDR.0b013e31818d6850; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Bellinger L, 2005, CLIN SCI, V109, P413, DOI 10.1042/CS20050127; Bellinger L, 2006, INT J OBESITY, V30, P729, DOI 10.1038/sj.ijo.0803205; Bischoff AR, 2018, BRIT J NUTR, V119, P1295, DOI [10.1017/S0007114518000892, 10.1017/s0007114518000892]; Bischoff AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177344; Boreham CA, 2001, PUBLIC HEALTH, V115, P373; BRUCH H, 1964, PSYCHOSOMATICS, V5, P269; Brutsaert TD, 2011, EARLY HUM DEV, V87, P663, DOI 10.1016/j.earlhumdev.2011.05.006; Cafiero G, 2014, ACTA PAEDIATR, V103, pE219, DOI 10.1111/apa.12571; Cameron AJ, 2011, ANN EPIDEMIOL, V21, P95, DOI 10.1016/j.annepidem.2010.11.001; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; CHARLES MA, 1994, AM J MED, V97, P250, DOI 10.1016/0002-9343(94)90008-6; Cleland VJ, 2008, AM J CLIN NUTR, V87, P1148, DOI 10.1093/ajcn/87.5.1148; Croker H, 2011, APPETITE, V57, P525, DOI 10.1016/j.appet.2011.05.320; Cunha FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118586; de Beer M, 2015, INT J OBESITY, V39, P586, DOI 10.1038/ijo.2014.200; de Jong E, 2013, INT J OBESITY, V37, P47, DOI 10.1038/ijo.2011.244; Dodds R, 2012, J NUTR HEALTH AGING, V16, P609, DOI 10.1007/s12603-012-0053-9; Dulloo AG, 2006, INT J OBESITY, V30, pS23, DOI 10.1038/sj.ijo.0803516; Eisenmann JC, 2004, OBES RES, V12, P1633, DOI 10.1038/oby.2004.203; Eisenstein SA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11283; Ekstrom S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3947; Eloranta AM, 2012, INT J OBESITY, V36, P950, DOI 10.1038/ijo.2012.89; Eriksson JG, 2004, PREV MED, V39, P164, DOI 10.1016/j.ypmed.2004.01.035; Escobar RS, 2014, APPETITE, V81, P337, DOI 10.1016/j.appet.2014.06.107; Ester WA, 2019, INT J EPIDEMIOL, V48, P124, DOI 10.1093/ije/dyy256; Fernandes FS, 2010, J DEV ORIG HLTH DIS, V1, P255, DOI 10.1017/S204017441000019X; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; Fowden AL, 2004, REPRODUCTION, V127, P515, DOI 10.1530/rep.1.00033; Gadermann A.M., 2012, PRACTICAL ASSESSMENT, V17, P3, DOI DOI 10.7275/N560-J767; Gubbels JS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-77; Gubbels JS, 2012, PUBLIC HEALTH NUTR, V15, P1402, DOI 10.1017/S1368980011003089; Gubbels JS, 2009, J PEDIATR-US, V155, P194, DOI 10.1016/j.jpeds.2009.02.027; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hancox RJ, 2012, J EPIDEMIOL COMMUN H, V66, P957, DOI 10.1136/jech-2011-200217; Hare-Bruun H, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-311; Hobbs M, 2018, PERSPECT PUBLIC HEAL, V138, P169, DOI 10.1177/1757913917748353; Inskip HM, 2007, J INTERN MED, V262, P368, DOI 10.1111/j.1365-2796.2007.01812.x; Jones RH, 2009, MOL CELL ENDOCRINOL, V297, P4, DOI 10.1016/j.mce.2008.06.020; Kajantie E, 2010, J PEDIATR-US, V157, P610, DOI 10.1016/j.jpeds.2010.04.002; Kakinami L, 2014, ARCH DIS CHILD, V99, P1020, DOI 10.1136/archdischild-2013-305163; Kaseva N, 2013, J PEDIATR-US, V163, P43, DOI 10.1016/j.jpeds.2012.12.076; Koyama S, 2015, J PEDIATR-US, V166, P309, DOI 10.1016/j.jpeds.2014.10.003; Kramer MS, 1999, PEDIATRICS, V103, P599, DOI 10.1542/peds.103.3.599; Kramer MS, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e35; Kremers SPJ, 2004, PSYCHOL HEALTH, V19, P595, DOI 10.1080/08870440412331279630; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; Lanfer A, 2012, INT J OBESITY, V36, P27, DOI 10.1038/ijo.2011.164; Laureano DP, 2016, NEUROSCIENCE, V322, P500, DOI 10.1016/j.neuroscience.2016.02.033; Laureano DP, 2016, J CHILD NEUROL, V31, P398, DOI 10.1177/0883073815592225; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P411, DOI 10.1007/s10654-008-9259-x; Leatherdale ST, 2009, HEALTH PROMOT PRACT, V10, P254, DOI 10.1177/1524839906298499; Lluch A, 2000, INT J OBESITY, V24, P1493, DOI 10.1038/sj.ijo.0801425; Lussana F, 2008, AM J CLIN NUTR, V88, P1648, DOI 10.3945/ajcn.2008.26140; McDonald L, 2015, INT J OBESITY, V39, P1463, DOI 10.1038/ijo.2015.132; Melkevik O, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-46; Mericq V, 2009, EUR J ENDOCRINOL, V161, P419, DOI 10.1530/EJE-09-0308; Molle RD, 2016, J DEV ORIG HLTH DIS, V7, P222, DOI 10.1017/S2040174415007187; Molle RD, 2015, BRAIN RES, V1618, P41, DOI 10.1016/j.brainres.2015.05.019; Murtaugh MA, 2003, DIABETES CARE, V26, P187, DOI 10.2337/diacare.26.1.187; Must A, 2005, INT J OBESITY, V29, pS84, DOI 10.1038/sj.ijo.0803064; Narayanan NS, 2010, FRONT NEUROENDOCRIN, V31, P104, DOI 10.1016/j.yfrne.2009.10.004; Noschang C, 2014, BRIT J MED MED RES, V4; Ortega FB, 2009, J PEDIATR, V154, P61, DOI 10.1016/j.jpeds.2008.07.041; Owens JA, 2000, SLEEP, V23, P1043; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Paquet C, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0540-9; Perala MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046139; Plagemann A, 2006, HORM RES, V65, P83, DOI 10.1159/000091511; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Portella AK, 2015, BEHAV BRAIN RES, V278, P66, DOI 10.1016/j.bbr.2014.09.033; Ridgway CL, 2009, MED SCI SPORT EXER, V41, P1212, DOI 10.1249/MSS.0b013e31819794ab; Rogers M, 2005, PEDIATRICS, V116, pE58, DOI 10.1542/peds.2004-1603; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; SALLIS JF, 1993, RES Q EXERCISE SPORT, V64, P25, DOI 10.1080/02701367.1993.10608775; Sallis JF, 1996, J CLIN EPIDEMIOL, V49, P125, DOI 10.1016/0895-4356(95)00514-5; Santos JL, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-108; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Seghers J, 2010, PUBLIC HEALTH NUTR, V13, P1838, DOI 10.1017/S1368980010000418; Shakir RN, 2018, NOT ALL SEDENTARY BE; Sigmund E, 2015, INT J ENV RES PUB HE, V12, P11848, DOI 10.3390/ijerph120911848; Silveira PP, 2012, PEDIATR RES, V71, P293, DOI 10.1038/pr.2011.39; Snoek HM, 2007, SCAND J PSYCHOL, V48, P23, DOI 10.1111/j.1467-9450.2006.00568.x; Sokolovic N, 2013, PEDIATR OBES, V8, pe41, DOI 10.1111/j.2047-6310.2012.00142.x; St-Onge MP, 2013, J CLIN SLEEP MED, V9, P73, DOI 10.5664/jcsm.2348; Stansfield BK, 2016, J PEDIATR-US, V174, P185, DOI 10.1016/j.jpeds.2016.04.012; Tam CHT, 2015, DIABETIC MED, V32, P220, DOI 10.1111/dme.12630; Tehranifar P, 2009, AM J EPIDEMIOL, V170, P910, DOI 10.1093/aje/kwp205; Tikanmaki M, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4237-4; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; van Deutekom AW, 2015, INT J OBESITY, V39, P593, DOI 10.1038/ijo.2014.204; van Deutekom AW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168186; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; van Strien T, 2013, PSYCHONEUROENDOCRINO, V38, P677, DOI 10.1016/j.psyneuen.2012.08.008; van Strien T, 2012, APPETITE, V59, P782, DOI 10.1016/j.appet.2012.08.009; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; WARDLE J, 1992, APPETITE, V18, P167, DOI 10.1016/0195-6663(92)90195-C; Webber L, 2009, INT J OBESITY, V33, P21, DOI 10.1038/ijo.2008.219; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Wicklow BA, 2015, INT J OBESITY, V39, P1070, DOI 10.1038/ijo.2015.55; World Health Organization (WHO), 2011, CHILD GROWTH STAND; Yiallourou SR, 2016, SLEEP MED REV, V26, P64, DOI 10.1016/j.smrv.2015.04.001; Yliharsila H, 2007, INT J OBESITY, V31, P1392, DOI 10.1038/sj.ijo.0803612; Yu ZB, 2011, OBES REV, V12, P525, DOI 10.1111/j.1467-789X.2011.00867.x; Zornoza-Moreno M, 2013, DIABETES-METAB RES, V29, P483, DOI 10.1002/dmrr.2417	115	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212290	10.1371/journal.pone.0212290	http://dx.doi.org/10.1371/journal.pone.0212290			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789933	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000459330800023
J	Yang, B; Pan, CS; Li, Q; Yang, Z; Long, FX; Fan, JY; Wang, CS; Han, JY; Tang, DX				Yang, Bing; Pan, Chun-Shui; Li, Quan; Yang, Zhu; Long, Feng-Xi; Fan, Jing-Yu; Wang, Chuan-She; Han, Jing-Yan; Tang, Dong-Xin			Inhibitory effects of Chanling Gao on the proliferation and liver metastasis of transplanted colorectal cancer in nude mice	PLOS ONE			English	Article							EXPRESSION; HYPOXIA; GROWTH; INJURY; CXCR4	This study aimed to explore the efficacy and mechanism of Chanling Gao (CLG), a compound Chinese medicine, on colorectal cancer (CRC). A model of transplanted CRC was established in nude mice. The mice were treated 7 days after CRC transplantation with either Capecitabine or CLG for 3 weeks. On the 28th day after the operation, CRC growth and liver metastasis were assessed by morphology, the changes in the expression of HIF-1 alpha (hypoxia inducible factor-1 alpha), stromal cell-derived factor-1 alpha (SDF-1 alpha), CXCR4 (C-X-C chemokine receptor type 4), PI3K, and Akt in the transplanted tumor and SDF-1 alpha and CXCR4 in the liver were detected by Western blot and immunohistochemistry. The protein contents of vascular endothelial growth factor (VEGF), matrix metalloproteinase (MMP)-2, and collagen IV in the serum and transplanted tumor and SDF-1 alpha and CXCR4 in liver tissues were detected by enzyme-linked immunosorbent assay. In the Capecitabine and high dose CLG groups, the growth and liver metastasis of CRC were significantly inhibited, the protein levels of HIF-1 alpha, SDF-1 alpha, CXCR4, MMP-2, VEGF, PI3K, Akt, P-PI3K and P-Akt in the transplanted tumor were lower, while the content of collagen IV in the transplanted tumor was higher, than in Model group. A high dose of CLG inhibited the growth of transplanted tumor and liver metastasis of CRC in nude mice, probably by inhibiting the HIF-1 alpha/SDF-1 alpha-CXCR4/PI3K-Akt signaling pathway reducing the synthesis and release of VEGF and degradation of collagen IV.	[Yang, Bing; Yang, Zhu; Long, Feng-Xi; Tang, Dong-Xin] Guizhou Univ Tradit Chinese Med, Guiyang, Guizhou, Peoples R China; [Pan, Chun-Shui; Li, Quan; Fan, Jing-Yu; Wang, Chuan-She; Han, Jing-Yan] Peking Univ, Hlth Sci Ctr, Tasly Microcirculat Res Ctr, Beijing, Peoples R China; [Wang, Chuan-She; Han, Jing-Yan] Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China; [Tang, Dong-Xin] Guizhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Oncol, Guiyang, Guizhou, Peoples R China	Guizhou University of Traditional Chinese Medicine; Peking University; Peking University; Guizhou University of Traditional Chinese Medicine	Tang, DX (corresponding author), Guizhou Univ Tradit Chinese Med, Guiyang, Guizhou, Peoples R China.; Han, JY (corresponding author), Peking Univ, Hlth Sci Ctr, Tasly Microcirculat Res Ctr, Beijing, Peoples R China.; Han, JY (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China.; Tang, DX (corresponding author), Guizhou Univ Tradit Chinese Med, Affiliated Hosp 1, Dept Oncol, Guiyang, Guizhou, Peoples R China.	hanjingyan@bjmu.edu.cn; tangdongxin@sina.com			National Natural Science Foundation of China [81460697, 81760814, 81860819]; Guizhou Province Traditional Chinese Medicine Modernization Project Foundation [SY-2014-3008-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guizhou Province Traditional Chinese Medicine Modernization Project Foundation	This work was supported in part by National Natural Science Foundation of China (grant number: 81460697 and 81760814 to DXT and 81860819 to BY) and by Guizhou Province Traditional Chinese Medicine Modernization Project Foundation (SY-2014-3008-1 to DXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan K, 2016, INT J CANCER, V138, P1058, DOI 10.1002/ijc.29519; Bing Y, 2016, LISHIZHEN MED MAT ME, V27, P1289; Canavese M, 2017, INT J CANCER, V140, P2183, DOI 10.1002/ijc.30567; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chen Q, 2013, ONCOL LETT, V6, P207, DOI 10.3892/ol.2013.1343; Cui YC, 2017, SCI REP-UK, V7, DOI 10.1038/srep44579; De Rosa M, 2016, THER ADV GASTROENTER, V9, P861, DOI 10.1177/1756283X16659790; Dongxin T, 2012, LISHIZHEN MED MAT ME, V23, P2213; Dongxin T, 2012, LISHIZHEN MED MAT ME, V23, P1452; Dongxin T, 2012, J MED REASERCH, V41, P79; Guo X, 2017, ONCOTARGET, V8, P80358, DOI 10.18632/oncotarget.18673; Guzman A, 2017, BIOMATERIALS, V115, P19, DOI 10.1016/j.biomaterials.2016.11.014; Hackl C, 2013, GUT, V62, P259, DOI 10.1136/gutjnl-2011-301585; Huang CY, 2010, J CELLULAR PHYSL, V221, P204; Iwai T, 2016, ONCOL REP, V36, P626, DOI 10.3892/or.2016.4902; Jianqiang C, 2016, CHINESE J PRACTICAL, V36, P858; Jones DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044294; Kjersti F, 2004, EUR J CANCER, V40, P1593, DOI [10.1016/j.ejca.2004.02.023, DOI 10.1016/J.EJCA.2004.02.023]; Liang Z, 2007, BIOCHEM BIOPH RES CO, V359, P716, DOI 10.1016/j.bbrc.2007.05.182; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Maddirela DR, 2013, INT J ONCOL, V42, P1279, DOI 10.3892/ijo.2013.1806; Moench R, 2016, ONCOTARGET, V7, P68749, DOI 10.18632/oncotarget.11899; Mu HN, 2015, FREE RADICAL BIO MED, V85, P237, DOI 10.1016/j.freeradbiomed.2015.04.033; Murakami T, 2013, INT J CANCER, V132, P276, DOI 10.1002/ijc.27670; Nogawa M, 2005, CANCER LETT, V217, P243, DOI 10.1016/j.canlet.2004.07.010; Ottaiano A, 2005, CANCER IMMUNOL IMMUN, V54, P781, DOI 10.1007/s00262-004-0636-3; Pan F, 2013, MOL BIOL REP, V40, P4139, DOI 10.1007/s11033-012-2225-4; Prasad S, 2012, CLIN CANCER RES, V18, P4942, DOI 10.1158/1078-0432.CCR-11-2805; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Romain B, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-58; Siegel R. L., 2018, CA-CANCER J CLIN, V60, P277; Stanisavljevic L, 2016, TUMOR BIOL, V37, P7441, DOI 10.1007/s13277-015-4591-8; Trudel D, 2010, HUM PATHOL, V41, P1694, DOI 10.1016/j.humpath.2010.05.001; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Veidal SS, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-22; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Wang X, 2008, BIOCH BIOPHYSICAL RE; Wenqi H, 2016, CONTINUED MED ED, V30, P137; Yamada S, 2014, J SURG RES, V187, P107, DOI 10.1016/j.jss.2013.10.030	39	4	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0201504	10.1371/journal.pone.0201504	http://dx.doi.org/10.1371/journal.pone.0201504			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789971	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800002
J	Agrawal, N; Lehtonen, SI; Uusi-Makela, M; Jain, P; Viitala, S; Maatta, JAE; Kahkonen, N; Azizi, L; Riihimaki, TA; Kulomaa, MS; Johnson, MS; Hytonen, VP; Airenne, TT				Agrawal, Nitin; Lehtonen, Soili I.; Uusi-Makela, Meri; Jain, Purvi; Viitala, Sari; Maatta, Juha A. E.; Kahkonen, Niklas; Azizi, Latifeh; Riihimaki, Tiina A.; Kulomaa, Markku S.; Johnson, Mark S.; Hytonen, Vesa P.; Airenne, Tomi T.			Molecular features of steroid-binding antidins and their use for assaying serum progesterone	PLOS ONE			English	Article							TAG II PEPTIDE; CHICKEN AVIDIN; STREP-TAG; AFFINITY PEPTIDE; EGG-WHITE; PROTEIN; STREPTAVIDIN; BIOTIN; PURIFICATION; DESIGN	Chicken avidin (Avd) and streptavidin from Streptomyces avidinii are extensively used in bionanotechnology due to their extremely tight binding to biotin (K-d similar to 10(-15) M for chicken Avd). We previously reported engineered Avds known as antidins, which have micro- to nanomolar affinities for steroids, non-natural ligands of Avd. Here, we report the 2.8 angstrom X-ray structure of the sbAvd-2 (1117Y) antidin co-crystallized with progesterone. We describe the creation of new synthetic phage display libraries and report the experimental as well as computational binding analysis of progesterone-binding antidins. We introduce a next-generation antidin with 5 nM binding affinity for progesterone, and demonstrate the use of anti dins for measuring progesterone in serum samples. Our data give insights on how to engineer and alter the binding preferences of Avds and to develop better molecular tools for modern bionanotechnological applications.	[Agrawal, Nitin; Johnson, Mark S.; Airenne, Tomi T.] Abo Akad Univ, Fac Sci & Engn, Biochem, Struct Bioinformat Lab, Turku, Finland; [Lehtonen, Soili I.; Uusi-Makela, Meri; Jain, Purvi; Maatta, Juha A. E.; Kahkonen, Niklas; Azizi, Latifeh; Riihimaki, Tiina A.; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ, BioMediTech Inst, Tampere, Finland; [Lehtonen, Soili I.; Uusi-Makela, Meri; Jain, Purvi; Maatta, Juha A. E.; Kahkonen, Niklas; Azizi, Latifeh; Riihimaki, Tiina A.; Kulomaa, Markku S.; Hytonen, Vesa P.] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Viitala, Sari] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Hytonen, Vesa P.] Fimlab Labs, Tampere, Finland	Abo Akademi University; Tampere University; Tampere University; University of Eastern Finland	Airenne, TT (corresponding author), Abo Akad Univ, Fac Sci & Engn, Biochem, Struct Bioinformat Lab, Turku, Finland.; Hytonen, VP (corresponding author), Tampere Univ, BioMediTech Inst, Tampere, Finland.; Hytonen, VP (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland.; Hytonen, VP (corresponding author), Fimlab Labs, Tampere, Finland.	vesa.hytonen@tuni.fi; tomi.airenne@abo.fi	Lehtonen, Soili/AAW-7751-2021; Hytonen, Vesa P./E-8855-2013	Lehtonen, Soili/0000-0003-2239-9377; Hytonen, Vesa P./0000-0002-9357-1480; Viitala, Sari/0000-0002-1401-3406; Agrawal, Nitin/0000-0002-9482-3440	Academy of Finland [257814, 272283, 263540, 290506, 261285, 272288]; Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Orion Research Foundation sr; Academy of Finland FIRI program [141398]; Abo Akademi Center of Excellence in Cell Stress and Aging; Fimlab Laboratories (Tampere, Finland)	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Joe, Pentti and Tor Borg Memorial Fund; Orion Research Foundation sr; Academy of Finland FIRI program; Abo Akademi Center of Excellence in Cell Stress and Aging; Fimlab Laboratories (Tampere, Finland)	This work was supported by grant funding from the Academy of Finland (257814 (M.S.J.), 272283 (M.S.J.), 263540 (V.P.H), 290506 (V.P.H.), 261285 (M.S.K.), and 272288 (M.S.K.)); Sigrid Juselius Foundation; Joe, Pentti and Tor Borg Memorial Fund; Orion Research Foundation sr; Academy of Finland FIRI program (141398); and Abo Akademi Center of Excellence in Cell Stress and Aging. Fimlab Laboratories (Tampere, Finland) provided support in the form of salaries for author VPH and research materials for the group led by VPH. Fimlab and the other funders had no influence in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Avraham O, 2015, J STRUCT BIOL, V191, P139, DOI 10.1016/j.jsb.2015.06.020; Bailey S, 1993, CCP4 SUITE PROGRAMS; Banta S, 2013, ANNU REV BIOMED ENG, V15, P93, DOI 10.1146/annurev-bioeng-071812-152412; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernard P, 1996, BIOTECHNIQUES, V21, P320; Concannon PW, 2011, ANIM REPROD SCI, V124, P200, DOI 10.1016/j.anireprosci.2010.08.028; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dundas CM, 2013, APPL MICROBIOL BIOT, V97, P9343, DOI 10.1007/s00253-013-5232-z; Eakin RE, 1941, J BIOL CHEM, V140, P535; ELO HA, 1979, COMP BIOCHEM PHYS B, V62, P237, DOI 10.1016/0305-0491(79)90205-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farid R, 2006, BIOORGAN MED CHEM, V14, P3160, DOI 10.1016/j.bmc.2005.12.032; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Gaj T, 2007, PROTEIN EXPRES PURIF, V56, P54, DOI 10.1016/j.pep.2007.06.010; Gebauer M, 2013, J MOL BIOL, V425, P780, DOI 10.1016/j.jmb.2012.12.004; Gebauer M, 2012, METHOD ENZYMOL, V503, P157, DOI 10.1016/B978-0-12-396962-0.00007-0; Gyorgy P, 1941, SCIENCE, V94, P261, DOI 10.1126/science.94.2437.261; Hytonen VP, 2005, PROTEINS, V61, P597, DOI 10.1002/prot.20604; Hytonen VP, 2005, J BIOL CHEM, V280, P10228, DOI 10.1074/jbc.M414196200; Hytonen VP, 2004, J BIOL CHEM, V279, P9337, DOI 10.1074/jbc.M310989200; Hytonen VR, 2004, BIOCHEM J, V384, P385, DOI 10.1042/BJ20041114; JOHNSON MS, 1993, J MOL BIOL, V233, P716, DOI 10.1006/jmbi.1993.1548; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Korndorfer IP, 2002, PROTEIN SCI, V11, P883, DOI 10.1110/ps.4150102; Laitinen OH, 2006, CELL MOL LIFE SCI, V63, P2992, DOI 10.1007/s00018-006-6288-z; Laitinen OH, 2007, TRENDS BIOTECHNOL, V25, P269, DOI 10.1016/j.tibtech.2007.04.001; Lamla T, 2004, PROTEIN EXPRES PURIF, V33, P39, DOI 10.1016/j.pep.2003.08.014; Le Trong L, 2006, J MOL BIOL, V356, P738, DOI 10.1016/j.jmb.2005.11.086; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Lehtonen SI, 2016, ACS CHEM BIOL, V11, P211, DOI 10.1021/acschembio.5b00906; Lehtonen SI, 2015, PROTEIN ENG DES SEL, V28, P23, DOI 10.1093/protein/gzu050; Leppiniemi J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035962; Leppiniemi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016576; LIVNAH O, 1993, P NATL ACAD SCI USA, V90, P5076, DOI 10.1073/pnas.90.11.5076; Maatta JAE, 2008, CHEMBIOCHEM, V9, P1124, DOI 10.1002/cbic.200700671; Maatta JAE, 2011, BIOTECHNOL BIOENG, V108, P481, DOI 10.1002/bit.22962; Marttila AT, 2003, BIOCHEM J, V369, P249, DOI 10.1042/BJ20020886; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer SC, 2006, CHEM BIOL DRUG DES, V68, P3, DOI 10.1111/j.1747-0285.2006.00401.x; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Niederhauser B, 2012, J BIOTECHNOL, V157, P38, DOI 10.1016/j.jbiotec.2011.10.014; Nordlund HR, 2005, BIOCHEM J, V392, P485, DOI 10.1042/BJ20051038; Nordlund HR, 2004, J BIOL CHEM, V279, P36715, DOI 10.1074/jbc.M403496200; Okura H, 2013, PROTEIN ENG DESIGN S, V26; Panek A, 2017, J MOL MODEL, V23, DOI 10.1007/s00894-017-3278-z; Perbandt M, 2007, PROTEINS, V67, P1147, DOI 10.1002/prot.21236; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PUGLIESE L, 1993, J MOL BIOL, V231, P698, DOI 10.1006/jmbi.1993.1321; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Repo S, 2006, CHEM BIOL, V13, P1029, DOI 10.1016/j.chembiol.2006.08.006; Riihimaki TA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-64; Riihimaki TA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020535; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schmidt TGM, 1996, J MOL BIOL, V255, P753, DOI 10.1006/jmbi.1996.0061; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Siitari H, 2015, AVIAN BIOL RES, V8, P244, DOI 10.3184/175815515X14460614674603; Sinkkonen A, 2014, SOIL BIOL BIOCHEM, V73, P93, DOI 10.1016/j.soilbio.2014.02.002; Skerra A, 1999, BIOMOL ENG, V16, P79, DOI 10.1016/S1050-3862(99)00033-9; Skerra A, 2000, METHOD ENZYMOL, V326, P271; Skerra A, 2008, FEBS J, V275, P2677, DOI 10.1111/j.1742-4658.2008.06439.x; Stahl S, 2013, J CHEM TECHNOL BIOT, V88, P25, DOI 10.1002/jctb.3929; SWILLENS S, 1995, MOL PHARMACOL, V47, P1197; Taskinen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092058; Traore SM, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-42; Turunen L, 2009, J BIOMOL SCREEN, V14, P282, DOI 10.1177/1087057108330113; Voss S, 1997, PROTEIN ENG, V10, P975, DOI 10.1093/protein/10.8.975; WEBER PC, 1994, J AM CHEM SOC, V116, P2717, DOI 10.1021/ja00086a004; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	73	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212339	10.1371/journal.pone.0212339	http://dx.doi.org/10.1371/journal.pone.0212339			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785944	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000057
J	Godwin, EM; Uglialoro, AD; Ali, A; Yearwood, L; Banerji, MA; Kral, JG				Godwin, Ellen M.; Uglialoro, Anthony D.; Ali, Andaleeb; Yearwood, Leah; Banerji, Mary Ann; Kral, John G.			A pilot study of metabolic fitness effects of weight-supported walking in women with obesity	PLOS ONE			English	Article							BODY POSITIVE-PRESSURE; PHYSICAL-ACTIVITY; GLYCEMIC CONTROL; RISK MARKERS; EXERCISE; APPETITE; TRIGLYCERIDES; OVERWEIGHT; RESPONSES; BEHAVIOR	Background This is an exploratory pilot study of novel technology enabling people with mobility disability to walk with minimal effort, in the "sedentary range". The study's premise is that impairment of the leading physical activity of daily living, walking, is a major contributor to a dysmetabolic state driving many prevalent "civilization diseases" associated with insulin resistance. Methods We explore within-subject changes in standard oral glucose tolerance (OGT) tests including metabotropic molecules after 22 twice-weekly, 30-minute bouts of weight-supported light-moderate physical activity in 16 non-diabetic obese, otherwise healthy, reproductive-age, volunteer women walking on an "anti-gravity" lower-body positive pressure (LBPP) treadmill. Results Subjects had reference base-line fasting plasma glucose and triglycerides (TG) but 2-hr OGT insulin levels of 467 +/- 276 pmol . liter(-1) (mean +/- S.D.) indicating nascent insulin resistance, compared to post-study 308 +/- 179 (p = 0.002). Fasting TG decreased from 0.80 +/- 0.30 mmol . liter(-1) to 0.71 0.25 (p = 0.03). Concomitantly plasma total ghrelin decreased from 69.6 +/- 41.6 pmol . liter(-1) to 56.0 +/- 41.3 (p = 0.008). There were no statistically significant changes in body weight or any correlations between weight change and cardiometabolic markers. However, there were robust positive correlations between changes among different classes of peptides including C-reactive protein-Interleukin 6, leptin-adiponectin, beta-endorphin oxytocin and orexin A (r(2) = 0.48-0.88). Conclusion We conclude that brief, low-dose physical activity, walking on an anti-gravity LBPP treadmill may improve cardiometabolic risk, exhibiting favorable changes in neuro-regulatory peptides without weight loss in people with problems walking.	[Godwin, Ellen M.] Long Isl Univ, Dept Phys Therapy, Brooklyn, NY USA; [Godwin, Ellen M.] Suny Downstate Med Ctr, Dept Orthoped Rehabil, Brooklyn, NY 11203 USA; [Uglialoro, Anthony D.; Kral, John G.] Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA; [Ali, Andaleeb; Yearwood, Leah; Banerji, Mary Ann; Kral, John G.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA; [Ali, Andaleeb] Providence Med Grp, Mobile, AL USA; [Yearwood, Leah] Cape Fear Valley Med Ctr, Fayetteville, NC USA	Long Island University-Brooklyn Campus; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Kral, JG (corresponding author), Suny Downstate Med Ctr, Dept Surg, Brooklyn, NY 11203 USA.; Kral, JG (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA.	jkral@downstate.edu		KRAL, John/0000-0003-0842-664X				Afzal A, 2014, J AM SOC HYPERTENS, V8, P388, DOI 10.1016/j.jash.2014.03.004; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Bailey DP, 2016, APPL PHYSIOL NUTR ME, V41, P324, DOI 10.1139/apnm-2015-0462; Baker PRA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008366.pub3; Batacan RB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/596367; Beaulieu K, 2018, PHYSIOL BEHAV, V192, P23, DOI 10.1016/j.physbeh.2017.12.032; BJORNTORP P, 1970, METABOLIS, V19, P631, DOI 10.1016/0026-0495(70)90020-X; Blevins JE, 2013, REV ENDOCR METAB DIS, V14, P311, DOI 10.1007/s11154-013-9260-x; Bos I, 2013, MED SCI SPORT EXER, V45, P439, DOI 10.1249/MSS.0b013e31827767fc; Brito JP, 2017, JAMA-J AM MED ASSOC, V317, P635, DOI 10.1001/jama.2016.20563; CarterNolan PL, 1996, J NATL MED ASSOC, V88, P558; Chastin SFM, 2015, OBESITY, V23, P1800, DOI 10.1002/oby.21180; Coplan JD, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/917981; Cutuk A, 2006, J APPL PHYSIOL, V101, P771, DOI 10.1152/japplphysiol.00644.2005; DeBoer LB, 2012, EXPERT REV NEUROTHER, V12, P1011, DOI 10.1586/ERN.12.73; Dohrn IM, 2018, CLIN EPIDEMIOL, V10, P179, DOI 10.2147/CLEP.S151613; Dulloo AG, 2018, EUR J CLIN NUTR, V72, P657, DOI 10.1038/s41430-018-0138-6; Duvivier BMFM, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00353; Eiken O, 1987, Acta Physiol Scand Suppl, V566, P1; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Figueroa MA, 2012, INT J APPL SCI TECHN, V2, P204; Francois ME, 2014, DIABETOLOGIA, V57, P1437, DOI 10.1007/s00125-014-3244-6; Freedhoff Y, 2016, LANCET, V388, P849, DOI 10.1016/S0140-6736(16)31338-1; Herisson FM, 2016, J NEUROENDOCRINOL, V28, DOI 10.1111/jne.12381; Herman AM, 2016, NATURE, V538, P253, DOI 10.1038/nature19789; Heymsfield SB, 2017, NEW ENGL J MED, V376, P1492, DOI 10.1056/NEJMc1701944; Inoue K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128720; Ito N, 2008, NEUROSCIENCE, V157, P720, DOI 10.1016/j.neuroscience.2008.09.042; Koehl M, 2008, FASEB J, V22, P2253, DOI 10.1096/fj.07-099101; KRAL JG, 1977, METABOLISM, V26, P1025, DOI 10.1016/0026-0495(77)90020-8; Kritchevsky SB, 2017, OBESITY, V25, P1199, DOI 10.1002/oby.21860; Larson-Meyer DE, 2012, J OBES, V2012, DOI 10.1155/2012/730409; Lee KY, 2016, ANN REHABIL MED-ARM, V40, P915, DOI 10.5535/arm.2016.40.5.915; Lin SX, 2011, METAB SYNDR RELAT D, V9, P35, DOI 10.1089/met.2010.0050; MacLean PS, 2015, OBESITY, V23, P7, DOI 10.1002/oby.20967; Malkova D, 2008, HORM METAB RES, V40, P410, DOI 10.1055/s-2008-1058100; MAYER J, 1967, SCIENCE, V156, P328, DOI 10.1126/science.156.3773.328; Mudaliar U, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002095; Nordestgaard BG, 2014, LANCET, V384, P626, DOI 10.1016/S0140-6736(14)61177-6; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Perello M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059625; Pontzer H, 2016, CURR BIOL, V26, P410, DOI 10.1016/j.cub.2015.12.046; Poulimeneas D, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8090174; Proudler AJ, 1996, METABOLISM, V45, P328, DOI 10.1016/S0026-0495(96)90286-3; Rasgon NL, 2016, MOL PSYCHIATR, V21, P1648, DOI 10.1038/mp.2016.162; Riebe D., 2014, ACSMS GUIDELINES EXE, P161; Rifkind JM, 2014, NITRIC OXIDE-BIOL CH, V40, P117, DOI 10.1016/j.niox.2014.06.007; Rodriguez D, 2011, INT J GEN MED, V4, P549, DOI 10.2147/IJGM.S23094; Ropelle ER, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000465; Ross R, 2016, CONTEMP CLIN TRIALS, V47, P275, DOI 10.1016/j.cct.2016.02.001; Salciccioli LF, 2017, J STRENGTH COND RES, V31, pE69, DOI 10.1519/JSC.0000000000000562; Schwartz MW, 2017, ENDOCR REV, V38, P267, DOI 10.1210/er.2017-00111; Shook RP, 2015, AM J CLIN NUTR, V102, P1332, DOI 10.3945/ajcn.115.115360; Simonson S, 2011, CLIN KINESIOL, V65, P29; Solomon TPJ, 2013, J CLIN ENDOCR METAB, V98, P4176, DOI 10.1210/jc.2013-2232; Voulgari C, 2013, METABOLISM, V62, P609, DOI 10.1016/j.metabol.2012.09.005; Whybrow S, 2008, BRIT J NUTR, V100, P1109, DOI 10.1017/S0007114508968240; WILDMANN J, 1986, LIFE SCI, V38, P997, DOI 10.1016/0024-3205(86)90233-X; Zschucke E, 2015, PSYCHONEUROENDOCRINO, V51, P414, DOI 10.1016/j.psyneuen.2014.10.019	60	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211529	10.1371/journal.pone.0211529	http://dx.doi.org/10.1371/journal.pone.0211529			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785891	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000029
J	Page, AP; Tremblay, J; Masson, L; Greer, CW				Page, Antoine P.; Tremblay, Julien; Masson, Luke; Greer, Charles W.			Nitrogen- and phosphorus-starved Triticum aestivum show distinct belowground microbiome profiles	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; PLANT-GROWTH; USE-EFFICIENCY; WINTER-WHEAT; PADDY RICE; ROOT; BACTERIA; SOIL; RHIZOSPHERE; FERTILIZATION	Many plants have natural partnerships with microbes that can boost their nitrogen (N) and/or phosphorus (P) acquisition. To assess whether wheat may have undiscovered associations of these types, we tested if N/P-starved Triticum aestivum show microbiome profiles that are simultaneously different from those of N/P-amended plants and those of their own bulk soils. The bacterial and fungal communities of root, rhizosphere, and bulk soil samples from the Historical Dryland Plots (Lethbridge, Canada), which hold T. aestivum that is grown both under N/P fertilization and in conditions of extreme N/P-starvation, were taxonomically described and compared (bacterial 16S rRNA genes and fungal Internal Transcribed Spacers ITS). As the list may include novel N- and/or P-providing wheat partners, we then identified all the operational taxonomic units (OTUs) that were proportionally enriched in one or more of the nutrient starvation- and plant-specific communities. These analyses revealed: a) distinct N-starvation root and rhizosphere bacterial communities that were proportionally enriched, among others, in OTUs belonging to families Enterobacteriaceae, Chitinophagaceae, Comamonadaceae, Caulobacteraceae, Cytophagaceae, Streptomycetaceae, b) distinct N-starvation root fungal communities that were proportionally enriched in OTUs belonging to taxa Lulworthia, Sordariomycetes, Apodus, Conocybe, Ascomycota, Crocicreas, c) a distinct P-starvation rhizosphere bacterial community that was proportionally enriched in an OTU belonging to genus Agrobacterium, and d) a distinct P-starvation root fungal community that was proportionally enriched in OTUs belonging to genera Parastagonospora and Phaeosphaeriopsis. Our study might have exposed wheat-microbe connections that can form the basis of novel complementary yield-boosting tools.	[Page, Antoine P.] Natl Res Council Canada, Aquat & Crop Resource Dev Res Ctr, Montreal, PQ, Canada; [Tremblay, Julien; Greer, Charles W.] Natl Res Council Canada, Energy Min & Environm Res Ctr, Montreal, PQ, Canada; [Masson, Luke] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada	National Research Council Canada; National Research Council Canada; National Research Council Canada	Page, AP (corresponding author), Natl Res Council Canada, Aquat & Crop Resource Dev Res Ctr, Montreal, PQ, Canada.	antoine.page@nrc-cnrc.gc.ca		Tremblay, Julien/0000-0002-6085-3481	National Research Council Canada	National Research Council Canada	This research was funded by the National Research Council Canada. Resources were awarded to LM and CWG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bretz F., 2016, MULTIPLE COMP USING; CADE-MENUN BJ, 1991, CAN J BOT, V69, P78, DOI 10.1139/b91-011; Calvo P, 2014, PLANT SOIL, V383, P3, DOI [10.1007/s11104-014-2131-8, 10.1109/BigData.2014.7004461]; Carroll B. J., 1990, Molecular biology of symbiotic nitrogen fixation., P159; Carvalho TLG, 2016, PLANT MOL BIOL, V90, P561, DOI 10.1007/s11103-016-0435-1; Castrillo G, 2017, NATURE, V543, P513, DOI 10.1038/nature21417; Chen XP, 2014, NATURE, V514, P486, DOI 10.1038/nature13609; Czarnecki O, 2013, INT J MOL SCI, V14, P7681, DOI 10.3390/ijms14047681; Duan JF, 2015, PLANT PHYSIOL BIOCH, V96, P199, DOI 10.1016/j.plaphy.2015.08.006; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El-Tarabily KA, 2006, SOIL BIOL BIOCHEM, V38, P1505, DOI 10.1016/j.soilbio.2005.12.017; Fonseca ED, 2018, MICROB ECOL, V75, P183, DOI 10.1007/s00248-017-1014-y; Foo E, 2013, ANN BOT-LONDON, V111, P769, DOI 10.1093/aob/mct041; Franche C., 2009, Plant and Soil, V321, P35, DOI 10.1007/s11104-008-9833-8; Fuentes-Ramirez LE, 1999, FEMS MICROBIOL ECOL, V29, P117, DOI 10.1016/S0168-6496(98)00125-1; Fukuda M, 2012, SOIL FERTILITY; Gao Y, 2015, MOL PLANT MICROBE IN, V28, P615, DOI 10.1094/MPMI-12-14-0396-R; Glick BR, 2007, CRIT REV PLANT SCI, V26, P227, DOI 10.1080/07352680701572966; Golzar H, 2012, AUSTRALAS PLANT DIS, V7, P13, DOI 10.1007/s13314-011-0035-5; Grassini P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3918; Han JI, 2011, J BACTERIOL, V193, P1183, DOI 10.1128/JB.00925-10; Han M, 2015, ANNU REV GENET, V49, P269, DOI 10.1146/annurev-genet-112414-055037; Hartmann M, 2015, ISME J, V9, P1177, DOI 10.1038/ismej.2014.210; Hasegawa S., 2006, ACTINOMYCETOLOGICA, V20, P72, DOI [10.3209/saj.20.72, DOI 10.3209/SAJ.20.72]; Heffer P., 2016, P INT NITR IN C MELB; Heyneke E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02048; Hodge A, 2015, PLANT SOIL, V386, P1, DOI 10.1007/s11104-014-2162-1; Huws SA, 2007, J MICROBIOL METH, V70, P565, DOI 10.1016/j.mimet.2007.06.013; Ikeda S, 2011, APPL ENV MICROBIOLOG; Ikeda S, 2014, MICROBES ENVIRON, V29, P50, DOI 10.1264/jsme2.ME13110; Ikeda S, 2010, ISME J, V4, P315, DOI 10.1038/ismej.2009.119; JANZEN HH, 1995, CAN J SOIL SCI, V75, P123, DOI 10.4141/cjss95-016; Johri AK, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.00934, 10.3389/fmicb.2015.00984]; Kabir Z, 1997, PLANT SOIL, V192, P285, DOI 10.1023/A:1004205828485; Kapulnik Y, 2016, J INTEGR PLANT BIOL, V58, P203, DOI 10.1111/jipb.12454; Kavamura VN, 2018, FRONTIERS MICROBIOLO, V9, DOI [10.3389/fmicb.2018.00009, DOI 10.3389/FMICB.2018.00009]; Kolde R., PHEATMAP PRETTY HEAT; Konishi N, 2017, MICROBES ENVIRON, V32, P314, DOI 10.1264/jsme2.ME17031; LEYVAL C, 1989, PLANT SOIL, V117, P103, DOI 10.1007/BF02206262; Leyval C, 1993, PHOSPHORUS SULFUR, V77, P133; Li HY, 2006, NEW PHYTOL, V172, P536, DOI 10.1111/j.1469-8137.2006.01846.x; Liu HW, 2017, SCI REP-UK, V7, DOI 10.1038/srep41766; Liu YJ, 2012, NEW PHYTOL, V194, P523, DOI 10.1111/j.1469-8137.2012.04050.x; Madhaiyan M, 2015, INT J SYST EVOL MICR, V65, P578, DOI 10.1099/ijs.0.069377-0; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mahoney AK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00132; Marcon E, 2015, J STAT SOFTW, V67, P1; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Minamisawa K, 2016, MICROBES ENVIRON, V31, P4, DOI 10.1264/jsme2.ME15180; Mitter B, 2016, MICROB BIOTECHNOL, V9, P635, DOI 10.1111/1751-7915.12382; Nabti E, 2014, EUR J SOIL BIOL, V61, P20, DOI 10.1016/j.ejsobi.2013.12.008; Nagahashi G, 2004, MYCOL RES, V108, P1079, DOI 10.1017/S0953756204000693; Nishida H, 2018, CURR OPIN PLANT BIOL, V44, P129, DOI 10.1016/j.pbi.2018.04.006; Oksanen J., VEGAN PACKAGE COMMUN; Oldroyd GED, 2011, ANNU REV GENET, V45, P119, DOI 10.1146/annurev-genet-110410-132549; Pantigoso HA, 2018, RHIZOSPHERE-NETH, V7, P1, DOI 10.1016/j.rhisph.2018.06.008; Reay DS, 2012, NAT CLIM CHANGE, V2, P410, DOI 10.1038/NCLIMATE1458; Robertson GP, 2009, ANNU REV ENV RESOUR, V34, P97, DOI 10.1146/annurev.environ.032108.105046; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson RJ, 2016, PLANT SOIL, V405, P381, DOI 10.1007/s11104-015-2495-4; Sagar A., 2018, INT J AGR ENV BIOTEC, V11, P159; Sala S, 2017, J CLEAN PROD, V140, P387, DOI 10.1016/j.jclepro.2016.09.054; Santos KFDN, 2017, PLANT SOIL, V415, P245, DOI 10.1007/s11104-016-3140-6; Sasse J, 2018, TRENDS PLANT SCI, V23, P25, DOI 10.1016/j.tplants.2017.09.003; Schlaeppi K, 2015, MOL PLANT MICROBE IN, V28, P212, DOI 10.1094/MPMI-10-14-0334-FI; SHAFFER JP, 1995, ANNU REV PSYCHOL, V46, P561, DOI 10.1146/annurev.ps.46.020195.003021; Sharpley A, 2016, SCI AGR, V73, P1, DOI 10.1590/0103-9016-2015-0107; Siciliano SD, 1999, FEMS MICROBIOL ECOL, V29, P263, DOI 10.1111/j.1574-6941.1999.tb00617.x; Sommermann L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195345; Steffen W, 2015, SCIENCE, V347, DOI 10.1126/science.1259855; Toju H, 2018, NAT PLANTS, V4, P247, DOI 10.1038/s41477-018-0139-4; Tremblay J, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00771; Treseder KK, 2004, NEW PHYTOL, V164, P347, DOI 10.1111/j.1469-8137.2004.01159.x; Van Vuuren DP, 2010, GLOBAL ENVIRON CHANG, V20, P428, DOI 10.1016/j.gloenvcha.2010.04.004; Vicre M, 2005, PLANT PHYSIOL, V138, P998, DOI 10.1104/pp.104.051813; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Yoneyama T, 2017, SOIL SCI PLANT NUTR, V63, P578, DOI 10.1080/00380768.2017.1407625; Zgadzaj R, 2016, P NATL ACAD SCI USA, V113, pE7996, DOI 10.1073/pnas.1616564113; Zhang Y, 2017, PLANT PHYSIOL BIOCH, V111, P30, DOI 10.1016/j.plaphy.2016.11.009; Zhu SS, 2016, APPL SOIL ECOL, V107, P324, DOI 10.1016/j.apsoil.2016.07.009	80	15	16	7	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210538	10.1371/journal.pone.0210538	http://dx.doi.org/10.1371/journal.pone.0210538			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785878	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000012
J	Yang, F; Jin, H; Que, B; Chao, YH; Zhang, HQ; Ying, XL; Zhou, ZY; Yuan, ZS; Su, JL; Wu, B; Zhang, WJ; Qi, DF; Chen, DM; Min, W; Lin, SB; Ji, WD				Yang, Fan; Jin, Huan; Que, Biao; Chao, Yinghui; Zhang, Haiqing; Ying, Xiaoling; Zhou, Zhongyang; Yuan, Zusen; Su, Jialin; Wu, Bin; Zhang, Wenjuan; Qi, Defeng; Chen, Demeng; Min, Wang; Lin, Shuibin; Ji, Weidong			Dynamic m(6)A mRNA methylation reveals the role of METTL3-m(6)A-CDCP1 signaling axis in chemical carcinogenesis	ONCOGENE			English	Article							INDUCED MALIGNANT-TRANSFORMATION; STEM-LIKE CELLS; EPITHELIAL-CELLS; NUCLEAR-RNA; N-6-METHYLADENOSINE; CDCP1; GENE; N6-METHYLADENOSINE; TRANSLATION; DEMETHYLASE	N6-methyladenosine (m(6)A) is the most abundant internal modification in mammalian mRNAs. Despite its functional importance in various physiological events, the role of m(6)A in chemical carcinogenesis remains largely unknown. Here we profiled the dynamic m(6)A mRNA modification during cellular transformation induced by chemical carcinogens and identified a subset of cell transformation-related, concordantly modulated m(6)A sites. Notably, the increased m(6)A in 3'-UTR mRNA of oncogene CDCP1 was found in malignant transformed cells. Mechanistically, the m(6)A methyltransferase METTL3 and demethylases ALKBH5 mediate the m(6)A modification in 3'-UTR of CDCP1 mRNA. METTL3 and m(6)A reader YTHDF1 preferentially recognize m(6)A residues on CPCP1 3'-UTR and promote CDCP1 translation. We further showed that METTL3 and CDCP1 are upregulated in the bladder cancer patient samples and the expression of METTL3 and CDCP1 is correlated with the progression status of the bladder cancers. Inhibition of the METTL3-m(6)A-CDCP1 axis resulted in decreased growth and progression of chemical-transformed cells and bladder cancer cells. Most importantly, METTL3-m(6)A-CDCP1 axis has synergistic effect with chemical carcinogens in promoting malignant transformation of uroepithelial cells and bladder cancer tumorigenesis in vitro and in vivo. Taken together, our results identify dynamic m(6)A modification in chemical-induced malignant transformation and provide insight into critical roles of the METTL3-m(6)A-CDCP1 axis in chemical carcinogenesis.	[Yang, Fan; Jin, Huan; Que, Biao; Chao, Yinghui; Zhang, Haiqing; Ying, Xiaoling; Zhou, Zhongyang; Su, Jialin; Chen, Demeng; Min, Wang; Lin, Shuibin; Ji, Weidong] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China; [Jin, Huan] Zunyi Med Coll, Dept Physiol, Zunyi 563000, Guizhou, Peoples R China; [Que, Biao; Yuan, Zusen; Qi, Defeng] Guangzhou Med Univ, Affiliated Hosp 1, Minimally Invas Surg Ctr, Guangdong Key Lab Urol,Dept Urol, Guangzhou 510230, Guangdong, Peoples R China; [Wu, Bin] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou 510080, Guangdong, Peoples R China; [Zhang, Wenjuan] Jinan Univ, Sch Med, Dept Prevent Med, Guangzhou 510632, Guangdong, Peoples R China; [Min, Wang] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA; [Min, Wang] Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06519 USA	Sun Yat Sen University; Zunyi Medical University; Guangzhou Medical University; Guangzhou University of Chinese Medicine; Jinan University; Yale University; Yale University	Min, W; Lin, SB; Ji, WD (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Translat Med, Guangzhou 510080, Guangdong, Peoples R China.; Min, W (corresponding author), Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06519 USA.; Min, W (corresponding author), Yale Univ, Sch Med, Vasc Biol & Therapeut Program, New Haven, CT 06519 USA.	wang.min@yale.edu; linshb6@mail.sysu.edu.cn; jiweidong@mail.sysu.edu.cn	ji, weidong/AAX-7397-2020	Lin, Shuibin/0000-0002-7065-614X	National Natural Science Foundation of China [81472999, 81772699, 81772999, 81473014, 81272350]; Key Natural Science Foundation of Guangdong [8151012003000011]; Guangzhou People's Livelihood Science and Technology Project [201803010052]; Key projects of Guangzhou Scientific Research [201804020023]; National Key Research and Development Program of China [2016YFC1300600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Natural Science Foundation of Guangdong; Guangzhou People's Livelihood Science and Technology Project; Key projects of Guangzhou Scientific Research; National Key Research and Development Program of China	This work was supported by grants from National Natural Science Foundation of China (Number 81472999, Number 81772699, Number 81772999, Number 81473014, and Number 81272350), Key Natural Science Foundation of Guangdong (Number 8151012003000011), Guangzhou People's Livelihood Science and Technology Project (201803010052), Key projects of Guangzhou Scientific Research (201804020023), National Key Research and Development Program of China (2016YFC1300600).	Achanzar WE, 2001, CANCER RES, V61, P455; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Clark SJ, 2017, CANCER CELL, V32, P278, DOI 10.1016/j.ccell.2017.08.016; Cui Q, 2017, CELL REP, V18, P2622, DOI 10.1016/j.celrep.2017.02.059; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; Feinberg AP, 2016, NAT REV GENET, V17, P284, DOI 10.1038/nrg.2016.13; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; He Y, 2016, ONCOGENE, V35, P468, DOI 10.1038/onc.2015.101; HEIDELBERGER C, 1975, ANNU REV BIOCHEM, V44, P79, DOI 10.1146/annurev.bi.44.070175.000455; Ji WD, 2006, BIOMED ENVIRON SCI, V19, P277; Ji WD, 2008, CARCINOGENESIS, V29, P1267, DOI 10.1093/carcin/bgn012; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Lence T, 2016, NATURE, V540, P242, DOI 10.1038/nature20568; Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lin SB, 2018, MOL CELL, V71, P244, DOI 10.1016/j.molcel.2018.06.001; Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Luch A, 2005, NAT REV CANCER, V5, P113, DOI 10.1038/nrc1546; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Meng J, 2014, METHODS, V69, P274, DOI 10.1016/j.ymeth.2014.06.008; Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Ravegnini G, 2015, TOXICOL SCI, V148, P2, DOI 10.1093/toxsci/kfv165; REZNIKOFF CA, 1988, CARCINOGENESIS, V9, P1427, DOI 10.1093/carcin/9.8.1427; Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311; Roundtree IA, 2016, CURR OPIN CHEM BIOL, V30, P46, DOI 10.1016/j.cbpa.2015.10.024; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Sens DA, 2004, TOXICOL SCI, V79, P56, DOI 10.1093/toxsci/kfh086; Tuck MT, 1996, CANCER LETT, V103, P107, DOI 10.1016/0304-3835(96)04203-6; Uekita T, 2014, MOL CANCER RES, V12, P1449, DOI 10.1158/1541-7786.MCR-13-0587; Vaz M, 2017, CANCER CELL, V32, P360, DOI 10.1016/j.ccell.2017.08.006; Visvanathan A, 2018, ONCOGENE, V37, P522, DOI 10.1038/onc.2017.351; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; Wright HJ, 2016, ONCOGENE, V35, P4762, DOI 10.1038/onc.2016.7; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	49	101	103	2	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4755	4772		10.1038/s41388-019-0755-0	http://dx.doi.org/10.1038/s41388-019-0755-0			18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30796352	hybrid, Green Published			2022-12-26	WOS:000471160500008
J	Kuehn, C; Tauchi, M; Furtmair, R; Urschel, K; Raaz-Schrauder, D; Neumann, AL; Frohberger, SJ; Hoerauf, A; Regus, S; Lang, W; Sagban, TA; Stumpfe, FM; Achenbach, S; Hubner, MP; Dietel, B				Kuehn, Constanze; Tauchi, Miyuki; Furtmair, Roman; Urschel, Katharina; Raaz-Schrauder, Dorette; Neumann, Anna-Lena; Frohberger, Stefan J.; Hoerauf, Achim; Regus, Susanne; Lang, Werner; Sagban, Tolga Atilla; Stumpfe, Florian Matthias; Achenbach, Stephan; Huebner, Marc P.; Dietel, Barbara			Filarial extract of Litomosoides sigmodontis induces a type 2 immune response and attenuates plaque development in hyperlipidemic ApoE-knockout mice	FASEB JOURNAL			English	Article						atherosclerosis; inflammation; helminth; endothelial activation; JNK	NONOBESE DIABETIC MICE; SHEAR-STRESS; ATHEROSCLEROTIC PLAQUES; T-LYMPHOCYTES; TH1; MECHANISMS; HELMINTHS; CYTOKINE; ANTIGEN; PROTEIN	A type 1 immune response is involved in atherosclerosis progression, whereas the role of a type 2 polarization, especially with regard to an enhanced T helper (T-h)2 cell differentiation, is still unclear. Helminths trigger type 2 immune responses, protecting the host from inflammatory disorders. We investigated whether an increased type 2 polarization by administration of Litomosoides sigmodontis adult worm extract (LsAg) affects atherosclerosis in apolipoprotein E-deficient (ApoE(-/-)) mice. Injections of 50 mu g LsAg, i.p. into ApoE(-/-) mice induced a type 2 immune response shown by increased frequencies of peritoneal eosinophils and alternatively activated macrophages. To analyze the effect of LsAg on atherosclerosis initiation, ApoE(-/-) mice received a high-fat diet for 12 wk and weekly injections of 50 mu g LsAg from wk 5 to 12. Therapeutic effects on advanced atherosclerosis were analyzed in mice that were fed a high-fat diet for 12 wk followed by 12 wk of normal chow and weekly LsAg injections. Both preventive and therapeutic LsAg application significantly decreased plaque size. Therapeutic treatment even caused regression of plaque size and macrophage density in the aortic root and reduced T(h)1-specific gene expression and intraplaque inflammation. In addition, plaque size after therapeutic treatment was inversely correlated with plaque-infiltrated alternatively activated macrophages. In vitro, LsAg treatment of HUVECs reduced intracellular levels of phosphorylated NF-B-p65, IB-, and JNK1/2. In bifurcation flow-through slides, THP-1 cell adhesion to a HUVEC monolayer was decreased by LsAg in regions of nonuniform shear stress. Applying inhibitors of the respective kinases suggests JNK1/2 inhibition is involved in the suppressed cell adhesion. A switch to an enhanced type 2 immune response by LsAg exerts antiatherogenic effects on murine plaque development, indicating a protective role of a hampered type 1 polarization. In vitro, LsAg affects endothelial signaling pathways, among which JNK1/2 inhibition seems to be involved in the suppression of monocytic cell adhesion under proatherogenic shear stress.Constanze, K., Tauchi, M., Furtmair, R., Urschel, K., Raaz-Schrauder, D., Neumann, A.-L., Frohberger, S. J., Hoerauf, A., Regus, S., Lang, W., Sagban, T. A., Stumpfe, F. M., Achenbach, S., Hubner, M. P., Dietel, B. Filarial extract of Litomosoides sigmodontis induces a type 2 immune response and attenuates plaque development in hyperlipidemic ApoE-knockout mice.	[Kuehn, Constanze; Tauchi, Miyuki; Furtmair, Roman; Urschel, Katharina; Raaz-Schrauder, Dorette; Achenbach, Stephan; Dietel, Barbara] Friedrich Alexander Univ FAU Erlangen Nuernberg, Dept Med Cardiol & Angiol 2, Erlangen, Germany; [Regus, Susanne; Lang, Werner; Sagban, Tolga Atilla] Univ Hosp Erlangen, Dept Vasc Surg, Erlangen, Germany; [Stumpfe, Florian Matthias] Univ Hosp Erlangen, Dept Obstet & Gynecol, Erlangen, Germany; [Neumann, Anna-Lena; Frohberger, Stefan J.; Hoerauf, Achim; Huebner, Marc P.] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Hoerauf, Achim] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany; [Sagban, Tolga Atilla] Sana Klinikum Hameln Pyrmt, Hameln, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bonn; German Center for Infection Research	Dietel, B (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Med Cardiol & Angiol 2, Schwabachanlage 12, D-91054 Erlangen, Germany.	barbara.dietel@uk-erlangen.de	Hübner, Marc P/O-1684-2019; Hübner, Marc P/W-9529-2018; Stumpfe, Florian/AAM-8821-2020	Hübner, Marc P/0000-0001-8885-418X; Hübner, Marc P/0000-0001-8885-418X; 	Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)-Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg [15-06-02-1-Dietel]; Else Kroner-Fresenius-Stiftung [2016_A104]; Excellence Cluster Immunosensation [Deutsche Forschungsgemeinschaft (DFG), Excellence Cluster (EXC)] [1023]	Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)-Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg; Else Kroner-Fresenius-Stiftung; Excellence Cluster Immunosensation [Deutsche Forschungsgemeinschaft (DFG), Excellence Cluster (EXC)]	The authors thank Nina Jaziri, Regina Altendorf, Doris Flick, and Heike Kloos (all from Friedrich-Alexander-University Erlangen-Nuernberg) for excellent technical assistance. This work was supported by the Erlanger leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN)-Fonds fur Forschung und Lehre des Klinikums der Friedrich-Alexander-Universitat Erlangen-Nurnberg (15-06-02-1-Dietel) and the Else Kroner-Fresenius-Stiftung (2016_A104). A.H. is a member of the Excellence Cluster Immunosensation [Deutsche Forschungsgemeinschaft (DFG), Excellence Cluster (EXC) 1023], which supported the study. The authors declare no conflicts of interest.	Ajendra J, 2016, CLIN IMMUNOL, V164, P119, DOI 10.1016/j.clim.2016.02.005; Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Aprahamian TR, 2015, INT J PARASITOL, V45, P203, DOI 10.1016/j.ijpara.2014.12.006; Berbudi A, 2016, J INNATE IMMUN, V8, P601, DOI 10.1159/000448401; Berbudi A, 2016, DIABETES-METAB RES, V32, P238, DOI 10.1002/dmrr.2673; Bhat OM, 2015, J CARDIOL, V66, P28, DOI 10.1016/j.jjcc.2014.10.012; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Daugherty A, 2004, J CLIN INVEST, V114, P317, DOI 10.1172/jci200422561; Daugherty A, 2002, CIRC RES, V90, P1039, DOI 10.1161/01.RES.0000021397.28936.F9; Dietel B, 2013, ATHEROSCLEROSIS, V230, P92, DOI 10.1016/j.atherosclerosis.2013.06.014; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Elliott DE, 2007, INT J PARASITOL, V37, P457, DOI 10.1016/j.ijpara.2006.12.009; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Elliott DE, 2003, AM J PHYSIOL-GASTR L, V284, pG385, DOI 10.1152/ajpgi.00049.2002; Fernandes JL, 2004, CYTOKINE, V26, P131, DOI 10.1016/j.cyto.2004.01.007; Frostegard J, 1999, ATHEROSCLEROSIS, V145, P33, DOI 10.1016/S0021-9150(99)00011-8; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Gimbrone MA, 1997, J CLIN INVEST, V99, P1809, DOI 10.1172/JCI119346; Gondorf F, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004616; Gurven MD, 2018, EUR HEART J, V39, P1653, DOI 10.1093/eurheartj/ehy129; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Hoffmann WH, 2000, PARASITOL TODAY, V16, P387, DOI 10.1016/S0169-4758(00)01738-5; Huber SA, 2001, CIRCULATION, V103, P2610; Hubner MP, 2009, IMMUNOLOGY, V127, P512, DOI 10.1111/j.1365-2567.2008.02958.x; Hubner MP, 2013, PATHOG DIS, V69, P127, DOI 10.1111/2049-632X.12080; Hubner MP, 2012, J IMMUNOL, V188, P559, DOI 10.4049/jimmunol.1100335; Hussaarts L, 2015, FASEB J, V29, P3027, DOI 10.1096/fj.14-266239; Kyaw T, 2013, CIRCULATION, V127, P1028, DOI 10.1161/CIRCULATIONAHA.112.001347; Lee WH, 2001, ARTERIOSCL THROM VAS, V21, P2004, DOI 10.1161/hq1201.098945; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Lucey DR, 1996, CLIN MICROBIOL REV, V9, P532, DOI 10.1128/CMR.9.4.532; Maizels RM, 2004, IMMUNOL REV, V201, P89, DOI 10.1111/j.0105-2896.2004.00191.x; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Oosterwegel MA, 1999, CURR OPIN IMMUNOL, V11, P294, DOI 10.1016/S0952-7915(99)80047-8; Pineda MA, 2014, MOL BIOCHEM PARASIT, V194, P1, DOI 10.1016/j.molbiopara.2014.03.003; Pothineni NVK, 2017, EUR HEART J, V38, P3195, DOI 10.1093/eurheartj/ehx362; Ria F, 1998, EUR J IMMUNOL, V28, P2003, DOI 10.1002/(SICI)1521-4141(199806)28:06<2003::AID-IMMU2003>3.0.CO;2-S; Sabio G, 2014, SEMIN IMMUNOL, V26, P237, DOI 10.1016/j.smim.2014.02.009; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Santos-Gallego CG, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0401-9; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Surendar J, 2017, PARASITE IMMUNOL, V39, DOI 10.1111/pim.12401; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tran DQ, 2012, J MOL CELL BIOL, V4, P29, DOI 10.1093/jmcb/mjr033; Traub O, 1998, ARTERIOSCL THROM VAS, V18, P677, DOI 10.1161/01.ATV.18.5.677; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Walunas TL, 1998, J IMMUNOL, V160, P3855; Wang J, 2011, MOL MED, V17, P990, DOI 10.2119/molmed.2011.00073; Wang YB, 2007, CIRCULATION, V116, P1413, DOI 10.1161/CIRCULATIONAHA.106.679589; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Xiong QY, 2009, AUTOIMMUNITY, V42, P475, DOI 10.1080/08916930902887086; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Ziewer S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001558	56	2	2	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6497	6513		10.1096/fj.201800947RR	http://dx.doi.org/10.1096/fj.201800947RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807258	Bronze			2022-12-26	WOS:000466932600054
J	Jing, J; Sun, YN				Jing, Jian; Sun, Yanna			An (IIb3)- and phosphatidylserine (PS)-binding recombinant fusion protein promotes PS-dependent anticoagulation and integrin-dependent antithrombosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						annexin; drug design; fusion protein; phosphatidylserine; protein chimera; protein engineering; protein expression; protein motif; protein-lipid interaction; thrombosis	BOUND ANNEXIN-V; PLATELET-AGGREGATION; CHIMERIC PROTEIN; BINDING; EXPRESSION; EXPOSURE; INHIBITORS; BLOOD; PURIFICATION; PROCOAGULANT	Blood platelets are required for normal wound healing, but they are also involved in thrombotic diseases, which are usually managed with anticoagulant drugs. Here, using genetic engineering, we coupled the disintegrin protein echistatin, which specifically binds to the platelet integrin (IIb3) receptor, to annexin V, which binds platelet membrane-associated phosphatidylserine (PS), to create the bifunctional antithrombotic molecule recombinant echistatin-annexin V fusion protein (r-EchAV). Lipid binding and plasma coagulation studies revealed that r-EchAV dose-dependently binds PS and delays plasma clotting time. Moreover, r-EchAV inhibited ADP-induced platelet aggregation in a dose-dependent manner and exhibited potent antiplatelet aggregation effects. r-EchAV significantly prolonged activated partial thromboplastin time, suggesting that it primarily affects the in vivo coagulation pathway. Flow cytometry results indicated that r-EchAV could effectively bind to the platelet (IIb3) receptor, indicating that r-EchAV retains echistatin's receptor-recognition region. In vivo experiments in mice disclosed that r-EchAV significantly prolongs bleeding time, indicating a significant anticoagulant effect in vivo resulting from the joint binding of r-EchAV to both PS and the (IIb3) receptor. We also report optimization of the r-EchAV production steps and its purification for high purity and yield. Our findings indicate that r-EchAV retains the active structural regions of echistatin and annexin V and that the whole molecule exhibits multitarget-binding ability arising from the dual functions of echistatin and annexin V. Therefore, r-EchAV represents a new class of anticoagulant that specifically targets the anionic membrane-associated coagulation enzyme complexes at thrombogenesis sites and may be a potentially useful antithrombotic agent.	[Jing, Jian; Sun, Yanna] Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Genet Engn & Biotechnol, Xinwai St 19, Beijing 100875, Peoples R China	Beijing Normal University	Jing, J (corresponding author), Beijing Normal Univ, Coll Life Sci, Beijing Key Lab Genet Engn & Biotechnol, Xinwai St 19, Beijing 100875, Peoples R China.	jjing@bnu.edu.cn			Joint Construction Project of the Beijing Education Committee [2017110651103]; Young Scholars Fund of Beijing Normal University [BNU10300104977]	Joint Construction Project of the Beijing Education Committee; Young Scholars Fund of Beijing Normal University	This work was supported by Joint Construction Project of the Beijing Education Committee to Beijing Normal University No. 2017110651103 and Grant BNU10300104977 (to J.J.) from the Young Scholars Fund of Beijing Normal University. The authors declare that they have no conflicts of interest with the contents of this article.	ANDREE HAM, 1992, J BIOL CHEM, V267, P17907; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Chen HH, 2005, BLOOD, V105, P3902, DOI 10.1182/blood-2004-11-4435; Chen YC, 2012, TOXICON, V60, P1342, DOI 10.1016/j.toxicon.2012.08.009; Choo HJ, 2017, ARTERIOSCL THROM VAS, V37, P1503, DOI 10.1161/ATVBAHA.117.309473; DEJANA E, 1982, THROMB HAEMOSTASIS, V48, P108; FLAHERTY MJ, 1990, J LAB CLIN MED, V115, P174; Fox SC, 2004, PLATELETS, V15, P85, DOI 10.1080/09537100310001645979; GAN ZR, 1988, J BIOL CHEM, V263, P19827; Heemskerk JWM, 2002, THROMB HAEMOSTASIS, V88, P186; Huang X, 2006, BLOOD, V107, P980, DOI 10.1182/blood-2005-07-2733; HUBER R, 1990, EMBO J, V9, P3867, DOI 10.1002/j.1460-2075.1990.tb07605.x; Kenis H, 2009, CURR PHARM DESIGN, V15, P2719, DOI 10.2174/138161209788923903; Kuypers FA, 2007, THROMB HAEMOSTASIS, V97, P478, DOI 10.1160/TH06-08-0436; Lane DA, 2005, BLOOD, V106, P2605, DOI 10.1182/blood-2005-04-1710; LEWITBENTLEY A, 1992, EUR J BIOCHEM, V210, P73, DOI 10.1111/j.1432-1033.1992.tb17392.x; Li C., 2001, J NANJING MED U, V21, P277; [梁盼盼 LIANG Panpan], 2009, [北京师范大学学报. 自然科学版, Journal of Beijing Normal University. Natural Science], V45, P378; Lord ST, 2007, CURR OPIN HEMATOL, V14, P236, DOI 10.1097/MOH.0b013e3280dce58c; Marder LS, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-33; MAURERFOGY I, 1988, EUR J BIOCHEM, V174, P585, DOI 10.1111/j.1432-1033.1988.tb14139.x; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Nagata S, 2016, CELL DEATH DIFFER, V23, P952, DOI 10.1038/cdd.2016.7; Nguyen-Ho P, 2001, Curr Atheroscler Rep, V3, P139, DOI 10.1007/s11883-001-0050-7; Obydennyy SI, 2016, J THROMB HAEMOST, V14, P1867, DOI 10.1111/jth.13395; Oling F, 2001, J STRUCT BIOL, V133, P55, DOI 10.1006/jsbi.2000.4337; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; REUTELINGSPERGER CPM, 1985, EUR J BIOCHEM, V151, P625, DOI 10.1111/j.1432-1033.1985.tb09150.x; REUTELINGSPERGER CPM, 1988, EUR J BIOCHEM, V173, P171, DOI 10.1111/j.1432-1033.1988.tb13981.x; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; SCARBOROUGH RM, 1993, J BIOL CHEM, V268, P1066; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAIT JF, 1994, THROMB RES, V75, P491, DOI 10.1016/0049-3848(94)90224-0; TAIT JF, 1995, J BIOL CHEM, V270, P21594, DOI 10.1074/jbc.270.37.21594; Tanaka K, 1996, BIOCHEMISTRY-US, V35, P922, DOI 10.1021/bi951528x; Tcheng JE, 1996, AM J CARDIOL, V78, P35, DOI 10.1016/S0002-9149(96)00490-0; THIAGARAJAN P, 1990, J BIOL CHEM, V265, P17420; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; Uchman B, 2015, CLIN APPL THROMB-HEM, V21, P584, DOI 10.1177/1076029613512417; van Genderen HO, 2008, BBA-MOL CELL RES, V1783, P953, DOI 10.1016/j.bbamcr.2008.01.030; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; VANHEERDE WL, 1994, BIOCHEM J, V302, P305, DOI 10.1042/bj3020305; Verlinden NJ, 2017, J CARDIOVASC PHARM T, V22, P546, DOI 10.1177/1074248417698042; VOGES D, 1994, J MOL BIOL, V238, P199, DOI 10.1006/jmbi.1994.1281; Vorchheimer DA, 2006, MAYO CLIN PROC, V81, P59, DOI 10.4065/81.1.59; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x; Xu Q, 2013, INT J CARDIOL, V162, P210, DOI 10.1016/j.ijcard.2012.06.001; Yang Chao, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1130; Yi XY, 2013, ANAL CHEM, V85, P3660, DOI 10.1021/ac303624z; Yuan H, 2004, MICROBIOL RES, V159, P147, DOI 10.1016/j.micres.2004.02.002; Zhao L, 2017, J NEUROSURG, V127, P1041, DOI 10.3171/2016.8.JNS16996	56	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6670	6684		10.1074/jbc.RA118.006044	http://dx.doi.org/10.1074/jbc.RA118.006044			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30803987	Green Published, hybrid			2022-12-26	WOS:000467394700002
J	Wagner, EK; Qerqez, AN; Stevens, CA; Nguyen, AW; Delidakis, G; Maynard, JA				Wagner, Ellen K.; Qerqez, Ahlam N.; Stevens, Christopher A.; Nguyen, Annalee W.; Delidakis, George; Maynard, Jennifer A.			Human cytomegalovirus-specific T-cell receptor engineered for high affinity and soluble expression using mammalian cell display	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylation; antibody engineering; protein engineering; recombinant protein expression; immunoglobulin fold; affinity; antiviral treatment; cytomegalovirus; T-cell receptor	MAJOR HISTOCOMPATIBILITY COMPLEXES; DIRECTED EVOLUTION; IN-VITRO; TCR; RECOGNITION; SELECTION; PROTEIN; LEVEL; SECRETION; FREQUENCY	T-cell receptors (TCR) have considerable potential as therapeutics and antibody-like reagents to monitor disease progression and vaccine efficacy. Whereas antibodies recognize only secreted and surface-bound proteins, TCRs recognize otherwise inaccessible disease-associated intracellular proteins when they are presented as processed peptides bound to major histocompatibility complexes (pMHC). TCRs have been primarily explored for cancer therapy applications but could also target infectious diseases such as cytomegalovirus (CMV). However, TCRs are more difficult to express and engineer than antibodies, and advanced methods are needed to enable their widespread use. Here, we engineered the human CMV-specific TCR RA14 for high-affinity and robust soluble expression. To achieve this, we adapted our previously reported mammalian display system to present TCR extracellular domains and used this to screen CDR3 libraries for clones with increased pMHC affinity. After three rounds of selection, characterized clones retained peptide specificity and activation when expressed on the surface of human Jurkat T cells. We obtained high yields of soluble, monomeric protein by fusing the TCR extracellular domains to antibody hinge and Fc constant regions, adding a stabilizing disulfide bond between the constant domains and disrupting predicted glycosylation sites. One variant exhibited 50 nm affinity for its cognate pMHC, as measured by surface plasmon resonance, and specifically stained cells presenting this pMHC. Our work has identified a human TCR with high affinity for the immunodominant CMV peptide and offers a new strategy to rapidly engineer soluble TCRs for biomedical applications.	[Wagner, Ellen K.; Qerqez, Ahlam N.; Stevens, Christopher A.; Nguyen, Annalee W.; Delidakis, George; Maynard, Jennifer A.] Univ Texas Austin, McKetta Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Maynard, JA (corresponding author), Univ Texas Austin, 200 E Dean Keeton,MC0400, Austin, TX 78712 USA.	maynard@che.utexas.edu		Nguyen, Annalee/0000-0003-1268-7164	Welch Foundation [F-1767]; Clayton Foundation for Biomedical Research; National Institutes of Health NRSA [F32GM111018]; National Science Foundation GRFP fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI144719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM111018] Funding Source: NIH RePORTER	Welch Foundation(The Welch Foundation); Clayton Foundation for Biomedical Research; National Institutes of Health NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation GRFP fellowships; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Welch Foundation Grant F-1767 (to J. A. M.), the Clayton Foundation for Biomedical Research (to G. D.), National Institutes of Health NRSA Grant F32GM111018 (to A. W. N.), and National Science Foundation GRFP fellowships (to E. K. W. and A. N. Q.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggen DH, 2011, PROTEIN ENG DES SEL, V24, P361, DOI 10.1093/protein/gzq113; Anikeeva N, 2009, CLIN IMMUNOL, V130, P98, DOI 10.1016/j.clim.2008.08.025; Borroto A, 1999, J IMMUNOL, V163, P25; Bossi G, 2014, CANCER IMMUNOL IMMUN, V63, P437, DOI 10.1007/s00262-014-1525-z; Bossi G, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26840; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Chervin AS, 2008, J IMMUNOL METHODS, V339, P175, DOI 10.1016/j.jim.2008.09.016; Chng J, 2015, MABS-AUSTIN, V7, P403, DOI 10.1080/19420862.2015.1008351; Cohen CJ, 2006, CANCER RES, V66, P8878, DOI 10.1158/0008-5472.CAN-06-1450; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Cole DK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00168; Feuchtinger T, 2010, BLOOD, V116, P4360, DOI 10.1182/blood-2010-01-262089; Foss S, 2016, J CONTROL RELEASE, V223, P42, DOI 10.1016/j.jconrel.2015.12.033; Gakamsky DM, 2007, P NATL ACAD SCI USA, V104, P16639, DOI 10.1073/pnas.0707061104; Gonzalez-Galarza FF, 2018, METHODS MOL BIOL, V1802, P49, DOI 10.1007/978-1-4939-8546-3_4; Goyarts EC, 1998, MOL IMMUNOL, V35, P593, DOI 10.1016/S0161-5890(98)00056-X; Gras S, 2009, J IMMUNOL, V183, P430, DOI 10.4049/jimmunol.0900556; GREGOIRE C, 1991, P NATL ACAD SCI USA, V88, P8077, DOI 10.1073/pnas.88.18.8077; Gunnarsen KS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01162; Harris DT, 2016, TRENDS PHARMACOL SCI, V37, P220, DOI 10.1016/j.tips.2015.11.004; Ho SKN, 1998, J CLIN MICROBIOL, V36, P638, DOI 10.1128/JCM.36.3.638-640.1998; Holler PD, 2000, P NATL ACAD SCI USA, V97, P5387, DOI 10.1073/pnas.080078297; Holler PD, 2003, NAT IMMUNOL, V4, P55, DOI 10.1038/ni863; Irving M, 2012, J BIOL CHEM, V287, P23068, DOI 10.1074/jbc.M112.357673; KAGEYAMA S, 1995, J IMMUNOL, V154, P567; Kessels HWHC, 2000, P NATL ACAD SCI USA, V97, P14578, DOI 10.1073/pnas.97.26.14578; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Kunaparaju R, 2005, BIOTECHNOL BIOENG, V91, P670, DOI 10.1002/bit.20534; Lebowitz MS, 1999, CELL IMMUNOL, V192, P175, DOI 10.1006/cimm.1999.1441; Li Y, 2005, NAT BIOTECHNOL, V23, P349, DOI 10.1038/nbt1070; Liddy N, 2012, NAT MED, V18, P980, DOI 10.1038/nm.2764; Lunde E, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-61; Makler O, 2010, EUR J IMMUNOL, V40, P1552, DOI 10.1002/eji.200939875; Malecek K, 2013, J IMMUNOL METHODS, V392, P1, DOI 10.1016/j.jim.2013.02.018; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Mosquera LA, 2005, J IMMUNOL, V174, P4381, DOI 10.4049/jimmunol.174.7.4381; Nguyen AW, 2018, PROTEIN ENG DES SEL, V31, P91, DOI 10.1093/protein/gzy004; Nguyen AW, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0966; Oates J, 2015, MOL IMMUNOL, V67, P67, DOI 10.1016/j.molimm.2015.01.024; Ozawa T, 2012, BIOCHEM BIOPH RES CO, V422, P245, DOI 10.1016/j.bbrc.2012.04.134; Plotkin SA, 2019, VACCINE, V37, P7437, DOI 10.1016/j.vaccine.2018.02.089; RIDDELL SR, 1991, J IMMUNOL, V146, P2795; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Sami M, 2007, PROTEIN ENG DES SEL, V20, P397, DOI 10.1093/protein/gzm033; Saulquin X, 2000, EUR J IMMUNOL, V30, P2531, DOI 10.1002/1521-4141(200009)30:9<2531::AID-IMMU2531>3.0.CO;2-O; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; van Boxel GI, 2009, J IMMUNOL METHODS, V350, P14, DOI 10.1016/j.jim.2009.08.008; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Walseng E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119559; Wang GC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003647; Wang XL, 2015, CLIN CANCER RES, V21, P2993, DOI 10.1158/1078-0432.CCR-14-2920; Wills MR, 1996, J VIROL, V70, P7569, DOI 10.1128/JVI.70.11.7569-7579.1996; WULFING C, 1994, J MOL BIOL, V242, P655, DOI 10.1006/jmbi.1994.1615; Yang HB, 2016, MOL THER, V24, P1913, DOI 10.1038/mt.2016.114; Yang XB, 2015, J BIOL CHEM, V290, P29106, DOI 10.1074/jbc.M115.691311; Zhao Y, 2007, J IMMUNOL, V179, P5845, DOI 10.4049/jimmunol.179.9.5845	61	16	17	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5790	5804		10.1074/jbc.RA118.007187	http://dx.doi.org/10.1074/jbc.RA118.007187			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30796163	Green Published, hybrid			2022-12-26	WOS:000465077500006
J	Ivlev, DA; Shirinli, SN; Guria, KG; Uzlova, SG; Guria, GT				Ivlev, Dmitry A.; Shirinli, Shakhla N.; Guria, Konstantin G.; Uzlova, Svetlana G.; Guria, Georgy Th.			Control of fibrinolytic drug injection via real-time ultrasonic monitoring of blood coagulation	PLOS ONE			English	Article							THROMBIN ACTIVATABLE FIBRINOLYSIS; DEEP-VEIN THROMBOSIS; FACTOR-XIII; WHOLE-BLOOD; REPERFUSION STRATEGIES; STROKE THROMBOLYSIS; CLOT STRUCTURE; FLOW-RATE; IN-VIVO; MODEL	In the present study, we investigated the capabilities of a novel ultrasonic approach for real-time control of fibrinolysis under flow conditions. Ultrasonic monitoring was performed in a specially designed experimental in vitro system. Fibrinolytic agents were automatically injected at ultrasonically determined stages of the blood clotting. The following clots dissolution in the system was investigated by means of ultrasonic monitoring. It was shown, that clots resistance to fibrinolysis significantly increases during the first 5 minutes since the formation of primary micro-clots. The efficiency of clot lysis strongly depends on the concentration of the fibrinolytic agent as well as the delay of its injection moment. The ultrasonic method was able to detect the coagulation at early stages, when timely pharmacological intervention can still prevent the formation of macroscopic clots in the experimental system. This result serves as evidence that ultrasonic methods may provide new opportunities for real-time monitoring and the early pharmacological correction of thrombotic complications in clinical practice.	[Ivlev, Dmitry A.; Uzlova, Svetlana G.; Guria, Georgy Th.] Natl Res Ctr Hematol, Moscow, Russia; [Shirinli, Shakhla N.; Guria, Konstantin G.; Guria, Georgy Th.] Moscow Inst Phys & Technol, Dolgoprudnyi, Russia	Russian Academy of Medical Sciences; National Medical Research Center for Hematology; Moscow Institute of Physics & Technology	Guria, GT (corresponding author), Natl Res Ctr Hematol, Moscow, Russia.; Guria, GT (corresponding author), Moscow Inst Phys & Technol, Dolgoprudnyi, Russia.	guria@blood.ru	Ivlev, Dmitriy A/G-6834-2014; Guria, Georgy/L-6873-2013	Guria, Georgy/0000-0002-5579-9820	Russian Foundation of Basic Research [14-04-01193, 16-34-01180]; Federal Program "5top100"	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Federal Program "5top100"	The present work was partially supported by the Russian Foundation of Basic Research (www.rfbr.ru) grants 14-04-01193 (DAI, SNS, SGU, GTG) & 16-34-01180 (KGG, DAI) and the Federal Program "5top100" (www.5top100.ru) (KGG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghourian MN, 2012, J THROMB HAEMOST, V10, P447, DOI 10.1111/j.1538-7836.2011.04615.x; Bagai A, 2014, CIRC RES, V114, P1918, DOI 10.1161/CIRCRESAHA.114.302744; Bhatt M, 2018, PHYS MED BIOL, V63, DOI 10.1088/1361-6560/aab46a; Bouma BN, 2006, ANN MED, V38, P378, DOI 10.1080/07853890600852898; Budhram GR, 2014, RESUSCITATION, V85, P689, DOI 10.1016/j.resuscitation.2014.01.030; Calor MM, 2006, ULTRASOUND MED BIOL, V32, P1055, DOI 10.1016/j.ultrasmedbio.2006.04.002; Campbell BCV, 2015, STROKE, V46, P2341, DOI 10.1161/STROKEAHA.114.007564; Campbell RA, 2010, THROMB HAEMOSTASIS, V104, P1281, DOI 10.1160/TH10-07-0442; Cannata JM, 2012, J ULTRAS MED, V31, P1795, DOI 10.7863/jum.2012.31.11.1795; CHANDLER AB, 1958, LAB INVEST, V7, P110; CUNNINGHAM GM, 1965, LANCET, V1, P729, DOI 10.1016/S0140-6736(65)92089-1; Fang J, 2015, SCI REP-UK, V5, DOI 10.1038/srep11669; Faxon DP, 2005, NAT CLIN PRACT CARD, V2, P22, DOI 10.1038/ncpcardio0065; Fraser SR, 2011, BLOOD, V117, P6371, DOI 10.1182/blood-2011-02-333203; Fuster V, 2012, CIRCULATION, V126, P1645, DOI 10.1161/CIRCULATIONAHA.112.105908; Gennisson JL, 2006, ULTRASOUND MED BIOL, V32, P1529, DOI 10.1016/j.ultrasmedbio.2006.06.008; Gersh KC, 2010, J THROMB HAEMOST, V8, P2826, DOI 10.1111/j.1538-7836.2010.04118.x; GRYBAUSKAS P, 1978, ULTRASONICS, V16, P33, DOI 10.1016/0041-624X(78)90007-0; Hethershaw EL, 2014, J THROMB HAEMOST, V12, P197, DOI 10.1111/jth.12455; Huang CC, 2005, ULTRASOUND MED BIOL, V31, P1567, DOI 10.1016/j.ultrasmedbio.2005.07.003; Huang CC, 2007, IEEE T BIO-MED ENG, V54, P2223, DOI 10.1109/TBME.2007.908334; Huang CC, 2011, J MED BIOL ENG, V31, P79, DOI 10.5405/jmbe.893; Huisman MV, 2013, J THROMB HAEMOST, V11, P412, DOI 10.1111/jth.12124; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jain A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10176; Key NS, 2017, PRACTICAL HEMOSTASIS, P484; King A, 2009, STROKE, V40, P3711, DOI 10.1161/STROKEAHA.109.563056; Komorowicz E, 1998, CIRC RES, V82, P1102, DOI 10.1161/01.RES.82.10.1102; Levi M, 2015, J THROMB HAEMOST, V13, P1960, DOI 10.1111/jth.13126; Libgot-Calle R, 2008, ULTRASOUND MED BIOL, V34, P252, DOI 10.1016/j.ultrasmedbio.2007.06.018; Lippi G, 2011, NAT REV CARDIOL, V8, P502, DOI 10.1038/nrcardio.2011.91; Marshall RS, 2015, JAMA NEUROL, V72, P928, DOI 10.1001/jamaneurol.2015.0835; Maufus M, 2018, THROMB RES, V161, P78, DOI 10.1016/j.thromres.2017.11.004; Meretoja A, 2014, STROKE, V45, P1053, DOI 10.1161/STROKEAHA.113.002910; Mfoumou E, 2014, THROMB RES, V133, P265, DOI 10.1016/j.thromres.2013.11.001; Mosnier LO, 2006, ARTERIOSCL THROM VAS, V26, P2445, DOI 10.1161/01.ATV.0000244680.14653.9a; Mutch NJ, 2010, J THROMB HAEMOST, V8, P2017, DOI 10.1111/j.1538-7836.2010.03963.x; Nam KH, 2012, ULTRASOUND MED BIOL, V38, P468, DOI 10.1016/j.ultrasmedbio.2011.11.013; Robbie LA, 1997, THROMB HAEMOSTASIS, V77, P510; Robinson BR, 2000, CIRCULATION, V102, P1151, DOI 10.1161/01.CIR.102.10.1151; Romero J, 2014, NAT REV CARDIOL, V11, P470, DOI 10.1038/nrcardio.2014.77; Sakharov DV, 2000, THROMB HAEMOSTASIS, V83, P469; Schmitt C, 2011, J BIOMECH, V44, P622, DOI 10.1016/j.jbiomech.2010.11.015; SHUNG KK, 1984, J CLIN ULTRASOUND, V12, P147; SHUNG KP, 1975, IEEE T BIO-MED ENG, VBM22, P334, DOI 10.1109/TBME.1975.324454; Smith S., 2003, DIGIT SIGNAL PROCESS, P650; Uzlova SG, 2008, B BAKOULEV SCI CTR C, P55; Uzlova SG, 2008, PHILOS T R SOC A, V366, P3649, DOI 10.1098/rsta.2008.0109; Varju I, 2011, J THROMB HAEMOST, V9, P979, DOI 10.1111/j.1538-7836.2011.04203.x; Viola F, 2004, ANN BIOMED ENG, V32, P696, DOI 10.1023/B:ABME.0000030235.72255.df; Voleisis A, 2002, ULTRASONICS, V40, P101, DOI 10.1016/S0041-624X(02)00098-7; Walsh JT, 2006, PUMPING INSULIN, P332; Weisel J. W., 2008, Cardiovascular & Hematological Agents in Medicinal Chemistry, V6, P161, DOI 10.2174/187152508784871963	53	3	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211646	10.1371/journal.pone.0211646	http://dx.doi.org/10.1371/journal.pone.0211646			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811424	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400028
J	Jaques, DL; Mills, KL; Selby, BG; Veit, RR; Ziccardi, MH				Jaques, Deborah L.; Mills, Kyra L.; Selby, Barton G.; Veit, Richard R.; Ziccardi, Michael H.			Use of plumage and gular pouch color to evaluate condition of oil spill rehabilitated California brown pelicans (Pelecanus occidentalis californicus) post-release	PLOS ONE			English	Article							PENGUINS EUDYPTULA-MINOR; CAROTENOID-BASED PLUMAGE; IMMUNE ACTIVATION; OXIDATIVE STRESS; COMMON MURRES; SURVIVAL; SEABIRDS; EVOLUTION; MOVEMENT; BEHAVIOR	Sublethal effects of oil spills may dampen seabird rehabilitation success due to lingering negative impacts of contamination and stress on reproduction and long-term survival. These effects can be difficult to measure while birds are in care as well as once birds are released. Expression of sexually selected traits that are sensitive to condition can provide information on physiological status of birds. We evaluated plumage molt and gular pouch skin color of California brown pelicans (Pelecanus occidentalis californicus) following oil contamination and rehabilitation to test for differences between previously oiled and rehabilitated (post-spill) and presumably uncontaminated pelicans. Post-spill pelicans released with either color leg bands alone, or bands plus harness-mounted satellite GPS tags, were relocated and visually assessed in the field at non-breeding communal roosts and compared to surrounding unmarked pelicans in the general population. Non-oiled pelicans bearing GPS tags were also included in the study. Post-spill pelicans lagged the general population in molt of ornamental yellow crown feathers but hind neck transition into white plumage was not significantly different. Both post-spill and non-oiled pelicans wearing GPS tags had lower gular redness scores than the unmarked, non-oiled population. Pre-breeding gular pouch redness of post-spill pelicans was more strongly influenced by wearing of a GPS tag than a history of oil contamination and rehabilitation. Gular pouch redness of post-spill pelicans in the first 18 months after release was positively correlated with long term survivorship. If gular pouch color is a condition-dependent sexual signal and overall health influences plumage molt progression, our results indicate that many post-spill pelicans marked with bands alone were in relatively good condition going into the next breeding season, but those released with electronic tags experienced additional stress due to wearing the equipment, introducing a confounding variable to the post-release study.	[Jaques, Deborah L.] Pacific Eco Log, Astoria, OR 97103 USA; [Mills, Kyra L.; Ziccardi, Michael H.] Univ Calif Davis, Sch Vet Med, Karen C Drayer Wildlife Hlth Ctr, Oiled Wildlife Care Network, Davis, CA 95616 USA; [Selby, Barton G.] EH1, San Carlos, CA USA; [Veit, Richard R.] CUNY Coll Staten Isl, Biol Dept, Staten Isl, NY USA	University of California System; University of California Davis; City University of New York (CUNY) System; College of Staten Island (CUNY)	Jaques, DL (corresponding author), Pacific Eco Log, Astoria, OR 97103 USA.	djaques@pacificecologic.org		Jaques, Deborah/0000-0002-9982-3052; Ziccardi, Michael/0000-0002-5430-2499	California Department of Fish and Wildlife's Oil Spill Prevention and Administration Fund through the Oiled Wildlife Care Network (OWCN) at the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; OWCN budget	California Department of Fish and Wildlife's Oil Spill Prevention and Administration Fund through the Oiled Wildlife Care Network (OWCN) at the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis; OWCN budget	Funding for this study was provided by the California Department of Fish and Wildlife's Oil Spill Prevention and Administration Fund through the Oiled Wildlife Care Network (OWCN) at the Karen C. Drayer Wildlife Health Center, School of Veterinary Medicine, University of California, Davis. Post-release studies are collaborative efforts between the OWCN and appropriate experts, with funding coming from a reserve within the OWCN budget. M. Ziccardi and K. Mills are staff members at OWCN and had roles in project concept and manuscript editing.	Aldrich JW, 1970, REV PROBLEM BIRDS CO; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Alonso-Alvarez C, 2007, P ROY SOC B-BIOL SCI, V274, P819, DOI 10.1098/rspb.2006.3764; Alonso-Alvarez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019403; Altwegg R, 2008, BIOL CONSERV, V141, P1924, DOI 10.1016/j.biocon.2008.04.030; AMADON D, 1966, CONDOR, V68, P263, DOI 10.2307/1365560; ANDERSON D W, 1976, American Birds, V30, P3; ANDERSON DW, 1988, WILDLIFE SOC B, V16, P339; Anderson DW, 1996, MAR POLLUT BULL, V32, P711, DOI 10.1016/0025-326X(96)00027-6; Anderson DW, 2017, BROWN PELICANS PELEC; [Anonymous], 2004, EFFECTS PETROLEUM EX; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; Blevin P, 2014, SCI TOTAL ENVIRON, V470, P248, DOI 10.1016/j.scitotenv.2013.09.049; Blount JD, 2003, SCIENCE, V300, P125, DOI 10.1126/science.1082142; Briggs KT, 1997, ICES J MAR SCI, V54, P718, DOI 10.1006/jmsc.1997.0254; BRIGGS KT, 1983, J FIELD ORNITHOL, V54, P353; Brush A.H., 1978, P141; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Chilvers BL, 2015, MAR POLLUT BULL, V100, P128, DOI 10.1016/j.marpolbul.2015.09.019; CROLL DA, 1986, CONDOR, V88, P258, DOI 10.2307/1368929; Dauwe T, 2008, NATURWISSENSCHAFTEN, V95, P969, DOI 10.1007/s00114-008-0400-1; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; De la Cruz SEW, 2013, MAR POLLUT BULL, V67, P100, DOI 10.1016/j.marpolbul.2012.11.027; Dearborn DC, 2002, J EVOLUTION BIOL, V15, P307, DOI 10.1046/j.1420-9101.2002.00388.x; Dey CJ, 2017, AUK, V134, P317, DOI 10.1642/AUK-16-119.1; DUNSTAN T C, 1972, Inland Bird-Banding News, V44, P4; Eisler R., 1987, POLYCYCLIC AROMATIC; EVANS RM, 1994, BEHAVIOUR, V129, P13, DOI 10.1163/156853994X00334; Faivre B, 2003, SCIENCE, V300, P103, DOI 10.1126/science.1081802; Fallon JA, 2018, ENVIRON TOXICOL CHEM, V37, P451, DOI 10.1002/etc.3983; Fiorello C, 2017, REF OIL SPILL INT OI; Freed LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029834; FRY DM, 1986, ARCH ENVIRON CON TOX, V15, P453, DOI 10.1007/BF01066414; FRY DM, 1985, ARCH ENVIRON CON TOX, V14, P725, DOI 10.1007/BF01055780; Geens A, 2009, COMP BIOCHEM PHYS C, V150, P155, DOI 10.1016/j.cbpc.2009.04.007; Giese M, 2000, WILDLIFE RES, V27, P583, DOI 10.1071/WR99077; Godfrey J.D., 2003, Science for Conservation (Wellington), V214, P83; Goldsworthy SD, 2000, WILDLIFE RES, V27, P573, DOI 10.1071/WR99076; Golightly RT, 2002, WILDLIFE SOC B, V30, P539; Goodwin T, 1980, BIOGEOCHEMISTRY CARO, P346; HAHN TP, 1992, ORNIS SCAND, V23, P314, DOI 10.2307/3676655; Helm RC, 2015, OVERVIEW EFFORTS DOC; Henkel LA, 2017, LIFE DEATH SHOULD WE, V9, P296; Hill G.E., 2006, BIRD COLOURATION FUN; HILL GE, 1995, BIOSCIENCE, V45, P25, DOI 10.2307/1312532; HUMPHREY PHILIP S., 1959, AUK, V76, P1; Johnsen S, 2016, J EXP BIOL, V219, P772, DOI 10.1242/jeb.124008; Juola FA, 2008, COMP BIOCHEM PHYS B, V149, P370, DOI 10.1016/j.cbpb.2007.10.010; Kesler DC, 2014, WILDLIFE SOC B, V38, P557, DOI 10.1002/wsb.437; KHAN RA, 1991, B ENVIRON CONTAM TOX, V46, P216, DOI 10.1007/BF01691940; Lamb JS, 2018, MAR POLLUT BULL, V131, P22, DOI 10.1016/j.marpolbul.2018.03.043; Lamb JS, 2017, J ORNITHOL, V158, P617, DOI 10.1007/s10336-016-1418-3; Leighton Frederick A., 1993, Environmental Reviews, V1, P92; Lumpkin DC, 2014, ECOL EVOL, V4, P3210, DOI 10.1002/ece3.1164; Mazet JAK, 2002, J AVIAN MED SURG, V16, P146, DOI 10.1647/1082-6742(2002)016[0146:AIOBEM]2.0.CO;2; McGraw K. J., 2006, BIRD COLORATION, VI; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ, BIRD COLORATION, P177; MCSWEENEY T, 1988, J ZOO WILDLIFE MED, V19, P116, DOI 10.2307/20094867; Miller EK, 2012, P 11 INT C EFF OIL W; Mills KL, 2016, WATERBIRDS, V39, P175, DOI 10.1675/063.039.0208; Montoya B, 2016, J EXP BIOL, V219, P3915, DOI 10.1242/jeb.141325; Montoya B, 2015, BEHAV ECOL, V26, P425, DOI 10.1093/beheco/aru204; Payne R.B., 1972, P103; Perez C, 2010, OECOLOGIA, V163, P875, DOI 10.1007/s00442-010-1677-2; Perez C, 2010, BIOL LETTERS, V6, P33, DOI 10.1098/rsbl.2009.0567; Pyle P, 2008, IDENTIFICATION GUIDE; Saks L, 2003, OECOLOGIA, V134, P301, DOI 10.1007/s00442-002-1125-z; Schreiber R, 1989, NATURAL HIST MUSEUM; Schreiber R.W., 1977, ORNITHOL MONOGR, V22, pIII; Schull Q, 2016, BEHAV ECOL, V27, P1684, DOI 10.1093/beheco/arw091; Sharp BE, 1996, IBIS, V138, P222, DOI 10.1111/j.1474-919X.1996.tb04332.x; Shields M., 2002, BROWN PELICAN PELECA; Team RC, 2015, R LANG ENV STAT COMP; Troisi G, 2016, INT J HYDROGEN ENERG, V41, P16549, DOI 10.1016/j.ijhydene.2016.04.011; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	76	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211932	10.1371/journal.pone.0211932	http://dx.doi.org/10.1371/journal.pone.0211932			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811430	Green Published, gold			2022-12-26	WOS:000459806400041
J	Luo, XF; Zhao, M; Wang, XZ; Jiang, MS; Yu, JZ; Li, X; Yang, L				Luo, Xuefeng; Zhao, Ming; Wang, Xiaoze; Jiang, Mingshan; Yu, Jiaze; Li, Xiao; Yang, Li			Long-term patency and clinical outcome of the transjugular intrahepatic portosystemic shunt using the expanded polytetrafluoroethylene stent-graft	PLOS ONE			English	Article							PORTAL-HYPERTENSION; EARLY MORTALITY; TIPS; CIRRHOSIS; CREATION; COMPLICATIONS; PREVENTION; PREDICTORS; MANAGEMENT; VS.	Background Transjugular intrahepatic portosystemic shunt (TIPS) creation is an established treatment option to management the complications of portal hypertension. Recent data on the long-term outcomes of TIPS are scarce. Materials and methods In this single-institution retrospective study, 495 patients underwent TIPS with the Fluency stent-grafts between December 2011 and June 2015 were evaluated. The cumulative rates of TIPS dysfunction, hepatic encephalopathy (HE), survival, and variceal rebleeding were determined using the Kaplan-Meier method. Cox regression analysis was used to assess the parameters on TIPS patency, occurrence of HE and all-cause mortality. Results Technical success was 98.2%. TIPS-related complications occurred in 67 patients (13.5%) during the index hospital stay. TIPS creation resulted in an immediate decrease in mean portosystemic pressure gradient from 23.4 +/- 7.1 mmHg to 7.6 +/- 3.5 mmHg. The median follow-up period was 649 days. Primary TIPS patency rates were 93%, and 75.9% at 1 and 3 years, respectively. Previous splenectomy was associated with a higher risk of TPS dysfunction. The cumulative survival rates were 93.4% and 77.2% at 1 and 3 years, respectively. The 1- and 3-year probability of remaining free of variceal bleeding rates were 94.2% and 71.4%, respectively. Conclusions This retrospective single-center experience with TIPS using the Fluency stent-grafts demonstrates good long-term patency and favorable good clinical results. Previous splenectomy strongly predicts shunt dysfunction.	[Luo, Xuefeng; Zhao, Ming; Wang, Xiaoze; Jiang, Mingshan; Yu, Jiaze; Yang, Li] Sichuan Univ, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Sichuan, Peoples R China; [Li, Xiao] Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Intervent Radiol, Beijing, Peoples R China; [Li, Xiao] Peking Union Med Coll, Beijing, Peoples R China	Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Yang, L (corresponding author), Sichuan Univ, West China Hosp, Dept Gastroenterol & Hepatol, Chengdu, Sichuan, Peoples R China.; Li, X (corresponding author), Chinese Acad Med Sci, Natl Canc Ctr, Canc Hosp, Dept Intervent Radiol, Beijing, Peoples R China.; Li, X (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	simonlixiao@126.com; yangli_hx@scu.edu.cn	LUO, XUEFENG/AAX-3762-2021		National Natural Science Foundation of China [81501566]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China (grant number 81501566). The URL of the funder's website is http://www.nsfc.gov.cn/. Initials of authors who received the funding: XFL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyer TD, 2010, HEPATOLOGY, V51, P306, DOI 10.1002/hep.23383; Charon JPM, 2004, J VASC INTERV RADIOL, V15, P1219, DOI 10.1097/01.RVI.0000137434.19522.E5; Chen L, 2009, LIVER INT, V29, P1101, DOI 10.1111/j.1478-3231.2009.02016.x; Clark TWI, 2008, TECH VASC INTERV RAD, V11, P212, DOI 10.1053/j.tvir.2009.04.003; Cura M, 2008, AM J ROENTGENOL, V191, P1751, DOI 10.2214/AJR.07.3534; Funes Fernanda Ribeiro, 2012, Arq. Gastroenterol., V49, P143; Gazzera C, 2012, RADIOL MED, V117, P46, DOI 10.1007/s11547-011-0682-9; Harrod-Kim P, 2006, J VASC INTERV RADIOL, V17, P1605, DOI 10.1097/01.RVI.0000240651.38289.4B; Holster IL, 2016, HEPATOLOGY, V63, P581, DOI 10.1002/hep.28318; Krajina A, 2012, CARDIOVASC INTER RAD, V35, P1295, DOI 10.1007/s00270-012-0493-y; Parvinian A, 2013, J VASC INTERV RADIOL, V24, P941, DOI 10.1016/j.jvir.2013.03.018; Perarnau JM, 2014, J HEPATOL, V60, P962, DOI 10.1016/j.jhep.2014.01.015; Rossle M, 2013, J HEPATOL, V59, P1081, DOI 10.1016/j.jhep.2013.06.014; Rossi P, 2004, RADIOLOGY, V231, P820, DOI 10.1148/radiol.2313030349; Salerno F, 2007, GASTROENTEROLOGY, V133, P825, DOI 10.1053/j.gastro.2007.06.020; Sauerbruch T, 2015, GASTROENTEROLOGY, V149, P660, DOI 10.1053/j.gastro.2015.05.011; Wang L, 2016, SCI REP-UK, V6, DOI 10.1038/srep21011; Weber CN, 2015, J VASC INTERV RADIOL, V26, P1257, DOI 10.1016/j.jvir.2015.04.005; Wu QH, 2013, EXP THER MED, V5, P263, DOI 10.3892/etm.2012.776; Wu XJ, 2013, AM SURGEON, V79, P305; Wu XJ, 2010, J HEPATO-BIL-PAN SCI, V17, P701, DOI 10.1007/s00534-010-0270-8; Zhang F, 2014, EUR J GASTROEN HEPAT, V26, P853, DOI 10.1097/MEG.0000000000000134	22	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212658	10.1371/journal.pone.0212658	http://dx.doi.org/10.1371/journal.pone.0212658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811467	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400082
J	Muise, ES; Guan, HP; Liu, JQ; Nawrocki, AR; Yang, XD; Wang, CL; Rodriguez, CG; Zhou, D; Gorski, JN; Kurtz, MM; Feng, DQ; Leavitt, KJ; Wei, L; Wilkening, RR; Apgar, JM; Xu, SY; Lu, K; Feng, W; Li, Y; He, HB; Previs, SF; Shen, XL; van Heek, M; Souza, SC; Rosenbach, MJ; Biftu, T; Erion, MD; Kelley, DE; Kemp, DM; Myers, RW; Sebhat, IK				Muise, Eric S.; Guan, Hong-Ping; Liu, Jinqi; Nawrocki, Andrea R.; Yang, Xiaodong; Wang, Chuanlin; Rodriguez, Carlos G.; Zhou, Dan; Gorski, Judith N.; Kurtz, Marc M.; Feng, Danqing; Leavitt, Kenneth J.; Wei, Lan; Wilkening, Robert R.; Apgar, James M.; Xu, Shiyao; Lu, Ku; Feng, Wen; Li, Ying; He, Huaibing; Previs, Stephen F.; Shen, Xiaolan; van Heek, Margaret; Souza, Sandra C.; Rosenbach, Mark J.; Biftu, Tesfaye; Erion, Mark D.; Kelley, David E.; Kemp, Daniel M.; Myers, Robert W.; Sebhat, Iyassu K.			Pharmacological AMPK activation induces transcriptional responses congruent to exercise in skeletal and cardiac muscle, adipose tissues and liver	PLOS ONE			English	Article							5'-AMP-ACTIVATED PROTEIN-KINASE; PHYSICAL-ACTIVITY; ENDURANCE EXERCISE; SIGNALING PATHWAY; GLUCOSE-UPTAKE; ENERGY SENSOR; MALONYL-COA; WEIGHT-LOSS; HEALTH; METABOLISM	Physical activity promotes metabolic and cardiovascular health benefits that derive in part from the transcriptional responses to exercise that occur within skeletal muscle and other organs. There is interest in discovering a pharmacologic exercise mimetic that could imbue wellness and alleviate disease burden. However, the molecular physiology by which exercise signals the transcriptional response is highly complex, making it challenging to identify a single target for pharmacological mimicry. The current studies evaluated the transcriptome responses in skeletal muscle, heart, liver, and white and brown adipose to novel small molecule activators of AMPK (pan-activators for all AMPK isoforms) compared to that of exercise. A striking level of congruence between exercise and pharmacological AMPK activation was observed across the induced transcriptome of these five tissues. However, differences in acute metabolic response between exercise and pharmacologic AMPK activation were observed, notably for acute glycogen balances and related to the energy expenditure induced by exercise but not pharmacologic AMPK activation. Nevertheless, intervention with repeated daily administration of short-acting activation of AMPK was found to mitigate hyperglycemia and hyperinsulinemia in four rodent models of metabolic disease and without the cardiac glycogen accretion noted with sustained pharmacologic AMPK activation. These findings affirm that activation of AMPK is a key node governing exercise mediated transcription and is an attractive target as an exercise mimetic.	[Muise, Eric S.] MRL, Genet & Pharmacogen Dept, Kenilworth, NJ 07033 USA; [Guan, Hong-Ping; Liu, Jinqi; Yang, Xiaodong; Wang, Chuanlin; Lu, Ku; Feng, Wen; Li, Ying; Previs, Stephen F.; Souza, Sandra C.; Rosenbach, Mark J.; Erion, Mark D.; Kelley, David E.; Kemp, Daniel M.] MRL, Biol Discovery Dept, Kenilworth, NJ USA; [Nawrocki, Andrea R.; Rodriguez, Carlos G.; Zhou, Dan; Gorski, Judith N.; van Heek, Margaret] MRL, Vivo Pharmacol Dept, Kenilworth, NJ USA; [Kurtz, Marc M.; Myers, Robert W.] MRL, Vitro Pharmacol Dept, Kenilworth, NJ USA; [Feng, Danqing; Leavitt, Kenneth J.; Wei, Lan; Wilkening, Robert R.; Apgar, James M.; Biftu, Tesfaye; Sebhat, Iyassu K.] MRL, Med Chem Dept, Kenilworth, NJ 07033 USA; [Xu, Shiyao; He, Huaibing] MRL, PPDM Preclin ADME Dept, Kenilworth, NJ USA; [Shen, Xiaolan] MRL, SALAR Dept, Kenilworth, NJ USA		Muise, ES (corresponding author), MRL, Genet & Pharmacogen Dept, Kenilworth, NJ 07033 USA.; Sebhat, IK (corresponding author), MRL, Med Chem Dept, Kenilworth, NJ 07033 USA.	eric_muise@merck.com; iyassu@gmail.com		Muise, Eric/0000-0002-1238-5118	Merck Co., Inc.; Merck Research Laboratories, Kenilworth, NJ, USA	Merck Co., Inc.(Merck & Company); Merck Research Laboratories, Kenilworth, NJ, USA	This work was fully funded by Merck & Co., Inc., Merck Research Laboratories, Kenilworth, NJ, USA. The strategic goal of Merck & Co., Inc., was to explore the drug development potential of an AMPK activator for the treatment of diabetes mellitus and potentially other metabolic disorders. The studies presented in this manuscript accordingly represent investigations undertaken toward this purpose, to gain preclinical proof of concept that long- and short-acting AMPK activators could influence diabetes mellitus in rodent and murine models of this disorder and further, to gain deeper insight into the mechanisms by which salutary effects were obtained through this mechanism. The investigators listed as authors designed the experiments, carried these out, including analysis and made the decision to prepare and publish the manuscript. Senior leaders within Merck & Co., Inc., specifically within Merck Research Laboratories, did periodically review the progress of the AMPK activator program, and as is customary, assign prioritization to the AMPK program. Additionally, through a standard internal review process, senior leaders within Merck authorized the submission of the manuscript for publication.	Arad M, 2002, J CLIN INVEST, V109, P357, DOI 10.1172/JCI200214571; Bijland S, 2013, CLIN SCI, V124, P491, DOI 10.1042/CS20120536; Booth FW, 2000, J APPL PHYSIOL, V88, P774, DOI 10.1152/jappl.2000.88.2.774; Borghouts LB, 2000, INT J SPORTS MED, V21, P1, DOI 10.1055/s-2000-8847; Cao YH, 2010, CELL RES, V20, P99, DOI 10.1038/cr.2009.141; Chen Y, 2007, J CELL BIOCHEM, V100, P1337, DOI 10.1002/jcb.21194; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Das Sarma J, 2008, CELL COMMUN ADHES, V15, P65, DOI 10.1080/15419060802014305; Fan WW, 2017, CELL METAB, V25, P242, DOI 10.1016/j.cmet.2016.10.022; Ferrera L, 2010, PHYSIOLOGY, V25, P357, DOI 10.1152/physiol.00030.2010; Frosig C, 2004, AM J PHYSIOL-ENDOC M, V286, pE411, DOI 10.1152/ajpendo.00317.2003; Fujii N, 2000, BIOCHEM BIOPH RES CO, V273, P1150, DOI 10.1006/bbrc.2000.3073; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hoffman NJ, 2015, CELL METAB, V22, P922, DOI 10.1016/j.cmet.2015.09.001; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; Iriyama T, 2009, EMBO J, V28, P843, DOI 10.1038/emboj.2009.32; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim AS, 2009, ACTA PHYSIOL, V196, P37, DOI 10.1111/j.1748-1716.2009.01978.x; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Liu Y, 2013, BIOCHEM J, V455, P195, DOI 10.1042/BJ20130644; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Menshikova EV, 2005, AM J PHYSIOL-ENDOC M, V288, pE818, DOI 10.1152/ajpendo.00322.2004; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Muise ES, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088908; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; O'Neill HM, 2011, P NATL ACAD SCI USA, V108, P16092, DOI 10.1073/pnas.1105062108; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Plaisier CL, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.21; Rasmussen BB, 1997, J APPL PHYSIOL, V83, P1104, DOI 10.1152/jappl.1997.83.4.1104; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Schaffer JE, 2003, CURR OPIN LIPIDOL, V14, P281, DOI 10.1097/00041433-200306000-00008; Schild M, 2015, J PROTEOMICS, V122, P119, DOI 10.1016/j.jprot.2015.03.028; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Toledo FGS, 2007, DIABETES, V56, P2142, DOI 10.2337/db07-0141; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Wang L, 2011, J APPL PHYSIOL, V111, P1335, DOI 10.1152/japplphysiol.00086.2011; Wang LW, 2011, CURR OPIN PHARMACOL, V11, P360, DOI 10.1016/j.coph.2011.03.008; Williamson DL, 2006, J PHYSIOL-LONDON, V573, P497, DOI 10.1113/jphysiol.2005.103481; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299; Wochnik GM, 2005, J BIOL CHEM, V280, P4609, DOI 10.1074/jbc.M407498200; Wojtaszewski JFP, 2002, J APPL PHYSIOL, V93, P384, DOI 10.1152/japplphysiol.00043.2002; Wojtaszewski JFP, 2000, J PHYSIOL-LONDON, V528, P221, DOI 10.1111/j.1469-7793.2000.t01-1-00221.x; Wolfgang MJ, 2006, J BIOL CHEM, V281, P37265, DOI 10.1074/jbc.R600016200; Yang XD, 2016, J BIOL CHEM, V291, P23428, DOI 10.1074/jbc.M116.738591; Yogi A, 2007, ARTERIOSCL THROM VAS, V27, P1960, DOI 10.1161/ATVBAHA.107.146746; Zhang J, 2017, EXP PHYSIOL, V102, P48, DOI 10.1113/EP086019	55	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211568	10.1371/journal.pone.0211568	http://dx.doi.org/10.1371/journal.pone.0211568			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811418	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400023
J	Olivieri, NF; Sabouhanian, A; Gallie, BL				Olivieri, Nancy F.; Sabouhanian, Amir; Gallie, Brenda L.			Single-center retrospective study of the effectiveness and toxicity of the oral iron chelating drugs deferiprone and deferasirox	PLOS ONE			English	Article							THALASSEMIA MAJOR PATIENTS; TRANSFUSION-DEPENDENT THALASSEMIA; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM TREATMENT; COMBINED THERAPY; LIVER IRON; LONGITUDINAL ANALYSIS; MYOCARDIAL IRON; CLINICAL-TRIAL; SAFETY PROFILE	Background Iron overload, resulting from blood transfusions in patients with chronic anemias, has historically been controlled with regular deferoxamine, but its parenteral requirement encouraged studies of orally-active agents, including deferasirox and deferiprone. Deferasirox, licensed by the US Food and Drug Administration in 2005 based upon the results of randomized controlled trials, is now first-line therapy worldwide. In contrast, early investigator-initiated trials of deferiprone were prematurely terminated after investigators raised safety concerns. The FDA declined market approval of deferiprone; years later, it licensed the drug as "last resort" therapy, to be prescribed only if first-line drugs had failed. We undertook to evaluate the long-term effectiveness and toxicities of deferiprone and deferasirox in one transfusion clinic. Methods and findings Under an IRB-approved study, we retrospectively inspected the electronic medical records of consented iron-loaded patients managed between 2009 and 2015 at The University Health Network (UHN), Toronto. We compared changes in liver and heart iron, adverse effects and other outcomes, in patients treated with deferiprone or deferasirox. Results Although deferiprone was unlicensed in Canada, one-third (n = 41) of locally-transfused patients had been switched from first-line, licensed therapies (deferoxamine or deferasirox) to regimens of unlicensed deferiprone. The primary endpoint of monitoring in iron overload, hepatic iron concentration (HIC), increased (worsened) during deferiprone monotherapy (mean 10 +/- 2-18 +/- 2 mg/g; p < 0.0003), exceeding the threshold for life-threatening complications (15 mg iron/g liver) in 50% patients. During deferasirox monotherapy, mean HIC decreased (improved) (11 +/- 1-6 +/- 1 mg/g; p < 0.0001). Follow-up HICs were significantly different following deferiprone and deferasirox monotherapies (p < 0.0000002). Addition of low-dose deferoxamine (<40 mg/kg/day) to deferiprone did not result in reductions of HIC to <15 mg/g (baseline 20 +/- 4 mg/g; follow-up, 18 +/- 4 mg/g; p < 0.2) or in reduction in the proportion of patients with HIC exceeding 15 mg/g (p < 0.2). During deferiprone exposure, new diabetes mellitus, a recognized consequence of inadequate iron control, was diagnosed in 17% patients, most of whom had sustained HICs exceeding 15 mg/g for years; one woman died after 13 months of a regimen of deferiprone and low-dose deferasirox. During deferiprone exposure, serum ALT increased over baseline in 65% patients. Mean serum ALT increased 6.6-fold (p < 0.001) often persisting for years. During deferasirox exposure, mean ALT was unchanged (p < 0.84). No significant differences between treatment groups were observed in the proportions of patients estimated to have elevated cardiac iron. Conclusions Deferiprone showed ineffectiveness and significant toxicity in most patients. Combination with low doses of first-line therapies did not improve the effectiveness of deferiprone. Exposure to deferiprone, over six years while the drug was unlicensed, in the face of ineffectiveness and serious toxicities, demands review of the standards of local medical practice. The limited scope of regulatory approval of deferiprone, worldwide, should restrict its exposure to the few patients genuinely unable to tolerate the two effective, first-line therapies.	[Olivieri, Nancy F.; Sabouhanian, Amir] Univ Toronto, Med & Publ Hlth Sci, Toronto, ON, Canada; [Olivieri, Nancy F.; Sabouhanian, Amir] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada; [Gallie, Brenda L.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Gallie, Brenda L.] Univ Toronto, Dept Ophthalmol & Vis Sci, Toronto, ON, Canada; [Gallie, Brenda L.] Univ Toronto, Dept Med Biophys & Mol Genet, Toronto, ON, Canada; [Gallie, Brenda L.] Univ Hlth Network, Techna Inst, Toronto, ON, Canada; [Gallie, Brenda L.] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Krembil Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Olivieri, NF (corresponding author), Univ Toronto, Med & Publ Hlth Sci, Toronto, ON, Canada.; Olivieri, NF (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Toronto, ON, Canada.	nancy@hemoglobal.org	Olivieri, Nancy/AAI-2250-2020	Sabouhanian, Amir/0000-0002-5573-5157; Gallie, Brenda/0000-0002-9697-9211				Abdelrazik N, 2007, HEMATOLOGY, V12, P577, DOI 10.1080/10245330701521614; AGARWAL MB, 1992, BRIT J HAEMATOL, V82, P460, DOI 10.1111/j.1365-2141.1992.tb06445.x; Al Hawsawi ZM, 2010, J TAIBAH UNIV MED SC, V5, P27, DOI 10.1016/S1658-3612(10)70121-9; Alpendurada F, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-8; ALREFAIE FN, 1992, BLOOD, V80, P593; Alymara V, 2004, HEMATOL J, V5, P475, DOI 10.1038/sj.thj.6200550; Angelucci E, 2000, NEW ENGL J MED, V343, P327, DOI 10.1056/NEJM200008033430503; [Anonymous], 2011, FERRIPROX DRUG MONOG; Aydinok Y, 1999, BRIT J HAEMATOL, V106, P252; Aydinok Y, 2007, HAEMATOLOGICA, V92, P1599, DOI 10.3324/haematol.11414; Balveer K, 2000, Med J Malaysia, V55, P493; Berdoukas Vasili, 2000, Transfusion Science, V23, P239, DOI 10.1016/S0955-3886(00)00092-8; Berdoukas V, 2011, EXPERT REV HEMATOL, V4, P17, DOI 10.1586/EHM.10.74; Berdoukas V, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-20; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Botzenhardt S, 2018, HAEMATOLOGICA, V103, DOI 10.3324/haematol.2017.176065; Botzenhardt S, 2016, CURR DRUG SAF, V11, P137, DOI 10.2174/1574886310666150930113957; Brittenham GM, 2011, NEW ENGL J MED, V364, P146, DOI 10.1056/NEJMct1004810; Brittenham GM, 2003, BLOOD, V101, P5089, DOI 10.1182/blood-2002-10-3173; BRITTENHAM GM, 1994, NEW ENGL J MED, V331, P567, DOI 10.1056/NEJM199409013310902; Canada H, 2008, GUID DOC IND PRACT S; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2014, ETH COND RES INV HUM; Cassinerio E, 2012, ANN HEMATOL, V91, P1443, DOI 10.1007/s00277-012-1480-8; Ceci A, 2002, BRIT J HAEMATOL, V118, P330, DOI 10.1046/j.1365-2141.2002.03554.x; Ceci A, 2011, ANEMIA, V2011, DOI 10.1155/2011/435683; Chen AC, 2006, HEMOGLOBIN, V30, P209, DOI 10.1080/03630260600642518; Choudhry V. P., 2004, Indian Journal of Pediatrics, V71, P213, DOI 10.1007/BF02724272; Christoforidis A, 2007, EUR J HAEMATOL, V78, P52, DOI 10.1111/j.0902-4441.2006.t01-1-EJH3013.x; Coates TD, 2014, BLOOD, V123, P1434, DOI 10.1182/blood-2014-01-548552; Cohen A, 1998, ANN NY ACAD SCI, V850, P223, DOI 10.1111/j.1749-6632.1998.tb10478.x; Cohen AR, 2003, BLOOD, V102, P1583, DOI 10.1182/blood-2002-10-3280; Cohen AR, 2000, BRIT J HAEMATOL, V108, P305; D'Angelo E, 2004, J PEDIAT HEMATOL ONC, V26, P451, DOI 10.1097/00043426-200407000-00011; Daar S, 2006, ANN HEMATOL, V85, P315, DOI 10.1007/s00277-005-0075-z; Danjou F, 2013, BLOOD CELL MOL DIS, V51, P142, DOI 10.1016/j.bcmd.2013.06.001; Del Vecchio GC, 2000, ACTA HAEMATOL-BASEL, V104, P99, DOI 10.1159/000039759; El-Beshlawy A, 2008, ANN HEMATOL, V87, P545, DOI 10.1007/s00277-008-0471-2; Farmaki K, 2010, BRIT J HAEMATOL, V148, P466, DOI 10.1111/j.1365-2141.2009.07970.x; Farrell AT, 2011, SUMMARY REV FERRIPRO; Filosa A, 2013, BLOOD CELL MOL DIS, V51, P85, DOI 10.1016/j.bcmd.2013.04.002; Fisher SA, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004839.pub3; Galanello R, 2006, HAEMATOLOGICA, V91, P1241; Galia M, 2003, HEMOGLOBIN, V27, P63, DOI 10.1081/HEM-120021538; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; Gomber Sunil, 2004, Indian Pediatr, V41, P21; Ha SY, 2006, HEMOGLOBIN, V30, P263, DOI 10.1080/03630260600642617; Hejazi S, 2016, INT J PEDIATR-MASSHA, V4, P1959; Hershko C, 2004, BRIT J HAEMATOL, V125, P545, DOI 10.1111/j.1365-2141.2004.04946.x; Hershko C, 1996, BRIT J HAEMATOL, V93, P570; Hoffbrand AV, 2005, BEST PRACT RES CL HA, V18, P299, DOI 10.1016/j.beha.2004.08.026; Hoffbrand AV, 1998, BLOOD, V91, P295, DOI 10.1182/blood.V91.1.295.295_295_300; Jamuar SS, 2011, J PAEDIATR CHILD H, V47, P812, DOI 10.1111/j.1440-1754.2011.02031.x; Kattamis A, 2006, BLOOD CELL MOL DIS, V36, P21, DOI 10.1016/j.bcmd.2005.11.002; Kolnagou A, 2008, HEMOGLOBIN, V32, P41, DOI 10.1080/03630260701727085; Kolnagou A, 2010, EUR J HAEMATOL, V85, P430, DOI 10.1111/j.1600-0609.2010.01499.x; Kolnagou A, 2010, HEMOGLOBIN, V34, P204, DOI 10.3109/03630269.2010.485890; Kontoghiorghe CN, 2016, DRUG DES DEV THER, V10, P465, DOI 10.2147/DDDT.S79458; Kwiatkowski JL, 2016, ANN NY ACAD SCI, V1368, P107, DOI 10.1111/nyas.13088; Kwiatkowski JL, 2011, HEMATOL-AM SOC HEMAT, P451, DOI 10.1182/asheducation-2011.1.451; Kwiatkowski JL, 2012, BLOOD, V119, P2746, DOI 10.1182/blood-2011-04-344507; Lai ME, 2010, BLOOD CELL MOL DIS, V45, P136, DOI 10.1016/j.bcmd.2010.05.005; Lucas G. N., 2002, Ceylon Medical Journal, V47, P119; Lucas G. N., 2000, Ceylon Medical Journal, V45, P71; Maggio A, 2002, BLOOD CELL MOL DIS, V28, P196, DOI 10.1006/bcmd.2002.0510; Maggio A, 2009, BLOOD CELL MOL DIS, V42, P247, DOI 10.1016/j.bcmd.2009.01.002; Maggio A, 2009, BRIT J HAEMATOL, V145, P245, DOI 10.1111/j.1365-2141.2009.07609.x; Mazza P, 1998, HAEMATOLOGICA, V83, P496; Mirbehbahani N, 2012, HEMATOLOGY, V17, P183, DOI 10.1179/102453312X13376952196610; Mirbehbahani N, 2015, J KRISHNA INST MED S, V4, P70; Miscevic F, 2011, BLOOD, V118, P1376; Mourad FH, 2003, BRIT J HAEMATOL, V121, P187, DOI 10.1046/j.1365-2141.2003.04240.x; Nathan DG, 2002, NEW ENGL J MED, V347, P1368, DOI 10.1056/NEJMsb020394; Neufeld EJ, 2006, BLOOD, V107, P3436, DOI 10.1182/blood-2006-02-002394; Noetzli LJ, 2008, BLOOD, V112, P2973, DOI 10.1182/blood-2008-04-148767; Olivieri N. F., 1997, Blood, V90, p264A; Olivieri NF, 1997, BLOOD, V89, P739, DOI 10.1182/blood.V89.3.739; OLIVIERI NF, 1994, NEW ENGL J MED, V331, P574, DOI 10.1056/NEJM199409013310903; Olivieri NF, 1998, NEW ENGL J MED, V339, P417, DOI 10.1056/NEJM199808133390701; OLIVIERI NF, 1995, NEW ENGL J MED, V332, P918, DOI 10.1056/NEJM199504063321404; Origa R, 2005, HAEMATOLOGICA, V90, P1309; Pantalone GR, 2011, HEMOGLOBIN, V35, P206, DOI 10.3109/03630269.2011.570674; Pazdur R., 2009, COMPLETE RESPONSE AP; Peng CT, 2006, HEMOGLOBIN, V30, P125, DOI 10.1080/03630260500455581; Peng CT, 2003, EUR J HAEMATOL, V70, P392, DOI 10.1034/j.1600-0609.2003.00071.x; Pennell DJ, 2006, BLOOD, V107, P3738, DOI 10.1182/blood-2005-07-2948; Pepe A, 2011, HAEMATOL-HEMATOL J, V96, P41, DOI 10.3324/haematol.2009.019042; Perifanis V, 2007, INT J HEMATOL, V86, P385, DOI 10.1532/IJH97.E0734; Pippard MJ, 1983, THALASSEMIAS METHODS, V6, P103; Pootrakul P, 2003, BRIT J HAEMATOL, V122, P305, DOI 10.1046/j.1365-2141.2003.04412.x; Porter JB, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-38; PROPPER RD, 1976, NEW ENGL J MED, V294, P1421, DOI 10.1056/NEJM197606242942603; Ricchi P, 2010, EUR J HAEMATOL, V85, P36, DOI 10.1111/j.1600-0609.2010.01447.x; Rombos Y, 2000, HAEMATOLOGICA, V85, P115; Saliba AN, 2016, EXPERT REV HEMATOL, V9, P151, DOI 10.1586/17474086.2016.1126176; Songdej D, 2015, ACTA HAEMATOL-BASEL, V133, P226, DOI 10.1159/000363210; Taher A, 2004, ACTA HAEMATOL-BASEL, V112, P179, DOI 10.1159/000081268; Tamaddoni A, 2010, IRAN RED CRESCENT ME, V12, P655; Tanner MA, 2007, CIRCULATION, V115, P1876, DOI 10.1161/CIRCULATIONAHA.106.648790; Thompson J., 2001, OLIVIERI REPORT COMP; Tondury P, 1998, BRIT J HAEMATOL, V101, P413, DOI 10.1046/j.1365-2141.1998.00725.x; Totadri S, 2015, PEDIATR BLOOD CANCER, V62, P1592, DOI 10.1002/pbc.25533; Tsiapras D, 2010, HEMOGLOBIN, V34, P210, DOI 10.3109/03630269.2010.485120; Tsironi M, 2008, HEMOGLOBIN, V32, P29, DOI 10.1080/03630260701680474; University Health Network Clinical Guidelines, 2012, UHN RED BLOOD CELL D; Viprakasit V, 2013, AM J HEMATOL, V88, P251, DOI 10.1002/ajh.23386; Waheed Nadia, 2014, J Ayub Med Coll Abbottabad, V26, P297; Wanless IR, 2002, BLOOD, V100, P1566, DOI 10.1182/blood-2002-01-0306; Ward R, COMMUNICATION; WOLFE L, 1985, NEW ENGL J MED, V312, P1600, DOI 10.1056/NEJM198506203122503; Won Sung Chul, 2010, Korean J Hematol, V45, P58, DOI 10.5045/kjh.2010.45.1.58; Wonke B, 1998, BRIT J HAEMATOL, V103, P361; Wu SF, 2006, HEMOGLOBIN, V30, P215, DOI 10.1080/03630260600642534; ZURLO MG, 1989, LANCET, V2, P27, DOI 10.1016/S0140-6736(89)90264-X	113	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211942	10.1371/journal.pone.0211942	http://dx.doi.org/10.1371/journal.pone.0211942			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811439	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400042
J	Xu, R; Li, CY; Paterson, AH				Xu, Rui; Li, Changying; Paterson, Andrew H.			Multispectral imaging and unmanned aerial systems for cotton plant phenotyping	PLOS ONE			English	Article							CROP SURFACE MODELS; WATER-STRESS; VEGETATION INDEXES; UAV; IMAGERY; BAND; TEMPERATURE; PLATFORM; BIOMASS; HEIGHT	This paper demonstrates the application of aerial multispectral images in cotton plant phenotyping. Four phenotypic traits (plant height, canopy cover, vegetation index, and flower) were measured from multispectral images captured by a multispectral camera on an unmanned aerial system. Data were collected on eight different days from two fields. Orthomosaic and digital elevation models (DEM) were constructed from the raw images using the structure from motion (SfM) algorithm. A data processing pipeline was developed to calculate plant height using the ortho-mosaic and DEM. Six ground calibration targets (GCTs) were used to correct the error of the calculated plant height caused by the georeferencing error of the DEM. Plant heights were measured manually to validate the heights predicted from the imaging method. The error in estimation of the maximum height of each plot ranged from -40.4 to 13.5 cm among six datasets, all of which showed strong linear relationships with the manual measurement (R-2 > 0.89). Plot canopy was separated from the soil based on the DEM and normalized differential vegetation index (NDVI). Canopy cover and mean canopy NDVI were calculated to show canopy growth over time and the correlation between the two indices was investigated. The spectral responses of the ground, leaves, cotton flower, and ground shade were analyzed and detection of cotton flowers was satisfactory using a support vector machine (SVM). This study demonstrated the potential of using aerial multispectral images for high throughput phenotyping of important cotton phenotypic traits in the field.	[Xu, Rui; Li, Changying] Univ Georgia, Coll Engn, Biosensing & Instrumentat Lab, Athens, GA 30602 USA; [Paterson, Andrew H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Li, CY (corresponding author), Univ Georgia, Coll Engn, Biosensing & Instrumentat Lab, Athens, GA 30602 USA.	cyli@uga.edu		Xu, Rui/0000-0002-5899-2503	Agricultural Sensing and Robotics Initiative of the College of Engineering; College of Agricultural and Environmental Sciences of the University of Georgia; National Robotics Initiative grant (NIFA) [2017-67021-25928]	Agricultural Sensing and Robotics Initiative of the College of Engineering; College of Agricultural and Environmental Sciences of the University of Georgia; National Robotics Initiative grant (NIFA)	This study was funded jointly by the Agricultural Sensing and Robotics Initiative of the College of Engineering, and the College of Agricultural and Environmental Sciences of the University of Georgia. The project was also partially supported by the National Robotics Initiative grant (NIFA grant No: 2017-67021-25928 to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baluja J, 2012, IRRIGATION SCI, V30, P511, DOI 10.1007/s00271-012-0382-9; Bendig J, 2015, INT J APPL EARTH OBS, V39, P79, DOI 10.1016/j.jag.2015.02.012; Bendig J, 2014, REMOTE SENS-BASEL, V6, P10395, DOI 10.3390/rs61110395; Berni JAJ, 2009, IEEE T GEOSCI REMOTE, V47, P722, DOI 10.1109/TGRS.2008.2010457; Busemeyer L, 2013, SENSORS-BASEL, V13, P2830, DOI 10.3390/s130302830; Cabrera-Bosquet L, 2012, J INTEGR PLANT BIOL, V54, P312, DOI 10.1111/j.1744-7909.2012.01116.x; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chu TX, 2016, J APPL REMOTE SENS, V10, DOI 10.1117/1.JRS.10.036018; Comar A, 2012, FUNCT PLANT BIOL, V39, P914, DOI 10.1071/FP12065; Diaz-Varela RA, 2015, REMOTE SENS-BASEL, V7, P4213, DOI 10.3390/rs70404213; Franks SJ, 2015, AM J BOT, V102, P1401, DOI 10.3732/ajb.1500234; Gago J, 2015, AGR WATER MANAGE, V153, P9, DOI 10.1016/j.agwat.2015.01.020; Garcia-Ruiz F, 2013, COMPUT ELECTRON AGR, V91, P106, DOI 10.1016/j.compag.2012.12.002; Holman FH, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8121031; Huang Y, 2016, T ASABE, V59, P1563, DOI 10.13031/trans.59.11831; JACKSON RD, 1983, AGR WATER MANAGE, V7, P351, DOI 10.1016/0378-3774(83)90095-1; JACKSON RD, 1981, WATER RESOUR RES, V17, P1133, DOI 10.1029/WR017i004p01133; Jiang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19142-2; Araus JL, 2014, TRENDS PLANT SCI, V19, P52, DOI 10.1016/j.tplants.2013.09.008; Mulla DJ, 2013, BIOSYST ENG, V114, P358, DOI 10.1016/j.biosystemseng.2012.08.009; Patrick A, 2017, IEEE INSTRU MEAS MAG, V20, P4, DOI 10.1109/MIM.2017.7951684; Phillips RL, 2010, CROP SCI, V50, pS99, DOI 10.2135/cropsci2009.09.0525; Sankaran S, 2015, EUR J AGRON, V70, P112, DOI 10.1016/j.eja.2015.07.004; Shi YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159781; Thompson A, 2015, COMP STUDY GENETIC M; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Torino MS, 2014, AGRON J, V106, P1389, DOI 10.2134/agronj13.0578; Torr PHS, 2000, COMPUT VIS IMAGE UND, V78, P138, DOI 10.1006/cviu.1999.0832; Torres-Sanchez J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130479; Zarco-Tejada PJ, 2014, EUR J AGRON, V55, P89, DOI 10.1016/j.eja.2014.01.004; Zarco-Tejada PJ, 2012, REMOTE SENS ENVIRON, V117, P322, DOI 10.1016/j.rse.2011.10.007; Zhao DH, 2007, ISPRS J PHOTOGRAMM, V62, P25, DOI 10.1016/j.isprsjprs.2007.01.003; Zhao DL, 2007, EUR J AGRON, V26, P335, DOI 10.1016/j.eja.2006.12.001	33	36	38	9	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0205083	10.1371/journal.pone.0205083	http://dx.doi.org/10.1371/journal.pone.0205083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811435	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400002
J	Guerra-Maupome, M; Vang, DX; McGill, JL				Guerra-Maupome, Mariana; Vang, Dua X.; McGill, Jodi L.			Aerosol vaccination with Bacille Calmette-Guerin induces a trained innate immune phenotype in calves	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; BCG VACCINATION; NONSPECIFIC PROTECTION; ACTIVATED MACROPHAGES; RANDOMIZED-TRIAL; NEONATAL CALVES; RESPONSES; MODEL; REINFECTION; EXPRESSION	Mycobacterium bovis Bacillus Calmette-Guerin (BCG) is a live attenuated vaccine for use against tuberculosis (TB); however, it is known to reduce childhood mortality from infections other than TB. The unspecific protection induced by BCG vaccination has been associated with the induction of memory-like traits of the innate immune system identified as 'trained' immunity. In humans and mouse models, in vitro and in vivo BCG training leads to enhanced production of monocyte-derived proinflammatory cytokines in response to secondary unrelated bacterial and fungal pathogens. While BCG has been studied extensively for its ability to induce innate training in humans and mouse models, BCG's nonspecific protective effects have not been defined in agricultural species. Here, we show that in vitro BCG training induces a functional change in bovine monocytes, characterized by increased transcription of proinflammatory cytokines upon restimulation with the toll-like receptor agonists. Importantly, in vivo, aerosol BCG vaccination in young calves also induced a 'trained' phenotype in circulating peripheral blood mononuclear cells (PBMCs), that lead to a significantly enhanced TLR-induced proinflammatory cytokine response and changes in cellular metabolism compared to PBMCs from unvaccinated control calves. Similar to the long-term training effects of BCG reported in humans, our results suggest that in young calves, the effects of BCG induced innate training can last for at least 3 months in circulating immune populations. Interestingly, however, aerosol BCG vaccination did not 'train' the innate immune response at the mucosal level, as alveolar macrophages from aerosol BCG vaccinated calves did not mount an enhanced inflammatory response to secondary stimulation, compared to cells isolated from control calves. Together, our results suggest that, like mice and humans, the innate immune system of calves can be 'trained'; and that BCG vaccination could be used as an immunomodulatory strategy to reduce disease burden in juvenile food animals before the adaptive immune system has fully matured.	[Guerra-Maupome, Mariana; McGill, Jodi L.] Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA; [Vang, Dua X.] Iowa State Univ, Interdept Microbiol Program, Ames, IA USA	Iowa State University; Iowa State University	McGill, JL (corresponding author), Iowa State Univ, Dept Vet Microbiol & Preventat Med, Ames, IA 50011 USA.	jlmcgill@iastate.edu		McGill, Jodi/0000-0001-7637-1455	National Institutes of Health [Kansas INBRE P20 GM103418, COBRE P20 GM103638]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, P20GM103638] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health: Kansas INBRE P20 GM103418 and COBRE P20 GM103638 to JLM. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aaby P, 2014, NAT IMMUNOL, V15, P895, DOI 10.1038/ni.2961; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Allard B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01777; Arts RJW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00298; Arts RJW, 2015, J LEUKOCYTE BIOL, V98, P995, DOI 10.1189/jlb.4MA0215-059R; Arts RJW, 2015, J LEUKOCYTE BIOL, V98, P129, DOI 10.1189/jlb.6AB0914-416R; Bekkering S, 2016, CLIN VACCINE IMMUNOL, V23, P926, DOI 10.1128/CVI.00349-16; Belyakov IM, 2009, J IMMUNOL, V183, P6883, DOI 10.4049/jimmunol.0901466; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Blok BA, 2015, J LEUKOCYTE BIOL, V98, P347, DOI 10.1189/jlb.5RI0315-096R; Buddle BM, 2003, INFECT IMMUN, V71, P6411, DOI 10.1128/IAI.71.11.6411-6419.2003; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; DILUZIO NR, 1978, INFECT IMMUN, V20, P804, DOI 10.1128/IAI.20.3.804-810.1978; Endsley JJ, 2009, VET IMMUNOL IMMUNOP, V128, P199, DOI 10.1016/j.vetimm.2008.10.312; Fu YH, 2013, VET IMMUNOL IMMUNOP, V151, P20, DOI 10.1016/j.vetimm.2012.09.039; Giudice EL, 2006, ADV DRUG DELIVER REV, V58, P68, DOI 10.1016/j.addr.2005.12.003; Hollm-Delgado MG, 2014, PEDIATRICS, V133, pE73, DOI 10.1542/peds.2013-2218; Hope JC, 2005, CLIN EXP IMMUNOL, V139, P48, DOI 10.1111/j.1365-2249.2005.02668.x; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kleinnijenhuis J, 2014, CLIN IMMUNOL, V155, P213, DOI 10.1016/j.clim.2014.10.005; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kurtz J, 2005, TRENDS IMMUNOL, V26, P186, DOI 10.1016/j.it.2005.02.001; Levy O, 2015, T ROY SOC TROP MED H, V109, P3, DOI 10.1093/trstmh/tru185; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marakalala MJ, 2013, MICROBES INFECT, V15, P511, DOI 10.1016/j.micinf.2013.03.002; McGill JL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151083; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mukherjee S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180143; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netea MG, 2014, SEMIN IMMUNOL, V26, P512, DOI 10.1016/j.smim.2014.09.006; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Parra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066115; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Sacco RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033074; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Semple PL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/438463; Stensballe LG, 2005, VACCINE, V23, P1251, DOI 10.1016/j.vaccine.2004.09.006; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; USDA, 1999, HLTH MAN BIOS FEE 3; USDA, 2007, CHANG US DAIR CATT 3; VANTWOUT JW, 1992, SCAND J IMMUNOL, V36, P713; Waters WR, 2007, VACCINE, V25, P7832, DOI 10.1016/j.vaccine.2007.08.029; Whittaker E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00532	49	26	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212751	10.1371/journal.pone.0212751	http://dx.doi.org/10.1371/journal.pone.0212751			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794653	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100131
J	Maguire, FB; Morris, CR; Parikh-Patel, A; Cress, RD; Keegan, THM; Li, CS; Lin, PS; Kizer, KW				Maguire, Frances B.; Morris, Cyllene R.; Parikh-Patel, Arti; Cress, Rosemary D.; Keegan, Theresa H. M.; Li, Chin-Shang; Lin, Patrick S.; Kizer, Kenneth W.			A text-mining approach to obtain detailed treatment information from free-text fields in population-based cancer registries: A study of non-small cell lung cancer in California	PLOS ONE			English	Article							LANGUAGE; IDENTIFICATION; PATTERNS; NLP	Background Population-based cancer registries have treatment information for all patients making them an excellent resource for population-level monitoring. However, specific treatment details, such as drug names, are contained in a free-text format that is difficult to process and summarize. We assessed the accuracy and efficiency of a text-mining algorithm to identify systemic treatments for lung cancer from free-text fields in the California Cancer Registry. Methods The algorithm used Perl regular expressions in SAS 9.4 to search for treatments in 24,845 free-text records associated with 17,310 patients in California diagnosed with stage IV non-small cell lung cancer between 2012 and 2014. Our algorithm categorized treatments into six groups that align with National Comprehensive Cancer Network guidelines. We compared results to a manual review (gold standard) of the same records. Results Percent agreement ranged from 91.1% to 99.4%. Ranges for other measures were 0.71-0.92 (Kappa), 74.3%-97.3% (sensitivity), 92.4%-99.8% (specificity), 60.4%-96.4% (positive predictive value), and 92.9%-99.9% (negative predictive value). The text-mining algorithm used one-sixth of the time required for manual review. Conclusion SAS-based text mining of free-text data can accurately detect systemic treatments administered to patients and save considerable time compared to manual review, maximizing the utility of the extant information in population-based cancer registries for comparative effectiveness research.	[Maguire, Frances B.; Morris, Cyllene R.; Parikh-Patel, Arti; Kizer, Kenneth W.] Univ Calif Davis Hlth, Inst Populat Hlth Improvement, Calif Canc Reporting & Epidemiol Surveillance Pro, Sacramento, CA 95817 USA; [Maguire, Frances B.] Univ Calif Davis, Grad Grp Epidemiol, Davis, CA 95616 USA; [Cress, Rosemary D.; Keegan, Theresa H. M.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Keegan, Theresa H. M.; Lin, Patrick S.] Univ Calif Davis, Sch Med, COHORT, Sacramento, CA 95817 USA; [Keegan, Theresa H. M.; Lin, Patrick S.] Univ Calif Davis, Sch Med, Div Hematol & Oncol, Sacramento, CA 95817 USA; [Li, Chin-Shang] SUNY Buffalo, Sch Nursing, Buffalo, NY USA; [Kizer, Kenneth W.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kizer, Kenneth W.] Univ Calif Davis, Betty Irene Moore Sch Nursing, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of California System; University of California Davis; University of California System; University of California Davis	Maguire, FB (corresponding author), Univ Calif Davis Hlth, Inst Populat Hlth Improvement, Calif Canc Reporting & Epidemiol Surveillance Pro, Sacramento, CA 95817 USA.; Maguire, FB (corresponding author), Univ Calif Davis, Grad Grp Epidemiol, Davis, CA 95616 USA.	fbmaguire@ucdavis.edu		Maguire, Frances/0000-0001-8490-6229	California Department of Public Health [103885]; National Cancer Institute's Surveillance, Epidemiology and End Results Program; Public Health Institute; Centers for Disease Control and Prevention's National Program of Cancer Registries; National Cancer Institute	California Department of Public Health; National Cancer Institute's Surveillance, Epidemiology and End Results Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Public Health Institute; Centers for Disease Control and Prevention's National Program of Cancer Registries(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the National Cancer Institute's Surveillance, Epidemiology and End Results Program under contracts awarded to the Cancer Prevention Institute of California, the University of Southern California, and the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries, under agreement awarded to the California Department of Public Health. The ideas and opinions expressed herein are those of the author(s) and endorsement by the State of California, Department of Public Health, the National Cancer Institute, the Centers for Disease Control and Prevention, or their Contractors and Subcontractors is not intended nor should be inferred.	Abernethy AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178420; Afzal N, 2018, INT J MED INFORM, V111, P83, DOI 10.1016/j.ijmedinf.2017.12.024; Bittoni MA, 2018, CLIN LUNG CANCER, V19, pE629, DOI 10.1016/j.cllc.2018.04.017; Brute SY, 2016, LUNG CANCER, V97, P15, DOI 10.1016/j.lungcan.2016.04.007; Cai TR, 2016, RADIOGRAPHICS, V36, P176, DOI 10.1148/rg.2016150080; California Department of Public Health, 2018, CANC REP CAL CAL CAN, VI; California Department of Public Health, 2016, PHYS REQ CANC REP CA, VIV; California Department of Public Health, 2018, CANC REP CAL STAND A, VII; California Department of Public Health, 2017, CANC REP CAL DAT STA, VIII; Carrell DS, 2014, AM J EPIDEMIOL, V179, P749, DOI 10.1093/aje/kwt441; Chang HM, 2016, STUD HEALTH TECHNOL, V225, P813, DOI 10.3233/978-1-61499-658-3-813; Chapman WW, 2011, J AM MED INFORM ASSN, V18, P540, DOI 10.1136/amiajnl-2011-000465; Dembe AE, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-252; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Enewold L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156728; Flight L, 2015, PHARM STAT, V14, P74, DOI 10.1002/pst.1659; Harpaz R, 2014, DRUG SAFETY, V37, P777, DOI 10.1007/s40264-014-0218-z; Hazlehurst B, 2005, AM J PREV MED, V29, P434, DOI 10.1016/j.amepre.2005.08.007; Isobe H, 2017, LUNG CANCER-TARGETS, V8, P191, DOI 10.2147/LCTT.S140491; Jones BE, 2018, APPL CLIN INFORM, V9, P122, DOI 10.1055/s-0038-1626725; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; National Comprehensive Cancer Network, 2017, NCCN CLIN PRACT GUID; Osborne JD, 2016, J AM MED INFORM ASSN, V23, P1077, DOI 10.1093/jamia/ocw006; Raja Uzma, 2008, J Healthc Inf Manag, V22, P52; Ruud KL, 2010, INT J QUAL HEALTH C, V22, P229, DOI 10.1093/intqhc/mzq012; Sacher AG, 2015, CANCER-AM CANCER SOC, V121, P2562, DOI 10.1002/cncr.29386; SAS Institute Inc, 2011, SAS FUNCT CALL ROUT; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Schulkes KJG, 2016, LUNG, V194, P967, DOI 10.1007/s00408-016-9943-7; Shenoy Premnath, 2015, Perspect Clin Res, V6, P184, DOI 10.4103/2229-3485.167099; Spence MM, 2017, J MANAG CARE SPEC PH, V23, P159, DOI 10.18553/jmcp.2017.23.2.195; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Verleye L, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12747; Viera AJ, 2005, FAM MED, V37, P360; Weng WH, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0556-8; Xie Fagen, 2017, J Pathol Inform, V8, P48, DOI 10.4103/jpi.jpi_55_17; Younis T, 2008, J THORAC ONCOL, V3, P1272, DOI 10.1097/JTO.0b013e318189f562	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212454	10.1371/journal.pone.0212454	http://dx.doi.org/10.1371/journal.pone.0212454			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794610	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100069
J	Ward, BP; Brown-Guedira, G; Kolb, FL; Van Sanford, DA; Tyagi, P; Sneller, CH; Griffey, CA				Ward, Brian P.; Brown-Guedira, Gina; Kolb, Frederic L.; Van Sanford, David A.; Tyagi, Priyanka; Sneller, Clay H.; Griffey, Carl A.			Genome-wide association studies for yield-related traits in soft red winter wheat grown in Virginia	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; SPRING BREAD WHEAT; GRAIN-YIELD; AGRONOMIC TRAITS; GAMYB GENE; STEM RUST; IDENTIFICATION; EXPRESSION; PROTEIN; RICE	Grain yield is a trait of paramount importance in the breeding of all cereals. In wheat (Triticum aestivum L.), yield has steadily increased since the Green Revolution, though the current rate of increase is not forecasted to keep pace with demand due to growing world population and increasing affluence. While several genome-wide association studies (GWAS) on yield and related component traits have been performed in wheat, the previous lack of a reference genome has made comparisons between studies difficult. In this study, a GWAS for yield and yield-related traits was carried out on a population of 322 soft red winter wheat lines across a total of four rain-fed environments in the state of Virginia using single-nucleotide polymorphism (SNP) marker data generated by a genotyping-by-sequencing (GBS) protocol. Two separate mixed linear models were used to identify significant marker-trait associations (MTAs). The first was a single-locus model utilizing a leave-one-chromosome-out approach to estimating kinship. The second was a sub-setting kinship estimation multi-locus method (FarmCPU). The single-locus model identified nine significant MTAs for various yield-related traits, while the FarmCPU model identified 74 significant MTAs. The availability of the wheat reference genome allowed for the description of MTAs in terms of both genetic and physical positions, and enabled more extensive post-GWAS characterization of significant MTAs. The results indicate a number of promising candidate genes contributing to grain yield, including an ortholog of the rice aberrant panicle organization (APO1) protein and a gibberellin oxidase protein (GA2ox-A1) affecting the trait grains per square meter, an ortholog of the Arabidopsis thaliana mother of flowering time and terminal flowering 1 (MFT) gene affecting the trait seeds per square meter, and a B2 heat stress response protein affecting the trait seeds per head.	[Ward, Brian P.; Griffey, Carl A.] Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA; [Brown-Guedira, Gina] USDA ARS, Eastern Reg Small Grains Genotyping Lab, Raleigh, NC 27695 USA; [Kolb, Frederic L.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Van Sanford, David A.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA; [Ward, Brian P.; Tyagi, Priyanka] North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA; [Sneller, Clay H.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Wooster, OH 44691 USA	Virginia Polytechnic Institute & State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Kentucky; University of North Carolina; North Carolina State University; University System of Ohio; Ohio State University	Ward, BP (corresponding author), Virginia Tech, Dept Crop & Soil Environm Sci, Blacksburg, VA 24061 USA.; Ward, BP (corresponding author), North Carolina State Univ, Dept Crop & Soil Sci, Raleigh, NC 27695 USA.	bpward2@ncsu.edu		Brown-Guedira, Gina/0000-0002-1958-2827; Ward, Brian/0000-0002-4129-7934	Agriculture and Food Research Initiative Competitive Grants (Tritaceae Coordinated Agricultural Project [TCAP]) from the USDA National Institute of Food and Agriculture [2011-68002-30029]; Agriculture and Food Research Initiative Competitive (Wheat Coordinated Agricultural Project [WheatCAP]) from the USDA National Institute of Food and Agriculture [2017-67007-25939]; Virginia Agricultural Council [617]; Virginia Small Grains Board	Agriculture and Food Research Initiative Competitive Grants (Tritaceae Coordinated Agricultural Project [TCAP]) from the USDA National Institute of Food and Agriculture; Agriculture and Food Research Initiative Competitive (Wheat Coordinated Agricultural Project [WheatCAP]) from the USDA National Institute of Food and Agriculture; Virginia Agricultural Council; Virginia Small Grains Board	CHS and GBG received funding from the Agriculture and Food Research Initiative Competitive Grants 2011-68002-30029 (Tritaceae Coordinated Agricultural Project [TCAP]) from the USDA National Institute of Food and Agriculture: https://www.triticeaecap.org/. GBG received funding from the Agriculture and Food Research Initiative Competitive Grant 2017-67007-25939 (Wheat Coordinated Agricultural Project [WheatCAP]) from the USDA National Institute of Food and Agriculture: https://www.triticeaecap.org/. BPW and CAG received funding from Virginia Agricultural Council Grant 617: http://www.vdacs.virginia.gov/boards-virginia-agricultural-council.shtml, and from the Virginia Small Grains Board (no grant number available): http://www.virginiagrains.com/leadership/va-small-grains-board/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ain QU, 2015, FRONT PLANT SCI, V6, DOI [10.3389/fpls.7015.00743, 10.3389/fpls.2015.00743]; ALLARD RW, 1954, PHYTOPATHOLOGY, V44, P266; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borras L, 2004, FIELD CROP RES, V86, P131, DOI 10.1016/j.fcr.2003.08.002; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bruinsma J., 2011, Looking ahead in world food and agriculture: perspectives to 2050, P233; Cabrera A, 2015, THEOR APPL GENET, V128, P2227, DOI 10.1007/s00122-015-2580-3; Cavanagh CR, 2013, P NATL ACAD SCI USA, V110, P8057, DOI 10.1073/pnas.1217133110; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chauhan H, 2011, PLANT MOL BIOL, V75, P35, DOI 10.1007/s11103-010-9702-8; Chen L, 2001, PLANT CELL ENVIRON, V24, P469, DOI 10.1046/j.1365-3040.2001.00688.x; Chen YH, 2009, THEOR APPL GENET, V118, P881, DOI 10.1007/s00122-008-0946-5; Cheng XX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11013; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Clevenger JP, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00564; Clevenger JP, 2015, G3-GENES GENOM GENET, V5, P1797, DOI 10.1534/g3.115.019703; COX MC, 1985, CROP SCI, V25, P435, DOI 10.2135/cropsci1985.0011183X002500030003x; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cullis BR, 2006, J AGR BIOL ENVIR ST, V11, P381, DOI 10.1198/108571106X154443; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Dodig D, 2012, INT J MOL SCI, V13, P6167, DOI 10.3390/ijms13056167; DONALD CM, 1968, EUPHYTICA, V17, P385, DOI 10.1007/BF00056241; Edae EA, 2014, THEOR APPL GENET, V127, P791, DOI 10.1007/s00122-013-2257-8; Ehdaie B, 2003, CROP SCI, V43, P710, DOI 10.2135/cropsci2003.0710; Eilers PHC, 2003, CHEMOMETR INTELL LAB, V66, P159, DOI 10.1016/S0169-7439(03)00029-7; Freiberg C, 2004, J BIOL CHEM, V279, P26066, DOI 10.1074/jbc.M402989200; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Gocal GFW, 1999, PLANT PHYSIOL, V119, P1271, DOI 10.1104/pp.119.4.1271; Godoy J, 2018, CROP SCI, V58, P1838, DOI 10.2135/cropsci2017.07.0423; Green AJ, 2012, CROP SCI, V52, P2097, DOI 10.2135/cropsci2012.01.0026; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; GUBLER F, 1995, PLANT CELL, V7, P1879, DOI 10.1105/tpc.7.11.1879; Guedira M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154242; Guo J, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1234-4; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hallab A, 2017, AUTOMATED ASSIGNMENT; Howells RM, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1433-z; Huang M, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giy154; Ikeda K, 2007, PLANT J, V51, P1030, DOI 10.1111/j.1365-313X.2007.03200.x; Jiang QY, 2011, FUNCT INTEGR GENOMIC, V11, P49, DOI 10.1007/s10142-010-0188-x; KaganZur V, 1995, PLANT MOL BIOL, V29, P1101, DOI 10.1007/BF00020455; Kaneko M, 2004, PLANT CELL, V16, P33, DOI 10.1105/tpc.017327; Kippes N, 2015, P NATL ACAD SCI USA, V112, pE5401, DOI 10.1073/pnas.1514883112; Kusmec A, 2018, PLANT DIRECT, V2, DOI 10.1002/pld3.53; Li GQ, 2013, PLANT J, V76, P742, DOI 10.1111/tpj.12326; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liang Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14261; Liu X, 2016, PLOS GENET, V12, DOI DOI 10.1371/JOURNAL.PGEN.1005767; Liu YX, 2017, PLANT J, V91, P861, DOI 10.1111/tpj.13614; Lozada DN, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-017-2005-2; Ma DY, 2012, MOL BREEDING, V29, P43, DOI 10.1007/s11032-010-9524-z; Ma FF, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0837-7; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Miao CY, 2019, PLANT BIOTECHNOL J, V17, P893, DOI 10.1111/pbi.13023; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; MORENOSEVILLA B, 1995, CROP SCI, V35, P1607, DOI 10.2135/cropsci1995.0011183X003500060015x; Murray K, 2016, J STAT COMPUT SIM, V86, P2946, DOI 10.1080/00949655.2016.1139582; Myles S, 2009, PLANT CELL, V21, P2194, DOI 10.1105/tpc.109.068437; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; NYQUIST W. E., 1957, AGRON JOUR, V49, P222; Ogbonnaya FC, 2017, THEOR APPL GENET, V130, P1819, DOI 10.1007/s00122-017-2927-z; Panavas T, 1998, PLANT PHYSIOL BIOCH, V36, P379, DOI 10.1016/S0981-9428(98)80079-X; Pearce S, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0520-7; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; R Core Team, 2021, R LANGUAGE ENV STAT; RADLEY M, 1976, J EXP BOT, V27, P1009, DOI 10.1093/jxb/27.5.1009; Reif JC, 2011, THEOR APPL GENET, V122, P961, DOI 10.1007/s00122-010-1502-7; Reynolds MP, 2005, ANN APPL BIOL, V146, P39, DOI 10.1111/j.1744-7348.2005.03100.x; Sado PE, 2009, FUNCT INTEGR GENOMIC, V9, P43, DOI 10.1007/s10142-008-0100-0; Salvi S, 2015, CURR OPIN BIOTECH, V32, P179, DOI 10.1016/j.copbio.2015.01.001; Schrader S, 1997, J PLANT PHYSIOL, V150, P63, DOI 10.1016/S0176-1617(97)80182-4; Segura V, 2012, NAT GENET, V44, P825, DOI 10.1038/ng.2314; Sehgal D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41578; Shan QW, 2014, NAT PROTOC, V9, P2395, DOI 10.1038/nprot.2014.157; Sharma RC, 2012, CROP SCI, V52, P1522, DOI 10.2135/cropsci2011.12.0634; Silva Simone Alves, 2000, Journal of New Seeds, V2, P55, DOI 10.1300/J153v02n02_05; Singh A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00642; Singh RP, 1998, CROP SCI, V38, P27, DOI 10.2135/cropsci1998.0011183X003800010005x; Slafer G.A., 1996, INCREASING YIELD POT, P101; Slafer GA, 2003, ANN APPL BIOL, V142, P117, DOI 10.1111/j.1744-7348.2003.tb00237.x; Soriano JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178290; Sorrells ME, 2011, GENOME, V54, P875, DOI [10.1139/G11-054, 10.1139/g11-054]; Spindel J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004982; Su ZQ, 2011, THEOR APPL GENET, V122, P211, DOI 10.1007/s00122-010-1437-z; Sukumaran S, 2018, THEOR APPL GENET, V131, P985, DOI 10.1007/s00122-017-3037-7; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Sukumaran S, 2015, THEOR APPL GENET, V128, P353, DOI 10.1007/s00122-014-2435-3; Tadesse W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141339; TERMAN GL, 1969, AGRON J, V61, P755, DOI 10.2134/agronj1969.00021962006100050031x; Tsilo TJ, 2008, CROP SCI, V48, P253, DOI 10.2135/cropsci2007.04.0204; Turuspekov Y, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1131-2; Valdar W, 2009, GENETICS, V182, P1263, DOI 10.1534/genetics.109.100727; Wallace JG, 2016, CROP SCI, V56, P2365, DOI 10.2135/cropsci2015.10.0632; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094829; Wang SX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188662; Ward BP, 2019, CROP SCI; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Widmer C, 2014, SCI REP-UK, V4, DOI 10.1038/srep06874; Wurschum T, 2013, THEOR APPL GENET, V126, P1477, DOI 10.1007/s00122-013-2065-1; Rodriguez-Alvarez MX, 2018, SPAT STAT-NETH, V23, P52, DOI 10.1016/j.spasta.2017.10.003; Yang Jian, 2011, Am J Hum Genet, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zanke C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00217; Zanke CD, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00644; Zanke CD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113287; Zhang JL, 2018, THEOR APPL GENET, V131, P1741, DOI 10.1007/s00122-018-3111-9; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	116	39	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0208217	10.1371/journal.pone.0208217	http://dx.doi.org/10.1371/journal.pone.0208217			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794545	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100008
J	Li, X; He, L; Wang, J; Wang, MX				Li, Xin; He, Lan; Wang, Jing; Wang, Mingxu			Illness uncertainty, social support, and coping mode in hospitalized patients with systemic lupus erythematosus in a hospital in Shaanxi, China	PLOS ONE			English	Article							QUALITY-OF-LIFE	Objective To analyze the relationships between illness uncertainty, social support, and coping mode in hospitalized patients with systematic lupus erythematosus (SLE). Methods The General Health Questionnaire, Mishel Uncertainty in Illness Scale, Social Support Rating Scale, and Medical Coping Modes Questionnaire were to the hospitalized patients with SLE (N = 200) in a tertiary hospital in Shaanxi. Results The hospitalized patients with SLE showed a moderate level of illness uncertainty. Furthermore, illness uncertainty was negatively correlated with support availability (r = -0.161, P = 0.023) and facing coping mode (r = -0.231, P = 0.001), and was positively correlated with the yielding coping mode (r = 0.249, P < 0.001). Conclusion These findings suggest that support availability and coping modes were associated with moderate level of illness uncertainty, indicating that support availability support should be strengthened in hospitalized patients to actively face their disease. This subsequently improves their treatment compliance and quality of life.	[Li, Xin; He, Lan; Wang, Jing] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China; [Wang, Mingxu] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University	Wang, MX (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Publ Hlth, Xian, Shaanxi, Peoples R China.	wangmx601@xjtu.edu.cn						[Anonymous], 2000, CHIN J BEHAV MED SCI, DOI DOI 10.3760/CMA.J.ISSN.1674-6554.2000.01.008; Chen L, 2017, NURSING REHABILITATI, V16, P7, DOI [10.1002/msc.220, DOI 10.1002/MSC.220]; Chen PL, 2013, CHINESE J PRACT NURS, V32, P48; Cleanthous S, 2013, PSYCHOL HEALTH, V28, P171, DOI 10.1080/08870446.2012.701628; Ge JB, 2013, INTERNAL MED, V815, P821; He MZH, 2016, MED SOC, V29, P87; Huang L, 2015, CHINESE J BLOOD PURI, V14, P85; Jiang LJ, 2011, J NURS ADMIN, V11, P457; La Paglia GMC, 2017, CLIN EXP RHEUMATOL, V35, P551; Li YY, 2014, CHINESE NURSING RES, V28, P4264; Maikranz JM, 2007, J PEDIATR PSYCHOL, V32, P571, DOI 10.1093/jpepsy/jsl046; Mattsson M, 2012, MUSCULOSKELET CARE, V10, P1, DOI 10.1002/msc.220; McElhone K, 2010, LUPUS, V19, P1640, DOI 10.1177/0961203310378668; Mishel M H, 1988, Image J Nurs Sch, V20, P225, DOI 10.1111/j.1547-5069.1988.tb00082.x; Mishel M H, 1997, Annu Rev Nurs Res, V15, P57; MISHEL MH, 1981, NURS RES, V30, P258; Parker PA, 2016, BJU INT, V117, P469, DOI 10.1111/bju.13099; Parker PA, 2013, EUR UROL, V63, P1122, DOI 10.1016/j.eururo.2013.01.034; Peralta-Ramirez MI, 2018, CLIN EXP RHEUMATOL, V36, P434; Sun XL, 2009, J NURS SCI SURG, V24; Sutanto B, 2013, ARTHRIT CARE RES, V65, P1752, DOI 10.1002/acr.22032; Tunnicliffe DJ, 2016, ARTHRIT CARE RES, V68, P828, DOI 10.1002/acr.22749; Wan WJ, 2013, CHINESE J MOD NURS, V19, P1303; Wang XD, 1999, CHINESE J MENT HLTH, V12, P256; Wang YH, 2006, CHINESE NURS RES, V20, P1801; [韦荣泉 Wei Rongquan], 2013, [中国护理管理, Chinese Nursing Management], V13, P20; Wu QX, 2017, J QIQIHAR MED U, V38, P1334; Wu YR, 2013, J NURS ADMIN, V13, P15; Xu MX, 2016, CHINESE FOREIGN MED, V14, P66; Zhang HY, 2017, MODERN DIGESTION INT, V22, P393; 张卫红, 2007, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V16, P623	31	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211313	10.1371/journal.pone.0211313	http://dx.doi.org/10.1371/journal.pone.0211313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789919	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800011
J	Shimada, S; Tanigawa, T; Watanabe, T; Nakata, A; Sugimura, N; Itani, S; Higashimori, A; Nadatani, Y; Otani, K; Taira, K; Hosomi, S; Nagami, Y; Tanaka, F; Kamata, N; Yamagami, H; Shiba, M; Fujiwara, Y				Shimada, Sunao; Tanigawa, Tetsuya; Watanabe, Toshio; Nakata, Akinobu; Sugimura, Naoki; Itani, Shigehiro; Higashimori, Akira; Nadatani, Yuji; Otani, Koji; Taira, Koichi; Hosomi, Shuhei; Nagami, Yasuaki; Tanaka, Fumio; Kamata, Noriko; Yamagami, Hirokazu; Shiba, Masatsugu; Fujiwara, Yasuhiro			Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damage	PLOS ONE			English	Article							SMALL-BOWEL INJURY; TIGHT JUNCTION PERMEABILITY; BARRIER FUNCTION; CAPSULE ENDOSCOPY; GUT PERMEABILITY; IMMUNE-RESPONSE; HUMAN ZONULIN; INDOMETHACIN; BILE; MECHANISMS	Gliadin, a component of wheat gluten known to be an important factor in the etiology of celiac disease, is related to several other diseases through its enhancing effect on intestinal paracellular permeability. We investigated the significance of gliadin in non-steroidal anti-inflammatory drug (NSAID)-induced small-intestinal damage in mice. 7-week-old C57BL/6 male mice were divided into the following groups: standard diet group, in which mice were fed with wheat-containing standard rodent diet (CE-2); gluten-free diet group, in which mice were fed with gluten-free diet (AIN-76A); and gliadin-administered group, in which mice fed with gluten-free diet were administered with gliadin (similar to 250 mg/kg BW). Each group was sub-divided into negative, healthy control group and NSAID-treated group. To some mice fed with gluten-free diet and administered with gliadin, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor was administered for clarification of the significance of EGFR in NSAID-induced small intestinal damage and intestinal permeability. In mice fed with a gluten-free diet, indomethacin or diclofenac induced very mild mucosal damage in the small intestine compared with that in mice fed with a wheat-containing standard diet. Gliadin exacerbated the NSAID-induced small-intestinal damage in mice fed with a gluten-free diet. With the administration of indomethacin, MPO activity, a marker of neutrophil infiltration into the mucosa and mRNA expression level of tumor necrosis factor a and interleukin-1 beta in the small intestine were higher in the gliadin-administered mice. Gliadin increased the intestinal paracellular permeability without indomethacin administration (4.3-fold) and further increased the permeability after indomethacin administration (2.1-fold). Gliadin induced phosphorylation of epidermal growth factor receptor (EGFR) in small-intestinal tissues, and erlotinib (an EGFR tyrosine kinase inhibitor) attenuated the indomethacin-induced intestinal damage and permeability exacerbated by gliadin, accompanied by inhibition of EGFR phosphorylation. These results suggest that gliadin plays an important role in the induction and exacerbation of NSAID-induced small-intestinal damage, and that increase in intestinal permeability via the EGFR signalling pathway is involved in its mechanism.	[Shimada, Sunao; Tanigawa, Tetsuya; Watanabe, Toshio; Nakata, Akinobu; Sugimura, Naoki; Itani, Shigehiro; Higashimori, Akira; Nadatani, Yuji; Otani, Koji; Taira, Koichi; Hosomi, Shuhei; Nagami, Yasuaki; Tanaka, Fumio; Kamata, Noriko; Yamagami, Hirokazu; Shiba, Masatsugu; Fujiwara, Yasuhiro] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan; [Tanigawa, Tetsuya; Watanabe, Toshio; Higashimori, Akira; Fujiwara, Yasuhiro] Osaka City Univ, Grad Sch Med, SAMURAI GI Res Ctr, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University	Tanigawa, T (corresponding author), Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan.; Tanigawa, T (corresponding author), Osaka City Univ, Grad Sch Med, SAMURAI GI Res Ctr, Osaka, Japan.	ttanigawa@med.osaka-cu.ac.jp	Tanaka, Fumio/HCI-5442-2022	Tanaka, Fumio/0000-0002-9186-1249; Tanigawa, Tetsuya/0000-0002-9305-1637				Antvorskov JC, 2014, DIABETOLOGIA, V57, P1770, DOI 10.1007/s00125-014-3265-1; Barak S, 2015, CRIT REV FOOD SCI, V55, P357, DOI 10.1080/10408398.2012.654863; BJARNASON I, 1993, GASTROENTEROLOGY, V104, P1832, DOI 10.1016/0016-5085(93)90667-2; Bjarnason I, 2018, GASTROENTEROLOGY, V154, P500, DOI 10.1053/j.gastro.2017.10.049; Bueno L, 2008, NEUROGASTROENT MOTIL, V20, P580, DOI 10.1111/j.1365-2982.2008.01139.x; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; de Punder K, 2013, NUTRIENTS, V5, P771, DOI 10.3390/nu5030771; DERITIS G, 1979, PEDIATR RES, V13, P1255; Drago S, 2006, SCAND J GASTROENTERO, V41, P408, DOI 10.1080/00365520500235334; Edogawa S, 2018, FASEB J, V32, P6615, DOI 10.1096/fj.201800560R; Elamin E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107421; Forsyth CB, 2007, J PHARMACOL EXP THER, V321, P84, DOI 10.1124/jpet.106.113019; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; Gujral N, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0104-1; Guo SH, 2015, J IMMUNOL, V195, P4999, DOI 10.4049/jimmunol.1402598; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Gupta JaN A. R, 2014, BIOPROTOCOL, V4, DOI [10.21769/BioProtoc.1296, DOI 10.21769/BIOPROTOC.1296]; Higashimori A, 2016, MUCOSAL IMMUNOL, V9, P659, DOI 10.1038/mi.2015.89; Higuchi K, 2009, J GASTROENTEROL, V44, P879, DOI 10.1007/s00535-009-0102-2; Jacob M, 2007, ARCH TOXICOL, V81, P291, DOI 10.1007/s00204-006-0149-2; Koszarny Arkadiusz, 2015, Wiad Lek, V68, P242; Lammers KM, 2008, GASTROENTEROLOGY, V135, P194, DOI 10.1053/j.gastro.2008.03.023; Lammers KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138338; Lammers KM, 2011, IMMUNOLOGY, V132, P432, DOI 10.1111/j.1365-2567.2010.03378.x; Lebwohl B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4347; Maiden L, 2005, GASTROENTEROLOGY, V128, P1172, DOI 10.1053/j.gastro.2005.03.020; Maiuri L, 2010, GUT, V59, P311, DOI 10.1136/gut.2009.183608; Nadatani Y, 2012, AM J PATHOL, V181, P98, DOI 10.1016/j.ajpath.2012.03.039; Raimondi F, 2008, AM J PHYSIOL-GASTR L, V294, pG906, DOI 10.1152/ajpgi.00043.2007; Reuter BK, 1997, GASTROENTEROLOGY, V112, P109, DOI 10.1016/S0016-5085(97)70225-7; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Samaroo D, 2010, SCHIZOPHR RES, V118, P248, DOI 10.1016/j.schres.2009.08.009; Sappington PL, 2002, GASTROENTEROLOGY, V123, P790, DOI 10.1053/gast.2002.35391; Sigthorsson G, 1998, GUT, V43, P506, DOI 10.1136/gut.43.4.506; Sugimori S, 2008, DIGESTION, V78, P208, DOI 10.1159/000190403; Tanigawa T, 2013, EUR J PHARMACOL, V704, P64, DOI 10.1016/j.ejphar.2013.02.010; Thomas KE, 2006, J IMMUNOL, V176, P2512, DOI 10.4049/jimmunol.176.4.2512; Thomsen HL, 2019, MULT SCLER RELAT DIS, V27, P156, DOI 10.1016/j.msard.2018.10.019; Tripathi A, 2009, P NATL ACAD SCI USA, V106, P16799, DOI 10.1073/pnas.0906773106; Van Buiten CB, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700879; Vincentini O, 2015, CLIN EXP MED, V15, P447, DOI 10.1007/s10238-014-0325-2; Wang WL, 2000, J CELL SCI, V113, P4435; Watanabe T, 2008, GUT, V57, P181, DOI 10.1136/gut.2007.125963; Watanabe T, 2013, DIGEST LIVER DIS, V45, P390, DOI 10.1016/j.dld.2012.12.005; Watanabe T, 2008, CLIN GASTROENTEROL H, V6, P1279, DOI 10.1016/j.cgh.2008.06.021; WHITTLE BJR, 1977, BRIT J PHARMACOL, V60, P455, DOI 10.1111/j.1476-5381.1977.tb07522.x; Wieser H, 2007, FOOD MICROBIOL, V24, P115, DOI 10.1016/j.fm.2006.07.004; YAMADA T, 1993, INFLAMMATION, V17, P641, DOI 10.1007/BF00920471; Zhou Y, 2010, AM J PHYSIOL-GASTR L, V298, pG722, DOI 10.1152/ajpgi.00387.2009	50	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211436	10.1371/journal.pone.0211436	http://dx.doi.org/10.1371/journal.pone.0211436			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785904	gold, Green Published			2022-12-26	WOS:000459307000026
J	Schwiebs, A; San Juan, MH; Schmidt, KG; Wiercinska, E; Anlauf, M; Ottenlinger, F; Thomas, D; Elwakeel, E; Weigert, A; Farin, HF; Bonig, H; Scholich, K; Geisslinger, G; Pfeilschifter, JM; Radeke, HH				Schwiebs, Anja; San Juan, Martina Herrero; Schmidt, Katrin G.; Wiercinska, Eliza; Anlauf, Martin; Ottenlinger, Florian; Thomas, Dominique; Elwakeel, Eiman; Weigert, Andreas; Farin, Henner F.; Bonig, Halvard; Scholich, Klaus; Geisslinger, Gerd; Pfeilschifter, Josef M.; Radeke, Heinfried H.			Cancer-induced inflammation and inflammation-induced cancer in colon: a role for S1P lyase	ONCOGENE			English	Article							PERSISTENT STAT3 ACTIVATION; SPHINGOSINE KINASE 1; BOWEL-DISEASE; INTESTINAL INFLAMMATION; COLORECTAL-CANCER; LYMPHOCYTE EGRESS; TUMOR PROGRESSION; DOWN-REGULATION; SPHINGOSINE-1-PHOSPHATE; RECEPTOR	A role of sphingolipids for inflammatory bowel disease and cancer is evident. However, the relative and separate contribution of sphingolipid deterioration in inflammation versus carcinogenesis for the pathophysiology of colitis-associated colon cancer (CAC) was unknown and therefore examined in this study. We performed isogenic bone marrow transplantation of inducible sphingosine-1-phosphate (S1P) lyase knockout mice to specifically modulate sphingolipids and associated genes and proteins in a compartment-specific way in a DSS/AOM mediated CAC model. 3D organoid cultures were used in vitro. S1P lyase (SGPL1) knockout in either immune cells or tissue, caused local sphingolipid accumulation leading to a dichotomic development of CAC: Immune cell SGPL1 knockout (I-SGPL(-/-)) augmented massive immune cell infiltration initiating colitis with lesions and calprotectin increase. Pathological crypt remodeling plus extracellular S1P-signaling caused delayed tumor formation characterized by S1P receptor 1, STAT3 mRNA increase, as well as programmed cell death ligand 1 expression, accompanied by a putatively counter regulatory STAT1(S727) phosphorylation. In contrast, tissue SGPL1 knockout (T-SGPL(-/-)) provoked immediate occurrence of epithelial-driven tumors with upregulated sphingosine kinase 1, S1P receptor 2 and epidermal growth factor receptor. Here, progressing carcinogenesis was accompanied by an IL-12 to IL-23 shift with a consecutive development of a Th2/GATA3-driven, tumor-favoring microenvironment. Moreover, the knockout models showed distinct lymphopenia and neutrophilia, different from the full SGPL1 knockout. This study shows that depending on the initiating cellular S1P source, the pathophysiology of inflammation-induced cancer versus cancer-induced inflammation develops through separate, discernible molecular steps.	[Schwiebs, Anja; San Juan, Martina Herrero; Schmidt, Katrin G.; Ottenlinger, Florian; Pfeilschifter, Josef M.; Radeke, Heinfried H.] Hosp Goethe Univ, ZAFES, Pharmazentrum Frankfurt, Inst Gen Pharmacol & Toxicol, Frankfurt, Germany; [Wiercinska, Eliza; Bonig, Halvard] German Red Cross Blood Serv Inst, Frankfurt, Germany; [Wiercinska, Eliza; Bonig, Halvard] Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Germany; [Anlauf, Martin] St Vincenz Hosp, Inst Pathol & Cytol, Limburg, Germany; [Thomas, Dominique; Scholich, Klaus; Geisslinger, Gerd] Hosp Goethe Univ, Pharmazentrum Frankfurt, Inst Clin Pharmacol, Frankfurt, Germany; [Elwakeel, Eiman; Weigert, Andreas] Hosp Goethe Univ, Pharmazentrum Frankfurt, Inst Biochem 1, Frankfurt, Germany; [Farin, Henner F.] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, Frankfurt, Germany; [Farin, Henner F.] German Canc Consortium DKTK, Heidelberg, Germany; [Farin, Henner F.] German Canc Res Ctr, Heidelberg, Germany; [Bonig, Halvard] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Geisslinger, Gerd] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol TMP, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Washington; University of Washington Seattle; Fraunhofer Gesellschaft	Schwiebs, A; Radeke, HH (corresponding author), Hosp Goethe Univ, ZAFES, Pharmazentrum Frankfurt, Inst Gen Pharmacol & Toxicol, Frankfurt, Germany.	schwiebs@med.uni-frankfurt.de; radeke@em.uni-frankfurt.de	Bönig, Halvard/AAG-3029-2021; Weigert, Andreas/E-6540-2010; Radeke, Heinfried H/E-3772-2013; Farin, Henner/AAC-2574-2021	Bönig, Halvard/0000-0003-0088-2675; Weigert, Andreas/0000-0002-7529-1952; Radeke, Heinfried H/0000-0002-4499-2510; Farin, Henner/0000-0003-1558-5366; Elwakeel, Eiman/0000-0002-0219-9653; Wiercinska, Eliza/0000-0002-8434-6492	Deutsche Forschungsgemeinschaft [SFB1039]; Else-Kroner-Fresenius-Graduiertenkolleg; Translational Research Innovation Pharma graduate school - Else-Kroner-Fresenius Foundation; LOEWE Cell and Gene Therapy Frankfurt faculty [III L 4 518/17.004]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner-Fresenius-Graduiertenkolleg; Translational Research Innovation Pharma graduate school - Else-Kroner-Fresenius Foundation; LOEWE Cell and Gene Therapy Frankfurt faculty	This work was supported by the Deutsche Forschungsgemeinschaft (grant number: SFB1039) to (HHR, AS, KGS, DT, EE, AW, KS, GG, JMP). We also acknowledge the support of the Else-Kroner-Fresenius-Graduiertenkolleg for (FO), the Translational Research Innovation Pharma graduate school for (KGS) funded by the Else-Kroner-Fresenius Foundation both awarded to (HHR), and the LOEWE Cell and Gene Therapy Frankfurt faculty (grant number: III L 4 518/17.004) for EW, awarded to HB.	Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; [Anonymous], 2010, WOODHEAD PUBL MATER; Arlt O, 2014, CELL PHYSIOL BIOCHEM, V34, P27, DOI 10.1159/000362982; Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z; Beswick EJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01125; Billich A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059630; Brizuela L, 2012, MOL CANCER THER, V11, P1841, DOI 10.1158/1535-7163.MCT-12-0227; Caini S, 2016, DIGEST LIVER DIS, V48, P1162, DOI 10.1016/j.dld.2016.07.008; Chumanevich AA, 2010, CARCINOGENESIS, V31, P1787, DOI 10.1093/carcin/bgq158; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Daub H, 1996, NATURE, V379, P557, DOI 10.1038/379557a0; Degagne E, 2014, CLIN EXP GASTROENTER, V7, P205, DOI 10.2147/CEG.S43453; Dillmann C, 2016, J IMMUNOL, V196, P1579, DOI 10.4049/jimmunol.1403168; Doll F, 2005, BBA-MOL CELL BIOL L, V1738, P72, DOI 10.1016/j.bbalip.2005.12.001; Duan RD, 2009, PROG LIPID RES, V48, P62, DOI 10.1016/j.plipres.2008.04.003; Foerster S, 2013, PROTEOMICS, V13, P3131, DOI 10.1002/pmic.201300154; Gandy KAO, 2013, FASEB J, V27, P3155, DOI 10.1096/fj.13-228460; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Gu YP, 2011, J CELL BIOL, V193, P667, DOI 10.1083/jcb.201010075; Helbling M, 2014, ONCOTARGET, V5, P4671, DOI 10.18632/oncotarget.2069; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Kroemer G, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1058597; Kumar A, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/7685142; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Linke B, 2009, J PROTEOME RES, V8, P4851, DOI 10.1021/pr900106v; Liu SQ, 2013, INT J ONCOL, V42, P617, DOI 10.3892/ijo.2012.1733; Minn AJ, 2016, CELL, V165, P272, DOI 10.1016/j.cell.2016.03.031; Monteleone G, 2012, INT J MOL SCI, V13, P11071, DOI 10.3390/ijms130911071; Nitulescu II, 2017, EBIOMEDICINE, V26, P112, DOI 10.1016/j.ebiom.2017.11.013; Oskouian B, 2006, P NATL ACAD SCI USA, V103, P17384, DOI 10.1073/pnas.0600050103; Ottenlinger FM, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00412; Pathria P, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2014.998529; Patmanathan SN, 2017, CELL SIGNAL, V34, P66, DOI 10.1016/j.cellsig.2017.03.002; Richter C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00044; Rizzo A, 2011, WORLD J GASTROENTERO, V17, P3092, DOI 10.3748/wjg.v17.i26.3092; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Schwiebs A, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00094; Shalapour S, 2015, J CLIN INVEST, V125, P3347, DOI 10.1172/JCI80007; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Shida D, 2004, FEBS LETT, V577, P333, DOI 10.1016/j.febslet.2004.10.024; Siso S, 2010, PRION, V4, P134; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Suh JH, 2015, TRANSL CANCER RES, V4, P469, DOI 10.3978/j.issn.221-676X.2015.10.06; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Timofeeva OA, 2006, ONCOGENE, V25, P7555, DOI 10.1038/sj.onc.1209742; Uddin S, 2002, J BIOL CHEM, V277, P14408, DOI 10.1074/jbc.M109671200; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Wang KP, 2015, ADV CANCER RES, V128, P173, DOI 10.1016/bs.acr.2015.04.014; Zamora-Pineda J, 2016, J EXP MED, V213, P2773, DOI 10.1084/jem.20160287; Zhang WW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01699; Zhong ZY, 2016, CELL, V166, P288, DOI 10.1016/j.cell.2016.05.051	62	23	27	3	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4788	4803		10.1038/s41388-019-0758-x	http://dx.doi.org/10.1038/s41388-019-0758-x			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30816345				2022-12-26	WOS:000471160500010
J	Zhang, L; Shen, ZY; Wang, K; Li, W; Shi, JM; Osoro, EK; Ullah, N; Zhou, Y; Ji, SR				Zhang, Lin; Shen, Zhi-Yuan; Wang, Ke; Li, Wei; Shi, Jing-Ming; Osoro, Ezra Kombo; Ullah, Naeem; Zhou, Yan; Ji, Shang-Rong			C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/-catenin and ERK signaling in streptozocin-induced diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic kidney disease; apoptotic cells; mesenchymal fibrosis; cell remodeling	ACUTE KIDNEY INJURY; TGF-BETA; CELLS; EMT; SMAD; PROGRESSION; MECHANISMS; APOPTOSIS; PATHWAY; ACTIVATION	Previous studies have reported the pathogenic role of C-reactive protein (CRP) during diabetic kidney disease (DKD) in human CRP transgenic and Crp(-/-) mice. However, because humans and mice have inverse acute phase expression patterns of CRP and serum amyloid P component, this could lead to the inaccurate evaluation of CRP function with the above-mentioned CRP transgenic mouse. But different from mice, rats have the same acute phase protein expression pattern as human, which might avoid this problem and be a better choice for CRP function studies. To dispel this doubt and accurately define the role of CRP during diabetic nephropathy, we created the first Crp(-/-) rat model, which we treated with streptozocin to induce DKD for in vivo studies. Moreover, an established cell line (human kidney 2) was used to further investigate the pathologic mechanisms of CRP. We found that CRP promotes epithelial-mesenchymal transition (EMT) through Wnt/-catenin and ERK1/2 signaling, which are dependent on CRP binding to FcRII on apoptotic cells. By promoting EMT, CRP was demonstrated to accelerate the development of DKD. We thus present convincing evidence demonstrating CRP as a therapeutic target for DKD treatment.Zhang, L., Shen, Z.-Y., Wang, K., Li, W., Shi, J.-M., Osoro, E. K., Ullah, N., Zhou, Y., Ji, S.-R. C-reactive protein exacerbates epithelial-mesenchymal transition through Wnt/-catenin and ERK signaling in streptozocin-induced diabetic nephropathy.	[Zhang, Lin; Li, Wei; Osoro, Ezra Kombo; Ullah, Naeem] Xi An Jiao Tong Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Xian, Shaanxi, Peoples R China; [Shen, Zhi-Yuan; Wang, Ke; Ji, Shang-Rong] Lanzhou Univ, Sch Life Sci, MOE, Key Lab Cell Activ & Stress Adaptat, Life Sci Bldg,Room 227, Lanzhou 730000, Gansu, Peoples R China; [Shi, Jing-Ming] Xizang Minzu Univ, Sch Basic Med Sci, Dept Anat, Xianyang, Peoples R China; [Zhou, Yan] Xi An Jiao Tong Univ, Dept Dermatol, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Lanzhou University; Xizang Minzu University; Xi'an Jiaotong University	Ji, SR (corresponding author), Lanzhou Univ, Sch Life Sci, MOE, Key Lab Cell Activ & Stress Adaptat, Life Sci Bldg,Room 227, Lanzhou 730000, Gansu, Peoples R China.	jsr@lzu.edu.cn	Osoro, Ezra Kombo/AAZ-3414-2021; Shi, Jing-Ming/ACS-3321-2022	Osoro, Ezra Kombo/0000-0001-6565-5911; Shi, Jing-Ming/0000-0002-8185-3130; Ji, Shang-Rong/0000-0001-8595-3756; Zhang, Lin/0000-0002-2157-1588	National Natural Science Foundation of China [31700685, 31671339, 81703130]; China Postdoctoral Science Foundation [2016M602800]; Scientific Research Fund of Xi'an Jiaotong University [Z201806118]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Scientific Research Fund of Xi'an Jiaotong University	This work was supported by the National Natural Science Foundation of China (Grants 31700685, 31671339, and 81703130), the China Postdoctoral Science Foundation (Grant 2016M602800), and the Scientific Research Fund of Xi'an Jiaotong University (Grant Z201806118). The authors declare no conflicts of interest.	Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Breyer MD, 2005, J AM SOC NEPHROL, V16, P27, DOI [10.1681/ASN.2009070721, 10.1681/ASN.2004080648]; Brosius FC, 2009, J AM SOC NEPHROL, V20, P2503, DOI 10.1681/ASN.2009070721; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Devaraj S, 2005, ARTERIOSCL THROM VAS, V25, P1359, DOI 10.1161/01.ATV.0000168573.10844.ae; El Mouedden M, 2000, ANTIMICROB AGENTS CH, V44, P665, DOI 10.1128/AAC.44.3.665-675.2000; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Gershov D, 2000, J EXP MED, V192, P1353, DOI 10.1084/jem.192.9.1353; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gupta S, 2016, CELL, V164, P840, DOI 10.1016/j.cell.2016.02.024; Hayashino Y, 2014, DIABETES CARE, V37, P2947, DOI 10.2337/dc14-1357; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Jones NR, 2011, ARTHRITIS RHEUM-US, V63, P2641, DOI 10.1002/art.30444; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Katsuno Y, 2013, CURR OPIN ONCOL, V25, P76, DOI 10.1097/CCO.0b013e32835b6371; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SH, 2012, LAB INVEST, V92, P488, DOI 10.1038/labinvest.2011.194; Kizu A, 2009, AM J PATHOL, V175, P1371, DOI 10.2353/ajpath.2009.090698; Lai WY, 2016, KIDNEY INT, V90, P610, DOI 10.1016/j.kint.2016.06.010; Li DD, 2015, MOL MED REP, V12, P8148, DOI 10.3892/mmr.2015.4445; Li L, 2015, METABOLISM, V64, P597, DOI 10.1016/j.metabol.2015.01.014; Li Z, 2011, LAB INVEST, V91, P837, DOI 10.1038/labinvest.2011.42; Liu F, 2011, DIABETOLOGIA, V54, P2713, DOI 10.1007/s00125-011-2237-y; Lloberas N, 2006, J AM SOC NEPHROL, V17, P1395, DOI 10.1681/ASN.2005050549; Lopez-Parra V, 2012, J AM SOC NEPHROL, V23, P1518, DOI 10.1681/ASN.2011080822; Lu JH, 2011, P NATL ACAD SCI USA, V108, P4974, DOI 10.1073/pnas.1018369108; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Ma LB, 2018, INT UROL NEPHROL, V50, P373, DOI 10.1007/s11255-017-1757-x; Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.004; McMorrow T, 2005, NEPHROL DIAL TRANSPL, V20, P2215, DOI 10.1093/ndt/gfh967; Menon V, 2005, KIDNEY INT, V68, P766, DOI 10.1111/j.1523-1755.2005.00455.x; Lopez-Novoa JM, 2009, EMBO MOL MED, V1, P303, DOI 10.1002/emmm.200900043; Ogden CA, 2005, ARTHRITIS RHEUM-US, V52, P378, DOI 10.1002/art.20847; Pegues MA, 2016, AM J PHYSIOL-RENAL, V311, pF176, DOI 10.1152/ajprenal.00107.2016; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; RASCH R, 1984, DIABETOLOGIA, V27, P32; Rastaldi MP, 2002, KIDNEY INT, V62, P137, DOI 10.1046/j.1523-1755.2002.00430.x; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Shen X, 2001, J BIOL CHEM, V276, P15362, DOI 10.1074/jbc.M009534200; Shih HH, 2009, AM J PHYSIOL-HEART C, V296, pH1643, DOI 10.1152/ajpheart.00938.2008; Stein MP, 2000, J IMMUNOL, V164, P1514, DOI 10.4049/jimmunol.164.3.1514; Strutz F, 2000, NEPHROL DIAL TRANSPL, V15, P1729, DOI 10.1093/ndt/15.11.1729; Szalai Alexander J, 2004, Clin Dev Immunol, V11, P221, DOI 10.1080/17402520400001751; Tang Y, 2014, CLIN SCI, V126, P645, DOI 10.1042/CS20130471; Verma S, 2004, CIRCULATION, V109, P1914, DOI 10.1161/01.CIR.0000127085.32999.64; Yoo JY, 2003, J BIOL CHEM, V278, P43001, DOI 10.1074/jbc.M307869200; You YK, 2016, SCI REP-UK, V6, DOI 10.1038/srep26740; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1819, DOI 10.1681/ASN.2010080793; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang L, 2015, J IMMUNOL, V194, P5243, DOI 10.4049/jimmunol.1402909; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhou C, 2017, J FORENSIC SCI, V62, P229, DOI 10.1111/1556-4029.13235	59	26	27	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6551	6563		10.1096/fj.201801865RR	http://dx.doi.org/10.1096/fj.201801865RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794428	Bronze			2022-12-26	WOS:000466932600058
J	Archer, CR; Enslow, BT; Taylor, AB; De la Rosa, V; Bhattacharya, A; Shapiro, MS				Archer, Crystal R.; Enslow, Benjamin T.; Taylor, Alexander B.; De la Rosa, Victor; Bhattacharya, Akash; Shapiro, Mark S.			A mutually induced conformational fit underlies Ca2+-directed interactions between calmodulin and the proximal C terminus of KCNQ4 K+ channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); potassium channel; nuclear magnetic resonance (NMR); X-ray crystallography; conformational change; calcium-binding protein; isothermal titration calorimetry (ITC); biophysical chemical analysis; calcium signaling; M current; microscale thermophoresis (MST); potassium voltage-gated channel subfamily Q member (KCNQ)	CALCIUM-FREE CALMODULIN; POTASSIUM CHANNEL; STRUCTURAL BASIS; CA2+ CHANNELS; BINDING SITE; ION CHANNELS; N-LOBE; COMPLEX; DOMAIN; CONDUCTANCE	Calmodulin (CaM) conveys intracellular Ca2+ signals to KCNQ (Kv7, M-type) K+ channels and many other ion channels. Whether this calmodulation involves a dramatic structural rearrangement or only slight perturbations of the CaM/KCNQ complex is as yet unclear. A consensus structural model of conformational shifts occurring between low nanomolar and physiologically high intracellular [Ca2+] is still under debate. Here, we used various techniques of biophysical chemical analyses to investigate the interactions between CaM and synthetic peptides corresponding to the A and B domains of the KCNQ4 subtype. We found that in the absence of CaM, the peptides are disordered, whereas Ca2+/CaM imposed helical structure on both KCNQ A and B domains. Isothermal titration calorimetry revealed that Ca2+/CaM has higher affinity for the B domain than for the A domain of KCNQ2-4 and much higher affinity for the B domain when prebound with the A domain. X-ray crystallography confirmed that these discrete peptides spontaneously form a complex with Ca2+/CaM, similar to previous reports of CaM binding KCNQ-AB domains that are linked together. Microscale thermophoresis and heteronuclear single-quantum coherence NMR spectroscopy indicated the C-lobe of Ca2+-free CaM to interact with the KCNQ4 B domain (K-d approximate to 10-20 m), with increasing Ca2+ molar ratios shifting the CaM-B domain interactions via only the CaM C-lobe to also include the N-lobe. Our findings suggest that in response to increased Ca2+, CaM undergoes lobe switching that imposes a dramatic mutually induced conformational fit to both the proximal C terminus of KCNQ4 channels and CaM, likely underlying Ca2+-dependent regulation of KCNQ gating.	[Archer, Crystal R.; De la Rosa, Victor; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cell & Integrat Physiol, San Antonio, TX 78229 USA; [Archer, Crystal R.; Taylor, Alexander B.; Bhattacharya, Akash] Univ Texas Hlth San Antonio, Dept Biochem & Struct Biol, San Antonio, TX 78229 USA; [Enslow, Benjamin T.] Univ Texas Hlth San Antonio, Long Sch Med, San Antonio, TX 78229 USA; [De la Rosa, Victor] Univ Autonoma San Luis Potosi, CONACYT, Fac Med, San Luis Potosi 78210, Mexico; [Bhattacharya, Akash] Beckman Coulter Life Sci, 5600 Lindbergh Dr, Loveland, CO 80538 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Universidad Autonoma de San Luis Potosi; Beckman Coulter Inc.	Shapiro, MS (corresponding author), Univ Texas Hlth San Antonio, STRF, Dept Cell & Integrat Physiol, MC 8253,8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu	De la Rosa, Victor/AAM-8583-2021; Bhattacharya, Akash/G-9154-2016	De la Rosa, Victor/0000-0001-5161-3083; Shapiro, Mark/0000-0002-9630-0600; Bhattacharya, Akash/0000-0001-8748-9969; Enslow, Benjamin/0000-0003-4822-0216; Taylor, Alexander/0000-0003-3517-6033	National Institutes of Health [R01 NS 043394, NS 094461]; Faculty Scholar Award; Morrison Trust Foundation; NINDS/National Institutes of Health NRSApredoctoral training fellowship [F31 NS090887]; National Institutes of Health/NHLBI postdoctoral training grant [T32 HL007446]; NIH [R01 AI104476]; IIMS CTSA at UT Health San Antonio (Department of Medicine); NIGMS/NIH [P30 GM124165]; NIH-ORIP HEI [S10-OD021527]; DOE, Argonne National Laboratory [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM124165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461, F31NS090887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty Scholar Award; Morrison Trust Foundation; NINDS/National Institutes of Health NRSApredoctoral training fellowship; National Institutes of Health/NHLBI postdoctoral training grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IIMS CTSA at UT Health San Antonio (Department of Medicine); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP HEI; DOE, Argonne National Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01 NS 043394 and NS 094461 (to M. S. S.), a Faculty Scholar Award (to M. S. S.), a grant from the Morrison Trust Foundation (to M. S. S.), NINDS/National Institutes of Health NRSApredoctoral training fellowship F31 NS090887 (to C. R. A.), National Institutes of Health/NHLBI postdoctoral training grant T32 HL007446 (to C. R. A.) (directed by James D. Stockand), NIH Grant R01 AI104476 (to Dmitri Ivanov supporting A. B.) and a core usage support grant from the IIMS CTSA at UT Health San Antonio (Department of Medicine). Part of this work was performed at the Northeastern Collaborative Access Team beamlines, which are funded by a program project grant from the NIGMS/NIH (P30 GM124165). The Eiger 16M detector on the 24-ID-E beam line is funded by NIH-ORIP HEI Grant S10-OD021527. This research used resources of the Advanced Photon Source, a user facility operated for the DOE, Argonne National Laboratory under Contract DE-AC02-06CH11357. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alaimo A, 2013, J CELL SCI, V126, P244, DOI 10.1242/jcs.114082; Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; BEECH DJ, 1991, P NATL ACAD SCI USA, V88, P652, DOI 10.1073/pnas.88.2.652; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bernardo-Seisdedos G, 2018, P NATL ACAD SCI USA, V115, P2395, DOI 10.1073/pnas.1800235115; Biris N, 2013, J MOL BIOL, V425, P5032, DOI 10.1016/j.jmb.2013.07.025; Black DJ, 2011, BIOCHEMISTRY-US, V50, P10061, DOI 10.1021/bi201300v; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Chang A, 2018, NEURON, V97, P836, DOI 10.1016/j.neuron.2018.01.035; Choveau FS, 2018, J BIOL CHEM, V293, P19411, DOI 10.1074/jbc.RA118.005401; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CRIVICI A, 1995, ANNU REV BIOPH BIOM, V24, P85, DOI 10.1146/annurev.bb.24.060195.000505; Cui YF, 2003, ANAL BIOCHEM, V315, P175, DOI 10.1016/S0003-2697(03)00007-1; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dixon RE, 2012, P NATL ACAD SCI USA, V109, P1749, DOI 10.1073/pnas.1116731109; Dutta Amit K, 2015, Methods Mol Biol, V1229, pE1, DOI 10.1007/978-1-4939-1714-3_48; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Etzioni A, 2011, J NEUROSCI, V31, P14158, DOI 10.1523/JNEUROSCI.2666-11.2011; Evans TIA, 2011, BIOPHYS CHEM, V159, P172, DOI 10.1016/j.bpc.2011.06.007; Faas GC, 2011, NAT NEUROSCI, V14, P301, DOI 10.1038/nn.2746; Falkenburger BH, 2010, J PHYSIOL-LONDON, V588, P3179, DOI 10.1113/jphysiol.2010.192153; Gabelli SB, 2016, CHANNELS, V10, P45, DOI 10.1080/19336950.2015.1075677; Gabelli SB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6126; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J GEN PHYSIOL, V122, P17, DOI 10.1085/jgp.200208783; Gamper N, 2015, HDB ION CHANNELS; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; Gao YH, 2013, J CELL MOL MED, V17, P889, DOI 10.1111/jcmm.12080; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Halling D Brent, 2006, Sci STKE, V2006, per1; Hernandez CC, 2008, J GEN PHYSIOL, V132, P361, DOI 10.1085/jgp.200810007; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Houdusse A, 1996, STRUCTURE, V4, P1475, DOI 10.1016/S0969-2126(96)00154-2; Johny MB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2727; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaleka KS, 2012, JOVE-J VIS EXP, DOI 10.3791/3502; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Keowmaneechai E, 2002, J AGR FOOD CHEM, V50, P7145, DOI 10.1021/jf020489a; Klingauf J, 1997, BIOPHYS J, V72, P674, DOI 10.1016/S0006-3495(97)78704-6; Kosenko A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082290; Kosenko A, 2012, EMBO J, V31, P3147, DOI 10.1038/emboj.2012.156; Kubota Y, 2007, BIOPHYS J, V93, P3848, DOI 10.1529/biophysj.107.106849; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee CH, 2018, SCIENCE, V360, P508, DOI 10.1126/science.aas9466; Li BX, 2016, SCIENCE, V351, P863, DOI 10.1126/science.aad3647; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Linley JE, 2012, P NATL ACAD SCI USA, V109, pE1578, DOI 10.1073/pnas.1201544109; LINSE S, 1991, J BIOL CHEM, V266, P8050; Liu WJ, 2014, MOL CELL NEUROSCI, V58, P40, DOI 10.1016/j.mcn.2013.12.005; Liu ZH, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00038; Malmendal A, 1999, BIOCHEMISTRY-US, V38, P11844, DOI 10.1021/bi9909288; Maylie J, 2004, J PHYSIOL-LONDON, V554, P255, DOI 10.1113/jphysiol.2003.049072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Mruk K, 2014, J GEN PHYSIOL, V144, P103, DOI 10.1085/jgp.201311140; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neufeld T, 1998, J MOL RECOGNIT, V11, P20, DOI 10.1002/(SICI)1099-1352(199812)11:1/6<20::AID-JMR383>3.0.CO;2-A; Ooi L, 2013, J NEUROSCI, V33, P6041, DOI 10.1523/JNEUROSCI.4275-12.2013; Peroz D, 2008, J PHYSIOL-LONDON, V586, P1785, DOI 10.1113/jphysiol.2007.148254; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Sachyani D, 2014, STRUCTURE, V22, P1582, DOI 10.1016/j.str.2014.07.016; Scheuermann TH, 2016, ANAL BIOCHEM, V496, P79, DOI 10.1016/j.ab.2015.12.013; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Senguen FT, 2012, BIOCHEMISTRY-US, V51, P6182, DOI 10.1021/bi300698h; Shahidullah M, 2005, P NATL ACAD SCI USA, V102, P16454, DOI 10.1073/pnas.0503966102; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Siloni S, 2015, J CELL SCI, V128, P3489, DOI 10.1242/jcs.173922; Strulovich R, 2016, BIOCHEMISTRY-US, V55, P5353, DOI 10.1021/acs.biochem.6b00477; Suh BC, 2007, J PHYSIOL-LONDON, V582, P911, DOI 10.1113/jphysiol.2007.132647; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; TJANDRA N, 1995, EUR J BIOCHEM, V230, P1014, DOI 10.1111/j.1432-1033.1995.tb20650.x; Tobelaim WS, 2017, P NATL ACAD SCI USA, V114, pE869, DOI 10.1073/pnas.1612622114; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Vivas O, 2017, ELIFE, V6, DOI 10.7554/eLife.28029; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang Q, 2013, P NATL ACAD SCI USA, V110, P20545, DOI 10.1073/pnas.1312788110; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Westerlund AM, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006072; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Xu Q, 2013, J MOL BIOL, V425, P378, DOI 10.1016/j.jmb.2012.11.023; Xu TH, 2007, J BIOL CHEM, V282, P23899, DOI 10.1074/jbc.M702108200; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zaika O, 2011, J BIOL CHEM, V286, P830, DOI 10.1074/jbc.M110.166033; Zamponi GW, 2003, NEURON, V39, P879, DOI 10.1016/S0896-6273(03)00564-6; Zaydman MA, 2013, P NATL ACAD SCI USA, V110, P13180, DOI 10.1073/pnas.1305167110; Zhang J, 2016, NEURON, V92, P461, DOI 10.1016/j.neuron.2016.09.014; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang PZ, 2017, BIOPHYS J, V112, P1105, DOI 10.1016/j.bpj.2017.01.020; Zhou QJ, 2015, NATURE, V525, P62, DOI 10.1038/nature14975; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200	108	5	5	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6094	6112		10.1074/jbc.RA118.006857	http://dx.doi.org/10.1074/jbc.RA118.006857			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30808708	Green Published, hybrid			2022-12-26	WOS:000465077500039
J	Neate, SL; Taylor, KL; Jelinek, GA; De Livera, AM; Brown, CR; Weiland, TJ				Neate, Sandra L.; Taylor, Keryn L.; Jelinek, George A.; De Livera, Alysha M.; Brown, Chelsea R.; Weiland, Tracey J.			Taking active steps: Changes made by partners of people with multiple sclerosis who undertake lifestyle modification	PLOS ONE			English	Article							QUALITY-OF-LIFE; SIGNIFICANT OTHERS; CAREGIVER BURDEN; IMPACT; EXPERIENCES; OUTCOMES; RISK; CARE	Background Multiple sclerosis (MS), a demyelinating condition of the central nervous system with an unpredictable course, has a major impact on the lives of people with MS. Partners of people with MS may be significantly affected by the diagnosis, management and uncertainty around disease progression and may provide substantial support and care. Modification of lifestyle risk factors in conjunction with standard medical management has been associated with improved physical and mental quality of life. Adopting major lifestyle modification may have a multi-faceted impact on the person with MS and their partner. Experiences of partners of people with MS have been previously explored, but the experiences of partners of people with MS who adopt this strategy have not. As part of a larger study that aimed to explore partners' lived experiences of and attitudes towards MS and lifestyle modification, this study reports the active steps and significant changes partners undertook to assist the person with MS and, at times, to also modify their own lives. Design Within an interpretive framework, using Heidegger's phenomenological philosophy, a qualitative study of semi-structured interviews was conducted. Participants Aged greater than 18 years and in a spousal relationship with a person with MS who had undertaken an intensive residential lifestyle educational intervention promoting healthy lifestyle. Results Themes identified were: adjusting to lifestyle modification, understanding motivations and practical aspects of adjustment; seeking knowledge and support, exploring the ways partners sought positive support for themselves and the person with MS and abandoned negative influences; and embracing well-being, commitment and change, describing the major changes that partners made to their lives professionally and personally. Conclusions The experiences of these partners provide clinicians with insight into potential motivations and outcomes of lifestyle modification and suggest potentially positive aspects for those directly and indirectly affected by MS.	[Neate, Sandra L.; Taylor, Keryn L.; Jelinek, George A.; De Livera, Alysha M.; Brown, Chelsea R.; Weiland, Tracey J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia	University of Melbourne	Neate, SL (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Neuroepidemiol Unit, Melbourne, Vic, Australia.	sandra.neate@unimelb.edu.au	De Livera, Alysha/AAU-6661-2021; Weiland, Tracey/Y-2029-2018	De Livera, Alysha/0000-0003-4981-4155; Weiland, Tracey/0000-0002-4053-5507				Ackroyd K, 2011, J CLIN PSYCHOL MED S, V18, P372, DOI 10.1007/s10880-011-9265-0; Akkus Y, 2011, DISABIL REHABIL, V33, P326, DOI 10.3109/09638288.2010.490866; Appleton D, 2018, SCAND J CARING SCI, V32, P1262, DOI 10.1111/scs.12601; Aronson KJ, 1997, NEUROLOGY, V48, P74, DOI 10.1212/WNL.48.1.74; Bogosian A, 2009, MULT SCLER J, V15, P876, DOI 10.1177/1352458508100048; Boland P, 2012, DISABIL REHABIL, V34, P1367, DOI 10.3109/09638288.2011.645115; Buchanan Robert J, 2011, Int J MS Care, V13, P76, DOI 10.7224/1537-2073-13.2.76; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Cheung J, 2004, J ADV NURS, V47, P475, DOI 10.1111/j.1365-2648.2004.03126.x; Duckworth A, 2014, CURR DIR PSYCHOL SCI, V23, P319, DOI 10.1177/0963721414541462; Figved N, 2007, J NEUROL NEUROSUR PS, V78, P1097, DOI 10.1136/jnnp.2006.104216; Fitzgerald KC, 2018, NEUROLOGY, V90, pE1, DOI 10.1212/WNL.0000000000004768; Giordano A, 2012, EUR J NEUROL, V19, P847, DOI 10.1111/j.1468-1331.2011.03638.x; Hadgkiss EJ, 2015, NEUROL SCI, V36, P845, DOI 10.1007/s10072-015-2089-1; Hadgkiss EJ, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/580596; Hadgkiss EJ, 2013, NEUROL SCI, V34, P187, DOI 10.1007/s10072-012-0982-4; Hakim EA, 2000, DISABIL REHABIL, V22, P288; Harrison R, 2015, PATIENTS EXPERIENCES; Heesen C, 2004, MULT SCLER J, V10, P643, DOI 10.1191/1352458504ms1112oa; HOHOL MJ, 1995, NEUROLOGY, V45, P251, DOI 10.1212/WNL.45.2.251; Holman H, 2004, PUBLIC HEALTH REP, V119, P239, DOI 10.1016/j.phr.2004.04.002; Horrigan- Kelly M, 2016, INT J QUAL METH, DOI [10.1007/s11135-017-0574-8, DOI 10.1007/S11135-017-0574-8]; Jamal SN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160343; Jelinek G., 2016, OVERCOMING MULTIPLE; Jelinek GA, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0763-4; Jelinek GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161701; Laverty S.M., 2003, INT J QUAL METH, V21-35, P21, DOI [10.1177/160940690300200303, DOI 10.1177/160940690300200303]; Lejbkowicz I, 2012, EXPERT REV NEUROTHER, V12, P343, DOI [10.1586/ERN.11.161, 10.1586/ern.11.161]; Li Michelle Pui-Ming, 2010, Qual Prim Care, V18, P379; Lincoln Y.S., 1985, NATURALISTIC ENQUIRY; Marck CH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197759; McKenzie Tamara, 2015, Int J MS Care, V17, P253, DOI 10.7224/1537-2073.2014-083; Neate SL, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00015; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Pakenham Kenneth I, 2007, Psychol Health Med, V12, P190, DOI 10.1080/13548500500465878; Pakenham KI, 2005, DISABIL REHABIL, V27, P985, DOI 10.1080/09638280500052583; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Sherman TE, 2007, MULT SCLER, V13, P238, DOI 10.1177/1352458506070754; Strickland K, 2015, J ADV NURS, V71, P2811, DOI 10.1111/jan.12758; Taylor KL, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0327-3; Tintore M, 2017, PATIENT PREFER ADHER, V11, P33, DOI 10.2147/PPA.S115090; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Vallerand RJ, 2003, J PERS SOC PSYCHOL, V85, P756, DOI 10.1037/0022-3514.85.4.756	43	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212422	10.1371/journal.pone.0212422	http://dx.doi.org/10.1371/journal.pone.0212422			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817765	Green Published, gold			2022-12-26	WOS:000460371500019
J	Suarez, CA; Franceschelli, JJ; Morbidoni, H				Alejandro Suarez, Cristian; Judith Franceschelli, Jorgelina; Ricardo Morbidoni, Hector			Mycobacteriophage CRB2 defines a new subcluster in mycobacteriophage classification	PLOS ONE			English	Article							BACTERIOPHAGE; HOST; VISUALIZATION; EVOLUTION; ORIGINS; GENOME; PHAGE; DNA	Mycobacteriophages are viruses -mostly temperates- that infect Mycobacterium smegmatis and sometimes Mycobacterium tuberculosis. Mycobacteriophages are grouped in clusters on the basis of the overall nucleotide sequence homology, being further divided in subclusters as more mycobacteriophage genomes are sequenced and annotated. As part of our on-going screening for novel isolates, we herein report the bioinformatics analysis of CRB2, a mycobacteriophage belonging into the Siphoviridae family that propagates at 30 degrees C. CRB2 has a 72,217 bp genome with a 69.78% GC content that belongs to Cluster B; nucleotide comparison with other B cluster members positions CRB2 as the sole member of a new subcluster, B9, being mycobacteriophage Saguaro (belonging into subcluster B7) its closest relative. Sequencing and annotation of 14 mycobacteriophages isolated by our group has yielded six cluster A members, a singleton, four of the five members of subcluster B6, one of the three reported members of subcluster G4, and CRB2 which defines subcluster B9. Considering the massive mycobacteriophage search performed in USA and the relatively rarity of our phages, we propose that factors other than size of the sampling determine the variability of mycobacteriophage distribution, and thus a world-wide concerted mining would most likely bring extremely rare and yet undiscovered mycobacteriophages.	[Alejandro Suarez, Cristian; Judith Franceschelli, Jorgelina; Ricardo Morbidoni, Hector] Univ Nacl Rosario, Fac Ciencias Med, Lab Microbiol Mol, Rosario, Santa Fe, Argentina	National University of Rosario	Morbidoni, H (corresponding author), Univ Nacl Rosario, Fac Ciencias Med, Lab Microbiol Mol, Rosario, Santa Fe, Argentina.	morbiatny@yahoo.com			National Agency for Science and Technology Promotion (ANPCyT), Argentina [PICT 02337, PICT 1406]	National Agency for Science and Technology Promotion (ANPCyT), Argentina(ANPCyT)	This work was supported by grants (PICT 02337 and PICT 1406 to HRM) from the National Agency for Science and Technology Promotion (ANPCyT), Argentina. HRM is a career member of Consejo de Investigaciones de la Universidad Nacional de Rosario (CIUNR), CAS and JJF are careerr member and post-doctoral fellow of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Broussard GW, 2013, MOL CELL, V49, P237, DOI 10.1016/j.molcel.2012.11.012; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Casjens Sherwood R., 2009, V502, P91, DOI 10.1007/978-1-60327-565-1_7; Dedrick RM, 2016, MOL MICROBIOL, V101, P625, DOI 10.1111/mmi.13414; Esposito LA, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000079; Franceschelli JJ, 2014, GENOME ANNOUNC, V2; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Ghosh G, 2018, J BACTERIOL, V200, P2066, DOI [10.1099/00221287-130-8-2059, DOI 10.1099/00221287-130-8-2059]; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hatfull GF, 2012, ADV VIRUS RES, V82, P179, DOI 10.1016/B978-0-12-394621-8.00015-7; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hendrix RW, 2003, RES MICROBIOL, V154, P253, DOI 10.1016/S0923-2508(03)00068-8; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Hutinet G, 2017, RNA BIOL, V14, P1175, DOI 10.1080/15476286.2016.1265200; Ko CC, 2018, MOL MICROBIOL, V108, P443, DOI 10.1111/mmi.13946; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Lee S, 2004, FEMS MICROBIOL LETT, V241, P271, DOI 10.1016/j.femsle.2004.10.032; Lu YY, 2017, NUCLEIC ACIDS RES, V45, pW554, DOI 10.1093/nar/gkx351; Mavrich TN, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.112; Merrill BD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3018-2; Morris P, 2008, J BACTERIOL, V190, P2172, DOI 10.1128/JB.01657-07; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Pope WH, 2017, MBIO, V8, DOI 10.1128/mBio.01069-17; Potter SC, 2018, NUCLEIC ACIDS RES, V46, pW200, DOI 10.1093/nar/gky448; RAJ CVS, 1970, NATURE, V228, P280; Sander M, 2001, APPL ENVIRON MICROB, V67, P1490, DOI 10.1128/AEM.67.4.1490-1493.2001; Smith KC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-410; Stella EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056384; TIMME TL, 1984, J GEN MICROBIOL, V130, P2059; van Kessel Julia C., 2008, V435, P203, DOI 10.1007/978-1-59745-232-8_15; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	34	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212365	10.1371/journal.pone.0212365	http://dx.doi.org/10.1371/journal.pone.0212365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811481	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400071
J	Devireddy, LR; Myers, M; Screven, R; Liu, ZM; Boxer, L				Devireddy, Laxminarayana R.; Myers, Michael; Screven, Rudell; Liu, Zhuoming; Boxer, Lynne			A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells	PLOS ONE			English	Article							STEM-CELLS; STROMAL CELLS; ASCORBIC-ACID; DIFFERENTIATION; CULTURE; GROWTH; HYDROCORTISONE; PROLIFERATION; TISSUE; EQUINE	Medium containing Fetal Bovine Serum (FBS) provides a supportive environment for isolation and expansion of mesenchymal stromal/stem cells (MSCs); however, the inherent variability of FBS may contribute to inconsistencies in cell growth and yield between batches of stem cell products. For this reason, we set out to develop a serum-free medium capable of supporting the in vitro expansion of MSCs. First a naive serum-free medium was formulated by Sato's approach. Once it was established that the naive serum-free medium supported the expansion of canine adipose-derived MSCs (Ad-MSCs), the serum-free medium was optimized by addition of growth factors. Combinations of growth factors were chosen and compared by their effect on cell proliferation and colony formation. Growth characteristics of canine adipose-derived MSCs cultured in the serum-free medium were comparable to those cultured in standard FBS containing medium. In addition, cell surface marker expression and differentiation potential of serum-free and FBS-based cultures were also comparable. However, a commercial serum-free medium developed for human MSC culture did not support growth of canine Ad-MSCs. In summary, canine Ad-MSCs isolated and cultured in serum-free medium retained the basic characteristics of MSCs cultured in FBS containing medium.	[Devireddy, Laxminarayana R.; Myers, Michael; Screven, Rudell; Liu, Zhuoming] US FDA, Div Appl Vet Res, Ctr Vet Med, Laurel, MD 20708 USA; [Boxer, Lynne] US FDA, Off New Anim Drug Evaluat, Ctr Vet Med, Rockville, MD 20857 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Devireddy, LR (corresponding author), US FDA, Div Appl Vet Res, Ctr Vet Med, Laurel, MD 20708 USA.	Laxminarayana.Devireddy@fda.hhs.gov						Arzi B, 2017, STEM CELL TRANSL MED, V6, DOI 10.1002/sctm.17-0035; Baer PC, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/812693; BARNES D, 1980, ANAL BIOCHEM, V102, P255, DOI 10.1016/0003-2697(80)90151-7; Benavente CA, 2003, GROWTH FACTORS, V21, P87, DOI 10.1080/08977190310001613789; Bianco P, 2014, ANNU REV CELL DEV BI, V30, P677, DOI 10.1146/annurev-cellbio-100913-013132; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Chase LG, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt8; Choi KM, 2008, J BIOSCI BIOENG, V105, P586, DOI 10.1263/jbb.105.586; Clark KC, 2016, STEM CELL REV REP, V12, P245, DOI 10.1007/s12015-015-9638-0; Colleoni S, 2009, VET RES COMMUN, V33, P811, DOI 10.1007/s11259-009-9229-0; CROISILLE L, 1994, BLOOD, V84, P4116, DOI 10.1182/blood.V84.12.4116.bloodjournal84124116; Francis GL, 2010, CYTOTECHNOLOGY, V62, P1, DOI 10.1007/s10616-010-9263-3; Fraser John K., 2008, V449, P59, DOI 10.1007/978-1-60327-169-1_4; Gottipamula S, 2013, CELL PROLIFERAT, V46, P608, DOI 10.1111/cpr.12063; Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009; Johnson M., 2013, MAT METHODS, V3, P175, DOI [10.13070/mm.en.2.117, DOI 10.13070/MM.EN.2.117]; Jung S, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/123030; Kyurkchiev DS, 2011, VITAM HORM, V87, P217, DOI 10.1016/B978-0-12-386015-6.00040-8; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Liu CH, 2007, BIOCHEM ENG J, V33, P1, DOI 10.1016/j.bej.2006.08.005; Liu ZM, 2018, TISSUE ENG PART C-ME, V24, P399, DOI [10.1089/ten.tec.2017.0409, 10.1089/ten.TEC.2017.0409]; Mather JP, 1998, METHOD CELL BIOL, V57, P19; Mimura S, 2011, INT J DEV BIOL, V55, P181, DOI 10.1387/ijdb.103232sm; Nakano R, 2015, J VET MED SCI, V77, P27, DOI 10.1292/jvms.14-0284; Ng F, 2008, BLOOD, V112, P295, DOI 10.1182/blood-2007-07-103697; Panchalingam KM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0228-5; Parker AM, 2007, CYTOTHERAPY, V9, P637, DOI 10.1080/14653240701508452; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Russell KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136621; Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926; Sato H, 2006, BIOCHEM BIOPH RES CO, V342, P107, DOI 10.1016/j.bbrc.2006.01.116; Savonniere S, 1996, J BIOTECHNOL, V48, P161, DOI 10.1016/0168-1656(96)01392-2; Schwarz C, 2012, RES VET SCI, V93, P457, DOI 10.1016/j.rvsc.2011.08.010; Screven R, 2014, VET IMMUNOL IMMUNOP, V161, P21, DOI 10.1016/j.vetimm.2014.06.002; Shih DTB, 2015, NEW BIOTECHNOL, V32, P199, DOI 10.1016/j.nbt.2014.06.001; Shipunova NN, 2013, B EXP BIOL MED+, V155, P159, DOI 10.1007/s10517-013-2102-8; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Tamama K, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795385; Trounson A, 2015, CELL STEM CELL, V17, P11, DOI 10.1016/j.stem.2015.06.007; Wodewotzky TI, 2012, BRAZ J MED BIOL RES, V45, P1157, DOI 10.1590/S0100-879X2012007500149; Zeve D, 2009, CELL STEM CELL, V5, P472, DOI 10.1016/j.stem.2009.10.014; Zhang DW, 2012, GENE DEV, V26, P461, DOI 10.1101/gad.182998.111; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	43	22	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210250	10.1371/journal.pone.0210250	http://dx.doi.org/10.1371/journal.pone.0210250			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811421	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400115
J	Suhr, OB; Wixner, J; Anan, I; Lundgren, HE; Wijayatunga, P; Westermark, P; Ihse, E				Suhr, Ole Bernt; Wixner, Jonas; Anan, Intissar; Lundgren, Hans-Erik; Wijayatunga, Priyantha; Westermark, Per; Ihse, Elisabet			Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; DEPOSITS; IMPACT; ATTR	Background The amyloid fibril in hereditary transthyretin (TTR) Val30Met (pVal50Met) amyloid (ATTR Val30Met) amyloidosis is composed of either a mixture of full-length and TTR fragments (Type A) or of only full-length TTR (Type B). The type of amyloid fibril exerts an impact on the phenotype of the disease, and on the outcome of diagnostic procedures and therapy. The aim of the present study was to investigate if the type of amyloid fibril remains the same within ATTR Val30Met amyloidosis families. Methods Fifteen families were identified in whom at least two first-degree relatives had their amyloid fibril composition determined. The type of ATTR was determined by Western blot in all but two patients. For these two patients a positive 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy indicated ATTR Type A. Results In 14 of the 15 families, the same amyloid fibril composition was noted irrespective of differences in age at onset. In the one family, different ATTR fibril types was found in two brothers with similar ages at onset. Conclusions Family predisposition appears to have an impact on amyloid fibril composition in members of the family irrespective of their age at onset of disease, but if genetically determined, the gene/genes are likely to be situated at another location than the TTR gene in the genome.	[Suhr, Ole Bernt; Wixner, Jonas; Anan, Intissar; Lundgren, Hans-Erik] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Wijayatunga, Priyantha] Umea Univ, Dept Stat, Umea, Sweden; [Westermark, Per; Ihse, Elisabet] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Umea University; Umea University; Uppsala University	Suhr, OB (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	Ole.suhr@umu.se	Wijayatunga, Priyantha/AAG-5817-2019; Wijayatunga, Priyantha/P-8098-2017; Wixner, Jonas/AAN-5812-2021	Wijayatunga, Priyantha/0000-0003-1654-9148; Wijayatunga, Priyantha/0000-0003-1654-9148; Wixner, Jonas/0000-0002-1536-1277; Suhr, Ole/0000-0002-1175-2369	Swedish Heart and Lung foundation [20160787]; Selander's foundation; patient organisation FAMY/AMYL, Vaster-and Norrbotten	Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Selander's foundation; patient organisation FAMY/AMYL, Vaster-and Norrbotten	This work was supported by: The Swedish Heart and Lung foundation grant no. 20160787, https://www3.hjart-lungfonden.se/(OBS); the patient organisation FAMY/AMYL, Vaster-and Norrbotten, https://www.famy.se/and https://www.famynorrbotten.se/sv-SE (OBS, PW); and Selander's foundation, https://www.stiftelsemedel.se/erik-karin-och-gsta-selandersstiftelse/(PW).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Coelho T, 2018, NEUROLOGY, V91, pE1999, DOI 10.1212/WNL.0000000000006543; Ericzon BG, 2015, TRANSPLANTATION, V99, P1847, DOI 10.1097/TP.0000000000000574; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; GUSTAVSSON A, 1995, LAB INVEST, V73, P703; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1; Ikeda S, 2011, AMYLOID, V18, P211, DOI 10.3109/13506129.2011.623199; Koike H, 2018, J NEUROL SCI, V394, P99, DOI 10.1016/j.jns.2018.09.011; Koike H, 2009, J NEUROL SCI, V287, P178, DOI 10.1016/j.jns.2009.07.028; Mangione PP, 2018, J BIOL CHEM, V293, P14192, DOI 10.1074/jbc.RA118.003990; Marcoux J, 2015, EMBO MOL MED, V7, P1337, DOI 10.15252/emmm.201505357; Oshima T, 2014, J NEUROL NEUROSUR PS, V85, P740, DOI 10.1136/jnnp-2013-305973; Pilebro B, 2016, UPSALA J MED SCI, V121, P17, DOI 10.3109/03009734.2015.1122687; SANDGREN O, 1986, OPHTHALMIC RES, V18, P98, DOI 10.1159/000265422; Suhr OB, 2017, J INTERN MED, V281, P337, DOI 10.1111/joim.12585; Tasaki M, 2018, 16 INT S AM KUM JAP, P80; Westermark P, 2017, AMYLOID, V24, P128, DOI 10.1080/13506129.2017.1294058	20	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211983	10.1371/journal.pone.0211983	http://dx.doi.org/10.1371/journal.pone.0211983			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811423	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400043
J	Yang, N; McLelland, J; McLelland, DJ; Clarke, J; Woolford, L; Eden, P; Phalen, DN				Yang, Nian; McLelland, Jennifer; McLelland, David J.; Clarke, Judy; Woolford, Lucy; Eden, Paul; Phalen, David N.			Psittacid Adenovirus-2 infection in the critically endangered orange-bellied parrot (Neophema chrysogastor): A key threatening process or an example of a host-adapted virus?	PLOS ONE			English	Article							INCLUSION-BODY HEPATITIS; FEATHER DISEASE VIRUS; CHICKEN ANEMIA VIRUS; BEAK; PARTICLES; BODIES; WILD; RECOVERY; BIRDS	Psittacid Adenovirus-2 (PsAdv-2) was identified in captive orange-bellied parrots (Neophema chrysogastor) during a multifactorial cluster of mortalities at the Adelaide Zoo, South Australia, and an outbreak of Pseudomonas aeruginosa septicaemia at the Tasmanian Department of Primary Industries, Parks, Water and Environment captive breeding facility, Taroona, Tasmania. This was the first time that an adenovirus had been identified in orange-bellied parrots and is the first report of PsAdv-2 in Australia. To investigate the status of PsAdv-2 in the captive population of orange-bellied parrots, 102 healthy birds from five breeding facilities were examined for the presence of PsAdv-2 DNA in droppings and/or cloacal swabs using a nested polymerase chain reaction assay. Additionally, eight birds released to the wild for the 2016 breeding season were similarly tested when they were recaptured prior to migration to be held in captivity for the winter. PsAdv-2 was identified in all breeding facilities as well as the birds recaptured from the wild. Prevalence of shedding ranged from 29.7 to 76.5%, demonstrating that PsAdv-2 is endemic in the captive population of orange-bellied parrots and that wild parrots may have been exposed to the virus. PsAdv-2 DNA was detected in both cloacal swabs and faeces of the orange-bellied parrots, but testing both samples from the same birds suggested that testing faeces would be more sensitive than cloacal swabs. PsAdv-2 was not found in other psittacine species housed in nearby aviaries at the Adelaide Zoo. The source of the infection in the orange-bellied parrots remains undetermined. In this study, PsAdv-2 prevalence of shedding was higher in adult birds as compared to birds less than one year old. Preliminary data also suggested a correlation between adenovirus shedding prevalence within the breeding collection and chick survival.	[Yang, Nian; Phalen, David N.] Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia; [McLelland, Jennifer; McLelland, David J.] Adelaide Zoo, Zoos South Australia, Adelaide, SA, Australia; [Clarke, Judy] Dept Primary Ind Pk Water & Environm, Hobart, Tas, Australia; [Woolford, Lucy] Univ Adelaide, Sch Anim & Vet Sci, Roseworthy, SA, Australia; [Eden, Paul] Zoos Victoria, Werribee Open Range Zoo, Werribee, Vic, Australia	University of Sydney; University of Adelaide	Phalen, DN (corresponding author), Univ Sydney, Sydney Sch Vet Sci, Camden, NSW, Australia.	david.phalen@sydney.edu.au		Woolford, Lucy/0000-0001-7271-2937; Yang, Nian/0000-0001-9775-2644	Sydney School of Veterinary Science, University of Study	Sydney School of Veterinary Science, University of Study	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All funds for this research came from the Sydney School of Veterinary Science, University of Study. There was no additional external funding received for this study.	BirdLife International, 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22685203A93063235.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22685203A93063235.EN]; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Clarke J, 2017, WILDL DIS ASS AUSTR; Das S, 2017, VIROLOGY, V502, P188, DOI 10.1016/j.virol.2016.12.031; DESMIDT M, 1991, AVIAN DIS, V35, P1001, DOI 10.2307/1591644; DROUAL R, 1995, J VET DIAGN INVEST, V7, P150, DOI 10.1177/104063879500700125; Eregae ME, 2014, AVIAN DIS, V58, P71, DOI 10.1637/10612-071113-Reg.1; Fenner J, 2017, INSECTS, V8, DOI 10.3390/insects8020050; Fogell DJ, 2016, ARCH VIROL, V161, P2059, DOI 10.1007/s00705-016-2871-2; Gabor M, 2013, VET PATHOL, V50, P1053, DOI 10.1177/0300985813490753; GOMEZVILLAMANDOS JC, 1992, J WILDLIFE DIS, V28, P319, DOI 10.7589/0090-3558-28.2.319; Grafl B, 2012, AVIAN PATHOL, V41, P599, DOI 10.1080/03079457.2012.740614; Hammer Sven, 2012, Zoologische Garten, V81, P81; Hess M., 2013, DIS POULTRY, V13th, P290; Howard JG, 2016, ANIM CONSERV, V19, P102, DOI 10.1111/acv.12229; Hulbert CL, 2015, AUST VET J, V93, P287, DOI 10.1111/avj.12350; Jarman H., 2016, AUSTR FIELD ORNITHOL, V2, P155; Kundu S, 2012, J VIROL, V86, P5221, DOI 10.1128/JVI.06504-11; Luschow D, 2007, AVIAN PATHOL, V36, P487, DOI 10.1080/03079450701691260; Meli ML, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004744; MENKHORST PW, 1990, MANAGEMENT AND CONSERVATION OF SMALL POPULATIONS, P239; Mfenyana N., 2007, THESIS; MORI F, 1989, AVIAN PATHOL, V18, P197, DOI 10.1080/03079458908418591; Orange-belled Parrot Recovery Team, 2006, NAT REC PLAN OR BELL; PASS DA, 1987, AVIAN PATHOL, V16, P581, DOI 10.1080/03079458708436408; Peniche G, 2017, ECOHEALTH, V14, pS106, DOI 10.1007/s10393-016-1108-x; Peters A, 2014, J WILDLIFE DIS, V50, P288, DOI 10.7589/2013-05-121; RAMIS A, 1992, AVIAN PATHOL, V21, P165, DOI 10.1080/03079459208418831; Raue R, 2005, ARCH VIROL, V150, P1933, DOI 10.1007/s00705-005-0578-x; Regnard GL, 2015, ARCH VIROL, V160, P47, DOI 10.1007/s00705-014-2226-9; Schneider A, 2010, DTSCH ARZTEBL INT, V107, P776, DOI [10.3238/arztebl.2010.0799, 10.3238/arztebl.2010.0776]; SCOTT PC, 1986, AUST VET J, V63, P337, DOI 10.1111/j.1751-0813.1986.tb02879.x; Seimon TA, 2013, MBIO, V4, DOI 10.1128/mBio.00410-13; Smales I., 2000, International Zoo Yearbook, V37, P171; Stojanovic D., 2017, EC RES, P1; Sutherland M, 2017, ANN C P ASS AV VET A, P16; To KKW, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003318; Toro H, 2000, AVIAN DIS, V44, P51, DOI 10.2307/1592507; Troy S., 2017, TASMANIAN ORANGE BEL; VanderWerf EA, 2014, CONDOR, V116, P609, DOI 10.1650/CONDOR-14-18.1; Walker SF, 2008, CURR BIOL, V18, pR853, DOI 10.1016/j.cub.2008.07.033; Weissenbock H, 2009, EMERG INFECT DIS, V15, P1453, DOI 10.3201/eid1509.090353; Wellehan JFX, 2009, AVIAN PATHOL, V38, P413, DOI 10.1080/03079450903183660; Wellehan JFX, 2005, J AVIAN MED SURG, V19, P191, DOI 10.1647/2004-003.1; Wellehan JFX, 2004, J VIROL, V78, P13366, DOI 10.1128/JVI.78.23.13366-13369.2004; Zippel K, 2011, HERPETOL CONSERV BIO, V6, P340	46	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0208674	10.1371/journal.pone.0208674	http://dx.doi.org/10.1371/journal.pone.0208674			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811501	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400004
J	Huminiecki, L				Huminiecki, Lukasz			Magic roundabout is an endothelial-specific ohnolog of ROBO1 which neo-functionalized to an essential new role in angiogenesis	PLOS ONE			English	Article							DETECTING POSITIVE SELECTION; GENE-EXPRESSION; EVOLUTIONARY ORIGINS; AXON GUIDANCE; DNA ELEMENTS; CNS MIDLINE; DUPLICATION; CELL; RECEPTOR; PROTEIN	Background Magic roundabout (ROBO4) is an unusual endothelial-specific paralog of the family of neuronally-expressed axon guidance receptors called roundabouts. Endothelial cells (ECs), whose uninterrupted sheet delimits the lumen of all vertebrate blood vessels and which are absent from invertebrate species, are a vertebrate-specific evolutionary novelty. Results Herein, the evolutionary mechanism of the duplication, retention and divergence of ROBO4 was investigated for the first time. Phylogenetic analyses carried out suggested that ROBO4 is a fast-evolving paralog of ROBO1 formed at the base of vertebrates. The ancestral expression pattern was neuronal. ROBO4 dramatically shifted its expression and became exceptionally specific to ECs. The data-mining of FANTOM5 and ENCODE reveals that ROBO4's endothelial expression arises from a single transcription start site (TSS), conserved in mouse, controlled by a proximal promoter with a complex architecture suggestive of regulatory neo-functionalization. (An analysis of promoter probabilities suggested the architecture was not due to a chance arrangement of TFBSes). Further evidence for the neo-functionalization of ROBO4 comes from the analysis of its protein interactions, the rates of protein evolution, and of positively selected sites. Conclusions The neo-functionalization model explains why ROBO4 protein acquired new context-specific biological functions in the control of angiogenesis. This endothelial-specific roundabout receptor is an illustrative example of the emergence of an essential vertebrate molecular novelty and an endothelial-specific signaling sub-network through 2R-WGD. The emergence of novel cell types, such as ECs, might be a neglected evolutionary force contributing to the high rate of retention of duplicates post-2R-WGD. Crucially, expression neo-functionalization to evolutionarily novel sites of expression conceptually extends the classical model of neo-functionalization.	[Huminiecki, Lukasz] Polskiej Akad Nauk, Inst Genet & Hodowli Zwierzat, Jastrzebiec, Magdalenka, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Huminiecki, L (corresponding author), Polskiej Akad Nauk, Inst Genet & Hodowli Zwierzat, Jastrzebiec, Magdalenka, Poland.	l.huminiecki@ighz.pl		Huminiecki, Lukasz/0000-0003-1943-4450	National Science Center, Poland [2016/21/P/NZ2/03926]; Marie Sklodowska-Curie actions from the European Union's Horizon 2020 research and innovation programme	National Science Center, Poland(National Science Centre, Poland); Marie Sklodowska-Curie actions from the European Union's Horizon 2020 research and innovation programme	LH received a POLONEZ 2 grant from the National Science Center, Poland, with the following agreement: 2016/21/P/NZ2/03926. (Note that the POLONEZ 2 scheme was co-funded by Marie Sklodowska-Curie actions from the European Union's Horizon 2020 research and innovation programme.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal CC, 2001, LECT NOTES COMPUT SC, V1973, P420; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Carelli FN, 2016, GENOME RES, V26, P301, DOI 10.1101/gr.198473.115; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Dubrac A, 2016, CIRCULATION, V133, P409, DOI 10.1161/CIRCULATIONAHA.115.017537; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emerson JJ, 2004, SCIENCE, V303, P537, DOI 10.1126/science.1090042; ENCODE-Consortium, ENCODE CHIP SEQ EXPT; Fares MA, 2006, MOL BIOL EVOL, V23, P245, DOI 10.1093/molbev/msj027; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Fisher WW, 2012, P NATL ACAD SCI USA, V109, P21330, DOI 10.1073/pnas.1209589110; Force A, 1999, GENETICS, V151, P1531; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Franceschini A, 2016, BIOINFORMATICS, V32, P1085, DOI 10.1093/bioinformatics/btv696; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Ghose A, 2002, BIOESSAYS, V24, P401, DOI 10.1002/bies.10080; Graur D, 2013, GENOME BIOL EVOL, V5, P578, DOI 10.1093/gbe/evt028; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guthrie S, 2001, CURR BIOL, V11, pR300, DOI 10.1016/S0960-9822(01)00169-5; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Huminiecki L, 2004, GENOME RES, V14, P1870, DOI 10.1101/gr.2705204; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Huminiecki L, 2000, GENOME RES, V10, P1796, DOI 10.1101/gr.150700; Huminiecki L, 2017, TRENDS BIOTECHNOL, V35, P530, DOI 10.1016/j.tibtech.2017.03.007; Huminiecki L, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-146; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Hurst LD, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002315; Jaccard P., 1912, NEW PHYTOLOGIST, V11; Jin J, 2012, CELL, V151, P384, DOI 10.1016/j.cell.2012.08.037; Jones CA, 2009, NAT CELL BIOL, V11, P1325, DOI 10.1038/ncb1976; Kalil K, 2014, NAT REV NEUROSCI, V15, P7, DOI 10.1038/nrn3650; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Koch AW, 2011, DEV CELL, V20, P33, DOI 10.1016/j.devcel.2010.12.001; LEE ME, 1991, J BIOL CHEM, V266, P16188; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Liao BY, 2010, P NATL ACAD SCI USA, V107, P7353, DOI 10.1073/pnas.0910339107; Likhite VS, 2004, J BIOL CHEM, V279, P16875, DOI 10.1074/jbc.M313155200; Lin ZH, 2018, MOL IMMUNOL, V103, P166, DOI 10.1016/j.molimm.2018.08.021; Littlewood TD, 2012, CELL, V151, P11, DOI 10.1016/j.cell.2012.09.006; Locascio A, 2002, P NATL ACAD SCI USA, V99, P16841, DOI 10.1073/pnas.262525399; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2001, GENETICS, V159, P1789; Meyer A, 2005, BIOESSAYS, V27, P937, DOI 10.1002/bies.20293; Monahan-Earley R, 2013, J THROMB HAEMOST, V11, P46, DOI 10.1111/jth.12253; Morlot C, 2007, P NATL ACAD SCI USA, V104, P14923, DOI 10.1073/pnas.0705310104; Munoz-Chapuli R, 2005, EVOL DEV, V7, P351, DOI 10.1111/j.1525-142X.2005.05040.x; Munoz-Chapuli R, 2011, INT J DEV BIOL, V55, P345, DOI 10.1387/ijdb.103212rm; Nery MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065491; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nielsen R, 1998, GENETICS, V148, P929; Ohno S., 1970, EVOLUTION GENE DUPLI, Vxv; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Pascual-Anaya J, 2013, DEV BIOL, V375, P182, DOI 10.1016/j.ydbio.2012.11.015; Peterson MW, 2007, SOURCE CODE BIOL MED, V2, DOI 10.1186/1751-0473-2-7; Rama N, 2015, NAT MED, V21, P483, DOI 10.1038/nm.3849; Risau W, 1995, ANNU REV CELL DEV BI, V11, P73, DOI 10.1146/annurev.cb.11.110195.000445; Rodriguez-Trelles F, 2003, P NATL ACAD SCI USA, V100, P13413, DOI 10.1073/pnas.1835646100; Seoighe C, 2004, TRENDS GENET, V20, P461, DOI 10.1016/j.tig.2004.07.008; Severin ML Jessica, 2013, NATURE BIOTECHNOLOGY; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Telford MJ, 2008, PHILOS T R SOC B, V363, P1529, DOI 10.1098/rstb.2007.2243; Telford MJ, 2004, CURR BIOL, V14, pR274, DOI 10.1016/j.cub.2004.03.022; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Warnefors M, 2013, GENOME BIOL EVOL, V5, P1324, DOI 10.1093/gbe/evt093; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; White MA, 2016, CELL REP, V17, P1247, DOI 10.1016/j.celrep.2016.09.066; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zelina P, 2014, NEURON, V84, P1258, DOI 10.1016/j.neuron.2014.11.004; Zhang B, 2009, BLOOD, V114, P4300, DOI 10.1182/blood-2008-12-193326; Zhang Fu-hua, 2016, Shanghai Kou Qiang Yi Xue, V25, P11; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhuang XD, 2011, BIOCHEM SOC T, V39, P1571, DOI 10.1042/BST20110746; Zmasek CM, 2001, BIOINFORMATICS, V17, P383, DOI 10.1093/bioinformatics/17.4.383; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	108	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0208952	10.1371/journal.pone.0208952	http://dx.doi.org/10.1371/journal.pone.0208952			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802244	Green Published, gold, Green Submitted			2022-12-26	WOS:000459710700003
J	Imai, Y; Yoshida, O; Watanabe, T; Yukimoto, A; Koizumi, Y; Ikeda, Y; Tokumoto, Y; Hirooka, M; Abe, M; Hiasa, Y				Imai, Yusuke; Yoshida, Osamu; Watanabe, Takao; Yukimoto, Atsushi; Koizumi, Yohei; Ikeda, Yoshio; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi			Stimulated hepatic stellate cell promotes progression of hepatocellular carcinoma due to protein kinase R activation	PLOS ONE			English	Article							NONALCOHOLIC STEATOHEPATITIS; INFLAMMASOME ACTIVATION; LIVER; PKR; LPS; FIBROGENESIS; INHIBITION; FIBROSIS; ACID; NASH	Hepatic stellate cells (HSCs) were reported to promote the progression of hepatocellular carcinoma (HCC), however its mechanism is uncertain. We previously reported that protein kinase R (PKR) in hepatocytes regulated HCC proliferation. In this study, we focused on the role of PKR in HSCs, and clarified the mechanism of its association with HCC progression. We confirmed the activation of PKR in a human HSC cell line (LX-2 cell). IL-1 beta is produced from HSCs stimulated by lipopolysaccharide (LPS) or palmitic acid which are likely activators of PKR in non-alcoholic steatohepatitis (NASH). Production was assessed by real-time PCR and ELISA. C16 and small interfering RNA (siRNA) were used to inhibit PKR in HSCs. The HCC cell line (HepG2 cell) was cultured with HSC conditioning medium to assess HCC progression, which was evaluated by proliferation and scratch assays. Expression of PKR was increased and activated in stimulated HSCs, and IL-1 beta production was also increased molecular. Key molecules of the mitogen-activated protein kinase pathway were also upregulated and activated by LPS. Otherwise, PKR inhibition by C16 and PKR siRNA decreased IL-1 beta production. HCC progression was promoted by HSC-stimulated conditioning medium although it was reduced by the conditioning medium from PKR-inhibited HSCs. Moreover, palmitic acid also upregulated IL-1 beta expression in HSCs, and conditioning medium from palmitic acid-stimulated HSCs promoted HCC proliferation. Stimulated HSCs by activators of PKR in NASH could play a role in promoting HCC progression through the production of IL-1 beta, via a mechanism that seems to be dependent on PKR activation.	[Imai, Yusuke; Yoshida, Osamu; Watanabe, Takao; Yukimoto, Atsushi; Koizumi, Yohei; Ikeda, Yoshio; Tokumoto, Yoshio; Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan	Ehime University	Yoshida, O (corresponding author), Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan.	yoshidao@m.ehime-u.ac.jp	Hiasa, Yoichi/ABD-2759-2021	Hiasa, Yoichi/0000-0003-4117-339X	Japan Society for the Promotion of Science (JSPS) [18K08007]; JSPS [15K19336, 17K15952]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-Aid for Scientific Research (C) (Grant no. 18K08007) from the Japan Society for the Promotion of Science (JSPS) (http://www.jsps.go.jp) to YH and Grant-in-Aid for Young Scientists (B) (Grant no. 15K19336, 17K15952) from JSPS to OY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Achiwa K, 2016, BIOCHEM BIOPH RES CO, V470, P15, DOI 10.1016/j.bbrc.2015.12.012; Balogh J, 2016, J HEPATOCELL CARCINO, V3, P41, DOI 10.2147/JHC.S61146; Blanc JF, 1997, GASTROEN CLIN BIOL, V21, P869; Boriushkin E, 2016, SCI REP-UK, V6, DOI 10.1038/srep25013; Bou-Dargham MJ, 2017, MED RES REV, V37, P180, DOI 10.1002/med.21406; Carloni V, 2014, LIVER INT, V34, P834, DOI 10.1111/liv.12465; Chen YH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0038-z; Connolly MK, 2009, J CLIN INVEST, V119, P3213, DOI 10.1172/JCI37581; Coulouarn C, 2014, J HEPATOL, V60, P1306, DOI 10.1016/j.jhep.2014.02.003; Csak T, 2011, HEPATOLOGY, V54, P133, DOI 10.1002/hep.24341; Duan NN, 2017, LIFE SCI, V176, P42, DOI 10.1016/j.lfs.2017.03.012; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gabele E, 2011, J HEPATOL, V55, P1391, DOI 10.1016/j.jhep.2011.02.035; Gandhi CR, 2017, J HEPATOL, V67, P1104, DOI 10.1016/j.jhep.2017.06.001; Gao Q, 2011, CANCER SCI, V102, P1522, DOI 10.1111/j.1349-7006.2011.01981.x; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Hiasa Y, 2003, AM J GASTROENTEROL, V98, P2528, DOI 10.1016/S0002-9270(03)01696-4; Liang W, 2014, LAB INVEST, V94, P491, DOI 10.1038/labinvest.2014.11; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Nakamura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144295; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Nicholas DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176793; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Robert S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153118; Saraswat VA, 2014, J CLIN EXP HEPATOL, V4, pS80, DOI 10.1016/j.jceh.2014.05.004; Siegel AB, 2010, HEPATOLOGY, V52, P360, DOI 10.1002/hep.23633; Su B, 2015, HEPATOLOGY, V61, P585, DOI 10.1002/hep.27551; Tateishi R, 2015, J GASTROENTEROL, V50, P350, DOI 10.1007/s00535-014-0973-8; Tokumoto Y, 2007, J MED VIROL, V79, P1120, DOI 10.1002/jmv.20902; Utsunomiya H, 2017, J GASTROENTEROL, V52, P940, DOI 10.1007/s00535-016-1298-6; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Voronov E, 2003, P NATL ACAD SCI USA, V100, P2645, DOI 10.1073/pnas.0437939100; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; Watanabe T, 2018, CANCER SCI, V109, P919, DOI 10.1111/cas.13551; Watanabe T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067750	38	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212589	10.1371/journal.pone.0212589	http://dx.doi.org/10.1371/journal.pone.0212589			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794626	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100093
J	Leighton, EA; Holle, D; Biery, DN; Gregor, TP; McDonald-Lynch, MB; Wallace, ML; Reagan, JK; Smith, GK				Leighton, Eldin A.; Holle, Dolores; Biery, Darryl N.; Gregor, Thomas P.; McDonald-Lynch, Mischa B.; Wallace, Mandy L.; Reagan, Jennifer K.; Smith, Gail K.			Genetic improvement of hip-extended scores in 3 breeds of guide dogs using estimated breeding values: Notable progress but more improvement is needed	PLOS ONE			English	Article							DEGENERATIVE JOINT DISEASE; LABRADOR-RETRIEVERS; RADIOGRAPHIC EVIDENCE; DISTRACTION INDEX; DIET RESTRICTION; 2 PALPATION; DYSPLASIA; OSTEOARTHRITIS; LAXITY; ASSOCIATION	Two hip quality phenotypes-a hip-extended score assigned by a board certified radiologist and the PennHIP distraction index-were analyzed to estimate genetic parameters and to calculate estimated breeding values used for selecting replacement breeders. Radiographs obtained at 12-18 months of age were available on 5,201 German Shepherd Dogs, 4,987 Labrador Retrievers and 2,308 Golden Retrievers. Obtained by fitting a two-trait model using Bayesian techniques, estimates of heritability for the hip-extended score were 0.76, 0.72, and 0.41 in German Shepherd Dogs, Labrador Retrievers, and Golden Retrievers, respectively, while estimated heritabilities for distraction index were 0.60, 0.66 and 0.59, respectively. Genetic correlations between the two hip quality measures were -0.28 in German Shepherd Dogs, -0.21 in Labrador Retrievers, and -0.29 in Golden Retrievers. Genetic selection for improved hip quality based upon the hip extended score phenotype began in 1980. Among first generation puppies, 34% of 273 German Shepherd Dogs, 55% of 323 Labrador Retrievers, and 43% of 51 Golden Retrievers had an Excellent hip extended score. After 8 generations of selection, mostly based on estimated breeding values derived from the hip extended score, over 93% of 695 German Shepherd Dogs, 94% of 528 Labrador Retrievers, and 87% of 116 Golden Retrievers received an Excellent hip extended score. With respect to PennHIP distraction index values among these same dogs, median values were at or above 0.30 for all 3 breeds meaning that half or more of dogs possessing the Excellent hip-extended-score phenotype remained susceptible to developing the osteoarthritis of canine hip dysplasia. Genetic improvement of the hip-extended-view phenotype to its desired biological endpoint left a surprising proportion of dogs expressing sufficient joint laxity to place them in an osteoarthritis at-risk state as they age. Only by directly applying selection pressure to reduce distraction index was marked reduction in joint laxity noted.	[Leighton, Eldin A.; Holle, Dolores] Seeing Eye Inc, Morristown, NJ 07960 USA; [Biery, Darryl N.; Gregor, Thomas P.; McDonald-Lynch, Mischa B.; Wallace, Mandy L.; Reagan, Jennifer K.; Smith, Gail K.] Univ Penn, Sch Vet Med, Dept Clin Sci & Adv Med, Philadelphia, PA 19104 USA; [Leighton, Eldin A.] Canine Genet Serv LLC, Great Falls, VA USA; [McDonald-Lynch, Mischa B.] Vet Specialty Hosp Carolinas, Cary, NC USA; [Wallace, Mandy L.] Univ Georgia, Dept Small Anim Med & Surg, Athens, GA 30602 USA; [Reagan, Jennifer K.] Seattle Vet Specialists, Seattle, WA USA	University of Pennsylvania; University System of Georgia; University of Georgia	Leighton, EA (corresponding author), Seeing Eye Inc, Morristown, NJ 07960 USA.; Leighton, EA (corresponding author), Canine Genet Serv LLC, Great Falls, VA USA.	eldin@caninegeneticservices.com		Leighton, Eldin/0000-0003-3032-0315	Seeing Eye, Inc., Morristown, NJ; Morris Animal Foundation [93CA-5]; commonwealth of the state of Pennsylvania	Seeing Eye, Inc., Morristown, NJ; Morris Animal Foundation; commonwealth of the state of Pennsylvania	Drs. Gail K. Smith and Daryl N. Biery acknowledge generous financial support from The Seeing Eye, Inc., Morristown, NJ, for funds obtained from and administered by Morris Animal Foundation under grant 93CA-5. All authors acknowledge generous financial support received from the governor and commonwealth of the state of Pennsylvania.	Adams WM, 2000, VET RADIOL ULTRASOUN, V41, P484, DOI 10.1111/j.1740-8261.2000.tb01875.x; Adams WM, 1998, J AM ANIM HOSP ASSOC, V34, P339, DOI 10.5326/15473317-34-4-339; Australian Veterinary Association and Australia New Zealand Kennel Club, 2000, AVA ANKC HIP ELB SCH; Boldman K.G., 1995, MANUAL USE MTDFREML; Breur GJ, 2001, GENETICS DOG; BRINKS JS, 1961, J ANIM SCI, V20, P903; Cameron N.D., 1997, SELECTION INDICES PR; Cole JR, 2004, J ANIM SCI, V82, P2906; Corley EA, 2000, HEREDITARY BONE JOIN, P284; Falconer D. S., 1989, Introduction to quantitative genetics.; Farese JP, 1998, VET SURG, V27, P393, DOI 10.1111/j.1532-950X.1998.tb00146.x; Fluckiger M, 2000, HEREDITARY BONE JOIN, P289; Henricson B, 1966, J Small Anim Pract, V7, P673, DOI 10.1111/j.1748-5827.1966.tb04393.x; Hollander M., 1973, NONPARAMETRIC STAT M; Hou YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076390; Hou YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009410; Janss LCM, 2011, NON TRADITIONAL REF; Janutta V, 2008, BERL MUNCH TIERARZTL, V121, P102, DOI 10.2376/0005-9366-121-102; Jessen C D, 1972, P CAN HIP DYSPL S WO, P93; JOHNSON JA, 1994, VET COMP ORTHOPAED, V7, P56; Kealy RD, 2000, J AM VET MED ASSOC, V217, P1678, DOI 10.2460/javma.2000.217.1678; Kealy RD, 2002, J AM VET MED ASSOC, V220, P1315, DOI 10.2460/javma.2002.220.1315; Krag K, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-79; LEIGHTON EA, 1977, AM J VET RES, V38, P241; Leighton EA, 1997, J AM VET MED ASSOC, V210, P1474; Lewis TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012797; LUST G, 1993, AM J VET RES, V54, P1990; Maki K, 2000, J ANIM SCI, V78, P1141; Mateescu RG, 2008, AM J VET RES, V69, P1294, DOI 10.2460/ajvr.69.10.1294; Morgan JP, 2000, HEREDITARY BONE JOIN; Mrode R.A, 2014, LINEAR MODELS PREDIC; Nicholas F., 1987, VET GENETICS; Nicholas FW, 2003, INTRO VET GENETICS; Oberbauer AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172918; PAATSAMA S, 2000, HEREDITARY BONE JOIN, P263; Paster ER, 2005, JAVMA, V226; POPOVITCH CA, 1995, J AM VET MED ASSOC, V206, P648; Powers MY, 2010, JAVMA-J AM VET MED A, V237, P532, DOI 10.2460/javma.237.5.532; Powers MY, 2004, JAVMA-J AM VET MED A, V225, P233, DOI 10.2460/javma.2004.225.233; QUAAS RL, 1976, BIOMETRICS, V32, P949, DOI 10.2307/2529279; R DEVELOPMENT CORE TEAM, 2011, NON TRADITIONAL REF; Reed AL, 2000, J AM VET MED ASSOC, V217, P675, DOI 10.2460/javma.2000.217.675; RISER WH, 1964, J AM VET MED ASSOC, V144, P709; Runge JJ, 2010, J SMALL ANIM PRACT, V51, P264, DOI 10.1111/j.1748-5827.2010.00937.x; Smith G, 2011, VET SURG SMALL ANI M, V1st, P824; Smith GK, 2006, JAVMA-J AM VET MED A, V229, P690, DOI 10.2460/javma.229.5.690; Smith GK, 2012, VET SURG, V41, P20, DOI 10.1111/j.1532-950X.2011.00935.x; SMITH GK, 1993, AM J VET RES, V54, P1021; SMITH GK, 1990, J AM VET MED ASSOC, V196, P59; Smith GK, 1997, AM J VET RES, V58, P1076; Smith GK, 2001, J AM VET MED ASSOC, V219, P1719, DOI 10.2460/javma.2001.219.1719; Smith GK, 2011, PUREBRED PARADOX HLT; Smith GK, 2018, VET SURG SMALL ANIMA; Smith GK, 2009, P 36 ANN C VET ORTH, P23; Smith GK, 2000, HEREDITARY BONE JOIN, P300; Soo M, 2015, NEW ZEAL VET J, V63, P69, DOI 10.1080/00480169.2014.949893; Soo M, 2015, NEW ZEAL VET J, V63, P79, DOI 10.1080/00480169.2014.961581; Vezzoni A, 2018, VET SURG SMALL ANIMA; Whittington K., 1961, J AM VET MED ASS, V139, P791; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Wilson BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077470; Wilson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039620; Wood JLN, 2002, PREV VET MED, V55, P95, DOI 10.1016/S0167-5877(02)00090-9; Zhang ZW, 2009, AM J VET RES, V70, P483, DOI 10.2460/ajvr.70.4.483; Zhou ZK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013219	65	12	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212544	10.1371/journal.pone.0212544	http://dx.doi.org/10.1371/journal.pone.0212544			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794614	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100085
J	Morozumi, N; Yotsumoto, T; Yamaki, A; Yoshikiyo, K; Yoshida, S; Nakamura, R; Jindo, T; Furuya, M; Maeda, H; Minamitake, Y; Kangawa, K				Morozumi, Naomi; Yotsumoto, Takafumi; Yamaki, Akira; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nakamura, Ryuichi; Jindo, Toshimasa; Furuya, Mayumi; Maeda, Hiroaki; Minamitake, Yoshiharu; Kangawa, Kenji			ASB20123: A novel C-type natriuretic peptide derivative for treatment of growth failure and dwarfism	PLOS ONE			English	Article							RECEPTOR; BRAIN; HYALURONAN; STRATEGY; GHRELIN; MOUSE; PLATE	C-type natriuretic peptide (CNP) and its receptor natriuretic peptide receptor B (NPR-B) are physiological potent positive regulators of endochondral bone growth; therefore, the CNP/NPR-B signaling pathway is one of the most promising therapeutic targets for treating growth failure and dwarfism. In this article, we summarized the pharmacological properties of a novel CNP analog peptide ASB20123 as a therapeutic agent for short stature. ASB20123, one of the CNP/ghrelin chimeric peptides, is composed of CNP(1-22) and human ghrelin(12-28, E17D). Compared to CNP(1-22), ASB20123 showed similar agonist activity for NPR-B and improved biokinetics with a longer plasma half-life in rats. In addition, the distribution of ASB20123 to the cartilage was higher than that of CNP(1-22) after single subcutaneous (sc) injection to mice. These results suggested that the C-terminal part of ghrelin, which has clusters of basic amino acid residues and a BX7B motif, might contribute to the retention of ASB20123 in the extracellular matrix of the growth plate. Multiple sc doses of ASB20123 potently stimulated skeletal growth in rats in a dose-dependent manner, and sc infusion was more effective than bolus injection at the same dose. Our data indicated that high plasma levels of ASB20123 would not necessarily be required for bone growth acceleration. Thus, pharmaceutical formulation approaches for sustained-release dosage forms to allow chronic exposure to ASB20123 might be suitable to ensure drug effectiveness and safety.	[Morozumi, Naomi; Yotsumoto, Takafumi; Yamaki, Akira; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nakamura, Ryuichi; Jindo, Toshimasa; Furuya, Mayumi; Maeda, Hiroaki; Minamitake, Yoshiharu] Asubio Pharma Co Ltd, Kobe, Hyogo, Japan; [Yotsumoto, Takafumi; Yamaki, Akira; Yoshikiyo, Kazunori; Yoshida, Sayaka; Nakamura, Ryuichi; Jindo, Toshimasa; Maeda, Hiroaki] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Kangawa, Kenji] Natl Cerebral & Cardiovasc Ctr, Res Inst, Osaka, Japan	Asubio Pharma Co., Ltd.; Daiichi Sankyo Company Limited; National Cerebral & Cardiovascular Center - Japan	Yotsumoto, T (corresponding author), Asubio Pharma Co Ltd, Kobe, Hyogo, Japan.; Yotsumoto, T (corresponding author), Daiichi Sankyo Co Ltd, Tokyo, Japan.	yotsumoto.takafumi.ur@daiichisankyo.co.jp						Chang CY, 2016, RADIOGRAPHICS, V36, P1871, DOI 10.1148/rg.2016160004; Holmes G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201492; HUNT PJ, 1994, J CLIN ENDOCR METAB, V78, P1428, DOI 10.1210/jc.78.6.1428; Iwaki T, 2017, BIOORGAN MED CHEM, V25, P6680, DOI 10.1016/j.bmc.2017.11.006; Jawetz ST, 2015, SPORTS HEALTH, V7, P142, DOI 10.1177/1941738114559380; Jean L, 2001, EUR J BIOCHEM, V268, P544, DOI 10.1046/j.1432-1327.2001.01890.x; Kake T, 2009, AM J PHYSIOL-ENDOC M, V297, pE1339, DOI 10.1152/ajpendo.00272.2009; KENNY AJ, 1993, BIOCHEM J, V291, P83, DOI 10.1042/bj2910083; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lorget F, 2012, AM J HUM GENET, V91, P1108, DOI 10.1016/j.ajhg.2012.10.014; Makino T, 2005, BIOPOLYMERS, V79, P238, DOI 10.1002/bip.20342; McLennan Danielle N, 2005, Drug Discov Today Technol, V2, P89, DOI 10.1016/j.ddtec.2005.05.006; MINAMINO N, 1991, BIOCHEM BIOPH RES CO, V179, P535, DOI 10.1016/0006-291X(91)91404-Z; MINAMINO N, 1990, BIOCHEM BIOPH RES CO, V170, P973, DOI 10.1016/0006-291X(90)92187-5; Morozumi N, 2017, PEPTIDES, V97, P16, DOI 10.1016/j.peptides.2017.09.008; Morozumi N, 2012, PEPTIDES, V33, P279, DOI 10.1016/j.peptides.2012.01.010; Morozumi N, 2011, PEPTIDES, V32, P1001, DOI 10.1016/j.peptides.2011.01.021; Moyes AJ, 2014, J CLIN INVEST, V124, P4039, DOI 10.1172/JCI74281; Myllyharju J, 2014, CURR OSTEOPOROS REP, V12, P439, DOI 10.1007/s11914-014-0232-1; Nakao K, 2013, BMC PHARM TOXICOL S1, V14, pP48, DOI [10.1186/2050-6511-14-S1-P48, DOI 10.1186/2050-6511-14-S1-P48]; Nakao K, 2015, SCI REP-UK, V5, DOI 10.1038/srep10554; OGAWA Y, 1995, CLIN EXP PHARMACOL P, V22, P49, DOI 10.1111/j.1440-1681.1995.tb01918.x; Ornitz DM, 2017, DEV DYNAM, V246, P291, DOI 10.1002/dvdy.24479; Pagel-Langenickel I, 2018, ADV EXP MED BIOL, V1067, P109, DOI 10.1007/5584_2018_143; Potter Lincoln R., 2009, V191, P341, DOI 10.1007/978-3-540-68964-5_15; Saito Y, 2010, J CARDIOL, V56, P262, DOI 10.1016/j.jjcc.2010.08.001; Serrat MA, 2009, J APPL PHYSIOL, V106, P2016, DOI 10.1152/japplphysiol.00295.2009; Stewart JM, 2012, EXPERT REV CARDIOVAS, V10, P1387, DOI [10.1586/ERC.12.139, 10.1586/erc.12.139]; STINGO AJ, 1992, AM J PHYSIOL, V263, pH1318, DOI 10.1152/ajpheart.1992.263.4.H1318; SUZUKI E, 1993, BIOCHEM BIOPH RES CO, V192, P532, DOI 10.1006/bbrc.1993.1448; Tamura N, 1996, J MOL CELL CARDIOL, V28, P1811, DOI 10.1006/jmcc.1996.0170; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Wendt DJ, 2015, J PHARMACOL EXP THER, V353, P132, DOI 10.1124/jpet.114.218560; Yasoda A, 2009, ENDOCRINOLOGY, V150, P3138, DOI 10.1210/en.2008-1676	35	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212680	10.1371/journal.pone.0212680	http://dx.doi.org/10.1371/journal.pone.0212680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794654	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100111
J	Le, TM; Morimoto, N; Mitsui, T; Notodihardjo, SC; Munisso, MC; Kakudo, N; Kusumoto, K				Tien Minh Le; Morimoto, Naoki; Mitsui, Toshihito; Notodihardjo, Sharon Claudia; Munisso, Maria Chiara; Kakudo, Natsuko; Kusumoto, Kenji			The sustained release of basic fibroblast growth factor accelerates angiogenesis and the engraftment of the inactivated dermis by high hydrostatic pressure	PLOS ONE			English	Article							COLLAGEN/GELATIN SCAFFOLD; CLINICAL-EFFICACY; BFGF; CELLS; PCR	We developed a novel skin regeneration therapy combining nevus tissue inactivated by high hydrostatic pressure (HHP) in the reconstruction of the dermis with a cultured epidermal autograft (CEA). The issue with this treatment is the unstable survival of CEA on the inactivated dermis. In this study, we applied collagen/gelatin sponge (CGS), which can sustain the release of basic fibroblast growth factor (bFGF), to the inactivated skin in order to accelerate angiogenesis. Murine skin grafts from C57BL6J/Jcl mice (8 mm in diameter) were prepared, inactivated by HHP and cryopreserved. One month later, the grafts were transplanted subcutaneously onto the back of other mice and covered by CGS impregnated with saline or bFGF. Grafts were harvested after one, two and eight weeks, at which point the engraftment was evaluated through the histology and angiogenesis-related gene expressions were determined by real-time polymerase chain reaction. Histological sections showed that the dermal cellular density and newly formed capillaries in the bFGF group were significantly higher than in the control group. The relative expression of FGF-2, PDGFA and VEGF-A genes in the bFGF group was significantly higher than in the control group at Week 1. This study suggested that the angiogenesis into grafts was accelerated, which might improve the engraftment of inactivated dermis in combination with the sustained release of bFGF by CGSs.	[Tien Minh Le; Morimoto, Naoki; Mitsui, Toshihito; Notodihardjo, Sharon Claudia; Munisso, Maria Chiara; Kakudo, Natsuko; Kusumoto, Kenji] Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan	Kansai Medical University	Morimoto, N (corresponding author), Kansai Med Univ, Dept Plast & Reconstruct Surg, Hirakata, Osaka, Japan.	morimotn@hirakata.kmu.ac.jp	Munisso, Maria Chiara/GXV-5409-2022	Morimoto, Naoki/0000-0002-0712-3172; Le, Tien Minh/0000-0003-4470-8433; Munisso, Maria Chiara/0000-0003-1616-4934	Practical Research for Innovative Cancer Control grant Agency for Medical Research and Development (AMED) [17ck0106304h0001];  [17H04360]	Practical Research for Innovative Cancer Control grant Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); 	This research was partially supported by Grants-in-Aid for Scientific Research (B) (17H04360) (https://kaken.nii.ac.jp/ja/index/) and partially supported by a Practical Research for Innovative Cancer Control grant (17ck0106304h0001) Agency for Medical Research and Development (AMED; http://www.amed.go.jp/en/); Dr. Naoki Morimoto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Akita S, 2005, BURNS, V31, P855, DOI 10.1016/j.burns.2005.04.008; Ayvazyan A, 2011, J SURG RES, V171, pE247, DOI 10.1016/j.jss.2011.06.059; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Bao P, 2009, J SURG RES, V153, P347, DOI 10.1016/j.jss.2008.04.023; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Funamoto S, 2010, BIOMATERIALS, V31, P3590, DOI 10.1016/j.biomaterials.2010.01.073; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; GOSPODAROWICZ D, 1974, NATURE, V249, P123, DOI 10.1038/249123a0; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hashimoto Y, 2010, BIOMATERIALS, V31, P3941, DOI 10.1016/j.biomaterials.2010.01.122; HAYEK A, 1987, BIOCHEM BIOPH RES CO, V147, P876, DOI 10.1016/0006-291X(87)91011-4; Hiemer B, 2016, SCI REP-UK, V6, DOI 10.1038/srep33747; Ito R, 2013, TISSUE ENG PT A, V19, P1398, DOI [10.1089/ten.tea.2012.0375, 10.1089/ten.TEA.2012.0375]; Jinno C, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/4567146; Jinno C, 2015, TISSUE ENG PART C-ME, V21, P1178, DOI [10.1089/ten.tec.2015.0054, 10.1089/ten.TEC.2015.0054]; Kanda N, 2014, J TISSUE ENG REGEN M, V8, P29, DOI 10.1002/term.1492; Kanda N, 2012, ANN PLAS SURG, V69, P569, DOI 10.1097/SAP.0b013e318222832f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahara A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/379607; Morimoto N, 2017, J BIOMED MATER RES B, V105, P2653, DOI 10.1002/jbm.b.33807; Morimoto N, 2017, J BIOMED MATER RES B, V105, P1091, DOI 10.1002/jbm.b.33631; Morimoto N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1320909; Morimoto N, 2015, CELLS TISSUES ORGANS, V201, P170, DOI 10.1159/000444048; Morimoto N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/587247; Ogino S, 2018, J SURG RES, V221, P173, DOI 10.1016/j.jss.2017.08.051; Ohura T, 2011, WOUND REPAIR REGEN, V19, P542, DOI 10.1111/j.1524-475X.2011.00726.x; Liem PH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133979; Liem PH, 2013, J ARTIF ORGANS, V16, P332, DOI 10.1007/s10047-013-0708-2; Rivalain N, 2010, BIOTECHNOL ADV, V28, P659, DOI 10.1016/j.biotechadv.2010.04.001; Sakamoto M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186958; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Takemoto S, 2008, TISSUE ENG PT A, V14, P1629, DOI 10.1089/ten.tea.2007.0215; Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x; Turabelidze A, 2010, WOUND REPAIR REGEN, V18, P460, DOI 10.1111/j.1524-475X.2010.00611.x; Uchi H, 2009, EUR J DERMATOL, V19, P461, DOI 10.1684/ejd.2009.0750; Watt AJ, 2004, PLAST RECONSTR SURG, V113, P1968, DOI [10.1097/01.PRS.0000122209.10277.2A, 10.1097/01.prs.0000122209.10277.2a]; Weiss EM, 2010, J IMMUNOTOXICOL, V7, P194, DOI 10.3109/15476911003657414; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wiles K, 2016, TISSUE ENG PART B-RE, V22, P208, DOI [10.1089/ten.TEB.2015.0376, 10.1089/ten.teb.2015.0376]	41	13	13	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0208658	10.1371/journal.pone.0208658	http://dx.doi.org/10.1371/journal.pone.0208658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789932	gold, Green Published, Green Submitted			2022-12-26	WOS:000459330800005
J	Zhou, DL; Yu, LF; Fu, H; Zhang, LL; Wei, L; Li, DP; Zhang, TS; Li, WM				Zhou Daliang; Yu Lifang; Fu Hong; Zhang Lingling; Wei Lin; Li Dapeng; Zhang Tianshu; Li Weimin			Netrin-1 plays a role in the effect of moderate exercise on myocardial fibrosis in rats	PLOS ONE			English	Article							TISSUE INHIBITOR; INFARCTION; ANGIOGENESIS; PATHWAY	Introduction This study aimed to investigate the effect of aerobic exercise on the expression of neitrin-1, DCC receptor and myocardial fibrosis in rats with acute myocardial infarction. Methods Twenty-four rats were randomly divided into three groups: the sham group (n = 8), the acute myocardial infarction (AMI) model group (n = 8), and the aerobic exercise treatment after acute myocardial infarction group (ET) (n = 8). After 10 weeks, the serum levels of netrin-1, tumor necrosis factor alpha a (TNF-alpha), and interleukin 6 (IL-6) were measured. The expression of matrix metalloproteinase 2 and 9 (MMP2, 9), and their inhibitor, tissue inhibitor of metalloproteinase 2 (TIMP2), myocardial netrin-1, and the deleted in colorectal cancer (DCC) receptor were evaluated. Histopathological results were also evaluated. The collagen volume fraction of the myocardial tissues was also calculated. Results Compared with the sham group, in the AMI and ET groups, left ventricular end diastolic pressure (LVEDP) were increased, while left ventricular systolic pressure (LVSP), and left ventricular pressure maximal rate of rise and fall (+/- dp/dtmax) were significantly decreased (P<0.05,). Compared with the AMI group, in the ET group, LVSP, and +/- dp/dtmax were significantly increased while LVEDP was decreased (P<0.05). Compared with the sham group, the AMI group and ET groups showed increased levels of serum TNF-alpha, IL-6 and significantly reduced levels of netrin-1. Levels of TNF-alpha and IL-6 were significantly reduced in the ET group compared with the AMI group, whereas the level of netrin-1 was increased. The expression of myocardial MMP2 and MMP9 was significantly increased in the AMI group compared with the sham group, whereas that of myocardial netrin-1, TIMP2 and the DCC receptor, was significantly reduced. Compared with the AMI group, the ET group showed reduced expression of myocardial MMP2 and MMP9 proteins, whereas expression of myocardial netrin-1, TIMP2 and the DCC receptor, was significantly increased. The collagen volume fraction of the myocardial tissues was significantly increased in the AMI group and the ET group compared with the sham group, with a greater increase in the AMI group. Conclusions Aerobic exercise increased levels of serum netrin-1, myocardial netrin-1, and the DCC receptor and reduced the expression of myocardial MMP2 and MMP9 proteins, to improve the degree of fibrosis following myocardial infarction in rats.	[Zhou Daliang; Fu Hong; Zhang Lingling; Wei Lin; Li Dapeng; Zhang Tianshu; Li Weimin] First Hosp Harbin City, Dept Cardiol, Harbin, Heilongjiang, Peoples R China; [Yu Lifang] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Clin Pharm, Harbin, Heilongjiang, Peoples R China	Heilongjiang University of Chinese Medicine	Wei, L; Li, WM (corresponding author), First Hosp Harbin City, Dept Cardiol, Harbin, Heilongjiang, Peoples R China.	weilin1964@163.com; zhoudaliang007@163.com	zhang, lingling/HDM-2189-2022; zhang, tian/GZK-6001-2022		Harbin, The First Hospital [2013SYYRCYJ06-3]	Harbin, The First Hospital	This study was funded by a grant fund from Harbin, The First Hospital (grant number 2013SYYRCYJ06-3).	Bonnema DD, 2007, J CARD FAIL, V13, P530, DOI 10.1016/j.cardfail.2007.04.010; Bouvree K, 2008, DEV BIOL, V318, P172, DOI 10.1016/j.ydbio.2008.03.023; Dumont O, 2007, ARTERIOSCL THROM VAS, V27, P317, DOI 10.1161/01.ATV.0000254684.80662.44; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Forcet C, 2002, NATURE, V417, P443, DOI 10.1038/nature748; Halade GV, 2013, PHARMACOL THERAPEUT, V139, P32, DOI 10.1016/j.pharmthera.2013.03.009; Hirai DM, 2014, AM J PHYSIOL-HEART C, V306, pH690, DOI 10.1152/ajpheart.00901.2013; Jugdutt BI., 2013, CARDIAC REMODELING M, P525; Ke TY, 2014, HUM GENE THER, V25, P787, DOI 10.1089/hum.2014.021; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kwak HB, 2011, FASEB J, V25, P1106, DOI 10.1096/fj.10-172924; Liu N, 2011, NEUROSCIENCE, V194, P349, DOI 10.1016/j.neuroscience.2011.07.037; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Puhl SL, 2015, AM J PHYSIOL-HEART C, V309, pH345, DOI 10.1152/ajpheart.00683.2014; Ribeiro LP, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20177033, 10.1590/1414-431x20177033]; Richardson WJ, 2015, COMPR PHYSIOL, V5, P1877, DOI 10.1002/cphy.c140067; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Silveira AC, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1549014; Szabo R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/6709742; Talman V, 2016, CELL TISSUE RES, V365, P563, DOI 10.1007/s00441-016-2431-9; Valente AJ, 2012, AM J PHYSIOL-HEART C, V303, pH282, DOI 10.1152/ajpheart.00231.2012; Xiao XB, 2016, MOL MED REP, V13, P5093, DOI 10.3892/mmr.2016.5178; Yaghooti Hamid, 2010, Avicenna Journal of Medical Biotechnology, V2, P79; Zhang J, 2010, J MOL CELL CARDIOL, V48, P1060, DOI 10.1016/j.yjmcc.2009.11.020	24	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0199802	10.1371/journal.pone.0199802	http://dx.doi.org/10.1371/journal.pone.0199802			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789913	Green Submitted, Green Published, gold			2022-12-26	WOS:000459330800001
J	Gilbert, JA; Corbin, JD				Gilbert, Jessica A.; Corbin, Jeffrey D.			Biological soil crusts inhibit seed germination in a temperate pine barren ecosystem	PLOS ONE			English	Article							XERIC FLORIDA SHRUBLAND; 2 ANNUAL GRASSES; POPULATION-DYNAMICS; PLANT-COMMUNITIES; VASCULAR PLANTS; ESTABLISHMENT; DISTURBANCE; BIOCRUSTS; SURVIVAL; SAVANNA	Biological soil crusts (BSCs) are known to affect plants' germination and seedling establishment in arid ecosystems, but their ecological role in more mesic climates is not so wellknown. We tested the effects of moss-crusted versus uncrusted soils on seed germination dynamics in a temperate pine barren ecosystem. We conducted a 35-day laboratory assay of seed germination on moss-crusted soils versus uncrusted soils from the Albany (NY) Pine Bush Preserve. We compared total seed germination and the number of days to 50% of total germination of two herbaceous perennial forb species in each soil type. Three and five times more seeds germinated on uncrusted soil than on crusted soil for bush clover (Lespedeza capitata) and wild lupine (Lupinus perennis), respectively. Seeds of both species also germinated approximately 10 days earlier on uncrusted soil than on crusted soil. This study, and others in similar habitats, show that BSCs in mesic climates can influence germination and other early life-history stages of plants. We hope that further study of the interactions between BSCs and vascular plants in mesic climates will contribute to our understanding of the ecology of BSCs outside the arid and semiarid climates where they are more extensively studied.	[Gilbert, Jessica A.; Corbin, Jeffrey D.] Union Coll, Dept Biol Sci, Schenectady, NY 12308 USA	Union College	Corbin, JD (corresponding author), Union Coll, Dept Biol Sci, Schenectady, NY 12308 USA.	corbinj@union.edu		Corbin, Jeffrey/0000-0002-3377-5916	Union College Summer Research Fellowship	Union College Summer Research Fellowship	JAG was funded by a Union College Summer Research Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes J.K., 2003, NATURAL HIST ALBANY; Belnap J, 2003, FRONT ECOL ENVIRON, V1, P181, DOI 10.2307/3868062; Belnap J, 1997, LAND DEGRAD DEV, V8, P355, DOI 10.1002/(SICI)1099-145X(199712)8:4<355::AID-LDR266>3.0.CO;2-H; Belnap J, 2002, BIOL FERT SOILS, V35, P128, DOI 10.1007/s00374-002-0452-x; Belnap J., 2001, BIOL SOIL CRUSTS STR; Bried JT, 2015, J SUSTAIN FOREST, V34, P147, DOI 10.1080/10549811.2014.973610; Bu CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127394; Budel B, 2014, BIODIVERS CONSERV, V23, P1639, DOI 10.1007/s10531-014-0645-2; Castillo-Monroy AP, 2010, PLANT SOIL, V333, P21, DOI 10.1007/s11104-009-0276-7; Chamizo S, 2016, ECOHYDROLOGY, V9, P1208, DOI 10.1002/eco.1719; CRAWLEY MJ, 1990, PHILOS T R SOC B, V330, P125, DOI 10.1098/rstb.1990.0187; Deines L, 2007, PLANT SOIL, V295, P23, DOI 10.1007/s11104-007-9256-y; Edinger G.J, 2014, ECOLOGICAL COMMUNITI; ERIKSSON O, 1992, OECOLOGIA, V91, P360, DOI 10.1007/BF00317624; Gawler S.C., 2010, NATURAL LANDSCAPES M; Godinez-Alvarez H, 2012, PLANT BIOLOGY, V14, P157, DOI 10.1111/j.1438-8677.2011.00495.x; Harper J. L., 1977, Population biology of plants.; Hawkes CV, 2004, PLANT ECOL, V170, P121, DOI 10.1023/B:VEGE.0000019035.56245.91; Hawkes CV, 2002, MICROBIAL ECOL, V43, P1, DOI 10.1007/s00248-001-1017-5; Hoffmann WA, 1999, ECOLOGY, V80, P1354, DOI 10.1890/0012-9658(1999)080[1354:FAPDOW]2.0.CO;2; Jeschke M, 2008, FLORA, V203, P557, DOI 10.1016/j.flora.2007.09.006; Aguilar AJ, 2009, J ARID ENVIRON, V73, P1158, DOI 10.1016/j.jaridenv.2009.05.009; Langhans TM, 2009, FLORA, V204, P157, DOI 10.1016/j.flora.2008.01.001; Motzkin G, 2002, J BIOGEOGR, V29, P1569, DOI 10.1046/j.1365-2699.2002.00769.x; Neher DA, 2003, J TORREY BOT SOC, V130, P244, DOI 10.2307/3557543; PLATT WJ, 1988, AM NAT, V131, P491, DOI 10.1086/284803; Prevey JS, 2015, OECOLOGIA, V179, P765, DOI 10.1007/s00442-015-3398-z; Rascher KG, 2012, ECOL LETT, V15, P484, DOI 10.1111/j.1461-0248.2012.01761.x; Rice SK, 2004, PLANT ECOL, V174, P97, DOI 10.1023/B:VEGE.0000046049.21900.5a; Sedia EG, 2003, OIKOS, V100, P447, DOI 10.1034/j.1600-0706.2003.12058.x; Serpe MD, 2008, PLANT SOIL, V303, P191, DOI 10.1007/s11104-007-9498-8; Smith SM, 2004, MICROB ECOL, V48, P200, DOI 10.1007/s00248-004-0254-9; Song G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185839; Sperduto D., 2011, NATURE NEW HAMPSHIRE; Thiet RK, 2014, PLANT SOIL, V377, P235, DOI 10.1007/s11104-013-2002-8; Thiet RK, 2005, PLANT SOIL, V278, P235, DOI 10.1007/s11104-005-8550-9; Weber B, 2016, BIOL SOIL CRUSTS ORG; Zaady E, 1997, PLANT SOIL, V190, P247, DOI 10.1023/A:1004269031844; Zhang Y., 2016, BIOL SOIL CRUSTS ORG, V226, DOI [10.1007/978-3-319-30214-0_19, DOI 10.1007/978-3-319-30214-0_19]; Zhang YM, 2015, ECOL RES, V30, P1037, DOI 10.1007/s11284-015-1305-z	40	7	7	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212466	10.1371/journal.pone.0212466	http://dx.doi.org/10.1371/journal.pone.0212466			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785942	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000063
J	Hill, N				Hill, Nicolette			Description of cranial elements and ontogenetic change within Tropidolaemus wagleri (Serpentes: Crotalinae)	PLOS ONE			English	Article							SKULL MORPHOLOGY; PIT VIPERS; TRIMERESURUS; PHYLOGENY; PITVIPERS; BIOGEOGRAPHY; TAXONOMY	Tropidolaemus wagleri is a species of Asian pitviper with a geographic range including Thailand, Vietnam, Malaysia, Singapore, Bruniei, parts of Indonesia, and the Philippines. Tropidolaemus is a member of the Crotalinae subfamily, within Viperidae. The genus Tropidolaemus includes five species, and was once included within the genus Trimeresurus. While some osteologic characteristics have been noted a comprehensive description of cranial elements has not been produced for T. wagleri. An in-depth description of the cranial skeleton of Tropidolaemus wagleri lays the foundation for future projects to compare and contrast other taxa within Crotalinae and Viperidae. The chosen reference specimen was compared to the presumed younger specimens to note any variation in ontogeny. The study here provides a comprehensive description of isolated cranial elements as well as a description of ontogenetic change within the specimens observed. This study contributes to the knowledge of osteological characters in T. wagleri and provides a foundation for a long term project to identify isolated elements in the fossil record.	[Hill, Nicolette] East Tennessee State Univ, Dept Geosci, Johnson City, TN 37614 USA	East Tennessee State University	Hill, N (corresponding author), East Tennessee State Univ, Dept Geosci, Johnson City, TN 37614 USA.	nicolettelhill@gmail.com						Brattstrom B. H., 1964, Transactions of the San Diego Society for Natural History, V13, P185; Burger W.L., 1971, THESIS; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Cundall David, 2008, Contributions to Herpetology, V23, P349; DULLEMEIJER P., 1956, ARCH NEERLAND ZOOL, V11, P387; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Gumprecht A., 2004, ASIAN PITVIPERS; Guo P, 2009, J ZOOL SYST EVOL RES, V47, P378, DOI 10.1111/j.1439-0469.2009.00525.x; Guo Peng, 1999, Zoological Research, V20, P415; Guo P, 2006, HERPETOL J, V16, P305; Guo P, 2010, ACTA ZOOL-STOCKHOLM, V91, P402, DOI 10.1111/j.1463-6395.2009.00413.x; Hoser Raymond T., 2013, Australasian Journal of Herpetology, V19, P43; Kuch Ulrich, 2007, Zootaxa, V1446, P1; LOMBARD RE, 1986, BIOL J LINN SOC, V27, P133, DOI 10.1111/j.1095-8312.1986.tb01730.x; Malhotra A, 2004, MOL PHYLOGENET EVOL, V32, P83, DOI 10.1016/j.ympev.2004.02.008; Malhotra A, 2000, MOL PHYLOGENET EVOL, V16, P199, DOI 10.1006/mpev.2000.0779; McDiarmid R. W., 1999, TAXONOMIC GEOAND, V1; Molles BE, 2002, J TOXICOL-TOXIN REV, V21, P273, DOI 10.1081/TXR-120014406; Orlov Nikolai, 2002, P345; Schlegel H, 1827, ISIS OKEN, V20, P281; Seba A, 1735, EX TOTO TERRARUM ORB, V2; Tu MC, 2000, ZOOL SCI, V17, P1147, DOI 10.2108/zsj.17.1147; Vogel G, 2007, ZOOTAXA, P1; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019	25	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0206023	10.1371/journal.pone.0206023	http://dx.doi.org/10.1371/journal.pone.0206023			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785876	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000006
J	Khan, MI; Yuan, T; Chou, RH; Yu, C				Khan, Md. Imran; Yuan, Tai; Chou, Ruey-Hwang; Yu, Chin			S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain	PLOS ONE			English	Article							END-PRODUCTS RAGE; CA2+-BINDING PROTEIN S100A1; THERAPEUTIC TARGET; BINDING-SITE; IN-VITRO; METASTASIS; EXPRESSION; RECEPTOR; CALMODULIN; MOUSE	The Ca2+-dependent human S100A4 (Mts1) protein is part of the S100 family. Here, we studied the interactions of S100A4 with S100A1 using nuclear magnetic resonance (NMR) spectroscopy. We used the chemical shift perturbed residues from HSQC to model S100A4 and S100A1 complex with HADDOCK software. We observed that S100A1 and the RAGE V domain have an analogous binding area in S100A4. We discovered that S100A4 acts as an antagonist among the RAGE V domain and S100A1, which inhibits tumorigenesis and cell proliferation. We used a WST-1 assay to examine the bioactivity of S100A1 and S100A4. This study could possibly be beneficial for evaluating new proteins for the treatment of diseases.	[Khan, Md. Imran; Yuan, Tai; Yu, Chin] Natl Tsing Hua Univ, Chem Dept, Hsinchu, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Chem Dept, Hsinchu, Taiwan.	cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	Ministry of Science and Technology (MOST) of Taiwan [MOST 104-2113-M-007-019-MY3]; Ministry of Health and Welfare (MOHW) [MOST 105-2320-B-039-059-MY3, MOHW107-TDU-B-212-114025]; Drug Development Center, China Medical University from The Featured Areas Research Center Program by the Ministry of Education (MOE) in Taiwan	Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health and Welfare (MOHW); Drug Development Center, China Medical University from The Featured Areas Research Center Program by the Ministry of Education (MOE) in Taiwan	This work was supported by the Ministry of Science and Technology (MOST) of Taiwan (grant number MOST 104-2113-M-007-019-MY3), MOST 105-2320-B-039-059-MY3 and MOHW107-TDU-B-212-114025 from Ministry of Health and Welfare (MOHW), and the Drug Development Center, China Medical University from The Featured Areas Research Center Program within the framework of the Higher Education Sprout Project by the Ministry of Education (MOE) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BB, 2001, FEBS LETT, V497, P95, DOI 10.1016/S0014-5793(01)02444-9; Afanador L, 2014, CELL CALCIUM, V56, P68, DOI 10.1016/j.ceca.2014.05.002; Ambartsumian N, 2005, J DAIRY RES, V72, P27, DOI 10.1017/S0022029905001093; Arumugam T, 2011, AMINO ACIDS, V41, P893, DOI 10.1007/s00726-010-0496-4; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Chen HY, 2014, AM J CANCER RES, V4, P89; Cho CC, 2015, J BIOMOL NMR, V62, P233, DOI 10.1007/s10858-015-9927-6; Christensen H, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00008; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Deloulme JC, 2003, MICROSC RES TECHNIQ, V60, P560, DOI 10.1002/jemt.10298; DeRycke MS, 2009, AM J CLIN PATHOL, V132, P846, DOI 10.1309/AJCPTK87EMMIKPFS; Diaconescu DE, 2014, ROM J MORPHOL EMBRYO, V55, P1371; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Durussel I, 2000, S100A13 BIOCH CHARAC, V275, P8686; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; FORD HL, 1995, ONCOGENE, V10, P1597; Gupta AA, 2012, BIOMOL NMR ASSIGN, V6, P213, DOI 10.1007/s12104-012-9360-7; Holakovska B, 2012, J BIOL CHEM, V287, P16645, DOI 10.1074/jbc.M112.350686; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Khan I., 2018, POLYM BLENDS, P1, DOI [10.1007/978-3-319-95987-0_16, DOI 10.1007/978-3-319-92067-2_16-1]; Kiewitz R, 2003, BIOCHEM BIOPH RES CO, V306, P550, DOI 10.1016/S0006-291X(03)00987-2; Kraus C, 2009, J MOL CELL CARDIOL, V47, P445, DOI 10.1016/j.yjmcc.2009.06.003; Kuniyasu H, 2002, J PATHOL, V196, P163, DOI 10.1002/path.1031; L.L.C. Schrodinger, 2018, PYMOL MOL GRAPH SYST, P2; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Leclerc Estelle, 2013, Methods Mol Biol, V963, P201, DOI 10.1007/978-1-62703-230-8_13; Leclerc Estelle, 2011, Front Biosci (Schol Ed), V3, P1232; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li G, 2007, HISTOPATHOLOGY, V50, P642, DOI 10.1111/j.1365-2559.2007.02655.x; Liang HS, 2011, CANCER LETT, V313, P91, DOI 10.1016/j.canlet.2011.08.028; Logsdon CD, 2007, CURR MOL MED, V7, P777, DOI 10.2174/156652407783220697; Ma L, 2002, J MOL BIOL, P279, DOI [10.1006/jmbi.2002.5421, DOI 10.1006/JMBI.2002.5421]; Maco B, 2001, PHYSIOL RES, V50, P567; Malashkevich VN, 2008, BIOCHEMISTRY-US, V47, P5111, DOI 10.1021/bi702537s; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Mishra SK, 2012, CANCER METAST REV, V31, P163, DOI 10.1007/s10555-011-9338-4; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Mori M, 1998, HISTOCHEM CELL BIOL, V110, P579, DOI 10.1007/s004180050320; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Naim R, 2006, ONCOL REP, V16, P671; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Prosser BL, 2008, J BIOL CHEM, V283, P5046, DOI 10.1074/jbc.M709231200; Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3; Rintala-Dempsey AC, 2006, BIOCHEMISTRY-US, V45, P14695, DOI 10.1021/bi061754e; Rohde D, 2010, J CARDIOVASC TRANSL, V3, P525, DOI 10.1007/s12265-010-9211-9; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Sastry M, 1998, STRUCTURE, V6, P223, DOI 10.1016/S0969-2126(98)00023-9; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Semov A, 2005, J BIOL CHEM, V280, P20833, DOI 10.1074/jbc.M412653200; Shanmugam N, 2008, J BIOL CHEM, V283, P36221, DOI 10.1074/jbc.M806322200; Sherbet GV, 1998, ANTICANCER RES, V18, P2415; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Tarabykina S, 2000, FEBS LETT, V475, P187, DOI 10.1016/S0014-5793(00)01652-5; Tian T, 2017, DISCOV MED, V23, P235; Tsoporis JN, 2010, CIRC RES, V106, P93, DOI 10.1161/CIRCRESAHA.109.195834; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; van Zundert GCP, 2014, METHODS MOL BIOL, V1137, P163, DOI 10.1007/978-1-4939-0366-5_12; Wang GZ, 2005, ONCOGENE, V24, P1445, DOI 10.1038/sj.onc.1208291; Wang GZ, 2000, J BIOL CHEM, V275, P11141, DOI 10.1074/jbc.275.15.11141; Wright NT, 2008, J BIOL CHEM, V283, P26676, DOI 10.1074/jbc.M804432200; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Yan SF, 2010, BIOCHEM PHARMACOL, V79, P1379, DOI 10.1016/j.bcp.2010.01.013; Yang WS, 2012, J PROTEOME RES, V11, P1078, DOI 10.1021/pr2008187; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Zimmer Danna B, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/728052	75	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212299	10.1371/journal.pone.0212299	http://dx.doi.org/10.1371/journal.pone.0212299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779808	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900043
J	Sato, T; Kohzuki, M; Ono, M; Muto, M; Osugi, T; Kawamura, K; Naganuma, W; Sato, M; Shishito, N				Sato, Toshimi; Kohzuki, Masahiro; Ono, Masahiro; Muto, Mitsuru; Osugi, Taku; Kawamura, Keiichi; Naganuma, Wakako; Sato, Masayuki; Shishito, Namiko			Association between physical activity and change in renal function in patients after acute myocardial infarction	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; PERCUTANEOUS CORONARY INTERVENTION; CARDIAC REHABILITATION; CARDIOVASCULAR OUTCOMES; DYSFUNCTION; MORTALITY; DECLINE; IMPACT; JAPAN	Background Combined renal dysfunction worsens the subsequent prognosis in patients after acute myocardial infarction (AMI). Therefore, establishing a therapeutic modality to maintain or improve renal function in AMI patients is necessary. This study aimed to elucidate the association between physical activity level and change in renal function in such patients. Design Prospective and observational study. Methods We enrolled 41 patients (35 men; average age, 67.5 +/- 12.6 years) after AMI onset. Blood biochemistry, urinalysis, and physical function tests were conducted at discharge and 3 months after discharge. Renal function was evaluated based on cystatin C based-estimated glomerular filtration rate (eGFRcys). The number of steps was recorded for 3 months postdischarge. Generalized estimating equations (GEE) was used to test the association between physical activity level and within-patient changes in eGFRcys. Results Patients were stratified into low (n = 21; number of steps, 2335 +/- 1219 steps/day) and high groups (n = 20; number of steps, 7102 +/- 2365 steps/day). eGFRcys significantly increased from baseline to after 3 months in the high group (76.5 +/- 13.8 to 83.2 +/- 16.0 mL/min/1.73 m(2), q = 0.004), whereas no significant change was observed in the low group (65.1 +/- 15.9 to 62.2 +/- 20.2 mL/min/1.73 m(2), q = 0.125). Result of GEE adjusted for potential confounding variables showed a significant positive association between physical activity level and within-patient changes in eGFRcys (p = 0.003). Changes in eGFRcys was -2.9 mL/min/1.73 m(2) among low group versus + 6.7 mL/min/1.73 m(2) among high group. Conclusions Physical activity level was positively associated with changes in renal function, demonstrating that high physical activity may suppress renal function decline in patients after AMI.	[Sato, Toshimi; Kohzuki, Masahiro] Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan; [Sato, Toshimi] Southern Tohoku Gen Hosp, Dept Rehabil, Koriyama, Fukushima, Japan; [Ono, Masahiro; Muto, Mitsuru; Osugi, Taku; Kawamura, Keiichi; Naganuma, Wakako; Shishito, Namiko] Southern Tohoku Gen Hosp, Dept Cardiol, Koriyama, Fukushima, Japan; [Sato, Masayuki] Ohara Gen Hosp, Dept Cardiol, Fukushima, Japan	Tohoku University	Kohzuki, M (corresponding author), Tohoku Univ, Grad Sch Med, Dept Internal Med & Rehabil Sci, Sendai, Miyagi, Japan.	kohzuki@med.tohoku.ac.jp		Sato, Toshimi/0000-0003-0586-9402				Ainsworth B, 2015, PROG CARDIOVASC DIS, V57, P387, DOI 10.1016/j.pcad.2014.10.005; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Aoyagi Y, 2009, GERONTOLOGY, V55, P523, DOI 10.1159/000236326; Arakawa T, 2016, CIRC J, V80, P1750, DOI 10.1253/circj.CJ-15-1392; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Eijkelkamp WBA, 2007, AM J CARDIOL, V100, P7, DOI 10.1016/j.amjcard.2007.02.047; Hama T, 2018, IJC HEART VASC, V19, P27, DOI 10.1016/j.ijcha.2018.04.001; Herber-Gast GCM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133864; Horio M, 2013, AM J KIDNEY DIS, V61, P197, DOI 10.1053/j.ajkd.2012.07.007; Imai E, 2008, HYPERTENS RES, V31, P433, DOI 10.1291/hypres.31.433; Iseki K, 2002, HYPERTENS RES, V25, P185, DOI 10.1291/hypres.25.185; Iso Y, 2015, INT J CARDIOL, V187, P283, DOI 10.1016/j.ijcard.2015.03.308; Kamiya K, 2017, AM J CARDIOL, V119, P186, DOI 10.1016/j.amjcard.2016.09.040; Kimura S, 2015, INT HEART J, V56, P105, DOI 10.1536/ihj.14-161; Koganei H, 2008, CIRC J, V72, P179, DOI 10.1253/circj.72.179; Kohzuki M, 2001, J HYPERTENS, V19, P1877, DOI 10.1097/00004872-200110000-00024; Kohzuki M, 2017, CARDIOVASC INNOV APP, V2, P387, DOI 10.15212/CVIA.2017.0006; Kohzuki M, 2016, CIRC J, V80, P1697, DOI 10.1253/circj.CJ-16-0619; Kraal JJ, 2017, EUR J PREV CARDIOL, V24, P1260, DOI 10.1177/2047487317710803; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Millor N, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-86; Muntner P, 2000, KIDNEY INT, V58, P293, DOI 10.1046/j.1523-1755.2000.00165.x; Oliveira J, 2008, J CARDIOPULM REHABIL, V28, P392, DOI 10.1097/HCR.0b013e31818c3b83; Poortmans JR, 2013, BRIT J SPORT MED, V47, P1166, DOI 10.1136/bjsports-2012-090976; Posma RA, 2015, CARDIOVASC DRUG THER, V29, P451, DOI 10.1007/s10557-015-6618-1; Robinson-Cohen C, 2014, J AM SOC NEPHROL, V25, P399, DOI 10.1681/ASN.2013040392; Robinson-Cohen C, 2009, ARCH INTERN MED, V169, P2116, DOI 10.1001/archinternmed.2009.438; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Shepherd J, 2016, AM J CARDIOL, V117, P1199, DOI 10.1016/j.amjcard.2016.01.014; Takaya Y, 2014, CIRC J, V78, P377, DOI 10.1253/circj.CJ-13-0779; Toyama K, 2010, J CARDIOL, V56, P142, DOI 10.1016/j.jjcc.2010.06.007; Yamagata K, 2004, AM J KIDNEY DIS, V43, P433, DOI 10.1053/j.ajkd.2003.11.005; Yamaguchi J, 2007, CIRC J, V71, P1354, DOI 10.1253/circj.71.1354; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212100	10.1371/journal.pone.0212100	http://dx.doi.org/10.1371/journal.pone.0212100			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779806	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900028
J	Tola, E; Al-Gaadi, KA; Madugundu, R				Tola, ElKamil; Al-Gaadi, Khalid A.; Madugundu, Rangaswamy			Employment of GIS techniques to assess the long-term impact of tillage on the soil organic carbon of agricultural fields under hyper-arid conditions	PLOS ONE			English	Article							MANAGEMENT; MATTER; VEGETATION; NITROGEN; LEVEL; YIELD	A study on six 50 ha agricultural fields was conducted to investigate the effect of conservation tillage practices on the long-term (1990-2016) changes in the soil organic carbon (SOC) content of the topsoil layers (0-10 cm) of agricultural fields. The experimental fields were selected from the 49 fields of the Tawdeehiya Arable Farm (TAF), located 200 kilometers southeast of Riyadh, the capital city of the Kingdom of Saudi Arabia. Data sets from laboratory determined SOC and the corresponding Landsat images generated vegetation indices, namely, the Normalized Difference Vegetation Index (NDVI) and the Bare Soil Index (BSI), were utilized for the prediction of SOC using multivariate regression techniques. Long-term changes in the SOC content of the experimental fields, as a result of different tillage practices, were also studied. The developed SOC prediction models exhibited high accuracy indicated by R-2 values ranging from 0.73 to 0.85, RMSE values of 0.34 to 0.85 g kg(-1) and P-values of less than 0.0001. The cross-validation results (R-2 of 0.61-0.70, RMSE value of 0.34-0.85 g kg(-1) and P-values of less than 0.0001) confirmed the high accuracy of the developed SOC prediction models. Results also revealed that the change in the SOC content was clearly associated with soil tillage practices. On the average, 76% of the all agricultural fields in the experimental farm showed a decrease of up to 24 g kg(-1) in their SOC content after 10 years (1990-2000) of continuous conventional tillage practices. On the other hand, an average increase of up to 37 g kg(-1) in the SOC content was observed in 88% of the studied fields at the end of the study period (2016), where conservation tillage was a continous and consistent practice in the experimental farm.	[Tola, ElKamil; Al-Gaadi, Khalid A.; Madugundu, Rangaswamy] King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia; [Al-Gaadi, Khalid A.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia	King Saud University; King Saud University	Tola, E (corresponding author), King Saud Univ, Precis Agr Res Chair, Riyadh, Saudi Arabia.	etola@ksu.edu.sa	Tola, ElKamil/AAX-8777-2021; Madugundu, Rangaswamy/N-9214-2013; Tola, ElKamil/E-8523-2017	Madugundu, Rangaswamy/0000-0002-5326-4785; Tola, ElKamil/0000-0003-0927-9688	Deanship of Scientific Research, King Saud University; Deanship of Scientific Research, King Saud University, Riyadh	Deanship of Scientific Research, King Saud University(King Saud University); Deanship of Scientific Research, King Saud University, Riyadh	This study was supported by the Deanship of Scientific Research, King Saud University. The authors confirm that the funders provided research funds for field trips, data collection, lab analysis, software programs, publication fees and research allowances. Also the authors confirm that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the Deanship of Scientific Research, King Saud University, Riyadh for funding this study through the Vice Deanship of Scientific Research Chairs. The unsustained cooperation and support extended by the staff of the Tawdeehia farm during the field campaign are gratefully acknowledged.	Abdullah L., 2015, J SUSTAIN DEV, V8, P66, DOI [10.5539/jsd.v8n2p66, DOI 10.5539/JSD.V8N2P66]; Amare T., 2013, ISRN Soil Science, V2013, P720589; [Anonymous], 2010, P 25 ANN C GRASSL SO; Bhunia GS, 2019, GEOCARTO INT, V34, P215, DOI 10.1080/10106049.2017.1381179; Choudhury SG, 2014, SOIL TILL RES, V136, P76, DOI 10.1016/j.still.2013.10.001; Dikgwatlhe SB, 2014, SOIL USE MANAGE, V30, P496, DOI 10.1111/sum.12143; Garten CT, 1999, J ENVIRON QUAL, V28, P1359, DOI 10.2134/jeq1999.00472425002800040041x; Gholizadeh A, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9101078; Griffin E, 2017, WHAT IS SOIL ORGANIC; Grinand C, 2017, INT J APPL EARTH OBS, V54, P1, DOI 10.1016/j.jag.2016.09.002; Haddaway NR, 2017, ENVIRON EVID, V6, DOI 10.1186/s13750-016-0079-2; Hernanz JL, 2002, SOIL TILL RES, V66, P129, DOI 10.1016/S0167-1987(02)00021-1; Hong YS, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010028; Jamalabad M., 2004, ISPRS C; Kingra P. K., 2016, Agricultural Research Journal, V53, P295, DOI 10.5958/2395-146X.2016.00058.2; Klemmedson J. O., 1989, Arid Soil Research and Rehabilitation, V3, P99, DOI 10.1080/15324988909381194; Kumar P, 2016, EGYPT J REMOTE SENS, V19, P109, DOI 10.1016/j.ejrs.2015.12.003; Liu X, 2006, PLANT SOIL ENVIRON, V52, P531, DOI 10.17221/3544-PSE; Loveland P, 2003, SOIL TILL RES, V70, P1, DOI 10.1016/S0167-1987(02)00139-3; Martin PD, 2002, CAN J SOIL SCI, V82, P413, DOI 10.4141/S01-054; McBratney A. B., 1999, Precision agriculture '99, Part 1 and Part 2. Papers presented at the 2nd European Conference on Precision Agriculture, Odense, Denmark, 11-15 July 1999, P101; McGranahan DA, 2013, LAND-BASEL, V2, P328, DOI 10.3390/land2030328; Mishra N, 2014, REMOTE SENS-BASEL, V6, P12619, DOI 10.3390/rs61212619; Mondal A, 2017, EGYPT J REMOTE SENS, V20, P61, DOI 10.1016/j.ejrs.2016.06.004; Ofori C.S., 1993, SOIL B, P77; Post WM, 2001, CLIMATIC CHANGE, V51, P73, DOI 10.1023/A:1017514802028; Quintero M., 2013, OPEN J SOIL SCI, V3, P361, DOI [DOI 10.4236/0JSS.2013.38042, 10.4236/ojss.2013.38042, DOI 10.4236/OJSS.2013.38042]; Reda GT, 2016, J ENV EARTH SCI, V6, P72; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Roy DP, 2016, REMOTE SENS ENVIRON, V185, P57, DOI 10.1016/j.rse.2015.12.024; Sapkota T.B., 2012, ORGANIC FERTILISATIO, V9, DOI [10.1007/978-94-007-4113-3_6, DOI 10.1007/978-94-007-4113-3_6]; Seyedmohammadi J, 2018, MODEL EARTH SYST ENV, V4, P777, DOI 10.1007/s40808-018-0450-0; Slepetiene A., 2008, Agronomy Research, V6, P543; Verma BC, 2010, ENVIRON MONIT ASSESS, V171, P579, DOI 10.1007/s10661-009-1301-2; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Ward JK, 2006, ASABE ANN INT M PORT; Whitehead D, 2010, 201236 MPI; Yeboah S, 2016, PLANT SOIL ENVIRON, V62, P279, DOI 10.17221/66/2016-PSE; Zarea MJ, 2010, SUSTAIN AGR REV, V5, P195, DOI 10.1007/978-90-481-9513-8_7; Zheng HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199523	40	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212521	10.1371/journal.pone.0212521	http://dx.doi.org/10.1371/journal.pone.0212521			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779819	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900063
J	Tsubosaka, Y; Maehara, T; Imai, D; Nakamura, T; Kobayashi, K; Nagata, N; Fujii, W; Murata, T				Tsubosaka, Yoshiki; Maehara, Toko; Imai, Daiki; Nakamura, Tatsuro; Kobayashi, Koji; Nagata, Nanae; Fujii, Wataru; Murata, Takahisa			Hematopoietic prostaglandin D synthase-derived prostaglandin D-2 ameliorates adjuvant-induced joint inflammation in mice	FASEB JOURNAL			English	Article						vascular permeability; angiogenesis; macrophage; DP receptor	RHEUMATOID-ARTHRITIS; CELLS; HYPERPERMEABILITY; OSTEOARTHRITIS	Although prostaglandins (PGs) are known to be involved in the progression of arthritis, the role of PGD(2) remains unclear. In this study, we evaluated the role of PGD(2) in joint inflammation using genetically modified mice. Injection of complete Freund's adjuvant (CFA) increased the production of PGD(2) and induced paw swelling and cartilage erosion in wild-type (WT) mice. These phenomena were accompanied with an increase in the mRNA levels of TNF-alpha, IL-6, IL-1 beta, and matrix-degrading metalloproteinase-9. Knockdown of hematopoietic PGD synthase (H-PGDS) abolished the PGD(2) production and exacerbated all of the arthritic manifestations in the inflamed paw. Immunostaining revealed that infiltrating macrophages strongly expressed H-PGDS in the CFA-injected paw. Morphologic studies revealed vascular hyperpermeability and angiogenesis in the inflamed WT paw. H-PGDS deficiency was accelerated, whereas daily administration of a PGD(2) receptor D prostanoid (DP) agonist attenuated the CFA-induced hyperpermeability and angiogenesis. We further confirmed that DP deficiency exacerbated, whereas the administration of the DP agonist improved, the CFA-induced arthritic manifestations. The findings demonstrate that H-PGDS-derived PGD(2) ameliorates joint inflammation by attenuating vascular permeability and subsequent angiogenesis and indicates the therapeutic potential of a DP agonist for arthritis.-Tsubosaka, Y., Maehara, T., Imai, D., Nakamura, T., Kobayashi, K., Nagata, N., Fujii, W., Murata, T. Hematopoietic prostaglandin D synthase-derived prostaglandin D-2 ameliorates adjuvant-induced joint inflammation in mice.	[Tsubosaka, Yoshiki; Maehara, Toko; Imai, Daiki; Nakamura, Tatsuro; Kobayashi, Koji; Nagata, Nanae; Murata, Takahisa] Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Tokyo, Japan; [Fujii, Wataru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Genet, Tokyo, Japan	University of Tokyo; University of Tokyo	Murata, T (corresponding author), Univ Tokyo, Dept Anim Radiol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1 Yayoi, Tokyo 1138657, Japan.	amurata@mail.ecc.u-tokyo.ac.jp		Fujii, Wataru/0000-0002-6438-7350; Murata, Takahisa/0000-0002-3328-0796	Research Fellowship for Young Scientists; Japan Society for the Promotion of Science; Novartis Foundation; Hoyu Science Foundation; Nakatomi Foundation	Research Fellowship for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Novartis Foundation(Novartis); Hoyu Science Foundation; Nakatomi Foundation	This work was supported by the Research Fellowship for Young Scientists (to Y.T. and T.M.), and a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, The Novartis Foundation, Hoyu Science Foundation, and The Nakatomi Foundation (to T.M.). The authors declare no conflicts of interest.	Bates DO, 2010, CARDIOVASC RES, V87, P262, DOI 10.1093/cvr/cvq105; Chen YF, 2008, HEALTH TECHNOL ASSES, V12, P1, DOI 10.3310/hta12110; Chillingworth NL, 2003, J NEUROSCI METH, V128, P45, DOI 10.1016/S0165-0270(03)00147-X; Fujii W, 2014, BIOCHEM BIOPH RES CO, V445, P791, DOI 10.1016/j.bbrc.2014.01.141; Hennigan Stephanie, 2008, Ther Clin Risk Manag, V4, P767; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Kobayashi K, 2013, ARTERIOSCL THROM VAS, V33, P565, DOI 10.1161/ATVBAHA.112.300993; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Lam J, 2000, J CLIN INVEST, V106, P1481, DOI 10.1172/JCI11176; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; McCoy JM, 2002, J CLIN INVEST, V110, P651, DOI 10.1172/JCI200215528; MIHARA M, 1995, BRIT J RHEUMATOL, V34, P321; Moghaddami M, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/329494; Mohri I, 2006, J NEUROSCI, V26, P4383, DOI 10.1523/JNEUROSCI.4531-05.2006; Murata T, 2013, P NATL ACAD SCI USA, V110, P5205, DOI 10.1073/pnas.1218091110; Murata T, 2008, P NATL ACAD SCI USA, V105, P20009, DOI 10.1073/pnas.0805171105; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Prasad R, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-14; Qu WM, 2006, P NATL ACAD SCI USA, V103, P17949, DOI 10.1073/pnas.0608581103; Quinteiro MS, 2014, EUR J PHARMACOL, V740, P58, DOI 10.1016/j.ejphar.2014.07.002; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; Ruiz-Miyazawa KW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32334-0; Sarashina H, 2014, J IMMUNOL, V192, P459, DOI 10.4049/jimmunol.1302080; Simon LS, 1998, ARTHRITIS RHEUM-US, V41, P1591, DOI 10.1002/1529-0131(199809)41:9<1591::AID-ART9>3.0.CO;2-J; Sone H, 2001, BIOCHEM BIOPH RES CO, V281, P562, DOI 10.1006/bbrc.2001.4395; Tanaka K, 2000, J IMMUNOL, V164, P2277, DOI 10.4049/jimmunol.164.5.2277; Toussirot E, 2007, EXPERT OPIN PHARMACO, V8, P2089, DOI 10.1517/14656566.8.13.2089; TRANG LE, 1977, SCAND J RHEUMATOL, V6, P151, DOI 10.3109/03009747709095440; Tsubosaka Y, 2014, J IMMUNOL, V193, P5835, DOI 10.4049/jimmunol.1303478; URADE Y, 1989, J IMMUNOL, V143, P2982; URADE Y, 1990, J BIOL CHEM, V265, P371; Wang MJ, 2015, DISCOV MED, V19, P23	32	8	9	2	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6829	6837		10.1096/fj.201802153R	http://dx.doi.org/10.1096/fj.201802153R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811953	Bronze			2022-12-26	WOS:000476114200013
J	Calvino-Sampedro, C; Gomez-Tourino, I; Cordero, OJ; Reche, PA; Gomez-Perosanz, M; Sanchez-Trincado, JL; Rodriguez, MA; Sueiro, AM; Vinuela, JE; Calvino, RV				Calvino-Sampedro, Cristina; Gomez-Tourino, Iria; Cordero, Oscar J.; Reche, Pedro A.; Gomez-Perosanz, Marta; Luis Sanchez-Trincado, Jose; Angel Rodriguez, Miguel; Sueiro, Aurelio M.; Vinuela, Juan E.; Varela Calvino, Ruben			Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-are targets of the autoimmune response in type 1 diabetes	FASEB JOURNAL			English	Article						cytotoxic lymphocytes; autoantigen; S100 peptide epitopes; immunotherapy; peri-insular Schwann cells	T-CELL TOLERANCE; SCHWANN-CELLS; RECENT-ONSET; PEPTIDE; IDENTIFICATION; ANTIGEN; VACCINATION; MOLECULES; AFFINITY; BINDING	Type 1 diabetes (T1D) results from the destruction of pancreatic -cells by the immune system, and CD8(+) T lymphocytes are critical actors in this autoimmune response. Pancreatic islets are surrounded by a mesh of nervous cells, the peri-insular Schwann cells, which are also targeted by autoreactive T lymphocytes and express specific antigens, such as the neurotrophic factor S100-. Previous work has shown increased proliferative responses to whole S100- in both human T1D patients and the nonobese diabetic (NOD) mouse model. We describe for the first time naturally processed and presented epitopes (NPPEs) presented by class I human leukocyte antigen-A*02:01 (A2.1) molecules derived from S100-. These NPPEs triggered IFN- responses more frequently in both newly diagnosed and long-term T1D patients compared with healthy donors. Furthermore, the same NPPEs are recognized during the autoimmune response leading to diabetes in A2.1-transgenic NOD mice as early as 4 wk of age. Interestingly, when these NPPEs are used to prevent diabetes in this animal model, an acceleration of the disease is observed together with an exacerbation in insulitis and an increase in S100--specific cytotoxicity in vaccinated animals. Whether these can be used in diabetes prevention needs to be carefully evaluated in animal models before use in future clinical assays.Calvino-Sampedro, C., Gomez-Tourino, I., Cordero, O. J., Reche, P. A., Gomez-Perosanz, M., Sanchez-Trincado, J. L., Rodriguez, M. a., Sueiro, A. M., Vinuela, J. E., Calvino, R. V. Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100- are targets of the autoimmune response in type 1 diabetes.	[Calvino-Sampedro, Cristina; Gomez-Tourino, Iria; Cordero, Oscar J.; Varela Calvino, Ruben] Univ Santiago Compostela, Dept Bioquim & Biol Mol, Fac Farm, Campus Vida S-N, Santiago De Compostela 15782, La Coruna, Spain; [Angel Rodriguez, Miguel] Univ Santiago Compostela, Dept Biol Func, Ctr Invest Bioloxia CIBUS, Santiago De Compostela, Spain; [Reche, Pedro A.; Gomez-Perosanz, Marta; Luis Sanchez-Trincado, Jose] Univ Complutense Madrid, Dept Inmunol, Fac Med, Madrid, Spain; [Sueiro, Aurelio M.] Complejo Hosp Univ Santiago Compostela CHUS, Hosp Clin Univ, Serv Endocrinol & Nutric, Santiago De Compostela, Spain; [Vinuela, Juan E.] Complejo Hosp Univ Santiago Compostela CHUS, Hosp Clin Univ, Serv Inmunol, Santiago De Compostela, Spain; [Gomez-Tourino, Iria] Univ Santiago Compostela, CIMUS Res Ctr, Dept Pharmacol Pharm & Pharmaceut Technol, BioFarma Res Grp, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; Complutense University of Madrid; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela	Calvino, RV (corresponding author), Univ Santiago Compostela, Dept Bioquim & Biol Mol, Fac Farm, Campus Vida S-N, Santiago De Compostela 15782, La Coruna, Spain.	ruben.varela@usc.es	Gomez-Tourino, Iria/AAA-9948-2019; Sampedro Torres Quevedo, Cristina/GVW-1493-2022; Varela-Calvino, Ruben/ABF-9910-2020; Reche, Pedro A/B-1881-2013; Calviño Sampedro, Cristina/AAC-3301-2021; Sanchez-Trincado, Jose Luis/AAH-5891-2020	Gomez-Tourino, Iria/0000-0001-6594-6110; Varela-Calvino, Ruben/0000-0002-4978-661X; Reche, Pedro A/0000-0003-3966-5838; Calviño Sampedro, Cristina/0000-0002-5121-0265; Sanchez-Trincado, Jose Luis/0000-0002-9150-1315; Gomez-Perosanz, Marta/0000-0002-2411-4358; Vinuela, Juan Evaristo/0000-0001-7778-901X	Ministerio de Economia y Competitividad [BIO2014-53091-C3-3-R]; Maria Barbeito predoctoral fellowship (Xunta de Galicia, La Coruna, Spain); Deputacion da Coruna grant	Ministerio de Economia y Competitividad(Spanish Government); Maria Barbeito predoctoral fellowship (Xunta de Galicia, La Coruna, Spain); Deputacion da Coruna grant	The authors thank Dr. Sefina Arif (King's College London, London, United Kingdom) for critically reviewing the manuscript. This work was funded by the Ministerio de Economia y Competitividad (Grant BIO2014-53091-C3-3-R to R.V.C.). During this work, I.G.-T. was supported by a Maria Barbeito predoctoral fellowship (Xunta de Galicia, La Coruna, Spain). During this work, C.C.-S. was supported by a Deputacion da Coruna grant (2012-2013 and 2016-2017). The authors declare no conflicts of interest.	AICHELE P, 1994, P NATL ACAD SCI USA, V91, P444, DOI 10.1073/pnas.91.2.444; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Banwell B, 2008, ANN NEUROL, V63, P98, DOI 10.1002/ana.21244; Bergman ML, 2017, J EXP MED, V214, P2153, DOI 10.1084/jem.20160471; Bunce Mike, 2003, Methods Mol Biol, V210, P143; Burbelo PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045216; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Daniel C, 2011, J EXP MED, V208, P1501, DOI 10.1084/jem.20110574; Diez-Rivero CM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-479; Gomez-Tourino I, 2015, CLIN EXP IMMUNOL, V180, P207, DOI 10.1111/cei.12572; Gomez-Tourino I, 2010, DIABETIC MED, V27, P247, DOI 10.1111/j.1464-5491.2009.02911.x; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; In't Veld P, 2011, ISLETS, V3, P131, DOI 10.4161/isl.3.4.15728; ITOH N, 1993, J CLIN INVEST, V92, P2313, DOI 10.1172/JCI116835; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Leete P, 2016, DIABETES, V65, P1362, DOI 10.2337/db15-1615; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Liu E, 2002, ANN NY ACAD SCI, V958, P224; LIU GY, 1995, INT IMMUNOL, V7, P1255, DOI 10.1093/intimm/7.8.1255; Marron MP, 2002, P NATL ACAD SCI USA, V99, P13753, DOI 10.1073/pnas.212221199; Morran MP, 2015, MOL ASPECTS MED, V42, P42, DOI 10.1016/j.mam.2014.12.004; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Neri S, 2001, CLIN DIAGN LAB IMMUN, V8, P1131, DOI 10.1128/CDLI.8.6.1131-1135.2001; Noble JA, 2010, DIABETES, V59, P2972, DOI 10.2337/db10-0699; Nussbaum AK, 2001, IMMUNOGENETICS, V53, P87, DOI 10.1007/s002510100300; PARKER KC, 1994, J IMMUNOL, V152, P163; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Reche PA, 2004, IMMUNOGENETICS, V56, P405, DOI 10.1007/s00251-004-0709-7; Redmond WL, 2005, IMMUNITY, V22, P275, DOI 10.1016/j.immuni.2005.01.010; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Roep BO, 2011, CURR OPIN IMMUNOL, V23, P746, DOI 10.1016/j.coi.2011.10.001; Serre L, 2015, EUR J IMMUNOL, V45, P1946, DOI 10.1002/eji.201445290; SETTE A, 1994, J IMMUNOL, V153, P5586; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Standifer NE, 2006, DIABETES, V55, P3061, DOI 10.2337/db06-0066; Tang SC, 2013, DIABETOLOGIA, V56, P2424, DOI 10.1007/s00125-013-2977-y; Taplin CE, 2008, AUTOIMMUNITY, V41, P11, DOI 10.1080/08916930701619169; Toes REM, 1996, P NATL ACAD SCI USA, V93, P7855, DOI 10.1073/pnas.93.15.7855; Tsui H, 2008, DIABETES, V57, P918, DOI 10.2337/db07-0226; Varela-Calvino R, 2004, J VIROL, V78, P13399, DOI 10.1128/JVI.78.24.13399-13408.2004; Wang B, 1996, EUR J IMMUNOL, V26, P1762, DOI 10.1002/eji.1830260815; WEKERLE H, 1986, EUR J IMMUNOL, V16, P1551, DOI 10.1002/eji.1830161214; Wenzlau JM, 2007, P NATL ACAD SCI USA, V104, P17040, DOI 10.1073/pnas.0705894104; Willcox A, 2009, CLIN EXP IMMUNOL, V155, P173, DOI 10.1111/j.1365-2249.2008.03860.x; Winer S, 2003, NAT MED, V9, P198, DOI 10.1038/nm818; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	51	3	3	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6390	6401		10.1096/fj.201802270R	http://dx.doi.org/10.1096/fj.201802270R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817223	Green Published, hybrid			2022-12-26	WOS:000466932600046
J	Rossl, A; Denoncourt, A; Lin, MS; Downey, M				Rossl, Anthony; Denoncourt, Alix; Lin, Mong-Shang; Downey, Michael			A synthetic non-histone substrate to study substrate targeting by the Gcn5 HAT and sirtuin HDACs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acetylation; yeast; sirtuin; fusion protein; transcription coactivator; Gcn5; SAGA; synthetic biology; yeast	HISTONE ACETYLTRANSFERASE COMPLEX; SACCHAROMYCES-CEREVISIAE; LYSINE ACETYLATION; GENE-EXPRESSION; TERMINAL DOMAIN; PROTEIN SIR2; YEAST SAGA; CELL-CYCLE; TRANSCRIPTION; ADA2	Gcn5 and sirtuins are highly conserved histone acetyltransferase (HAT) and histone deacetylase (HDAC) enzymes that were first characterized as regulators of gene expression. Although histone tails are important substrates of these enzymes, they also target many nonhistone proteins that function in diverse biological processes. However, the mechanisms used by these enzymes to choose their nonhistone substrates are unknown. Previously, we used SILAC-based MS to identify novel nonhistone substrates of Gcn5 and sirtuins in yeast and found a shared target consensus sequence. Here, we use a synthetic biology approach to demonstrate that this consensus sequence can direct acetylation and deacetylation targeting by these enzymes in vivo. Remarkably, fusion of the sequence to a nonsubstrate confers de novo acetylation that is regulated by both Gcn5 and sirtuins. We exploit this synthetic fusion substrate as a tool to define subunits of the Gcn5-containing SAGA and ADA complexes required for nonhistone protein acetylation. In particular, we find a key role for the Ada2 and Ada3 subunits in regulating acetylations on our fusion substrate. In contrast, other subunits tested were largely dispensable, including those required for SAGA stability. In an extended analysis, defects in proteome-wide acetylation observed in ada3 mutants mirror those in ada2 mutants. Altogether, our work argues that nonhistone protein acetylation by Gcn5 is determined in part by specific amino acids surrounding target lysines but that even optimal sequences require both Ada2 and Ada3 for robust acetylation. The synthetic fusion substrate we describe can serve as a tool to further dissect the regulation of both Gcn5 and sirtuin activities in vivo.	[Rossl, Anthony; Denoncourt, Alix; Downey, Michael] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Rossl, Anthony; Denoncourt, Alix; Downey, Michael] Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Lin, Mong-Shang] BioLegend, San Diego, CA 92121 USA	University of Ottawa; University of Ottawa	Downey, M (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada.; Downey, M (corresponding author), Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada.	mdowne2@uottawa.ca		Rossl, Anthony/0000-0002-2496-6358	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2016-05015]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grant RGPIN-2016-05015 (to M. D.). MongShang Lin is an employee of BioLegend, and the monoclonal antibody generation was carried out in BioLegend's facility in San Diego, CA.	Balasubramanian R, 2002, J BIOL CHEM, V277, P7989, DOI 10.1074/jbc.M110849200; Bentley-DeSousa A, 2018, CELL REP, V22, P3427, DOI 10.1016/j.celrep.2018.02.104; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Bloemendal S, 2012, MOL MICROBIOL, V84, P310, DOI 10.1111/j.1365-2958.2012.08024.x; BRACHMANN CB, 1995, GENE DEV, V9, P2888, DOI 10.1101/gad.9.23.2888; Cai L, 2013, CELL REP, V4, P1063, DOI 10.1016/j.celrep.2013.08.016; Cai L, 2011, MOL CELL, V42, P426, DOI 10.1016/j.molcel.2011.05.004; Candau R, 1996, MOL CELL BIOL, V16, P593; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; Che J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004990; Cherry JM, 2012, NUCLEIC ACIDS RES, V40, pD700, DOI 10.1093/nar/gkr1029; Choi JK, 2008, MOL CELL BIOL, V28, P6967, DOI 10.1128/MCB.00570-08; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Downey M, 2016, BRIEF FUNCT GENOMICS, V15, P109, DOI 10.1093/bfgp/elv045; Downey M, 2015, MOL CELL PROTEOMICS, V14, P162, DOI 10.1074/mcp.M114.043141; Downey M, 2013, CURR BIOL, V23, P1638, DOI 10.1016/j.cub.2013.06.050; Eberharter A, 1999, MOL CELL BIOL, V19, P6621; Froyd CA, 2011, MOL CELL BIOL, V31, P3351, DOI 10.1128/MCB.05175-11; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Helmlinger D, 2017, TRENDS BIOCHEM SCI, V42, P850, DOI 10.1016/j.tibs.2017.09.001; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; KRUGER W, 1991, MOL CELL BIOL, V11, P4135, DOI 10.1128/MCB.11.8.4135; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Laprade L, 2007, GENETICS, V177, P2007, DOI 10.1534/genetics.107.081976; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Madsen CT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8726; MARCUS GA, 1994, EMBO J, V13, P4807, DOI 10.1002/j.1460-2075.1994.tb06806.x; McCord R, 2003, MOL CELL BIOL, V23, P2009, DOI 10.1128/MCB.23.6.2009-2016.2003; McCormick MA, 2014, CELL REP, V8, P476, DOI 10.1016/j.celrep.2014.06.037; Mead J, 2007, MOL CELL BIOL, V27, P2466, DOI 10.1128/MCB.01641-06; Niedenthal RK, 1996, YEAST, V12, P773, DOI 10.1002/(SICI)1097-0061(19960630)12:8<773::AID-YEA972>3.3.CO;2-C; Peng WM, 2008, GENETICS, V179, P277, DOI 10.1534/genetics.107.085068; Perez-Martin J, 1998, MOL CELL BIOL, V18, P4157, DOI 10.1128/MCB.18.7.4157; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Pracheil T, 2013, J BIOL CHEM, V288, P16986, DOI 10.1074/jbc.M113.451674; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Rossl A, 2016, GENETICS, V204, P569, DOI 10.1534/genetics.116.193524; Sermwittayawong D, 2006, EMBO J, V25, P3791, DOI 10.1038/sj.emboj.7601265; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Starr AE, 2017, GUT, V66, P1573, DOI 10.1136/gutjnl-2015-310705; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Sterner DE, 2002, J BIOL CHEM, V277, P8178, DOI 10.1074/jbc.M108601200; Sun J, 2018, P NATL ACAD SCI USA, V115, P10010, DOI 10.1073/pnas.1805343115; Tanny JC, 2004, MOL CELL BIOL, V24, P6931, DOI 10.1128/MCB.24.16.6931-6946.2004; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Wierman MB, 2014, FEMS YEAST RES, V14, P73, DOI 10.1111/1567-1364.12115; Wilson JM, 2006, EMBO REP, V7, P1247, DOI 10.1038/sj.embor.7400829; Wu PYJ, 2002, MOL CELL BIOL, V22, P5367, DOI 10.1128/MCB.22.15.5367-5379.2002; Xie JX, 1999, EMBO J, V18, P6448, DOI 10.1093/emboj/18.22.6448; Yen YM, 2001, TRAFFIC, V2, P449, DOI 10.1034/j.1600-0854.2001.20703.x; Zhang X, 2018, J PROTEOMICS, V180, P120, DOI 10.1016/j.jprot.2017.07.001	69	6	6	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6227	6239		10.1074/jbc.RA118.006051	http://dx.doi.org/10.1074/jbc.RA118.006051			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30804216	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000468402000003
J	Amit, A; Sabo, E; Movsas, A; Efrat-Tamam, Y; Reiss, A; Matanes, E; Klorin, G				Amit, Amnon; Sabo, Edmond; Movsas, Avielle; Efrat-Tamam, Yamit; Reiss, Ari; Matanes, Emad; Klorin, Geula			Can morphometric analysis of the fallopian tube fimbria predict the presence of uterine papillary serous carcinoma (UPSC)?	PLOS ONE			English	Article							PRECURSOR LESIONS; CANCER; EPITHELIUM; ADENOCARCINOMA; ENDOMETRIUM; DYSPLASIA; PROGNOSIS; GRADE	Uterine serous papillary carcinoma (UPSC) is an aggressive tumor, often diagnosed as a metastatic disease and characterized by a high recurrence rate and poor prognosis. UPSC represents a distinct subtype of endometrial cancer which is different in clinical and pathological behaviors from endometrioid endometrial carcinoma (EEC) and resembles more to serous ovarian carcinoma. Since tumors of serous papillary of the ovary are hypothesized to stem from cells of the fallopian tube's fimbria, we hypothesized that UPSC may also origin in the fallopian tubes. In our previous study, using a novel method of computerized morphometry of the fimbrial epithelium we have found significant differences between fimbriae of healthy women and serous ovarian cancer patients. In this study we showed the presence of morphologic differences between twenty-four fimbriae from healthy women, and twenty six fimbriae from uterus cancer (13 from UPSC patients and 13 from EEC patients). All fimbriae reported by the pathologist as "normal" were subjected to a computerized histomorphometric analysis. Two-step method of computerized histomorphometry, i.e. Fast Fourier transformation (FFT) followed by a co-occurrence matrix analysis and an additional analysis of the nuclear symmetry of the tubal fimbrial epithelium were applied. Using these novel methods, we were able to show differences in the morphometric characteristics of the fimbriae in UPSC patients compared to EEC and healthy patients. It is yet to be determined the clinical significance of this observation.	[Amit, Amnon; Reiss, Ari; Matanes, Emad; Klorin, Geula] Rambam Hlth Care Campus, Dept Obstet & Gynecol, Haifa, Israel; [Amit, Amnon; Sabo, Edmond; Movsas, Avielle; Efrat-Tamam, Yamit; Matanes, Emad; Klorin, Geula] Technion Israel Inst Technol, Fac Med, Haifa, Israel; [Sabo, Edmond] Carmel Hosp, Inst Pathol, Haifa, Israel	Rambam Health Care Campus; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Clalit Health Services; Carmel Medical Center	Klorin, G (corresponding author), Rambam Hlth Care Campus, Dept Obstet & Gynecol, Haifa, Israel.; Klorin, G (corresponding author), Technion Israel Inst Technol, Fac Med, Haifa, Israel.	g_klorin@rambam.health.gov.il						Amit A, 2017, INT J GYNECOLOGICAL, P1, DOI [10.1097/PGP.0000000000000379, DOI 10.1097/PGP.0000000000000379]; Bahar-Shany K, 2014, GYNECOL ONCOL, V132, P322, DOI 10.1016/j.ygyno.2013.12.015; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Colombo N, 2013, ANN ONCOL, V24, P33, DOI 10.1093/annonc/mdt353; Creasman W, 2009, INT J GYNECOL OBSTET, V105, P109, DOI 10.1016/j.ijgo.2009.02.010; Darvishian T, 2004, AM J SURG PATHOL, V28, P1568, DOI 10.1097/00000478-200412000-00004; del Carmen MG, 2012, GYNECOL ONCOL, V127, P651, DOI 10.1016/j.ygyno.2012.09.012; Deligdisch L, 1999, CANCER-AM CANCER SOC, V86, P1544, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I; Egeblad M, 2010, DEV CELL, V18, P884, DOI 10.1016/j.devcel.2010.05.012; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Huang CY, 2014, GYNECOL ONCOL, V133, P221, DOI 10.1016/j.ygyno.2014.02.010; Jarboe EA, 2009, INT J GYNECOL PATHOL, V28, P308, DOI 10.1097/PGP.0b013e3181934390; Mu Tian, 2015, Zhonghua Fu Chan Ke Za Zhi, V50, P757; NAKAJO S, 1989, VIRCHOWS ARCH A, V416, P133, DOI 10.1007/BF01606318; Sabo E, 2006, LAB INVEST, V86, P1261, DOI 10.1038/labinvest.3700481; Shaw PA, 2009, MODERN PATHOL, V22, P1133, DOI 10.1038/modpathol.2009.89; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Singh P, 2008, INT J GYNECOL CANCER, V18, P1344, DOI 10.1111/j.1525-1438.2007.01181.x; Solmaz U, 2016, TUMORI, V102, P593, DOI 10.5301/tj.5000531; Tolcher MC, 2015, INT J GYNECOL PATHOL, V34, P57, DOI 10.1097/PGP.0000000000000109; Vang R, 2013, HISTOPATHOLOGY, V62, P44, DOI 10.1111/his.12046; Villella JA, 2006, INT J GYNECOL CANCER, V16, P1897, DOI 10.1111/j.1525-1438.2006.00664.x; Zhang B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-868	23	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0211329	10.1371/journal.pone.0211329	http://dx.doi.org/10.1371/journal.pone.0211329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30818325	Green Submitted, gold, Green Published			2022-12-26	WOS:000460371500012
J	Wang, XQ; Miao, J; Chang, TP; Xia, JW; An, BX; Li, Y; Xu, LY; Zhang, LP; Gao, X; Li, JY; Gao, HJ				Wang, Xiaoqiao; Miao, Jian; Chang, Tianpeng; Xia, Jiangwei; An, Binxin; Li, Yan; Xu, Lingyang; Zhang, Lupei; Gao, Xue; Li, Junya; Gao, Huijiang			Evaluation of GBLUP, BayesB and elastic net for genomic prediction in Chinese Simmental beef cattle	PLOS ONE			English	Article							RIDGE-REGRESSION; SELECTION; TRAITS	Chinese Simmental beef cattle are the most economically important cattle breed in China. Estimated breeding values for growth, carcass, and meat quality traits are commonly used as selection criteria in animal breeding. The objective of this study was to evaluate the accuracy of alternative statistical methods for the estimation of genomic breeding values. Analyses of the accuracy of genomic best linear unbiased prediction (GBLUP), BayesB, and elastic net (EN) were performed with an Illumina BovineHD BeadChip on 1,217 animals by applying 5-fold cross-validation. Overall, the accuracies ranged from 0.17 to 0.296 for ten traits, and the heritability estimates ranged from 0.36 to 0.63. The EN (alpha = 0.001) model provided the most accurate prediction, which was also slightly higher (0.2-2%) than that of GBLUP for most traits, such as average daily weight gain (ADG) and carcass weight (CW). BayesB was less accurate for each trait than were EN (alpha = 0.001) and GBLUP. These findings indicate the importance of using an appropriate variable selection method for the genomic selection of traits and suggest the influence of the genetic architecture of the traits we analyzed.	[Wang, Xiaoqiao; Miao, Jian; Chang, Tianpeng; Xia, Jiangwei; An, Binxin; Xu, Lingyang; Zhang, Lupei; Gao, Xue; Li, Junya; Gao, Huijiang] Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing, Peoples R China; [Li, Yan] Vet Bur Wulagai Precinct Xilin Gol League, Wulagai, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Li, JY; Gao, HJ (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, Lab Mol Biol & Bovine Breeding, Beijing, Peoples R China.	lijunya@caas.cn; gaohuijiang@caas.cn	Xu, Lingyang/W-8664-2019		National Natural Science Foundation of China [31872975, 31672384, 31572376]; Chinese Academy of Agricultural Sciences of Technology Innovation Project [CAAS-XTCX2016010, CAAS-ZDXT2018006, ASTIP-IAS03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Agricultural Sciences of Technology Innovation Project	This work was supported by funds from the National Natural Science Foundation of China 31872975 for Huijiang Gao, National Natural Science Foundation of China 31672384 for Lupei Zhang, National Natural Science Foundation of China 31572376 for Xue Gao, and the Chinese Academy of Agricultural Sciences of Technology Innovation Project (CAAS-XTCX2016010, CAAS-ZDXT2018006 and ASTIP-IAS03) for Junya Li.	Angeles Perez-Cabal M., 2012, Frontiers in Genetics, V3, P27, DOI 10.3389/fgene.2012.00027; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Clark SA, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-4; Fan HZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep18389; Fernandes GA, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0188-y; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2009, NAT REV GENET, V10, P381, DOI 10.1038/nrg2575; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Grandvalet Y., 1998, LEAST ABSOLUTE SHRIN, P201; Guo P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179885; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001139; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Legarra A, 2011, GENET RES, V93, P77, DOI 10.1017/S0016672310000534; Lu D, 2016, J ANIM SCI, V94, P1342, DOI 10.2527/jas.2015-0126; Mehrban H, 2017, GENET SEL EVOL, V49, DOI 10.1186/s12711-016-0283-0; Meuwissen THE, 2001, GENETICS, V157, P1819; Ogutu Joseph O, 2012, BMC Proc, V6 Suppl 2, pS10, DOI 10.1186/1753-6561-6-S2-S10; Onogi A, 2014, J ANIM SCI, V92, P1931, DOI 10.2527/jas.2014-7168; Piepho HP, 2009, CROP SCI, V49, P1165, DOI 10.2135/cropsci2008.10.0595; Saatchi M, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-40; Shikha M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00550; Somavilla AL, 2017, G3-GENES GENOM GENET, V7, P1855, DOI 10.1534/g3.117.041442; Sun Xiaochen, 2011, BMC Proc, V5 Suppl 3, pS13, DOI 10.1186/1753-6561-5-S3-S13; Tibshirani R., 1996, REGRESSION SELECTION; Tutz G, 2009, STAT COMPUT, V19, P239, DOI 10.1007/s11222-008-9088-5; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Waldmann Patrik, 2013, Frontiers in Genetics, V4, P270, DOI 10.3389/fgene.2013.00270; Xu SZ, 2013, GENETICS, V195, P1103, DOI 10.1534/genetics.113.155309; Zhang Z, 2010, PLOS ONE, V5; Zhu B, 2016, PLOS ONE, V11; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	32	16	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0210442	10.1371/journal.pone.0210442	http://dx.doi.org/10.1371/journal.pone.0210442			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817758	Green Submitted, Green Published, gold			2022-12-26	WOS:000460371500006
J	Kim, D				Kim, Dongwon			A computational scheme for internal models not requiring precise system parameters	PLOS ONE			English	Article							EQUILIBRIUM-POINT CONTROL; TRAJECTORY FORMATION; REACHING MOVEMENTS; TIME-DELAY; INTERMEDIATE CEREBELLUM; FEEDBACK-CONTROL; PARIETAL CORTEX; ARM MOVEMENTS; MOTOR CONTROL; ADAPTATION	Utilization by humans of a precise and adaptable internal model of the dynamics of the body in generating movements is a well-supported concept. The prevailing opinion is that such an internal model ceaselessly develops through long-term repetition and accumulation in the central nervous system (CNS). However, a long-term learning process would not be absolutely necessary for the formation of internal models. It is possible to estimate the dynamics of the system by using a motor command and its resulting output, instead of constructing a model of the dynamics with precise parameters. In this study, a computational model is proposed that uses a motor command and its corresponding output to estimate the dynamics of the system and it is examined whether the proposed model is capable of describing a series of empirical movements. The proposed model was found to be capable of describing humans' fast movements which require compensation for system dynamics as well as sensory delays. In addition, the proposed model shows equifinality under inertial perturbations as seen in several experimental studies. This satisfactory reproducibility of the proposed computation raises the possibility that humans make a movement by estimating the system dynamics with a copy of motor command and sensory output on a momentary basis, without the need to identify precise system parameters.	[Kim, Dongwon] Univ Maryland, Sch Engn, Dept Biongineering, College Pk, MD 20742 USA; [Kim, Dongwon] Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore	Kim, D (corresponding author), Univ Maryland, Sch Engn, Dept Biongineering, College Pk, MD 20742 USA.; Kim, D (corresponding author), Univ Maryland, Sch Med, Dept Phys Therapy & Rehabil Sci, Baltimore, MD 21201 USA.	dwkim@umd.edu		Kim, Dongwon/0000-0003-1051-0031				Baek J, 2016, IEEE T IND ELECTRON, V63, P3628, DOI 10.1109/TIE.2016.2522386; Bard C, 1999, EXP BRAIN RES, V125, P410, DOI 10.1007/s002210050697; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; BIZZI E, 1984, J NEUROSCI, V4, P2738; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Chang PH, 2012, IEEE T ROBOT, V28, P773, DOI 10.1109/TRO.2012.2187397; Cluff T, 2013, J NEUROSCI, V33, P15903, DOI 10.1523/JNEUROSCI.0263-13.2013; Crevecoeur F, 2014, PLOS COMPUT BIOL, V10, DOI [10.1371/journal.pcbi.1003869, 10.1371/journal.pcbi.1003996]; Crevecoeur F, 2018, BIORXIV; de Lussanet MHE, 2002, HUM MOVEMENT SCI, V21, P85, DOI 10.1016/S0167-9457(02)00075-1; de Rugy A, 2012, J NEUROSCI, V32, P7384, DOI 10.1523/JNEUROSCI.5792-11.2012; Desmurget M, 2000, TRENDS COGN SCI, V4, P423, DOI 10.1016/S1364-6613(00)01537-0; DESMURGET M, 1995, CAN J PHYSIOL PHARM, V73, P262, DOI 10.1139/y95-037; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Dingwell JB, 2002, J NEUROPHYSIOL, V88, P222, DOI 10.1152/jn.2002.88.1.222; Feldman AG, 2005, EXP BRAIN RES, V161, P91, DOI 10.1007/s00221-004-2049-0; FELDMAN AG, 1986, J MOTOR BEHAV, V18, P17; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; Feldman AG, 2009, ADV EXP MED BIOL, V629, P699, DOI 10.1007/978-0-387-77064-2_38; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fortney K, 2012, NEURAL COMPUT, V24, P611, DOI 10.1162/NECO_a_00237; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Gawthrop P, 2011, BIOL CYBERN, V104, P31, DOI 10.1007/s00422-010-0416-4; Gritsenko V, 2009, J NEUROPHYSIOL, V102, P914, DOI 10.1152/jn.91324.2008; Hinder MR, 2003, J PHYSIOL-LONDON, V549, P953, DOI 10.1113/jphysiol.2002.033845; HOFF B, 1993, J MOTOR BEHAV, V25, P175, DOI 10.1080/00222895.1993.9942048; Hsia T. C., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P2070, DOI 10.1109/ROBOT.1990.126310; HSIA TCS, 1991, IEEE T IND ELECTRON, V38, P21, DOI 10.1109/41.103479; Hwang EJ, 2006, EXP BRAIN RES, V169, P496, DOI 10.1007/s00221-005-0163-2; Ilic DB, 1996, HUM MOVEMENT SCI, V15, P101, DOI 10.1016/0167-9457(95)00042-9; Jagacinski R. J., 2002, CONTROL THEORY HUMAN; JARIC S, 1994, EXP BRAIN RES, V100, P353; Jaric S, 1999, HUM MOVEMENT SCI, V18, P49, DOI 10.1016/S0167-9457(98)00033-5; Jin M, 2009, IEEE T IND ELECTRON, V56, P3593, DOI 10.1109/TIE.2009.2024097; KALASKA JF, 1990, EXP BRAIN RES, V80, P351; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kim D., 2013, NONLINEAR DYN, P1; Kim S., 2017, IEEE ASME T MECHATRO; Kistemaker DA, 2006, J NEUROPHYSIOL, V95, P2898, DOI 10.1152/jn.00983.2005; KLEINMAN DL, 1969, IEEE T AUTOMAT CONTR, VAC14, P524, DOI 10.1109/TAC.1969.1099242; KOIKE Y, 1995, BIOL CYBERN, V73, P291, DOI 10.1007/BF00199465; Krakauer JW, 1999, NAT NEUROSCI, V2, P1026, DOI 10.1038/14826; Kurtzer IL, 2008, CURR BIOL, V18, P449, DOI 10.1016/j.cub.2008.02.053; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Latash ML, 2008, J HUM KINET, V19, P3, DOI 10.2478/v10078-008-0001-2; Lee BC, 2016, EXP BRAIN RES, V234, P3523, DOI 10.1007/s00221-016-4750-1; MCINTYRE J, 1993, J MOTOR BEHAV, V25, P193, DOI 10.1080/00222895.1993.9942049; Miall RC, 2006, EXP BRAIN RES, V172, P77, DOI 10.1007/s00221-005-0306-5; MIALL RC, 1993, J MOTOR BEHAV, V25, P203, DOI 10.1080/00222895.1993.9942050; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Pinter IJ, 2011, J ELECTROMYOGR KINES, V21, P960, DOI 10.1016/j.jelekin.2011.08.001; Popa LS, 2013, CEREBELLUM, V12, P331, DOI 10.1007/s12311-013-0452-4; Popescu FC, 2000, J NEUROPHYSIOL, V84, P2670, DOI 10.1152/jn.2000.84.5.2670; Popescu FC, 2003, MOTOR CONTROL, V7, P323, DOI 10.1123/mcj.7.4.323; ROTHWELL JC, 1982, BRAIN RES, V248, P33, DOI 10.1016/0006-8993(82)91144-1; Schmid M, 2011, HUM MOVEMENT SCI, V30, P262, DOI 10.1016/j.humov.2011.02.002; Schweighofer N, 1998, EUR J NEUROSCI, V10, P86, DOI 10.1046/j.1460-9568.1998.00006.x; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 2008, EXP BRAIN RES, V185, P359, DOI 10.1007/s00221-008-1280-5; Shadmehr R, 2017, J NEUROSCI, V37, P1663, DOI 10.1523/JNEUROSCI.1675-16.2016; Smith O. J., 1959, ISA J, V6, P28; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; Van Ooteghem K, 2008, EXP BRAIN RES, V187, P603, DOI 10.1007/s00221-008-1329-5; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P57, DOI 10.1152/jn.1993.69.1.57; VANSOEST AJ, 1993, BIOL CYBERN, V69, P195, DOI 10.1007/BF00198959; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931; Wolpert DM, 1998, TRENDS COGN SCI, V2, P338, DOI 10.1016/S1364-6613(98)01221-2; YOUCEFTOUMI K, 1990, J DYN SYST-T ASME, V112, P133, DOI 10.1115/1.2894130; Zhou T, 2014, EXP BRAIN RES, V232, P3847, DOI 10.1007/s00221-014-4059-x	75	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210616	10.1371/journal.pone.0210616	http://dx.doi.org/10.1371/journal.pone.0210616			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811420	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400008
J	Ventero, MP; Fuentes-Baile, M; Quereda, C; Perez-Valeciano, E; Alenda, C; Garcia-Morales, P; Esposito, D; Dorado, P; Barbera, VM; Saceda, M				Paz Ventero, Maria; Fuentes-Baile, Maria; Quereda, Cristina; Perez-Valeciano, Elizabeth; Alenda, Cristina; Garcia-Morales, Pilar; Esposito, Danilo; Dorado, Pilar; Manuel Barbera, Victor; Saceda, Miguel			Radiotherapy resistance acquisition in Glioblastoma. Role of SOCS1 and SOCS3	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; CENTRAL-NERVOUS-SYSTEM; IDH2 MUTATIONS; PHASE-III; TUMORS; EXPRESSION; TEMOZOLOMIDE; METHYLATION; HYPERMETHYLATION; CLASSIFICATION	Glioblastoma multiforme (GBM) is a poor prognosis type of tumour due to its resistance to chemo and radiotherapy. SOCS1 and SOCS3 have been associated with tumour progression and response to treatments in different kinds of cancers, including GBM. In this study, cell lines of IDH-wildtype GBM from primary cultures were obtained, and the role of SOCS1 and SOCS3 in the radiotherapy response was analysed. Fifty-two brain aspirates from GBM patients were processed, and six new cell lines of IDH-wildtype GBM were established. These new cell lines were characterized according to the WHO classification of CNS tumours. SOCS1 and SOCS3 expression levels were determined, at mRNA level by Q-PCR, at protein level by immunocytochemistry, and Western blot analysis. The results showed that SOCS1 and SOCS3 are overexpressed in GBM, as compared to a non-tumoral brain RNA pool. SOCS1 and SOCS3 expression were reduced by siRNA, and it was found that SOCS3 inhibition increases radioresistance in GBM cell lines, suggesting a key role of SOCS3 in radioresistant acquisition. In addition, radioresistant clonal populations obtained by selective pressure on these cell cultures also showed a significant decrease in SOCS3 expression, while SOCS1 remained unchanged. Furthermore, the induction of SOCS3 expression, under a heterologous promoter, in a radiotherapy resistant GBM cell line increased its radiosensitivity, supporting an important implication of SOCS3 in radiotherapy resistance acquisition. Finally, the treatment with TSA in the most radioresistant established cell line produced an increase in the effect of radiotherapy, that correlated with an increase in the expression of SOCS3. These effects of TSA disappeared if the increase in the expression of SOCS3 prevented with an siRNA against SOCS3. Thus, SOCS3 signal transduction pathway (JAK/STAT) could be useful to unmask new putative targets to improve radiotherapy response in GBM.	[Paz Ventero, Maria; Manuel Barbera, Victor; Saceda, Miguel] Hosp Gen Univ Elche, FISABIO, Elx, Alicante, Spain; [Fuentes-Baile, Maria; Alenda, Cristina] Care Of Maestro Alonso, Hosp Gen Univ Alicante, Inst Invest Biomed & Sanitaria Alicante ISABIAL, Alicante, Alicante, Spain; [Quereda, Cristina; Manuel Barbera, Victor] Univ Alicante, Fac Ciencias, Dept Fisiol Genet & Microbiol, Alicante, Spain; [Perez-Valeciano, Elizabeth; Garcia-Morales, Pilar; Saceda, Miguel] Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain; [Esposito, Danilo; Dorado, Pilar] Hosp Gen Univ Elche, ERESA, Unidad Oncol Radioterap, Elche, Alicante, Spain	General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); Universitat d'Alacant; Universidad Miguel Hernandez de Elche	Barbera, VM; Saceda, M (corresponding author), Hosp Gen Univ Elche, FISABIO, Elx, Alicante, Spain.; Barbera, VM (corresponding author), Univ Alicante, Fac Ciencias, Dept Fisiol Genet & Microbiol, Alicante, Spain.; Saceda, M (corresponding author), Univ Miguel Hernandez, Inst Biol Mol & Celular, Elche, Alicante, Spain.	barbera_vicjua@gva.es; msaceda@umh.es	Alenda, Cristina/AAR-3433-2020; Saceda, Miguel/A-1581-2008; Garcia Morales, Pilar/ABD-4362-2021; Fuentes-Baile, María/ABF-7110-2021; Quereda, Cristina/AAB-7516-2019	Saceda, Miguel/0000-0002-1564-3602; Alenda, Cristina/0000-0002-0560-1759; Fuentes-Baile, Maria/0000-0003-3653-2407; Barbera, Victor-Manuel/0000-0002-4012-6973; Ventero, Maria Paz/0000-0003-1979-0949; Quereda, Cristina/0000-0003-2970-6712	"Instituto de Salud Carlos III" - FEDER funds [PI012/02025]; "Fundacion ERESA" small project; FISABIO grant [UGP-15-237]	"Instituto de Salud Carlos III" - FEDER funds; "Fundacion ERESA" small project; FISABIO grant	This article has been funded by a grant from "Instituto de Salud Carlos III" (Grant PI012/02025), co-supported by FEDER funds, to M. Saceda; "Fundacion ERESA" small project to M. Saceda, FISABIO grant (UGP-15-237) to V. M. Barbera, and a donation from AFECANCER to M. Saceda.	Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Beier D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-128; Blumenthal DT, 2015, INT J CLIN ONCOL, V20, P650, DOI 10.1007/s10147-014-0769-0; Cappellacci L, 2020, CURR MED CHEM, V27, P2449, DOI 10.2174/0929867325666181016163110; Carlsson SK, 2014, EMBO MOL MED, V6, P1359, DOI 10.15252/emmm.201302627; Carrasco-Garcia E, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090131; Chen Y, 2013, ARCH MED RES, V44, P281, DOI 10.1016/j.arcmed.2013.04.004; Chevrier M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3141-8; Culig Zoran, 2013, Front Biosci (Schol Ed), V5, P277; Evans MK, 2007, ONCOGENE, V26, P1941, DOI 10.1038/sj.onc.1209993; Festuccia C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0576-6; Gao SM, 2013, EXP HEMATOL, V41, P261, DOI 10.1016/j.exphem.2012.10.012; Goyal R, 2015, J NEUROSCI RURAL PRA, V6, P499, DOI 10.4103/0976-3147.168426; Handle F, 2016, MOL CANCER RES, V14, P574, DOI 10.1158/1541-7786.MCR-15-0495; Horbach L, 2018, MOL CLIN ONCOL, V8, P719, DOI 10.3892/mco.2018.1608; Jeuken JW, 2007, LAB INVEST, V87, P1055, DOI 10.1038/labinvest.3700664; Kim MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123133; Li GH, 2015, J CANCER RES CLIN, V141, P443, DOI 10.1007/s00432-014-1838-5; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Martini M, 2008, INT J CANCER, V123, P2955, DOI 10.1002/ijc.23805; Minegaki T, 2018, ONCOL LETT, V16, P6202, DOI 10.3892/ol.2018.9388; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Ohgaki H, 2005, ACTA NEUROPATHOL, V109, P93, DOI 10.1007/s00401-005-0991-y; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ostrom QT, 2016, NEURO-ONCOLOGY, V18, pv1, DOI 10.1093/neuonc/now207; Perazzoli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140131; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Rivera S, 2017, ONCOTARGET, V8, P56210, DOI 10.18632/oncotarget.14813; Sasi Walid, 2014, Mol Biol Int, V2014, P630797, DOI 10.1155/2014/630797; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thomas SJ, 2015, BRIT J CANCER, V113, P365, DOI 10.1038/bjc.2015.233; Trengove MC, 2013, AM J CLIN EXP IMMUNO, V2, P1; van den Bent MJ, 2010, CLIN CANCER RES, V16, P1597, DOI 10.1158/1078-0432.CCR-09-2902; Wang K, 2014, ONCOTARGET, V5, P12428, DOI 10.18632/oncotarget.2660; Xiong H, 2012, MOL CARCINOGEN, V51, P174, DOI 10.1002/mc.20777; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Zhou H, 2007, CLIN CANCER RES, V13, P2344, DOI 10.1158/1078-0432.CCR-06-2303	42	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212581	10.1371/journal.pone.0212581	http://dx.doi.org/10.1371/journal.pone.0212581			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811476	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400078
J	Rittenhouse, KJ; Vwalika, B; Keil, A; Winston, J; Stoner, M; Price, JT; Kapasa, M; Mubambe, M; Banda, V; Muunga, W; Stringer, JSA				Rittenhouse, Katelyn J.; Vwalika, Bellington; Keil, Alexander; Winston, Jennifer; Stoner, Marie; Price, Joan T.; Kapasa, Monica; Mubambe, Mulaya; Banda, Vanilla; Muunga, Whyson; Stringer, Jeffrey S. A.			Improving preterm newborn identification in low-resource settings with machine learning	PLOS ONE			English	Article							LAST MENSTRUAL PERIOD; GESTATIONAL-AGE ESTIMATION; FETAL-GROWTH; INFANTS BORN; ULTRASOUND; MORTALITY; OUTCOMES; TERM; SUPPLEMENTATION; STANDARDS	Background Globally, preterm birth is the leading cause of neonatal death with estimated prevalence and associated mortality highest in low-and middle-income countries (LMICs). Accurate identification of preterm infants is important at the individual level for appropriate clinical intervention as well as at the population level for informed policy decisions and resource allocation. As early prenatal ultrasound is commonly not available in these settings, gestational age (GA) is often estimated using newborn assessment at birth. This approach assumes last menstrual period to be unreliable and birthweight to be unable to distinguish preterm infants from those that are small for gestational age (SGA). We sought to leverage machine learning algorithms incorporating maternal factors associated with SGA to improve accuracy of preterm newborn identification in LMIC settings. Methods and findings This study uses data from an ongoing obstetrical cohort in Lusaka, Zambia that uses early pregnancy ultrasound to estimate GA. Our intent was to identify the best set of parameters commonly available at delivery to correctly categorize births as either preterm (<37 weeks) or term, compared to GA assigned by early ultrasound as the gold standard. Trained midwives conducted a newborn assessment (<72 hours) and collected maternal and neonatal data at the time of delivery or shortly thereafter. New Ballard Score (NBS), last menstrual period (LMP), and birth weight were used individually to assign GA at delivery and categorize each birth as either preterm or term. Additionally, machine learning techniques incorporated combinations of these measures with several maternal and newborn characteristics associated with prematurity and SGA to develop GA at delivery and preterm birth prediction models. The distribution and accuracy of all models were compared to early ultrasound dating. Within our live-born cohort to date (n = 862), the median GA at delivery by early ultrasound was 39.4 weeks (IQR: 38.3-40.3). Among assessed newborns with complete data included in this analysis (n = 468), the median GA by ultrasound was 39.6 weeks (IQR: 38.4-40.3). Using machine learning, we identified a combination of six accessible parameters (LMP, birth weight, twin delivery, maternal height, hypertension in labor, and HIV serostatus) that can be used by machine learning to outperform current GA prediction methods. For preterm birth prediction, this combination of covariates correctly classified >94% of newborns and achieved an area under the curve (AUC) of 0.9796. Conclusions We identified a parsimonious list of variables that can be used by machine learning approaches to improve accuracy of preterm newborn identification. Our best-performing model included LMP, birth weight, twin delivery, HIV serostatus, and maternal factors associated with SGA. These variables are all easily collected at delivery, reducing the skill and time required by the frontline health worker to assess GA.	[Rittenhouse, Katelyn J.; Keil, Alexander; Winston, Jennifer; Stoner, Marie; Price, Joan T.; Stringer, Jeffrey S. A.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Rittenhouse, Katelyn J.; Price, Joan T.] Univ N Carolina, Global Projects Zambia, Lusaka, Zambia; [Vwalika, Bellington; Kapasa, Monica; Mubambe, Mulaya; Banda, Vanilla; Muunga, Whyson] Univ Zambia, Sch Med, Lusaka, Zambia	University of North Carolina; University of North Carolina Chapel Hill; University of Zambia	Rittenhouse, KJ (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.; Rittenhouse, KJ (corresponding author), Univ N Carolina, Global Projects Zambia, Lusaka, Zambia.	katelyn_rittenhouse@med.unc.edu	Stringer, Jeffrey S. A./AAU-2342-2021; Rittenhouse, Katelyn/G-2446-2017	Stringer, Jeffrey/0000-0002-9590-7216; Keil, Alexander/0000-0002-0955-6107; Stoner, Marie/0000-0002-7189-8669; Rittenhouse, Katelyn/0000-0002-5571-0793	Bill and Melinda Gates Foundation [GAPPS 13008/OPP1033514]; US National Institutes of Health through the UNC Center for AIDS Research [P30 AI50410, T32 HD075731, K01 TW010857, D43 TW009340]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, T32HD075731] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW010857, D43TW009340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050410] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US National Institutes of Health through the UNC Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Bill and Melinda Gates Foundation grant to the Global Alliance to Prevent Prematurity and Stillbirth (Seattle Children's Hospital/GAPPS 13008/OPP1033514). Additional support was provided by the US National Institutes of Health through the UNC Center for AIDS Research (P30 AI50410) and trainee / mentor support: T32 HD075731 (JTP), K01 TW010857 (JTP), and D43 TW009340 (KR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, ZAMBIA CONSOLIDATION; [Anonymous], 2017, GENMOD PROC SAS STAT; [Anonymous], 2017, GAM PROC SAS STAT 14; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; BAUMANN C, 1993, Z GEBURTSH PERINATOL, V197, P135; Bembom O, 2007, STAT APPL GENET MOL, V6; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Castillo Marcela C, 2018, Gates Open Res, V2, P25, DOI 10.12688/gatesopenres.12820.2; Chi BH, 2011, INT J GYNECOL OBSTET, V113, P131, DOI 10.1016/j.ijgo.2010.11.013; CONSTANTINE NA, 1987, J PEDIATR-US, V110, P921, DOI 10.1016/S0022-3476(87)80416-X; Gernand AD, 2016, J HEALTH POPUL NUTR, V35, DOI 10.1186/s41043-016-0072-y; Hoffman CS, 2008, PAEDIATR PERINAT EP, V22, P587, DOI 10.1111/j.1365-3016.2008.00965.x; Huybregts L, 2009, AM J CLIN NUTR, V90, P1593, DOI 10.3945/ajcn.2009.28253; Jehan I, 2010, INT J GYNECOL OBSTET, V110, P231, DOI 10.1016/j.ijgo.2010.03.030; Katz J, 2013, LANCET, V382, P417, DOI 10.1016/S0140-6736(13)60993-9; Keil A., 2018, SUPERLEARNERMACRO; KRAMER MS, 1988, JAMA-J AM MED ASSOC, V260, P3306, DOI 10.1001/jama.260.22.3306; Lawn JE, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S5; Lee A, 2016, PUBLIC HEALTH, V138, P1, DOI 10.1016/j.puhe.2016.07.020; Lee ACC, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1423; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Lynch CD, 2007, PAEDIATR PERINAT EP, V21, P86, DOI 10.1111/j.1365-3016.2007.00865.x; Malaba LC, 2005, AM J CLIN NUTR, V81, P454, DOI 10.1093/ajcn.81.2.454; Montagu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017155; Mwaniki MK, 2012, LANCET, V379, P445, DOI 10.1016/S0140-6736(11)61577-8; Neufeld LM, 2006, PAEDIATR PERINAT EP, V20, P290, DOI 10.1111/j.1365-3016.2006.00741.x; Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V48, P719, DOI 10.1002/uog.15894; Papageorghiou AT, 2014, ULTRASOUND OBST GYN, V44, P641, DOI 10.1002/uog.13448; Roberfroid D, 2008, AM J CLIN NUTR, V88, P1330, DOI 10.3945/ajcn.2008.26296; Rosenberg RE, 2009, J HEALTH POPUL NUTR, V27, P332; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Schmiegelow C, 2012, ACTA OBSTET GYN SCAN, V91, P1061, DOI 10.1111/j.1600-0412.2012.01478.x; Stirnemann J, 2017, ULTRASOUND OBST GYN, V49, P478, DOI 10.1002/uog.17347; Stringer EM, 2011, OBSTET GYNECOL, V117, P1151, DOI 10.1097/AOG.0b013e3182167627; Taylor RAM, 2010, ANN TROP PAEDIATR, V30, P197, DOI 10.1179/146532810X12786388978526; The HPFOREST Procedure, 2016, HPFOREST PROC SAS EN; UNICEF, 2005, STAT WORLDS CHILDR; Villar J, 2018, AM J OBSTET GYNECOL, V218, pS841, DOI 10.1016/j.ajog.2017.11.564; Vwalika B, 2017, INT J GYNECOL OBSTET, V136, P180, DOI 10.1002/ijgo.12036; Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372; Woythaler MA, 2011, PEDIATRICS, V127, pE622, DOI 10.1542/peds.2009-3598; YOUDEN W. J., 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	43	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0198919	10.1371/journal.pone.0198919	http://dx.doi.org/10.1371/journal.pone.0198919			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811399	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400001
J	Wakasugi, T; Shimizu, I; Yoshida, Y; Hayashi, Y; Ikegami, R; Suda, M; Katsuumi, G; Nakao, M; Hoyano, M; Kashimura, T; Nakamura, K; Ito, H; Nojiri, T; Soga, T; Minamino, T				Wakasugi, Takayuki; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Suda, Masayoshi; Katsuumi, Goro; Nakao, Masaaki; Hoyano, Makoto; Kashimura, Takeshi; Nakamura, Kazufumi; Ito, Hiroshi; Nojiri, Takashi; Soga, Tomoyoshi; Minamino, Tohru			Role of smooth muscle cell p53 in pulmonary arterial hypertension	PLOS ONE			English	Article							CARDIAC DYSFUNCTION; INSULIN-RESISTANCE; SENESCENT CELLS; INFLAMMATION; INHIBITION; PROMOTES; CANCER	Pulmonary arterial hypertension (PAH) is characterized by remodeling and narrowing of the pulmonary arteries, which lead to elevation of right ventricular pressure, heart failure, and death. Proliferation of pulmonary artery smooth muscle cells (PASMCs) is thought to be central to the pathogenesis of PAH, although the underlying mechanisms are still being explored. The protein p53 is involved in cell cycle coordination, DNA repair, apoptosis, and cellular senescence, but its role in pulmonary hypertension (PH) is not fully known. We developed a mouse model of hypoxia-induced pulmonary hypertension (PH) and found significant reduction of p53 expression in the lungs. Our in vitro experiments with metabolomic analyses and the Seahorse XF extracellular flux analyzer indicated that suppression of p53 expression in PASMCs led to upregulation of glycolysis and downregulation of mitochondrial respiration, suggesting a proliferative phenotype resembling that of cancer cells. It was previously shown that systemic genetic depletion of p53 in a murine PH model led to more severe lung manifestations. Lack of information about the role of cell-specific p53 signaling promoted us to investigate it in our mouse PH model with the inducible Cre-loxP system. We generated a mouse model with SMC-specific gain or loss of p53 function by crossing Myh11-Cre/ ERT2 mice with floxed Mdm4 mice or floxed Trp53 mice. After these animals were exposed to hypoxia for 4 weeks, we conducted hemodynamic and echocardiographic studies. Surprisingly, the severity of PH was similar in both groups of mice and there were no differences between the genotypes. Our findings in these mice indicate that activation or suppression of p53 signaling in SMCs has a minor role in the pathogenesis of PH and suggest that p53 signaling in other cells (endothelial cells, immune cells, or fibroblasts) may be involved in the progression of this condition.	[Wakasugi, Takayuki; Shimizu, Ippei; Yoshida, Yohko; Hayashi, Yuka; Ikegami, Ryutaro; Suda, Masayoshi; Katsuumi, Goro; Nakao, Masaaki; Hoyano, Makoto; Kashimura, Takeshi; Minamino, Tohru] Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan; [Shimizu, Ippei; Yoshida, Yohko] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol Aging & Cell Biol, Niigata, Japan; [Nakamura, Kazufumi; Ito, Hiroshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Med, Okayama, Japan; [Nojiri, Takashi] Natl Cerebral & Cardiovascular Ctr Res Inst, Dept Biochem, Suita, Osaka, Japan; [Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata, Japan	Niigata University; Niigata University; Okayama University; Keio University	Minamino, T (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Dept Cardiovasc Biol & Med, Niigata, Japan.	t_minamino@yahoo.co.jp		Shimizu, Ippei/0000-0003-3333-8131	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) [17H04172, 26115008, 18K19536]; Japan Agency for Medical Research and Development (AMED); Takeda Medical Research Foundation; Takeda Science Foundation; SENSHIN Medical Research Foundation; Terumo Foundation; Manpei Suzuki Diabetes Foundation; Naito Foundation; NOVARTIS foundation; Japan Heart Foundation Research Grant; Senri Life Science Foundation; MEXT [16K19531, 18K08098]; Bourbon	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Takeda Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Terumo Foundation; Manpei Suzuki Diabetes Foundation; Naito Foundation(Naito Memorial Foundation); NOVARTIS foundation(Novartis); Japan Heart Foundation Research Grant; Senri Life Science Foundation; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bourbon	This work was supported by a Grant-in-Aid for Scientific Research (Grant number 17H04172), a Grant-in-Aid for Scientific Research on Innovative Areas (Grant number 26115008), and a Grant-in-Aid for Exploratory Research (Grant number 18K19536) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) and grants from the Japan Agency for Medical Research and Development (AMED), the Takeda Medical Research Foundation, the Takeda Science Foundation, the SENSHIN Medical Research Foundation, the Terumo Foundation, the Manpei Suzuki Diabetes Foundation, the Naito Foundation, and the NOVARTIS foundation (to T.M.), as well as by Japan Heart Foundation Research Grant, The Senri Life Science Foundation, SENSHIN Medical Research Foundation (to I.S.); by a Grant-in-Aid for Encouragement of Young Scientists (B) from MEXT (Grant Number 16K19531) (to Y.Y.); by a Grant-in-Aid for Scientific Research (C) from MEXT (Grant Number 18K08098) (to M.H.); and by a grant from Bourbon (to T.M., I.S. and Y.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer SL, 2010, CIRCULATION, V121, P2045, DOI 10.1161/CIRCULATIONAHA.108.847707; Baar MP, 2017, CELL, V169, P132, DOI 10.1016/j.cell.2017.02.031; Boehme J, 2016, AM J PHYSIOL-HEART C, V311, pH944, DOI 10.1152/ajpheart.00040.2016; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Galie N, 2015, NEW ENGL J MED, V373, P834, DOI 10.1056/NEJMoa1413687; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Grier JD, 2006, MOL CELL BIOL, V26, P192, DOI 10.1128/MCB.26.1.192-198.2006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Mizuno S, 2011, AM J PHYSIOL-LUNG C, V300, pL753, DOI 10.1152/ajplung.00286.2010; Paulin R, 2014, CIRC RES, V115, P148, DOI 10.1161/CIRCRESAHA.115.301130; Roos CM, 2016, AGING CELL, V15, P973, DOI 10.1111/acel.12458; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Shimizu I, 2014, CELL METAB, V20, P967, DOI 10.1016/j.cmet.2014.10.008; Shimizu I, 2013, CELL METAB, V18, P491, DOI 10.1016/j.cmet.2013.09.001; Shimizu I, 2012, CELL METAB, V15, P51, DOI 10.1016/j.cmet.2011.12.006; Sitbon O, 2014, EUROPEAN RESP J, V44; Sutendra G, 2014, CELL METAB, V19, P558, DOI 10.1016/j.cmet.2014.01.004; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thenappan T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5492; Xiao YB, 2017, CELL PHYSIOL BIOCHEM, V42, P1603, DOI 10.1159/000479401; Yokoyama M, 2014, CELL REP, V7, P1691, DOI 10.1016/j.celrep.2014.04.046; Yoshida Y, 2015, J MOL CELL CARDIOL, V85, P183, DOI 10.1016/j.yjmcc.2015.06.001	24	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212889	10.1371/journal.pone.0212889	http://dx.doi.org/10.1371/journal.pone.0212889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807606	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100028
J	Isomura, ET; Nakagawa, K; Matsukawa, M; Mitsui, R; Kogo, M				Isomura, Emiko Tanaka; Nakagawa, Kiyoko; Matsukawa, Makoto; Mitsui, Ryou; Kogo, Mikihiko			Evaluation of sites of velopharyngeal structure augmentation in dogs for improvement of velopharyngeal insufficiency	PLOS ONE			English	Article							AUTOLOGOUS FAT TRANSPLANTATION; PHARYNGEAL FLAP SURGERY; LEVATOR VELI PALATINI; SOFT PALATE; CLEFT-PALATE; CONSTRICTOR	Background Velopharyngeal structure augmentation methods are used as alternatives to velopharyngeal plasty. Anatomic sites of implantation/injection vary widely due to a lack of standardized criteria. Here, we experimentally investigated optimal sites of velopharyngeal structure augmentation via saline injection in dogs as they naturally exhibit velopharyngeal insufficiency (VPI). Methods Velopharyngeal structure augmentation was performed on 10 beagles (age range: 20-24 months; weight range: 9-12 kg). Saline containing 1/80,000 epinephrine was injected intraorally in 1-mL increments into the nasal mucosa of the soft palate (n = 4), posterior pharyngeal wall (n = 3), or bilateral pharyngeal walls (n = 3) of each dog. Nasal air leakage was measured under rebreathing until velopharyngeal closure was achieved; the measurement was performed using flow meter sensors on both nasal apertures, and the oral cavity was filled with alginate impression material to prevent oral air leakage. Results Pre-injection, the dogs exhibited an average of 0.455 L/s air leakage from the nasal cavity. The dogs with saline injected into the nasal mucosa of the soft palate achieved steady augmentation, and nasal air leakage disappeared under rebreathing following 6-mL saline injection. Conversely, nasal air leakage remained in the dogs with saline injected in the posterior pharyngeal wall or bilateral pharyngeal walls. Conclusions During VPI treatment in dogs, augmentation was most effective at the nasal mucosa of the soft palate. Improvement in nasal air leakage was highly dependent on the saline injection volume. Although velopharyngeal structures vary between dogs and humans, velopharyngeal closure style is similar. Thus, our results may aid in the treatment of VPI patients.	[Isomura, Emiko Tanaka; Nakagawa, Kiyoko; Matsukawa, Makoto; Mitsui, Ryou; Kogo, Mikihiko] Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan; [Isomura, Emiko Tanaka] Osaka Univ Hosp, Unit Dent, Suita, Osaka, Japan	Osaka University; Osaka University	Isomura, ET (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Maxillofacial Surg 1, Suita, Osaka, Japan.; Isomura, ET (corresponding author), Osaka Univ Hosp, Unit Dent, Suita, Osaka, Japan.	tanaemi@dent.osaka-u.ac.jp	Kogo, Mikihiko/ABD-7080-2020; Isomura, Emiko/AAG-7594-2021; Isomura, Emiko Tanaka/GPP-3788-2022	Kogo, Mikihiko/0000-0002-4556-2491; Isomura, Emiko Tanaka/0000-0002-7855-9600				Aboloyoun Ali Ibrahim, 2013, Acta Med Acad, V42, P55, DOI 10.5644/ama2006-124.71; Adachi T, 1997, J DENT RES, V76, P1745, DOI 10.1177/00220345970760110501; Bishop A, 2014, J PLAST RECONSTR AES, V67, P1, DOI 10.1016/j.bjps.2013.09.021; Boneti C, 2015, ANN PLAS SURG, V74, pS190, DOI 10.1097/SAP.0000000000000442; BRAUER RO, 1973, PLAST RECONSTR SURG, V51, P254, DOI 10.1097/00006534-197303000-00003; BROWN AS, 1983, PLAST RECONSTR SURG, V72, P1; Campos LD, 2016, CLEFT PALATE-CRAN J, V53, pE53, DOI 10.1597/14-152; CANADY JW, 1995, CLEFT PALATE-CRAN J, V32, P1, DOI 10.1597/1545-1569(1995)032<0001:AOOTIR>2.3.CO;2; Cantarella G, 2011, OTOLARYNG HEAD NECK, V145, P401, DOI 10.1177/0194599811411655; Dejonckere PH, 2001, ANN OTO RHINOL LARYN, V110, P168, DOI 10.1177/000348940111000213; Filip C, 2014, J PLAST RECONSTR AES, V67, P1155, DOI 10.1016/j.bjps.2014.02.001; Filip C, 2013, J PLAST RECONSTR AES, V66, P337, DOI 10.1016/j.bjps.2012.11.006; Filip C, 2011, CLEFT PALATE-CRAN J, V48, P708, DOI 10.1597/09-161; Klotz DA, 2001, LARYNGOSCOPE, V111, P2157, DOI 10.1097/00005537-200112000-00015; Kodama A., 1983, PRACTICA OTO RHINO L, V76, P2671; Kogo M, 1997, CLEFT PALATE-CRAN J, V34, P338, DOI 10.1597/1545-1569(1997)034<0337:AOSPCA>2.3.CO;2; KOGO M, 1992, CLEFT PALATE-CRAN J, V29, P174, DOI 10.1597/1545-1569(1992)029<0174:RAIRTP>2.3.CO;2; Kogo M, 2017, J CLEFT LIP PALATE C, V4, P189; KOIZUMI H, 1995, J DENT RES, V74, P1235, DOI 10.1177/00220345950740051401; Koizumi H, 1996, CLEFT PALATE-CRAN J, V33, P459, DOI 10.1597/1545-1569(1996)033<0459:CBPALM>2.3.CO;2; Lau D, 2013, CLEFT PALATE-CRAN J, V50, P51, DOI 10.1597/11-038; Leboulanger N, 2011, INT J PEDIATR OTORHI, V75, P1401; Leuchter I, 2010, EUR ARCH OTO-RHINO-L, V267, P977, DOI 10.1007/s00405-009-1157-7; Naran S, 2017, PLAST RECONSTR SURG, V139, p1343E, DOI 10.1097/PRS.0000000000003335; ORR WC, 1987, PLAST RECONSTR SURG, V80, P226, DOI 10.1097/00006534-198708000-00010; REMACLE M, 1990, LARYNGOSCOPE, V100, P269; RODENSTEIN DO, 1986, AM REV RESPIR DIS, V134, P311; RODENSTEIN DO, 1984, J APPL PHYSIOL, V57, P651, DOI 10.1152/jappl.1984.57.3.651; Rogers C, 2016, J CRANIOFAC SURG, V27, P1746, DOI 10.1097/SCS.0000000000003050; RUDING R, 1964, Plast Reconstr Surg, V33, P132, DOI 10.1097/00006534-196402000-00004; VALNICEK SM, 1994, PLAST RECONSTR SURG, V93, P954, DOI 10.1097/00006534-199404001-00009; Woo Albert S, 2012, Semin Plast Surg, V26, P170, DOI 10.1055/s-0033-1333882	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212752	10.1371/journal.pone.0212752	http://dx.doi.org/10.1371/journal.pone.0212752			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802272	Green Published, gold, Green Submitted			2022-12-26	WOS:000459710700018
J	Balyan, R; Crossley, SA; Brown, W; Karter, AJ; McNamara, DS; Liu, JY; Lyles, CR; Schillinger, D				Balyan, Renu; Crossley, Scott A.; Brown, William, III; Karter, Andrew J.; McNamara, Danielle S.; Liu, Jennifer Y.; Lyles, Courtney R.; Schillinger, Dean			Using natural language processing and machine learning to classify health literacy from secure messages: The ECLIPPSE study	PLOS ONE			English	Article							MEDICATION ADHERENCE; DIABETES PATIENTS; TEXT; READABILITY; COMMUNICATION; RECORD; VALIDATION; PHARMACY; VALIDITY; ENGINE	Limited health literacy is a barrier to optimal healthcare delivery and outcomes. Current measures requiring patients to self-report limitations are time-consuming and may be considered intrusive by some. This makes widespread classification of patient health literacy challenging. The objective of this study was to develop and validate "literacy profiles" as automated indicators of patients' health literacy to facilitate a non-intrusive, economic and more comprehensive characterization of health literacy among a health care delivery system's membership. To this end, three literacy profiles were generated based on natural language processing (combining computational linguistics and machine learning) using a sample of 283,216 secure messages sent from 6,941 patients to their primary care physicians. All patients were participants in Kaiser Permanente Northern California's DISTANCE Study. Performance of the three literacy profiles were compared against a gold standard of patient self-reported health literacy. Associations were analyzed between each literacy profile and patient demographics, health outcomes and healthcare utilization. T-tests were used for numeric data such as A1C, Charlson comorbidity index and healthcare utilization rates, and chi-square tests for categorical data such as sex, race, poor adherence and severe hypoglycemia. Literacy profiles varied in their test characteristics, with C-statistics ranging from 0.61-0.74. Relations between literacy profiles and health outcomes revealed patterns consistent with previous health literacy research: patients identified via literacy profiles indicative of limited health literacy: (a) were older and more likely of minority status; (b) had poorer medication adherence and glycemic control; and (c) exhibited higher rates of hypoglycemia, comorbidities and healthcare utilization. This represents the first successful attempt to employ natural language processing to estimate health literacy. Literacy profiles can offer an automated and economical way to identify patients with limited health literacy and greater vulnerability to poor health outcomes.	[Balyan, Renu] Arizona State Univ, Ira A Fulton Sch Engn, Mesa, AZ USA; [Crossley, Scott A.] Georgia State Univ, Coll Arts & Sci, ESL, Dept Appl Linguist, Atlanta, GA 30303 USA; [Brown, William, III; Lyles, Courtney R.; Schillinger, Dean] Univ Calif San Francisco, Dept Med, UCSF Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Karter, Andrew J.; Liu, Jennifer Y.; Lyles, Courtney R.; Schillinger, Dean] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA; [McNamara, Danielle S.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Lyles, Courtney R.; Schillinger, Dean] Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94110 USA	Arizona State University; University System of Georgia; Georgia State University; University of California System; University of California San Francisco; Kaiser Permanente; Arizona State University; Arizona State University-Tempe	Schillinger, D (corresponding author), Univ Calif San Francisco, Dept Med, UCSF Ctr Vulnerable Populat, San Francisco, CA 94143 USA.; Schillinger, D (corresponding author), Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA.; Schillinger, D (corresponding author), Zuckerberg San Francisco Gen Hosp & Trauma Ctr, San Francisco, CA 94110 USA.	dean.schillinger@ucsf.edu		, Renu/0000-0003-1393-2416	National Institutes of Health [NLM R01 LM012355]; NIDDK Centers for Diabetes Translational Research [P30 DK092924, R01 DK065664]; NICHD [R01 HD46113]; Institute of Education Sciences, U.S. Department of Education [R305A120707, R305A180261]; KPNC; ALT LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092924] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM012355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK Centers for Diabetes Translational Research; NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Institute of Education Sciences, U.S. Department of Education(US Department of Education); KPNC; ALT LLC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work has been supported by grants NLM R01 LM012355 from the National Institutes of Health, NIDDK Centers for Diabetes Translational Research (P30 DK092924), R01 DK065664, NICHD R01 HD46113 and Institute of Education Sciences, U.S. Department of Education, through grants R305A120707 and R305A180261. Even though Andrew J. Karter and Jennifer Y. Liu are employed by Kaiser Permanente Northern California and Danielle S. McNamara owns a company (Adaptive Literacy Technologies LLC), none of their work has been funded by KPNC or ALT LLC, not even in the form of salaries. The funders or KPNC or ALT LLC did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2006, P LREC; [Anonymous], 2004, P 20 INT C COMP LING, DOI DOI 10.3115/1220355.1220409; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Baayen R. H, 1995, CELEX LEXICAL DATABA; Bailey SC, 2014, DIABETES EDUCATOR, V40, P581, DOI 10.1177/0145721714540220; Balyan R, 2017, P 10 INT C ED DAT MI; Bauer AM, 2013, J GEN INTERN MED, V28, P1181, DOI 10.1007/s11606-013-2402-8; BNC Consortium, 2001, BRIT NAT CORP VERS 2; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Carrell DS, 2015, INT J MED INFORM, V84, P1057, DOI 10.1016/j.ijmedinf.2015.09.002; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Crossley S. A., 2016, J ED DATA MINING, V8, P1; Crossley SA., 2014, MULTIDIMENSIONAL ANA, P197, DOI [10.1075/scl.60.07cro, DOI 10.1075/SCL.60.07CRO]; Crossley SA, 2013, FLAIRS C MAY 19; Crossley S, 2017, LECT NOTES ARTIF INT, V10318, P330, DOI 10.1007/978-3-319-59888-8_28; Crossley S, 2016, LAK '16 CONFERENCE PROCEEDINGS: THE SIXTH INTERNATIONAL LEARNING ANALYTICS & KNOWLEDGE CONFERENCE,, P6, DOI 10.1145/2883851.2883931; Crossley SA, 2017, DISCOURSE PROCESS, V54, P340, DOI 10.1080/0163853X.2017.1296264; Crossley SA, 2017, BEHAV RES METHODS, V49, P803, DOI 10.3758/s13428-016-0743-z; Crossley SA, 2016, BEHAV RES METHODS, V48, P1227, DOI 10.3758/s13428-015-0651-7; Cunningham JW, 2018, READ WRIT, V31, P813, DOI 10.1007/s11145-017-9815-4; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Denny Joshua C, 2003, AMIA Annu Symp Proc, P195; DeWalt DA, 2012, CIRCULATION; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Diviani N, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4018; Doak CC, 1996, TEACHING PATIENTS LO; Doak L G, 1987, Promot Health, V8, P6; Doan S, 2016, ACAD EMERG MED, V23, P628, DOI 10.1111/acem.12925; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Francois T., 2012, P 1 WORKSH PRED IMPR, P49; Frantzi K., 2000, INT J DIGITAL LIB, V3, P115, DOI [DOI 10.1007/S007999900023, 10.1007/s007999900023]; Friedman C, 1995, Proc Annu Symp Comput Appl Med Care, P347; Gemoets D, 2004, ST HEAL T, V107, P869; Ginde Adit A, 2008, BMC Endocr Disord, V8, P4, DOI 10.1186/1472-6823-8-4; Grigonyte G., 2014, P 3 WORKSH PRED IMPR, P74; Gunning R., 1952, TECHNIQUE CLEAR WRIT; Han J, 2012, MOR KAUF D, P1; Harris LT, 2013, DIABETES CARE, V36, P2726, DOI 10.2337/dc12-2003; Heintzelman NH, 2013, J AM MED INFORM ASSN, V20, P898, DOI 10.1136/amiajnl-2012-001076; Hewett M, 2002, NUCLEIC ACIDS RES, V30, P163, DOI 10.1093/nar/30.1.163; Joachims T., 1998, Machine Learning: ECML-98. 10th European Conference on Machine Learning. Proceedings, P137, DOI 10.1007/BFb0026683; Johnson SB, 1999, J AM MED INFORM ASSN, V6, P205, DOI 10.1136/jamia.1999.0060205; Kandula Sasikiran, 2008, AMIA Annu Symp Proc, P353; Karter AJ, 2015, HEALTH SERV RES, V50, P537, DOI 10.1111/1475-6773.12223; Kauchak D, 2014, P ANN HICSS, P2616, DOI 10.1109/HICSS.2014.330; Kim H, 2017, PATIENT EDUC COUNS, V100, P1073, DOI 10.1016/j.pec.2017.01.015; Kim Hyeoneui, 2007, AMIA Annu Symp Proc, P418; Kyle K, 2017, BEHAV RES METHODS, P1; Kyle K, MEASURING SYNTACTIC; Kyle K, 2015, TESOL QUART, V49, P757, DOI 10.1002/tesq.194; Lu XF, 2010, INT J CORPUS LINGUIS, V15, P474, DOI 10.1075/ijcl.15.4.02lu; Lyles CR, 2016, J AM MED INFORM ASSN, V23, pE28, DOI 10.1093/jamia/ocv126; Lyles CR, 2013, J AM MED INFORM ASSN, V20, P1128, DOI 10.1136/amiajnl-2012-001567; Machtinger EL, 2007, JT COMM J QUAL PATIE, V33, P625, DOI 10.1016/S1553-7250(07)33072-9; MCLAUGHLIN GH, 1969, J READING, V12, P639; McNamara DS, 2013, BEHAV RES METHODS, V45, P499, DOI 10.3758/s13428-012-0258-1; MILLER GA, 1995, COMMUN ACM, V38, P39, DOI 10.1145/219717.219748; Mitchell, 1997, MACH LEARN, V45, P870; Moffet HH, 2009, INT J EPIDEMIOL, V38, P38, DOI 10.1093/ije/dyn040; Nadkarni PM, 2011, J AM MED INFORM ASSN, V18, P544, DOI 10.1136/amiajnl-2011-000464; Nobata C, 2008, P 31 ANN INT ACM SIG, P787, DOI DOI 10.1145/1390334.1390504; Oda K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S5; Osborne JD, 2016, J AM MED INFORM ASSN, V23, P1077, DOI 10.1093/jamia/ocw006; Raebel MA, 2013, MED CARE, V51, pS11, DOI 10.1097/MLR.0b013e31829b1d2a; Ratanawongsa N, 2013, JAMA INTERN MED, V173, P210, DOI 10.1001/jamainternmed.2013.1216; Reed M, 2013, JAMA-J AM MED ASSOC, V310, P1060, DOI 10.1001/jama.2013.276733; Reed M, 2012, ANN INTERN MED, V157, P482, DOI 10.7326/0003-4819-157-7-201210020-00004; Sarkar U, 2014, MED CARE, V52, P194, DOI 10.1097/MLR.0000000000000069; Sarkar U, 2011, J GEN INTERN MED, V26, P265, DOI 10.1007/s11606-010-1552-1; Sarkar U, 2010, J GEN INTERN MED, V25, P962, DOI 10.1007/s11606-010-1389-7; Sasaki Y, 2008, P 3 INT S SEM MIN BI, V3, P109; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schillinger D, 2004, PATIENT EDUC COUNS, V52, P315, DOI 10.1016/S0738-3991(03)00107-1; Schillinger D, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/1348242; Semere W, 2018, SOC GEN INT MED ANN; Smith S., 2015, J EPIDEMIOL COMMUNIT; Soysal E, 2017, J AM MED INFORM ASS; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Thompson P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144717; Thorn Caroline F, 2013, Methods Mol Biol, V1015, P311, DOI 10.1007/978-1-62703-435-7_20; Tsuruoka Y, 2008, BIOINFORMATICS, V24, P2559, DOI 10.1093/bioinformatics/btn469; Uzuner O, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Uzuner O, 2007, J AM MED INFORM ASSN, V14, P550, DOI 10.1197/jamia.M2444; Uzuner O, 2010, J AM MED INFORM ASSN, V17, P514, DOI 10.1136/jamia.2010.003947; Uzuner O, 2009, J AM MED INFORM ASSN, V16, P561, DOI 10.1197/jamia.M3115; Van Gurp M, 2006, KR MED; Venturi G, 2015, P 6 INT WORKSH HLTH, P131; Wu DTY, 2013, STUD HEALTH TECHNOL, V192, P647, DOI 10.3233/978-1-61499-289-9-647; Zeng-Treitler Q, 2012, METHOD ESTIMATE READ; Zheng JP, 2018, JMIR MED INF, V6, DOI 10.2196/medinform.8611	97	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212488	10.1371/journal.pone.0212488	http://dx.doi.org/10.1371/journal.pone.0212488			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794616	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100078
J	Bistoletti, M; Caputi, V; Baranzini, N; Marchesi, N; Filpa, V; Marsilio, I; Cerantola, S; Terova, G; Baj, A; Grimaldi, A; Pascale, A; Frigo, G; Crema, F; Giron, MC; Giaroni, C				Bistoletti, Michela; Caputi, Valentina; Baranzini, Nicolo; Marchesi, Nicoletta; Filpa, Viviana; Marsilio, Ilaria; Cerantola, Silvia; Terova, Genciana; Baj, Andreina; Grimaldi, Annalisa; Pascale, Alessia; Frigo, Gianmario; Crema, Francesca; Giron, Maria Cecilia; Giaroni, Cristina			Antibiotic treatment-induced dysbiosis differently affects BDNF and TrkB expression in the brain and in the gut of juvenile mice	PLOS ONE			English	Article							NEUROTROPHIC FACTOR CONTRIBUTES; ENTERIC NERVOUS-SYSTEM; MYENTERIC PLEXUS; MICROBIOTA; STRESS; AXIS; LOCALIZATION; PLASTICITY; RECEPTORS; ISCHEMIA	Antibiotic use during adolescence may result in dysbiosis-induced neuronal vulnerability both in the enteric nervous system (ENS) and central nervous system (CNS) contributing to the onset of chronic gastrointestinal disorders, such as irritable bowel syndrome (IBS), showing significant psychiatric comorbidity. Intestinal microbiota alterations during adolescence influence the expression of molecular factors involved in neuronal development in both the ENS and CNS. In this study, we have evaluated the expression of brain-derived neurotrophic factor (BDNF) and its high-affinity receptor tropomyosin-related kinase B (TrkB) in juvenile mice ENS and CNS, after a 2-week antibiotic (ABX) treatment. In both mucosa and mucosa-deprived whole-wall small intestine segments of ABX-treated animals, BDNF and TrKB mRNA and protein levels significantly increased. In longitudinal muscle-myenteric plexus preparations of ABX-treated mice the percentage of myenteric neurons staining for BDNF and TrkB was significantly higher than in controls. After ABX treatment, a consistent population of BDNF-and TrkB-immunoreactive neurons costained with SP and CGRP, suggesting up-regulation of BDNF signaling in both motor and sensory myenteric neurons. BDNF and TrkB protein levels were downregulated in the hippocampus and remained unchanged in the prefrontal cortex of ABX-treated animals. Immunostaining for BDNF and TrkB decreased in the hippocampus CA3 and dentate gyrus subregions, respectively, and remained unchanged in the prefrontal cortex. These data suggest that dysbiosis differentially influences the expression of BDNF-TrkB in the juvenile mice ENS and CNS. Such changes may potentially contribute later to the development of functional gut disorders, such as IBS, showing psychiatric comorbidity.	[Bistoletti, Michela; Filpa, Viviana; Baj, Andreina; Giaroni, Cristina] Univ Insubria, Dept Med & Surg, Varese, Italy; [Caputi, Valentina; Marsilio, Ilaria; Cerantola, Silvia; Giron, Maria Cecilia] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Caputi, Valentina] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland; [Baranzini, Nicolo; Terova, Genciana; Grimaldi, Annalisa] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Marchesi, Nicoletta; Pascale, Alessia] Univ Pavia, Dept Drug Sci, Pavia, Italy; [Frigo, Gianmario; Crema, Francesca] Univ Pavia, Sect Pharmacol, Dept Internal Med & Therapeut, Pavia, Italy	University of Insubria; University of Padua; University College Cork; University of Insubria; University of Pavia; University of Pavia	Giaroni, C (corresponding author), Univ Insubria, Dept Med & Surg, Varese, Italy.	cristina.giaroni@uninsubria.it	Terova, Genciana/AAL-6412-2021; Marchesi, Nicoletta/GQZ-7428-2022; Giron, Maria Cecilia/AAL-4438-2021; Baj, Andreina/C-8047-2013; Terova, Genciana/G-1779-2010; Baranzini, Nicoló/AAK-9531-2021; Baranzini, Nicolò/AFW-4561-2022; giaroni, cristina/A-8181-2011	Terova, Genciana/0000-0002-7532-7951; Marchesi, Nicoletta/0000-0001-6271-1420; Giron, Maria Cecilia/0000-0002-0825-7965; Baj, Andreina/0000-0003-0088-2712; Terova, Genciana/0000-0002-7532-7951; GIARONI, CRISTINA/0000-0002-3760-3441; Baranzini, Nicolo/0000-0001-6996-4797	University of Insubria (FAR 2016-2018); University of Pavia (FAR 2016-2018); University of Padova (UNIPD-Assegno di Ricerca 2016, San Camillo Hospital, Treviso (Italy)); University of Padova (UNIPD-ex 60%-2017); University of Padova (UNIPD-PRID 2017)	University of Insubria (FAR 2016-2018); University of Pavia (FAR 2016-2018); University of Padova (UNIPD-Assegno di Ricerca 2016, San Camillo Hospital, Treviso (Italy)); University of Padova (UNIPD-ex 60%-2017); University of Padova (UNIPD-PRID 2017)	This research was supported by the University of Insubria (FAR 2016-2018 to CG, AB, AG), the University of Pavia (FAR 2016-2018 to FC) and the University of Padova (UNIPD-Assegno di Ricerca 2016, San Camillo Hospital, Treviso (Italy), UNIPD-ex 60%-2017, UNIPD-PRID 2017 to MCG).	Aguirre JE, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13081; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Autry AE, 2012, PHARMACOL REV, V64, P238, DOI 10.1124/pr.111.005108; Bercik P, 2011, GASTROENTEROLOGY, V141, P599, DOI 10.1053/j.gastro.2011.04.052; Bin A, 2018, PURINERG SIGNAL, V14, P409, DOI 10.1007/s11302-018-9623-6; Boesmans W, 2008, GUT, V57, DOI 10.1136/gut.2007.131839; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Brun P, 2015, MOL CELL NEUROSCI, V68, P24, DOI 10.1016/j.mcn.2015.03.018; Brun P, 2013, GASTROENTEROLOGY, V145, P1323, DOI 10.1053/j.gastro.2013.08.047; Caputi V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061689; Caputi V, 2017, BRIT J PHARMACOL, V174, P3623, DOI 10.1111/bph.13965; Carpanese E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113613; Ceccotti C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201760; Champagne-Jorgensen K, 2019, BRAIN BEHAV IMMUN, V77, P7, DOI 10.1016/j.bbi.2018.12.014; Chen F, 2014, ACTA PHYSIOL, V212, P226, DOI 10.1111/apha.12374; Chen FX, 2012, REGUL PEPTIDES, V178, P86, DOI 10.1016/j.regpep.2012.07.001; Coulie B, 2000, GASTROENTEROLOGY, V119, P41, DOI 10.1053/gast.2000.8553; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Deltheil T, 2008, NEUROPHARMACOLOGY, V55, P1006, DOI 10.1016/j.neuropharm.2008.08.001; Desbonnet L, 2015, BRAIN BEHAV IMMUN, V48, P165, DOI 10.1016/j.bbi.2015.04.004; Duman RS, 2001, J PHARMACOL EXP THER, V299, P401; Enck P, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.14; Farzaei MH, 2016, J NEUROGASTROENTEROL, V22, P558, DOI 10.5056/jnm16001; Filpa V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18020-7; Filpa V, 2017, AM J PHYSIOL-GASTR L, V312, pG374, DOI 10.1152/ajpgi.00386.2016; Filpa V, 2016, NEUROPHARMACOLOGY, V111, P14, DOI 10.1016/j.neuropharm.2016.08.024; Foster JA, 2017, NEUROBIOL STRESS, V7, P124, DOI 10.1016/j.ynstr.2017.03.001; Giaroni C, 2011, NEUROGASTROENT MOTIL, V23, pe91, DOI 10.1111/j.1365-2982.2010.01644.x; Giaroni C, 2015, AUTON NEUROSCI-BASIC, V191, P67, DOI 10.1016/j.autneu.2015.04.009; Grider JR, 2007, AM J PHYSIOL-GASTR L, V292, pG429, DOI 10.1152/ajpgi.00376.2006; Grider JR, 2006, GASTROENTEROLOGY, V130, P771, DOI 10.1053/j.gastro.2005.12.026; Guida F, 2018, BRAIN BEHAV IMMUN, V67, P230, DOI 10.1016/j.bbi.2017.09.001; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hoehner JC, 1996, GASTROENTEROLOGY, V110, P756, DOI 10.1053/gast.1996.v110.pm8608885; Hyland NP, 2016, DEV BIOL, V417, P182, DOI 10.1016/j.ydbio.2016.06.027; Kabouridis PS, 2015, J CLIN INVEST, V125, P956, DOI 10.1172/JCI76308; Lai KO, 2012, NAT NEUROSCI, V15, P1506, DOI 10.1038/nn.3237; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Lima Giacobbo B, 2018, MOL NEUROBIOL; Lommatzsch M, 1999, AM J PATHOL, V155, P1183, DOI 10.1016/S0002-9440(10)65221-2; Luo XG, 2001, NEUROSCI RES, V39, P377, DOI 10.1016/S0168-0102(00)00238-8; Maqsood R, 2016, NEUROCHEM RES, V41, P2819, DOI 10.1007/s11064-016-2039-1; Matto J, 2005, FEMS IMMUNOL MED MIC, V43, P213, DOI 10.1016/j.femsim.2004.08.009; Minichiello L, 2002, NEURON, V36, P121, DOI 10.1016/S0896-6273(02)00942-X; Moloney RD, 2014, MAMM GENOME, V25, P49, DOI 10.1007/s00335-013-9488-5; Murphy MC, 2010, J COMP NEUROL, V518, P2934, DOI 10.1002/cne.22372; Olen O, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13436; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Paus T, 2008, NAT REV NEUROSCI, V9, P947, DOI 10.1038/nrn2513; Pawlowska K, 2018, J PEDIATR-US, V199, P171, DOI 10.1016/j.jpeds.2018.02.069; Qu ZD, 2008, CELL TISSUE RES, V334, P147, DOI 10.1007/s00441-008-0684-7; Quan XJ, 2015, DIGEST DIS SCI, V60, P2316, DOI 10.1007/s10620-015-3695-8; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Salio C, 2007, DEV NEUROBIOL, V67, P326, DOI 10.1002/dneu.20358; Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; von Boyen GBT, 2002, J GASTROENTEROL, V37, P583, DOI 10.1007/s005350200093; Wang P, 2016, SCI REP, V6, P20230, DOI [10.1038/srep20230, DOI 10.1038/SREP20230]; Wellman CL, 2018, PSYCHOPHARMACOLOGY B; Wessels JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094036; Xia CM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-30; Yang J, 2010, EUR J PAIN, V14, P574, DOI 10.1016/j.ejpain.2009.10.007; Yu YB, 2012, GUT, V61, P685, DOI 10.1136/gutjnl-2011-300265	65	37	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212856	10.1371/journal.pone.0212856	http://dx.doi.org/10.1371/journal.pone.0212856			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794676	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100149
J	Cao, YP; Meng, DD; Chen, TZ; Chen, Y; Zeng, W; Zhang, L; Wang, Q; Hen, W; Abdullah, M; Jin, Q; Lin, Y; Cai, YP				Cao, Yunpeng; Meng, Dandan; Chen, Tianzhe; Chen, Yu; Zeng, Wei; Zhang, Lei; Wang, Qi; Hen, Wei; Abdullah, Muhammad; Jin, Qing; Lin, Yi; Cai, Yongping			Metacaspase gene family in Rosaceae genomes: Comparative genomic analysis and their expression during pear pollen tube and fruit development	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; WIDE IDENTIFICATION; RESPONSIVE EXPRESSION; PYRUS-BRETSCHNEIDERI; PRUNUS-PERSICA; STRESS; SOFTWARE; BARLEY	Metacaspase (MC), which is discovered gene family with distant caspase homologs in plants, fungi, and protozoa, may be involved in programmed cell death (PCD) processes during plant development and respond abiotic and biotic stresses. To reveal the evolutionary relationship of MC gene family in Rosaceae genomes, we identified 8, 7, 8, 12, 12, and 23 MC genes in the genomes of Fragaria vesca, Prunus mume, Prunus persica, Pyrus communis, Pyrus bretschneideri and Malus domestica, respectively. Phylogenetic analysis suggested that the MC genes could be grouped into three clades: Type I*, Type I and Type II, which was supported by gene structure and conserved motif analysis. Microsynteny analysis revealed that MC genes present in the corresponding syntenic blocks of P. communis, P. bretschneideri and M. domestica, and further suggested that large-scale duplication events play an important role in the expansion of MC gene family members in these three genomes than other Rosaceae plants (F. vesca, P. mume and P. persica). RNA-seq data showed the specific expression patterns of PbMC genes in response to drought stress. The expression analysis of MC genes demonstrated that PbMC01 and PbMC03 were able to be detected in all four pear pollen tubes and seven fruit development stages. The current study highlighted the evolutionary relationship and duplication of the MC gene family in these six Rosaceae genomes and provided appropriate candidate genes for further studies in P. bretschneideri.	[Cao, Yunpeng; Meng, Dandan; Chen, Tianzhe; Chen, Yu; Zeng, Wei; Zhang, Lei; Abdullah, Muhammad; Jin, Qing; Lin, Yi; Cai, Yongping] Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China; [Wang, Qi; Hen, Wei] Anhui Agr Univ, Coll Hort, Hefei, Anhui, Peoples R China	Anhui Agricultural University; Anhui Agricultural University	Cai, YP (corresponding author), Anhui Agr Univ, Sch Life Sci, Hefei, Anhui, Peoples R China.	swkx12@ahau.edu.cn	Cao, Yunpeng/E-8960-2019	Cao, Yunpeng/0000-0001-5976-2382; Zeng, wei/0000-0002-5613-867X	National Natural Science Foundation of China [31640068]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by The National Natural Science Foundation of China (grant 31640068; Yongping Can). The Funding bodies were not involved in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.	Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bollhoner B, 2013, NEW PHYTOL, V200, P498, DOI 10.1111/nph.12387; Bostancioglu SM, 2018, MOL BIOL REP, V45, P211, DOI 10.1007/s11033-018-4154-3; Cai B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-79; Cao Yunpeng, 2018, R Soc Open Sci, V5, P171463, DOI 10.1098/rsos.171463; Cao YP, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7070077; Cao YP, 2018, FUNCT INTEGR GENOMIC, V18, P519, DOI 10.1007/s10142-018-0609-9; Cao YP, 2018, GENES-BASEL, V9, DOI 10.3390/genes9040224; Cao YP, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1105-4; Cao YP, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00078; Cao YP, 2017, PEERJ, V5, DOI 10.7717/peerj.3400; Cao YP, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00577; Chagne D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092644; Chen C., 2020, TBTOOLS TOOLKIT BIOL, V289660, P289660, DOI DOI 10.1101/289660; Choi CJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.21; Coll NS, 2010, SCIENCE, V330, P1393, DOI 10.1126/science.1194980; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Duan YF, 2010, NEW PHYTOL, V186, P681, DOI 10.1111/j.1469-8137.2010.03207.x; Fagundes D, 2015, FUNCT INTEGR GENOMIC, V15, P639, DOI 10.1007/s10142-015-0459-7; Hao L, 2007, PLANT CELL REP, V26, P1879, DOI 10.1007/s00299-007-0387-7; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Huang L, 2015, INT J MOL SCI, V16, P16216, DOI 10.3390/ijms160716216; Huang SL, 2014, PLANT PHYSIOL, V165, P810, DOI 10.1104/pp.114.239335; Jiang L, 2018, PEERJ, V6, DOI 10.7717/peerj.4615; Jiang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141037; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim SM, 2013, MOL PLANT PATHOL, V14, P557, DOI 10.1111/mpp.12027; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwon SI, 2013, J PLANT BIOL, V56, P391, DOI 10.1007/s12374-013-0290-4; Lam E, 2012, TRENDS PLANT SCI, V17, P487, DOI 10.1016/j.tplants.2012.05.003; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li Z, 2012, NEW PHYTOL, V195, P85, DOI 10.1111/j.1469-8137.2012.04131.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu H, 2016, BIOCHEM BIOPH RES CO, V479, P523, DOI 10.1016/j.bbrc.2016.09.103; Liu H, 2016, PLANT PHYSIOL BIOCH, V105, P90, DOI 10.1016/j.plaphy.2016.04.011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minina EA, 2013, J CELL BIOL, V203, P917, DOI 10.1083/jcb.201307082; Mistry J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt263; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Olvera-Carrillo Y, 2015, PLANT PHYSIOL, V2015; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Tombuloglu H, 2013, MOL GENET GENOMICS, V288, P141, DOI 10.1007/s00438-013-0740-1; Tombuloglu H, 2012, CHEMOSPHERE, V86, P433, DOI 10.1016/j.chemosphere.2011.09.035; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsiatsiani L, 2011, CELL DEATH DIFFER, V18, P1279, DOI 10.1038/cdd.2011.66; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang LK, 2014, J GENET, V93, P93, DOI 10.1007/s12041-014-0343-6; Wang XD, 2012, MOL PLANT MICROBE IN, V25, P755, DOI 10.1094/MPMI-11-11-0283-R; Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI [10.1093/nar/gkr1132, 10.1093/nar/gkr1293]; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Watanabe N, 2011, PLANT J, V66, P969, DOI 10.1111/j.1365-313X.2011.04554.x; Wertman J, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-115; Wu J, 2013, GENOME RES, V23, P396, DOI 10.1101/gr.144311.112; Zhang CH, 2013, GENE, V528, P267, DOI 10.1016/j.gene.2013.06.062; Zhang QX, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2290; Zhou HS, 2016, GENE EXPR PATTERNS, V20, P11, DOI 10.1016/j.gep.2015.10.004; Zhou Y, 2018, GENOME, V61, P187, DOI 10.1139/gen-2017-0174	62	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211635	10.1371/journal.pone.0211635	http://dx.doi.org/10.1371/journal.pone.0211635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794567	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100021
J	He, H; Yang, X; Xu, ZH; Deng, N; Shang, YJ; Liu, G; Ji, MY; Zheng, WH; Zhao, JF; Dong, LY				He, Hu; Yang, Xu; Xu, Zhiheng; Deng, Ning; Shang, Yingjie; Liu, Guo; Ji, Mengyao; Zheng, Wenhao; Zhao, Jinfeng; Dong, Liya			Implementing artificial neural networks through bionic construction	PLOS ONE			English	Article								It is evident through biology research that, biological neural network could be implemented through two means: by congenital heredity, or by posteriority learning. However, traditionally, artificial neural network, especially the Deep learning Neural Networks (DNNs) are implemented only through exhaustive training and learning. Fixed structure is built, and then parameters are trained through huge amount of data. In this way, there are a lot of redundancies in the implemented artificial neural network. This redundancy not only requires more effort to train the network, but also costs more computing resources when used. In this paper, we proposed a bionic way to implement artificial neural network through construction rather than training and learning. The hierarchy of the neural network is designed according to analysis of the required functionality, and then module design is carried out to form each hierarchy. We choose the Drosophila's visual neural network as a test case to verify our method's validation. The results show that the bionic artificial neural network built through our method could work as a bionic compound eye, which can achieve the detection of the object and their movement, and the results are better on some properties, compared with the Drosophila's biological compound eyes.	[He, Hu; Xu, Zhiheng; Deng, Ning; Shang, Yingjie; Dong, Liya] Tsinghua Univ, Inst Microelect, Beijing, Peoples R China; [Yang, Xu; Liu, Guo; Ji, Mengyao; Zheng, Wenhao; Zhao, Jinfeng] Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China	Tsinghua University; Beijing Institute of Technology	Yang, X (corresponding author), Beijing Inst Technol, Sch Comp Sci & Technol, Beijing, Peoples R China.	yangxu@tsinghua.edu.cn		Yang, Xu/0000-0001-7983-6473	National Natural Science Foundation of China [91846303, 61502032]; Core Electronic Devices, High-End General Purpose Processor, and Fundamental System Software of China [2012ZX01034-001-002]; Tsinghua National Laboratory for Information Science and Technology (TNList); Samsung Tsinghua Joint Laboratory	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Core Electronic Devices, High-End General Purpose Processor, and Fundamental System Software of China; Tsinghua National Laboratory for Information Science and Technology (TNList); Samsung Tsinghua Joint Laboratory(Samsung)	This work is supported by the National Natural Science Foundation of China under Grant No. 91846303 (for Xu Yang), the National Natural Science Foundation of China under Grant No. 61502032 (for Xu Yang), the Core Electronic Devices, High-End General Purpose Processor, and Fundamental System Software of China under Grant No. 2012ZX01034-001-002 (for Hu He), Tsinghua National Laboratory for Information Science and Technology (TNList) (for Hu He), and Samsung Tsinghua Joint Laboratory (for Hu He). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmedova S, 2015, ICIMCO 2015 PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON INFORMATICS IN CONTROL, AUTOMATION AND ROBOTICS, VOL. 1, P310; Nguyen A, 2015, PROC CVPR IEEE, P427, DOI 10.1109/CVPR.2015.7298640; Arena P, 2011, INSECT BRAIN INSPIRE; Arena P, 2013, INT JOINT C NEUR NET; Chang H M, 2013, 2013 IEEE 2 NETW SCI; Chen L, 2016, ASSEMBLY AUTOM, V36, P172, DOI 10.1108/AA-11-2015-105; Egmont-Petersen M, 2002, PATTERN RECOGN, V35, P2279, DOI 10.1016/S0031-3203(01)00178-9; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Li Dingyuan, 2015, Journal of Mechanical Engineering, V51, P128, DOI 10.3901/JME.2015.22.128; Lin CY, 2013, IEEE INT C BIOINFORM; Ma  Hailin, 2016, INT C ART NEUR NETW; Ma  Hailin, 2016, 25 ANN COMP NEUR M; Masland RH, 2013, NATURE, V500, P154, DOI 10.1038/500154a; Mauss AS, 2014, J NEUROSCI, V34, P2254, DOI 10.1523/JNEUROSCI.3938-13.2014; Morante J, 2008, CURR BIOL, V18, P553, DOI 10.1016/j.cub.2008.02.075; Rigosi E, 2017, SCI REP-UK, V7, DOI 10.1038/srep45972; Rowley H A, 1996, IEEE T PATTERN ANAL, V20, P203, DOI DOI 10.1109/CVPR.1996.517075; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Zaknich A, 1998, IEEE T SIGNAL PROCES, V46, P1980, DOI 10.1109/78.700969; Zhang J, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P2733; Zhu Y, 2013, CELL ADHES MIGR, V7, P333, DOI 10.4161/cam.25521; Zuker C. S, 1996, P NATL ACAD SCI US	23	4	4	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212368	10.1371/journal.pone.0212368	http://dx.doi.org/10.1371/journal.pone.0212368			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794587	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100057
J	Tassew, AA; Tekle, DY; Belachew, AB; Adhena, BM				Tassew, Aberash Abay; Tekle, Dejen Yemane; Belachew, Abate Bekele; Adhena, Beyene Meressa			Factors affecting feeding 6-23 months age children according to minimum acceptable diet in Ethiopia: A multilevel analysis of the Ethiopian Demographic Health Survey	PLOS ONE			English	Article							SECONDARY DATA-ANALYSIS; YOUNG-CHILDREN; DETERMINANTS	Background Though infant and young children should be fed according to a minimum acceptable diet to ensure appropriate growth and development, only 7% of Ethiopian 6-23 months age children meet the minimum acceptable dietary standards, which is lower than the national target of 11% set for 2016. Therefore, this study aims to assess the individual and community level factors affecting feeding according to minimum acceptable diet among 6-23 months age children in Ethiopia. Methods This study analyzed retrospectively a cross-sectional data on a weighted sample of 2919 children aged 6-23 months nested within 617 clusters after extracting from Ethiopian Demographic and Health Survey 2016 via the link www.measuredhs.com. By employing bi-variate multilevel logistic regression model, variables which were significant at the p-value < 0.25 were included in multivariable multilevel logistic regression analysis. Finally, variables with a p-value < 0.05 were considered as significant predictors of minimum acceptable diet. Results Only 6.1% of 6-23 months age children feed minimum acceptable diet in Ethiopia. Children 18-23 months age (AOR = 3.7, 95% CI 1.9, 7.2), father's with secondary or higher education (AOR = 2.1, 95% CI 1.2, 3.6), Employed mothers (AOR = 1.7, 95% CI 1.2, 2.5), mothers have access to drinking water (AOR = 1.9, 95% CI 1.2, 2.9), mothers with media exposure (AOR = 2.1 95% CI 1.1, 2.7) were positive individual level predictors. Urban mothers (AOR = 4.8, 95% CI 1.7, 13.2)) and agrarian dominant region (AOR = 5.6, 95% CI 2.2, 14.5) were community level factors that significantly associated with a minimum acceptable diet of 6-23 months age children. Conclusion Both individual and community level factors were significantly associated with a minimum acceptable diet of 6-23 months age children in Ethiopia, suggesting that nutritional interventions designed to improve child health should not only be implemented at the individual level but tailored to community context as well.	[Tassew, Aberash Abay; Belachew, Abate Bekele] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Biostat, Mekelle, Tigray, Ethiopia; [Tekle, Dejen Yemane; Adhena, Beyene Meressa] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Environm Hlth & Behav Sci, Mekelle, Tigray, Ethiopia	Mekelle University; Mekelle University	Adhena, BM (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Environm Hlth & Behav Sci, Mekelle, Tigray, Ethiopia.	beyene2006m@gmail.com	Tekle, Dejen/AAR-8865-2021; Meressa, Beyene/W-6568-2019; Belachew, Abate Bekele/I-1758-2019; Meressa, Beyene/ABA-8501-2021	Meressa, Beyene/0000-0002-1864-0765; Belachew, Abate Bekele/0000-0003-2583-9913; 	Mekelle University -Norwegian University of Life Sciences (MU-NMBU project) [PG/CHS/01MSc-HI02/09MU-NMBU/2010]; Mekelle University, College of Health Sciences; MU-NMBU	Mekelle University -Norwegian University of Life Sciences (MU-NMBU project); Mekelle University, College of Health Sciences; MU-NMBU	AAT was supported by Mekelle University -Norwegian University of Life Sciences (MU-NMBU project) Grant number: PG/CHS/01MSc-HI02/09MU-NMBU/2010. http://www.mu.edu.et.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Our sincere and deepest gratitude goes to Mekelle University, College of Health Sciences and MU-NMBU for financial support of this study. We are also very grateful to Measure DHS for making the data freely available and we would like to extend our heartfelt thanks and appreciation to family members of Mrs. Aberash Abay (Haset Beyene, Nobel Beyene, Lidiya Beyene and Beyene Meressa) and friends for their endless support and providing the required courage during the research work.	[Anonymous], 2020, BMC PUBLIC HEALTH; Armenia National Statistical Service, 2015, ARM DEM HLTH SURV; Beyene M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2333-x; Browne WJ, 2005, J ROY STAT SOC A STA, V168, P599, DOI 10.1111/j.1467-985X.2004.00365.x; Central Statistics of Afghanistan, 2015, AFGH DEM HLTH SURV; Department of Community Medicine Faculty of Medicine University of Colombo 25 K, 2012, MATERN CHILD NUTR, V8, P5; Ethiopia Health and Nutrition Research Institute and U Suggested, 2010, IYCF PRACT BEL INFL; Federal Democratic Republic of Ethiopia, 2016, IMPL PLAN 2016 2030; Issaka AI, 2015, PUBLIC HEALTH NUTR, V18, P669, DOI 10.1017/S1368980014000834; Kabir I, 2012, MATERN CHILD NUTR, V8, P11, DOI 10.1111/j.1740-8709.2011.00379.x; Khanal V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-131; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mokori A, 2017, S AFR J CLIN NUTR, V30, P7, DOI 10.1080/16070658.2016.1225887; Na M, 2017, MATERN CHILD NUTR, V13, P1; National Institute of Statistics of Rwanda, 2014, RWAND DEM HLTH SURV; National Statistical Office ICF, 2018, MAL DEM HLTH SURV 20; Nepal Ministry of Health, 2016, NEP DEM HLTH SURV; Ng CS, 2012, PUBLIC HLTH NUTR, V15; Pakistan National Institute of Population Studies, 2012, PAK DEM HLTH SURV; Patel A, 2012, MATERN CHILD NUTR, V8, P28, DOI 10.1111/j.1740-8709.2011.00385.x; Senarath U, 2012, MATERN CHILD NUTR, V8, P60, DOI 10.1111/j.1740-8709.2011.00375.x; UNICEF, 2016, C4D COMM DEV C4D CAP; USAID, 2010, NUTR IND REF SHEETS; World Health Organization, 2001, GUID PRINC COMPL FEE; Zimbabwe National Statistics Agency The DHS Program ICF International, 2015, ZIMB DEM HLTH SURV	25	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0203098	10.1371/journal.pone.0203098	http://dx.doi.org/10.1371/journal.pone.0203098			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789922	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800003
J	Kim, SH; Kim, JK; Park, EY; Joo, J; Lee, KH; Seo, HK; Joung, JY; Chung, J				Kim, Sung Han; Kim, Jung Kwon; Park, Eun Young; Joo, Jungnam; Lee, Kang Hyun; Seo, Ho Kyung; Joung, Jae Young; Chung, Jinsoo			Liver metastasis and Heng risk are prognostic factors in patients with non-nephrectomized synchronous metastatic renal cell carcinoma treated with systemic therapy	PLOS ONE			English	Article							TRANSARTERIAL CHEMOEMBOLIZATION; SURVIVAL; SUNITINIB; VALIDATION; SORAFENIB; CRITERIA; TUMORS; ERA	Objective This study aimed to determine the prognostic factors of progression-free survival (PFS) and overall survival (OS) in non-nephrectomized patients with synchronous metastatic renal cell carcinoma (mRCC) receiving first-line vascular endothelial growth factor (VEGF)-targeted therapy or immunotherapy. Methods Of 70 patients, 57 (81.4%) were treated with targeted therapy, including 5 (7.1%) with previous immunotherapy and 13 (18.6%) with immunotherapy only. The medical records of patients were retrospectively reviewed and analyzed to determine factors of PFS and OS using the Cox proportional hazards model with a statistical significance p-value <0.05. Results The median treatment and follow-up periods were 3.9 and 30.9 months, respectively. Disease progression was reported in 90.0% of patients, with an objective response rate and clinical benefit rate of 26.1% and 76.8%, respectively. The lung (77.1%) was the most common site of metastasis. Multivariable analysis showed that poor Heng risk (hazard ratio [HR]: 2.37) and liver metastasis (HR: 2.34) were significant prognostic factors for PFS, and female sex (HR: 2.13), poor Heng risk (HR: 3.14), and liver metastasis (HR: 2.78) were significant prognostic factors for OS (p < 0.05). A subset analysis of risk factors among patients without previous history of immunotherapy also showed poor Heng risk (HR 2.92 and HR 4.24 for PFS) and liver metastasis (HR 2.87 and HR 4.81 for OS) as significant factors for both PFS and OS (p<0.05). Conclusion Poor Heng risk, sex, and liver metastasis were associated with survival outcomes after first-line systemic therapy in patients with non-nephrectomized synchronous mRCC.	[Kim, Sung Han; Kim, Jung Kwon; Lee, Kang Hyun; Seo, Ho Kyung; Joung, Jae Young; Chung, Jinsoo] Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea; [Park, Eun Young; Joo, Jungnam] Natl Canc Ctr, Res Inst & Hosp, Div Canc Epidemiol & Prevent, Biometr Res Branch, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Chung, J (corresponding author), Natl Canc Ctr, Dept Urol, Ctr Prostate Canc, Goyang, South Korea.	cjs5225@ncc.re.kr		KIM, Sung Han/0000-0002-1689-5203	Research and institute of National Cancer Center Grant [1710290-2]	Research and institute of National Cancer Center Grant	This study was supported by the Research and institute of National Cancer Center Grant (No. 1710290-2) to JC.	Aloia Thomas A, 2006, HPB (Oxford), V8, P100, DOI 10.1080/13651820500496266; Alves A, 2003, ANN SURG ONCOL, V10, P705, DOI 10.1245/ASO.2003.07.024; Bianchi M, 2012, ANN ONCOL, V23, P973, DOI 10.1093/annonc/mdr362; Buchler T, 2016, EUR UROL, V70, P469, DOI 10.1016/j.eururo.2015.12.031; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dumitru CA, 2013, SEMIN CANCER BIOL, V23, P141, DOI 10.1016/j.semcancer.2013.02.005; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gills J, 2017, J UROLOGY, V198, P538, DOI 10.1016/j.juro.2017.03.076; Ha Y, 2016, ONCOTARGET, V7, P74303, DOI 10.18632/oncotarget.11030; Hu B, 2012, UROL CLIN N AM, V39, P233, DOI 10.1016/j.ucl.2012.02.002; Iacovelli R, 2014, CANCER TREAT REV, V40, P271, DOI 10.1016/j.ctrv.2013.09.003; Jonasch E, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4797; Kim SH, 2016, CANCER RES TREAT, V48, P1092, DOI 10.4143/crt.2015.316; Kroeger N, 2014, EUR UROL, V65, P1086, DOI 10.1016/j.eururo.2013.07.031; Kwon WA, 2013, ANN SURG ONCOL, V20, P4397, DOI 10.1245/s10434-013-3290-1; Langan RC, 2012, J CANCER, V3, P184, DOI 10.7150/jca.4456; Leon L, 2014, TARGET ONCOL, V9, P9, DOI 10.1007/s11523-013-0304-7; Mckay RR, 2014, EUR UROL, V65, P577, DOI 10.1016/j.eururo.2013.08.012; Mekhail TM, 2005, J CLIN ONCOL, V23, P832, DOI 10.1200/JCO.2005.05.179; Motzer RJ, 2008, CANCER-AM CANCER SOC, V113, P1552, DOI 10.1002/cncr.23776; Motzer Robert J, 2015, J Natl Compr Canc Netw, V13, P151; Motzer RJ, 2011, ONCOLOGIST, V16, P1, DOI 10.1634/theoncologist.2011-S2-01; Negrier S, 2002, ANN ONCOL, V13, P1460, DOI 10.1093/annonc/mdf257; Pecuchet N, 2013, ONCOLOGY-BASEL, V84, P22, DOI 10.1159/000342962; Segarra I, 2016, CLIN DRUG INVEST, V36, P791, DOI 10.1007/s40261-016-0428-5; Stafford HS, 2008, J UROLOGY, V179, P1704, DOI 10.1016/j.juro.2008.01.027; Stewart GD, 2014, EUR UROL, V66, P85, DOI 10.1016/j.eururo.2014.03.004; van der Veldt AAM, 2008, BRIT J CANCER, V99, P259, DOI 10.1038/sj.bjc.6604456; Wang GL, 2016, HEPATOL INT, V10, P501, DOI 10.1007/s12072-015-9700-7	30	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211105	10.1371/journal.pone.0211105	http://dx.doi.org/10.1371/journal.pone.0211105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785902	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000018
J	Cao, DC; Song, JP; Ling, SK; Niu, SS; Lu, L; Cui, ZZ; Li, YH; Hao, SS; Zhong, GH; Qi, ZH; Sun, WJ; Yuan, XX; Li, HX; Zhao, DS; Jin, XY; Liu, CZ; Wu, XR; Kan, GH; Cao, HQ; Kang, YM; Yu, SY; Li, YX				Cao, Dengchao; Song, Jinping; Ling, Shukuan; Niu, Shuaishuai; Lu, Liang; Cui, Zhengzhi; Li, Yuheng; Hao, Shanshan; Zhong, Guohui; Qi, Zhihong; Sun, Weijia; Yuan, Xinxin; Li, Hongxing; Zhao, Dingsheng; Jin, Xiaoyan; Liu, Caizhi; Wu, Xiaorui; Kan, Guanghan; Cao, Hongqing; Kang, Youmin; Yu, Shuyang; Li, Yingxian			Hematopoietic stem cells and lineage cells undergo dynamic alterations under microgravity and recovery conditions	FASEB JOURNAL			English	Article						spaceflight; immune dysfunction; hindlimb unloading; differentiation	BONE-MARROW; SIMULATED MICROGRAVITY; INDUCED APOPTOSIS; DIFFERENTIATION; SPACE; PROLIFERATION; HOMEOSTASIS; PRECURSORS; EXPRESSION; MIGRATION	Spaceflight leads to health risks including bone demineralization, skeletal muscle atrophy, cardiovascular dysfunction, and disorders of almost all physiologic systems. However, the impacts of microgravity on blood lineage cells and hematopoietic stem cells (HSCs) in vivo are largely unknown. In this study, we analyzed peripheral blood samples from 6 astronauts who had participated in spaceflight missions and found significant changes in several cell populations at different time points. These dynamic alterations of lineage cells and the role of HSCs were further studied in a mouse model, using hindlimb unloading (HU) to simulate microgravity. Large reductions in the frequency of NK cells, B cells, and erythrocyte precursors in the bone marrow of the HU mice were observed, together with an increased frequency of T cells, neutrophils, and HSCs. T cell levels recovered faster than those of B cells and erythrocyte precursors, whereas the recovery rates of NK cells and granulocytes were slow. In addition, competitive reconstitution experiments demonstrated the impaired function of HSCs, although these changes were reversible. Deep sequencing showed changes in the expression of regulatory molecules important for the differentiation of HSCs. This study provides the first determination of altered HSC function under simulated microgravity in vivo. The impairment of HSC function and differentiation provides an explanation for the immune disorders that occur under simulated microgravity. Thus, our findings demonstrated that spaceflight and simulated microgravity disrupt the homeostasis of immune system and cause dynamic alterations on both HSCs and lineage cells.-Cao, D., Song, J., Ling, S., Niu, S., Lu, L., Cui, Z., Li, Y., Hao, S., Zhong, G., Qi, Z., Sun, W., Yuan, X., Li, H., Zhao, D., Jin, X., Liu, C., Wu, X., Kan, G., Cao, H., Kang, Y., Yu, S., Li, Y. Hematopoietic stem cells and lineage cells undergo dynamic alterations under microgravity and recovery conditions.	[Cao, Dengchao; Niu, Shuaishuai; Cui, Zhengzhi; Hao, Shanshan; Qi, Zhihong; Yuan, Xinxin; Yu, Shuyang] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Cao, Dengchao; Niu, Shuaishuai; Cui, Zhengzhi; Hao, Shanshan; Yuan, Xinxin; Kang, Youmin; Yu, Shuyang] China Agr Univ, Coll Life Sci, State Key Lab Agrobiotechnol, 2 Yuan Mingyuan West Rd, Beijing 100193, Peoples R China; [Cao, Dengchao; Song, Jinping; Ling, Shukuan; Lu, Liang; Li, Yuheng; Zhong, Guohui; Qi, Zhihong; Sun, Weijia; Yuan, Xinxin; Li, Hongxing; Zhao, Dingsheng; Jin, Xiaoyan; Liu, Caizhi; Wu, Xiaorui; Kan, Guanghan; Cao, Hongqing; Li, Yingxian] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, 26 Beiqing Rd, Beijing 100094, Peoples R China	China Agricultural University; China Agricultural University	Yu, SY (corresponding author), China Agr Univ, Coll Life Sci, State Key Lab Agrobiotechnol, 2 Yuan Mingyuan West Rd, Beijing 100193, Peoples R China.; Li, YX (corresponding author), China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, 26 Beiqing Rd, Beijing 100094, Peoples R China.	ysy@cau.edu.cn; yingxianli@aliyun.com	Song, Jin/HHS-8731-2022; Cao, Dengchao/AIA-7934-2022	Cao, Dengchao/0000-0001-9808-991X; Ling, Shukuan/0000-0002-4622-4160	National Natural Science Foundation of China [31571522, 31422037, 31630038]; National Key Research and Development Program of China [2017YFA0104401]; Project for Extramural Scientists (State Key Laboratory of Agrobiotechnology, China Agricultural University) [2018SKLAB6-30]; 1226 Project [AWS16J018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Project for Extramural Scientists (State Key Laboratory of Agrobiotechnology, China Agricultural University); 1226 Project	This work was supported by the National Natural Science Foundation of China (31630038) and 1226 Project (AWS16J018), the National Key Research and Development Program of China (2017YFA0104401), the National Natural Science Foundation of China (31571522 and 31422037), and the Project for Extramural Scientists (State Key Laboratory of Agrobiotechnology, China Agricultural University) (2018SKLAB6-30). The authors declare no conflicts of interest.	Cheng LZ, 2000, J CELL PHYSIOL, V184, P58, DOI 10.1002/(SICI)1097-4652(200007)184:1<58::AID-JCP6>3.0.CO;2-B; Crucian BE, 2000, J INTERF CYTOK RES, V20, P547, DOI 10.1089/10799900050044741; Crucian B, 2015, NPJ MICROGRAVITY, V1, DOI 10.1038/npjmgrav.2015.13; Ferrero E, 2003, BLOOD, V101, P186, DOI 10.1182/blood-2002-03-0768; Gridley DS, 2009, J APPL PHYSIOL, V106, P194, DOI 10.1152/japplphysiol.91126.2008; Hua C, 2017, NEURAL REGEN RES, V12, P153, DOI 10.4103/1673-5374.199008; Kunz Hawley, 2017, BMC Hematol, V17, P12, DOI 10.1186/s12878-017-0083-y; Kuo YH, 2009, BLOOD, V113, P3323, DOI 10.1182/blood-2008-06-162248; Laurenti E, 2018, NATURE, V553, P418, DOI 10.1038/nature25022; Lescale C, 2015, FASEB J, V29, P455, DOI 10.1096/fj.14-259770; Li PP, 2015, FASEB J, V29, P3263, DOI 10.1096/fj.15-271700; Link DC, 2005, IMMUNOL RES, V32, P169, DOI 10.1385/IR:32:1-3:169; Mehta SK, 2001, J APPL PHYSIOL, V91, P1814, DOI 10.1152/jappl.2001.91.4.1814; Mills PJ, 2001, PSYCHOSOM MED, V63, P886, DOI 10.1097/00006842-200111000-00006; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Ochiai K, 2012, NAT IMMUNOL, V13, P300, DOI 10.1038/ni.2210; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Paredes F, 2016, FREE RADICAL BIO MED, V90, P206, DOI 10.1016/j.freeradbiomed.2015.11.024; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Plett RA, 2001, IN VITRO CELL DEV-AN, V37, P73, DOI 10.1290/1071-2690(2001)037<0073:POHHBM>2.0.CO;2; Rankin EB, 2012, CELL, V149, P63, DOI 10.1016/j.cell.2012.01.051; Sonnenfeld G, 2005, CURR PHARM BIOTECHNO, V6, P343, DOI 10.2174/1389201054553699; Sotnezova EV, 2017, B EXP BIOL MED+, V162, P496, DOI 10.1007/s10517-017-3647-8; Sun ZY, 2015, BONE, V76, P121, DOI 10.1016/j.bone.2015.04.006; Tober J, 2013, DEVELOPMENT, V140, P3765, DOI 10.1242/dev.094961; Williams DR, 2003, ANNU REV MED, V54, P245, DOI 10.1146/annurev.med.54.101601.152215; Zheng L, 2011, AVIAT SPACE ENVIR MD, V82, P513, DOI 10.3357/ASEM.2838.2011; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	29	15	17	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6904	6918		10.1096/fj.201802421RR	http://dx.doi.org/10.1096/fj.201802421RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811956				2022-12-26	WOS:000476114200019
J	Sharma, S; Oot, RA; Khan, MM; Wilkens, S				Sharma, Stuti; Oot, Rebecca A.; Khan, Md Murad; Wilkens, Stephan			Functional reconstitution of vacuolar H+-ATPase from V-o proton channel and mutant V-1-ATPase provides insight into the mechanism of reversible disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						vacuolar ATPase; protein-protein interaction; biophysics; membrane protein; molecular motor; biolayer interferometry; lipid nanodisc; reversible disassembly	YEAST VACUOLAR; AFFINITY PURIFICATION; SUBUNIT INTERACTIONS; STRUCTURAL FEATURES; CRYSTAL-STRUCTURE; DISSOCIATION; MEMBRANES; DOMAIN; ISOFORM; COMPLEX	The vacuolar H+-ATPase (V-ATPase; V1Vo-ATPase) is an ATP-dependent proton pump that acidifies subcellular compartments in all eukaryotic organisms. V-ATPase activity is regulated by reversible disassembly into autoinhibited V-1-ATPase and V-o proton channel subcomplexes, a process that is poorly understood on the molecular level. V-ATPase is a rotary motor, and recent structural analyses have revealed different rotary states for disassembled V-1 and V-o, a mismatch that is likely responsible for their inability to reconstitute into holo V-ATPase in vitro. Here, using the model organism Saccharomyces cerevisiae, we show that a key impediment for binding of V-1 to V-o is the conformation of the inhibitory C-terminal domain of subunit H (H-CT). Using biolayer interferometry and biochemical analyses of purified mutant V-1-ATPase and V-o proton channel reconstituted into vacuolar lipid-containing nanodiscs, we further demonstrate that disruption of H-CT's V-1-binding site facilitates assembly of a functionally coupled and stable V1Vo-ATPase. Unlike WT, this mutant enzyme was resistant to MgATP hydrolysis-induced dissociation, further highlighting H-CT's role in the mechanism of V-ATPase regulation. Our findings provide key insight into the molecular events underlying regulation of V-ATPase activity by reversible disassembly.	[Sharma, Stuti; Oot, Rebecca A.; Khan, Md Murad; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Sharma, Stuti] Harvard Med Sch, Dept Cell Biol, 250 Longwood Ave, Boston, MA 02115 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu		Khan, Md. Murad/0000-0002-7371-2995	National Institutes of Health [GM058600]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM058600 (to S. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bodzeta A, 2017, CELL REP, V20, P1348, DOI 10.1016/j.celrep.2017.07.040; Brown D, 1997, J EXP BIOL, V200, P257; Chan CY, 2014, J BIOL CHEM, V289, P19448, DOI 10.1074/jbc.M114.569855; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Funakoshi M, 2009, YEAST, V26, P185, DOI 10.1002/yea.1658; HO MN, 1993, J BIOL CHEM, V268, P18286; Kane PM, 2012, CURR PROTEIN PEPT SC, V13, P117; KANE PM, 1995, J BIOL CHEM, V270, P17025; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lu M, 2007, J BIOL CHEM, V282, P24495, DOI 10.1074/jbc.M702598200; Mazhab-Jafari MT, 2016, NATURE, V539, P118, DOI 10.1038/nature19828; Muench SP, 2011, Q REV BIOPHYS, V44, P311, DOI 10.1017/S0033583510000338; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2014, EUKARYOT CELL, V13, P706, DOI 10.1128/EC.00050-14; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1996, J BIOL CHEM, V271, P19592, DOI 10.1074/jbc.271.32.19592; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; PUOPOLO K, 1990, J BIOL CHEM, V265, P14836; Roh SH, 2018, MOL CELL, V69, P993, DOI 10.1016/j.molcel.2018.02.006; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sharma S, 2018, J BIOL CHEM, V293, P10718, DOI 10.1074/jbc.RA118.002951; Sharma S, 2017, PROTEIN SCI, V26, P1070, DOI 10.1002/pro.3143; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Stam NJ, 2017, J BIOL CHEM, V292, P1749, DOI 10.1074/jbc.M116.766790; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Tabke K, 2014, BIOCHEM J, V462, P185, DOI 10.1042/BJ20131293; Thudium CS, 2012, CURR PROTEIN PEPT SC, V13, P141; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; UCHIDA E, 1985, J BIOL CHEM, V260, P1090; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Williamson W Ryan, 2010, Commun Integr Biol, V3, P604, DOI 10.4161/cib.3.6.13364; XIE XS, 1994, J BIOL CHEM, V269, P25809; Xu T, 2001, J BIOL CHEM, V276, P24855, DOI 10.1074/jbc.M100637200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	51	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6439	6449		10.1074/jbc.RA119.007577	http://dx.doi.org/10.1074/jbc.RA119.007577			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792311	Green Published, hybrid			2022-12-26	WOS:000468402000021
J	Cheng, YL; Tang, QN; Li, YT; Zhang, YS; Zhao, CY; Yan, J; You, HJ				Cheng, Yuanlei; Tang, Qingnan; Li, Yutong; Zhang, Yashuo; Zhao, Chuyuan; Yan, Jie; You, Huijuan			Folding/unfolding kinetics of G-quadruplexes upstream of the P1 promoter of the human BCL-2 oncogene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G-quadruplex; B-cell lymphoma 2 (Bcl-2); single-molecule biophysics; promoter; transcription regulation; DNA secondary structure; folding; unfolding kinetics; force spectroscopy; magnetic tweezers; force spectroscopy; oncogene promoter	MAGNETIC TWEEZERS; FORMING REGION; EXPRESSION; PROTEIN; LOOP; POTASSIUM; STABILITY; DYNAMICS; TRACT; GENE	The G-rich Pu39 region of the P1 promoter of the oncogene BCL-2, an apoptosis regulator, can fold into multiple G-quadruplex (G4) structures. Bcl2-2345 and Bcl2-1245 are two major G4 species forming with high thermal stability and distinct topologies in the Pu39 region, but their folding/unfolding kinetics have not yet been investigated. Here, we used magnetic tweezers to measure the mechanical stability and the folding/unfolding kinetics of the Bcl2-2345 and Bcl2-1245 G4 structures. We report that the hybrid-stranded Bcl2-2345 G4 had a lower mechanical stability than the parallel-stranded Bcl2-1245 G4. We observed that the Bcl2-2345 G4 is a kinetically favored structure, whereas the Bcl2-1245 G4, with a slow unfolding rate, may function as a kinetic barrier for transcription. We also determined that in addition to the Bcl2-2345 and Bcl2-1245 G4s, other stable DNA secondary structures, such as a hybrid-stranded Bcl2-1234 G4, can also form in the Pu39 sequence. The characterization of the folding/unfolding kinetics of specific G4s reported here sheds light on the participation of G4s during gene transcription and provides information for designing G4-targeting small molecules that could modulate BCL-2 gene expression.	[Cheng, Yuanlei; Li, Yutong; Zhang, Yashuo; You, Huijuan] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Hubei, Peoples R China; [Tang, Qingnan; Zhao, Chuyuan; Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore 117542, Singapore; [Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore 117411, Singapore	Huazhong University of Science & Technology; National University of Singapore; National University of Singapore	You, HJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430030, Hubei, Peoples R China.	youhuijuan@hust.edu.cn	cheng, sanshi/GQZ-2396-2022; Yan, Jie/G-2725-2012; You, Huijuan/A-1018-2015	Yan, Jie/0000-0002-8555-7291; You, Huijuan/0000-0001-5371-9666; Cheng, Yuanlei/0000-0002-6081-559X	National Natural Science Foundation of China [21708009]; Fundamental Research Fund for the Central Universities [2017KFYXJJ153]; National Research Foundation, Prime Minister's Office, Singapore; Ministry of Education under the Research Centres of Excellence programme	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities; National Research Foundation, Prime Minister's Office, Singapore(National Research Foundation, Singapore); Ministry of Education under the Research Centres of Excellence programme	This work was supported by National Natural Science Foundation of China Grant 21708009 (to H. Y.); Fundamental Research Fund for the Central Universities Grant 2017KFYXJJ153 (to H. Y.); National Research Foundation, Prime Minister's Office, Singapore and the Ministry of Education under the Research Centres of Excellence programme (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Agrawal P, 2014, J AM CHEM SOC, V136, P1750, DOI 10.1021/ja4118945; Agrawal P, 2013, NUCLEIC ACIDS RES, V41, P10584, DOI 10.1093/nar/gkt784; Amato J, 2018, CHEMMEDCHEM, V13, P406, DOI 10.1002/cmdc.201700749; Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700; Chen Y., 2012, CURR PROTOC NUCL ACI, DOI [10.1002/0471142700.nc1705s50, DOI 10.1002/0471142700.NC1705S50]; Cocco S, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.011910; Cui YX, 2016, BIOCHEMISTRY-US, V55, P2291, DOI 10.1021/acs.biochem.6b00016; Cui YX, 2014, NUCLEIC ACIDS RES, V42, P5755, DOI 10.1093/nar/gku185; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; De Armond R, 2005, BIOCHEMISTRY-US, V44, P16341, DOI 10.1021/bi051618u; Dexheimer TS, 2006, J AM CHEM SOC, V128, P5404, DOI 10.1021/ja0563861; Falanga AP, 2019, BIOCONJUGATE CHEM, V30, P572, DOI 10.1021/acs.bioconjchem.8b00674; Heckman C, 1997, J BIOL CHEM, V272, P19609, DOI 10.1074/jbc.272.31.19609; Hsu STD, 2009, J AM CHEM SOC, V131, P13399, DOI 10.1021/ja904007p; JOENSUU H, 1994, AM J PATHOL, V145, P1191; LINZELL JL, 1971, J PHYSIOL-LONDON, V216, P683, DOI 10.1113/jphysiol.1971.sp009547; Long X, 2013, NUCLEIC ACIDS RES, V41, P2746, DOI 10.1093/nar/gks1341; Lynch S, 2009, CHEM-EUR J, V15, P8113, DOI 10.1002/chem.200901390; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Onel B, 2016, J AM CHEM SOC, V138, P2563, DOI 10.1021/jacs.5b08596; PEZZELLA F, 1993, NEW ENGL J MED, V329, P690, DOI 10.1056/NEJM199309023291003; Rankin S, 2005, J AM CHEM SOC, V127, P10584, DOI 10.1021/ja050823u; REED JC, 1994, ANN ONCOL, V5, pS61, DOI 10.1093/annonc/5.suppl_1.S61; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; Wang XD, 2010, J MED CHEM, V53, P4390, DOI 10.1021/jm100445e; You HJ, 2017, JOVE-J VIS EXP, DOI 10.3791/56328; You HJ, 2015, J AM CHEM SOC, V137, P2424, DOI 10.1021/ja511680u; You HJ, 2014, NUCLEIC ACIDS RES, V42, P8789, DOI 10.1093/nar/gku581; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686; Yu ZB, 2009, J AM CHEM SOC, V131, P1876, DOI 10.1021/ja806782s; Zhang XH, 2014, J AM CHEM SOC, V136, P16073, DOI 10.1021/ja5090805; Zhao XD, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa837e	32	28	28	2	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5890	5895		10.1074/jbc.RA119.007516	http://dx.doi.org/10.1074/jbc.RA119.007516			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30787104	Green Published, hybrid			2022-12-26	WOS:000465077500020
J	Choi, US; Kawaguchi, H; Matsuoka, Y; Kober, T; Kida, I				Choi, Uk-Su; Kawaguchi, Hirokazu; Matsuoka, Yuichiro; Kober, Tobias; Kida, Ikuhiro			Brain tissue segmentation based on MP2RAGE multi-contrast images in 7 T MRI	PLOS ONE			English	Article							WHITE-MATTER SUPPRESSION; C-MEANS ALGORITHM; GRAY-MATTER; FRAMEWORK; FIELD; MODEL; FLUID	We proposed a method for segmentation of brain tissues-gray matter, white matter, and cerebrospinal fluid-using multi-contrast images, including a T1 map and a uniform T1-weighted image, from a magnetization-prepared 2 rapid acquisition gradient echoes (MP2RAGE) sequence at 7 Tesla. The proposed method was evaluated with respect to the processing time and the similarity of the segmented masks of brain tissues with those obtained using FSL, FreeSurfer, and SPM12. The processing time of the proposed method (28 +/- 0 s) was significantly shorter than those of FSL and SPM12 (444 +/- 4 s and 159 +/- 2 s for FSL and SPM12, respectively). In the similarity assessment, the tissue mask of the brain obtained by the proposed method showed higher consistency with those obtained using FSL than with those obtained using SPM12. The proposed method misclassified the subcortical structures and large vessels since it is based on the intensities of multi-contrast images obtained using MP2RAGE, which uses a similar segmentation approach as FSL but is not based on a template image or a parcellated brain atlas, which are used for FreeSurfer and SPM12, respectively. However, the proposed method showed good segmentation in the cerebellum and white matter in the medial part of the brain in comparison with the other methods. Thus, because the proposed method using different contrast images of MP2RAGE sequence showed the shortest processing time and similar segmentation ability as the other methods, it may be useful for both neuroimaging research and clinical diagnosis.	[Choi, Uk-Su; Matsuoka, Yuichiro; Kida, Ikuhiro] Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan; [Choi, Uk-Su; Matsuoka, Yuichiro; Kida, Ikuhiro] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Kawaguchi, Hirokazu] Siemens Healthcare KK, Osaka, Japan; [Kober, Tobias] Siemens Healthcare AG, Adv Clin Imaging Technol, Lausanne, Switzerland; [Kober, Tobias] Univ Hosp CHUV, Dept Radiol, Lausanne, Switzerland; [Kober, Tobias] Ecole Polytech Fed Lausanne, LTS5, Lausanne, Switzerland	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; Siemens AG; Siemens AG; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kida, I (corresponding author), Natl Inst Informat & Commun Technol, Ctr Informat & Neural Networks, Osaka, Japan.; Kida, I (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan.	ikuhiro.kida@nict.go.jp	Kida, Ikuhiro/A-4704-2011	Kida, Ikuhiro/0000-0001-6592-3349	JSPS KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology [15K06731]	JSPS KAKENHI from the Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported by the JSPS KAKENHI grant number 15K06731 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (IK). Siemens Healthcare provided support in the form of salaries for authors [HK, TK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A Javadpour, 2016, J Biomed Phys Eng, V6, P95; Ahmed MN, 2002, IEEE T MED IMAGING, V21, P193, DOI 10.1109/42.996338; Akselrod-Ballin A, 2009, IEEE T BIO-MED ENG, V56, P2461, DOI 10.1109/TBME.2008.926671; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Balafar MA, 2010, ARTIF INTELL REV, V33, P261, DOI 10.1007/s10462-010-9155-0; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; Dell'Acqua F, 2013, CEREBELLUM, V12, P923, DOI 10.1007/s12311-013-0503-x; Despotovic I, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/450341; DUBUISSON MP, 1994, INT C PATT RECOG, P566, DOI 10.1109/ICPR.1994.576361; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Keuken MC, 2013, J NEUROSCI, V33, P4896, DOI 10.1523/JNEUROSCI.3241-12.2013; Li H, 2005, LECT NOTES COMPUT SC, V3765, P335; Lotjonen J, 2011, NEUROIMAGE, V56, P185, DOI 10.1016/j.neuroimage.2011.01.062; Marques JP, 2017, NEUROIMAGE, V147, P152, DOI 10.1016/j.neuroimage.2016.12.009; Marques JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069294; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; O'Brien KR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099676; Obusez EC, 2018, NEUROIMAGE, V168, P459, DOI 10.1016/j.neuroimage.2016.11.030; Okubo G, 2016, J MAGN RESON IMAGING, V43, P55, DOI 10.1002/jmri.24960; Ozer S, 2010, MED PHYS, V37, P1873, DOI 10.1118/1.3359459; Pham DL, 1999, PATTERN RECOGN LETT, V20, P57, DOI 10.1016/S0167-8655(98)00121-4; Tanner M, 2012, J MAGN RESON IMAGING, V35, P1063, DOI 10.1002/jmri.23532; Hernandez MDV, 2010, EUR RADIOL, V20, P1684, DOI 10.1007/s00330-010-1718-6; Viviani R, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00258; Wang L, 2015, NEUROIMAGE, V108, P160, DOI 10.1016/j.neuroimage.2014.12.042; Wang YS, 2018, J MAGN RESON IMAGING, V48, P1540, DOI 10.1002/jmri.26014; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	31	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0210803	10.1371/journal.pone.0210803	http://dx.doi.org/10.1371/journal.pone.0210803			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30818328	Green Published, Green Submitted, gold			2022-12-26	WOS:000460371500009
J	Khan, NA; Yogeswaran, S; Wang, QX; Muthumalage, T; Sundar, IK; Rahman, I				Khan, Naushad Ahmad; Yogeswaran, Shaiesh; Wang, Qixin; Muthumalage, Thivanka; Sundar, Isaac K.; Rahman, Irfan			Waterpipe smoke and e-cigarette vapor differentially affect circadian molecular clock gene expression in mouse lungs	PLOS ONE			English	Article							REV-ERB-ALPHA; INFLAMMATION; DISRUPTION; DEFENSE; RHYTHM	The use of emerging tobacco products, such as waterpipe or hookah and electronic cigarettes (e-cigs), has gained significant popularity and are promoted as safer alternatives to conventional cigarettes. Circadian systems are internal biological oscillations that are considered important regulators of immune functions in mammals. Tobacco induced inflammatory lung diseases frequently exhibit time-of-day/night variation in lung function and symptom severity. We investigated the impact of inhaled e-cig vapor and waterpipe smoke (WPS) on pulmonary circadian molecular clock disruption by determining the changes in expression levels and abundance of core clock component genes (BMAL1, CLOCK) and clock-controlled output genes (Rev-erb alpha, Per2, Rev-erb beta, Cry2, Ror alpha) in mouse lungs. We showed that the expression levels of these pulmonary core clock genes and clock-controlled output genes were altered significantly following exposure to WPS (Bmal1, Clock, and Rev-erb alpha). We further showed a significant yet differential effect on expression levels of core clock and clock-controlled genes (Bmal1, Per2) in the lungs of mice exposed to e-cig vapor containing nicotine. Thus, acute exposure to WPS and e-cig vapor containing nicotine contributes to altered expression of circadian molecular clock genes in mouse lungs, which may have repercussions on lung cellular and biological functions.	[Khan, Naushad Ahmad; Yogeswaran, Shaiesh; Wang, Qixin; Muthumalage, Thivanka; Sundar, Isaac K.; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA	University of Rochester	Rahman, I (corresponding author), Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA.	irfan_rahman@urmc.rochester.edu	Wang, Qixin/W-2259-2019; Sundar, Isaac K/F-8764-2012	Wang, Qixin/0000-0001-9051-8388; Sundar, Isaac K/0000-0001-6742-3460; Yogeswaran, Shaiesh/0000-0002-7736-9346	National Institutes of Health (NIH) [1R01HL135613, NIH 1R01HL085613]; Food and Drug Administration (FDA) Center for Tobacco Products (CTP) NIH-FDA-CTP grant [1R01DA042470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613, R01HL135613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042470] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Food and Drug Administration (FDA) Center for Tobacco Products (CTP) NIH-FDA-CTP grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by a National Institutes of Health (NIH) Grants, 1R01HL135613, NIH 1R01HL085613, and the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) NIH-FDA-CTP grant 1R01DA042470 (all granted to IR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Gaddameedhi S, 2012, CELL CYCLE, V11, P3481, DOI 10.4161/cc.21771; Garcia-Arcos I, 2016, THORAX, V71, P1119, DOI 10.1136/thoraxjnl-2015-208039; Gebel S, 2006, TOXICOL SCI, V93, P422, DOI 10.1093/toxsci/kfl071; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Hadden H, 2012, J APPL PHYSIOL, V113, P385, DOI 10.1152/japplphysiol.00244.2012; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hwang JW, 2014, FASEB J, V28, P176, DOI 10.1096/fj.13-232629; Hwang JH, 2016, J MOL MED, V94, P667, DOI 10.1007/s00109-016-1378-3; Javed F, 2017, INHAL TOXICOL, V29, P389, DOI 10.1080/08958378.2017.1384084; Khabour OF, 2012, INHAL TOXICOL, V24, P667, DOI 10.3109/08958378.2012.710918; Khan NA, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13579; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Lechasseur A, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13440; Maouche K, 2009, AM J PATHOL, V175, P1868, DOI 10.2353/ajpath.2009.090212; MILLER JD, 1993, AM J PHYSIOL, V264, pR821, DOI 10.1152/ajpregu.1993.264.5.R821; Minegishi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30425-6; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; O'Hara BF, 1998, PSYCHONEUROENDOCRINO, V23, P161, DOI 10.1016/S0306-4530(97)00077-2; Pariollaud M, 2018, J CLIN INVEST, V128, P2281, DOI 10.1172/JCI93910; Pekovic-Vaughan V, 2014, GENE DEV, V28, P548, DOI 10.1101/gad.237081.113; Polosa R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14043-2; Raad D, 2011, CHEST, V139, P764, DOI 10.1378/chest.10-0991; Robinson I, 2014, FEBS LETT, V588, P2477, DOI 10.1016/j.febslet.2014.06.005; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; Song P., 2017, INT J ENV RES PUBLIC, V14; Spengler CM, 2000, AM J RESP CRIT CARE, V162, P1038, DOI 10.1164/ajrccm.162.3.9911107; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Sundar IK, 2018, FREE RADICAL BIO MED, V119, P121, DOI 10.1016/j.freeradbiomed.2017.10.383; Sundar IK, 2017, BIOCHEM BIOPH RES CO, V493, P1390, DOI 10.1016/j.bbrc.2017.09.157; Sundar IK, 2015, AM J PHYSIOL-LUNG C, V309, pL1056, DOI 10.1152/ajplung.00152.2015; Sundar IK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09927; Sundar IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087999; Tsai CL, 2007, CHRONOBIOL INT, V24, P699, DOI 10.1080/07420520701535753; Vasu VT, 2009, INTEGR CANCER THER, V8, P321, DOI 10.1177/1534735409352027; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yan J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000193; Yang G, 2014, ANTIOXID REDOX SIGN, V21, P17, DOI 10.1089/ars.2013.5539; Yao HW, 2015, AM J RESP CELL MOL, V53, P782, DOI 10.1165/rcmb.2014-0474OC	40	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211645	10.1371/journal.pone.0211645	http://dx.doi.org/10.1371/journal.pone.0211645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811401	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400027
J	Ghazal, F; Theobald, H; Rosenqvist, M; Al-Khalili, F				Ghazal, Faris; Theobald, Holger; Rosenqvist, Marten; Al-Khalili, Faris			Assessment of N-terminal pro-B-type natriuretic peptide level in screening for atrial fibrillation in primary health care	PLOS ONE			English	Article							PREDICTING STROKE; RISK; VALIDATION; BIOMARKERS; AGE	Background Atrial fibrillation (AF), an important cause of thromboembolic events, is often silent and intermittent, thus presenting a diagnostic challenge. The aim of this study was to assess whether the plasma level of N-terminal pro-brain natriuretic peptide (NT-proBNP) is related to the presence of AF and thereby might be used to facilitate screening programs for AF in primary care. Methods This was a cross sectional screening study. A population of 70-74-year-old individuals registered at a single primary care center in Stockholm were invited to AF screening. Intermittent ECG recording, 30 seconds twice a day using a hand-held device over 2 weeks, was offered to participants without previously known AF. Of the 324 participating persons, 34 patients had already known AF and 16 new cases of AF were detected by screening. Plasma NT-proBNP was measured in patients with previously known AF, newly detected AF, and 53 control participants without AF. Findings The median NT-proBNP was 697 ng/L in patients with previously known AF, 335 ng/L in new cases of AF, and 146 ng/L in patients without AF. After adjustment for several clinical variables and morbidities, the differences of median NT-proBNP levels were statistically significant between cases of previously known AF and new cases of AF as well as between new cases of AF and those without AF. The area under receiver operating characteristic curve of detection of new AF was 0.68 (95% CI 0.56 to 0.79) yielding a cut-off point of 124 ng/L with 75% sensitivity, 45% specificity, and 86% negative predictive value. Conclusions The NT-proBNP plasma levels among patients with known AF are higher than those with newly detected AF, and the latter have higher levels than those without AF. Therefore NT-proBNP might be a useful screening marker for the detection of AF and its persistence.	[Ghazal, Faris; Rosenqvist, Marten; Al-Khalili, Faris] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Cardiol Unit, Stockholm, Sweden; [Theobald, Holger] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Karolinska Institutet	Ghazal, F (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Cardiol Unit, Stockholm, Sweden.	faris.ghazal@ki.se		Ghazal, Faris/0000-0001-5529-4243; , Faris/0000-0003-4891-0639				Alonso A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000102; Bjork J, 2011, SCAND J CLIN LAB INV, V71, P232, DOI 10.3109/00365513.2011.557086; Ghazal F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198069; Hijazi Z, 2016, EUR HEART J, V37, P1582, DOI 10.1093/eurheartj/ehw054; Hijazi Z, 2013, J AM COLL CARDIOL, V61, P2274, DOI 10.1016/j.jacc.2012.11.082; Hijazi Z, 2012, CIRCULATION, V125, P1605, DOI 10.1161/CIRCULATIONAHA.111.038729; Kirchhof P, 2016, EUROPACE, V18, DOI [10.1016/j.rec.2016.11.033, 10.1093/europace/euw295, 10.5603/KP.2016.0172]; Lee-Lewandrowski E, 2007, CLIN CHIM ACTA, V386, P20, DOI 10.1016/j.cca.2007.07.015; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Llombart V, 2015, STROKE, V46, P1187, DOI 10.1161/STROKEAHA.114.008311; Lowres N, 2013, THROMB HAEMOSTASIS, V110, P213, DOI 10.1160/TH13-02-0165; Patton KK, 2013, HEART, V99, P1832, DOI 10.1136/heartjnl-2013-304724; Prontera C, 2009, CLIN CHIM ACTA, V400, P70, DOI 10.1016/j.cca.2008.10.011; Seegers J, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000182; Svennberg E, 2017, HEART, V103, P1271, DOI 10.1136/heartjnl-2016-310236; Svennberg E, 2016, INT J CARDIOL, V223, P74, DOI 10.1016/j.ijcard.2016.08.001	16	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212974	10.1371/journal.pone.0212974	http://dx.doi.org/10.1371/journal.pone.0212974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807614	Green Submitted, Green Published, gold			2022-12-26	WOS:000459712100031
J	Tenland, E; Pochert, A; Krishnan, N; Rao, KU; Kalsum, S; Braun, K; Glegola-Madejska, I; Lerm, M; Robertson, BD; Linden, M; Godaly, G				Tenland, Erik; Pochert, Alexander; Krishnan, Nitya; Rao, Komal Umashankar; Kalsum, Sadaf; Braun, Katharina; Glegola-Madejska, Izabela; Lerm, Maria; Robertson, Brian D.; Linden, Mika; Godaly, Gabriela			Effective delivery of the anti-mycobacterial peptide NZX in mesoporous silica nanoparticles	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; DRUG-DELIVERY; PHAGOCYTOSIS; PARTICLES; CARRIERS; THERAPY	Background Intracellular delivery of antimicrobial agents by nanoparticles, such as mesoporous silica particles (MSPs), offers an interesting strategy to treat intracellular infections. In tuberculosis (TB), Mycobacterium tuberculosis avoids components of the immune system by residing primarily inside alveolar macrophages, which are the desired target for TB therapy. Methods and findings We have previously identified a peptide, called NZX, capable of inhibiting both clinical and multi-drug resistant strains of M. tuberculosis at therapeutic concentrations. In this study we analysed the potential of MSPs containing NZX for the treatment of tuberculosis. The MSPs released functional NZX gradually into simulated lung fluid and the peptide filled MSPs were easily taken up by primary macrophages. In an intracellular infection model, the peptide containing particles showed increased mycobacterial killing compared to free peptide. The therapeutic potential of peptide containing MSPs was investigated in a murine infection model, showing that MSPs preserved the effect to eliminate M. tuberculosis in vivo. Conclusions In this study we found that loading the antimicrobial peptide NZX into MSPs increased the inhibition of intracellular mycobacteria in primary macrophages and preserved the ability to eliminate M. tuberculosis in vivo in a murine model. Our studies provide evidence for the feasibility of using MSPs for treatment of tuberculosis.	[Tenland, Erik; Rao, Komal Umashankar; Braun, Katharina; Godaly, Gabriela] Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden; [Pochert, Alexander; Linden, Mika] Ulm Univ, Inorgan Chem 2, Ulm, Germany; [Krishnan, Nitya; Glegola-Madejska, Izabela; Robertson, Brian D.] Imperial Coll London, Dept Med, MRC Ctr Mol Bacteriol & Infect, London, England; [Kalsum, Sadaf; Lerm, Maria] Fac Med & Hlth Sci, Dept Clin & Expt Med, Linkoping, Sweden	Lund University; Ulm University; Imperial College London	Godaly, G (corresponding author), Lund Univ, Inst Lab Med, Dept Microbiol Immunol & Glycobiol, Lund, Sweden.	gabriela.godaly@med.lu.se	Godaly, Gabriela/AAD-7545-2019; Linden, Mika/GRX-9017-2022; Lerm, Maria/AAA-1780-2020; Lerm, Maria/AAM-8705-2020	Godaly, Gabriela/0000-0002-3467-1350; Lerm, Maria/0000-0002-5092-9892; Robertson, Brian D./0000-0001-5785-5307; Linden, Mika/0000-0003-1736-0638	European Union's Seventh Framework Programme (FP7/2007-2013) [604182]; DFG [SFB 1279]; UK Medical Research Council; Swedish Heart-Lung Foundation [20150733]; Alfred Osterlunds Foundation; Royal Physiographic Society of Lund; MRC [MR/P028225/1] Funding Source: UKRI	European Union's Seventh Framework Programme (FP7/2007-2013); DFG(German Research Foundation (DFG)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Alfred Osterlunds Foundation; Royal Physiographic Society of Lund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ET, AP and KB were funded by the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 604182, FORMAMP-Innovative Nanoformulation of Antimicrobial Peptides to Treat Bacterial Infectious Diseases (https://cordis.europa.eu/project/rcn/110784/factsheet/en).Furthermore, the support from the DFG funded SFB 1279 project "Nutzung des menschlichen Peptidoms zur Entwicklung neuer antimikrobieller und anti-Krebs Therapeutika"is gratefully acknowledged (ML). Prof. Paul Walther, Central Facility for Electron Microscopy, Ulm University, is gratefully acknowledged for the preparation of the microtomed cell samples for TEM analysis. NK, IGM and BR thank the UK Medical Research Council for support in the MRC Centre for Molecular Bacteriology and Infection, Imperial College London. The research was also funded by the Swedish Heart-Lung Foundation (20150733) to GG, Alfred Osterlunds Foundation to GG and the Royal Physiographic Society of Lund to ET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ahsan FL, 2002, J CONTROL RELEASE, V79, P29, DOI 10.1016/S0168-3659(01)00549-1; Braun K, 2017, MOL SYST DES ENG, V2, P393, DOI 10.1039/c7me00059f; Braun K, 2016, J COLLOID INTERF SCI, V475, P161, DOI 10.1016/j.jcis.2016.05.002; Castillo RR, 2017, EXPERT OPIN DRUG DEL, V14, P229, DOI 10.1080/17425247.2016.1211637; Chibowski E, 2010, ADSORPTION, V16, P305, DOI 10.1007/s10450-010-9242-1; Gallud A, 2017, BIOMATERIALS, V121, P28, DOI 10.1016/j.biomaterials.2016.12.029; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Heidegger S, 2016, NANOSCALE, V8, P938, DOI 10.1039/c5nr06122a; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Kalsum S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00278; Kumar A, 2017, PHARM RES-DORDR, V34, P2454, DOI 10.1007/s11095-017-2169-4; Li X, 2011, BIOMATERIALS, V32, P9546, DOI 10.1016/j.biomaterials.2011.08.068; Li ZX, 2012, CHEM SOC REV, V41, P2590, DOI 10.1039/c1cs15246g; Mamaeva V, 2016, MOL THER, V24, P926, DOI 10.1038/mt.2016.42; Mamaeva V, 2013, ADV DRUG DELIVER REV, V65, P689, DOI 10.1016/j.addr.2012.07.018; Mamaeva V, 2011, MOL THER, V19, P1538, DOI 10.1038/mt.2011.105; Marques MRC, 2011, DISSOLUT TECHNOL, V18, P15, DOI 10.14227/DT180311P15; Marquina-Castillo B, 2009, IMMUNOLOGY, V128, P123, DOI 10.1111/j.1365-2567.2008.03004.x; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Monopoli MP, 2012, NAT NANOTECHNOL, V7, P779, DOI [10.1038/NNANO.2012.207, 10.1038/nnano.2012.207]; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Pasqua L, 2016, MINI-REV MED CHEM, V16, P743, DOI 10.2174/1389557516666160321113620; Patel A, 2014, PROTEIN PEPTIDE LETT, V21, P1102, DOI 10.2174/0929866521666140807114240; Raffetseder J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112426; Rosenholm JM, 2009, ACS NANO, V3, P197, DOI 10.1021/nn800781r; Snewin VA, 1999, INFECT IMMUN, V67, P4586, DOI 10.1128/IAI.67.9.4586-4593.1999; Tenland E, 2018, TUBERCULOSIS, V113, P231, DOI 10.1016/j.tube.2018.10.008; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	29	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212858	10.1371/journal.pone.0212858	http://dx.doi.org/10.1371/journal.pone.0212858			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807612	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100026
J	Kandel, Y; Vulcan, J; Rodriguez, SD; Moore, E; Chung, HN; Mitra, S; Cordova, JJ; Martinez, KJL; Moon, AS; Kulkarni, A; Ettestad, P; Melman, S; Xu, JN; Buenemann, M; Hanley, KA; Hansen, IA				Kandel, Yashoda; Vulcan, Julia; Rodriguez, Stacy D.; Moore, Emily; Chung, Hae-Na; Mitra, Soumi; Cordova, Joel J.; Martinez, Kalli J. L.; Moon, Alex S.; Kulkarni, Aditi; Ettestad, Paul; Melman, Sandra; Xu, Jiannong; Buenemann, Michaela; Hanley, Kathryn A.; Hansen, Immo A.			Widespread insecticide resistance in Aedes aegypti L. from New Mexico, USA	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; KNOCKDOWN RESISTANCE; ZIKA VIRUS; PYRETHROID INSECTICIDES; POINT MUTATIONS; DIPTERA; CHLORPYRIFOS; MOSQUITOS; F1534C; DDT	Background Aedes aegypti mosquitoes are vectors of a variety of emerging viral pathogens, including yellow fever, dengue, chikungunya, and Zika virus. This species has established endemic populations in all cities across southern New Mexico sampled to date. Presently, control of Aedes-borne viruses relies on deployment of insecticides to suppress mosquito populations, but the evolution of insecticide resistance threatens the success of vector control programs. While insecticide resistance is quite common in Ae. aegypti field populations across much of the U.S., the resistance status of this species in populations from New Mexico has not previously been assessed. Results First, we collected information on pesticide use in cities in southern New Mexico and found that the most commonly used active ingredients were pyrethroids. The use of insecticides with the same mode-of-action over multiple years is likely to promote the evolution of resistance. To determine if there was evidence of resistance in some cities in southern New Mexico, we collected Ae. aegypti from the same cities and established laboratory strains to assess resistance to pyrethroid insecticides and, for a subset of populations, to organophosphate insecticides. F2 or F4 generation mosquitoes were assessed for insecticide resistance using bottle test bioassays. The majority of the populations from New Mexico that we analyzed were resistant to the pyrethroids permethrin and deltamethrin. A notable exception to this trend were mosquitoes from Alamogordo, a city that did not report using pyrethroid insecticides for vector control. We screened individuals from each population for known knock down resistance (kdr) mutations via PCR and found a strong association between the presences of the F1534C kdr mutation in the para gene of Ae. aegypti (homologue to F1534C in Musca domestica L.) and pyrethroid resistance. Conclusion High-level pyrethroid resistance is common in Ae. aegypti from New Mexico and geographic variation in such resistance is likely associated with variation in usage of pyrethroids for vector control. Resistance monitoring and management is recommended in light of the potential for arbovirus outbreaks in this state. Also, alternative approaches to mosquito control that do not involve insecticides should be explored.	[Kandel, Yashoda; Vulcan, Julia; Rodriguez, Stacy D.; Moore, Emily; Chung, Hae-Na; Mitra, Soumi; Cordova, Joel J.; Martinez, Kalli J. L.; Moon, Alex S.; Kulkarni, Aditi; Xu, Jiannong; Hanley, Kathryn A.; Hansen, Immo A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA; [Ettestad, Paul; Melman, Sandra] New Mexico Dept Hlth, Santa Fe, NM USA; [Buenemann, Michaela] New Mexico State Univ, Dept Geog, Las Cruces, NM 88003 USA	New Mexico State University; New Mexico Department of Health; New Mexico State University	Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.	immoh@nmsu.edu	Xu, Jiannong/N-1583-2019	Xu, Jiannong/0000-0001-7332-4370; , Soumi/0000-0002-3354-5934	New Mexico Department of Health [17/665.0300.20615]; Regents of New Mexico State University, MOA [17/665.0300.20615]; Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) continuation grant from the Centers of Disease Control and Prevention (CDC) [CK14-1401]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061222] Funding Source: NIH RePORTER	New Mexico Department of Health; Regents of New Mexico State University, MOA; Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) continuation grant from the Centers of Disease Control and Prevention (CDC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded under a Memorandum of Agreement between the New Mexico Department of Health and the Regents of New Mexico State University, MOA#: 17/665.0300.20615. Funding was procured by an Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) continuation grant (section M1, under CK14-1401) from the Centers of Disease Control and Prevention (CDC) awarded to the New Mexico Department of Health.	Alout H, 2016, HEREDITY, V116, P224, DOI 10.1038/hdy.2015.92; Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846; [Anonymous], 2016, WORLD HLTH ORG TECHN, DOI [10.1021/jp052915b, DOI 10.1021/JP052915B]; Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692; Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25; Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878; Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410; Brogdon WG., 2010, GUIDELINES EVALUATIN, V2; Carrerwe Y, 2018, J MED ENTOMOLOGY; Center SE, 2004, CIT GUID PEST US REG; Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001; Clements AN., 1992, BIOL MOSQUITOES DEV; Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3; Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Chaves LF, 2015, B INSECTOL, V68, P61; Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022; Grossman MK, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2865-x; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549; Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072; Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623; Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z; HEMINGWAY J, 1989, B ENTOMOL RES, V79, P123, DOI 10.1017/S0007485300018630; Hendrichs J., 2009, ENCY INSECTS, V2nd ed., P953, DOI DOI 10.1016/B978-0-12-374144-8.00252-6; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kasai S, 2011, JPN J INFECT DIS, V64, P217; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332; Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x; Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329; Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828; Lopez B, 2014, J MED ENTOMOL, V51, P644, DOI 10.1603/ME13185; Lopez-Monroy B, 2018, PEST MANAGEMENT SCI; Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424; Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390; MARQUARDT WC, 2004, BIOL DIS VECTORS; Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Pasteur N, 1999, J MED ENTOMOL, V36, P794, DOI 10.1093/jmedent/36.6.794; Pittendrigh B, 1997, MOL GEN GENET, V256, P602, DOI 10.1007/s004380050608; Plernsub S, 2013, TROP BIOMED, V30, P621; Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019; Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718; Powers A.M., 2018, EMERGENCE CHIKUNGUNY, P215, DOI [10.1016/B978-0-12-811865-8.00007%E2%80%936, DOI 10.1016/B978-0-12-811865-8.00007%E2%80%936, DOI 10.1016/B978-0-12-811865-8.00007-6]; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x; Saavedra-Rodriguez K, 2018, SCI REPORTS; Silver J, 2007, MOSQUITO ECOLOGY FIE, Vthird; Smith LB, 2018, PEST MANAG SCI, V74, P737, DOI 10.1002/ps.4771; SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P536; Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275; Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24; Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1; Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009; WILLIAMSON MS, 1993, MOL GEN GENET, V240, P17, DOI 10.1007/BF00276878; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Wu Y, 2001, Afr J Med Med Sci, V30 Suppl, P52; Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6; Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	68	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212693	10.1371/journal.pone.0212693	http://dx.doi.org/10.1371/journal.pone.0212693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794644	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100117
J	Norowitz, HL; Morello, T; Kupfer, HM; Kohlhoff, SA; Smith-Norowitz, TA				Norowitz, Hadara L.; Morello, Timothy; Kupfer, Hadassah M.; Kohlhoff, Stephan A.; Smith-Norowitz, Tamar A.			Association between otitis media infection and failed hearing screenings in children	PLOS ONE			English	Article							DAY-CARE ATTENDANCE; EAR INFECTIONS; FAMILY-SIZE; ASTHMA; EFFUSION; PREVALENCE; FREQUENCY; OUTCOMES; VIRUSES; RISK	This study aims to assess prospectively whether there is an association between frequencies of upper respiratory tract infections (URTI) or asthma in early childhood and failed otoacoustic emission (OAE) screenings later in life. There are no clear recommendations for hearing testing following acute otitis media (AOM) infection. This is a retrospective, practice based chart review. Participants from a primary care setting were 517 pre-adolescent and adolescent children (49.9% female) (ages 10-21; mean, 15 y/o), who had presented with at least one specific bacterial URTI (AOM, Group A Streptococcus (GAS) tonsillitis, or Influenza) during childhood. Hearing testing was recorded incidentally at all subsequent routine health care maintenance visits (OAE hearing screen). Simple linear regression analyses were performed using R (v3.4.4). We found that number of episodes of AOM infections strongly correlated with number of failed OAE screenings later in life (F = 76.37; P = < 0.001; R-2 = 0.1279), while GAS (F = 1.859; P = 0.1733; R-2 = 0.0016) or Influenza infection (F = 2.624; P = 0.1059; R-2 = 0.0031) were not associated with failed OAE screening. Correlation between number of AOM infections and number of failed OAE screenings was not strengthened by presence of asthma. This study found evidence of an association between childhood history of AOM and failed OAE screenings in adolescence. Since this population may be at a higher risk for developing permanent or fluctuating hearing losses, further studies to clarify indications and timing of standard audiological testing among these children should be considered.	[Norowitz, Hadara L.; Morello, Timothy; Kupfer, Hadassah M.; Kohlhoff, Stephan A.; Smith-Norowitz, Tamar A.] Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Smith-Norowitz, TA (corresponding author), Suny Downstate Med Ctr, Dept Pediat, Brooklyn, NY 11203 USA.	tamar.smith-norowitz@downstate.edu		Morello, Timothy/0000-0001-9035-4862				Aarhus L, 2015, EAR HEARING, V36, P302, DOI 10.1097/AUD.0000000000000118; [Anonymous], PRESCRIBER; BALDWIN RL, 1993, AM J OTOL, V14, P601; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; Casey JR, 2004, PEDIATR INFECT DIS J, V23, P824, DOI 10.1097/01.inf.0000136871.51792.19; Coyte PC, 1999, INT J PEDIATR OTORHI, V49, P27, DOI 10.1016/S0165-5876(99)00041-5; Cunningham M, 2003, PEDIATRICS, V111, P436, DOI 10.1542/peds.111.2.436; Doyle WJ, 1999, LARYNGOSCOPE, V109, P324, DOI 10.1097/00005537-199902000-00027; Eldeirawi K, 2004, CHEST, V125, P1685, DOI 10.1378/chest.125.5.1685; ELLULMICALLEF R, 1980, BRIT J CLIN PHARMACO, V9, P479, DOI 10.1111/j.1365-2125.1980.tb05843.x; Foust T, 2013, PEDIATRICS, V132, P118, DOI 10.1542/peds.2012-3868; Hall A, 2017, ORTHOD CRANIOFAC RES, V20, P8, DOI 10.1111/ocr.12184; Hall JW, 2017, HEARING J, V6; Halloran DR, 2005, ARCH PEDIAT ADOL MED, V159, P949, DOI 10.1001/archpedi.159.10.949; HARDY AM, 1993, AM J PUBLIC HEALTH, V83, P1321, DOI 10.2105/AJPH.83.9.1321; Heikkinen T, 2003, CLIN MICROBIOL REV, V16, P230, DOI 10.1128/CMR.16.2.230-241.2003; Ibrahim HM, 2011, INT J PEDIATR OTORHI, V75, P39, DOI 10.1016/j.ijporl.2010.10.002; Infante-Rivard C, 2001, AM J EPIDEMIOL, V153, P653, DOI 10.1093/aje/153.7.653; Krakau M, 2017, ACTA OTO-LARYNGOL, V137, P1238, DOI 10.1080/00016489.2017.1362111; Lack G, 2001, J ALLERGY CLIN IMMUN, V108, pS9, DOI 10.1067/mai.2001.115562; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Lieu JEC, 2002, ARCH PEDIAT ADOL MED, V156, P147, DOI 10.1001/archpedi.156.2.147; Luo H, 2001, Zhonghua Er Bi Yan Hou Ke Za Zhi, V36, P295; Micillo E, 2000, ALLERGY, V55, P42; Qureishi A, 2014, INFECT DRUG RESIST, V7, P15, DOI 10.2147/IDR.S39637; Rovers MM, 2008, VACCINE, V26, pG2, DOI 10.1016/j.vaccine.2008.11.005; RUUSKANEN O, 1991, PEDIATR INFECT DIS J, V10, P425, DOI 10.1097/00006454-199106000-00001; Shirakawa T, 1997, SCIENCE, V275, P77, DOI 10.1126/science.275.5296.77; STOOL SE, 1994, PEDIATRICS, V94, P766; von Mutius E, 1999, EUR RESPIR J, V14, P4, DOI 10.1034/j.1399-3003.1999.14a03.x; Wickens KL, 1999, EPIDEMIOLOGY, V10, P699, DOI 10.1097/00001648-199911000-00009; Zernotti ME, 2017, WORLD ALLERGY ORGAN, V10, DOI 10.1186/s40413-017-0168-x	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212777	10.1371/journal.pone.0212777	http://dx.doi.org/10.1371/journal.pone.0212777			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794686	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100134
J	Wellek, S; Ziegler, A				Wellek, Stefan; Ziegler, Andreas			Testing for goodness rather than lack of fit of an X-chromosomal SNP to the Hardy-Weinberg model	PLOS ONE			English	Article							GENETIC-MARKERS; EQUILIBRIUM; ASSOCIATION; HYPOTHESIS; TRIALS	The problem of checking the genotype distribution obtained for some diallelic marker for compatibility with the Hardy-Weinberg equilibrium (HWE) condition arises also for loci on the X chromosome. The possible genotypes depend on the sex of the individual in this case: for females, the genotype distribution is trinomial, as in the case of an autosomal locus, whereas a binomial proportion is observed for males. Like in genetic association studies with autosomal SNPs, interest is typically in establishing approximate compatibility of the observed genotype frequencies with HWE. This requires to replace traditional methods tailored for detecting lack of fit to the model with an equivalence testing procedure to be derived by treating approximate compatibility with the model as the alternative hypothesis. The test constructed here is based on an upper confidence bound and a simple to interpret combined measure of distance between true and HWE conforming genotype distributions in female and male subjects. A particular focus of the paper is on the derivation of the asymptotic distribution of the test statistic under null alternatives which is not of the usual Gaussian form. A closed sample size formula is also provided and shown to behave satisfactorily in terms of the approximation error.	[Wellek, Stefan] Heidelberg Univ, Mannheim Med Sch, CIMH Mannheim, Dept Biostat, Mannheim, Germany; [Wellek, Stefan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Biostat Epidemiol & Informat, Mainz, Germany; [Ziegler, Andreas] Univ Lubeck, Inst Med Biometry & Stat, Lubeck, Germany; [Ziegler, Andreas] StatSol, Moenring 2, Lubeck, Germany; [Ziegler, Andreas] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; University of Lubeck; University of Kwazulu Natal	Wellek, S (corresponding author), Heidelberg Univ, Mannheim Med Sch, CIMH Mannheim, Dept Biostat, Mannheim, Germany.; Wellek, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Biostat Epidemiol & Informat, Mainz, Germany.	stefan.wellek@zi-mannheim.de	Ziegler, Andreas/G-4246-2012	Ziegler, Andreas/0000-0002-8386-5397; Wellek, Stefan/0000-0001-8369-8122				[Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; BERGER RL, 1982, TECHNOMETRICS, V24, P295, DOI 10.2307/1267823; Bishop YM., 2007, DISCRETE MULTIVARIAT; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Goddard KAB, 2009, GENET EPIDEMIOL, V33, P569, DOI 10.1002/gepi.20409; Graffelman J, 2016, HEREDITY, V116, P558, DOI 10.1038/hdy.2016.20; Graffelman J, 2018, MOL ECOL RESOUR, V18, P461, DOI 10.1111/1755-0998.12748; Graffelman J, 2015, J STAT SOFTW, V64, P1; Loley C, 2016, SCI REP-UK, V6, DOI 10.1038/srep35278; NHGRI, 2011, GENEVA GEN WID ASS S; Panoutsopoulou K, 2018, METHODS MOL BIOL, V1793, P7, DOI 10.1007/978-1-4939-7868-7_2; Puig X, 2017, HEREDITY, V119, P226, DOI 10.1038/hdy.2017.30; Ryckman K, 2008, CURRENT PROTOCOLS HU; Wang J, METHODS MOL BIOL, V1666; Wang P, 2019, STAT METHODS MED RES, V28, P3260, DOI 10.1177/0962280218799532; Wellek S, 2005, BIOMETRICAL J, V47, P48, DOI 10.1002/bimj.200410090; Wellek S, 2004, BIOMETRICS, V60, P694, DOI 10.1111/j.0006-341X.2004.00219.x; Wellek S, 2010, BIOMETRICAL J, V52, P253, DOI 10.1002/bimj.200900249; WellsLassagne S, 2017, ROUT ADV TELEVIS, P1; WESTLAKE WJ, 1972, J PHARM SCI, V61, P1340, DOI 10.1002/jps.2600610845; You XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145032; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244; Ziegler A., 2010, STAT APPROACH GENETI; Ziegler A, 2011, BREAST CANCER RES TR, V128, P197, DOI 10.1007/s10549-010-1295-z	25	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212344	10.1371/journal.pone.0212344	http://dx.doi.org/10.1371/journal.pone.0212344			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789927	gold, Green Published, Green Submitted			2022-12-26	WOS:000459330800025
J	Cannizzo, ZJ; Griffen, BD				Cannizzo, Zachary J.; Griffen, Blaine D.			An artificial habitat facilitates a climate-mediated range expansion into a suboptimal novel ecosystem	PLOS ONE			English	Article							MANGROVE TREE CRAB; RESPONSES; ECOLOGY; BIODIVERSITY; POPULATION; EVOLUTION; PREDATION; COMMUNITY; HISTORY; SHIFTS	As the geographic ranges of tropical species and ecosystems continue to shift poleward with climate change, it is critical to prediction and management to identify factors that facilitate these expansions. This is especially true for range shifts that involve the decoupling of a shifting species from its historic ecosystem and the colonization of an ecosystem that it has not previously inhabited (i.e. is novel to the shifting species). In cases where the colonized ecosystem is suboptimal for the shifting species, stepping stone refuges may play a critical role in facilitating further expansion. Here we document the facilitation of the northward range expansion of the mangrove tree crab (Aratus pisonii) into the previously uninhabited salt marsh ecosystem by artificial boat docks. While the cold tolerance of crabs did not differ between habitats, they were found on docks 36 km and 22 km further north than elsewhere in the salt marsh after the winters of 2016-'17 and '17-'18, respectively. This extended range-edge appears to be a result of docks within the salt marsh acting as a stepping stone refuge by providing this historically tropical species with a relatively warm thermal refuge during the winter that mitigates seasonal population die-backs exhibited elsewhere at the range-edge. Further, population abundances were higher on docks at the range-edge than in the surrounding salt marsh. While artificial habitats often favor the expansion of non-indigenous species, our results demonstrate the facilitation of a native species' range shift into a suboptimal ecosystem which it has not previously inhabited. The potential for analogous and refuge habitats, artificial or otherwise, to increase the rate and success of range shifts could be critical to the fate of many current and future range shifting species.	[Cannizzo, Zachary J.] Univ South Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA; [Griffen, Blaine D.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	University of South Carolina System; University of South Carolina Columbia; Brigham Young University	Cannizzo, ZJ (corresponding author), Univ South Carolina, Marine Sci Program, Sch Earth Ocean & Environm, Columbia, SC 29208 USA.	cannizzz@email.sc.edu	Griffen, Blaine/AAC-6384-2021					Baum KA, 2004, ECOLOGY, V85, P2671, DOI 10.1890/04-0500; BEEVER JW, 1979, OECOLOGIA, V43, P317, DOI 10.1007/BF00344958; Canning-Clode J, 2017, DIVERS DISTRIB, V23, P463, DOI 10.1111/ddi.12551; Canning-Clode J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029657; Cannizzo ZJ, 2018, HYDROBIOLOGIA, V809, P79, DOI 10.1007/s10750-017-3449-z; Cannizzo ZJ, 2018, ECOL EVOL, V8, P1521, DOI 10.1002/ece3.3739; Cannizzo ZJ, 2016, ANIM BEHAV, V121, P79, DOI 10.1016/j.anbehav.2016.08.025; Chester ET, 2013, BIOL CONSERV, V166, P64, DOI 10.1016/j.biocon.2013.06.016; Chuang A, 2016, GLOBAL CHANGE BIOL, V22, P494, DOI 10.1111/gcb.13107; Crozier L, 2004, ECOLOGY, V85, P231, DOI 10.1890/02-0607; D'Odorico P, 2013, GLOBAL ECOL BIOGEOGR, V22, P364, DOI 10.1111/geb.12000; Davis AY, 2014, BIOL INVASIONS, V16, P415, DOI 10.1007/s10530-013-0530-z; Dayton P.K., 1972, P C CONSERVATION PRO, P81; Burroni NE, 2011, INSECT CONSERV DIVER, V4, P39, DOI 10.1111/j.1752-4598.2010.00100.x; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Gilchrist A, 2016, LANDSCAPE RES, V41, P26, DOI 10.1080/01426397.2015.1045466; Glasby TM, 2007, MAR BIOL, V151, P887, DOI 10.1007/s00227-006-0552-5; Gledhill DG, 2008, LANDSCAPE ECOL, V23, P1219, DOI 10.1007/s10980-008-9292-x; Grant G., 2006, URBAN HABITATS, V4, P51; Grieg E. I., 2017, P R SOC B, V284, DOI DOI 10.1098/RSPB.2017; Hannah L, 2001, ADV GLOB CHANGE RES, V9, P413; Hewitt CL, 2004, MAR BIOL, V144, P183, DOI 10.1007/s00227-003-1173-x; Holt RD, 2005, SPECIES INVASIONS: INSIGHTS INTO ECOLOGY, EVOLUTION, AND BIOGEORGRAPHY, P259; Jiang J, 2016, ECOL MODEL, V326, P168, DOI 10.1016/j.ecolmodel.2015.04.013; Johnston CA, 2018, BEHAV ECOL, V29, P1124, DOI 10.1093/beheco/ary075; Jurgens LJ, 2018, ECOL LETT, V21, P190, DOI 10.1111/ele.12881; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kramer-Schadt S, 2011, LANDSCAPE ECOL, V26, P501, DOI 10.1007/s10980-011-9576-4; Krosby M, 2010, CONSERV BIOL, V24, P1686, DOI 10.1111/j.1523-1739.2010.01585.x; Lundholm JT, 2010, J APPL ECOL, V47, P966, DOI 10.1111/j.1365-2664.2010.01857.x; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Rahel FJ, 2002, ANNU REV ECOL SYST, V33, P291, DOI 10.1146/annurev.ecolsys.33.010802.150429; Rathbun M. J., 1918, GRAPSOID CRABS AM, V97; Riley M, 2015, THESIS; Riley ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176263; Riley ME, 2014, SOUTHEAST NAT, V13, pN43, DOI 10.1656/058.013.0405; Robillard CM, 2015, CONSERV BIOL, V29, P1586, DOI 10.1111/cobi.12556; Saintilan N, 2014, GLOBAL CHANGE BIOL, V20, P147, DOI 10.1111/gcb.12341; Santoul F, 2009, HYDROBIOLOGIA, V634, P107, DOI 10.1007/s10750-009-9886-6; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; Sheehy DJ, 2010, ECOL ENG, V36, P1, DOI 10.1016/j.ecoleng.2009.09.012; Shoo LP, 2011, J APPL ECOL, V48, P487, DOI 10.1111/j.1365-2664.2010.01942.x; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Souter NJ, 2004, BIOL CONSERV, V116, P403, DOI 10.1016/S0006-3207(03)00232-5; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Uezu A, 2008, BIODIVERS CONSERV, V17, P1907, DOI 10.1007/s10531-008-9329-0; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARNER GF, 1967, J ZOOL, V153, P321, DOI 10.1111/j.1469-7998.1967.tb04066.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; Webb JK, 2000, BIOL CONSERV, V92, P93, DOI 10.1016/S0006-3207(99)00056-7; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; WILSON KA, 1989, B MAR SCI, V44, P263	55	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211638	10.1371/journal.pone.0211638	http://dx.doi.org/10.1371/journal.pone.0211638			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785918	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000034
J	Laugesen, K; Petersen, I; Sorensen, HT; Jorgensen, JOL				Laugesen, Kristina; Petersen, Irene; Sorensen, Henrik Toft; Jorgensen, Jens Otto Lunde			Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis	PLOS ONE			English	Article							SHORT-TERM; SUPPRESSION; RECOVERY; BURST	Background Biochemical adrenal insufficiency induced by glucocorticoid treatment is prevalent, but data on the clinical implications are sparse. We investigated clinical consequences of glucocorticoid-induced adrenal insufficiency after oral glucocorticoid cessation. Methods We conducted a Danish population-based self-controlled case series utilizing medical registries. In this design each individual serves as their own control allowing event rates to be compared as a function of time and treatment. Clinical indicators of adrenal insufficiency were defined as diagnoses of gastrointestinal symptoms, hypotension, cardiovascular collapse, syncope, hyponatremia, and hypoglycaemia. We included 286,680 persons who discontinued long-term (>= 3 months) oral glucocorticoid treatment. We defined five risk periods and a reference period (before treatment): period 0 (on treatment), withdrawal period (1 month before and after cessation), followed by three consecutive 2 month-risk periods after withdrawal (periods 2-4). Results Median age at cessation was 69 years and 57% were female. Median treatment duration was 297 days and median cumulative dose was 3000 mg prednisolone equivalents. The incidence rates of hypotension, gastrointestinal symptoms, hypoglycemia and hyponatremia were increased in the withdrawal period compared to before treatment started (reference period). Incidence rate ratios comparing the withdrawal period with the reference period were 2.5 [95% confidence interval (CI): 1.4-4.3] for hypotension, 1.7 (95% CI: 1.6-1.9) for gastrointestinal symptoms, 2.2 (95% CI: 0.7-7.3) for hypoglycemia, and 1.5 (95% CI: 1.1-2.0) for hyponatremia. During 7 months of follow up, the rates of hypotension and gastrointestinal symptoms remained elevated compared to the reference period. Risk factors included use of antibiotics, increasing average daily dose of glucocorticoids, cumulative dose, and age. Conclusion Oral glucocorticoid withdrawal was associated with adverse outcomes attributable to adrenal insufficiency. Our study underscores the need for future research to establish evidence-based clinical guidance on management of patients who discontinue oral glucocorticoids.	[Laugesen, Kristina; Petersen, Irene; Sorensen, Henrik Toft] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Petersen, Irene] UCL, Dept Primary Care & Populat Hlth, London, England; [Jorgensen, Jens Otto Lunde] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark	Aarhus University; University of London; University College London; Aarhus University	Laugesen, K (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.	Kristina.laugesen@clin.au.dk	Sorensen, Henrik Toft/Z-6181-2019; Jorgensen, Jens Otto Lunde/O-8003-2019	Sorensen, Henrik Toft/0000-0003-4299-7040; Laugesen, Kristina/0000-0001-7971-8223	Fonden af 1870; Max og Anna Friedmanns legat til sygdomsbekaempelse; Aarhus University Research Foundation	Fonden af 1870; Max og Anna Friedmanns legat til sygdomsbekaempelse; Aarhus University Research Foundation	KL recieved funding from "Fonden af 1870" and "Max og Anna Friedmanns legat til sygdomsbekaempelse". HTS recieved funding from "Aarhus University Research Foundation". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt W, 2005, ENDOCRIN METAB CLIN, V34, P293, DOI 10.1016/j.ecl.2005.01.002; Arlt W, 2003, LANCET, V361, P1881, DOI 10.1016/S0140-6736(03)13492-7; Boots JMM, 2002, TRANSPLANT P, V34, P1696, DOI 10.1016/S0041-1345(02)02987-1; Bornstein SR, 2009, NEW ENGL J MED, V360, P2328, DOI 10.1056/NEJMra0804635; Broersen LHA, 2015, J CLIN ENDOCR METAB, V100, P2171, DOI 10.1210/jc.2015-1218; CARELLA MJ, 1993, J CLIN ENDOCR METAB, V76, P1188, DOI 10.1210/jc.76.5.1188; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; Einaudi S, 2008, PEDIATR BLOOD CANCER, V50, P537, DOI 10.1002/pbc.21339; Endocrine Society, 2018, CLIN PRACT GUD; European Society of Endocrinology, 2018, GUIDELINES; Henzen C, 2000, LANCET, V355, P542, DOI 10.1016/S0140-6736(99)06290-X; Jamilloux Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068713; Joseph RM, 2016, SEMIN ARTHRITIS RHEU, V46, P133, DOI 10.1016/j.semarthrit.2016.03.001; Krasner AS, 1999, JAMA-J AM MED ASSOC, V282, P671, DOI 10.1001/jama.282.7.671; Laugesen K, 2017, CLIN EPIDEMIOL, V9, P591, DOI 10.2147/CLEP.S148671; Laugesen K, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015237; Nguyen KL, 2003, ANN ALLERG ASTHMA IM, V91, P38, DOI 10.1016/S1081-1206(10)62056-X; Petersen I, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4515; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; Rix M, 2005, J PEDIATR-US, V147, P645, DOI 10.1016/j.jpeds.2005.06.006; RODGER RSC, 1986, Q J MED, V61, P1039; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; SPIEGEL RJ, 1979, LANCET, V1, P630; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415; Wass JAH, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6333; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Woods CP, 2015, EUR J ENDOCRINOL, V173, P633, DOI 10.1530/EJE-15-0608	30	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212259	10.1371/journal.pone.0212259	http://dx.doi.org/10.1371/journal.pone.0212259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779776	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900037
J	Paries, S; Funcke, S; Kershaw, O; Failing, K; Lierz, M				Paries, S.; Funcke, S.; Kershaw, O.; Failing, K.; Lierz, M.			The role of Virus "X" (Tortoise Picornavirus) in kidney disease and shell weakness syndrome in European tortoise species determined by experimental infection	PLOS ONE			English	Article								Tortoise Picornavirus (ToPV) commonly known as Virus "X" was recently discovered in juvenile European tortoises suffering from soft carapace and plastron as well as kidney disease. Therefore, this virus was a potential candidate to be a causative agent for these disease patterns. Spur thighed tortoises (Testudo graeca) seemed to be more susceptible to establish clinical symptoms than other European species like T. hermanni. Thus this trial investigated the role of ToPV in the described syndrome. Two groups of juvenile European tortoises (T. graeca and T. hermanni) each of 10 animals, were cloacally, oronasally and intracoelomically inoculated with an infectious dose (similar to 2000 TICD) of a ToPV strain isolated from a diseased T. graeca. A control group of two animals of each species received non-infected cell culture supernatant. The tortoises were examined daily and pharyngeal and cloacal swabs for detection of ToPV-RNA by RT-PCR were taken from each animal every six days for a period of 6 months. At the end of the study the remaining animals were euthanised and dissected. Bacteriological and parasitological tests were performed and organ samples of all tortoises were investigated by RT-PCR for the presence of ToPV and histopathology. Animals that were euthanised at the end of the experiment, were examined for presence of specific anti-ToPV antibodies. Several animals in both inoculated groups showed retarded growth and a light shell weakness, in comparison to the control animals. Three animals were euthanised during the trial, showing reduced weight gain, retarded growth, severe shell weakness and apathy, in parallel to clinical observations in naturally infected animals. In all inoculated animals of both species an intermittent virus shedding, starting from 18 days post inoculation (d.p.i.), till 164 d.p.i. was detected, while the control animals remained negative. The virus was successfully reisolated in terrapene heart cell culture in 16 of 20 inoculated animals of both species. Histopathology of most inoculated animals revealed a lack of bone remodeling and vacuolisation in kidney tubuli which supports the described pathogenesis of nephropathy and osteodystrophy. Anti-ToPV antibody titres ranged from 1:2 to > 1:256 in 13 of 20 animals, whereas all control animals were seronegative. The study proofed the Henle Koch's postulates of ToPV as causative agent for shell dystrophy and kidney disease in both testudo species. The proposed species specific sensitivity towards clinical disease was not observed.	[Paries, S.; Funcke, S.; Lierz, M.] Justus Liebig Univ, Fac Vet Med, Clin Birds Reptiles Amphibians & Fish, Giessen, Germany; [Kershaw, O.] Free Univ Berlin, Dept Vet Pathol, Berlin, Germany; [Failing, K.] Justus Liebig Univ, Unit Biomath & Data Proc, Giessen, Germany	Justus Liebig University Giessen; Free University of Berlin; Justus Liebig University Giessen	Paries, S (corresponding author), Justus Liebig Univ, Fac Vet Med, Clin Birds Reptiles Amphibians & Fish, Giessen, Germany.	pariessu@hotmail.com						AMBROSIUS H, 1965, Z IMMUN-UND ALLERG, V128, P81; COE JE, 1972, IMMUNOLOGY, V23, P45; Cooper E. L., 1985, BIOL REPTILIA, V14, P601; Cytel Studio, STATXACT 9 0 0 V 201; Deplazes P, 2013, LEHRBUCH PARASITOLOG, P508; Dixon W. J, 1993, BMDP STAT SOFTWARE M, V1; Dixon W. J., 1993, BMDP STAT SOFTWARE M, V2; Donoghue Susan, 1997, Proceedings of the Annual Conference of the Association of Reptilian & Amphibian Veterinarians, V3, P21; Farkas SL, 2014, ARCH VIROL, P1; Gerlach Justin, 2004, African Journal of Herpetology, V53, P77; Hafeli W, 2000, PRAKT TIERARZT, V81, P129; Heuser W, 2014, TIERAERZTL PRAX K H, V42, P310, DOI 10.1055/s-0038-1623777; Heuser W, 2010, EUROPIC 2010 16 M EU, P147; Heuser W, 2012, THESIS; Kolesnik E, 2017, J VET DIAGN INVEST, V29, P820, DOI 10.1177/1040638717722387; LYKAKIS JJ, 1968, IMMUNOLOGY, V14, P799; Marschang RE, 2007, VET REC, V161, P102, DOI 10.1136/vr.161.3.102; Marschang RE, 2016, J VET DIAGN INVEST, V28, P309, DOI 10.1177/1040638716628584; Marschang RE, 2002, P ASS REPT AMPH VET, P101; Marschang RE, 2000, THESIS; MAUNG ROBERT TUN, 1963, JOUR PATHOL AND BACTERIOL, V85, P51, DOI 10.1002/path.1700850106; Origgi Francesco C., 2007, P131, DOI 10.1201/9781420004038.ch2; Paries S, 2018, TIERARZTL PRAX; Pees M, 2010, VET REC, V166, P422, DOI 10.1136/vr.b4819; Rolle M, 2007, ALLGEMEINE SPEZIELLE, P344; SIDKY YA, 1968, J EXP ZOOL, V167, P187, DOI 10.1002/jez.1401670207; UHLENBROK C, 2010, NACHWEIS RANAVIRUSIN; ZWART P, 1980, P EUR HERP S COTSW W, P75	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0210790	10.1371/journal.pone.0210790	http://dx.doi.org/10.1371/journal.pone.0210790			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779796	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900009
J	Contreras-Zarate, MJ; Day, NL; Ormond, DR; Borges, VF; Tobet, S; Gril, B; Steeg, PS; Cittelly, DM				Contreras-Zarate, Maria J.; Day, Nicole L.; Ormond, D. Ryan; Borges, Virginia F.; Tobet, Stuart; Gril, Brunilde; Steeg, Patricia S.; Cittelly, Diana M.			Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; NEUROTROPHIC FACTOR; TUMOR-GROWTH; ASTROCYTES; CELLS; BDNF; SURVIVAL; TRKB; MICROENVIRONMENT; IDENTIFICATION	Breast cancer brain metastases (BM) affect younger women disproportionally, including those lacking estrogen receptor (ER), progesterone receptor, and HER2 (known as triple-negative breast cancer; TNBC). Previous studies in preclinical models showed that pre-menopausal levels of estradiol (E2) promote TNBC-BM through incompletely understood mechanisms involving reactive astrocytes. Herein, a novel mechanism involving E2-dependent upregulation of brain-derived neurotrophic factor (BDNF) in astrocytes, and subsequent activation of tumor cell tropomyosin kinase receptor B (TrkB), is identified. E2 increased experimental BM of TNBC 4T1BR5 and E0771 cells by 21 and 3.6 fold, respectively, compared to E2-depleted mice. ER alpha(+) reactive astrocytes were found at early and late stages of BM, and E2 upregulated BDNF in ER+ reactive astrocytes in vitro and in vivo. TrkB was expressed in TNBC brain-trophic cell lines, BM-patient-derived xenografts, and breast cancer BM. Conditioned media from E2-treated astrocytes (CM-E2) activated TrkB and downstream AKT, ERK, and PLC-gamma signaling in TNBC cells, increasing their invasiveness and tumor-initiating capability in vitro. The promotion of BM by E2-activated astrocytes was found to be more complex, involving feedback loops and other receptor tyrosine kinases. In 4T1BR5 cells, there was a positive feedback loop whereby astrocytic BDNF induced cancer cell BDNF translation. Upregulation of cancer cell BDNF was required to promote full invasiveness of 4T1BR5 in response to CM-E2, and was observed in brain metastatic cells in E2-treated mice in vivo. Moreover, the non-competitive BDNF/TrkB inhibitor ANA-12 reduced E2-induced 4T1BR5 BM to levels similar to OVX mice. BDNF also activated EGFR in TrkB(+)EGFR(+) TNBC cells, suggesting that E2 action through astrocytes activates redundant pathways promoting BM. These findings have important therapeutic implications, as they provide a rationale to use E2-depletion therapies or TrkB inhibitors to prevent or delay development of BM in younger women.	[Contreras-Zarate, Maria J.; Day, Nicole L.; Cittelly, Diana M.] Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA; [Ormond, D. Ryan] Univ Colorado Denver, Dept Neurosurg, Anschutz Med Campus, Aurora, CO USA; [Borges, Virginia F.] Univ Colorado Denver, Div Med Oncol, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Tobet, Stuart] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Gril, Brunilde; Steeg, Patricia S.] NCI, Womens Malignancies Branch, Bethesda, MD 20892 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado State University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cittelly, DM (corresponding author), Univ Colorado Denver, Dept Pathol, Anschutz Med Campus, Aurora, CO 80045 USA.	Diana.Cittelly@ucdenver.edu	; Ormond, David Ryan/R-4847-2017	Cittelly, Diana/0000-0002-8392-0800; Day, Nicole/0000-0003-3490-4908; Ormond, David Ryan/0000-0001-7027-2915; CONTRERAS-ZARATE, MARIA J/0000-0002-0045-549X	ACS IRG [57-001-53, K22CA181250, R37 CA227984]; Drink for Pink and Cancer League of Colorado; Metavivor Research Foundation; NCI [P30CA046934]; CTSA [UL1TR001082]; NATIONAL CANCER INSTITUTE [ZIABC010538, R37CA227984, P30CA046934] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER	ACS IRG(American Cancer Society); Drink for Pink and Cancer League of Colorado; Metavivor Research Foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by ACS IRG #57-001-53, K22CA181250, R37 CA227984, Drink for Pink and Cancer League of Colorado, and the Metavivor Research Foundation (DMC). University of Colorado Cancer Center Shared Resources were supported by NCI P30CA046934 and CTSA UL1TR001082 Center grants.	Anders C, 2008, ONCOLOGY-NY, V22, P1233; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Anders CK, 2009, SEMIN ONCOL, V36, P237, DOI 10.1053/j.seminoncol.2009.03.001; Azcoitia I, 2011, NEUROSCIENCE, V191, P139, DOI 10.1016/j.neuroscience.2011.02.012; Azcoitia I, 2006, ANN NY ACAD SCI, V1007, P298; Azcoitia I, 2010, EUR J NEUROSCI, V32, P1995, DOI 10.1111/j.1460-9568.2010.07516.x; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Biegon A, 2015, J NUCL MED, V56, P580, DOI 10.2967/jnumed.114.150383; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Boyle P, 2012, ANN ONCOL, V23, P7, DOI 10.1093/annonc/mds187; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Choy C, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0844-3; Contreras-Zarate MJ, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00252; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; de Vellis J, 2012, METHODS MOL BIOL, V814, P49, DOI 10.1007/978-1-61779-452-0_4; Dittrich F, 1999, P NATL ACAD SCI USA, V96, P8241, DOI 10.1073/pnas.96.14.8241; Dougherty KD, 2000, NEUROBIOL DIS, V7, P574, DOI 10.1006/nbdi.2000.0318; Douma S, 2004, NATURE, V430, P1034, DOI 10.1038/nature02765; Evans AJ, 2004, CLIN ONCOL-UK, V16, P345, DOI 10.1016/j.clon.2004.03.012; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Gotz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100944; Gravanis I, 2005, GLIA, V49, P177, DOI 10.1002/glia.20115; Hicks DG, 2006, AM J SURG PATHOL, V30, P1097; Howe EN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049987; Hung MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089389; Iyer V, 2012, CANCER RES, V72, P2705, DOI 10.1158/0008-5472.CAN-11-3287; Ji YY, 2010, NAT NEUROSCI, V13, P302, DOI 10.1038/nn.2505; Kim MS, 2015, ONCOTARGET, V6, P40158, DOI 10.18632/oncotarget.5522; Kim SJ, 2011, NEOPLASIA, V13, P286, DOI 10.1593/neo.11112; Kodack DP, 2015, CANCER CELL, V27, P163, DOI 10.1016/j.ccell.2015.01.001; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lockman PR, 2010, CLIN CANCER RES, V16, P5664, DOI 10.1158/1078-0432.CCR-10-1564; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007; Micevych P, 2009, J NEUROENDOCRINOL, V21, P249, DOI 10.1111/j.1365-2826.2009.01833.x; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Miyamoto N, 2015, J NEUROSCI, V35, P14002, DOI 10.1523/JNEUROSCI.1592-15.2015; Morris PG, 2012, BREAST J, V18, P345, DOI 10.1111/j.1524-4741.2012.01246.x; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Palmieri D, 2007, CANCER RES, V67, P4190, DOI 10.1158/0008-5472.CAN-06-3316; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pequeux C, 2012, CANCER RES, V72, P3010, DOI 10.1158/0008-5472.CAN-11-3768; Priego N, 2018, NAT MED, V24, P1024, DOI 10.1038/s41591-018-0044-4; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Sartori CR, 2011, NEUROSCIENCE, V180, P9, DOI 10.1016/j.neuroscience.2011.02.055; Sartorius CA, 2016, ONCOGENE, V35, P2881, DOI 10.1038/onc.2015.353; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao MM, 2011, MED MOL MORPHOL, V44, P15, DOI 10.1007/s00795-010-0495-2; Sinkevicius KW, 2014, P NATL ACAD SCI USA, V111, P10299, DOI 10.1073/pnas.1404399111; SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110; Spence RD, 2011, P NATL ACAD SCI USA, V108, P8867, DOI 10.1073/pnas.1103833108; Svoronos N, 2017, CANCER DISCOV, V7, P72, DOI 10.1158/2159-8290.CD-16-0502; Tham YL, 2006, CANCER, V107, P696, DOI 10.1002/cncr.22041; Tseng LM, 2013, NEOPLASMA, V60, P290, DOI 10.4149/neo_2013_038; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080933; Yin B, 2015, ONCOGENE, V34, P761, DOI 10.1038/onc.2014.8; Yoneda T, 2001, J BONE MINER RES, V16, P1486, DOI 10.1359/jbmr.2001.16.8.1486; Zagar TM, 2016, ONCOLOGY-NY, V30, P923; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhou L, 2010, ENDOCRINOLOGY, V151, P1153, DOI 10.1210/en.2009-0254	65	43	44	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4685	4699		10.1038/s41388-019-0756-z	http://dx.doi.org/10.1038/s41388-019-0756-z			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30796353	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000471160500003
J	Cao, SF; Chung, S; Kim, S; Li, ZL; Manor, D; Buck, M				Cao, Shufen; Chung, Stacey; Kim, SoonJeung; Li, Zhenlu; Manor, Danny; Buck, Matthias			K-Ras G-domain binding with signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2): membrane association, protein orientation, and function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Ras protein; protein structure; phosphoinositide; cancer; nuclear magnetic resonance (NMR); molecular dynamics; cell signaling; cell transformation; PIP2; protein-membrane interactions; Ras GTPase	PLASMA-MEMBRANE; H-RAS; MOLECULAR-DYNAMICS; FORCE-FIELD; ANIONIC MEMBRANES; NMR; K-RAS4B; 4,5-BISPHOSPHATE; ORGANIZATION; LOCALIZATION	Ras genes potently drive human cancers, with mutated proto-oncogene GTPase KRAS4B (K-Ras4B) being the most abundant isoform. Targeted inhibition of oncogenic gene products is considered the holy grail of present-day cancer therapy, and recent discoveries of small-molecule KRas4B inhibitors were made thanks to a deeper understanding of the structure and dynamics of this GTPase. Because interactions with biological membranes are key for Ras function, Ras-lipid interactions have become a major focus, especially because such interactions evidently involve both the Ras C terminus for lipid anchoring and its G-protein domain. Here, using NMR spectroscopy and molecular dynamics simulations complemented by biophysical- and cell-biology assays, we investigated the interaction between K-Ras4B with the signaling lipid phosphatidylinositol (4,5)-phosphate (PIP2). We discovered that the 2 and 3 strands as well as helices 4 and 5 of the GTPase G-domain bind to PIP2 and identified the specific residues in these structural elements employed in these interactions, likely occurring in two K-Ras4B orientation states relative to the membrane. Importantly, we found that some of these residues known to be oncogenic when mutated (D47K, D92N, K104M, and D126N) are critical for K-Ras-mediated transformation of fibroblast cells, but do not substantially affect basal and assisted nucleotide hydrolysis and exchange. Moreover, the K104M substitution abolished localization of K-Ras to the plasma membrane. The findings suggest that specific G-domain residues can critically regulate Ras function by mediating interactions with membrane-associated PIP2 lipids; these insights that may inform the future design of therapeutic reagents targeting Ras activity.	[Cao, Shufen; Kim, SoonJeung; Li, Zhenlu; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Chung, Stacey; Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Manor, Danny] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; [Manor, Danny; Buck, Matthias] Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA.; Manor, D (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.; Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.; Manor, D; Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.; Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.	Danny.Manor@case.edu; Matthias.Buck@case.edu	LI, ZHENLU/ABA-2654-2020	LI, ZHENLU/0000-0003-2101-8237	National Institutes of Health NIGMS [R01GM112491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116961, R01GM112491] Funding Source: NIH RePORTER	National Institutes of Health NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health NIGMS Grant R01GM112491 (to the Buck lab). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; Ambrogio C, 2018, CELL, V172, P857, DOI 10.1016/j.cell.2017.12.020; Baker TL, 2003, J BIOL CHEM, V278, P19292, DOI 10.1074/jbc.M206956200; Banerjee A, 2016, CURR OPIN STRUC BIOL, V36, P10, DOI 10.1016/j.sbi.2015.11.010; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Barnard A, 2012, ANGEW CHEM INT EDIT, V51, P6572, DOI 10.1002/anie.201200076; Barrett PJ, 2013, BIOCHEMISTRY-US, V52, P1303, DOI 10.1021/bi4000436; Bouguet-Bonnet S, 2008, J MOL BIOL, V377, P1474, DOI 10.1016/j.jmb.2008.01.081; Brunsveld L, 2009, BBA-BIOMEMBRANES, V1788, P273, DOI 10.1016/j.bbamem.2008.08.006; Buck M, 2006, BIOPHYS J, V90, pL36, DOI 10.1529/biophysj.105.078154; Buhrman G, 2010, P NATL ACAD SCI USA, V107, P4931, DOI 10.1073/pnas.0912226107; Cao SF, 2013, BIOMOL NMR ASSIGN, V7, P121, DOI 10.1007/s12104-012-9391-0; Castellano Esther, 2011, Genes Cancer, V2, P216, DOI 10.1177/1947601911408081; Ceccon A, 2016, J AM CHEM SOC, V138, P5789, DOI 10.1021/jacs.6b02654; Chadli M, 2017, LANGMUIR, V33, P10385, DOI 10.1021/acs.langmuir.7b01636; Chenette EJ, 2011, ENZYMES, V29, P59, DOI 10.1016/B978-0-12-381339-8.00005-6; Chung JK, 2018, BIOPHYS J, V114, P137, DOI 10.1016/j.bpj.2017.10.042; Clore GM, 2015, METHOD ENZYMOL, V564, P485, DOI 10.1016/bs.mie.2015.06.032; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Cox Adrienne D, 2010, Small GTPases, V1, P2; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dowler Simon, 2002, Sci STKE, V2002, ppl6, DOI 10.1126/stke.2002.129.pl6; Dror RO, 2010, J GEN PHYSIOL, V135, P555, DOI 10.1085/jgp.200910373; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; El-Sibai M, 2007, EUR J IMMUNOL, V37, P261, DOI 10.1002/eji.200635875; Fang ZH, 2018, CELL CHEM BIOL, V25, P1327, DOI 10.1016/j.chembiol.2018.07.009; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Gagliardi PA, 2015, BBA-REV CANCER, V1856, P178, DOI 10.1016/j.bbcan.2015.07.003; Gluck JM, 2009, J AM CHEM SOC, V131, P12060, DOI 10.1021/ja904897p; Gorfe AA, 2010, CURR MED CHEM, V17, P1, DOI 10.2174/092986710789957832; Gorfe AA, 2007, J MED CHEM, V50, P674, DOI 10.1021/jm061053f; Graber ZT, 2017, PHYS CHEM CHEM PHYS, V19, P15285, DOI 10.1039/c7cp00718c; Gregory MC, 2017, BIOCHEM BIOPH RES CO, V487, P351, DOI 10.1016/j.bbrc.2017.04.063; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Gulyas G, 2017, J BIOL CHEM, V292, P18862, DOI 10.1074/jbc.M117.806679; Hedger G, 2015, SCI REP-UK, V5, DOI 10.1038/srep09198; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Inouye K, 2000, J BIOL CHEM, V275, P3737, DOI 10.1074/jbc.275.6.3737; Jang H, 2016, BIOCHEM J, V473, P1719, DOI 10.1042/BCJ20160031; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Kearney BN, 2014, J MOL BIOL, V426, P611, DOI 10.1016/j.jmb.2013.10.036; Kolay S, 2016, BIOCHEM J, V473, P1681, DOI 10.1042/BCJ20160069; Koldso H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003911; Kucharska I, 2015, J BIOMOL NMR, V61, P261, DOI 10.1007/s10858-015-9905-z; LEONARD DA, 1994, BIOCHEMISTRY-US, V33, P12323, DOI 10.1021/bi00206a040; Li ZL, 2018, ACS CENTRAL SCI, V4, P298, DOI 10.1021/acscentsci.7b00593; Li ZL, 2017, STRUCTURE, V25, P679, DOI 10.1016/j.str.2017.02.007; Li ZL, 2016, BIOPHYS J, V110, P1033, DOI 10.1016/j.bpj.2016.01.020; Lien EC, 2017, CURR OPIN CELL BIOL, V45, P62, DOI 10.1016/j.ceb.2017.02.007; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lobell RB, 2002, MOL CANCER THER, V1, P747; Lobell RB, 2001, CANCER RES, V61, P8758; Lu SM, 2018, CRIT REV BIOCHEM MOL, V53, P192, DOI 10.1080/10409238.2018.1436515; MAGEE AI, 1987, EMBO J, V6, P3353, DOI 10.1002/j.1460-2075.1987.tb02656.x; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Martin CB, 2001, ONCOGENE, V20, P1953, DOI 10.1038/sj.onc.1204281; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; Mazhab-Jafari MT, 2013, J AM CHEM SOC, V135, P3367, DOI 10.1021/ja312508w; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Nussinov R, 2013, TRENDS MOL MED, V19, P695, DOI 10.1016/j.molmed.2013.07.009; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Prakash Priyanka, 2017, Small GTPases, V8, P129, DOI 10.1080/21541248.2016.1211067; Prakash P, 2016, BIOPHYS J, V110, P1125, DOI 10.1016/j.bpj.2016.01.019; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Prior IA, 2012, CANCER RES, V72, P2457, DOI 10.1158/0008-5472.CAN-11-2612; Prosser RS, 2006, BIOCHEMISTRY-US, V45, P8453, DOI 10.1021/bi060615u; Puthenveetil R, 2017, NANOTECHNOL REV, V6, P111, DOI 10.1515/ntrev-2016-0076; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Solman M, 2015, ELIFE, V4, DOI 10.7554/eLife.08905; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Sosa MS, 2009, BIOCHEMISTRY-US, V48, P8171, DOI 10.1021/bi9010623; Suladze S, 2014, J PHYS CHEM B, V118, P966, DOI 10.1021/jp411466r; Sung PJ, 2013, P NATL ACAD SCI USA, V110, P20593, DOI 10.1073/pnas.1306431110; Ubbink M, 2002, ANNU REV BIOPH BIOM, V31, P393, DOI 10.1146/annurev.biophys.31.091701.171000; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van der Hoeven D, 2013, MOL CELL BIOL, V33, P237, DOI 10.1128/MCB.00884-12; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vinogradova O, 2012, TOP CURR CHEM, V326, P35, DOI 10.1007/128_2011_216; Vo U, 2013, BIOMOL NMR ASSIGN, V7, P215, DOI 10.1007/s12104-012-9413-y; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Wang J, 2012, BIOL OPEN, V1, P857, DOI 10.1242/bio.20122071; Wang YH, 2012, J AM CHEM SOC, V134, P3387, DOI 10.1021/ja208640t; Whorton MR, 2011, CELL, V147, P199, DOI 10.1016/j.cell.2011.07.046; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Yamaguchi H, 2010, CANCER SCI, V101, P1632, DOI 10.1111/j.1349-7006.2010.01574.x; Yang MH, 2012, P NATL ACAD SCI USA, V109, P10843, DOI 10.1073/pnas.1201487109; Yang YB, 2018, J BIOL CHEM, V293, P6230, DOI 10.1074/jbc.R117.000582; Ye LB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03314-9; Yin GW, 2017, J BIOL CHEM, V292, P4446, DOI 10.1074/jbc.M116.762435; Zhang XF, 2018, J BIOL CHEM, V293, P7659, DOI 10.1074/jbc.RA118.001779; Zhou Y, 2017, CELL, V168, P239, DOI 10.1016/j.cell.2016.11.059; Zhou Y, 2015, SCIENCE, V349, P873, DOI 10.1126/science.aaa5619; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008	110	32	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					7068	7084		10.1074/jbc.RA118.004021	http://dx.doi.org/10.1074/jbc.RA118.004021			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30792310	hybrid, Green Published			2022-12-26	WOS:000467394700038
J	Coorens, M; Rao, A; Grafe, SK; Unelius, D; Lindforss, U; Agerberth, B; Mjosberg, J; Bergman, P				Coorens, Maarten; Rao, Anna; Grafe, Stefanie Katharina; Unelius, Daniel; Lindforss, Ulrik; Agerberth, Birgitta; Mjosberg, Jenny; Bergman, Peter			Innate lymphoid cell type 3-derived interleukin-22 boosts lipocalin-2 production in intestinal epithelial cells via synergy between STAT3 and NF-B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; antimicrobial peptide (AMP); microbiology; mucosal immunology; signal transduction; interleukin-22; STAT3	KAPPA-B; ANTIMICROBIAL DEFENSE; HOST-DEFENSE; EXPRESSION; INFECTION; IL-22; ACTIVATION; TH17; GUT; MACROPHAGES	Escherichia coli and Klebsiella pneumoniae are opportunistic pathogens that are commonly associated with infections at mucosal surfaces, such as the lung or the gut. The host response against these types of infections includes the release of epithelial-derived antimicrobial factors such as lipocalin-2 (LCN-2), a protein that specifically inhibits the iron acquisition of Enterobacteriaceae by binding and neutralizing the bacterial iron-scavenging molecule enterobactin. Regulation of epithelial antimicrobial responses, including the release of LCN-2, has previously been shown to depend on IL-22, a cytokine produced by innate lymphoid cells type 3 (ILC3) during Enterobacteriaceae infections. However, much remains unknown about the extent to which antimicrobial responses are regulated by IL-22 and how IL-22 regulates the expression and production of LCN-2 in intestinal epithelial cells (IECs). Our study demonstrates how IL-22-induced activation of STAT3 synergizes with NF-B-activating cytokines to enhance LCN-2 expression in human IECs and elucidates how ILC3 are involved in LCN-2-mediated host defense against Enterobacteriaceae. Together, these results provide new insight into the role of ILC3 in regulating LCN-2 expression in human IECs and could prove useful in future studies aimed at understanding the host response against Enterobacteriaceae as well as for the development of antimicrobial therapies against Enterobacteriaceae-related infections.	[Coorens, Maarten; Grafe, Stefanie Katharina; Unelius, Daniel; Agerberth, Birgitta; Bergman, Peter] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, S-14186 Stockholm, Sweden; [Rao, Anna; Mjosberg, Jenny] Karolinska Inst, Dept Med, Ctr Infect Med, SE-17177 Stockholm, Sweden; [Lindforss, Ulrik] Linkoping Univ, Dept Clin & Expt Med, S-58183 Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Linkoping University	Bergman, P (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, S-14186 Stockholm, Sweden.	peter.bergman@ki.se		Bergman, Peter/0000-0003-3306-3713	Swedish Research Council (Vetenskapsradet); Scandinavian Society for Antimicrobial Chemotherapy (SSAC); Groschinsky Foundation; Karolinska Institutet; German Research Foundation (Deutsche Forschungsgemeinschaft) [RA 2986/1-1]	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Scandinavian Society for Antimicrobial Chemotherapy (SSAC); Groschinsky Foundation; Karolinska Institutet(Karolinska Institutet); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	This work was supported by the Swedish Research Council (Vetenskapsradet), the Scandinavian Society for Antimicrobial Chemotherapy (SSAC), The Groschinsky Foundation, the Karolinska Institutet (to P. B.), and German Research Foundation (Deutsche Forschungsgemeinschaft) Postdoctoral Fellowship RA 2986/1-1 (to A. R.). The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], 2013, MIMS MED MICROBIOLOG; Antoni Lena, 2013, J Crohns Colitis, V7, pe652, DOI 10.1016/j.crohns.2013.05.006; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Bachman MA, 2011, INFECT IMMUN, V79, P3309, DOI 10.1128/IAI.05114-11; Backert I, 2014, J IMMUNOL, V193, P3779, DOI 10.4049/jimmunol.1303076; Bambou JC, 2004, J BIOL CHEM, V279, P42984, DOI 10.1074/jbc.M405410200; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Borenshtein D, 2007, INFECT IMMUN, V75, P3271, DOI 10.1128/IAI.01810-06; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Byndloss MX, 2018, MUCOSAL IMMUNOL, V11, P1299, DOI 10.1038/s41385-018-0010-y; Canas MA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00498; Cayatte C, 2012, CLIN TRANSL GASTROEN, V3, DOI 10.1038/ctg.2012.2; Cervantes-Barragan L, 2018, CURR OPIN IMMUNOL, V50, P112, DOI 10.1016/j.coi.2018.01.004; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Cramer EP, 2017, BLOOD, V129, P2813, DOI 10.1182/blood-2016-11-753434; Dalli J, 2017, IMMUNITY, V46, P92, DOI 10.1016/j.immuni.2016.12.009; De Simone V, 2015, ONCOGENE, V34, P3493, DOI 10.1038/onc.2014.286; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Fischer N, 2016, P NATL ACAD SCI USA, V113, pE2993, DOI 10.1073/pnas.1605997113; Fletcher SM, 2013, J PUBLIC HEALTH RES, V2, P42, DOI 10.4081/jphr.2013.e9; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Friedrich C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006357; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Geddes K, 2011, NAT MED, V17, P837, DOI 10.1038/nm.2391; Geremia A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01296; Giacomin PR, 2015, J EXP MED, V212, P1513, DOI 10.1084/jem.20141831; Glatzer T, 2013, IMMUNITY, V38, P1223, DOI 10.1016/j.immuni.2013.05.013; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Hoorweg K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00072; Jung M, 2012, MOL CELL BIOL, V32, P3938, DOI 10.1128/MCB.00413-12; Kalanuria AA, 2014, CRIT CARE, V18, DOI 10.1186/cc13775; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kara EE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003905; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Kesanakurti D, 2013, ONCOGENE, V32, P5144, DOI 10.1038/onc.2012.546; Konya V, 2018, J ALLERGY CLIN IMMUN, V141, P279, DOI 10.1016/j.jaci.2017.01.045; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Lewis SB, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00068; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu JZ, 2012, CELL HOST MICROBE, V11, P227, DOI 10.1016/j.chom.2012.01.017; Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y; Loonen LMP, 2014, MUCOSAL IMMUNOL, V7, P939, DOI 10.1038/mi.2013.109; Maeshima K, 2015, J PHYS-CONDENS MAT, V27, DOI 10.1088/0953-8984/27/6/064116; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Martin JC, 2016, MUCOSAL IMMUNOL, V9, P539, DOI 10.1038/mi.2015.83; Mizuno S, 2014, INFLAMM BOWEL DIS, V20, P1426, DOI 10.1097/MIB.0000000000000105; Mjosberg J, 2016, J ALLERGY CLIN IMMUN, V138, P1265, DOI 10.1016/j.jaci.2016.09.009; Mukherjee S, 2015, IMMUNITY, V42, P28, DOI 10.1016/j.immuni.2014.12.028; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Okumura R, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.20; Pioli PA, 2006, J IMMUNOL, V176, P6647, DOI 10.4049/jimmunol.176.11.6647; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Revu S, 2018, CELL REP, V22, P2642, DOI 10.1016/j.celrep.2018.02.044; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Seo SU, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9010; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Singh V, 2016, CELL MOL GASTROENTER, V2, P482, DOI 10.1016/j.jcmgh.2016.03.007; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Steigedal M, 2014, J IMMUNOL, V193, P6081, DOI 10.4049/jimmunol.1401528; Tourret J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153034; Tsai PY, 2017, CELL HOST MICROBE, V21, P671, DOI 10.1016/j.chom.2017.05.009; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Wehkamp K, 2006, J INVEST DERMATOL, V126, P121, DOI 10.1038/sj.jid.5700020; Weiner J, 2017, TRANSPLANTATION, V101, P2449, DOI 10.1097/TP.0000000000001593; Wozniak KL, 2014, MICROBIOL-SGM, V160, P1440, DOI 10.1099/mic.0.073445-0; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Zheng MQ, 2016, INFECT IMMUN, V84, P782, DOI 10.1128/IAI.01268-15; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zindl CL, 2013, P NATL ACAD SCI USA, V110, P12768, DOI 10.1073/pnas.1300318110	82	19	19	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6027	6041		10.1074/jbc.RA118.007290	http://dx.doi.org/10.1074/jbc.RA118.007290			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782844	Green Published, hybrid			2022-12-26	WOS:000465077500033
J	Song, PY; Yang, SP; Hua, H; Zhang, HY; Kong, QB; Wang, J; Luo, T; Jiang, YF				Song, Peiying; Yang, Songpeng; Hua, Hui; Zhang, Hongying; Kong, Qingbin; Wang, Jiao; Luo, Ting; Jiang, Yangfu			The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; cancer; drug resistance; oncogene; Trail; GADD34; MCL-1; TRAF	GROWTH ARREST; MCL-1; ACTIVATION; STRESS; DEPHOSPHORYLATION; SUPPRESSION; EXPRESSION; REPRESSION; RESISTANCE; PATHWAY	GADD34 (growth arrest and DNA damage-inducible gene 34) plays a critical role in responses to DNA damage and endoplasmic reticulum stress. GADD34 has opposing effects on different stimuli-induced cell apoptosis events, but the reason for this is unclear. Here, using immunoblotting analyses and various molecular genetic approaches in HepG2 and SMMC-7721 cells, we demonstrate that GADD34 protects hepatocellular carcinoma (HCC) cells from tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by stabilizing a BCL-2 family member, myeloid cell leukemia 1 (MCL-1). We found that GADD34 knockdown decreased MCL-1 levels and that GADD34 overexpression up-regulated MCL-1 expression in HCC cells. GADD34 did not affect MCL-1 transcription but enhanced MCL-1 protein stability. The proteasome inhibitor MG132 abrogated GADD34 depletion-induced MCL-1 down-regulation, suggesting that GADD34 inhibits the proteasomal degradation of MCL-1. Furthermore, GADD34 overexpression promoted extracellular signal-regulated kinase (ERK) phosphorylation through a signaling axis that consists of the E3 ubiquitin ligase tumor necrosis factor receptor-associated factor 6 (TRAF6) and transforming growth factor--activated kinase 1 (MAP3K7)-binding protein 1 (TAB1), which mediated the up-regulation of MCL-1 by GADD34. Of note, TRAIL up-regulated both GADD34 and MCL-1 levels, and knockdown of GADD34 and TRAF6 suppressed the induction of MCL-1 by TRAIL. Correspondingly, GADD34 knockdown potentiated TRAIL-induced apoptosis, and MCL-1 overexpression rescued TRAIL-treated and GADD34-depleted HCC cells from cell death. Taken together, these findings suggest that GADD34 inhibits TRAIL-induced HCC cell apoptosis through TRAF6- and ERK-mediated stabilization of MCL-1.	[Song, Peiying; Yang, Songpeng; Zhang, Hongying; Kong, Qingbin; Jiang, Yangfu] Sichuan Univ, West China Hosp, Natl Clin Res Ctr Geriatr, State Key Lab Biotherapy,Sect Oncogene, Chengdu 610041, Peoples R China; [Hua, Hui] West China Hosp, Lab Stem Cell Biol, Chengdu 610041, Peoples R China; [Wang, Jiao] Chengdu Univ Tradit Chinese Med, Sch Basic Med, Chengdu 610075, Sichuan, Peoples R China; [Luo, Ting] West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China	Sichuan University; Chengdu University of Traditional Chinese Medicine	Jiang, YF (corresponding author), Sichuan Univ, West China Hosp, Sect Oncogene, State Key Lab Biotherapy, Chengdu 610041, Peoples R China.	jyangfu@scu.edu.cn	Jiang, Yangfu/AAX-2645-2020	Jiang, Yangfu/0000-0002-8696-2651	National Natural Science Foundation of China [81672814, 81872388]; Fundamental Research Fund for the Central Universities [2018SCUH0009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities	This work was supported by Grants 81672814 and 81872388 from the National Natural Science Foundation of China and Grant 2018SCUH0009 from the Fundamental Research Fund for the Central Universities. The authors declare that they have no conflicts of interest with the contents of this article.	Chung JY, 2007, ADV EXP MED BIOL, V597, P93; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, MOL CELL BIOL, V27, P4006, DOI 10.1128/MCB.00620-06; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Ebinger S, 2016, CANCER CELL, V30, P849, DOI 10.1016/j.ccell.2016.11.002; Emadali A, 2005, J PATHOL, V207, P111, DOI 10.1002/path.1798; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Fransson L, 2014, CELL BIOCHEM FUNCT, V32, P445, DOI 10.1002/cbf.3036; French R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0478-y; Ge BX, 2002, SCIENCE, V295, P1291, DOI 10.1126/science.1067289; Gomez-Bougie P, 2016, CANCER LETT, V383, P204, DOI 10.1016/j.canlet.2016.09.030; Grishin AV, 2001, P NATL ACAD SCI USA, V98, P10172, DOI 10.1073/pnas.191130798; Hollander MC, 1997, J BIOL CHEM, V272, P13731, DOI 10.1074/jbc.272.21.13731; Hsu TS, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0165-6; Inoue J, 2007, ADV EXP MED BIOL, V597, P72; Isomoto H, 2005, HEPATOLOGY, V42, P1329, DOI 10.1002/hep.20966; Ito S, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.116; Ito S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08327; Jeong M, 2017, ONCOGENE, V36, P458, DOI 10.1038/onc.2016.215; Kashiwada M, 1998, J EXP MED, V187, P237, DOI 10.1084/jem.187.2.237; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146073; Kotschy A, 2016, NATURE, V538, P477, DOI 10.1038/nature19830; Kuo ML, 2001, ONCOGENE, V20, P677, DOI 10.1038/sj.onc.1204140; Lee JE, 2018, J BIOL CHEM, V293, P5947, DOI 10.1074/jbc.RA118.002124; Lemke J, 2014, CELL DEATH DIFFER, V21, P491, DOI 10.1038/cdd.2013.179; Liu LT, 2016, ANTICANCER RES, V36, P4623, DOI 10.21873/anticanres.11012; Liu LT, 2015, ANTICANCER RES, V35, P5317; Maji S, 2018, ADV CANCER RES, V137, P37, DOI 10.1016/bs.acr.2017.11.001; Merino D, 2016, ONCOGENE, V35, P1877, DOI 10.1038/onc.2015.287; Murphy AC, 2014, APOPTOSIS, V19, P629, DOI 10.1007/s10495-013-0935-2; Ori D, 2013, J IMMUNOL, V190, P4037, DOI 10.4049/jimmunol.1300173; Perini GF, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0608-2; Rojas M, 2015, P NATL ACAD SCI USA, V112, pE3466, DOI 10.1073/pnas.1501557112; Safa A. R., 2012, Experimental Oncology, V34, P176; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Shlyakhtina Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.423; Tanaka Y, 2015, BRIT J CANCER, V113, P669, DOI 10.1038/bjc.2015.263; Teng Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.24; Timucin AC, 2019, MED RES REV, V39, P146, DOI 10.1002/med.21516; Van Geelen CMM, 2004, DRUG RESIST UPDATE, V7, P345, DOI 10.1016/j.drup.2004.11.002; von Karstedt S, 2017, NAT REV CANCER, V17, P352, DOI 10.1038/nrc.2017.28; Yuan X, 2018, CANCER METAST REV, V37, P733, DOI 10.1007/s10555-018-9728-y; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	43	16	17	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5945	5955		10.1074/jbc.RA118.006029	http://dx.doi.org/10.1074/jbc.RA118.006029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782845	Green Published, hybrid			2022-12-26	WOS:000465077500026
J	Nguyen, HA; Hoffer, ED; Dunham, CM				Ha An Nguyen; Hoffer, Eric D.; Dunham, Christine M.			Importance of a tRNA anticodon loop modification and a conserved, noncanonical anticodon stem pairing in tRNA(CGG)(Pro) for decoding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						translation; ribosome; transfer RNA (tRNA); RNA modification; mRNA; structural biology; decoding; mRNA frame maintenance	READING FRAME MAINTENANCE; RIBOSOMAL P-SITE; MESSENGER-RNA; EF-P; POSTTRANSCRIPTIONAL MODIFICATIONS; STRUCTURAL INSIGHTS; PEPTIDYL-TRANSFER; WOBBLE BASE; A-SITE; TRANSLATION	Modification of anticodon nucleotides allows tRNAs to decode multiple codons, expanding the genetic code. Additionally, modifications located in the anticodon loop, but outside the anticodon itself, stabilize tRNA-codon interactions, increasing decoding fidelity. Anticodon loop nucleotide 37 is 3 to the anticodon and, in tRNAPro, is methylated at the N1 position in its nucleobase (m(1)G37). The m(1)G37 modification in tRNAPro stabilizes its interaction with the codon and maintains the mRNA frame. However, it is unclear how m(1)G37 affects binding at the decoding center to both cognate and +1 slippery codons. Here, we show that the tRNAPro m(1)G37 modification is important for the association step during binding to a cognate CCG codon. In contrast, m(1)G37 prevented association with a slippery CCC-U or +1 codon. Similar analyses of frameshift suppressor tRNA(SufA6), a tRNAPro derivative containing an extra nucleotide in its anticodon loop that undergoes +1 frameshifting, reveal that m(1)G37 destabilizes interactions with both the cognate CCG and slippery codons. One reason for this destabilization is the disruption of a conserved U32<bold>A</bold>38 nucleotide pairing in the anticodon stem through insertion of G37.5. Restoring the tRNA(SufA6) U32<bold>A</bold>37.5 pairing results in a high-affinity association on the slippery CCC-U codon. Further, an X-ray crystal structure of the 70S ribosome bound to tRNA(SufA6) U32<bold>A</bold>37.5 at 3.6 angstrom resolution shows a reordering of the anticodon loop consistent with the findings from the high-affinity measurements. Our results reveal how the tRNA modification at nucleotide 37 stabilizes interactions with the mRNA codon to preserve the mRNA frame.	[Ha An Nguyen; Hoffer, Eric D.; Dunham, Christine M.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Ha An Nguyen; Dunham, Christine M.] Emory Univ, Dept Chem, 1515 Pierce Dr, Atlanta, GA 30322 USA	Emory University; Emory University	Dunham, CM (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	christine.m.dunham@emory.edu		Nguyen, Ha An/0000-0003-2620-2893	NIGMS, National Institutes of Health [P30 GM124165]; National Institutes of Health [RR25528, RR028976]; APS, a United States Department of Energy Office of Science User Facility [DE-AC02-06CH11357, W-31-109-Eng-38]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); APS, a United States Department of Energy Office of Science User Facility	We thank Dunham laboratory members for advice and encouragement, Dr. Kurt Fredrick for advice on kinetic binding assays, Stacey Miles for technical assistance, Dr. Tatsuya Maehigashi for crystallization advice, and Dr. Graeme Conn for comments on the manuscript. Crystals were screened and X-ray crystallography data sets were collected at the NE-CAT beamlines (funded by NIGMS, National Institutes of Health, Grant P30 GM124165), using a Pilatus detector (RR029205) and an Eiger detector (OD021527), and at the SER-CAT beamlines (funded by its member institutions and National Institutes of Health Equipment Grants RR25528 and RR028976). This research used resources of the APS, a United States Department of Energy Office of Science User Facility operated by Argonne National Laboratory under Contracts DE-AC02-06CH11357 (NE-CAT) and W-31-109-Eng-38 (SER-CAT).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agris PF, 2018, RNA BIOL, V15, P537, DOI 10.1080/15476286.2017.1356562; Agris PF, 2004, NUCLEIC ACIDS RES, V32, P223, DOI 10.1093/nar/gkh185; AGRIS PF, 1991, BIOCHIMIE, V73, P1345, DOI 10.1016/0300-9084(91)90163-U; Ashraf SS, 1999, RNA, V5, P503, DOI 10.1017/S1355838299981931; Atkins JF, 2016, NUCLEIC ACIDS RES, V44, P7007, DOI 10.1093/nar/gkw530; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; BJORK GR, 1989, SCIENCE, V244, P986, DOI 10.1126/science.2471265; BJORK GR, 1987, ANNU REV BIOCHEM, V56, P263, DOI 10.1146/annurev.bi.56.070187.001403; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Cabello-Villegas J, 2002, J MOL BIOL, V319, P1015, DOI 10.1016/S0022-2836(02)00382-0; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Demeshkina N, 2012, NATURE, V484, P256, DOI 10.1038/nature10913; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dunham CM, 2007, RNA, V13, P817, DOI 10.1261/rna.367307; Dunkle JA, 2015, BIOCHIMIE, V114, P90, DOI 10.1016/j.biochi.2015.02.007; Durant PC, 1999, J MOL BIOL, V285, P115, DOI 10.1006/jmbi.1998.2297; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fagan CE, 2014, RNA, V20, P1944, DOI 10.1261/rna.046953.114; Fagan CE, 2013, P NATL ACAD SCI USA, V110, P9716, DOI 10.1073/pnas.1301585110; Fahlman RP, 2004, BIOCHEMISTRY-US, V43, P7575, DOI 10.1021/bi0495836; Gamper HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8226; HAGERVALL TG, 1993, J MOL BIOL, V232, P756, DOI 10.1006/jmbi.1993.1429; Hoffer ED, 2019, NUCLEIC ACIDS RES, V47, P1557, DOI 10.1093/nar/gky1178; Hong S, 2018, P NATL ACAD SCI USA, V115, P11226, DOI 10.1073/pnas.1809319115; Hou YM, 2015, RNA, V21, P642, DOI 10.1261/rna.049825.115; Huter P, 2017, MOL CELL, V68, P515, DOI 10.1016/j.molcel.2017.10.014; Jenner LB, 2010, NAT STRUCT MOL BIOL, V17, P555, DOI 10.1038/nsmb.1790; Johansson M, 2011, P NATL ACAD SCI USA, V108, P79, DOI 10.1073/pnas.1012612107; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konevega AL, 2004, RNA, V10, P90, DOI 10.1261/rna.5142404; Kothe U, 2007, MOL CELL, V25, P167, DOI 10.1016/j.molcel.2006.11.014; Kruger MK, 1998, J MOL BIOL, V284, P621, DOI 10.1006/jmbi.1998.2196; KUCHINO Y, 1984, NUCLEIC ACIDS RES, V12, P1559, DOI 10.1093/nar/12.3.1559; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Li JN, 1997, J MOL BIOL, V271, P209, DOI 10.1006/jmbi.1997.1176; Machnicka MA, 2014, RNA BIOL, V11, P1619, DOI 10.4161/15476286.2014.992273; Maehigashi T, 2014, P NATL ACAD SCI USA, V111, P12740, DOI 10.1073/pnas.1409436111; Murakami H, 2009, NAT STRUCT MOL BIOL, V16, P353, DOI 10.1038/nsmb.1580; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P1186, DOI 10.1038/nsmb861; Murphy FV, 2004, NAT STRUCT MOL BIOL, V11, P11251, DOI 10.1038/nsmb866; Muto H, 2008, BIOCHEM BIOPH RES CO, V366, P1043, DOI 10.1016/j.bbrc.2007.12.072; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; O'Connor M, 2002, NUCLEIC ACIDS RES, V30, P759, DOI 10.1093/nar/30.3.759; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Olejniczak M, 2005, NAT STRUCT MOL BIOL, V12, P788, DOI 10.1038/nsmb978; Olejniczak M, 2006, BIOCHIMIE, V88, P943, DOI 10.1016/j.biochi.2006.06.005; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; PERRET V, 1990, BIOCHIMIE, V72, P735, DOI 10.1016/0300-9084(90)90158-D; Phelps SS, 2002, MOL CELL, V10, P799, DOI 10.1016/S1097-2765(02)00686-X; Qian Q, 1998, MOL CELL, V1, P471, DOI 10.1016/S1097-2765(00)80048-9; RIDDLE DL, 1970, J MOL BIOL, V54, P131, DOI 10.1016/0022-2836(70)90451-1; Rozov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10457; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shoji S, 2009, NUCLEIC ACIDS RES, V37, P4033, DOI 10.1093/nar/gkp296; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; SROGA GE, 1992, NUCLEIC ACIDS RES, V20, P3463, DOI 10.1093/nar/20.13.3463; Sundaram M, 2000, BIOCHEMISTRY-US, V39, P12575, DOI 10.1021/bi0014655; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Urbonavicius J, 2001, EMBO J, V20, P4863, DOI 10.1093/emboj/20.17.4863; Walker SE, 2006, J MOL BIOL, V360, P599, DOI 10.1016/j.jmb.2006.05.006; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P498, DOI 10.1038/nsmb1242; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Yarian C, 2000, BIOCHEMISTRY-US, V39, P13390, DOI 10.1021/bi001302g; Yarian C, 2002, J BIOL CHEM, V277, P16391, DOI 10.1074/jbc.M200253200; YOURNO J, 1970, NATURE, V225, P422, DOI 10.1038/225422a0; YOURNO J, 1972, NATURE-NEW BIOL, V239, P219, DOI 10.1038/newbio239219a0; Zhang Y, 2018, STRUCTURE, V26, P437, DOI 10.1016/j.str.2018.01.013	72	17	18	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5281	5291		10.1074/jbc.RA119.007410	http://dx.doi.org/10.1074/jbc.RA119.007410			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30782843	Green Published, hybrid			2022-12-26	WOS:000464517500004
J	Panca, M; Livingston, G; Barber, J; Cooper, C; La Frenais, F; Marston, L; Cousins, S; Hunter, RM				Panca, Monica; Livingston, Gill; Barber, Julie; Cooper, Claudia; La Frenais, Francesca; Marston, Louise; Cousins, Sian; Hunter, Rachael M.			Healthcare resource utilisation and costs of agitation in people with dementia living in care homes in England - The Managing Agitation and Raising QUality of LifE in Dementia (MARQUE) study	PLOS ONE			English	Article							NEUROPSYCHIATRIC SYMPTOMS; PREVALENCE; INVENTORY; PSYCHOPATHOLOGY; DEMOGRAPHICS; PREDICTORS	Background People with dementia living in care homes often experience clinically significant agitation; however, little is known about its economic impact. Objective To calculate the cost of agitation in people with dementia living in care homes. Methods We used the baseline data from 1,424 residents with dementia living in care homes (part of Managing Agitation and Raising QUality of lifE in dementia (MARQUE) study) that had Cohen-Mansfield Agitation Inventory (CMAI) scores recorded. We investigated the relationship between residents' health and social care costs and severity of agitation based on the CMAI total score. In addition, we assessed resource utilisation and compared costs of residents with and without clinically significant symptoms of agitation using the CMAI over and above the cost of the care home. Results Agitation defined by the CMAI was a significant predictor of costs. On average, a one-point increase in the CMAI will lead to a 0.5 percentage points (cost ratio 1.005, 95% CI 1.001 to 1.010) increase in the annual costs. The excess annual cost associated with agitation per resident with dementia was 1,125.35 pound. This suggests that, on average, agitation accounts for 44% of the annual health and social care costs of dementia in people living in care homes. Conclusion Agitation in people with dementia living in care homes contributes significantly to the overall costs increasing as the level of agitation increases. Residents with the highest level of agitation cost nearly twice as much as those with the lowest levels of agitation, suggesting that effective strategies to reduce agitation are likely to be cost-effective in this setting.	[Panca, Monica; Marston, Louise; Hunter, Rachael M.] UCL, Inst Epidemiol & Hlth Care, Res Dept Primary Care & Populat Hlth, London, England; [Panca, Monica; Marston, Louise; Hunter, Rachael M.] UCL, Inst Epidemiol & Hlth Care, Priment Clin Trials Unit, London, England; [Livingston, Gill; Cooper, Claudia; La Frenais, Francesca; Cousins, Sian] UCL, Div Psychiat, Dept Old Age Psychiat, London, England; [Barber, Julie] UCL, Dept Stat Sci, London, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Panca, M (corresponding author), UCL, Inst Epidemiol & Hlth Care, Res Dept Primary Care & Populat Hlth, London, England.; Panca, M (corresponding author), UCL, Inst Epidemiol & Hlth Care, Priment Clin Trials Unit, London, England.	m.panca@ucl.ac.uk	Marston, Louise/A-8535-2012; Hunter, Rachael Maree/H-7846-2019; Cooper, Claudia/C-1556-2008	Marston, Louise/0000-0002-9973-1131; Hunter, Rachael Maree/0000-0002-7447-8934; Cooper, Claudia/0000-0002-2777-7616; Livingston, Gill/0000-0001-6741-5516; Barber, Julie/0000-0001-5762-762X	Economic and Social Research Council; National Institute of Health Research [NIHR/ESCRC ES/L001780/1]; UCLH NIHR Biomedical Research Centre; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; ESRC [ES/L001780/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); UCLH NIHR Biomedical Research Centre; National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The MARQUE study was funded by a grant from the Economic and Social Research Council (https://esrc.ukri.org/) and the National Institute of Health Research (https://www.nihr.ac.uk/) Grant number NIHR/ESCRC ES/L001780/1. CC and GL are supported by the UCLH NIHR Biomedical Research Centre. GL was supported in part by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) North Thames at Bart's Health NHS Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, ESRC or the Department of Health.	Alzheimer's Disease International, 2016, WORLD ALZHEIMER REPO; Alzheimer's Society, 2014, DEMENTIA UK UPDATE; Barber Julie, 2004, J Health Serv Res Policy, V9, P197, DOI 10.1258/1355819042250249; Beecham J., 2001, MEASURING MENTAL HLT, P200; Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073; COHENMANSFIELD J, 1989, J GERONTOL, V44, pM77, DOI 10.1093/geronj/44.3.M77; COHENMANSFIELD J, 1986, J AM GERIATR SOC, V34, P711, DOI 10.1111/j.1532-5415.1986.tb04302.x; Costa N, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.10.013; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Department of Health, 2015, 2014 2015 NHS REF CO; Finkel SI, 2003, CLIN GERIATR MED, V19, P799, DOI 10.1016/S0749-0690(03)00046-6; Gustavsson A, 2011, ALZHEIMERS DEMENT, V7, P318, DOI 10.1016/j.jalz.2010.09.001; Husebo BS, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4065; Kales HC, 2014, J AM GERIATR SOC, V62, P762, DOI 10.1111/jgs.12730; Laing & Buisson, 2016, CAR OLD PEOPL UK MAR; LEVIN E, 1989, FAMILIES SERVICES CO; Livingston G, 2014, HEALTH TECHNOL ASSES, V18, pVII, DOI 10.3310/hta18610; Livingston G, 2017, BJPSYCH OPEN, V3, P171, DOI 10.1192/bjpo.bp.117.005181; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Moriarty J., 2000, PART THEIR LIVES COM; Morris S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007382; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; Okura T, 2011, J AM GERIATR SOC, V59, P473, DOI 10.1111/j.1532-5415.2011.03314.x; Okura T, 2011, ALZ DIS ASSOC DIS, V25, P116, DOI 10.1097/WAD.0b013e318203f208; Okura T, 2010, J AM GERIATR SOC, V58, P330, DOI 10.1111/j.1532-5415.2009.02680.x; Personal Social Services Research Unit (PSSRU), 2017, UNIT COSTS HLTH SOCI; Shega Joseph W, 2005, J Palliat Med, V8, P567, DOI 10.1089/jpm.2005.8.567; StataCorp, 2014, STAT REL 14 STAT SOF; Sutherland Debbie, 2004, Nurs Times, V100, P32; Vance DE, 2003, J GERONTOL B-PSYCHOL, V58, pP129, DOI 10.1093/geronb/58.2.P129; Wubker A, 2015, EUR J HEALTH ECON, V16, P689, DOI 10.1007/s10198-014-0620-6; Zuidema SU, 2011, INT J GERIATR PSYCH, V26, P127, DOI 10.1002/gps.2499	33	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211953	10.1371/journal.pone.0211953	http://dx.doi.org/10.1371/journal.pone.0211953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EU	30807569	Green Published, Green Submitted, gold			2022-12-26	WOS:000459712100007
J	Hulman, A; Ibsen, DB; Laursen, ASD; Dahm, CC				Hulman, Adam; Ibsen, Daniel B.; Laursen, Anne Sofie D.; Dahm, Christina C.			Body mass index trajectories preceding first report of poor self-rated health: A longitudinal case-control analysis of the English Longitudinal Study of Ageing	PLOS ONE			English	Article							WEIGHT CHANGE; PREDICTORS; ASSOCIATION; MORTALITY; OBESITY; DISEASE; COHORT; IMPACT	Background Studies have consistently found that obesity is associated with poor self-rated health, but how body mass index (BMI) developed in the lead up to poor self-rated health is unknown. Methods We nested a longitudinal case-control study in the English Longitudinal Study of Ageing (1998-2015) to investigate BMI trajectories in the years preceding a first self-report of poor health. Participants rated their health at each data collection; every other collection included a BMI assessment by a nurse. Case status was defined as a first report of poor health during follow-up. Three age-and sex-matched controls were identified per case using density sampling. BMI trajectories were fitted to time backwards prior to first report of poor health using mixed-effects models. Age and sex were potential modifiers. We conducted subgroup analyses of those not reporting certain chronic diseases or smoking. Results We identified 732 cases and 2195 controls. Age, but not sex, modified the association between BMI and self-rated health. Participants reporting poor health at age 60 had a 1.5 kg/m(2) (95% CI: 0.8 to 2.1) higher BMI at the time of reporting than controls, and their BMI had previously increased markedly (1.3 kg/m(2) 95% CI: 0.9 to 1.8 over ten years). After age 75, cases no longer had higher BMI than controls, and their BMI had decreased sharply prior to reporting poor health (e.g. -2.0 kg/m(2) 95% CI: -2.6 to -1.5 per decade on average for those reporting poor health at age 90). Age was also an effect modifier among those without diabetes, however BMI trajectories were more similar among the middle-aged. The subgroup analysis of those without cardiovascular disease, cancer and chronic lung disease showed similar results to the main findings. Conclusion Development of BMI was associated with poor self-rated health; however, the nature of the association depended markedly on age.	[Hulman, Adam; Ibsen, Daniel B.; Laursen, Anne Sofie D.; Dahm, Christina C.] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Hulman, Adam] Danish Diabet Acad, Odense, Denmark; [Hulman, Adam] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark	Aarhus University; Aarhus University	Hulman, A (corresponding author), Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark.; Hulman, A (corresponding author), Danish Diabet Acad, Odense, Denmark.; Hulman, A (corresponding author), Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark.	adam.hulman@ph.au.dk	Dahm, Christina C/G-9787-2014; Laursen, Anne Sofie Dam/ABF-7784-2020; Hulman, Adam/AAI-5859-2021; Ibsen, Daniel Borch/AAD-1193-2019	Dahm, Christina C/0000-0003-0481-2893; Laursen, Anne Sofie Dam/0000-0003-2827-0582; Hulman, Adam/0000-0002-3969-1000; Ibsen, Daniel Borch/0000-0002-7038-4770	Danish Diabetes Academy; Novo Nordisk Foundation; Steno Diabetes Center Aarhus (SDCA) - Novo Nordisk Foundation	Danish Diabetes Academy; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Steno Diabetes Center Aarhus (SDCA) - Novo Nordisk Foundation(Novo Nordisk Foundation)	AH is supported by the Danish Diabetes Academy. The Danish Diabetes Academy is funded by the Novo Nordisk Foundation. Support was provided by the Steno Diabetes Center Aarhus (SDCA) which is partially funded by an unrestricted donation from the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman CE, 2016, J HEALTH SOC BEHAV, V57, P39, DOI 10.1177/0022146515626218; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Bamia C, 2017, MATURITAS, V103, P37, DOI 10.1016/j.maturitas.2017.06.023; Bombak Andrea E, 2013, Front Public Health, V1, P15, DOI 10.3389/fpubh.2013.00015; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; de Souza VA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176230; Dennerstein L, 2003, J PSYCHOSOM RES, V54, P147, DOI 10.1016/S0022-3999(02)00415-4; Feng XQ, 2017, BMJ OPEN DIAB RES CA, V5, DOI 10.1136/bmjdrc-2016-000198; Giovannucci E, 2018, JNCI-J NATL CANCER I, V110, P935, DOI 10.1093/jnci/djy091; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jackson SE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-926; Mavaddat N, 2011, J EPIDEMIOL COMMUN H, V65, P800, DOI 10.1136/jech.2009.090845; Miller SL, 2008, J NUTR HEALTH AGING, V12, P487, DOI 10.1007/BF02982710; Olivarius ND, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122219; Ruhunuhewa I, 2017, OBESITY, V25, P1254, DOI 10.1002/oby.21853; Shahar DR, 2001, J AGING HEALTH, V13, P186, DOI 10.1177/089826430101300202; Simonsen MK, 2008, BMC WOMENS HEALTH, V8, P13, DOI [10.1186/1472-6874-8-1318691402, DOI 10.1186/1472-6874-8-13]; Sirola J, 2010, MATURITAS, V65, P244, DOI 10.1016/j.maturitas.2009.11.014; Stenholm S, 2017, INT J OBESITY, V41, P769, DOI 10.1038/ijo.2017.29; Steptoe A, 2013, INT J EPIDEMIOL, V42, P1640, DOI 10.1093/ije/dys168; Svedberg P, 2006, EUR J EPIDEMIOL, V21, P767, DOI 10.1007/s10654-006-9064-3; Vanfleteren L, 2013, EUR RESP J S57, V42, pP4652; Wagner DC, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130241; Wang M, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/7014857; Wannamethee SG, 2005, J EPIDEMIOL COMMUN H, V59, P134, DOI 10.1136/jech.2003.015651	25	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212862	10.1371/journal.pone.0212862	http://dx.doi.org/10.1371/journal.pone.0212862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794702	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100153
J	Kopeika, J; Oyewo, A; Punnialingam, S; Reddy, N; Khalaf, Y; Howard, J; Mononen, S; Oteng-Ntim, E				Kopeika, Julia; Oyewo, Adeola; Punnialingam, Sinthiya; Reddy, Nivedita; Khalaf, Yacoub; Howard, Jo; Mononen, Sofia; Oteng-Ntim, Eugene			Ovarian reserve in women with sickle cell disease	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; ANTRAL FOLLICLE COUNT; AGE; CONTRACEPTION; FERTILITY; SURVIVAL; ENGLAND; OBESITY; USERS; FSH	Background It has been proposed that ovarian sickling and/or iron overload in women with sickle cell disease (SCD) could contribute to gonadal dysfunction, but there are very few published studies. We hypothesised that the above phenomena might impair ovarian reserve. Methods A total of 50 SCD patients were case-matched by age, ethnicity, and presence of regular cycles (28 5 days) with 73 patients without a known haemoglobinopathy who required anti-Mullerian hormone (AMH) assessment in a gynaecology clinic. SCD patients had AMH levels taken as part of routine care. The patients were case-controlled and matched with patients who had no haemoglobinopathy in a tertiary centre over a period of one year. Results The mean AMH in the SCD case group was 7.6 pmol/l compared with 13.4 pmol/l in the control group (p<0.001). The AMH distributions were subsequently categorised. This showed that SCD patients had a significantly higher chance of having lower AMH in comparison with the control group (OR 2.6 (CI 1.1-6.5, P = 0.02). The proportion of women with AMH > 20 pmol/l was significantly lower in the SCD group (6%) in comparison with the control group (19%) (P = 0.04). Conclusions This is the first study showing that women of reproductive age with SCD are more likely to have a low ovarian reserve at a younger age in comparison with patients with no haemoglobinopathy.	[Kopeika, Julia; Reddy, Nivedita; Khalaf, Yacoub] Guys & St Thomas NHS Trust, Assisted Concept Unit, Great Maze Pond London, England; [Oyewo, Adeola; Mononen, Sofia; Oteng-Ntim, Eugene] Kings Coll London, Guys & St Thomas NHS Trust, Dept Women & Childrens Hlth, London, England; [Punnialingam, Sinthiya] Kings Coll Hosp London, Haematol Dept, Denmark Hill, London, England; [Howard, Jo] Guys & St Thomas NHS Trust, Haematol Dept, Great Maze Pond London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Kopeika, J (corresponding author), Guys & St Thomas NHS Trust, Assisted Concept Unit, Great Maze Pond London, England.	julia_kop@yahoo.com						ABBASI AA, 1976, ANN INTERN MED, V85, P601, DOI 10.7326/0003-4819-85-5-601; AlJuburi G, 2012, J PUBLIC HEALTH-UK, V34, P570, DOI 10.1093/pubmed/fds035; Anderson RA, 2012, CLIN ENDOCRINOL, V77, P652, DOI 10.1111/j.1365-2265.2012.04451.x; Ashcroft RE, 2004, CLIN RES, V23, P103; Baird DT, 2005, HUM REPROD UPDATE, V11, P261, DOI 10.1093/humupd/dmi006; Breart G, 1997, EUR J OBSTET GYN R B, V75, P71, DOI 10.1016/S0301-2115(97)00190-5; Chang HH, 2011, BJOG-INT J OBSTET GY, V118, P825, DOI 10.1111/j.1471-0528.2011.02927.x; Chase A R, 2009, Menopause Int, V15, P70, DOI 10.1258/mi.2009.009015; DADA OA, 1980, CLIN CHIM ACTA, V105, P269, DOI 10.1016/0009-8981(80)90469-6; Deb S, 2012, ULTRASOUND OBST GYN, V39, P574, DOI 10.1002/uog.10114; Dewailly D, 2014, HUM REPROD UPDATE, V20, P370, DOI 10.1093/humupd/dmt062; Elchuri SV, 2015, BLOOD CELL MOL DIS, V55, P56, DOI 10.1016/j.bcmd.2015.03.012; Fanchin R, 2003, HUM REPROD, V18, P323, DOI 10.1093/humrep/deg042; Farooqui MW, 2014, BLOOD, V124, DOI 10.1182/blood.V124.21.4932.4932; Fleming R, 2015, REPROD BIOMED ONLINE, V31, P486, DOI 10.1016/j.rbmo.2015.06.015; Freeman EW, 2007, FERTIL STERIL, V87, P101, DOI 10.1016/j.fertnstert.2006.05.074; Gardner K, 2016, BLOOD, V128, P1436, DOI 10.1182/blood-2016-05-716910; Gavish Z, 2014, HUM REPROD, V29, P989, DOI 10.1093/humrep/deu015; Gleicher N, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-77; Halawaty S, 2010, J OBSTET GYNAECOL CA, V32, P687, DOI 10.1016/S1701-2163(16)34573-X; Heck K E, 1997, Matern Child Health J, V1, P81, DOI 10.1023/A:1026218322723; Hvidman HW, 2016, HUM REPROD, V31, P1034, DOI 10.1093/humrep/dew032; Jamil Z, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/5246217; Jayaprakasan K, 2010, FERTIL STERIL, V93, P855, DOI 10.1016/j.fertnstert.2008.10.042; La Marca A, 2007, HUM REPROD, V22, P766, DOI 10.1093/humrep/del421; Lauritsen MP, 2014, HUM REPROD, V29, P791, DOI 10.1093/humrep/det469; Odetunde OI, 2016, PAK J MED SCI, V32, P341, DOI 10.12669/pjms.322.9046; Ojodu J, 2014, MMWR-MORBID MORTAL W, V63, P1155; Parise LV, 2016, BLOOD, V127, P789, DOI 10.1182/blood-2015-12-674606; Petersen KB, 2015, HUM REPROD, V30, P2364, DOI 10.1093/humrep/dev197; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Schram CA, 2015, J CYST FIBROS, V14, P398, DOI 10.1016/j.jcf.2014.09.008; Seifer DB, 2009, FERTIL STERIL, V92, P1674, DOI 10.1016/j.fertnstert.2008.08.110; Serjeant GR, 2001, ARCH DIS CHILD, V85, P375, DOI 10.1136/adc.85.5.375; Smith-Whitley K, 2014, BLOOD, V124, P3538, DOI 10.1182/blood-2014-07-577619; Somunkiran A, 2007, EUR J OBSTET GYN R B, V134, P196, DOI 10.1016/j.ejogrb.2007.01.012; Steiner AZ, 2010, CONTRACEPTION, V81, P245, DOI 10.1016/j.contraception.2009.10.004; Streetly A, 2010, J CLIN PATHOL, V63, P626, DOI 10.1136/jcp.2010.077560; Tal R, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/818912; van den Berg MH, 2010, HUM REPROD, V25, P1520, DOI 10.1093/humrep/deq071; van Rooij IAJ, 2002, HUM REPROD, V17, P3065, DOI 10.1093/humrep/17.12.3065; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5	43	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0213024	10.1371/journal.pone.0213024	http://dx.doi.org/10.1371/journal.pone.0213024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794713	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100171
J	Lanz, J; Wyss, D; Raber, L; Stortecky, S; Hunziker, L; Blochlinger, S; Reineke, D; Englberger, L; Zanchin, T; Valgimigli, M; Heg, D; Windecker, S; Pilgrim, T				Lanz, Jonas; Wyss, Dorte; Raber, Lorenz; Stortecky, Stefan; Hunziker, Lukas; Blochlinger, Stefan; Reineke, David; Englberger, Lars; Zanchin, Thomas; Valgimigli, Marco; Heg, Dik; Windecker, Stephan; Pilgrim, Thomas			Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experience	PLOS ONE			English	Article							VENTRICULAR SEPTAL-DEFECT; CARDIAC RUPTURE; FREE-WALL; THROMBOLYTIC THERAPY; CORONARY; ANGIOPLASTY; REGISTRY; RISK; ERA; MORTALITY	Background The study aims to assess characteristics and outcomes of patients suffering a mechanical complication (MC) after ST-segment elevation myocardial infarction (STEMI) in a contemporary cohort of patients in the percutaneous coronary intervention era. Methods and results This retrospective single-center cohort study encompasses 2508 patients admitted with STEMI between March 9, 2009 and June 30, 2014. A total of 26 patients (1.1%) suffered a mechanical complication: ventricular septal rupture (VSR) in 17, ventricular free wall rupture (VFWR) in 2, a combination of VSD and VFWR in 2, and papillary muscle rupture (PMR) in 5 patients. Older age (74.5 +/- 10.4 years versus 63.9 +/- 13.1 years, p < 0.001), female sex (42.3% versus 23.3%, p = 0.034), and a longer latency period between symptom onset and angiography (> 24h: 42.3% versus 16.2%, p = 0.002) were more frequent among patients with MC as compared to patients without MC. The majority of MC patients had multivessel disease (77%) and presented in cardiogenic shock (Killip class IV: 73.1%). Nine patients (7 VSR, 2 VFWR & VSR) were treated conservatively and died. Out of the remaining 10 VSR patients, four underwent surgery, three underwent implantation of an occluder device, and another three patients had surgical repair following occluder device implantation. All patients with isolated VFWR and PMR underwent emergency surgery. At 30 days, mortality for VSR, VFWR, VFWR & VSR and PMR amounted to 71%, 50%, 100% and 0%, respectively. Conclusions Despite advances in the management of STEMI patients, mortality of mechanical complications stays considerable in this contemporary cohort. Older age, female sex, and a prolonged latency period between symptom onset and angiography are associated with the occurrence of these complications.	[Lanz, Jonas; Raber, Lorenz; Stortecky, Stefan; Hunziker, Lukas; Blochlinger, Stefan; Zanchin, Thomas; Valgimigli, Marco; Windecker, Stephan; Pilgrim, Thomas] Univ Hosp Bern, Dept Cardiol, Swiss Cardiovascr Ctr, Bern, Switzerland; [Wyss, Dorte; Reineke, David; Englberger, Lars] Univ Hosp Bern, Dept Cardiovasc Surg, Swiss Cardiovasc Ctr, Bern, Switzerland; [Heg, Dik] Univ Bern, Clin Trials Unit, Bern, Switzerland; [Heg, Dik] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Bern	Pilgrim, T (corresponding author), Univ Hosp Bern, Dept Cardiol, Swiss Cardiovascr Ctr, Bern, Switzerland.	thomas.pilgrim@insel.ch	Pilgrim, Thomas/AAS-9120-2021; Stortecky, Stefan/AAS-9140-2021; Valgimigli, Marco/AAE-9103-2019	Pilgrim, Thomas/0000-0001-8721-4068; Valgimigli, Marco/0000-0002-4353-7110; Lanz, Jonas/0000-0002-5035-6625; Stortecky, Stefan/0000-0002-5076-0177; Heg, Dik/0000-0002-8766-7945; Hunziker, Lukas/0000-0003-0081-8518				Bajaj A, 2015, J INVEST MED, V63, P844, DOI 10.1097/JIM.0000000000000232; BATTS KP, 1990, HUM PATHOL, V21, P530, DOI 10.1016/0046-8177(90)90010-3; Becker RC, 1999, J AM COLL CARDIOL, V33, P479, DOI 10.1016/S0735-1097(98)00582-8; Becker RC, 1996, J AM COLL CARDIOL, V27, P1321, DOI 10.1016/0735-1097(96)00008-3; Crenshaw BS, 2000, CIRCULATION, V101, P27, DOI 10.1161/01.CIR.101.1.27; Figueras J, 1998, J AM COLL CARDIOL, V32, P135, DOI 10.1016/S0735-1097(98)00180-6; Figueras J, 1997, AM J CARDIOL, V80, P625, DOI 10.1016/S0002-9149(97)00435-9; Figueras J, 2008, CIRCULATION, V118, P2783, DOI 10.1161/CIRCULATIONAHA.108.776690; French JK, 2010, AM J CARDIOL, V105, P59, DOI 10.1016/j.amjcard.2009.08.653; GERTZ SD, 1990, AM J CARDIOL, V66, P904, DOI 10.1016/0002-9149(90)90923-O; HONAN MB, 1990, J AM COLL CARDIOL, V16, P359, DOI 10.1016/0735-1097(90)90586-E; Jones BM, 2014, EUR HEART J, V35, P2060, DOI 10.1093/eurheartj/ehu248; Liebelt JJ, 2016, AM J CARDIOVASC DIS, V6, P10; Lopez-Sendon J, 2010, EUR HEART J, V31, P1449, DOI 10.1093/eurheartj/ehq061; McLaughlin A, 2016, HEART LUNG CIRC, V25, P1063, DOI 10.1016/j.hlc.2016.02.024; Moreno R, 2002, J AM COLL CARDIOL, V39, P598, DOI 10.1016/S0735-1097(01)01796-X; MORISHIMA I, 1995, AM HEART J, V130, P239, DOI 10.1016/0002-8703(95)90434-4; Nakatani D, 2003, AM J CARDIOL, V92, P785, DOI 10.1016/S0002-9149(03)00883-X; Navarro-Cuartero J, 2016, REV ESP CARDIOL, V69, P874, DOI 10.1016/j.rec.2016.04.032; Patel MR, 2006, AM HEART J, V151, P316, DOI 10.1016/j.ahj.2005.04.014; Puerto E, 2018, J AM COLL CARDIOL, V72, P959, DOI 10.1016/j.jacc.2018.06.031; Qian G, 2017, AM J EMERG MED, V35, P589, DOI 10.1016/j.ajem.2016.12.033; Singh V, 2017, AM J MED, V130, DOI 10.1016/j.amjmed.2016.12.004; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; STEVENSON WG, 1989, AM HEART J, V118, P1182, DOI 10.1016/0002-8703(89)90007-0	25	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0209502	10.1371/journal.pone.0209502	http://dx.doi.org/10.1371/journal.pone.0209502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794547	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100009
J	Vonk, M; Wikkerink, S; Regan, K; Middleton, LE				Vonk, Matthew; Wikkerink, Spencer; Regan, Kayla; Middleton, Laura Elizabeth			Similar changes in executive function after moderate resistance training and loadless movement	PLOS ONE			English	Article							EXERCISE-INDUCED AROUSAL; MIDDLE-AGED ADULTS; COGNITIVE PERFORMANCE; INTENSITY	Growing evidence suggests that physical exercise may improve cognitive function in the short- and long-term. Aerobic exercise has been studied most extensively. Preliminary work suggests that resistance training also improves cognitive function, particularly executive function. Conversely, most studies found little dose-effect by intensity. Consequently, cognitive benefits may be elicited, at least in part, by the movement rather than the physical exertion of resistance training. The objective here was to examine and compare acute changes in executive function after resistance training and a loadless movement control among young, healthy adults. Twenty-two young healthy adults (mean age 23.4 years [2.4]; 50% female) completed three conditions, a baseline condition and two experimental conditions (moderate intensity resistance training, loadless movement control). Participants completed a computerized modified Stroop task with concurrent electroencephalography (EEG) before and 10, 20, 30, and 40min after each intervention. Outcomes (incongruent and congruent response time, accuracy, EEG P3 amplitude and latency) were analyzed using mixed linear regression models (factors: condition, time, condition* time). There was a main effect of time for Stroop response time (F-4,F-84 = 3.94, p = 0.006 and F-4,F-84 = 10.27, p< 0.0001 respectively) and incongruent and congruent P3 amplitude (F-4,F-76 = 4.40, p = 0.003 and F-4,F-76 = 5.09, p = 0.001 respectively). Post-hoc analyses indicated that both incongruent and congruent P3 amplitude were elevated at time points up to and including 40min after the interventions (compared to pre-intervention, p< 0.05). Both incongruent and congruent response times were faster at 10min post-intervention than pre-intervention (p< 0.04). There was no main effect of condition or interaction between condition and time for either outcome (p >= 0.53). Similar improvements in executive function were observed after loadless movement and resistance training, suggesting that movement is at least partially responsible for the benefits to executive function. Future research should continue to probe the influence of movement versus physical exertion in resistance training by including a movement and nonmovement control.	[Vonk, Matthew; Wikkerink, Spencer; Regan, Kayla; Middleton, Laura Elizabeth] Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada	University of Waterloo	Middleton, LE (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON, Canada.	Laura.middleton@uwaterloo.ca	Middleton, Laura/ABG-8940-2021; Middleton, Laura/C-6024-2009	Middleton, Laura/0000-0001-8624-3123	Natural Sciences and Engineering Research Council (Canada) Discovery Award	Natural Sciences and Engineering Research Council (Canada) Discovery Award	LM received funding from a Natural Sciences and Engineering Research Council (Canada) Discovery Award.	Angevaren M, 2008, COCHRANE COLLAB; [Anonymous], 2007, AM COLL SPORT MED; [Anonymous], 2014, GLOB STRAT DIET PHYS; Baechle T, 2000, HUMAN KINETICS; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Brody H, 2000, J FAM PRACTICE, V49, P649; Byun KH, 2014, NEUROIMAGE, V98, P336, DOI 10.1016/j.neuroimage.2014.04.067; Canadian Society Of Exercise Physiology, 2016, PRESCR PHYS ACT PART; Cassilhas RC, 2007, MED SCI SPORT EXER, V39, P1401, DOI 10.1249/mss.0b013e318060111f; Chang YK, 2012, BRAIN RES, V1453, P87, DOI 10.1016/j.brainres.2012.02.068; Chang YK, 2014, J SCI MED SPORT, V17, P51, DOI 10.1016/j.jsams.2013.02.007; Chang YK, 2012, MED SCI SPORT EXER, V44, P1773, DOI 10.1249/MSS.0b013e3182574e0b; Chang YK, 2011, J SPORT EXERCISE PSY, V33, P866, DOI 10.1123/jsep.33.6.866; Chang YK, 2009, RES Q EXERCISE SPORT, V80, P78; Chang YK, 2009, PSYCHOL SPORT EXERC, V10, P19, DOI 10.1016/j.psychsport.2008.05.004; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Compumedics Neuroscan, 2015, CURR NEUR SUIT 7 0 1; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dunsky A, 2017, PLOS ONE, V12, P1; Harveson AT, 2016, RES Q EXERCISE SPORT, V1367, P1; Henckens MJAG, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00066; Hillman CH, 2003, INT J PSYCHOPHYSIOL, V48, P307, DOI 10.1016/S0167-8760(03)00080-1; Holroyd CB, 2015, PSYCHOL REV, V122, P54, DOI 10.1037/a0038339; Hommel B, 2002, PSYCHOL RES-PSYCH FO, V66, P215, DOI 10.1007/s00426-002-0096-3; Kamijo K, 2004, EUR J APPL PHYSIOL, V92, P305, DOI 10.1007/s00421-004-1097-2; Kamijo K, 2007, INT J PSYCHOPHYSIOL, V65, P114, DOI 10.1016/j.ijpsycho.2007.04.001; Kamijo K, 2009, J GERONTOL B-PSYCHOL, V64, P356, DOI 10.1093/geronb/gbp030; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lambourne K, 2010, BRAIN RES, V1341, P12, DOI 10.1016/j.brainres.2010.03.091; Lansbergen MM, 2008, CLIN NEUROPHYSIOL, V119, P2247, DOI 10.1016/j.clinph.2008.07.218; Liu-Ambrose T, 2010, ARCH INTERN MED, V170, P170, DOI 10.1001/archinternmed.2009.494; Luck S.J, 2005, MONOGR SOC RES CHILD, V78, P388; Luis G.Tassinary, 2013, PRINCIPLES COGNITIVE; McMorris T, 2011, PHYSIOL BEHAV, V102, P421, DOI 10.1016/j.physbeh.2010.12.007; Moretti DV, 2003, INT J PSYCHOPHYSIOL, V47, P199, DOI 10.1016/S0167-8760(02)00153-8; Nagamatsu LS, 2012, ARCH INTERN MED, V172, P666, DOI 10.1001/archinternmed.2012.379; Nashed JY, 2014, J NEUROSCI, V34, P1769, DOI 10.1523/JNEUROSCI.3063-13.2014; Nikolov I., 2015, REP SCHEME CALCULATO; Penner IK, 2012, CLIN NEUROPSYCHOL, V26, P1142, DOI 10.1080/13854046.2012.713513; Pontifex MB, 2009, MED SCI SPORT EXER, V41, P927, DOI 10.1249/MSS.0b013e3181907d69; Public Health Agency of Canada, 2014, PHYS ACT BEN, V54, P1; Rockwood K, 2007, ALZHEIMERS DEMENT, V3, pS38, DOI 10.1016/j.jalz.2007.01.003; Alves CRR, 2012, J SPORT EXERCISE PSY, V34, P539, DOI 10.1123/jsep.34.4.539; de Asteasu MLS, 2017, AGEING RES REV, V37, P117, DOI 10.1016/j.arr.2017.05.007; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Tsai CL, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00023; Tsai CL, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00262; Wessinger C., 2009, ENCY NEUROSCIENCE, P1117	50	8	8	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212122	10.1371/journal.pone.0212122	http://dx.doi.org/10.1371/journal.pone.0212122			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794593	Green Submitted, gold, Green Published			2022-12-26	WOS:000459709100038
J	Lopez, MY; Pardon, MC; Baiker, K; Prior, M; Ding, YC; Agostini, A; Bai, L; Auer, DP; Faas, HM				Lopez, Maria Yanez; Pardon, Marie-Christine; Baiker, Kerstin; Prior, Malcolm; Ding Yuchun; Agostini, Alessandra; Bai, Li; Auer, Dorothee P.; Faas, Henryk M.			Myoinositol CEST signal in animals with increased Iba-1 levels in response to an inflammatory challenge-Preliminary findings	PLOS ONE			English	Article							SATURATION-TRANSFER CEST; MAGNETIC-RESONANCE-SPECTROSCOPY; IN-VIVO; ALZHEIMERS-DISEASE; MOUSE MODEL; RAT-BRAIN; EXCHANGE; NEUROINFLAMMATION; ACTIVATION; AGENTS	Neuroinflammation plays an important role in the pathogenesis of a range of brain disorders. Non-invasive imaging of neuroinflammation is critical to help improve our understanding of the underlying disease mechanisms, monitor therapies and guide drug development. Generally, MRI lacks specificity to molecular imaging biomarkers, but molecular MR imaging based on chemical exchange saturation transfer (CEST) can potentially detect changes of myoinositol, a putative glial marker that may index neuroinflammation. In this pilot study we aimed to investigate, through validation with immunohistochemistry and in vivo magnetic resonance spectroscopy (MRS), whether CEST imaging can reflect the microglial response to a mild inflammatory challenge with lipopolysaccharide (LPS), in the APPSwe/PS1 mouse model of Alzheimer's disease and wild type controls. The response to the immune challenge was variable and did not align with genotype. Animals with a strong response to LPS (Iba1+, n = 6) showed an increase in CEST contrast compared with those who did not (Iba1-, n = 6). Changes of myoinositol levels after LPS were not significant. We discuss the difficulties of this mild inflammatory model, the role of myoinositol as a glial biomarker, and the technical challenges of CEST imaging at 0.6ppm.	[Lopez, Maria Yanez; Auer, Dorothee P.; Faas, Henryk M.] Univ Nottingham, Sch Med, Sir Peter Mansfield Imaging Ctr, Nottingham, England; [Pardon, Marie-Christine; Agostini, Alessandra] Univ Nottingham, Sch Life Sci, Nottingham, England; [Baiker, Kerstin] Univ Nottingham, Sch Vet Sci, Nottingham, England; [Prior, Malcolm] Univ Nottingham, Med Imaging Unit, Nottingham, England; [Ding Yuchun; Bai, Li] Univ Nottingham, Sch Comp Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Faas, HM (corresponding author), Univ Nottingham, Sch Med, Sir Peter Mansfield Imaging Ctr, Nottingham, England.	henryk.faas@nottingham.ac.uk	Lopez, Maria Yanez/AAB-6740-2019	Lopez, Maria Yanez/0000-0001-5187-2501; Baiker, Kerstin/0000-0003-4855-6879; Auer, Dorothee P./0000-0002-4745-3635; Pardon, Marie-Christine/0000-0003-4737-9479	UNICAS - a University of Nottingham initiative [UNICAS-A2B177]; Medical Research Council [CiC2014029]; BBSRC [BB/N021460/1] Funding Source: UKRI	UNICAS - a University of Nottingham initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge support from UNICAS - a University of Nottingham initiative to fund interdisciplinary equipment based research (UNICAS-A2B177), as well as a Medical Research Council Confidence in Concept award (CiC2014029).; We acknowledge support on interpretation of histology from Diana Cash and Camilla Simmons, BRAIN Centre, Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; [Anonymous], 2013, R LANG ENV STAT COMP; Bagga P, 2016, J NEUROCHEM, V139, P432, DOI 10.1111/jnc.13771; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Bitsch A, 1999, AM J NEURORADIOL, V20, P1619; BRAND A, 1993, DEV NEUROSCI-BASEL, V15, P289, DOI 10.1159/000111347; Cai KJ, 2015, NMR BIOMED, V28, P1, DOI 10.1002/nbm.3216; Carrillo-de Sauvage MA, 2015, J CEREBR BLOOD F MET, V35, P917, DOI 10.1038/jcbfm.2015.48; Chan KWY, 2016, NMR BIOMED, V29, P806, DOI 10.1002/nbm.3526; Chang LD, 2013, J NEUROIMMUNE PHARM, V8, P576, DOI 10.1007/s11481-013-9460-x; Clark DJ, 2016, MAGN RESON MED, V76, P826, DOI 10.1002/mrm.25987; Cunningham C, 2005, J NEUROSCI, V25, P9275, DOI 10.1523/JNEUROSCI.2614-05.2005; Datta G, 2017, MULT SCLER J, V23, P1469, DOI 10.1177/1352458516681504; DiCarlo G, 2001, NEUROBIOL AGING, V22, P1007, DOI 10.1016/S0197-4580(01)00292-5; Ding YC, 2017, IEEE ACM T COMPUT BI, V14, P1366, DOI 10.1109/TCBB.2016.2591520; Garwood M, 2001, J MAGN RESON, V153, P155, DOI 10.1006/jmre.2001.2340; Go M, 2016, BIOCHEM BIOPH RES CO, V479, P331, DOI 10.1016/j.bbrc.2016.09.073; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Haris M, 2013, NMR BIOMED, V26, P386, DOI 10.1002/nbm.2875; Haris M, 2011, NEUROIMAGE, V54, P2079, DOI 10.1016/j.neuroimage.2010.10.017; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; HENKELMAN RM, 1993, MAGNET RESON MED, V29, P759, DOI 10.1002/mrm.1910290607; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Herber DL, 2004, EXP NEUROL, V190, P245, DOI 10.1016/j.expneurol.2004.07.007; Huang W, 1999, AM J PSYCHIAT, V156, P1879; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jin T, 2014, NMR BIOMED, V27, P1313, DOI 10.1002/nbm.3191; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kim M, 2009, MAGN RESON MED, V61, P1441, DOI 10.1002/mrm.21873; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kozlowski C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031814; Kreisel T, 2014, MOL PSYCHIATR, V19, P699, DOI 10.1038/mp.2013.155; Lee DH, 2017, MAGN RESON MED, V77, P855, DOI 10.1002/mrm.26131; Lee JS, 2016, CONTRAST MEDIA MOL I, V11, P4, DOI 10.1002/cmmi.1652; Liu GS, 2013, MAGN RESON MED, V70, P1690, DOI 10.1002/mrm.24955; Liu Z, 2015, BRAIN, V138, P1239, DOI 10.1093/brain/awv065; Marjanska M, 2014, NEUROSCIENCE, V259, P94, DOI 10.1016/j.neuroscience.2013.11.052; McAteer MA, 2007, NAT MED, V13, P1253, DOI 10.1038/nm1631; Melah KE, 2016, J ALZHEIMERS DIS, V50, P873, DOI 10.3233/JAD-150897; Michaud JP, 2013, P NATL ACAD SCI USA, V110, P1941, DOI 10.1073/pnas.1215165110; Murray ME, 2014, J NEUROSCI, V34, P16247, DOI 10.1523/JNEUROSCI.2027-14.2014; Pardon MC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19880; Pepin J, 2016, NEUROIMAGE, V139, P53, DOI 10.1016/j.neuroimage.2016.06.023; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Roalf DR, 2017, MOL PSYCHIATR, V22, P1298, DOI 10.1038/mp.2016.258; Robinson KM, 2010, MOL IMAGING BIOL, V12, P240, DOI 10.1007/s11307-009-0272-6; Schneider P, 2012, BRAIN BEHAV IMMUN, V26, P277, DOI 10.1016/j.bbi.2011.09.011; Sled JG, 2001, MAGNET RESON MED, V46, P923, DOI 10.1002/mrm.1278; Song XL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7719; Stefaniak J, 2016, J NEUROL NEUROSUR PS, V87, P21, DOI 10.1136/jnnp-2015-311336; Sulzer D, 2017, NATURE, V546, P656, DOI 10.1038/nature22815; Suridjan I, 2014, NEUROIMAGE, V84, P868, DOI 10.1016/j.neuroimage.2013.09.021; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tu TW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19094-z; Turkheimer FE, 2015, BIOCHEM SOC T, V43, P586, DOI 10.1042/BST20150058; Ward KM, 2000, J MAGN RESON, V143, P79, DOI 10.1006/jmre.1999.1956; Wells JA, 2015, NEUROIMAGE, V111, P369, DOI 10.1016/j.neuroimage.2015.02.023; Woessner DE, 2005, MAGN RESON MED, V53, P790, DOI 10.1002/mrm.20408; Zahr NM, 2014, BRAIN PATHOL, V24, P654, DOI 10.1111/bpa.12197; Zhang XY, 2017, MAGN RESON MED, V78, P881, DOI 10.1002/mrm.26802; Zhang XY, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3716; Zhong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140238	65	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212002	10.1371/journal.pone.0212002	http://dx.doi.org/10.1371/journal.pone.0212002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789943	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800016
J	Adesokan, HK; Streicher, EM; van Helden, PD; Warren, RM; Cadmus, SIB				Adesokan, Hezekiah K.; Streicher, Elizabeth M.; van Helden, Paul D.; Warren, Rob M.; Cadmus, Simeon I. B.			Genetic diversity of Mycobacterium tuberculosis complex strains isolated from livestock workers and cattle in Nigeria	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; BOVINE TUBERCULOSIS; AFRICANUM; DIFFERENTIATION; INFECTION; LINEAGE	Molecular typing techniques are useful in understanding tuberculosis epidemiology; yet, they have been under-utilised at the human-animal interface in Nigeria. Sixty-four Mycobacterium tuberculosis complex (MTBC) isolates including 42 M. tuberculosis, 13 M. bovis and nine M. africanum obtained from livestock workers (LW, n = 47) and their cattle (n = 17) in three geographical zones of Nigeria were genotyped to identify and evaluate the genetic diversity of the circulating MTBC using spoligotyping. Distribution into clades of M. tuberculosis revealed; 45.3% Uganda I- [SIT46- cattle: 1; LW: 28], 14.1% Latin American Mediterranean- [SIT61, cattle: 1; LW: 8], and 1.6% T- [SIT53-LW: 1]. The M. bovis strains were 6.3% SB0944 [cattle: 4] and 1.6% each of SB0300, SB1026, SB1027 and SB1439 [cattle: 4]. Seventeen MTBC isolates [cattle: 7; LW: 10] yielded 14 new spoligotype patterns including three M. tuberculosis strains (three isolates), five M. bovis strains (five isolates) and six M. africanum strains (nine isolates), two of which belonged to MAF1. Only few families namely, the not previously described Uganda I-, LAM and SB0944 are predominant among the LW and cattle, with other types in lower prevalences. The strain population structure indicates an intriguing diversity and possible zoonotic linkage with consequences for TB control in the country. The need to employ newer molecular techniques such as Mycobacterial Interspersed Repetitive Unit-Variable Number Tandem Repeats and whole genome sequence to decipher circulating MTBC strains in Nigeria is advocated.	[Adesokan, Hezekiah K.; Cadmus, Simeon I. B.] Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Ibadan, Nigeria; [Streicher, Elizabeth M.; van Helden, Paul D.; Warren, Rob M.] Stellenbosch Univ, DST NRF Ctr Excellence Biomed TB Res, SAMRC Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Cadmus, Simeon I. B.] Univ Ibadan, Ctr Control & Prevent Zoonoses, Fac Vet Med, Ibadan, Nigeria	University of Ibadan; National Research Foundation - South Africa; Stellenbosch University; University of Ibadan	Adesokan, HK; Cadmus, SIB (corresponding author), Univ Ibadan, Dept Vet Publ Hlth & Prevent Med, Ibadan, Nigeria.; Cadmus, SIB (corresponding author), Univ Ibadan, Ctr Control & Prevent Zoonoses, Fac Vet Med, Ibadan, Nigeria.	greaterglory2008@gmail.com; simeonc5@gmail.com	Adesokan, Hezekiah/R-8488-2019; Streicher, Elizabeth/I-7780-2018	Streicher, Elizabeth/0000-0003-3901-1981; Warren, Robin/0000-0001-5741-7358; Adesokan, Hezekiah/0000-0001-5050-8580	Tertiary Education Trust Fund (TETFund); Tertiary Education Trust Fund (TETFund) of the Federal Republic of Nigeria	Tertiary Education Trust Fund (TETFund); Tertiary Education Trust Fund (TETFund) of the Federal Republic of Nigeria	This work was sponsored by the authors and partly supported by a grant received by HKA from Tertiary Education Trust Fund (TETFund, 2015) under the Staff Training and Development (ST&D) Scheme of the University of Ibadan, Nigeria. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; The authors appreciate the kind assistance of the Veterinary Officers of the sites where the study was carried out. This work was sponsored by the authors and partly supported by Tertiary Education Trust Fund (TETFund) of the Federal Republic of Nigeria.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Adesokan HK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198810; Affolabi D, 2009, INT J TUBERC LUNG D, V13, P317; Ani A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-189; [Anonymous], 2018, GLOB TUB REP; Asante-Poku A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003370; Assam JPA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-431; Ayele WY, 2004, INT J TUBERC LUNG D, V8, P924; Becton D., 1999, BBLTM MYCOPREPTM SPE, P2; Bonard D, 2000, INT J TUBERC LUNG D, V4, P1176; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Cadmus S, 2006, J CLIN MICROBIOL, V44, P29, DOI 10.1128/JCM.44.1.29-34.2006; Cadmus S, 2011, J CLIN MICROBIOL, V49, P220, DOI 10.1128/JCM.01241-10; Cadmus SIB, 2010, TROP ANIM HEALTH PRO, V42, P1047, DOI 10.1007/s11250-010-9533-2; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; DEKANTOR I, 1979, B ACAD VET FRANCE, V52, P499; Demay C, 2012, INFECT GENET EVOL, V12, P755, DOI 10.1016/j.meegid.2012.02.004; Diguimbaye-Djaibe C, 2006, EMERG INFECT DIS, V12, P769; Fritsche A, 2004, INT J TUBERC LUNG D, V8, P903; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Godreuil S, 2007, J CLIN MICROBIOL, V45, P921, DOI 10.1128/JCM.01918-06; Groenheit R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018601; Hirsh AE, 2004, P NATL ACAD SCI USA, V101, P4871, DOI 10.1073/pnas.0305627101; Jenkins AO, 2011, VET MICROBIOL, V151, P139, DOI 10.1016/j.vetmic.2011.02.037; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kato-Maeda M, 2011, INT J TUBERC LUNG D, V15, P131; Koro FK, 2015, REV SCI TECH OIE, V34, P1001, DOI 10.20506/rst.34.3.2390; Krajewska M, 2012, VET MICROBIOL, V159, P269, DOI 10.1016/j.vetmic.2012.04.001; Lawson L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038409; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; Mbugi EV, 2015, TUBERCULOSIS, V95, P170, DOI 10.1016/j.tube.2014.11.006; Niobe-Eyangoh SN, 2003, J CLIN MICROBIOL, V41, P2547, DOI 10.1128/JCM.41.6.2547-2553.2003; Njanpop-Lafourcade BM, 2001, J CLIN MICROBIOL, V39, P222, DOI 10.1128/JCM.39.1.222-227.2001; Pang Y, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-354; Shitaye JE, 2007, VET MED-CZECH, V52, P317, DOI 10.17221/1872-VETMED; Smith NH, 2012, INFECT GENET EVOL, V12, P873, DOI 10.1016/j.meegid.2011.08.002; Uzoewulu GN, 2016, INT J MYCOBACT, V5, P74, DOI 10.1016/j.ijmyco.2015.06.008; Warren RM, 2006, INT J TUBERC LUNG D, V10, P818; Weber A, 1998, BERL MUNCH TIERARZTL, V111, P6; WHO/ FAO/ OIE/ IUATLD, 48 UN WORLD C LUNG H; Wilkins MJ, 2008, EMERG INFECT DIS, V14, P657, DOI 10.3201/eid1404.070408; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906; Zumarraga MJ, 2013, RES VET SCI, V94, P9, DOI 10.1016/j.rvsc.2012.07.012	43	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211637	10.1371/journal.pone.0211637	http://dx.doi.org/10.1371/journal.pone.0211637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785899	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000033
J	Gavilan-Carrera, B; da Silva, JG; Vargas-Hitos, JA; Sabio, JM; Morillas-de-Laguno, P; Rios-Fernandez, R; Delgado-Fernandez, M; Soriano-Maldonado, A				Gavilan-Carrera, Blanca; Garcia da Silva, Jaqueline; Vargas-Hitos, Jose A.; Sabio, Jose M.; Morillas-de-Laguno, Pablo; Rios-Fernandez, Raquel; Delgado-Fernandez, Manuel; Soriano-Maldonado, Alberto			Association of physical fitness components and health-related quality of life in women with systemic lupus erythematosus with mild disease activity	PLOS ONE			English	Article							PATIENT-REPORTED OUTCOMES; CARDIORESPIRATORY FITNESS; FUNCTIONAL FITNESS; AEROBIC EXERCISE; ACTIVITY PROGRAM; MUSCLE STRENGTH; SF-36; FIBROMYALGIA; CAPACITY; FATIGUE	Objectives To study the association of different components of physical fitness [flexibility, muscle strength and cardiorespiratory fitness (CRF)] and a clustered fitness score with health related quality of life (HRQoL) in women with systemic lupus erythematosus (SLE) and to analyze whether participants with high fitness level have better HRQoL. Methods This cross-sectional study included 70 women with SLE (aged 42.5; SD 13.9 years). The back-scratch test assessed flexibility, the 30-sec chair stand and handgrip strength tests assessed muscle strength, and the 6-min walk test (n = 49) assessed CRF. HRQoL was assessed through the 36-item Short-Form Health Survey (SF-36). Results Flexibility was positively associated with the physical function dimension and the physical component summary (PCS) (r(partial) between 0.26 and 0.31; p<0.05), and negatively related with social functioning dimension (r(partial) = -0.26; p<0.05). Muscle strength was positively associated with the physical function, physical role, bodily pain dimensions and the PCS (r(partial) between 0.27 and 0.49; all p<0.05). CRF was positively associated with the physical function and bodily pain dimensions, and PCS (r(partial) between 0.39 and 0.65; all p<0.05). The clustered fitness score was associated with the physical function (B = 17.16) and bodily pain (B = 14.35) dimensions, and the PCS (B = 6.02), all p<0.005. Patients with high fitness level had greater scores in the physical function, physical role, and bodily pain dimensions and the PCS, all p <= 0.05. Conclusions Our study suggests that muscle strength and CRF are positively associated with HRQoL, while flexibility showed contradictory results. These findings highlight the importance of maintaining adequate fitness levels in women with SLE.	[Gavilan-Carrera, Blanca; Morillas-de-Laguno, Pablo; Delgado-Fernandez, Manuel] Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain; [Garcia da Silva, Jaqueline] Univ Granada, Sch Psychol, Dept Personal Assessment & Psychol Treatment, Granada, Spain; [Vargas-Hitos, Jose A.; Sabio, Jose M.] Virgen de las Nieves Univ Hosp, Dept Internal Med, Syst Autoimmune Dis Unit, Granada, Spain; [Rios-Fernandez, Raquel] San Cecilio Univ Hosp, Dept Internal Med, Syst Autoimmune Dis Unit, Granada, Spain; [Soriano-Maldonado, Alberto] Univ Almeria, Fac Educ Sci, Dept Educ, Almeria, Spain; [Soriano-Maldonado, Alberto] Univ Almeria, CERNEP Res Ctr, SPORT Res Grp CTS 1024, Almeria, Spain	University of Granada; University of Granada; Hospital Universitario Virgen de las Nieves; Hospital Universitario San Cecilio; Universidad de Almeria; Universidad de Almeria	Gavilan-Carrera, B (corresponding author), Univ Granada, Fac Sport Sci, Dept Phys Educ & Sport, Granada, Spain.	bgavilan@ugr.es	Vargas-Hitos, José Antonio/ABG-4532-2020; Delgado-Fernández, Manuel/N-2990-2013; Soriano-Maldonado, Alberto/I-6379-2015; Gavilán-Carrera, Blanca/AAB-5424-2021	Vargas-Hitos, José Antonio/0000-0002-0596-8710; Delgado-Fernández, Manuel/0000-0003-0636-9258; Soriano-Maldonado, Alberto/0000-0002-4626-420X; Garcia Da Silva, Jaqueline/0000-0002-1663-9031; Morillas de Laguno, Pablo/0000-0002-7838-3625; Gavilan Carrera, Blanca/0000-0002-9223-7181; Rios-Fernandez, Raquel/0000-0001-6630-8292	Consejeria de Salud, Junta de Andalucia [PI-0525-2016]; Ilustre Colegio Oficial de Medicos de Granada (Premios de Investigacion); Spanish Ministry of Education [FPU15/00002]	Consejeria de Salud, Junta de Andalucia(Junta de Andalucia); Ilustre Colegio Oficial de Medicos de Granada (Premios de Investigacion); Spanish Ministry of Education(Spanish Government)	This work was supported by the Consejeria de Salud, Junta de Andalucia (grant number: PI-0525-2016) and the Ilustre Colegio Oficial de Medicos de Granada (Premios de Investigacion 2017). BG-C was supported by the Spanish Ministry of Education (FPU15/00002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao MI, 2016, SCAND J RHEUMATOL, V45, P197, DOI 10.3109/03009742.2015.1094126; Alarcon GS, 2004, ARTHRIT RHEUM-ARTHR, V51, P465, DOI 10.1002/art.20409; ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Andrews JS, 2015, ARTHRIT CARE RES, V67, P1070, DOI 10.1002/acr.22560; Andrews JS, 2015, ARTHRIT CARE RES, V67, P120, DOI 10.1002/acr.22399; Annapureddy N, 2016, LUPUS, V25, P1111, DOI 10.1177/0961203316652494; Baba S, 2018, LUPUS, V27, P407, DOI 10.1177/0961203317725586; Balsamo S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-263; Balsamo S, 2013, REV BRAS REUMATOL, V53, P75, DOI 10.1016/S2255-5021(13)70008-7; Beck AT., 1996, BECK DEPRESSION INVE, pb9; Bogdanovic G, 2015, TOHOKU J EXP MED, V237, P193, DOI 10.1620/tjem.237.193; Bostrom C, 2016, LUPUS, V25, P602, DOI 10.1177/0961203315622817; Chaigne B, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-017-0200-5; Chung PK, 2017, ARCH GERONTOL GERIAT, V68, P44, DOI 10.1016/j.archger.2016.08.007; Colangelo KJ, 2009, J RHEUMATOL, V36, P2231, DOI 10.3899/jrheum.090193; de Carvalho MRP, 2005, ARTHRIT RHEUM-ARTHR, V53, P838, DOI 10.1002/art.21605; Di Franco M, 2014, REUMATISMO, V66, P33, DOI 10.4081/reumatismo.2014.762; FANGTHAM M, 2017, ARTHRITIS RHEUMA S10, V69, P91327; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Golder V, 2017, MED J AUSTRALIA, V206, P215, DOI 10.5694/mja16.01229; Gregorio-Arenas E, 2016, MATURITAS, V92, P162, DOI 10.1016/j.maturitas.2016.08.008; Griffiths B, 2005, BEST PRACT RES CL RH, V19, P685, DOI 10.1016/j.berh.2005.03.010; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Houghton KM, 2008, ARTHRIT RHEUM-ARTHR, V59, P537, DOI 10.1002/art.23534; Jolly M, 2005, J RHEUMATOL, V32, P1706; Kasikcioglu E, 2006, MED HYPOTHESES, V66, P950, DOI 10.1016/j.mehy.2005.11.028; Katz DL, 2007, MED HYPOTHESES, V69, P517, DOI 10.1016/j.mehy.2005.10.037; Kell RT, 2001, SPORTS MED, V31, P863, DOI 10.2165/00007256-200131120-00003; Keyser RE, 2003, ARTHRIT RHEUM-ARTHR, V49, P16, DOI 10.1002/art.10926; Khanna S, 2004, RHEUMATOLOGY, V43, P1536, DOI 10.1093/rheumatology/keh376; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Lee WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160876; McElhone K, 2006, LUPUS, V15, P633, DOI 10.1177/0961203306071710; Metsios GS, 2015, RHEUMATOLOGY, V54, P2215, DOI 10.1093/rheumatology/kev035; Moldovan I, 2011, LUPUS, V20, P1285, DOI 10.1177/0961203311412097; Montalban-Mendez C, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12885; Montero-Marin J, 2013, ATEN PRIM, V45, P376, DOI 10.1016/j.aprim.2013.03.002; O'Dwyer T, 2017, SEMIN ARTHRITIS RHEU, V47, P204, DOI 10.1016/j.semarthrit.2017.04.003; Perandini LA, 2015, EXERC IMMUNOL REV, V21, P174; Timoteo RP, 2018, LUPUS, V27, P1159, DOI 10.1177/0961203318768880; Pinto AJ, 2016, ARTHRIT CARE RES, V68, P1780, DOI 10.1002/acr.22905; Plantinga L, 2016, LUPUS SCI MED, V3, DOI 10.1136/lupus-2016-000161; Ramsey-Goldman R, 2000, ARTHRIT CARE RES, V13, P262, DOI 10.1002/1529-0131(200010)13:5<262::AID-ANR4>3.0.CO;2-8; Rikli RE, 1999, J AGING PHYS ACTIV, V7, P129, DOI 10.1123/japa.7.2.129; Rikli RE, 2013, GERONTOLOGIST, V53, P255, DOI 10.1093/geront/gns071; Ruiz-Ruiz J, 2002, J HAND SURG-AM, V27A, P897, DOI 10.1053/jhsu.2002.34315; Sedlock DA, 2010, INT J SPORT NUTR EXE, V20, P336, DOI 10.1123/ijsnem.20.4.336; Soriano-maldonado A, 2018, ERYTHEMATOSUS NONRAN, P1, DOI [10.3390/jcm7120477, DOI 10.3390/JCM7120477]; Soriano-Maldonado A, 2015, ARTHRIT CARE RES, V67, P1561, DOI 10.1002/acr.22610; Soriano-Maldonado A, 2015, ARCH PHYS MED REHAB, V96, P1599, DOI 10.1016/j.apmr.2015.03.015; Soriano-Maldonado A, 2015, RHEUMATOL INT, V35, P899, DOI 10.1007/s00296-014-3203-z; Stoll T, 1997, J RHEUMATOL, V24, P1608; Tench C, 2002, J RHEUMATOL, V29, P474; Tench CM, 2003, RHEUMATOLOGY, V42, P1050, DOI 10.1093/rheumatology/keg289; Urowitz M, 2014, ARTHRIT CARE RES, V66, P1374, DOI 10.1002/acr.22299; van Vollenhoven RF, 2014, ANN RHEUM DIS, V73, P958, DOI 10.1136/annrheumdis-2013-205139; Vaquero-Cristobol R, 2015, RETOS NUEVAS TENDENC, V27, P127; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076	58	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212436	10.1371/journal.pone.0212436	http://dx.doi.org/10.1371/journal.pone.0212436			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785923	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000061
J	Junaid, M; Islam, N; Hossain, MK; Ullah, MO; Halim, MA				Junaid, Md.; Islam, Nazrul; Hossain, Md. Kamal; Ullah, M. Obayed; Halim, Mohammad A.			Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease	PLOS ONE			English	Article							PERIPHERAL ANIONIC SITE; MOLECULAR-DYNAMICS; DOCKING; COMPLEXES; DERIVATIVES; CHALLENGES; PREDICTION; HARDNESS	Among neurodegenerative disorders, Alzheimer's disease (AD) is one of the most common disorders showing slow progressive cognitive decline. Targeting acetylcholinesterase (AChE) is one of the major strategies for AD therapeutics, as cholinergic pathways in the cerebral cortex and basal forebrain are compromised. Herein, we report the design of some copper and other metal based donepezil derivatives, employing density functional theory (DFT). All designed compounds are optimized at the B3LYP/SDD level of theory. Dipole moments, electronic energie, enthalpies, Gibbs free energies, and HOMO-LUMO gaps of these modified compounds are also investigated in the subsequent analysis. The molecules were then subjected to molecular docking analysis with AChE to study the molecular interactions broadly. Ensemble based docking and molecular dynamics (MD) simulations of the best candidates were also performed. Docking and MD simulation reveal that modified drugs are more potent than unmodified donepezil, where Trp86, Tyr337, Phe330 residues play some important roles in drug-receptor interactions. According to ensemble based docking, D9 shows greater binding affinity compared to the parent in most conformations obtained from protein data bank and MD simulation. In addition, it is observed that the pi-pi stacking with the residues of Trp86, Tyr337, Tyr341, Tyr124 and Trp286 may be required for strong ligand binding. Moreover, ADME/T analysis suggests that modified derivatives are less toxic and have improved pharmacokinetic properties than those of the parent drug. These results further confirm the ability of metal-directed drugs to bind simultaneously to the active sites of AChE and support them as potential candidates for the future treatment of Alzheimer's disease.	[Junaid, Md.; Islam, Nazrul; Ullah, M. Obayed] North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh; [Hossain, Md. Kamal] Jahangirnagar Univ, Dept Chem, Dhaka, Bangladesh; [Halim, Mohammad A.] Red Green Res Ctr, Div Comp Aided Drug Design, Dhaka, Bangladesh	North South University (NSU); Jahangirnagar University	Ullah, MO (corresponding author), North South Univ, Dept Pharmaceut Sci, Dhaka, Bangladesh.; Halim, MA (corresponding author), Red Green Res Ctr, Div Comp Aided Drug Design, Dhaka, Bangladesh.	obayed.ullah@northsouth.edu; mahalim@grc-bd.org	Ullah, M Obayed/AAR-7211-2020; Halim, Mohammad A./D-1359-2011; Halim, Mohammad/GZA-9474-2022; Junaid, Md./G-3188-2018	Ullah, M Obayed/0000-0002-1175-3636; Halim, Mohammad A./0000-0002-1698-7044; HOSSAIN, MD KAMAL/0000-0002-8092-1728; Junaid, Md./0000-0003-3588-4937				Anand P, 2012, BIOORGAN MED CHEM, V20, P1175, DOI 10.1016/j.bmc.2011.12.042; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BERGNER A, 1993, MOL PHYS, V80, P1431, DOI 10.1080/00268979300103121; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bourne Y, 2004, P NATL ACAD SCI USA, V101, P1449, DOI 10.1073/pnas.0308206100; Chan KY, 2013, LANCET, V381, P2016, DOI 10.1016/S0140-6736(13)60221-4; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Colombres M, 2004, CURR PHARM DESIGN, V10, P3123, DOI 10.2174/1381612043383359; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dash Raju, 2017, Adv Appl Bioinform Chem, V10, P11, DOI 10.2147/AABC.S115859; Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e; Faerman C, 1996, FEBS LETT, V386, P65, DOI 10.1016/0014-5793(96)00374-2; Fang JS, 2014, ACTA PHARM SIN B, V4, P430, DOI 10.1016/j.apsb.2014.10.002; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fisher A, 2012, J NEUROCHEM, V120, P22, DOI 10.1111/j.1471-4159.2011.07507.x; Flood DG, 2011, BIOCHEM PHARMACOL, V81, P1422, DOI 10.1016/j.bcp.2011.01.021; Frezza M, 2010, CURR PHARM DESIGN, V16, P1813, DOI 10.2174/138161210791209009; Greig NH, 2001, CURR MED RES OPIN, V17, P159; GRUBIC Z, 1995, BBA-PROTEIN STRUCT M, V1249, P155, DOI 10.1016/0167-4838(95)00036-T; Hartinger CG, 2008, CURR MED CHEM, V15, P2574, DOI 10.2174/092986708785908978; Hoque MM, 2015, J PHYS ORG CHEM, V28, P732, DOI 10.1002/poc.3477; Huang L, 2010, BIOORGAN MED CHEM, V18, P1244, DOI 10.1016/j.bmc.2009.12.035; Huijbregts SCJ, 2003, NEUROPSYCHOLOGY, V17, P369, DOI 10.1037/0894-4105.17.3.369; Johnson G, 2006, CURR PHARM DESIGN, V12, P217, DOI 10.2174/138161206775193127; Khan AM, 2017, J MOL GRAPH MODEL, V77, P386, DOI 10.1016/j.jmgm.2017.09.010; Lahiri DK, 2003, CURR DRUG TARGETS, V4, P97, DOI 10.2174/1389450033346957; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Mjos KD, 2014, CHEM REV, V114, P4540, DOI 10.1021/cr400460s; Ordentlich A, 1998, J BIOL CHEM, V273, P19509, DOI 10.1074/jbc.273.31.19509; Parr R. G., 1989, DENSITY FUNCTIONAL T; PARR RG, 1993, ACCOUNTS CHEM RES, V26, P256, DOI 10.1021/ar00029a005; PEARSON RG, 1986, P NATL ACAD SCI USA, V83, P8440, DOI 10.1073/pnas.83.22.8440; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rahman A, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2996-5; Silman I, 2008, CHEM-BIOL INTERACT, V175, P3, DOI 10.1016/j.cbi.2008.05.035; Somani G, 2015, J PHARM BIOALLIED SC, V7, P32, DOI 10.4103/0975-7406.148775; Susnow RG, 2003, J CHEM INF COMP SCI, V43, P1308, DOI 10.1021/ci030283p; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; Tang Q., 2012, ADMETSAR COMPREHENSI, V134, P16909; Thompson KH, 2006, DALTON T, P761, DOI 10.1039/b513476e; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Ying W, 2008, METAL BASED DRUGS, V2008	47	18	18	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211935	10.1371/journal.pone.0211935	http://dx.doi.org/10.1371/journal.pone.0211935			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785927	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000046
J	Yang, BH; Gao, Y; Li, HM; Ye, SB; He, HX; Xie, SR				Yang, Baohua; Gao, Yuan; Li, Hongmin; Ye, Shengbo; He, Hongxia; Xie, Shenru			Rapid prediction of yellow tea free amino acids with hyperspectral images	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; SUCCESSIVE PROJECTIONS ALGORITHM; VARIABLE SELECTION; SPECTROSCOPY; REGRESSION; QUALITY; GREEN; CHEMOMETRICS; COMPONENTS; BLACK	Free amino acids are an important indicator of the freshness of yellow tea. This study investigated a novel procedure for predicting the free amino acid (FAA) concentration of yellow tea. It was developed based on the combined spectral and textural features from hyperspectral images. For the purposes of exploration and comparison, hyperspectral images of yellow tea (150 samples) were captured and analyzed. The raw spectra were preprocessed with Savitzky-Golay (SG) smoothing. To reduce the dimension of spectral data, five feature wavelengths were extracted using the successive projections algorithm (SPA). Five textural features (angular second moment, entropy, contrast, correlation, and homogeneity) were extracted as textural variables from the characteristic grayscale images of the five characteristic wavelengths using the gray-level co-occurrence matrix (GLCM). The FAA content prediction model with different variables was established by a genetic algorithm-support vector regression (GA-SVR) algorithm. The results showed that better prediction results were obtained by combining the feature wavelengths and textural variables. Compared with other data, this prediction result was still very satisfactory in the GA-SVR model, indicating that data fusion was an effective way to enhance hyperspectral imaging ability for the determination of free amino acid values in yellow tea.	[Yang, Baohua; Gao, Yuan; Ye, Shengbo; He, Hongxia; Xie, Shenru] Anhui Agr Univ, Sch Informat & Comp, Hefei, Anhui, Peoples R China; [Yang, Baohua] Minist Agr, Key Lab Agr IoT Technol Integrat & Applicat, Hefei, Anhui, Peoples R China; [Yang, Baohua] Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Nanjing, Jiangsu, Peoples R China; [Yang, Baohua; Li, Hongmin] Kansas State Univ, Dept Comp Sci, Manhattan, KS 66506 USA	Anhui Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Kansas State University	Yang, BH (corresponding author), Anhui Agr Univ, Sch Informat & Comp, Hefei, Anhui, Peoples R China.; Yang, BH (corresponding author), Minist Agr, Key Lab Agr IoT Technol Integrat & Applicat, Hefei, Anhui, Peoples R China.; Yang, BH (corresponding author), Nanjing Agr Univ, Natl Engn & Technol Ctr Informat Agr, Nanjing, Jiangsu, Peoples R China.; Yang, BH (corresponding author), Kansas State Univ, Dept Comp Sci, Manhattan, KS 66506 USA.	ybh@ahau.edu.cn	Li, Hongmin/HHZ-6644-2022; Li, Hongmin/AAA-3405-2020	Li, Hongmin/0000-0003-4928-3534; yang, Baohua/0000-0003-4996-492X	Natural Science Foundation of Anhui Province [1808085MF195]; Natural Science Research Project of Anhui Province [KJ2016A837]; Open Fund of the Key Laboratory of Technology Integration and Application in Agricultural Internet of Things, Ministry of Agriculture [2016KL02]; National Key RD Program [2016YFD0300608]	Natural Science Foundation of Anhui Province(Natural Science Foundation of Anhui Province); Natural Science Research Project of Anhui Province; Open Fund of the Key Laboratory of Technology Integration and Application in Agricultural Internet of Things, Ministry of Agriculture; National Key RD Program	Funded by Natural Science Foundation of Anhui Province (1808085MF195 to BY), http://www.ahkjt.gov.cn/; the Natural Science Research Project of Anhui Province (KJ2016A837 to BY), http://www.ahedu.gov.cn/; the Open Fund of the Key Laboratory of Technology Integration and Application in Agricultural Internet of Things, Ministry of Agriculture (2016KL02 to BY), http://www.ahau.edu.cn/; and the National Key R&D Program (2016YFD0300608 to BY), http://www.most.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasalvar C, 2012, J AGR FOOD CHEM, V60, P6323, DOI 10.1021/jf301498p; Andersen CM, 2010, J CHEMOMETR, V24, P728, DOI 10.1002/cem.1360; Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Balabin RM, 2011, ANAL CHIM ACTA, V692, P63, DOI 10.1016/j.aca.2011.03.006; Bian M., 2012, REMOTE SENS SPATIAL, V1, P237; Bian M, 2010, PHOTOGRAMM ENG REM S, V76, P1385, DOI 10.14358/PERS.76.12.1385; Bulcock H., 2009, HYDROL EARTH SYST SC, V6, P5783, DOI DOI 10.5194/HESSD-6-5783-2009; Cheng JH, 2015, LWT-FOOD SCI TECHNOL, V62, P1060, DOI 10.1016/j.lwt.2015.01.021; Cheng JH, 2014, TRENDS FOOD SCI TECH, V37, P78, DOI 10.1016/j.tifs.2014.03.006; Dai Q, 2015, J FOOD ENG, V149, P97, DOI 10.1016/j.jfoodeng.2014.10.001; Deng SG, 2015, COMPUT ELECTRON AGR, V118, P38, DOI 10.1016/j.compag.2015.08.014; ElMasry G, 2008, J AGR FOOD CHEM, V56, P7672, DOI 10.1021/jf801074s; Gowen AA, 2007, TRENDS FOOD SCI TECH, V18, P590, DOI 10.1016/j.tifs.2007.06.001; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; He HJ, 2014, J FOOD ENG, V126, P156, DOI 10.1016/j.jfoodeng.2013.11.015; Horie H, 2000, J CHROMATOGR A, V881, P425, DOI 10.1016/S0021-9673(99)01345-X; Hsieh MM, 2007, TALANTA, V73, P326, DOI 10.1016/j.talanta.2007.03.049; Hu MH, 2015, POSTHARVEST BIOL TEC, V106, P1, DOI 10.1016/j.postharvbio.2015.03.014; Gonzalez-Martin MI, 2015, SENSORS-BASEL, V15, P27854, DOI 10.3390/s151127854; Kausar T, 2013, RADIAT PHYS CHEM, V86, P96, DOI 10.1016/j.radphyschem.2012.12.011; Li LQ, 2019, J SCI FOOD AGR, V99, P1787, DOI 10.1002/jsfa.9371; Liu D, 2014, FOOD CHEM, V160, P330, DOI 10.1016/j.foodchem.2014.03.096; Liu F, 2008, ANAL CHIM ACTA, V615, P10, DOI 10.1016/j.aca.2008.03.030; Pierna JAF, 2012, CHEMOMETR INTELL LAB, V117, P233, DOI 10.1016/j.chemolab.2012.02.004; Pourbasheer E, 2009, EUR J MED CHEM, V44, P5023, DOI 10.1016/j.ejmech.2009.09.006; Ramedani Z, 2014, SOL ENERGY, V109, P135, DOI 10.1016/j.solener.2014.08.023; Ribaldo PDB, 2009, J NUTR, V139, P96, DOI 10.3945/jn.108.095018; ROBERTS GR, 1966, J SCI FOOD AGR, V17, P182, DOI 10.1002/jsfa.2740170409; Ryu ChanSeok, 2010, Journal of the Japanese Society of Agricultural Machinery, V72, P46; Siripatrawan U, 2015, INT J FOOD MICROBIOL, V199, P93, DOI 10.1016/j.ijfoodmicro.2015.01.001; Sohara Y., 2010, IFAC PROC VOL, V43, P172, DOI [10.3182/20101206-3-JP-3009-00030, DOI 10.3182/20101206-3-JP-3009-00030, 10.3182/20101206-3-JP-3009.00030, DOI 10.3182/20101206-3-JP-3009.00030]; STENSVOLD I, 1992, PREV MED, V21, P546, DOI 10.1016/0091-7435(92)90062-M; Tan FY, 2011, J AGR FOOD CHEM, V59, P10839, DOI 10.1021/jf2023325; Wang Q, 2013, EXP THER MED, V6, P423, DOI 10.3892/etm.2013.1117; WOLD S, 1993, TECHNOMETRICS, V35, P136, DOI 10.2307/1269657; Xie CQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113422; Yang YC, 2015, COMPUT ELECTRON AGR, V113, P203, DOI 10.1016/j.compag.2015.02.008; Ye SF, 2008, CHEMOMETR INTELL LAB, V91, P194, DOI 10.1016/j.chemolab.2007.11.005; Zhang QX, 2012, SPECTROSC-INT J, V27, P93, DOI 10.1155/2012/276795; Zhao JW, 2011, SPECTROSC SPECT ANAL, V31, P512, DOI 10.3964/j.issn.1000-0593(2011)02-0512-04; Zhao JW, 2009, APPL OPTICS, V48, P3557, DOI 10.1364/AO.48.003557; Zhao M, 2011, J AGR FOOD CHEM, V59, P3641, DOI 10.1021/jf104601v; Zhao YR, 2015, J ANAL METHODS CHEM, V2015, DOI 10.1155/2015/343782	43	8	9	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210084	10.1371/journal.pone.0210084	http://dx.doi.org/10.1371/journal.pone.0210084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785888	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000009
J	Kamada, R; Kimura, N; Yoshimura, F; Tanino, K; Sakaguchi, K				Kamada, Rui; Kimura, Nozomi; Yoshimura, Fumihiko; Tanino, Keiji; Sakaguchi, Kazuyasu			Inhibition of lipid droplet formation by Ser/Thr protein phosphatase PPM1D inhibitor, SL-176	PLOS ONE			English	Article							PPAR-GAMMA; WIP1; DIFFERENTIATION; CYCLE	Obesity is a worldwide public health problem, which is associated with various severe diseases including diabetes, hypertension, atherosclerosis, and cancer. Recent studies have revealed that combination treatment of several different compounds using low doses is effective to reduce side effects. Thus, there is a need to develop an efficient inhibitor for reducing lipid droplets with a divergent target/pathway. Ser/Thr protein phosphatase PPM1D is involved in cellular metabolic processes and is a promising target for anti-obesity treatment. We have previously developed a potent and specific PPM1D inhibitor, SL-176. In this study, we demonstrated that significant reduction of lipid droplet formation in adipocytes by the PPM1D specific inhibitor, SL-176. Using Oil-red O staining and fluorescent imaging of lipid droplet, we found that treatment of SL-176 significantly suppressed lipid droplet formation of 3T3-L1 cells both in amount and in size. SL-176 also repressed mRNA and protein expression of PPAR gamma and C/EBP alpha, adipogenic markers, at nontoxic conditions. Thus, SL-176 is a unique and potent inhibitor of lipid droplet formation that acts via PPM1D, a novel target toward inhibiting adipocyte differentiation.	[Kamada, Rui; Kimura, Nozomi; Sakaguchi, Kazuyasu] Hokkaido Univ, Dept Chem, Biol Chem Lab, Fac Sci, Sapporo, Hokkaido, Japan; [Yoshimura, Fumihiko] Univ Shizuoka, Sch Pharmaceut Sci, Shizuoka, Japan; [Tanino, Keiji] Hokkaido Univ, Dept Chem, Lab Organ Chem 2, Fac Sci, Sapporo, Hokkaido, Japan	Hokkaido University; University of Shizuoka; Hokkaido University	Sakaguchi, K (corresponding author), Hokkaido Univ, Dept Chem, Biol Chem Lab, Fac Sci, Sapporo, Hokkaido, Japan.	kazuyasu@sci.hokudai.ac.jp	Kamada, Rui/P-9714-2019; Yoshimura, Fumihiko/A-4116-2012; Tanino, Keiji/D-8399-2012; Tanino, Keiji/M-3564-2019	Yoshimura, Fumihiko/0000-0002-1187-6062; Tanino, Keiji/0000-0002-0580-0125; Tanino, Keiji/0000-0002-0580-0125; Sakaguchi, Kazuyasu/0000-0002-8434-4171	JSPS-Japan [17K1756507]; Toyota RIKEN, Japan; Japan Foundation for Applied Enzymology [JP15H05842, JP18H01970]; Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU)	JSPS-Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Toyota RIKEN, Japan; Japan Foundation for Applied Enzymology; Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU)	This work was supported in part by Grant-in-Aid for Young Scientists (B) (No. 17K1756507) (to R.K.) from JSPS-Japan, Toyota RIKEN, Japan (to R.K.), Japan Foundation for Applied Enzymology (to K.S.), JP15H05842 in Middle Molecular Strategy and JP18H01970 (to K.T.). This work was also supported in part through Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU), found by MEXT under "Support Program for Implementation of New Equipment Sharing System". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Accioly MT, 2008, CANCER RES, V68, P1732, DOI 10.1158/0008-5472.CAN-07-1999; Armata HL, 2015, MOL ENDOCRINOL, V29, P28, DOI 10.1210/me.2014-1136; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Daneschvar HL, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.009; Fernhough ME, 2007, DOMEST ANIM ENDOCRIN, V33, P367, DOI 10.1016/j.domaniend.2007.05.001; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Kamada R, 2017, J BIOCHEM, V162, P303, DOI 10.1093/jb/mvx032; Konige M, 2014, BBA-MOL BASIS DIS, V1842, P393, DOI 10.1016/j.bbadis.2013.05.007; Le Guezennec X, 2012, CELL METAB, V16, P68, DOI 10.1016/j.cmet.2012.06.003; Li DH, 2017, CELL MOL LIFE SCI, V74, P2067, DOI 10.1007/s00018-016-2450-4; Ogasawara S, 2015, BIOORGAN MED CHEM, V23, P6246, DOI 10.1016/j.bmc.2015.08.042; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Rauta J, 2006, BREAST CANCER RES TR, V95, P257, DOI 10.1007/s10549-005-9017-7; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Wong CP, 2014, J NAT MED-TOKYO, V68, P253, DOI 10.1007/s11418-014-0822-3; Yagi H, 2012, BIOORG MED CHEM LETT, V22, P729, DOI 10.1016/j.bmcl.2011.10.084; Yun JW, 2010, PHYTOCHEMISTRY, V71, P1625, DOI 10.1016/j.phytochem.2010.07.011	19	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212682	10.1371/journal.pone.0212682	http://dx.doi.org/10.1371/journal.pone.0212682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811466	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400083
J	Le Goff, M; Cornec, D; Guellec, D; Marhadour, T; Devauchelle-Pensec, V; Jousse-Joulin, S; Herbette, M; Cauvin, JM; Le Guillou, C; Renaudineau, Y; Jamin, C; Pers, JO; Saraux, A				Le Goff, Maelle; Cornec, Divi; Guellec, Dewi; Marhadour, Thierry; Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Herbette, Marion; Cauvin, Jean Michel; Le Guillou, Clara; Renaudineau, Yves; Jamin, Christophe; Pers, Jacques Olivier; Saraux, Alain			Peripheral-blood b-cell subset disturbances in inflammatory joint diseases induced by Tropheryma whipplei	PLOS ONE			English	Article							SYNOVIAL-FLUID; PATHOGENESIS; PREVALENCE; INFECTION; ARTHRITIS; PROFILE; DNA	Objective To look for abnormalities in circulating B-cell subsets in patients with rheumatic symptoms of Whipple's disease (WD). Method Consecutive patients seen between 2010 and 2016 for suspected inflammatory joint disease were identified retrospectively. Results of standardized immunological and serological tests and of peripheral-blood B-cell and T-cell subset analysis by flow cytometry were collected. Patients with criteria suggesting WD underwent PCR testing for Tropheryma whipplei, and those with diagnosis of WD (cases) were compared to those without diagnosis (controls). We used ROC curve analysis to evaluate the diagnostic value of flow cytometry findings for WD. Results Among 2917 patients seen for suspected inflammatory joint disease, 121 had suspected WD, including 9 (9/121, 7.4%) confirmed WD. Proportions of T cells and NK cells were similar between suspected and confirmed WD, whereas cases had a lower proportion of circulating memory B cells (IgD(-)CD38(low), 18.0%+/- 9.7% vs. 26.0%+/- 14.2%, P = 0.041) and higher ratio of activated B cells over memory B cells (4.4 +/- 2.0 vs. 2.9 +/- 2.2, P = 0.023). Among peripheral-blood B-cells, the proportion of IgD+CD27- naive B cells was higher (66.2%+/- 18.2% vs. 54.6%+/- 18.4%, P = 0.047) and that of IgD-CD27+ switched memory B cells lower (13.3%+/- 5.7% vs. 21.4%+/- 11.9%, P = 0.023), in cases vs. controls. The criterion with the best diagnostic performance was a proportion of IgD+CD27- naive B cells above 70.5%, which had 73% sensitivity and 80% specificity. Conclusion Our study provides data on peripheral-blood B-cell disturbances that may have implications for the diagnosis and pathogenetic understanding of WD.	[Le Goff, Maelle; Cornec, Divi; Guellec, Dewi; Marhadour, Thierry; Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Herbette, Marion; Saraux, Alain] Brest Teaching Hosp, Victor Hugo Network, Ctr Natl Reference Malad Autoimmunes Rares CERAIN, Rheumatol Unit, Brest, France; [Cornec, Divi; Devauchelle-Pensec, Valerie; Jousse-Joulin, Sandrine; Renaudineau, Yves; Jamin, Christophe; Pers, Jacques Olivier; Saraux, Alain] Brest Univ, Brest Teaching Hosp, INSERM, UMR1227,Lymphocytes B & Autoimmun,LabEx IGO, Brest, France; [Cauvin, Jean Michel; Le Guillou, Clara] La Cavale Blanche Hosp, DIM, Brest, France; [Cauvin, Jean Michel; Le Guillou, Clara] La Cavale Blanche Hosp, CDC, Brest, France	CHU Brest; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; CHU Brest	Saraux, A (corresponding author), Brest Teaching Hosp, Victor Hugo Network, Ctr Natl Reference Malad Autoimmunes Rares CERAIN, Rheumatol Unit, Brest, France.; Saraux, A (corresponding author), Brest Univ, Brest Teaching Hosp, INSERM, UMR1227,Lymphocytes B & Autoimmun,LabEx IGO, Brest, France.	alain.saraux@chu-brest.fr	Pers, Jacques-Olivier/AGG-7221-2022; Renaudineau, Yves/K-5191-2013	Renaudineau, Yves/0000-0001-5098-5002				Alegria GC, 2017, CLIN REV ALLERG IMMU, V53, P219, DOI 10.1007/s12016-017-8608-5; Alegria GC, 2017, RHEUMATOLOGY, V56, P1401, DOI 10.1093/rheumatology/kex169; Amsler L, 2003, INFECTION, V31, P81, DOI 10.1007/s15010-002-3083-0; Anolik JH, 2008, J IMMUNOL, V180, P688, DOI 10.4049/jimmunol.180.2.688; Binard A, 2009, ANN RHEUM DIS, V68, P1447, DOI 10.1136/ard.2008.096172; Bonhomme CJ, 2008, EUR J CLIN MICROBIOL, V27, P959, DOI 10.1007/s10096-008-0528-0; Bonhomme CJ, 2009, J INFECT DIS, V199, P1043, DOI 10.1086/597277; Desnues B, 2005, J INFECT DIS, V192, P1642, DOI 10.1086/491745; Edouard S, 2012, J CLIN MICROBIOL, V50, P3917, DOI 10.1128/JCM.01517-12; El-Abassi R, 2017, J NEUROL SCI, V377, P197, DOI 10.1016/j.jns.2017.01.048; Fenollar F, 2001, Expert Rev Mol Diagn, V1, P299, DOI 10.1586/14737159.1.3.299; Fenollar F, 2002, J CLIN MICROBIOL, V40, P1119, DOI 10.1128/JCM.40.3.1119-1120.2002; Fenollar F, 2008, CLIN INFECT DIS, V47, P659, DOI 10.1086/590559; Fenollar F, 2008, J INFECT DIS, V197, P880, DOI 10.1086/528693; Fenollar F, 2014, J INFECTION, V69, P103, DOI 10.1016/j.jinf.2014.05.008; Fenollar F, 2007, NEW ENGL J MED, V356, P55, DOI 10.1056/NEJMra062477; Feurle GE, 2010, ANN INTERN MED, V153, P710, DOI 10.7326/0003-4819-153-11-201012070-00004; Glaesener S, 2014, ARTHRITIS RHEUMATOL, V66, P2590, DOI 10.1002/art.38736; Gunther U, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000714; Guerin Antoine, 2018, Elife, V7, DOI 10.7554/eLife.32340; Herbette M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200645; Kalt A, 2006, INT J COLORECTAL DIS, V21, P114, DOI 10.1007/s00384-005-0778-6; Keita AK, 2013, FUTURE MICROBIOL, V8, P57, DOI [10.2217/FMB.12.124, 10.2217/fmb.12.124]; La Scola B, 2001, INT J SYST EVOL MICR, V51, P1471, DOI 10.1099/00207713-51-4-1471; Lagier JC, 2017, FUTURE MICROBIOL, V12, P247, DOI 10.2217/fmb-2017-0178; Lagier JC, 2014, J ANTIMICROB CHEMOTH, V69, P219, DOI 10.1093/jac/dkt310; Lagier JC, 2010, MEDICINE, V89, P337, DOI 10.1097/MD.0b013e3181f204a8; Marth T, 2015, ALIMENT PHARM THER, V41, P709, DOI 10.1111/apt.13140; Marth T, 2002, GASTROENTEROLOGY, V123, P1468, DOI 10.1053/gast.2002.36583; Marth T, 1997, GASTROENTEROLOGY, V113, P442, DOI 10.1053/gast.1997.v113.pm9247462; Marth T, 2016, ACTA CLIN BELG, V71, P373, DOI 10.1080/17843286.2016.1256586; Marth T, 2016, LANCET INFECT DIS, V16, pE13, DOI 10.1016/S1473-3099(15)00537-X; Martinetti M, 2009, GASTROENTEROLOGY, V136, P2289, DOI 10.1053/j.gastro.2009.01.051; Moos V, 2006, J IMMUNOL, V177, P2015, DOI 10.4049/jimmunol.177.3.2015; Moos V, 2012, EXPERT REV ANTI-INFE, V10, P253, DOI [10.1586/ERI.12.4, 10.1586/eri.12.4]; Moos V, 2010, GASTROENTEROLOGY, V138, P210, DOI 10.1053/j.gastro.2009.07.066; O'Duffy JD, 1999, ARTHRITIS RHEUM, V42, P812, DOI 10.1002/1529-0131(199904)42:4<812::AID-ANR27>3.0.CO;2-S; Puechal X, 2007, ARTHRITIS RHEUM, V56, P1713, DOI 10.1002/art.22596; Qin SL, 2016, AM J RESP CRIT CARE, V194, P243, DOI 10.1164/rccm.201601-0162LE; RELMAN DA, 1992, NEW ENGL J MED, V327, P293, DOI 10.1056/NEJM199207303270501; Sack U, 2016, AUTOIMMUN REV, V15, P883, DOI 10.1016/j.autrev.2016.07.010; Schneider T, 2008, LANCET INFECT DIS, V8, P179, DOI 10.1016/S1473-3099(08)70042-2; Vitali C, 2002, ANN RHEUM DIS, V61, P554, DOI 10.1136/ard.61.6.554; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	44	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211536	10.1371/journal.pone.0211536	http://dx.doi.org/10.1371/journal.pone.0211536			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811404	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400021
J	Ruetzler, K; Leung, S; Chmiela, M; Rivas, E; Szarpak, L; Khanna, S; Mao, G; Drake, RL; Sessler, DI; Turan, A				Ruetzler, Kurt; Leung, Steve; Chmiela, Mark; Rivas, Eva; Szarpak, Lukasz; Khanna, Sandeep; Mao, Guangmei; Drake, Richard L.; Sessler, Daniel I.; Turan, Alparslan			Regurgitation and pulmonary aspiration during cardio-pulmonary resuscitation (CPR) with a laryngeal tube: A pilot crossover human cadaver study	PLOS ONE			English	Article							ESOPHAGEAL-TRACHEAL COMBITUBE(TM); ADVANCED AIRWAY MANAGEMENT; HOSPITAL CARDIAC-ARREST; ENDOTRACHEAL INTUBATION; LIFE-SUPPORT; EUROPEAN RESUSCITATION; RETROSPECTIVE ANALYSIS; CHEST COMPRESSIONS; COUNCIL GUIDELINES; SURVIVAL	Background High-quality chest compressions are imperative for Cardio-Pulmonary-Resuscitation (CPR). International CPR guidelines advocate, that chest compressions should not be interrupted for ventilation once a patient's trachea is intubated or a supraglottic-airway-device positioned. Supraglottic-airway-devices offer limited protection against pulmonary aspiration. Simultaneous chest compressions and positive pressure ventilation both increase intrathoracic pressure and potentially enhances the risk of pulmonary aspiration. The hypothesis was, that regurgitation and pulmonary aspiration is more common during continuous versus interrupted chest compressions in human cadavers ventilated with a laryngeal tube airway. Methods Twenty suitable cadavers were included, and were positioned supine, the stomach was emptied, 500 ml of methylene-blue-solution instilled and laryngeal tube inserted. Cadavers were randomly assigned to: 1) continuous chest compressions; or, 2) interrupted chest compressions for ventilation breaths. After 14 minutes of the initial designated CPR strategy, pulmonary aspiration was assessed with a flexible bronchoscope. The methylene-blue-solution was replaced by 500 ml barium-sulfate radiopaque suspension. 14 minutes of CPR with the second designated ventilation strategy was performed. Pulmonary aspiration was then assessed with a conventional chest X-ray. Results Two cadavers were excluded for technical reasons, leaving 18 cadavers for statistical analysis. Pulmonary aspiration was observed in 9 (50%) cadavers with continuous chest compressions, and 7 (39%) with interrupted chest compressions (P = 0.75). Conclusion Our pilot study indicate, that incidence of pulmonary aspiration is generally high in patients undergoing CPR when a laryngeal tube is used for ventilation. Our study was not powered to identify potentially important differences in regurgitation or aspiration between ongoing vs. interrupted chest compression. Our results nonetheless suggest that interrupted chest compressions might better protect against pulmonary aspiration when a laryngeal tube is used for ventilation.	[Ruetzler, Kurt; Leung, Steve; Rivas, Eva; Khanna, Sandeep; Mao, Guangmei; Sessler, Daniel I.; Turan, Alparslan] Cleveland Clin, Inst Anesthesiol, Dept Outcomes Res, Cleveland, OH 44106 USA; [Ruetzler, Kurt; Chmiela, Mark; Khanna, Sandeep; Turan, Alparslan] Cleveland Clin, Dept Gen Anesthesiol, Inst Anesthesiol, Cleveland, OH 44106 USA; [Rivas, Eva] Hosp Clin Barcelona, Dept Anesthesiol, Barcelona, Spain; [Szarpak, Lukasz] Univ Warszaw, Dept Emergency Med, Warsaw, Poland; [Mao, Guangmei] Cleveland Clin, Dept Quantitat Hlth Sci, Cleveland, OH 44106 USA; [Drake, Richard L.] Cleveland Clin, Lerner Coll Med, Dept Anat, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University of Barcelona; Hospital Clinic de Barcelona; University of Warsaw; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Ruetzler, K (corresponding author), Cleveland Clin, Inst Anesthesiol, Dept Outcomes Res, Cleveland, OH 44106 USA.; Ruetzler, K (corresponding author), Cleveland Clin, Dept Gen Anesthesiol, Inst Anesthesiol, Cleveland, OH 44106 USA.	kr@or.org	Rivas, Eva/AFU-7933-2022; Szarpak, Lukasz/N-5222-2018; Ruetzler, Kurt/P-7101-2019; Ruetzler, Kurt/W-2596-2017	Rivas, Eva/0000-0002-5816-998X; Szarpak, Lukasz/0000-0002-0973-5455; Ruetzler, Kurt/0000-0003-0467-1736; Ruetzler, Kurt/0000-0003-0467-1736	Research Program Committee of the Cleveland Clinic Foundation; Instituto Salud Carlos III [BA17/00032]	Research Program Committee of the Cleveland Clinic Foundation; Instituto Salud Carlos III(Instituto de Salud Carlos III)	This study project was funded by a grant by the Research Program Committee of the Cleveland Clinic Foundation and the Instituto Salud Carlos III (BA17/00032 to ER). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Beck-Schimmer B, 2011, EUR J ANAESTH, V28, P78, DOI 10.1097/EJA.0b013e32834205a8; Bein B, 2005, EUR J ANAESTH, V22, P341, DOI 10.1017/S026502150500058X; Benoit JL, 2015, RESUSCITATION, V93, P20, DOI 10.1016/j.resuscitation.2015.05.007; Berg RA, 2001, CIRCULATION, V104, P2465, DOI 10.1161/hc4501.098926; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; Bollig G, 2006, RESUSCITATION, V71, P107, DOI 10.1016/j.resuscitation.2006.02.016; Deakin CD, 2010, RESUSCITATION, P81; Garza AG, 2009, CIRCULATION, V119, P2597, DOI 10.1161/CIRCULATIONAHA.108.815621; Genbrugge C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0837-5; Goliasch G, 2013, EUR J EMERG MED, V20, P310, DOI 10.1097/MEJ.0b013e328358455e; Greif R, 2015, RESUSCITATION, V95, P288, DOI 10.1016/j.resuscitation.2015.07.032; Kellum MJ, 2006, AM J MED, V119, P335, DOI 10.1016/j.amjmed.2005.11.014; KNIGHT B H, 1975, Forensic Science, V6, P229, DOI 10.1016/0300-9432(75)90014-X; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; McCarthy JJ, 2018, CIRCULATION, V137, pE645, DOI 10.1161/CIR.0000000000000557; McClave Stephen A., 2002, Journal of Parenteral and Enteral Nutrition, V26, pS80, DOI 10.1177/014860710202600613; MENDELSON CL, 1946, AM J OBSTET GYNECOL, V52, P191; Mulcaster JT, 2003, ANESTHESIOLOGY, V98, P23, DOI 10.1097/00000542-200301000-00007; Nichol G, 2015, NEW ENGL J MED, V373, P2203, DOI 10.1056/NEJMoa1509139; Perbet S, 2011, AM J RESP CRIT CARE, V184, P1048, DOI 10.1164/rccm.201102-0331OC; Perkins GD, 2015, RESUSCITATION, V95, pE43, DOI 10.1016/j.resuscitation.2015.07.041; Piegeler T, 2016, RESUSCITATION, V105, P66, DOI 10.1016/j.resuscitation.2016.04.020; Piegeler T, 2016, RESUSCITATION, V102, P70, DOI 10.1016/j.resuscitation.2016.02.017; Rabitsch W, 2003, RESUSCITATION, V57, P27, DOI 10.1016/S0300-9572(02)00435-5; Radu RR, 2018, EUR J EMERG MED, V25, P362, DOI 10.1097/MEJ.0000000000000465; Schebesta K, 2012, ANESTHESIOLOGY, V116, P1204, DOI 10.1097/ALN.0b013e318254cf41; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; Stone BJ, 1998, RESUSCITATION, V38, P3, DOI 10.1016/S0300-9572(98)00068-9; Thoeni N, 2015, RESUSCITATION, V90, P42, DOI 10.1016/j.resuscitation.2015.02.010; Virkkunen I, 2007, ACTA ANAESTH SCAND, V51, P202, DOI 10.1111/j.1399-6576.2006.01229.x; Wang HE, 2018, JAMA-J AM MED ASSOC, V320, P769, DOI 10.1001/jama.2018.7044; Wenzel V, 2001, RESUSCITATION, V49, P123, DOI 10.1016/S0300-9572(00)00349-X; Yeung J, 2014, RESUSCITATION, V85, P898, DOI 10.1016/j.resuscitation.2014.02.018	34	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212704	10.1371/journal.pone.0212704	http://dx.doi.org/10.1371/journal.pone.0212704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811470	gold, Green Submitted, Green Published			2022-12-26	WOS:000459806400085
J	Tominaga, T; Akiyoshi, T; Yamamoto, N; Taguchi, S; Mori, S; Nagasaki, T; Fukunaga, Y; Ueno, M				Tominaga, Tetsuro; Akiyoshi, Takashi; Yamamoto, Noriko; Taguchi, Senzo; Mori, Seiichi; Nagasaki, Toshiya; Fukunaga, Yosuke; Ueno, Masashi			Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; PD-L1; SURVIVAL; CHEMORADIATION; EXPRESSION; CHEMOTHERAPY; LYMPHOMA; FEATURES; CD274	Background Inhibition of the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) axis in combination with radiotherapy may be a promising approach to treat cancer. In the present study, we aimed to evaluate serum soluble PD-1/PD-L1 levels in patients with advanced rectal cancer treated with neoadjuvant chemoradiotherapy (CRT). Methods Serum soluble PD-L1 and PD-1 levels were measured using an enzyme-linked immunosorbent assay before and after CRT in 117 patients with low rectal cancer. Changes in the levels of sPD-L1/PD-1 after CRT, and the correlation between sPD-L1/PD-1 level and clinicopathological characteristics or disease-free survival (DFS) were evaluated. Results sPD-L1 levels significantly increased after CRT (p < 0.0001), whereas sPD-1 levels did not change significantly (p = 0.1050). High sPD-L1 before CRT was significantly associated with younger age (p = 0.044), and after CRT, with lymphovascular invasion (p = 0.021). High sPD-1 before and after CRT was significantly associated with a longer distance of the tumor from the anal verge (both p < 0.001). There was no correlation between sPD-L1 level and local PD-L1 expression on stromal immune cells. High sPD-L1 level after CRT tended to be associated with worse DFS (p = 0.0752). The multivariate analysis could not demonstrate an independent association for sPD-L1 levels after CRT with DFS. Conclusions Significant increase of sPD-L1 levels after CRT suggests that anti-PD-L1 therapy might be a potential treatment strategy in combination with CRT in advanced rectal cancer.	[Tominaga, Tetsuro; Akiyoshi, Takashi; Nagasaki, Toshiya; Fukunaga, Yosuke; Ueno, Masashi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr,Koto Ku, Tokyo, Japan; [Yamamoto, Noriko] Japanese Fdn Canc Res, Canc Inst, Div Pathol, Tokyo, Japan; [Taguchi, Senzo] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Radiat Oncol, Tokyo, Japan; [Mori, Seiichi] Japanese Fdn Canc Res, Canc Precis Med Ctr, Tokyo, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research	Akiyoshi, T (corresponding author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Gastroenterol Surg, Gastroenterol Ctr,Koto Ku, Tokyo, Japan.	takashi.akiyoshi@jfcr.or.jp	Fukunaga, Yosuke/AAR-8933-2021; nagasaki, toshiya/AAE-6844-2020	Fukunaga, Yosuke/0000-0002-6397-0907; nagasaki, toshiya/0000-0001-5853-314X; Akiyoshi, Takashi/0000-0002-2321-1412	JSPS KAKENHI [15K10156, 18K08664]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI under Grant number 15K10156 (TA) and 18K08664 (TA). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bando H, 2018, ANN ONCOL, V29, DOI [10.1093/annonc/mdy151.227, DOI 10.1093/ANNONC/MDY151.227]; Breugom AJ, 2015, ANN ONCOL, V26, P696, DOI 10.1093/annonc/mdu560; Bujko K, 2016, ANN ONCOL, V27, P834, DOI 10.1093/annonc/mdw062; Chen YJ, 2011, CYTOKINE, V56, P231, DOI 10.1016/j.cyto.2011.06.004; Dworak O, 1997, INT J COLORECTAL DIS, V12, P19, DOI 10.1007/s003840050072; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Frigola X, 2012, IMMUNOL LETT, V142, P78, DOI 10.1016/j.imlet.2011.11.001; Frigola X, 2011, CLIN CANCER RES, V17, P1915, DOI 10.1158/1078-0432.CCR-10-0250; Hecht M, 2016, EUR J CANCER, V65, P52, DOI 10.1016/j.ejca.2016.06.015; Kim HJ, 2018, RADIOTHER ONCOL, V129, P130, DOI 10.1016/j.radonc.2017.11.027; Kruger S, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1310358; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Lee KS, 2017, CANCER IMMUNOL IMMUN, V66, P927, DOI 10.1007/s00262-017-1999-6; Lee LH, 2016, MODERN PATHOL, V29, P1433, DOI 10.1038/modpathol.2016.139; Lim YJ, 2017, INT J RADIAT ONCOL, V99, P1216, DOI 10.1016/j.ijrobp.2017.07.004; Ma WJ, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0277-y; Nilsson PJ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-279; Ogura A, 2018, EUR J CANCER, V91, P11, DOI 10.1016/j.ejca.2017.12.005; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Rossille D, 2017, LEUKEMIA, V31, P988, DOI 10.1038/leu.2016.385; Rossille D, 2014, LEUKEMIA, V28, P2367, DOI 10.1038/leu.2014.137; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Sorensen SF, 2016, LUNG CANCER, V100, P77, DOI 10.1016/j.lungcan.2016.08.001; Teng FF, 2015, TRANSL RES, V166, P721, DOI 10.1016/j.trsl.2015.06.019; Wei W, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009617; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zhu XX, 2017, ONCOTARGET, V8, P97671, DOI 10.18632/oncotarget.18311	27	30	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212978	10.1371/journal.pone.0212978	http://dx.doi.org/10.1371/journal.pone.0212978			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807610	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100032
J	Martin-Yebraid, A; Martinez, JP				Martin-Yebraid, Alba; Pablo Martinez, Juan			Automatic diagnosis of strict left bundle branch block using a wavelet-based approach	PLOS ONE			English	Article							CARDIAC-RESYNCHRONIZATION THERAPY; EUROPEAN-SOCIETY; HEART-FAILURE; TASK-FORCE; CARDIOLOGY; GUIDELINES; ESC	Patients with left bundle branch block (LBBB) are known to have a good clinical response to cardiac resynchronization therapy. However, the high number of false positive diagnosis obtained with the conventional LBBB criteria limits the effectiveness of this therapy, which has yielded to the definition of new stricter criteria. They require prolonged QRS duration, a QS or rS pattern in the QRS complexes at leads V1 and V2 and the presence of mid-QRS notch/slurs in 2 leads within V1, V2, V5, V6, I and aVL. The aim of this work was to develop and assess a fully-automatic algorithm for strict LBBB diagnosis based on the wavelet transform. Twelve-lead, high-resolution, 10-second ECGs from 602 patients enrolled in the MADIT-CRT trial were available. Data were labelled for strict LBBB by 2 independent experts and divided into training (n = 300) and validation sets (n = 302) for assessing algorithm performance. After QRS detection, a wavelet-based delineator was used to detect individual QRS waves (Q, R, S), QRS onsets and ends, and to identify the morphological QRS pattern on each standard lead. Then, multilead QRS boundaries were defined in order to compute the global QRS duration. Finally, an automatic algorithm for notch/slur detection within the QRS complex was applied based on the same wavelet approach used for delineation. In the validation set, LBBB was diagnosed with a sensitivity and specificity of Se = 92.9% and Sp = 65.1% (Acc = 79.5%, PPV = 74% and NPV = 89.6%). The results confirmed that diagnosis of strict LBBB can be done based on a fully automatic extraction of temporal and morphological QRS features. However, it became evident that consensus in the definition of QRS duration as well as notch and slurs definitions is necessary in order to guarantee accurate and repeatable diagnosis of complete LBBB.	[Martin-Yebraid, Alba; Pablo Martinez, Juan] Univ Zaragoza, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Zaragoza, Spain; [Martin-Yebraid, Alba; Pablo Martinez, Juan] Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, BSICoS Grp, Zaragoza, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Zaragoza; University of Zaragoza	Martinez, JP (corresponding author), Univ Zaragoza, Ctr Invest Biomed Red Bioingn Biomat & Nanomed, Zaragoza, Spain.; Martinez, JP (corresponding author), Univ Zaragoza, IIS Aragon, Aragon Inst Engn Res, BSICoS Grp, Zaragoza, Spain.	jpmart@unizar.es	Martinez, Juan/GXM-4393-2022; Martínez, Juan Pablo/A-2759-2009	Martínez, Juan Pablo/0000-0002-7503-3339; Martin-Yebra, Alba/0000-0003-0226-4950	CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through FEDER (Spain) - MINECO [DPI2016-75458-R]; FEDER; Gobierno de Aragon through BSICoS Reference Group (T39-17R); European Social Fund (EU) through BSICoS Reference Group (T39-17R)	CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III; CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through FEDER (Spain) - MINECO; FEDER(European Commission); Gobierno de Aragon through BSICoS Reference Group (T39-17R); European Social Fund (EU) through BSICoS Reference Group (T39-17R)	This work was supported by CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III and FEDER (Spain), project DPI2016-75458-R funded by MINECO and FEDER, and by Gobierno de Aragon and European Social Fund (EU) through BSICoS Reference Group (T39-17R). The computation was performed by the ICTS NANBIOSIS, specifically by the High Performance Computing Unit of the CIBER-BBN at the University of Zaragoza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by CIBER in Bioengineering, Biomaterials & Nanomedicne (CIBER-BBN) through Instituto de Salud Carlos III and FEDER (Spain), project DPI2016-75458-R funded by MINECO and FEDER, and by Gobierno de Aragon and European Social Fund (EU) through BSICoS Reference Group (T39-17R). The computation was performed by the ICTS NANBIOSIS, specifically by the High Performance Computing Unit of the CIBER-BBN at the University of Zaragoza.	Auricchio A, 2004, CIRCULATION, DOI [10.1161/01.CIR.0000118502.91105.F6?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed, DOI 10.1161/01.CIR.0000118502.91105.F6?URL_VER=Z39.88-2003&RFR_ID=ORI:RID:CROSSREF.ORG&RFR_DAT=CR_PUB%3DPUBMED]; BayesdeLuna A, 2006, MORPHOLOGY ELECTROCA; Brignole M, 2013, EUR HEART J, V34, P2281, DOI 10.1093/eurheartj/eht150; Caputo ML, 2018, INT J CARDIOL, V269, P165, DOI 10.1016/j.ijcard.2018.07.060; GRANT RP, 1956, AM J MED, V20, P834, DOI 10.1016/0002-9343(56)90204-2; Martinez JP, 2004, IEEE T BIO-MED ENG, V51, P570, DOI 10.1109/TBME.2003.821031; Mascioli G, 2012, PACE, V35, P927, DOI 10.1111/j.1540-8159.2012.03427.x; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Smisek R, 2018, J ELECTROCARDIOL, V51, pS31, DOI 10.1016/j.jelectrocard.2018.06.013; Strauss DG, 2011, AM J CARDIOL, V107, P927, DOI 10.1016/j.amjcard.2010.11.010; Surawicz B, 2009, J AM COLL CARDIOL, V53, P976, DOI 10.1016/j.jacc.2008.12.013; Wagner Galen S, 2014, MARRIOTTS PRACTICAL; Xia XJ, 2017, ANN NONINVAS ELECTRO, V22, DOI 10.1111/anec.12398; Zareba W, 2011, CIRCULATION, DOI [10.1161/CIRCULATIONAHA.110.960898?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed, DOI 10.1161/CIRCULATIONAHA.110.960898?URL_VER=Z39.88-2003&RFR_ID=ORI:RID:CROSSREF.ORG&RFR_DAT=CR_PUB%3DPUBMED]; Zusterzeel R, 2018, J ELECTROCARDIOL, V51, pS25, DOI 10.1016/j.jelectrocard.2018.08.001	16	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212971	10.1371/journal.pone.0212971	http://dx.doi.org/10.1371/journal.pone.0212971			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802276	Green Submitted, Green Published, gold			2022-12-26	WOS:000459710700027
J	Diaz, M; Novo, J; Cutrin, P; Gomez-Ulla, F; Penedo, MG; Ortega, M				Diaz, Macarena; Novo, Jorge; Cutrin, Paula; Gomez-Ulla, Francisco; Penedo, Manuel G.; Ortega, Marcos			Automatic segmentation of the foveal avascular zone in ophthalmological OCT-A images	PLOS ONE			English	Article							WEB-BASED SYSTEM; DIAGNOSIS	Angiography by Optical Coherence Tomography (OCT-A) is a non-invasive retinal imaging modality of recent appearance that allows the visualization of the vascular structure at predefined depths based on the detection of the blood movement through the retinal vasculature. In this way, OCT-A images constitute a suitable scenario to analyze the retinal vascular properties of regions of interest as is the case of the macular area, measuring the characteristics of the foveal vascular and avascular zones. Extracted parameters of this region can be used as prognostic factors that determine if the patient suffers from certain pathologies (such as diabetic retinopathy or retinal vein occlusion, among others), indicating the associated pathological degree. The manual extraction of these biomedical parameters is a long, tedious and subjective process, introducing a significant intra and inter expert variability, which penalizes the utility of the measurements. In addition, the absence of tools that automatically facilitate these calculations encourages the creation of computer -aided diagnosis frameworks that ease the doctor's work, increasing their productivity and making viable the use of this type of vascular biomarkers. In this work we propose a fully automatic system that identifies and precisely segments the region of the foveal avascular zone (FAZ) using a novel ophthalmological image modality as is OCT-A. The system combines different image processing techniques to firstly identify the region where the FAZ is contained and, secondly, proceed with the extraction of its precise contour. The system was validated using a representative set of 213 healthy and diabetic OCT-A images, providing accurate results with the best correlation with the manual measurements of two experts clinician of 0.93 as well as a Jaccard's index of 0.82 of the best experimental case in the experiments with healthy OCT-A images. The method also provided satisfactory results in diabetic OCT-A images, with a best correlation coefficient with the manual labeling of an expert clinician of 0.93 and a Jaccard's index of 0.83. This tool provides an accurate FAZ measurement with the desired objectivity and reproducibility, being very useful for the analysis of relevant vascular diseases through the study of the retinal micro circulation.	[Diaz, Macarena; Novo, Jorge; Penedo, Manuel G.; Ortega, Marcos] Univ A Coruna, Dept Comp Sci, La Coruna, Spain; [Diaz, Macarena; Novo, Jorge; Penedo, Manuel G.; Ortega, Marcos] Univ A Coruna, CITIC Res Ctr Informat & Commun Technol, La Coruna, Spain; [Cutrin, Paula; Gomez-Ulla, Francisco] Complejo Hosp Unversitario Santiago, Santiago De Compostela, Spain; [Gomez-Ulla, Francisco] Inst Oftalmol Gomez Ulla, Santiago De Compostela, Spain	Universidade da Coruna; Universidade da Coruna	Diaz, M (corresponding author), Univ A Coruna, Dept Comp Sci, La Coruna, Spain.; Diaz, M (corresponding author), Univ A Coruna, CITIC Res Ctr Informat & Commun Technol, La Coruna, Spain.	macarena.diaz1@udc.es	Díaz, Macarena/S-1369-2019; Buján, Jorge Novo/N-3366-2014; Penedo, Manuel F. González/N-7767-2015; Hortas, Marcos Ortega/A-5955-2011	Díaz, Macarena/0000-0002-6904-2968; Buján, Jorge Novo/0000-0002-0125-3064; Penedo, Manuel F. González/0000-0002-6881-0865; Hortas, Marcos Ortega/0000-0002-2798-0788	Ministerio de Economia y Competitividad, Government of Spain [DPI2015-69948-R]; European Union (European Regional Development Fund - ERDF); Xunta de Galicia, Centro singular de investigacion de Galicia accreditation 2016-2019 [ED431G/01]; Grupos de Referencia Competitiva [ED431C 2016-047]; Instituto de salud Carlos III [PI-00940]; Fundacion Mutua Madrilena project [2017/365]	Ministerio de Economia y Competitividad, Government of Spain; European Union (European Regional Development Fund - ERDF); Xunta de Galicia, Centro singular de investigacion de Galicia accreditation 2016-2019; Grupos de Referencia Competitiva; Instituto de salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fundacion Mutua Madrilena project	This work is supported by the Ministerio de Economia y Competitividad, Government of Spain through the DPI2015-69948-R research project. Also, this work has received financial support from the European Union (European Regional Development Fund - ERDF) and the Xunta de Galicia, Centro singular de investigacion de Galicia accreditation 2016-2019, Ref. ED431G/01; Grupos de Referencia Competitiva, Ref. ED431C 2016-047 and Instituto de salud Carlos III, Ref. PI-00940. Also, this work has received partial financial support from the Fundacion Mutua Madrilena project, Ref. 2017/365.	Balaratnasingam C., 2016, AM ACAD OPHTHALMOLOG, V123; Bouix S, 2007, NEUROIMAGE, V36, P1207, DOI 10.1016/j.neuroimage.2007.04.031; Carpineto P, 2016, BRIT J OPHTHALMOL, V100, P671, DOI 10.1136/bjophthalmol-2015-307330; CHANG YL, 1994, IEEE T IMAGE PROCESS, V3, P868, DOI 10.1109/83.336259; de Carlo Talisa E, 2015, Int J Retina Vitreous, V1, P5; de Moura J, 2017, MED BIOL ENG COMPUT, V55, P2209, DOI 10.1007/s11517-017-1660-8; Diaz M, 2018, OCTAGON; Ding LJ, 2001, PATTERN RECOGN, V34, P721, DOI 10.1016/S0031-3203(00)00023-6; Goncalves L, 2016, EXPERT SYST APPL, V61, P1, DOI 10.1016/j.eswa.2016.05.024; Hwang TS, 2016, JAMA OPHTHALMOL, V134, P367, DOI 10.1001/jamaophthalmol.2015.5658; Ilea DE, 2011, PATTERN RECOGN, V44, P2479, DOI 10.1016/j.patcog.2011.03.005; Lassen BC, 2015, PHYS MED BIOL, V60, P1307, DOI 10.1088/0031-9155/60/3/1307; Leroy F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027128; Lu YS, 2018, INVEST OPHTH VIS SCI, V59, P2212, DOI 10.1167/iovs.17-23498; Mastropasqua R, 2016, BRIT J OPHTHALMOLOGY, P100; Mastropasqua R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170343; Nishio M, 2018, PLOS ONE, P4; Novo J, 2017, COMPUT METH PROG BIO, V139, P61, DOI 10.1016/j.cmpb.2016.10.019; Novo J, 2017, J MED BIOL ENG, V37, P920, DOI 10.1007/s40846-017-0256-y; Real R, 1996, SYST BIOL, V45, P380, DOI 10.2307/2413572; Silva S, 2011, IEEE ENG MED BIO, P3411, DOI 10.1109/IEMBS.2011.6090923; Spet zer RF, 1990, BNI, V6, P35; Zhu SC, 1996, IEEE T PATTERN ANAL, V18, P884, DOI 10.1109/34.537343	23	33	33	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212364	10.1371/journal.pone.0212364	http://dx.doi.org/10.1371/journal.pone.0212364			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794594	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100056
J	Josa-Prado, F; Luo, J; Rubin, P; Henley, JM; Wilkinson, KA				Josa-Prado, Fernando; Luo, Jia; Rubin, Philip; Henley, Jeremy M.; Wilkinson, Kevin A.			Developmental profiles of SUMOylation pathway proteins in rat cerebrum and cerebellum	PLOS ONE			English	Article							SUMO; CONJUGATION; EXPRESSION; BRAIN; MODIFIER; HYPOTHERMIA; MECHANISMS; COMPONENTS; TARGET	Protein SUMOylation regulates multiple processes involved in the differentiation and maturation of cells and tissues during development. Despite this, relatively little is known about the spatial and temporal regulation of proteins that mediate SUMOylation and deSUMOylation in the CNS. Here we monitor the expression of key SUMO pathway proteins and levels of substrate protein SUMOylation in the forebrain and cerebellum of Wistar rats during development. Overall, the SUMOylation machinery is more highly-expressed at E18 and decreases thereafter, as previously described. All of the proteins investigated are less abundant in adult than in embryonic brain. Furthermore, we show for first time that the profiles differ between cerebellum and cerebrum, indicating differential regional regulation of some of the proteins analysed. These data provide further basic observation that may open a new perspective of research about the role of SUMOylation in the development of different brain regions.	[Josa-Prado, Fernando] Univ Alfonso X Sabio, Madrid, Spain; [Josa-Prado, Fernando; Luo, Jia; Rubin, Philip; Henley, Jeremy M.; Wilkinson, Kevin A.] Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol, Avon, England	Universidad Alfonso X el Sabio (UAX); University of Bristol	Josa-Prado, F (corresponding author), Univ Alfonso X Sabio, Madrid, Spain.; Josa-Prado, F; Wilkinson, KA (corresponding author), Univ Bristol, Sch Biochem, Med Sci Bldg, Bristol, Avon, England.	f.josaprado@gmail.com; kevin.wilkinson@bristol.ac.uk	Wilkinson, Kevin/AAM-2888-2020; Prado, Fernando Josa/G-1334-2016; Prado, Fernando Josa/M-3087-2019	Wilkinson, Kevin/0000-0002-8115-8592; Prado, Fernando Josa/0000-0002-6162-3231; Prado, Fernando Josa/0000-0002-6162-3231; Henley, Jeremy/0000-0003-3589-8335	Project "SyMBaD" Synapses: from molecules to higher brain function and diseases / Marie Curie Action: "Networks for Initial Training" / European Commission [238608/FP7-PEOPLE-ITN-2008]; MSCA ITN "SyMBaD"; European Commission (MSCAs); European Commission (European Research Council); SUMOBRAIN - Mechanisms and consequences of synaptic SUMOylation in health and disease' / European Research Council [232881]; BBSRC [BB/R00787X/1] Funding Source: UKRI	Project "SyMBaD" Synapses: from molecules to higher brain function and diseases / Marie Curie Action: "Networks for Initial Training" / European Commission; MSCA ITN "SyMBaD"; European Commission (MSCAs); European Commission (European Research Council)(European CommissionEuropean Commission Joint Research CentreEuropean Research Council (ERC)); SUMOBRAIN - Mechanisms and consequences of synaptic SUMOylation in health and disease' / European Research Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by: to JMH: Project "SyMBaD" Synapses: from molecules to higher brain function and diseases / Project ID 238608/FP7-PEOPLE-ITN-2008 - Marie Curie Action: "Networks for Initial Training" / European Commission/https://cordis.europa.eu/project/rcn/92985_en.html/ Joint award between 14 academic and commercial partners co-ordinated by University of Bordeaux; SUMOBRAIN - Mechanisms and consequences of synaptic SUMOylation in health and disease' / Proposal no 232881 / European Research Council/https://cordis.europa.eu/project/rcn/90355_es.html/ (Sole applicant). FJP and KAW received no specific funding for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fernando Josa Prado was an ESR fellow funded by the MSCA ITN "SyMBaD". We are grateful to the European Commission (MSCAs and European Research Council) for funding this work.	Anderson DB, 2009, DRUG NEWS PERSPECT, V22, P255, DOI 10.1358/dnp.2009.22.5.1378636; Buckby LE, 2004, DEV BRAIN RES, V150, P1, DOI 10.1016/j.devbrainres.2004.01.006; Chamberlain SEL, 2012, NAT NEUROSCI, V15, P845, DOI 10.1038/nn.3089; Chen L, 2000, MOL BRAIN RES, V78, P196, DOI 10.1016/S0169-328X(00)00076-0; Cimarosti H, 2008, NEUROPHARMACOLOGY, V54, P280, DOI 10.1016/j.neuropharm.2007.09.010; Cimarosti H, 2012, J CEREBR BLOOD F MET, V32, P17, DOI 10.1038/jcbfm.2011.146; Craig TJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17669; Craig TJ, 2012, J BIOL CHEM, V287, P22781, DOI 10.1074/jbc.M112.356337; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Curras MC, 1998, DEV BRAIN RES, V109, P1, DOI 10.1016/S0165-3806(98)00060-1; Datwyler AL, 2011, J CEREBR BLOOD F MET, V31, P2152, DOI 10.1038/jcbfm.2011.112; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; GRAY EG, 1962, J ANAT, V96, P79; Guo C, 2013, EMBO J; Guo C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43811; Guo C, 2013, EMBO J, V32, P1514, DOI 10.1038/emboj.2013.65; Hannoun Z, 2010, TOXICOLOGY, V278, P288, DOI 10.1016/j.tox.2010.07.013; Hasegawa Y, 2014, J COMP NEUROL, V522, P3020, DOI 10.1002/cne.23563; Hashiyama K, 2009, GENE EXPR PATTERNS, V9, P50, DOI 10.1016/j.gep.2008.08.001; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Henley JM, 2018, TRENDS NEUROSCI, V41, P198, DOI 10.1016/j.tins.2018.02.004; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Ho CW, 2011, J BIOL CHEM, V286, P21826, DOI 10.1074/jbc.M111.234914; Jaafari N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052345; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jourdi H, 2003, DEV BIOL, V263, P216, DOI 10.1016/j.ydbio.2003.07.008; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; La Salle S, 2008, DEV BIOL, V321, P227, DOI 10.1016/j.ydbio.2008.06.020; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Ling W, 2012, ACTA HISTOCHEM, V114, P285, DOI 10.1016/j.acthis.2011.06.005; Loriol C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033757; Lu H, 2009, BIOCHEM BIOPH RES CO, V390, P872, DOI 10.1016/j.bbrc.2009.10.065; Martin LJ, 1998, NEUROSCIENCE, V83, P917, DOI 10.1016/S0306-4522(97)00411-9; Martin S, 2007, NATURE, V447, P321, DOI 10.1038/nature05736; McManus FP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25150-z; Miyazaki H, 2005, FEBS LETT, V579, P6834, DOI 10.1016/j.febslet.2005.11.022; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Rocca DL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00707-6; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Schmidt D, 2002, P NATL ACAD SCI USA, V99, P2872, DOI 10.1073/pnas.052559499; Tang LTH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8728; Wilkinson KA, 2010, BRAIN RES REV, V64, P195, DOI 10.1016/j.brainresrev.2010.04.002; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Yang W, 2008, J NEUROCHEM, V106, P989, DOI 10.1111/j.1471-4159.2008.05404.x; Yang W, 2008, J CEREBR BLOOD F MET, V28, P269, DOI 10.1038/sj.jcbfm.9600523; Yang W, 2009, J CEREBR BLOOD F MET, V29, P886, DOI 10.1038/jcbfm.2009.16; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhu B, 2018, BIOCHEM BIOPH RES CO, V500, P645, DOI 10.1016/j.bbrc.2018.04.125	54	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212857	10.1371/journal.pone.0212857	http://dx.doi.org/10.1371/journal.pone.0212857			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794696	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100150
J	Walker, RE; Walker, CG; Camargo, CA; Bartley, J; Flint, D; Thompson, JMD; Mitchell, EA				Walker, Rebecca E.; Walker, Caroline G.; Camargo, Carlos A., Jr.; Bartley, Jim; Flint, David; Thompson, John M. D.; Mitchell, Edwin A.			Nasal microbial composition and chronic otitis media with effusion: A case-control study	PLOS ONE			English	Article							UPPER RESPIRATORY-TRACT; BACTERIAL INTERFERENCE; INFECTION; COLONIZATION; CHILDREN; PATHOGENS; HEALTH; CAVITY; RISK	Objectives Chronic otitis media with effusion (COME) in children can cause prolonged hearing loss, which is associated with an increased risk of learning delays and behavioural problems. Dispersal of bacterial pathogens from the nasal passages to the middle ear is implicated in COME. We sought to determine whether there is an association between nasal microbial composition and COME in children. Methods A case-control study of children aged 3 and 4 years was conducted. Cases undergoing placement of tympanostomy tubes for COME were compared to healthy controls. Nasal swabs were collected and a questionnaire was administered. The V1-3 region of the 16S rRNA gene was amplified, and sequenced on the Illumina MiSeq. Results 73 children with COME had a lower Shannon diversity index than 105 healthy controls (1.62 [.80] versus 1.88 [.84], respectively; P = .046). The nasal microbiota of cases and controls differed in composition using Bray-Curtis dissimilarity (p = 0.002). Children with COME had a higher abundance of otopathogens and lower abundance of commensals including alpha haemolytic Streptococci and Lactococcus. Cluster analysis revealed 4 distinct nasal microbial profiles. Profiles that were Corynebacterium-dominated (aOR 4.18 [95% CI, 1.6810.39], Streptococcus-dominated (aOR 3.12 [95% CI, 1.08-9.06], or Moraxella-dominated (aOR 4.70 [95% CI, 1.73-12.80] were associated with COME, compared to a more mixed microbial profile when controlling for age, ethnicity, and recent antibiotics use. Conclusions Children with COME have a less diverse nasal microbial composition with a higher abundance of pathogens, compared to healthy children who have a more mixed bacterial profile with a higher abundance of commensals. Further research is required to determine how nasal microbiota may relate to the pathogenesis or maintenance of COME, and whether modification of the nasal microbiota can prevent or treat children at risk of COME.	[Walker, Rebecca E.; Thompson, John M. D.; Mitchell, Edwin A.] Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand; [Walker, Caroline G.] Univ Auckland, Dept Populat Hlth, Ctr Longitudinal Res He Ara Ki Mua, Auckland, New Zealand; [Camargo, Carlos A., Jr.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02115 USA; [Bartley, Jim; Flint, David] Manukau SuperClin, Counties Manukau Dist Hlth Board, Div Otolaryngol Head & Neck Surg, Auckland, New Zealand	University of Auckland; University of Auckland; Harvard University; Harvard Medical School; Massachusetts General Hospital	Walker, RE (corresponding author), Univ Auckland, Dept Paediat Child & Youth Hlth, Auckland, New Zealand.	r.walker@auckland.ac.nz	Camargo, Carlos A./C-2145-2008	Camargo, Carlos A./0000-0002-5071-7654; Walker, Rebecca/0000-0002-7825-1438	REW -The Oticon Foundation [3701863]; REW -CRC Starship Foundation [18071300]; REW -Brian Johns Fellowship Trust [4711]; EAM -Deafness Research Foundation [2013/08]	REW -The Oticon Foundation; REW -CRC Starship Foundation; REW -Brian Johns Fellowship Trust; EAM -Deafness Research Foundation	This work was supported by: REW -The Oticon Foundation (Grant no. 3701863) http://www.oticon.org.nz/; REW -CRC Starship Foundation (Grant No. 18071300) https://www.starship.org.nz/; REW -Brian Johns Fellowship Trust (Grant no. 4711); EAM -Deafness Research Foundation (Grant no. 2013/08) https://www.nfd.org.nz/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KE, 2001, ARCH DIS CHILD, V85, P91, DOI 10.1136/adc.85.2.91; Bluestone CD, 2002, ANN OTO RHINOL LARYN, V111, P8, DOI 10.1177/00034894021110S304; Brook I, 2005, OTOLARYNG HEAD NECK, V133, P139, DOI 10.1016/j.otohns.2005.03.012; Brook I, 1999, PEDIATR INFECT DIS J, V18, P835, DOI 10.1097/00006454-199909000-00021; Camello TCF, 2009, LETT APPL MICROBIOL, V48, P458, DOI 10.1111/j.1472-765X.2009.02553.x; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Chonmaitree T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180630; Coates H, 2008, OTOLARYNG HEAD NECK, V138, P778, DOI 10.1016/j.otohns.2007.02.009; Depner M, 2017, J ALLERGY CLIN IMMUN, V139, P826, DOI 10.1016/j.jaci.2016.05.050; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Hall-Stoodley L, 2006, JAMA-J AM MED ASSOC, V296, P202, DOI 10.1001/jama.296.2.202; Hao Q, 2011, COCHRANE DATABASE SY, V9; Hasegawa K, 2016, EUR RESP J; Hatakka K, 2007, CLIN NUTR, V26, P314, DOI 10.1016/j.clnu.2007.01.003; Hilty M, 2012, J INFECT DIS, V205, P1048, DOI 10.1093/infdis/jis024; Krishnamurthy A, 2009, MICROBES INFECT, V11, P545, DOI 10.1016/j.micinf.2009.03.001; Lappan R, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1154-3; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maechler M, 2017, CLUSTER CLUSTER ANAL; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; Marks LR, 2013, MBIO, V4, DOI 10.1128/mBio.00438-13; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Ngo CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150949; Oksanen J, 2013, PACKAGE VEGAN COMMUN, P2; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Pittet LA, 2010, AM J RESP CELL MOL, V42, P450, DOI 10.1165/rcmb.2007-0417OC; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Sajjan U, 2008, AM J RESP CRIT CARE, V178, P1271, DOI 10.1164/rccm.200801-136OC; Short KR, 2011, J INFECT DIS, V204, P1857, DOI 10.1093/infdis/jir618; Siegel SJ, 2014, CELL HOST MICROBE, V16, P55, DOI 10.1016/j.chom.2014.06.005; Stearns JC, 2015, ISME J, V9; Stol K, 2013, INT J PEDIAT OTORHIN; Teo SM, 2015, CELL HOST MICROBE, V17, P704, DOI 10.1016/j.chom.2015.03.008; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Tonnaer EL, 2005, J CLIN MICROBIOL, V43, P3140, DOI 10.1128/JCM.43.7.3140-3144.2005; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Walker RE, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-016-0767-7; Wren JT, 2014, INFECT IMMUN, V82, P4802, DOI 10.1128/IAI.01856-14; Xu QF, 2017, J INFECTION, V75, P26, DOI 10.1016/j.jinf.2017.04.003; Yang K, 2018, PNEUMONIA, V10, DOI 10.1186/s41479-018-0054-5	43	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212473	10.1371/journal.pone.0212473	http://dx.doi.org/10.1371/journal.pone.0212473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794625	Green Submitted, gold, Green Published			2022-12-26	WOS:000459709100073
J	Wilke, ABB; Carvajal, A; Medina, J; Anderson, M; Nieves, VJ; Ramirez, M; Vasquez, C; Petrie, W; Cardenas, G; Beier, JC				Wilke, Andre B. B.; Carvajal, Augusto; Medina, Johana; Anderson, Melissa; Nieves, Veronica J.; Ramirez, Monica; Vasquez, Chalmers; Petrie, William; Cardenas, Gabriel; Beier, John C.			Assessment of the effectiveness of BG-Sentinel traps baited with CO2 and BG-Lure for the surveillance of vector mosquitoes in Miami-Dade County, Florida	PLOS ONE			English	Article							ZIKA VIRUS; AEDES-AEGYPTI; DIPTERA-CULICIDAE; TRANSMISSION; DENGUE; EFFICACY	Vector-borne diseases are an increasing issue to public health, endangering billions of people worldwide. Controlling vector mosquitoes is widely accepted as the most effective way to prevent vector-borne disease outbreaks. Mosquito surveillance is critical for the development of control strategies under the integrated vector management framework. We hypothesize that the effectiveness and reliability of using BG-Sentinel traps for the surveillance strongly depend on the bait used to attract mosquitoes. The objective of this study was to compare the effectiveness of BG-Sentinel traps baited with CO2 and BG-Lure. A total of 72 traps were deployed for 48 hours once a week for four weeks. For the initial 24-hour period, the traps were baited with CO2, and then for an additional 24 hours using the BG-Lure. Collected mosquitoes were analyzed using the Generalized Estimating Equation for repeated measures analysis. Biodiversity was assessed by the Shannon and Simpson indices and by individual rarefaction curves and SHE profiles. A total of 5,154 mosquitoes were collected, from which 3,514 by traps baited with CO2 and 1,640 mosquitoes by traps baited with BG-Lure. Aedes aegypti and Culex quinquefasciatus were the most abundant and dominant species. Results from the Generalized Estimating Equation models indicated that more than twice as many mosquitoes were attracted CO2 than to the BG-Lure. The comparison of attractiveness of CO2 and BG-Lure to Ae. aegypti and Cx. quinquefasciatus was non-significant, suggesting that both species were equally attracted by the baits. The individual rarefaction curves for Ae. aegypti and Cx. quinquefasciatus imply that traps baited with BG-Lure underestimated mosquito species richness compared to those baited with CO2. BG-Lure were less effective in attracting mosquitoes with low abundances and failed to collect Cx. coronator and Cx. nigripalpus, which were consistently collected by traps baited with CO2. According to our results, CO2 significantly (P< 0.05) attracted more mosquitoes (2.67 adjusted odds ratios) than the BG-Lure when adjusted for time and species, being more effective in assessing the relative abundance of vector mosquitoes and yielding more trustworthy results. Traps baited with CO2 collected not only more specimens, but also more species in a more consistent pattern.	[Wilke, Andre B. B.; Cardenas, Gabriel; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Carvajal, Augusto; Medina, Johana; Anderson, Melissa; Nieves, Veronica J.; Ramirez, Monica; Vasquez, Chalmers; Petrie, William] Miami Dade Cty Mosquito Control Div, Miami, FL USA	University of Miami	Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.	axb1737@med.miami.edu	Wilke, Andre B B/J-9973-2014	Wilke, Andre B B/0000-0002-6629-7666	CDC: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program [1U01CK000510-01]	CDC: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program	This research was supported by CDC (https://www.cdc.gov/) grant 1U01CK000510-01: Southeastern Regional Center of Excellence in Vector-Borne Diseases: The Gateway Program. CDC had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. JCB is the recipient of the grant.	Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150; Buzas MA, 1998, J FORAMIN RES, V28, P233; Cardoso JD, 2011, J VECTOR ECOL, V36, P175, DOI 10.1111/j.1948-7134.2011.00155.x; Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608; Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013; Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630; Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401; de Azara TMF, 2013, MEM I OSWALDO CRUZ, V108, P229, DOI 10.1590/0074-0276108022013016; Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082; Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2; Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015; Lee B. Y., 2017, PLOS NEGLECT TROP D, V11, DOI DOI 10.1371/JOURNAL.PNTD.0005531; Li YJ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1724-x; Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1; Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959; Ludwig GV, 2002, AM J TROP MED HYG, V67, P67, DOI 10.4269/ajtmh.2002.67.67; Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017; Mcnamara TS, 2014, MICROBIOL SPECTR, V1, P1; Morris C. D, 2000, TECH B FLORIDA MOSQ, V1; Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155; Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328; Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361; Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860; Pombi M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0580-9; Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369; Roche B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125600; Roiz D, 2016, J MED ENTOMOL, V53, P460, DOI 10.1093/jme/tjv184; Roiz D, 2012, AM J TROP MED HYG, V86, P642, DOI 10.4269/ajtmh.2012.11-0326; Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1; Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863; Stoddard PK, 2018, ACTA TROP, V187, P108, DOI 10.1016/j.actatropica.2018.07.031; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Vitek CJ, 2008, J MED ENTOMOL, V45, P483, DOI 10.1603/0022-2585(2008)45[483:ATBCNI]2.0.CO;2; Watts J, 2000, WORLD HLTH, V78, P8; WHO, 2013, OUTLOOKS PEST MANAGE, V24, P142; WHO, 2017, EST MAN CAP HUM VACC, P1; Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9; Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003; Zannoli S, 2018, CHIKUNGUNYA ZIKA VIR, P193, DOI DOI 10.1016/B978-0-12-811865-8.00006-4; Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114; Zinser Margaret, 2004, Journal of Insect Science (Tucson), V4, P1	51	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212688	10.1371/journal.pone.0212688	http://dx.doi.org/10.1371/journal.pone.0212688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794670	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100115
J	Kfoury, R; Marzban, B; Makki, E; Greenfield, ML; Yuan, HY				Kfoury, Ralph; Marzban, Bahador; Makki, Emad; Greenfield, Michael L.; Yuan, Hongyan			Effect of pressure profile of shock waves on lipid membrane deformation	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; BILAYERS	Use of shock waves to temporarily increase the permeability of the cell membrane is a promising approach in drug delivery and gene therapy to allow the translocation of macromolecules and small polar molecules into the cytoplasm. Our understanding of how the characteristics of the pressure profile of shock waves, such as peak pressure and pulse duration, influences membrane properties is limited. Here we study the response of lipid bilayer membranes to shock pulses with different pressure profiles using atomistic molecular dynamics simulations. From our simulation results, we find that the transient deformation/disordering of the membrane depends on both the magnitude and the pulse duration of the pressure profile of the shock pulse. For a low pressure impulse, peak pressure has a dominant effect on membrane structural changes, while for the high pressure impulse, we find that there exists an optimal pulse duration at which membrane deformation/disordering is maximized.	[Kfoury, Ralph; Marzban, Bahador; Yuan, Hongyan] Univ Rhode Isl, Dept Mech Ind & Syst Engn, Kingston, RI 02881 USA; [Makki, Emad] Umm Al Qura Univ, Coll Engn & Islamic Architecture, Dept Mech Engn, Mecca, Saudi Arabia; [Greenfield, Michael L.] Univ Rhode Isl, Dept Chem Engn, Kingston, RI 02881 USA	University of Rhode Island; Umm Al Qura University; University of Rhode Island	Yuan, HY (corresponding author), Univ Rhode Isl, Dept Mech Ind & Syst Engn, Kingston, RI 02881 USA.	hongyan_yuan@uri.edu	Yuan, Hongyan/C-3816-2011	Yuan, Hongyan/0000-0001-8225-0211; Marzban, Bahador/0000-0002-0724-7749; Makki, Emad/0000-0002-2089-9776; Greenfield, Michael/0000-0002-4704-1489	Haythornthwaite Research Initiation Grant Award of ASME; US Fulbright Program	Haythornthwaite Research Initiation Grant Award of ASME; US Fulbright Program	H.Y. acknowledges funding support from the Haythornthwaite Research Initiation Grant Award of ASME. M.L.G. acknowledges support from the US Fulbright Program.	BALLHAUS WF, 1974, PHYS FLUIDS, V17, P1068, DOI 10.1063/1.1694845; Ganzenmuller GC, 2011, SOFT MATTER, V7, P4307, DOI 10.1039/c0sm01296c; Guixa-Gonzalez R, 2014, BIOINFORMATICS, V30, P1478, DOI 10.1093/bioinformatics/btu037; Han WB, 2014, MAT SCI ENG C-MATER, V36, P49, DOI 10.1016/j.msec.2013.11.033; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung WC, 2007, BIOPHYS J, V92, P3960, DOI 10.1529/biophysj.106.099234; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kodama T, 2000, BIOPHYS J, V79, P1821, DOI 10.1016/S0006-3495(00)76432-0; Koshiyama K, 2008, BBA-BIOMEMBRANES, V1778, P1423, DOI 10.1016/j.bbamem.2008.03.010; Koshiyama K, 2006, BIOPHYS J, V91, P2198, DOI 10.1529/biophysj.105.077677; Koshiyama K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.018105; Kucerka N, 2005, J MEMBRANE BIOL, V208, P193, DOI 10.1007/s00232-005-7006-8; Lauer U, 1997, GENE THER, V4, P710, DOI 10.1038/sj.gt.3300462; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Rivera AL, 2014, PHYS LIFE REV, V11, P184, DOI 10.1016/j.plrev.2014.01.007; Rivera AL, 2012, PHYS LIFE REV, V9, P308, DOI 10.1016/j.plrev.2012.06.002; Li Y, 2013, P NATL ACAD SCI; Lu XM, 2017, APPL PHYS LETT, V110, DOI 10.1063/1.4973592; Ohl C. D., 2003, PHYS REV LETT, V90, P4; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Santo KP, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4862987; Sun DD, 2016, J PHYS CHEM C, V120, P18803, DOI 10.1021/acs.jpcc.6b04086; Yuan HY, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011905; Zhang L., 2017, SCI REP, V7, P1, DOI DOI 10.1038/S41598-016-0028-X	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212566	10.1371/journal.pone.0212566	http://dx.doi.org/10.1371/journal.pone.0212566			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789948	Green Submitted, Green Published, gold			2022-12-26	WOS:000459330800041
J	Kraen, M; Frantz, S; Nihlen, U; Engstrom, G; Lofdahl, CG; Wollmer, P; Dencker, M				Kraen, M.; Frantz, S.; Nihlen, U.; Engstrom, G.; Lofdahl, C. G.; Wollmer, P.; Dencker, M.			Matrix Metalloproteinases in COPD and atherosclerosis with emphasis on the effects of smoking	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MACROPHAGES; EXPRESSION; PLAQUES; MICE	Background Matrix metalloproteinases (MMP's) are known biomarkers of atherosclerosis. MMP's are also involved in the pathophysiological processes underlying chronic obstructive pulmonary disease (COPD). Cigarette smoking plays an important role in both disease states and is also known to affect the concentration and activity of MMP's systemically. Unfortunately, the epidemiological data concerning the value of MMP's as biomarkers of COPD and atherosclerosis with special regards to smoking habits are limited. Methods 450 middle-aged subjects with records of smoking habits and tobacco consumption were examined with comprehensive spirometry, carotid ultrasound examination and biomarker analysis of MMP-1, -3, -7, -10 and -12. Due to missing data 33 subjects were excluded. Results The remaining 417 participants were divided into 4 different groups. Group I (n = 157, no plaque and no COPD), group II (n = 136, plaque but no COPD), group III (n = 43, COPD but no plaque) and group IV (n = 81, plaque and COPD). Serum levels of MMP-1,-7,-10-12 were significantly influenced by smoking, and MMP-1, -3, -7 and-12 were elevated in subjects with COPD and carotid plaque. This remained statistically significant for MMP-1 and-12 after adjusting for traditional risk factors. Conclusion COPD and concomitant plaque in the carotid artery were associated with elevated levels of MMP-1 and -MMP-12 even when adjusting for risk factors. Further studies are needed to elucidate if these two MMP's could be useful as biomarkers in a clinical setting. Smoking was associated with increased serum levels of MMP's (except for MMP-3) and should be taken into account when interpreting serum MMP results.	[Kraen, M.; Frantz, S.; Wollmer, P.; Dencker, M.] Lund Univ, Dept Translat Med, Clin Physiol & Nucl Med Unit, Malmo, Sweden; [Nihlen, U.; Lofdahl, C. G.] Lund Univ, Dept Clin Sci, Resp Med & Allergol Unit, Lund, Sweden; [Engstrom, G.] Lund Univ, Dept Clin Sci, Cardiovasc Epidemiol Res Grp, Malmo, Sweden	Lund University; Lund University; Lund University	Kraen, M (corresponding author), Lund Univ, Dept Translat Med, Clin Physiol & Nucl Med Unit, Malmo, Sweden.	morten.kraen@skane.se	Wollmer, Per/S-5895-2019; Nihlén, Ulf/AAO-7145-2020	Frantz, Sophia/0000-0003-2147-2077	Lund University; Skane University Hospital; Region Skane	Lund University; Skane University Hospital; Region Skane	Financial support for this study was received from Lund University, Skane University Hospital and Region Skane. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support for this study was received from Lund University, Skane University Hospital and Region Skane.	Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Chaudhuri R, 2012, J ALLERGY CLIN IMMUN, V129, P655, DOI 10.1016/j.jaci.2011.12.996; Churg A, 2012, EUR RESPIR J, V39, P197, DOI 10.1183/09031936.00121611; COTES JE, 1993, EUR RESPIR J, V6, P41, DOI 10.1183/09041950.041s1693; Culpitt SV, 2005, RESP MED, V99, P703, DOI 10.1016/j.rmed.2004.10.022; D'Armiento JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056352; Davey A, 2011, EUR RESPIR J, V38, P959, DOI 10.1183/09031936.00032111; Frantz S, 2012, RESP MED, V106, P1116, DOI 10.1016/j.rmed.2012.04.010; Frantz S, 2012, CLIN PHYSIOL FUNCT I, V32, P120, DOI 10.1111/j.1475-097X.2011.01065.x; Gharib SA, 2018, MATRIX BIOL J INT SO; Goncalves I, 2015, ARTERIOSCL THROM VAS, V35, P1723, DOI 10.1161/ATVBAHA.115.305631; Huang B, 2016, ATHEROSCLEROSIS, V254, P52, DOI 10.1016/j.atherosclerosis.2016.09.014; Ilumets H, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-19; Imai K, 2001, AM J RESP CRIT CARE, V163, P786, DOI 10.1164/ajrccm.163.3.2001073; Johnson JL, 2005, P NATL ACAD SCI USA, V102, P15575, DOI 10.1073/pnas.0506201102; Lemaitre V, 2001, J CLIN INVEST, V107, P1227, DOI 10.1172/JCI9626; Loffek S, 2011, EUR RESPIR J, V38, P191, DOI 10.1183/09031936.00146510; Lundberg M, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr424; Luttun A, 2004, CIRCULATION, V109, P1408, DOI 10.1161/01.CIR.0000121728.14930.DE; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Mercer BA, 2009, AM J RESP CELL MOL, V40, P4, DOI 10.1165/rcmb.2007-0310OC; Morgan AR, 2004, STROKE, V35, P1310, DOI 10.1161/01.STR.0000126822.01756.99; Mullerova H, 2013, CHEST, V144, P1163, DOI 10.1378/chest.12-2847; Myasoedova VA, 2018, J MOL CELLULAR CARDI; Navratilova Z, 2016, ARCH IMMUNOL THER EX, V64, P177, DOI 10.1007/s00005-015-0375-5; Navratilova Z, 2012, RESPIROLOGY, V17, P1006, DOI 10.1111/j.1440-1843.2012.02197.x; Peeters SA, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0539-1; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Ruddy JM, 2016, J VASC RES, V53, P1, DOI 10.1159/000446703; Simpson JL, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/462934; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Wallace AM, 2008, COPD, V5, P13, DOI 10.1080/15412550701817789; Wollmer P, 2017, CLIN PHYSIOL FUNCT I, V37, P263, DOI 10.1111/cpf.12294	33	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211987	10.1371/journal.pone.0211987	http://dx.doi.org/10.1371/journal.pone.0211987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789935	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800015
J	Lev, S; Rupasinghe, T; Desmarini, D; Kaufman-Francis, K; Sorrell, TC; Roessner, U; Djordjevic, JT				Lev, Sophie; Rupasinghe, Thusitha; Desmarini, Desmarini; Kaufman-Francis, Keren; Sorrell, Tania Christine; Roessner, Ute; Djordjevic, Julianne Teresa			The PHO signaling pathway directs lipid remodeling in Cryptococcus neoformans via DGTS synthase to recycle phosphate during phosphate deficiency	PLOS ONE			English	Article							ACIDIC PHOSPHOLIPIDS; BETAINE LIPIDS; BIOSYNTHESIS; REPLACEMENT; GLYCOLIPIDS; PLANTS; PHOSPHATIDYLCHOLINE; ACCUMULATION; DEPRIVATION; ACQUISITION	The phosphate sensing and acquisition (PHO) pathway of Cryptococcus neoformans is essential for growth in phosphate-limiting conditions and for dissemination of infection in a mouse model. Its key transcription factor, Pho4, regulates expression of genes controlling the acquisition of phosphate from both external and cellular sources. One such gene, BTA1, is highly up-regulated during phosphate starvation. Given that a significant proportion of cellular phosphate is incorporated into phospholipids, and that the Pho4-dependent BTA1 gene encodes an enzyme predicted to catalyse production of a phosphorus-free betaine lipid, we investigated whether phospholipids provide an accessible reservoir of phosphate during phosphate deficiency. By comparing lipid profiles of phosphate-starved WT C. neoformans, PHO4 (pho4 Delta) and BTA1 (bta1 Delta) deletion mutants using thin layer chromatography and liquid chromatography mass spectrometry, we showed that phosphatidylcholine (PC) is substituted by the phosphorus-free betaine lipids diacylglyceryl-N,N,N-trimethylhomoserine (DGTS) and diacylgyceryl hydroxymethyl-N,N,N-trimethyl-beta-alanine (DGTA) in a Pho4- and Bta1-dependent manner, and that BTA1 encodes a functional DGTS synthase. Synthesis of DGTA tightly correlated with that of DGTS, consistent with DGTS being the precursor of DGTA. Similar to pho4 Delta bta1 Delta grew more slowly than WT in cell culture medium (RPMI) and was hypovirulent in a murine model of cryptococcosis. In contrast to pho4 Delta bta1 Delta tolerated alkaline pH and disseminated to the brain. Our results demonstrate that Bta1-dependent substitution of PC by betaine lipids is tightly regulated in C. neoformans by the PHO pathway, to conserve phosphate and preserve membrane integrity and function. This phospholipid remodeling strategy may also contribute to cryptococcal virulence during host infection.	[Lev, Sophie; Desmarini, Desmarini; Kaufman-Francis, Keren; Sorrell, Tania Christine; Djordjevic, Julianne Teresa] Westmead Inst Med Res, Fungal Pathogenesis Grp, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia; [Lev, Sophie; Kaufman-Francis, Keren; Sorrell, Tania Christine; Djordjevic, Julianne Teresa] Univ Sydney, Westmead Hosp, Sydney Med Sch Westmead, Westmead, NSW, Australia; [Lev, Sophie; Kaufman-Francis, Keren; Sorrell, Tania Christine; Djordjevic, Julianne Teresa] Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Rupasinghe, Thusitha; Roessner, Ute] Univ Melbourne, Sch Biosci, Metabol Australia, Melbourne, Vic, Australia	University of Sydney; Westmead Institute for Medical Research; University of Sydney; University of Sydney; University of Melbourne	Djordjevic, JT (corresponding author), Westmead Inst Med Res, Fungal Pathogenesis Grp, Ctr Infect Dis & Microbiol, Westmead, NSW, Australia.; Djordjevic, JT (corresponding author), Univ Sydney, Westmead Hosp, Sydney Med Sch Westmead, Westmead, NSW, Australia.; Djordjevic, JT (corresponding author), Univ Sydney, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.	julianne.djordjevic@sydney.edu.au	Sorrell, Tania/AAZ-5286-2020	Djordjevic, Julianne/0000-0003-4207-4115; Desmarini, Desmarini/0000-0001-9322-3198	National Health and Medical Research Council of Australia [APP1058779]; National Collaborative Research Infrastructure Strategy; Westmead Institute for Medical research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Collaborative Research Infrastructure Strategy(Australian GovernmentDepartment of Industry, Innovation and Science); Westmead Institute for Medical research(University of Sydney)	This work was supported by a National Health and Medical Research Council of Australia project grant APP1058779 (JTD, SL, TCS) and a grant from the National Collaborative Research Infrastructure Strategy (JTD). SL is supported by a Career Development Grant from the Westmead Institute for Medical research. TCS is a Payne-Scott Distinguished Professor of the University of Sydney and a Sydney Medical Foundation Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abida H, 2015, PLANT PHYSIOL, V167, P118, DOI 10.1104/pp.114.252395; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Banskota AH, 2013, J APPL PHYCOL, V25, P1513, DOI 10.1007/s10811-012-9967-1; Botte CY, 2013, P NATL ACAD SCI USA, V110, P7506, DOI 10.1073/pnas.1301251110; Dembitsky VM, 1996, PROG LIPID RES, V35, P1, DOI 10.1016/0163-7827(95)00009-7; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Gaude N, 2008, PLANT J, V56, P28, DOI 10.1111/j.1365-313X.2008.03582.x; Geske T, 2013, GLYCOBIOLOGY, V23, P69, DOI 10.1093/glycob/cws124; Hartel H, 2000, BIOCHEM SOC T, V28, P729, DOI 10.1042/BST0280729; Ikeh MAC, 2016, MOL BIOL CELL, V27, P2784, DOI 10.1091/mbc.E16-05-0266; Kalisch B, 2016, SUBCELL BIOCHEM, V86, P51, DOI 10.1007/978-3-319-25979-6_3; Kennedy EP, 1986, BIOSYNTHESIS PHOSPHO, P171; Klug RM, 2001, P NATL ACAD SCI USA, V98, P5910, DOI 10.1073/pnas.101037998; Kretschmer M, 2014, INFECT IMMUN, V82, P2697, DOI 10.1128/IAI.01607-14; Kunzler K, 1997, PHYTOCHEMISTRY, V46, P883, DOI 10.1016/S0031-9422(97)81274-5; Lev S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007021; Lev S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00381-16, 10.1128/msphere.00381-16]; Lev S, 2014, MBIO, V5, DOI 10.1128/mBio.01649-14; Marini NJ, 1996, EMBO J, V15, P3040, DOI 10.1002/j.1460-2075.1996.tb00667.x; MINNIKIN DE, 1974, NATURE, V249, P268, DOI 10.1038/249268a0; MINNIKIN DE, 1974, FEBS LETT, V43, P257, DOI 10.1016/0014-5793(74)80655-1; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Riekhof WR, 2014, EUKARYOT CELL, V13, P749, DOI 10.1128/EC.00004-14; Riekhof WR, 2005, EUKARYOT CELL, V4, P242, DOI 10.1128/EC.4.2.242-252.2005; Senik SV, 2015, PHYTOCHEMISTRY, V117, P34, DOI 10.1016/j.phytochem.2015.05.021; Singh A, 2017, J LIPID RES, V58, P2017, DOI [10.1194/jlr.M078600, 10.1194/jlr.m078600]; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Toh-e A, 2015, FUNGAL GENET BIOL, V80, P19, DOI 10.1016/j.fgb.2015.04.019; Tomar P, 2014, J BIOSCIENCES, V39, P525, DOI 10.1007/s12038-014-9435-y; VOGEL G, 1992, PLANT CELL PHYSIOL, V33, P427; Zavaleta-Pastor M, 2010, P NATL ACAD SCI USA, V107, P302, DOI 10.1073/pnas.0912930107; Zhang Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005485	32	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212651	10.1371/journal.pone.0212651	http://dx.doi.org/10.1371/journal.pone.0212651			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789965	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800047
J	Radoi, A; Poca, MA; Gandara, D; Castro, L; Cevallos, M; Pacios, ME; Sahuquillo, J				Radoi, Andreea; Poca, Maria A.; Gandara, Dario; Castro, Lidia; Cevallos, Mauricio; Pacios, Maria E.; Sahuquillo, Juan			The Sport Concussion Assessment Tool (SCAT2) for evaluating civilian mild traumatic brain injury. A pilot normative study	PLOS ONE			English	Article							WHITE-MATTER HYPERINTENSITIES; HEAD-INJURY; HOSPITAL ANXIETY; HIGH-SCHOOL; SYMPTOMS; QUESTIONNAIRE; PREVALENCE; CONSENSUS; RECOVERY; SAMPLE	Self-report measures, particularly symptom inventories, are critical tools for identifying patients with persistent post-concussion symptoms and their follow-up. Unlike in military or sports-related assessment, in general civilian settings pre-injury levels of concussion-like symptoms are lacking. Normative data are available in adolescent and college populations, but no reference data exist to guide clinical adult explorations. The purpose of this study was to use the second edition of the Sport Concussion Assessment Tool (SCAT2) to profile a cohort of 60 healthy community volunteers who had not sustained a head injury. Participating volunteers underwent MRI scanning and were evaluated with the Hospital Anxiety and Depression Scale (HADS). Participants reported a median of 3 concussion-like symptoms and the 97.5 percentile score was found at 10.5 symptoms, out of a total of 22. The median severity score was 4.9 points, and 28.9 was the upper limit of the reference interval. Only 10 participants (16.7%) did not endorse any symptom. The most frequently endorsed symptom was feeling difficulty in concentrating, with 41.7% of the sample reporting it. Age, sex and general distress, anxiety and depressive symptoms were not associated with concussion-like symptoms. Our data yielded elevated cut-offs scores for both the number of symptoms and the symptom severity. In conclusion, postconcussive-like symptoms are frequent in the general non-concussed adult population and it should be taken into account in any future models developed for screening patients at risk of developing physical, cognitive, and psychological complaints following mild traumatic injury.	[Radoi, Andreea; Poca, Maria A.; Castro, Lidia; Sahuquillo, Juan] Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain; [Radoi, Andreea; Poca, Maria A.; Castro, Lidia; Sahuquillo, Juan] Univ Autonoma Barcelona, Barcelona, Spain; [Poca, Maria A.; Gandara, Dario; Cevallos, Mauricio; Sahuquillo, Juan] Vall dHebron Univ Hosp, Dept Neurosurg, Barcelona, Spain; [Pacios, Maria E.] Vall dHebron Univ Hosp, Neurotraumatol Emergency Unit, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Hospital Universitari Vall d'Hebron	Radoi, A (corresponding author), Vall dHebron Res Inst VHIR, Neurotraumatol & Neurosurg Res Unit UNINN, Barcelona, Spain.; Radoi, A (corresponding author), Univ Autonoma Barcelona, Barcelona, Spain.	aradoi@neurotrauma.net	Rădoi, Andreea/N-5613-2019; Sahuquillo, Juan/B-3577-2008; Poca, Maria A./B-8475-2008; Sabatini, Darío Fabián Gándara/AAB-6699-2019	Rădoi, Andreea/0000-0002-0677-3544; Sahuquillo, Juan/0000-0003-0713-5875; Poca, Maria A./0000-0002-3831-0536; Sabatini, Darío Fabián Gándara/0000-0003-1303-9847	Generalitat de Catalunya [SGR 2014-844]; Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III) [FIS PI11/00700, FIS PI13/02397]; European Regional Development Fund (ERDF); Fundacio Institut de Recerca VHIR [PRED-VHIR-2012-26]	Generalitat de Catalunya(Generalitat de Catalunya); Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III)(Instituto de Salud Carlos III); European Regional Development Fund (ERDF)(European Commission); Fundacio Institut de Recerca VHIR	UNINN is supported by a Grant from the Generalitat de Catalunya (SGR 2014-844, http://agaur.gencat.cat). This work has been supported in part by the Fondo de Investigacion Sanitaria (Instituto de Salud Carlos III, https://portalfis.isciii.es) with grants FIS PI11/00700 (J.S.) and grant FIS PI13/02397 (M.A.P.), which were co-financed by the European Regional Development Fund (ERDF). A.R. was a recipient of a pre-doctoral grant from the Fundacio Institut de Recerca VHIR (PRED-VHIR-2012-26, http://en.vhir.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alla S, 2009, BRIT J SPORT MED, V43, pI3, DOI 10.1136/bjsm.2009.058339; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00010]; Asken BM, 2017, ARCH CLIN NEUROPSYCH, V32, P963, DOI 10.1093/arclin/acx018; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; BJELLAND I, 2002, J PSYCHOSOM RES, V0052; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Edmed SL, 2014, BRAIN INJURY, V28, P1277, DOI 10.3109/02699052.2014.915988; Evans WA, 1942, ARCH NEURO PSYCHIATR, V47, P931, DOI 10.1001/archneurpsyc.1942.02290060069004; FAZEKAS F, 1987, AM J NEURORADIOL, V8, P421; Garden N, 2010, APPL NEUROPSYCHOL, V17, P1, DOI 10.1080/09084280903297495; Hastie T, 2001, ELEMENTS STAT LEARNI, Vxvi; Horn PS, 2001, CLIN CHEM, V47, P2137; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Horn PS, 1998, CLIN CHEM, V44, P622; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V319, P1429, DOI 10.1001/jama.2018.1536; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korley FK, 2017, J NEUROTRAUM, V34, P1531, DOI 10.1089/neu.2016.4723; Kraus JF, 2014, BRAIN INJURY, V28, P1248, DOI 10.3109/02699052.2014.916420; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; Luoto TM, 2014, J NEUROTRAUM, V31, P728, DOI 10.1089/neu.2013.3174; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2009, J CLIN NEUROSCI, V16, P755, DOI [10.1016/j.jocn.2009.02.002, 10.4085/1062-6050-44.4.434]; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Rose SC, 2015, BRAIN INJURY, V29, P798, DOI 10.3109/02699052.2015.1004756; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Sharp David J, 2015, Pract Neurol, V15, P172, DOI 10.1136/practneurol-2015-001087; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P981, DOI 10.1076/jcen.24.8.981.8372; Thomas RE., 2016, BMJ OPEN SPORT EXERC, V2, DOI DOI 10.1136/BMJSEM-2015-000095; Vargo MM, 2016, PM&R, V8, P241, DOI 10.1016/j.pmrj.2015.07.006; Wang Y, 2006, ARCH CLIN NEUROPSYCH, V21, P339, DOI 10.1016/j.acn.2006.03.006; Wen W, 2009, HUM BRAIN MAPP, V30, P1155, DOI 10.1002/hbm.20586; World Health Organization, 2013, COUNTR PROF NUTR PHY; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmer A, 2015, APPL NEUROPSYCH-ADUL, V22, P132, DOI 10.1080/23279095.2013.867265	45	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212541	10.1371/journal.pone.0212541	http://dx.doi.org/10.1371/journal.pone.0212541			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785950	gold, Green Submitted, Green Published			2022-12-26	WOS:000459307000068
J	Cao, ZY; Xue, JH; Cheng, YN; Wang, JY; Liu, YJ; Li, H; Jiang, W; Li, G; Gui, YT; Zhang, XW				Cao, Zhengyi .; Xue, Junhui; Cheng, Yuning; Wang, Jiyin; Liu, Yujuan; Li, Hui; Jiang, Wei; Li, Gang; Gui, Yaoting; Zhang, Xiaowei			MDM2 promotes genome instability by ubiquitinating the transcription factor HBP1	ONCOGENE			English	Article							TUMOR-SUPPRESSOR PROTEIN; DNA-DAMAGE; CELL-CYCLE; EXPRESSION; DEGRADATION; GENE; OVEREXPRESSION; CANCER; APOPTOSIS; PATHWAY	Genome instability is a common feature of tumor cells, and the persistent presence of genome instability is a potential mechanism of tumorigenesis. The E3 ubiquitin ligase MDM2 is intimately involved in genome instability, but its mechanisms are unclear. Our data demonstrated that the transcription factor HBP1 is a target of MDM2. MDM2 facilitates HBP1 proteasomal degradation by ubiquitinating HBP1, regardless of p53 status, thus attenuating the transcriptional inhibition of HBP1 in the expression of its target genes, such as the DNA methyltransferase DNMT1 and histone methyltransferase EZH2, which results in global DNA hypermethylation and histone hypermethylation and ultimately genome instability. The repression of HBP1 by MDM2 finally promotes cell growth and tumorigenesis. Next, we thoroughly explored the regulatory mechanism of the MDM2/HBP1 axis in DNA damage repair following ionizing radiation. Our data indicated that MDM2 overexpression-mediated repression of HBP1 delays DNA damage repair and causes cell death in a p53-independent manner. This investigation elucidated the mechanism of how MDM2 promotes genome instability and enhances tumorigenesis in the absence of p53, thus providing a theoretical and experimental basis for targeting MDM2 as a cancer therapy.	[Cao, Zhengyi .; Xue, Junhui; Cheng, Yuning; Wang, Jiyin; Liu, Yujuan; Li, Hui; Jiang, Wei; Li, Gang; Zhang, Xiaowei] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol,Sch Basic Med Sci, Beijing Key Lab Prot Posttranslat Modificat & Cel, Beijing 100191, Peoples R China; [Gui, Yaoting] Hong Kong Univ Sci & Technol, Shenzhen Peking Univ, Peking Univ Shenzhen Hosp,Inst Urol,Med Ctr, Guangdong & Shenzhen Key Lab Male Reprod Med & Ge, Shenzhen 518000, Peoples R China	Peking University; Hong Kong University of Science & Technology; Peking University	Zhang, XW (corresponding author), Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol,Sch Basic Med Sci, Beijing Key Lab Prot Posttranslat Modificat & Cel, Beijing 100191, Peoples R China.	xiaoweizhang@bjmu.edu.cn	gui, yaoting/GLT-3684-2022; Cheng, Yuning/GSE-2360-2022	Cheng, Yuning/0000-0002-8171-8748	National Natural Science Foundation of China [81672717, 31471292, 81874141, 81572705]; Beijing Natural Science Foundation [5162013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by grants of the National Natural Science Foundation of China (No. 81672717, 31471292, 81874141, and 81572705) and Beijing Natural Science Foundation Grant (No. 5162013).	Alt JR, 2005, J BIOL CHEM, V280, P18771, DOI 10.1074/jbc.M413387200; Bartel F, 2002, CANCER CELL, V2, P9, DOI 10.1016/S1535-6108(02)00091-0; Berasi SP, 2004, MOL CELL BIOL, V24, P3011, DOI 10.1128/MCB.24.7.3011-3024.2004; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Carroll PE, 1999, ONCOGENE, V18, P1935, DOI 10.1038/sj.onc.1202515; Chen YF, 2016, J BIOL CHEM, V291, P12688, DOI 10.1074/jbc.M116.714147; Chene P, 2004, MOL CANCER RES, V2, P20; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CORDONCARDO C, 1994, CANCER RES, V54, P794; Deb Swati Palit, 2014, Subcell Biochem, V85, P215, DOI 10.1007/978-94-017-9211-0_12; Eischen CM, 2017, J MOL CELL BIOL, V9, P69, DOI 10.1093/jmcb/mjw052; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Escamilla-Powers JR, 2010, J BIOL CHEM, V285, P4847, DOI 10.1074/jbc.M109.074856; FAKHARZADEH SS, 1991, EMBO J, V10, P1565, DOI 10.1002/j.1460-2075.1991.tb07676.x; FINLAY CA, 1993, MOL CELL BIOL, V13, P301, DOI 10.1128/MCB.13.1.301; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Gartel AL, 1998, ONCOGENE, V17, P3463, DOI 10.1038/sj.onc.1202240; Iwasa H, 2013, J BIOL CHEM, V288, P30320, DOI 10.1074/jbc.M113.507384; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Jones SN, 1998, P NATL ACAD SCI USA, V95, P15608, DOI 10.1073/pnas.95.26.15608; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; Lehmann C, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0280-3; Lemercier C, 2000, MOL CELL BIOL, V20, P6627, DOI 10.1128/MCB.20.18.6627-6637.2000; Li H, 2010, ONCOGENE, V29, P5083, DOI 10.1038/onc.2010.252; Li Q, 2013, CLIN CANCER RES, V19, P34, DOI 10.1158/1078-0432.CCR-12-0053; Li YL, 2014, CANCER CELL, V26, P262, DOI 10.1016/j.ccr.2014.06.014; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; Lundgren K, 1997, GENE DEV, V11, P714, DOI 10.1101/gad.11.6.714; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Momand J, 1998, NUCLEIC ACIDS RES, V26, P3453, DOI 10.1093/nar/26.15.3453; Pan KW, 2013, MOL CELL BIOL, V33, P887, DOI 10.1128/MCB.00637-12; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Riley MF, 2016, ONCOGENE, V35, P358, DOI 10.1038/onc.2015.88; Saadatzadeh MR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102216; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Wang P, 2008, ONCOGENE, V27, P1590, DOI 10.1038/sj.onc.1210788; Wang P, 2006, ONCOGENE, V25, P3708, DOI 10.1038/sj.onc.1209411; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Wang SY, 2017, J BIOL CHEM, V292, P8207, DOI 10.1074/jbc.M116.768101; Watanabe T, 1996, LEUKEMIA LYMPHOMA, V21, P391, DOI 10.3109/10428199609093436; Wen W, 2014, ONCOGENE, V33, P421, DOI 10.1038/onc.2012.605; Wienken M, 2016, MOL CELL, V61, P68, DOI 10.1016/j.molcel.2015.12.008; Xiu M, 2003, MOL CELL BIOL, V23, P8890, DOI 10.1128/MCB.23.23.8890-8901.2003; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang JY, 2006, MOL CELL BIOL, V26, P7269, DOI 10.1128/MCB.00172-06; Yao CJ, 2005, LEUKEMIA, V19, P1958, DOI 10.1038/sj.leu.2403918; Yu JW, 2016, CELL PROLIFERAT, V49, P79, DOI 10.1111/cpr.12238; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zhao YJ, 2015, J MED CHEM, V58, P1038, DOI 10.1021/jm501092z; Zhou YL, 2018, CANCER BIOL THER, V19, P465, DOI 10.1080/15384047.2018.1433500	53	16	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4835	4855		10.1038/s41388-019-0761-2	http://dx.doi.org/10.1038/s41388-019-0761-2			21	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30816344	Green Published, hybrid			2022-12-26	WOS:000471160500013
J	Dang, SW; Zhou, JS; Chen, YJ; Chen, P; Ji, MJ; Shi, BY; Yang, Q; Hou, P				Dang, Siwen; Zhou, Jingshi; Chen, Yijun; Chen, Pu; Ji, Meiju; Shi, Bingyin; Yang, Qi; Hou, Peng			Dynamic expression of ZNF382 and its tumor-suppressor role in hepatitis B virus-related hepatocellular carcinogenesis	ONCOGENE			English	Article							MAJOR SIGNALING PATHWAYS; X-PROTEIN; PROGNOSTIC-SIGNIFICANCE; CANCER STATISTICS; THYROID-CANCER; C-JUN; METHYLATION; GENE; ACTIVATION; GENOME	Hepatitis B virus (HBV) infection is the primary cause of hepatocellular carcinoma (HCC). Zinc-finger protein 382 (ZNF382), which belongs to zinc-finger protein family, has been documented to be downregulated in certain types of cancer. However, its role in HCC remains largely unknown. In this study, we demonstrated that ZNF382 expression was significantly elevated in HBV-infected liver cirrhosis tissues relative to HBV-negative normal liver tissues at protein levels, but not at mRNA levels, and was positively correlated with the levels of HBV DNA and hepatitis B virus X protein (HBx). Further studies revealed that ZNF382 was a target of miR-6867, and HBx promoted the translation of ZNF382 during HBV chronic infection through Erk-mediated miR-6867 inhibition. In addition, our data showed that ZNF382 was frequently downregulated by promoter methylation in HBV-related HCCs relative to HBV-infected liver cirrhosis tissues, and decreased expression of ZNF382 was strongly correlated with poor survival in early-stage HCC patients. Functional studies demonstrated that ZNF382 was a potent tumor suppressor in HCC cells through inhibiting cell proliferation, colony formation, migration, invasion, and tumorigenic potential in nude mice, and inducing cell apoptosis. Mechanistically, ZNF382 exerted its tumor-suppressor functions in HCC through transcriptionally repressing its downstream targets such as Fos proto-oncogene (FOS), Jun proto-oncogene (JUN), disheveled segment polarity protein 2 (DVL2), and frizzled class receptor 1 (FZD1), thereby impairing the activities of activating protein 1 (AP-1) and Wnt/beta-catenin pathways and activating p53 signaling. Altogether, our data show that ZNF382 acts as a tumor suppressor, and is co-regulated by HBx and epigenetic mechanism in HBV-related hepatocellular carcinogenesis.	[Dang, Siwen; Chen, Yijun; Chen, Pu; Shi, Bingyin; Yang, Qi; Hou, Peng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Key Lab Tumor Precis Med Shaanxi Prov, Xian 710061, Shaanxi, Peoples R China; [Dang, Siwen; Chen, Yijun; Chen, Pu; Shi, Bingyin; Yang, Qi; Hou, Peng] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710061, Shaanxi, Peoples R China; [Zhou, Jingshi] Fourth Mil Med Univ, Xijing Hosp, Dept Hepatobiliary Surg, Xian 710032, Shaanxi, Peoples R China; [Ji, Meiju] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, Xian 710061, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Air Force Military Medical University; Xi'an Jiaotong University	Yang, Q; Hou, P (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Key Lab Tumor Precis Med Shaanxi Prov, Xian 710061, Shaanxi, Peoples R China.; Yang, Q; Hou, P (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Endocrinol, Xian 710061, Shaanxi, Peoples R China.	docqiyang@163.com; phou@xjtu.edu.cn			National Nature Science Foundation of China [81402340, 81572627, 81672645]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Nature Science Foundation of China (no. 81402340, 81572627, and 81672645).	ANTUNOVIC J, 1993, CELL MOL BIOL RES, V39, P463; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Arzumanyan A, 2012, CANCER RES, V72, P5912, DOI 10.1158/0008-5472.CAN-12-2329; BENN J, 1994, P NATL ACAD SCI USA, V91, P10350, DOI 10.1073/pnas.91.22.10350; Berindan-Neagoe I, 2014, CA-CANCER J CLIN, V64, P311, DOI 10.3322/caac.21244; Bui-Nguyen TM, 2010, ONCOGENE, V29, P1179, DOI 10.1038/onc.2009.404; Calvisi DF, 2007, J CLIN INVEST, V117, P2713, DOI 10.1172/JCI31457; Chan SL, 2016, J CLIN ONCOL, V34, P83, DOI 10.1200/JCO.2015.61.5724; Chen JL, 2014, MOL THER, V22, P303, DOI 10.1038/mt.2013.212; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Cheng YD, 2010, CANCER RES, V70, P6516, DOI 10.1158/0008-5472.CAN-09-4566; Chiu CM, 2007, P NATL ACAD SCI USA, V104, P2571, DOI 10.1073/pnas.0609498104; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; KEKULE AS, 1993, NATURE, V361, P742, DOI 10.1038/361742a0; Kim DJ, 2014, J CLIN ONCOL, V32, P745, DOI 10.1200/JCO.2013.49.9525; Li YJ, 2018, CANCER RES, V78, P5216, DOI 10.1158/0008-5472.CAN-18-0003; Lim SO, 2008, GASTROENTEROLOGY, V135, P2128, DOI 10.1053/j.gastro.2008.07.027; Liu ZJ, 2014, CLIN CANCER RES, V20, P4598, DOI 10.1158/1078-0432.CCR-13-3380; Luo KM, 2002, BIOCHEM BIOPH RES CO, V299, P606, DOI 10.1016/S0006-291X(02)02700-6; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Muthukrishnan D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10027; Neuveut C, 2010, J HEPATOL, V52, P594, DOI 10.1016/j.jhep.2009.10.033; Nishida N, 2012, HEPATOLOGY, V56, P994, DOI 10.1002/hep.25706; Niu YD, 2017, HEPATOLOGY, V65, P893, DOI 10.1002/hep.28924; Qiang W, 2014, J CLIN ENDOCR METAB, V99, pE1163, DOI 10.1210/jc.2013-3729; Qiu X, 2013, ONCOGENE, V32, P3296, DOI 10.1038/onc.2013.150; Revill K, 2013, GASTROENTEROLOGY, V145, P1424, DOI 10.1053/j.gastro.2013.08.055; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Shan CL, 2010, CELL RES, V20, P563, DOI 10.1038/cr.2010.49; Shi J, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.346; Shi J, 2015, ONCOTARGET, V6, P14344, DOI 10.18632/oncotarget.3852; Shi J, 2012, INT J MOL SCI, V13, P4714, DOI 10.3390/ijms13044714; Shi J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-50; Shi J, 2012, AM J CANCER RES, V2, P116; Shin YJ, 2013, CANCER BIOL THER, V14, P213, DOI 10.4161/cbt.23292; Song K, 2013, HEPATOLOGY, V58, P1681, DOI 10.1002/hep.26514; Sun HL, 2016, CANCER CELL, V30, P723, DOI 10.1016/j.ccell.2016.10.001; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Wang C, 2012, HEPATOLOGY, V55, P108, DOI 10.1002/hep.24675; Wang D, 2014, AM J CANCER RES, V4, P725; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265; Ye H, 2014, ONCOGENE, V33, P5133, DOI 10.1038/onc.2013.468; Zhang C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0604-z; Zhang T, 2012, HEPATOLOGY, V56, P2051, DOI 10.1002/hep.25899; Zhou SJ, 2017, CELL DEATH DIFFER, V24, P1577, DOI 10.1038/cdd.2017.87	48	24	24	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4804	4819		10.1038/s41388-019-0759-9	http://dx.doi.org/10.1038/s41388-019-0759-9			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30804458				2022-12-26	WOS:000471160500011
J	Kim, HK; Garcia, AB; Siu, E; Tilstam, P; Das, R; Roberts, S; Leng, L; Bucala, R				Kim, Hee Kyung; Garcia, Alvaro Baeza; Siu, Edwin; Tilstam, Pathricia; Das, Rita; Roberts, Scott; Leng, Lin; Bucala, Richard			Macrophage migration inhibitory factor regulates innate gamma delta T-cell responses via IL-17 expression	FASEB JOURNAL			English	Article						MIF; TSST-1; M; bovis	SHOCK-SYNDROME TOXIN-1; FACTOR GENE; FACTOR MIF; LISTERIA-MONOCYTOGENES; CRITICAL MEDIATOR; PRIMARY INFECTION; DISEASE SEVERITY; IMMUNE-RESPONSE; PROTECTIVE ROLE; ALPHA-BETA	T cells expressing invariant gamma delta antigen receptors (gamma delta T cells) bridge innate and adaptive immunity and facilitate barrier responses to pathogens. Macrophage migration inhibitory factor (MIF) is an upstream mediator of host defense that up-regulates the expression of pattern recognition receptors and sustains inflammatory responses by inhibiting activation-induced apoptosis in monocytes and macrophages. Surprisingly, Mif(-/-) gamma delta T cells, when compared with wild type, were observed to produce >10-fold higher levels of the proinflammatory cytokine IL-17 after stimulation with gram-positive exotoxins. High-IL-17 expression was associated with the characteristic features of IL-17-producing gamma delta T (gamma delta 17) cells, including expression of IL-23R, IL-1R1, and the transcription factors ROR gamma t and Sox13. In the gram-positive model of shock mediated by toxic shock syndrome toxin (TSST-1), Mif(-/-) mice succumbed to death more quickly with increased pulmonary neutrophil accumulation and higher production of cytokines, including IL-1 beta and IL-23. Mif(-/-) gamma delta T cells also produced high levels of IL-17 in response to Mycobacterium lipomannan, and depletion of gamma delta T cells improved survival from acutely lethal Mycobacterium infection or TSST-1 administration. These data indicate that MIF deficiency is associated with a compensatory amplification of gamma delta 17 cell responses, with implications for innate immunity and IL-17-mediated pathology in situations such as gram-positive toxic shock or Mycobacterium infection.-Kim, H. K., Garcia, A. B., Siu, E., Tilstam, P., Das, R., Roberts, S., Leng, L., Bucala, R. Macrophage migration inhibitory factor regulates innate gamma delta T-cell responses via IL-17 expression.	[Kim, Hee Kyung; Garcia, Alvaro Baeza; Siu, Edwin; Tilstam, Pathricia; Das, Rita; Roberts, Scott; Leng, Lin] Yale Sch Med, Dept Med, New Haven, CT USA; [Das, Rita; Bucala, Richard] Yale Sch Med, Dept Pathol, New Haven, CT USA	Yale University; Yale University	Bucala, R (corresponding author), Yale Univ, Sch Med, TAC S521,POB 208031,300 Cedar St, New Haven, CT 06520 USA.	richard.bucala@yale.edu	Garcia, Alvaro Baeza/AAB-7387-2021	Garcia, Alvaro Baeza/0000-0001-6032-7847; Leng, Lin/0000-0002-0605-358X; Siu, Edwin/0000-0003-1046-2279	U.S. National Institutes of Health (NIH) [AR049610, HL130669]; Arthritis Foundation [548970]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049610] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health (NIH) Grants AR049610 (National Institute of Arthritis and Musculoskeletal and Skin Diseases) and HL130669 (National Heart, Lung, and Blood Institute) and Arthritis Foundation Grant 548970. The authors declare no conflicts of interest.	Akitsu A, 2018, IMMUNOLOGY, V155, P418, DOI 10.1111/imm.12993; Avau A, 2014, ARTHRITIS RHEUMATOL, V66, P1340, DOI 10.1002/art.38359; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; Benedek G, 2017, P NATL ACAD SCI USA, V114, pE8421, DOI 10.1073/pnas.1712288114; Bezdek S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02262; Bozza M, 1999, J EXP MED, V189, P341, DOI 10.1084/jem.189.2.341; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Calandra T, 1998, P NATL ACAD SCI USA, V95, P11383, DOI 10.1073/pnas.95.19.11383; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Das R, 2013, P NATL ACAD SCI USA, V110, pE2997, DOI 10.1073/pnas.1301128110; De Benedetti F, 2003, ARTHRITIS RHEUM, V48, P1398, DOI 10.1002/art.10882; Dieli F, 2003, J IMMUNOL, V170, P463, DOI 10.4049/jimmunol.170.1.463; Doernberg S, 2011, CYTOKINE, V53, P292, DOI 10.1016/j.cyto.2010.12.010; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; Donnelly SC, 1997, NAT MED, V3, P320, DOI 10.1038/nm0397-320; Eberl M, 2002, IMMUNOLOGY, V106, P200, DOI 10.1046/j.1365-2567.2002.01414.x; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Flores M, 2008, FASEB J, V22, P3661, DOI 10.1096/fj.08-111666; Floret D, 2001, ARCH PEDIATRIE, V8, p70S; Fogli LK, 2013, J IMMUNOL, V191, P3100, DOI 10.4049/jimmunol.1301360; Fox RJ, 2018, NEW ENGL J MED, V379, P846, DOI 10.1056/NEJMoa1803583; HIROMATSU K, 1992, J EXP MED, V175, P49, DOI 10.1084/jem.175.1.49; Hirota K, 2007, J EXP MED, V204, P41, DOI 10.1084/jem.20062259; IKEJIMA T, 1988, J INFECT DIS, V158, P1017, DOI 10.1093/infdis/158.5.1017; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kessel C, 2017, ARTHRITIS RHEUMATOL, V69, P1480, DOI 10.1002/art.40099; Kevill KA, 2008, J IMMUNOL, V180, P601, DOI 10.4049/jimmunol.180.1.601; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P975, DOI 10.1002/art.20885; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; LEE J, 1995, J IMMUNOL, V155, P2158; Lockhart E, 2006, J IMMUNOL, V177, P4662, DOI 10.4049/jimmunol.177.7.4662; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; McGill JL, 2014, J IMMUNOL, V192, P2756, DOI 10.4049/jimmunol.1302567; Melichar HJ, 2007, SCIENCE, V315, P230, DOI 10.1126/science.1135344; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Ness-Schwickerath KJ, 2011, CELL MOL LIFE SCI, V68, P2371, DOI 10.1007/s00018-011-0700-z; Nigrovic PA, 2014, ARTHRITIS RHEUMATOL, V66, P1405, DOI 10.1002/art.38615; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; PARSONNET J, 1985, J INFECT DIS, V151, P514, DOI 10.1093/infdis/151.3.514; Radstake TRDJ, 2005, ARTHRITIS RHEUM, V52, P3020, DOI 10.1002/art.21285; Renner P, 2012, FASEB J, V26, P907, DOI 10.1096/fj.11-195065; Satoskar AR, 2001, INFECT IMMUN, V69, P906, DOI 10.1128/IAI.69.2.906-911.2001; Savva A, 2016, P NATL ACAD SCI USA, V113, P3597, DOI 10.1073/pnas.1520727113; Shibata K, 2007, J IMMUNOL, V178, P4466, DOI 10.4049/jimmunol.178.7.4466; Sreih A, 2011, ARTHRITIS RHEUM-US, V63, P3942, DOI 10.1002/art.30624; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; UCHIYAMA T, 1986, MICROBIOL IMMUNOL, V30, P469, DOI 10.1111/j.1348-0421.1986.tb02973.x; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; USAMI J, 1995, IMMUNOLOGY, V86, P199; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yende S, 2009, FASEB J, V23, P2403, DOI 10.1096/fj.09-129445; YOO ZB, 1995, J IMMUNOL, V155, P5483; Yoshida YO, 2010, J IMMUNOL, V184, P4414, DOI 10.4049/jimmunol.0903332; Zachariadis O, 2006, INFECT IMMUN, V74, P1837, DOI 10.1128/IAI.74.3.1837-1845.2006	62	5	8	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6919	6932		10.1096/fj.201802433R	http://dx.doi.org/10.1096/fj.201802433R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30817226	Green Published			2022-12-26	WOS:000476114200020
J	Li, XF; Yu, XJ; Chen, XB; Liu, ZZ; Wang, GQ; Li, C; Wong, EYM; Sham, MH; Tang, J; He, JF; Xiong, W; Liu, ZY; Huang, PB				Li, Xiaofen; Yu, Xiaojie; Chen, Xibing; Liu, Zhengzhao; Wang, Guangqin; Li, Chao; Wong, Elaine Y. M.; Sham, Mai Har; Tang, Jie; He, Jufang; Xiong, Wei; Liu, Zhiyong; Huang, Pingbo			Localization of TMC1 and LHFPL5 in auditory hair cells in neonatal and adult mice	FASEB JOURNAL			English	Article						mechanotransduction channel; mechanotransduction complex; tip link; stereocilia; hearing	MECHANOTRANSDUCTION MACHINERY; ESSENTIAL COMPONENT; INNER; PROTOCADHERIN-15; DEAFNESS; CHANNEL; MUTATIONS; DOMINANT; COMPLEX; PROTEIN	The channel that governs mechanotransduction (MT) by hair cells in the inner ear has been investigated intensively for 4 decades, but its precise molecular composition remains enigmatic. Transmembrane channel-like protein 1 (TMC1) was recently identified as a component of the MT channel, and lipoma HMGIC fusion partner-like 5 (LHFPL5) is considered to be part of the MT complex and may functionally couple the tip link to the MT channel. As components of the MT complex, TMC1 and LHFPL5 are expected to localize at the lower end of the tip link in hair cells, a notion generally supported by previous studies on neonatal mice. However, the localization of these 2 proteins, particularly in the hair cells of adult mice, remains incompletely elucidated. Because determination of TMC1 and LHFPL5 localization at distinct developmental stages is essential for understanding their function and regulation, we used several approaches to examine the localization of these proteins in neonatal and adult hair cells in the mouse. We report several notable findings: 1) TMC1 and LHFPL5 predominantly localize at the tip of the shorter rows of stereocilia in neonatal hair cells, which largely verifies the previously published findings in neonatal hair cells; 2) LHFPL5 persists in the hair bundle of hair cells after postnatal day (P)7, which clarifies the previously reported unexpected absence of LHFPL5 after P7 and supports the view that LHFPL5 is a permanent component in the MT complex; and 3) TMC1 and LHFPL5 remain at the tip of the shorter rows of stereocilia in adult outer hair cells, but in adult inner hair cells, TMC1 is uniformly distributed in both the tallest row and the shorter rows of stereocilia, whereas LHFPL5 is uniformly distributed in the shorter rows of stereocilia. These findings raise intriguing questions regarding the turnover rate, regulation, additional functions, and functional interaction of TMC1 and LHFPL5. Our study confirms the previous findings in neonatal hair cells and reveals several previously unidentified aspects of TMC1 and LHFPL5 localization in more mature hair cells.-Li, X., Yu, X., Chen, X., Liu, Z., Wang, G., Li, C., Wong, E. Y. M., Sham, M. H., Tang, J., He, J., Xiong, W., Liu, Z., Huang, P. Localization of TMC1 and LHFPL5 in auditory hair cells in neonatal and adult mice.	[Li, Xiaofen; Huang, Pingbo] HKUST, Dept Chem & Biol Engn, Hong Kong, Peoples R China; [Yu, Xiaojie; Chen, Xibing; Liu, Zhengzhao; Huang, Pingbo] HKUST, Div Life Sci, Hong Kong, Peoples R China; [Huang, Pingbo] HKUST, State Key Lab Mol Neurosci, Hong Kong, Peoples R China; [Huang, Pingbo] HKUST, Shenzhen Res Inst, Hong Kong, Peoples R China; [Wang, Guangqin; Li, Chao; Liu, Zhiyong] Chinese Acad Sci, Inst Neurosci, Shanghai, Peoples R China; [Wong, Elaine Y. M.; Sham, Mai Har] Univ Hong Kong, Li Ka Shing Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China; [Wong, Elaine Y. M.] Ear Sci Inst Australia, Subiaco, WA, Australia; [Tang, Jie] Southern Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [He, Jufang] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Xiong, Wei] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Chinese Academy of Sciences; University of Hong Kong; Ear Science Institute Australia; Southern Medical University - China; City University of Hong Kong; Tsinghua University	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Kowloon, Clear Water Bay, Hong Kong, Peoples R China.	bohuangp@ust.hk	Xiong, Wei/AAY-5944-2020; Tang, Jie/GNW-2318-2022; Sham, Mai Har/AAX-3781-2020; Liu, Zheng-Zhao/ADR-0038-2022; yu, xiaojie/GSI-9676-2022	Xiong, Wei/0000-0002-2784-7696; Sham, Mai Har/0000-0003-1179-7839; Liu, Zheng-Zhao/0000-0003-0659-2775; WANG, GUANGQIN/0000-0002-8613-7619; Huang, Pingbo/0000-0002-4560-8760; Li, Xiaofen/0000-0002-2079-9038; Tang, Jie/0000-0001-7882-4462	Hong Kong Research Grants Council [GRF16111616, GRF16102417]; Innovation and Technology Commission [ITCPD/17-9]; Chinese Major National Science and Technology Project [2017YFA0103900/2017YFA0103901]; National Natural Science Foundation of China [81771012, 31571080, 3181101148]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Innovation and Technology Commission; Chinese Major National Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Hong Kong Research Grants Council (GRF16111616 and GRF16102417 to P.H.); in part, by the Innovation and Technology Commission (ITCPD/17-9); by the Chinese Major National Science and Technology Project 2017YFA0103900/2017YFA0103901 (to Zhiyong Liu); and by the National Natural Science Foundation of China (Grants 81771012 to Zhiyong Liu, and 31571080, and 3181101148 to W.X.). The authors declare no conflicts of interest.	Adato A, 2005, HUM MOL GENET, V14, P3921, DOI 10.1093/hmg/ddi416; Ahmed ZM, 2006, J NEUROSCI, V26, P7022, DOI 10.1523/JNEUROSCI.1163-06.2006; Beurg M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04589-8; Beurg M, 2015, P NATL ACAD SCI USA, V112, P1589, DOI 10.1073/pnas.1420906112; Beurg M, 2009, NAT NEUROSCI, V12, P553, DOI 10.1038/nn.2295; Fang J, 2012, GENESIS, V50, P124, DOI 10.1002/dvg.20810; Giese APJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00061-1; Goodyear RJ, 2005, J COMP NEUROL, V485, P75, DOI 10.1002/cne.20513; Grillet N, 2009, NEURON, V62, P375, DOI 10.1016/j.neuron.2009.04.006; Hu WB, 2017, ELIFE, V6, DOI 10.7554/eLife.28021; Hughes AJ, 2014, NAT METHODS, V11, P749, DOI [10.1038/NMETH.2992, 10.1038/nmeth.2992]; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kim KX, 2013, J GEN PHYSIOL, V141, P141, DOI 10.1085/jgp.201210913; Kurima K, 2002, NAT GENET, V30, P277, DOI 10.1038/ng842; Kurima K, 2015, CELL REP, V12, P1606, DOI 10.1016/j.celrep.2015.07.058; Li C, 2018, HEARING RES, V364, P12, DOI 10.1016/j.heares.2018.04.006; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Liu ZY, 2015, SCIENCE, V350, P317, DOI 10.1126/science.aad1886; Longo-Guess CM, 2007, MAMM GENOME, V18, P646, DOI 10.1007/s00335-007-9049-x; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mahendrasingam S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185285; Marcotti W, 2006, J PHYSIOL-LONDON, V574, P677, DOI 10.1113/jphysiol.2005.095661; Michel V, 2017, EMBO MOL MED, V9, P1711, DOI 10.15252/emmm.201708087; Pan BF, 2018, NEURON, V99, P736, DOI 10.1016/j.neuron.2018.07.033; Pan BF, 2013, NEURON, V79, P504, DOI 10.1016/j.neuron.2013.06.019; Pepermans E, 2014, EMBO MOL MED, V6, P984, DOI 10.15252/emmm.201403976; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Senften M, 2006, J NEUROSCI, V26, P2060, DOI 10.1523/JNEUROSCI.4251-05.2006; Vreugde S, 2002, NAT GENET, V30, P257, DOI 10.1038/ng848; Xiong W, 2012, CELL, V151, P1283, DOI 10.1016/j.cell.2012.10.041; Zhao B, 2014, NEURON, V84, P954, DOI 10.1016/j.neuron.2014.10.041	32	11	11	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6838	6851		10.1096/fj.201802155RR	http://dx.doi.org/10.1096/fj.201802155RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30808210				2022-12-26	WOS:000476114200014
J	Zhang, F; Zhang, CX; Xu, XX; Zhang, YX; Gong, X; Yang, ZQ; Zhang, H; Tang, DF; Liang, SP; Liu, ZH				Zhang, Fan; Zhang, Changxin; Xu, Xunxun; Zhang, Yunxiao; Gong, Xue; Yang, Zuqin; Zhang, Heng; Tang, Dongfang; Liang, Songping; Liu, Zhonghua			Naja atra venom peptide reduces pain by selectively blocking the voltage-gated sodium channel Nav1.8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						voltage-dependent anion channel (VDAC); pain; animal model; peptides; electrophysiology; Nav1; 8; snake venom; three-finger peptide; selectivity; neuropathic pain; analgesic	LOW CYTOTOXIC ACTIVITY; AMINO-ACID-SEQUENCE; COBRA CARDIOTOXIN; NEUROPATHIC PAIN; NA(V)1.8; MODEL; INTEGRIN; BINDING; PROTEIN; IDENTIFICATION	The voltage-gated sodium channel Nav1.8 is preferentially expressed in peripheral nociceptive neurons and contributes to inflammatory and neuropathic pain. Therefore, Nav1.8 has emerged as one of the most promising analgesic targets for pain relief. Using large-scale screening of various animal-derived toxins and venoms for Nav1.8 inhibitors, here we identified -EPTX-Na1a, a 62-residue three-finger peptide from the venom of the Chinese cobra (Naja atra), as a potent inhibitor of Nav1.8, exhibiting high selectivity over other voltage-gated sodium channel subtypes. Using whole-cell voltage-clamp recordings, we observed that purified -EPTX-Na1a blocked the Nav1.8 current. This blockade was associated with a depolarizing shift of activation and repolarizing shift of inactivation, a mechanism distinct from that of any other gating modifier toxin identified to date. In rodent models of inflammatory and neuropathic pain, -EPTX-Na1a alleviated nociceptive behaviors more potently than did morphine, indicating that -EPTX-Na1a has a potent analgesic effect. -EPTX-Na1a displayed no evident cytotoxicity and cardiotoxicity and produced no obvious adverse responses in mice even at a dose 30-fold higher than that producing a significant analgesic effect. Our study establishes -EPTX-Na1a as a promising lead for the development of Nav1.8-targeting analgesics to manage pain.	[Zhang, Fan; Zhang, Changxin; Xu, Xunxun; Zhang, Yunxiao; Gong, Xue; Yang, Zuqin; Zhang, Heng; Tang, Dongfang; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Coll Life Sci, Changsha 410081, Hunan, Peoples R China	Hunan Normal University	Liang, SP; Liu, ZH (corresponding author), Hunan Normal Univ, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Coll Life Sci, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; liuzh@hunnu.edu.cn			National Science Foundation [31570782]; Science Fund for Distinguished Young Scholars of Hunan Province [14JJ1018]	National Science Foundation(National Science Foundation (NSF)); Science Fund for Distinguished Young Scholars of Hunan Province(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by National Science Foundation Project 31570782, the Science Fund for Distinguished Young Scholars of Hunan Province under Grant 14JJ1018. The authors declare that they have no conflicts of interest with the contents of this article.	Bennett DLH, 2014, LANCET NEUROL, V13, P587, DOI 10.1016/S1474-4422(14)70024-9; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Bierhaus A, 2012, NAT MED, V18, P926, DOI 10.1038/nm.2750; Blasius AL, 2011, P NATL ACAD SCI USA, V108, P19413, DOI 10.1073/pnas.1117020108; Bradman MJG, 2015, J NEUROSCI METH, V255, P92, DOI 10.1016/j.jneumeth.2015.08.010; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Doherty KR, 2015, TOXICOL APPL PHARM, V285, P51, DOI 10.1016/j.taap.2015.03.008; Ekberg J, 2006, P NATL ACAD SCI USA, V103, P17030, DOI 10.1073/pnas.0601819103; Erdemli G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00006; Fischer M, 2014, PAIN, V155, P511, DOI 10.1016/j.pain.2013.11.015; Gold MS, 2003, J NEUROSCI, V23, P158; Gong S, 2015, TOXICON, V93, P31, DOI 10.1016/j.toxicon.2014.11.222; Han CY, 2016, NEUROLOGY, V86, P473, DOI 10.1212/WNL.0000000000002333; Han CY, 2015, J NEUROPHYSIOL, V113, P3172, DOI 10.1152/jn.00113.2015; Han ZL, 2015, EUR J PHARMACOL, V754, P58, DOI 10.1016/j.ejphar.2015.02.019; Hoeijmakers JGJ, 2015, NEUROSCI LETT, V596, P51, DOI 10.1016/j.neulet.2014.12.056; Huang C.-F., 2012, INT J ANTENN PROPAG, V2012, P2012, DOI DOI 10.1155/2012/364741; INOUE S, 1987, FEBS LETT, V218, P17, DOI 10.1016/0014-5793(87)81009-8; Jarvis MF, 2007, P NATL ACAD SCI USA, V104, P8520, DOI 10.1073/pnas.0611364104; Kamiya K, 2008, J PHARMACOL SCI, V108, P301, DOI 10.1254/jphs.08102FP; King GF, 2008, TOXICON, V52, P264, DOI 10.1016/j.toxicon.2008.05.020; Kini RM, 2013, TOXICON, V62, P1, DOI 10.1016/j.toxicon.2012.09.002; Le Bars D, 2001, PHARMACOL REV, V53, P597; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Maingret F, 2008, J GEN PHYSIOL, V131, P211, DOI 10.1085/jgp.200709935; McCleary RJR, 2013, TOXICON, V62, P56, DOI 10.1016/j.toxicon.2012.09.008; McNamara CR, 2007, P NATL ACAD SCI USA, V104, P13525, DOI 10.1073/pnas.0705924104; Mechaly I, 2005, NEUROSCIENCE, V130, P389, DOI 10.1016/j.neuroscience.2004.09.034; Nogueira-Neto FD, 2008, PHARMACOL BIOCHEM BE, V91, P252, DOI 10.1016/j.pbb.2008.08.016; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Payne CE, 2015, BRIT J PHARMACOL, V172, P2654, DOI 10.1111/bph.13092; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; Rowe AH, 2013, SCIENCE, V342, P441, DOI 10.1126/science.1236451; Scanio MJC, 2010, BIOORGAN MED CHEM, V18, P7816, DOI 10.1016/j.bmc.2010.09.057; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Seo JA, 2016, CANCER LETT, V371, P30, DOI 10.1016/j.canlet.2015.11.021; Shewell LK, 2014, P NATL ACAD SCI USA, V111, pE5312, DOI 10.1073/pnas.1412703111; TAKECHI M, 1985, BIOCHEM INT, V11, P795; Tang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09241; Thakor DK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-14; Wang CH, 2006, J BIOL CHEM, V281, P656, DOI 10.1074/jbc.M507880200; Wang WJ, 2008, BIOCHEM BIOPH RES CO, V369, P753, DOI 10.1016/j.bbrc.2008.02.091; Wang WJ, 2010, BRIT J PHARMACOL, V160, P1338, DOI 10.1111/j.1476-5381.2010.00781.x; Wu PL, 2006, J BIOL CHEM, V281, P7937, DOI 10.1074/jbc.M513035200; Xiao XC, 2003, EUR J PHARMACOL, V477, P1, DOI 10.1016/S0014-2999(03)02190-3	49	11	13	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 3	2019	294	18					7324	7334		10.1074/jbc.RA118.007370	http://dx.doi.org/10.1074/jbc.RA118.007370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PT	30804211	hybrid, Green Published			2022-12-26	WOS:000468402900020
J	Kienzl, P; Polacek, R; Reithofer, M; Reitermaier, R; Hagenbach, P; Tajpara, PA; Vierhapper, M; Gschwandtner, M; Mildner, M; Jahn-Schmid, B; Elbe-Burger, A				Kienzl, Philip; Polacek, Romana; Reithofer, Manuel; Reitermaier, Rene; Hagenbach, Pia; Tajpara, Pooj A.; Vierhapper, Martin; Gschwandtner, Maria; Mildner, Michael; Jahn-Schmid, Beatrice; Elbe-Buerger, Adelheid			The cytokine environment influence on human skin-derived T cells	FASEB JOURNAL			English	Article						T-cell plasticity; IL-9; neutrophil; IL-8; CXCL13	TRANSCRIPTION FACTOR PU.1; TGF-BETA; T(H)9 CELLS; MAST-CELLS; IL-9; EXPRESSION; DIFFERENTIATION; RECEPTOR; INTERLEUKIN-4; LYMPHOCYTES	Skin resident T cells provide immediate immunologic responses at their specific location and play a role in the pathogenesis of skin diseases such as psoriasis. Recently, IL-9-producing T cells were described as a major T-cell subtype present in the skin, but knowledge on the biology and in situ regulation of this T-cell subtype is scarce. Here, we investigated the cytokine influence on skin T cells with focus on IL-9-producing T cells because a better understanding of their biology may identify novel therapeutic approaches. Healthy human skin biopsies were cultured either in the presence of IL-2, IL-4, and TGF- [T helper (T-h)9-promoting condition (T(h)9-PC)] or IL-2 and IL-15 [standard condition (SC)]. Paired analysis of enzymatically isolated skin T cells and emigrated T cells after 4 wk of skin culture showed significant alterations of T-cell phenotypes, cytokine production, and IL-9-producing T-cell frequency. RNA sequencing analysis revealed differentially regulated pathways and identified CXCL8 and CXCL13 as top up-regulated genes in T(h)9-PC compared with SC. Functionally supernatant of stimulated skin-derived T cells, CXCL8 and CXCL13 increased neutrophil survival. We report that the cytokine environment alters skin-derived T-cell phenotype and functional properties.Kienzl, P., Polacek, R., Reithofer, M., Reitermaier, R., Hagenbach, P., Tajpara, P., Vierhapper, M., Gschwandtner, M., Mildner, M. Jahn-Schmid, B., Elbe-Burger, A. The cytokine environment influence on human skin-derived T cells.	[Kienzl, Philip; Polacek, Romana; Reitermaier, Rene; Hagenbach, Pia; Tajpara, Pooj A.; Elbe-Buerger, Adelheid] Med Univ Vienna, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria; [Reithofer, Manuel; Jahn-Schmid, Beatrice] Med Univ Vienna, Inst Pathophysiol & Allergy Res, Vienna, Austria; [Vierhapper, Martin] Med Univ Vienna, Div Plast & Reconstruct Surg, Dept Surg, Vienna, Austria; [Gschwandtner, Maria; Mildner, Michael] Med Univ Vienna, Res Div Biol & Pathobiol Skin, Dept Dermatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Elbe-Burger, A (corresponding author), Med Univ Vienna, Dept Dermatol, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	adelheid.elbe-buerger@meduniwien.ac.at		Mildner, Michael/0000-0002-6892-925X; Lazki-Hagenbach, Pia/0000-0003-0521-7981; Kienzl, Philip/0000-0002-0114-6904; Reithofer, Manuel/0000-0003-2845-1826	Austrian Science Fund (FWK) [DK W1248-B30]	Austrian Science Fund (FWK)	The authors thank Wolfgang Bauer, Barbel Reininger, Johanna Strobl, Christopher Schuster (Medical University of Vienna), and Robert Sabat (University Hospital Charite, Berlin, Germany) for excellent help and valuable discussions and for providing reagents. The authors thank Rachel Clark, Jessica E. Teague (Harvard University, Boston, MA, USA), and Emmanuella Guenova (University of Zurich, Zurich, Switzerland) for the skin explant protocols. The authors thank Christian Schneeberger and Iveta Yotova (Medical Univerity of Vienna) for access to the BD FacsVerse instrument. RNA sequencing was carried out by Markus Jeitler and Martin Bilban (Medical University of Vienna). The authors also thank Barbara Bohle and Dominika Polak (Medical University of Vienna) for the human blood neutrophil isolation protocol. This work was supported by the Austrian Science Fund (FWF; DK W1248-B30). The authors declare no conflicts of interest.	Aratani Y, 2018, ARCH BIOCHEM BIOPHYS, V640, P47, DOI 10.1016/j.abb.2018.01.004; Bang K, 2005, EXP DERMATOL, V14, P391, DOI 10.1111/j.0906-6705.2005.00294.x; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; BOS JD, 1986, IMMUNOL TODAY, V7, P235, DOI 10.1016/0167-5699(86)90111-8; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Cheng GZ, 2008, CURR CANCER DRUG TAR, V8, P2; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Clark RA, 2017, SEMIN IMMUNOPATHOL, V39, P47, DOI 10.1007/s00281-016-0607-8; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Dienz O, 2009, CLIN IMMUNOL, V130, P27, DOI 10.1016/j.clim.2008.08.018; El Kebir D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00060; Erwig LP, 2016, NAT REV MICROBIOL, V14, P163, DOI 10.1038/nrmicro.2015.21; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gerlach K, 2014, NAT IMMUNOL, V15, P676, DOI 10.1038/ni.2920; GEROSA F, 1992, CELL IMMUNOL, V141, P342, DOI 10.1016/0008-8749(92)90153-G; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Gschwandtner M, 2018, J INVEST DERMATOL, V138, P1318, DOI 10.1016/j.jid.2018.01.002; Guo S, 2014, CELL DEATH DIFFER, V21, P888, DOI 10.1038/cdd.2014.9; Hebel K, 2011, J IMMUNOL, V187, P5627, DOI 10.4049/jimmunol.1003998; Hirahara K, 2013, J ALLERGY CLIN IMMUN, V131, P1276, DOI 10.1016/j.jaci.2013.03.015; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Humblin E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01070-w; Jabeen R, 2012, CURR OPIN IMMUNOL, V24, P303, DOI 10.1016/j.coi.2012.02.001; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Kaplan MH, 2017, SEMIN IMMUNOPATHOL, V39, P11, DOI 10.1007/s00281-016-0600-2; Kieffer JD, 2001, BIOCHEM BIOPH RES CO, V285, P577, DOI 10.1006/bbrc.2001.5230; Liao W, 2008, NAT IMMUNOL, V9, P1288, DOI 10.1038/ni.1656; Licona-Limon P, 2013, IMMUNITY, V39, P744, DOI 10.1016/j.immuni.2013.07.020; Liu J, 2014, J INVEST DERMATOL, V134, P1903, DOI 10.1038/jid.2014.61; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Michalak-Stoma A, 2011, EUR CYTOKINE NETW, V22, P160, DOI 10.1684/ecn.2011.0294; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622; Netea MG, 2008, NAT REV MICROBIOL, V6, P67, DOI 10.1038/nrmicro1815; Norii M, 2006, ACTA MED OKAYAMA, V60, P149; PARTRIDGE M, 1989, BRIT J CANCER, V60, P542, DOI 10.1038/bjc.1989.310; Perlroth J, 2007, MED MYCOL, V45, P321, DOI 10.1080/13693780701218689; Polak D, 2019, J ALLERGY CLIN IMMUN, V143, P1143, DOI 10.1016/j.jaci.2018.06.005; Purwar R, 2012, NAT MED, V18, P1248, DOI 10.1038/nm.2856; Rincon M, 1997, J EXP MED, V185, P461, DOI 10.1084/jem.185.3.461; Rodriguez RS, 2014, J CLIN INVEST, V124, P1027, DOI 10.1172/JCI72932; Romagnani S, 1999, INFLAMM BOWEL DIS, V5, P285, DOI 10.1097/00054725-199911000-00009; Salgado FJ, 2002, IMMUNOL CELL BIOL, V80, P138, DOI 10.1046/j.1440-1711.2002.01055.x; Salimi M, 2016, CLIN EXP DERMATOL, V41, P552, DOI 10.1111/ced.12802; Schlapbach C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007828; SCHMITT E, 1994, J IMMUNOL, V153, P3989; Schuster C, 2009, J EXP MED, V206, P169, DOI 10.1084/jem.20081747; Stassen M, 2001, J IMMUNOL, V166, P4391, DOI 10.4049/jimmunol.166.7.4391; Stassen M, 2000, J IMMUNOL, V164, P5549, DOI 10.4049/jimmunol.164.11.5549; Stassen M, 2007, MOL IMMUNOL, V44, P926, DOI 10.1016/j.molimm.2006.03.019; STREILEIN JW, 1983, J INVEST DERMATOL, V80, pS12, DOI 10.1111/1523-1747.ep12536743; Takagi R, 2008, J IMMUNOL, V181, P186, DOI 10.4049/jimmunol.181.1.186; Teague TK, 1997, J IMMUNOL, V158, P5791; van der Graaf CAA, 2006, CLIN VACCINE IMMUNOL, V13, P423, DOI 10.1128/CVI.13.3.423-425.2006; Vieyra-Garcia PA, 2016, CLIN CANCER RES, V22, P3328, DOI 10.1158/1078-0432.CCR-15-1784; Wang DH, 2004, J IMMUNOL, V172, P214, DOI 10.4049/jimmunol.172.1.214; Watanabe R, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010302; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Wong MT, 2010, IMMUNOL CELL BIOL, V88, P624, DOI 10.1038/icb.2010.53; Yoshie O, 2015, INT IMMUNOL, V27, P11, DOI 10.1093/intimm/dxu079; Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010	65	3	4	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6514	6525		10.1096/fj.201801416R	http://dx.doi.org/10.1096/fj.201801416R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807238	hybrid, Green Published			2022-12-26	WOS:000466932600055
J	Wang, M; Hu, J; Yan, LL; Yang, YP; He, M; Wu, M; Li, Q; Gong, W; Yang, Y; Wang, Y; Handy, DE; Lu, B; Hao, CM; Wang, QH; Li, YM; Hu, RG; Stanton, RC; Zhang, ZY				Wang, Meng; Hu, Ji; Yan, Linling; Yang, Yeping; He, Min; Wu, Meng; Li, Qin; Gong, Wei; Yang, Yang; Wang, Yi; Handy, Diane E.; Lu, Bin; Hao, Chuanming; Wang, Qinghua; Li, Yiming; Hu, Ronggui; Stanton, Robert C.; Zhang, Zhaoyun			High glucose-induced ubiquitination of G6PD leads to the injury of podocytes	FASEB JOURNAL			English	Article						diabetic kidney disease; G6PD; reactive oxygen species; ubiquitin proteasome pathway; von Hippel-Lindau	CAPILLARY ENDOTHELIAL FENESTRATION; INCREASED OXIDATIVE STRESS; PENTOSE-PHOSPHATE PATHWAY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE ACTIVITY; DIABETIC-NEPHROPATHY; INSULIN-RESISTANCE; KIDNEY-DISEASE; GROWTH-FACTOR; OVEREXPRESSION; PROTEIN	Oxidative stress contributes substantially to podocyte injury, which plays an important role in the development of diabetic kidney disease. The mechanism of hyperglycemia-induced oxidative stress in podocytes is not fully understood. Glucose-6-phosphate dehydrogenase (G6PD) is critical in maintaining NADPH, which is an important cofactor for the antioxidant system. Here, we hypothesized that high glucose induced ubiquitination and degradation of G6PD, which injured podocytes by reactive oxygen species (ROS) accumulation. We found that G6PD protein expression was decreased in kidneys of both diabetic patients and diabetic rodents. G6PD activity was also reduced in diabetic mice. Overexpressing G6PD reversed redox imbalance and podocyte apoptosis induced by high glucose and palmitate. Inhibition of G6PD with small interfering RNA induced podocyte apoptosis. In kidneys of G6PD-deficient mice, podocyte apoptosis was significantly increased. Interestingly, high glucose had no effect on G6PD mRNA expression. Decreased G6PD protein expression was mediated by the ubiquitin proteasome pathway. We found that the von Hippel-Lindau (VHL) protein, an E3 ubiquitin ligase subunit, directly bound to G6PD and degraded G6PD through ubiquitylating G6PD on K-366 and K-403. In summary, our data suggest that high glucose induces ubiquitination of G6PD by VHL E3 ubiquitin ligase, which leads to ROS accumulation and podocyte injury.Wang, M., Hu, J., Yan, L., Yang, Y., He, M., Wu, M., Li, Q., Gong, W., Yang, Y., Wang, Y., Handy, D. E., Lu, B., Hao, C., Wang, Q., Li, Y., Hu, R., Stanton, R. C., Zhang, Z. High glucose-induced ubiquitination of G6PD leads to the injury of podocytes.	[Wang, Meng; Yang, Yeping; He, Min; Gong, Wei; Wang, Yi; Lu, Bin; Wang, Qinghua; Li, Yiming; Zhang, Zhaoyun] Fudan Univ, Div Endocrinol & Metab, Shanghai, Peoples R China; [Hao, Chuanming] Fudan Univ, Div Nephrol, Huashan Hosp, Shanghai, Peoples R China; [Hu, Ji; Wu, Meng] Soochow Univ, Affiliated Hosp 2, Dept Endocrinol, Suzhou, Peoples R China; [Yan, Linling] First Peoples Hosp Taicang, Dept Endocrinol, Suzhou, Peoples R China; [Li, Qin] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Yang, Yang; Hu, Ronggui] Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Handy, Diane E.] Harvard Med Sch, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Stanton, Robert C.] Harvard Med Sch, Res Div, Joslin Diabet Ctr, Boston, MA 02115 USA; [Li, Yiming] St Michaels Hosp, Keenan Res Ctr Biomed Sci, Div Endocrinol & Metab, Toronto, ON, Canada	Fudan University; Fudan University; Soochow University - China; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Zhang, ZY (corresponding author), Fudan Univ, Huashan Hosp, Dept Endocrinol & Metab, 12 Wulumuqi Zhong Rd, Shanghai 200040, Peoples R China.	zhaoyunzhang@fudan.edu.cn	Stanton, Robert C/AAG-7584-2020; Wang, Qinghua/GVT-3252-2022	Stanton, Robert C/0000-0002-3056-1277; Handy, Diane/0000-0002-4310-8527	National Natural Science Foundation of China [81370938, 81471041, 81400796]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Zhihong Yang at the Joslin Diabetes Center for supplying podocytes. The authors thank Min Zhang (Huashan Hospital) for cell culturing guidance. The authors thank Wei Huang (Fudan University) for helpful comments with the manuscript. The authors also acknowledge the excellent support from all members of R.H.'s laboratory. This study was supported by the National Natural Science Foundation of China (Grants 81370938, 81471041, and 81400796). The authors declare no conflicts of interest.	Anderson K, 2011, J BIOL CHEM, V286, P42027, DOI 10.1074/jbc.M111.303222; Arias-Gonzalez L, 2013, NEOPLASIA, V15, P649, DOI 10.1593/neo.121896; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Chen JC, 2015, J AM SOC NEPHROL, V26, P1115, DOI 10.1681/ASN.2014020192; Chen JX, 2015, CELL SIGNAL, V27, P2314, DOI 10.1016/j.cellsig.2015.08.011; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Damjanovic SS, 2016, EXP MOL PATHOL, V101, P323, DOI 10.1016/j.yexmp.2016.11.003; Diaz-Flores M, 2006, LIFE SCI, V78, P2601, DOI 10.1016/j.lfs.2005.10.022; Ding M, 2013, AM J PHYSIOL-RENAL, V304, pF120, DOI 10.1152/ajprenal.00416.2012; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gupte RS, 2009, FREE RADICAL BIO MED, V47, P219, DOI 10.1016/j.freeradbiomed.2009.01.028; Gurley SB, 2010, AM J PHYSIOL-RENAL, V298, pF788, DOI 10.1152/ajprenal.90515.2008; Hartner A, 2014, BBA-MOL BASIS DIS, V1842, P558, DOI 10.1016/j.bbadis.2014.01.001; Jiang XS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42764; Johnson SA, 2015, AM J PHYSIOL-RENAL, V309, pE807, DOI 10.1152/ajprenal.00266.2015; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirkman HN, 1999, J BIOL CHEM, V274, P13908, DOI 10.1074/jbc.274.20.13908; Kitada M, 2016, INT J NEPHROL RENOV, V9, P279, DOI 10.2147/IJNRD.S103784; Kumar PA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00151; Kuo WY, 1998, FREE RADICAL BIO MED, V24, P1130, DOI 10.1016/S0891-5849(97)00413-9; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lee JW, 2011, ENDOCRINOLOGY, V152, P793, DOI 10.1210/en.2010-0606; Leopold JA, 2003, J BIOL CHEM, V278, P32100, DOI 10.1074/jbc.M301293200; Leopold JA, 2003, ARTERIOSCL THROM VAS, V23, P411, DOI 10.1161/01.ATV.0000056744.26901.BA; Li CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089233; Lin JS, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0735-5; Liu WJ, 2016, KIDNEY INT, V90, P1023, DOI 10.1016/j.kint.2016.06.018; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Mahmood DFD, 2013, ANTIOXID REDOX SIGN, V19, P1266, DOI 10.1089/ars.2012.4757; Mima A, 2012, FASEB J, V26, P2963, DOI 10.1096/fj.11-202994; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Park J, 2005, MOL CELL BIOL, V25, P5146, DOI 10.1128/MCB.25.12.5146-5157.2005; Park J, 2006, DIABETES, V55, P2939, DOI 10.2337/db05-1570; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; Puri S, 2009, DIABETES, V58, P433, DOI 10.2337/db08-0749; Rao XJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9468; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Scarpa A, 2017, NATURE, V543, P65, DOI 10.1038/nature21063; Siddiqi FS, 2016, J AM SOC NEPHROL, V27, P2021, DOI 10.1681/ASN.2014090898; Stanton RC, 2011, CURR DIABETES REP, V11, P330, DOI 10.1007/s11892-011-0196-9; Sun J, 2017, BIOCHEM BIOPH RES CO, V483, P318, DOI 10.1016/j.bbrc.2016.12.145; Tao RK, 2017, NAT METHODS, V14, P720, DOI 10.1038/nmeth.4306; Thilo F, 2014, BIOCHEM BIOPH RES CO, V450, P312, DOI 10.1016/j.bbrc.2014.05.116; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Toyoda M, 2007, DIABETES, V56, P2155, DOI 10.2337/db07-0019; Udeshi ND, 2013, MOL CELL PROTEOMICS, V12, P825, DOI 10.1074/mcp.O112.027094; Wang YP, 2014, EMBO J, V33, P1304, DOI 10.1002/embj.201387224; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Xu J, 2012, CELL STRESS CHAPERON, V17, P485, DOI 10.1007/s12192-012-0325-7; Xu YZ, 2010, FASEB J, V24, P609, DOI 10.1096/fj.09-135731; Xu YZ, 2005, AM J PHYSIOL-RENAL, V289, pF1040, DOI 10.1152/ajprenal.00076.2005; YOSHIMOTO K, 1983, J BIOL CHEM, V258, P2355; Zehetner J, 2008, GENE DEV, V22, P3135, DOI 10.1101/gad.496908; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064601, 10.1371/journal.pone.0071243, 10.1371/journal.pone.0067564]; Zhang ZY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049128; Zhang ZY, 2010, FASEB J, V24, P1497, DOI 10.1096/fj.09-136572; Zhou LS, 2016, EMBO REP, V17, P811, DOI 10.15252/embr.201541643	63	20	22	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6296	6310		10.1096/fj.201801921R	http://dx.doi.org/10.1096/fj.201801921R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30785802	Bronze			2022-12-26	WOS:000466932600039
J	O'Connor, CM; Hoffa, MT; Taylor, SE; Avelar, RA; Narla, G				O'Connor, Caitlin M.; Hoffa, Matthew T.; Taylor, Sarah E.; Avelar, Rita A.; Narla, Goutham			Protein phosphatase 2A A regulates A protein expression and stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein phosphatase 2 (PP2A); protein phosphatase; cancer biology; cell signaling; tumor suppressor gene; protein expression; PR65A; PR65B; PPP2R1A; PPP2R1B; interactome	11Q DELETIONS; PP2A COMPLEXES; A-ALPHA; SUBUNIT; LUNG; IDENTIFICATION; MUTATIONS	Protein phosphatase 2A (PP2A) represses many oncogenic signaling pathways and is an important tumor suppressor. PP2A comprises three distinct subunits and forms through a highly regulated biogenesis process, with the scaffolding A subunit existing as two highly related isoforms, A and A. PP2A's tumor-suppressive functions have been intensely studied, and PP2A inactivation has been shown to be a prerequisite for tumor formation. Interestingly, although partial loss of the A isoform is growth promoting, complete A loss has no transformative properties. Additionally, in cancer patients, A is found to be inactivated in a haploinsufficient manner. Using both cellular and in vivo systems, colorectal and endometrial cancer cell lines, and biochemical and cellular assays, here we examined why the complete loss of A does not promote tumorigenesis. CRISPR/Cas9-mediated homozygous A deletion resulted in decreased colony formation and tumor growth across multiple cell lines. Protein expression analysis of PP2A family members revealed that the A deletion markedly up-regulates A protein expression by increasing A protein stability. A knockdown in control and A knockout cell lines indicated that A is necessary for cell survival in the A knockout cells. In the setting of A deficiency, co-immunoprecipitation analysis revealed increased binding of specific PP2A regulatory subunits to A, and knockdown of these regulatory subunits restored colony-forming ability. Taken together, our results uncover a mechanism by which PP2A A regulates A protein stability and activity and suggests why homozygous loss of A is rarely seen in cancer patients.	[O'Connor, Caitlin M.; Narla, Goutham] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Hoffa, Matthew T.] Univ Michigan, Div Med Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Taylor, Sarah E.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Avelar, Rita A.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Case Western Reserve University; University of Michigan System; University of Michigan; Case Western Reserve University; University of Michigan System; University of Michigan	Narla, G (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	gnarla@med.umich.edu	O'Connor, Caitlin M./AAC-5203-2020; Narla, Goutham/AAZ-5710-2020	O'Connor, Caitlin M./0000-0002-7840-6399; Narla, Goutham/0000-0003-4098-4203; Taylor, Sarah/0000-0003-2743-8099	National Cancer Institute, National Institutes of Health [R01 CA181654, T32 GM008803, F30 CA224979]; NATIONAL CANCER INSTITUTE [F30CA224979, R01CA181654, R01CA240993] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR002549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250, T32GM008803] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Cancer Institute, National Institutes of Health Grants R01 CA181654 (to G. N.), T32 GM008803 (to C. M. O.), and F30 CA224979 (to S. E. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chen HG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007019; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Dohner H, 1997, BLOOD, V89, P2516, DOI 10.1182/blood.V89.7.2516; Grinthal A, 2010, P NATL ACAD SCI USA, V107, P2467, DOI 10.1073/pnas.0914073107; Haesen D, 2016, CANCER RES, V76, P5719, DOI 10.1158/0008-5472.CAN-15-3342; HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002; KELDYSH PL, 1993, GENE CHROMOSOME CANC, V6, P45, DOI 10.1002/gcc.2870060109; Lange L, 2017, BIOL OPEN, V6, P752, DOI 10.1242/bio.023200; Little SC, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5876; Liu J, 2012, CURR MOL MED, V12, P982, DOI 10.2174/156652412802480916; Oberg EA, 2012, J BIOL CHEM, V287, P43378, DOI 10.1074/jbc.M112.420281; Petzmann S, 2004, VIRCHOWS ARCH, V445, P151, DOI 10.1007/s00428-004-1052-y; Petzmann S, 2001, HUM PATHOL, V32, P333, DOI 10.1053/hupa.2001.22762; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Ruediger R, 2011, MOL CELL BIOL, V31, P3832, DOI 10.1128/MCB.05744-11; Ruvolo PP, 2016, BBA CLIN, V6, P87, DOI 10.1016/j.bbacli.2016.08.002; Sablina AA, 2007, CELL, V129, P969, DOI 10.1016/j.cell.2007.03.047; Sablina AA, 2010, CANCER RES, V70, P10474, DOI 10.1158/0008-5472.CAN-10-2855; Sablina AA, 2007, CELL ADHES MIGR, V1, P140, DOI 10.4161/cam.1.3.4986; Sangodkar J, 2016, FEBS J, V283, P1004, DOI 10.1111/febs.13573; Shih IM, 2011, AM J PATHOL, V178, P1442, DOI 10.1016/j.ajpath.2011.01.009; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Walch AK, 1998, AM J PATHOL, V153, P1089, DOI 10.1016/S0002-9440(10)65653-2; Wiemann S, 2016, NAT METHODS, V13, P191, DOI 10.1038/nmeth.3776; Xiao G, 2018, CELL, V173, P470, DOI 10.1016/j.cell.2018.02.048; Zhou J, 2003, BIOCHEM J, V369, P387, DOI 10.1042/BJ20021244	27	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5923	5934		10.1074/jbc.RA119.007593	http://dx.doi.org/10.1074/jbc.RA119.007593			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30796164	Green Published, hybrid			2022-12-26	WOS:000465077500024
J	Tang, K; Li, YJ; Yu, C; Wei, ZY				Tang, Kun; Li, Yujie; Yu, Cong; Wei, Zhiyi			Structural mechanism for versatile cargo recognition by the yeast class V myosin Myo2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						myosin; intracellular trafficking; protein-protein interaction; protein complex; mitochondrial transport; peroxisome; structural biology; X-ray crystallography; cargo binding domain; enzyme evolution; Myo2p; MyoVa; organelle transport	KINESIN-RELATED PROTEIN; GLOBULAR TAIL; MITOCHONDRIAL INHERITANCE; UNCONVENTIONAL MYOSIN; POLARIZED GROWTH; BINDING; DOMAIN; REGIONS; ASSOCIATION; CONTRIBUTE	Class V myosins are actin-dependent motors, which recognize numerous cellular cargos mainly via the C-terminal globular tail domain (GTD). Myo2, a yeast class V myosin, can transport a broad range of organelles. However, little is known about the capacity of Myo2-GTD to recognize such a diverse array of cargos specifically at the molecular level. Here, we solved crystal structures of Myo2-GTD (at 1.9-3.1 resolutions) in complex with three cargo adaptor proteins: Smy1 (for polarization of secretory vesicles), Inp2 (for peroxisome transport), and Mmr1 (for mitochondria transport). The structures of Smy1- and Inp2-bound Myo2-GTD, along with site-directed mutagenesis experiments, revealed a binding site in subdomain-I having a hydrophobic groove with high flexibility enabling Myo2-GTD to accommodate different protein sequences. The Myo2-GTD-Mmr1 complex structure confirmed and complemented a previously identified mitochondrion/vacuole-specific binding region. Moreover, differences between the conformations and locations of cargo-binding sites identified here for Myo2 and those reported for mammalian MyoVA (MyoVA) suggest that class V myosins potentially have co-evolved with their specific cargos. Our structural and biochemical analysis not only uncovers a molecular mechanism that explains the diverse cargo recognition by Myo2-GTD, but also provides structural information useful for future functional studies of class V myosins in cargo transport.	[Tang, Kun; Li, Yujie; Yu, Cong; Wei, Zhiyi] Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China; [Yu, Cong] Shenzhen Key Lab Cell Microenvironm, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [Wei, Zhiyi] SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology	Tang, K; Wei, ZY (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen 518055, Peoples R China.; Wei, ZY (corresponding author), SUSTech, Neural & Cognit Sci Res Ctr, Shenzhen, Peoples R China.	tangk@sustc.edu.cn; weizy@sustc.edu.cn	Li, YuJie/HGT-8657-2022; Wei, Zhiyi/C-4315-2014; Tang, Kun/GSD-3218-2022; Li, yu/HHZ-5236-2022; Wei, Zhiyi/N-9995-2019; , 余聪/AAK-9457-2020	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; 	National Natural Science Foundation of China [31770791, 31570741, 31600612, 31870757]; Natural Science Foundation of Guangdong Province [2016A030312016]; Science and Technology Planning Project of Guangdong Province [2017B030301018]; Shenzhen Science and Technology Innovation Commission [JCYJ20160229153100269, ZDSYS20140509142721429]; Recruitment Program of Global Youth Experts of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Shenzhen Science and Technology Innovation Commission; Recruitment Program of Global Youth Experts of China	This work was supported by the National Natural Science Foundation of China Grants 31770791 and 31570741 (to Z. W.), 31600612 (to K. T.), and 31870757 (to C. Y.), Natural Science Foundation of Guangdong Province Grant 2016A030312016, Science and Technology Planning Project of Guangdong Province Grant 2017B030301018, Shenzhen Science and Technology Innovation Commission Grants JCYJ20160229153100269 and ZDSYS20140509142721429, and the Recruitment Program of Global Youth Experts of China (to Z. W. and C. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beningo KA, 2000, MOL BIOL CELL, V11, P691, DOI 10.1091/mbc.11.2.691; Casavola EC, 2008, MOL MICROBIOL, V67, P1051, DOI 10.1111/j.1365-2958.2008.06106.x; Catlett NL, 2000, J CELL BIOL, V150, P513, DOI 10.1083/jcb.150.3.513; Chen WT, 2018, MOL BIOL CELL, V29, P2346, DOI 10.1091/mbc.E18-02-0122; CHENEY RE, 1993, CELL, V75, P13, DOI 10.1016/0092-8674(93)90675-G; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Donovan KW, 2015, J CELL BIOL, V209, P359, DOI 10.1083/jcb.201411010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eskin JA, 2016, MOL BIOL CELL, V27, P828, DOI 10.1091/mbc.E15-09-0639; Eves PT, 2012, J CELL BIOL, V198, P69, DOI 10.1083/jcb.201201024; Fagarasanu A, 2007, CURR OPIN MICROBIOL, V10, P528, DOI 10.1016/j.mib.2007.10.002; Fagarasanu A, 2006, DEV CELL, V10, P587, DOI 10.1016/j.devcel.2006.04.012; Fagarasanu A, 2009, J CELL BIOL, V186, P541, DOI 10.1083/jcb.200904050; Frederick RL, 2008, GENETICS, V178, P825, DOI 10.1534/genetics.107.083055; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Heuck A, 2007, P NATL ACAD SCI USA, V104, P19778, DOI 10.1073/pnas.0706780104; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Higuchi-Sanabria R, 2016, MOL BIOL CELL, V27, P776, DOI 10.1091/mbc.E15-07-0455; Hodges AR, 2009, CURR BIOL, V19, P2121, DOI 10.1016/j.cub.2009.10.069; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Ishikawa K, 2003, J CELL BIOL, V160, P887, DOI 10.1083/jcb.200210139; Itoh T, 2004, EMBO J, V23, P2520, DOI 10.1038/sj.emboj.7600271; Jin Y, 2011, DEV CELL, V21, P1156, DOI 10.1016/j.devcel.2011.10.009; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar S, 2018, J CELL SCI, V131, DOI 10.1242/jcs.207522; LILLIE SH, 1992, NATURE, V356, P358, DOI 10.1038/356358a0; LILLIE SH, 1994, J CELL BIOL, V125, P825, DOI 10.1083/jcb.125.4.825; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lwin KM, 2016, MOL BIOL CELL, V27, P2450, DOI 10.1091/mbc.E16-03-0185; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pashkova N, 2005, J CELL BIOL, V168, P359, DOI 10.1083/jcb.200407146; Pruyne D, 2004, ANNU REV CELL DEV BI, V20, P559, DOI 10.1146/annurev.cellbio.20.010403.103108; Pylypenko O, 2016, ELIFE, V5, DOI [10.7554/eLife.17523, 10.7554/elife.17523]; Pylypenko O, 2013, P NATL ACAD SCI USA, V110, P20443, DOI 10.1073/pnas.1314329110; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; Seabra MC, 2004, TRAFFIC, V5, P393, DOI 10.1111/j.1398-9219.2004.00190.x; Swayne TC, 2011, CURR BIOL, V21, P1994, DOI 10.1016/j.cub.2011.10.019; Tang FS, 2003, NATURE, V422, P87, DOI 10.1038/nature01453; Trybus KM, 2008, CELL MOL LIFE SCI, V65, P1378, DOI 10.1007/s00018-008-7507-6; Wei ZY, 2013, P NATL ACAD SCI USA, V110, P11314, DOI 10.1073/pnas.1306768110; Zhang WB, 2016, J BIOL CHEM, V291, P13571, DOI 10.1074/jbc.M116.724328	43	7	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5896	5906		10.1074/jbc.RA119.007550	http://dx.doi.org/10.1074/jbc.RA119.007550			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30804213	hybrid, Green Published			2022-12-26	WOS:000465077500021
J	Keppel, MH; Piecha, G; Marz, W; Cadamuro, J; Auer, S; Felder, TK; Mrazek, C; Oberkofler, H; Trummer, C; Grubler, MR; Schwetz, V; Verheyen, N; Pandis, M; Borzan, V; Haschke-Becher, E; Tomaschitz, A; Pilz, S				Keppel, Martin H.; Piecha, Grzegorz; Maerz, Winfried; Cadamuro, Janne; Auer, Simon; Felder, Thomas K.; Mrazek, Cornelia; Oberkofler, Hannes; Trummer, Christian; Grubler, Martin R.; Schwetz, Verena; Verheyen, Nicolas; Pandis, Marlene; Borzan, Valentin; Haschke-Becher, Elisabeth; Tomaschitz, Andreas; Pilz, Stefan			The endogenous cardiotonic steroid Marinobufagenin and decline in estimated glomerular filtration rate at follow-up in patients with arterial hypertension	PLOS ONE			English	Article							MINERALOCORTICOID RECEPTOR ANTAGONIST; HIGH-SALT INTAKE; PRIMARY ALDOSTERONISM; DIABETIC-NEPHROPATHY; RENAL FIBROSIS; PROTEINURIA; BLOCKER; MODEL	Background Marinobufagenin (MBG) is an endogenous cardiotonic steroid (CTS) that inhibits the Na+/ K+-ATPase. Human MBG is significantly increased in end-stage renal disease and immunization against MBG attenuates cardiovascular fibrosis in a rat model of uremic cardiomyopathy. Mineralocorticoid antagonists (MRA) block MBG binding sites and decrease proteinuria in chronic kidney disease (CKD) patients. We therefore aimed to investigate the association of MBG and albuminuria, as a marker of renal damage, as well as MBG and decline of glomerular filtration rate (GFR). Methods The Graz endocrine causes of hypertension (GECOH) study is a single center study of adults routinely referred for screening of endocrine hypertension. Plasma MBG was measured by an enzyme-linked immunoassay, and in a post-hoc analysis, follow-up creatinine levels were obtained. Patients with proteinuria >3.5g/day at baseline were excluded from further evaluation. Results We measured MBG concentrations in 40 hypertensive subjects and excluded one patient due to pre-existing proteinuria. Plasma MBG was significantly correlated with albuminuria (Spearman rho=.357; p=.028) and proteinuria (rho=.336; p=.039). In linear regression analysis, the association remained significant after adjustment for age, sex, and BMI (beta=.306; p=.036), and for mean systolic blood pressure (beta=.352; p=.034). In follow-up analyses (N=30), MBG was significantly associated with decline in GFR after adjustment for time-to-follow-up (beta=-.374; p=.042). Conclusion The findings suggest that MBG plasma concentrations were associated with albuminuria as well as decline in kidney function. Whether MBG predicts hard renal endpoints warrants further investigations.	[Keppel, Martin H.; Cadamuro, Janne; Auer, Simon; Felder, Thomas K.; Mrazek, Cornelia; Oberkofler, Hannes; Haschke-Becher, Elisabeth] Paracelsus Med Univ, Univ Inst Med & Chem Lab Diagnost, Salzburg, Austria; [Piecha, Grzegorz] Med Univ Silesia, Dept Nephrol Transplantat & Internal Med, Katowice, Poland; [Maerz, Winfried] Synlab Acad, Mannheim, Germany; [Maerz, Winfried] Heidelberg Univ, Med Fac Mannheim, Med Clin Nephrol Hypertensiol Rheumatol Endocrino, Heidelberg, Germany; [Maerz, Winfried] Karl Franzens Univ Graz, Clin Inst Med & Chem Lab Diagnost Med, Graz, Austria; [Trummer, Christian; Schwetz, Verena; Pandis, Marlene; Borzan, Valentin; Pilz, Stefan] Med Univ Graz, Dept Endocrinol & Diabetol, Graz, Austria; [Grubler, Martin R.] Univ Bern, Univ Hosp Bern, Swiss Cardiovasc Ctr Bern, Dept Cardiol, Bern, Switzerland; [Verheyen, Nicolas] Med Univ Graz, Dept Cardiol, Graz, Austria; [Tomaschitz, Andreas] Bad Gleichenberg Clin, Bad Gleichenberg, Austria	Paracelsus Private Medical University; Medical University Silesia; SYNLAB Group; Ruprecht Karls University Heidelberg; University of Graz; Medical University of Graz; University of Bern; University Hospital of Bern; Medical University of Graz	Keppel, MH (corresponding author), Paracelsus Med Univ, Univ Inst Med & Chem Lab Diagnost, Salzburg, Austria.	keppel.martin@gmail.com	Felder, Thomas K/A-8342-2017	Felder, Thomas K/0000-0001-8266-5513; Piecha, Grzegorz/0000-0001-8371-0195; Theiler-Schwetz, Verena/0000-0002-2378-689X; Keppel, Martin/0000-0003-3448-3349; Pilz, Stefan/0000-0002-7959-1311				[Anonymous], JAMA-J AM MED ASSOC, DOI [10.1001/jama.2011.451, DOI 10.1001/JAMA.2011.451]; [Anonymous], KIDNEY INT, DOI [10.1046/j.1523-1755.2003.00914.x, DOI 10.1046/J.1523-1755.2003.00914.X]; [Anonymous], 2009, MAR, DOI [10.2215/CJN.04750908, DOI 10.2215/CJN.04750908]; Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bianchi S, 2006, KIDNEY INT, V70, P2116, DOI 10.1038/sj.ki.5001854; Bolignano D, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007004.pub3; Bomback AS, 2008, AM J KIDNEY DIS, V51, P199, DOI 10.1053/j.ajkd.2007.10.040; Chou KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054863; Currie G, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0337-0; Esteghamati A, 2013, NEPHROL DIAL TRANSPL, V28, P2823, DOI 10.1093/ndt/gft281; Fedorova LV, 2009, AM J PHYSIOL-RENAL, V296, pF922, DOI 10.1152/ajprenal.90605.2008; Fedorova OV, 2015, J HYPERTENS, V33, P1602, DOI 10.1097/HJH.0000000000000591; Grigorova YN, 2016, AM J HYPERTENS, V29, P641, DOI 10.1093/ajh/hpv155; Haller ST, 2014, AM J HYPERTENS, V27, P603, DOI 10.1093/ajh/hpt169; Hamlyn JM, 2015, ADV CHRONIC KIDNEY D, V22, P232, DOI 10.1053/j.ackd.2014.12.005; Hill NR, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0158765, DOI 10.1371/J0URNAL.P0NE.0158765]; Karavas E., 2013, TEACHING PRACTICE PR; Kolmakova EV, 2011, NEPHROL DIAL TRANSPL, V26, P2912, DOI 10.1093/ndt/gfq772; Komiyama Y, 2005, CLIN BIOCHEM, V38, P36, DOI 10.1016/j.clinbiochem.2004.08.005; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Ma TKW, 2012, RENAL FAILURE, V34, P810, DOI 10.3109/0886022X.2012.672156; Pascual JM, 2014, HYPERTENSION, V64, P1228, DOI 10.1161/HYPERTENSIONAHA.114.04273; Mavrakanas TA, 2014, EUR J INTERN MED, V25, P173, DOI 10.1016/j.ejim.2013.11.007; Mehdi UF, 2009, J AM SOC NEPHROL, V20, P2641, DOI 10.1681/ASN.2009070737; Navaneethan SD, CLIN J AM SOC NEPHRO; Paczula A, 2016, POSTEP HIG MED DOSW, V70, P243, DOI 10.5604/17322693.1197486; Piecha G, 2018, AM J PHYSL RENAL PHY; Piecha G, 2012, NEPHROL DIAL TRANSPL, V27, P3464, DOI 10.1093/ndt/gfs027; Pilz S, 2012, J CLIN ENDOCR METAB, V97, pE75, DOI 10.1210/jc.2011-2183; Pilz S, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-11; Priyadarshi S, 2003, KIDNEY INT, V63, P1785, DOI 10.1046/j.1523-1755.2003.00914.x; Shelykh T N, 2014, Dokl Biol Sci, V458, P278, DOI 10.1134/S0012496614050111; Simonini M, 2014, NEPHROL DIAL TRANSPL, V29, P1696, DOI 10.1093/ndt/gfu200; Simundic AM, 2018, CLIN CHEM LAB MED; Stella P, 2008, J INTERN MED, V263, P274, DOI 10.1111/j.1365-2796.2007.01883.x; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tian J, 2009, HYPERTENSION, V54, P1313, DOI 10.1161/HYPERTENSIONAHA.109.140038; Tomaschitz A, 2015, CLIN EXP HYPERTENS, V37, P108, DOI 10.3109/10641963.2014.913604; Zhou H, 2016, DRUG DES DEV THER, V10, P1581, DOI 10.2147/DDDT.S100095	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212973	10.1371/journal.pone.0212973	http://dx.doi.org/10.1371/journal.pone.0212973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817774	gold, Green Submitted, Green Published			2022-12-26	WOS:000460371500064
J	Mejia, CR; Cardenas, MM; Benites-Gamboa, D; Minan-Tapia, A; Torres-Riveros, GS; Paz, M; Perez, Y; Rojas-Camayo, J				Mejia, Christian R.; Cardenas, Matlin M.; Benites-Gamboa, Dayanne; Minan-Tapia, Armando; Torres-Riveros, Gloria S.; Paz, Michael; Perez, Yomayra; Rojas-Camayo, Jose			Values of heart rate at rest in children and adults living at different altitudes in the Andes	PLOS ONE			English	Article							OXYGEN-SATURATION; ARTERIAL OXYGEN; ANESTHESIA	Introduction The heart rate (HR) is useful for the monitoring of patients, but almost no studies have been found which describe their variations according to different geographic locales and altitudes using centiles in children and adults. Methodology Descriptive, cross-sectional study of secondary data. Measurements were taken with a calibrated pulse oximeter; our participants resided in host cities for more than 2 months and underwent clinical evaluations by physicians. The results were categorized according to their age group and the altitude of residence using centile charts. Results Our sample size consisted of 6,289 subjects across different villages in Peru. Using Pearson correlation between HR and altitude, it was found in the group of patients aged 1-5 years, a coefficient of -0.118 (p value = 0.012), in the group of patients aged 6-17, 0.047 (p value = 0.025), in the group of patients aged 18-50, -0.044 (p value = 0.041) and for the group of patients aged 51-80, 0.042 (p value = 0.256). In the groups of 1-5, 6-17 and 18-50 years of age, the variations were negligible but statistically significant due to our large sample size. When all of the data was evaluated, HR values were also found to have negligible variations according to the residence altitude, with a Pearson coefficient of -0.033 (p value = 0.009). Centiles charts were used to describe the distribution of HR for different age groups by altitude of residence. Conclusion There are minimal variations of the HR according to the altitude of residence in all age groups.	[Mejia, Christian R.] Univ Continental, Escuela Med Humana, Huancayo, Peru; [Cardenas, Matlin M.; Benites-Gamboa, Dayanne] Asociac Med Invest & Serv Salud, Lima, Peru; [Cardenas, Matlin M.; Benites-Gamboa, Dayanne] Univ Ricardo Palma, Fac Med, Lima, Peru; [Minan-Tapia, Armando; Torres-Riveros, Gloria S.] Univ Privada Tacna, Tacna, Peru; [Paz, Michael; Perez, Yomayra] Lincoln Med & Mental Hlth Ctr, Bronx, NY 10451 USA; [Rojas-Camayo, Jose] Univ Peruana Cayetano Heredia, Inst Invest Altura, Lima, Peru	Universidad Continental; Universidad Ricardo Palma; Universidad Privada De Tacna; Universidad Peruana Cayetano Heredia	Mejia, CR (corresponding author), Univ Continental, Escuela Med Humana, Huancayo, Peru.	christian.mejia.md@gmail.com		Minan-Tapia, Armando/0000-0002-0104-780X; Mejia, Christian R./0000-0002-5940-7281; Torres-Riveros, Gloria S./0000-0001-5540-2611				Battestini R, 2005, MED CLIN-BARCELONA, V124, P177, DOI 10.1157/13071486; Bhattarai P, 2018, ANN OCCUP ENVIRON ME, V30, DOI 10.1186/s40557-018-0240-1; Borderias-Clau L, 2005, ARCH BRONCONEUMOL, V41, P537, DOI 10.1157/13079835; Checketts MR, 2016, ANAESTHESIA, V71, P85, DOI 10.1111/anae.13316; Fleming S, 2011, LANCET, V377, P1011, DOI 10.1016/S0140-6736(10)62226-X; Gong MW, 2017, INT J CLIN PHARM-NET, V39, P139, DOI 10.1007/s11096-016-0411-5; Hainsworth R, 2007, RESP PHYSIOL NEUROBI, V158, P204, DOI 10.1016/j.resp.2007.05.006; Hainsworth R, 2007, CLIN AUTON RES, V17, P13, DOI 10.1007/s10286-006-0395-7; Huicho L, 2001, AM J HUM BIOL, V13, P761, DOI 10.1002/ajhb.1122; Ke J, 2017, INTECHOPEN; Lorente-Aznar T, 2016, MED CLIN-BARCELONA, V147, P435, DOI 10.1016/j.medcli.2016.07.025; Mason N.P., 2000, CURR ANAESTH CRIT CA, V11, P41, DOI [10.1054/cacc.2000.0242, DOI 10.1054/CACC.2000.0242]; Moore LG, 2011, RESP PHYSIOL NEUROBI, V178, P181, DOI 10.1016/j.resp.2011.04.017; Nishiyama T, 2016, ANAESTH INTENSIVE TH, V48, P248, DOI 10.5603/AIT.a2016.0041; Penaloza D, 2007, CIRCULATION, V115, P1132, DOI 10.1161/CIRCULATIONAHA.106.624544; Pereira-Victorio César J, 2014, Rev. perú. med. exp. salud publica, V31, P473; Pinto M, 2016, ED TERRIT, V5, P55; Princi Tanja, 2008, Biomed Sci Instrum, V44, P380; REULAND DS, 1991, J PEDIATR-US, V119, P900, DOI 10.1016/S0022-3476(05)83040-9; Rojas-Camayo J, 2018, THORAX, V73, P776, DOI 10.1136/thoraxjnl-2017-210598; Sharshenova Ainash A, 2006, Anadolu Kardiyol Derg, V6, P335; Subhi R, 2009, ARCH DIS CHILD, V94, P6, DOI 10.1136/adc.2008.138362; Windsor JS, 2010, HIGH ALT MED BIOL, V11, P51, DOI 10.1089/ham.2009.1065	23	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0213014	10.1371/journal.pone.0213014	http://dx.doi.org/10.1371/journal.pone.0213014			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817775	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500067
J	Kapumba, BM; King, R				Kapumba, Blessings Msango; King, Rebecca			Perceived HIV-protective benefits of male circumcision: Risk compensatory behaviour among women in Malawi	PLOS ONE			English	Article							PREVENTION; MEN	Background Male circumcision (MC) reduces men's risk of contracting HIV by approximately 60% and has the potential to significantly alter HIV epidemics. However, MC does not significantly reduce the risk of HIV transmission to women from a circumcised man. In Malawi, several researchers has examined the acceptability, accessibility and sexual behaviour change after circumcision in men but behaviour change in women following their partner's circumcision remains uncertain. In order to fully realise the protective benefits of MC against HIV, factors related to risky sexual behaviour is imperative as some studies have shown potentials of increased risky behaviour in men following voluntary medical male circumcision (VMMC). This study aimed to explore the perceptions and opinions of female school teachers and health workers on HIV-protective benefits of MC and its impact on risk compensatory behaviour among women in Malawi. Methods We conducted a cross-sectional survey of women (N = 68) between May and June 2016 in three districts of southern Malawi. Risk compensatory behaviour was measured by number of sexual partners and use of protection during sex among female teachers and health care workers who are involved with educating people on benefits of VMMC. The bivariable analysis was conducted to test for association between HIV-protective benefits and risk compensatory behaviour. Purposive sampling was used to conduct eight qualitative in-depth interviews with women from the selected districts and the qualitative data was analysed thematically. Results The mean age of women who participated in the survey was 30 years. Most women (94.1%) correctly indicated that HIV-positive circumcised men can still infect their partner and approximately, 90% of were knowledgeable of risky sexual behaviour for HIV. However, 55.9% perceived MC can lead women to adopt risky sexual behaviour. On the contrary to this finding, qualitative data indicate women's misconceptions regarding their partners' circumcision and HIV-protective benefits. Most women expressed that risky sexual behaviour such as having multiple sexual partners and inconsistent or non-use of condoms can easily be observed among women if they learn of their partners' partial HIV-protective benefits circumcision. Conclusion Exploring women's sexual behaviour change in the right of HIV-protective benefits of MC fills in a research knowledge important to public health. In-depth studies are therefore required to give more evidence that will guide the development of HIV risk-reduction interventions.	[Kapumba, Blessings Msango] Malawi Liverpool Wellcome Trust, Dept Behav & Hlth, Blantyre, Malawi; [King, Rebecca] Univ Leeds, Leeds Inst Hlth Sci, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England	University of Malawi; University of Leeds	Kapumba, BM (corresponding author), Malawi Liverpool Wellcome Trust, Dept Behav & Hlth, Blantyre, Malawi.	mblessingsk012@gmail.com	Kapumba, Blessings/GXF-7996-2022	Kapumba, Blessings Msango/0000-0002-8210-3454				Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Bryman A., 2006, QUAL RES, V6, P97, DOI [10.1177/1468794106058877, DOI 10.1177/1468794106058877]; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Clark V. L. P., 2010, QUALITATIVE INQUIRY; Eaton Lisa A, 2007, Curr HIV/AIDS Rep, V4, P165, DOI 10.1007/s11904-007-0024-7; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Greene J. C., 2007, MIXED METHODS SOCIAL; Haberland NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149517; Hallett TB, 2011, SEX TRANSM INFECT, V87, P88, DOI 10.1136/sti.2010.043372; Hankins C, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000109; John W.C., 2013, RES DESIGN QUALITATI, V4th; Jung J. H., 2012, Consilience: The Journal of Sustainable Development, P103; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Layer EH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074391; Lurie M. N., 2014, AIDS BEHAV, V18, P1; Marshall MN, 1996, FAM PRACT, V13, P522, DOI 10.1093/fampra/13.6.522; Maughan-Brown B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040753; NAC, 2014, MAL NAT HIV PREV SST; NAC, 2012, COMM DEM CREAT COMM; Osaki H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139009; Pett M.A., 2015, NONPARAMETRIC STAT H; Ritchie J., 2013, QUALITATIVE RES PRAC; Thompson MS, 2013, QUANT METH EDUC BEHA, P163; UNAIDS/WHO, 2007, NEW DAT MAL CIRC HIV; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4; WHO,, 2014, WHO PROGR BRIEF VOL; WHO & UNAIDS, 2011, JOINT STRAT ACT FRAM; World Health Organization & World Health Organization, 2009, WHO HDB INDOOR RADON	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211015	10.1371/journal.pone.0211015	http://dx.doi.org/10.1371/journal.pone.0211015			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811397	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400012
J	Unrine, JM; Slone, SA; Sanderson, W; Johnson, N; Durbin, EB; Shrestha, S; Hahn, EJ; Feltner, F; Huang, B; Christian, WJ; Mellon, I; Orren, DK; Arnold, SM				Unrine, Jason M.; Slone, Stacey A.; Sanderson, Wayne; Johnson, Nancy; Durbin, Eric B.; Shrestha, Shristi; Hahn, Ellen J.; Feltner, Fran; Huang, Bin; Christian, W. Jay; Mellon, Isabel; Orren, David K.; Arnold, Susanne M.			A case-control study of trace-element status and lung cancer in Appalachian Kentucky	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; DRINKING-WATER; ARSENIC CONCENTRATIONS; TOENAIL CHROMIUM; BLADDER-CANCER; HUMAN NAILS; BIOMARKER; HAIR; RISK; SELENIUM	Appalachian Kentucky (App KY) leads the nation in lung cancer incidence and mortality. Trace elements, such as As, have been associated with lung cancers in other regions of the country and we hypothesized that a population-based study would reveal higher trace element concentrations in App KY individuals with cancer compared to controls. Using toenail and drinking water trace element concentrations, this study investigated a possible association between lung cancer incidence and trace-element exposure in residents of this region. This population-based case-control study had 520 subjects, and 367 subjects provided toenail samples. Additionally, we explored the relationship between toenail and fingernail trace-element concentrations to determine if fingernails could be used as a surrogate for toenails when patients are unable to provide toenail samples. We found that, contrary to our initial hypothesis, trace element concentrations (Al, As, Cr, Mn, Co, Fe, Ni, Cu, Se, and Pb) were not higher in cancer cases than controls with the exception of Zn where concentrations were slightly higher in cases. In fact, univariate logistic regression models showed that individuals with lower concentrations of several elements (Al, Mn, Cr, and Se) were more likely to have lung cancer, although only Mn was significant in multivariate models which controlled for confounding factors. While drinking water concentrations of Al, Cr and Co were positively related to cancer incidence in univariate models, only Co remained significant in multivariate models. However, since the drinking water concentrations were extremely low and not reflected in the toenail concentrations, the significance of this finding is unclear. We also found that fingernail concentrations were not consistently predictive of toenail concentrations, indicating that fingernails should not be used as surrogates for toenails in future studies.	[Unrine, Jason M.; Shrestha, Shristi] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA; [Unrine, Jason M.; Mellon, Isabel; Orren, David K.] Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA; [Slone, Stacey A.; Durbin, Eric B.; Huang, Bin; Arnold, Susanne M.] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA; [Sanderson, Wayne; Johnson, Nancy] Univ Kentucky, Dept Preventat Med & Environm Hlth, Lexington, KY USA; [Sanderson, Wayne; Christian, W. Jay] Univ Kentucky, Dept Epidemiol, Lexington, KY USA; [Durbin, Eric B.; Huang, Bin] Univ Kentucky, Kentucky Canc Registry, Lexington, KY USA; [Durbin, Eric B.; Arnold, Susanne M.] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; [Hahn, Ellen J.] Univ Kentucky, Coll Nursing, BREATHE, Lexington, KY USA; [Feltner, Fran] Univ Kentucky, Ctr Excellence Rural Hlth, Hazard, KY USA; [Huang, Bin] Univ Kentucky, Dept Biostat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Unrine, JM (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40506 USA.; Unrine, JM (corresponding author), Univ Kentucky, Dept Toxicol & Canc Biol, Lexington, KY 40506 USA.; Arnold, SM (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40506 USA.; Arnold, SM (corresponding author), Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA.	jason.unrine@uky.edu; susanne.arnold@uky.edu	Slone, Stacey/AAM-5464-2021	Slone, Stacey/0000-0002-4355-7672; Durbin, Eric/0000-0002-5600-7645; Hahn, Ellen/0000-0002-8480-1010; Unrine, Jason/0000-0003-3012-5261; Arnold, Susanne/0000-0001-6542-9551; Christian, Warren/0000-0001-6904-3971	U.S. Army Medical Research and Materiel Command [W81XWH-11-1-0781]; Center for Appalachian Research in Environmental Sciences, National Institute of Environmental Health Sciences [1P30ES026529-01A1]; Biostatistics and Bioinformatics, Cancer Research Informatics, and Biospecimen and Tissue Procurement Shared Resources of the University of Kentucky Markey Cancer Center - National Cancer Institute [P30CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES026529] Funding Source: NIH RePORTER	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Center for Appalachian Research in Environmental Sciences, National Institute of Environmental Health Sciences; Biostatistics and Bioinformatics, Cancer Research Informatics, and Biospecimen and Tissue Procurement Shared Resources of the University of Kentucky Markey Cancer Center - National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the U.S. Army Medical Research and Materiel Command through grant number W81XWH-11-1-0781. Supplemental support was provided by the Analytical Core of the Center for Appalachian Research in Environmental Sciences, National Institute of Environmental Health Sciences grant number 1P30ES026529-01A1. This research was supported by the Biostatistics and Bioinformatics, Cancer Research Informatics, and Biospecimen and Tissue Procurement Shared Resources of the University of Kentucky Markey Cancer Center which is funded by the National Cancer Institute through P30CA177558.	Agency for Toxicological Substances and Disease Registry (ATSDR), 2004, TOX PROF COB; Amaral AFS, 2012, GUT, V61, P1583, DOI 10.1136/gutjnl-2011-301086; [Anonymous], 2017, CANC PAT DAT MAN SYS; Case AJ, 2013, FREE RADICAL BIO MED, V56, P17, DOI 10.1016/j.freeradbiomed.2012.11.018; CDC, 2010, FDN HLTH MEAS GEN HL; CDC, 2010, NAT HLTH INT SURV NH; Christian WJ, 2011, PUBLIC HEALTH REP, V126, P789, DOI 10.1177/003335491112600604; Davis CM, 1997, BIOCHEMISTRY-US, V36, P4382, DOI 10.1021/bi963154t; Ferdosi H, 2016, J ENVIRON PUBLIC HEA, V2016, DOI 10.1155/2016/1602929; Freeman LEB, 2015, AM J EPIDEMIOL, V181, P488, DOI 10.1093/aje/kwu324; GAMMELGAARD B, 1985, ANALYST, V110, P1197, DOI 10.1039/an9851001197; Garland M, 1996, AM J EPIDEMIOL, V144, P653, DOI 10.1093/oxfordjournals.aje.a008977; Golasik M, 2015, J TRACE ELEM MED BIO, V31, P67, DOI 10.1016/j.jtemb.2015.03.001; Goulle JP, 2009, J ANAL TOXICOL, V33, P92, DOI 10.1093/jat/33.2.92; Grashow R, 2014, J OCCUP ENVIRON HYG, V11, P397, DOI 10.1080/15459624.2013.875182; Guallar E, 2005, AM J EPIDEMIOL, V162, P157, DOI 10.1093/aje/kwi180; Hayes RB, 1997, CANCER CAUSE CONTROL, V8, P371, DOI 10.1023/A:1018457305212; Heck J, 2008, ENV HLTH PERSPECT, V117, P1718; Hinwood AL, 2003, ENVIRON HEALTH PERSP, V111, P187, DOI 10.1289/ehp.5455; Holley AK, 2012, AMINO ACIDS, V42, P139, DOI 10.1007/s00726-010-0600-9; Hopenhayn-Rich C, 1998, INT J EPIDEMIOL, V27, P561, DOI 10.1093/ije/27.4.561; HUNTER DJ, 1990, AM J EPIDEMIOL, V132, P114, DOI 10.1093/oxfordjournals.aje.a115623; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Johnson N, 2011, J ENVIRON PATHOL TOX, V30, P213, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i3.40; Karagas MR, 1996, CANCER EPIDEM BIOMAR, V5, P849; KCHFS, 2017, KENT DIAB REP; LANGARD S, 1990, AM J IND MED, V17, P189, DOI 10.1002/ajim.4700170205; Mahata J, 2003, MUTAT RES-GEN TOX EN, V534, P133, DOI 10.1016/S1383-5718(02)00255-3; Mahoney GN, 2001, J CHROMATOGR B, V753, P179, DOI 10.1016/S0378-4347(00)00540-5; Masto RE, 2017, J GEOCHEM EXPLOR, V176, P100, DOI 10.1016/j.gexplo.2015.12.009; Mendez WM, 2017, J EXPO SCI ENV EPID, V27, P235, DOI 10.1038/jes.2016.58; NCPHSBBR, 1977, BELM REP ETH PRINC G; Ndilila W, 2014, INT J HYG ENVIR HEAL, V217, P62, DOI 10.1016/j.ijheh.2013.03.011; Qayyum MA, 2014, BIOL TRACE ELEM RES, V162, P46, DOI 10.1007/s12011-014-0123-4; Rajpathak S, 2004, DIABETES CARE, V27, P2211, DOI 10.2337/diacare.27.9.2211; SHEN HM, 1994, ENVIRON HEALTH PERSP, V102, P275, DOI 10.1289/ehp.94102s1275; Slotnick MJ, 2008, BIOMARKERS, V13, P451, DOI 10.1080/13547500802029050; Slotnick MJ, 2007, J TOXICOL ENV HEAL A, V70, P148, DOI 10.1080/15287390600755232; Slotnick MJ, 2006, ENVIRON RES, V102, P125, DOI 10.1016/j.envres.2005.12.001; Steenland K, 1996, AM J IND MED, V29, P474, DOI 10.1002/(SICI)1097-0274(199605)29:5<474::AID-AJIM6>3.0.CO;2-M; Taylor V, 2017, SCI TOTAL ENVIRON, V580, P266, DOI 10.1016/j.scitotenv.2016.12.113; Tucker T., 2017, CANC INCIDENCE REPOR; Uddin AH, 2016, J ANAL SCI TECHNOL, V7, DOI 10.1186/s40543-016-0085-6; WHO, 1977, MAN INT STAT CALSS D; Wild Pascal, 2009, V472, P139, DOI 10.1007/978-1-60327-492-0_6; Yaemsiri S, 2010, J EUR ACAD DERMATOL, V24, P420, DOI 10.1111/j.1468-3083.2009.03426.x	46	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212340	10.1371/journal.pone.0212340	http://dx.doi.org/10.1371/journal.pone.0212340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811496	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400068
J	Berg, JS; Jezequel, D; Duverger, A; Lamy, D; Laberty-Robert, C; Miot, J				Berg, Jasmine S.; Jezequel, Didier; Duverger, Arnaud; Lamy, Dominique; Laberty-Robert, Christel; Miot, Jennyfer			Microbial diversity involved in iron and cryptic sulfur cycling in the ferruginous, low-sulfate waters of Lake Pavin	PLOS ONE			English	Article							ORGANIC-MATTER; CRATER LAKE; GEN. NOV.; MEROMICTIC LAKE; SULFUROSPIRILLUM-DELEYIANUM; FE(III) REDUCTION; FERRIC IRON; BACTERIA; OCEAN; OXIDATION	Both iron-and sulfur-reducing bacteria strongly impact the mineralogy of iron, but their activity has long been thought to be spatially and temporally segregated based on the higher thermodynamic yields of iron over sulfate reduction. However, recent evidence suggests that sulfur cycling can predominate even under ferruginous conditions. In this study, we investigated the potential for bacterial iron and sulfur metabolisms in the iron-rich (1.2 mM dissolved Fe2+), sulfate-poor (< 20 mu M) Lake Pavin which is expected to host large populations of iron-reducing and iron-oxidizing microorganisms influencing the mineralogy of iron precipitates in its permanently anoxic bottom waters and sediments. 16S rRNA gene amplicon libraries from at and below the oxycline revealed that highly diverse populations of sulfur/sulfate-reducing (SRB) and sulfur/sulfide-oxidizing bacteria represented up to 10% and 5% of the total recovered sequences in situ, respectively, which together was roughly equivalent to the fraction of putative iron cycling bacteria. In enrichment cultures amended with key iron phases identified in situ (ferric iron phosphate, ferrihydrite) or with soluble iron (Fe2+), SRB were the most competitive microorganisms, both in the presence and absence of added sulfate. The large fraction of Sulfurospirillum, which are known to reduce thiosulfate and sulfur but not sulfate, present in all cultures was likely supported by Fe(III)-driven sulfide oxidation. These results support the hypothesis that an active cryptic sulfur cycle interacts with iron cycling in the lake. Analyses of mineral phases showed that ferric phosphate in cultures dominated by SRB was transformed to vivianite with concomitant precipitation of iron sulfides. As colloidal FeS and vivianite have been reported in the monimolimnion, we suggest that SRB along with iron-reducing bacteria strongly influence iron mineralogy in the water column and sediments of Lake Pavin.	[Berg, Jasmine S.; Duverger, Arnaud; Miot, Jennyfer] Sorbonne Univ, CNRS, Inst Mineral Phys Mat00E9riaux & Cosmochim, Museum Natl Hist Nat,UMR 7590, Paris, France; [Jezequel, Didier] Univ Paris Diderot, CNRS, Inst Phys Globe Paris, Lab Geochim Eaux,UMR 7154, Paris, France; [Lamy, Dominique] Univ Antilles, Univ Caen Normandie, Sorbonne Univ,Museum Natl Hist Nat,IRD, Unite Biol Organismes & Ecosyst Aquat BOREA,CNRS, Paris, France; [Laberty-Robert, Christel] Univ Paris 06, Lab Chim Matiere Condensee Paris, Paris, France; [Berg, Jasmine S.] Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite de Caen Normandie; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; Chimie ParisTech; College de France; Centre National de la Recherche Scientifique (CNRS); Swiss Federal Institutes of Technology Domain; ETH Zurich	Berg, JS (corresponding author), Sorbonne Univ, CNRS, Inst Mineral Phys Mat00E9riaux & Cosmochim, Museum Natl Hist Nat,UMR 7590, Paris, France.; Berg, JS (corresponding author), Swiss Fed Inst Technol, Dept Environm Syst Sci, Zurich, Switzerland.	jasmine.berg@usys.ethz.ch	Berg, Jasmine/ABD-4858-2020; Laberty, Christel/G-8847-2011; Duverger, Arnaud/R-6589-2017; JEZEQUEL, DIDIER/K-8269-2012	Berg, Jasmine/0000-0003-3461-4759; Duverger, Arnaud/0000-0001-5347-1701; 	Labex MATISSE; French state funds; Agence Nationale de la Recherche (ANR) within the Investissements d'Avenir programme [ANR-11-IDEX-0004-02]; ANR [ANR-07-BLAN-0124-01]; Region Ile de France grant SESAME [I-07-593/R]; INSU/CNRS; UPMC-Paris 6; IPGP multidisciplinary program PARI; Paris-IdF region SESAME [12015908]	Labex MATISSE; French state funds; Agence Nationale de la Recherche (ANR) within the Investissements d'Avenir programme; ANR(French National Research Agency (ANR)); Region Ile de France grant SESAME(Region Ile-de-France); INSU/CNRS(Centre National de la Recherche Scientifique (CNRS)); UPMC-Paris 6; IPGP multidisciplinary program PARI; Paris-IdF region SESAME	JSB was funded by Labex MATISSE, supported by French state funds managed by the Agence Nationale de la Recherche (ANR) within the Investissements d'Avenir programme under reference ANR-11-IDEX-0004-02, and more specifically within the framework of the Cluster of Excellence MATISSE led by Sorbonne Universites.; We acknowledge support from the ANR (project SRB - ANR-14-CE33-0003-01, PI: JM). The SEM facility at the IMPMC is funded by Region Ile de France grant SESAME 2006 No I-07-593/R, INSU/CNRS, UPMC-Paris 6, and by the ANR (ANR-07-BLAN-0124-01). Parts of this work were supported by IPGP multidisciplinary program PARI, and by Paris-IdF region SESAME Grant No 12015908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aeschbach-Hertig W, 2002, HYDROBIOLOGIA, V487, P111, DOI 10.1023/A:1022942226198; Alberic P, 2000, LIMNOL OCEANOGR, V45, P1088, DOI 10.4319/lo.2000.45.5.1088; Berg JS, 2016, ENVIRON MICROBIOL, V18, P5288, DOI 10.1111/1462-2920.13587; Bethke CM, 2008, GEOLOGY, V36, P739, DOI 10.1130/G24859A.1; Bethke CM, 2011, AM J SCI, V311, P183, DOI 10.2475/03.2011.01; Biderre-Petit C, 2011, MICROB ECOL, V61, P313, DOI 10.1007/s00248-010-9769-4; Bonhomme C., 2016, LAKE PAVIN MIXING NE, P177, DOI [10.1007/978-3-319-39961-4_10, DOI 10.1007/978-3-319-39961-4_10]; Bonhomme C, 2011, CR GEOSCI, V343, P749, DOI 10.1016/j.crte.2011.09.006; Borch T, 2007, DEV EARTH ENV SCI, P321, DOI [10.1016/S1571-9197(07)07012-7, DOI 10.1016/S1571-9197(07)07012-7]; Bura-Nakic E, 2009, CHEM GEOL, V266, P311, DOI 10.1016/j.chemgeo.2009.06.020; Busigny V, 2014, GEOCHIM COSMOCHIM AC, V133, P443, DOI 10.1016/j.gca.2014.03.004; Camacho A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00323; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Cornell R.M., 2004, IRON OXIDES, P525, DOI DOI 10.1002/3527602097.CH20; Cosmidis J., 2016, LAKE PAVIN, P205; Cosmidis J, 2014, GEOCHIM COSMOCHIM AC, V126, P78, DOI 10.1016/j.gca.2013.10.037; Crowe SA, 2014, GEOBIOLOGY, V12, P322, DOI 10.1111/gbi.12089; Crowe SA, 2008, P NATL ACAD SCI USA, V105, P15938, DOI 10.1073/pnas.0805313105; Czaja AD, 2013, EARTH PLANET SC LETT, V363, P192, DOI 10.1016/j.epsl.2012.12.025; EHRENREICH A, 1994, APPL ENVIRON MICROB, V60, P4517, DOI 10.1128/AEM.60.12.4517-4526.1994; EISENMANN E, 1995, ARCH MICROBIOL, V164, P180, DOI 10.1007/BF02529969; Elferink SJWHO, 1999, INT J SYST BACTERIOL, V49, P345, DOI 10.1099/00207713-49-2-345; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson D, 2010, ANNU REV MICROBIOL, V64, P561, DOI 10.1146/annurev.micro.112408.134208; Finneran KT, 2003, INT J SYST EVOL MICR, V53, P669, DOI 10.1099/ijs.0.02298-0; Fuller SJ, 2014, APPL ENVIRON MICROB, V80, P128, DOI 10.1128/AEM.02282-13; Hansel CM, 2003, GEOCHIM COSMOCHIM AC, V67, P2977, DOI 10.1016/S0016-7037(03)00276-X; Hansel CM, 2015, ISME J, V9, P2400, DOI 10.1038/ismej.2015.50; Hubert C, 2007, APPL ENVIRON MICROB, V73, P2644, DOI 10.1128/AEM.02332-06; Humayoun SB, 2003, APPL ENVIRON MICROB, V69, P1030, DOI 10.1128/AEM.69.2.1030-1042.2003; Inoue K, 2011, ENV MICROBIOL REP, V3, P211, DOI 10.1111/j.1758-2229.2010.00210.x; Jakobsen R, 1999, GEOCHIM COSMOCHIM AC, V63, P137, DOI 10.1016/S0016-7037(98)00272-5; Johnson DB, 2009, INT J SYST EVOL MICR, V59, P1082, DOI 10.1099/ijs.0.65409-0; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; JORGENSEN BB, 1990, SCIENCE, V249, P152, DOI 10.1126/science.249.4965.152; Kappler A, 2005, GEOLOGY, V33, P865, DOI 10.1130/G21658.1; Kasten S., 2000, MARINE GEOCHEMISTRY, P263, DOI [10.1007/978-3-662-04242-7-8, DOI 10.1007/978-3-662-04242-7_8, DOI 10.1007/978-3-662-04242-7-8]; Kojima H, 2011, INT J SYST EVOL MICR, V61, P1651, DOI 10.1099/ijs.0.024968-0; Konhauser KO, 2005, GEOBIOLOGY, V3, P167, DOI 10.1111/j.1472-4669.2005.00055.x; Lehours AC, 2005, APPL ENVIRON MICROB, V71, P7389, DOI 10.1128/AEM.71.11.7389-7400.2005; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Lehours AC, 2009, GEOMICROBIOL J, V26, P212, DOI 10.1080/01490450902744012; Li WQ, 2013, GEOCHIM COSMOCHIM AC, V120, P65, DOI 10.1016/j.gca.2013.06.033; Lohmayer R, 2014, APPL ENVIRON MICROB, V80, P3141, DOI 10.1128/AEM.04220-13; Lopes F, 2011, APPL GEOCHEM, V26, P1919, DOI 10.1016/j.apgeochem.2011.06.021; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; LOVLEY DR, 1991, MICROBIOL REV, V55, P259, DOI 10.1128/MMBR.55.2.259-287.1991; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P2636, DOI 10.1128/AEM.53.11.2636-2641.1987; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; LOVLEY DR, 1993, MAR GEOL, V113, P41, DOI 10.1016/0025-3227(93)90148-O; Lu SP, 2013, APPL ENVIRON MICROB, V79, P4272, DOI 10.1128/AEM.00467-13; Lyons TW, 2014, NATURE, V506, P307, DOI 10.1038/nature13068; Ma SF, 2006, ESTUAR COAST SHELF S, V70, P461, DOI 10.1016/j.ecss.2006.06.033; MICHARD G, 1994, CHEM GEOL, V115, P103, DOI 10.1016/0009-2541(94)90147-3; Miot J, 2016, MINERALS-BASEL, V6, DOI 10.3390/min6020024; Miot J, 2009, GEOCHIM COSMOCHIM AC, V73, P696, DOI 10.1016/j.gca.2008.10.033; Mirvaux B, 2016, J ELECTROCHEM SOC, V163, pA2139, DOI 10.1149/2.0101610jes; Mosher JJ, 2012, APPL ENVIRON MICROB, V78, P2082, DOI 10.1128/AEM.07165-11; Nevin KP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005628; Newman DK, 2000, NATURE, V405, P94, DOI 10.1038/35011098; O'Loughlin EJ, 2010, ENVIRON SCI TECHNOL, V44, P4570, DOI 10.1021/es100294w; OVERMANN J, 1992, LIMNOL OCEANOGR, V37, P150, DOI 10.4319/lo.1992.37.1.0150; PARKIN TB, 1980, ARCH MICROBIOL, V125, P19, DOI 10.1007/BF00403193; Pester M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00072; Planavsky N, 2009, EARTH PLANET SC LETT, V286, P230, DOI 10.1016/j.epsl.2009.06.033; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Posth NR, 2013, CHEM GEOL, V362, P66, DOI 10.1016/j.chemgeo.2013.05.031; Poulton SW, 2011, ELEMENTS, V7, P107, DOI 10.2113/gselements.7.2.107; Poulton SW, 2003, CHEM GEOL, V202, P79, DOI 10.1016/S0009-2541(03)00237-7; PYZIK AJ, 1981, GEOCHIM COSMOCHIM AC, V45, P687, DOI 10.1016/0016-7037(81)90042-9; Rees GN, 2001, INT J SYST EVOL MICR, V51, P1911, DOI 10.1099/00207713-51-5-1911; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; Rivas-Lamelo S, 2017, GEOCHEM PERSPECT LET, V5, P35, DOI 10.7185/geochemlet.1743; Shelobolina ES, 2007, INT J SYST EVOL MICR, V57, P126, DOI 10.1099/ijs.0.64221-0; Straub KL, 2004, APPL ENVIRON MICROB, V70, P5744, DOI 10.1128/AEM.70.10.5744-5749.2004; Thamdrup B, 2000, ADV MICROB ECOL, V16, P41; THAMDRUP B, 1994, GEOCHIM COSMOCHIM AC, V58, P5115, DOI 10.1016/0016-7037(94)90298-4; TSCHECH A, 1984, ARCH MICROBIOL, V137, P163, DOI 10.1007/BF00414460; VANDAMME P, 1992, INT J SYST BACTERIOL, V42, P344, DOI 10.1099/00207713-42-3-344; Viollier E, 1997, CHEM GEOL, V142, P225, DOI 10.1016/S0009-2541(97)00093-4; VOORDOUW G, 1995, APPL ENVIRON MICROB, V61, P2813, DOI 10.1128/AEM.61.8.2813-2819.1995; Walter XA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00713; Widdel F, 1980, ANAEROBER ABBAU FETT; Yao WS, 1996, MAR CHEM, V52, P1, DOI 10.1016/0304-4203(95)00072-0; Zopfi J, 2004, BIOGEOCHEMISTRY SULF	87	24	25	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212787	10.1371/journal.pone.0212787	http://dx.doi.org/10.1371/journal.pone.0212787			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794698	Green Published, gold			2022-12-26	WOS:000459709100139
J	Blumel, B; Diercke, M; Sagebiel, D; Gilsdorf, A				Bluemel, Benjamin; Diercke, Michaela; Sagebiel, Daniel; Gilsdorf, Andreas			Positive predictive value of the German notification system for infectious diseases: Surveillance data from eight local health departments, Berlin, 2012	PLOS ONE			English	Article							TIMELINESS	The German Infection Protection Act requires notifying certain cases of infectious diseases to local health departments (LHD) in Germany. LHDs transmit notifications meeting case definitions to the national health authority, where the proportion of discarded notifications is not known. The proportion of discarded cases at the level of LHDs can be expressed as the positive predictive value (PPV) of the notification system. The PPV can be used to assess the efficiency of the system. We quantified the proportion of discarded notifications to calculate the PPV of the German notification system at the level of LHDs using electronic notification data from Berlin LHDs from 2012. We also analysed reasons for discarding notifications by reviewing notification forms. Data was available from eight LHDs (67%) receiving 10,113 notifications in 2012. Overall PPV was 89% (minimum-maximum = 77-97% across LHDs) and ranging from 30% (Hepatitis B) to 99% (Rotavirus). Of 166 individual investigation forms 84% were on hepatitis B or C cases, most of them discarded because of previously diagnosed chronic disease. LHDs investigate many notifications that do not lead to public health action and useful surveillance data leading to inefficient use of resources. Adaptation of case definitions or the legal framework concerning notifications may increase the efficiency of the notification system and lead to better use of data from notified cases.	[Bluemel, Benjamin] Robert Koch Inst, Dept Infect Dis Epidemiol, German FETP, Postgrad Training Appl Epidemiol PAE, Berlin, Germany; [Bluemel, Benjamin] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Bluemel, Benjamin; Diercke, Michaela; Gilsdorf, Andreas] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Sagebiel, Daniel] Berlin State Off Hlth & Social Affairs, Berlin, Germany; [Bluemel, Benjamin] Univ Freiburg, Fac Med, Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany	Robert Koch Institute; European Centre for Disease Prevention & Control; Robert Koch Institute; University of Freiburg	Blumel, B (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, German FETP, Postgrad Training Appl Epidemiol PAE, Berlin, Germany.; Blumel, B (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.; Blumel, B (corresponding author), Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany.; Blumel, B (corresponding author), Univ Freiburg, Fac Med, Med Ctr, Inst Med Microbiol & Hyg, Freiburg, Germany.	benjamin.blumel@gmail.com		Gilsdorf, Andreas/0000-0001-8572-2798; Diercke, Michaela/0000-0002-4678-1813				Altmann M, 2011, EMERG INFECT DIS, V17, P1906, DOI 10.3201/eid1710.111027; [Anonymous], 2004, FRAM TOOLS EV HLTH S; Centers for Disease Control (CDC), 1988, MMWR Suppl, V37, P1; Cui FQ, 2013, VACCINE, V31, pJ79, DOI 10.1016/j.vaccine.2013.05.054; Diercke M, 2014, BUNDESGESUNDHEITSBLA, V57, P1107, DOI 10.1007/s00103-014-2023-3; Diercke M., 2017, EPIDEMIOL B, V30, P291, DOI [DOI 10.17886/EPIBULL-2017-039, DOI 10.17886/EPIBULL-2017-03]; European Centre for Disease Prevention and Control (ECDC), 2014, HDB METH APPL; German R R, 2001, MMWR Recomm Rep, V50, P1; Hauri AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017341; Krause G, 2006, Euro Surveill, V11, P3, DOI 10.2807/esm.11.11.00657-en; Krause G, 2003, GESUNDHEITSWESEN S, V65, pS8, DOI [10.1055/s-2003-38113, DOI 10.1055/S-2003-38113]; Krause G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-129; Krause G, 2007, EMERG INFECT DIS, V13, P1548, DOI 10.3201/eid1310.070253; Mazurek J, 2002, EPIDEMIOL INFECT, V129, P119, DOI 10.1017/S0950268802007124; National Public Health Institute (KTL) of Finland, 2004, PROT EV WID SURV NET; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P707, DOI 10.1007/s00103-013-1673-x; Robert Koch-Institut, 2007, FALLD ROB KOCH I OD; Schumacher J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187037; WHO, 2006, COMM DIS SURV RESP S; Williams CJ, 2009, EPIDEMIOL INFECT, V137, P597, DOI 10.1017/S095026880800112X	20	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212908	10.1371/journal.pone.0212908	http://dx.doi.org/10.1371/journal.pone.0212908			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794677	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100157
J	Martinez, R; Vera-Chang, MN; Haddad, M; Zon, J; Navarro-Martin, L; Trudeau, VL; Mennigen, JA				Martinez, Ruben; Vera-Chang, Marilyn N.; Haddad, Majd; Zon, Jessica; Navarro-Martin, Laia; Trudeau, Vance L.; Mennigen, Jan A.			Developmental fluoxetine exposure in zebrafish reduces offspring basal cortisol concentration via life stage-dependent maternal transmission	PLOS ONE			English	Article							SEROTONIN REUPTAKE INHIBITOR; ENVIRONMENTAL RISK-ASSESSMENT; PITUITARY-INTERRENAL AXIS; DANIO-RERIO; GENE-EXPRESSION; NEUROENDOCRINE RESPONSES; EMBRYONIC-DEVELOPMENT; ANTIDEPRESSANT USE; STRESS REACTIVITY; SOCIAL-STATUS	Fluoxetine (FLX) is a pharmaceutical used to treat affective disorders in humans, but as environmental contaminant also affects inadvertently exposed fish in urban watersheds. In humans and fish, acute FLX treatment and exposure are linked to endocrine disruption, including effects on the reproductive and stress axes. Using the zebrafish model, we build on the recent finding that developmental FLX exposure reduced cortisol production across generations, to determine possible parental and/or life-stage-dependent (age and/or breeding experience) contributions to this phenotype. Specifically, we combined control and developmentally FLX-exposed animals of both sexes (F-0) into four distinct breeding groups mated at 5 and 9 months, and measured offspring (F-1) basal cortisol at 12 dpf. Basal cortisol was lower in F1 descended from developmentally FLX-exposed F-0 females bred at 5, but not 9 months, revealing a maternal, life-stage dependent effect. To investigate potential molecular contributions to this phenotype, we profiled maternally deposited transcripts involved in endocrine stress axis development and regulation, epigenetic (de novo DNA methyltransferases) and post-transcriptional (miRNA pathway components and specific miRNAs) regulation of gene expression in unfertilized eggs. Maternal FLX exposure resulted in decreased transcript abundance of glucocorticoid receptor, dnmt3 paralogues and miRNA pathway components in eggs collected at 5 months, and increased transcript abundance of miRNA pathway components at 9 months. Specific miRNAs predicted to target stress axis transcripts decreased (miR-740) or increased (miR-26, miR-30d, miR-92a, miR-103) in eggs collected from FLX females at 5 months. Increased abundance of miRNA-30d and miRNA-92a persisted in eggs collected from FLX females at 9 months. Clustering and principal component analyses of egg transcript profiles separated eggs collected from FLX-females at 5 months from other groups, suggesting that oocyte molecular signatures, and miRNAs in particular, may serve as predictive tools for the offspring phenotype of reduced basal cortisol in response to maternal FLX exposure.	[Martinez, Ruben; Navarro-Martin, Laia] CSIC, IDAEA, Dept Environm Chem, Barcelona, Spain; [Martinez, Ruben] UB, Dept Cellular Biol Physiol & Immunol, Barcelona, Spain; [Vera-Chang, Marilyn N.; Haddad, Majd; Zon, Jessica; Trudeau, Vance L.; Mennigen, Jan A.] Univ Ottawa, Dept Biol, Ottawa, ON, Canada	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); University of Barcelona; University of Ottawa	Mennigen, JA (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	jan.mennigen@uottawa.ca	Navarro-Martin, Laia/A-3588-2011; Martinez Lopez, Ruben Francisco/R-5986-2018	Navarro-Martin, Laia/0000-0001-6554-8833; Mennigen, Jan/0000-0003-4117-6654; Martinez Lopez, Ruben Francisco/0000-0001-9965-7042; Vera-Chang, Marilyn/0000-0002-5234-9971	FPU predoctoral fellowship [FPU15/03332]; Spanish Ministry of Education, Culture and Sport [EST16/00695, EST17/00830]; Natural Sciences and Engineering Research Council of Canada [2114456-2017]; Canada Foundation of Innovation [148035]; FPU [FPU15/03332]; Natural Sciences and Engineering Research Council of Canada (NSERC) [2114456-2017]; Canada Foundation of Innovation John R. Evans Leaders Fund [148035]	FPU predoctoral fellowship(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry of Education, Culture and Sport; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation of Innovation(Canada Foundation for Innovation); FPU(Spanish Government); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation of Innovation John R. Evans Leaders Fund	RM was supported also by a FPU predoctoral fellowship (www.ciencia.gob.es), grant #FPU15/03332, and research mobility grants from the Spanish Ministry of Education, Culture and Sport (www.mecd.gob.es), grant #EST16/00695 and grant #EST17/00830, respectively. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) under the Discovery Grant program, grant #2114456-2017, and The Canada Foundation of Innovation (www.innovation.ca), under the John R. Evans Leaders Fund (https://www.innovation.ca) program, grant #148035, awarded to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; RM was supported also by a FPU predoctoral fellow (FPU15/03332) and the research stay grants EST16/00695 and EST17/00830 from the Spanish Ministry of Education, Culture and Sport. This work was supported by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC discovery grant #2114456-2017) and The Canada Foundation of Innovation John R. Evans Leaders Fund (grant #148035) to JAM.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Abreu MS, 2017, PEERJ, V5, DOI 10.7717/peerj.3330; Airhart MJ, 2007, NEUROTOXICOL TERATOL, V29, P652, DOI 10.1016/j.ntt.2007.07.005; Airhart MJ, 2012, NEUROTOXICOL TERATOL, V34, P152, DOI 10.1016/j.ntt.2011.08.008; Alboni S, 2017, MOL PSYCHIATR, V22, P552, DOI 10.1038/mp.2015.142; Alderman SL, 2009, GEN COMP ENDOCR, V164, P61, DOI 10.1016/j.ygcen.2009.04.007; Alsop D, 2008, AM J PHYSIOL-REG I, V294, pR711, DOI 10.1152/ajpregu.00671.2007; BALDWIN D, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D1199; Barreiro-Iglesias A, 2015, CELL REP, V13, P924, DOI 10.1016/j.celrep.2015.09.050; Best C, 2018, COMP BIOCHEM PHYS B, V224, P210, DOI 10.1016/j.cbpb.2018.01.006; Binder EB, 2009, PSYCHONEUROENDOCRINO, V34, P99, DOI 10.1016/j.psyneuen.2009.05.021; Brooks B. W., 2005, ENV TOXICOL CHEM; Brooks BW, 2014, AQUAT TOXICOL, V151, P61, DOI 10.1016/j.aquatox.2014.01.007; Byatt N, 2013, ACTA PSYCHIAT SCAND, V127, P94, DOI 10.1111/acps.12042; Crago J, 2018, CHEMOSPHERE, V193, P1226, DOI 10.1016/j.chemosphere.2017.11.043; Craig PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095351; Cunha V, 2016, AQUAT TOXICOL, V178, P182, DOI 10.1016/j.aquatox.2016.08.003; Currie Janet, 2005, MARKETIZATION DEPRES; Damjanoska KJ, 2003, J PHARMACOL EXP THER, V306, P563, DOI 10.1124/jpet.103.050534; de Abreu MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103232; De Assis H. C.Silva, 2013, ENVIRON SCI TECHNOL, V47, P5372, DOI DOI 10.1021/ES3044888; Despic V, 2018, J CELL SCI, V131, DOI 10.1242/jcs.201996; DeVane CL, 1999, CELL MOL NEUROBIOL, V19, P443, DOI 10.1023/A:1006934807375; Dinan TG, 1996, LIFE SCI, V58, P1683, DOI 10.1016/0024-3205(96)00066-5; Duncan GE, 1998, J PHARMACOL EXP THER, V285, P579; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Etain B, 2001, ENCEPHALE, V27, P280; Ewing G, 2015, CLIN PHARMACOKINET, V54, P359, DOI 10.1007/s40262-014-0233-3; Facchinello N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04535-6; Faught E, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160032; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freimer JW, 2018, CURR BIOL, V28, P296, DOI 10.1016/j.cub.2017.11.067; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gobinath AR, 2016, NEUROPHARMACOLOGY, V101, P165, DOI 10.1016/j.neuropharm.2015.09.001; Harvey SA, 2013, DEVELOPMENT, V140, P2703, DOI 10.1242/dev.095091; Henry TB, 2008, ARCH ENVIRON CON TOX, V54, P325, DOI 10.1007/s00244-007-9018-0; Herculano AM, 2014, PROG NEURO-PSYCHOPH, V55, P50, DOI 10.1016/j.pnpbp.2014.03.008; Hiemke C, 2000, PHARMACOL THERAPEUT, V85, P11, DOI 10.1016/S0163-7258(99)00048-0; Homberg JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016646; Huang SSY, 2017, AQUAT TOXICOL, V182, P102, DOI 10.1016/j.aquatox.2016.11.016; Jeffrey JD, 2016, J EXP BIOL, V219, P1734, DOI 10.1242/jeb.138826; Jorgensen HS, 2007, DAN MED BULL, V54, P266; Kendrick T, 2015, J AFFECT DISORDERS, V186, P171, DOI 10.1016/j.jad.2015.06.052; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaepen L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057608; Kostyniuk DJ, 2018, AM J PHYSIOL-REG I, V315, pR241, DOI 10.1152/ajpregu.00402.2017; Kreke N, 2008, CRIT REV TOXICOL, V38, P215, DOI 10.1080/10408440801891057; Kristensen JH, 1999, BRIT J CLIN PHARMACO, V48, P521, DOI 10.1046/j.1365-2125.1999.00040.x; Lee MT, 2014, ANNU REV CELL DEV BI, V30, P581, DOI 10.1146/annurev-cellbio-100913-013027; Li Q, 1996, J PHARMACOL EXP THER, V279, P1035; Li YX, 2012, GENOME RES, V22, P1899, DOI 10.1101/gr.128488.111; Lillesaar C, 2011, J CHEM NEUROANAT, V41, P294, DOI 10.1016/j.jchemneu.2011.05.009; Lim JE, 2013, GEN COMP ENDOCR, V192, P246, DOI 10.1016/j.ygcen.2013.08.008; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lykke-Andersen K, 2008, MOL BIOL CELL, V19, P4383, DOI 10.1091/mbc.E08-02-0219; Marvanova Marketa, 2018, Ment Health Clin, V8, P127, DOI 10.9740/mhc.2018.05.127; Matthews SG, 2012, EXP NEUROL, V233, P95, DOI 10.1016/j.expneurol.2011.01.009; McDonald MD, 2017, COMP BIOCHEM PHYS C, V197, P19, DOI 10.1016/j.cbpc.2017.03.007; Mennigen JA, 2018, BIOMED CTR, V17, P18, DOI DOI 10.1186/S12940-018-0362-5; Mennigen JA, 2017, COMP BIOCHEM PHYS C, V202, P70, DOI 10.1016/j.cbpc.2017.08.003; Mennigen JA, 2011, J TOXICOL ENV HEAL B, V14, P387, DOI 10.1080/10937404.2011.578559; Mennigen JA, 2010, AQUAT TOXICOL, V100, P354, DOI 10.1016/j.aquatox.2010.08.016; Metcalfe CD, 2010, ENVIRON TOXICOL CHEM, V29, P79, DOI 10.1002/etc.27; Mishra P, 2017, CHEMOSPHERE, V188, P157, DOI 10.1016/j.chemosphere.2017.08.149; Nakamura Y, 2008, CHEMOSPHERE, V70, P865, DOI 10.1016/j.chemosphere.2007.06.089; Nesan D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22582; Nesan D, 2013, GEN COMP ENDOCR, V181, P35, DOI 10.1016/j.ygcen.2012.10.006; Oakes Ken D., 2010, Integrated Environmental Assessment and Management, V6, P524, DOI 10.1002/ieam.77; Pan CY, 2018, CHEMOSPHERE, V205, P8, DOI 10.1016/j.chemosphere.2018.04.082; Park JW, 2012, ENVIRON POLLUT, V167, P163, DOI 10.1016/j.envpol.2012.03.039; Pasquier J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2709-z; Paterson G, 2008, CHEMOSPHERE, V74, P125, DOI 10.1016/j.chemosphere.2008.08.022; Pawluski JL, 2012, NEUROSCIENCE, V220, P131, DOI 10.1016/j.neuroscience.2012.06.034; Pelegri F, 2016, METHOD CELL BIOL, V135, P39, DOI 10.1016/bs.mcb.2016.05.006; Pinzon N, 2017, GENOME RES, V27, P234, DOI 10.1101/gr.205146.116; Pratt Laura A, 2017, NCHS Data Brief, P1; Presslauer C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43850; Raap DK, 1999, J PHARMACOL EXP THER, V288, P561; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Raz E, 2006, CURR OPIN GENET DEV, V16, P355, DOI 10.1016/j.gde.2006.06.007; Rodgers AB, 2015, P NATL ACAD SCI USA, V112, P13699, DOI 10.1073/pnas.1508347112; Safarinejad MR, 2008, J UROLOGY, V180, P2124, DOI 10.1016/j.juro.2008.07.034; Santos D, 2017, AQUAT TOXICOL, V191, P141, DOI 10.1016/j.aquatox.2017.08.005; Schultz MM, 2010, ENVIRON SCI TECHNOL, V44, P1918, DOI 10.1021/es9022706; Sebire M, 2015, AQUAT TOXICOL, V168, P78, DOI 10.1016/j.aquatox.2015.09.009; Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099; Sepede G, 2016, CLIN NEUROPHARMACOL, V39, P241, DOI 10.1097/WNF.0000000000000173; Silva LJG, 2015, ENVIRON POLLUT, V197, P127, DOI 10.1016/j.envpol.2014.12.002; Smith EM, 2012, AQUAT TOXICOL, V109, P259, DOI 10.1016/j.aquatox.2011.08.022; Sopinka NM, 2017, PHYSIOL BIOCHEM ZOOL, V90, P15, DOI 10.1086/689994; Steenbergen PJ, 2011, PROG NEURO-PSYCHOPH, V35, P1432, DOI 10.1016/j.pnpbp.2010.10.010; Szymanska M, 2009, PSYCHONEUROENDOCRINO, V34, P822, DOI 10.1016/j.psyneuen.2008.12.012; The Australian Bureau of Statistics Bureau, 2011, 4329000003 AUSTR BUR; Theodoridi A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00223; Vera-Chang MN, 2018, P NATL ACAD SCI USA, V115, pE12435, DOI 10.1073/pnas.1811695115; Vilhelmsson Andreas, 2013, Front Public Health, V1, P30, DOI 10.3389/fpubh.2013.00030; Weinberger J, 2014, AQUAT TOXICOL, V151, P77, DOI 10.1016/j.aquatox.2013.10.012; Wilson KS, 2016, J ENDOCRINOL, V230, P125, DOI 10.1530/JOE-15-0376; Wilson KS, 2013, J PHYSIOL-LONDON, V591, P6209, DOI 10.1113/jphysiol.2013.256826; Winberg S, 1997, NEUROSCI LETT, V230, P113, DOI 10.1016/S0304-3940(97)00488-6; Winberg S, 2016, CURR ZOOL, V62, P317, DOI 10.1093/cz/zow037; Wong DT, 2005, NAT REV DRUG DISCOV, V4, P764, DOI 10.1038/nrd1821; Wong RY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-348; Workman JL, 2016, NEUROPHARMACOLOGY, V105, P443, DOI 10.1016/j.neuropharm.2015.11.027; Wu MH, 2017, AQUAT TOXICOL, V192, P274, DOI 10.1016/j.aquatox.2017.09.027; Yonkers KA, 2014, ANNU REV CLIN PSYCHO, V10, P369, DOI 10.1146/annurev-clinpsy-032813-153626; Yoshida K, 1998, BRIT J PSYCHIAT, V172, P175, DOI 10.1192/bjp.172.2.175; Young EA, 2004, PSYCHONEUROENDOCRINO, V29, P1198, DOI 10.1016/j.psyneuen.2004.02.002; Zoega H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144474; Zou C, 2013, NEUROPSYCH DIS TREAT, V9, P1661, DOI 10.2147/NDT.S38899	111	12	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212577	10.1371/journal.pone.0212577	http://dx.doi.org/10.1371/journal.pone.0212577			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789953	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800042
J	Wetterauer, C; Winkel, DJ; Federer-Gsponer, JR; Halla, A; Subotic, S; Deckart, A; Seifert, HH; Boll, DT; Ebbing, J				Wetterauer, C.; Winkel, D. J.; Federer-Gsponer, J. R.; Halla, A.; Subotic, S.; Deckart, A.; Seifert, H. H.; Boll, D. T.; Ebbing, J.			Structured reporting of prostate magnetic resonance imaging has the potential to improve interdisciplinary communication	PLOS ONE			English	Article							MRI; RADIOLOGY; IMPACT	Background Effective interdisciplinary communication of imaging findings is vital for patient care, as referring physicians depend on the contained information for the decision-making and subsequent treatment. Traditional radiology reports contain non-structured free text and potentially tangled information in narrative language, which can hamper the information transfer and diminish the clarity of the report. Therefore, this study investigates whether newly developed structured reports (SRs) of prostate magnetic resonance imaging (MRI) can improve interdisciplinary communication, as compared to non-structured reports (NSRs). Methods 50 NSRs and 50 SRs describing a single prostatic lesion were presented to four urologists with expert level experience in prostate cancer surgery or targeted MRI TRUS fusion biopsy. They were subsequently asked to plot the tumor location in a 2-dimensional prostate diagram and to answer a questionnaire focusing on information on clinically relevant key features as well as the perceived structure of the report. A validated scoring system that distinguishes between "major" and "minor" mistakes was used to evaluate the accuracy of the plotting of the tumor position in the prostate diagram. Results The mean total score for accuracy for SRs was significantly higher than for NSRs (28.46 [range 13.33-30.0] vs. 21.75 [range 0.0-30.0], p < 0.01). The overall rates of major mistakes (54% vs. 10%) and minor mistakes (74% vs. 22%) were significantly higher (p < 0.01) for NSRs than for SRs. The rate of radiologist re-consultations was significantly lower (p < 0.01) for SRs than for NSRs (19% vs. 85%). Furthermore, SRs were rated as significantly superior to NSRs in regard to determining the clinical tumor stage (p < 0.01), the quality of the summary (4.4 vs. 2.5; p < 0.01), and overall satisfaction with the report (4.5 vs. 2.3; p < 0.01), and as more valuable for further clinical decision-making and surgical planning (p < 0.01). Conclusions Structured reporting of prostate MRI has the potential to improve interdisciplinary communication. Through SRs, expert urologists were able to more accurately assess the exact location of single prostate cancer lesions, which can facilitate surgical planning. Furthermore, structured reporting of prostate MRI leads to a higher satisfaction level of the referring physician.	[Wetterauer, C.; Federer-Gsponer, J. R.; Halla, A.; Subotic, S.; Deckart, A.; Seifert, H. H.; Ebbing, J.] Urol Univ Clin Basel Liestal, Univ Basel Hosp, Basel, Switzerland; [Winkel, D. J.; Boll, D. T.] Univ Hosp Basel, Dept Radiol, Basel, Switzerland	University of Basel; University of Basel	Winkel, DJ (corresponding author), Univ Hosp Basel, Dept Radiol, Basel, Switzerland.	davidjean.winkel@usb.ch		Wetterauer, Christian/0000-0003-2947-4245				Ahmed HU, 2017, LANCET, V389, P815, DOI 10.1016/S0140-6736(16)32401-1; Barentsz JO, 2012, EUR RADIOL, V22, P746, DOI 10.1007/s00330-011-2377-y; Brook OR, 2015, RADIOLOGY, V274, P464, DOI 10.1148/radiol.14140206; Ebbing J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199477; Faggioni L, 2017, EUR RADIOL, V27, P1934, DOI 10.1007/s00330-016-4553-6; Franconeri A, 2018, EUR RADIOL, V28, P3009, DOI 10.1007/s00330-017-5161-9; Ganeshan D, 2018, ACAD RADIOL, V25, P66, DOI 10.1016/j.acra.2017.08.005; Gassenmaier S, 2017, EUR RADIOL, V27, P4110, DOI 10.1007/s00330-017-4778-z; Hawkins CM, 2014, J DIGIT IMAGING, V27, P581, DOI 10.1007/s10278-014-9699-7; James JT, 2013, J PATIENT SAF, V9, P122, DOI 10.1097/PTS.0b013e3182948a69; Magnetta MJ, 2018, AM J ROENTGENOL, V210, P108, DOI 10.2214/AJR.17.18260; Norenberg D, 2017, INVEST RADIOL, V52, P232, DOI 10.1097/RLI.0000000000000336; Powell DK, 2015, ACAD RADIOL, V22, P226, DOI 10.1016/j.acra.2014.08.014; Sahni VA, 2015, AM J ROENTGENOL, V205, P584, DOI 10.2214/AJR.14.14053; Schwartz LH, 2011, RADIOLOGY, V260, P174, DOI 10.1148/radiol.11101913; Spilseth B, 2018, AM J ROENTGENOL, V210, P101, DOI 10.2214/AJR.17.18241; Weinreb JC, 2016, EUR UROL, V69, P16, DOI 10.1016/j.eururo.2015.08.052; Zhang L, 2017, EUR RADIOL, V27, P5204, DOI 10.1007/s00330-017-4843-7	18	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212444	10.1371/journal.pone.0212444	http://dx.doi.org/10.1371/journal.pone.0212444			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779810	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900056
J	Schnittert, J; Bansal, R; Mardhian, DF; van Baarlen, J; Ostman, A; Prakash, J				Schnittert, Jonas; Bansal, Ruchi; Mardhian, Deby F.; van Baarlen, Joop; Ostman, Arne; Prakash, Jai			Integrin 11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer	FASEB JOURNAL			English	Article						tumor microenvironment; cancer-associated fibroblasts; transforming growth factor; cell migration; metastasis	FIBROBLASTS; FIBROSIS; CARCINOMA; MYOFIBROBLASTS; EXPRESSION; TARGETS; BIOLOGY; TISSUE	Pancreatic ductal adenocarcinoma (PDAC) is the deadliest tumor due to its highly abundant tumor stroma. Pancreatic stellate cells (PSCs) are considered precursor cells of cancer-associated fibroblasts (CAFs), which induce tumor progression, invasion, and metastasis. In this study, we investigated the role of integrin subunit (ITGA) 11, the receptor for collagen type I, in tumor stroma interaction. Clinical sample analysis showed that ITGA11 was overexpressed by CAFs in PDAC stroma, as shown with colocalization immunostaining with -smooth muscle actin. In contrast, there was no expression in healthy pancreas. Public transcriptomic data confirmed a reduced expression of ITGA11 in healthy pancreas and adjacent nontumoral tissues compared with human tumor tissues. Primary human PSCs (hPSCs) activated with either TGF- or pancreatic cancer cell (PANC-1)-conditioned medium (CM) resulted in the significant up-regulation of ITGA11 and various CAF markers. Furthermore, short hairpin RNA (shRNA)-mediated stable ITGA11 knockdown (shITGA11) in hPSCs significantly inhibited TGF-- and PANC-1 CM-mediated activation at both gene and protein levels of extracellular matrix, cytokines, and adhesion molecules. Additionally, shITGA11 hPSCs had a reduced migration and contractility compared with shRNA control (shCTR) PSCs. Furthermore, we investigated the effect of ITGA11 on the paracrine effects of hPSCs. Interestingly, the CM from shITGA11 hPSCs, activated with either TGF- or PANC-1 CM, caused tumor cells to migrate and invade lesser compared with their counterpart, activated shCTR PSCs. In summary, this study presents ITGA11 as an interesting stromal therapeutic target that plays a crucial role in the regulation of the differentiation of PSCs into CAFs and paracrine effects.Schnittert, J., Bansal, R., Mardhian, D. F., van Baarlen, J., ostman, A., Prakash, J. Integrin 11 in pancreatic stellate cells regulates tumor stroma interaction in pancreatic cancer.	[Schnittert, Jonas; Bansal, Ruchi; Mardhian, Deby F.; Prakash, Jai] Univ Twente, Dept Biomat Sci & Technol, TechMed Ctr, Targeted Therapeut Sect,Fac Sci & Technol, Zuidhorst 254, NL-7500 AE Enschede, Netherlands; [van Baarlen, Joop] Lab Pathol East Netherlands LabPON, Hengelo, Netherlands; [Ostman, Arne; Prakash, Jai] Karolinska Inst, Dept Oncol Pathol, Canc Ctr Karolinska, Stockholm, Sweden	University of Twente; Karolinska Institutet	Prakash, J (corresponding author), Univ Twente, Dept Biomat Sci & Technol, TechMed Ctr, Targeted Therapeut Sect,Fac Sci & Technol, Zuidhorst 254, NL-7500 AE Enschede, Netherlands.	j.prakash@utwente.nl	Mardhian, Deby/AAD-6215-2022; Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016	Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876; Mardhian, Deby/0000-0003-0162-4926	Swedish Research Council [2011-5389]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Swedish Research Council (Project 2011-5389). J.P. is a founder and stakeholder of ScarTec Therapeutics (Enschede). The remaining authors declare no conflicts of interest.	Apte MV, 2013, GASTROENTEROLOGY, V144, P1210, DOI 10.1053/j.gastro.2012.11.037; Apte MV, 2012, J GASTROEN HEPATOL, V27, P69, DOI 10.1111/j.1440-1746.2011.07000.x; Bachem MG, 2005, GASTROENTEROLOGY, V128, P907, DOI 10.1053/j.gastro.2004.12.036; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Bansal R, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.213; Bansal R, 2011, J CONTROL RELEASE, V154, P233, DOI 10.1016/j.jconrel.2011.05.027; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Conroy KP, 2016, CELL TISSUE RES, V365, P511, DOI 10.1007/s00441-016-2407-9; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Habisch Hansjorg, 2010, Cancers (Basel), V2, P1661, DOI 10.3390/cancers2031661; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Juuti A, 2004, J CLIN PATHOL, V57, P1151, DOI 10.1136/jcp.2003.015818; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kuninty PR, 2016, ONCOTARGET, V7, P16396, DOI 10.18632/oncotarget.7651; Kuninty PR, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00003; Lu N, 2010, MATRIX BIOL, V29, P166, DOI 10.1016/j.matbio.2009.11.003; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Navab R, 2016, ONCOGENE, V35, P1899, DOI 10.1038/onc.2015.254; Neesse A, 2013, P NATL ACAD SCI USA, V110, P12325, DOI 10.1073/pnas.1300415110; Netti PA, 2000, CANCER RES, V60, P2497; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Ohlund D, 2017, J EXP MED, V214, P579, DOI 10.1084/jem.20162024; Parajuli H, 2017, J ORAL PATHOL MED, V46, P267, DOI 10.1111/jop.12493; Prakash J, 2016, TRENDS CANCER, V2, P277, DOI 10.1016/j.trecan.2016.04.005; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Reed NI, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5094; Sarper M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27639; Schnittert J, 2018, ADV DRUG DELIVER REV, V129, P37, DOI 10.1016/j.addr.2018.01.020; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Shields MA, 2012, BIOCHEM J, V441, P541, DOI 10.1042/BJ20111240; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Xie DH, 2015, GENES DIS, V2, P133, DOI 10.1016/j.gendis.2015.01.002; Yazdani S, 2017, ADV DRUG DELIVER REV, V121, P101, DOI 10.1016/j.addr.2017.07.010; Zhang G, 2013, CLIN CANCER RES, V19, P4983, DOI 10.1158/1078-0432.CCR-13-0209; Zhang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031507	44	27	27	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6609	6621		10.1096/fj.201802336R	http://dx.doi.org/10.1096/fj.201802336R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30808244				2022-12-26	WOS:000466932600063
J	Zhang, HZ; Ren, LL; Ding, Y; Li, FY; Chen, XF; Ouyang, Y; Zhang, Y; Zhang, DS				Zhang, Huizhong; Ren, Liangliang; Ding, Ya; Li, Fengyan; Chen, Xiangfu; Ouyang, Ying; Zhang, Yan; Zhang, Dongsheng			Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGF/Smad2-induced epithelial-mesenchymal transition in gastric cancer	FASEB JOURNAL			English	Article						HMMR; chemoresistance; EMT; cancer stem cell	TGF-BETA; STEM-CELLS; RHAMM; METASTASIS; CHEMORADIOTHERAPY; CHEMORESISTANCE; ADENOCARCINOMA; TUMORIGENICITY; IDENTIFICATION; HETEROGENEITY	Chemotherapy is one of the vital treatments for gastric cancer (GC) patients, especially those suffering advanced stages. Chemoresistance results in tumor relapse, leading to poor prognosis in GC patients; thus, identifying key regulators in this process might provide novel clues for GC therapy. Herein, we identify hyaluronan-mediated motility receptor (HMMR) as a key regulator of chemoresistance in GC. HMMR was found to be substantially up-regulated in 5-fluorouracil (5-Fu)-resistant GC biopsies and cell lines. High expression of HMMR significantly correlates with tumor relapse and predicts poorer prognosis in GC patients. Moreover, we observed that HMMR induced epithelial-mesenchymal transition and increased the cancer stem cell properties of GC, thus rendering resistance to chemotherapy. Importantly, silencing of HMMR effectively increased the susceptibility to 5-Fu therapy both in vitro and in vivo. Furthermore, we demonstrated that HMMR activates the TGF-/Smad2 signaling pathway, which was required for the HMMR-mediated oncogenic effects and exhibited significant clinical relevance with HMMR expression. These findings reveal a critical role for HMMR in the chemoresistance of GC and suggest that HMMR might be a potential prognostic marker or therapeutic target against the disease.Zhang, H., Ren, L., Ding, Y., Li, F., Chen, X., Ouyang, Y., Zhang, Y., Zhang, D. Hyaluronan-mediated motility receptor confers resistance to chemotherapy via TGF/Smad2-induced epithelial-mesenchymal transition in gastric cancer.	[Zhang, Huizhong; Ren, Liangliang; Ding, Ya; Li, Fengyan; Chen, Xiangfu; Ouyang, Ying; Zhang, Dongsheng] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, 651 Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China; [Zhang, Huizhong] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Ding, Ya] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Biotherapy, Guangzhou, Guangdong, Peoples R China; [Li, Fengyan] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Radiat Oncol, Guangzhou, Guangdong, Peoples R China; [Zhang, Dongsheng] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, Dept Med Oncol,State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Ren, Liangliang] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Biochem, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Yan] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhang, DS (corresponding author), Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, 651 Dongfeng Rd, Guangzhou 510060, Guangdong, Peoples R China.; Zhang, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Dept Med Oncol, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, 26 Yuancun Erheng Rd, Guangzhou 510655, Guangdong, Peoples R China.	zhangy338@mail.sysu.edu.cn; zhangdsh@sysucc.org.cn	LI, feng/HIR-1703-2022; Ren, Liangliang/AAR-6436-2020	Ren, Liangliang/0000-0001-6219-4304	China Cancer Society Fund [201606]; Nature Science Foundation of China [81602141]; Natural Science Foundation of Guangdong Province [2016A030308002]	China Cancer Society Fund; Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the China Cancer Society Fund (201606), Nature Science Foundation of China (81602141), and the Natural Science Foundation of Guangdong Province (2016A030308002). The authors declare no conflict of interest.	Abraham I, 2002, NEW ENGL J MED, V346, P210; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Assmann V, 1999, J CELL SCI, V112, P3943; Bekaii-Saab T, 2017, CANCER-AM CANCER SOC, V123, P1303, DOI 10.1002/cncr.30538; Blanco I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120020; Buttermore ST, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0360-1; Cai JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15870; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Corso S, 2016, TRENDS MOL MED, V22, P534, DOI 10.1016/j.molmed.2016.05.004; Easwaran H, 2014, MOL CELL, V54, P716, DOI 10.1016/j.molcel.2014.05.015; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Gust KM, 2009, NEOPLASIA, V11, P956, DOI 10.1593/neo.09694; Hayashida T, 2003, FASEB J, V17, P1576, DOI 10.1096/fj.03-0037fje; Huang Hao, 2016, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V38, P739, DOI 10.3881/j.issn.1000-503X.2016.06.020; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Kim TY, 2015, EXPERT REV GASTROENT, V9, P1471, DOI 10.1586/17474124.2015.1096774; Koelzer VH, 2015, HUM PATHOL, V46, P1573, DOI 10.1016/j.humpath.2015.07.010; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Li CY, 2016, MED SCI MONITOR, V22, P4509, DOI 10.12659/MSM.898415; Lloyd DAJ, 2006, NEW ENGL J MED, V355, P1387; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MAXWELL C, 2011, S B, V9, DOI DOI 10.1371/JOURNAL.PBIO.1001199; Misra S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00201; Mitra T, 2018, J CELL BIOCHEM, V119, P5775, DOI 10.1002/jcb.26753; Niedworok C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075681; Orditura M, 2014, WORLD J GASTROENTERO, V20, P1635, DOI 10.3748/wjg.v20.i7.1635; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Peitzsch C, 2017, SEMIN CANCER BIOL, V44, P10, DOI 10.1016/j.semcancer.2017.02.011; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Purnell MC, 2017, DISCOV MED, V23, P259; Qiu Zhen-Qin, 2015, Asian Pac J Cancer Prev, V16, P3447; Scheel C, 2012, SEMIN CANCER BIOL, V22, P396, DOI 10.1016/j.semcancer.2012.04.001; Schutze A, 2016, ONCOTARGET, V7, P21428, DOI 10.18632/oncotarget.7258; Shah MA, 2015, J CLIN ONCOL, V33, P1760, DOI 10.1200/JCO.2014.60.1799; Stavropoulou V, 2016, CANCER CELL, V30, P43, DOI 10.1016/j.ccell.2016.05.011; Stevens LE, 2017, CANCER RES, V77, P1905, DOI 10.1158/0008-5472.CAN-16-1978; Sun WJ, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0147-6; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Tang YA, 2018, P NATL ACAD SCI USA, V115, pE5990, DOI 10.1073/pnas.1801348115; Tilghman J, 2014, CANCER RES, V74, P3168, DOI 10.1158/0008-5472.CAN-13-2103; Tolg C, 2006, J CELL BIOL, V175, P1017, DOI 10.1083/jcb.200511027; Tolg C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/103923; Unternaehrer JJ, 2014, STEM CELL REP, V3, P691, DOI 10.1016/j.stemcr.2014.09.008; Xiao YB, 2018, MOL MED REP, V17, P6379, DOI 10.3892/mmr.2018.8726; YANG BH, 1994, EMBO J, V13, P286, DOI 10.1002/j.1460-2075.1994.tb06261.x; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhuang JL, 2017, THERANOSTICS, V7, P3053, DOI 10.7150/thno.19542	52	33	34	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6365	6377		10.1096/fj.201802186R	http://dx.doi.org/10.1096/fj.201802186R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802150	Bronze			2022-12-26	WOS:000466932600044
J	Kim, SSY; Sze, L; Lam, KP				Kim, Susana Soo-Yeon; Sze, Lynette; Lam, Kong-Peng			The stress granule protein G3BP1 binds viral dsRNA and RIG-I to enhance interferon- response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						innate immunity; viral immunology; RIG-I-like receptor (RLR); interferon; double-stranded RNA (dsRNA)	ENDORIBONUCLEASE G3BP; RNA; PHOSPHORYLATION; INDUCTION; COMPLEXES; MEDIATE	RIG-I senses viral RNA in the cytosol and initiates host innate immune response by triggering the production of type 1 interferon. A recent RNAi knockdown screen yielded close to hundred host genes whose products affected viral RNA-induced IFN- production and highlighted the complexity of the antiviral response. The stress granule protein G3BP1, known to arrest mRNA translation, was identified as a regulator of RIG-I-induced IFN- production. How G3BP1 functions in RIG-I signaling is not known, however. Here, we overexpress G3BP1 with RIG-I in HEK293T cells and found that G3BP1 significantly enhances RIG-I-induced ifn-b mRNA synthesis. More importantly, we demonstrate that G3BP1 binds RIG-I and that this interaction involves the C-terminal RGG domain of G3BP1. Confocal microscopy studies also show G3BP1 co-localization with RIG-I and with infecting vesicular stomatitis virus in Cos-7 cells. Interestingly, immunoprecipitation studies using biotin-labeled viral dsRNA or poly(I<bold>C</bold>) and cell lysate-derived or in vitro translated G3BP1 indicated that G3BP1 could directly bind these substrates and again via its RGG domain. Computational modeling further revealed a juxtaposed interaction between G3BP1 RGG and RIG-I RNA-binding domains. Together, our data reveal G3BP1 as a critical component of RIG-I signaling and possibly acting as a co-sensor to promote RIG-I recognition of pathogenic RNA.	[Kim, Susana Soo-Yeon; Sze, Lynette; Lam, Kong-Peng] ASTAR, Immunol Grp, Bioproc Technol Inst, Singapore, Singapore; [Lam, Kong-Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Lam, Kong-Peng] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Kim, SSY; Lam, KP (corresponding author), Bioproc Technol Inst, 20 Biopolis Way, Singapore 138668, Singapore.	Susana_kim@bti.a-star.edu.sg; lam_kong_peng@bti.a-star.edu.sg			Agency for Science, Technology and Research	Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research. The authors declare that they have no conflicts of interest with the contents of this article.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Brierley MM, 2002, J INTERF CYTOK RES, V22, P835, DOI 10.1089/107999002760274845; Cobos Jimenez V., 2015, RNA VIROLOGY, V486, P94, DOI [10.1016/j.virol.2015.09.007 26432022, DOI 10.1016/J.VIROL.2015.09.007]; Dinh PX, 2013, J VIROL, V87, P372, DOI 10.1128/JVI.02305-12; Dougherty JD, 2015, VIRUSES-BASEL, V7, P6127, DOI 10.3390/v7122922; Gadaleta P, 2002, VIRUS RES, V86, P87, DOI 10.1016/S0168-1702(02)00049-7; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kim SSY, 2014, J IMMUNOL, V193, P840, DOI 10.4049/jimmunol.1301601; Lee KG, 2015, CELL REP, V10, P1055, DOI 10.1016/j.celrep.2015.01.039; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Liu ZS, 2019, NAT IMMUNOL, V20, P18, DOI 10.1038/s41590-018-0262-4; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Lu C, 2011, NUCLEIC ACIDS RES, V39, P1565, DOI 10.1093/nar/gkq974; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; Nikolic J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005942; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oshiumi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014258; Ozdilek BA, 2017, NUCLEIC ACIDS RES, V45, P7984, DOI 10.1093/nar/gkx460; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Ramachandran B, 2018, J BIOL CHEM, V293, P7942, DOI 10.1074/jbc.RA118.002046; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; van der Lee R, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004553; Yagi R, 2018, NUCLEIC ACIDS RES, V46, P5894, DOI 10.1093/nar/gky391; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	34	48	52	3	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6430	6438		10.1074/jbc.RA118.005868	http://dx.doi.org/10.1074/jbc.RA118.005868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30804210	Green Published, hybrid			2022-12-26	WOS:000468402000020
J	McCoy, JC; Walker, RG; Murray, NH; Thompson, TB				McCoy, Jason C.; Walker, Ryan G.; Murray, Nathan H.; Thompson, Thomas B.			Crystal structure of the WFIKKN2 follistatin domain reveals insight into how it inhibits growth differentiation factor 8 (GDF8) and GDF11	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						transforming growth factor beta (TGF-); protein structure; X-ray crystallography; inhibitor; myostatin; structural biology; muscle development; tissue homeostasis; GDF8; GDF11; WFIKKN; follistatin; antagonism	MUSCLE MASS; DAN-FAMILY; ACTIVIN-A; PROTEINASE-INHIBITOR; EXTRACELLULAR DOMAIN; SKELETAL-MUSCLE; MYOSTATIN; COMPLEX; BINDING; CANCER	Growth differentiation factor 8 (GDF8; also known as myostatin) and GDF11 are closely related members of the transforming growth factor (TGF-) family. GDF8 strongly and negatively regulates skeletal muscle growth, and GDF11 has been implicated in various age-related pathologies such as cardiac hypertrophy. GDF8 and GDF11 signaling activities are controlled by the extracellular protein antagonists follistatin; follistatin-like 3 (FSTL3); and WAP, follistatin/kazal, immunoglobulin, Kunitz, and netrin domain-containing (WFIKKN). All of these proteins contain a follistatin domain (FSD) important for ligand binding and antagonism. Here, we investigated the structure and function of the FSD from murine WFIKKN2 and compared it with the FSDs of follistatin and FSTL3. Using native gel shift and surface plasmon resonance analyses, we determined that the WFIKKN2 FSD can interact with both GDF8 and GDF11 and block their interactions with the type II receptor activin A receptor type 2B (ActRIIB). Further, we solved the crystal structure of the WFIKKN2 FSD to 1.39 resolution and identified surface-exposed residues that, when substituted with alanine, reduce antagonism of GDF8 in full-length WFIKKN2. Comparison of the WFIKKN2 FSD with those of follistatin and FSTL3 revealed differences in both the FSD structure and position of residues within the domain that are important for ligand antagonism. Taken together, our results indicate that both WFIKKN and follistatin utilize their FSDs to block the type II receptor but do so via different binding interactions.	[McCoy, Jason C.; Walker, Ryan G.; Murray, Nathan H.; Thompson, Thomas B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA; [Walker, Ryan G.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Murray, Nathan H.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University System of Ohio; University of Cincinnati; Harvard University; University of Wisconsin System; University of Wisconsin Madison	Thompson, TB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA.	Tom.Thompson@uc.edu		Murray, Nathan/0000-0001-7185-2591; Thompson, Thomas/0000-0002-7041-5047	NIGMS, National Institutes of Health [R01 GM114640]; American Heart Association [12PRE11790027, 18PRE33990312]; Elevian; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127726, R01GM114640] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); Elevian; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant R01 GM114640 and American Heart Association Grants 12PRE11790027 (to R.G.W.) and 18PRE33990312 (to J.C.M.). Thomas B. Thompson is a consultant for Acceleron Pharma. Ryan G. Walker is a co-founder, scientific advisor, and holder of private equity in Elevian, a company that aims to develop medicines to restore regenerative capacity. Elevian provides sponsored research support for R.G.W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; [Anonymous], 2018, PYMOL MOL GRAPHICS S; Brun C, 2014, CELL PHYSIOL BIOCHEM, V34, P1241, DOI 10.1159/000366335; Cash JN, 2012, MOL ENDOCRINOL, V26, P1167, DOI 10.1210/me.2012-1061; Cash JN, 2012, J BIOL CHEM, V287, P1043, DOI 10.1074/jbc.M111.270801; Cash JN, 2009, EMBO J, V28, P2662, DOI 10.1038/emboj.2009.205; Chang CB, 2003, DEV BIOL, V255, P1, DOI 10.1016/S0012-1606(02)00075-1; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Costelli P, 2008, EUR J CLIN INVEST, V38, P531, DOI 10.1111/j.1365-2362.2008.01970.x; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Geng Y, 2011, P NATL ACAD SCI USA, V108, P7058, DOI 10.1073/pnas.1007293108; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Hill JJ, 2003, MOL ENDOCRINOL, V17, P1144, DOI 10.1210/me.2002-0366; Hinck AP, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022103; Ibrahim BS, 2004, BIOCHEM BIOPH RES CO, V313, P8, DOI 10.1016/j.bbrc.2003.11.082; JOHANSSON MW, 1994, EUR J BIOCHEM, V223, P389, DOI 10.1111/j.1432-1033.1994.tb19005.x; Kattamuri C, 2012, J MOL BIOL, V424, P313, DOI 10.1016/j.jmb.2012.10.003; Keutmann HT, 2004, MOL ENDOCRINOL, V18, P228, DOI 10.1210/me.2003-0112; Kondas K, 2008, J BIOL CHEM, V283, P23677, DOI 10.1074/jbc.M803025200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lee YS, 2013, P NATL ACAD SCI USA, V110, pE3713, DOI 10.1073/pnas.1309907110; Loumaye A, 2015, J CLIN ENDOCR METAB, V100, P2030, DOI 10.1210/jc.2014-4318; Lu L, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00205; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; McPherron AC, 1997, P NATL ACAD SCI USA, V94, P12457, DOI 10.1073/pnas.94.23.12457; Mendell JR, 2015, MOL THER, V23, P192, DOI 10.1038/mt.2014.200; Miura T, 2006, BIOCHEM BIOPH RES CO, V340, P675, DOI 10.1016/j.bbrc.2005.12.060; Monestier O, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-541; Monestier O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043710; Nolan K, 2016, CELL REP, V16, P2077, DOI 10.1016/j.celrep.2016.07.046; Nolan K, 2014, PROTEIN SCI, V23, P999, DOI 10.1002/pro.2485; Oh SP, 2002, GENE DEV, V16, P2749, DOI 10.1101/gad.1021802; Ozek C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35716-6; Pariani S, 2016, BIOCHIMIE, V123, P85, DOI 10.1016/j.biochi.2016.02.002; PATTHY L, 1993, TRENDS NEUROSCI, V16, P76, DOI 10.1016/0166-2236(93)90021-D; Rebbapragada A, 2003, MOL CELL BIOL, V23, P7230, DOI 10.1128/MCB.23.20.7230-7242.2003; Rinaldi F, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0092-8; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Sidis Y, 2006, ENDOCRINOLOGY, V147, P3586, DOI 10.1210/en.2006-0089; Singh P, 2016, CTS-CLIN TRANSL SCI, V9, P302, DOI 10.1111/cts.12420; Smith RC, 2013, CURR OPIN SUPPORT PA, V7, P352, DOI 10.1097/SPC.0000000000000013; Szlama G, 2010, FEBS J, V277, P5040, DOI 10.1111/j.1742-4658.2010.07909.x; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Thomas M, 2000, J BIOL CHEM, V275, P40235, DOI 10.1074/jbc.M004356200; Thompson TB, 2005, DEV CELL, V9, P535, DOI 10.1016/j.devcel.2005.09.008; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Tsuchida K, 2008, CURR OPIN DRUG DISC, V11, P487; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Walker RG, 2018, P NATL ACAD SCI USA, V115, pE866, DOI 10.1073/pnas.1714622115; Walker RG, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0350-1; Walker RG, 2016, CIRC RES, V118, P1125, DOI 10.1161/CIRCRESAHA.116.308391; Walker RG, 2015, J BIOL CHEM, V290, P7506, DOI 10.1074/jbc.M114.624130; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525; Zimmers TA, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0639-9	63	8	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6333	6343		10.1074/jbc.RA118.005831	http://dx.doi.org/10.1074/jbc.RA118.005831			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814254	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000468402000011
J	Shoushtarian, M; Weder, S; Innes-Brown, H; McKay, CM				Shoushtarian, Mehrnaz; Weder, Stefan; Innes-Brown, Hamish; McKay, Colette M.			Assessing hearing by measuring heartbeat: The effect of sound level	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; RATE RESPONSE; STIMULUS REPETITION; RATE AUDIOMETRY; THRESHOLD; COMPONENT; NEWBORN	Functional near-infrared spectroscopy (fNIRS) is a non-invasive brain imaging technique that measures changes in oxygenated and de-oxygenated hemoglobin concentration and can provide a measure of brain activity. In addition to neural activity, fNIRS signals contain components that can be used to extract physiological information such as cardiac measures. Previous studies have shown changes in cardiac activity in response to different sounds. This study investigated whether cardiac responses collected using fNIRS differ for different loudness of sounds. fNIRS data were collected from 28 normal hearing participants. Cardiac response measures evoked by broadband, amplitude-modulated sounds were extracted for four sound intensities ranging from near-threshold to comfortably loud levels (15, 40, 65 and 90 dB Sound Pressure Level (SPL)). Following onset of the noise stimulus, heart rate initially decreased for sounds of 15 and 40 dB SPL, reaching a significantly lower rate at 15 dB SPL. For sounds at 65 and 90 dB SPL, increases in heart rate were seen. To quantify the timing of significant changes, inter-beat intervals were assessed. For sounds at 40 dB SPL, an immediate significant change in the first two inter-beat intervals following sound onset was found. At other levels, the most significant change appeared later (beats 3 to 5 following sound onset). In conclusion, changes in heart rate were associated with the level of sound with a clear difference in response to near-threshold sounds compared to comfortably loud sounds. These findings may be used alone or in conjunction with other measures such as fNIRS brain activity for evaluation of hearing ability.	[Shoushtarian, Mehrnaz; Weder, Stefan; Innes-Brown, Hamish; McKay, Colette M.] Bion Inst, East Melbourne, Vic, Australia; [Weder, Stefan] Bern Univ Hosp, Dept ENT Head & Neck Surg, Inselspital, Bern, Switzerland; [Innes-Brown, Hamish; McKay, Colette M.] Univ Melbourne, Dept Med Bion, Melbourne, Vic, Australia	Bionics Institute; University of Bern; University Hospital of Bern; University of Melbourne	Shoushtarian, M (corresponding author), Bion Inst, East Melbourne, Vic, Australia.	mshoushtarian@bionicsinstitute.org	Innes-Brown, Hamish/H-3298-2019	Innes-Brown, Hamish/0000-0002-1512-2823; Shoushtarian, Mehrnaz/0000-0002-3611-9877	Victorian Government through its Operational Infrastructure Support Program; Swiss National Science Foundation (SNSF) [P2BSP3_ 161929]; NHMRC; Veski Fellowship	Victorian Government through its Operational Infrastructure Support Program; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Veski Fellowship	The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program. Stefan Weder is funded by the Swiss National Science Foundation (SNSF), award number P2BSP3_ 161929. Hamish Innes-Brown is supported by a NHMRC early career fellowship. Colette McKay is supported by a Veski Fellowship.	Amitay S, 2006, J ACOUST SOC AM, V119, P1616, DOI 10.1121/1.2164988; Chase WG, 1967, PSYCHON SCI, V9, P181, DOI [10.3758/bf03330819, DOI 10.3758/BF03330819]; Dreschler WA, 2001, AUDIOLOGY, V40, P148; GERMANA J, 1968, PSYCHOPHYSIOLOGY, V4, P324, DOI 10.1111/j.1469-8986.1968.tb02774.x; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; Hong KS, 2016, HEARING RES, V333, P157, DOI 10.1016/j.heares.2016.01.009; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; KAGAN JEROME, 1965, MERRILL PALMER QUART, V11, P95; KEEFE FB, 1970, PSYCHON SCI, V19, P335; LANG PJ, 1962, J COMP PHYSIOL PSYCH, V55, P781, DOI 10.1037/h0044474; MCDONALD DG, 1964, PSYCHOPHYSIOLOGY, V1, P163, DOI 10.1111/j.1469-8986.1964.tb03231.x; MEYERS WJ, 1967, PSYCHOPHYSIOLOGY, V4, P56, DOI 10.1111/j.1469-8986.1967.tb02737.x; Molavi B, 2012, PHYSIOL MEAS, V33, P259, DOI 10.1088/0967-3334/33/2/259; MORRONGIELLO BA, 1984, J EXP CHILD PSYCHOL, V38, P429, DOI 10.1016/0022-0965(84)90086-9; PERDUE KL, 2014, J BIOMED OPT, V19, DOI DOI 10.1117/1.JBO.19.6.067010; Pollonini L, 2016, BIOMED OPT EXPRESS, V7, P5104, DOI 10.1364/BOE.7.005104; ROESSLER R, 1969, PSYCHOPHYSIOLOGY, V5, P359, DOI 10.1111/j.1469-8986.1969.tb02834.x; SCHULMAN CA, 1974, NEUROPADIATRIE, V5, P19, DOI 10.1055/s-0028-1091684; SCHULMAN CA, 1973, NEUROPADIATRIE, V4, P362, DOI 10.1055/s-0028-1091753; SMITH DBD, 1968, PSYCHON SCI, V10, P71; SMITH DBD, 1969, PSYCHOPHYSIOLOGY, V6, P317, DOI 10.1111/j.1469-8986.1969.tb02909.x; Sokolov E.N., 1963, PERCEPTION CONDITION; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; Themelis G, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2710250; Trajkovic I, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3606560; Weder S, 2018, JARO-J ASSOC RES OTO, V19, P273, DOI 10.1007/s10162-018-0661-0; Wiggins IM, 2016, HEARING RES, V339, P142, DOI 10.1016/j.heares.2016.07.007; WOOD DM, 1964, J EXP PSYCHOL, V68, P221, DOI 10.1037/h0045199	28	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212940	10.1371/journal.pone.0212940	http://dx.doi.org/10.1371/journal.pone.0212940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817808	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500059
J	Franczak, C; Dubouis, L; Gilson, P; Husson, M; Rouyer, M; Demange, J; Leroux, A; Merlin, JL; Harle, A				Franczak, Claire; Dubouis, Ludovic; Gilson, Pauline; Husson, Marie; Rouyer, Marie; Demange, Jessica; Leroux, Agnes; Merlin, Jean-Louis; Harle, Alexandre			Integrated routine workflow using next-generation sequencing and a fully-automated platform for the detection of KRAS, NRAS and BRAF mutations in formalin-fixed paraffin embedded samples with poor DNA quality in patients with colorectal carcinoma	PLOS ONE			English	Article							RAS MUTATIONS; CANCER	Background KRAS and NRAS mutations are identified resistance mutations to anti-epidermal growth factor receptor monoclonal antibodies in patients with metastatic colorectal cancer. BRAF status is also routinely assessed for its poor prognosis value. In our institute, next-generation sequencing (NGS) is routinely used for gene-panel mutations detection including KRAS, NRAS and BRAF, but DNA quality is sometimes not sufficient for sequencing. In our routine practice, Idylla platform is used for the analysis of samples that don't reach sufficient quality criteria for NGS assay. Methods In this study, data from mCRC samples analyzed from May 2017 to 2018 were retrospectively collected. All samples with a poor DNA quality for sequencing have been assessed using Idylla platform. First, KRAS Idylla assay cartridge has been used for the determination of KRAS mutational status. All KRAS wild-type samples have then been analyzed using NRAS-BRAF assay. Among 669 samples, 67 samples failed the DNA quality control and have been assessed on Idylla KRAS mutation test. Results Among 67 samples, 50 (75%) samples had a valid result with Idylla KRAS mutation test including 22 carrying a KRAS mutation. For 28 samples, NRAS and BRAF mutational statuses have been assessed using Idylla NRAS-BRAF mutation test. Among 28 samples, 27 (96%) had a valid result including 2 samples bearing a NRAS mutation and 3 samples bearing a BRAF mutation. Conclusions Our study shows that an integrated workflow using NGS and Idylla platform allows the determination of KRAS, NRAS and BRAF mutational statuses of 651/669 (97.3%) samples and retrieve 49/67 (73.1%) samples that don't reach DNA quality requirements for NGS.	[Franczak, Claire; Dubouis, Ludovic; Gilson, Pauline; Leroux, Agnes; Merlin, Jean-Louis; Harle, Alexandre] Univ Lorraine, CNRS, UMR 7039, CRAN,Inst Cancerol Lorraine,Serv Biopathol, Nancy, France; [Husson, Marie; Rouyer, Marie; Demange, Jessica] Inst Cancerol Lorraine, Serv Biopathol, Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; UNICANCER; Institut de cancerologie de Lorraine (ICL)	Harle, A (corresponding author), Univ Lorraine, CNRS, UMR 7039, CRAN,Inst Cancerol Lorraine,Serv Biopathol, Nancy, France.	a.harle@nancy.unicancer.fr		Harle, Alexandre/0000-0001-9548-6522				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chung J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26732; De Luca C, 2018, J CLIN PATHOL; De Luca C, 2017, J CLIN PATHOL, V70, P295, DOI 10.1136/jclinpath-2016-203989; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Douillard JY, 2013, NEW ENGL J MED, V369, P1023, DOI 10.1056/NEJMoa1305275; Harle A, 2016, TARGET ONCOL, V11, P363, DOI 10.1007/s11523-015-0404-7; Harle A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153576; International Agency for Research on Cancer, GLOBOCAN 2012 EST CA, DOI [10.3109/00365521.2011.574732, DOI 10.3109/00365521.2011.574732]; Leufkens AM, 2011, SCAND J GASTROENTERO, V46, P887, DOI 10.3109/00365521.2011.574732; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Marino P, 2018, EUR J HUM GENET, V26, P314, DOI 10.1038/s41431-017-0081-3; Shinozaki E, 2017, BRIT J CANCER, V117, P1450, DOI 10.1038/bjc.2017.308; Uguen A, 2018, J CLIN PATHOL, V71, P757, DOI 10.1136/jclinpath-2018-205189; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Weyn C, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3112-0	18	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212801	10.1371/journal.pone.0212801	http://dx.doi.org/10.1371/journal.pone.0212801			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811471	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400089
J	Jang, Y; Ahn, SH; Lee, K; Lee, J; Kim, JH				Jang, Yeonsoo; Ahn, Sang Hoon; Lee, Kyunghwa; Lee, Jiyeon; Kim, Jeong Hyun			Psychometric evaluation of the Korean version of the Hepatitis B Quality of Life Questionnaire	PLOS ONE			English	Article							TRANSLATION; INSTRUMENT; CRITERIA; DISEASE; SAMPLE	Purpose The purpose of this study was to conduct a psychometric evaluation of the Korean version of the Hepatitis B Quality of Life Questionnaire (K-HBQOL), which is designed to assess the quality of life of patients with the hepatitis B virus (HBV). Methods The K-HBQOL was developed by converting the original English version to Korean using a back-and-forth translation method. The translated questionnaire was distributed to 168 adults with HBV. Descriptive statistics were used to summarize the demographic characteristics of these participants. Confirmatory factor analysis and exploratory principal components analysis (CFA and PCA) were performed, applying varimax rotation and using Kaiser's eigenvalue-greater-than-one rule to examine the factor structure. The minimum average partial rule was also used to identify the number of components. Results The original factor model was not confirmed by CFA in this sample. Six components (Psychological Well-being, Stigmatization, Anticipation Anxiety, Weakness, Vitality, and Vulnerability) were extracted by PCA, with 69.11% of the total variance explained. In this process, one component present in the original factor model (Transmission) was not found, while another component (Weakness) was extracted. Conclusions This study revealed the psychometric characteristics of the Korean version of the HBQOL for patients with hepatitis B. We suggest a study with a larger sample is needed to evaluate validity and reliability of the K-HBQOL for other Korean populations.	[Jang, Yeonsoo] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul, South Korea; [Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Lee, Kyunghwa; Lee, Jiyeon; Kim, Jeong Hyun] Yonsei Univ, Grad Sch, Dept Nursing, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University	Kim, JH (corresponding author), Yonsei Univ, Grad Sch, Dept Nursing, Seoul, South Korea.	jjeonghyuni@gmail.com		Jang, Yeonsoo/0000-0002-1898-025X	Yonsei University Faculty Research Grant [2014-32-0046]	Yonsei University Faculty Research Grant	This work was supported by Yonsei University Faculty Research Grant, Grant numbers: 2014-32-0046 (https://www.yonsei.ac.kr). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; [Anonymous], 2016, HLTH REL QUAL LIF HR; [Anonymous], 1992, APPL MULTIVARIATE ST; Bollen KA, 1989, STRUCTURAL EQUATIONS; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Burckhardt Carol S, 2003, Health Qual Life Outcomes, V1, P60, DOI 10.1186/1477-7525-1-60; Chang SJ, 2014, RES THEOR NURS PRACT, V28, P113, DOI 10.1891/1541-6577.28.2.113; Cho EJ, 2017, CLIN MOL HEPATOL, V23, P205, DOI 10.3350/cmh.2017.0104; Chung W, 2015, CLIN MOL HEPATOL, V21, P14, DOI 10.3350/cmh.2015.21.1.14; Gaskin CJ, 2012, EXPLORATORY FACTOR A; Han HR, 2002, NURS RES, V51, P309, DOI 10.1097/00006199-200209000-00007; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34842-5; Kagawa-Singer Marjorie, 2010, Semin Oncol Nurs, V26, P59, DOI 10.1016/j.soncn.2009.11.008; Kim H, 2013, KOREAN J INTERN MED, V28, P413, DOI 10.3904/kjim.2013.28.4.413; King CR, 2011, QUALITY LIFE NURSING; Korea National Health & Nutrition Examination Survey, 2016, MAJ RES; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lee Jung Eun, 2011, [Korean Journal of Adult Nursing, 성인간호학회지], V23, P20; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Marko Sarstedt, 2014, ADV METHODS DETERMIN; Mei YX, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186680; Ong SC, 2008, HEPATOLOGY, V47, P1108, DOI 10.1002/hep.22138; Ozer ZC, 2009, QUAL LIFE RES, V18, P913, DOI 10.1007/s11136-009-9503-1; Poorkaveh A, 2012, ARCH IRAN MED, V15, P290, DOI 012155/AIM.009; Schmitt TA, 2011, J PSYCHOEDUC ASSESS, V29, P304, DOI 10.1177/0734282911406653; Spiegel BMR, 2007, HEPATOLOGY, V46, P113, DOI 10.1002/hep.21692; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; WHO, 2017, HEPA B; Yu DSF, 2004, WESTERN J NURS RES, V26, P307, DOI 10.1177/0193945903260554; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	32	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0213001	10.1371/journal.pone.0213001	http://dx.doi.org/10.1371/journal.pone.0213001			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811491	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400105
J	Li, HM; Ren, CH; Jiang, X; Cheng, CH; Ruan, Y; Zhang, X; Huang, W; Chen, T; Hu, CQ				Li, Hongmei; Ren, Chunhua; Jiang, Xiao; Cheng, Chuhang; Ruan, Yao; Zhang, Xin; Huang, Wen; Chen, Ting; Hu, Chaoqun			Na+/H+ exchanger (NHE) in Pacific white shrimp (Litopenaeus vannamei): Molecular cloning, transcriptional response to acidity stress, and physiological roles in pH homeostasis	PLOS ONE			English	Article							INTRACELLULAR PH; ION-TRANSPORT; EXPRESSION; SALINITY; GILLS; CELLS; ANTIPORTER; ISOFORMS; KIDNEY; FISH	Na+/H+ exchangers are the most common membrane proteins involved in the regulation of intracellular pH that concurrently transport Na+ into the cells and H+ out of the cells. In this study, the full-length cDNA of the Na+/H+ exchanger (NHE) from the Pacific white shrimp (Litopenaeus vannamei) was cloned. The LvNHE cDNA is 3167 bp long, contains a 5'-untranslated region (UTR) of 74 bp and a 3'-UTR of 456 bp and an open reading frame (ORF) of 2637 bp, coding for a protein of 878 amino acids with 11 putative transmembrane domains and a long cytoplasmic tail. LvNHE shows high sequence homology with mud crab NHE at the amino acid level. LvNHE mRNA was detected in the hepatopancreas, gill, eyestalk, skin, heart, intestine, muscle, brain and stomach, with the highest abundance in the intestine. In the shrimp intestinal fragment cultures exposed to gradually declining pH medium (from pH 8.0 to pH 6.4), the LvNHE mRNA expression was significantly stimulated, with the highest response when incubated in pH 7.0 medium for 6 h. To investigate the functional roles of LvNHE in pH regulation at the physiological and cellular levels, the LvNHE mRNA expression was silenced by siRNA knockdown. Upon low-pH challenge, the hemolymph pH was significantly reduced in the LvNHE mRNA knockdown shrimp. In addition, knockdown of LvNHE mRNA reduced the recovery capacity of intracellular pH in intestinal fragment cultures after acidification. Altogether, this study demonstrates the role of NHE in shrimp response to low pH stress and provides new insights into the acid/base homeostasis mechanisms of crustaceans.	[Li, Hongmei; Ren, Chunhua; Jiang, Xiao; Cheng, Chuhang; Ruan, Yao; Zhang, Xin; Huang, Wen; Chen, Ting; Hu, Chaoqun] Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol LMB, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China; [Li, Hongmei; Cheng, Chuhang; Ruan, Yao; Zhang, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ren, Chunhua; Jiang, Xiao; Huang, Wen; Chen, Ting; Hu, Chaoqun] South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Sea Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Chen, T; Hu, CQ (corresponding author), Chinese Acad Sci, CAS Key Lab Trop Marine Bioresources & Ecol LMB, South China Sea Inst Oceanol, Guangzhou, Guangdong, Peoples R China.; Chen, T; Hu, CQ (corresponding author), South China Sea Bioresource Exploitat & Utilizat, Guangzhou, Guangdong, Peoples R China.	chan1010@scsio.ac.cn; hucq@scsio.ac.cn	huang, wen/GXW-0661-2022	Chen, Ting/0000-0002-5777-909X; Ruan, Yao/0000-0001-5176-0729	National Natural Science Foundation of China [31402287, 31602135]; Guangdong Province Program [2015B020231007, 2016A030310112, 2016A020210062, 2014A020208136, 2017B030314052, 2017A030310429]; Program of Fishery Problem Tackling of Guangdong Province [A201701B03]; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province [A201601A03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Program; Program of Fishery Problem Tackling of Guangdong Province; Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province	This work was supported by grants the National Natural Science Foundation of China (31402287 to Dr. Ting Chen and 31602135 to Dr. Wen Huang), the Guangdong Province Program (2015B020231007 to Prof. Chaoqun Hu and 2016A030310112 to Prof. Chaoqun Hu, 2016A020210062 to Dr. Ting Chen and 2014A020208136 to Dr. Ting Chen, 2017B030314052 to Dr. Wen Huang, 2017A030310429 to Dr. Xiao Jiang), the Program of Fishery Problem Tackling of Guangdong Province (A201701B03 to Prof. Chaoqun Hu), and the Science & Technology Promoting Projects for Oceanic & Fishery in Guangdong Province (A201601A03 to Prof. Chaoqun Hu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahearn GA, 1999, PHYSIOL BIOCHEM ZOOL, V72, P1, DOI 10.1086/316643; AMEMIYA M, 1995, AM J PHYSIOL-CELL PH, V269, pC126, DOI 10.1152/ajpcell.1995.269.1.C126; Bass L, 1973, PROG BIOPHYS MOLEC B, V27, P143; Boedtkjer E, 2006, CIRC RES, V98, P515, DOI 10.1161/01.RES.0000204750.04971.76; BORON WF, 1976, J GEN PHYSIOL, V67, P91, DOI 10.1085/jgp.67.1.91; Cai YM, 2017, FISH SHELLFISH IMMUN, V64, P226, DOI 10.1016/j.fsi.2017.02.047; Chen T, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01784; Chen T, 2016, AQUACULTURE, V451, P405, DOI 10.1016/j.aquaculture.2015.10.005; Claiborne JB, 1999, J EXP BIOL, V202, P315; Datta S., 2012, MANAGEMENT WATER QUA; Do TTH, 2010, AQUACULTURE, V304, P88, DOI 10.1016/j.aquaculture.2010.03.025; Duerr JM, 1998, J EXP ZOOL, V281, P97, DOI 10.1002/(SICI)1097-010X(19980601)281:2<97::AID-JEZ4>3.0.CO;2-5; Edwards SL, 2005, J EXP ZOOL PART A, V303A, P464, DOI 10.1002/jez.a.175; Faber S, 1998, CELL PHYSIOL BIOCHEM, V8, P202, DOI 10.1159/000016283; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Gralinski M, 2016, H EXCHANGE, P1; GRINSTEIN S, 1986, J MEMBRANE BIOL, V90, P1, DOI 10.1007/BF01869680; Guh YJ, 2015, EXCLI J, V14, P627, DOI 10.17179/excli2015-246; Han SY, 2018, ECOTOX ENVIRON SAFE, V149, P203, DOI 10.1016/j.ecoenv.2017.11.052; HENRY RP, 1992, AM ZOOL, V32, P407; Huang W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178604; Hwang PP, 2011, AM J PHYSIOL-REG I, V301, pR28, DOI 10.1152/ajpregu.00047.2011; Jr S G, 2005, AM J PHYSIOL-GASTR L, V289, P991; Koster S, 2011, J BIOL CHEM, V286, P40954, DOI 10.1074/jbc.M111.286906; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; LANTZ RC, 1978, J GEN PHYSIOL, V72, P219, DOI 10.1085/jgp.72.2.219; Liao IC, 2011, ASIA WORLDS MOST WID, P489; Lin M. N, 1990, PENAEID PARENTAL SHR; Liu MQ, 2015, AQUACULTURE, V448, P391, DOI 10.1016/j.aquaculture.2015.04.038; Malapert M, 1997, J EXP BIOL, V200, P353; Murer H, 1998, J AM SOC NEPHROL, V9, P143; NADALA EC, 1993, IN VITRO CELL DEV-AN, V29A, P620; Pan LQ, 2007, AQUACULTURE, V273, P711, DOI 10.1016/j.aquaculture.2007.07.218; Pan luqing, 2002, Journal of Ocean University of Qingdao, V32, P903; Prasad H, 2015, J BIOL CHEM, V290, P5311, DOI 10.1074/jbc.M114.602219; Speake PF, 2005, PFLUG ARCH EUR J PHY, V450, P123, DOI 10.1007/s00424-005-1382-x; Sun HY, 2011, MAR BIOL RES, V7, P623, DOI 10.1080/17451000.2010.538063; Taylor SE, 1999, J THERM BIOL, V24, P199, DOI 10.1016/S0306-4565(99)00013-3; Toullec Jean-Yves, 1999, Methods in Cell Science, V21, P193, DOI 10.1023/A:1009833924792; TURIN L, 1977, NATURE, V270, P56, DOI 10.1038/270056a0; Valles-Jimenez R., 2005, INT S GEN AQ; VANDYKE RW, 1988, HEPATOLOGY, V8, P960, DOI 10.1002/hep.1840080441; Wagner CA, 2003, PFLUG ARCH EUR J PHY, V446, P623, DOI 10.1007/s00424-003-1082-3; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wang L, 2012, MOL BIOL REP, V39, P6427, DOI 10.1007/s11033-012-1461-y; Wang WN, 2012, ECOTOXICOLOGY, V21, P1609, DOI 10.1007/s10646-012-0937-9; Wheatly MG, 2010, J EXPT ZOOLOGY, V263; Xu H, 2008, CELL PHYSIOL BIOCHEM, V21, P109, DOI 10.1159/000113752	49	8	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212887	10.1371/journal.pone.0212887	http://dx.doi.org/10.1371/journal.pone.0212887			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811482	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400095
J	Ali, F; Yilmaz, A; Nadeem, MA; Habyarimana, E; Subasi, I; Nawaz, MA; Chaudhary, HJ; Shahid, MQ; Ercisli, S; Zia, MA; Chung, G; Baloch, FS				Ali, Fawad; Yilmaz, Abdurrahim; Nadeem, Muhammad Azhar; Habyarimana, Ephrem; Subasi, Ilhan; Nawaz, Muhammad Amjad; Chaudhary, Hassan Javed; Shahid, Muhammad Qasim; Ercisli, Sezai; Zia, Muhammad Abu Bakar; Chung, Gyuhwa; Baloch, Faheem Shehzad			Mobile genomic element diversity in world collection of safflower (Carthamus tinctorius L.) panel using iPBS-retrotransposon markers	PLOS ONE			English	Article							POPULATION GENETIC-STRUCTURE; MICROSATELLITE MARKERS; GERM PLASM; WILD; GERMPLASM; ASTERACEAE; SELECTION; CLUSTERS; CENTERS; TRAITS	Safflower (Carthamus tinctorius L.) is a multipurpose crop of dry land yielding very high quality of edible oil. Present study was aimed to investigate the genetic diversity and population structure of 131 safflower accessions originating from 28 different countries using 13 iPBS-retrotransposon markers. A total of 295 iPBS bands were observed among which 275 (93.22%) were found polymorphic. Mean Polymorphism information content (0.48) and diversity parameters including mean effective number of alleles (1.33), mean Shannon's information index (0.33), overall gene diversity (0.19), Fstatistic (0.21), and inbreeding coefficient (1.00) reflected the presence of sufficient amount of genetic diversity in the studied plant materials. Analysis of molecular variance (AMOVA) showed that more than 40% of genetic variation was derived from populations. Model-based structure, principal coordinate analysis (PCoA) and unweighted pair-group method with arithmetic means (UPGMA) algorithms clustered the 131 safflower accessions into four main populations A, B, C, D and an unclassified population, with no meaningful geographical origin. Most diverse accessions originated from Asian countries including Afghanistan, Pakistan, China, Turkey, and India. Four accessions, Turkey3, Afghanistan4, Afghanistan2, and Pakistan24 were found most genetically distant and might be recommended as a candidate parents for breeding purposes. The findings of this study are most probably supported by the seven similarity centers hypothesis of safflower. This is a first study to explore the genetic diversity and population structure in safflower accessions using the iPBS-retrotransposon markers. The information provided in this work will therefore be helpful for scientists interested in safflower breeding.	[Ali, Fawad; Yilmaz, Abdurrahim; Nadeem, Muhammad Azhar; Baloch, Faheem Shehzad] Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey; [Ali, Fawad; Chaudhary, Hassan Javed] Quaid I Azam Univ, Dept Plant Sci, Islamabad, Pakistan; [Habyarimana, Ephrem] Consiglio Ric Agr & Anal Econ Agr, Ctr Ric Cerealicoltura & Colture Ind, Bologna, Italy; [Subasi, Ilhan] Cent Res Inst Field Crops, Ankara, Turkey; [Nawaz, Muhammad Amjad] Far Eastern Fed Univ, Educ Sci Ctr Nanotechnol, Vladivostok, Russia; [Shahid, Muhammad Qasim] South China Agr Univ, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Ercisli, Sezai] Ataturk Univ, Fac Agr, Dept Hort, Erzurum, Turkey; [Zia, Muhammad Abu Bakar] Muhammad Nawaz Sharif Univ Agr, Dept Plant Breeding & Genet, Multan, Pakistan; [Chung, Gyuhwa] Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea	Abant Izzet Baysal University; Quaid I Azam University; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Ministry of Food, Agriculture & Livestock - Turkey; Far Eastern Federal University; South China Agricultural University; Ataturk University; Chonnam National University	Baloch, FS (corresponding author), Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Dept Field Crops, Bolu, Turkey.; Chung, G (corresponding author), Chonnam Natl Univ, Dept Biotechnol, Chungnam, South Korea.	chung@chonnam.ac.kr; balochfaheem13@gmail.com	Shahid, Muhammad Qasim/K-2304-2019; Zia, Muhammad Abu Bakar/AAC-2532-2022; YILMAZ, Abdurrahim/ABF-8217-2021; Baloch, Faheem Shehzad/ABG-8788-2020; Habyarimana, Ephrem/AAK-3957-2020; SUBAŞI, İLHAN/AAT-6201-2020; Nawaz, Muhammad Amjad/L-9934-2018; Azhar Nadeem, Muhammad/AAE-2747-2020	Shahid, Muhammad Qasim/0000-0002-6767-4355; YILMAZ, Abdurrahim/0000-0001-9991-1792; Baloch, Faheem Shehzad/0000-0002-7470-0080; Habyarimana, Ephrem/0000-0003-2731-2744; SUBAŞI, İLHAN/0000-0001-7237-937X; Azhar Nadeem, Muhammad/0000-0002-0637-9619; Amjad Nawaz, Muhammad/0000-0001-9901-7555	TUBITAK (The Scientific and Technological Research Council of Turkey)	TUBITAK (The Scientific and Technological Research Council of Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	The authors express their gratitude to TUBITAK (The Scientific and Technological Research Council of Turkey) for providing a doctoral fellowship to Fawad Ali under the TUBITAK-2216 fellowship program for international researchers.; The authors express their gratitude to TUBITAK (The Scientific and Technological Research Council of Turkey) for providing a doctoral fellowship to Fawad Ali under the TUBITAK2216 fellowship program for international researchers.	Ambreen H, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00402; Ambreen H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135443; Amini F, 2008, EUPHYTICA, V163, P21, DOI 10.1007/s10681-007-9556-6; Andeden EE, 2013, J PLANT BIOCHEM BIOT, V22, P453, DOI 10.1007/s13562-012-0175-5; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Arystanbekkyzy M, 2019, INT J AGRIC BIOL, V21, P155, DOI 10.17957/IJAB/15.0876; ASHRI A, 1975, EUPHYTICA, V24, P651, DOI 10.1007/BF00132903; Aydin MF, 2019, LEGUME RES, V42, P18, DOI 10.18805/LR-423; Baloch FS, 2016, TURK J AGRIC FOR, V40, P352, DOI 10.3906/tar-1508-27; Baloch FS, 2015, BIOCHEM SYST ECOL, V61, P244, DOI 10.1016/j.bse.2015.06.017; Baloch FS, 2015, BIOCHEM SYST ECOL, V58, P162, DOI 10.1016/j.bse.2014.12.002; Barati M, 2012, BIOCHEM SYST ECOL, V44, P117, DOI 10.1016/j.bse.2012.04.013; Bouchet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033470; Casacuberta JM, 1997, GENETICA, V100, P109, DOI 10.1023/A:1018309007841; Chapman MA, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-60; Chapman MA, 2010, AM J BOT, V97, P831, DOI 10.3732/ajb.0900137; Collard BCY, 2005, EUPHYTICA, V142, P169, DOI 10.1007/s10681-005-1681-5; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Derakhshan E, 2014, BIOCHEM SYST ECOL, V54, P130, DOI 10.1016/j.bse.2014.01.003; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Garcia-Moreno MJ, 2010, EUPHYTICA, V175, P145, DOI 10.1007/s10681-010-0139-6; Golkar P, 2011, INT J MOL SCI, V12, P2664, DOI 10.3390/ijms12042664; Goudet J, 1996, GENETICS, V144, P1933; Guo DL, 2014, BIOCHEM SYST ECOL, V52, P27, DOI 10.1016/j.bse.2013.10.008; Habyarimana E., 2016, Australian Journal of Crop Science, V10, P127; Hamdan YAS, 2011, PLANT BREEDING, V130, P237, DOI 10.1111/j.1439-0523.2010.01826.x; Houmanat K, 2016, INT J AGRIC BIOL, V18, P1081, DOI 10.17957/IJAB/15.0144; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Johnson RC, 2007, CROP SCI, V47, P1728, DOI 10.2135/cropsci2006.12.0757; Kalendar R, 2010, THEOR APPL GENET, V121, P1419, DOI 10.1007/s00122-010-1398-2; Khan MA, 2009, GENET RESOUR CROP EV, V56, P19, DOI 10.1007/s10722-008-9338-6; KNOWLES PF, 1969, ECON BOT, V23, P324, DOI 10.1007/BF02860678; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Kumar S, 2015, PLANT MOL BIOL REP, V33, P1299, DOI 10.1007/s11105-014-0828-8; Kumari S., 2017, J PHARMACOGN PHYTOCH, V6, P2723; Lee GA, 2014, MOL ECOL RESOUR, V14, P69, DOI 10.1111/1755-0998.12146; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Marinova E, 2009, VEG HIST ARCHAEOBOT, V18, P341, DOI 10.1007/s00334-009-0212-z; Mokhtari N, 2018, J GENET, V97, P67, DOI 10.1007/s12041-018-0956-2; Nadeem MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205363; Nadeem MA, 2018, BIOTECHNOL BIOTEC EQ, V32, P261, DOI 10.1080/13102818.2017.1400401; Newell MA, 2013, ANN APPL STAT, V7, P1898, DOI 10.1214/13-AOAS671; Nimbkar N, 2008, SAFFLOWER UNEXPLOITE; Panahi B, 2013, PHYSIOL MOL BIOL PLA, V19, P239, DOI 10.1007/s12298-012-0155-1; Pearl SA, 2014, AM J BOT, V101, P1640, DOI 10.3732/ajb.1400079; R Core Team, 2021, R LANGUAGE ENV STAT; SanMiguel P, 1996, SCIENCE, V274, P765, DOI 10.1126/science.274.5288.765; Sehgal D, 2009, GENETICA, V135, P457, DOI 10.1007/s10709-008-9292-4; SungJungsook, 2010, [Journal of Life Science, 생명과학회지], V20, P1764; Varshney Rajeev K., 2007, P207, DOI 10.1007/978-1-4020-6297-1_10; Weiss EA, 2000, SAFFLOWER OIL SEED C; Wodajo B, 2015, INT J SCI RES PUBL, V5, P434; Xu JY, 2018, CHIN J NAT MEDICINES, V16, P1, DOI 10.1016/S1875-5364(18)30024-4; Yang RC, 1998, EVOLUTION, V52, P950, DOI 10.1111/j.1558-5646.1998.tb01824.x; Yang YX, 2007, GENET RESOUR CROP EV, V54, P1043, DOI 10.1007/s10722-006-9192-3; Yeh F. C., 2000, POPGENE32 MICROSOFT; Yildiz M, 2015, GENET MOL RES, V14, P10588, DOI 10.4238/2015.September.8.20; Zhang ZW, 2000, J AIR FORCE ENG U, V1, P6	60	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211985	10.1371/journal.pone.0211985	http://dx.doi.org/10.1371/journal.pone.0211985			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807571	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100009
J	Mazumdar, R; Nobauer, K; Hummel, K; Hess, M; Bilic, I				Mazumdar, Rounik; Noebauer, Katharina; Hummel, Karin; Hess, Michael; Bilic, Ivana			Molecular characterization of Histomonas meleagridis exoproteome with emphasis on protease secretion and parasite-bacteria interaction	PLOS ONE			English	Article							ESCHERICHIA-COLI; C-ALPHA; PROTEINS; EXPRESSION; IDENTIFICATION; ADAPTATION; INSIGHTS; PATHOGEN; SURFACE; INDOLE	The exoproteome of parasitic protists constitutes extracellular proteins that play a fundamental role in host-parasite interactions. Lytic factors, especially secreted proteases, are capable of modulating tissue invasion, thereby aggravating host susceptibility. Despite the important role of exoproteins during infection, the exoproteomic data on Histomonas meleagridis are non-existent. The present study employed traditional 1D-in-gel-zymography (1DIGZ) and micro-LC-ESI-MS/MS (shotgun proteomics), to investigate H. meleagridis exoproteomes, obtained from a clonal virulent and an attenuated strain. Both strains were maintained as mono-eukaryotic monoxenic cultures with Escherichia coli. We demonstrated active in vitro secretion kinetics of proteases by both parasite strains, with a widespread proteolytic activity ranging from 17 kDa to 120 kDa. Based on protease inhibitor susceptibility assay, the majority of proteases present in both exoproteomes belonged to the family of cysteine proteases and showed stronger activity in the exoproteome of a virulent H. meleagridis. Shotgun proteomics, aided by customized database search, identified 176 proteins including actin, potential moonlighting glycolytic enzymes, lytic molecules such as poreforming proteins (PFPs) and proteases like cathepsin-L like cysteine protease. To quantify the exoproteomic differences between the virulent and the attenuated H. meleagridis cultures, a sequential window acquisition of all theoretical spectra mass spectrometric (SWATH-MS) approach was applied. Surprisingly, results showed most of the exoproteomic differences to be of bacterial origin, especially targeting metabolism and locomotion. By deciphering such molecular signatures, novel insights into a complex in vitro protozoan-bacteria relationship were elucidated.	[Mazumdar, Rounik; Hess, Michael; Bilic, Ivana] Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria; [Noebauer, Katharina; Hummel, Karin] Univ Vet Med Vienna, VetCORE, Facil Res, Vienna, Austria; [Hess, Michael] Univ Vet Med Vienna, Christian Doppler Lab Innovat Poultry Vaccines IP, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Bilic, I (corresponding author), Univ Vet Med Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Poultry & Fish Med, Vienna, Austria.	ivana.bilic@vetmeduni.ac.at		Mazumdar, Rounik/0000-0003-0580-5628; Hess, Michael/0000-0002-6991-0120; Bilic, Ivana/0000-0003-3296-5117	Austrian Science Fund (FWF) [P 25519-B25]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funded by Austrian Science Fund (FWF), grant number P 25519-B25.	Alvarez-Sanchez ME, 2000, MICROB PATHOGENESIS, V28, P193, DOI 10.1006/mpat.1999.0336; Amin A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037417; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Armengaud J, 2012, EXPERT REV PROTEOMIC, V9, P561, DOI [10.1586/epr.12.52, 10.1586/EPR.12.52]; Atkinson HJ, 2009, TRENDS PARASITOL, V25, P573, DOI 10.1016/j.pt.2009.09.006; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Beynon R, 2000, BIOCHEM EDUC, V18, P359, DOI [10.1016/0307-4412(90)90038-P, DOI 10.1016/0307-4412(90)90038-P]; Bilic I, 2009, PARASITOLOGY, V136, P379, DOI 10.1017/S0031182008005477; Bilic I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092438; Bischofberger M, 2012, CELL HOST MICROBE, V12, P266, DOI 10.1016/j.chom.2012.08.005; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Chevallet M, 2007, PROTEOMICS, V7, P1757, DOI 10.1002/pmic.200601024; Corbalan-Garcia S, 2014, BBA-BIOMEMBRANES, V1838, P1536, DOI 10.1016/j.bbamem.2014.01.008; Cuervo P, 2008, J PROTEOMICS, V71, P109, DOI 10.1016/j.jprot.2008.01.010; De Jesus JB, 2007, J MASS SPECTROM, V42, P1463, DOI 10.1002/jms.1286; Cardenas-Guerra RE, 2013, MICROBES INFECT, V15, P958, DOI 10.1016/j.micinf.2013.09.002; Erde J, 2014, J PROTEOME RES, V13, P1885, DOI 10.1021/pr4010019; Ferenci T, 1996, FEMS MICROBIOL REV, V18, P301, DOI 10.1016/0168-6445(96)00019-8; Flynn JM, 2004, GENE DEV, V18, P2292, DOI 10.1101/gad.1240104; Ganas P, 2012, INT J PARASITOL, V42, P893, DOI 10.1016/j.ijpara.2012.07.007; Gonzalez-Miguel J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124445; Gruber J, 2018, EXP PARASITOL, V185, P53, DOI 10.1016/j.exppara.2018.01.007; Gruber J, 2017, PARASITOLOGY, V144, P1253, DOI 10.1017/S0031182017000646; Guan YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13370; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Hernandez HM, 2014, PARASITE, V21, DOI 10.1051/parasite/2014054; Hernandez-Gutierrez R, 2004, EXP PARASITOL, V107, P125, DOI 10.1016/j.exppara.2004.05.004; Hess M, 2006, PARASITOLOGY, V133, P547, DOI 10.1017/S0031182006000758; Hess M, 2017, BRIT POULTRY SCI, V58, P1, DOI 10.1080/00071668.2016.1245849; Hess M, 2008, VACCINE, V26, P4187, DOI 10.1016/j.vaccine.2008.05.071; Hess M, 2015, VET PARASITOL, V208, P67, DOI 10.1016/j.vetpar.2014.12.018; Hirt RP, 2007, TRENDS PARASITOL, V23, P540, DOI 10.1016/j.pt.2007.08.020; Klemba M, 2002, ANNU REV BIOCHEM, V71, P275, DOI 10.1146/annurev.biochem.71.090501.145453; Klodnicki ME, 2013, J PARASITOL, V99, P264, DOI 10.1645/GE-3256.1; Kohout SC, 2003, BIOCHEMISTRY-US, V42, P1254, DOI 10.1021/bi026596f; Kopitar-Jerala N, 2012, CURR PROTEIN PEPT SC, V13, P767, DOI 10.2174/138920312804871102; Leberl M, 2010, MOL BIOCHEM PARASIT, V169, P101, DOI 10.1016/j.molbiopara.2009.10.007; Lee J, 2010, J APPL MICROBIOL, V108, P2088, DOI 10.1111/j.1365-2672.2009.04611.x; Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x; Liebhart D, 2017, AVIAN PATHOL, V46, P1, DOI 10.1080/03079457.2016.1229458; Rosales-Colunga LM, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-74; Mazet M, 2008, INT J PARASITOL, V38, P177, DOI 10.1016/j.ijpara.2007.06.006; Mazumdar R, 2017, PROTIST, V168, P663, DOI 10.1016/j.protis.2017.09.004; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Mol O, 1996, FEMS MICROBIOL REV, V19, P25, DOI 10.1016/0168-6445(96)00022-8; MOLLBY R, 1976, J GEN MICROBIOL, V96, P137, DOI 10.1099/00221287-96-1-137; Monoyios A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00407; Monoyios A, 2018, INT J PARASITOL, V48, P145, DOI 10.1016/j.ijpara.2017.08.017; Mueller RS, 2009, J BACTERIOL, V191, P3504, DOI 10.1128/JB.01240-08; NEWTON WA, 1965, J BIOL CHEM, V240, P1211; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pina-Vazquez Carolina, 2012, Journal of Parasitology Research, P748206, DOI 10.1155/2012/748206; Pirkmajer S, 2011, AM J PHYSIOL-CELL PH, V301, pC272, DOI 10.1152/ajpcell.00091.2011; PLOW EF, 1995, FASEB J, V9, P939, DOI 10.1096/fasebj.9.10.7615163; Ranganathan S, 2009, GENOME MED, V1, DOI 10.1186/gm113; RAWLINGS ND, 1995, METHOD ENZYMOL, V248, P183; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Roditi I, 2016, MOL BIOCHEM PARASIT, V208, P16, DOI 10.1016/j.molbiopara.2016.05.008; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; Schwebke JR, 2004, CLIN MICROBIOL REV, V17, P794, DOI 10.1128/CMR.17.4.794-803.2004; Shafqat J, 1999, EUR J BIOCHEM, V263, P305, DOI 10.1046/j.1432-1327.1999.00323.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tsatsaronis JA, 2018, TRENDS MICROBIOL, V26, P401, DOI 10.1016/j.tim.2018.02.009; Vanacova S, 2001, MICROBIOL-UK, V147, P53; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Worden CR, 2009, FEMS MICROBIOL LETT, V293, P58, DOI 10.1111/j.1574-6968.2009.01508.x; Zhao K, 2007, NUCLEIC ACIDS RES, V35, P4441, DOI 10.1093/nar/gkm456	70	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212429	10.1371/journal.pone.0212429	http://dx.doi.org/10.1371/journal.pone.0212429			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807611	gold, Green Published, Green Submitted			2022-12-26	WOS:000459712100015
J	Dunbar, MBN; Finnie, TJR; Sloane, B; Hall, IM				Dunbar, Maria Bekker-Nielsen; Finnie, Thomas J. R.; Sloane, Barney; Hall, Ian M.			Methods for calculating credible intervals for ratios of beta distributions with application to relative risks of death during the second plague pandemic	PLOS ONE			English	Article							SPREAD	Employing historical records we are able to estimate the risk of premature death during the second plague pandemic, and identify the Black Death and pestis secunda epidemics. We show a novel method of calculating Bayesian credible intervals for a ratio of beta distributed random variables and use this to quantify uncertainty of relative risk estimates for these two epidemics which we consider in a 2 x 2 contingency table framework.	[Dunbar, Maria Bekker-Nielsen; Finnie, Thomas J. R.; Hall, Ian M.] Publ Hlth England, Emergency Response Dept, Salisbury, Wilts, England; [Sloane, Barney] Hist England, Swindon, Wilts, England; [Hall, Ian M.] Univ Manchester, Manchester, Lancs, England	Public Health England; English Heritage; University of Manchester	Dunbar, MBN (corresponding author), Publ Hlth England, Emergency Response Dept, Salisbury, Wilts, England.	maria.dunbar@phe.gov.uk	Hall, ian/AAF-9135-2019; Dunbar, Maria Bekker-Nielsen/J-4082-2019	Hall, ian/0000-0002-3033-2335; Dunbar, Maria Bekker-Nielsen/0000-0002-7249-3524; Finnie, Thomas/0000-0001-5962-4211	National Institute for Health Research-Health Protection Research Unit for Modelling Methodology; National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (HPRU MM)	National Institute for Health Research-Health Protection Research Unit for Modelling Methodology; National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (HPRU MM)	MBND, TJRF, IMH were supported by National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (https://www.imperial.ac.uk/hpru-modelling).; The research leading to these results has received grant-in-aid funding. MBND, TJRF, and IMH are funded by the National Institute for Health Research-Health Protection Research Unit for Modelling Methodology (HPRU MM). The funding bodies (UK government and HPRU MM) did not play any role in the formulation of this manuscript. The authors declare no conflict of interest. The views expressed in this publication are those of the authors and not necessarily those of Public Health England or English Heritage. We gratefully acknowledge the help and contributions of Steven Dyke who contributed to the calculation of the posterior distribution.	Agresti A, 2005, BIOMETRICS, V61, P515, DOI 10.1111/j.1541-0420.2005.031228.x; [Anonymous], 2010, J JPN STATIST SOC; Chen MH, 1999, J COMPUT GRAPH STAT, V8, P69, DOI 10.2307/1390921; Creighton C., 1891, HIST EPIDEMICS BRITA, VI; Dean KR, 2018, P NATL ACAD SCI USA, V115, P1304, DOI 10.1073/pnas.1715640115; dIrsay Stephen, 1926, ISIS, V8, P328, DOI [10.1086/358397, DOI 10.1086/358397]; Evans CM, 2018, EMERG INFECT DIS, V24, P952, DOI 10.3201/eid2405.172067; Gage KL, 1999, WHOCDSCSREDC992; Gottfried Robert Steven, 1986, BLACK DEATH NATURAL; GROSS L, 1995, P NATL ACAD SCI USA, V92, P7609, DOI 10.1073/pnas.92.17.7609; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Karlen A., 1995, PLAGUES PROGR SOCIAL; Kerman J, 2011, ELECTRON J STAT, V5, P1450, DOI 10.1214/11-EJS648; Khan IA, 2004, T ROY SOC TROP MED H, V98, P270, DOI 10.1016/S0035-9203(03)00059-2; LETHEM W. A., 1923, Journal of State Medicine, V31, P508; NURMINEN M, 1987, SCAND J STAT, V14, P67; O'Hagan A., 2004, KENDALLS ADV THEOR B, V2B; Pham-Gia T, 2000, COMMUN STAT-THEOR M, V29, P2693, DOI 10.1080/03610920008832632; Sharpe RR, 1889, CALENDAR WILLS PRO 1, P1258; Sharpe RR, 1889, CALENDAR WILLS PRO 2, P1358; Sherman IW, 2017, THE POWER OF PLAGUES; Sloane Barney, 2011, BLACK DEATH LONDON; Wong B, 2011, NAT METHODS, V8, P441, DOI 10.1038/nmeth.1618; World Health Organization, 2017, PLAG; World Health Organization, 2000, WHO REP GLOB SURV EP; Zietz BP, 2004, INT J HYG ENVIR HEAL, V207, P165, DOI 10.1078/1438-4639-00259	26	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211633	10.1371/journal.pone.0211633	http://dx.doi.org/10.1371/journal.pone.0211633			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794569	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100020
J	Hall, C; Rodriguez, M; Garcia, J; Posfai, D; DuMez, R; Wictor, E; Quintero, OA; Hill, MS; Rivera, AS; Hill, AL				Hall, Chelsea; Rodriguez, Melanie; Garcia, Josephine; Posfai, Dora; DuMez, Rachel; Wictor, Erik; Quintero, Omar A.; Hill, Malcolm S.; Rivera, Ajna S.; Hill, April L.			Secreted frizzled related protein is a target of PaxB and plays a role in aquiferous system development in the freshwater sponge, Ephydatia muelleri	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; EVOLUTIONARY ORIGINS; WNT; EXPRESSION; GENE; SPECIFICATION; PERFORMANCE; REGULATORS; FAMILIES; ACCURATE	Canonical and non-canonical Wnt signaling, as well as the Pax/ Six gene network, are involved in patterning the freshwater sponge aquiferous system. Using computational approaches to identify transcription factor binding motifs in a freshwater sponge genome, we located putative PaxB binding sites near a Secreted Frizzled Related Protein (SFRP) gene in Ephydatia muelleri. EmSFRP is expressed throughout development, but with highest levels in juvenile sponges. In situ hybridization and antibody staining show EmSFRP expression throughout the pinacoderm and choanoderm in a subpopulation of amoeboid cells that may be differentiating archeocytes. Knockdown of EmSFRP leads to ectopic oscula formation during development, suggesting that EmSFRP acts as an antagonist of Wnt signaling in E. muelleri. Our findings support a hypothesis that regulation of the Wnt pathway by the Pax/ Six network as well as the role of Wnt signaling in body plan morphogenesis was established before sponges diverged from the rest of the metazoans.	[Hall, Chelsea; Rodriguez, Melanie; Garcia, Josephine; Posfai, Dora; DuMez, Rachel; Quintero, Omar A.; Hill, Malcolm S.; Hill, April L.] Univ Richmond, Dept Biol, Richmond, VA 23173 USA; [Wictor, Erik; Rivera, Ajna S.] Univ Pacific, Dept Biol Sci, Stockton, CA 95211 USA; [Hill, Malcolm S.; Hill, April L.] Bates Coll, Dept Biol, Lewiston, ME 04240 USA	University of Richmond; University of the Pacific	Hill, AL (corresponding author), Univ Richmond, Dept Biol, Richmond, VA 23173 USA.; Hill, AL (corresponding author), Bates Coll, Dept Biol, Lewiston, ME 04240 USA.	ahill5@bates.edu		Quintero-Carmona, Omar/0000-0002-9314-1704	NIGMS NIH HHS [P20 GM103423] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103423] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adamska M, 2016, CURR OPIN GENET DEV, V39, P21, DOI 10.1016/j.gde.2016.05.026; Adamska M, 2010, EVOL DEV, V12, P494, DOI 10.1111/j.1525-142X.2010.00435.x; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Baker NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058266; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Blake JA, 2014, DEVELOPMENT, V141, P737, DOI 10.1242/dev.091785; Borisenko I, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0700-6; Brate J, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1746; Brophy PD, 2003, J BIOL CHEM, V278, P52401, DOI 10.1074/jbc.M305614200; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cramer JM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40674; Dunn CW, 2015, TRENDS ECOL EVOL, V30, P282, DOI 10.1016/j.tree.2015.03.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandez-Valverde SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep22496; Feuda R, 2017, CURR BIOL, V27, P3864, DOI 10.1016/j.cub.2017.11.008; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fortunato SAV, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-23; Friedrich M, 2006, ARTHROPOD STRUCT DEV, V35, P357, DOI 10.1016/j.asd.2006.08.010; Funayama N, 2010, DEV GROWTH DIFFER, V52, P1, DOI 10.1111/j.1440-169X.2009.01162.x; Gaiti Federico, 2018, Non-Coding RNA, V4, P6, DOI 10.3390/ncrna4010006; Gaiti F, 2017, ELIFE, V6, DOI 10.7554/eLife.22194; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Halanych KM, 2016, P NATL ACAD SCI USA, V113, pE946, DOI 10.1073/pnas.1525332113; Harcet M, 2010, MOL BIOL EVOL, V27, P2747, DOI 10.1093/molbev/msq174; Hill A, 2010, DEV BIOL, V343, P106, DOI 10.1016/j.ydbio.2010.03.010; Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim AS, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0002.2001; Kumar JP, 2009, CELL MOL LIFE SCI, V66, P565, DOI 10.1007/s00018-008-8335-4; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Lapebie P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005823; Leys SP, 2012, ADV MAR BIOL, V62, P1, DOI 10.1016/B978-0-12-394283-8.00001-1; Loh KM, 2016, DEV CELL, V38, P643, DOI 10.1016/j.devcel.2016.08.011; Lopez-Rios J, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-19; Ludeman DA, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-3; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; Okamoto K, 2012, MECH DEVELOP, V129, P24, DOI 10.1016/j.mod.2012.03.001; Pisani D, 2016, P NATL ACAD SCI USA, V113, pE948, DOI 10.1073/pnas.1525718113; Pisani D, 2015, P NATL ACAD SCI USA, V112, P15402, DOI 10.1073/pnas.1518127112; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; R Core Team, 2021, R LANGUAGE ENV STAT; Reid PJW, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1118-0; Riesgo A, 2014, MOL BIOL EVOL, V31, P1102, DOI 10.1093/molbev/msu057; Rivera A, 2013, EVOL DEV, V15, P186, DOI 10.1111/ede.12032; Rivera AS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-67; Schenkelaars Q, 2016, DEV BIOL, V412, P298, DOI 10.1016/j.ydbio.2016.02.026; Schippers KJ, 2018, MOL BIOL EVOL, V35, P1407, DOI 10.1093/molbev/msy033; STREKAL TA, 1974, BIOL BULL, V146, P267, DOI 10.2307/1540623; Telford MJ, 2016, NATURE, V529, P286, DOI 10.1038/529286a; Telford MJ, 2016, P NATL ACAD SCI USA, V113, pE948, DOI [10.1038/529286a, DOI 10.1038/529286A]; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Windsor PJ, 2010, EVOL DEV, V12, P484, DOI 10.1111/j.1525-142X.2010.00434.x; Yan J, 2014, GENE, V533, P229, DOI 10.1016/j.gene.2013.09.083	62	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212005	10.1371/journal.pone.0212005	http://dx.doi.org/10.1371/journal.pone.0212005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794564	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100030
J	Kumar, K; Kumar, S; Singh, A; Ram, F; Singh, A				Kumar, Kaushalendra; Kumar, Santosh; Singh, Ashish; Ram, Faujdar; Singh, Abhishek			Heterogeneity in the effect of mid-childhood height and weight gain on human capital at age 14-15 years: Evidence from Ethiopia, India, Peru, and Vietnam	PLOS ONE			English	Article							5 BIRTH COHORTS; EARLY-LIFE; GROWTH-PATTERNS; LINEAR GROWTH; NUTRITION; HEALTH; IMPACT; ASSOCIATIONS; ADIPOSITY; ADULTHOOD	Background Under-nutrition in early childhood has harmful impacts on human capital formation in children, with implications for educational, adult health, and labor market outcomes. We investigate the association of linear growth and weight gain in mid-childhood with years of schooling, the Peabody Picture Vocabulary Test score, and math test score during the adolescent age of 14-15 years. Methods Data were derived from the Young Lives study conducted in four low-and middle-income countries (Ethiopia, India, Peru, and Vietnam). The data had detailed information on the children anthropometry and characteristics of the child, household, and community. Multivariate regression analysis, adjusted for the confounding variables, was used to investigate the association between mid-childhood health, measured by conditional linear growth and relative weight gain, and human capital outcomes in adolescent age. Results After controlling for several confounders, one cm increase in conditional linear growth increased years of schooling by 0.034 years and the Peabody Picture Vocabulary Test score and math test score by 0.474 and 0.083 points respectively. Relative weight gain was negatively associated with years of schooling and math test score. There is no evidence of heterogeneous effects by rural, gender, and household wealth. In the quantile regression analyses, the association between conditional linear growth and outcomes is stronger at the lower level of years of schooling and the Peabody Picture Vocabulary Test score. Conclusion Our study highlights that mid-childhood nutritional intervention targeted for students at the lower level of education distribution can accelerate the rate of human capital accumulation in low- and middle-income countries.	[Kumar, Kaushalendra; Ram, Faujdar; Singh, Abhishek] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India; [Kumar, Santosh] Sam Houston State Univ, Coll Business Adm, Dept Econ & Int Business, Huntsville, TX 77340 USA; [Singh, Ashish] Indian Inst Technol, Shailesh J Mehta Sch Management, Mumbai, Maharashtra, India	International Institute for Population Sciences; Texas State University System; Sam Houston State University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Kumar, K (corresponding author), Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India.	kaushal@iips.net	Singh, Abhishek/ABC-7813-2020; Kumar, Kaushalendra/ABC-7943-2020	Singh, Abhishek/0000-0001-6263-4410; Kumar, Kaushalendra/0000-0001-5913-0297; Kumar, Santosh/0000-0002-8663-3006				Adair LS, 2013, LANCET, V382, P525, DOI 10.1016/S0140-6736(13)60103-8; Almond D, 2011, J ECON PERSPECT, V25, P153, DOI 10.1257/jep.25.3.153; Barnett I, 2013, INT J EPIDEMIOL, V42, P701, DOI 10.1093/ije/dys082; Cueto S, 2013, PSYCHOMETRIC CHARACT; Currie J, 2013, ANNU REV ECON, V5, P1, DOI 10.1146/annurev-economics-081412-103704; Demerath EW, 2009, OBESITY, V17, P2060, DOI 10.1038/oby.2009.105; DEOLALIKAR AB, 1988, REV ECON STAT, V70, P406, DOI 10.2307/1926778; Glewwe P, 2001, WORLD BANK ECON REV, V15, P81, DOI 10.1093/wber/15.1.81; Hales CN, 2003, J PHYSIOL-LONDON, V547, P5, DOI 10.1113/jphysiol.2002.024406; Horta BL, 2017, J PEDIATR-US, V182, P85, DOI 10.1016/j.jpeds.2016.12.020; Kumar S, 2016, APPL ECON LETT, V23, P1325, DOI 10.1080/13504851.2016.1156225; Kumar S, 2016, POPUL DEV REV, V42, P53, DOI 10.1111/j.1728-4457.2016.00107.x; Duc LT, 2017, ECON HUM BIOL, V26, P86, DOI 10.1016/j.ehb.2017.02.002; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Liem ET, 2013, J PEDIATR-US, V162, P287, DOI 10.1016/j.jpeds.2012.07.053; Maluccio JA, 2009, ECON J, V119, P734, DOI 10.1111/j.1468-0297.2009.02220.x; Mani S, 2012, OXFORD B ECON STAT, V74, P691, DOI 10.1111/j.1468-0084.2011.00670.x; Martorell R, 2010, J NUTR, V140, P348, DOI 10.3945/jn.109.112300; Ong Ken K, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P30, DOI 10.1097/MED.0b013e328013da6c; Outes-Leon ID, 2009, SURVEY ATTRITION ATT; Prentice AM, 2013, AM J CLIN NUTR, V97, P911, DOI 10.3945/ajcn.112.052332; Sanchez A, 2017, ECON HUM BIOL, V27, P33, DOI 10.1016/j.ehb.2017.04.001; SCHROEDER DG, 1995, J NUTR, V125, pS1051; Stein AD, 2010, AM J HUM BIOL, V22, P353, DOI 10.1002/ajhb.20998; Stettler N, 2010, CURR OPIN CLIN NUTR, V13, P294, DOI 10.1097/MCO.0b013e328337d7b9; Strauss J, 1998, J ECON LIT, V36, P766; Strauss J, 2008, HBK ECON, V9, P3375, DOI 10.1016/S1573-4471(07)04054-5; Victora CG, 2001, INT J EPIDEMIOL, V30, P1325, DOI 10.1093/ije/30.6.1325; World Health Organization (WHO), 2015, AD DEV MAT NEWB CHIL	29	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212783	10.1371/journal.pone.0212783	http://dx.doi.org/10.1371/journal.pone.0212783			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794669	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100138
J	Subban, K; Subramani, R; Srinivasan, VPM; Johnpaul, M; Chelliah, J				Subban, Kamalraj; Subramani, Ramesh; Srinivasan, Vishnu Priya Madambakkam; Johnpaul, Muthumary; Chelliah, Jayabaskaran			Salicylic acid as an effective elicitor for improved taxol production in endophytic fungus Pestalotiopsis microspora	PLOS ONE			English	Article							CELL-SUSPENSION CULTURES; TAXUS-CHINENSIS; GLUTATHIONE-PEROXIDASE; FUNCTIONAL EXPRESSION; TAXANE PRODUCTION; BIOSYNTHESIS; PATHOGEN; STRESS; DEGRADATION; CLONING	Salicylic acid (SA) is an effective elicitor to increase taxol production in Pestalotiopsis microspora. Addition of SA at the concentration of 300 mu M yielded taxol 625.47 mu g L-1, 45-fold higher than that of the control. Elicitation of the role of SA in the fungal taxol biosynthetic pathway revealed that SA enhanced reactive oxygen species and lipid peroxidation of unsaturated fatty acids of P. microspora mycelia. This oxidative process stimulates isoprene biosynthetic pathway by triggering expression of the geranylgeranyl pyrophosphate synthase gene leading to improved biosynthesis of taxol in P. microspora.	[Subban, Kamalraj; Chelliah, Jayabaskaran] Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India; [Subban, Kamalraj; Srinivasan, Vishnu Priya Madambakkam; Johnpaul, Muthumary] Univ Madras, Ctr Adv Studies Bot, Guindy Campus, Chennai, Tamil Nadu, India; [Subramani, Ramesh] Univ South Pacific, Sch Biol & Chem Sci, Fac Sci Technol & Environm, Laucala Campus,Private Mail Bag, Suva, Fiji	Indian Institute of Science (IISC) - Bangalore; University of Madras; University of the South Pacific	Chelliah, J (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore, Karnataka, India.	cjb@iisc.ac.in	Subramani, Ramesh/AAM-2316-2020	Subramani, Ramesh/0000-0001-8168-2215; Subban, Kamalraj/0000-0003-2720-0697	Department of Science and Technology, GOI, New Delhi, India [EMR/2015/001071]; IISc-DBT partnership programme; DST-FIST; UGC; Society for Innovation and Development-IISc-Phytobiotech Pvt. Ltd; DST-SERB, Govt. of India (DST) [SERB/LS-412/2013]	Department of Science and Technology, GOI, New Delhi, India(Department of Science & Technology (India)Department of Science & Technology (DOST), Philippines); IISc-DBT partnership programme(Indian Institute of Science (IISC) - Bangalore); DST-FIST(Department of Science & Technology (India)); UGC(University Grants Commission, India); Society for Innovation and Development-IISc-Phytobiotech Pvt. Ltd; DST-SERB, Govt. of India (DST)	This study was supported by the grant EMR/2015/001071 from Department of Science and Technology, GOI, New Delhi, India, IISc-DBT partnership programme, DST-FIST and UGC special assistance programme for financial support. This work also was supported by the Society for Innovation and Development-IISc-Phytobiotech Pvt. Ltd and DST-SERB, Govt. of India (DST No: SERB/LS-412/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H., 1984, METHOD ENZYMOL, P114; Amini SA, 2014, TURK J BIOL, V38, P528, DOI 10.3906/biy-1401-47; Bai ZH, 2003, CRIT REV BIOTECHNOL, V23, P267, DOI 10.1080/07388550390449294; Bian GK, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600697; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Chen J, 2007, J ENVIRON SCI, V19, P44, DOI 10.1016/S1001-0742(07)60007-2; Chen JY, 2006, POSTHARVEST BIOL TEC, V40, P64, DOI 10.1016/j.postharvbio.2005.12.017; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; COURCHAINE AJ, 1959, CLIN CHEM, V5, P609; Decker LA., 1977, WORTHINGTON ENZYME M, DOI [10.1002/tox.20212, DOI 10.1002/TOX.20212]; DIDIER E, 1994, TETRAHEDRON LETT, V35, P3063, DOI 10.1016/S0040-4039(00)76828-6; Dieryckx C, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00859; Dong HD, 2001, BIOCHEM ENG J, V8, P145, DOI 10.1016/S1369-703X(01)00096-1; Eraslan F, 2007, SCI HORTIC-AMSTERDAM, V113, P120, DOI 10.1016/j.scienta.2007.03.012; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gangadevi V, 2008, CHIN J CHROMATOGR, V26, P50; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Hefner J, 1998, ARCH BIOCHEM BIOPHYS, V360, P62, DOI 10.1006/abbi.1998.0926; Herrera-Vasquez A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00171; HOLTON RA, 1994, J AM CHEM SOC, V116, P1599, DOI 10.1021/ja00083a067; Hu YM, 2003, ACTA BOT SIN, V45, P373; Isah T, 2015, BRIT J PHARM RES, V6, P214, DOI 10.9734/BJPR/2015/16293; JENKINSON SG, 1982, J NUTR, V112, P197, DOI 10.1093/jn/112.1.197; Jennewein S, 2003, ARCH BIOCHEM BIOPHYS, V413, P262, DOI 10.1016/S0003-9861(03)00090-0; Jennewein S, 2001, P NATL ACAD SCI USA, V98, P13595, DOI 10.1073/pnas.251539398; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Kim HB, 2010, PLANT PHYSIOL, V152, P192, DOI 10.1104/pp.109.149088; Kusari S, 2014, TRENDS BIOTECHNOL, V32, P304, DOI 10.1016/j.tibtech.2014.03.011; LARSEN TO, 1995, MYCOL RES, V99, P1153, DOI 10.1016/S0953-7562(09)80271-2; Li JY, 1998, MYCOL RES, V102, P461, DOI 10.1017/S0953756297005078; Li JY, 1998, J IND MICROBIOL BIOT, V20, P259, DOI 10.1038/sj.jim.2900521; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Miao LY, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0567-6; Mirjalili MH, 2012, FEMS MICROBIOL LETT, V328, P122, DOI 10.1111/j.1574-6968.2011.02488.x; MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; NOHL H, 1979, MECH AGEING DEV, V11, P145, DOI 10.1016/0047-6374(79)90050-2; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Penn CD, 2013, CURR MICROBIOL, V67, P218, DOI 10.1007/s00284-013-0349-y; Qiao WC, 2017, FUNGAL BIOL-UK, V121, P1037, DOI 10.1016/j.funbio.2017.08.011; Rabe F, 2013, MOL MICROBIOL, V89, P179, DOI 10.1111/mmi.12269; Rovenich H, 2014, CURR OPIN PLANT BIOL, V20, P96, DOI 10.1016/j.pbi.2014.05.001; Sambrook J., 2001, MOL CLONING LAB MANU, P2344; Sarmadi M, 2018, PLANT PHYSIOL BIOCH, V132, P271, DOI 10.1016/j.plaphy.2018.09.013; Schoendorf A, 2001, P NATL ACAD SCI USA, V98, P1501, DOI 10.1073/pnas.98.4.1501; SIEGEL MR, 1981, PLANT DIS, V65, P986, DOI 10.1094/PD-65-986; Soliman SSM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00353; Soliman SSM, 2017, APPL MICROBIOL BIOT, V101, P7523, DOI 10.1007/s00253-017-8509-9; Soliman SSM, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00003; Somjaipeng S, 2016, ENZYME MICROB TECH, V90, P69, DOI 10.1016/j.enzmictec.2016.05.002; Strobel GA, 1996, J IND MICROBIOL BIOT, V17, P417, DOI 10.1007/BF01574772; Subban K, 2016, CANADIAN J PURE APPL, V10, P3951; Tabata H, 2004, ADV BIOCHEM ENG BIOT, V87, P1; Wang YD, 2007, CELL BIOL INT, V31, P1179, DOI 10.1016/j.cellbi.2007.03.038; Wu HS, 2008, CHEMOSPHERE, V74, P45, DOI 10.1016/j.chemosphere.2008.09.027; Xiong ZQ, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-71; Xu F, 2006, BIOCHEM ENG J, V31, P67, DOI 10.1016/j.bej.2006.05.024; Yu LJ, 2001, PROCESS BIOCHEM, V37, P477, DOI 10.1016/S0032-9592(01)00243-6; Yuan JS, 2008, TRENDS PLANT SCI, V13, P165, DOI 10.1016/j.tplants.2008.02.003; Yuan YJ, 2001, ENZYME MICROB TECH, V29, P372, DOI 10.1016/S0141-0229(01)00406-9; Zhou XW, 2010, APPL MICROBIOL BIOT, V86, P1707, DOI 10.1007/s00253-010-2546-y	64	19	19	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212736	10.1371/journal.pone.0212736	http://dx.doi.org/10.1371/journal.pone.0212736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794656	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000459709100126
J	Suzuki, Y; Maekawa, S; Komatsu, N; Sato, M; Tatsumi, A; Miura, M; Matsuda, S; Muraoka, M; Nakakuki, N; Amemiya, F; Takano, S; Fukasawa, M; Nakayama, Y; Yamaguchi, T; Inoue, T; Sato, T; Sakamoto, M; Yamashita, A; Moriishi, K; Enomoto, N				Suzuki, Yuichiro; Maekawa, Shinya; Komatsu, Nobutoshi; Sato, Mitsuaki; Tatsumi, Akihisa; Miura, Mika; Matsuda, Shuya; Muraoka, Masaru; Nakakuki, Natsuko; Amemiya, Fumitake; Takano, Shinichi; Fukasawa, Mitsuharu; Nakayama, Yasuhiro; Yamaguchi, Tatsuya; Inoue, Taisuke; Sato, Tadashi; Sakamoto, Minoru; Yamashita, Atsuya; Moriishi, Kohji; Enomoto, Nobuyuki			HBV preS deletion mapping using deep sequencing demonstrates a unique association with viral markers	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; GROUND GLASS HEPATOCYTES; CORE-RELATED ANTIGEN; CYCLIN-A EXPRESSION; CLOSED CIRCULAR DNA; SURFACE-ANTIGEN; HEPATOCELLULAR-CARCINOMA; ENDOPLASMIC-RETICULUM; S DELETION; MUTATIONS	Aim Deletions are observed frequently in the preS1/S2 region of hepatitis B virus (HBV) genome, in association with liver disease advancement. However, the most significant preS1/S2 region and its influences on viral markers are unclear. Methods The preS1/S2 HBV regions of 90 patients without antiviral therapy were subjected to deep sequencing and deleted regions influencing viral markers were investigated. Results From the deletion frequency analysis in each patient, deletions were observed most frequently in the preS2 codon 132-141 region. When the patients were divided into three groups (0-0.1%: n = 27, 0.1%-10%: n = 34, 10-100%: n = 29), based on the deletion frequency, FIB-4 (p < 0.01), HBV DNA (p < 0.01), HBcrAg (p < 0.01) and preS1/S2 start codon mutations (p < 0.01, both) were significantly associated with the deletion. When clinical and viral markers were investigated by multivariate analysis for their association with the deletion, FIB-4 (p < 0.05), HBcrAg (p < 0.05), and preS1 start codon mutation (p < 0.01) were extracted as independent variables. When the influence of the preS codon 132-141deletions on HBsAg and HBcrAg, relative to HBV DNA, was investigated, the HBsAg/HBV DNA ratio was lower (0-10% vs. 10%-100%, p<0.05), while the HBcrAg/HBV DNA rati o was higher (0-0.1% vs. 10%-100%, p<0.05) in the presence of the preS codon 132-141deletions. Conclusion The preS codon. 132-141 deletions have a significant influence on the clinical characteristics and viral markers, even when present as a minor population. Importantly, the preS codon 132-141 deletions have a clear influence on the viral life cycle and pathogenesis.	[Suzuki, Yuichiro; Maekawa, Shinya; Komatsu, Nobutoshi; Sato, Mitsuaki; Tatsumi, Akihisa; Miura, Mika; Matsuda, Shuya; Muraoka, Masaru; Nakakuki, Natsuko; Amemiya, Fumitake; Takano, Shinichi; Fukasawa, Mitsuharu; Nakayama, Yasuhiro; Yamaguchi, Tatsuya; Inoue, Taisuke; Sato, Tadashi; Sakamoto, Minoru; Enomoto, Nobuyuki] Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi, Japan; [Yamashita, Atsuya; Moriishi, Kohji] Univ Yamanashi, Dept Microbiol, Chuo Ku, Yamanashi, Japan	University of Yamanashi; University of Yamanashi	Maekawa, S (corresponding author), Univ Yamanashi, Fac Med, Dept Internal Med 1, Chuo Ku, Yamanashi, Japan.	maekawa@yamanashi.ac.jp	Moriishi, Kohji/I-4173-2019; Maekawa, Shinya/AAF-1349-2019	Moriishi, Kohji/0000-0002-9542-5188; 	Research Program on Hepatitis from Japanese Agency for Medical Research and Development (AMED) Japan [16 fk 0210301h0003, 16fk0210102h0001, 16 fk 0210308h0003]; JSPS KAKENHI [16K09349]; Japanese Agency for Medical Research and Development (AMED) Japan [17fk0310103j0001, 17fk0310113h0001, 17fk0210202h0002]	Research Program on Hepatitis from Japanese Agency for Medical Research and Development (AMED) Japan(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japanese Agency for Medical Research and Development (AMED) Japan(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by Research Program on Hepatitis from Japanese Agency for Medical Research and Development (AMED) Japan (Grant Number 16 fk 0210301h0003, 16fk0210102h0001, and 16 fk 0210308h0003 to NE), and partly by JSPS KAKENHI (Grant Number 16K09349). This study was also supported partly from Japanese Agency for Medical Research and Development (AMED) Japan (Grant Number 17fk0310103j0001, 17fk0310113h0001 and 17fk0210202h0002 to NE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai X, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007206; Chan HLY, 2007, CLIN GASTROENTEROL H, V5, P1462, DOI 10.1016/j.cgh.2007.09.005; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chen BF, 2006, GASTROENTEROLOGY, V130, P1153, DOI 10.1053/j.gastro.2006.01.011; Chen CH, 2007, GASTROENTEROLOGY, V133, P1466, DOI 10.1053/j.gastro.2007.09.002; Chua PK, 2005, J VIROL, V79, P13483, DOI 10.1128/JVI.79.21.13483-13496.2005; Fang ZL, 2008, J GEN VIROL, V89, P2882, DOI 10.1099/vir.0.2008/002824-0; Gao ZY, 2007, J GASTROENTEROL, V42, P761, DOI 10.1007/s00535-007-2085-1; Hsieh YH, 2004, CARCINOGENESIS, V25, P2023, DOI 10.1093/carcin/bgh207; Hsieh YH, 2015, J PATHOL, V236, P337, DOI 10.1002/path.4531; Li YW, 2016, WORLD J GASTROENTERO, V22, P1943, DOI 10.3748/wjg.v22.i6.1943; Lin LY, 2010, J MED VIROL, V82, P1494, DOI 10.1002/jmv.21863; Liu SJ, 2009, JNCI-J NATL CANCER I, V101, P1066, DOI 10.1093/jnci/djp180; Maasoumy B, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.02.010; Pollicino T, 2014, J HEPATOL, V61, P408, DOI 10.1016/j.jhep.2014.04.041; Pollicino T, 2012, HEPATOLOGY, V56, P434, DOI 10.1002/hep.25592; Rodriguez-Frias F, 2013, WORLD J GASTROENTERO, V19, P6995, DOI 10.3748/wjg.v19.i41.6995; Rokuhara A, 2003, J VIRAL HEPATITIS, V10, P324, DOI 10.1046/j.1365-2893.2003.00437.x; Sato M, 2015, J VIROL, V89, P6105, DOI 10.1128/JVI.03127-14; Su IJ, 2008, J GASTROEN HEPATOL, V23, P1169, DOI 10.1111/j.1440-1746.2008.05348.x; Su IJ, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0098-7; Sueki R, 2012, J MED VIROL, V84, P1360, DOI 10.1002/jmv.23314; Sugauchi F, 2003, J MED VIROL, V70, P537, DOI 10.1002/jmv.10428; Suzuki F, 2009, J MED VIROL, V81, P27, DOI 10.1002/jmv.21339; Testoni B, 2018, J HEPATOL; Wang HC, 2005, HEPATOLOGY, V41, P761, DOI 10.1002/hep.20615; Wang HC, 2003, AM J PATHOL, V163, P2441, DOI 10.1016/S0002-9440(10)63599-7; Wang HC, 2006, CANCER SCI, V97, P683, DOI 10.1111/j.1349-7006.2006.00235.x; Wang LHC, 2012, CARCINOGENESIS, V33, P466, DOI 10.1093/carcin/bgr296; World Health Organization, 2017, GLOB HEP REP 2017 EX; Zhang D. B., 2013, YANGTZE RIVER, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0065044; Zhang XN, 2015, LIVER INT, V35, P1087, DOI 10.1111/liv.12642	32	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212559	10.1371/journal.pone.0212559	http://dx.doi.org/10.1371/journal.pone.0212559			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794632	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100088
J	Turcios, L; Chacon, E; Garcia, C; Eman, P; Cornea, V; Jiang, JY; Spear, B; Liu, CM; Watt, DS; Marti, F; Gedaly, R				Turcios, Lilia; Chacon, Eduardo; Garcia, Catherine; Eman, Pedro; Cornea, Virgilius; Jiang, Jieyun; Spear, Brett; Liu, Chunming; Watt, David S.; Marti, Francesc; Gedaly, Roberto			Autophagic flux modulation by Wnt/beta-catenin pathway inhibition in hepatocellular carcinoma	PLOS ONE			English	Article							BETA-CATENIN; CELL-PROLIFERATION; CANCER-CELLS; SORAFENIB; RAS/RAF/MAPK; ACTIVATION; RESISTANCE; INITIATION; ROLES; FH535	Autophagy targets cellular components for lysosomal-dependent degradation in which the products of degradation may be recycled for protein synthesis and utilized for energy production. Autophagy also plays a critical role in cell homeostasis and the regulation of many physiological and pathological processes and prompts this investigation of new agents to effect abnormal autophagy in hepatocellular carcinoma (HCC). 2,5-Dichloro-N-(2-methyl-4-nitrophenyl) benzenesulfonamide (FH535) is a synthetic inhibitor of the Wnt/beta-catenin pathway that exhibits anti-proliferative and anti-angiogenic effects on different types of cancer cells. The combination of FH535 with sorafenib promotes a synergistic inhibition of HCC and liver cancer stem cell proliferation, mediated in part by the simultaneous disruption of mitochondrial respiration and glycolysis. We demonstrated that FH535 decreased HCC tumor progression in a mouse xenograft model. For the first time, we showed the inhibitory effect of an FH535 derivative, FH535-N, alone and in combination with sorafenib on HCC cell proliferation. Our study revealed the contributing effect of Wnt/beta-catenin pathway inhibition by FH535 and its derivative (FH535-N) through disruption of the autophagic flux in HCC cells.	[Turcios, Lilia; Chacon, Eduardo; Garcia, Catherine; Eman, Pedro; Cornea, Virgilius; Marti, Francesc; Gedaly, Roberto] Univ Kentucky, Coll Med, Dept Surg, Transplant Ctr, Lexington, KY 40506 USA; [Turcios, Lilia; Cornea, Virgilius; Jiang, Jieyun; Spear, Brett; Liu, Chunming; Watt, David S.; Marti, Francesc; Gedaly, Roberto] Univ Kentucky, Lucille Parker Markey Canc Ctr, Lexington, KY 40506 USA; [Jiang, Jieyun; Spear, Brett] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY USA; [Liu, Chunming; Watt, David S.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY USA; [Watt, David S.] Univ Kentucky, Coll Pharm, Ctr Pharmaceut Res & Innovat, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Gedaly, R (corresponding author), Univ Kentucky, Coll Med, Dept Surg, Transplant Ctr, Lexington, KY 40506 USA.; Gedaly, R (corresponding author), Univ Kentucky, Lucille Parker Markey Canc Ctr, Lexington, KY 40506 USA.	rgeda2@uky.edu		Eman, Pedro/0000-0001-6236-1723	Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30CA177558]; Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center [P30CA177558]; Office of the Vice President for Research; Markey Cancer Center; NCI Center Core Support Grant [P30 CA177558]; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER	Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center; Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center; Office of the Vice President for Research; Markey Cancer Center; NCI Center Core Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558). The research was also supported by the Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Biospecimen Procurement and Translational Pathology Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558). The UK Flow Cytometry & Immune Function core facility is supported in part by the Office of the Vice President for Research, the Markey Cancer Center and an NCI Center Core Support Grant (P30 CA177558) to the University of Kentucky Markey Cancer Center. The research was supported by the Redox Metabolism Shared Resource Facility of the University of Kentucky Markey Cancer Center (P30CA177558).	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Cai Z, 2018, CANCER RES, V78, P2536, DOI 10.1158/0008-5472.CAN-17-0028; Chen Y, 2017, J CANC, V8, P3142, DOI [10.7150/jca.19273, DOI 10.7150/JCA.19273]; Chi KH, 2016, ONCOTARGET, V7, P58075, DOI 10.18632/oncotarget.10873; Damsky WE, 2011, CANCER CELL, V20, P741, DOI 10.1016/j.ccr.2011.10.030; Dimitroulis D, 2017, WORLD J GASTROENTERO, V23, P5282, DOI 10.3748/wjg.v23.i29.5282; Fu YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102535; Galuppo R, 2014, ANTICANCER RES, V34, P1709; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Gao CX, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-13; Gedaly R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099272; Gedaly R, 2010, ANTICANCER RES, V30, P4951; Gekas C, 2016, LEUKEMIA, V30, P2002, DOI 10.1038/leu.2016.106; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Iida J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044418; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Jia ZQ, 2014, CELL SIGNAL, V26, P2299, DOI 10.1016/j.cellsig.2014.07.028; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kobayashi M, 2000, BRIT J CANCER, V82, P1689; Kril LM, 2015, BIOORG MED CHEM LETT, V25, P3897, DOI 10.1016/j.bmcl.2015.07.040; Kuhn K, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.31; Lee HC, 2006, FRONT BIOSCI-LANDMRK, V11, P1901, DOI 10.2741/1933; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Lin RK, 2015, CELL PHYSIOL BIOCHEM, V35, P926, DOI 10.1159/000369749; Liu L, 2016, ONCOTARGET, V7, P47145, DOI 10.18632/oncotarget.9975; Mittal S, 2013, J CLIN GASTROENTEROL, V47, pS2, DOI 10.1097/MCG.0b013e3182872f29; NAKABAYASHI H, 1982, CANCER RES, V42, P3858; Petherick KJ, 2013, EMBO J, V32, P1903, DOI 10.1038/emboj.2013.123; Poillet-Perez L, 2015, REDOX BIOL, V4, P184, DOI 10.1016/j.redox.2014.12.003; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Shi YH, 2011, AUTOPHAGY, V7, P1159, DOI 10.4161/auto.7.10.16818; Shiah SG, 2016, J DENT RES, V95, P129, DOI 10.1177/0022034515613507; Shimizu S, 2012, INT J CANCER, V131, P548, DOI 10.1002/ijc.26374; Society AC, 2018, NON TRADITIONAL REF; Su HF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0464-6; Su N, 2016, ONCOL LETT, V12, P4623, DOI 10.3892/ol.2016.5289; Sun T, 2017, CELL PHYSIOL BIOCHEM, V44, P716, DOI 10.1159/000485285; Tao H, 2017, MOL MED REP, V16, P1701, DOI 10.3892/mmr.2017.6828; Turcios L, 2017, DIGEST LIVER DIS, V49, P697, DOI 10.1016/j.dld.2017.01.146; Ullman-Cullere MH, 1999, LAB ANIM SCI, V49, P319; Wands JR, 2014, HEPATOLOGY, V60, P452, DOI 10.1002/hep.27081	42	24	25	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212538	10.1371/journal.pone.0212538	http://dx.doi.org/10.1371/journal.pone.0212538			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794613	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100082
J	Colitti, B; Coradduzza, E; Puggioni, G; Capucchio, MT; Reina, R; Bertolotti, L; Rosati, S				Colitti, Barbara; Coradduzza, Elisabetta; Puggioni, Giantonella; Capucchio, Maria Teresa; Reina, Ramses; Bertolotti, Luigi; Rosati, Sergio			A new approach for Small Ruminant Lentivirus full genome characterization revealed the circulation of divergent strains	PLOS ONE			English	Article							GENETIC-CHARACTERIZATION; IMMUNODOMINANT EPITOPE; ANTIBODY-RESPONSE; GOAT TRANSMISSION; SHEEP; ANTIGEN; CAPRINE	Small Ruminant Lentiviruses (SRLV) include at least 4 viral highly divergent genotypes. Genotypes A and B are widely distributed and genotypes C and E have been recognized in restricted geographic areas. New phylogroups have been identified targeting conserved regions. However, this approach suffers from the potential risk to misamplify highly divergent strains. Pathogenic strains are easily adapted to fibroblastic cells, but non-pathogenic strains isolation may require a different approach. We developed a fast and effective method for SRLV full genome characterization after cell culture isolation. Spleen samples were collected during regular slaughter from sheep and goats in northwestern Italy. Spleen-derived macrophage cultures were monitored for reverse transcriptase activity and RNA was extracted from the supernatant of positive cultures. Using Illumina MiSeq platform 22 new full genome sequences were obtained. The success of this approach is based on the following features: spleen is one of the main target for SRLV persistence; red pulp is a reserve of resident macrophages, the main target for SRLV replication in vivo; RTA is a sensitive assay for any replicating retrovirus; de novo sequencing do not require genetic knowledge in advance.	[Colitti, Barbara; Capucchio, Maria Teresa; Bertolotti, Luigi; Rosati, Sergio] Univ Turin, Dept Vet Sci, Turin, Italy; [Coradduzza, Elisabetta; Puggioni, Giantonella] Ist Zooprofilatt Sperimentale Sardegna, Sassari, Italy; [Reina, Ramses] Govt Navarra, UPNA, CSIC, Inst Agrobiotechnol, Navarra, Spain	University of Turin; IZS Della Sardegna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-GN-UPNA - Instituto de Agrobiotecnologia (IDAB); Universidad Publica de Navarra	Bertolotti, L (corresponding author), Univ Turin, Dept Vet Sci, Turin, Italy.	luigi.bertolotti@unito.it	Reina, Ramsés/AAL-3924-2020; Arias, Ramses Reina/E-3247-2012; Capucchio, Maria/AAA-6589-2022; Coradduzza, Elisabetta/GRS-3669-2022; Coradduzza, Elisabetta/AAA-4886-2020; Bertolotti, Luigi/F-9236-2013	Arias, Ramses Reina/0000-0003-1265-9139; Coradduzza, Elisabetta/0000-0001-6942-3296; Coradduzza, Elisabetta/0000-0001-6942-3296; Rosati, Sergio/0000-0002-8315-0316; Bertolotti, Luigi/0000-0001-7931-4528; Puggioni, Giantonella/0000-0001-9013-8203	University of Torino; Ramon y Cajal contract	University of Torino; Ramon y Cajal contract(Spanish Government)	This research was funded by the University of Torino (Ricerca Locale ex60% 2016 grant to SR). RR was supported by Ramon y Cajal contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by "Ricerca Locale ex60% 2016" grant provided by the University of Torino. The authors acknowledge all the slaughterhouse owners for the collaboration during the sample collection. RR was supported by Ramon y Cajal contract.	Bertolotti L, 2011, J GEN VIROL, V92, P1923, DOI 10.1099/vir.0.032334-0; BERTONI G, 1994, J VIROL, V68, P7139, DOI 10.1128/JVI.68.11.7139-7147.1994; Cardinaux L, 2013, VET MICROBIOL, V162, P572, DOI 10.1016/j.vetmic.2012.11.017; de Andres X, 2013, VET IMMUNOL IMMUNOP, V152, P277, DOI 10.1016/j.vetimm.2012.12.017; Deubelbeiss M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-65; Gjerset B, 2009, VET MICROBIOL, V135, P231, DOI 10.1016/j.vetmic.2008.09.069; Grego E, 2002, CLIN DIAGN LAB IMMUN, V9, P828, DOI 10.1128/CDLI.9.4.828-832.2002; Grego E, 2007, J GEN VIROL, V88, P3423, DOI 10.1099/vir.0.83292-0; Juganaru M, 2011, VIROLOGY, V410, P88, DOI 10.1016/j.virol.2010.10.031; Juganaru M, 2010, VET RES COMMUN, V34, pS47, DOI 10.1007/s11259-010-9390-5; Mordasini F, 2006, J CLIN MICROBIOL, V44, P981, DOI 10.1128/JCM.44.3.981-991.2006; Olech M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193892; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; PERRY LL, 1995, J INFECT DIS, V171, P328, DOI 10.1093/infdis/171.2.328; Ramirez H, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-8; Reina R, 2010, VET MICROBIOL, V144, P24, DOI 10.1016/j.vetmic.2009.12.020; Reina R, 2009, VET MICROBIOL, V138, P251, DOI 10.1016/j.vetmic.2009.04.005; Reina R, 2009, J VIROL, V83, P1152, DOI 10.1128/JVI.01627-08; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; ROSATI S, 1995, J VET DIAGN INVEST, V7, P437, DOI 10.1177/104063879500700403; Santry LA, 2013, VIRUS RES, V175, P30, DOI 10.1016/j.virusres.2013.03.019; Shah C, 2004, VIROLOGY, V319, P12, DOI 10.1016/j.virol.2003.09.047; Tolari F, 1991, ATTI SOC ITALIANA SC, P1083	23	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212585	10.1371/journal.pone.0212585	http://dx.doi.org/10.1371/journal.pone.0212585			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789950	Green Submitted, Green Published, gold			2022-12-26	WOS:000459330800043
J	Caro, T; Argueta, Y; Briolat, ES; Bruggink, J; Kasprowsky, M; Lake, J; Mitchell, MJ; Richardson, S; How, M				Caro, Tim; Argueta, Yvette; Briolat, Emmanuelle Sophie; Bruggink, Joren; Kasprowsky, Maurice; Lake, Jai; Mitchell, Matthew J.; Richardson, Sarah; How, Martin			Benefits of zebra stripes: Behaviour of tabanid flies around zebras and horses	PLOS ONE			English	Article							ADVANTAGE; PATTERNS; DIPTERA; TSETSE; TRAPS	Averting attack by biting flies is increasingly regarded as the evolutionary driver of zebra stripes, although the precise mechanism by which stripes ameliorate attack by ectoparasites is unknown. We examined the behaviour of tabanids (horse flies) in the vicinity of captive plains zebras and uniformly coloured domestic horses living on a horse farm in Britain. Observations showed that fewer tabanids landed on zebras than on horses per unit time, although rates of tabanid circling around or briefly touching zebra and horse pelage did not differ. In an experiment in which horses sequentially wore cloth coats of different colours, those wearing a striped pattern suffered far lower rates of tabanid touching and landing on coats than the same horses wearing black or white, yet there were no differences in attack rates to their naked heads. In separate, detailed video analyses, tabanids approached zebras faster and failed to decelerate before contacting zebras, and proportionately more tabanids simply touched rather than landed on zebra pelage in comparison to horses. Taken together, these findings indicate that, up close, striped surfaces prevented flies from making a controlled landing but did not influence tabanid behaviour at a distance. To counteract flies, zebras swished their tails and ran away from fly nuisance whereas horses showed higher rates of skin twitching. As a consequence of zebras' striping, very few tabanids successfully landed on zebras and, as a result of zebras' changeable behaviour, few stayed a long time, or probed for blood.	[Caro, Tim; Argueta, Yvette] Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA; [Briolat, Emmanuelle Sophie; Kasprowsky, Maurice; Mitchell, Matthew J.; Richardson, Sarah] Univ Exeter, Ctr Ecol & Conservat Biosci, Coll Life & Environm Sci, Penryn Campus, Penryn, Cornwall, England; [Bruggink, Joren] Aeres Univ Appl Sci, Almere, Netherlands; [Lake, Jai; How, Martin] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	University of California System; University of California Davis; University of Exeter; University of Bristol	Caro, T (corresponding author), Univ Calif Davis, Dept Wildlife Fish & Conservat Biol, Davis, CA 95616 USA.	tmcaro@ucdavis.edu	How, Martin J./G-1925-2010	How, Martin J./0000-0001-5135-8828; Richardson, Sarah/0000-0001-8942-7286; Briolat, Emmanuelle/0000-0001-5695-1065; Mitchell, Matt/0000-0001-7599-8926	University of California, Davis; Royal Society	University of California, Davis(University of California System); Royal Society(Royal Society of London)	TC was funded by the University of California, Davis; MH by the Royal Society.	ALLAN SA, 1986, J MED ENTOMOL, V23, P83, DOI 10.1093/jmedent/23.1.83; Baird E, 2013, P NAT ACAD SCI; BALLARD JWO, 1988, MED VET ENTOMOL, V2, P265, DOI 10.1111/j.1365-2915.1988.tb00194.x; Benesch Annette R., 2003, Zoologische Garten, V73, P74; BRADY J, 1988, B ENTOMOL RES, V78, P301, DOI 10.1017/S0007485300013067; Britten KH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154504; Caro T, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150323; Caro T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4535; Caro Tim, 2016, ZEBRA STRIPES; CENA K, 1973, Journal of Mammalogy, V54, P1003, DOI 10.2307/1379105; Egri A, 2012, J EXP BIOL, V215, P736, DOI 10.1242/jeb.065540; FOIL LD, 1989, PARASITOL TODAY, V5, P88, DOI 10.1016/0169-4758(89)90009-4; GIBSON G, 1992, PHYSIOL ENTOMOL, V17, P141, DOI 10.1111/j.1365-3032.1992.tb01191.x; Harris RHTP, 1940, REPORT BIONOMICS TSE; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; Hogan BG, 2016, BEHAV ECOL, V27, P1547, DOI 10.1093/beheco/arw081; Horvath G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27637-1; Horvath G, 2010, P ROY SOC B-BIOL SCI, V277, P1643, DOI 10.1098/rspb.2009.2202; How MJ, 2014, ZOOLOGY, V117, P163, DOI 10.1016/j.zool.2013.10.004; Krcmar S, 2014, PARASITE, V21, DOI 10.1051/parasite/2014068; Larison B, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140452; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Melin AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145679; MORRIS K. R. S., 1963, ACTA TROP, V20, P16; MULLENS BA, 1979, ENVIRON ENTOMOL, V8, P1047, DOI 10.1093/ee/8.6.1047; ROBERTS RH, 1972, MOSQ NEWS, V32, P542; Ruxton GD, 2002, MAMMAL REV, V32, P237, DOI 10.1046/j.1365-2907.2002.00108.x; Santer RD, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0811; Scott-Samuel NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020233; SIEGFRIED WR, 1990, J MAMMAL, V71, P75, DOI 10.2307/1381320; Srinivasan MV, 2004, ANNU REV NEUROSCI, V27, P679, DOI 10.1146/annurev.neuro.27.070203.144343; WAAGE J K, 1981, Journal of the Entomological Society of Southern Africa, V44, P351	32	19	19	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210831	10.1371/journal.pone.0210831	http://dx.doi.org/10.1371/journal.pone.0210831			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785882	gold, Green Submitted, Green Published			2022-12-26	WOS:000459307000015
J	Finnamore, E; Waugh, C; Solomons, L; Ryan, M; West, C; Scott, A				Finnamore, Evan; Waugh, Charlotte; Solomons, Lyndal; Ryan, Michael; West, Christopher; Scott, Alexander			Transverse tendon stiffness is reduced in people with Achilles tendinopathy: A cross-sectional study	PLOS ONE			English	Article							ELASTOGRAPHY; ALTERS; STRAIN	Objectives The objective of the current cross-sectional study was to examine Achilles tendon transverse stiffness in a group of recreational runners with Achilles tendinopathy, in comparison to an asymptomatic group of runners with similar training history. We also aimed to determine the between-week intra-individual reliability of this measurement technique. Design Cross-sectional cohort study. Methods A hand-held dynamometer was used to assess the transverse stiffness of the Achilles tendon (AT) in twenty-five recreational runners. In ten people with midportion Achilles tendinopathy (5 men, 5 women), measurements were taken directly over the most symptomatic location. In 15 people who were free of AT symptoms (7 men, 8 women), measurements were taken at an equivalent location on the tendon. Participants returned after one week to determine measurement reliability (intra-class correlation coefficient/ICC and minimum detectable change/MDC95). We also collected information about people's tendon loading activities, tendon thickness (ultrasound mesaurement), and symptoms (Victorian Institute of Sports Assessment-Achilles / VISA-A score). Results The AT transverse stiffness was lower in people with Achilles tendinopathy (777 N/m +/- 86) compared to those who were asymptomatic (873 N/m +/- 72) (p < 0.05). AT transverse stiffness was negatively correlated with age and tendon thickness, and positively correlated with VISA-A score and waist circumference. Reliability was good, with ICC of 0.81 in people with tendinopathy and 0.80 in healthy controls, and an MDC95 of 118 and 87N/m in these two respective groups. Conclusions Transverse Achilles tendon stiffness can be reliably measured in people with midportion Achilles tendinopathy, and appears to be lower in people who are older, more symptomatic, and with more extensive tendon thickening. The potential clinical utility of monitoring tendon stiffness in the management of tendon injuries merits further study.	[Finnamore, Evan; Waugh, Charlotte; Solomons, Lyndal; Scott, Alexander] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Finnamore, Evan; Waugh, Charlotte; Solomons, Lyndal; Scott, Alexander] Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada; [Ryan, Michael] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC, Canada; [West, Christopher] Univ British Columbia Okanagan, Southern Med Program, Dept Cellular & Physiol Sci, Kelowna, BC, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; Simon Fraser University; University of British Columbia; University of British Columbia Okanagan	Scott, A (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.; Scott, A (corresponding author), Univ British Columbia, Dept Phys Therapy, Fac Med, Vancouver, BC, Canada.	ascott@mail.ubc.ca	Waugh, Charlie/J-3687-2015	Waugh, Charlie/0000-0002-3090-046X; Scott, Alex/0000-0003-0366-8404				Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Bohm S, 2015, SCAND J MED SCI SPOR, V25, pE124, DOI 10.1111/sms.12242; Bohm S, 2015, SPORTS MED OPEN, V1, P9, DOI [10.1186/s40798-015-0012-1, DOI 10.1186/S40798-015-0012-1]; Coombes BK, 2018, SCAND J MED SCI SPOR, V28, P1201, DOI 10.1111/sms.12986; Couppe C, 2008, J APPL PHYSIOL, V105, P805, DOI 10.1152/japplphysiol.90361.2008; de Sa A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199645; Delabastita T, 2019, J AGING PHYS ACTIV, V27, P116, DOI 10.1123/japa.2017-0359; Docking SI, 2015, J SCI MED SPORT, V18, P383, DOI 10.1016/j.jsams.2014.06.004; Eekhoff JD, 2018, CONNECT TISSUE RES, V59, P410, DOI 10.1080/03008207.2018.1449837; Habets B, 2018, SPORTS MED, V48, P705, DOI 10.1007/s40279-017-0833-9; Haen TX, 2017, J MECH BEHAV BIOMED, V69, P178, DOI 10.1016/j.jmbbm.2017.01.007; Hassler U, 2003, J ROY STAT SOC D-STA, V52, P367, DOI 10.1111/1467-9884.00365; Kongsgaard M, 2010, AM J SPORT MED, V38, P749, DOI 10.1177/0363546509350915; Lai A, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0391; Leung JL, 2008, J CLIN ULTRASOUND, V36, P27, DOI 10.1002/jcu.20388; Martin JA, 2018, NAT COMMUN, V9, P6, DOI [10.1038/s41467-017-02251-3, DOI 10.1038/S41467-017-02251-3]; Ooi CC, 2014, SKELETAL RADIOL, V43, P1, DOI 10.1007/s00256-013-1695-3; Paavola M, 2000, AM J SPORT MED, V28, P634, DOI 10.1177/03635465000280050301; Robinson JM, 2001, BRIT J SPORT MED, V35, P335, DOI 10.1136/bjsm.35.5.335; Schepull T, 2015, KNEE SURG SPORT TR A, V23, P884, DOI 10.1007/s00167-013-2720-8; Schneider S, 2015, MED BIOL ENG COMPUT, V53, P57, DOI 10.1007/s11517-014-1211-5; Scott A, 2015, J ORTHOP SPORT PHYS, V45, P833, DOI 10.2519/jospt.2015.5884; Sohirad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184463; Sussmilch-Leitch SP, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-15; Vandenbroucke JP, 2009, GAC SANIT, V23, P158, DOI 10.1016/j.gaceta.2008.12.001; Videbaek S, 2015, SPORTS MED, V45, P1017, DOI 10.1007/s40279-015-0333-8; Waugh CM, 2018, SCAND J MED SCI SPOR, V28, P436, DOI 10.1111/sms.12930; Wearing SC, 2013, J BODYW MOV THER, V17, P316, DOI 10.1016/j.jbmt.2012.11.004	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211863	10.1371/journal.pone.0211863	http://dx.doi.org/10.1371/journal.pone.0211863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785895	Green Submitted, gold, Green Published			2022-12-26	WOS:000459307000043
J	Miller, BA; Chapwanya, A; Kilminster, T; Scanlon, T; Milton, J; Osorio, H; Oldham, C; Greeff, J; Bergfelt, DR; Campos, AMO; Almeida, AM				Miller, Blake A.; Chapwanya, Aspinas; Kilminster, Tanya; Scanlon, Tim; Milton, John; Osorio, Hugo; Oldham, Chris; Greeff, Johan; Bergfelt, Don R.; Campos, Alexandre M. O.; Almeida, Andre M.			The ovine hepatic mitochondrial proteome: Understanding seasonal weight loss tolerance in two distinct breeds	PLOS ONE			English	Article							AUSTRALIAN MERINO LAMBS; GENETIC-RESOURCES; ANIMAL PRODUCTION; GUINEA-BISSAU; LIVE WEIGHT; GOAT BREEDS; DAMARA; PARAMETERS; MAJORERA; DORPER	Seasonal weight loss (SWL) is a primary constraint for farmers in the Mediterranean and tropics. One cost-effective solution to SWL is utilizing breeds like the Damara sheep that have adapted to deal with nutritional stress. Previous studies concluded that one of the adaptation mechanisms of SWL is a specialized fatty acid metabolism. Accordingly, hepatic-mitochondrial proteomes were compared across two different breeds (24 sheep total, Merino, n = 12 and Damara, n = 12) and two different diets (restricted vs unrestricted diet, 6 per breed, per diet, 24 total). Mitochondrial-proteins were isolated and relatively quantified using Blue native PAGE/2D-electrophoresis and then analyzed via mass spectrometry. The tool ReviGO summarized the proteomes' gene-ontology terms. A total of 50 proteins were identified with 7 changing significantly in abundance (ANOVA p-value<0.05). Specific abundance patterns of corticosteroid and inflammatory response-associated proteins such as annexin and glutamate dehydrogenase suggests that the Damara has an unusual inflammation response when subjected to SWL in addition to its unique metabolism. All significant proteins warrant further study; Annexin in particular shows promise as a potentially useful biomarker.	[Miller, Blake A.; Chapwanya, Aspinas; Bergfelt, Don R.] Ross Univ Sch Vet Med, Dept Clin Sci, Basseterre, St Kitts & Nevi; [Kilminster, Tanya; Scanlon, Tim; Oldham, Chris; Greeff, Johan] Dept Agr & Food Western Australia, Perth, WA, Australia; [Milton, John] Univ Western Australia, Perth, WA, Australia; [Osorio, Hugo] Univ Porto, Inst Invest & Inovacao Saude, Porto, Portugal; [Osorio, Hugo] Univ Porto, Inst Mol Pathol & Immunol, Porto, Portugal; [Osorio, Hugo] Univ Porto, Dept Pathol, Fac Med, Porto, Portugal; [Campos, Alexandre M. O.] Univ Porto, Interdisciplinary Ctr Marine & Environm Res, Matosinhos, Portugal; [Almeida, Andre M.] Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food, Lisbon, Portugal	University of Western Australia; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade de Lisboa	Almeida, AM (corresponding author), Univ Lisbon, Inst Super Agron, Linking Landscape Environm Agr & Food, Lisbon, Portugal.	aalmeida@isa.ulisboa.pt	Campos, Alexandre/AGP-3558-2022; Almeida, Andre/I-4369-2013; Osorio, Hugo/A-7847-2012	Campos, Alexandre/0000-0003-4621-885X; Almeida, Andre/0000-0002-7810-3988; Scanlon, Timothy/0000-0001-5706-5487; Osorio, Hugo/0000-0002-6362-8255	Fundacao para a Ciencia e a Tecnologia [ROTEIRO/0028/2013, LISBOA-01-0145-FEDER-022125]; Centre for Integrative Mammalian Research of Ross University School of Veterinary Medicine (St. Kitts and Nevis, West Indies); LEAF [UID/AGR/04129/2013]	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Centre for Integrative Mammalian Research of Ross University School of Veterinary Medicine (St. Kitts and Nevis, West Indies); LEAF	Mass spectrometry work was performed at the Proteomics i3S Scientific Platform that has support from the Fundacao para a Ciencia e a Tecnologia (ROTEIRO/0028/2013; LISBOA-01-0145-FEDER-022125). This work was supported by an Intra-Mural grant (Ovinomics II) from the Centre for Integrative Mammalian Research of Ross University School of Veterinary Medicine (St. Kitts and Nevis, West Indies). Author AM Almeida acknowledges funding from LEAF (UID/AGR/04129/2013).	Almeida AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146367; Almeida AM, 2013, TROP ANIM HEALTH PRO, V45, P1305, DOI 10.1007/s11250-013-0361-z; Almeida AM, 2011, TROP ANIM HEALTH PRO, V43, P1427, DOI 10.1007/s11250-011-9868-3; Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077313; Binns D, 2009, BIOINFORMATICS, V25, P3045, DOI 10.1093/bioinformatics/btp536; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Ceciliani F, 2018, J PROTEOMICS, V178, P92, DOI 10.1016/j.jprot.2017.10.010; Cugno G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151599; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P529, DOI 10.1007/s11250-008-9130-9; de Almeida AM, 2008, TROP ANIM HEALTH PRO, V40, P537, DOI 10.1007/s11250-008-9131-8; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Eswaramoorthy S, 2006, P NATL ACAD SCI USA, V103, P9832, DOI 10.1073/pnas.0602398103; Ferreira AM, 2017, J PROTEOMICS, V161, P57, DOI 10.1016/j.jprot.2017.03.020; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Lerias JR, 2015, J DAIRY RES, V82, P416, DOI 10.1017/S0022029915000412; Lerias JR, 2013, TROP ANIM HEALTH PRO, V45, P1731, DOI 10.1007/s11250-013-0423-2; Liu AJ, 2011, CANCER EPIDEMIOL, V35, P490, DOI 10.1016/j.canep.2010.10.004; McKenna MC, 2016, ADV NEUROBIOL, V13, P59, DOI 10.1007/978-3-319-45096-4_4; Miller B, 2018, J PROTEOMICS; Mondov? B., 1982, STRUCTURE FUNCTION R, P141; Palma M, 2016, SCI REP-UK, V6, DOI 10.1038/srep39120; Plaitakis A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010011; Scanlon TT, 2013, SMALL RUMINANT RES, V109, P101, DOI 10.1016/j.smallrumres.2012.08.004; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Uhlmann T, 2012, MOL CELL PROTEOMICS, V11, P1489, DOI 10.1074/mcp.M112.020743; Vassilopoulos A, 2014, ANTIOXID REDOX SIGN, V21, P551, DOI 10.1089/ars.2013.5420; WALKER JE, 1984, BIOCHIM BIOPHYS ACTA, V768, P164, DOI 10.1016/0304-4173(84)90003-X; Zane NR, 2018, PEDIATR RES, V83, P527, DOI 10.1038/pr.2017.226	28	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212580	10.1371/journal.pone.0212580	http://dx.doi.org/10.1371/journal.pone.0212580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785939	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000073
J	Petruzziello, A; Sabatino, R; Loquercio, G; Guzzo, A; Di Capua, L; Labonia, F; Cozzolino, A; Azzaro, R; Botti, G				Petruzziello, Arnolfo; Sabatino, Rocco; Loquercio, Giovanna; Guzzo, Annunziata; Di Capua, Lucia; Labonia, Francesco; Cozzolino, Anna; Azzaro, Rosa; Botti, Gerardo			Nine-year distribution pattern of hepatitis C virus (HCV) genotypes in Southern Italy	PLOS ONE			English	Article							GENERAL-POPULATION; RISK-FACTORS; MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY; METROPOLITAN-AREA; VIRAL LOAD; B-VIRUS; INFECTION; PREVALENCE; SUBTYPES	Introduction It has been greatly described that different hepatitis C virus (HCV) genotypes are strictly correlated to various evolution, prognosis and response to therapy during the chronic liver disease. Aim of this study was to outline the changes in the epidemiology of Hepatitis C genotypes in Southern Italy regions from 2006 to 2014. Material/Methods Prevalence of HCV genotypes was analyzed in 535 HCV-RNA positive patients with chronic Hepatitis C infection, selected during the period 2012-2014, and compared with our previous data, referred to periods 2006-2008 and 2009-2011. Results In all the three periods analyzed, genotype 1 b is predominant (51.8% in 2006-08, 48.3% in 2009-11 and 54.4% in 2012-14) while genotype 2 showed an increase in prevalence (27.9% in 2006-08, 31.7% in 2009-11 and 35.2% in 2012-14) and genotypes 3a and 1a a decrease during the same period (6.8% in 2006-08, 4.7% in 2009-11 and 3.2% in 2012-14 and 7.9% in 2006-08, 4.7% in 2009-11 and 2.6% in 2012-14, respectively). Subtype 1 b seems to be equally distributed between males and females (52.7% vs 56.6%) and the prevalence in the age range 31-40 years is significantly higher in the 2012-14 period than in both previous periods (53.8% vs. 16.6% in 2009-11, p < 0.001 and 13.4% in 2006-08, p < 0.001). Conclusions Genotype 1 b is still the most prevalent, even if shows a significantly increase in the under 40 years old population. Instead, genotype 3a seems to have a moderate increase among young people. Overall, the alarming finding is the "returning" role of the iatrogenic transmission as risk factor for the diffusion of Hepatitis C infection.	[Petruzziello, Arnolfo; Sabatino, Rocco; Loquercio, Giovanna; Guzzo, Annunziata; Di Capua, Lucia; Labonia, Francesco; Cozzolino, Anna; Botti, Gerardo] IRCCS Italia, SSD Virol & Mol Biol, Dept Diagnost Area, Ist Nazl Tumori,Fdn G Pascale, Naples, Italy; [Azzaro, Rosa] IRCCS Italia, Transfus Serv, Dept Hemathol, Ist Nazl Tumori,Fdn G Pascale, Naples, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale	Petruzziello, A (corresponding author), IRCCS Italia, SSD Virol & Mol Biol, Dept Diagnost Area, Ist Nazl Tumori,Fdn G Pascale, Naples, Italy.	a.petruzziello@istitutotumori.na.it	di capua, lucia/D-8605-2019; Labonia, Francesco/AAA-4083-2021; Guzzo, Annunziata/ABF-2550-2020; PETRUZZIELLO, ARNOLFO/O-1163-2017	Labonia, Francesco/0000-0001-5819-1290; Guzzo, Annunziata/0000-0001-5001-6383; PETRUZZIELLO, ARNOLFO/0000-0003-0353-9151; Botti, Gerardo/0000-0002-6287-733X; Sabatino, Rocco/0000-0003-1113-8665				Aguilera A, 2017, J VIRAL HEPATITIS, V24, P725, DOI 10.1111/jvh.12700; Anderson JC, 2003, J CLIN VIROL, V28, P27, DOI 10.1016/S1386-6532(02)00235-4; [Anonymous], 41 ANN M EUR ASS STU; Ansaldi F, 2005, J MED VIROL, V76, P327, DOI 10.1002/jmv.20376; Antaki N, 2013, J VIRAL HEPATITIS, V20, P59, DOI 10.1111/j.1365-2893.2012.01621.x; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Campello C, 2002, INFECTION, V30, P7, DOI 10.1007/s15010-001-1197-4; Cenci M, 2007, ANTICANCER RES, V27, P1219; Cooke GS, 2013, J VIRAL HEPATITIS, V20, P600, DOI 10.1111/jvh.12123; Coppola RC, 2000, J VIRAL HEPATITIS, V7, P130; Dal Molin G, 2002, J MED VIROL, V68, P352, DOI 10.1002/jmv.10210; De Conto F, 2016, ARCH VIROL, V161, P2727, DOI 10.1007/s00705-016-2975-8; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Grimaldi E, 2017, INTERVIROLOGY, V60, P82, DOI 10.1159/000481821; Guadagnino V, 1997, HEPATOLOGY, V26, P1006, DOI 10.1053/jhep.1997.v26.pm0009328327; Guadagnino V, 2013, DIGEST LIVER DIS, V45, P403, DOI 10.1016/j.dld.2012.10.014; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Haldeda M, 2014, INT J INFECT DIS, V18, P90, DOI 10.1016/j.ijid.2013.08.015; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Karmochkine M, 2006, J VIRAL HEPATITIS, V13, P775, DOI 10.1111/j.1365-2893.2006.00742.x; Magiorkinis G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000198; Maio G, 2000, J HEPATOL, V33, P116, DOI 10.1016/S0168-8278(00)80167-1; Marascio N, 2014, BMC INFECT DIS S5, V14, P52; Marascio N, 2014, INFECT GENET EVOL, V26, P352, DOI 10.1016/j.meegid.2014.06.006; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Negro F, 2014, DIGEST LIVER DIS, V46, pS158, DOI 10.1016/j.dld.2014.09.023; Osella AR, 2001, CLIN INFECT DIS, V33, P70, DOI 10.1086/320887; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Petruzziello A, 2018, J MED VIROL; Petruzziello Arnolfo, 2018, Open Virol J, V12, P26, DOI 10.2174/1874357901812010026; Petruzziello A, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0162-5; Petruzziello A, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0099-0; Petruzziello A, 2016, WORLD J GASTROENTERO, V22, P7824, DOI 10.3748/wjg.v22.i34.7824; Petruzziello A, 2014, INTERVIROLOGY, V57, P311, DOI 10.1159/000363386; Petruzziello A, 2013, INTERVIROLOGY, V56, P206, DOI 10.1159/000348506; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Raffaele A, 2001, EUR J EPIDEMIOL, V17, P41, DOI 10.1023/A:1010932832190; Razavi H, 2014, J VIRAL HEPATITIS, V21, P34, DOI 10.1111/jvh.12248; Roffi L, 1998, J HEPATOL, V29, P701, DOI 10.1016/S0168-8278(98)80249-3; Romeo R, 2018, EPIDEMIOL INFECT, V146, P1612, DOI [10.1017/S0950268818001942, 10.1017/s0950268818001942]; SAGNELLI E, 1991, INFECTION, V19, P155, DOI 10.1007/BF01643238; Sereno S, 2009, J CLIN VIROL, V45, P354, DOI 10.1016/j.jcv.2009.04.022; SIMMONDS P, 1994, HEPATOLOGY, V19, P1321, DOI 10.1016/0270-9139(94)90887-7; Simmonds P, 2001, J GEN VIROL, V82, P693, DOI 10.1099/0022-1317-82-4-693; Smith DB, 1997, J GEN VIROL, V78, P321, DOI 10.1099/0022-1317-78-2-321; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Stamouli M, 2012, CLIN LAB, V58, P173; STROFFOLINI T, 1992, HEPATO-GASTROENTEROL, V39, P62; Svirtlih N, 2007, WORLD J GASTROENTERO, V13, P355, DOI 10.3748/wjg.v13.i3.355; Wedemeyer H, 2014, J VIRAL HEPATITIS, V21, P60, DOI 10.1111/jvh.12249; Wyles DL, 2014, J VIRAL HEPATITIS, V21, P229, DOI 10.1111/jvh.12230; Zhang Y, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0710-z	55	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212033	10.1371/journal.pone.0212033	http://dx.doi.org/10.1371/journal.pone.0212033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785909	gold, Green Published, Green Submitted			2022-12-26	WOS:000459307000047
J	Kwon, E; Li, X; Deng, YF; Chang, HW; Kim, DY				Kwon, Eunju; Li, Xian; Deng, Yifeng; Chang, Hyeun Wook; Kim, Dong Young			AMPK is down-regulated by the CRL4A-CRBN axis through the polyubiquitination of AMPK isoforms	FASEB JOURNAL			English	Article						proteasomal degradation; BMMC; allergy	ACTIVATED PROTEIN-KINASE; E3 UBIQUITIN LIGASE; STRUCTURAL BASIS; BETA; IDENTIFICATION; DEGRADATION; CELL; BINDING; THALIDOMIDE; EXPRESSION	As a master regulator for metabolic and energy homeostasis, AMPK controls the activity of metabolic enzymes and transcription factors in response to cellular ATP status. AMPK has been thus recognized as a main target for the regulation of cellular energy metabolism. Here, we report that AMPK can be down-regulated by the cullin-RING ubiquitin E3 ligase 4A (CRL4A) with cereblon (CRBN). CRL4A interacted with AMPK holoenzymes and mediated AMPK-specific polyubiquitination for its proteasomal degradation through non-K48 polyubiquitin linkages. In the ubiquitination system, CRBN was required for efficient polyubiquitination of AMPK subunits. Consistently, polyubiquitination of AMPK subunits was reduced by inhibitors of CRL4A-CRBN. Physiologic function of AMPK down-regulation by CRL4-CRBN was also confirmed using mouse bone marrow-derived mast cells (BMMCs). The inactivation of CRL4A-CRBN in BMMC increased AMPK stability and suppressed secretion of allergic mediators via AMPK activation followed by MAPK inhibition. In addition, CRBN knockout of BMMC also decreased allergic responses in mice. Our results suggest that the CRL4A-CRBN axis could be a target for the regulation of AMPK-dependent responses.Kwon, E., Li, X., Deng, Y., Chang, H. W., Kim, D. Y. AMPK is down-regulated by the CRL4A-CRBN axis through the polyubiquitination of AMPK isoforms.	[Kwon, Eunju; Li, Xian; Deng, Yifeng; Chang, Hyeun Wook; Kim, Dong Young] Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, South Korea	Yeungnam University	Chang, HW; Kim, DY (corresponding author), Yeungnam Univ, Coll Pharm, 280 Daehak Ro, Gyongsan 38541, South Korea.	hwchang@ynu.ac.kr; dyokim@ynu.ac.kr		Kim, Dong Young/0000-0001-7594-9083	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science and Information and Communications Technology (ICT) [2014R1A4A1071040]; Ministry of Education [2017R1A6A3A11029218, 2017R1D1A1B03034088]	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science and Information and Communications Technology (ICT); Ministry of Education	The authors thank Prof. John D. Gross (University of California-San Francisco, San Francisco, CA, USA), for the helpful discussion. This work was supported by Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and Information and Communications Technology (ICT) (2014R1A4A1071040), and the Ministry of Education (2017R1A6A3A11029218; 2017R1D1A1B03034088). The authors declare no conflicts of interest.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bartlett JB, 2004, NAT REV CANCER, V4, P314, DOI 10.1038/nrc1323; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chen L, 2012, NAT STRUCT MOL BIOL, V19, P716, DOI 10.1038/nsmb.2319; Chen YA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10667; Cheung PCF, 2000, BIOCHEM J, V346, P659, DOI 10.1042/0264-6021:3460659; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Fionda C, 2015, ONCOTARGET, V6, P23609, DOI 10.18632/oncotarget.4603; Fischer ES, 2014, NATURE, V512, P49, DOI 10.1038/nature13527; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Higgins JJ, 2004, NEUROLOGY, V63, P1927, DOI 10.1212/01.WNL.0000146196.01316.A2; Hwang SL, 2014, J ALLERGY CLIN IMMUN, V134, P714, DOI 10.1016/j.jaci.2014.05.001; Hwang SL, 2013, J ALLERGY CLIN IMMUN, V132, P729, DOI 10.1016/j.jaci.2013.02.018; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jager S, 2012, NATURE, V481, P371, DOI 10.1038/nature10693; Kronke J, 2015, NATURE, V523, P183, DOI 10.1038/nature14610; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; Lee JO, 2013, J BIOL CHEM, V288, P4673, DOI 10.1074/jbc.M112.406009; Lee KM, 2013, DIABETES, V62, P1855, DOI 10.2337/db12-1030; Lee KM, 2011, BBA-MOL CELL RES, V1813, P448, DOI 10.1016/j.bbamcr.2011.01.005; Li X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00596-9; Matyskiela ME, 2016, NATURE, V535, P252, DOI 10.1038/nature18611; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petzold G, 2016, NATURE, V532, P127, DOI 10.1038/nature16979; Pineda CT, 2015, CELL, V160, P715, DOI 10.1016/j.cell.2015.01.034; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Polekhina G, 2005, STRUCTURE, V13, P1453, DOI 10.1016/j.str.2005.07.008; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Quentin T, 2011, HISTOL HISTOPATHOL, V26, P589, DOI 10.14670/HH-26.589; Rubio T, 2013, MOL BIOL CELL, V24, P1801, DOI 10.1091/mbc.E12-11-0806; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Thornton C, 1998, J BIOL CHEM, V273, P12443, DOI 10.1074/jbc.273.20.12443; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhu YX, 2014, BLOOD, V124, P536, DOI 10.1182/blood-2014-02-557819	51	20	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6539	6550		10.1096/fj.201801766RRR	http://dx.doi.org/10.1096/fj.201801766RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807229				2022-12-26	WOS:000466932600057
J	Wang, XH; Wang, XX; Zhang, SY; Sun, HW; Li, SJ; Ding, HW; You, Y; Zhang, XW; Ye, SD				Wang, Xiaohu; Wang, Xiaoxiao; Zhang, Shuyuan; Sun, Hongwei; Li, Sijia; Ding, Huiwen; You, Yu; Zhang, Xuewu; Ye, Shou-Dong			The transcription factor TFCP2L1 induces expression of distinct target genes and promotes self-renewal of mouse and human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						embryonic stem cell; STAT3; pluripotency; Wnt pathway; differentiation; naive; Tfcp2l1	GROUND-STATE; SIGNALING PATHWAYS; PLURIPOTENCY; DIFFERENTIATION; NETWORK; ESRRB; KLF4; FIBROBLASTS; CIRCUITRY; LINES	TFCP2L1 (transcription factor CP2-like 1) is a transcriptional regulator critical for maintaining mouse and human embryonic stem cell (ESC) pluripotency. However, the direct TFCP2L1 target genes are uncharacterized. Here, using gene overexpression, immunoblotting, quantitative real-time PCR, ChIP, and reporter gene assays, we show that TFCP2L1 primarily induces estrogen-related receptor (Esrrb) expression that supports mouse ESC identity and also selectively enhances Kruppel-like factor 4 (Klf4) expression and thereby promotes human ESC self-renewal. Specifically, we found that in mouse ESCs, TFCP2L1 binds directly to the Esrrb gene promoter and regulates its transcription. Esrrb knockdown impaired Tfcp2l1's ability to induce interleukin 6 family cytokine (leukemia inhibitory factor)-independent ESC self-renewal and to reprogram epiblast stem cells to naive pluripotency. Conversely, Esrrb overexpression blocked differentiation induced by Tfcp2l1 down-regulation. Moreover, we identified Klf4 as a direct TFCP2L1 target in human ESCs, bypassing the requirement for activin A and basic fibroblast growth factor in short-term human ESC self-renewal. Enforced Klf4 expression recapitulated the self-renewal-promoting effect of Tfcp2l1, whereas Klf4 knockdown eliminated these effects and caused loss of colony-forming capability. These findings indicate that TFCP2L1 functions differently in naive and primed pluripotency, insights that may help elucidate the different states of pluripotency.	[Wang, Xiaohu; Zhang, Shuyuan; Sun, Hongwei; Li, Sijia; Ding, Huiwen; You, Yu; Ye, Shou-Dong] Anhui Univ, Sch Life Sci, Ctr Stem Cell & Translat Med, Hefei 230601, Anhui, Peoples R China; [You, Yu; Ye, Shou-Dong] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei 230601, Anhui, Peoples R China; [Wang, Xiaoxiao] Univ Sci & Technol China, Affiliated Hosp 1, Anhui Prov Hosp, Dept Anesthesiol, Hefei 230001, Anhui, Peoples R China; [Zhang, Xuewu] Zhejiang Univ, Dept Hematol, Inst Hematol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China	Anhui University; Anhui University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Zhejiang University	Ye, SD (corresponding author), Anhui Univ, Sch Life Sci, 111 Jiu Long Rd, Hefei 230601, Anhui, Peoples R China.	shdye@126.com			Natural Science Foundation of China [31671535]; Scientific Research Startup Fund of Anhui University [J01006068]; Open Fund for Discipline Construction, Institute of Physical Science and Information Technology, Anhui University [S01003106]; Undergraduate Research Training Program of Anhui University [KYXL2017034]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Startup Fund of Anhui University; Open Fund for Discipline Construction, Institute of Physical Science and Information Technology, Anhui University; Undergraduate Research Training Program of Anhui University(Anhui University)	This work was supported by Grant 31671535 from the Natural Science Foundation of China; Grant J01006068 from the Scientific Research Startup Fund of Anhui University; Grant S01003106 from the Open Fund for Discipline Construction, Institute of Physical Science and Information Technology, Anhui University; and Grant KYXL2017034 from the Undergraduate Research Training Program of Anhui University. The authors declare that they have no conflicts of interest with the contents of this article.	Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Davidson KC, 2012, P NATL ACAD SCI USA, V109, P4485, DOI 10.1073/pnas.1118777109; Dunn SJ, 2014, SCIENCE, V344, P1156, DOI 10.1126/science.1248882; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Festuccia N, 2012, CELL STEM CELL, V11, P477, DOI 10.1016/j.stem.2012.08.002; Guo G, 2017, DEVELOPMENT, V144, P2748, DOI 10.1242/dev.146811; Guo G, 2016, STEM CELL REP, V6, P437, DOI 10.1016/j.stemcr.2016.02.005; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; Huang DL, 2018, BIOL OPEN, V7, DOI 10.1242/bio.029264; Huang GY, 2015, CELL MOL LIFE SCI, V72, P1741, DOI 10.1007/s00018-015-1833-2; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kelly KF, 2011, CELL STEM CELL, V8, P214, DOI 10.1016/j.stem.2010.12.010; Kim H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3403; Kim H, 2011, CELL STEM CELL, V8, P695, DOI 10.1016/j.stem.2011.04.002; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Liu KS, 2017, J CELL SCI, V130, P3809, DOI 10.1242/jcs.206532; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Martello G, 2013, EMBO J, V32, P2561, DOI 10.1038/emboj.2013.177; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Leary T, 2012, NAT BIOTECHNOL, V30, P278, DOI 10.1038/nbt.2135; Qiu DB, 2015, STEM CELL REP, V5, P314, DOI 10.1016/j.stemcr.2015.07.014; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun HW, 2018, J CELL PHYSIOL, V233, P6944, DOI 10.1002/jcp.26483; Sun HW, 2017, DEV BIOL, V431, P272, DOI 10.1016/j.ydbio.2017.09.004; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2014, CELL, V158, P1254, DOI 10.1016/j.cell.2014.08.029; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JC, 2014, NATURE, V516, P405, DOI 10.1038/nature13804; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamane M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162404; Ye SD, 2013, EMBO J, V32, P2548, DOI 10.1038/emboj.2013.175; Yeo JC, 2014, CELL STEM CELL, V14, P864, DOI 10.1016/j.stem.2014.04.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200	48	16	17	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6007	6016		10.1074/jbc.RA118.006341	http://dx.doi.org/10.1074/jbc.RA118.006341			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782842	hybrid, Green Published			2022-12-26	WOS:000465077500031
J	Wu, CX; Liao, JL; Park, Y; Reed, X; Engel, VA; Hoang, NC; Takagi, Y; Johnson, SM; Wang, M; Federici, M; Nichols, RJ; Sanishvili, R; Cookson, MR; Hoang, QQ				Wu, Chun-Xiang; Liao, Jingling; Park, Yangshin; Reed, Xylena; Engel, Victoria A.; Hoang, Neo C.; Takagi, Yuichiro; Johnson, Steven M.; Wang, Mu; Federici, Mark; Nichols, R. Jeremy; Sanishvili, Ruslan; Cookson, Mark R.; Hoang, Quyen Q.			Parkinson's disease-associated mutations in the GTPase domain of LRRK2 impair its nucleotide-dependent conformational dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						leucine-rich repeat kinase 2 (LRRK2); Parkinson disease; GTPase; conformational change; molecular dynamics; conformational dynamics; disease mutation; enzyme activation; kinase; Ras of complex proteins (ROC)	KINASE-ACTIVITY; PROTEIN; BINDING; GENE	Mutation in leucine-rich repeat kinase 2 (LRRK2) is a common cause of familial Parkinson's disease (PD). Recently, we showed that a disease-associated mutation R1441H rendered the GTPase domain of LRRK2 catalytically less active and thereby trapping it in a more persistently on conformation. However, the mechanism involved and characteristics of this on conformation remained unknown. Here, we report that the Ras of complex protein (ROC) domain of LRRK2 exists in a dynamic dimer-monomer equilibrium that is oppositely driven by GDP and GTP binding. We also observed that the PD-associated mutations at residue 1441 impair this dynamic and shift the conformation of ROC to a GTP-bound-like monomeric conformation. Moreover, we show that residue Arg-1441 is critical for regulating the conformational dynamics of ROC. In summary, our results reveal that the PD-associated substitutions at Arg-1441 of LRRK2 alter monomer-dimer dynamics and thereby trap its GTPase domain in an activated state.	[Wu, Chun-Xiang; Liao, Jingling; Park, Yangshin; Engel, Victoria A.; Hoang, Neo C.; Takagi, Yuichiro; Johnson, Steven M.; Wang, Mu; Hoang, Quyen Q.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hoang, Quyen Q.] Indiana Univ Sch Med, Dept Neurol, Indianapolis, IN 46202 USA; [Wu, Chun-Xiang; Liao, Jingling; Park, Yangshin; Engel, Victoria A.; Hoang, Neo C.; Hoang, Quyen Q.] Indiana Univ Sch Med, Stark Neurosci Inst, Indianapolis, IN 46202 USA; [Liao, Jingling] Wuhan Univ Sci & Technol, Sch Med, Dept Publ Hlth, Wuhan 430081, Hubei, Peoples R China; [Reed, Xylena; Cookson, Mark R.] NIH, Neurogenet Lab, Bldg 10, Bethesda, MD 20892 USA; [Wang, Mu] Xian Jiaotong Liverpool Univ, Dept Biol Sci, Suzhou 215123, Jiangsu, Peoples R China; [Federici, Mark] ThermoFisher Sci, Carlsbad, CA 92087 USA; [Nichols, R. Jeremy] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Xray Sci Div, 9700 S Cass Ave, Argonne, IL 60439 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Wuhan University of Science & Technology; National Institutes of Health (NIH) - USA; Xi'an Jiaotong-Liverpool University; Stanford University; United States Department of Energy (DOE); Argonne National Laboratory	Hoang, QQ (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.	qqhoang@iu.edu	Cookson, Mark/AAW-2516-2021	Cookson, Mark/0000-0002-1058-3831; Nichols, R Jeremy/0000-0002-5228-7571	National Institutes of Health [R01GM111639, R01GM115844, R01GM120350]; Michael J. Fox Foundation [R01GM111695]; U.S. National Science Foundation [MCB-1157688]; Intramural Research Program of the National Institutes of Health, National Institute on Aging; Travel and Learn program of the Indiana Association of Chinese-Americans (IACA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM111695, T32GM077229, R01GM111639, R01GM120350, R01GM115844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael J. Fox Foundation; U.S. National Science Foundation(National Science Foundation (NSF)); Intramural Research Program of the National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Travel and Learn program of the Indiana Association of Chinese-Americans (IACA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01GM111639 and R01GM115844 and the Michael J. Fox Foundation(to Q. Q. H.), Grant R01GM111695 and U.S. National Science Foundation Grant MCB-1157688 (to Y. T.), the Intramural Research Program of the National Institutes of Health, National Institute on Aging (to M. R. C.), National Institutes of Health Grant R01GM120350 (to S. M. J.), and funding from the Travel and Learn program of the Indiana Association of Chinese-Americans (IACA) (to N. C. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beilina A, 2014, P NATL ACAD SCI USA, V111, P2626, DOI 10.1073/pnas.1318306111; Cookson MR, 2010, NAT REV NEUROSCI, V11, P791, DOI 10.1038/nrn2935; Deyaert E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01103-4; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gotthardt K, 2008, EMBO J, V27, P2352, DOI 10.1038/emboj.2008.167; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guo LX, 2007, EXP CELL RES, V313, P3658, DOI 10.1016/j.yexcr.2007.07.007; Huang X., 2018, FASEB J, DOI [10.1096/fj201802031R, DOI 10.1096/FJ201802031R]; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Li YC, 2009, BBA-MOL BASIS DIS, V1792, P1194, DOI 10.1016/j.bbadis.2009.09.010; Liao JL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124074; Liao JL, 2014, P NATL ACAD SCI USA, V111, P4055, DOI 10.1073/pnas.1323285111; Liu ZY, 2015, FASEB J, V29, DOI 10.1096/fj.15-277095; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Oueslati A, 2010, PROG BRAIN RES, V183, P115, DOI 10.1016/S0079-6123(10)83007-9; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Petsko GA, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-108; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	22	14	15	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5907	5913		10.1074/jbc.RA119.007631	http://dx.doi.org/10.1074/jbc.RA119.007631			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30796162	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000465077500022
J	Borg, C; Oosterwijk, TA; Lisy, D; Boesveldt, S; de Jong, PJ				Borg, Charmaine; Oosterwijk, Tamara A.; Lisy, Dominika; Boesveldt, Sanne; de Jong, Peter J.			The influence of olfactory disgust on (Genital) sexual arousal in men	PLOS ONE			English	Article							DECISION-MAKING; INFORMATION; MODEL	Background The generation or persistence of sexual arousal may be compromised when inhibitory processes such as negative emotions, outweigh sexual excitation. Disgust particularly, has been proposed as one of the emotions that may counteract sexual arousal. In support of this view, previous research has shown that disgust priming can reduce subsequent sexual arousal. As a crucial next step, this experimental study tested whether disgust (by means of odor) can also diminish sexual arousal in individuals who are already in a state of heightened sexual excitation. Methodology In this study, participants were all men (N = 78). To elicit sexual arousal, participants watched a pornographic video. Following 4.30 minutes from the start of the video clip, they were exposed to either a highly aversive/disgusting odor (n = 42), or an odorless diluent/solvent (n = 36), that was delivered via an olfactometer, while the pornographic video continued. In both conditions the presentation of the odor lasted 1 second and was repeated 11 times with intervals of 26 seconds. Sexual arousal was indexed by both self-reports and penile circumference. Principal findings The disgusting odor (released when the participants were already sexually aroused) resulted in a significant decrease of both subjective and genital sexual arousal compared to the control (odorless) condition. Significance The finding that the inhibitory effect of disgust was not only expressed in self-report but also expressed on the penile response further strengthens the idea that disgust might hamper behavioral actions motivated by sexual arousal (e.g., poor judgment, coercive sexual behavior). Thus, the current findings indicate that exposure to an aversive odor is sufficiently potent to reduce already present (subjective and) genital sexual arousal. This finding may also have practical relevance for disgust to be used as a tool for self-defence (e.g., Invi Bracelet).	[Borg, Charmaine; Oosterwijk, Tamara A.; Lisy, Dominika; de Jong, Peter J.] Univ Groningen, Fac Behav & Social Sci, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands; [Boesveldt, Sanne] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	University of Groningen; Wageningen University & Research	Borg, C (corresponding author), Univ Groningen, Fac Behav & Social Sci, Dept Clin Psychol & Expt Psychopathol, Groningen, Netherlands.	c.borg@rug.nl	de Jong, Peter/E-9095-2014; de Jong, Peter/ABB-1750-2020	de Jong, Peter/0000-0002-3512-3663; de Jong, Peter/0000-0002-3512-3663; Borg, Charmaine/0000-0002-0122-1118				Andrews AR, 2015, MOTIV EMOTION, V39, P766, DOI 10.1007/s11031-015-9485-y; [Anonymous], APA HDB SEXUALITY PS; Araujo AB, 2004, J AM GERIATR SOC, V52, P1502, DOI 10.1111/j.0002-8614.2004.52413.x; Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Bancroft J, 1999, NEUROSCI BIOBEHAV R, V23, P763, DOI 10.1016/S0149-7634(99)00019-6; Bancroft J, 2000, NEUROSCI BIOBEHAV R, V24, P571, DOI 10.1016/S0149-7634(00)00024-5; Blanca MJ, 2017, PSICOTHEMA, V29, P552, DOI 10.7334/psicothema2016.383; Blanton H, 1997, HEALTH PSYCHOL, V16, P374, DOI 10.1037/0278-6133.16.4.374; Borg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044111; Bosman RC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148626; Bouffard JA, 2002, J CRIM JUST, V30, P121, DOI 10.1016/S0047-2352(01)00130-1; Bouffard JA, 2014, J INTERPERS VIOLENCE, V29, P1967, DOI 10.1177/0886260513515950; Chivers ML, 2010, SEX RELATSH THER, V25, P415, DOI 10.1080/14681994.2010.518727; Chivers ML, 2010, ARCH SEX BEHAV, V39, P5, DOI 10.1007/s10508-009-9556-9; De Houwer J, 2001, COGNITION EMOTION, V15, P189, DOI 10.1080/0269993004200051; de Jong PJ, 2013, J SEX RES, V50, P247, DOI 10.1080/00224499.2012.746280; de Jong PJ., 2009, DISGUST ITS DISORDER, P253, DOI DOI 10.1037/11856-012; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fergus TA, 2009, J ANXIETY DISORD, V23, P703, DOI 10.1016/j.janxdis.2009.02.009; Fleischman DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118151; Freeman NJ, 2008, J INTERPERS VIOLENCE, V23, P1394, DOI 10.1177/0886260508314304; Goodson P., 2000, J SEX EDUC THER, V25, P252, DOI DOI 10.1080/01614576.2000.11074358; Harris GT., 1992, PSYCHOL ASSESSMENT, V4, P502, DOI [10.1037/1040-3590.4.4.502, DOI 10.1037/1040-3590.4.4.502]; Hengeveld HME, 2013, THESIS; Herz RS, 1997, HUM NATURE-INT BIOS, V8, P275, DOI 10.1007/BF02912495; Janssen E, 1997, PSYCHOPHYSIOLOGY, V34, P717, DOI 10.1111/j.1469-8986.1997.tb02147.x; Janssen E, 2000, J SEX RES, V37, P8, DOI 10.1080/00224490009552016; Janssen E, 2011, HORM BEHAV, V59, P708, DOI 10.1016/j.yhbeh.2011.03.004; Laier C, 2014, ARCH SEX BEHAV, V43, P473, DOI 10.1007/s10508-013-0119-8; Liuzza MT, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.171091; Loewenstein G, 1997, J RES CRIME DELINQ, V34, P443, DOI 10.1177/0022427897034004003; Lundstrom JN, 2010, INT J PSYCHOPHYSIOL, V78, P179, DOI 10.1016/j.ijpsycho.2010.07.007; Parada M, 2015, SEXOLOGIES, V24, pE1, DOI 10.1016/j.sexol.2014.05.008; Pfaus J. G., 2014, AP HDB PSYCHOL, V1, P145; RICHARDS JC, 1985, PSYCHOPHYSIOLOGY, V22, P568, DOI 10.1111/j.1469-8986.1985.tb01653.x; ROZIN P, 1994, J PERS SOC PSYCHOL, V66, P870, DOI 10.1037//0022-3514.66.5.870; Sachs BD, 2007, HORM BEHAV, V51, P569, DOI 10.1016/j.yhbeh.2007.03.011; Schaller M, 2011, CURR DIR PSYCHOL SCI, V20, P99, DOI 10.1177/0963721411402596; Stevenson RJ, 2011, ARCH SEX BEHAV, V40, P79, DOI 10.1007/s10508-009-9529-z; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Tassinary LG, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P267, DOI 10.1017/CBO9780511546396.012; Tybur JM, 2009, J PERS SOC PSYCHOL, V97, P103, DOI 10.1037/a0015474; van Overveld M, 2013, J SEX MED, V10, P396, DOI 10.1111/j.1743-6109.2012.02979.x; van Overveld M, 2010, PERS INDIV DIFFER, V49, P706, DOI 10.1016/j.paid.2010.06.008; van Overveld WJM, 2006, PERS INDIV DIFFER, V41, P1241, DOI 10.1016/j.paid.2006.04.021; VRANA SR, 1993, PSYCHOPHYSIOLOGY, V30, P279, DOI 10.1111/j.1469-8986.1993.tb03354.x; West R, 2014, REV ENVIRON CONTAM T, V232, P107, DOI 10.1007/978-3-319-06746-9_5	47	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0213059	10.1371/journal.pone.0213059	http://dx.doi.org/10.1371/journal.pone.0213059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817770	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500072
J	Lindholm, E; Londahl, M; Fagher, K; Apelqvist, J; Dahlin, LB				Lindholm, Eero; Londahl, Magnus; Fagher, Katarina; Apelqvist, Jan; Dahlin, Lars B.			Strong association between vibration perception thresholds at low frequencies (4 and 8 Hz), neuropathic symptoms and diabetic foot ulcers	PLOS ONE			English	Article							BIMODALITY; AFFERENTS; TOOLS; HAND; SOLE	Aims To investigate whether multi-frequency measurement of vibration perception thresholds (VPTs) can identify individuals with a high risk of developing diabetic foot ulcer or neuropathic symptoms. Methods VPTs were measured at six different frequencies (4, 8, 16, 32, 64 and 125 Hz) on metatarsal heads 1 and 5 on the sole of the foot using a standard VibroSense Meter device in 535 type 1 diabetic (T1DM) patients and 717 non-diabetic control subjects. VPTs in control subjects were used to establish normal values for five different age groups for male and female subjects respectively. Normal values were defined as a VPT below the mean plus 1.66 x standard deviation for each group. Various definitions of abnormal VPTs were tested using either all frequencies, only lowest VPT frequencies (4 and 8 Hz) or only highest VPT frequencies (64 and 125 Hz). Results The VPTs were higher in T1DM patients than in non-diabetic control subjects matched for age and gender. The low frequencies, 4 and 8 Hz, particularly were associated with the risk of diabetic foot ulcer (OR 40.7 [5.4-308.4], p = 0.0003) and with difficulties in balance and or gait (OR 1.89 [1.04-3.46], p = 0.04) difficulties and weakness (OR 2.77 [1.25-6.16], p = 0.01). The VPTs at the 125 Hz frequency were higher in short duration (<= 10 yrs.) T1DM patients compared to age-and gender-matched control subjects. Conclusions Vibration perception thresholds at low frequencies seem to be a better indicator of the risk of developing diabetic foot ulcers, gait or balance problems or weakness of the foot. The 125 Hz frequency, however, seemed to be impaired earlier and it was the only pathological VPT frequency in patients with short duration of diabetes. This study suggests that at least four different frequencies (4, 8, 64 and 125 Hz) should be included in any examination in order to obtain a complete evaluation of the risk factors for diabetic neuropathy and diabetic foot ulcers.	[Lindholm, Eero; Apelqvist, Jan] Lund Univ, Endocrinol, Dept Clin Sci, Malmo, Sweden; [Londahl, Magnus; Fagher, Katarina] Lund Univ, Endocrinol, Dept Clin Sci, Lund, Sweden; [Dahlin, Lars B.] Lund Univ, Dept Translat Med Hand Surg, Malmo, Sweden; [Dahlin, Lars B.] Skane Univ Hosp, Dept Hand Surg, Malmo, Sweden	Lund University; Lund University; Lund University; Lund University; Skane University Hospital	Lindholm, E (corresponding author), Lund Univ, Endocrinol, Dept Clin Sci, Malmo, Sweden.	eero.lindholm@med.lu.se	Fagher, Katarina/GSN-7633-2022	Lindholm, Eero/0000-0002-8869-681X	Swedish Governmental Agency for Innovation Systems; Skane Research and Development	Swedish Governmental Agency for Innovation Systems(Vinnova); Skane Research and Development	This work was supported by the Swedish Governmental Agency for Innovation Systems https://www.vinnova.se/en/(E.L 1 282 000 SEK and L.D 921 200 SEK) and the Skane Research and Development http://www.researchweb.org/is/ssvr/(E.L 180 000 SEK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Brown JJ, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/1467213; Dahlin LB, 2011, DIABETIC MED, V28, P1045, DOI 10.1111/j.1464-5491.2011.03328.x; Dahlin LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119753; Fan JJ, 2005, DIABETES CARE, V28, P1451, DOI 10.2337/diacare.28.6.1451; Gandhi MS, 2011, J HAND THER, V24, P240, DOI 10.1016/j.jht.2011.01.001; Gerhardsson L, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/s12995-014-0038-1; Ising E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196243; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; LUNDBORG G, 1992, SCAND J PLAST RECONS, V26, P275, DOI 10.3109/02844319209015271; Mildren RL, 2016, J APPL PHYSIOL, V120, P855, DOI 10.1152/japplphysiol.00810.2015; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; Nelander J, 2012, DIABETIC MED, V29, pe449, DOI 10.1111/dme.12024; Orneholm H, 2017, WOUND REPAIR REGEN, V25, P309, DOI 10.1111/wrr.12522; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; Pourhamidi K, 2014, PRIM CARE DIABETES, V8, P77, DOI 10.1016/j.pcd.2013.04.004; RUSHFORT.NB, 1971, DIABETES, V20, P756, DOI 10.2337/diab.20.11.756; Strzalkowski NDJ, 2017, J NEUROPHYSIOL, V118, P1931, DOI 10.1152/jn.00647.2016; van Deursen RWM, 2001, DIABETIC MED, V18, P469, DOI 10.1046/j.1464-5491.2001.00503.x; Vinik AI, 2016, INT REV NEUROBIOL, V127, P235, DOI 10.1016/bs.irn.2016.03.010; WILES PG, 1991, DIABETIC MED, V8, P157, DOI 10.1111/j.1464-5491.1991.tb01563.x; YOUNG MJ, 1994, DIABETES CARE, V17, P557, DOI 10.2337/diacare.17.6.557; Zehr EP, 2014, BMC SPORTS SCI MED R, V6, DOI 10.1186/2052-1847-6-33	24	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212921	10.1371/journal.pone.0212921	http://dx.doi.org/10.1371/journal.pone.0212921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817797	Green Submitted, Green Published, gold			2022-12-26	WOS:000460371500058
J	Liu, RY; Jagannathan, R; Li, F; Lee, J; Balasubramanyam, N; Kim, BS; Yang, P; Yechoor, VK; Moulik, M				Liu, Ruya; Jagannathan, Rajaganapathi; Li, Feng; Lee, Jeongkyung; Balasubramanyam, Nikhil; Kim, Byung S.; Yang, Ping; Yechoor, Vijay K.; Moulik, Mousumi			Tead1 is required for perinatal cardiomyocyte proliferation	PLOS ONE			English	Article							FETAL GENE PROGRAM; HIPPO PATHWAY; CELL-PROLIFERATION; HEART; PROMOTES; INHIBITION; EXPRESSION; GROWTH; RETURN	Adult heart size is determined predominantly by the cardiomyocyte number and size. The cardiomyocyte number is determined primarily in the embryonic and perinatal period, as adult cardiomyocyte proliferation is restricted in comparison to that seen during the perinatal period. Recent evidence has implicated the mammalian Hippo kinase pathway as being critical in cardiomyocyte proliferation. Though the transcription factor, Tead1, is the canonical downstream transcriptional factor of the hippo kinase pathway in cardiomyocytes, the specific role of Tead1 in cardiomyocyte proliferation in the perinatal period has not been determined. Here, we report the generation of a cardiomyocyte specific perinatal deletion of Tead1, using Myh6-Cre deletor mice (Tead1-cKO). Perinatal Tead1 deletion was lethal by postnatal day 9 in Tead1-cKO mice due to dilated cardiomyopathy. Tead1-deficient cardiomyocytes have significantly decreased proliferation during the immediate postnatal period, when proliferation rate is normally high. Deletion of Tead1 in HL-1 cardiac cell line confirmed that cell-autonomous Tead1 function is required for normal cardiomyocyte proliferation. This was secondary to significant decrease in levels of many proteins, in vivo, that normally promote cell cycle in cardiomyocytes. Taken together this demonstrates the non-redundant critical requirement for Tead1 in regulating cell cycle proteins and proliferation in cardiomyocytes in the perinatal heart.	[Liu, Ruya; Li, Feng; Lee, Jeongkyung; Yang, Ping; Yechoor, Vijay K.] Univ Pittsburgh, Dept Med, Div Diabet Endocrinol & Metab, Pittsburgh, PA 15260 USA; [Liu, Ruya; Lee, Jeongkyung; Balasubramanyam, Nikhil; Kim, Byung S.; Yechoor, Vijay K.] Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA; [Jagannathan, Rajaganapathi; Moulik, Mousumi] Univ Pittsburgh, Dept Pediat, Div Cardiol, Pittsburgh, PA 15260 USA; [Moulik, Mousumi] UTHlth McGovern Med Sch, Dept Pediat, Div Cardiol, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Baylor College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yechoor, VK (corresponding author), Univ Pittsburgh, Dept Med, Div Diabet Endocrinol & Metab, Pittsburgh, PA 15260 USA.; Yechoor, VK (corresponding author), Baylor Coll Med, Dept Med, Div Diabet Endocrinol & Metab, Houston, TX 77030 USA.; Moulik, M (corresponding author), Univ Pittsburgh, Dept Pediat, Div Cardiol, Pittsburgh, PA 15260 USA.; Moulik, M (corresponding author), UTHlth McGovern Med Sch, Dept Pediat, Div Cardiol, Houston, TX 77030 USA.	yechoorv@pitt.edu; moulikm@pitt.edu	Yechoor, Vijay/AAX-3244-2021	Liu, Ruya/0000-0003-1986-6800	National Institutes of Health (NIH) [K08-HL091176]; Veterans Affairs VA-ORD-BLR D [I01BX002678]; Baylor College of Medicine Advanced Core Lab: Mouse Metabolism and Phenotyping Core - NIH [UM1HG006348, 1R01DK114356]; Baylor College of Medicine Advanced Core Lab: Pathology and Histology Core - P30 Cancer Center Support Grant [NCI-CA125123]; Baylor College of Medicine Advanced Core Lab: Gene Vector Core; Baylor College of Medicine Advanced Core Lab: Mouse Metabolism and Phenotyping Core; Baylor College of Medicine Advanced Core Lab: Pathology and Histology Core; NIH [R01 DK097160]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG006348] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK114356, R01DK097160] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs VA-ORD-BLR D; Baylor College of Medicine Advanced Core Lab: Mouse Metabolism and Phenotyping Core - NIH; Baylor College of Medicine Advanced Core Lab: Pathology and Histology Core - P30 Cancer Center Support Grant; Baylor College of Medicine Advanced Core Lab: Gene Vector Core; Baylor College of Medicine Advanced Core Lab: Mouse Metabolism and Phenotyping Core; Baylor College of Medicine Advanced Core Lab: Pathology and Histology Core; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (NIH) K08-HL091176 (M.M.), Veterans Affairs VA-ORD-BLR& D I01BX002678 and NIH R01 DK097160 (V.K.Y.). This work was also supported by Baylor College of Medicine Advanced Core Labs: Mouse Metabolism and Phenotyping Core funded by NIH (UM1HG006348, 1R01DK114356), Pathology and Histology Core funded by P30 Cancer Center Support Grant (NCI-CA125123), and Gene Vector Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was also supported by Baylor College of Medicine Advanced Core Labs: Mouse Metabolism and Phenotyping Core, Pathology and Histology Core, and Gene Vector Core.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; Del Re DP, 2014, MOL CELL, V54, P639, DOI 10.1016/j.molcel.2014.04.007; Ehler E, 2013, JOVE-J VIS EXP, DOI 10.3791/50154; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Heallen T, 2013, DEVELOPMENT, V140, P4683, DOI 10.1242/dev.102798; Heallen T, 2011, SCIENCE, V332, P458, DOI 10.1126/science.1199010; Iwaki H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088610; Joshi S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006600; Lin ZQ, 2016, DEV CELL, V39, P466, DOI 10.1016/j.devcel.2016.09.005; Lin ZQ, 2014, CIRC RES, V115, P354, DOI 10.1161/CIRCRESAHA.115.303632; Liu RY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93343; Morikawa Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005781; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Santucci M, 2015, J MED CHEM, V58, P4857, DOI 10.1021/jm501615v; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tsika RW, 2010, J BIOL CHEM, V285, P13721, DOI 10.1074/jbc.M109.063057; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Wackerhage H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005096; Xin M, 2013, P NATL ACAD SCI USA, V110, P13839, DOI 10.1073/pnas.1313192110; Xin M, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002278; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216	28	14	14	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212017	10.1371/journal.pone.0212017	http://dx.doi.org/10.1371/journal.pone.0212017			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811446	Green Published, gold			2022-12-26	WOS:000459806400046
J	Mihailovic, PM; Lio, WM; Herscovici, R; Chyu, KY; Yano, J; Zhao, XN; Zhou, JC; Zhou, B; Freeman, MR; Yang, W; Shah, PK; Cercek, B; Dimayuga, PC				Mihailovic, Peter M.; Lio, Wai Man; Herscovici, Romana; Chyu, Kuang-Yuh; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Zhou, Bo; Freeman, Michael R.; Yang, Wei; Shah, Prediman K.; Cercek, Bojan; Dimayuga, Paul C.			Keratin 8 is a potential self-antigen in the coronary artery disease immunopeptidome: A translational approach	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; T-CELLS; BLEOMYCIN HYDROLASE; ATHEROSCLEROTIC LESIONS; SEXUAL-DIMORPHISM; EXPRESSION; PEPTIDES; IMMUNIZATION; MEMORY; CYTOKERATIN-18	Background Inflammation is an important risk factor in atherosclerosis, the underlying cause of coronary artery disease (CAD). Unresolved inflammation may result in maladaptive immune responses and lead to immune reactivity to self-antigens. We hypothesized that inflammation in CAD patients would manifest in immune reactivity to self-antigens detectable in soluble HLA-I/peptide complexes in the plasma. Methods Soluble HLA-I/peptide complexes were immuno-precipitated from plasma of male acute coronary syndrome (ACS) patients or age-matched controls and eluted peptides were subjected to mass spectrometry to generate the immunopeptidome. Self-peptides were ranked according to frequency and signal intensity, then mouse homologs of selected peptides were used to test immunologic recall in spleens of male apoE-/- mice fed either normal chow or high fat diet. The peptide detected with highest frequency in patient plasma samples and provoked T cell responses in mouse studies was selected for use as a self-antigen to stimulate CAD patient peripheral blood mononuclear cells (PBMCs). Results The immunopeptidome profile identified self-peptides unique to the CAD patients. The mouse homologs tested showed immune responses in apoE-/- mice. Keratin 8 was selected for further study in patient PBMCs which elicited T Effector cell responses in CAD patients compared to controls, associated with reduced PD-1 mRNA expression. Conclusion An immunopeptidomic strategy to search for self-antigens potentially involved in CAD identified Keratin 8. Self-reactive immune response to Keratin 8 may be an important factor in the inflammatory response in CAD.	[Mihailovic, Peter M.; Lio, Wai Man; Herscovici, Romana; Chyu, Kuang-Yuh; Yano, Juliana; Zhao, Xiaoning; Zhou, Jianchang; Shah, Prediman K.; Cercek, Bojan; Dimayuga, Paul C.] Cedars Sinai Med Ctr, Smidt Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA; [Mihailovic, Peter M.] Univ Ljubljana, Fac Med, Ljubljana, Slovenia; [Zhou, Bo; Freeman, Michael R.; Yang, Wei] Cedars Sinai Med Ctr, Dept Biomed Sci, Div Canc Biol & Therapeut, Los Angeles, CA 90048 USA; [Zhou, Bo; Freeman, Michael R.; Yang, Wei] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of Ljubljana; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Dimayuga, PC (corresponding author), Cedars Sinai Med Ctr, Smidt Heart Inst, Oppenheimer Atherosclerosis Res Ctr, Los Angeles, CA 90048 USA.	Paul.Dimayuga@cshs.org	Yang, Wei/ABA-5268-2020; Yang, Wei/C-3047-2008; Mihailovic, Peter Marko/ABG-5713-2020	Yang, Wei/0000-0003-2575-3570; 	Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund; Joe Weider Foundation; Heart Foundation; Petersen Foundation; Steinberg Foundation; Annenberg Foundation	Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund; Joe Weider Foundation; Heart Foundation; Petersen Foundation; Steinberg Foundation; Annenberg Foundation	This work was supported by the Eleanor and Harold Foonberg Endowed Chair in Cardiac Intensive Care Fund (BC, PMM); The Joe Weider Foundation (PCD); The Heart Foundation (PKS); The Petersen Foundation (PKS); Steinberg Foundation (PKS); Annenberg Foundation (PKS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli S, 1996, ARTERIOSCL THROM VAS, V16, P1074, DOI 10.1161/01.ATV.16.8.1074; Ammirati E, 2012, J AM HEART ASSOC, V1, P27, DOI 10.1161/JAHA.111.000125; Ashmaig M, 2015, N AM J MED SCI, V7, P459, DOI 10.4103/1947-2714.168673; Bar H, 2001, BASIC RES CARDIOL, V96, P50, DOI 10.1007/s003950170077; Bassani-Sternberg M, 2010, P NATL ACAD SCI USA, V107, P18769, DOI 10.1073/pnas.1008501107; Biessen EAL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001909; Bourdetsky D, 2014, P NATL ACAD SCI USA, V111, pE1591, DOI 10.1073/pnas.1321902111; Broere F, 2011, PRINCIPLES IMMUNOPHA, P15; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Cercek B, 2003, LANCET, V361, P809, DOI 10.1016/S0140-6736(03)12706-7; Chyu KY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030780; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Boer OJ, 1999, J PATHOL, V188, P174, DOI 10.1002/(SICI)1096-9896(199906)188:2<174::AID-PATH333>3.0.CO;2-3; Dhanji S, 2006, J IMMUNOL, V177, P138, DOI 10.4049/jimmunol.177.1.138; Diedrichs-Mohring M, 2005, IMMUNOBIOLOGY, V209, P711, DOI 10.1016/j.imbio.2004.12.004; Dimayuga PC, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005318; Dong XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep32710; Eichmann M, 2014, TISSUE ANTIGENS, V84, P378, DOI 10.1111/tan.12413; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Gelfand JM, 2006, JAMA-J AM MED ASSOC, V296, P1735, DOI 10.1001/jama.296.14.1735; Gianchecchi E, 2013, AUTOIMMUN REV, V12, P1091, DOI 10.1016/j.autrev.2013.05.003; Hickman HD, 2010, P NATL ACAD SCI USA, V107, P18747, DOI 10.1073/pnas.1013851107; Hoogeveen RC, 2014, ARTERIOSCL THROM VAS, V34, P1069, DOI 10.1161/ATVBAHA.114.303284; JAHN L, 1993, ARTERIOSCLER THROMB, V13, P1631, DOI 10.1161/01.ATV.13.11.1631; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kamata Y, 2012, ARCH DERMATOL RES, V304, P31, DOI 10.1007/s00403-011-1180-6; Kim Y, 2012, NUCLEIC ACIDS RES, V40, pW525, DOI 10.1093/nar/gks438; Klingenberg R, 2010, ARTERIOSCL THROM VAS, V30, P946, DOI 10.1161/ATVBAHA.109.202671; Lamason R, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-2; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Lee LH, 2016, HUM PATHOL, V53, P97, DOI 10.1016/j.humpath.2016.02.004; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Lu Y, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.116.003470; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Maecker HT, 2012, NAT REV IMMUNOL, V12, P191, DOI 10.1038/nri3158; Maisel A, 1998, CIRC RES, V82, P458, DOI 10.1161/01.RES.82.4.458; Mihailovic PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187432; Moon MC, 2008, CAN J PHYSIOL PHARM, V86, P223, DOI 10.1139/Y08-019; Morley S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12136; Nielsen M, 2003, PROTEIN SCI, V12, P1007, DOI 10.1110/ps.0239403; Nilsson J, 2008, J INTERN MED, V263, P464, DOI 10.1111/j.1365-2796.2008.01945.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; PALINSKI W, 1995, P NATL ACAD SCI USA, V92, P821, DOI 10.1073/pnas.92.3.821; Papathanasiou S, 2015, NAT MED, V21, P1076, DOI 10.1038/nm.3925; Perek B, 2013, CARDIOL J, V20, P583, DOI 10.5603/CJ.2013.0142; Peters B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-132; Proto JD, 2018, J CLIN INVEST, V128, P2370, DOI 10.1172/JCI97785; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Ricketts CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140257; Ridker PM, 2017, CIRC RES, V120, P617, DOI 10.1161/CIRCRESAHA.116.310527; Ridker PM, 2017, N ENGL J MED; Rubtsova K, 2015, J CLIN INVEST, V125, P2187, DOI 10.1172/JCI78082; Sallusto F, 2004, ANNU REV IMMUNOL, V22, P745, DOI 10.1146/annurev.immunol.22.012703.104702; Schwartz DR, 1999, P NATL ACAD SCI USA, V96, P4680, DOI 10.1073/pnas.96.8.4680; Sidney John, 2008, Immunome Res, V4, P2, DOI 10.1186/1745-7580-4-2; Singh AP, 2014, NUCLEIC ACIDS RES, V42, P2958, DOI 10.1093/nar/gkt1232; STEMME S, 1992, ARTERIOSCLER THROMB, V12, P206, DOI 10.1161/01.ATV.12.2.206; Tian Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01728-5; Towne CF, 2007, J IMMUNOL, V178, P6923, DOI 10.4049/jimmunol.178.11.6923; Tse K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00493; Tuomisto TT, 2003, ARTERIOSCL THROM VAS, V23, P2235, DOI 10.1161/01.ATV.0000102551.91154.96; van Dijk RA, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001403; Van Vre EA, 2008, ARTERIOSCL THROM VAS, V28, P511, DOI 10.1161/ATVBAHA.107.157016; Vezys V, 2000, IMMUNITY, V12, P505, DOI 10.1016/S1074-7613(00)80202-2; Wang XX, 2015, BIOCHEM BIOPH RES CO, V465, P665, DOI 10.1016/j.bbrc.2015.07.161; Wildner G, 2002, EUR J IMMUNOL, V32, P299, DOI 10.1002/1521-4141(200201)32:1<299::AID-IMMU299>3.0.CO;2-Q; Wu MS, 2013, BIOCHEM BIOPH RES CO, V441, P618, DOI 10.1016/j.bbrc.2013.10.105; Yan Jun, 2010, Immun Ageing, V7, P4, DOI 10.1186/1742-4933-7-4; YOUNG BJJ, 1979, BRIT MED J, V2, P97, DOI 10.1136/bmj.2.6182.97; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	73	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0213025	10.1371/journal.pone.0213025	http://dx.doi.org/10.1371/journal.pone.0213025			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811493	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400108
J	Bouchard, B; Barnagaud, JY; Poupard, M; Glotin, H; Gauffier, P; Ortiz, ST; Lisney, TJ; Campagna, S; Rasmussen, M; Celerier, A				Bouchard, Bertrand; Barnagaud, Jean-Yves; Poupard, Marion; Glotin, Herve; Gauffier, Pauline; Ortiz, Sara Torres; Lisney, Thomas J.; Campagna, Sylvie; Rasmussen, Marianne; Celerier, Aurelie			Behavioural responses of humpback whales to food-related chemical stimuli	PLOS ONE			English	Article							DIMETHYL SULFIDE; MEGAPTERA-NOVAEANGLIAE; BOWHEAD WHALE; CETACEA; SEABIRDS; IDENTIFICATION; PERCEPTION; MYSTICETI; ABUNDANCE; DOLPHINS	Baleen whales face the challenge of finding patchily distributed food in the open ocean. Their relatively well-developed olfactory structures suggest that they could identify the specific odours given off by planktonic prey such as krill aggregations. Like other marine predators, they may also detect dimethyl sulfide (DMS), a chemical released in areas of high marine productivity. However, dedicated behavioural studies still have to be conducted in baleen whales in order to confirm the involvement of chemoreception in their feeding ecology. We implemented 56 behavioural response experiments in humpback whales using two food-related chemical stimuli, krill extract and DMS, as well as their respective controls (orange clay and vegetable oil) in their breeding (Madagascar) and feeding grounds (Iceland and Antarctic Peninsula). The whales approached the stimulus area and stayed longer in the trial zone during krill extract trials compared to control trials, suggesting that they were attracted to the chemical source and spent time exploring its surroundings, probably in search of prey. This response was observed in Iceland, and to a lesser extend in Madagascar, but not in Antarctica. Surface behaviours indicative of sensory exploration, such as diving under the stimulus area and stopping navigation, were also observed more often during krill extract trials than during control trials. Exposure to DMS did not elicit such exploration behaviours in any of the study areas. However, acoustic analyses suggest that DMS and krill extract both modified the whales' acoustic activity in Madagascar. Altogether, these results provide the first behavioural evidence that baleen whales actually perceive prey-derived chemical cues over distances of several hundred metres. Chemoreception, especially olfaction, could thus be used for locating prey aggregations and for navigation at sea, as it has been shown in other marine predators including seabirds.	[Bouchard, Bertrand; Barnagaud, Jean-Yves; Lisney, Thomas J.; Celerier, Aurelie] Univ Paul Valery Montpelllier EPHE, Univ Montpellier, CNRS, Behav Ecol Grp,CEFE,UMR 5175, Montpellier, France; [Bouchard, Bertrand; Lisney, Thomas J.; Celerier, Aurelie] Univ Montpellier, Montpellier, France; [Poupard, Marion; Glotin, Herve] Univ Aix Marseille, Univ Toulon, LIS, DYNI Team,CNRS, Marseille, France; [Gauffier, Pauline] CIRCE, Conservat Informat & Res Cetaceans, Cadiz, Spain; [Ortiz, Sara Torres] Univ Southern Denmark, Dept Biol, Marine Biol Res Ctr, Kerteminde, Denmark; [Campagna, Sylvie] Univ Nimes, Univ, France; [Rasmussen, Marianne] Univ Iceland, Husavik Res Ctr, Husavik, Iceland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Southern Denmark; Universite de Nimes; University of Iceland	Bouchard, B (corresponding author), Univ Paul Valery Montpelllier EPHE, Univ Montpellier, CNRS, Behav Ecol Grp,CEFE,UMR 5175, Montpellier, France.; Bouchard, B (corresponding author), Univ Montpellier, Montpellier, France.	bertrand.bouchard@gmail.com	Lisney, Thomas/AAA-3288-2021; Gauffier, Pauline/M-3952-2014; Gauffier, Pauline/W-8148-2019	Lisney, Thomas/0000-0001-5149-3720; Gauffier, Pauline/0000-0003-2984-6993; Gauffier, Pauline/0000-0003-2984-6993; Glotin, Herve/0000-0001-7338-8518; Poupard, Marion/0000-0002-8235-5184; Bouchard, Bertrand/0000-0002-8670-0299	Fondation Total [144903]; Ministere de l'Enseignement Superieur et de la Recherche	Fondation Total; Ministere de l'Enseignement Superieur et de la Recherche	This research was funded by the Fondation Total (www.fondation.total.com), grant #144903 to A.C., and the Ministere de l'Enseignement Superieur et de la Recherche (www.enseignementsup-recherche.gouv.fr) to B.B., Bourse doctorale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderwald P, 2011, MAR ECOL PROG SER, V424, P219, DOI 10.3354/meps08947; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Barth M, 2015, ROUTL STUD SUSTAIN, P1; Berta A, 2015, ANAT REC, V298, P648, DOI 10.1002/ar.23112; Berta A, 2014, ANAT REC, V297, P2205, DOI 10.1002/ar.23034; Bouchard B, 2016, ANN C EUR CET SOC FU, P92; Bouchard B, 2017, APPL ANIM BEHAV SCI, V194, P120, DOI 10.1016/j.applanim.2017.05.013; Brierley AS, 1997, MAR ECOL PROG SER, V150, P87, DOI 10.3354/meps150087; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; CAVE AJE, 1988, J ZOOL, V214, P307, DOI 10.1111/j.1469-7998.1988.tb04724.x; Cerchio S, 2016, MAR ECOL PROG SER, V562, P193, DOI 10.3354/meps11951; Cerchio Salvatore, 2001, Bioacoustics, V11, P277; Christiansen F, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00277; Clapham PJ, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P582; Clua E, 2001, AQUAT LIVING RESOUR, V14, P11, DOI 10.1016/S0990-7440(00)01097-4; Cronin TW, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0067; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; Dallas LJ, 2010, J FISH BIOL, V77, P947, DOI 10.1111/j.1095-8649.2010.02738.x; Daly KL, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P223; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; Derby CD, 2008, J CHEM ECOL, V34, P898, DOI 10.1007/s10886-008-9489-0; Dove ADM, 2015, BIOL BULL-US, V228, P65, DOI 10.1086/BBLv228n1p65; Drake SE, 2015, ANAT REC, V298, P1327, DOI 10.1002/ar.23163; Dulau V, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0101-5; Dunlop RA, 2013, J EXP BIOL, V216, P759, DOI 10.1242/jeb.071498; Edinger T, 1955, MON PSYCHIATR NEUROL, V129, P37; Eisenmann P, 2016, ISOTOPIC EVIDENCE WI, P1, DOI [10.1371/journal.pone.0156698, DOI 10.1371/JOURNAL.PONE.0156698]; Endres CS, 2012, J EXP BIOL, V215, P3535, DOI 10.1242/jeb.073221; EVANS PGH, 1982, MAMMAL REV, V12, P187, DOI 10.1111/j.1365-2907.1982.tb00015.x; Fan Y, 2017, INT J FOOD PROP, V20, pS820, DOI 10.1080/10942912.2017.1315589; Felix Fernando, 2004, Latin American Journal of Aquatic Mammals, V3, P25; Feng P, 2014, GENOME BIOL EVOL, V6, P1254, DOI 10.1093/gbe/evu095; FOWLKES EB, 1983, J AM STAT ASSOC, V78, P553, DOI 10.2307/2288117; FRANKEL AS, 1995, CAN J ZOOL, V73, P1134, DOI 10.1139/z95-135; FRIEDL WA, 1990, NATO ADV SCI I A-LIF, V196, P447; Friedlaender AS, 2006, MAR ECOL PROG SER, V317, P297, DOI 10.3354/meps317297; Friedlaender AS, 2009, MAR ECOL PROG SER, V395, P91, DOI 10.3354/meps08003; Friedlaender AS, 2009, MAR MAMMAL SCI, V25, P402, DOI 10.1111/j.1748-7692.2008.00263.x; Fristrup KM, 2003, J ACOUST SOC AM, V113, P3411, DOI 10.1121/1.1573637; Godfrey SJ, 2013, ANAT REC, V296, P257, DOI 10.1002/ar.22637; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Hagelin JC, 2012, ASS CHEM SCI ANN M, P13; Hazen EL, 2009, MAR ECOL PROG SER, V395, P75, DOI 10.3354/meps08108; Henningsen A, 2013, CENSREG CENSORED REG, P1; HUTCHISON LV, 1980, CONDOR, V82, P314, DOI 10.2307/1367400; Keller M. D., 1989, BIOL OCEANOGR, V6, P375, DOI DOI 10.1080/01965581.1988.10749540; Kienle SS, 2015, ANAT REC, V298, P660, DOI 10.1002/ar.23107; Kim Min-A, 2014, Fisheries and Aquatic Sciences, V17, P409, DOI 10.5657/FAS.2014.0409; Kishida T, 2015, ZOOL LETT, V1, DOI 10.1186/s40851-014-0002-z; Kowalewsky S, 2006, BIOL LETT-UK, V2, P106, DOI 10.1098/rsbl.2005.0380; KREMERS D, 2016, FRONT ECOL EVOL, V4, P1, DOI DOI 10.3389/FEV0.2016.00050; KUZNETZOV VB, 1990, NATO ADV SCI I A-LIF, V196, P481; Leck C, 1996, TELLUS B, V48, P272, DOI 10.1034/j.1600-0889.48.issue2.1.x; McGowen MR, 2008, SYST BIOL, V57, P574, DOI 10.1080/10635150802304787; Miller PJO, 2000, NATURE, V405, P903, DOI 10.1038/35016148; MuMIn Barton K, 2010, MULTIMODEL INFERENCE; Nevitt G, 1999, MAR ECOL PROG SER, V177, P235, DOI 10.3354/meps177235; NEVITT GA, 1995, NATURE, V376, P680, DOI 10.1038/376680ao; Nevitt GA, 2008, J EXP BIOL, V211, P1706, DOI 10.1242/jeb.015412; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; POYSA H, 1992, ORNIS SCAND, V23, P159, DOI 10.2307/3676444; Reilly S, 2004, DEEP-SEA RES PT II, V51, P1397, DOI 10.1016/j/dsr2.2004.06.008; Rinberg D, 2006, SEMIN CELL DEV BIOL, V17, P454, DOI 10.1016/j.semcdb.2006.04.009; Risch D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029741; Safi K, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00175; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007322; Savoca MS, 2014, P NATL ACAD SCI USA, V111, P4157, DOI 10.1073/pnas.1317120111; Silva T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187360; Silverman ED, 2004, MAR ECOL PROG SER, V277, P25, DOI 10.3354/meps277025; Simon M, 2012, J EXP BIOL, V215, P3786, DOI 10.1242/jeb.071092; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Stamation KA, 2010, MAR MAMMAL SCI, V26, P98, DOI 10.1111/j.1748-7692.2009.00320.x; Stamation Kasey A., 2007, Aquatic Mammals, V33, P165, DOI 10.1578/AM.33.2.2007.165; Stimpert AK, 2007, BIOL LETTERS, V3, P467, DOI 10.1098/rsbl.2007.0281; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Thewissen JGM, 2011, MAR MAMMAL SCI, V27, P282, DOI 10.1111/j.1748-7692.2010.00406.x; THOMPSON PO, 1986, J ACOUST SOC AM, V80, P735, DOI 10.1121/1.393947; Torres LG, 2017, MAR MAMMAL SCI, V33, P1170, DOI 10.1111/mms.12426; Torres LG, 2018, FRONT MAR SCI, V5, DOI [10.3389/fmars.2018.00043, DOI 10.3389/FMARS.2018.00043]; Turner SM, 1996, MAR CHEM, V54, P245, DOI 10.1016/0304-4203(96)00028-X; van der Maaten L, 2012, MACH LEARN, V87, P33, DOI 10.1007/s10994-011-5273-4; Vikingsson G. A., 2015, FRONT ECOL EVOL, V3, P1, DOI DOI 10.3389/FEV0.2015.00006; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; Wikelski M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17061; Wright KLB, 2011, J EXP BIOL, V214, P2509, DOI 10.1242/jeb.058230	85	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212515	10.1371/journal.pone.0212515	http://dx.doi.org/10.1371/journal.pone.0212515			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807595	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100016
J	Takakusagi, Y; Kawamura, H; Okamoto, M; Kaminuma, T; Kubo, N; Mizukami, T; Sato, H; Onishi, M; Ohtake, N; Sekihara, T; Nakano, T				Takakusagi, Yosuke; Kawamura, Hidemasa; Okamoto, Masahiko; Kaminuma, Takuya; Kubo, Nobuteru; Mizukami, Tatsuji; Sato, Hiro; Onishi, Masahiro; Ohtake, Nobuaki; Sekihara, Tetsuo; Nakano, Takashi			Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study	PLOS ONE			English	Article							RADIATION-DOSE RESPONSE; HELICAL TOMOTHERAPY; ALPHA/BETA RATIO; 5-YEAR OUTCOMES; NON-INFERIORITY; GY; FRACTIONATION; TOXICITY; THERAPY; RATES	Background Recently, the clinical outcome of prostate cancer treated by hypofractionated radiation therapy has been reported. However, there are few reports from Japan. In Hidaka Hospital, hypofractionated intensity-modulated radiotherapy (HIMRT) for prostate cancer was initiated in 2007. The purpose of this study is to analyze the long-term outcome. Methods Ninety-two patients with localized prostate cancer treated with HIMRT at Hidaka Hospital between 2007 and 2009 were retrospectively analyzed. HIMRT was delivered using TomoTherapy. The prescription dose was 66 Gy at 95% of the PTV in 22 fractions performed 3 days a week over 7 weeks in all patients. The overall survival rate, biochemical relapse-free rate, and acute and late toxicities were evaluated. Results The median follow-up duration was 78 (range 14-100) months. The median age at the start of the HIMRT was 72 (range 46-84) years. The disease characteristics were as follows: stage T1c, 45; T2a, 20; T2b, 5; T2c, 1; T3a, 13; T3b, 6; T4, 2; Gleason score 6, 13; 7, 44; 8, 20; 9, 15; 10, 0; pretreatment PSA <= 10 ng/mL, 42; 10 to <= 20, 27; and >20, 23. According to the D'Amico classification system, 10, 37, and 45 patients were classified as low-risk, intermediate-risk, and high-risk. The overall survival rate, the cause-specific survival rate, and the biochemical relapse-free rate at 5 years was 94.7%, 100% and 98.9%, respectively. Severe acute toxicity (grade 3 or more) was not observed. The late urinary toxicity was 52.2% in grade 0, 28.3% in grade 1, 19.6% in grade 2, and 2.2% in grade 3. The late rectal toxicity was 78.3% in grade 0, 7.6% in grade 1, 9.8% in grade 2, and 4.3% in grade 3. Conclusions The present study demonstrated that HIMRT using TomoTherapy for prostate cancer has a favorable outcome with tolerable toxicity.	[Takakusagi, Yosuke; Kawamura, Hidemasa; Okamoto, Masahiko; Kaminuma, Takuya; Kubo, Nobuteru; Mizukami, Tatsuji; Sato, Hiro; Onishi, Masahiro; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Showa Machi, Maebashi, Gunma, Japan; [Takakusagi, Yosuke; Kawamura, Hidemasa] Hidaka Hosp, Oncol Ctr, Nakao Machi, Takasaki, Gunma, Japan; [Ohtake, Nobuaki; Sekihara, Tetsuo] Hidaka Hosp, Dept Urol, Nakao Machi, Takasaki, Gunma, Japan	Gunma University	Kawamura, H (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Showa Machi, Maebashi, Gunma, Japan.; Kawamura, H (corresponding author), Hidaka Hosp, Oncol Ctr, Nakao Machi, Takasaki, Gunma, Japan.	kawa@gunma-u.ac.jp	Kaminuma, Takuya/ABG-1541-2021; Sato, Hiro/GWU-7659-2022	Kaminuma, Takuya/0000-0003-3527-5525; 				Akimoto T, 2004, INT J RADIAT ONCOL, V60, P1033, DOI 10.1016/j.ijrobp.2004.07.695; Akimoto T, 2004, INT J RADIAT ONCOL, V59, P372, DOI 10.1016/j.ijrobp.2003.10.033; Aluwini S, 2016, LANCET ONCOL, V17, P464, DOI 10.1016/S1470-2045(15)00567-7; Brenner DJ, 2004, INT J RADIAT ONCOL, V60, P1013, DOI 10.1016/j.ijrobp.2004.04.014; Brenner DJ, 2002, INT J RADIAT ONCOL, V52, P6; Brenner DJ, 1999, INT J RADIAT ONCOL, V43, P1095, DOI 10.1016/S0360-3016(98)00438-6; Catton CN, 2017, J CLIN ONCOL, V35, P1884, DOI 10.1200/JCO.2016.71.7397; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; D'Souza WD, 2001, INT J RADIAT ONCOL, V51, P1, DOI 10.1016/S0360-3016(01)01650-9; Dearnaley D, 2016, LANCET ONCOL, V17, P1047, DOI 10.1016/S1470-2045(16)30102-4; Fowler JF, 2005, ACTA ONCOL, V44, P265, DOI 10.1080/02841860410002824; Fowler JF, 2003, INT J RADIAT ONCOL, V56, P1093, DOI 10.1016/S0360-3016(03)00132-9; Hashimoto Y, 2018, INT J CLIN ONCOL, V23, P165, DOI 10.1007/s10147-017-1175-1; Haustermans K, 2000, INT J RADIAT ONCOL, V48, P303, DOI 10.1016/S0360-3016(00)00562-9; King CR, 2001, INT J RADIAT ONCOL, V51, P213, DOI 10.1016/S0360-3016(01)01651-0; Kong M, 2014, ONCOTARGETS THER, V7, P553, DOI 10.2147/OTT.S61465; Kupelian PA, 2000, INT J RADIAT ONCOL, V46, P567, DOI 10.1016/S0360-3016(99)00455-1; Kupelian PA, 2002, INT J RADIAT ONCOL, V53, P904, DOI 10.1016/S0360-3016(02)02836-5; Kupelian PA, 2001, INT J RADIAT ONCOL, V50, P621, DOI 10.1016/S0360-3016(01)01466-3; Lyons JA, 2000, UROLOGY, V55, P85, DOI 10.1016/S0090-4295(99)00380-5; Mackie TR, 2006, PHYS MED BIOL, V51, pR427, DOI 10.1088/0031-9155/51/13/R24; MACKIE TR, 1993, MED PHYS, V20, P1709, DOI 10.1118/1.596958; Pollack A, 2002, INT J RADIAT ONCOL, V53, P1097, DOI 10.1016/S0360-3016(02)02829-8; Sanfilippo NJ, 2014, AM J CLIN EXP UROL, V2, P286; Sanguineti G, 2006, INT J RADIAT ONCOL, V64, P151, DOI 10.1016/j.ijrobp.2005.06.026; Spyropoulou Despina, 2012, ISRN Oncol, V2012, P410892, DOI 10.5402/2012/410892; Takeda K, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-105; Tomita N, 2013, J RADIAT RES, V54, P919, DOI 10.1093/jrr/rrt025; Tucker SL, 2011, INT J RADIAT ONCOL, V81, P600, DOI 10.1016/j.ijrobp.2010.11.080; Zelefsky MJ, 2008, INT J RADIAT ONCOL, V70, P1124, DOI 10.1016/j.ijrobp.2007.11.044	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211370	10.1371/journal.pone.0211370	http://dx.doi.org/10.1371/journal.pone.0211370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807581	Green Published, Green Submitted, gold			2022-12-26	WOS:000459712100004
J	Huang, Q; Sun, D; Hussain, MZ; Liu, YG; Morozova-Roche, LA; Zhang, C				Huang, Qin; Sun, Dan; Hussain, Muhammad Zubair; Liu, Yonggang; Morozova-Roche, Ludmilla A.; Zhang, Ce			HEWL interacts with dissipated oleic acid micelles, and decreases oleic acid cytotoxicity	PLOS ONE			English	Article							FATTY-ACIDS; TRANSPORT; BRAIN; NEUROTOXICITY; PROTEINS	Senile plaques are well-known hallmarks of Alzheimer's Diseases (AD). However, drugs targeting tangles of the protein tau and plaques of beta-amyloid have no significant effect on disease progression, and the studies on the underlying mechanism of AD remain in high demand. Growing evidence supports the protective role of senile plaques in local inflammation driven by S100A9. We herein demonstrate that oleic acid (OA) micelles interact with hen egg white lysozyme (HEWL) and promote its amyloid formation. Consequently, SH-SY5Y cell line and mouse neural stem cells are rescued from OA toxicity by co-aggregation of OA and HEWL. Using atomic force microscopy in combination with fluorescence microscopy, we revealed that HEWL forms round-shaped aggregates in the presence of OA micelles instead of protofibrils of HEWL alone. These HEWL amyloids act as a sink for toxic OA micelles and their co-aggregate form large clumps, suggesting a protective function in amyloid and OA cytotoxicity.	[Huang, Qin; Liu, Yonggang] Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing, Peoples R China; [Huang, Qin; Sun, Dan; Zhang, Ce] Northwest Univ, Inst Photon & Photon Technol, State Key Lab Cultivat Base Photoelect Technol &, Xian, Shaanxi, Peoples R China; [Hussain, Muhammad Zubair] Govt Emerson Coll, Dept Zool, Multan, Pakistan; [Hussain, Muhammad Zubair; Liu, Yonggang; Morozova-Roche, Ludmilla A.; Zhang, Ce] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden	Chongqing Medical University; Northwest University Xi'an; Umea University	Liu, YG (corresponding author), Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing, Peoples R China.; Zhang, C (corresponding author), Northwest Univ, Inst Photon & Photon Technol, State Key Lab Cultivat Base Photoelect Technol &, Xian, Shaanxi, Peoples R China.; Liu, YG; Morozova-Roche, LA; Zhang, C (corresponding author), Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.	100418@cqmu.edu.cn; ludmilla.morozova-roche@umu.se; zhangce.univ@gmail.com	Morozova-Roche, Ludmilla A./AAU-9044-2021; Liu, Yong/GWQ-6163-2022	Zhang, Ce/0000-0003-1284-7279	Chongqing Basic and Frontier Research Program [cstc2015jcyjA10034]; Swedish Medical Research Council [2014-3241]; Insamlingsstiftelsen [FS 2.1.12-1605-14]; Biochemical Imaging Platform, Umea University	Chongqing Basic and Frontier Research Program; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Insamlingsstiftelsen; Biochemical Imaging Platform, Umea University	This work was supported by the Chongqing Basic and Frontier Research Program. Project (cstc2015jcyjA10034), Swedish Medical Research Council (2014-3241 to L.A.M.-R.), Insamlingsstiftelsen (FS 2.1.12-1605-14 to L.A.M.-R.), Biochemical Imaging Platform, Umea University (to L.A.M.-R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedini A, 2009, PROTEIN ENG DES SEL, V22, P453, DOI 10.1093/protein/gzp036; Aisen PS, 1997, GERONTOLOGY, V43, P143; Behnan J, 2016, NEUROEPIGENETICS, V7, P6, DOI DOI 10.1016/j.nepig.2016.08.002; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; Di Sabatino A, 2011, MUCOSAL IMMUNOL, V4, P574, DOI 10.1038/mi.2011.18; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Fontana A, 2013, BBA-PROTEINS PROTEOM, V1834, P1125, DOI 10.1016/j.bbapap.2013.02.041; Fraser PE, 2010, J NEUROCHEM, V61, P298; Golde TE, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt233; Grela A, 2016, CLIN CHEM LAB MED, V54, P197, DOI 10.1515/cclm-2015-0394; Grimm MOW, 2012, J NUTR BIOCHEM, V23, P1214, DOI 10.1016/j.jnutbio.2011.06.015; Guardia P, 2007, J MAGN MAGN MATER, V316, pE756, DOI 10.1016/j.jmmm.2007.03.085; Hamazaki K, 2013, PSYCHIAT RES, V210, P346, DOI 10.1016/j.psychres.2013.05.006; Hamilton JA, 1999, PROSTAG LEUKOTR ESS, V60, P291, DOI 10.1016/S0952-3278(99)80002-7; Hamilton LK, 2017, FATE FAT NEUTRAL LIP; Hussain MM, 2013, CLIN LIPIDOL, V8, P481, DOI [10.2217/CLP.13.40, 10.2217/clp.13.40]; Kamijima T, 2008, BIOCHEM BIOPH RES CO, V376, P211, DOI 10.1016/j.bbrc.2008.08.127; Ketones CSC, 2018, EDP SCI; Krajnak K, 2018, BIOORGANIC MED CHEM; LAI JCK, 1991, NEUROCHEM RES, V16, P795, DOI 10.1007/BF00965689; Lim GP, 2005, J NEUROSCIENCE OFFIC, P3032; Liskova K, 2010, J AGR FOOD CHEM, V58, P4421, DOI 10.1021/jf903901j; Liu J, 2016, DRUGS AGING, V33, P1; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Ma BL, 2017, INT J BIOL MACROMOL, V98, P717, DOI 10.1016/j.ijbiomac.2017.01.128; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martins DLT, 2006, CLIN SCI, P307, DOI DOI 10.1016/J.IJBIOMAC.2017.01.128; Mitchell RW, 2011, J NEUROCHEM, V117, P735, DOI 10.1111/j.1471-4159.2011.07245.x; Onur B, 2010, EUROPEAN J NEUROSCIE, V25, P1006; Pan YJ, 2015, MOL PHARMACEUT, V12, P4375, DOI 10.1021/acs.molpharmaceut.5b00580; Passingham RE, 2002, NAT REV NEUROSCI, V3, P606, DOI 10.1038/nrn893; PERLMUTTER LS, 1990, NEUROSCI LETT, V119, P32, DOI 10.1016/0304-3940(90)90748-X; Podtelezhnikov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029610; Reynolds LM, 2001, NEUROSCI LETT, V309, P193, DOI 10.1016/S0304-3940(01)02071-7; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Schappe MS, 2018, IMMUNITY, V48, P59, DOI 10.1016/j.immuni.2017.11.026; Schneider SA, 2017, CURRENT DRUG; Schweiger M, 2012, J LIPID RES, V53, P2307, DOI 10.1194/jlr.M027409; Sebastien CD, 2010, TARGETED TRANSGENE E, V24, P1535; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Svensson M, 2000, CONVERSION MIN PROTE, V97, P4375; Sykova Eva, 2013, Laser Ther, V22, P87, DOI 10.3136/islsm.22.87; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Tarasoff-Conway JM, 2016, NAT REV NEUROL, V12, P248, DOI 10.1038/nrneurol.2016.36; Tugizov S, 2005, J VIROL, V79, P1099, DOI 10.1128/JVI.79.2.1099-1112.2005; van Dyck CH, 2018, BIOL PSYCHIAT, V83, P311, DOI 10.1016/j.biopsych.2017.08.010; Wilson DM, 1997, AM J PATHOL, V150, P2181; Yadav RS, 2014, MOL NEUROBIOL, V50, P168, DOI 10.1007/s12035-014-8661-5; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032953	54	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212648	10.1371/journal.pone.0212648	http://dx.doi.org/10.1371/journal.pone.0212648			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794655	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100105
J	Lage, R; Cebro-Marquez, M; Rodriguez-Manero, M; Gonzalez-Juanatey, JR; Moscoso, I				Lage, Ricardo; Cebro-Marquez, Maria; Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel			Omentin protects H9c2 cells against docetaxel cardiotoxicity	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; BREAST-CANCER; RISK-FACTORS; APOPTOSIS; DOXORUBICIN; CHEMOTHERAPY; OBESITY; ANTHRACYCLINES	Background Association between obesity and cardiovascular diseases is well known, however increased susceptibility of obese patients to develop several cancer types is not so commonly known. Current data suggest that poorer overall survival in cancer patients might be associated to non-cancer-related causes such as higher risk of cardiotoxicity in obese patients treated with chemotherapeutic agents. Omentin, a novel adipokine decreased in obesity, is actually in the spotlight due to its favourable effects on inflammation, glucose homeostasis and cardiovascular diseases. Also, recent data showed that in vitro anthracycline-induced cardiomyocyte apoptosis is counteracted by omentin suggesting its cardioprotective role. Objective Our aim was to evaluate omentin effects against docetaxel toxicity. Results Our data indicate that omentin inhibits docetaxel-induced viability loss and that increased viability is associated to decreased caspase-3 expression and cell death. Although omentin reduces NOX4 expression, it failed to reduce docetaxel-induced reactive oxygen species production. Our results indicate that omentin decreases docetaxel-induced endoplasmic reticulum stress, suggesting that cardioprotective role might be associated to ERS inhibition. Conclusion These data suggest that omentin treatment may contribute to decrease susceptibility to DTX-induced cardiotoxicity.	[Lage, Ricardo; Cebro-Marquez, Maria; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel] Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Cardiol Grp, Santiago De Compostela, Spain; [Lage, Ricardo; Cebro-Marquez, Maria; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel] Univ Clin Hosp Santiago De Compostela, Hlth Res Inst, Santiago De Compostela, Spain; [Lage, Ricardo; Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose; Moscoso, Isabel] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp Santiago De Compostela, Dept Cardiol, Santiago De Compostela, Spain; [Rodriguez-Manero, Moises; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp Santiago De Compostela, Coronary Unit, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Lage, R; Moscoso, I (corresponding author), Univ Santiago de Compostela, Ctr Res Mol Med & Chron Dis CIMUS, Cardiol Grp, Santiago De Compostela, Spain.; Lage, R; Moscoso, I (corresponding author), Univ Clin Hosp Santiago De Compostela, Hlth Res Inst, Santiago De Compostela, Spain.; Lage, R; Moscoso, I (corresponding author), Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain.	rlagef@gmail.com; imosgal@gmail.com	Moscoso, Isabel/GXZ-9513-2022; Rodríguez-Mañero, Moisés/R-6110-2019	Moscoso, Isabel/0000-0002-6078-4666; Rodríguez-Mañero, Moisés/0000-0001-7566-9321; Cebro-Marquez, Maria/0000-0001-6427-7955; Lage Fernandez, Ricardo/0000-0002-8779-7723; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388	Fundacion Mutua Madrilena 2014; Red de Investigacion Cardiovascular (RIC) an initiative of ISCIII [RD12/0042/0039]; Programa de Consolidacion de Unidades de Investigacion Competitivas do SUG of Xunta de Galicia [GPC 2013-051]; Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) of Instituto de Salud Carlos III [CB16/11/00226]	Fundacion Mutua Madrilena 2014; Red de Investigacion Cardiovascular (RIC) an initiative of ISCIII; Programa de Consolidacion de Unidades de Investigacion Competitivas do SUG of Xunta de Galicia; Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) of Instituto de Salud Carlos III	This work was supported by Fundacion Mutua Madrilena 2014 (R.L.), Red de Investigacion Cardiovascular (RIC) (RD12/0042/0039) an initiative of ISCIII (J.R.G-J), Programa de Consolidacion de Unidades de Investigacion Competitivas do SUG (GPC 2013-051) of Xunta de Galicia (J.R.G-J) and Centro de Investigacion Biomedica en Red de Enfermedades Cardiovasculares (CIBERCV) (CB16/11/00226) of Instituto de Salud Carlos III (J.R.G-J). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avril T, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.72; Azfer A, 2006, AM J PHYSIOL-HEART C, V291, pH1411, DOI 10.1152/ajpheart.01378.2005; Batista CMDS, 2007, DIABETES, V56, P1655, DOI 10.2337/db06-1506; Berardi R, 2013, CRIT REV ONCOL HEMAT, V88, P75, DOI 10.1016/j.critrevonc.2013.02.007; Brown SA, 2015, NAT REV CLIN ONCOL, V12, P718, DOI 10.1038/nrclinonc.2015.168; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chong WC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040771; Cueva JF, 2017, CLIN TRANSL ONCOL, V19, P1067, DOI 10.1007/s12094-017-1648-8; Curigliano G, 2016, CA-CANCER J CLIN, V66, P310, DOI 10.3322/caac.21341; Duarte CW, 2017, JCO CLIN CANCER INFO, V1, DOI 10.1200/CCI.16.00071; Fulbright JM, 2015, CANCER CHEMOTH PHARM, V76, P1297, DOI 10.1007/s00280-015-2879-4; Gu NB, 2017, BRAIN RES BULL, V130, P27, DOI 10.1016/j.brainresbull.2016.12.006; Guenancia C, 2016, J CLIN ONCOL, V34, P3157, DOI 10.1200/JCO.2016.67.4846; Guenancia C, 2016, CANCER CHEMOTH PHARM, V77, P777, DOI 10.1007/s00280-016-2995-9; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Hickson J, 2010, CELL DEATH DIFFER, V17, P1003, DOI 10.1038/cdd.2009.205; Hung CH, 2015, TOXICOL SCI, V145, P59, DOI 10.1093/toxsci/kfv017; Iida S, 2013, IN VIVO, V27, P321; Johnson CB, 2016, CAN J CARDIOL, V32, P900, DOI 10.1016/j.cjca.2016.04.008; Kataoka Y, 2014, J AM COLL CARDIOL, V63, P2722, DOI 10.1016/j.jacc.2014.03.032; Kazama K, 2015, BIOCHEM BIOPH RES CO, V457, P602, DOI 10.1016/j.bbrc.2015.01.032; Kazama K, 2014, AM J PHYSIOL-HEART C, V306, pH1714, DOI 10.1152/ajpheart.00048.2014; Kazama K, 2012, EUR J PHARMACOL, V686, P116, DOI 10.1016/j.ejphar.2012.04.033; Kovesdy CP, 2017, J NEPHROL, V30, P1, DOI 10.1007/s40620-017-0377-y; Kuznetsov AV, 2015, BBA-MOL CELL RES, V1853, P276, DOI 10.1016/j.bbamcr.2014.11.015; Maeda K, 2016, J CANCER, V7, P207, DOI 10.7150/jca.13732; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Maruyama S, 2012, J BIOL CHEM, V287, P408, DOI 10.1074/jbc.M111.261818; Maruyama S, 2011, J BIOL CHEM, V286, P32790, DOI 10.1074/jbc.M111.245985; Mathur A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103109; Mhaidat N, 2008, APOPTOSIS, V13, P1505, DOI 10.1007/s10495-008-0276-8; Mitra MS, 2008, TOXICOL APPL PHARM, V231, P413, DOI 10.1016/j.taap.2008.05.006; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; Ogura T, 2016, INT J ONCOL, V48, P2330, DOI 10.3892/ijo.2016.3482; Olsen SR, 2005, BIOMED PHARMACOTHER, V59, pS306, DOI 10.1016/S0753-3322(05)80052-6; Picon-Ruiz M, 2017, CA-CANCER J CLIN, V67, P379, DOI 10.3322/caac.21405; Qian DZ, 2010, PROSTATE, V70, P433, DOI 10.1002/pros.21077; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Rohena CC, 2014, NAT PROD REP, V31, P335, DOI 10.1039/c3np70092e; Sahin F, 2008, HEMATOLOGY, V13, P215, DOI 10.1179/102453308X315997; Shibata R, 2014, CYTOKINE GROWTH F R, V25, P483, DOI 10.1016/j.cytogfr.2014.07.005; Smekal A, 2017, BIOMED PAP, V161, P31, DOI 10.5507/bp.2017.002; Spallarossa P, 2016, J CARDIOVASC MED, V17, pS84, DOI 10.2459/JCM.0000000000000381; Staren'kii V P, 2003, Radiats Biol Radioecol, V43, P640; Tabaczar S, 2013, GEN PHYSIOL BIOPHYS, V32, P535, DOI 10.4149/gpb_2013048; Tan YL, 2015, CLIN CHIM ACTA, V448, P98, DOI 10.1016/j.cca.2015.05.019; Theccanat T, 2016, CELL SIGNAL, V28, P190, DOI 10.1016/j.cellsig.2015.11.013; Todaro MC, 2013, INT J CARDIOL, V168, P680, DOI 10.1016/j.ijcard.2013.03.133; Tsuru A, 2016, SCI REP-UK, V6, DOI 10.1038/srep24217; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Wu S, 2007, CLIN EXP PHARMACOL P, V34, P81, DOI 10.1111/j.1440-1681.2007.04540.x; Yang ZJ, 2009, J LIPOSOME RES, V19, P122, DOI 10.1080/08982100802632649; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zhang ZM, 2017, APOPTOSIS, V22, P647, DOI 10.1007/s10495-017-1351-9	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212782	10.1371/journal.pone.0212782	http://dx.doi.org/10.1371/journal.pone.0212782			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794687	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100137
J	Martinez, GQ; Gordon, SE				Martinez, Gilbert Q.; Gordon, Sharona E.			Multimerization of Homo sapiens TRPA1 ion channel cytoplasmic domains	PLOS ONE			English	Article							RECEPTOR POTENTIAL A1; TRPV1 STRUCTURES; STRUCTURAL BASIS; T1 DOMAIN; ACTIVATION; COLD; REVEALS; MECHANISM; LIGAND; ITCH	The transient receptor potential Ankyrin-1 (TRPA1) ion channel is modulated by myriad noxious stimuli that interact with multiple regions of the channel, including cysteine-reactive natural extracts from onion and garlic which modify residues in the cytoplasmic domains. The way in which TRPA1 cytoplasmic domain modification is coupled to opening of the ion-conducting pore has yet to be elucidated. The cryo-EM structure of TRPA1 revealed a tetrameric C-terminal coiled-coil surrounded by N-terminal ankyrin repeat domains (ARDs), an architecture shared with the canonical transient receptor potential (TRPC) ion channel family. Similarly, structures of the TRP melastatin (TRPM) ion channel family also showed a C-terminal coiled-coil surrounded by N-terminal cytoplasmic domains. This conserved architecture may indicate a common gating mechanism by which modification of cytoplasmic domains can transduce conformational changes to open the ion-conducting pore. We developed an in vitro system in which N-terminal ARDs and C-terminal coiled-coil domains can be expressed in bacteria and maintain the ability to interact. We tested three gating regulators: temperature; the polyphosphate compound IP6; and the covalent modifier allyl isothiocyanate to determine whether they alter N- and C-terminal interactions. We found that none of the modifiers tested abolished ARD-coiled-coil interactions, though there was a significant reduction at 37 degrees C. We found that coiled-coils tetramerize in a concentration dependent manner, with monomers and trimers observed at lower concentrations. Our system provides a method for examining the mechanism of oligomerization of TRPA1 cytoplasmic domains as well as a system to study the transmission of conformational changes resulting from covalent modification.	[Martinez, Gilbert Q.; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.	seg@uw.edu			National Eye Institute of the National Institutes of Health [R01EY017564]; National Institute of General Medical Sciences of the National Institutes of Health [R01GM100718, R01GM125351]; National Institutes of Health [S10RR025429, P30DK017047, P30EY001730]; University of Washington Royalty Research Fund; NATIONAL EYE INSTITUTE [R01EY017564, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM125351] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Royalty Research Fund(University of Washington); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by the National Eye Institute of the National Institutes of Health under award numbers R01EY017564 (to SEG), by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers R01GM100718 and R01GM125351 (to SEG), and by the following additional awards from the National Institutes of Health: S10RR025429, P30DK017047, and P30EY001730, and the University of Washington Royalty Research Fund.	Arrigoni C, 2016, CELL, V164, P922, DOI 10.1016/j.cell.2016.02.001; Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2013, ANNU REV PHYSIOL, V75, P181, DOI 10.1146/annurev-physiol-030212-183811; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cavanaugh EJ, 2008, NEUROSCIENCE, V154, P1467, DOI 10.1016/j.neuroscience.2008.04.048; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Collauto A, 2017, PHYS CHEM CHEM PHYS, V19, P15324, DOI 10.1039/c7cp01925d; DeBerg HA, 2016, J BIOL CHEM, V291, P371, DOI 10.1074/jbc.M115.696450; Fan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36852; Feng Q, 2014, CURR TOP MEMBR, V74, P19, DOI 10.1016/B978-0-12-800181-3.00002-6; Fujiwara Y, 2008, J MOL BIOL, V383, P854, DOI 10.1016/j.jmb.2008.08.059; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Geppetti P, 2010, LUNG, V188, pS63, DOI 10.1007/s00408-009-9201-3; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Gupta R, 2016, SCI REP-UK, V6, DOI 10.1038/srep37460; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Ji RR, 2015, PULM PHARMACOL THER, V35, P81, DOI 10.1016/j.pupt.2015.09.001; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kim D, 2007, J NEUROSCI, V27, P6500, DOI 10.1523/JNEUROSCI.0623-07.2007; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Laursen Willem J, 2015, Temperature (Austin), V2, P214, DOI 10.1080/23328940.2014.1000702; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Moore C, 2018, NEUROSCI BULL, V34, P120, DOI 10.1007/s12264-017-0200-8; Moran MM, 2018, BRIT J PHARMACOL, V175, P2185, DOI 10.1111/bph.14044; Nilius B, 2012, PFLUG ARCH EUR J PHY, V464, P425, DOI 10.1007/s00424-012-1158-z; Palovcak E, 2015, J GEN PHYSIOL, V146, P37, DOI 10.1085/jgp.201411329; Pau VPT, 2011, P NATL ACAD SCI USA, V108, P17684, DOI 10.1073/pnas.1107229108; Paulsen CE, 2015, NATURE, V520, P511, DOI 10.1038/nature14367; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Sadofsky LR, 2011, PHARMACOL RES, V63, P30, DOI 10.1016/j.phrs.2010.11.004; Samanta A, 2018, J GEN PHYSIOL, V150, P751, DOI 10.1085/jgp.201711876; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Strang C, 2001, J BIOL CHEM, V276, P28493, DOI 10.1074/jbc.M010540200; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tang QL, 2018, CELL RES, V28, P746, DOI 10.1038/s41422-018-0038-2; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Vinayagam D, 2018, ELIFE, V7, DOI 10.7554/eLife.36615; Voets T, 2014, HANDB EXP PHARMACOL, V223, P729, DOI 10.1007/978-3-319-05161-1_1; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhou YY, 2018, P NATL ACAD SCI USA, V115, pE11864, DOI 10.1073/pnas.1813162115; Zimova L, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aan8621	47	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207835	10.1371/journal.pone.0207835	http://dx.doi.org/10.1371/journal.pone.0207835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794546	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100005
J	Armas, F; Pacor, S; Ferrari, E; Guida, F; Pertinhez, TA; Romani, AA; Scocchi, M; Benincasa, M				Armas, Federica; Pacor, Sabrina; Ferrari, Elena; Guida, Filomena; Pertinhez, Thelma A.; Romani, Antonello A.; Scocchi, Marco; Benincasa, Monica			Design, antimicrobial activity and mechanism of action of Arg-rich ultra-short cationic lipopeptides	PLOS ONE			English	Article							BACTERIAL OUTER-MEMBRANE; ANTIBACTERIAL ACTIVITY; CYTOPLASMIC MEMBRANE; PLAUSIBLE MODE; SIDE-CHAINS; POLYMYXIN-B; IN-VITRO; PEPTIDES; ANTIFUNGAL; CONJUGATION	The increasing emergence of multidrug-resistant microorganisms represents one of the greatest challenges in the clinical management of infectious diseases, and requires the development of novel antimicrobial agents. To this aim, we de novo designed a library of Arg-rich ultra-short cationic antimicrobial lipopeptides (USCLs), based on the Arg-X-Trp-Arg-NH2 peptide moiety conjugated with a fatty acid, and investigated their antibacterial potential. USCLs exhibited an excellent antimicrobial activity against clinically pathogenic microorganisms, in particular Gram-positive bacteria, including multidrug resistant strains, with MIC values ranging between 1.56 and 6.25 mu g/mL. The capability of the two most active molecules, Lau-RIWR-NH2 and Lau-RRIWRR-NH2, to interact with the bacterial membranes has been predicted by molecular dynamics and verified on liposomes by surface plasmon resonance. Both compounds inhibited the growth of S. aureus even at sub MIC concentrations and induced cell membranes permeabilization by producing visible cell surface alterations leading to a significant decrease in bacterial viability. Interestingly, no cytotoxic effects were evidenced for these lipopeptides up to 50-100 mu g/mL in hemolysis assay, in human epidermal model and HaCaT cells, thus highlighting a good cell selectivity. These results, together with the simple composition of USCLs, make them promising lead compounds as new antimicrobials.	[Armas, Federica; Pacor, Sabrina; Guida, Filomena; Scocchi, Marco; Benincasa, Monica] Univ Trieste, Dept Life Sci, Trieste, Italy; [Armas, Federica] Area Sci Pk, Trieste, Italy; [Ferrari, Elena; Pertinhez, Thelma A.] Univ Parma, Dept Med & Surg, Parma, Italy; [Guida, Filomena] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [Pertinhez, Thelma A.] AUSL IRCCS Reggio Emilia, Transfus Med Unit, Reggio Emilia, Italy; [Romani, Antonello A.] Arta Peptid Srls, Parma, Italy	University of Trieste; University of Parma; University of Trieste	Benincasa, M (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	mbenincasa@units.it		Armas, Federica/0000-0001-8034-2972	University of Trieste (FRA 2016); Area Science Park of Trieste	University of Trieste (FRA 2016); Area Science Park of Trieste	This study was carried out with the financial support of the University of Trieste (FRA 2016). F. Armas was supported by the fellowship grant "Made in Trieste" from the Area Science Park of Trieste. I declare that the commercial affiliation Arta Peptidion only provided support in the form of research materials, in particular this company provided us the lipopeptides used in this study. The company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	Ageitos JM, 2017, BIOCHEM PHARMACOL, V133, P117, DOI 10.1016/j.bcp.2016.09.018; Ahlstrom B, 1997, ANTIMICROB AGENTS CH, V41, P544, DOI 10.1128/AAC.41.3.544; Aoki W, 2013, PHARMACEUTICALS-BASE, V6, P1055, DOI 10.3390/ph6081055; Arias M, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8020019; Avrahami D, 2004, J BIOL CHEM, V279, P12277, DOI 10.1074/jbc.M312260200; Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; Benincasa M, 2004, PEPTIDES, V25, P2055, DOI 10.1016/j.peptides.2004.08.004; Benincasa M, 2006, J ANTIMICROB CHEMOTH, V58, P950, DOI 10.1093/jac/dkl382; Bin Zaman S, 2017, CUREUS, V9, DOI 10.7759/cureus.1403; BLONDELLE SE, 1995, J APPL BACTERIOL, V78, P39, DOI 10.1111/j.1365-2672.1995.tb01671.x; Brandenburg Klaus, 2010, Anti-Infective Agents in Medicinal Chemistry, V9, P9; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cirioni O, 2011, J ANTIMICROB CHEMOTH, V66, P859, DOI 10.1093/jac/dkr001; Clifton LA, 2015, LANGMUIR, V31, P404, DOI 10.1021/la504407v; de Lucca AJ, 1999, ANTIMICROB AGENTS CH, V43, P1, DOI 10.1093/jac/43.1.1; DOLZANI L, 1994, FEMS MICROBIOL LETT, V119, P167, DOI 10.1016/0378-1097(94)90409-X; Dryden MS, 2009, INT J ANTIMICROB AG, V34, pS2, DOI 10.1016/S0924-8579(09)70541-2; ECDC ECfDPaC, 2016, SURV ATL INF DIS; Eckhard LH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162537; Falagas ME, 2006, CRIT CARE, V10, DOI 10.1186/cc3995; Falagas ME, 2010, DRUG RESIST UPDATE, V13, P132, DOI 10.1016/j.drup.2010.05.002; Findlay B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041141; Findlay B, 2012, INT J ANTIMICROB AG, V40, P36, DOI 10.1016/j.ijantimicag.2012.03.013; Gordon YJ, 2005, CURR EYE RES, V30, P505, DOI 10.1080/02713680590968637; Grau-Campistany A, 2016, BBA-BIOMEMBRANES, V1858, P333, DOI 10.1016/j.bbamem.2015.11.011; Ha BY, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051902; HOBDEN C, 1995, MICROBIOL-UK, V141, P1875, DOI 10.1099/13500872-141-8-1875; Horn JN, 2013, BIOCHEMISTRY-US, V52, P5604, DOI 10.1021/bi400773q; Huang E, 2014, APPL ENVIRON MICROB, V80, P2700, DOI 10.1128/AEM.03775-13; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; Kawashima S, 1999, NUCLEIC ACIDS RES, V27, P368, DOI 10.1093/nar/27.1.368; Lam PL, 2018, CRIT REV MICROBIOL, V44, P40, DOI 10.1080/1040841X.2017.1313811; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Li LB, 2013, J PHYS CHEM B, V117, P11906, DOI 10.1021/jp405418y; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Matsumoto M., 1998, ACM Transactions on Modeling and Computer Simulation, V8, P3, DOI 10.1145/272991.272995; Meir O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02373-0; Nasompag S, 2015, BBA-BIOMEMBRANES, V1848, P2351, DOI 10.1016/j.bbamem.2015.07.004; Nguyen LT, 2011, BBA-BIOMEMBRANES, V1808, P2297, DOI 10.1016/j.bbamem.2011.05.015; Pacor S, 2018, PEP SCI; Pirtskhalava M, 2016, NUCLEIC ACIDS RES, V44, P6503, DOI 10.1093/nar/gkw243; Podda E, 2006, BBA-GEN SUBJECTS, V1760, P1732, DOI 10.1016/j.bbagen.2006.09.006; Radzishevsky IS, 2005, ANTIMICROB AGENTS CH, V49, P2412, DOI 10.1128/AAC.49.6.2412-2420.2005; Rhodes KA, 2016, DRUG RESIST UPDATE, V28, P82, DOI 10.1016/j.drup.2016.07.003; Roberts KD, 2015, ACS INFECT DIS, V1, P568, DOI 10.1021/acsinfecdis.5b00085; Roch M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02303; Romani AA, 2013, J PEPT SCI, V19, P554, DOI 10.1002/psc.2532; Rotem S, 2008, FASEB J, V22, P2652, DOI 10.1096/fj.07-105015; Sarig H, 2008, ANTIMICROB AGENTS CH, V52, P4308, DOI 10.1128/AAC.00656-08; Serrano GN, 2009, ANTIMICROB AGENTS CH, V53, P2215, DOI 10.1128/AAC.01100-08; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Tam JP, 2002, EUR J BIOCHEM, V269, P923, DOI 10.1046/j.0014-2956.2001.02728.x; Thomas S, 2010, NUCLEIC ACIDS RES, V38, pD774, DOI 10.1093/nar/gkp1021; Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278; Wang WY, 2016, SCI REP-UK, V6, DOI 10.1038/srep24112; WHO, 2017, WHO PUBLISHES LIST B; Xhindoli D, 2015, BIOCHEM J, V465, P443, DOI 10.1042/BJ20141016; Yang X, 2017, MICROBIOL RES, V195, P18, DOI 10.1016/j.micres.2016.11.002	67	25	26	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212447	10.1371/journal.pone.0212447	http://dx.doi.org/10.1371/journal.pone.0212447			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789942	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800028
J	Chakraborty, N; Gautam, A; Muhie, S; Miller, SA; Moyler, C; Jett, M; Hammamieh, R				Chakraborty, Nabarun; Gautam, Aarti; Muhie, Seid; Miller, Stacy-Ann; Moyler, Candace; Jett, Marti; Hammamieh, Rasha			The responses of lungs and adjacent lymph nodes in responding to Yersinia pestis infection: A transcriptomic study using a non-human primate model	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; PRIMARY PNEUMONIC PLAGUE; HEAT-SHOCK PROTEINS; EPITHELIAL-CELLS; IMMUNE-SYSTEM; HOST RESPONSE; MOUSE MODEL; UBIQUITIN; BINDING; APOPTOSIS	Initiation of treatment during the pre-symptomatic phase of Yersinia pestis (Y. pestis) infection is particularly critical. The rapid proliferation of Y. pestis typically couples with the manifestation of common flu-like early symptoms that often misguides the medical intervention. Our study used African green monkeys (AGM) that did not exhibit clear clinical symptoms for nearly two days after intranasal challenge with Y. pestis and succumbed within a day after showing the first signs of clinical symptoms. The lung, and mediastinal and submandibular lymph nodes (LN) accumulated significant Y. pestis colonization immediately after the intranasal challenge. Hence, organ-specific molecular investigations are deemed to be the key to elucidating mechanisms of the initial host response. Our previous study focused on the whole blood of AGM, and we found early perturbations in the ubiquitin-microtubule-mediated host defense. Altered expression of the genes present in ubiquitin and microtubule networks indicated an early suppression of these networks in the submandibular lymph nodes. In concert, the upstream toll-like receptor signaling and downstream NF kappa B signaling were inhibited at the multi-omics level. The inflammatory response was suppressed in the lungs, submandibular lymph nodes and mediastinal lymph nodes. We posited a causal chain of molecular mechanisms that indicated Y. pestis was probably able to impair host-mediated proteolysis activities and evade autophagosome capture by dysregulating both ubiquitin and microtubule networks in submandibular lymph nodes. Targeting these networks in a submandibular LN-specific and time-resolved fashion could be essential for development of the next generation therapeutics for pneumonic plague.	[Chakraborty, Nabarun; Muhie, Seid] US Army, Geneva Fdn, Ctr Environm Hlth Res, Ft Detrick, MD USA; [Gautam, Aarti; Jett, Marti; Hammamieh, Rasha] US Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA; [Muhie, Seid; Miller, Stacy-Ann; Moyler, Candace] US Army, ORISE, Ctr Environm Hlth Res, Ft Detrick, MD USA	United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Hammamieh, R (corresponding author), US Army, Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA.	Rasha.Hammamieh1.civ@mail.mil		Hammamieh, Rasha/0000-0001-8643-6232	Defense Threat Reduction Agency [TMTI0029_09_WR_T]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	The authors would like to acknowledge Defense Threat Reduction Agency (TMTI0029_09_WR_T to M.J.) for funding this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aepfelbacher M, 2005, CURR TOP MICROBIOL, V291, P167; Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Alem F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00050; Araki N, 2006, FRONT BIOSCI, V11, P1479, DOI 10.2741/1897; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Asrat S, 2015, CELL MICROBIOL, V17, P785, DOI 10.1111/cmi.12445; Banerjee S, 2011, J IMMUNOL, V187, P4686, DOI 10.4049/jimmunol.1101500; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beyer W, 2009, MOL ASPECTS MED, V30, P481, DOI 10.1016/j.mam.2009.08.004; Byron A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7135; Chitra P, 2011, CLIN CHIM ACTA, V412, P1151, DOI 10.1016/j.cca.2011.01.037; Chitta K, 2015, BRIT J HAEMATOL, V169, P377, DOI 10.1111/bjh.13304; Cho KI, 2014, J BIOL CHEM, V289, P4600, DOI 10.1074/jbc.M113.538215; Choi JA, 2016, COMP IMMUNOL MICROB, V44, P54, DOI 10.1016/j.cimid.2016.01.001; Chung LK, 2016, CURR OPIN MICROBIOL, V29, P56, DOI 10.1016/j.mib.2015.11.001; Chung LK, 2014, MBIO, V5, DOI 10.1128/mBio.01402-14; Collins CA, 2010, TRENDS CELL BIOL, V20, P205, DOI 10.1016/j.tcb.2010.01.002; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Cui ZM, 2010, J NEUROL SCI, V294, P29, DOI 10.1016/j.jns.2010.04.009; Dehmelt L, 2005, GENOME BIOL, V6; Dufner A, 2015, NAT IMMUNOL, V16, P950, DOI 10.1038/ni.3230; Dumoux M, 2015, J CELL SCI, V128, P3420, DOI 10.1242/jcs.169318; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Fullgrabe J, 2010, CELL DEATH DIFFER, V17, P1238, DOI 10.1038/cdd.2010.58; Galindo CL, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/914762; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Glatigny S, 2016, J IMMUNOL, V196, P3542, DOI 10.4049/jimmunol.1502614; Grizenkova J, 2012, P NATL ACAD SCI USA, V109, P13722, DOI 10.1073/pnas.1208917109; GTEx Consortium, 2018, Nature, V553, P530, DOI 10.1038/nature25160; Gusev NB, 2005, BIOCHEMISTRY-MOSCOW+, V70, P629, DOI 10.1007/s10541-005-0162-8; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hamilton DH, 2014, CANCER RES, V74, P2510, DOI 10.1158/0008-5472.CAN-13-1894; Hammamieh R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151788; Haslbeck M, 2015, J MOL BIOL, V427, P1537, DOI 10.1016/j.jmb.2015.02.002; He F, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.56; Holzer M, 2016, SCI REP-UK, V6, DOI 10.1038/srep34589; Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160; Ikeda T, 2008, FEBS LETT, V582, P1413, DOI 10.1016/j.febslet.2008.02.081; Jahan AS, 2016, P NATL ACAD SCI USA, V113, pE705, DOI 10.1073/pnas.1521763113; Jamart C, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-166; Kang LH, 2013, NEUROCHEM RES, V38, P311, DOI 10.1007/s11064-012-0922-y; Kawabe J, 2006, BIOCHEM BIOPH RES CO, V342, P164, DOI 10.1016/j.bbrc.2006.01.125; Kim Minsoo, 2014, Cells, V3, P848, DOI 10.3390/cells3030848; Kuo JC, 2013, J CELL MOL MED, V17, P704, DOI 10.1111/jcmm.12054; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Lancini C, 2014, J EXP MED, V211, P1759, DOI 10.1084/jem.20131436; Lanneau D, 2008, J CELL MOL MED, V12, P743, DOI 10.1111/j.1582-4934.2008.00273.x; LaRock CN, 2012, CELL HOST MICROBE, V12, P799, DOI 10.1016/j.chom.2012.10.020; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Layton RC, 2011, J MED PRIMATOL, V40, P6, DOI 10.1111/j.1600-0684.2010.00443.x; Leduc F, 2008, BIOL REPROD, V78, P324, DOI 10.1095/biolreprod.107.064162; Lee SY, 2014, CELL MOL LIFE SCI, V71, P2747, DOI 10.1007/s00018-013-1526-7; Li CM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002416; Likhite Neah, 2011, J Biomol Tech, V22, P37; Liu JH, 2014, DIGEST DIS SCI, V59, P1452, DOI 10.1007/s10620-014-3049-y; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; MacDonald E, 2014, TRAFFIC, V15, P879, DOI 10.1111/tra.12180; Mangahas PM, 2008, J CELL BIOL, V180, P357, DOI 10.1083/jcb.200708130; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Muhie S, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.91; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Nakamura S, 2010, J COMP PATHOL, V143, P150, DOI 10.1016/j.jcpa.2010.01.017; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Naro C, 2014, NUCLEIC ACIDS RES, V42, P3218, DOI 10.1093/nar/gkt1307; Neely KM, 2011, J NEUROSCI, V31, P2781, DOI 10.1523/JNEUROSCI.5156-10.2010; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; O'Hagan RC, 2000, GENE DEV, V14, P2185, DOI 10.1101/gad.827200; Ogrunc M, 2016, CELL REP, V15, P1401, DOI 10.1016/j.celrep.2016.04.033; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Pechous RD, 2016, TRENDS MICROBIOL, V24, P190, DOI 10.1016/j.tim.2015.11.008; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Popova A, 2012, IMMUNOBIOLOGY, V217, P321, DOI 10.1016/j.imbio.2011.10.004; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Radhakrishnan Girish K, 2012, Biomol Concepts, V3, P571; Ritho J, 2015, CELL REP, V12, P734, DOI 10.1016/j.celrep.2015.07.002; Sandoval D, 2015, J BIOL CHEM, V290, P1106, DOI 10.1074/jbc.M114.615559; Schroder M, 2008, CELL MOL LIFE SCI, V65, P862, DOI 10.1007/s00018-007-7383-5; Sevin M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/970242; Singla V, 2010, DEV CELL, V18, P410, DOI 10.1016/j.devcel.2009.12.022; Sivaraman V, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004688; St John AL, 2014, IMMUNITY, V41, P440, DOI 10.1016/j.immuni.2014.07.013; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; Tang LJ, 2016, GENE, V578, P92, DOI 10.1016/j.gene.2015.12.006; Tao T, 2014, TUMOR BIOL, V35, P9053, DOI 10.1007/s13277-014-1974-1; Tourdjman M, 2012, CLIN INFECT DIS, V55, pE58, DOI 10.1093/cid/cis578; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238; Verma SK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00602; Wang WY, 2012, J BIOL CHEM, V287, P15143, DOI 10.1074/jbc.M111.317859; White TE, 2015, FRONTIERS NEUROENGIN; Xie J, 2003, BLOOD, V101, P4005, DOI 10.1182/blood-2002-11-3368; Zaucha GM, 1998, ARCH PATHOL LAB MED, V122, P982; Zdolec N, 2015, FOLIA MICROBIOL, V60, P131, DOI 10.1007/s12223-014-0356-9; Zhang M, 2016, J BIOL CHEM, V291, P10783, DOI 10.1074/jbc.M115.700047; Zhang ZQ, 2015, ARCH VIROL, V160, P1449, DOI 10.1007/s00705-015-2403-5; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194; Zhou YZ, 2018, MICROBES INFECT, V20, P166, DOI 10.1016/j.micinf.2017.11.005; Zimbler DL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8487; Zuehlke AD, 2015, GENE, V570, P8, DOI 10.1016/j.gene.2015.06.018	106	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0209592	10.1371/journal.pone.0209592	http://dx.doi.org/10.1371/journal.pone.0209592			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789917	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800006
J	Hardy, SA; Mabotuwana, NS; Murtha, LA; Coulter, B; Sanchez-Bezanilla, S; Al-Omary, MS; Senanayake, T; Loering, S; Starkey, M; Lee, RJ; Rainer, PP; Hansbro, PM; Boyle, AJ				Hardy, Sean A.; Mabotuwana, Nishani S.; Murtha, Lucy A.; Coulter, Brianna; Sanchez-Bezanilla, Sonia; Al-Omary, Mohammed S.; Senanayake, Tharindu; Loering, Svenja; Starkey, Malcolm; Lee, Randall J.; Rainer, Peter P.; Hansbro, Philip M.; Boyle, Andrew J.			Novel role of extracellular matrix protein 1 (ECM1) in cardiac aging and myocardial infarction	PLOS ONE			English	Article							HEART; INFLAMMATION; EXPRESSION; FIBROSIS; AGE; FIBROBLASTS; LYMPHOCYTES; MACROPHAGES; ACTIVATION; NETWORKS	Introduction The prevalence of heart failure increases in the aging population and following myocardial infarction (MI), yet the extracellular matrix (ECM) remodeling underpinning the development of aging- and MI-associated cardiac fibrosis remains poorly understood. A link between inflammation and fibrosis in the heart has long been appreciated, but has mechanistically remained undefined. We investigated the expression of a novel protein, extracellular matrix protein 1 (ECM1) in the aging and infarcted heart. Methods Young adult (3-month old) and aging (18-month old) C57BL/6 mice were assessed. Young mice were subjected to left anterior descending artery-ligation to induce MI, or transverse aortic constriction (TAC) surgery to induce pressure-overload cardiomyopathy. Left ventricle (LV) tissue was collected early and late post-MI/TAC. Bone marrow cells (BMCs) were isolated from young healthy mice, and subject to flow cytometry. Human cardiac fibroblast (CFb), myocyte, and coronary artery endothelial & smooth muscle cell lines were cultured; human CFbs were treated with recombinant ECM1. Primary mouse CFbs were cultured and treated with recombinant angiotensin-II or TGF-beta 1. Immunoblotting, qPCR and mRNA fluorescent in-situ hybridization (mRNA-FISH) were conducted on LV tissue and cells. Results ECM1 expression was upregulated in the aging LV, and in the infarct zone of the LV early post-MI. No significant differences in ECM1 expression were found late post-MI or at any time-point post-TAC. ECM1 was not expressed in any resident cardiac cells, but ECM1 was highly expressed in BMCs, with high ECM1 expression in granulocytes. Flow cytometry of bone marrow revealed ECM1 expression in large granular leucocytes. mRNA-FISH revealed that ECM1 was indeed expressed by inflammatory cells in the infarct zone at day-3 post-MI. ECM1 stimulation of CFbs induced ERK1/2 and AKT activation and collagen-I expression, suggesting a pro-fibrotic role. Conclusions ECM1 expression is increased in ageing and infarcted hearts but is not expressed by resident cardiac cells. Instead it is expressed by bone marrow-derived granulocytes. ECM1 is sufficient to induce cardiac fibroblast stimulation in vitro. Our findings suggest ECM1 is released from infiltrating inflammatory cells, which leads to cardiac fibroblast stimulation and fibrosis in aging and MI. ECM1 may be a novel intermediary between inflammation and fibrosis.	[Hardy, Sean A.; Mabotuwana, Nishani S.; Murtha, Lucy A.; Coulter, Brianna; Al-Omary, Mohammed S.; Senanayake, Tharindu; Boyle, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Hardy, Sean A.; Mabotuwana, Nishani S.; Murtha, Lucy A.; Coulter, Brianna; Al-Omary, Mohammed S.; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.; Boyle, Andrew J.] Hunter Med Res Inst, New Lambton Hts, NSW, Australia; [Sanchez-Bezanilla, Sonia; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Sanchez-Bezanilla, Sonia; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.] Univ Newcastle, Sch Biomed Sci & Pharm, Prior Res Ctr Hlth Lungs, Callaghan, NSW, Australia; [Sanchez-Bezanilla, Sonia; Loering, Svenja; Starkey, Malcolm; Hansbro, Philip M.] Univ Newcastle, Sch Biomed Sci & Pharm, Prior Res Ctr GrowUpWell, Callaghan, NSW, Australia; [Al-Omary, Mohammed S.; Boyle, Andrew J.] John Hunter Hosp, Dept Cardiovasc Med, New Lambton Hts, NSW, Australia; [Lee, Randall J.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Lee, Randall J.] Univ Calif San Francisco, Edyth & Eli Broad Ctr Regenerat Med & Stem Cell R, San Francisco, CA USA; [Rainer, Peter P.] Med Univ Graz, Div Cardiol, Graz, Austria; [Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Sydney, NSW, Australia; [Hansbro, Philip M.] Univ Technol, Fac Sci, Ultimo, NSW, Australia	University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle; John Hunter Hospital; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Medical University of Graz; University of Sydney; Centenary Institute; University of Technology Sydney; University of Technology Sydney	Boyle, AJ (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia.; Boyle, AJ (corresponding author), Hunter Med Res Inst, New Lambton Hts, NSW, Australia.; Boyle, AJ (corresponding author), John Hunter Hosp, Dept Cardiovasc Med, New Lambton Hts, NSW, Australia.	Andrew.boyle@newcastle.edu.au	Al-Omary, Mohammed/AAQ-4822-2021; Hansbro, Phil/G-7486-2013	Hansbro, Phil/0000-0002-4741-3035; Starkey, Malcolm/0000-0002-7359-7464; Coulter, Brianna/0000-0002-0492-9234; Sanchez Bezanilla, Sonia/0000-0003-2753-2691; Loering, Svenja/0000-0003-3267-0239; Rainer, Peter P/0000-0002-2840-6454	John Hunter Charitable Trust [G1800510]	John Hunter Charitable Trust	This work was supported by the John Hunter Charitable Trust [grant number G1800510], awarded to S.H. To my knowledge there is no URL for the funding source website. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biernacka A, 2011, AGING DIS, V2, P158; Boyle AJ, 2013, CARDIOVASC THER, V31, pE102, DOI 10.1111/1755-5922.12043; Boyle AJ, 2011, EXP GERONTOL, V46, P549, DOI 10.1016/j.exger.2011.02.010; Burkauskiene A, 2006, ACTA CARDIOL, V61, P513, DOI 10.2143/AC.61.5.2017765; Chan I, 2004, CLIN EXP DERMATOL, V29, P52, DOI 10.1111/j.1365-2230.2004.01440.x; Chen H, 2016, WORLD J SURG ONCOL, V14, DOI 10.1186/s12957-016-0952-z; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Chen WY, 2015, P NATL ACAD SCI USA, V112, P7249, DOI 10.1073/pnas.1424236112; Cieslik KA, 2014, J MOL CELL CARDIOL, V70, P56, DOI 10.1016/j.yjmcc.2013.10.017; Cieslik KA, 2011, J MOL CELL CARDIOL, V50, P248, DOI 10.1016/j.yjmcc.2010.10.019; Dai DF, 2012, CIRC RES, V110, P1109, DOI 10.1161/CIRCRESAHA.111.246140; Diez C, 2001, CARDIOVASC RES, V49, P731, DOI 10.1016/S0008-6363(00)00296-0; Ertl G, 2005, CARDIOVASC RES, V66, P22, DOI 10.1016/j.cardiores.2005.01.011; Fang L, 2015, J GERIATR CARDIOL, V12, P305, DOI 10.11909/j.issn.1671-5411.2015.03.020; Gagliano N, 2000, J GERONTOL A-BIOL, V55, pB365, DOI 10.1093/gerona/55.8.B365; Gao Y, 2014, J THORAC DIS, V6, P1458, DOI 10.3978/j.issn.2072-1439.2014.08.31; Geng XY, 2017, AM J CARDIOVASC DIS, V7, P72; Han ZQ, 2001, FASEB J, V15, P988, DOI 10.1096/fj.99-0934com; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Horckmans M, 2017, EUR HEART J, V38, P187, DOI 10.1093/eurheartj/ehw002; Horn MA, 2016, J MOL CELL CARDIOL, V93, P175, DOI 10.1016/j.yjmcc.2015.11.005; Kim RY, 2017, AM J RESP CRIT CARE, V196, P283, DOI 10.1164/rccm.201609-1830OC; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kwak HB, 2013, J EXERC REHABIL, V9, P212, DOI [10.12965/jer.130049, 10.12965/jer.130002]; Lakatta EG, 2003, CIRCULATION, V107, P490, DOI 10.1161/01.CIR.0000048894.99865.02; Landmesser U, 2009, EUR HEART J, V30, P1310, DOI 10.1093/eurheartj/ehp181; Lee KM, 2015, ONCOGENE, V34, P6055, DOI 10.1038/onc.2015.54; Lee KM, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0479-6; Li L, 2011, CARDIOVASC RES, V91, P80, DOI 10.1093/cvr/cvr067; Li ZH, 2011, NAT IMMUNOL, V12, P178, DOI 10.1038/ni.1983; Liu Xiaoyu, 2015, Bio Protoc, V5; Lu C, 2015, J MOL CELL CARDIOL, V89, P87, DOI 10.1016/j.yjmcc.2015.10.011; Lu L, 2017, CLIN EXP PHARMACOL P, V44, P55, DOI 10.1111/1440-1681.12753; Luo SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep43242; Ma YG, 2017, TRENDS PHARMACOL SCI, V38, P448, DOI 10.1016/j.tips.2017.03.001; Meschiari CA, 2017, GEROSCIENCE, V39, P7, DOI 10.1007/s11357-017-9959-9; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Murtha LA, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00777; Nah Deuk-Young, 2009, Korean Circ J, V39, P393, DOI 10.4070/kcj.2009.39.10.393; Oyama N, 2013, EXTRACELLULAR MATRIX; Oyama N, 2017, TXB AGING SKIN, P91; Prabhu SD, 2016, CIRC RES, V119, P91, DOI 10.1161/CIRCRESAHA.116.303577; Quan TH, 2015, GERONTOLOGY, V61, P427, DOI 10.1159/000371708; Ramirez TA, 2012, HYPERTENS RES, V35, P811, DOI 10.1038/hr.2012.32; Repnik K, 2016, J APPL GENET, V57, P363, DOI 10.1007/s13353-015-0334-1; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Sander CS, 2006, BRIT J DERMATOL, V154, P218, DOI 10.1111/j.1365-2133.2005.07001.x; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; Sercu S, 2009, MATRIX BIOL, V28, P160, DOI 10.1016/j.matbio.2009.02.003; Sercu S, 2009, IMPORTANCE EXTRACELL; Smits P, 1997, GENOMICS, V45, P487, DOI 10.1006/geno.1997.4918; Song YX, 1999, FORENSIC SCI INT, V104, P133, DOI 10.1016/S0379-0738(99)00103-6; Steenman Marja, 2017, Biophys Rev, V9, P131, DOI 10.1007/s12551-017-0255-9; Strait JB, 2012, HEART FAIL CLIN, V8, P143, DOI 10.1016/j.hfc.2011.08.011; Suthahar Navin, 2017, Curr Heart Fail Rep, V14, P235, DOI 10.1007/s11897-017-0343-y; Toor IS, 2017, HEART, V103, pA152, DOI 10.1136/heartjnl-2017-311726.236; Townsend N, 2016, EUR HEART J, V37, P3232, DOI [10.1093/eurheartj/ehw334, 10.1093/eurheartj/ehy342]; Walter W, 2018, CELL REP, V23, P622, DOI 10.1016/j.celrep.2018.03.029; Wei L, 2011, EXP MOL PATHOL, V90, P74, DOI 10.1016/j.yexmp.2010.10.004; Wick G, 2010, TRENDS IMMUNOL, V31, P110, DOI 10.1016/j.it.2009.12.001; Wojakowski W, 2004, CIRCULATION, V110, P3213, DOI 10.1161/01.CIR.0000147609.39780.02; Wu JZ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/615312; Yu QL, 2006, HYPERTENSION, V48, P98, DOI 10.1161/01.HYP.0000227247.27111.B2	64	14	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212230	10.1371/journal.pone.0212230	http://dx.doi.org/10.1371/journal.pone.0212230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789914	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800021
J	Lepczyk, CA; Fantle-Lepczyk, JE; Misajon, K; Hu, D; Duffy, DC				Lepczyk, Christopher A.; Fantle-Lepczyk, Jean E.; Misajon, Kathleen; Hu, Darcy; Duffy, David C.			Long-term history of vehicle collisions on the endangered Nene (Branta sandvicensis)	PLOS ONE			English	Article							WARNING SIGNS; MORTALITY; PATTERNS; MAGNITUDE; BEHAVIOR	Millions of birds in the United States die annually due to vehicle collisions on roads. Collisions may be of particular interest for species of conservation concern, such as the endangered Hawaiian goose (Nene), which is endemic to Hawaii. Using a nearly 40-year dataset of Nene road mortality in and around Hawaii Volcanoes National Park, we sought to answer the following research questions: 1) has Nene mortality changed over time? 2) are there times of the year in which mortality is greatest and does it relate to specific events in the species' lifecycle? 3) does age at mortality differ over time, space, or sex? 4) given that existing mortalities appear to occur only in certain locations, do the number of mortality events differ across these locations; 5) does mortality rate show any density dependence? and, 6) are mortality rates related to numbers of visitors or vehicles? Between 1977 and 2014, a total of 92 Nene died from vehicle collisions; while absolute mortality increased over this time, the mortality rate remained the same. Similarly, average age of mortality increased over time, but did not differ by location or sex. Between 1995 and 2014, Nene population size and mortality rates were not correlated. Mortality was greatest in November and December (breeding season) and lowest in June. Most of the mortality occurred along just three stretches of road in and around the park, with the number of mortalities split about evenly inside and outside of the park. Furthermore, Nene mortality was unrelated to the number of visitors or traffic volume in the park. These findings suggest vehicle collisions are a growing concern for Nene, but that management actions to reduce mortality can be targeted at specific road segments and times of the year.	[Lepczyk, Christopher A.; Fantle-Lepczyk, Jean E.] Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA; [Fantle-Lepczyk, Jean E.] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; [Misajon, Kathleen; Hu, Darcy] Hawai Volcanoes Natl Pk, US Natl Pk Serv, Hawaii Natl Pk, HI USA; [Duffy, David C.] Univ Hawaii Manoa, Dept Bot, Pacific Cooperat Studies Unit, Honolulu, HI 96822 USA	Auburn University System; Auburn University; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa	Lepczyk, CA (corresponding author), Auburn Univ, Sch Forestry & Wildlife Sci, Auburn, AL 36849 USA.	lepczyk@auburn.edu		Lepczyk, Christopher/0000-0002-5316-3159; Fantle-Lepczyk, Jean/0000-0001-5388-0871	NPS [P14AC01740]	NPS	Funding for this work was provided by the NPS to the University of Hawai'i through the Hawai' i-Pacific Islands Cooperative Ecosystem Studies Unit, Task Agreement No. P14AC01740 with CAL and DCD. Sponsors collected and analyzed the nene data, assisted in design of project and preparation of the manuscript.	Baldwin Paul H., 1945, CONDOR, V47, P27, DOI 10.2307/1364446; Banko PC, 1999, BIRDS N AM; BENNETT AF, 1991, NAT CONSERV SER, P99; BLACK JM, 1995, IBIS, V137, pS153, DOI 10.1111/j.1474-919X.1995.tb08436.x; Black JM, 1998, AVIAN CONSERVATION: RESEARCH AND MANAGEMENT, P125; Calvert AM, 2013, AVIAN CONSERV ECOL, V8, DOI 10.5751/ACE-00581-080211; Canal D, 2018, ANIM BIODIV CONSERV, V41, P281, DOI 10.32800/abc.2018.41.0281; Cian LC, 2015, J CONSUM RES, V41, P1426, DOI 10.1086/680673; Clevenger AP, 2003, BIOL CONSERV, V109, P15, DOI 10.1016/S0006-3207(02)00127-1; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; Fahrig L, 2009, ECOL SOC, V14; Found R, 2011, WILDLIFE SOC B, V35, P291, DOI 10.1002/wsb.12; Gunson KE, 2011, J ENVIRON MANAGE, V92, P1074, DOI 10.1016/j.jenvman.2010.11.027; Huijser M, 2007, REPORT C; Huijser MP, 2008, FHWAHRT08034; Husby A, 2014, BEHAV ECOL, V25, P504, DOI 10.1093/beheco/aru011; Husby M, 2016, ORNIS FENNICA, V93, P212; Jagerbrand AK, 2016, ACCIDENT ANAL PREV, V86, P229, DOI 10.1016/j.aap.2015.11.004; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Loss Scott R, 2013, Nat Commun, V4, P1396, DOI 10.1038/ncomms2380; Loss SR, 2014, J WILDLIFE MANAGE, V78, P763, DOI 10.1002/jwmg.721; Loss SR, 2012, FRONT ECOL ENVIRON, V10, P357, DOI 10.1890/110251; Nene Recovery Action Group, 2016, STAT WID POP EST NEN; Rave E. H., 2005, Wildfowl, V55, P7; Rytwinski T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166941; Sullivan TL, 2004, WILDLIFE SOC B, V32, P907, DOI 10.2193/0091-7648(2004)032[0907:EOTWSI]2.0.CO;2; Ujvari M, 1998, J WILDLIFE MANAGE, V62, P1094, DOI 10.2307/3802562; van der Ree R, 2011, ECOL SOC, V16; Work TM, 2015, J WILDLIFE DIS, V51, P688, DOI 10.7589/2014-11-256	29	3	3	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210180	10.1371/journal.pone.0210180	http://dx.doi.org/10.1371/journal.pone.0210180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785887	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000010
J	Arriagada, C; Luchsinger, C; Gonzalez, AE; Schwenke, T; Arriagada, G; Folch, H; Ehrenfeld, P; Burgos, PV; Mardones, GA				Arriagada, Cecilia; Luchsinger, Charlotte; Gonzalez, Alexis E.; Schwenke, Tomas; Arriagada, Gloria; Folch, Hugo; Ehrenfeld, Pamela; Burgos, Patricia V.; Mardones, Gonzalo A.			The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; POOR-PROGNOSIS; SIGNALING PATHWAY; RAPAMYCIN SENSITIVITY; HIGH EXPRESSION; BREAST-CANCER; LUNG-CANCER; DNA-DAMAGE; GOLPH3; OVEREXPRESSION	Golgi phosphoprotein 3 (GOLPH3) is a conserved protein of the Golgi apparatus that in humans has been implicated in tumorigenesis. However, the precise function of GOLPH3 in malignant transformation is still unknown. Nevertheless, clinicopathological data shows that in more than a dozen kinds of cancer, including gliomas, GOLPH3 could be found overexpressed, which correlates with poor prognosis. Experimental data shows that overexpression of GOLPH3 leads to transformation of primary cells and to tumor growth enhancement. Conversely, the knocking down of GOLPH3 in GOLPH3-overexpressing tumor cells reduces tumorigenic features, such as cell proliferation and cell migration and invasion. The cumulative evidence indicate that GOLPH3 is an oncoprotein that promotes tumorigenicity by a mechanism that impact at different levels in different types of cells, including the sorting of Golgi glycosyltransferases, signaling pathways, and the actin cytoskeleton. How GOLPH3 connects mechanistically these processes has not been determined yet. Further studies are important to have a more complete understanding of the role of GOLPH3 as oncoprotein. Given the genetic diversity in cancer, a still outstanding aspect is how in this inherent heterogeneity GOLPH3 could possibly exert its oncogenic function. We have aimed to evaluate the contribution of GOLPH3 overexpression in the malignant phenotype of different types of tumor cells. Here, we analyzed the effect on cell migration that resulted from stable, RNAi-mediated knocking down of GOLPH3 in T98G cells of glioblastoma multiforme, a human glioma cell line with unique features. We found that the reduction of GOLPH3 levels produced dramatic changes in cell morphology, involving rearrangements of the actin cytoskeleton and reduction in the number and dynamics of focal adhesions. These effects correlated with decreased cell migration and invasion due to affected persistence and directionality of cell motility. Moreover, the knocking down of GOLPH3 also caused a reduction in autoactivation of focal adhesion kinase (FAK), a cytoplasmic tyrosine kinase that regulates focal adhesions. Our data support a model in which GOLPH3 in T98G cells promotes cell migration by stimulating the activity of FAK.	[Arriagada, Cecilia; Luchsinger, Charlotte; Gonzalez, Alexis E.; Burgos, Patricia V.; Mardones, Gonzalo A.] Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile; [Arriagada, Cecilia; Luchsinger, Charlotte; Gonzalez, Alexis E.; Ehrenfeld, Pamela; Mardones, Gonzalo A.] Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile; [Gonzalez, Alexis E.] Fdn Ciencia & Vida, Santiago, Chile; [Schwenke, Tomas; Arriagada, Gloria] Univ Andres Bello, Fac Ciencias Vida, Dept Ciencias Biol, Vina Del Mar, Chile; [Folch, Hugo] Univ Austral Chile, Sch Med, Dept Immunol, Valdivia, Chile; [Ehrenfeld, Pamela] Univ Austral Chile, Dept Anat Histol & Pathol, Sch Med, Valdivia, Chile; [Burgos, Patricia V.; Mardones, Gonzalo A.] Univ San Sebastian, Ctr Cell Biol & Biomed, Sch Sci & Med, Santiago, Chile; [Burgos, Patricia V.] Pontificia Univ Catolica Chile, Ctr Aging & Regenerat CARE, Fac Ciencias Biol, Santiago, Chile; [Arriagada, Cecilia] Univ Chile, Fac Dent, Inst Res Dent Sci, Santiago, Chile; [Gonzalez, Alexis E.] Goethe Univ Frankfurt, Buchmann Inst Mol Life Sci, Frankfurt, Germany	Universidad Austral de Chile; Universidad Austral de Chile; Universidad Andres Bello; Universidad Austral de Chile; Universidad Austral de Chile; Universidad San Sebastian; Pontificia Universidad Catolica de Chile; Universidad de Chile; Goethe University Frankfurt	Mardones, GA (corresponding author), Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile.; Mardones, GA (corresponding author), Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile.; Mardones, GA (corresponding author), Univ San Sebastian, Ctr Cell Biol & Biomed, Sch Sci & Med, Santiago, Chile.	gonzalo.mardones@uach.cl	Luchsinger, Charlotte/AAZ-6028-2021; Arriagada, Gloria/AAS-1427-2021	Arriagada, Cecilia/0000-0002-5351-2240; EHRENFELD, INGRID/0000-0002-2519-7570	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT) [1130710, 1161252, 1171649]; Fondo de Equipamiento Cientifico y Tecnologico of Chile (FONDEQUIP) [EQM150118]; Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo of Chile [NC130011]; Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT) [21120450, 21130116]	Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo de Equipamiento Cientifico y Tecnologico of Chile (FONDEQUIP); Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo of Chile; Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh); Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT)	This work was funded by grants 1130710, 1161252 (G.A.M.) and 1171649 (P.V.B.) from Fondo Nacional de Desarrollo Cientifico y Tecnologico of Chile (FONDECYT; http://www.conicyt.cl/fondecyt), EQM150118 (P.V.B.) from Fondo de Equipamiento Cientifico y Tecnologico of Chile (FONDEQUIP; http://www.conicyt.cl/fondequip), NC130011 (G.A.) to Nucleo Milenio Biology of Neuropsiquiatric Disorders NuMIND from Iniciativa Cientifica Milenio del Ministerio de Economia, Fomento y Turismo of Chile (http://www.iniciativamilenio.cl), and from Direccion de Investigacion y Desarrollo de la Universidad Austral de Chile (DID-UACh; http://investigacion.uach.cl) (G.A.M. and P.V.B.). C.A. and C.L. were supported by fellowships 21120450 and 21130116, respectively, from Comision Nacional de Investigacion Cientifica y Tecnologica of Chile (CONICYT; http://www.conicyt.cl).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanko J, 2016, TRENDS CELL BIOL, V26, P391, DOI 10.1016/j.tcb.2016.02.001; Ali MF, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.346528; Bays JL, 2017, CELL MOL LIFE SCI, V74, P2999, DOI 10.1007/s00018-017-2511-3; Bear JE, 2014, CURR OPIN CELL BIOL, V30, P74, DOI 10.1016/j.ceb.2014.06.005; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bershadsky A, 1996, CURR BIOL, V6, P1279, DOI 10.1016/S0960-9822(02)70714-8; Bhide GP, 2017, HISTOCHEM CELL BIOL, V147, P149, DOI 10.1007/s00418-016-1520-x; Buschman MD, 2015, CANCER RES, V75, P624, DOI 10.1158/0008-5472.CAN-14-3081; Cai Xue, 2018, Oncotarget, V9, P9540, DOI 10.18632/oncotarget.23476; Cavieres VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136313; Chen JY, 2011, CANCER RES, V71, P473, DOI 10.1158/0008-5472.CAN-10-1303; Dai T, 2015, J PATHOL, V235, P490, DOI 10.1002/path.4479; Dippold HC, 2009, CELL, V139, P337, DOI 10.1016/j.cell.2009.07.052; Donizy P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101619; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Farber-Katz SE, 2014, CELL, V156, P413, DOI 10.1016/j.cell.2013.12.023; Gkretsi V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00145; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Guo YT, 2015, WORLD J GASTROENTERO, V21, P13473, DOI 10.3748/wjg.v21.i48.13473; Hall A, 2012, BIOCHEM SOC T, V40, P1378, DOI 10.1042/BST20120103; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Hanks SK, 2003, FRONT BIOSCI-LANDMRK, V8, pD982, DOI 10.2741/1114; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; HOEBEKE J, 1976, BIOCHEM BIOPH RES CO, V69, P319, DOI 10.1016/0006-291X(76)90524-6; Holroyd AK, 2018, IMMUNOL LETT, V196, P74, DOI 10.1016/j.imlet.2018.01.015; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Hu BS, 2013, TUMOR BIOL, V34, P515, DOI 10.1007/s13277-012-0576-z; Hu GS, 2014, TUMOR BIOL, V35, P8625, DOI 10.1007/s13277-014-2105-8; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Hua X, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-127; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Jansen S, 2018, PHARMACOL THERAPEUT, V183, P1, DOI 10.1016/j.pharmthera.2017.09.002; Jiang YQ, 2015, INT J CLIN EXP PATHO, V8, P10615; Kim DH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7010001; Kim ND, 2006, CURR CANCER DRUG TAR, V6, P681; Kleinschmidt EG, 2017, CURR OPIN CELL BIOL, V45, P24, DOI 10.1016/j.ceb.2017.01.003; Labernadie A, 2018, CURR OPIN CELL BIOL, V54, P57, DOI 10.1016/j.ceb.2018.04.008; Li H, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-168; Li Q, 2015, MOL MED REP, V11, P4315, DOI 10.3892/mmr.2015.3267; Li WZ, 2015, INT J CLIN EXP PATHO, V8, P3691; Li XY, 2011, J NEURO-ONCOL, V105, P159, DOI 10.1007/s11060-011-0573-x; Liu L, 2010, J BIOL CHEM, V285, P38362, DOI 10.1074/jbc.M110.141168; Longmate Whitney, 2017, F1000Res, V6, P1612, DOI 10.12688/f1000research.11877.1; Ma YC, 2014, TUMOR BIOL, V35, P11845, DOI 10.1007/s13277-014-2411-1; Maritzen T, 2015, CELL MOL LIFE SCI, V72, P2119, DOI 10.1007/s00018-015-1855-9; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Nakashima-Kamimura N, 2005, J CELL SCI, V118, P5357, DOI 10.1242/jcs.02645; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pereira NA, 2014, J BIOL CHEM, V289, P14762, DOI 10.1074/jbc.M114.548305; Rasband W., 2006, IMAGEJ; Rizzo R, 2017, TISSUE CELL, V49, P170, DOI 10.1016/j.tice.2016.06.008; Rodrigues J, 2018, G3-GENES GENOM GENET, V8, P1807, DOI 10.1534/g3.118.200172; Ross BC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087357; Salem AF, 2012, CELL CYCLE, V11, P2545, DOI 10.4161/cc.20920; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schmitz KR, 2008, DEV CELL, V14, P523, DOI 10.1016/j.devcel.2008.02.016; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scott KL, 2010, CLIN CANCER RES, V16, P2229, DOI 10.1158/1078-0432.CCR-09-1695; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Sechi S, 2015, ONCOTARGET, V6, P3493, DOI 10.18632/oncotarget.3051; Sechi S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004305; Snyder CM, 2006, MOL BIOL CELL, V17, P511, DOI 10.1091/mbc.E05-07-0682; Sotgia F, 2012, CELL CYCLE, V11, P4390, DOI 10.4161/cc.22777; Stoyanov George St, 2018, Folia Med (Plovdiv), V60, P48, DOI 10.1515/folmed-2017-0069; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Sun J, 2017, CANCER MED-US, V6, P834, DOI 10.1002/cam4.1040; Sun M, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1365; Szeliga M, 2015, NEUROCHEM INT, V88, P6, DOI 10.1016/j.neuint.2014.11.004; Teicher BA, 2009, TOXICOL PATHOL, V37, P114, DOI 10.1177/0192623308329473; Tenorio MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154719; Tokuda E, 2014, CANCER RES, V74, P3054, DOI 10.1158/0008-5472.CAN-13-2441; Tripathi BK, 2017, J CELL BIOL, V216, P4255, DOI 10.1083/jcb.201703105; Tu L, 2008, SCIENCE, V321, P404, DOI 10.1126/science.1159411; Valle-Tenney R, 2016, J VIROL, V90, P6896, DOI 10.1128/JVI.00863-16; Wang JH, 2017, MOL MED REP, V16, P7138, DOI 10.3892/mmr.2017.7495; Wang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045622; Wang R, 2015, CELL PHYSIOL BIOCHEM, V35, P969, DOI 10.1159/000369753; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Wood CS, 2009, J CELL BIOL, V187, P967, DOI 10.1083/jcb.200909063; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Wu SS, 2018, J NEURO-ONCOL, V139, P269, DOI 10.1007/s11060-018-2884-7; Wu W, 2017, J CANCER, V8, P2163, DOI 10.7150/jca.19940; Xie ZG, 2018, DEV CELL, V44, P725, DOI 10.1016/j.devcel.2018.02.025; Xing MK, 2016, MOL BIOL CELL, V27, P3828, DOI 10.1091/mbc.E16-01-0005; Xue Y, 2014, BRIT J CANCER, V110, P2250, DOI 10.1038/bjc.2014.124; Zeng ZL, 2012, CLIN CANCER RES, V18, P4059, DOI 10.1158/1078-0432.CCR-11-3156; Zhang JW, 2013, CELL REP, V3, P2008, DOI 10.1016/j.celrep.2013.05.021; Zhang LJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-571; Zhang Q, 2015, ONCOTARGET, V6, P32177, DOI 10.18632/oncotarget.4867; Zhang X, 2015, MOL CARCINOGEN, V54, P1252, DOI 10.1002/mc.22197; Zhang Y, 2014, TUMOR BIOL, V35, P10833, DOI 10.1007/s13277-014-2357-3; Zhou JX, 2012, J NEURO-ONCOL, V110, P195, DOI 10.1007/s11060-012-0970-9; Zhou XP, 2017, NEURO-ONCOLOGY, V19, P1628, DOI 10.1093/neuonc/nox104; Zhou XP, 2013, BIOCHEM BIOPH RES CO, V433, P338, DOI 10.1016/j.bbrc.2013.03.003	97	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212321	10.1371/journal.pone.0212321	http://dx.doi.org/10.1371/journal.pone.0212321			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779783	gold, Green Published, Green Submitted			2022-12-26	WOS:000459062900046
J	Lyon, YA; Collier, MP; Riggs, DL; Degiacomi, MT; Benesch, JLP; Julian, RR				Lyon, Yana A.; Collier, Miranda P.; Riggs, Dylan L.; Degiacomi, Matteo T.; Benesch, Justin L. P.; Julian, Ryan R.			Structural and functional consequences of age-related isomerization in alpha-crystallins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aging; mass spectrometry (MS); radical; chaperone; protein structure; protein self-assembly; protein phosphorylation; protein chemical modification; molecular dynamics; epimer	HEAT-SHOCK-PROTEIN; B-CRYSTALLIN; QUATERNARY STRUCTURE; CHAPERONE ACTIVITY; ASPARTYL RESIDUES; MASS-SPECTROMETRY; SUBUNIT EXCHANGE; BETA-CRYSTALLIN; CRYAB MUTATION; PHOSPHORYLATION	Long-lived proteins are subject to spontaneous degradation and may accumulate a range of modifications over time, including subtle alterations such as side-chain isomerization. Recently, tandem MS has enabled identification and characterization of such peptide isomers, including those differing only in chirality. However, the structural and functional consequences of these perturbations remain largely unexplored. Here, we examined the impact of isomerization of aspartic acid or epimerization of serine at four sites mapping to crucial oligomeric interfaces in human A- and B-crystallin, the most abundant chaperone proteins in the eye lens. To characterize the effect of isomerization on quaternary assembly, we utilized synthetic peptide mimics, enzyme assays, molecular dynamics calculations, and native MS experiments. The oligomerization of recombinant forms of A- and B-crystallin that mimic isomerized residues deviated from native behavior in all cases. Isomerization also perturbs recognition of peptide substrates, either enhancing or inhibiting kinase activity. Specifically, epimerization of serine (ASer-162) dramatically weakened inter-subunit binding. Furthermore, phosphorylation of BSer-59, known to play an important regulatory role in oligomerization, was severely inhibited by serine epimerization and altered by isomerization of nearby BAsp-62. Similarly, isomerization of BAsp-109 disrupted a vital salt bridge with BArg-120, a contact that when broken has previously been shown to yield aberrant oligomerization and aggregation in several disease-associated variants. Our results illustrate how isomerization of amino acid residues, which may seem to be only a minor structural perturbation, can disrupt native structural interactions with profound consequences for protein assembly and activity.	[Lyon, Yana A.; Riggs, Dylan L.; Julian, Ryan R.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Collier, Miranda P.; Benesch, Justin L. P.] Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, South Parks Rd, Oxford OX1 3QZ, England; [Degiacomi, Matteo T.] Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England	University of California System; University of California Riverside; University of Oxford; Durham University	Julian, RR (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.; Benesch, JLP (corresponding author), Univ Oxford, Dept Chem, Phys & Theoret Chem Lab, South Parks Rd, Oxford OX1 3QZ, England.	justin.benesch@chem.ox.ac.uk; ryan.julian@ucr.edu	Julian, Ryan/AAE-9781-2020; Degiacomi, Matteo/M-4342-2017	Degiacomi, Matteo/0000-0003-4672-471X; Julian, Ryan/0000-0003-1580-8355	National Institutes of Health from NIGMS [R01GM107099]; Oxford University Press Clarendon Award; Engineering and Physical Sciences Research Council [EP/P016499/1, EP/J01835X/1]; BBSRC [BB/J018082/1] Funding Source: UKRI; EPSRC [EP/J01835X/1, EP/P016499/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107099] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Oxford University Press Clarendon Award; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM107099 from NIGMS (to R.R.J.), Oxford University Press Clarendon Award (to M.P.C.), and Engineering and Physical Sciences Research Council Grants EP/P016499/1 (to M.T.D.) and EP/J01835X/1 (to J.L.P.B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmad MF, 2008, J MOL BIOL, V375, P1040, DOI 10.1016/j.jmb.2007.11.019; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Aquilina JA, 2003, P NATL ACAD SCI USA, V100, P10611, DOI 10.1073/pnas.1932958100; Bakthisaran R, 2016, BBA-GEN SUBJECTS, V1860, P167, DOI 10.1016/j.bbagen.2015.09.017; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Boelens WC, 2014, PROG BIOPHYS MOL BIO, V115, P3, DOI 10.1016/j.pbiomolbio.2014.02.005; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Braun N, 2011, P NATL ACAD SCI USA, V108, P20491, DOI 10.1073/pnas.1111014108; Brodehl A, 2017, HUM MUTAT, V38, P947, DOI 10.1002/humu.23248; CASPERS GJ, 1995, J MOL EVOL, V40, P238, DOI 10.1007/BF00163229; Catterall JB, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2675; Chandler SA, 2018, CURR OPIN CHEM BIOL, V42, P130, DOI 10.1016/j.cbpa.2017.11.019; Ciano M, 2016, BIOCHEM BIOPH RES CO, V479, P325, DOI 10.1016/j.bbrc.2016.09.071; Clark AR, 2011, J MOL BIOL, V408, P118, DOI 10.1016/j.jmb.2011.02.020; Clark AR, 2012, INT J BIOCHEM CELL B, V44, P1687, DOI 10.1016/j.biocel.2012.02.015; Delbecq SP, 2012, EMBO J, V31, P4587, DOI 10.1038/emboj.2012.318; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; El-Hawiet A, 2010, J AM SOC MASS SPECTR, V21, P1893, DOI 10.1016/j.jasms.2010.07.008; Fichna JP, 2017, BBA CLIN, V7, P1, DOI 10.1016/j.bbacli.2016.11.004; Fujii N, 2016, BBA-GEN SUBJECTS, V1860, P183, DOI 10.1016/j.bbagen.2015.08.001; GEIGER T, 1987, J BIOL CHEM, V262, P785; Grey AC, 2008, MOL VIS, V14, P171; Haslbeck M, 2016, BBA-GEN SUBJECTS, V1860, P149, DOI 10.1016/j.bbagen.2015.06.008; Hilton GR, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0405; Hochberg GKA, 2014, PROG BIOPHYS MOL BIO, V115, P11, DOI 10.1016/j.pbiomolbio.2014.03.003; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; Hooi MYS, 2013, PROTEIN SCI, V22, P93, DOI 10.1002/pro.2191; Hooi MYS, 2011, AGE, V33, P131, DOI 10.1007/s11357-010-9171-7; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1999, EYE, V13, P403, DOI 10.1038/eye.1999.114; IWAKI T, 1990, J HISTOCHEM CYTOCHEM, V38, P31, DOI 10.1177/38.1.2294148; IWAKI T, 1992, AM J PATHOL, V140, P345; Jansson ET, 2018, J SEP SCI, V41, P385, DOI 10.1002/jssc.201700852; Jehle S, 2010, NAT STRUCT MOL BIOL, V17, P1037, DOI 10.1038/nsmb.1891; Kato K, 1998, J BIOL CHEM, V273, P28346, DOI 10.1074/jbc.273.43.28346; Kato K, 2001, J NEUROCHEM, V76, P730, DOI 10.1046/j.1471-4159.2001.00038.x; Kondrat Frances D L, 2015, Methods Mol Biol, V1261, P349, DOI 10.1007/978-1-4939-2230-7_18; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; Li HL, 2017, ANAL CHEM, V89, P2731, DOI 10.1021/acs.analchem.6b02377; Li RY, 2011, J NEUROCHEM, V118, P354, DOI 10.1111/j.1471-4159.2011.07317.x; Lyon YA, 2018, EXP EYE RES, V171, P131, DOI 10.1016/j.exer.2018.03.018; Lyon YA, 2017, J PROTEOME RES, V16, P1797, DOI 10.1021/acs.jproteome.7b00073; Maddala R, 2005, EXP CELL RES, V306, P203, DOI 10.1016/j.yexcr.2005.01.026; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mainz A, 2012, J BIOL CHEM, V287, P1128, DOI 10.1074/jbc.M111.309047; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; MASTERS PM, 1978, P NATL ACAD SCI USA, V75, P1204, DOI 10.1073/pnas.75.3.1204; MCFADDEN PN, 1987, ARCH BIOCHEM BIOPHYS, V259, P227, DOI 10.1016/0003-9861(87)90490-5; Michiel M, 2009, BIOCHEMISTRY-US, V48, P442, DOI 10.1021/bi8014967; Ni WQ, 2010, ANAL CHEM, V82, P7485, DOI 10.1021/ac101806e; Noguchi S, 1998, J MOL BIOL, V278, P231, DOI 10.1006/jmbi.1998.1674; Noguchi S, 2010, BIOPOLYMERS, V93, P1003, DOI 10.1002/bip.21514; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qin ZX, 2015, NEUROBIOL AGING, V36, P1029, DOI 10.1016/j.neurobiolaging.2014.10.036; Rehder DS, 2008, BIOCHEMISTRY-US, V47, P2518, DOI 10.1021/bi7018223; RENKAWEK K, 1994, ACTA NEUROPATHOL, V87, P155, DOI 10.1007/BF00296185; Riggs DL, 2017, ACS CHEM BIOL, V12, P2875, DOI 10.1021/acschembio.7b00686; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/nmeth.2208, 10.1038/NMETH.2208]; Savas JN, 2012, SCIENCE, V335, P942, DOI 10.1126/science.1217421; Simon S, 2007, BIOCHEMISTRY-US, V46, P9605, DOI 10.1021/bi7003125; Takata T, 2016, FEBS J, V283, P850, DOI 10.1111/febs.13635; Tao YQ, 2014, ANAL CHEM, V86, P9733, DOI 10.1021/ac502296c; Tardieu A, 1998, INT J BIOL MACROMOL, V22, P211, DOI 10.1016/S0141-8130(98)00018-X; Truscott RJW, 2016, TRENDS BIOCHEM SCI, V41, P654, DOI 10.1016/j.tibs.2016.06.004; Truscott RJW, 2016, BBA-GEN SUBJECTS, V1860, P192, DOI 10.1016/j.bbagen.2015.08.016; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Yamamoto A, 1998, J NEUROSCI, V18, P2063; ZIGLER JS, 1981, TRENDS BIOCHEM SCI, V6, P133	72	20	20	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 10	2019	294	19					7546	7555		10.1074/jbc.RA118.007052	http://dx.doi.org/10.1074/jbc.RA118.007052			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IB3FL	30804217	Green Accepted, Green Submitted, hybrid, Green Published			2022-12-26	WOS:000470153300002
J	Cai, MX; Han, LC; Liu, LS; He, F; Chu, WY; Zhang, JS; Tian, ZJ; Du, SJ				Cai, Mengxin; Han, Lichen; Liu, Lusha; He, Feng; Chu, Wuying; Zhang, Jianshe; Tian, Zhenjun; Du, Shaojun			Defective sarcomere assembly in smyd1a and smyd1b zebrafish mutants	FASEB JOURNAL			English	Article						muscle development; myofibrillogenesis; CRISPR; chaperone	CARDIAC-MUSCLE FUNCTION; LYSINE-METHYLATION; MYOFIBRIL ORGANIZATION; HEAVY-CHAIN; SKELETAL; PROTEIN; SKNAC; METHYLTRANSFERASE; EXPRESSION; HEART	Two smyd1 paralogues, smyd1a and smyd1b, have been identified in zebrafish. Although Smyd1b function has been reported in fast muscle, its function in slow muscle and the function of Smyd1a, in general, are uncertain. In this study, we generated 2 smyd1a mutant alleles and analyzed the muscle defects in smyd1a and smyd1b single and double mutants in zebrafish. We demonstrated that knockout of smyd1a alone had no visible effect on muscle development and fish survival. This was in contrast to the smyd1b mutant, which exhibited skeletal and cardiac muscle defects, leading to early embryonic lethality. The smyd1a and smyd1b double mutants, however, showed a stronger muscle defect compared with smyd1a or smyd1b mutation alone, namely, the complete disruption of sarcomere organization in slow and fast muscles. Immunostaining revealed that smyd1a; smyd1b double mutations had no effect on myosin gene expression but resulted in a dramatic reduction of myosin protein levels in muscle cells of zebrafish embryos. This was accompanied by the up-regulation of hsp40 and hsp90-1 gene expression. Together, our studies indicate that both Smyd1a and Smyd1b partake in slow and fast muscle development although Smyd1b plays a dominant role compared with Smyd1a.Cai, M., Han, L., Liu, L., He, F., Chu, W., Zhang, J., Tian, Z., Du, S. Defective sarcomere assembly in smyd1a and smyd1b zebrafish mutants.	[Cai, Mengxin; Han, Lichen; Liu, Lusha; He, Feng; Du, Shaojun] Univ Maryland, Sch Med, Inst Marine & Environm Technol, Dept Biochem & Mol Biol, Baltimore, MD 21202 USA; [Cai, Mengxin; Tian, Zhenjun] Shaanxi Normal Univ, Inst Sports & Exercise Biol, Xian, Shaanxi, Peoples R China; [He, Feng] Ocean Univ China, Sch Fisheries, Qingdao, Shandong, Peoples R China; [Chu, Wuying; Zhang, Jianshe] Changsha Univ, Dept Bioengn & Environm Sci, Changsha, Hunan, Peoples R China	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology; Shaanxi Normal University; Ocean University of China; Changsha University	Du, SJ (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, 701 East Pratt St, Baltimore, MD 21202 USA.	sdu@som.umaryland.edu			U.S. National Institute of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR072703-01A1]; National Natural Science Foundation of China [31701039, 31820103016]; NIH Shared Instrument Grant [1S10 RR26870]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR072703] Funding Source: NIH RePORTER	U.S. National Institute of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH Shared Instrument Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Ming-Yuan Liu (University of Maryland, Baltimore) for fish care, Siping Li (University of Maryland, Baltimore) for statistical analysis of the qRT-PCR data, and Nick Du (University of Washington, Seattle, WA, USA) for proofreading the manuscript. This research was supported by funding from the U.S. National Institute of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR072703-01A1 to S.D.), and National Natural Science Foundation of China (Grants 31701039 to M.C. and 31820103016 to J.Z.). The authors also acknowledge the contribution of Electron Microscopy Core Imaging Facility of the University of Maryland. This work utilized electron microscopy sample preparation instruments purchased with funding from the NIH Shared Instrument Grant (1S10 RR26870). The authors declare no conflicts of interest.	Anderson JL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007105; Berkholz J, 2018, MICRON, V108, P6, DOI 10.1016/j.micron.2018.02.009; Berkholz J, 2015, EXP CELL RES, V336, P182, DOI 10.1016/j.yexcr.2015.06.019; Bernick EP, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-70; Cai MX, 2018, MAR BIOTECHNOL, V20, P168, DOI 10.1007/s10126-018-9794-8; Clark KJ, 2011, NAT METHODS, V8, P506, DOI [10.1038/NMETH.1606, 10.1038/nmeth.1606]; Coda DM, 2015, CELL CYCLE, V14, P1389, DOI 10.1080/15384101.2015.1005993; de Winter Josine M, 2017, J Neuromuscul Dis, V4, P99, DOI 10.3233/JND-160200; Dooley C.M., 2013, SANGER I ZEBRAFISH M; Du SJ, 2008, P NATL ACAD SCI USA, V105, P554, DOI 10.1073/pnas.0707330105; Du SJ, 2014, ANAT REC, V297, P1650, DOI 10.1002/ar.22972; Du SJ, 2006, DEV DYNAM, V235, P3306, DOI 10.1002/dvdy.20984; Egorova KS, 2010, BIOCHEMISTRY-MOSCOW+, V75, P535, DOI 10.1134/S0006297910050019; Ehler E, 2008, ADV EXP MED BIOL, V642, P1; Etard C, 2007, DEV BIOL, V308, P133, DOI 10.1016/j.ydbio.2007.05.014; Franklin S, 2016, AM J PHYSIOL-HEART C, V311, pH1234, DOI 10.1152/ajpheart.00235.2016; Gao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086808; Gottlieb PD, 2002, NAT GENET, V31, P25, DOI 10.1038/ng866; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Hwang PM, 2015, NAT REV DRUG DISCOV, V14, P313, DOI 10.1038/nrd4554; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Iwabata H, 2005, PROTEOMICS, V5, P4653, DOI 10.1002/pmic.200500042; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kok FO, 2015, DEV CELL, V32, P97, DOI 10.1016/j.devcel.2014.11.018; Laing N. G., 2008, ADV EXPT MED BIOL, V642; Lalonde S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178700; Li DL, 2009, NUCLEIC ACIDS RES, V37, P7059, DOI 10.1093/nar/gkp773; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Nagandla H, 2016, DEV BIOL, V410, P86, DOI 10.1016/j.ydbio.2015.12.005; Paone C, 2018, BIOCHEM BIOPH RES CO, V496, P339, DOI 10.1016/j.bbrc.2018.01.060; Park CY, 2010, P NATL ACAD SCI USA, V107, P20750, DOI 10.1073/pnas.1013493107; Phan D, 2005, DEVELOPMENT, V132, P2669, DOI 10.1242/dev.01849; Prill K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142528; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Sanger JW, 2005, J MUSCLE RES CELL M, V26, P343, DOI 10.1007/s10974-005-9016-7; Sanger JW, 2009, CELL MOTIL CYTOSKEL, V66, P556, DOI 10.1002/cm.20365; Sims RJ, 2002, J BIOL CHEM, V277, P26524, DOI 10.1074/jbc.M204121200; Stewart MD, 2016, DIS MODEL MECH, V9, P347, DOI 10.1242/dmm.022491; Sun XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001499; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; TONG SW, 1983, J BIOL CHEM, V258, P3100; Warren JS, 2018, P NATL ACAD SCI USA, V115, pE7871, DOI 10.1073/pnas.1800680115; Wohlgemuth SL, 2007, DEV BIOL, V303, P483, DOI 10.1016/j.ydbio.2006.11.027; Xu J, 2012, J GENET GENOMICS, V39, P69, DOI 10.1016/j.jgg.2012.01.005; Yang XD, 2009, EPIGENETICS-US, V4, P429, DOI 10.4161/epi.4.7.9787; Zhang X, 2012, ACTA BIOCH BIOPH SIN, V44, P14, DOI 10.1093/abbs/gmr100	48	9	9	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6209	6225		10.1096/fj.201801578R	http://dx.doi.org/10.1096/fj.201801578R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817176	Bronze, Green Published			2022-12-26	WOS:000466932600033
J	Zeng, Y; Li, BH; Liang, YY; Reeves, PM; Qu, XY; Ran, CZ; Liu, QY; Callahan, MV; Studer, AE; Gelfand, JA; Chen, HB; Poznansky, MC				Zeng, Yang; Li, Binghao; Liang, Yingying; Reeves, Patrick M.; Qu, Xiying; Ran, Chongzhao; Liu, Qiuyan; Callahan, Michael, V; Studer, Ann E.; Gelfand, Jeffrey A.; Chen, Huabiao; Poznansky, Mark C.			Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment	FASEB JOURNAL			English	Article						CXCR4 antagonist; immune checkpoint inhibitor; combination immunotherapy	REGULATORY T-CELLS; VACCINE STRATEGIES; CHEMOKINE CXCL12; CXCR4 INHIBITION; IMMUNE EVASION; MOUSE MODEL; CANCER; IMMUNOTHERAPY; PD-1; MACROPHAGES	Blockade of immune-checkpoint programmed cell death protein 1 (PD-1) or programmed cell death ligand 1 can enhance effector T-cell responses. However, the lack of response in many patients to checkpoint-inhibitor therapies emphasizes the need for combination immunotherapies to pursue maximal antitumor efficacy. We have previously demonstrated that antagonism of C-X-C chemokine receptor type 4 (CXCR4) by plerixafor (AMD3100) can decrease regulatory T (T-reg)-cell intratumoral infiltration. Therefore, a combination of these 2 therapies might increase antitumor effects. Here, we evaluated the antitumor efficacy of AMD3100 and anti-PD-1 (PD-1) antibody alone or in combination in an immunocompetent syngeneic mouse model of ovarian cancer. We found that AMD3100, a highly specific CXCR4 antagonist, directly down-regulated the expression of both C-X-C motif chemokine 12 (CXCL12) and CXCR4 in vitro and in vivo in tumor cells. AMD3100 and PD-1 significantly inhibited tumor growth and prolonged the survival of tumor-bearing mice when given as monotherapy. Combination of these 2 agents significantly enhanced antitumor effects compared with single-agent administration. Benefits of tumor control and animal survival were associated with immunomodulation mediated by these 2 agents, which were characterized by increased effector T-cell infiltration, increased effector T-cell function, and increased memory T cells in tumor microenvironment. Intratumoral T-reg cells were decreased, and conversion of T-reg cells into T helper cells was increased by AMD3100 treatment. Intratumoral myeloid-derived suppressor cells were decreased by the combined treatment, which was associated with decreased IL-10 and IL-6 in the ascites. Also, the combination therapy decreased suppressive leukocytes and facilitated M2-to-M1 macrophage polarization in the tumor. These results suggest that AMD3100 could be used to target the CXCR4-CXCL12 axis to inhibit tumor growth and prevent multifaceted immunosuppression alone or in combination with PD-1 in ovarian cancer, which could be clinically relevant to patients with this disease.Zeng, Y., Li, B., Liang, Y., Reeves, P. M., Qu, X., Ran, C., Liu, Q., Callahan, M. V., Sluder, A. E., Gelfand, J. A., Chen, H., Poznansky, M. C. Dual blockade of CXCL12-CXCR4 and PD-1-PD-L1 pathways prolongs survival of ovarian tumor-bearing mice by prevention of immunosuppression in the tumor microenvironment.	[Zeng, Yang; Li, Binghao; Liang, Yingying; Reeves, Patrick M.; Qu, Xiying; Callahan, Michael, V; Studer, Ann E.; Gelfand, Jeffrey A.; Chen, Huabiao; Poznansky, Mark C.] Harvard Med Sch, Massachusetts Gen Hosp, Vaccine & Immunotherapy Ctr, Charlestown, MA USA; [Ran, Chongzhao] Harvard Med Sch, Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Liu, Qiuyan] Second Mil Med Univ, Natl Key Lab Med Immunol Second, Shanghai, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Naval Medical University	Chen, HB (corresponding author), Massachusetts Gen Hosp East, Vaccine & Immunotherapy Ctr, 149 13th St, Charlestown, MA 02129 USA.	huabiao.chen@mgh.harvard.edu	Poznansky, Mark C/M-4996-2015; Gelfand, Jeffrey A/G-1885-2018; Reeves, Patrick/I-1066-2018	Poznansky, Mark C/0000-0003-1344-7103; Gelfand, Jeffrey A/0000-0002-4118-5676; Reeves, Patrick/0000-0001-8202-0723	Vaccine and Immunotherapy Center (VIC) Innovation Fund; Massachusetts General Hospital (MGH) Research Scholar Award; U.S. National Institutes of Health (NIH) [1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, 1S10RR023440-01A1]	Vaccine and Immunotherapy Center (VIC) Innovation Fund; Massachusetts General Hospital (MGH) Research Scholar Award; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The ID8 cell line was a kind gift from Dr. Kathy Roby (University of Kansas Medical Center, Kansas City, KS, USA). This work was supported by the Vaccine and Immunotherapy Center (VIC) Innovation Fund and the Massachusetts General Hospital (MGH) Research Scholar Award (to H.C., Y.Z., and M.C.P.). Cytometric findings reported here were performed in the MGH Department of Pathology Flow and Image Cytometry Research Core, which is supported by the U.S. National Institutes of Health (NIH) Shared Instrumentation Grants 1S10OD012027-01A1, 1S10OD016372-01, 1S10RR020936-01, and 1S10RR023440-01A1. M.C.P. is the Scientific Founder of AperiSys. The remaining authors declare no conflicts of interest.	Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Benslimane-Ahmim Z, 2017, CANCER LETT, V395, P11, DOI 10.1016/j.canlet.2017.02.032; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Berzofsky JA, 2004, J CLIN INVEST, V113, P1515, DOI 10.1172/JCI200421926; Berzofsky JA, 2012, SEMIN ONCOL, V39, P348, DOI 10.1053/j.seminoncol.2012.02.002; Bu XN, 2018, CARCINOGENESIS, V39, P242, DOI 10.1093/carcin/bgx137; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Che FY, 2017, CANCER IMMUNOL IMMUN, V66, P717, DOI 10.1007/s00262-017-1961-7; Chen YC, 2015, HEPATOLOGY, V61, P1591, DOI 10.1002/hep.27665; Chodon T, 2018, HEMATOL ONCOL CLIN N, V32, P1025, DOI 10.1016/j.hoc.2018.07.011; Chowdhury PS, 2018, J INTERN MED, V283, P110, DOI 10.1111/joim.12708; Conrad C, 2012, CANCER RES, V72, P5240, DOI 10.1158/0008-5472.CAN-12-2271; Deng J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111713; Domanska UM, 2012, NEOPLASIA, V14, P709, DOI 10.1593/neo.12324; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Drake CG, 2012, ANN ONCOL, V23, P41, DOI 10.1093/annonc/mds262; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Flint TR, 2016, CELL METAB, V24, P672, DOI 10.1016/j.cmet.2016.10.010; Gabrilovich DI, 2007, CANCER RES, V67, P425, DOI 10.1158/0008-5472.CAN-06-3037; Georgoudaki AM, 2016, CELL REP, V15, P2000, DOI 10.1016/j.celrep.2016.04.084; Guo ZH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087029; Hart KM, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00029; Heckmann D, 2013, TRANSL ONCOL, V6, P124, DOI 10.1593/tlo.12268; Hu YP, 2012, LEUKEMIA LYMPHOMA, V53, P130, DOI 10.3109/10428194.2011.601698; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Jiang CM, 2017, BIOMED PHARMACOTHER, V86, P677, DOI 10.1016/j.biopha.2016.12.055; Kaka AS, 2009, J IMMUNOTHER, V32, P726, DOI 10.1097/CJI.0b013e3181ad4071; Karakasheva TA, 2015, CANCER RES, V75, P4074, DOI 10.1158/0008-5472.CAN-14-3639; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Li BH, 2018, CANCER IMMUNOL RES, V6, P539, DOI 10.1158/2326-6066.CIR-17-0530; Li HP, 2017, ACTA BIOMATER, V53, P399, DOI 10.1016/j.actbio.2017.01.070; Liao YX, 2015, ONCOL REP, V34, P33, DOI 10.3892/or.2015.3992; Luster AD, 2002, CURR OPIN IMMUNOL, V14, P129, DOI 10.1016/S0952-7915(01)00308-9; Mantia-Smaldone GM, 2012, HUM VACC IMMUNOTHER, V8, P1179, DOI 10.4161/hv.20738; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mayer CT, 2011, EUR J IMMUNOL, V41, P716, DOI 10.1002/eji.201040913; Mittica G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071169; Peng LS, 2012, CANCER IMMUNOL IMMUN, V61, P2183, DOI 10.1007/s00262-012-1277-6; Righi E, 2011, CANCER RES, V71, P5522, DOI 10.1158/0008-5472.CAN-10-3143; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sanchez-Martin L, 2011, BLOOD, V117, P88, DOI 10.1182/blood-2009-12-258186; Sarchio SNE, 2014, J INVEST DERMATOL, V134, P1091, DOI 10.1038/jid.2013.424; Scala S, 2015, CLIN CANCER RES, V21, P4278, DOI 10.1158/1078-0432.CCR-14-0914; Scotton CJ, 2002, CANCER RES, V62, P5930; Shaaban S, 2016, Int J Cancer Res, V12, P69; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Spranger S, 2013, J IMMUNOTHER CANCER, V1, DOI 10.1186/2051-1426-1-16; Szebeni GJ, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9294018; Tabouret E, 2015, ONCOTARGET, V6, P11664, DOI 10.18632/oncotarget.3256; Terabe M, 2004, CURR OPIN IMMUNOL, V16, P157, DOI 10.1016/j.coi.2004.01.010; Wang SC, 2012, LAB INVEST, V92, P151, DOI 10.1038/labinvest.2011.128; Xu DS, 2016, CURR TOP MED CHEM, V16, P1441, DOI 10.2174/1568026615666150915120218; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869; Zboralski D, 2017, CANCER IMMUNOL RES, V5, P950, DOI 10.1158/2326-6066.CIR-16-0303; Zeng Y., 2016, INT J CANC CLIN RES, V3, P51; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhu XX, 2016, GYNECOL ONCOL, V142, P184, DOI 10.1016/j.ygyno.2016.04.002; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	65	86	93	2	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6596	6608		10.1096/fj.201802067RR	http://dx.doi.org/10.1096/fj.201802067RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30802149	Green Published, Bronze			2022-12-26	WOS:000466932600062
J	Li, WT; Liu, WJ; Kakoki, A; Wang, RJ; Adebali, O; Jiang, YC; Sancar, A				Li, Wentao; Liu, Wenjie; Kakoki, Ayano; Wang, Rujin; Adebali, Ogun; Jiang, Yuchao; Sancar, Aziz			Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleotide excision repair; cancer stem cells; differentiation; neuron; vascular smooth muscle cells; muscle cell; neuron; nucleotide excision repair; stem cell; cell differentiation; genome stability; transcriptomics; NT2 cell; retinoic acid (RA); bone morphogenetic protein-2 (BMP-2)	TRANSCRIPTION-COUPLED REPAIR; XPC DNA-REPAIR; STEM-CELLS; UV DAMAGE; ESCHERICHIA-COLI; THYMINE DIMER; NUCLEASE; COMPLEX; GENOME; COACTIVATOR	Embryonic stem cells can self-renew and differentiate, holding great promise for regenerative medicine. They also employ multiple mechanisms to preserve the integrity of their genomes. Nucleotide excision repair, a versatile repair mechanism, removes bulky DNA adducts from the genome. However, the dynamics of the capacity of nucleotide excision repair during stem cell differentiation remain unclear. Here, using immunoslot blot assay, we measured repair rates of UV-induced DNA damage during differentiation of human embryonic carcinoma (NTERA-2) cells into neurons and muscle cells. Our results revealed that the capacity of nucleotide excision repair increases as cell differentiation progresses. We also found that inhibition of the apoptotic signaling pathway has no effect on nucleotide excision repair capacity. Furthermore, RNA-Seq-based transcriptomic analysis indicated that expression levels of four core repair factors, xeroderma pigmentosum (XP) complementation group A (XPA), XPC, XPG, and XPF-ERCC1, are progressively up-regulated during differentiation, but not those of replication protein A (RPA) and transcription factor IIH (TFIIH). Together, our findings reveal that increase of nucleotide excision repair capacity accompanies cell differentiation, supported by the up-regulated transcription of genes encoding DNA repair enzymes during differentiation of two distinct cell lineages.	[Li, Wentao; Liu, Wenjie; Kakoki, Ayano; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Liu, Wenjie] Xiamen Univ, Sch Pharmaceut Sci, Fujian Prov Key Lab Innovat Drug Target Res, Xiamen 361102, Fujian, Peoples R China; [Wang, Rujin] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Biostat, Chapel Hill, NC 27599 USA; [Jiang, Yuchao] Univ N Carolina, Sch Med, Dept Genet, Chapel Hill, NC 27599 USA; [Jiang, Yuchao] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Adebali, Ogun] Sabanci Univ, Fac Engn & Nat Sci, Mol Biol Genet & Bioengn Program, TR-34956 Istanbul, Turkey	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Xiamen University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Sabanci University	Sancar, A (corresponding author), Genet Med Bldg 3073 CB 7260, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu	Li, Wentao/AAU-1637-2020; Adebali, Ogun/N-4159-2016	Li, Wentao/0000-0003-2313-6384; Adebali, Ogun/0000-0001-9213-4070; Jiang, Yuchao/0000-0001-6905-6377	National Institutes of Health [GM118102, ES027255, CA142538]; UNC Lineberger Comprehensive Cancer Center developmental award [2017T109]; China Scholarship Council [201506315077]; Fundamental Research Funds of Xiamen University; EMBO - Scientific and Technological Research Council of Turkey (TUBITAK); NATIONAL CANCER INSTITUTE [P01CA142538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES027255, P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UNC Lineberger Comprehensive Cancer Center developmental award; China Scholarship Council(China Scholarship Council); Fundamental Research Funds of Xiamen University; EMBO - Scientific and Technological Research Council of Turkey (TUBITAK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM118102 and ES027255 (to A. S.) and CA142538 (to Y. J.) and UNC Lineberger Comprehensive Cancer Center developmental award 2017T109 (to Y. J.). This work was also supported by the Financial Funds of China Scholarship Council (201506315077) and the Fundamental Research Funds of Xiamen University (to W. Liu) and by EMBO Installation Grant Award funded by the Scientific and Technological Research Council of Turkey (TUBITAK) (to O. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Cattoglio C, 2015, P NATL ACAD SCI USA, V112, pE2317, DOI 10.1073/pnas.1505569112; Chadalavada Rajendrakumar S. V., 2005, Functional & Integrative Genomics, V5, P59, DOI 10.1007/s10142-005-0132-7; de Waard H, 2008, DNA REPAIR, V7, P1659, DOI 10.1016/j.dnarep.2008.06.009; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Fong YW, 2011, CELL, V147, P120, DOI 10.1016/j.cell.2011.08.038; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Heyer BS, 2000, GENE DEV, V14, P2072; Hsu PH, 2007, MUTAT RES-FUND MOL M, V614, P3, DOI 10.1016/j.mrfmmm.2006.06.008; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; HUANG JC, 1992, P NATL ACAD SCI USA, V89, P3664, DOI 10.1073/pnas.89.8.3664; Ito S, 2014, FEBS LETT, V588, P1128, DOI 10.1016/j.febslet.2014.02.033; Kemp MG, 2016, J BIOL CHEM, V291, P9330, DOI 10.1074/jbc.M116.719740; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; LEE VMY, 1986, J NEUROSCI, V6, P514; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mao P, 2016, P NATL ACAD SCI USA, V113, P9057, DOI 10.1073/pnas.1606667113; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Moser J, 2007, MOL CELL, V27, P311, DOI 10.1016/j.molcel.2007.06.014; MU D, 1995, J BIOL CHEM, V270, P2415, DOI 10.1074/jbc.270.6.2415; Nouspikel T, 2000, MOL CELL BIOL, V20, P1562, DOI 10.1128/MCB.20.5.1562-1570.2000; Nouspikel T, 2002, DNA REPAIR, V1, P59, DOI 10.1016/S1568-7864(01)00005-2; Nouspikel T, 2013, FUTURE ONCOL, V9, P867, DOI [10.2217/FON.13.22, 10.2217/fon.13.22]; PEDERSEN RA, 1975, EXP CELL RES, V95, P247, DOI 10.1016/0014-4827(75)90548-0; Potten CS, 1997, STEM CELLS, V15, P82, DOI 10.1002/stem.150082; RASKO I, 1993, SOMAT CELL MOLEC GEN, V19, P245, DOI 10.1007/BF01233072; Reardon JT, 2003, GENE DEV, V17, P2539, DOI 10.1101/gad.1131003; Rocha CRR, 2013, MUTAT RES-REV MUTAT, V752, P25, DOI 10.1016/j.mrrev.2012.09.001; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Selby CP, 1997, J BIOL CHEM, V272, P1885, DOI 10.1074/jbc.272.3.1885; Sugasawa K, 1998, MOL CELL, V2, P223, DOI 10.1016/S1097-2765(00)80132-X; SVOBODA DL, 1993, J BIOL CHEM, V268, P1931; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tichy ED, 2008, EXP CELL RES, V314, P1929, DOI 10.1016/j.yexcr.2008.02.007; Van Sloun PPH, 1999, NUCLEIC ACIDS RES, V27, P3276, DOI 10.1093/nar/27.16.3276; Vreeswijk MPG, 1998, CANCER RES, V58, P1978; Wakasugi M, 1998, P NATL ACAD SCI USA, V95, P6669, DOI 10.1073/pnas.95.12.6669; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Yimit A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08290-2; Zhang ET, 2015, P NATL ACAD SCI USA, V112, P14817, DOI 10.1073/pnas.1520104112	54	9	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					5914	5922		10.1074/jbc.RA119.007861	http://dx.doi.org/10.1074/jbc.RA119.007861			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30808711	Green Published, hybrid			2022-12-26	WOS:000465077500023
J	Elsayed, M; Torres, R; Sterkers, O; Bernardeschi, D; Nguyen, Y				Elsayed, Mohamed; Torres, Renato; Sterkers, Olivier; Bernardeschi, Daniele; Yann Nguyen			Pig as a large animal model for posterior fossa surgery in oto-neurosurgery: A cadaveric study	PLOS ONE			English	Article							TRAINING MODEL; TEMPORAL BONE; BRAIN; EAR	This study proposes a practical model for a new approach to the posterior fossa in common domestic pigs. Several surgical procedures can be simulated in the nonliving pig model, including soft tissue dissection, drilling of temporal bone, dural incision, access to the cerebellopontine angle, exposure of cranial nerves and drilling of the internal auditory canal. The pig model perfectly simulates standard otological and neurosurgical procedures, and we highlight the feasibility of our approach for further experiments in a living pig model with the possibility of reproducing the model for research on cranial nerves in pigs to study their electrophysiological behavior.	[Elsayed, Mohamed; Torres, Renato; Sterkers, Olivier; Bernardeschi, Daniele; Yann Nguyen] Sorbonne Univ, INSERM, Unite Rehabil Chirurg Miniinvas & Robotisee Audit, Paris, France; [Elsayed, Mohamed; Torres, Renato; Sterkers, Olivier; Bernardeschi, Daniele; Yann Nguyen] GHU Pitie Salpetriere, AP HP, Serv ORL Otol Implants Auditifs & Chirurg Base Cr, Paris, France; [Elsayed, Mohamed] Alexandria Univ, Fac Med, ORL Dept, Alexandria, Egypt	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Egyptian Knowledge Bank (EKB); Alexandria University	Elsayed, M (corresponding author), Sorbonne Univ, INSERM, Unite Rehabil Chirurg Miniinvas & Robotisee Audit, Paris, France.; Elsayed, M (corresponding author), GHU Pitie Salpetriere, AP HP, Serv ORL Otol Implants Auditifs & Chirurg Base Cr, Paris, France.; Elsayed, M (corresponding author), Alexandria Univ, Fac Med, ORL Dept, Alexandria, Egypt.	Mohamed.Elsayed@inserm.fr	Torres, Renato/AAU-5149-2020; ELSAYED, MOHAMED/AAG-6106-2020; Nguyen, Yann/AAX-5740-2020	Torres, Renato/0000-0001-6701-6793; ELSAYED, MOHAMED/0000-0001-8753-5152; Nguyen, Yann/0000-0003-4635-0658	Ministry of higher education, Mission sector, Egypt; Ministry of Scientific Research, Egypt	Ministry of higher education, Mission sector, Egypt(Ministry of Higher Education & Scientific Research (MHESR)); Ministry of Scientific Research, Egypt(Science and Technology Development Fund (STDF)Ministry of Higher Education & Scientific Research (MHESR))	This work was supported by the Ministry of higher education, Mission sector, Egypt (http://www.mohe-casm.edu.eg) and the Ministry of Scientific Research, Egypt to ME. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurich LA, 2014, ACTA CIR BRAS, V29, P405, DOI 10.1590/S0102-86502014000600010; Garcia LD, 2014, ACTA CIR BRAS, V29, P77, DOI 10.1590/S0102-86502014001700014; Gurr A, 2010, LARYNGO RHINO OTOL, V89, P17, DOI 10.1055/s-0029-1224158; Gurr A, 2010, EUR ARCH OTO-RHINO-L, V267, P213, DOI 10.1007/s00405-009-1040-6; Hamamcioglu MK, 2008, BRIT J NEUROSURG, V22, P769, DOI 10.1080/02688690802477573; Hicdonmez T, 2006, TURKISH NEUROSURG, V16, P111; Hoffstetter M, 2011, BIOMED TECH, V56, P159, DOI 10.1515/BMT.2011.011; Jarrahy R, 1999, J INVEST SURG, V12, P335; Lind NM, 2007, NEUROSCI BIOBEHAV R, V31, P728, DOI 10.1016/j.neubiorev.2007.02.003; Lovell JM, 2007, J MICROSC-OXFORD, V228, P345, DOI 10.1111/j.1365-2818.2007.01852.x; Oertel J, 2016, NEUROMETHODS, V116, P151, DOI 10.1007/978-1-4939-3730-1_12; Regelsberger J, 2011, CENT EUR NEUROSURG, V72, P192, DOI 10.1055/s-0030-1261906; Regelsberger J, 2015, NEUROSURG REV, V38, P157, DOI 10.1007/s10143-014-0572-4; Sauleau P, 2009, ANIMAL, V3, P1138, DOI 10.1017/S1751731109004649; Singh V, 2017, J ANAT SOC INDIA, V66, P78, DOI 10.1016/j.jasi.2017.05.008; Suslu HT, 2013, BRIT J NEUROSURG, V27, P812, DOI 10.3109/02688697.2013.772095	16	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212855	10.1371/journal.pone.0212855	http://dx.doi.org/10.1371/journal.pone.0212855			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807592	Green Submitted, Green Published, gold			2022-12-26	WOS:000459712100025
J	Dong, ZY				Dong, Zhengyang			Dynamic Advisor-Based Ensemble (dynABE): Case study in stock trend prediction of critical metal companies	PLOS ONE			English	Article							PRICE; RETURNS; MACHINE	Stock trend prediction is a challenging task due to the market's noise, and machine learning techniques have recently been successful in coping with this challenge. In this research, we create a novel framework for stock prediction, Dynamic Advisor-Based Ensemble (dynABE). dynABE explores domain-specific areas based on the companies of interest, diversifies the feature set by creating different "advisors" that each handles a different area, follows an effective model ensemble procedure for each advisor, and combines the advisors together in a second-level ensemble through an online update strategy we developed. dynABE is able to adapt to price pattern changes of the market during the active trading period robustly, without needing to retrain the entire model. We test dynABE on three cobalt-related companies, and it achieves the best-case misclassification error of 31.12% and an annualized absolute return of 359.55% with zero maximum drawdown. dynABE also consistently outperforms the baseline models of support vector machine, neural network, and random forest in all case studies.	[Dong, Zhengyang] Middlesex Sch, Concord, MA 01742 USA		Dong, ZY (corresponding author), Middlesex Sch, Concord, MA 01742 USA.	zdong@mxschool.edu	Chanelian, Serena/ABE-4873-2021	Chanelian, Serena/0000-0001-5727-6137; Dong, Zhengyang/0000-0001-6368-8103				ALLEN H, 1990, ECON J, V100, P49, DOI 10.2307/2234183; [Anonymous], 2018, EL COB SUM MET MIN C; Apodaca LE, 2014, 2014 MINERALS YB; Ballings M, 2015, EXPERT SYST APPL, V42, P7046, DOI 10.1016/j.eswa.2015.05.013; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Berk RA, 2006, SOCIOL METHOD RES, V34, P263, DOI 10.1177/0049124105283119; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chen YM, 2018, CIKM'18: PROCEEDINGS OF THE 27TH ACM INTERNATIONAL CONFERENCE ON INFORMATION AND KNOWLEDGE MANAGEMENT, P1655, DOI 10.1145/3269206.3269269; Das S., 2018, PROCEDIA COMPUTER SC, V132, P956, DOI [10.1016/j.procs.2018.05.111, DOI 10.1016/J.PROCS.2018.05.111]; Ding X, 2015, P 24 INT JOINT C ART, P7; FAMA EF, 1988, J FINANC ECON, V22, P3, DOI 10.1016/0304-405X(88)90020-7; Flannery MJ, 2002, REV FINANC STUD, V15, P751, DOI 10.1093/rfs/15.3.751; Fu XK, 2019, J IND ECOL, V23, P452, DOI 10.1111/jiec.12757; Golzadeh M, 2018, APPL SOFT COMPUT, V64, P109, DOI 10.1016/j.asoc.2017.12.013; Gunn G, 2014, CRITICAL METALS HDB, DOI [10.1016/S0065-3233(08)60135-7, DOI 10.1016/S0065-3233(08)60135-7]; Hagenau M, 2013, DECIS SUPPORT SYST, V55, P685, DOI 10.1016/j.dss.2013.02.006; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; He ZF, 2019, EMERG MARK FINANC TR, V55, P704, DOI 10.1080/1540496X.2018.1460724; Huang Y, 2017, EUR J OPER RES, V258, P692, DOI 10.1016/j.ejor.2016.08.058; Huang Y, 2014, DECIS SUPPORT SYST, V64, P31, DOI 10.1016/j.dss.2014.04.004; Investing News Network, 2018, INVESTING NEWS NETWO; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Lee MC, 2009, EXPERT SYST APPL, V36, P10896, DOI 10.1016/j.eswa.2009.02.038; Levesque M, 2014, J CLEAN PROD, V84, P233, DOI 10.1016/j.jclepro.2013.12.088; Magdon-Ismail M, 2004, J APPL PROBAB, V41, P147, DOI 10.1239/jap/1077134674; Meyer  David, 2015, HIGH CORR CHIL PES C; Nelson DMQ, 2017, IEEE IJCNN, P1419, DOI 10.1109/IJCNN.2017.7966019; Olivetti EA, 2017, JOULE, V1, P229, DOI 10.1016/j.joule.2017.08.019; OU JA, 1989, J ACCOUNT ECON, V11, P295, DOI 10.1016/0165-4101(89)90017-7; Patel J, 2015, EXPERT SYST APPL, V42, P259, DOI 10.1016/j.eswa.2014.07.040; PESARAN MH, 1994, J FORECASTING, V13, P335, DOI 10.1002/for.3980130402; Refinitiv, DAT MACR AN; Rice JA, 2007, NON TRADITIONAL REF; Robnik-Sikonja M., 1997, MACHINE LEARNING P 1, P296, DOI [10.5555/645526.657141, DOI 10.1119/1.880454]; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Saad EW, 1998, IEEE T NEURAL NETWOR, V9, P1456, DOI 10.1109/72.728395; Schumaker RP, 2009, ACM T INFORM SYST, V27, DOI 10.1145/1462198.1462204; Sharpe W, J BUS, V39, P21; SHARPE WF, 1994, J PORTFOLIO MANAGE, V21, P49, DOI 10.3905/jpm.1994.409501; Spencer E, 2016, COB DEV I C MAY 11 S; Sumitomo Metal Mining Co.  Ltd, 2017, NON TRADITIONAL REF, P164; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1007/BF00115009; Tsai CF, 2010, DECIS SUPPORT SYST, V50, P258, DOI 10.1016/j.dss.2010.08.028; Tsang PM, 2007, ENG APPL ARTIF INTEL, V20, P453, DOI 10.1016/j.engappai.2006.10.002; Tufano P, 1998, J FINANC, V53, P1015, DOI 10.1111/0022-1082.00042; Xiao JH, 2018, ENERG ECON, V74, P777, DOI 10.1016/j.eneco.2018.07.026; Zijin Mining Group Co.  Ltd, 2018, COPPER	47	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212487	10.1371/journal.pone.0212487	http://dx.doi.org/10.1371/journal.pone.0212487			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794608	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100077
J	Takasaki, Y; Irisawa, A; Shibukawa, G; Sato, A; Abe, Y; Yamabe, A; Arakawa, N; Maki, T; Yoshida, Y; Igarashi, R; Yamamoto, S; Ikeda, T				Takasaki, Yusuke; Irisawa, Atsushi; Shibukawa, Goro; Sato, Ai; Abe, Yoko; Yamabe, Akane; Arakawa, Noriyuki; Maki, Takumi; Yoshida, Yoshitsugu; Igarashi, Ryo; Yamamoto, Shogo; Ikeda, Tsunehiko			New endoscopic ultrasonography criteria for malignant lymphadenopathy based on inter-rater agreement	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; LYMPH-NODE METASTASIS; ENDOSONOGRAPHIC FEATURES; INTEROBSERVER AGREEMENT; ESOPHAGEAL CANCER; PANCREATIC-CANCER; EUS; ULTRASOUND; BENIGN; DIAGNOSIS	Background and aims Various studies have been previously conducted on the diagnosis of lymphadenopathy as benign or malignant, but the results vary. These studies did not describe the inter-rater agreement on the EUS features of lymphadenopathy. In this study, we evaluate the inter-rater agreement on EUS features and propose EUS diagnostic norms for lymphadenopathy based on inter-rater agreement. Method A total of 68 lymph nodes subjected to EUS-fine needle aspiration (FNA) were reviewed by five endoscopic experts. The EUS features evaluated lymph node size, shape, border, margin, echogenicity, homogeneity, and the hilum of the lymph node. Inter-rater agreement (multi-rater kappa statics) was performed. We established new criteria using results with a high degree of inter-rater agreement from EUS features and compared them with the former criteria. Result There was a moderate agreement on shape, kappa (K) = 0.44 (95% confidence interval [CI]: 0.34-0.54), and fair agreement on echogenicity, homogeneity, border, and hilum of the lymph node, K (95% CI) = 0.33 (0.17-0.38), 0.34 (0.26-0.35), 0.22 (0.21-0.31), and 0.22 (0.11-0.26), respectively. This resulted in the establishment of new EUS diagnostic criteria using shape, long axis > 20 mm and short axis > 10 mm. New criteria were superior to old criteria (area under the curve 0.82 vs 0.52, P < 0.001). Conclusion EUS diagnostic criteria for lymphadenopathy based on inter-rater agreement were more accurate than old criteria. This result will be useful for the diagnosis of lymphadenopathy.	[Takasaki, Yusuke; Irisawa, Atsushi; Shibukawa, Goro; Sato, Ai; Abe, Yoko; Yamabe, Akane; Arakawa, Noriyuki; Maki, Takumi; Yoshida, Yoshitsugu; Igarashi, Ryo; Yamamoto, Shogo; Ikeda, Tsunehiko] Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan; [Takasaki, Yusuke] Juntendo Univ, Dept Gastroenterol, Tokyo, Japan; [Irisawa, Atsushi] Dokkyo Med Univ, Dept Gastroenterol, Mibu, Tochigi, Japan; [Abe, Yoko; Arakawa, Noriyuki] Sendai Kousei Hosp, Dept Gastroenterol, Sendai, Miyagi, Japan	Juntendo University; Dokkyo Medical University; Sendai Kousei Hospital	Irisawa, A (corresponding author), Fukushima Med Univ, Aizu Med Ctr, Dept Gastroenterol, Aizu Wakamatsu, Fukushima, Japan.; Irisawa, A (corresponding author), Dokkyo Med Univ, Dept Gastroenterol, Mibu, Tochigi, Japan.	irisawa@dokkyomed.ac.jp		Takasaki, Yusuke/0000-0002-5036-4545				Bhutani MS, 1997, GASTROINTEST ENDOSC, V45, P474, DOI 10.1016/S0016-5107(97)70176-7; CATALANO MF, 1994, GASTROINTEST ENDOSC, V40, P442, DOI 10.1016/S0016-5107(94)70206-3; Chen VK, 2004, AM J GASTROENTEROL, V99, P628, DOI 10.1111/j.1572-0241.2004.04064.x; Chin YK, 2017, WORLD J GASTROENTERO, V23, P5755, DOI 10.3748/wjg.v23.i31.5755; de Melo SW, 2011, DIGEST DIS SCI, V56, P3204, DOI 10.1007/s10620-011-1725-8; Eloubeidi MA, 2001, GASTROINTEST ENDOSC, V54, P714, DOI 10.1067/mge.2001.119873; Faigel DO, 2001, GASTROINTEST ENDOSC, V53, P593, DOI 10.1067/mge.2001.114060; GIOVANNINI M, 1995, ENDOSCOPY, V27, P171, DOI 10.1055/s-2007-1005657; Hocke M, 2008, J CANCER RES CLIN, V134, P473, DOI 10.1007/s00432-007-0309-7; Irisawa A, 2004, J GASTROEN HEPATOL, V19, P1199, DOI 10.1111/j.1440-1746.2004.03468.x; Kalmin B, 2011, CAN J GASTROENTEROL, V25, P261, DOI 10.1155/2011/302382; Kumon RE, 2012, GASTROINTEST ENDOSC, V75, P1175, DOI 10.1016/j.gie.2012.01.039; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Okasha H, 2017, ARAB J GASTROENTEROL, V18, P74, DOI 10.1016/j.ajg.2017.05.015; Thomas M, 2019, CLIN GASTROENTEROLOG, V17, P148; TOHNOSU N, 1989, J CLIN ULTRASOUND, V17, P101, DOI 10.1002/jcu.1870170206; Topazian M, 2007, GASTROINTEST ENDOSC, V66, P62, DOI 10.1016/j.gie.2006.09.018; Vazquez-Sequeiros E, 2006, GASTROINTEST ENDOSC, V63, P204, DOI 10.1016/j.gie.2005.08.053; Wang L, 2015, ANN THORAC SURG, V100, P1203, DOI 10.1016/j.athoracsur.2015.04.143; Zhang MM, 2010, GASTROINTEST ENDOSC, V72, P978, DOI 10.1016/j.gie.2010.06.042; Zhu ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063820	21	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212427	10.1371/journal.pone.0212427	http://dx.doi.org/10.1371/journal.pone.0212427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794598	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100067
J	Leinonen, T; Solovieva, S; Husgafvel-Pursiainen, K; Laaksonen, M; Viikari-Juntura, E				Leinonen, Taina; Solovieva, Svetlana; Husgafvel-Pursiainen, Kirsti; Laaksonen, Mikko; Viikari-Juntura, Eira			Do individual and work-related factors differentiate work participation trajectories before and after vocational rehabilitation?	PLOS ONE			English	Article							EMPLOYMENT OUTCOMES; SICKNESS ABSENCE; SUPPORTED EMPLOYMENT; GENDER-DIFFERENCES; FOLLOW-UP; RETURN; PEOPLE; DISABILITY; SERVICES; PREDICTORS	Background Understanding diverse labor market trajectories around vocational rehabilitation provides important insight into potential effectiveness of rehabilitation efforts. We examined factors associated with work participation trajectories before and after vocational rehabilitation. Methods Using nationwide Finnish register data of 7180 vocational rehabilitees, we constructed latent trajectory groups of work participation two years before and two years after their rehabilitation episode starting in 2008-2010. We plotted changes in labor market statuses in these groups and examined other associated factors using multinomial logistic regression. Results We identified four trajectories based on work participation levels before and after vocational rehabilitation. The "High-Resumed" group (35.6%) typically returned to full duties. The "High-to-Negligible" group (20.7%) typically transitioned to full disability retirement or unemployment. Among the "Medium-Resumed" (25.5%) and "Longstanding Negligible" (18.3%) groups, work disability and unemployment were common before rehabilitation, but afterwards those assigned to the former group often returned to full or partial duties. Overall, older age, male gender, living in areas with lower employment rates, having lower education, being employed in the private sector, and having mental diagnoses were associated with the other three trajectories than the most favorable "High-Resumed" trajectory. Furthermore, certain industrial sectors, job exposures, and less common diagnoses further separated specific trajectories. Conclusions Work participation trajectories around vocational rehabilitation are diverse, only partly dependent on initial levels of work participation, and determined by various individual and work-related factors. Future nationwide studies should assess the effectiveness of vocational rehabilitation taking into consideration both individual and work-related factors.	[Leinonen, Taina; Solovieva, Svetlana; Husgafvel-Pursiainen, Kirsti; Viikari-Juntura, Eira] Finnish Inst Occupat Hlth, Helsinki, Finland; [Laaksonen, Mikko] Finnish Ctr Pens, Helsinki, Finland	Finnish Institute of Occupational Health	Leinonen, T (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	taina.leinonen@ttl.fi			Academy of Finland [303534]	Academy of Finland(Academy of Finland)	This study was supported by the Academy of Finland (project number 303534 to Viikari-Juntura). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren Asa, 2007, Work, V28, P343; Bekker MHJ, 2009, PSYCHOL HEALTH MED, V14, P405, DOI 10.1080/13548500903012830; Blackwell TL, 2003, REHABIL COUNS BULL, V46, P108, DOI 10.1177/00343552030460020501; Bolton BF, 2000, REHABIL COUNS BULL, V44, P10, DOI 10.1177/003435520004400103; Burke-Miller JK, 2006, COMMUNITY MENT HLT J, V42, P143, DOI 10.1007/s10597-005-9017-4; Burstrom B, 2011, DISABIL REHABIL, V33, P453, DOI 10.3109/09638288.2010.493596; Card D, 2018, J EUR ECON ASSOC, V16, P894, DOI 10.1093/jeea/jvx028; Chan JY, 2014, REHABIL COUNS BULL, V57, P209, DOI 10.1177/0034355213509855; Cook JA, 2006, J VOCAT REHABIL, V25, P71; Corbiere M, 2017, J NERV MENT DIS, V205, P275, DOI 10.1097/NMD.0000000000000612; Dean D, 2017, J HUM RESOUR, V52, P826, DOI 10.3368/jhr.52.3.0114-6111R1; Dutta A, 2008, J OCCUP REHABIL, V18, P326, DOI 10.1007/s10926-008-9154-z; Finnish Centre for Pensions, BACK WORK REH; Friberg IO, 2016, SCAND J PUBLIC HEALT, V44, P264, DOI 10.1177/1403494815618843; Gran JM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2408-8; Jang Y, 2014, J OCCUP REHABIL, V24, P11, DOI 10.1007/s10926-013-9433-1; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Karasek R, 1990, HLTH WORK STRESS PRO; Kausto J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001752; Kuoppala J, 2008, J REHABIL MED, V40, P796, DOI 10.2340/16501977-0270; Laaksonen M, 2015, J OCCUP REHABIL, V25, P471, DOI 10.1007/s10926-014-9554-1; Leinonen T, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019822; Leinonen T, 2018, ANN WORK EXPOS HEAL, V62, P438, DOI 10.1093/annweh/wxx107; Lindholdt L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015661; Mann DR, 2017, J VOCAT REHABIL, V46, P159, DOI 10.3233/JVR-160852; Mastekaasa A, 2014, EUR SOCIOL REV, V30, P582, DOI 10.1093/esr/jcu059; Mastekaasa A, 2014, EUR J PUBLIC HEALTH, V24, P656, DOI 10.1093/eurpub/cku075; Michon H, 2005, SOC PSYCH PSYCH EPID, V40, P408, DOI 10.1007/s00127-005-0910-5; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Organisation for Economic Co-operation and Development, 2008, SICKN DIS WORK BREAK, DOI [10.1787/9789264049826-en, DOI 10.1787/9789264049826-EN]; Oyeflaten I, 2014, J OCCUP REHABIL, V24, P199, DOI 10.1007/s10926-013-9466-5; Pedersen P, 2018, SCAND J PUBLIC HEALT, V46, P383, DOI 10.1177/1403494817722290; Rinaldo U, 2016, WORK, V55, P115, DOI 10.3233/WOR-162387; Saarnio L, 2017, TYOELAKEKUNTOUTUS VU; Solovieva S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108987; Solovieva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048680; Suijkerbuijk YB, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011867.pub2; The Social Insurance Institution of Finland, VOC REH; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; van Vilsteren M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006955.pub3; Viikari-Juntura E, 2017, SCAND J WORK ENV HEA, V43, P447, DOI 10.5271/sjweh.3664; Wang YY, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003320; Wasiak R, 2007, J OCCUP REHABIL, V17, P766, DOI 10.1007/s10926-007-9101-4; Young AE, 2005, J OCCUP REHABIL, V15, P543, DOI 10.1007/s10926-005-8033-0; Young AE, 2016, J OCCUP REHABIL, V26, P434, DOI 10.1007/s10926-016-9675-9	45	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212498	10.1371/journal.pone.0212498	http://dx.doi.org/10.1371/journal.pone.0212498			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2WC	30789938	Green Published, gold, Green Submitted			2022-12-26	WOS:000459330800030
J	Marshall, N; Marshall, P; Curnock, M; Pert, P; Smith, A; Visperas, B				Marshall, Nadine; Marshall, Paul; Curnock, Matt; Pert, Petina; Smith, Adam; Visperas, Bernard			Identifying indicators of aesthetics in the Great Barrier Reef for the purposes of management	PLOS ONE			English	Article							NATURAL-RESOURCE MANAGEMENT; WATER APPEARANCE; HUMAN PERCEPTION; LANDSCAPE; HEALTH; PLACE; COLOR; CONSERVATION; EXPERIENCE; TOURISTS	The aesthetic appreciation of natural places is one of the most fundamental ways in which people relate to their environment. It provides wellbeing, an opportunity for recreation and reflection, a sense of place, and cultural enrichment. It also motivates people to take care of natural places and to conserve them for current and future appreciation. Aesthetically valuable places also support significant economic activity. However, there is little guidance available to assist environmental managers and policy-makers to consider and integrate aesthetic values into decision-making processes. In this study, we present an approach for developing robust and practical indicators of aesthetic value to enable environmental managers to consider, assess and report on aesthetic condition and trend. We demonstrate its utility using the case of the Great Barrier Reef, a region currently undergoing significant social, economic and environmental change and an area formally protected, in part, for its aesthetic values. A qualitative scoping study with 30 key informants identified over 180 potential qualities contributing to reef aesthetics. We tested five for their utility in capturing key aspects of the coral reef aesthetic: (i) coral cover, (ii) coral pattern, (iii) coral topography, (iv) fish abundance, and (v) visibility. We asked 1,417 online Australians to aesthetically rate 50 out of 181 underwater coral reef images that varied in relation to these five attributes. Coral topography, fish abundance, and visibility were significantly correlated with aesthetic ratings, whilst coral cover and coral pattern were not. We also tested for demographic patterns in aesthetic ratings. Our pilot study has demonstrated that readily measurable characteristics of coral reefs can provide useful indicators of aesthetic quality, opening up opportunities for coral reef managers and policymakers to assess and track changes in aesthetics in ways that are relevant to the public. There is considerable scope to further advance capacity for monitoring and managing aesthetic values of coral reefs through additional research that resolves nuances in the meanings associated with aesthetics in coral reef settings.	[Marshall, Nadine; Curnock, Matt; Pert, Petina] CSIRO Land & Water Oceans & Atmosphere, Townsville, Qld, Australia; [Marshall, Paul; Smith, Adam] Ecologic, Townsville, Qld, Australia; [Visperas, Bernard] Pollinate, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Marshall, N (corresponding author), CSIRO Land & Water Oceans & Atmosphere, Townsville, Qld, Australia.	nadine.marshall@csiro.au	Pert, Petina Lesley/F-5211-2010; Curnock, Matthew I/I-2578-2013	Pert, Petina Lesley/0000-0002-7738-7691; Curnock, Matthew I/0000-0002-2365-810X	National Environmental Science Program (Australia)	National Environmental Science Program (Australia)	This research was funded by the National Environmental Science Program (Australia) to NM, PM and AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Please note that one of the authors is employed by a commercial company: Pollinate. Pollinate did not provide any financial support (just collegial).	Arriaza M, 2004, LANDSCAPE URBAN PLAN, V69, P115, DOI 10.1016/j.landurbplan.2003.10.029; Balmford A, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000144; Bauske EM, 2013, ACTA HORTIC, V999, P37, DOI 10.17660/ActaHortic.2013.999.3; Bengston DN, 1999, SOC NATUR RESOUR, V12, P493, DOI 10.1080/089419299279560; Birkoff G, 1933, AESTHETIC MEASURE; Brady E, 2006, ENVIRON VALUE, V15, P277, DOI 10.3197/096327106778226202; Bratman GN, 2015, LANDSCAPE URBAN PLAN, V138, P41, DOI 10.1016/j.landurbplan.2015.02.005; Brown G, 2007, APPL GEOGR, V27, P89, DOI 10.1016/j.apgeog.2006.11.002; Carson Rachel, 1994, SILENT SPRING; Coss RG, 2002, ECOL PSYCHOL, V14, P181, DOI 10.1207/S15326969ECO1404_1; Datta R, 2006, LECT NOTES COMPUT SC, V3953, P288, DOI 10.1007/11744078_23; de Vries S, 2013, SOC SCI MED, V94, P26, DOI 10.1016/j.socscimed.2013.06.030; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Deloitte Access Economics, 2017, WHAT PRIC EC SOC IC; Dinsdale EA, 2006, SOC NATUR RESOUR, V19, P239, DOI 10.1080/08941920500460815; Farr M, 2016, TOURISM ECON, V22, P331, DOI 10.5367/te.2014.0426; FENTON DM, 1989, COAST MANAGE, V17, P295, DOI 10.1080/08920758909362092; Fenton DM, 1998, LEISURE SCI, V20, P177, DOI 10.1080/01490409809512279; Folke C, 2011, AMBIO, V40, P719, DOI 10.1007/s13280-011-0184-y; Fry G, 2009, ECOL INDIC, V9, P933, DOI 10.1016/j.ecolind.2008.11.008; Fuller RA, 2007, BIOLOGY LETT, V3, P390, DOI 10.1098/rsbl.2007.0149; Ghermandi A, 2011, TREATISE ON ESTUARINE AND COASTAL SCIENCE, VOL 12: ECOLOGICAL ECONOMICS OF ESTUARIES AND COASTS, P217; Haas AF, 2015, PEERJ, V3, DOI 10.7717/peerj.1390; HARTIG T, 1991, ENVIRON BEHAV, V23, P3, DOI 10.1177/0013916591231001; Hekkert P, 2003, BRIT J PSYCHOL, V94, P111, DOI 10.1348/000712603762842147; Herzog T. R., 1985, J ENVIRON PSYCHOL, V5, P225, DOI [10.1016/S0272-4944(85)80024-4, DOI 10.1016/S0272-4944(85)80024-4]; Hinds J., 2011, EVOLUTIONARY PSYCHOL, V9, DOI [10.1177/147470491100900314, DOI 10.1177/147470491100900314]; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jarvis D, 2016, TOURISM MANAGE, V52, P1, DOI 10.1016/j.tourman.2015.06.003; Jones PJ, 2016, LAND USE POLICY, V53, P112, DOI 10.1016/j.landusepol.2015.01.038; Kellert SR, 2016, GREEN EXERCISE: LINKING NATURE, HEALTH AND WELL-BEING, P17; Kirillova K, 2014, TOURISM MANAGE, V42, P282, DOI 10.1016/j.tourman.2013.12.006; Larson S, 2015, AMBIO, V44, P166, DOI 10.1007/s13280-014-0554-3; Larson S, 2013, J ENVIRON MANAGE, V117, P226, DOI 10.1016/j.jenvman.2012.11.035; Lee LH, 2017, WETLANDS, V37, P381, DOI 10.1007/s13157-016-0873-1; Lee LeeHsueh, 2016, Journal of Water Resource and Protection, V8, P787; Lee Z, 2016, REMOTE SENS ENVIRON, V177, P101, DOI 10.1016/j.rse.2016.02.033; Lohr VI, 2006, ENVIRON BEHAV, V38, P667, DOI 10.1177/0013916506287355; Ltd CP, 2013, DEF AESTH VAL GREAT; Marselle MR, 2015, INT J ENV RES PUB HE, V12, P106, DOI 10.3390/ijerph120100106; Marshall NA, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/11/114020; Marshall NA, 2018, FRONT ECOL ENV; Maslow AH, 1943, PSYCHOL REV, V50, P370, DOI 10.1037/h0054346; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Nava H, 2011, REV BIOL TROP, V59, P1487; Palmer SE, 2010, P NATL ACAD SCI USA, V107, P8877, DOI 10.1073/pnas.0906172107; Pfluger Y, 2010, LANDSCAPE URBAN PLAN, V95, P68, DOI 10.1016/j.landurbplan.2009.12.004; Richling A, 1995, EKOL BRATISLAVA, V14, P11; Rosley MSF, 2014, PROCD SOC BEHV, V153, P349, DOI 10.1016/j.sbspro.2014.10.068; Rosley MSF, 2013, PROCD SOC BEHV, V85, P318, DOI 10.1016/j.sbspro.2013.08.362; Roughley A, 2005, J RES PRACT, V1; Seppelt R, 2011, J APPL ECOL, V48, P630, DOI 10.1111/j.1365-2664.2010.01952.x; Seresinhe CI, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170170; Seresinhe CI, 2015, SCI REP-UK, V5, DOI 10.1038/srep16899; SMITH DG, 1995, NEW ZEAL J MAR FRESH, V29, P45, DOI 10.1080/00288330.1995.9516638; SMITH DG, 1995, NEW ZEAL J MAR FRESH, V29, P29, DOI 10.1080/00288330.1995.9516637; Sonntag-Ostrom E, 2011, SCAND J FOREST RES, V26, P245, DOI 10.1080/02827581.2011.558521; Spalding M, 2017, MAR POLICY, V82, P104, DOI 10.1016/j.marpol.2017.05.014; Stamps AE, 2004, J ENVIRON PSYCHOL, V24, P1, DOI 10.1016/S0272-4944(03)00023-9; Tribot AS, 2016, SCI REP-UK, V6, DOI 10.1038/srep34229; Tveit M, 2006, LANDSCAPE RES, V31, P229, DOI 10.1080/01426390600783269; ULRICH RS, 1990, PROCEEDINGS OF THE FOURTH URBAN FORESTRY CONFERENCE, P25; UNESCO, UN C SUST DEV RIO DE; van den Berg AE, 1998, J ENVIRON PSYCHOL, V18, P141, DOI 10.1006/jevp.1998.0080; Volker S, 2013, SOC SCI MED, V78, P113, DOI 10.1016/j.socscimed.2012.09.047; White MP, 2013, HEALTH PLACE, V23, P97, DOI 10.1016/j.healthplace.2013.05.006; Wynveen CJ, 2010, LEISURE SCI, V32, P270, DOI 10.1080/01490401003712705; Yamashita S, 2002, LANDSCAPE URBAN PLAN, V62, P3, DOI 10.1016/S0169-2046(02)00093-2; Zhang JW, 2014, J ENVIRON PSYCHOL, V37, P61, DOI 10.1016/j.jenvp.2013.11.008; Zhang MWB, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2827	71	12	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210196	10.1371/journal.pone.0210196	http://dx.doi.org/10.1371/journal.pone.0210196			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785877	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000011
J	Mottaleb, KA; Singh, PK; Sonder, K; Kruseman, G; Erenstein, O				Mottaleb, Khondoker A.; Singh, Pawan K.; Sonder, Kai; Kruseman, Gideon; Erenstein, Olaf			Averting wheat blast by implementing a 'wheat holiday': In search of alternative crops in West Bengal, India	PLOS ONE			English	Article							PUCCINIA-STRIIFORMIS; 1ST REPORT; ADAPTATION; RUST	The emergence of wheat-blast in Bangladesh in the 2015-16 wheat (Triticum aestivum L.) crop threatens the food security of South Asia. A potential spread of the disease from Bangladesh to India could have devastating impacts on India's overall food security as wheat is its second most important staple food crop. West Bengal state in eastern India shares a 2,217 km-long border with Bangladesh and has a similar agro-ecology, enhancing the prospects of the disease entering India via West Bengal. The present study explores the possibility of a 'wheat holiday' policy in the nine border districts of West Bengal. Under the policy, farmers in these districts would stop wheat cultivation for at least two years. The present scoping study assesses the potential economic feasibility of alternative crops to wheat. Of the ten crops considered, maize, gram (chickpea), urad (black gram), rapeseed and mustard, and potatoes are found to be potentially feasible alternative crops. Any crop substitution would need support to ease the transition including addressing the challenges related to the management of alternative crops, ensuring adequate crop combinations and value chain development. Still, as wheat is a major staple, there is some urgency to support further research on disease epidemiology and forecasting, as well as the development and dissemination of blast-resistant wheat varieties across South Asia.	[Mottaleb, Khondoker A.; Kruseman, Gideon; Erenstein, Olaf] CIMMYT Int Maize & Wheat Improvement Ctr, Socioecon Program, Texcoco, Mexico; [Singh, Pawan K.] CIMMYT, Global Wheat Program, Texcoco, Mexico; [Sonder, Kai] CIMMYT, Geog Informat Syst Unit, Socioecon Program, Texcoco, Mexico	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Mottaleb, KA (corresponding author), CIMMYT Int Maize & Wheat Improvement Ctr, Socioecon Program, Texcoco, Mexico.	k.mottaleb@cgiar.org	Kruseman, Gideon/S-6377-2016	Kruseman, Gideon/0000-0002-3392-4176; Singh, Pawan/0000-0003-4610-3120; Sonder, Kai/0000-0001-9672-5361; Erenstein, Olaf/0000-0002-7491-5786	CGIAR research program on WHEAT agro-food systems; Australian Center for International Agriculture Research (ACIAR) [CIM/2016/170]; CGIAR research program on wheat agri-food systems (CRP WHEAT); Australian Center for International Agriculture Research (ACIAR)	CGIAR research program on WHEAT agro-food systems(CGIAR); Australian Center for International Agriculture Research (ACIAR); CGIAR research program on wheat agri-food systems (CRP WHEAT)(CGIAR); Australian Center for International Agriculture Research (ACIAR)	This paper was supported by the CGIAR research program on WHEAT agro-food systems to GK and Australian Center for International Agriculture Research (ACIAR) CIM/2016/170 to PKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Disclaimer: This study was supported by the CGIAR research program on wheat agri-food systems (CRP WHEAT) and the Australian Center for International Agriculture Research (ACIAR). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The views expressed here are those of the authors and do not necessarily reflect the views of the funders or associated institutions. The usual disclaimer applies.	Adhikari B., 2011, STATUS PAPER RICE W; Anjos J R. N. D., 1995, PESQUISA AGROPECUARI, V31, P79; [Anonymous], 2016, BANGL DEM HLTH SURV; Barea G, 1996, CTR INVESTIGACION AG, P76; Bebber DP, 2013, NAT CLIM CHANGE, V3, P985, DOI [10.1038/nclimate1990, 10.1038/NCLIMATE1990]; Bueno-Sancho V, 2017, GENOME BIOL EVOL, V9, P3282, DOI 10.1093/gbe/evx241; Cabrera M.G., 2007, JORNADA ACTUALIZACIO, P60; Callaway E, 2016, NATURE, V532, P421, DOI 10.1038/532421a; Ceresini PC, 2018, ANNU REV PHYTOPATHOL, V56, P427, DOI 10.1146/annurev-phyto-080417-050036; Chowdhury Sachchidananda D., 2005, Journal of Poultry Science, V42, P308, DOI 10.2141/jpsa.42.308; CIMMYT (International Maize and Wheat Improvement Center), 2017, SEM REP 2017; Deaton A., 2009, Economic and Political Weekly, V44, P42; Duveiller E, 2011, PHYTOPATHOLOGY, V101, pS220; Duveiller E., 2016, WORLD WHEAT BOOK, V3, P1107; Erenstein O, 2011, AGR SYST, V104, P42, DOI 10.1016/j.agsy.2010.09.004; Gandhi V. P., 2004, Economic and Political Weekly, V39, P4737; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; GoI, 2018, COST CULT PROD REL D; GoI (Government of India), 2017, PRER 2017 DAC FW ICA; GoI (Government of India), 2016, AGR STAT YB IND 2016; GoI (Government of India), 1996, 401 GOI NAT SAMPL SU; GoI (Government of India), 2017, FARM HARV PRIC PRINC; GoI (Government of India), 2013, PRIC POL RAB CROPS C; GoI (Government of India), 2014, LEV PATT CONS EXP 20; GoI (Government of India), 2017, AGR STAT GLANC 2016; GOULART A C P, 1990, Fitopatologia Brasileira, V15, P112; Goulart Augusto C. P., 2000, Summa Phytopathologica, V26, P279; Gupta DR, 2019, PHYTOPATHOLOGY, V109, P504, DOI 10.1094/PHYTO-06-18-0199-LE; Hellin J, 2015, INT FOOD AGRIBUS MAN, V18, P151; ICAR-CRIDA (Indian Council of Agriculture Research-Central Research Institute for Dryland Agriculture), 2012, AGR CONT PLAN DISTR; Igarashi s, 1990, P INT C FOZ DO IG BR, P480; Igarashi S., 1986, FITOPATOL BRAS, V11, P351; Indian Council of Agricultural Research (ICAR)-National Bureau of Agricultural Insect Resources, 2018, SPOD FRUG JE SMITH I; Islam MT, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0309-7; Loladze A, 2014, PLANT PATHOL, V63, P572, DOI 10.1111/ppa.12132; Malaker PK, 2016, PLANT DIS, V100, P2330, DOI 10.1094/PDIS-05-16-0666-PDN; MoAFW (Ministry of Agriculture and Farmers Welfare) India, 2018, AR PROD STAT; Mottaleb K. A., 2018, BRIT FOOD J, V20, P392; Mottaleb KA, 2018, EUR J DEV RES, V30, P252, DOI 10.1057/s41287-017-0096-1; Nagarajan S, 2005, CURR SCI INDIA, V89, P1467; Goulart Augusto César Pereira, 2007, Summa phytopathol., V33, P358, DOI [10.1590/S0100-54052007000400007, 10.1590/S0100-54052007000300011]; Perello A, 2015, PLANT DIS, V99, P1177, DOI 10.1094/PDIS-11-14-1182-PDN; Piccinini E. C, 1989, FITOPATOL BRAS, V14, P126; Pingali P, 2007, FOOD POLICY, V32, P281, DOI 10.1016/j.foodpol.2006.08.001; Praduman Kumar, 2007, Economic and Political Weekly, V42, P3567; Ranganathan T., 2015, FARMERS INCOME INDIA; Rao CHH, 2000, ECON POLIT WEEKLY, V35, P201; Reis Erlei Melo, 1995, Summa Phytopathologica, V21, P43; Sazzad S. R., 2018, BANGLADESH EXPERIENC; Singh R.P., 2006, CAB REV, V1, P54, DOI [10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, DOI 10.1079/PAVSNNR20061054"10.1079/PAVSNNR20061054, 10.1079/PAVSNNR20061054]; Surabhi Mittal, 2007, Economic and Political Weekly, V42, P444; Theisen K., 2009, INDIA INT POTATO CTR; United Nations, 2019, UN COMTR DAT; Urashima A. S., 2005, Czech Journal of Genetics and Plant Breeding, V41, P238; Urashima AS, 2009, ADVANCES IN GENETICS, GENOMICS AND CONTROL OF RICE BLAST DISEASE, P267, DOI 10.1007/978-1-4020-9500-9_27; USDA (United States Department of Agriculture), 2018, FAS HOM MARK TRAD DA; Viedma LQ, 2005, PHYTOPATHOLOGY, V95, pS152; Wangai AW, 2012, PLANT DIS, V96, P1582, DOI 10.1094/PDIS-06-12-0576-PDN; Wellings CR, 2007, AUST J AGR RES, V58, P567, DOI 10.1071/AR07130; World Hunger Education Service, 2018, AS HUNG FACTS WHAT E	60	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211410	10.1371/journal.pone.0211410	http://dx.doi.org/10.1371/journal.pone.0211410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785905	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000025
J	Wagnew, F; Dejenu, G; Eshetie, S; Alebel, A; Worku, W; Abajobir, AA				Wagnew, Fasil; Dejenu, Getiye; Eshetie, Setegn; Alebel, Animut; Worku, Wubet; Abajobir, Amanuel Alemu			Treatment cure rate and its predictors among children with severe acute malnutrition in northwest Ethiopia: A retrospective record review	PLOS ONE			English	Review							MANAGEMENT	Background More than 29 million that is an estimated 5%, under-five children suffer from severe acute malnutrition (SAM) globally, with a nine times higher risk of mortality than that of well-nourished children. However, little is known regarding outcomes and predictors of SAM in Ethiopia. Therefore, this study aims to determine treatment cure rate and its predictors among children aged 6-59 months with SAM admitted to a stabilization center. Methodology A retrospective record review was employed in SAM children at the University of Gondar Comprehensive Specialized Hospital (UOGCSH) from 2014 to 2016. SAM defined as weight for height below-3 z scores of the median World Health Organization (WHO) growth standards or presence of bilateral edema or mid upper arm circumference < 115mm for a child >= 6months age. All SAM patients with medical complication(s) or failure to pass appetite test are admitted to the malnutrition treatment center for inpatient follow-up. Data were extracted from a randomly selected records after getting ethical clearance. Data were cleaned, coded and entered to Epi-info version-7, and analyzed using STATA/se version-14. Descriptive statistics and analytic analyses schemes including bivariable and multivariable Cox proportional hazards model were conducted. Result Among a total of 416 records recruited for this study, 288 (69.2%) SAM children were cured at the end of the follow up, with a median cure time of 11 days. Kwash-dermatosis (AHR (Adjusted Hazard Ratio): 1.48(95% CI: 1.01, 2.16)), anemia (AHR: 1.36(95% CI: 1.07, 1.74)), tuberculosis (AHR: 1.6(95% CI: 1.04, 2.43)) and altered body temperature at admission (AHR: 1.58(95% CI: 1.04, 2.4) were independent predictors of time to cure. Conclusion The cure rate in SAM children was low relative to sphere standard guideline. Prognosis of SAM largely depends on the presence of other comorbidities at admission. Available intervention modalities need to address coexisting morbidities to achieve better outcomes in SAM children.	[Wagnew, Fasil; Dejenu, Getiye; Alebel, Animut] Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia; [Eshetie, Setegn; Worku, Wubet] Univ Gondar, Coll Hlth Sci, Gondar, Ethiopia; [Abajobir, Amanuel Alemu] Univ Queensland, Fac Med, Brisbane, Qld, Australia	University of Gondar; University of Queensland	Wagnew, F (corresponding author), Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia.	fasilw.n@gmail.com	Alebel, Animut/L-4278-2019; Kibret, Getiye Dejenu/ACX-4494-2022; Ayalew, Animut Alebel/U-6092-2019; Eshetie, Setegn/AAF-5419-2020	Alebel, Animut/0000-0003-2822-2062; Kibret, Getiye Dejenu/0000-0002-1374-5744; Eshetie, Setegn/0000-0001-9130-0882; Wagnew, Fasil/0000-0003-3087-2312				[Anonymous], 2014, FEDERAL MINISTRY HLT; [Anonymous], 2011, SPHERE PROJECT HUMAN; Asres DT, 2018, BMC NUTR, V4, DOI 10.1186/s40795-018-0224-0; Bank UW, 2012, LEV TRENDS CHILD MAL; Chamois S, 2007, ETHIOPIA PROTOCOL MA; Collins S, 2006, LANCET, V368, P1992, DOI 10.1016/S0140-6736(06)69443-9; Collins S, 2006, FOOD NUTR BULL, V27, pS49, DOI 10.1177/15648265060273S304; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Deolalikar A., 2008, MALNUTRITION HUNGER; Desta K, 2015, J NUTR DISORDERS THE, V5, P2161; Desta K., 2015, J NUTR DISORD THER, V5, P160, DOI DOI 10.4172/2161-0509.1000160; Desyibelew HD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171020; Firehiwot M, 2016, SURVIVAL STATUS PRED; Fuchs G, 2004, J PEDIATR GASTR NUTR, V39, pS670, DOI 10.1097/00005176-200406002-00014; Gathara D, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0850-8; Gebremichael DY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2593-5; Girum T, 2017, THER CLIN RISK MANAG, V13, P101, DOI 10.2147/TCRM.S119826; GOLDEN M, 1988, T ROY SOC TROP MED H, V82, P3, DOI 10.1016/0035-9203(88)90245-3; Golden MH GY, 2011, GUIDELINES INTEGRATE; Jarso H, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0398-4; Mekuria Getnet, 2017, BMC Nutr, V3, P42, DOI 10.1186/s40795-017-0161-3; Melaku G, 2014, OPEN ACCESS LIB J, V1, P1, DOI DOI 10.4236/OALIB.1100446; Munthali T, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0072-1; Saaka M, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/641784; Tadele Girum Adal MK, 2016, J BIOL AGR HEALTHCAR, V6; Tadesse E, 2017, SURVIVAL STATUS ITS; Tefera Chane, 2014, Journal of Nutrition and Food Sciences, V4, P329; Teferi E., 2010, ETHIOP J HEALTH DEV, V24, P3; UNICEF, 2017, ESS NUTR TREATM 5 CH; Unicef, 2013, IMPR CHILD NUTR ACH; UNICEF G MOH, 2011, GHAN MULT IND CLUST; UNICEF WaWBG, 2012, LEV TRENDS CHILD MAL; WHO, 2013, GUID UPD MAN SEV AC, P6; WHO, 2013, GUID UPD MAN SEV AC; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2013, POCK BOOK HOSP CAR C; Yebyo HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065840	37	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211628	10.1371/journal.pone.0211628	http://dx.doi.org/10.1371/journal.pone.0211628			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785917	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000032
J	Sun, Y; Ding, YY; Guo, C; Liu, CM; Ma, P; Ma, S; Wang, Z; Liu, J; Qian, T; Ma, LY; Deng, Y; Wu, CY				Sun, Ying; Ding, Yanyan; Guo, Chen; Liu, Chengmin; Ma, Ping; Ma, Shuang; Wang, Zhe; Liu, Jie; Qian, Tao; Ma, Luyao; Deng, Yi; Wu, Chuanyue			alpha-Parvin promotes breast cancer progression and metastasis through interaction with G3BP2 and regulation of TWIST1 signaling	ONCOGENE			English	Article							INTEGRIN-LINKED KINASE; FOCAL ADHESION PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; CH-ILKBP; TUMOR-METASTASIS; CELL-SURVIVAL; MATRIX; PHOSPHORYLATION; ACTOPAXIN; INVASION	Identification of molecular alterations driving breast cancer progression is critical for the development of effective therapy. In this study, we show that the level of alpha-parvin is elevated in triple-negative breast cancer cells. The depletion of alpha-parvin from triple-negative breast cancer cells effectively inhibits breast cancer cell growth, migration, and invasion in vitro, and tumor progression and metastasis in vivo. At the molecular level, we identify Ras-GTPase-activing protein SH3-domain-binding protein 2 (G3BP2) as an alpha-parvin-binding protein. Knockdown of alpha-parvin promotes G3BP2 interaction with TWIST1, increases ubiquitination and proteasome-dependent degradation of TWIST1, and consequently reduces the cellular level of TWIST1 and its downstream signaling. Importantly, the depletion of G3BP2 reverses the reduction in the level and signaling of TWIST1 and the suppression of breast cancer progression induced by the loss of alpha-parvin. Furthermore, the reexpression of an alpha-parvin mutant in which the G3BP2-binding site is ablated, unlike that of wild-type alpha-parvin, in alpha-parvin-deficient breast cancer cells, is unable to restore the level and signaling of TWIST1 and promote breast cancer progression. Finally, we show that protein level of alpha-parvin is highly positively correlated with that of TWIST1 in human triple-negative breast cancer patients. Our studies reveal a novel signaling pathway consisting of alpha-parvin, G3BP2, and TWIST1 that regulates breast cancer progression and metastasis, and suggest that the activation of this signaling pathway is a key factor for driving the progression and poor clinical outcome of human ER-negative breast cancer.	[Sun, Ying; Ding, Yanyan; Guo, Chen; Liu, Chengmin; Ma, Ping; Ma, Shuang; Wang, Zhe; Liu, Jie; Qian, Tao; Ma, Luyao; Deng, Yi] Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China; [Sun, Ying; Ding, Yanyan; Guo, Chen; Liu, Chengmin; Ma, Ping; Ma, Shuang; Wang, Zhe; Liu, Jie; Qian, Tao; Ma, Luyao; Deng, Yi] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China; [Wu, Chuanyue] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Wu, Chuanyue] Univ Pittsburgh, Canc Inst, Pittsburgh, PA 15260 USA	Southern University of Science & Technology; Southern University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sun, Y (corresponding author), Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen 518055, Peoples R China.; Sun, Y (corresponding author), Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen 518055, Peoples R China.; Wu, CY (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.; Wu, CY (corresponding author), Univ Pittsburgh, Canc Inst, Pittsburgh, PA 15260 USA.	suny@sustc.edu.cn; carywu@pitt.edu	ding, yy/HHS-9589-2022; Sun, Ying/F-9124-2019; Liu, Chengmin/GRO-0365-2022; MA, ShuangYue/GWV-0339-2022	Deng, Yi/0000-0003-1378-015X; Liu, Chengmin/0000-0002-0882-582X	Chinese Ministry of Science and Technology [2016YFC1302100]; National Natural Science Foundation of China [81772983, 81430068, 31471311]; Natural Science Foundation of Guangdong Province [2017B030301018]; Shenzhen Innovation Committee of Science and Technology, China [JCYJ20170817104854302, ZDSYS20140509142721429, JCYJ20150831142427959]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen Innovation Committee of Science and Technology, China	We thank Dr. Ruijun Tian of the Department of Chemistry, Southern University of Science and Technology, for help with nano LC-MS/MS analyses, Dr. Z-M Yuan (Harvard School of Public Health) for the Flag-G3BP2a construct, and Drs. Jason D. Weber (Washington University) and Yandong Zhang (Southern University of Science and Technology) for pLVX-AcGFP1-N1 and pLVX-IRES-Hyg vectors. This work was supported by the Chinese Ministry of Science and Technology (2016YFC1302100), the National Natural Science Foundation of China (81772983, 81430068, and 31471311), the Natural Science Foundation of Guangdong Province (2017B030301018), and the Shenzhen Innovation Committee of Science and Technology, China (JCYJ20170817104854302, ZDSYS20140509142721429, and JCYJ20150831142427959).	Ashikari D, 2017, ONCOGENE, V36, P6272, DOI 10.1038/onc.2017.225; Attwell S, 2003, MOL BIOL CELL, V14, P4813, DOI 10.1091/mbc.E03-05-0308; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Chen WD, 2016, ANAL CHEM, V88, P4864, DOI 10.1021/acs.analchem.6b00631; Cheng GZ, 2008, J BIOL CHEM, V283, P14665, DOI 10.1074/jbc.M707429200; Cheng GZ, 2008, CANCER RES, V68, P957, DOI 10.1158/0008-5472.CAN-07-5067; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Clarke DM, 2004, J CELL BIOL, V166, P901, DOI 10.1083/jcb.200404024; Ellsworth RE, 2017, SEMIN CELL DEV BIOL, V64, P65, DOI 10.1016/j.semcdb.2016.08.025; Fu JJ, 2011, CELL RES, V21, P275, DOI 10.1038/cr.2010.118; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Fukuda T, 2003, J CELL BIOL, V160, P1001, DOI 10.1083/jcb.200212113; Guo L, 2002, FASEB J, V16, P1298, DOI 10.1096/fj.02-0089fje; Gupta N, 2017, P NATL ACAD SCI USA, V114, P1033, DOI 10.1073/pnas.1525387114; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hu W, 2017, ELIFE, V6, DOI 10.7554/eLife.26057; Huang AH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118530; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Ito M, 2014, BREAST CANCER RES TR, V144, P59, DOI 10.1007/s10549-014-2859-0; Jin X, 2015, BREAST CANCER-BASIC, V9, P23, DOI 10.4137/BCBCR.S25460; Kim MM, 2007, ONCOGENE, V26, P4209, DOI 10.1038/sj.onc.1210212; Koren S, 2015, MOL CELL, V60, P537, DOI 10.1016/j.molcel.2015.10.031; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; LaLonde DP, 2005, J BIOL CHEM, V280, P21680, DOI 10.1074/jbc.m500752200; Lambert AW, 2017, CELL, V168, P670, DOI 10.1016/j.cell.2016.11.037; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li CW, 2016, CANCER RES, V76, P1451, DOI 10.1158/0008-5472.CAN-15-1941; Li QQ, 2009, CLIN CANCER RES, V15, P2657, DOI 10.1158/1078-0432.CCR-08-2372; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martin TA, 2005, ANN SURG ONCOL, V12, P488, DOI 10.1245/ASO.2005.04.010; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Moon S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04376; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nikolopoulos SN, 2000, J CELL BIOL, V151, P1435, DOI 10.1083/jcb.151.7.1435; Olski TM, 2001, J CELL SCI, V114, P525; Pignatelli J, 2012, J BIOL CHEM, V287, P37309, DOI 10.1074/jbc.M112.385229; Prigent M, 2000, J BIOL CHEM, V275, P36441, DOI 10.1074/jbc.M004751200; Qin L, 2009, CANCER RES, V69, P3819, DOI 10.1158/0008-5472.CAN-08-4389; Qin Q, 2012, CELL RES, V22, P90, DOI 10.1038/cr.2011.144; Rivenbark AG, 2013, AM J PATHOL, V183, P1113, DOI 10.1016/j.ajpath.2013.08.002; Sepulveda JL, 2006, CELL MOL LIFE SCI, V63, P25, DOI 10.1007/s00018-005-5355-1; STETLERSTEVENSON WG, 1993, ANNU REV CELL BIOL, V9, P541, DOI 10.1146/annurev.cb.09.110193.002545; Sun Y, 2017, J AM SOC NEPHROL, V28, P3545, DOI 10.1681/ASN.2016091021; Sun Y, 2012, J CELL SCI, V125, P4507, DOI 10.1242/jcs.105023; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Turashvili G, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00227; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Watson MA, 2007, CLIN CANCER RES, V13, P5001, DOI 10.1158/1078-0432.CCR-07-0024; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006; Xu Y, 2013, AM J PATHOL, V183, P1281, DOI 10.1016/j.ajpath.2013.06.021; Xu YX, 2017, P NATL ACAD SCI USA, V114, P11494, DOI 10.1073/pnas.1618091114; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	57	7	7	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4856	4874		10.1038/s41388-019-0762-1	http://dx.doi.org/10.1038/s41388-019-0762-1			19	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30804457				2022-12-26	WOS:000471160500014
J	Xiang, YX; Wei, XB; Du, PC; Zhao, H; Liu, AC; Chen, YG				Xiang, Yanxiao; Wei, Xinbing; Du, Pengchao; Zhao, Hua; Liu, Anchang; Chen, Yuguo			beta-Arrestin-2-ERK1/2 cPLA(2) axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain	FASEB JOURNAL			English	Article						stroke; ischemic injury; neuroinflammation; -arrestin-2; PGE(2)	INFLAMMATORY RESPONSE; PHOSPHOLIPASE A(2); BETA-ARRESTINS; NADPH OXIDASE; ACTIVATION; EXPRESSION; STROKE; GENERATION; RECEPTORS; RELEASE	LPS has been shown to elicit neuroinflammation associated with the up-regulation of the eicosanoid pathway in animal models; however, the regulatory mechanisms of TLR4 in brain neuroinflammatory conditions remain elusive. -Arrestins are key regulators of the GPCR signaling pathway and are involved in the leukotriene B4-induced leukocyte migration to initiate inflammatory response. However, the roles of -arrestins in eicosanoid regulation and related diseases are not clear. To address this issue, we conducted a study to investigate the effect of TLR4 on the eicosanoid pathway in ischemic stroke brain and to explore the underlying molecular regulation mechanism. Cerebral ischemia was produced by occlusion of the middle cerebral artery, followed by reperfusion for 24 h. We demonstrated that knockout of TLR4 improves ischemic stroke brain associated with eicosanoid down-regulation. Interestingly, genetic disruption of -arrestin-2 failed to decrease neuroinflammation in the damaged brain of TLR4(-/-) mice, which indicates the requirement of -arrestin-2 for TLR4 knockdown protection. Further study showed that the negative regulation of phosphorylated (phospho-)ERK1/2 and phospho-cytosolic phospholipase A(2) (cPLA(2)) by TLR4 deficiency was eliminated by genetic disruption of -arrestin-2. In addition, -arrestin-2 deficiency reversed the reduction of colocalization of phospho-ERK1/2 with phospho-cPLA(2) in TLR4(-/-) mice following ischemic stroke. Mechanistic studies indicated that -arrestin-2 specifically colocalized and associated with ERK1/2 to prevent ERK1/2-dependent cPLA(2) activation following ischemic injury, and -arrestin-2 deficiency blocked the negative regulation of phospho-ERK1/2, revived the association of phospho-ERK1/2 with phospho-cPLA(2), and subsequently increased the prostaglandin E2 and thromboxane A2 production remarkably. Our findings may provide novel insights that -arrestin-2 is responsible for ischemic brain improvement in TLR4(-/-) mice via negative regulation of eicosanoid production.Xiang, Y., Wei, X., Du, P., Zhao, H., Liu, A., Chen, Y. -Arrestin-2-ERK1/2 cPLA(2) axis mediates TLR4 signaling to influence eicosanoid induction in ischemic brain.	[Xiang, Yanxiao; Liu, Anchang] Shandong Univ, Inst Emergency & Crit Care Med, Dept Pharm, Jinan, Shandong, Peoples R China; [Xiang, Yanxiao; Chen, Yuguo] Shandong Univ, Inst Emergency & Crit Care Med, Dept Emergency Med, Jinan, Shandong, Peoples R China; [Zhao, Hua] Shandong Univ, Inst Emergency & Crit Care Med, Dept Orthoped, Jinan, Shandong, Peoples R China; [Chen, Yuguo] Shandong Univ, Inst Emergency & Crit Care Med, Clin Res Ctr Emergency & Crit Care Med Shandng Pr, Jinan, Shandong, Peoples R China; [Chen, Yuguo] Shandong Univ, Qilu Hosp, Key Lab Emergency & Crit Care Med Shandong Prov, Key Lab Cardiopulm Cerebral Resuscitat Shandong P, Jinan, Shandong, Peoples R China; [Chen, Yuguo] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res,State &, Chinese Minist Educ,Chinese Minist Hlth,Chinese A, Jinan, Shandong, Peoples R China; [Wei, Xinbing] Shandong Univ, Dept Pharmacol, Sch Med, Jinan, Shandong, Peoples R China; [Du, Pengchao] Binzhou Med Univ, Coll Basic Med, Yantai, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Shandong University; Binzhou Medical University	Xiang, YX; Liu, AC (corresponding author), Shandong Univ, Qilu Hosp, Dept Pharm, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.; Xiang, YX; Chen, YG (corresponding author), Shandong Univ, Qilu Hosp, Dept Emergency Med, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.; Xiang, YX; Chen, YG (corresponding author), Shandong Univ, Qilu Hosp, Chest Pain Ctr, 107 Wenhua West Rd, Jinan 250012, Shandong, Peoples R China.	11xiaoxiao23@163.com; anchang.liu@gmail.com; chen919085@sdu.edu.cn			National Science Foundation of China [81503061, 81601067, 81500557, 81570401, 81772036, 81571934, 81671952]; China Postdoctoral Science Foundation [2018M630784]; Taishan Young Scholar Program of Shandong Province [tsqn20161065]; Key Research and Development Program of Shandong Province [2016GSF201235, 2016ZDJS07A14, 2018GSF118003]; Fundamental Research Funds of Shandong University [2014QLKY04]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Taishan Young Scholar Program of Shandong Province; Key Research and Development Program of Shandong Province; Fundamental Research Funds of Shandong University	This study was supported by the National Science Foundation of China (81503061, 81601067, 81500557, 81570401, 81772036, 81571934, and 81671952), the China Postdoctoral Science Foundation(2018M630784), the Taishan Young Scholar Program of Shandong Province (tsqn20161065), the Key Research and Development Program of Shandong Province (2016GSF201235, 2016ZDJS07A14, and 2018GSF118003), and the Fundamental Research Funds of Shandong University (2014QLKY04). The authors declare no conflicts of interest.	Breckwoldt MO, 2008, P NATL ACAD SCI USA, V105, P18584, DOI 10.1073/pnas.0803945105; Capra V, 2013, MED RES REV, V33, P364, DOI 10.1002/med.21251; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Diegelmann J, 2012, J BIOL CHEM, V287, P286, DOI 10.1074/jbc.M111.294355; FAGAN SC, 1986, CLIN EXP PHARMACOL P, V13, P629, DOI 10.1111/j.1440-1681.1986.tb00948.x; Fan HK, 2007, MOL IMMUNOL, V44, P3092, DOI 10.1016/j.molimm.2007.02.009; Jacobs AH, 2012, J CEREBR BLOOD F MET, V32, P1393, DOI 10.1038/jcbfm.2012.53; Jala V. R., 2010, JOVE-J VIS EXP, P2315; Kawano T, 2006, NAT MED, V12, P225, DOI 10.1038/nm1362; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Li XQ, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0246-3; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Liu HQ, 2015, INT J BIOL SCI, V11, P525, DOI 10.7150/ijbs.10927; Loniewski K, 2008, MOL IMMUNOL, V45, P2312, DOI 10.1016/j.molimm.2007.11.012; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luttrell LM, 2002, J CELL SCI, V115, P455; Lyden P, 2008, NEW ENGL J MED, V359, P1393, DOI 10.1056/NEJMe0806335; Macrez R, 2011, LANCET NEUROL, V10, P471, DOI 10.1016/S1474-4422(11)70066-7; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Mocco J, 2006, CIRC RES, V99, P209, DOI 10.1161/01.RES.0000232544.90675.42; Naini SM, 2016, FASEB J, V30, P1155, DOI 10.1096/fj.15-278416; Nogawa S, 1997, J NEUROSCI, V17, P2746; Parameswaran N, 2006, J BIOL CHEM, V281, P34159, DOI 10.1074/jbc.M605376200; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Rost NS, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002433; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shichita T, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00132; Sugimoto K, 2003, BRAIN RES, V960, P273, DOI 10.1016/S0006-8993(02)03805-2; Thathiah A, 2013, NAT MED, V19, P43, DOI 10.1038/nm.3023; Wang ZY, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/7191856; Xiang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077909; Yagami T, 2004, NEUROBIOL DIS, V16, P481, DOI 10.1016/j.nbd.2004.04.013; Yagami T, 2014, MOL NEUROBIOL, V49, P863, DOI 10.1007/s12035-013-8565-9; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yokota C, 2004, NEUROSCI LETT, V357, P219, DOI 10.1016/j.neulet.2003.12.109; Zaro-Weber O, 2010, STROKE, V41, P1939, DOI 10.1161/STROKEAHA.110.584029; Zheng H, 2008, MOL PHARMACOL, V73, P178, DOI 10.1124/mol.107.039842	39	2	2	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6584	6595		10.1096/fj.201802020R	http://dx.doi.org/10.1096/fj.201802020R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794438				2022-12-26	WOS:000466932600061
J	Wang, JC; Kinch, LN; Denard, B; Lee, CE; Gharehdaghi, EE; Grishin, N; Ye, J				Wang, Jingcheng; Kinch, Lisa N.; Denard, Bray; Lee, Ching-En; Gharehdaghi, Elina Esmaeilzadeh; Grishin, Nick; Ye, Jin			Identification of residues critical for topology inversion of the transmembrane protein TM4SF20 through regulated alternative translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						membrane protein; protein translocation; protein chimera; transmembrane domain; ceramide; TM4SF20; Topology	MEMBRANE-PROTEIN; ORGANIZATION; TRAM	Adopting a proper topology is crucial for transmembrane proteins to perform their functions. We previously reported that ceramide regulates a transmembrane protein called TM4SF20 (transmembrane 4 L six family member 20) through topological inversion by altering the direction through which the protein is translocated across membranes during translation. This regulatory mechanism, denoted regulated alternative translocation (RAT), depends on a GXXXN motif present in the first transmembrane helix of TM4SF20. Here, using site-directed mutagenesis, we show that Asn-26 in the motif is crucial for RAT of TM4SF20, as it cannot be replaced even by Gln. In contrast, Gly-22 in the motif could be substituted by other small residues such as Ala and Ser without affecting RAT of TM4SF20. We further demonstrate that the GXXXN motif alone is insufficient to induce RAT of a transmembrane protein because TM4SF4, a relative of TM4SF20 that also contains the motif in the first transmembrane helix, did not undergo RAT. Using TM4SF40-TM4SF20 chimeras, we identified Pro-29 of TM4SF20 as another important element required for RAT of the protein. Substituting Pro-29 alone did not affect RAT of TM4SF20, whereas replacing Pro-29 together with either Leu-25 or Val-17 of TM4SF20 with the corresponding residues of TM4SF4 abolished RAT of TM4SF20. Because Val-17, Gly-22, Leu-25, Asn-26, and Pro-29 are predicted to reside along the same surface of the transmembrane helix, our results suggest that interactions with other proteins mediated by this surface during translocation may be critical for RAT of TM4SF20.	[Wang, Jingcheng; Denard, Bray; Lee, Ching-En; Gharehdaghi, Elina Esmaeilzadeh; Ye, Jin] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys & Biochem, Dallas, TX 75390 USA; [Kinch, Lisa N.; Grishin, Nick] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ye, J (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Jin.Ye@UTSouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615; Wang, Jingcheng/0000-0001-7109-3222	National Institutes of Health [GM-116106, HL-20948]; Welch Foundation [I-1832]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM116106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM-116106 and HL-20948 and Welch Foundation Grant I-1832 (to J. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altenhoff AM, 2018, NUCLEIC ACIDS RES, V46, pD477, DOI 10.1093/nar/gkx1019; Bogdanov M, 2014, BBA-MOL CELL RES, V1843, P1475, DOI 10.1016/j.bbamcr.2013.12.007; Bogdanov M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.404103; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chen QY, 2016, MOL CELL, V63, P567, DOI 10.1016/j.molcel.2016.06.032; Chen QY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108528; DeCaprio J., 2017, COLD SPRING HARB PRO, V2017; Denard B, 2012, ELIFE, V1, DOI 10.7554/eLife.00090; Denard B, 2011, CELL HOST MICROBE, V10, P65, DOI 10.1016/j.chom.2011.06.006; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; Huang YH, 2012, J COMPUT AID MOL DES, V26, P1171, DOI 10.1007/s10822-012-9607-5; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kearse MG, 2017, GENE DEV, V31, P1717, DOI 10.1101/gad.305250.117; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Langelaan DN, 2010, J CHEM INF MODEL, V50, P2213, DOI 10.1021/ci100324n; Lear JD, 2003, BIOCHEMISTRY-US, V42, P6400, DOI 10.1021/bi020573j; Mol A. R., 2018, 416347 BIORXIV; Rapoport TA, 2017, ANNU REV CELL DEV BI, V33, P369, DOI 10.1146/annurev-cellbio-100616-060439; Van Rhee A M, 1995, Drug Des Discov, V13, P133; Vitrac H, 2017, J BIOL CHEM, V292, P1613, DOI 10.1074/jbc.M116.765719; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Zhang J, 2014, NATURE, V509, P119, DOI 10.1038/nature13288; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	29	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6054	6061		10.1074/jbc.RA119.007681	http://dx.doi.org/10.1074/jbc.RA119.007681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30808712	hybrid, Green Published			2022-12-26	WOS:000465077500035
J	Asseffa, NA; Demissie, BW				Asseffa, Netsanet Abera; Demissie, Birhanu Wondimeneh			Perinatal outcomes of hypertensive disorders in pregnancy at a referral hospital, Southern Ethiopia	PLOS ONE			English	Article							PREECLAMPSIA; DEATHS	Introduction Hypertensive Disorders in Pregnancy (HDP) complicate about 10% of pregnancies. It accounts to 50% of maternal death in sub-Saharan Africa and precedes 15% of perinatal deaths worldwide. In this study, we looked at the perinatal outcomes and factors associated with unfavorable perinatal outcomes among women with hypertensive disorders in pregnancy at Wolaita Sodo teaching and referral hospital, southern Ethiopia. Methods A hospital based retrospective cross-sectional study design was employed among women hospitalized for hypertensive disorders in pregnancy. Socio-demographic, obstetrics, clinical laboratory, pregnancy complications and outcome were checked from patient records. Descriptive statistics were used to describe parameters collected from patient records. Bivariate and multiple logistic regressions were done to determine factors associated with unfavorable perinatal outcome. A P-value of less than 0.05 and 95% confidence interval not including 1 were considered statically significant. Results There were 168 (2.3%) cases of HDP of the total 7, 347 deliveries during the period of the study from January 2014-December 2016. 72.5% of mothers (72.5%) had vaginal delivery and 26.1% had Caesarean Section. This study revealed a perinatal mortality rate of 111.1 per 1000 live births. On bivariate logistic regression variables such as referral status, diastolic blood pressure, ANC use, types of HDP, fetal weight at birth, maternal complication and maternal outcome were found to be associated with unfavorable perinatal outcomes. On multiple logistic regression fetal weight at birth and maternal outcome were found to be an independent predictors of unfavorable perinatal outcome. Conclusion Our study shows higher perinatal mortality in a tertiary hospital where emergency obstetric and newborn care is set and quality obstetric care is expected. However, tertiary facilities manage difficult cases which can explain the high PMR. But it is high which means there is enough room for improvement. Hence, the referral hospital and neighboring health facilities should give due emphasis for early detection and management of women with HDP.	[Asseffa, Netsanet Abera; Demissie, Birhanu Wondimeneh] Wolaita Sodo Univ, Coll Hlth Sci & Med, Sodo, Ethiopia		Asseffa, NA (corresponding author), Wolaita Sodo Univ, Coll Hlth Sci & Med, Sodo, Ethiopia.	aberanet@gmail.com	Asseffa, Netsanet Abera/AFM-7982-2022	Asseffa, Netsanet Abera/0000-0001-8848-2822				Adu-Bonsaffoh K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1575-2; [Anonymous], 2005, NEW ENGL J MED, V352, P2047, DOI [10.1056/NEJMp058032, DOI 10.1056/NEJMP058032]; Anthony J, 2016, CARDIOVASC J AFR, V27, P104, DOI 10.5830/CVJA-2016-051; Asseffa NA, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1151-1; Bellizzi S, 2017, BJOG-INT J OBSTET GY, V124, P1558, DOI 10.1111/1471-0528.14422; Berhan Y., 2016, ETHIOP J HLTH SCI, V26; Berhan Y, 2004, ETHIOP J HLTH DEV, V18, P96, DOI DOI 10.4314/EJHD.V18I2.9944; Berhan Yifru, 2008, Ethiop Med J, V46 Suppl 1, P1; Berhe AK, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1667-7; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Canavan ME, 2017, B WORLD HEALTH ORGAN, V95, P473, DOI [10.2471/BLT.16.178806, 10.2471/blt.16.178806]; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20, P1; CHSM management, 2015, CHSM STRAT MAN; Endeshaw G, 2015, INT SCHOLARLY RES NO; Gebregzabiherher Y, 2017, OBSTET GYNECOL INT, V2017, DOI 10.1155/2017/2149156; Hodgins S, 2015, GLOB HEALTH-SCI PRAC, V3, P525, DOI 10.9745/GHSP-D-15-00350; Hopkins Leisher S, 2016, STILLBIRTHS INVESTME; Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Livingston JC, 2003, OBSTET GYNECOL, V101, P217, DOI 10.1016/S0029-7844(02)03053-3; Lotufo FA, 2012, CLINICS, V67, P225, DOI 10.6061/clinics/2012(03)04; Mooij R, 2015, BMC PREGNANCY CHILDB, P1; Moyer CA, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-40; Naderi Tayebeh, 2015, Int J Reprod Med, V2015, P914713, DOI 10.1155/2015/914713; NAEYE RL, 1977, BRIT J OBSTET GYNAEC, V84, P747, DOI 10.1111/j.1471-0528.1977.tb12485.x; Ogbonna Ajah Leonard, 2016, J CLIN DIAGNOSTIC RE, V10; Saxena N, 2016, INT J REPROD CONTRAC, V5, P2171; Science S, 1994, SOC SCI MED, V38, P1091; Seyom E, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0135-5; Souza JP, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-286; Vata PK, 2015, BMC RES NOTES, P4; von Dadelszen P, 2016, BEST PRACT RES CL OB, V36, P83, DOI 10.1016/j.bpobgyn.2016.05.005; Wagnew M, 2016, ETHIOPIA RETROSPE S2, V363, P1; Yirgu R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159390	34	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0213240	10.1371/journal.pone.0213240	http://dx.doi.org/10.1371/journal.pone.0213240			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817780	Green Submitted, Green Published, gold			2022-12-26	WOS:000460371500092
J	Nguyen, DT; Agarwal, S; Graviss, EA				Nguyen, Duc T.; Agarwal, Saroochi; Graviss, Edward A.			Trends of tuberculosis meningitis and associated mortality in Texas, 2010-2017, a large population-based analysis	PLOS ONE			English	Article							ADULTS	Background As the most severe form of tuberculosis (TB), TB meningitis (TBM) is still associated with high mortality even in developed countries. In certain areas of the United States (U.S.), more than 50% of the TBM patients die with TB or have neurological sequelae and complications despite the availability of advanced health care. This population-based analysis aimed to determine the risk factors and trends associated with TBM morbidity and mortality using state-wide surveillance data. Methods De-identified surveillance data of all confirmed TB patients from the state of Texas between 01/2010 and 12/2017 reported to the National TB Surveillance System was analyzed. Spatial distribution of TBM cases was presented by Stata's Geographic Information Systems mapping. Univariate and multiple generalized linear modeling were used to identify risk factors associated with meningitis morbidity and mortality. Non-parametric testing was used to analyze morbidity and mortality trends. Results Among 10,103 TB patients reported in Texas between 2010 and 2017, 192 (1.9%) had TBM. During this 8-year period, the TBM proportion fluctuated between 1.5% and 2.7% with peaks in 2011 (2.7%) and 2016 (2.1%) and an overall non-significant trend (z=-1.32, p= 0.19). TBM had a higher mortality at diagnosis (8.9%), during treatment (14.1%) and overall (22.9%) compared to non-TBM (1.9%, 5.3%, and 7.2%, respectively, p<0.001). While mortality during treatment was unchanged over time in non-TBM patients (z=0.5, p=0.62), it consistently increased in TBM patients after 2013 (z=3.09, p=0.002). TBM patients had nearly five times the risk for overall death in multivariate analysis [aRR 4.91 (95% CI 3.71, 6.51), p<0.001]. TBM patients were younger, and more likely to present with miliary TB or HIV (+). Age. 45 years, resident of a long-term care facility, IDU, diabetes, chronic kidney disease, abnormal chest radiography, positive AFB smear or culture and HIV (+) were independently associated with higher mortality. Conclusion TBM remains challenging in Texas with significantly high mortality. Risk factors determined by multivariate modeling will inform health professionals and lay a foundation for the development of more effective strategies for TBM prevention and management.	[Nguyen, Duc T.; Agarwal, Saroochi; Graviss, Edward A.] Houston Methodist Res Inst, Houston, TX 77030 USA	The Methodist Hospital System; The Methodist Hospital - Houston	Graviss, EA (corresponding author), Houston Methodist Res Inst, Houston, TX 77030 USA.	eagraviss@houstonmethodist.org	Nguyen, Duc T/ABH-7913-2020; Nguyen, Duc/AAX-1819-2021	Nguyen, Duc T/0000-0002-5059-4404; Nguyen, Duc/0000-0002-5059-4404				Bourgi K, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0595-4; Centers for Disease Control and Prevention, 2017, REP TUB US; Centers for Disease Control and Prevention (CDC), 2009, REP VER CAS TUB RVCT; Centers for Disease Control and Prevention. Department of Health and Human Services, 2015, NAT TUB SURV SYST NT; Chiang SS, 2014, LANCET INFECT DIS, V14, P947, DOI 10.1016/S1473-3099(14)70852-7; El Sahly HM, 2007, J INFECTION, V55, P502, DOI 10.1016/j.jinf.2007.08.008; Thao LTP, 2018, CLIN INFECT DIS, V66, P523, DOI 10.1093/cid/cix849; Marais S, 2013, CLIN INFECT DIS, V56, P450, DOI 10.1093/cid/cis899; Marx Grace E, 2011, Tuberc Res Treat, V2011, P798764, DOI 10.1155/2011/798764; Merlder AE, 2017, J NEUROL SCI, V375, P460, DOI 10.1016/j.jns.2017.02.051; Nguyen DT, 2018, J INFECT; Nguyen DT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196022; Oursler KK, 2002, CLIN INFECT DIS, V34, P752, DOI 10.1086/338784; Qian X, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0106-1; Reed GW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058044; Reis-Santos B, 2013, J BRAS PNEUMOL, V39, P585, DOI 10.1590/S1806-37132013000500009; Restrepo BI, 2007, EPIDEMIOL INFECT, V135, P483, DOI 10.1017/S0950268806006935; Restrepo BI, 2011, B WORLD HEALTH ORGAN, V89, P352, DOI 10.2471/BLT.10.085738; Seipone ID, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192060; Texas Department of State Health Services, TB CONTR STAND TEXT; Texas Department of State Health Services. Epidemiology and Supplemental Projects Group, 2017, TEX TB SURV ANN REP; Thwaites GE, 2005, J INFECT DIS, V192, P2134, DOI 10.1086/498220; Torok ME, 2011, CLIN INFECT DIS, V52, P1374, DOI 10.1093/cid/cir230; Underwood J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2397-6; Vidhate MR, 2011, J INFECTION, V62, P400, DOI 10.1016/j.jinf.2011.03.009; WHO, GLOB TUB REP 2018; Wilkinson RJ, 2017, NAT REV NEUROL, V13, P581, DOI 10.1038/nrneurol.2017.120; Woldeamanuel YW, 2014, J NEUROL, V261, P851, DOI 10.1007/s00415-013-7060-6	28	4	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212729	10.1371/journal.pone.0212729	http://dx.doi.org/10.1371/journal.pone.0212729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817805	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500032
J	de Necker, M; de Beer, JC; Stander, MP; Connell, CD; Mwai, D				de Necker, M.; de Beer, J. C.; Stander, M. P.; Connell, C. D.; Mwai, D.			Economic and public health impact of decentralized HIV viral load testing: A modelling study in Kenya	PLOS ONE			English	Article							FOLLOW-UP; CARE	Kenya has the world's 4th largest HIV burden. Various strategies to control the epidemic have been implemented, including the implementation of viral load (VL) testing to monitor HIV patients on ARVs. Like many resource limited settings, Kenya's healthcare system faces serious challenges in effectively providing quality health services to its population. Increased investments to strengthen the country's capacity to diagnose, monitor and treat diseases, particularly HIV and TB, continue to be made but are still inadequate in the face of global health goals like the UNAIDS 90:90:90 which require scaling up of VL tests amid existing constraints. In Kenya, there is an increase in the demand for VL tests amidst these existing constraints. The GeneXpert system is a diagnostic point-of-care technology that can quantify, amongst others, HIV VL. Currently, GeneXpert technology is widely distributed in Kenya for testing of tuberculosis. This study aimed to determine the economic and public health impact of incorporating VL test modules on the existing GeneXpert infrastructure. Markov models were constructed for different populations (non-pregnant adults, pregnant women and children). The scenarios analysed were 100% centralized VL testing compared to 50% GeneXpert plus 50% centralized VL testing, with time horizons of 5 years for the adult and child populations, and 31 months for the pregnant population. Incremental effectiveness was measured in terms of the number of HIV transmissions or opportunistic infections avoided when implementing the GeneXpert scenario compared to a 100% centralized scenario. The model indicated that, for all three populations combined, the GeneXpert scenario resulted in 117 less HIV transmissions and 393 less opportunistic infections. The cost decreased by $21,978,755 for the non-pregnant and pregnant adults and $22,808,533 for non-pregnant adults, pregnant adults and children. The model showed that GeneXpert would cost less and be more effective in terms of total cost per HIV transmission avoided and the total cost per opportunistic infection avoided, except for the pregnant population, when considered separately.	[de Necker, M.; de Beer, J. C.; Stander, M. P.; Connell, C. D.] TCD Outcomes Res Pty Ltd, Centurion, South Africa; [Mwai, D.] Univ Nairobi, Sch Econ, Hlth Econ Unit, Nairobi, Kenya	University of Nairobi	de Necker, M (corresponding author), TCD Outcomes Res Pty Ltd, Centurion, South Africa.	margreet.denecker@tcd-global.com		Bergh, Margreet/0000-0001-9927-122X	Cepheid Inc; TCD Outcomes Research	Cepheid Inc; TCD Outcomes Research	Yes, Cepheid Inc funded the economic analysis. The funder provided support in the form of funding to conduct the economic analysis but did not have any additional role in the study design, data collection and analysis. The funder was involved in the decision to publish and did review the manuscript after finalisation. The responsible parties from the funder are not part of the author list. The specific roles of the authors listed are articulated in the 'author contributions' section. TCD Outcomes Research was the appointed external service provider to perform the economic analysis, including study design, data collection, analysis, writing of the manuscript.	Albert H, 2016, EUR RESPIR J, V48, P516, DOI 10.1183/13993003.00543-2016; [Anonymous], NAT AV TURN TIM; Arnedo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047391; AVERT, HIV AIDS KEN; Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Calmy A, 2007, CLIN INFECT DIS, V44, P128, DOI 10.1086/510073; CDC and Kenya Ministry of Health, 2013, COST COMPR HIV TREAT; Cintron C, 2017, 9 INT AIDS SOC HIV S; Cintron C., IAS2017 TULBPED44 PO; Estill J, 2014, JAIDS-J ACQ IMM DEF, V65, pE179, DOI 10.1097/QAI.0000000000000075; Gous N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168244; Jouquet G, 2016, EC EVALUATION VIRAL; Kaplan JE, 2001, AIDS, V15, P1831, DOI 10.1097/00002030-200109280-00012; Kenya AIDS Indicator Survey, 2012, FIN RE JUN 2014; Kenya Ministry of Health, 2016, KEN AIDS RESP PROGR; KNBS-Kenyan National Bureau of Statistics, EC SURV 2017; Lupia R., 2012, Journal of Experimental and Clinical Medicine, V4, P231, DOI 10.1016/j.jecm.2012.06.007; Maman D, 2015, AIDS, V29, P1557, DOI 10.1097/QAD.0000000000000741; Medecins Sans Frontieres Access Campaign, LOW CAN WE GO PRIC H; Ministry of Health, 2016, GUIDELINES USE ANTIR; Ndlovu Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193577; Olney JJ, 2016, LANCET HIV, V3, pE592, DOI 10.1016/S2352-3018(16)30120-5; Owiti EA, 2015, INT J INNOVATIVE RES, V4, P28; Phillips AN, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw161; Rachlis B, GAPS CARE ADULTS REC; Roberts T., WILL POC MAKE ANY DI; Roberts T, 2016, CLIN INFECT DIS, V62, P1043, DOI 10.1093/cid/ciw001; Sigaloff KCE, 2011, JAIDS-J ACQ IMM DEF, V58, P23, DOI 10.1097/QAI.0b013e318227fc34; Thomas TK, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001015; UNAIDS, 2016, KEN COUNTR FACTSH; Waruru A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158881; WHO, 2016, CONGUID UANT DRU; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212972	10.1371/journal.pone.0212972	http://dx.doi.org/10.1371/journal.pone.0212972			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811510	gold, Green Submitted, Green Published			2022-12-26	WOS:000459806400102
J	Kato, Y; Tabata, K; Kimura, T; Yachie-Kinoshita, A; Ozawa, Y; Yamada, K; Ito, J; Tachino, S; Hori, Y; Matsuki, M; Matsuoka, Y; Ghosh, S; Kitano, H; Nomoto, K; Matsui, J; Funahashi, Y				Kato, Yu; Tabata, Kimiyo; Kimura, Takayuki; Yachie-Kinoshita, Ayako; Ozawa, Yoichi; Yamada, Kazuhiko; Ito, Junichi; Tachino, Sho; Hori, Yusaku; Matsuki, Masahiro; Matsuoka, Yukiko; Ghosh, Samik; Kitano, Hiroaki; Nomoto, Kenichi; Matsui, Junji; Funahashi, Yasuhiro			Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8(+) T cells through reduction of tumor-associated macrophage and activation of the interferon pathway	PLOS ONE			English	Article							CANCER; VEGF; EXPRESSION; CARCINOMA; MIGRATION; RESPONSES; THERAPY; SAFETY; GENE; PD-1	Lenvatinib is a multiple receptor tyrosine kinase inhibitor targeting mainly vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) receptors. We investigated the immunomodulatory activities of lenvatinib in the tumor microenvironment and its mechanisms of enhanced antitumor activity when combined with a programmed cell death-1 (PD-1) blockade. Antitumor activity was examined in immunodeficient and immunocompetent mouse tumor models. Single-cell analysis, flow cytometric analysis, and immunohistochemistry were used to analyze immune cell populations and their activation. Gene co-expression network analysis and pathway analysis using RNA sequencing data were used to identify lenvatinib-driven combined activity with anti-PD-1 antibody (anti-PD-1). Lenvatinib showed potent antitumor activity in the immunocompetent tumor microenvironment compared with the immunodeficient tumor microenvironment. Antitumor activity of lenvatinib plus anti-PD-1 was greater than that of either single treatment. Flow cytometric analysis revealed that lenvatinib reduced tumor-associated macrophages (TAMs) and increased the percentage of activated CD8(+) T cells secreting interferon (IFN)-gamma(+) and granzyme B (GzmB). Combination treatment further increased the percentage of T cells, especially CD8(+) T cells, among CD45(+) cells and increased IFN-gamma(+) and GzmB(+) CD8(+) T cells. Transcriptome analyses of tumors resected from treated mice showed that genes specifically regulated by the combination were significantly enriched for type-I IFN signaling. Pretreatment with lenvatinib followed by anti-PD-1 treatment induced significant antitumor activity compared with anti-PD-1 treatment alone. Our findings show that lenvatinib modulates cancer immunity in the tumor microenvironment by reducing TAMs and, when combined with PD-1 blockade, shows enhanced antitumor activity via the IFN signaling pathway. These findings provide a scientific rationale for combination therapy of lenvatinib with PD-1 blockade to improve cancer immunotherapy.	[Kato, Yu; Tabata, Kimiyo; Kimura, Takayuki; Ozawa, Yoichi; Yamada, Kazuhiko; Ito, Junichi; Tachino, Sho; Hori, Yusaku; Matsuki, Masahiro; Matsui, Junji; Funahashi, Yasuhiro] Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan; [Yachie-Kinoshita, Ayako; Matsuoka, Yukiko; Ghosh, Samik; Kitano, Hiroaki] Syst Biol Inst, Shinagawa Ku, Tokyo, Japan; [Nomoto, Kenichi; Matsui, Junji] Eisai Inc, Oncol Business Grp, Woodcliff Lake, NJ 07677 USA	Eisai Co Ltd; Eisai Co Ltd	Matsui, J; Funahashi, Y (corresponding author), Eisai & Co Ltd, Tsukuba Res Labs, Tsukuba, Ibaraki, Japan.; Matsui, J (corresponding author), Eisai Inc, Oncol Business Grp, Woodcliff Lake, NJ 07677 USA.	Junji_Matsui@eisai.com; y-funahashi@hhc.eisai.co.jp	Ghosh, Samik/AAF-6207-2021	Ghosh, Samik/0000-0002-0239-5400; Yachie, Ayako/0000-0003-2032-227X				Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cesano A, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0088-7; Choueiri TK, 2016, CLIN CANCER RES, V22, P5461, DOI 10.1158/1078-0432.CCR-15-2839; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Frey B, 2017, IMMUNOL REV, V280, P231, DOI 10.1111/imr.12572; Frey B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00231; Fukurnura D, 2018, NAT REV CLIN ONCOL, V15, P325, DOI 10.1038/nrclinonc.2018.29; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hettich M, 2016, CANCER RES, V76, P4673, DOI 10.1158/0008-5472.CAN-15-3451; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Ivashkiv LB, 2018, NAT REV IMMUNOL, V18, P545, DOI 10.1038/s41577-018-0029-z; Kimura T, 2018, CANCER SCI, DOI [10.1158/0008-5472.CAN-15-3451, DOI 10.1158/0008-5472.CAN-15-3451]; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06890-y; Lucarini V, 2017, J INVEST DERMATOL, V137, P159, DOI 10.1016/j.jid.2016.08.024; McDermott DF, 2018, NAT MED, V24, P749, DOI 10.1038/s41591-018-0053-3; McDermott DF, 2013, CANCER MED-US, V2, P662, DOI 10.1002/cam4.106; Motzer RJ, 2015, LANCET ONCOL, V16, P1473, DOI 10.1016/S1470-2045(15)00290-9; Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010; Okamoto K, 2015, ACS MED CHEM LETT, V6, P89, DOI 10.1021/ml500394m; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Tahara M, 2017, EUR J CANCER, V75, P213, DOI 10.1016/j.ejca.2017.01.013; Takase N, 2016, CANCER LETT, V380, P47, DOI 10.1016/j.canlet.2016.06.009; Tohyama O, 2014, J THROID RES, V2014, DOI 10.1155/2014/638747; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Wu XQ, 2017, CANCER IMMUNOL RES, V5, P446, DOI 10.1158/2326-6066.CIR-16-0385; Yamamoto Y, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-18	38	174	180	12	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212513	10.1371/journal.pone.0212513	http://dx.doi.org/10.1371/journal.pone.0212513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811474	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400074
J	Marcinkowska, UM; Helle, S; Jones, BC; Jasienska, G				Marcinkowska, Urszula M.; Helle, Samuli; Jones, Benedict C.; Jasienska, Grazyna			Does testosterone predict women's preference for facial masculinity?	PLOS ONE			English	Article							MENSTRUAL-CYCLE; SALIVARY TESTOSTERONE; SOCIOSEXUALITY; ATTRACTIVENESS; HORMONES; STRESS; FACES	The influence of sex hormones on women's mate preferences has been an intensively discussed topic for more than a decade. Yet the extent to which levels of sex hormones, and testosterone in particular, influence women's mate preferences is unclear. Thus, the current study used multilevel modelling to investigate putative relationships between salivary testosterone and facial masculinity preferences in a sample of 68 women, while controlling for their age, partnership status, and sociosexuality. We found no significant associations between masculinity preferences and either individual differences or within-woman changes in testosterone. We did find however, that sociosexuality was positively correlated with masculinity preferences. Although it has previously been suggested that testosterone is related to women's facial masculinity preference, our data do not support this proposal.	[Marcinkowska, Urszula M.; Jasienska, Grazyna] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Environm Hlth, Krakow, Poland; [Helle, Samuli] Univ Turku, Sect Ecol, Dept Biol, Turku, Finland; [Jones, Benedict C.] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland	Jagiellonian University; Collegium Medicum Jagiellonian University; University of Turku; University of Glasgow	Marcinkowska, UM (corresponding author), Jagiellonian Univ, Coll Med, Fac Hlth Sci, Dept Environm Hlth, Krakow, Poland.	ummarcinkowska@gmail.com	Marcinkowska, Urszula/R-9738-2019; Jones, Benedict/A-7850-2008	Marcinkowska, Urszula/0000-0002-6851-4513; Jones, Benedict/0000-0001-7777-0220; Jasienska, Grazyna/0000-0001-8716-6342	Polish National Science Center [2014/12/S/NZ8/00722]; Jagiellonian University Medical College [K/DSC/004283]; Kone foundation [088423, 090026]	Polish National Science Center; Jagiellonian University Medical College; Kone foundation	This work was supported to UMM by the Polish National Science Center (grant number 2014/12/S/NZ8/00722) and by the structural funds of Jagiellonian University Medical College (grant number K/DSC/004283) and to SH by Kone foundation (grant numbers 088423 and 090026).	Akihito K, 2010, HDB ADV MULTILEVEL A; Blake KR, 2016, HORM BEHAV, V81, P74, DOI 10.1016/j.yhbeh.2016.03.004; Bloch M, 1998, BIOL PSYCHIAT, V43, P897, DOI 10.1016/S0006-3223(98)00403-X; Bobst C, 2014, PSYCHONEUROENDOCRINO, V41, P142, DOI 10.1016/j.psyneuen.2013.12.012; Boothroyd LG, 2014, ARCH SEX BEHAV, V43, P983, DOI 10.1007/s10508-013-0204-z; DABBS JM, 1991, HORM RES, V35, P182, DOI 10.1159/000181899; Ditzen B, 2017, PSYCHONEUROENDOCRINO, V82, P67, DOI 10.1016/j.psyneuen.2017.05.006; Gangestad SW, 1998, P ROY SOC B-BIOL SCI, V265, P927, DOI 10.1098/rspb.1998.0380; Glassenberg AN, 2010, ARCH SEX BEHAV, V39, P1289, DOI 10.1007/s10508-009-9559-6; Grimm K.J., 2016, GROWTH MODELING STRU; Johnston VS, 2001, EVOL HUM BEHAV, V22, P251, DOI 10.1016/S1090-5138(01)00066-6; Jones B. C., 2017, BIORXIV; Jones BC, 2018, PSYCHOL SCI, V29, P996, DOI 10.1177/0956797618760197; Jones BC, 2018, PSYCHONEUROENDOCRINO, V88, P153, DOI 10.1016/j.psyneuen.2017.12.015; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Little AC, 2007, BEHAV ECOL SOCIOBIOL, V61, P967, DOI 10.1007/s00265-006-0325-7; Marcinkowska UM, 2018, HORM BEHAV, V102, P114, DOI 10.1016/j.yhbeh.2018.05.013; Marcinkowska UM, 2018, ARCH SEX BEHAV, V47, P1367, DOI 10.1007/s10508-017-1093-3; Marcinkowska UM, 2018, PSYCHONEUROENDOCRINO, V88, P47, DOI 10.1016/j.psyneuen.2017.11.007; Moore FR, 2011, P ROY SOC B-BIOL SCI, V278, P774, DOI 10.1098/rspb.2010.1678; Muthen L. K., 2009, MPLUS VERSION 5; Penke L, 2008, J PERS SOC PSYCHOL, V95, P1113, DOI 10.1037/0022-3514.95.5.1113; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pisanski K, 2014, HORM BEHAV, V66, P493, DOI 10.1016/j.yhbeh.2014.07.006; Provost MP, 2006, ARCH SEX BEHAV, V35, P305, DOI 10.1007/s10508-006-9029-3; Puts DA, 2006, HUM NATURE-INT BIOS, V17, P114, DOI 10.1007/s12110-006-1023-x; Roney JR, 2008, HORM BEHAV, V53, P14, DOI 10.1016/j.yhbeh.2007.09.008; Roney JR, 2011, PSYCHONEUROENDOCRINO, V36, P742, DOI 10.1016/j.psyneuen.2010.10.010; Schultheiss OC, 2003, HORM BEHAV, V43, P293, DOI 10.1016/S0018-506X(03)00003-5; Scott IML, 2013, BEHAV ECOL, V24, P579, DOI 10.1093/beheco/ars092; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Tofighi D., 2007, IDENTIFYING CORRECT; van Anders SM, 2012, ARCH SEX BEHAV, V41, P1471, DOI 10.1007/s10508-012-9946-2; Wang HY, 2014, PSYCHONEUROENDOCRINO, V50, P246, DOI 10.1016/j.psyneuen.2014.08.022; Waynforth D, 2005, EVOL HUM BEHAV, V26, P409, DOI 10.1016/j.evolhumbehav.2005.03.003; Welling LLM, 2007, HORM BEHAV, V52, P156, DOI 10.1016/j.yhbeh.2007.01.010; Wilcox AJ, 2004, HUM REPROD, V19, P1539, DOI 10.1093/humrep/deh305	38	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0210636	10.1371/journal.pone.0210636	http://dx.doi.org/10.1371/journal.pone.0210636			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811400	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000459806400009
J	Otim, O; Juma, T; Otunnu, O				Otim, Ochan; Juma, Tom; Otunnu, Olara			Assessing the health risks of consuming 'sachet' alcohol in Acoli, Uganda	PLOS ONE			English	Article							DISPLACED PERSONS; CANCER; CONSUMPTION; DRINKING; ALUMINUM; BLOOD	The increased mortality rate among the Acoli people of northern Uganda is anecdotally blamed on excessive consumption of cheap and widely available sachet-packaged alcohol in the region. In this paper, we quantify this perceived association by determining statistically the health risks associated with ingesting 20 heavy metals in 17 popular spirits products consumed in Acoli. Thirteen of these products were industrially packaged in sachets (locally known as 'sachet,' waragi, arege or moo lyec) and four were locally produced Lira-Lira spirits from Bolo, Awere and Teso Bar in the region and Nsambya in southern Uganda. A Scottish whisky purchased in San Diego (USA) was our reference. Risk assessment was performed according to standardized protocols developed by the United States Environmental Protection Agency (US EPA). Our results show that a strong correlation indeed exists between health risks and ingestion of spirits in Acoli. At >2.5 sachets/day for 240 day/year over a lifetime for example, the risk of developing cancer due to exposure to As, Pb and Cr alone is 1 in 102,041. This estimate excludes ethanol, a known carcinogen, and 17 heavy metals also studied due to lack of their cancer slope factors. The primary non-cancer related health risk factor in all samples tested is ethanol with unacceptably high health index of four. The Lira-Lira spirits, with 100-6000% copper above the US EPA limit for intake by oral ingestion in water, would be the 'cleanest'without copper and at par with the Scottish whisky. Collectively, we find that no amount of alcohol consumed in Acoli is safe. Preventive measures are therefore recommended to reduce mortality in Acoli in particular, and in Uganda in general. These measures should include public education, better public policies, creating productive economic activities other than brewing alcohol, and social activities that engage people away from drinking.	[Otim, Ochan] Univ Calif Los Angeles, Dept Humanities & Sci, Los Angeles, CA 90095 USA; [Otim, Ochan; Juma, Tom] City Los Angeles, Environm Monitoring Div, Playa Del Rey, CA USA; [Otunnu, Olara] UN, New York, NY 10017 USA	University of California System; University of California Los Angeles	Otim, O (corresponding author), Univ Calif Los Angeles, Dept Humanities & Sci, Los Angeles, CA 90095 USA.; Otim, O (corresponding author), City Los Angeles, Environm Monitoring Div, Playa Del Rey, CA USA.	ootim@g.ucla.edu	Otim, Ochan/AAN-7301-2020	Otim, Ochan/0000-0001-7272-4356				Adam T, 2002, J I BREWING, V108, P459, DOI 10.1002/j.2050-0416.2002.tb00576.x; Aka S., 2014, AM J RECOMMUNICATI, V2, P103; [Anonymous], [No title captured]; [Anonymous], 2009, NAT PRIM DRINK WAT R; [Anonymous], 2017, REG SCREEN LEV RSLS; [Anonymous], 1988, IARC MONOGR EVAL CAR, V44, P1; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Bagnardi V, 2013, ANN ONCOL, V24, P301, DOI 10.1093/annonc/mds337; Bamuwamye M., 2015, J ENV POLLUT HUM HEA, V3, P24, DOI [DOI 10.12691/JEPHH-3-2-1, 10.12691/jephh-3-2-1]; Beyersmann D, 2008, ARCH TOXICOL, V82, P493, DOI 10.1007/s00204-008-0313-y; Clatworthy J, 2005, BRIT J HEALTH PSYCH, V10, P329, DOI 10.1348/135910705X25697; Deshpande SS, 2002, HDB FOOD TOXICITY; Ferreira-Borges C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040346; Ferreira-Borges C, 2016, TROP MED INT HEALTH, V21, P52, DOI 10.1111/tmi.12618; Ferreira-Borges C, 2015, ALCOHOL ALCOHOLISM, V50, P470, DOI 10.1093/alcalc/agv036; Francis JM, 2017, J STUD ALCOHOL DRUGS, V78, P476, DOI 10.15288/jsad.2017.78.476; Grewal P, 2012, CLIN LIVER DIS, V16, P839, DOI 10.1016/j.cld.2012.08.011; HARPER DAT, 2001, PALAEONTOLOGIA ELECT, V4; Human Rights Watch, 2005, UPR FORG IMP HUM RIG; Iida-Ueno A, 2017, WORLD J GASTROENTERO, V23, P2651, DOI 10.3748/wjg.v23.i15.2651; Kabwama SN, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.31302; Kalema D, 2015, DRUG-EDUC PREV POLIC, V22, P476, DOI 10.3109/09687637.2015.1006180; Kamukama E., 2018, DAILY MONITOR; Kamunda C, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070663; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P1, DOI 10.1080/10937400701597766; Kunzmann AT, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002585; Laing T., 2017, PROBLEM SACHET ALCOH; Lee MY, 2003, ENVIRON HEALTH PERSP, V111, P513, DOI 10.1289/ehp.5916; LoConte NK, 2018, J CLIN ONCOL, V36, P83, DOI 10.1200/JCO.2017.76.1155; Lyumugabe F, 2012, BIOTECHNOL AGRON SOC, V16, P509; Maret W, 2013, METAL IONS LIFE SCI, V11, P1, DOI 10.1007/978-94-007-5179-8_1; Morales ME, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151367; Muto-Ono p'Lajur J., 2017, UGANDA MUSEVENIS HID; Muyanja C., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P4124; Naamara W, 2014, J SOC WORK PRACT ADD, V14, P322, DOI 10.1080/1533256X.2014.936251; Namugumya B. S., 2009, African Journal of Food, Agriculture, Nutrition and Development, V9, P1046; Naughton DP, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-22; Ogwok P, 2014, J ENV POLLUT HUM HLT, V2, P73, DOI [10.12691/jephh-2-3-3, DOI 10.12691/JEPHH-2-3-3]; Otto A., 2013, GULU DISTRICT WANTS; p'Chong Lubwa, 1975, GENEROSITY KILLS LAS; Peer N, 2017, AM J DRUG ALCOHOL AB, V43, P631, DOI 10.1080/00952990.2017.1316986; Petrick JL, 2018, BRIT J CANCER, V118, P1005, DOI 10.1038/s41416-018-0007-z; Psaltopoulou T, 2018, INT J CANCER, V143, P486, DOI 10.1002/ijc.31330; Roberts B, 2009, J EPIDEMIOL COMMUN H, V63, P227, DOI 10.1136/jech.2008.076356; Roberts B, 2011, ADDICT BEHAV, V36, P870, DOI 10.1016/j.addbeh.2011.03.006; Roberts Bayard, 2009, Confl Health, V3, P10, DOI 10.1186/1752-1505-3-10; Roberts B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-108; Shi HL, 2004, FREE RADICAL BIO MED, V37, P582, DOI 10.1016/j.freeradbiomed.2004.03.012; Time Magazine, 1967, TIME MAGAZINE; Tramacere I, 2012, ANN ONCOL, V23, P2791, DOI 10.1093/annonc/mds013; Uganda Ministry of Trade Industry and Cooperatives, 2016, BAN PACK ALC SACH; Uganda National Bureau of Standards, 2017, 141 US EAS UG NAT BU; Uganda Youth Development Link, 2010, ROAD MAP ALC POL REG; Uganda Youth Development Link, 2008, STAT ALC AB UG; United States Environmental Protection Agency, 1994, 20088 USEPA; US Environmental Protection Agency, 1986, EPA630R98002; US EPA, 1989, RISK ASS GUID SUP, VI; US EPA, 2000, EPA630R00002 US EPA; Vinceti M, 2001, Rev Environ Health, V16, P233; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2011, GUID DRINK WAT QUAL; Wu C, 2014, NAT GENET, V46, P1001, DOI 10.1038/ng.3064; Zeneli L, 2015, J ENVIRON SCI HEAL A, V50, P540, DOI 10.1080/10934529.2015.994936	64	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212938	10.1371/journal.pone.0212938	http://dx.doi.org/10.1371/journal.pone.0212938			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811520	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400098
J	Xu, MH; Zhang, SX; Wen, J; Yang, XY				Xu, Manhou; Zhang, Shixiong; Wen, Jing; Yang, Xiaoyan			Multiscale spatial patterns of species diversity and biomass together with their correlations along geographical gradients in subalpine meadows	PLOS ONE			English	Article							ALTITUDINAL GRADIENT; STRUCTURAL DIVERSITY; BIODIVERSITY; PRODUCTIVITY; ECOSYSTEM; SCALE; RICHNESS; ROOT; GRASSLANDS; ALLOCATION	Researchers frequently discuss spatial distribution patterns of species diversity and biomass together with their correlations along geographical gradients. Typical subalpine meadows occur widely on the east of the Loess Plateau, China; here, we selected nine mountains belonging to four mountain systems from north to south on the east of the plateau. We analyzed five latitudinal and longitudinal gradients together with six elevational gradients to study the spatial distribution patterns of species diversity (including alpha, beta, and gamma diversity) and biomass plus with their relationships at various scales. Results showed that (1) for diversity, alpha-Diversity manifested unimodal variation patterns in horizontal spaces, peaking at high latitude and low longitude. However, alpha-diversity was not sensitive to elevation in vertical spaces and tended to decrease with increasing elevation. With increased latitude, longitude, and elevation, beta-Diversity diminished; meanwhile, the rate of species turnover decreased and the similarity of community composition enlarged. gamma-Diversity demonstrated quadratic function changes that were initially incremental and then decreased with increasing longitude, elevation, and latitude from 37.5 degrees to 40 degrees. In general, beta-diversity had positive correlation with gamma-diversity and negative correlation with alpha-diversity, which conformed to the function of beta = gamma/alpha. (2) For biomass, changes of aboveground biomass (AB) were more obvious along latitudinal gradients, whereas variations of belowground biomass (BB) had smaller differences along longitudinal and latitudinal gradients. More biomass was allocated to BB toward the north and east, whereas root-to-shoot ratio (R/S) was more evident at greater latitude than greater longitude. With increased elevation, more biomass was also allocated to BB, and the relationship of biomass to elevation was closer in AB. In short, the relation of biomass allocation tended to belowground plant parts with different geographical scales. (3) Species diversity had the strongest positive influence on AB. The Patrick and Shannon indices had correlations of power functions with AB and R/S, respectively, indicating that an allometric model could be used to model relationships between species diversity and biomass. In conclusion, the unique geomorphological structures with a series of basins between mountain systems on the east of the Loess Plateau, meant that subalpine meadows were mostly distributed along latitudinal directions, so the spatial distribution of species diversity and biomass was more evident along latitudinal gradients, and thus the response of above-ground biomass was more sensitive to variations of spatial gradients and species diversity.	[Xu, Manhou; Zhang, Shixiong; Wen, Jing; Yang, Xiaoyan] Taiyuan Normal Univ, Inst Geog Sci, Jinzhong, Peoples R China	Taiyuan Normal University	Xu, MH (corresponding author), Taiyuan Normal Univ, Inst Geog Sci, Jinzhong, Peoples R China.	xumh@tynu.edu.cn	manhou, xu/AAA-3630-2019	manhou, xu/0000-0001-7558-6227	National Natural Science Foundation of China [41501219]; Applied Basic Research Project of Shanxi Province [2016021136]; Higher School of Science and Technology Innovation Project of Shanxi Province [4]; Higher School of Key Discipline Construction Project of Shanxi Province [4]; 1331 Construction Planning Project of Taiyuan Normal University [34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Applied Basic Research Project of Shanxi Province; Higher School of Science and Technology Innovation Project of Shanxi Province; Higher School of Key Discipline Construction Project of Shanxi Province; 1331 Construction Planning Project of Taiyuan Normal University	This work was supported by the National Natural Science Foundation of China (Grant No. 41501219), the Applied Basic Research Project of Shanxi Province (Grant No. 2016021136), the Higher School of Science and Technology Innovation Project of Shanxi Province (No. 4 document in 2016), the Higher School of Key Discipline Construction Project of Shanxi Province (No. 4 document in 2016), and the 1331 Construction Planning Project of Taiyuan Normal University (No. 34 document in 2017).	Adler PB, 2011, SCIENCE, V333, P1750, DOI 10.1126/science.1204498; Ali A, 2016, BIOGEOSCIENCES, V13, P4627, DOI 10.5194/bg-13-4627-2016; Bai YF, 2007, J APPL ECOL, V44, P1023, DOI 10.1111/j.1365-2664.2007.01351.x; Benayas JMR, 2002, J VEG SCI, V13, P245, DOI 10.1658/1100-9233(2002)013[0245:PDBAEI]2.0.CO;2; Bracken MES, 2017, ECOLOGY, V98, P1434, DOI [10.1002/ecy.1812/suppinfo, 10.1002/ecy.1812]; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Carnicer J, 2015, J PLANT PHYSIOL, V172, P82, DOI 10.1016/j.jplph.2014.07.022; Chen Chao, 2016, Acta Ecologica Sinica, V36, P661; Chen DM, 2016, J BIOGEOGR, V43, P955, DOI 10.1111/jbi.12683; Coates M, 1998, GLOBAL ECOL BIOGEOGR, V7, P115, DOI 10.2307/2997814; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Declerck S, 2005, ECOLOGY, V86, P1905, DOI 10.1890/04-0373; Dolezal J, 2002, PLANT ECOL, V158, P201, DOI 10.1023/A:1015564303206; Dorji T, 2014, ARCT ANTARCT ALP RES, V46, P308, DOI 10.1657/1938-4246-46.2.308; [段敏杰 Duan Minjie], 2011, [草业科学, Pratacultural Science], V28, P1845; Duncanson LI, 2015, GLOBAL ECOL BIOGEOGR, V24, P1465, DOI 10.1111/geb.12371; Fabbro T, 2004, FLORA, V199, P70, DOI 10.1078/0367-2530-00128; Feng TJ, 2018, EARTH SURF PROC LAND, V43, P1860, DOI 10.1002/esp.4361; Fraser LH, 2015, SCIENCE, V349, P302, DOI 10.1126/science.aab3916; Gao QZ, 2009, CLIMATIC CHANGE, V97, P515, DOI 10.1007/s10584-009-9617-z; [葛颂 Ge Song], 2017, [科学通报, Chinese Science Bulletin], V62, P2033; Godfray HCJ, 2001, TRENDS ECOL EVOL, V16, P400, DOI 10.1016/S0169-5347(01)02150-4; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; GREEN J, 1994, HYDROBIOLOGIA, V272, P13, DOI 10.1007/BF00006509; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Harrison S, 2007, AM NAT, V170, pS5, DOI 10.1086/519010; He J.S., 1997, ACTA ECOL SIN, V17, P91; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Holscher D, 2002, FORSTWISS CENTRALBL, V121, P229, DOI 10.1046/j.1439-0337.2002.02031.x; Hooper DU, 2000, BIOSCIENCE, V50, P1049, DOI 10.1641/0006-3568(2000)050[1049:IBAABB]2.0.CO;2; Nguyen H, 2012, FOREST ECOL MANAG, V274, P81, DOI 10.1016/j.foreco.2012.02.022; Huston M A, 2000, Science, V289, P1255; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Jin ShaoHong, 2017, Acta Prataculturae Sinica, V26, P29; KAUFMAN DM, 1995, J MAMMAL, V76, P322, DOI 10.2307/1382344; Kessler M, 2014, J ECOL, V102, P1623, DOI 10.1111/1365-2745.12299; KORNER C, 1987, OECOLOGIA, V74, P411, DOI 10.1007/BF00378938; Li WenHan, 2017, Acta Prataculturae Sinica, V26, P200; Li Y, 2008, J VEG SCI, V19, P245, DOI 10.3170/2007-8-18365; [林敦梅 Lin Dunmei], 2017, [科学通报, Chinese Science Bulletin], V62, P1861; Liu Jing, 2016, Acta Prataculturae Sinica, V25, P36; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; [卢训令 Lu Xunling], 2010, [生态学报, Acta Ecologica Sinica], V30, P5790; Luo LM, 2014, PRATACULT SCI, V23, P320, DOI DOI 10.11686/CYXB20140638; Luo TX, 2005, FOREST ECOL MANAG, V206, P349, DOI 10.1016/j.foreco.2004.11.016; Ma Li, 2018, Shengtaixue Zazhi, V37, P2244, DOI 10.13292/j.1000-4890.201808.036; Ma WH, 2010, SCI CHINA LIFE SCI, V53, P841, DOI 10.1007/s11427-010-4020-6; Mack MC, 2003, ECOL APPL, V13, P154, DOI 10.1890/1051-0761(2003)013[0154:EGACOS]2.0.CO;2; Martinez-Hernandez C, 2017, HYDROL PROCESS, V31, P3095, DOI 10.1002/hyp.11251; McCarthy MC, 2007, FUNCT ECOL, V21, P713, DOI 10.1111/j.1365-2435.2007.01276.x; Mokany K, 2006, GLOBAL CHANGE BIOL, V12, P84, DOI 10.1111/j.1365-2486.2005.001043.x; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NOSS RF, 1990, CONSERV BIOL, V4, P355, DOI 10.1111/j.1523-1739.1990.tb00309.x; Odland A, 1999, ECOGRAPHY, V22, P548, DOI 10.1111/j.1600-0587.1999.tb01285.x; Oleksyn J, 1998, FUNCT ECOL, V12, P573, DOI 10.1046/j.1365-2435.1998.00236.x; OLEKSYN J, 1992, NEW PHYTOL, V120, P561, DOI 10.1111/j.1469-8137.1992.tb01806.x; Panagos P, 2014, SCI TOTAL ENVIRON, V479, P189, DOI 10.1016/j.scitotenv.2014.02.010; Pedro MS, 2017, J VEG SCI, V28, P649, DOI 10.1111/jvs.12505; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Qiong La, 2014, Biodiversity Science, V22, P337, DOI 10.3724/SP.J.1003.2014.13186; Shanafelt DW, 2015, J THEOR BIOL, V380, P426, DOI 10.1016/j.jtbi.2015.06.017; Sklenar Petr, 2001, Diversity and Distributions, V7, P113, DOI 10.1046/j.1472-4642.2001.00101.x; Sun YongXiu, 2017, Acta Prataculturae Sinica, V26, P54; [唐志尧 Tang Zhiyao], 2004, [生物多样性, Chinese Biodiversity], V12, P20; Thiele-Bruhn S, 2005, CHEMOSPHERE, V59, P457, DOI 10.1016/j.chemosphere.2005.01.023; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; [仝莉棉 Tong Limian], 2016, [水土保持研究, Research of Soil and Water Conservation], V23, P194; Wang GH, 2003, PLANT ECOL, V165, P169, DOI 10.1023/A:1022236115186; Wang Yang, 2017, Chinese Journal of Plant Ecology, V41, P105, DOI 10.17521/cjpe.2016.0217; Wardle D.A., 2000, B ECOL SOC AM, V81, P235, DOI DOI 10.2307/20168451; Weiner J, 2004, PERSPECT PLANT ECOL, V6, P207, DOI 10.1078/1433-8319-00083; Whittaker RJ, 2001, J BIOGEOGR, V28, P453, DOI 10.1046/j.1365-2699.2001.00563.x; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109; [颉洪涛 Xie Hongtao], 2016, [生态学报, Acta Ecologica Sinica], V36, P3621; Xu MH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174231; Yang YH, 2010, GLOBAL ECOL BIOGEOGR, V19, P268, DOI 10.1111/j.1466-8238.2009.00502.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Yao Jing, 2017, Acta Prataculturae Sinica, V26, P108; Yuan F, 2015, LANDSCAPE ECOL, V30, P1737, DOI 10.1007/s10980-015-0154-z; Zhang Y, 2015, J ECOL, V103, P1245, DOI 10.1111/1365-2745.12425; Zhao Jie, 2017, Acta Prataculturae Sinica, V26, P54; [赵丽娅 Zhao Liya], 2017, [生态学报, Acta Ecologica Sinica], V37, P4108; [朱丽 Zhu Li], 2017, [生态学报, Acta Ecologica Sinica], V37, P1912	90	6	12	8	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211560	10.1371/journal.pone.0211560	http://dx.doi.org/10.1371/journal.pone.0211560			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811410	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400022
J	Ban, HY; Ahn, JB; Lee, BW				Ban, Ho-Young; Ahn, Joong-Bae; Lee, Byun-Woo			Assimilating MODIS data-derived minimum input data set and water stress factors into CERES-Maize model improves regional corn yield predictions	PLOS ONE			English	Article							REMOTE-SENSING INFORMATION; ENSEMBLE KALMAN FILTER; CROP GROWTH-MODEL; LEAF-AREA INDEX; DEFICIT STRESS; DROUGHT STRESS; VEGETATION; AGRICULTURE; VARIABILITY; SIMULATION	Crop growth models and remote sensing are useful tools for predicting crop growth and yield, but each tool has inherent drawbacks when predicting crop growth and yield at a regional scale. To improve the accuracy and precision of regional corn yield predictions, a simple approach for assimilating Moderate Resolution Imaging Spectroradiometer (MODIS) products into a crop growth model was developed, and regional yield prediction performance was evaluated in a major corn-producing state, Illinois, USA. Corn growth and yield were simulated for each grid using the Crop Environment Resource Synthesis (CERES)-Maize model with minimum inputs comprising planting date, fertilizer amount, genetic coefficients, soil, and weather data. Planting date was estimated using a phenology model with a leaf area duration (LAD)-logistic function that describes the seasonal evolution of MODIS-derived leaf area index (LAI). Genetic coefficients of the corn cultivar were determined to be the genetic coefficients of the maturity group [included in Decision Support System for Agro-technology Transfer (DSSAT) 4.6], which shows the minimum difference between the maximum LAI derived from the LAD-logistic function and that simulated by the CERES-Maize model. In addition, the daily water stress factors were estimated from the ratio between daily leaf area/weight growth rates estimated from the LAD-logistic function and that simulated by the CERES-Maize model under the rain-fed and auto-irrigation conditions. The additional assimilation of MODIS data-derived water stress factors and LAI under the auto-irrigation condition showed the highest prediction accuracy and precision for the yearly corn yield prediction (R-2 is 0.78 and the root mean square error is 0.75 t ha(-1)). The present strategy for assimilating MODIS data into a crop growth model using minimum inputs was successful for predicting regional yields, and it should be examined for spatial portability to diverse agro-climatic and agro-technology regions.	[Ban, Ho-Young; Lee, Byun-Woo] Seoul Natl Univ, Dept Plant Sci, Coll Agr & Life Sci, Seoul, South Korea; [Ban, Ho-Young; Lee, Byun-Woo] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Ahn, Joong-Bae] Pusan Natl Univ, Dept Earth Environm Syst, Busan, South Korea	Seoul National University (SNU); Seoul National University (SNU); Pusan National University	Lee, BW (corresponding author), Seoul Natl Univ, Dept Plant Sci, Coll Agr & Life Sci, Seoul, South Korea.; Lee, BW (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	leebw@snu.ac.kr		, Byun-Woo/0000-0003-2284-1348; Ban, Ho-Young/0000-0001-9024-9683	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea [010115022017]	Cooperative Research Program for Agriculture Science & Technology Development, Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	This study was conducted with the support of the Cooperative Research Program for Agriculture Science & Technology Development (Project NO. 010115022017), Rural Development Administration, Republic of Korea (www.rda.go.kr). HB, JA, BL received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2012, J METEOROL SOC JPN, V90, P493, DOI 10.2151/jmsj.2012-404; Ban HY, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9010016; Boote K.J., 2008, RESPONSE CROPS LTD W, V1, P59; BOUMAN BAM, 1995, NETH J AGR SCI, V43, P143; BOYER JS, 1968, PLANT PHYSIOL, V43, P1056, DOI 10.1104/pp.43.7.1056; Boyer JS, 2004, J EXP BOT, V55, P2385, DOI 10.1093/jxb/erh219; Bridges K, 2016, ISWS PUBLICATIONS SE, V12, P5; Cabrera VE, 2007, AGR ECOSYST ENVIRON, V122, P479, DOI 10.1016/j.agee.2007.03.005; Chisanga C. B., 2015, Journal of Agricultural Science (Toronto), V7, P79; Dadhwal VK, 2003, P TRAIN WORKSH HELD, P263; Davis RF, 2014, J NEMATOL, V46, P108; de Wit AM, 2007, AGR FOREST METEOROL, V146, P38, DOI 10.1016/j.agrformet.2007.05.004; DE WIT C. T., 1965, Agric. Res. Reps Centre agric. Publ. Docum., V663; Delecolle R, 1988, SPECTRAL SIGNATURES, P125; Dorigo WA, 2007, INT J APPL EARTH OBS, V9, P165, DOI 10.1016/j.jag.2006.05.003; DUNCAN WG, 1967, HILGARDIA, V38, P181, DOI 10.3733/hilg.v38n04p181; Evensen G., 2003, OCEAN DYNAM, V53, P343, DOI [DOI 10.1007/S10236-003-0036-9, 10.1007/s10236-003-0036-9]; Faivre R, 2004, AGRONOMIE, V24, P205, DOI 10.1051/agro:2004016; Fang HL, 2011, INT J REMOTE SENS, V32, P1039, DOI 10.1080/01431160903505310; Guo YY, 2015, TURK J BIOL, V39, P532, DOI 10.3906/biy-1412-20; Hadjimitsis DG, 2010, NAT HAZARD EARTH SYS, V10, P89, DOI 10.5194/nhess-10-89-2010; Hansen JW, 2000, AGR SYST, V65, P43, DOI 10.1016/S0308-521X(00)00025-1; Heinemann AB, 2016, AGR FOREST METEOROL, V225, P57, DOI 10.1016/j.agrformet.2016.05.010; Hoogenboom G., 2015, DECIS SUPPORT SYST; Ines AVM, 2013, REMOTE SENS ENVIRON, V138, P149, DOI 10.1016/j.rse.2013.07.018; Jiang Z, 2014, 3 INT C AGR 11 14 AU, DOI [10.1109/agro-geoinformatics.2014.6910599, DOI 10.1109/AGRO-GEOINFORMATICS.2014.6910599]; Jiang ZW, 2014, IEEE J-STARS, V7, P4422, DOI 10.1109/JSTARS.2014.2316012; Jin XL, 2018, EUR J AGRON, V92, P141, DOI 10.1016/j.eja.2017.11.002; Jones C., 1986, SIMULATION MODEL MAI; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; JORDAN CF, 1969, ECOLOGY, V50, P663, DOI 10.2307/1936256; Kiniry JR, 1991, PREDICTING CROP PHEN, P115; Kryvobok O., 2000, P INT ARCH PHOT R B7, V33, P717; Launay M, 2003, AGRONOMIE, V23, P135, DOI 10.1051/agro:2002078; Lenz-Wiedemann VIS, 2012, PROCEDIA ENVIRON SCI, V13, P1946, DOI 10.1016/j.proenv.2012.01.188; Leon Chris T., 2003, Precision Agriculture, V4, P359, DOI 10.1023/A:1026387830942; Li FL, 2009, AGROFOREST SYST, V77, P193, DOI 10.1007/s10457-008-9199-1; Li Y, 2014, ECOL MODEL, V291, P15, DOI 10.1016/j.ecolmodel.2014.07.013; Lilienthal H, 2007, D GREID S ADV TECHN, P87; Lopez-Cedron FX, 2005, EUR J AGRON, V23, P89, DOI 10.1016/j.eja.2005.01.001; Ma YP, 2008, INT J APPL EARTH OBS, V10, P426, DOI 10.1016/j.jag.2007.09.002; Marra M. C., 2012, AgBioForum, V15, P217; Medeiros David Barbosa, 2012, Braz. J. Plant Physiol., V24, P181, DOI 10.1590/S1677-04202012000300005; Morel J., 2014, European Journal of Agronomy, V61, P60, DOI 10.1016/j.eja.2014.08.004; Moulin S, 1998, INT J REMOTE SENS, V19, P1021, DOI 10.1080/014311698215586; Nafziger E., 2009, ILLINOIS AGRONOMY HD, P13; Nguy-Robertson A, 2012, AGRON J, V104, P1336, DOI 10.2134/agronj2012.0065; Oteng-Darko P, 2013, E3 J AGR RES DEV, V2, P1, DOI DOI 10.1007/s40003-012-0046-2; Ozdogan M, 2010, REMOTE SENS-BASEL, V2, P2274, DOI 10.3390/rs2092274; Perie C, 2008, CAN J SOIL SCI, V88, P315, DOI 10.4141/CJSS06008; Ralph EN, 1987, NATL CORN HDB; Reidsma P, 2008, ECOL SOC, V13; Rouse J.W., 1973, EARTH RES TECHN SAT, P309; Sehgal VK, 2016, REMOTE SENSING CROP, V7, P21; Shao HB, 2009, CRIT REV BIOTECHNOL, V29, P131, DOI 10.1080/07388550902869792; Singh R, 2008, 8 ASABE, DOI [10.13031/2013.24598, DOI 10.13031/2013.24598]; Soler CMT, 2007, EUR J AGRON, V27, P165, DOI 10.1016/j.eja.2007.03.002; Tsvetsinskaya EA, 2001, J CLIMATE, V14, P692, DOI 10.1175/1520-0442(2001)014<0692:ITEOSP>2.0.CO;2; Wang X, 2009, CROP MODELING DECISI, P203, DOI [10.1007/978-3-642-01132-0_21, DOI 10.1007/978-3-642-01132-0_21]; Weerts AH, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004093; Weng QH, 2012, REMOTE SENS ENVIRON, V117, P34, DOI 10.1016/j.rse.2011.02.030; Wu S, 2011, INT C COMP COMP TECH, P410, DOI [10.1007/978-3-642-27275-2_46, DOI 10.1007/978-3-642-27275-2_46]; Xiong D.L., 2014, SENSORS TRANSDUCERS, V169, P174; Yin JF, 2015, GEOPHYS RES LETT, V42, P6710, DOI 10.1002/2015GL063366; Zhao YX, 2013, ECOL MODEL, V270, P30, DOI 10.1016/j.ecolmodel.2013.08.016; Zhu XH, 2013, CHINESE GEOGR SCI, V23, P550, DOI 10.1007/s11769-013-0621-x	66	4	4	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0211874	10.1371/journal.pone.0211874	http://dx.doi.org/10.1371/journal.pone.0211874			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802254	gold, Green Submitted, Green Published			2022-12-26	WOS:000459710700007
J	Limmade, Y; Fransisca, L; Rodriguez-Fernandez, R; Bangs, MJ; Rothe, C				Limmade, Yuriko; Fransisca, Liony; Rodriguez-Fernandez, Rodrigo; Bangs, Michael J.; Rothe, Camilla			HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia	PLOS ONE			English	Article							RECOVERY; COUNT; DETERMINANTS; PREDICTORS; COHORT	Background Papua Province, Indonesia is experiencing an on-going epidemic of Human Immunodeficiency Virus (HIV) infection, with an estimated 9-fold greater prevalence than the overall national rate. This study reviewed the treatment outcomes of an HIV-infected cohort on Antiretroviral Therapy (ART) and the predictors in terms of immunological recovery and virological response. Methods ART-naive individuals in a workplace HIV program in southern Papua were retrospectively analyzed. Patients were assessed at 6, 12 and 36 months after ART initiation for treatment outcomes, and risk factors for virological suppression (viral load (VL) <1,000 copies/ml), poor immune response (CD4 <200 cells/mm(3)) and immunological failure (CD4 <100 cells/mm 3) after at least 6 months on ART, using a longitudinal Generalized Estimating Equations multivariate model. Results Assessment of 105 patients were included in the final analysis with a median age of 34 years, 88% male, median baseline CD4 236 cells/mm(3), and VL 179,000 copies/ml. There were 74, 73, and 39 patients at 6, 12, and 36 months follow-up, respectively, with 5 deaths over the entire period. For the three observation periods, 68, 80, and 75% of patents achieved virological suppression, poor immune responders decreased from 15, 16 to 10%, whilst 15, 16, 10% met the immunological failure criteria, respectively. Using multivariate analysis, the independent predictor for viral suppression at 12 and 36 months was >= 1 log decrease in VL at 6 months (OR 19.25, p<0.001). Higher baseline CD4 was significantly correlated with better immunological outcomes, and lower likelihood of experiencing immunological failure (p <0.001). Conclusion Virological response at six months after beginning ART is the strongest predictor of viral suppression at 12 and 36 months, and may help in identifying patients needing additional adherence therapy support. Higher baseline CD4 positively affects the immunological outcomes of patients. The findings indicate HIV control programs should prioritize the availability of VL testing and begin ART regardless of CD4 counts in infected patients.	[Limmade, Yuriko] Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany; [Fransisca, Liony] Int SOS, PT Freeport Indonesia, Kuala Kencana Clin, Papua, Indonesia; [Rodriguez-Fernandez, Rodrigo] Int SOS, Noncommunicable Dis, London, England; [Rodriguez-Fernandez, Rodrigo] NCD Asia Pacific Alliance, Tokyo, Japan; [Bangs, Michael J.] Int SOS, PT Freeport Indonesia, Publ Hlth & Malaria Control Dept, Papua, Indonesia; [Rothe, Camilla] Ludwig Maximilians Univ Munchen, Univ Hosp, Div Infect Dis & Trop Med, Munich, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Freeport Indonesia; International SOS; Freeport Indonesia; International SOS; University of Munich	Limmade, Y (corresponding author), Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany.	ylimmade@gmail.com		Limmade, Yuriko/0000-0003-3923-4261	PT Freeport Indonesia, an affiliate of Freeport McMoRan, Inc.; International SOS, Ltd.	PT Freeport Indonesia, an affiliate of Freeport McMoRan, Inc.; International SOS, Ltd.	The publication cost of this study was funded by PT Freeport Indonesia, an affiliate of Freeport McMoRan, Inc., and International SOS, Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583; Autran B, 1999, IMMUNOL LETT, V66, P207, DOI 10.1016/S0165-2478(98)00159-X; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Bonner K, 2013, JAIDS-J ACQ IMM DEF, V64, P74, DOI 10.1097/QAI.0b013e31829f05ac; Butt L, 2002, PAPUAN SEXUALITY PRO; Costenaro P, 2014, J CLIN MICROBIOL, V52, P2665, DOI 10.1128/JCM.00961-14; Ditjen PP, 2017, CASES HIV AIDS INDON; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Ekouevi DK, 2007, AIDS RES HUM RETROV, V23, P1469, DOI 10.1089/aid.2007.0059; Estill J, 2016, LANCET HIV, V3, pE132, DOI 10.1016/S2352-3018(16)00016-3; Ferreyra C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049834; Fielding KL, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-93; Ford N, 2015, LANCET INFECT DIS, V15, P241, DOI 10.1016/S1473-3099(14)70896-5; Gilson R, 2010, HIV MED, V11, P152, DOI 10.1111/j.1468-1293.2009.00755.x; Gray RT, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/891593; Haas AD, 2015, LANCET HIV, V2, pE271, DOI 10.1016/S2352-3018(15)00087-9; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Indonesia Ministry of Health, 2014, ISL BANK STAT, P1; Jevtovic D, 2014, BIOMED PHARMACOTHER, V68, P391, DOI 10.1016/j.biopha.2014.01.001; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; KPAD Mimika, 2015, MIM DISTR HIV AIDS S, V1, p[1, 15, 33]; KPAD Mimika, 2016, LAP SIT HIV AIDS DAN, P1; Kwofie Theophilus B, 2015, BMC Res Notes, V8, P413, DOI 10.1186/s13104-015-1406-3; Lohse N, 2006, CLIN INFECT DIS, V42, P136, DOI 10.1086/498515; McMahon JH, 2013, B WORLD HEALTH ORGAN, V91, P377, DOI 10.2471/BLT.12.112946; Mehari M, 2017, FACTORS AFFECTING TR, V3; MoH Indonesia, 2014, PED PENG ANT, P33; Naftalin CM, 2015, INT J STD AIDS, V26, P803, DOI 10.1177/0956462414553826; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Powderly WG, 1999, AIDS, V13, P1873, DOI 10.1097/00002030-199910010-00009; Reda AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058595; Renaud M, 1999, AIDS, V13, P669, DOI 10.1097/00002030-199904160-00007; Sempa JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073190; Smith CJ, 2004, JAIDS-J ACQ IMM DEF, V37, P1155, DOI 10.1097/01.qai.0000135958.80919.e4; Staszewski S, 1999, AIDS, V13, P951, DOI 10.1097/00002030-199905280-00011; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Teshome W, 2014, PLOS ONE, V9, P1; United Nations Data Retrieval System, 2016, UNDATA COUNTR PROF I; Vanobberghen FM, 2015, TROP MED INT HEALTH, V20, P880, DOI 10.1111/tmi.12507; WHO, 2010, ANT THER HIV INF AD; WHO, 2015, WHO ISS NEW HIV REC; WHO, 2016, GLOB REP EARL WARN I; Wijayanti F, 2016, J VIRUS ERAD, V2, P27; World Health Organization, 2016, CONS GUID US ANT DRU; World Health Organization, 2016, CONGUID UANT DRU, P72; Young W, 2013, AIDS RES THER, V10, P1; Yunifiar MQ, 2017, ACTA MED INDONES, V49, P205; Zhou JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-361	49	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212432	10.1371/journal.pone.0212432	http://dx.doi.org/10.1371/journal.pone.0212432			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802257	gold, Green Published, Green Submitted			2022-12-26	WOS:000459710700012
J	Lind, L; Sundstrom, J; Larsson, A; Lampa, E; Arnlov, J; Ingelsson, E				Lind, Lars; Sundstrom, Johan; Larsson, Anders; Lampa, Erik; Arnlov, Johan; Ingelsson, Erik			Longitudinal effects of aging on plasma proteins levels in older adults - associations with kidney function and hemoglobin levels	PLOS ONE			English	Article							PROTEOMICS	Background A targeted proteomics chip has been shown to be useful to discover novel associations of proteins with cardiovascular disease. We investigated how these proteins change with aging, and whether this change is related to a decline in kidney function, or to a change in hemoglobin levels. Material and methods In the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study, including 1,016 participants from the general population aged 70 at baseline, 84 proteins were measured at ages 70, 75, 80. At these occasions, glomerular filtration rate (eGFR) was estimated and the hemoglobin levels were measured. Results Sixty-one of the 84 evaluated proteins changed significantly during the 10-year follow-up (multiple testing-adjusted alpha = 0.00059), most showing an increase. The change in eGFR was inversely related to changes of protein levels for the vast majority of proteins (74%). The change in hemoglobin was significantly related to the change in 40% of the evaluated proteins, with no obvious preference of the direction of these relationships. Conclusion The majority of evaluated proteins increased with aging in adults. Therefore, normal ranges for proteins might be given in age-strata. The increase in protein levels was associated with the degree of reduction in eGFR for the majority of proteins, while no clear pattern was seen for the relationships between the proteins and the change in hemoglobin levels. Studies on changes in urinary proteins are warranted to understand the association between the reduction in eGFR and increase in plasma protein levels.	[Lind, Lars; Sundstrom, Johan; Larsson, Anders] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Sundstrom, Johan; Lampa, Erik] Uppsala Clin Res Ctr, Uppsala, Sweden; [Arnlov, Johan] Dalarna Univ, Sch Hlth & Social Studies, Falun, Sweden; [Arnlov, Johan] Karolinska Inst, Div Family Med, Dept Neurobiol Care Sci & Soc, Huddinge, Sweden; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Mol Epidemiol & Sci Life Lab, Uppsala, Sweden; [Ingelsson, Erik] Stanford Univ, Dept Med, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Ingelsson, Erik] Stanford Univ, Stanford Diabet Res Ctr, Stanford, CA 94305 USA	Uppsala University; Uppsala University; Dalarna University; Karolinska Institutet; Uppsala University; Stanford University; Stanford University; Stanford University	Lind, L (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	lars.lind@medsci.uu.se	Ärnlöv, Johan/AAF-2746-2019; Sundstrom, Johan/R-2139-2019; Sundström, Johan/A-6286-2009	Ärnlöv, Johan/0000-0002-6933-4637; Sundstrom, Johan/0000-0003-2247-8454; Sundström, Johan/0000-0003-2247-8454; Ingelsson, Erik/0000-0003-2256-6972	Knut och Alice Wallenberg Foundation [2013.0126]; National Institutes of Health [R01DK106236]; Uppsala University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK106236, P30DK116074] Funding Source: NIH RePORTER	Knut och Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uppsala University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was conducted with support from Knut och Alice Wallenberg Foundation (2013.0126), National Institutes of Health (R01DK106236), and Uppsala University. The funding agencies did not have any influence over design, analysis or interpretation of data in the present study.	Alis R, 2015, SCAND J MED SCI SPOR, V25, pE630, DOI 10.1111/sms.12393; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Bjurman C, 2015, CLIN BIOCHEM, V48, P302, DOI 10.1016/j.clinbiochem.2015.01.008; Carlsson AC, 2017, CLIN J AM SOC NEPHRO, V12, P1226, DOI 10.2215/CJN.08780816; Carlsson AC, 2014, J AM SOC NEPHROL, V25, P1313, DOI 10.1681/ASN.2013080860; Christensson A, 2018, PROTEOM CLIN APPL, V12, DOI 10.1002/prca.201700067; Eggers KM, 2016, CLIN CHEM, V62, P485, DOI 10.1373/clinchem.2015.246876; Enroth S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5684; Fitzmaurice G.M., 2012, APPL LONGITUDINAL AN; Ignjatovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017213; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jia LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005146; KOISO K, 1975, UROL RES, V2, P167; Lietzen N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24019-5; Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da; Lind L, 2017, HEART, V103, P379, DOI 10.1136/heartjnl-2016-309764; Lind L, 2015, STROKE, V46, P3340, DOI 10.1161/STROKEAHA.115.010829; Lind L, 2015, ATHEROSCLEROSIS, V242, P205, DOI 10.1016/j.atherosclerosis.2015.07.023; Liu CW, 2017, J PROTEOMICS, V152, P321, DOI 10.1016/j.jprot.2016.11.016; Lu JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039726; Menni C, 2015, J GERONTOL A-BIOL, V70, P809, DOI 10.1093/gerona/glu121; Naseeb U, 2015, JCPSP-J COLL PHYSICI, V25, P606, DOI 08.2015/JCPSP.606609; Schenk S, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-41	23	9	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212060	10.1371/journal.pone.0212060	http://dx.doi.org/10.1371/journal.pone.0212060			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802263	Green Published, Green Submitted, gold			2022-12-26	WOS:000459710700009
J	Calvo-Lerma, J; Fornes-Ferrer, V; Peinado, I; Heredia, A; Ribes-Koninckx, C; Andres, A				Calvo-Lerma, Joaquim; Fornes-Ferrer, Victoria; Peinado, Irene; Heredia, Ana; Ribes-Koninckx, Carmen; Andres, Ana			A first approach for an evidence-based in vitro digestion method to adjust pancreatic enzyme replacement therapy in cystic fibrosis	PLOS ONE			English	Article							NUTRITIONAL-STATUS; DAIRY MATRICES; PH; LIPOLYSIS; PROFILES; RELEASE; DIGESTIBILITY; INSUFFICIENCY; CHILDREN; OUTCOMES	Background Patients with cystic fibrosis have to take enzymatic supplements to allow for food digestion. However, an evidence-based method to adjust Pancreatic Enzyme Replacement Therapy (PERT) is inexistent, and lipid content of meals is used as a rough criterion. Objective In this study, an in vitro digestion model was set up to determine the theoretical optimal dose (TOD) of enzymatic supplement for a selection of foods, which is the dose that allows for maximum lipolysis extent. Methods A static in vitro digestion model was applied to simulate digestion of eight foods covering a wide range of lipid contents. First, the dose of the enzymatic supplement was fixed at 2000 lipase units per gram of fat (LU/g fat) using intestinal pH and bile salt concentration as variables. Second, intestinal pH and bile salt concentrations were fixed and the variable was the dose of the enzymatic supplement. Lipolysis extent was determined by measuring the free fatty acids released from initial triglycerides content of foods after digestion. Results in terms of percentage of lipolysis extent were fitted into a linear-mixed segmented model and the deducted equations were used to predict the TOD to reach 90% of lipolysis in every food. In addition, the effect of intestinal pH and bile salt concentration were investigated. Results The predictive equations obtained for the assessed foods showed that lipolysis was not only dependent on the dose of the enzyme supplement or the lipid content. Moreover, intestinal pH and bile salt concentration had significant effects on lipolysis. Therefore an evidence-based model can be developed taking into account these variables. Conclusions Depending on food characteristics, a specific TOD should be assigned to achieve an optimal digestion extent. This work represents a first step towards an evidence-based method for PERT dosing, which will be applied in an in vivo setting to validate its efficacy.	[Calvo-Lerma, Joaquim; Peinado, Irene; Heredia, Ana; Andres, Ana] Univ Politecn Valencia, Res Inst Food Engn Dev, Valencia, Spain; [Calvo-Lerma, Joaquim; Fornes-Ferrer, Victoria; Ribes-Koninckx, Carmen] Inst Invest Sanitaria La Fe Valencia, Valencia, Spain	Universitat Politecnica de Valencia	Calvo-Lerma, J (corresponding author), Univ Politecn Valencia, Res Inst Food Engn Dev, Valencia, Spain.; Calvo-Lerma, J (corresponding author), Inst Invest Sanitaria La Fe Valencia, Valencia, Spain.	joaquin_calvo@iislafe.es	Heredia, Ana/C-7107-2016; Ribes-Koninckx, Maria Carmen/ABH-5577-2020; Calvo-Lerma, Joaquim/P-4605-2016; Grau, Ana M Andrés/C-9521-2016; Calvo-Lerma, Joaquim/AAB-2783-2020	Heredia, Ana/0000-0001-6629-9779; Calvo-Lerma, Joaquim/0000-0001-7818-0652; Grau, Ana M Andrés/0000-0002-6132-3167; Calvo-Lerma, Joaquim/0000-0001-7818-0652; Ribes-Koninckx, Carmen/0000-0002-0038-6324	European Union [643806]	European Union(European Commission)	This work was fully funded by the European Union and the Horizon 2020 Research and Innovation Framework Programme (PHC-26-2014 call Self management of health and disease: citizen engagement and mHealth) under grant number 643806.	Aburub A, 2018, INT J PHARMACEUT, V544, P158, DOI 10.1016/j.ijpharm.2018.04.031; Aloulou A, 2008, ALIMENT PHARM THERAP, V27, P283, DOI 10.1111/j.1365-2036.2007.03563.x; Andree M., 1996, NEW ENGL J MED, V289, P1001; BLACKBERG L, 1979, J CLIN INVEST, V64, P1303, DOI 10.1172/JCI109586; Bornhorst GM, 2015, J FOOD SCI, V80, pR924, DOI 10.1111/1750-3841.12846; Borowitz D, 2005, J PEDIATR GASTR NUTR, V41, P273, DOI 10.1097/01.mpg.0000178439.64675.8d; Calvo-Leima J, 2017, J CYST FIBROS, V16, P510, DOI 10.1016/j.jcf.2017.03.005; Calvo-Lerma J, 2018, J FOOD SCI, V83, P2629, DOI 10.1111/1750-3841.14343; Calvo-Lerma J, 2017, REV ESP ENFERM DIG, V109, P684, DOI 10.17235/reed.2017.4951/2017; Calvo-Lerma J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014931; Carriere F, 2000, GASTROENTEROLOGY, V119, P949, DOI 10.1053/gast.2000.18140; COLOMBO C, 1988, SCAND J GASTROENTERO, V23, P151, DOI 10.3109/00365528809090237; Fang XX, 2016, FOOD RES INT, V88, P276, DOI 10.1016/j.foodres.2016.04.008; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; Fieker A, 2011, CLIN EXP GASTROENTER, V4, P55, DOI 10.2147/CEG.S17634; Gelfond D, 2013, DIGEST DIS SCI, V58, P2275, DOI 10.1007/s10620-012-2209-1; Gonzalez- Bacerio J., 2010, REV COLOMBIANA DELEL, V12, P113; Helbig A, 2012, FOOD HYDROCOLLOID, V28, P10, DOI 10.1016/j.foodhyd.2011.11.007; Heneen WK, 2003, STARCH-STARKE, V55, P546, DOI 10.1002/star.200300187; Hu M, 2010, FOOD HYDROCOLLOID, V24, P719, DOI 10.1016/j.foodhyd.2010.03.010; Humbert L, 2018, J LIPID RES, V59, P2202, DOI 10.1194/jlr.M084830; Hunter JE, 2001, LIPIDS, V36, P655, DOI 10.1007/s11745-001-0770-0; Kim EHJ, 2008, FOOD BIOPHYS, V3, P229, DOI 10.1007/s11483-008-9066-7; Lamothe S, 2017, FOOD RES INT, V92, P138, DOI 10.1016/j.foodres.2016.12.026; Lamothe S, 2014, FOOD FUNCT, V5, P2621, DOI [10.1039/c4fo00203b, 10.1039/C4FO00203B]; Layer P, 2003, PANCREAS, V26, P1, DOI 10.1097/00006676-200301000-00001; Lesmes U, 2012, FOOD HYDROCOLLOID, V26, P221, DOI 10.1016/j.foodhyd.2011.05.011; Li Y, 2011, FOOD CHEM, V126, P498, DOI 10.1016/j.foodchem.2010.11.027; Mcclements DJ, 2009, CRIT REV FOOD SCI, V49, P48, DOI 10.1080/10408390701764245; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Muggeo V.M.R., 2016, SEGMENTED MIXED MODE; Norman A. P., 1979, ARCH DIS CHILD, V54, P19; PRAZERES DMF, 1994, BIOPROCESS ENG, V10, P21, DOI 10.1007/BF00373531; RESMINI P, 1983, FOOD MICROSTRUCT, V2, P1; ROBINSON PJ, 1990, DIGEST DIS SCI, V35, P1299, DOI 10.1007/BF01536423; Rovner AJ, 2014, INFLAMM BOWEL DIS MO, V14, P65; Schall JI, 2006, J PEDIATR GASTR NUTR, V43, P651, DOI 10.1097/01.mpg.0000234082.47884.d9; Sikkens ECM, 2010, BEST PRACT RES CL GA, V24, P337, DOI 10.1016/j.bpg.2010.03.006; Turck D, 2016, CLIN NUTR, V35, P557, DOI 10.1016/j.clnu.2016.03.004; VERGER R, 1976, ANNU REV BIOPHYS BIO, V5, P77, DOI 10.1146/annurev.bb.05.060176.000453; Whitcomb DC, 2010, AM J GASTROENTEROL, V105, P2276, DOI 10.1038/ajg.2010.201; Ye XT, 2016, INT J BIOL MACROMOL, V84, P428, DOI 10.1016/j.ijbiomac.2015.12.054; Yen EH, 2013, J PEDIATR-US, V162, P530, DOI 10.1016/j.jpeds.2012.08.040; YOUNGBERG CA, 1987, DIGEST DIS SCI, V32, P472, DOI 10.1007/BF01296029; Zhu XQ, 2013, FOOD CHEM, V139, P398, DOI 10.1016/j.foodchem.2012.12.060	45	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212459	10.1371/journal.pone.0212459	http://dx.doi.org/10.1371/journal.pone.0212459			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794618	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100071
J	Samarin, AM; Samarin, AM; Ostbye, TKK; Ruyter, B; Sampels, S; Burkina, V; Blecha, M; Gela, D; Policar, T				Samarin, Azin Mohagheghi; Samarin, Azadeh Mohagheghi; Ostbye, Tone-Kari Knutsdatter; Ruyter, Bente; Sampels, Sabine; Burkina, Viktoriia; Blecha, Miroslav; Gela, David; Policar, Tomas			Alteration of mRNA abundance, oxidation products and antioxidant enzyme activities during oocyte ageing in common carp Cyprinus carpio	PLOS ONE			English	Article							RAINBOW-TROUT; IN-VITRO; EGG QUALITY; CALCIUM OSCILLATIONS; GENE-EXPRESSION; MOUSE OOCYTES; STRESS; APOPTOSIS; ACTIVATION; TIME	Oocyte ageing is the most important factor affecting egg quality of several fish species after ovulation. Oxidative stress has been proposed as the initiator of the oocyte ageing process in other vertebrates. To identify the role of oxidative stress and apoptosis on the progress of oocyte ageing in the common carp Cyprinus carpio, changes in the relative mRNA abundance of selected transcripts were examined. The possible alteration in the oxidation status of the oocytes during ageing was also studied. In addition, the activity of antioxidant enzymes during oocyte ageing was evaluated. Oocytes from 6 females were incubated in vivo for 14 hours post-ovulation (HPO) and in vitro for 10 hours post-stripping (HPS) at 20 degrees C before fertilization. Hatching rates were over 65% up to 4-6 HPO, finally dropping to 1.3% at 12-14 HPO. Hatching rates were over 65% up to 4-6 HPO, finally dropping to 1.3% at 1214 HPO. Hatching rates were more than 70% for the eggs stored in vitro up to 6 HPS and then decreased to 21.3% at 10 HPS. The results demonstrated no significant changes in the relative mRNA levels of oxidative stress-related genes or genes involved in the cell cycle during the progress of oocyte ageing in common carp. Additionally, the amount of TBARS and carbonyls did not change as time elapsed following ovulation. The apoptosis-related genes however, were significantly altered following the prolonged time interval between ovulation and fertilization. The lack of response of both activities of antioxidant enzymes and oxidation products during oocyte ageing strengthens the conclusion that oxidative stress is unlikely to be a main factor determining the progress of oocyte ageing in common carp. However, an increase in the mRNA abundance of apoptosis-related genes demonstrates that apoptotic pathway might be involved in the progress of oocyte ageing.	[Samarin, Azin Mohagheghi; Samarin, Azadeh Mohagheghi; Burkina, Viktoriia; Blecha, Miroslav; Gela, David; Policar, Tomas] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic; [Ostbye, Tone-Kari Knutsdatter; Ruyter, Bente] Nofima Norwegian Inst Food Fisheries & Aquacultur, As, Norway; [Sampels, Sabine] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden	University of South Bohemia Ceske Budejovice; Nofima; Swedish University of Agricultural Sciences	Samarin, AM (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic.	mohagheghi@frov.jcu.cz	Policar, Tomas/G-4896-2015; Samarin, Azin Mohagheghi/G-3468-2015	Policar, Tomas/0000-0001-9245-4381; Ostbye, Tone-Kari Knutsdatter/0000-0001-5173-7115	Ministry of Education, Youth and Sports of the Czech Republic [LM2018099]; project Reproductive and Genetic Procedures for Preserving Fish Biodiversity and Aquaculture [CZ.02.1.01/0.0/0.0/16_025/0007370]; Ministry of Agriculture of the Czech Republic: project NAZV [QK1710310];  [NF-CZ07-MOP-3-184-2015];  [NF-CZ07-ICP-3-185-2015]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); project Reproductive and Genetic Procedures for Preserving Fish Biodiversity and Aquaculture; Ministry of Agriculture of the Czech Republic: project NAZV; ; 	The study was financially supported by the Ministry of Education, Youth and Sports of the Czech Republic - project "CENAKVA" (LM2018099), project Reproductive and Genetic Procedures for Preserving Fish Biodiversity and Aquaculture (CZ.02.1.01/0.0/0.0/16_025/0007370), the Ministry of Agriculture of the Czech Republic: project NAZV (QK1710310) and by NF-CZ07-MOP-3-184-2015 and NF-CZ07-ICP-3-185-2015.	Aegerter S, 2005, MOL REPROD DEV, V72, P377, DOI 10.1002/mrd.20361; Aegerter S, 2004, AQUACULTURE, V231, P59, DOI 10.1016/j.aquaculture.2003.08.019; Aegerter S, 2004, MOL REPROD DEV, V67, P127, DOI 10.1002/mrd.10384; Babiak I, 2003, J EXP ZOOL PART A, V300A, P140, DOI 10.1002/jez.a.10319; Bobe J, 2010, GEN COMP ENDOCR, V165, P535, DOI 10.1016/j.ygcen.2009.02.011; BOERJAN ML, 1990, MOL REPROD DEV, V25, P155, DOI 10.1002/mrd.1080250208; Bonnet E, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-55; Bonnet E, 2007, THERIOGENOLOGY, V67, P786, DOI 10.1016/j.theriogenology.2006.10.008; Butt AJ, 1999, IMMUNOL CELL BIOL, V77, P256, DOI 10.1046/j.1440-1711.1999.00822.x; Claiborne A, 1985, CRC HDB METHODS OXYG, P283; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CRIBB AE, 1989, ANAL BIOCHEM, V183, P195, DOI 10.1016/0003-2697(89)90188-7; DEAN RT, 1993, TRENDS BIOCHEM SCI, V18, P437, DOI 10.1016/0968-0004(93)90145-D; Esponda P, 2006, AGE INDUCED APOPTOSI, p184a; Flajshans M, 2007, J FISH BIOL, V71, P868, DOI 10.1111/j.1095-8649.2007.01557.x; Fujino Y, 1996, HUM REPROD, V11, P1480; Gordo AC, 2002, BIOL REPROD, V66, P1828, DOI 10.1095/biolreprod66.6.1828; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; Headlam HA, 2004, FREE RADICAL BIO MED, V36, P1175, DOI 10.1016/j.freeradbiomed.2004.02.017; Horvath L, 1985, COMMON CARP PT 1 MAS; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Huang JC, 2007, BIOL REPROD, V77, P666, DOI 10.1095/biolreprod.107.062703; Kagedal K, 2001, FASEB J, V15, P1592, DOI 10.1096/fj.00-0708fje; Kikuchi Kazuhiro, 2002, Cloning and Stem Cells, V4, P211, DOI 10.1089/15362300260339494; Komrakova M, 2009, AQUACULTURE, V286, P156, DOI 10.1016/j.aquaculture.2008.09.019; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lahnsteiner F, 2001, AQUACULTURE, V195, P331, DOI 10.1016/S0044-8486(00)00550-0; LAM TJ, 1978, CAN J ZOOL, V56, P2029, DOI 10.1139/z78-273; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Li P, 2010, BIOL REPROD, V83, P852, DOI 10.1095/biolreprod.110.085852; Liang XW, 2008, BIOCHEM BIOPH RES CO, V371, P16, DOI 10.1016/j.bbrc.2008.03.105; Liang XW, 2011, MOL HUM REPROD, V17, P562, DOI 10.1093/molehr/gar018; Liu W, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2130-z; Lord T, 2013, REPRODUCTION, V146, pR217, DOI 10.1530/REP-13-0111; Lord T, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106450; Ma H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1400-0; Ma W, 2005, BIOL REPROD, V72, P373, DOI 10.1095/biolreprod.104.030999; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; MCEVOY LA, 1984, J FISH BIOL, V24, P437, DOI 10.1111/j.1095-8649.1984.tb04814.x; Minami N, 2007, J REPROD DEVELOP, V53, P707, DOI 10.1262/jrd.19029; MOHANDAS J, 1984, BIOCHEM PHARMACOL, V33, P1801, DOI 10.1016/0006-2952(84)90353-8; Mok HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148577; Mommens Maren, 2010, BMC Research Notes, V3, DOI 10.1186/1756-0500-3-138; Nikolic A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1741072; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; OLIVER CN, 1987, J BIOL CHEM, V262, P5488; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Raz E., 2000, GENOME BIOL, V1; Rime Helene, 2004, Reprod Biol Endocrinol, V2, P26, DOI 10.1186/1477-7827-2-26; Saffman EE, 1999, CELL MOL LIFE SCI, V55, P1141, DOI 10.1007/s000180050363; Samarin AM, 2017, ANIMAL, V11, P78, DOI 10.1017/S1751731116001361; Samarin AM, 2015, J APPL ICHTHYOL, V31, P51, DOI 10.1111/jai.12855; Samarin AM, 2018, AQUAC RES, V49, P1037, DOI 10.1111/are.13552; Samarin AM, 2016, AQUACULTURE, V450, P431, DOI 10.1016/j.aquaculture.2015.08.017; Samarin AM, 2015, REV FISH SCI AQUAC, V23, P302, DOI 10.1080/23308249.2015.1053560; SCHULTZ GA, 1992, MUTAT RES, V296, P17, DOI 10.1016/0165-1110(92)90029-9; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Takahashi T, 2003, MOL REPROD DEV, V66, P143, DOI 10.1002/mrd.10341; Takahashi T, 2013, J OBSTET GYNAECOL RE, V39, P1431, DOI 10.1111/jog.12111; Tarin JJ, 2002, BIOL REPROD, V66, P495, DOI 10.1095/biolreprod66.2.495; Tarin JJ, 2000, HUM REPROD UPDATE, V6, P532, DOI 10.1093/humupd/6.6.532; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; Tzung KW, 2015, STEM CELL REP, V4, P61, DOI 10.1016/j.stemcr.2014.10.011; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Xu Z, 1997, BIOL REPROD, V57, P743, DOI 10.1095/biolreprod57.4.743; Yang HW, 1998, HUM REPROD, V13, P998, DOI 10.1093/humrep/13.4.998; Yoshida N, 2007, DEV BIOL, V301, P464, DOI 10.1016/j.ydbio.2006.08.006; Zuccotti M, 2011, HUM REPROD UPDATE, V17, P525, DOI 10.1093/humupd/dmr009	71	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212694	10.1371/journal.pone.0212694	http://dx.doi.org/10.1371/journal.pone.0212694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794661	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100118
J	Ware, HH; Kulkarni, VV; Wang, YX; Garcia, JP; Juarez, ML; Kirkpatrick, CT; Wali, S; Syed, S; Kontoyiannis, AD; Sikkema, WKA; Tour, JM; Evans, SE				Ware, Hayden H.; Kulkarni, Vikram V.; Wang, Yongxing; Garcia, Jezreel Pantaleon; Juarez, Miguel Leiva; Kirkpatrick, Carson T.; Wali, Shradha; Syed, Sarah; Kontoyiannis, Alexander D.; Sikkema, William K. A.; Tour, James M.; Evans, Scott E.			Inducible lung epithelial resistance requires multisource reactive oxygen species generation to protect against bacterial infections	PLOS ONE			English	Article							INDUCED ROS RELEASE; INFLUENZA-A VIRUS; CEREBROVASCULAR DYSFUNCTION; RISK-FACTORS; PNEUMONIA; MITOCHONDRIA; DUOX; EFFECTORS; THERAPY; BIOLOGY	Pneumonia remains a global health threat, in part due to expanding categories of susceptible individuals and increasing prevalence of antibiotic resistant pathogens. However, therapeutic stimulation of the lungs' mucosal defenses by inhaled exposure to a synergistic combination of Toll-like receptor (TLR) agonists known as Pam2-ODN promotes mouse survival of pneumonia caused by a wide array of pathogens. This inducible resistance to pneumonia relies on intact lung epithelial TLR signaling, and inducible protection against viral pathogens has recently been shown to require increased production of epithelial reactive oxygen species (ROS) from multiple epithelial ROS generators. To determine whether similar mechanisms contribute to inducible antibacterial responses, the current work investigates the role of ROS in therapeutically-stimulated protection against Pseudomonas aerugnosa challenges. Inhaled Pam2-ODN treatment one day before infection prevented hemorrhagic lung cytotoxicity and mouse death in a manner that correlated with reduction in bacterial burden. The bacterial killing effect of Pam2-ODN was recapitulated in isolated mouse and human lung epithelial cells, and the protection correlated with inducible epithelial generation of ROS. Scavenging or targeted blockade of ROS production from either dual oxidase or mitochondrial sources resulted in near complete loss of Pam2-ODN-induced bacterial killing, whereas deficiency of induced antimicrobial peptides had little effect. These findings support a central role for multisource epithelial ROS in inducible resistance against a bacterial pathogen and provide mechanistic insights into means to protect vulnerable patients against lethal infections.	[Ware, Hayden H.; Kulkarni, Vikram V.; Wang, Yongxing; Garcia, Jezreel Pantaleon; Juarez, Miguel Leiva; Kirkpatrick, Carson T.; Wali, Shradha; Syed, Sarah; Kontoyiannis, Alexander D.; Evans, Scott E.] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA; [Kulkarni, Vikram V.; Wali, Shradha; Evans, Scott E.] Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA; [Sikkema, William K. A.; Tour, James M.] Rice Univ, Smalley Inst Nanoscale Sci & Technol, Houston, TX 77005 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Rice University	Evans, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA.; Evans, SE (corresponding author), Univ Texas MD Anderson Canc Ctr, UT Hlth Grad Sch Biomed Sci, Houston, TX 77030 USA.	seevans@mdanderson.org	Wali, Shradha/GNP-5631-2022	Pantaleon Garcia, Jezreel/0000-0002-9647-2584; Evans, Scott/0000-0003-4503-0644; Wali, Shradha/0000-0002-6077-7618	US National Institutes of Health (NIH) [R01 HL117976, DP2 HL123229, P30 CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117976] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by US National Institutes of Health (NIH) grants R01 HL117976 and DP2 HL123229 to S.E.E. and P30 CA016672 to the MD Anderson Cancer Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro VY, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00008; Bitner BR, 2012, ACS NANO, V6, P8007, DOI 10.1021/nn302615f; Blake Francis G., 2000, Yale Journal of Biology and Medicine, V73, P103; Blasi F, 2007, RESP MED, V101, P875, DOI 10.1016/j.rmed.2007.02.016; Cegolon L, 2014, INT J HYG ENVIR HEAL, V217, P17, DOI 10.1016/j.ijheh.2013.03.001; Cleaver JO, 2014, MUCOSAL IMMUNOL, V7, P78, DOI 10.1038/mi.2013.26; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Dryden M, 2018, INT J ANTIMICROB AG, V51, P299, DOI 10.1016/j.ijantimicag.2017.08.029; Duggan JM, 2011, J IMMUNOL, V186, P5916, DOI 10.4049/jimmunol.1002122; Evans SE, 2011, BRIT J PHARMACOL, V163, P195, DOI 10.1111/j.1476-5381.2011.01237.x; Evans SE, 2010, ANNU REV PHYSIOL, V72, P413, DOI 10.1146/annurev-physiol-021909-135909; Fang FC, 2011, MBIO, V2, DOI 10.1128/mBio.00141-11; File TM, 2003, LANCET, V362, P1991, DOI 10.1016/S0140-6736(03)15021-0; Fischer H, 2009, ANTIOXID REDOX SIGN, V11, P2453, DOI [10.1089/ars.2009.2558, 10.1089/ARS.2009.2558]; Forteza R, 2005, AM J RESP CELL MOL, V32, P462, DOI 10.1165/rcmb.2004-0302OC; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Garaude J, 2016, NAT IMMUNOL, V17, P1037, DOI 10.1038/ni.3509; Grandvaux N, 2015, CLIN SCI, V128, P337, DOI 10.1042/CS20140321; Guirao-Abad JP, 2017, INT J MED MICROBIOL, V307, P241, DOI 10.1016/j.ijmm.2017.03.005; James John S, 2004, AIDS Treat News, P7; Jeon YJ, 2018, APPL MICROBIOL BIOT, V102, P4339, DOI 10.1007/s00253-018-8956-y; Joos Ladina, 2005, Proc Am Thorac Soc, V2, P445, DOI 10.1513/pats.200508-097JS; Kim S, 2015, ANTIVIR RES, V119, P78, DOI 10.1016/j.antiviral.2015.04.011; Kim YM, 2017, AM J PHYSIOL-CELL PH, V312, pC749, DOI 10.1152/ajpcell.00346.2016; Kirkpatrick CT, 2018, MBIO, V9, DOI 10.1128/mBio.00696-18; KLEBANOFF SJ, 1966, BIOCHIM BIOPHYS ACTA, V117, P63, DOI 10.1016/0304-4165(66)90152-8; Knust J, 2009, ANAT REC, V292, P113, DOI 10.1002/ar.20747; Leiva-Juarez MM, 2018, MUCOSAL IMMUNOL, V11, P21, DOI 10.1038/mi.2017.71; Leiva-Juarez MM, 2016, BLOOD, V128, P982, DOI 10.1182/blood-2016-03-708511; Marcano DC, 2013, J NEUROTRAUM, V30, P789, DOI 10.1089/neu.2011.2301; Memar MY, 2018, INFECT DRUG RESIST, V11, P567, DOI 10.2147/IDR.S142397; Mizgerd JP, 2006, PLOS MED, V3, P155, DOI 10.1371/journal.pmed.0030076; Munro D, 2017, J EXP BIOL, V220, P1170, DOI 10.1242/jeb.132142; Patton JS, 2010, J AEROSOL MED PULM D, V23, pS71, DOI 10.1089/jamp.2010.0836; Pinegin B, 2018, J CELL PHYSIOL, V233, P3745, DOI 10.1002/jcp.26117; Samuel ELG, 2015, P NATL ACAD SCI USA, V112, P2343, DOI 10.1073/pnas.1417047112; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shekhova E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00978-17, 10.1128/aac.00978-17]; SOCIETY FOR, 2012, INFECT CONT HOSP EP, V33, P322, DOI DOI 10.1086/665010; Stocks CJ, 2018, J LEUKOCYTE BIOL, V103, P35, DOI 10.1002/JLB.4RI0917-358R; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; Thomsen RW, 2006, J INTERN MED, V259, P410, DOI 10.1111/j.1365-2796.2006.01629.x; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; Trotter CL, 2008, EMERG INFECT DIS, V14, P727, DOI 10.3201/eid1405.071011; van der Vliet A, 2008, FREE RADICAL BIO MED, V44, P938, DOI 10.1016/j.freeradbiomed.2007.11.016; Vatansever F, 2013, FEMS MICROBIOL REV, V37, P955, DOI 10.1111/1574-6976.12026; Vinogradova Y, 2009, BRIT J GEN PRACT, V59, P742, DOI 10.3399/bjgp09X472629; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wong JL, 2017, CLIN CHEST MED, V38, P263, DOI 10.1016/j.ccm.2016.12.005; World Health Organization, 2004, WORLD HLTH REP 2004; Zhang X, 2015, FREE RADICAL RES, V49, P374, DOI 10.3109/10715762.2015.1014813; Zinkevich NS, 2011, AM J PHYSIOL-HEART C, V301, pH647, DOI 10.1152/ajpheart.01271.2010; Zou LL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29313-w	55	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0208216	10.1371/journal.pone.0208216	http://dx.doi.org/10.1371/journal.pone.0208216			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794556	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100007
J	Park, JW; Kim, DK; Jung, JY; Lee, SU; Chang, I; Kwak, YH; Hwang, S				Park, Joong Wan; Kim, Do Kyun; Jung, Jae Yun; Lee, Se Uk; Chang, Ikwan; Kwak, Young Ho; Hwang, Soyun			Dog-bite injuries in Korea and risk factors for significant dog-bite injuries: A 6-year cross-sectional study	PLOS ONE			English	Article							EPIDEMIOLOGY	Introduction An accurate understanding of the current status of dog-bite injuries in Korea is essential for establishing preventive strategies. There have been no national reports about dog-bite injuries in Korea. This study investigated dog-bite injuries in Korea that were registered in the nationwide injury surveillance database and analysed the risk factors for significant dog-bite injury. Methods A multicentre cross-sectional study was conducted using the emergency department (ED)-based Injury In-depth Surveillance (EDIIS) registry in Korea between 2011 and 2016. We defined significant injury as death, admission, surgery, or fracture or amputation. A multivariable logistic regression model was used to obtain the adjusted odds ratios (aORs) for the factors associated with significant dog-bite injuries. Results Among 1,537,617 injured patients, 9,966 (6.5 per 1,000 injured patients) presented to the ED for dog-bite injuries (5.6 in 2011 to 7.6 in 2016, P for trend < 0.001), and 489 (4.9%) were significant injuries. In the age-specific analysis, there were increasing trends only among teenagers (12-18 years) and adults (> 18 years). Being elderly (>= 60 years) (aOR: 2.70, 95% CI: 2.15-3.39), having injuries to multiple anatomic sites (aOR: 4.37, 95% CI: 2.96-6.45), being bitten outdoors (aOR: 2.71, 95% CI: 2.20-3.34), and being bitten by a relative's dog (aOR: 2.37, 95% CI: 1.09-5.17) were strongly associated with significant dog-bite injury. Conclusion Dog-bite injuries are increasing in Korea, especially in teenagers and adults. A relative's or neighbour's dog may be more dangerous than a stranger's dog. Preventive strategies are needed to prevent dog-bite injuries in adults and children.	[Park, Joong Wan; Kim, Do Kyun; Jung, Jae Yun; Lee, Se Uk; Kwak, Young Ho; Hwang, Soyun] Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea; [Chang, Ikwan] Kangwon Natl Univ, Coll Med, Dept Emergency Med, Chunchon, Gangwon Do, South Korea	Seoul National University (SNU); Seoul National University Hospital; Kangwon National University	Kim, DK (corresponding author), Seoul Natl Univ Hosp, Dept Emergency Med, Seoul, South Korea.	birdbeak@naver.com	Kim, Do Kyun/Q-3070-2018	Kim, Do Kyun/0000-0002-6144-302X; Hwang, Soyun/0000-0002-4290-0213				Abrahamian, 2000, Curr Infect Dis Rep, V2, P446, DOI 10.1007/s11908-000-0075-z; Alberghina D, 2017, VET ITAL, V53, P315, DOI 10.12834/VetIt.1063.5709.2; BROGAN TV, 1995, PEDIATRICS, V96, P947; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P605; Ellis R, 2014, AM FAM PHYSICIAN, V90, P239; Gilchrist J, 2008, INJURY PREV, V14, P296, DOI 10.1136/ip.2007.016220; GOLDSTEIN EJC, 1989, J AM ACAD DERMATOL, V21, P1275, DOI 10.1016/S0190-9622(89)70343-1; Golinko MS, 2017, CLIN PEDIATR, V56, P316, DOI 10.1177/0009922816657153; Kaye AE, 2009, PLAST RECONSTR SURG, V124, P551, DOI 10.1097/PRS.0b013e3181addad9; Medeiros I, 2001, COCHRANE DB SYST REV, V1; Meslin FX, 2005, J TRAVEL MED, V12, pS30, DOI 10.2310/7060.2005.12055; National Emergency Medical Center, 2015, 2014 YB NEDIS STAT; Ostanello F, 2005, EMERG MED J, V22, P260, DOI 10.1136/emj.2004.014886; Overall KL, 2001, J AM VET MED ASSOC, V218, P1923, DOI 10.2460/javma.2001.218.1923; Park GJ, 2018, INJURY, V49, P1097, DOI 10.1016/j.injury.2018.04.001; Peters V, 2004, J PEDIATR-US, V144, P121, DOI 10.1016/j.jpeds.2003.10.024; Rhea S, 2014, ACAD EMERG MED, V21, P196, DOI 10.1111/acem.12312; Rosado B, 2009, VET J, V179, P383, DOI 10.1016/j.tvjl.2008.02.002; Steele MT, 2007, ACAD EMERG MED, V14, P398, DOI 10.1111/j.1553-2712.2007.tb01797.x; Talan DA, 1999, NEW ENGL J MED, V340, P85, DOI 10.1056/NEJM199901143400202; Weiss HB, 1998, JAMA-J AM MED ASSOC, V279, P51, DOI 10.1001/jama.279.1.51; Westgarth C, 2018, J EPIDEMIOL COMMUN H, V72, P331, DOI 10.1136/jech-2017-209330	22	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0210541	10.1371/journal.pone.0210541	http://dx.doi.org/10.1371/journal.pone.0210541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789915	Green Published, gold, Green Submitted			2022-12-26	WOS:000459330800009
J	Wang, TY; Song, P; Zhong, TT; Wang, XJ; Xiang, XP; Liu, Q; Chen, HY; Xia, T; Liu, H; Niu, YM; Hu, YS; Xu, L; Shao, YK; Zhu, LJ; Qi, HY; Shen, J; Hou, TJ; Fodde, RCRO; Shao, JM				Wang, Tingyang; Song, Ping; Zhong, Tingting; Wang, Xianjun; Xiang, Xueping; Liu, Qian; Chen, Haiyi; Xia, Tian; Liu, Hong; Niu, Yumiao; Hu, Yanshi; Xu, Lei; Shao, Yingkuan; Zhu, Lijun; Qi, Hongyan; Shen, Jing; Hou, Tingjun; Fodde, Riccardo; Shao, Jimin			The inflammatory cytokine IL-6 induces FRA1 deacetylation promoting colorectal cancer stem-like properties	ONCOGENE			English	Article							HISTONE DEACETYLASE; SELF-RENEWAL; C-JUN; CELLS; PROTEIN; NANOG; INTERLEUKIN-6; P53; ACCUMULATION; MACROPHAGES	Colorectal cancer (CRC) has long been known for its tight association with chronic inflammation, thought to play a key role in tumor onset and malignant progression through the modulation of cancer stemness. However, the underlying molecular and cellular mechanisms are still largely elusive. Here we show that the IL-6/STAT3 inflammatory signaling axis induces the deacetylation of FRA1 at the Lys-116 residue located within its DNA-binding domain. The HDAC6 deacetylase underlies this key modification leading to the increase of FRA1 transcriptional activity, the subsequent transactivation of NANOG expression, and the acquisition of stem-like cellular features. As validated in a large (n = 123) CRC cohort, IL-6 secretion was invariably accompanied by increased FRA1 deacetylation at K116 and an overall increase in its protein levels, coincident with malignant progression and poor prognosis. Of note, combined treatment with the conventional cytotoxic drug 5-FU together with Tubastatin A, a HDAC6-specific inhibitor, resulted in a significant in vivo synergistic inhibitory effect on tumor growth through suppression of CRC stemness. Our results reveal a novel transcriptional and posttranslational regulatory cross-talk between inflammation and stemness signaling pathways that underlie self-renewal and maintenance of CRC stem cells and promote their malignant behavior. Combinatorial treatment aimed at the core regulatory mechanisms downstream of IL-6 may offer a novel promising approach for CRC treatment.	[Wang, Tingyang; Song, Ping; Zhong, Tingting; Wang, Xianjun; Xiang, Xueping; Liu, Qian; Xia, Tian; Liu, Hong; Niu, Yumiao; Shao, Yingkuan; Qi, Hongyan; Shen, Jing; Shao, Jimin] Zhejiang Univ, Affiliated Hosp 2, Dept Pathol & Pathophysiol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Tingyang; Song, Ping; Zhong, Tingting; Wang, Xianjun; Xiang, Xueping; Liu, Qian; Xia, Tian; Liu, Hong; Niu, Yumiao; Shao, Yingkuan; Qi, Hongyan; Shen, Jing; Shao, Jimin] Zhejiang Univ, Affiliated Hosp 2, Canc Inst, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Tingyang; Song, Ping; Xiang, Xueping; Shao, Yingkuan; Shao, Jimin] Zhejiang Univ, Sch Med, Key Lab Dis Prote Zhejiang Prov, Key Lab Canc Prevent & Intervent,China Natl Minis, Hangzhou, Zhejiang, Peoples R China; [Wang, Tingyang; Song, Ping; Xiang, Xueping; Shao, Yingkuan; Shao, Jimin] Zhejiang Univ, Sch Med, Res Ctr Air Pollut & Hlth, Hangzhou, Zhejiang, Peoples R China; [Chen, Haiyi; Hou, Tingjun] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China; [Hu, Yanshi] Zhejiang Univ, Coll Life Sci, Dept Bioinformat, Hangzhou, Zhejiang, Peoples R China; [Xu, Lei; Hou, Tingjun] Jiangsu Univ Technol, Sch Elect & Informat Engn, Inst Bioinformat & Med Engn, Changzhou, Peoples R China; [Zhu, Lijun] Zhejiang Univ, Affiliated Hosp 1, Key Lab Precis Diag & Treatment Hepatobiliary & P, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Fodde, Riccardo] Erasmus MC, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands; [Zhong, Tingting] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Pathol, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Liu, Hong] Zhejiang Normal Univ Jinhua Peoples Hosp Joint Ct, Jinhua, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Jiangsu University of Technology; Zhejiang University; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Zhejiang University	Shao, JM (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Dept Pathol & Pathophysiol, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Shao, JM (corresponding author), Zhejiang Univ, Affiliated Hosp 2, Canc Inst, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Shao, JM (corresponding author), Zhejiang Univ, Sch Med, Key Lab Dis Prote Zhejiang Prov, Key Lab Canc Prevent & Intervent,China Natl Minis, Hangzhou, Zhejiang, Peoples R China.; Shao, JM (corresponding author), Zhejiang Univ, Sch Med, Res Ctr Air Pollut & Hlth, Hangzhou, Zhejiang, Peoples R China.; Fodde, RCRO (corresponding author), Erasmus MC, Erasmus MC Canc Inst, Dept Pathol, Rotterdam, Netherlands.	r.fodde@erasmusmc.nl; shaojimin@zju.edu.cn	Shao, Yingkuan/AAO-9244-2020; Fodde, Riccardo/AAW-9394-2021; Hou, Tingjun/C-7492-2011; Hu, Yanshi/G-1650-2017	Shao, Yingkuan/0000-0001-9683-5691; Fodde, Riccardo/0000-0001-9839-4324; Hou, Tingjun/0000-0001-7227-2580; Hu, Yanshi/0000-0003-3219-3778	National Natural Science Foundation of China [81572384, 81372138, 81702401, 81771518]; National Key R&D Program of China [2016YFC1303401]; National Science and Technology Major Project of China [2018ZX10302206-006-007]; ZJU funds; Dutch Digestive Foundation [FP 15-09]; Dutch Cancer Society; Erasmus MC [EMCR 2015-8090]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; National Science and Technology Major Project of China; ZJU funds; Dutch Digestive Foundation; Dutch Cancer Society(KWF Kankerbestrijding); Erasmus MC	The authors are grateful to the contribution of the specimen donors. We thank Professor Xin-Hua Feng from Life Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University for providing HDAC6 overexpressing plasmids; Professor Qun-Ying Lei from Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, Fudan University for providing HDAC1-6 overexpressing plasmids; Professor Cheng Qian from the Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University for providing Lv-NANOG, Lv-shNANOG, and Lv-scrambled plasmids; and Professor Chong Liu from the Department of Pathology & Pathophysiology, Zhejiang University School of Medicine for help with immunofluorescence technology. This work was supported by National Natural Science Foundation of China (81572384, 81372138, 81702401 and 81771518), National Key R&D Program of China (2016YFC1303401), and National Science and Technology Major Project of China (2018ZX10302206-006-007). RF is supported by ZJU funds and by the Dutch Digestive Foundation (FP 15-09), Dutch Cancer Society, and the Erasmus MC (EMCR 2015-8090).	Ali I, 2018, CHEM REV, V118, P340, DOI 10.1021/acs.chemrev.7b00181; Belguise K, 2012, ONCOGENE, V31, P4889, DOI 10.1038/onc.2011.659; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; Grivennikov SI, 2011, ANN RHEUM DIS, V70, pI104, DOI 10.1136/ard.2010.140145; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WZ, 2018, CANCER RES, V78, P3293, DOI 10.1158/0008-5472.CAN-17-3131; Hong A, 2018, CANCER DISCOV, V8, P74, DOI 10.1158/2159-8290.CD-17-0682; Hou T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089575; Hou TJ, 2012, J PROTEOME RES, V11, P2982, DOI 10.1021/pr3000688; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Ibrahim EE, 2012, STEM CELLS, V30, P2076, DOI 10.1002/stem.1182; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Kakumoto K, 2006, P NATL ACAD SCI USA, V103, P5490, DOI 10.1073/pnas.0601222103; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Lasry A, 2016, NAT IMMUNOL, V17, P230, DOI 10.1038/ni.3384; Lau EYT, 2016, CELL REP, V15, P1175, DOI 10.1016/j.celrep.2016.04.019; Lee TKW, 2011, CELL STEM CELL, V9, P50, DOI 10.1016/j.stem.2011.06.005; Liu H, 2015, CARCINOGENESIS, V36, P459, DOI 10.1093/carcin/bgv017; Liu YJ, 2012, J BIOL CHEM, V287, P29168, DOI 10.1074/jbc.M112.371120; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Pakay JL, 2012, ONCOGENE, V31, P1817, DOI 10.1038/onc.2011.375; Qi J, 2015, CELL STEM CELL, V17, P597, DOI 10.1016/j.stem.2015.08.004; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ryu HW, 2017, CANCER LETT, V391, P162, DOI 10.1016/j.canlet.2017.01.033; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Sayan AE, 2012, ONCOGENE, V31, P1493, DOI 10.1038/onc.2011.336; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P22035, DOI 10.1039/c4cp03179b; Sveen A, 2011, GENOME MED, V3, DOI 10.1186/gm248; Tam WL, 2013, CANCER CELL, V24, P347, DOI 10.1016/j.ccr.2013.08.005; van der Zee M, 2015, CANCER RES, V75, P3608, DOI 10.1158/0008-5472.CAN-14-2498; Vries RGJ, 2001, EMBO J, V20, P6095, DOI 10.1093/emboj/20.21.6095; Wan SS, 2014, GASTROENTEROLOGY, V147, P1393, DOI 10.1053/j.gastro.2014.08.039; Wang DZ, 2015, GASTROENTEROLOGY, V149, P1884, DOI 10.1053/j.gastro.2015.07.064; Wang DL, 2016, NATURE, V538, P118, DOI 10.1038/nature19759; Wang QS, 2010, CELL RES, V20, P701, DOI 10.1038/cr.2010.52; Xu L, 2013, J PHYS CHEM B, V117, P8408, DOI 10.1021/jp404160y; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yang W, 2018, CANCER LETT, V415, P164, DOI 10.1016/j.canlet.2017.12.005; Yang XJ, 2005, MOL CELL BIOL, V25, P2873, DOI 10.1128/MCB.25.8.2873-2884.2005; Yao C, 2016, STEM CELLS, V34, P820, DOI 10.1002/stem.2320; Yoon DS, 2014, STEM CELLS, V32, P3219, DOI 10.1002/stem.1811; Zerbini LF, 2003, CANCER RES, V63, P2206; Zhang J, 2013, ONCOGENE, V32, P4397, DOI 10.1038/onc.2012.461	49	32	35	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 20	2019	38	25					4932	4947		10.1038/s41388-019-0763-0	http://dx.doi.org/10.1038/s41388-019-0763-0			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IE1KY	30804456	hybrid, Green Published			2022-12-26	WOS:000472145900004
J	Yuan, C; Freeman, BT; McArdle, TJ; Jung, JP; Ogle, BM				Yuan, Ce; Freeman, Brian T.; McArdle, Tanner J.; Jung, Jangwook P.; Ogle, Brenda M.			Conserved pathway activation following xenogeneic, heterotypic fusion	FASEB JOURNAL			English	Article						cell fusion; human growth hormone; mesenchymal stem cell; cardiomyocyte; ribosome	MESENCHYMAL STEM-CELLS; MARROW-DERIVED CELLS; MYOBLAST FUSION; MACROPHAGE FUSION; DIFFERENTIATION; CARDIOMYOCYTES; RECEPTOR; GENE; METASTASIS; MYOCARDIUM	Fusion between cells of different organisms (i.e., xenogeneic hybrids) can occur, and for humans this may occur in the course of tissue transplantation, animal handling, and food production. Previous work shows that conferred advantages are rare in xenogeneic hybrids, whereas risks of cellular dysregulation are high. Here, we explore the transcriptome of individual xenogeneic hybrids of human mesenchymal stem cells and murine cardiomyocytes soon after fusion and ask whether the process is stochastic or involves conserved pathway activation. Toward this end, single-cell RNA sequencing was used to analyze the transcriptomes of hybrid cells with respect to the human and mouse genomes. Consistent with previous work, hybrids possessed a unique transcriptome distinct from either fusion partner but were dominated by the cardiomyocyte transcriptome. New in this work is the documentation that a few genes that were latent in both fusion partners were consistently expressed in hybrids. Specifically, human growth hormone 1, murine ribosomal protein S27, and murine ATP synthase H+ transporting, mitochondrial Fo complex subunit C2 were expressed in nearly all hybrids. The consistent activation of latent genes between hybrids suggests conserved signaling mechanisms that either cause or are the consequence of fusion of these 2 cell types and might serve as a target for limiting unwanted xenogeneic fusion in the future.-Yuan, C., Freeman, B. T., McArdle, T. J., Jung, J. P., Ogle, B. M. Conserved pathway activation following xenogeneic, heterotypic fusion.	[Yuan, Ce] Univ Minnesota Twin Cities, Bioinformat & Computat Biol Program, Minneapolis, MN 55455 USA; [Yuan, Ce; Freeman, Brian T.; McArdle, Tanner J.; Jung, Jangwook P.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Stem Cell Inst, Minneapolis, MN 55455 USA; [Freeman, Brian T.; McArdle, Tanner J.; Jung, Jangwook P.; Ogle, Brenda M.] Univ Minnesota Twin Cities, Dept Biomed Engn, 312 Church St SE, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Lillehei Heart Inst, Minneapolis, MN 55455 USA; [Ogle, Brenda M.] Univ Minnesota Twin Cities, Inst Engn Med, Minneapolis, MN 55455 USA; [Freeman, Brian T.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; University of Wisconsin Madison	Ogle, BM (corresponding author), Univ Minnesota Twin Cities, Dept Biomed Engn, 312 Church St SE, Minneapolis, MN 55455 USA.	ogle@umn.edu	Yuan, Ce/AAI-2721-2020	Yuan, Ce/0000-0002-4323-7353	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL137204]; University of Minnesota Genomics Center New Investigator Award (NSF-GRFP) [2010105691]; Minnesota's Discover, Research, and Innovation Economy, University of Minnesota Informatics Institute Graduate Fellowship; Minnesota Stem Cell Institute	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Minnesota Genomics Center New Investigator Award (NSF-GRFP); Minnesota's Discover, Research, and Innovation Economy, University of Minnesota Informatics Institute Graduate Fellowship; Minnesota Stem Cell Institute	The authors thank Dr. Peiman Hematti (University of Wisconsin-Madison) for the kind donation of pluripotent stem cell-derived mesenchymal stem cells. The authors also thank Joshua Baller and John Garbe (University of Minnesota Supercomputing Institute) for assistance in setting up single-cell RNA sequencing workflow analyses for multiple genomes. This study was funded by the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (Grant HL137204); University of Minnesota Genomics Center New Investigator Award (NSF-GRFP, 2010105691); Minnesota's Discover, Research, and Innovation Economy, University of Minnesota Informatics Institute Graduate Fellowship; and the Minnesota Stem Cell Institute. The authors declare no conflicts of interest.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Chitwood CA, 2018, APL BIOENG, V2, DOI 10.1063/1.5024744; Perez-Ibave DC, 2014, GROWTH HORM IGF RES, V24, P47, DOI 10.1016/j.ghir.2014.01.005; de la Garza-Rodea AS, 2012, CELL TRANSPLANT, V21, P153, DOI 10.3727/096368911X580554; Dedja A, 2006, FASEB J, V20, P2534, DOI 10.1096/fj.06-6586fje; Degrelle SA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42173; Deng S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005381; Ding Z, 2016, DISCOV MED, V21, P331; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019569; Freeman BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep23270; Freeman BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20283; Freeman BT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136199; Freeman BT, 2015, STEM CELL TRANSL MED, V4, P685, DOI 10.5966/sctm.2014-0198; Gauster M, 2009, PLACENTA, V30, pS49, DOI 10.1016/j.placenta.2008.10.011; Goh ELK, 1997, ENDOCRINOLOGY, V138, P3207, DOI 10.1210/en.138.8.3207; Goncalves MAFV, 2006, HUM MOL GENET, V15, P213, DOI 10.1093/hmg/ddi438; Hamoud N, 2014, P NATL ACAD SCI USA, V111, P3745, DOI 10.1073/pnas.1313886111; Harvey S, 2010, ENDOCRINE, V38, P335, DOI 10.1007/s12020-010-9403-8; Ho Y, 2013, MOL CELL BIOL, V33, P1723, DOI 10.1128/MCB.01166-12; Huda F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164202; Huppertz B, 2006, MICRON, V37, P509, DOI 10.1016/j.micron.2005.12.011; Ishikawa F, 2006, FASEB J, V20, P950, DOI 10.1096/fj.05-4863fje; Kemp K, 2011, NEUROPATH APPL NEURO, V37, P166, DOI 10.1111/j.1365-2990.2010.01122.x; Kim JH, 2015, CURR OPIN GENET DEV, V32, P162, DOI 10.1016/j.gde.2015.03.006; Kobayashi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36780; Kopchick JJ, 2000, MOL GENET METAB, V71, P293, DOI 10.1006/mgme.2000.3068; Kouris NA, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/414038; Kruglyakov PV, 2006, B EXP BIOL MED+, V142, P503, DOI 10.1007/s10517-006-0403-x; Lazova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066731; Li H, 2014, ONCOL REP, V32, P539, DOI 10.3892/or.2014.3264; Luo F, 2016, ONCOTARGET, V7, P30924, DOI 10.18632/oncotarget.9045; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; Ogle BM, 2004, AM SCI, V92, P420; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Ogle Brenda M., 2004, FASEB Journal, V18, P548; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Park SY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10871; Pawelek JM, 2014, CHIN J CANCER, V33, P133, DOI 10.5732/cjc.013.10243; Pizza FX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05283-3; Sun C, 2015, ONCOL REP, V34, P2022, DOI 10.3892/or.2015.4135; Toufaily C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121468; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Vassilopoulos G, 2003, NATURE, V422, P901, DOI 10.1038/nature01539; Verma SK, 2014, BIOCHEM J, V464, P293, DOI 10.1042/BJ20141233; Vignery A, 2005, J EXP MED, V202, P337, DOI 10.1084/jem.20051123; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Willenbring H, 2004, CELL CYCLE, V3, P1489, DOI 10.4161/cc.3.12.1304; Zhang P, 2005, J BIOCHEM MOL BIOL, V38, P373; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006	54	0	0	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6767	6777		10.1096/fj.201801700R	http://dx.doi.org/10.1096/fj.201801700R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30807240	Green Published			2022-12-26	WOS:000476114200008
J	Liu, YY; Harashima, SI; Wang, Y; Suzuki, K; Tokumoto, S; Usui, R; Tatsuoka, H; Tanaka, D; Yabe, D; Harada, N; Hayashi, Y; Inagaki, N				Liu, Yanyan; Harashima, Shin-ichi; Wang, Yu; Suzuki, Kazuyo; Tokumoto, Shinsuke; Usui, Ryota; Tatsuoka, Hisato; Tanaka, Daisuke; Yabe, Daisuke; Harada, Norio; Hayashi, Yoshitaka; Inagaki, Nobuya			Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion	FASEB JOURNAL			English	Article						inflammation; lipid metabolism; obesity	GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; RECEPTOR AGONISTS; ADIPOSE-TISSUE; ADIPONECTIN RECEPTORS; INFLAMMATORY MARKERS; OBESITY; LIPOPROTEIN; RESISTANCE; RESPONSES	Our previous study demonstrated that sphingosine kinase 1-interacting protein (SKIP, or Sphkap) is expressed in pancreatic -cells, and depletion of SKIP enhances glucose-stimulated insulin secretion. We find here that SKIP is also expressed in intestinal K- and L-cells and that secretion of gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) as well as insulin are significantly increased, and blood glucose levels are decreased in SKIP-deficient (SKIP-/-) mice compared with those in wild-type mice. Plasma triglyceride (Tg), LDL cholesterol, and mRNA levels of proinflammatory cytokines in adipose tissues, livers, and intestines were found to be significantly decreased in SKIP-/- mice. The phenotypic characteristics of SKIP-/- mice, including adiposity and attenuation of basal inflammation, were abolished by genetic depletion of GIP. The improvement of glucose tolerance and lipid profiles in SKIP-/- mice were cancelled by GLP-1 receptor antagonist exendin-(9-39) treatment. In summary, depletion of SKIP ameliorates glucose tolerance by enhancing secretion of insulin and incretins, improves lipid metabolism, and reduces basal inflammation levels. Thus, inhibition of SKIP action may emerge as a new option for treatment of type 2 diabetes mellitus with metabolic dysfunction.Liu, Y., Harashima, S., Wang, Y., Suzuki, K., Tokumoto, S., Usui, R., Tatsuoka, H., Tanaka, D., Yabe, D., Harada, N., Hayashi, Y., Inagaki, N. Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion.	[Liu, Yanyan; Harashima, Shin-ichi; Wang, Yu; Suzuki, Kazuyo; Tokumoto, Shinsuke; Usui, Ryota; Tatsuoka, Hisato; Tanaka, Daisuke; Yabe, Daisuke; Harada, Norio; Inagaki, Nobuya] Kyoto Univ, Dept Diabet Endocrinol & Nutr, Grad Sch Med, Kyoto, Japan; [Hayashi, Yoshitaka] Nagoya Univ, Div Stress Adaptat & Protect, Dept Genet, Res Inst Environm Med, Nagoya, Aichi, Japan	Kyoto University; Nagoya University	Inagaki, N (corresponding author), Kyoto Univ, Grad Sch Med, Sakyo Ku, 54 Kawaharacho, Kyoto 6068507, Japan.	inagaki@kuhp.kyoto-u.ac.jp	Yabe, Daisuke/J-6682-2014; Hayashi, Yoshitaka/I-6168-2014; tokumoto, shinsuke/AAF-7515-2020	Yabe, Daisuke/0000-0002-5334-7687; Hayashi, Yoshitaka/0000-0002-7557-4303; tokumoto, shinsuke/0000-0002-4070-6724; HARADA, NORIO/0000-0001-8720-1013; Tatsuoka, Hisato/0000-0002-0669-6825	Japan Society for the Promotion of Sciences; Japan Agency for Medical Research and Development (AMED); KAKENHI [24591325, 18K08474, 26111004, 17K09825, 17K19654, 16H05326]; AMED Grants [JP17lm0203006j0001, 19ek0210111h0002, 17ek0210079h0001]	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED Grants	This work was supported by grants from the Japan Society for the Promotion of Sciences and Japan Agency for Medical Research and Development (AMED); Grants-in-Aid for Scientific Research (KAKENHI) Grants 24591325 (to S.H.), 18K08474 (to S.H.), 26111004 (to D.Y.), 17K09825 (to D.Y.), 17K19654 (to N.I.), and 16H05326 (to N.I.); and AMED Grants JP17lm0203006j0001 (to S.H.), 19ek0210111h0002 (to D.Y.), 17ek0210079h0001 (to N.I.). The authors declare no conflicts of interest.	Ballinger A, 2003, GUT, V52, P319, DOI 10.1136/gut.52.3.319; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochud M, 2009, J CLIN ENDOCR METAB, V94, P3969, DOI 10.1210/jc.2008-2428; Chen S, 2015, AM J PHYSIOL-ENDOC M, V308, pE414, DOI 10.1152/ajpendo.00418.2014; Choi KM, 2007, DIABETES RES CLIN PR, V75, P235, DOI 10.1016/j.diabres.2006.06.019; Cote M, 2005, J CLIN ENDOCR METAB, V90, P1434, DOI 10.1210/jc.2004-1711; Creutzfeldt M, 1974, Gastroenterology, V67, P748; Dobrian AD, 2011, AM J PHYSIOL-ENDOC M, V300, pE410, DOI 10.1152/ajpendo.00463.2010; ECKEL RH, 1979, DIABETES, V28, P1141, DOI 10.2337/diabetes.28.12.1141; Engeli S, 2003, DIABETES, V52, P942, DOI 10.2337/diabetes.52.4.942; Farr Sarah, 2014, Cardiovascular & Hematological Disorders - Drug Targets, V14, P126; Hayashi Y, 2009, MOL ENDOCRINOL, V23, P1990, DOI 10.1210/me.2009-0296; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hsieh J, 2010, DIABETOLOGIA, V53, P552, DOI 10.1007/s00125-009-1611-5; Iwai T, 2006, NEUROSCI RES, V55, P352, DOI 10.1016/j.neures.2006.04.008; Joo E, 2017, DIABETES, V66, P868, DOI 10.2337/db16-0758; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KOMATSU R, 1989, DIABETES, V38, P902, DOI 10.2337/diabetes.38.7.902; Kovanich D, 2010, CHEMBIOCHEM, V11, P963, DOI 10.1002/cbic.201000058; Lacana E, 2002, J BIOL CHEM, V277, P32947, DOI 10.1074/jbc.M202841200; Lee YS, 2012, DIABETOLOGIA, V55, P2456, DOI 10.1007/s00125-012-2592-3; Maceyka M, 2012, TRENDS CELL BIOL, V22, P50, DOI 10.1016/j.tcb.2011.09.003; Marques C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/538737; Nasteska D, 2014, DIABETES, V63, P2332, DOI 10.2337/db13-1563; Nijhuis J, 2009, OBESITY, V17, P2014, DOI 10.1038/oby.2009.113; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Pennington KL, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0063-5; Qi YF, 2013, FASEB J, V27, P4294, DOI 10.1096/fj.13-230052; Ryo M, 2004, CIRC J, V68, P975, DOI 10.1253/circj.68.975; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; SCHMIDT WE, 1985, DIABETOLOGIA, V28, P704, DOI 10.1007/BF00291980; Scholten A, 2006, J PROTEOME RES, V5, P1435, DOI 10.1021/pr0600529; Shetty GK, 2004, DIABETES CARE, V27, P2450, DOI 10.2337/diacare.27.10.2450; Sun F, 2015, DIABETES RES CLIN PR, V110, P26, DOI 10.1016/j.diabres.2015.07.015; Sun F, 2015, CLIN THER, V37, P225, DOI 10.1016/j.clinthera.2014.11.008; Suzuki K, 2013, J BIOL CHEM, V288, P1929, DOI 10.1074/jbc.M112.423137; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Tsukiyama K, 2006, MOL ENDOCRINOL, V20, P1644, DOI 10.1210/me.2005-0187; Usui S, 2002, J LIPID RES, V43, P805; Wang J, 2014, AM J PHYSIOL-ENDOC M, V306, pE756, DOI 10.1152/ajpendo.00549.2013; Wang XC, 2014, WORLD J GASTROENTERO, V20, P14821, DOI 10.3748/wjg.v20.i40.14821; Wang Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03901-8; Willms B, 1996, J CLIN ENDOCR METAB, V81, P327, DOI 10.1210/jc.81.1.327; Yabe D, 2011, PROG BIOPHYS MOL BIO, V107, P248, DOI 10.1016/j.pbiomolbio.2011.07.010; Yamane S, 2016, J DIABETES INVEST, V7, P20, DOI 10.1111/jdi.12467; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Zhong JX, 2015, CLIN LIPIDOL, V10, P103, DOI 10.2217/CLP.14.59	49	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6239	6253		10.1096/fj.201801783RR	http://dx.doi.org/10.1096/fj.201801783RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30789757	Bronze, Green Submitted			2022-12-26	WOS:000466932600035
J	Mohd-Tahir, NA; Li, SC				Mohd-Tahir, Nurul-Ain; Li, Shu-Chuen			Budget impact analysis of increasing prescription of renin-angiotensin system inhibitors drugs to standard anti-hypertensive treatments in patients with diabetes and hypertension in a hypothetical cohort of Malaysian population	PLOS ONE			English	Article							ECONOMIC-EVALUATION; COST-EFFECTIVENESS; RECEPTOR BLOCKERS; NEPHROPATHY; IRBESARTAN; PREVALENCE; RISK	Introduction Renin-angiotensin system inhibitors (RAS) drugs have a proteinuria-reducing effect that could prevent the progression of kidney disease in diabetic patients. Our study aimed to assess the budget impact based on healthcare payer perspective of increasing uptake of RAS drugs into the current treatment mix of standard anti-hypertensive treatments to prevent progression of kidney disease in patient's comorbid with hypertension and diabetes. Methods A Markov model of a Malaysian hypothetical cohort aged >= 30 years (N = 14,589,900) was used to estimate the total and per-member-per-month (PMPM) costs of RAS uptake. This involved an incidence and prevalence rate of 9.0% and 10.53% of patients with diabetes and hypertension respectively. Transition probabilities of health stages and costs were adapted from published data. Results An increasing uptake of RAS drugs would incur a projected total treatment cost ranged from MYR 4.89 billion (PMPM of MYR 27.95) at Year 1 to MYR 16.26 billion (PMPM of MYR 92.89) at Year 5. This would represent a range of incremental costs between PMPM of MYR 0.20 at Year 1 and PMPM of MYR 1.62 at Year 5. Over the same period, the care costs showed a downward trend but drug acquisition costs were increasing. Sensitivity analyses showed the model was minimally affected by the changes in the input parameters. Conclusion Mild impact to the overall healthcare budget has been reported with an increased utilization of RAS. The long-term positive health consequences of RAS treatment would reduce the cost of care in preventing deterioration of kidney function, thus offsetting the rising costs of purchasing RAS drugs. Optimizing and increasing use of RAS drugs would be considered an affordable and rational strategy to reduce the overall healthcare costs in Malaysia.	[Mohd-Tahir, Nurul-Ain; Li, Shu-Chuen] Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth, Callaghan, NSW, Australia; [Mohd-Tahir, Nurul-Ain] Univ Kebangsaan Malaysia, Fac Pharm, Kuala Lumpur, Malaysia	University of Newcastle; Universiti Kebangsaan Malaysia	Li, SC (corresponding author), Univ Newcastle, Sch Biomed Sci & Pharm, Fac Hlth, Callaghan, NSW, Australia.	ShuChuen.Li@newcastle.edu.au	Tahir, Nurul Ain Mohd/S-6818-2019	Tahir, Nurul Ain Mohd/0000-0003-0353-4799				Abougalambou SSI, 2011, DIABETES METAB SYND, V5, P115, DOI 10.1016/j.dsx.2012.03.001; Annemans L, 2008, VALUE HEALTH, V11, P354, DOI 10.1111/j.1524-4733.2007.00250.x; Atkins RC, 2010, MED J AUSTRALIA, V192, P272, DOI 10.5694/j.1326-5377.2010.tb03506.x; Azimatun NA, 2014, MALAYSIAN J PUBLIC H, V14, P18; Blak BT, 2009, VALUE HEALTH, V12, P302, DOI 10.1111/j.1524-4733.2008.00423.x; Boersma C, 2006, PHARMACOECONOMICS, V24, P523, DOI 10.2165/00019053-200624060-00001; Gerstein HC, 2000, LANCET, V355, P253; Goh BL, 2015, 22 REPORT MALAYSIAN; Hooi LS, 2005, NEPHROLOGY, V10, P25, DOI 10.1111/j.1440-1797.2005.00360.x; Huang YY, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-15; Institute for Public Health (IPH), 2015, NONC DIS RISK FACT O, VII; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Low WY, 2015, INT J OCCUP MED ENV, V28, P20, DOI 10.2478/s13382-014-0326-0; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; MOH, 2015, CLIN PRACT GUID MAN; MOH, 2011, MOH ANN REP 2011; Mohamed M, 2008, CURR MED RES OPIN, V24, P507, DOI [10.1185/030079908X261131, 10.1185/030079908X261131 ]; Mohd-Tahir NA, 2015, SAGE OPEN MED, V3, DOI 10.1177/2050312115596864; Palmer AJ, 2004, J HUM HYPERTENS, V18, P733, DOI 10.1038/sj.jhh.1001729; PSD, 2014, MAL STAT MED 2009 20; Ramachandran A, 2007, DIABETES CARE, V30, P2548, DOI 10.2337/dc07-0150; Ravera M, 2006, J AM SOC NEPHROL, V17, pS44, DOI 10.1681/ASN.2005121323; Rodby RA, 2003, CLIN THER, V25, P2102, DOI 10.1016/S0149-2918(03)80208-4; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003967.pub2; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; World Health Organization, 2015, LIF TABL 194 COUNTR; Wu HY, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6008	29	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212832	10.1371/journal.pone.0212832	http://dx.doi.org/10.1371/journal.pone.0212832			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817790	Green Submitted, Green Published, gold			2022-12-26	WOS:000460371500045
J	Nagel, ZD; Beharry, AA; Mazzucato, P; Kitange, GJ; Sarkaria, JN; Kool, ET; Samson, LD				Nagel, Zachary D.; Beharry, Andrew A.; Mazzucato, Patrizia; Kitange, Gaspar J.; Sarkaria, Jann N.; Kool, Eric T.; Samson, Leona D.			Fluorescent reporter assays provide direct, accurate, quantitative measurements of MGMT status in human cells	PLOS ONE			English	Article							O-6-METHYLGUANINE DNA METHYLTRANSFERASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; TEMOZOLOMIDE RESISTANCE; PROMOTER METHYLATION; REPAIR; GENE; INHIBITION; EXPRESSION; BLOOD; IMMUNOHISTOCHEMISTRY	The DNA repair protein O-6 - methylguanine DNA methyltransferase (MGMT) strongly influences the effectiveness of cancer treatment with chemotherapeutic alkylating agents, and MGMT status in cancer cells could potentially contribute to tailored therapies for individual patients. However, the promoter methylation and immunohistochemical assays presently used for measuring MGMT in clinical samples are indirect, cumbersome and sometimes do not accurately report MGMT activity. Here we directly compare the accuracy of 6 analytical methods, including two fluorescent reporter assays, against the in vitro MGMT activity assay that is considered the gold standard for measuring MGMT DNA repair capacity. We discuss the relative advantages of each method. Our data indicate that two recently developed fluorescence-based assays measure MGMT activity accurately and efficiently, and could provide a functional dimension to clinical efforts to identify patients who are likely to benefit from alkylating chemotherapy.	[Nagel, Zachary D.; Mazzucato, Patrizia; Samson, Leona D.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Beharry, Andrew A.; Kool, Eric T.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Kitange, Gaspar J.; Sarkaria, Jann N.] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA; [Nagel, Zachary D.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Beharry, Andrew A.] Univ Toronto Mississauga, Dept Chem & Phys Sci, Toronto, ON, Canada; [Mazzucato, Patrizia] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Stanford University; Mayo Clinic; Harvard University; Harvard T.H. Chan School of Public Health; University of Toronto; University Toronto Mississauga; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Samson, LD (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lsamson@mit.edu		Kool, Eric/0000-0002-7310-2935; Nagel, Zachary/0000-0003-2104-2093	National Institutes of Health [DP1-ES022567, R01-CA217809]; NATIONAL CANCER INSTITUTE [R01CA217809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants DP1-ES022567 awarded to L.D.S. and R01-CA217809 to E.T.K. by the National Institutes of Health.	Beharry AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152684; Brandwein JM, 2014, BRIT J HAEMATOL, V167, P664, DOI 10.1111/bjh.13094; Bugni JM, 2007, DNA REPAIR, V6, P1116, DOI 10.1016/j.dnarep.2007.03.023; Chen XY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05373-4; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Cros J, 2016, ENDOCR-RELAT CANCER, V23, P625, DOI 10.1530/ERC-16-0117; Esteller M, 2004, ONCOGENE, V23, P1, DOI 10.1038/sj.onc.1207316; Fry RC, 2008, GENE DEV, V22, P2621, DOI 10.1101/gad.1688508; Fu D, 2012, NAT REV CANCER, V12, P104, DOI 10.1038/nrc3185; Fumagalli C, 2012, BREAST CANCER RES TR, V134, P131, DOI 10.1007/s10549-011-1945-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassel JC, 2010, BRIT J CANCER, V103, P820, DOI 10.1038/sj.bjc.6605796; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hong QX, 2016, ONCOL LETT, V11, P2851, DOI 10.3892/ol.2016.4317; Inno A, 2014, WORLD J CLIN CASES, V2, P835, DOI 10.12998/wjcc.v2.i12.835; Jiang XY, 2013, J NEURO-ONCOL, V114, P135, DOI 10.1007/s11060-013-1162-y; Khalil S, 2016, ONCOTARGET, V7, P28195, DOI 10.18632/oncotarget.8618; Kitange GJ, 2012, CLIN CANCER RES, V18, P4070, DOI 10.1158/1078-0432.CCR-12-0560; Kitange GJ, 2009, NEURO-ONCOLOGY, V11, P281, DOI 10.1215/15228517-2008-090; Kreth S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017156; Liu LL, 1998, CLIN CANCER RES, V4, P475; Liu LP, 2002, CANCER RES, V62, P3037; Mendelsohn J, 2013, J CLIN ONCOL, V31, P1904, DOI 10.1200/JCO.2012.45.3605; MYRNES B, 1983, CARCINOGENESIS, V4, P1565, DOI 10.1093/carcin/4.12.1565; Nagel ZD, 2017, CANCER RES, V77, P198, DOI 10.1158/0008-5472.CAN-16-1151; Nagel ZD, 2014, P NATL ACAD SCI USA, V111, pE1823, DOI 10.1073/pnas.1401182111; Nagel ZD, 2016, CANC RES; Noonan EM, 2012, INTEGR BIOL-UK, V4, P1237, DOI 10.1039/c2ib20091k; Pearson SJ, 2005, NUCLEIC ACIDS RES, V33, P3837, DOI 10.1093/nar/gki696; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Pegg AE, 2007, DNA REPAIR, V6, P1071, DOI 10.1016/j.dnarep.2007.03.012; Pegg AE, 2011, CHEM RES TOXICOL, V24, P618, DOI 10.1021/tx200031q; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; RUDIGER HW, 1989, CANCER RES, V49, P5623; Sabharwal A, 2011, MELANOMA RES, V21, P502, DOI 10.1097/CMR.0b013e32832ccd58; SAGHER D, 1988, CANCER RES, V48, P3084; SKOPEK TR, 1978, BIOCHEM BIOPH RES CO, V84, P411, DOI 10.1016/0006-291X(78)90185-7; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Thomas A, 2017, CANCER RES, V77, P823, DOI 10.1158/0008-5472.CAN-16-2983; VAHAKANGAS K, 1991, CARCINOGENESIS, V12, P1389, DOI 10.1093/carcin/12.8.1389; Zaidi NH, 1996, CLIN CANCER RES, V2, P577; Zhang ZD, 2010, DNA REPAIR, V9, P558, DOI 10.1016/j.dnarep.2010.02.006	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0208341	10.1371/journal.pone.0208341	http://dx.doi.org/10.1371/journal.pone.0208341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811507	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400003
J	Guerra, GES; Caldeira, AP; de Oliveira, FPSL; Brito, MFSF; Gerra, KDDS; D'Angelis, CEM; dos Santos, LAN; de Pinho, L; Rocha, JSB; Popoff, DAV				Souza Guerra Junior, Geraldo Edson; Caldeira, Antonio Prates; Santos Lima de Oliveira, Fernanda Piana; Santos Figueiredo Brito, Maria Fernanda; de Oliveira Silva Gerra, Kelma Dayana; Mendes D'Angelis, Carlos Eduardo; Nogueira dos Santos, Luis Antonio; de Pinho, Lucineia; Brant Rocha, Josiane Santos; Veloso Popoff, Daniela Araujo			Quality of life in climacteric women assisted by primary health care	PLOS ONE			English	Article							MENOPAUSAL SYMPTOMS; QUESTIONNAIRE; IMPACT; ASSOCIATION; VERSION; SLEEP	This cross-sectional study evaluated the quality of life and associated factors of climacteric women in Brazil using a random and representative sample of women assisted by primary care professionals. We investigated the variables using the Menopause-Specific Quality of Life Questionnaire, MENQOL, whose mean scores were compared using Mann-Whitney and Kruskal-Wallis tests according to the sample characteristics. The variables associated with the outcomes in univariate analyses with a p <= 0.2 were jointly evaluated using multiple linear regression. In this study, 849 women ranging in age from 40 to 65 years were evaluated. The predictors of poor quality of life in the vasomotor domain were women with severe climacteric symptoms (p<0.001), increased Body Mass Index (BMI) (p = 0.006), sleep (p = 0.022), and postmenopausal (p<0.001) alterations. For the psychosocial domain, the associated variables were severe climacteric symptoms (p<0.001) and sleep alterations (p<0.001); for the physical domain, the associated variables were severe climacteric symptoms (p<0.001), increased BMI (p<0.001), sleep (p<0.001), and postmenopausal (p<0.001) alterations. Severe climacteric symptoms, low sleep quality, increased BMI, and postmenopausal status were factors that were more associated with impairments in quality of life. With the increase in life expectancy, we suggest that greater attention should be paid to women's quality of life associated with climacteric symptoms.	[Souza Guerra Junior, Geraldo Edson; Caldeira, Antonio Prates; Santos Figueiredo Brito, Maria Fernanda; de Oliveira Silva Gerra, Kelma Dayana; Mendes D'Angelis, Carlos Eduardo; Nogueira dos Santos, Luis Antonio; de Pinho, Lucineia; Brant Rocha, Josiane Santos; Veloso Popoff, Daniela Araujo] Univ Estadual Montes Claros, Postgrad Program Primary Hlth Care, Montes Claros, MG, Brazil; [Souza Guerra Junior, Geraldo Edson; Caldeira, Antonio Prates; Santos Lima de Oliveira, Fernanda Piana; Brant Rocha, Josiane Santos; Veloso Popoff, Daniela Araujo] Fipmoc Univ Ctr UNIFIPMoc, Montes Claros, MG, Brazil	Universidade Estadual de Montes Claros	de Oliveira, FPSL (corresponding author), Fipmoc Univ Ctr UNIFIPMoc, Montes Claros, MG, Brazil.	fernandapiana@gmail.com	brito, maria/HDO-2541-2022; SANTOS, LUIS ANTONIO NOGUEIRA/ABF-6642-2020	SANTOS, LUIS ANTONIO NOGUEIRA/0000-0002-3778-8124; Guerra, Kelma/0000-0003-0591-1914; Piana Santos Lima de Oliveira, Fernanda/0000-0002-8826-6852; Santos Brant Rocha, Josiane/0000-0002-7317-3880; Souza Guerra Junior, Geraldo Edson/0000-0001-5755-0968				Alwi SARS, 2009, CLIMACTERIC, V12, P548, DOI 10.3109/13697130902919519; Asghari M, 2017, WOMEN HEALTH, V57, P173, DOI 10.1080/03630242.2016.1157128; Bertolazi AN, 2011, SLEEP MED, V12, P70, DOI 10.1016/j.sleep.2010.04.020; Blumel JE, 2011, MENOPAUSE, V18, P778, DOI 10.1097/gme.0b013e318207851d; Ceylan B, 2014, CLIMACTERIC, V17, P705, DOI 10.3109/13697137.2014.929108; Donati S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085121; Fallahzadeh H, 2010, QUAL LIFE RES, V19, P813, DOI 10.1007/s11136-010-9644-2; Freedman RR, 2014, J STEROID BIOCHEM, V142, P115, DOI 10.1016/j.jsbmb.2013.08.010; Freitas ER, 2015, ARQ BRAS PSICOL APL, V67, P112; Ghazanfarpour M, 2013, GYNECOL ENDOCRINOL, V29, P917, DOI 10.3109/09513590.2013.819078; Hilditch JR, 1996, MATURITAS, V24, P161, DOI 10.1016/0378-5122(96)01038-9; Kim MJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192934; Kim MJ, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-122; Lewis JE, 2005, MATURITAS, V50, P209, DOI 10.1016/j.maturitas.2004.06.015; Lorenzi Dino Roberto Soares De, 2009, Rev. Bras. Saude Mater. Infant., V9, P459, DOI 10.1590/S1519-38292009000400011; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Matsudo S., 2012, REV BRASILEIRA ATIVI, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; de Morais MSM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184031; Menezes Daianne Vieira, 2016, Fisioter. mov., V29, P219, DOI 10.1590/0103-5150.029.002.AO01; Miranda Gabriella Morais Duarte, 2016, Rev. bras. geriatr. gerontol., V19, P507, DOI 10.1590/1809-98232016019.150140; Mirhaghjou SN, 2016, APPL NURS RES, V30, P252, DOI 10.1016/j.apnr.2015.10.004; Nisar Nusrat, 2009, JPMA Journal of the Pakistan Medical Association, V59, P752; Norozi Ensiyeh, 2013, J Educ Health Promot, V2, P58, DOI 10.4103/2277-9531.120857; Poomalar GK, 2013, J CLIN DIAGN RES, V7, P135, DOI 10.7860/JCDR/2012/4910.2688; Schneider HPG, 2017, CLIMACTERIC, V20, P187, DOI 10.1080/13697137.2017.1279599; Shaver JL, 2015, MENOPAUSE, V22, P899, DOI 10.1097/GME.0000000000000499; Shobeiri Fatemeh, 2016, J Menopausal Med, V22, P31, DOI 10.6118/jmm.2016.22.1.31; Sociedade Brasileira de Climaterio, CONS BRAS MULT ASS M; Som N, 2014, CLIMACTERIC, V17, P713, DOI 10.3109/13697137.2014.913283; Sousa RL, 2000, REV BRAS GINECOL OBS, V22, P481; Sydora BC, 2016, MENOPAUSE, V23, P1038, DOI 10.1097/GME.0000000000000636; Utian W H, 1999, Climacteric, V2, P284, DOI 10.3109/13697139909038088; Verma, 2015, JSAFMS, V3, P20, DOI [10.5005/JP, DOI 10.5005/JP]; Williams RE, 2009, MATURITAS, V62, P153, DOI 10.1016/j.maturitas.2008.12.006; World Health Organization (WHO), 1998, OB PREV MAN GLOB EP, P98; Yanikkerem E, 2012, CLIMACTERIC, V15, P552, DOI 10.3109/13697137.2011.637651; Zollner YF, 2005, QUAL LIFE RES, V14, P309, DOI 10.1007/s11136-004-0688-z	37	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211617	10.1371/journal.pone.0211617	http://dx.doi.org/10.1371/journal.pone.0211617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811409	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400025
J	Sahrmann, AS; Stott, NS; Besier, TF; Fernandez, JW; Handsfield, GG				Sahrmann, Annika S.; Stott, Ngaire Susan; Besier, Thor F.; Fernandez, Justin W.; Handsfield, Geoffrey G.			Soleus muscle weakness in cerebral palsy: Muscle architecture revealed with Diffusion Tensor Imaging	PLOS ONE			English	Article							CROSS-SECTIONAL AREA; GROSS MOTOR FUNCTION; MEDIAL GASTROCNEMIUS; SARCOMERE LENGTHS; FASCICLE LENGTH; CHILDREN; CLASSIFICATION; STRENGTH; MRI; DTI	Cerebral palsy (CP) is associated with movement disorders and reduced muscle size. This latter phenomenon has been observed by computing muscle volumes from conventional MRI, with most studies reporting significantly reduced volumes in leg muscles. This indicates impaired muscle growth, but without knowing muscle fiber orientation, it is not clear whether muscle growth in CP is impaired in the along-fiber direction (indicating shortened muscles and limited range of motion) or the cross-fiber direction (indicating weak muscles and impaired strength). Using Diffusion Tensor Imaging (DTI) we can determine muscle fiber orientation and construct 3D muscle architectures which can be used to examine both along-fiber length and cross-sectional area. Such an approach has not been undertaken in CP. Here, we use advanced DTI sequences with fast imaging times to capture fiber orientations in the soleus muscle of children with CP and age-matched, able-bodied controls. Cross sectional areas perpendicular to the muscle fiber direction were reduced (37 +/- 11%) in children with CP compared to controls, indicating impaired muscle strength. Along-fiber muscle lengths were not different between groups. This study is the first to demonstrate along-fiber and cross-fiber muscle architecture in CP using DTI and implicates impaired cross-sectional muscle growth in children with cerebral palsy.	[Sahrmann, Annika S.; Besier, Thor F.; Fernandez, Justin W.; Handsfield, Geoffrey G.] Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand; [Stott, Ngaire Susan] Univ Auckland, Dept Orthopaed Surg, Fac Med & Hlth Sci, Auckland, New Zealand; [Besier, Thor F.; Fernandez, Justin W.] Univ Auckland, Dept Engn Sci, Fac Engn, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland	Handsfield, GG (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland, New Zealand.	g.handsfield@auckland.ac.nz	Besier, Thor F/P-6425-2019	Handsfield, Geoffrey/0000-0001-5661-0631	Wishbone Trust of the NZ Orthopaedic Association [3710689]; Whitaker Foundation; Robertson Foundation Aotearoa Fellowship Program [3715249]	Wishbone Trust of the NZ Orthopaedic Association; Whitaker Foundation; Robertson Foundation Aotearoa Fellowship Program	GGH and TFB received funding from the Wishbone Trust of the NZ Orthopaedic Association to pursue this study. [Award Number 3710689; https://nzoa.org.nz/wishbone-orthopaedic-research-foundation-new-zealand; The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.] GGH received fellowships from the Whitaker Foundation [Award Number N/A; https://www.whitaker.org/] and the Robertson Foundation Aotearoa Fellowship Program [Award Number 3715249; http://robertsonfoundation.org/index.html] during the pursuit of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agur AM, 2003, CLIN ANAT, V16, P285, DOI 10.1002/ca.10112; Alexander R.M., 1975, J HUMAN MOVEMENT STU, V1, P115; Alipour M, 2017, BIOMECH MODEL MECHAN, V16, P1729, DOI 10.1007/s10237-017-0916-4; Arkin AM, 1941, ARCH SURG-CHICAGO, V42, P395, DOI 10.1001/archsurg.1941.01210080195012; Barber L, 2011, J BIOMECH, V44, P2496, DOI 10.1016/j.jbiomech.2011.06.008; Barber L, 2011, DEV MED CHILD NEUROL, V53, P543, DOI 10.1111/j.1469-8749.2011.03913.x; Barrett RS, 2010, DEV MED CHILD NEUROL, V52, P794, DOI 10.1111/j.1469-8749.2010.03686.x; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Bolsterlee B, 2015, J BIOMECH, V48, P1133, DOI 10.1016/j.jbiomech.2015.01.012; Buck AKW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126953; CAPADAY C, 1986, J NEUROSCI, V6, P1308; Chen XF, 2016, J BIOMECH, V49, P4164, DOI 10.1016/j.jbiomech.2016.11.010; Cromie MJ, 2013, MUSCLE NERVE, V48, P286, DOI 10.1002/mus.23760; Damon BM, 2002, MAGN RESON MED, V48, P97, DOI 10.1002/mrm.10198; Fernandez J, 2017, LECT NOTES COMPUT SC, V10549, P71, DOI 10.1007/978-3-319-67552-7_9; Foran JRH, 2005, DEV MED CHILD NEUROL, V47, P713, DOI 10.1017/S0012162205001465; Fukunaga T, 1997, J APPL PHYSIOL, V82, P354, DOI 10.1152/jappl.1997.82.1.354; Handsfield GG, 2017, BIOMECH MODEL MECHAN, V16, P1845, DOI 10.1007/s10237-017-0923-5; Handsfield GG, 2016, MUSCLE NERVE, V53, P933, DOI 10.1002/mus.24972; Handsfield GG, 2014, J BIOMECH, V47, P631, DOI 10.1016/j.jbiomech.2013.12.002; Heemskerk AM, 2010, NMR BIOMED, V23, P294, DOI 10.1002/nbm.1463; Hodgson JA, 2006, J MORPHOL, V267, P584, DOI 10.1002/jmor.10421; Holzbaur KRS, 2007, J BIOMECH, V40, P742, DOI 10.1016/j.jbiomech.2006.11.011; Hooijmans MT, 2015, NMR BIOMED, V28, P1589, DOI 10.1002/nbm.3427; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Ko IH, 2013, J EXERC REHABIL, V9, P368, DOI 10.12965/jer.130045; Lansdown DA, 2007, J APPL PHYSIOL, V103, P673, DOI 10.1152/japplphysiol.00290.2007; Lieber RL, 2000, MUSCLE NERVE, V23, P1647, DOI 10.1002/1097-4598(200011)23:11<1647::AID-MUS1>3.0.CO;2-M; Llewellyn ME, 2008, NATURE, V454, P784, DOI 10.1038/nature07104; Malaiya R, 2007, J ELECTROMYOGR KINES, V17, P657, DOI 10.1016/j.jelekin.2007.02.009; Mathewson MA, 2015, J ORTHOP RES, V33, P33, DOI 10.1002/jor.22728; Moreau NG, 2010, PHYS THER, V90, P1619, DOI 10.2522/ptj.20090377; Moreau NG, 2009, DEV MED CHILD NEUROL, V51, P800, DOI 10.1111/j.1469-8749.2009.03307.x; Morrell DS, 2002, RADIOGRAPHICS, V22, P257, DOI 10.1148/radiographics.22.2.g02mr19257; Morse CI, 2005, J APPL PHYSIOL, V99, P1050, DOI 10.1152/japplphysiol.01186.2004; NARICI MV, 1992, EUR J APPL PHYSIOL O, V65, P438, DOI 10.1007/BF00243511; Noble JJ, 2017, BMC NEUROL BMC NEURO, V17, P1, DOI [10.1186/s12883-016-0787-9, DOI 10.1186/S12883-016-0787-9]; Noble JJ, 2014, BRAIN DEV-JPN, V36, P294, DOI 10.1016/j.braindev.2013.05.008; Oberhofer K, 2010, CLIN BIOMECH, V25, P88, DOI 10.1016/j.clinbiomech.2009.09.007; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; PRUIM GJ, 1980, J BIOMECH, V13, P755, DOI 10.1016/0021-9290(80)90237-7; Reid SL, 2015, DISABIL REHABIL, V37, P579, DOI 10.3109/09638288.2014.935492; Rodda JM, 2004, J BONE JOINT SURG BR, V86B, P251, DOI 10.1302/0301-620X.86B2.13878; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V49, P8, DOI 10.1111/j.1469-8749.2007.tb12610.x; Schenk P, 2013, J ANAT, V223, P61, DOI 10.1111/joa.12062; Shortland AP, 2002, DEV MED CHILD NEUROL, V44, P158, DOI 10.1017/S0012162201001864; Sinha U, 2011, J APPL PHYSIOL, V110, P807, DOI 10.1152/japplphysiol.00923.2010; Sinkjaer T, 2000, J PHYSIOL-LONDON, V523, P817, DOI 10.1111/j.1469-7793.2000.00817.x; Smith LR, 2011, J PHYSIOL-LONDON, V589, P2625, DOI 10.1113/jphysiol.2010.203364; Van Donkelaar CC, 1999, J ANAT, V194, P79, DOI 10.1046/j.1469-7580.1999.19410079.x; Ward SR, 2009, CLIN ORTHOP RELAT R, V467, P1074, DOI 10.1007/s11999-008-0594-8; Wood E, 2000, DEV MED CHILD NEUROL, V42, P292, DOI 10.1017/S0012162200000529; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	55	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0205944	10.1371/journal.pone.0205944	http://dx.doi.org/10.1371/journal.pone.0205944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802250	Green Published, Green Submitted, gold			2022-12-26	WOS:000459710700002
J	Jeon, SM; Kwon, JW; Choi, SH; Park, HY				Jeon, Soo Min; Kwon, Jin-Won; Choi, Sun Ha; Park, Hae-Young			Economic burden of lung cancer: A retrospective cohort study in South Korea, 2002-2015	PLOS ONE			English	Article							INTERNATIONAL EPIDEMIOLOGY; FOLLOW-UP; OF-LIFE; COSTS; CARE; DIAGNOSIS; POPULATION; DECEDENTS; PATTERNS; MODALITY	We evaluated the survival rates and medical expenditure in patients with lung cancer using a nationwide claims database in South Korea. A retrospective observational cohort study design was used, and 2,919 lung cancer patients and their matched controls were included. Medical expenditures were analyzed with the Kaplan-Meier sample average method, and patients were categorized into 4 groups by operation and primary treatment method (i.e. Patients with operation: OP = surgery, OP+CTx/RTx = surgery with anti-cancer drugs or radiotherapy; Patients without operation: CTx/RTx = anti-cancer drugs or radiotherapy, Supportive treatment). The 5-year medical expenditure per case was highest in the OP+CTx/RTx group ($36,013), followed by the CTx/RTx ($23,134), OP ($22,686), and supportive treatment group ($3,700). Lung cancer-related anti-cancer drug therapy was the major cost driver, with an average 53% share across all patients. Generalized linear regression revealed that monthly medical expenditure in lung cancer patients, after adjustment for follow-up month, was approximately 3.1-4.3 times higher than that in the control group (cost ratio for OP = 3.116, OP+CTx/RTx = 3.566, CTx/RTx = 4.340,supportive treatment = 4.157). The monthly medical expenditure at end of life was estimated at $2,139 for all decedents, and approximately a quarter of patients had received chemotherapy in the last 3 months. In conclusion, this study presented the quantified treatment costs of lung cancer on various aspects compared with matched controls according to the treatment of choice. In this study, patients with operation incurred lower lifetime treatment costs than patients with CTx/RTx or supportive treatment, indicating that the economic burden of lung cancer was affected by treatment method. Further studies including both cancer stage and treatment modality are needed to confirm these results and to provide more information on the economic burden according to disease severity.	[Jeon, Soo Min; Kwon, Jin-Won; Park, Hae-Young] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea; [Jeon, Soo Min; Kwon, Jin-Won; Park, Hae-Young] Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea; [Choi, Sun Ha] Kyungpook Natl Univ, Chilgok Hosp, Lung Canc Ctr, Daegu, South Korea	Kyungpook National University; Kyungpook National University; Kyungpook National University	Park, HY (corresponding author), Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea.; Park, HY (corresponding author), Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea.	hypark0303@gmail.com		CHOI, SUNHA/0000-0002-9665-7466; Park, Hae-Young/0000-0001-8348-0887	National Research Foundation of Korea [NRF-2018R1D1A3B07047356]; Korea National Research Foundation [NRF-2018R1D1A3B07047356]; National Health Insurance Service [NHIS-2018-2-101]	National Research Foundation of Korea(National Research Foundation of Korea); Korea National Research Foundation(National Research Foundation of Korea); National Health Insurance Service	HYP received the grant (NRF-2018R1D1A3B07047356) funded by the National Research Foundation of Korea (https://www.nrf.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.; We thank the Korea National Research Foundation for supporting this research (NRF-2018R1D1A3B07047356). We also thank the National Health Insurance Service for providing data for this study (NHIS-2018-2-101).	Blakely T, 2015, MED CARE, V53, P302, DOI 10.1097/MLR.0000000000000330; Cancer IAFRO, 2012, GLOBOCAN 2012 EST CA; Cheng TYD, 2016, J THORAC ONCOL, V11, P1653, DOI 10.1016/j.jtho.2016.05.021; Choi Y, 2015, CANCER RES TREAT, V47, P555, DOI 10.4143/crt.2014.200; Cipriano LE, 2011, VALUE HEALTH, V14, P41, DOI 10.1016/j.jval.2010.10.006; Davis KL, 2015, LUNG CANCER, V87, P176, DOI 10.1016/j.lungcan.2014.11.002; Ettinger DS, 2018, J NATL COMPR CANC NE, V16, P807, DOI 10.6004/jnccn.2018.0062; Etzioni R, 1996, J CLIN EPIDEMIOL, V49, P95, DOI 10.1016/0895-4356(96)89259-6; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; FLEHINGER BJ, 1992, CHEST, V101, P1013, DOI 10.1378/chest.101.4.1013; Gildea TR, 2017, CLINICOECONOMIC OUTC, V9, P261, DOI 10.2147/CEOR.S132259; Hung YN, 2017, ONCOLOGIST, V22, P460, DOI 10.1634/theoncologist.2016-0283; In KH, 2009, LUNG CANCER, V64, P232, DOI 10.1016/j.lungcan.2008.08.005; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lang K, 2009, CLIN GASTROENTEROL H, V7, P198, DOI 10.1016/j.cgh.2008.08.034; Langton JM, 2016, BRIT J CANCER, V114, P1293, DOI 10.1038/bjc.2016.75; Lin DY, 1997, BIOMETRICS, V53, P419, DOI 10.2307/2533947; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Malhotra J, 2017, TRANSL LUNG CANCER R, V6, P196, DOI 10.21037/tlcr.2017.03.01; Manegold C, 2016, ESMO OPEN, V1, DOI 10.1136/esmoopen-2016-000118; McGuire A, 2015, J MED ECON, V18, P525, DOI 10.3111/13696998.2015.1032974; Meng XJ, 2017, CANCER LETT, V405, P29, DOI 10.1016/j.canlet.2017.06.033; Miller DL, 2016, ANN THORAC SURG, V101, P1864, DOI 10.1016/j.athoracsur.2015.11.001; Onukwugha E, 2016, PHARMACOECONOMICS, V34, P43, DOI 10.1007/s40273-015-0325-4; Park YS, 2010, LUNG CANCER, V68, P299, DOI 10.1016/j.lungcan.2009.06.016; Prigerson HG, 2015, JAMA ONCOL, V1, P778, DOI 10.1001/jamaoncol.2015.2378; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rasmussen SR, 2007, SCAND J PUBLIC HEALT, V35, P365, DOI 10.1080/14034940701219642; Schnipper LE, 2012, J CLIN ONCOL, V30, P1715, DOI 10.1200/JCO.2012.42.8375; Schwarzkopf L, 2015, LUNG CANCER, V90, P274, DOI 10.1016/j.lungcan.2015.09.005; Shin JY, 2012, ASIAN PAC J CANCER P, V13, P3767, DOI 10.7314/APJCP.2012.13.8.3767; Torre LA, 2016, ADV EXP MED BIOL, V893, P1, DOI 10.1007/978-3-319-24223-1_1; Tremblay L, 2013, THORAC SURG CLIN, V23, P429, DOI 10.1016/j.thorsurg.2013.05.010; Vansteenkiste J, 2013, ANN ONCOL, V24, P89, DOI 10.1093/annonc/mdt241; Yabroff KR, 2008, JNCI-J NATL CANCER I, V100, P630, DOI 10.1093/jnci/djn103; Youlden DR, 2008, J THORAC ONCOL, V3, P819, DOI 10.1097/JTO.0b013e31818020eb	37	8	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212878	10.1371/journal.pone.0212878	http://dx.doi.org/10.1371/journal.pone.0212878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794674	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100155
J	Navarrete, E; Arcara, G; Mondini, S; Penolazzi, B				Navarrete, Eduardo; Arcara, Giorgio; Mondini, Sara; Penolazzi, Barbara			Italian norms and naming latencies for 357 high quality color images	PLOS ONE			English	Article							WORD-FREQUENCY; SURFACE DETAIL; NAME AGREEMENT; STANDARDIZED SET; AGE; ACQUISITION; PICTURES; SNODGRASS; FRENCH; TIMES	In the domain of cognitive studies on the lexico-semantic representational system, one of the most important means of ensuring effective experimental designs is using ecological stimulus sets accompanied by normative data on the most relevant variables affecting the processing of their items. In the context of image sets, color photographs are particularly suited to this purpose as they reduce the difficulty of visual decoding processes that may emerge with traditional image sets of line drawings. This is especially so in clinical populations. In this study we provide Italian norms for a set of 357 high quality image-items belonging to 23 semantic subcategories from the Moreno-Martinez and Montoro database. Data from several variables affecting image processing were collected from a sample of 255 Italian-speaking participants: age of acquisition, familiarity, lexical frequency, manipulability, name agreement, typicality and visual complexity. Lexical frequency data were derived from the CoLFIS corpus. Furthermore, we collected data on image oral naming latencies to explore how the variance in these latencies could be explained by these critical variables. Multiple regression analyses on the naming latencies show classical psycholinguistic phenomena, such as the effects of age of acquisition and name agreement. In addition, manipulability was also a significant predictor. The described Italian normative data and naming latencies are available for download as supplementary material.	[Navarrete, Eduardo] Univ Padua, Dept Dev & Social Psychol, Padua, Italy; [Arcara, Giorgio] IRCCS Fdn Osped San Camillo, Venice, Italy; [Mondini, Sara] Univ Padua, Dept Gen Psychol, Padua, Italy; [Mondini, Sara] Human Inspired Technol Res Ctr HIT, Padua, Italy; [Penolazzi, Barbara] Univ Trieste, Dept Life Sci, Trieste, Italy	University of Padua; IRCCS Ospedale San Camillo; University of Padua; University of Trieste	Navarrete, E (corresponding author), Univ Padua, Dept Dev & Social Psychol, Padua, Italy.; Arcara, G (corresponding author), IRCCS Fdn Osped San Camillo, Venice, Italy.	eduardo.navarrete@unipd.it; giorgio.arcara@gmail.com	Navarrete, Eduardo/AEW-8408-2022	Navarrete, Eduardo/0000-0002-7619-8397	MIUR	MIUR(Ministry of Education, Universities and Research (MIUR))	The present work was carried out within the scope of the research program "Dipartimenti di Eccellenza", which is supported by a grant from MIUR to the Department of General Psychology, University of Padua.	Adlington RL, 2009, NEUROPSYCHOLOGIA, V47, P2574, DOI 10.1016/j.neuropsychologia.2009.05.004; Alario FX, 1999, BEHAV RES METH INS C, V31, P531, DOI 10.3758/BF03200732; Alario FX, 2004, BEHAV RES METH INS C, V36, P140, DOI 10.3758/BF03195559; Almeida J, 2007, PSYCHON B REV, V14, P1177, DOI 10.3758/BF03193109; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barca L, 2002, BEHAV RES METH INS C, V34, P424, DOI 10.3758/BF03195471; Barry C, 1997, Q J EXP PSYCHOL-A, V50, P560, DOI 10.1080/783663595; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bates E, 2001, MEM COGNITION, V29, P986, DOI 10.3758/BF03195761; Bertinetto P. M., 2005, COLFIS CORPUS LESSI; Besken M, 2016, J EXP PSYCHOL LEARN, V42, P1417, DOI 10.1037/xlm0000246; Bonin P, 2002, BRIT J PSYCHOL, V93, P89, DOI 10.1348/000712602162463; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brodeur MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010773; BRODIE EE, 1991, AM J PSYCHOL, V104, P517, DOI 10.2307/1422939; Brysbaert M, 2006, VIS COGN, V13, P992, DOI 10.1080/13506280544000165; Chalard M, 2003, EUR J COGN PSYCHOL, V15, P209, DOI 10.1080/09541440244000076; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Dell'acqua R, 2000, BEHAV RES METH INS C, V32, P588, DOI 10.3758/BF03200832; Dunabeiti A J. A., 2017, Q J EXPT PSYCHOL, P1; Field A.P., 2020, DISCOVERING STAT USI, V4th; Forster KI, 2003, BEHAV RES METH INS C, V35, P116, DOI 10.3758/BF03195503; Garcea Frank E, 2013, Front Hum Neurosci, V7, P120, DOI 10.3389/fnhum.2013.00120; Gerhand S, 1998, J EXP PSYCHOL LEARN, V24, P267, DOI 10.1037/0278-7393.24.2.267; Gimenes M, 2016, BEHAV RES METHODS, V48, P963, DOI 10.3758/s13428-015-0621-0; Griffin ZM, 1998, J MEM LANG, V38, P313, DOI 10.1006/jmla.1997.2547; Guerard K, 2015, BEHAV RES METHODS, V47, P443, DOI 10.3758/s13428-014-0488-5; Harry A, 2014, CLIN NEUROPSYCHOL, V28, P486, DOI 10.1080/13854046.2014.892155; Moreno-Martinez FJ, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/960725; Moreno-Martinez FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037527; Moreno-Martinez FJ, 2011, AGING NEUROPSYCHOL C, V18, P293, DOI 10.1080/13825585.2010.540849; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Johnston RA, 2005, MEM COGNITION, V33, P905, DOI 10.3758/BF03193084; Juhasz BJ, 2005, PSYCHOL BULL, V131, P684, DOI 10.1037/0033-2909.131.5.684; Kan IP, 2004, COGN AFFECT BEHAV NE, V4, P43, DOI 10.3758/CABN.4.1.43; Kittredge AK, 2008, COGN NEUROPSYCHOL, V25, P463, DOI 10.1080/02643290701674851; Lorenzoni A, 2018, J COGNITION, V1, DOI [10.5334/joc.28, DOI 10.5334/JOC.28]; MORRISON CM, 1992, MEM COGNITION, V20, P705, DOI 10.3758/BF03202720; Navarrete E, 2015, MEM COGNITION, V43, P1085, DOI 10.3758/s13421-015-0525-3; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; Perret C, 2019, BEHAV RES METHODS, V51, P2533, DOI 10.3758/s13428-018-1100-1; PRICE CJ, 1989, Q J EXP PSYCHOL-A, V41, P797, DOI 10.1080/14640748908402394; Protopapas A, 2007, BEHAV RES METHODS, V39, P859, DOI 10.3758/BF03192979; R Core Team, 2021, R LANGUAGE ENV STAT; Ralph MAL, 2006, VIS COGN, V13, P928, DOI 10.1080/13506280544000110; Rhodes MG, 2008, J EXP PSYCHOL GEN, V137, P615, DOI 10.1037/a0013684; Rossion B, 2004, PERCEPTION, V33, P217, DOI 10.1068/p5117; Salmon JP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01187; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shao ZSS, 2016, BEHAV RES METHODS, V48, P577, DOI 10.3758/s13428-015-0613-0; SNODGRASS JG, 1980, J EXP PSYCHOL-HUM L, V6, P174, DOI 10.1037/0278-7393.6.2.174; Snodgrass JG, 1996, BEHAV RES METH INSTR, V28, P516, DOI 10.3758/BF03200540; Undorf M, 2017, J MEM LANG, V92, P293, DOI 10.1016/j.jml.2016.07.003; Venables WN, MODERN APPL STAT S P; Viggiano MP, 2004, CORTEX, V40, P491, DOI 10.1016/S0010-9452(08)70142-4; WURM LH, 1993, J EXP PSYCHOL HUMAN, V19, P899, DOI 10.1037/0096-1523.19.4.899	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0209524	10.1371/journal.pone.0209524	http://dx.doi.org/10.1371/journal.pone.0209524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794543	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100010
J	Limwattananon, C; Waleekhachonloet, O				Limwattananon, Chulaporn; Waleekhachonloet, Onanong			Access to and price trends of antidiabetic, antihypertensive, and antilipidemic drugs in outpatient settings of the Universal Coverage Scheme in Thailand	PLOS ONE			English	Article								Under the Universal Coverage Scheme (UCS) with payment per capita for outpatient (OP) services, hospitals' financial risks will rise if access to essential drugs increases. This study examined trends in access to and price of essential drugs for noncommunicable diseases (NCDs) and an overall purchasing price index (PPI) for an OP drug basket from public hospitals. To examine drug access, OP prescription data from 2010-2012 were obtained from the UCS. Access to thirteen drugs for diabetes, hypertension, and dyslipidemia was examined for trend using a time-series analysis. To calculate the PPI, drugs in the same dataset in 2010 that each contributed at least 0.2% of the total OP drug expenditure (N = 118 items) were selected together with drugs expected for near future growth (N = 48 items). The PPI was constructed from purchasing prices in 16 hospitals using a standard method developed by the International Labour Organization. Based on 166 drug items accounting for 75% of OP drug expenditures, the overall PPI continually declined by 6.8% from 2010 to 2012. Access to the 13 selected NCD drugs, accounting for 22% of the total OP drug expenditure increased from 22 to 30 per 1,000 population for antidiabetics, 27 to 47 for antihypertensive agents, and 32 to 53 for antilipidemics from 2010-2012. Growth in the study drug recipients was relatively higher than that in the population and diagnosed patients. Due to generic market competition, metformin, glipizide, amlodipine, losartan, simvastatin, atorvastatin, and fenofibrate prices decreased by 6-22%. Antiretrovirals and risperidone prices decreased by more than 10% due to price negotiation by the UCS. Access to essential drugs for diabetes, hypertension and dyslipidemia has increased. A decline in the PPI could contain essential drug expenditure when the demand for the drugs increased. Generic market competition and price negotiation by the UCS led to price reduction.	[Limwattananon, Chulaporn] Khon Kaen Univ, Fac Pharmaceut Sci, Div Clin Pharm, Khon Kaen, Thailand; [Waleekhachonloet, Onanong] Mahasarakham Univ, Dept Clin Pharm, Fac Pharm, Maha Sarakham, Thailand	Khon Kaen University; Mahasarakham University	Limwattananon, C (corresponding author), Khon Kaen Univ, Fac Pharmaceut Sci, Div Clin Pharm, Khon Kaen, Thailand.	limw0002@kku.ac.th		Waleekhachonloet, Onanong/0000-0002-3692-6302	Health Systems Research Institute [55-050]; URL	Health Systems Research Institute; URL	This work was supported by Health Systems Research Institute, grant number 55-050, URL https://www.hsri.or.th, Authors who received the funding are CL and OW. Health Insurance System Research Office, URL https://www.hisro.or.th. Author who received the funding is OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARP, RX PRIC WATCH REP TR; Aekplakorn W, 2014, THAI NATL HLTH EXAMI; Agency for Healthcare Research and Quality, 2004, AHRQ QUAL IND GUID P; [Anonymous], 2017, DIABETES CARE, V40, pS1, DOI 10.2337/dc17-S001; [Anonymous], 2012, THAIL U COV SCHEM AN; [Anonymous], 1985, THEORY PRACTICE ECON; [Anonymous], 2014, ACC MED RES PROGR CA; Bigdeli M, 2013, HEALTH POLICY PLANN, V28, P692, DOI 10.1093/heapol/czs108; Bureau of policy and strategy Ministry of Public Health, PUBL HLTH STAT; Garber AJ, 2017, ENDOCR PRACT, V23, P207, DOI 10.4158/EP161682.CS; Hogerzeil HV, 2013, LANCET, V381, P680, DOI 10.1016/S0140-6736(12)62128-X; ILO/ IMF/ OECD/ UNECE/ Eurostat/ The World Bank, 2004, CONS PRIC IND MAN TH; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Patent Medicine Prices Review Board, PRIC TREND ANN RAT C; Prakongsai P., 2009, INNOVATIONS HLTH SYS; Rice N, 2001, MILBANK Q, V79, P81, DOI 10.1111/1468-0009.00197; Sanderson C, 2000, J Health Serv Res Policy, V5, P222; Tangcharoensathien V, 2011, EQUITY IMPACT UNIVER; WHO, 2012, PROMOTING ACCESS TO MEDICAL TECHNOLOGIES AND INNOVATION: INTERSECTIONS BETWEEN PUBLIC HEALTH, INTELLECTUAL PROPERTY AND TRADE, P1; WHO Collaborating Centre for Drug Statistics Methodology, ATC STRUCT PRINC; WHO Health Action International, 2008, MEAS MED PRIC AV AFF, V2nd; Yoongthong W, 2012, VALUE HEALTH, V15, pS126, DOI 10.1016/j.jval.2011.11.003	22	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211759	10.1371/journal.pone.0211759	http://dx.doi.org/10.1371/journal.pone.0211759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785916	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000036
J	Liu, GL; Zhang, FF; Wang, RX; London, SD; London, L				Liu, Guangliang; Zhang, Fangfang; Wang, Ruixue; London, Steven D.; London, Lucille			Salivary gland immunization via Wharton's duct activates differential T-cell responses within the salivary gland immune system	FASEB JOURNAL			English	Article						mucosal immunity; vaccine development; T helper cells	ROR-GAMMA-T; SJOGRENS-SYNDROME; MURINE CYTOMEGALOVIRUS; PROMOTES ACCUMULATION; MUCOSAL; EXPRESSION; MEMORY; INFECTION; CYTOKINES; TRANSCRIPTION	Salivary glands are a major component of the mucosal immune system that confer adaptive immunity to mucosal pathogens. As previously demonstrated, immunization of the submandibular gland with tissue culture-derived murine cytomegalovirus (tcMCMV) or replication-deficient adenoviruses expressing individual murine cytomegalovirus (MCMV) genes protected mice against a lethal MCMV challenge. Here, we report that salivary gland inoculation of BALB/cByJ mice with tcMCMV or recombinant adenoviruses differentially activates T helper (T-h)1, -2, and -17 cells in the salivary glands vs. the associated lymph nodes. After inoculation with tcMCMV, lymphocytes from the submandibular gland preferentially express the transcription factor T-cell-specific T-box transcription factor (T-bet), which controls the expression of the hallmark T(h)1 cytokine, IFN-. Lymphocytes from the periglandular lymph nodes (PGLNs) express both T-bet and GATA-binding protein 3 (GATA3), which promotes the secretion of IL-4, -5, and -10 from T(h)2 cells. In contrast, after inoculation with replication-deficient adenoviruses, lymphocytes from the submandibular gland express T-bet, GATA3, and RAR-related orphan receptor , thymus-specific isoform (RORt) (required for differentiation of T(h)17 cells) and forkhead box P3 (Foxp3) (required for the differentiation of regulatory T cells). Lymphocytes from the PGLNs were not activated. The differential induction of T-h responses in the salivary gland vs. the PGLNs after inoculation with attenuated virus vs. a nominal protein antigen supports the use of the salivary as an alternative mucosal route for administering vaccines.Liu, G., Zhang, F., Wang, R., London, S. D., London, L. Salivary gland immunization via Wharton's duct activates differential T-cell responses within the salivary gland immune system.	[Liu, Guangliang; Zhang, Fangfang; Wang, Ruixue; London, Steven D.; London, Lucille] SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, 231 Dutchess Hall, Stony Brook, NY 11794 USA; [Liu, Guangliang] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Sate Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Zhang, Fangfang] Lanzhou Univ, Sch Basic Sci, Inst Pathol, Lanzhou, Gansu, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Lanzhou University	London, L (corresponding author), SUNY Stony Brook, Sch Dent Med, Dept Oral Biol & Pathol, 231 Dutchess Hall, Stony Brook, NY 11794 USA.	lucille.london@stonybrook.edu	Zhang, Fang/HHN-2153-2022; Liu, Guangliang/I-8173-2013	Liu, Guangliang/0000-0001-8158-5749	U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research Grant [1R01 DE016652, 1R15DE024313]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R15DE024313] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research Grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors thank Dr. John D. Shanley and Dr. Carol A. Wu (University of Connecticut, Farmington, CT, USA) for providing recombinant adenovirus vectors and cell lines. This project was supported by U.S. National Institutes of Health/National Institute of Dental and Craniofacial Research Grant 1R01 DE016652 (to S.D.L.) and 1R15DE024313 (to S.D.L.). The authors declare no conflicts of interest.	Bergsbaken T, 2015, NAT IMMUNOL, V16, P406, DOI 10.1038/ni.3108; Bikker A, 2010, ARTHRITIS RHEUM-US, V62, P969, DOI 10.1002/art.27318; Brandtzaeg P, 2007, VACCINE, V25, P5467, DOI 10.1016/j.vaccine.2006.12.001; Brune W, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1907s43; Caldeira-Dantas S, 2018, J IMMUNOL, V200, P1133, DOI 10.4049/jimmunol.1701272; Campbell AE, 2008, MED MICROBIOL IMMUN, V197, P205, DOI 10.1007/s00430-008-0077-2; Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Cavanaugh VJ, 2003, J VIROL, V77, P1703, DOI 10.1128/JVI.77.3.1703-1717.2003; Fox RI, 2005, LANCET, V366, P321, DOI 10.1016/S0140-6736(05)66990-5; Fu HM, 2013, FRONT BIOSCI-LANDMRK, V18, P422, DOI 10.2741/4111; Gagliani N, 2017, METHODS MOL BIOL, V1514, P19, DOI 10.1007/978-1-4939-6548-9_2; Geist LJ, 2001, J INVEST MED, V49, P434, DOI 10.2310/6650.2001.33788; Grewal JS, 2011, FASEB J, V25, P1680, DOI 10.1096/fj.10-174656; Guggino G, 2017, EUR J IMMUNOL, V47, P2002, DOI 10.1002/eji.201747140; Hansen A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2210; Hillen MR, 2016, ANN RHEUM DIS, V75, P1735, DOI 10.1136/annrheumdis-2016-209236; Hofmann M, 2011, P NATL ACAD SCI USA, V108, P16741, DOI 10.1073/pnas.1107200108; Hryniewicz A, 2006, BLOOD, V108, P3834, DOI 10.1182/blood-2006-04-010637; Iizuka M, 2015, J IMMUNOL, V194, P56, DOI 10.4049/jimmunol.1401118; Ivetic A, 2013, INT J BIOCHEM CELL B, V45, P550, DOI 10.1016/j.biocel.2012.12.023; Kallies A, 2017, TRENDS IMMUNOL, V38, P287, DOI 10.1016/j.it.2017.02.003; Katsifis GE, 2009, AM J PATHOL, V175, P1167, DOI 10.2353/ajpath.2009.090319; Khor B, 2017, TRANSFUS MED REV, V31, P36, DOI 10.1016/j.tmrv.2016.07.003; Liu GL, 2014, FASEB J, V28, P1698, DOI 10.1096/fj.13-244178; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma Xiaojing, 2015, F1000Res, V4, DOI 10.12688/f1000research.7010.1; Maehara T, 2012, CLIN EXP IMMUNOL, V169, P89, DOI 10.1111/j.1365-2249.2012.04606.x; Mieliauskaite D, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/187258; Min B, 2017, J INTERF CYTOK RES, V37, P386, DOI 10.1089/jir.2017.0027; Na H, 2016, IMMUNE NETW, V16, P1, DOI 10.4110/in.2016.16.1.1; Nalbant Ayten, 2016, Front Biosci (Elite Ed), V8, P427; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; Oswald-Richter K, 2004, PLOS BIOL, V2, P955, DOI 10.1371/journal.pbio.0020198; Picarda G, 2018, J IMMUNOL, V200, P3881, DOI 10.4049/jimmunol.1800171; Pilgrim MJ, 2007, EXP MOL PATHOL, V82, P269, DOI 10.1016/j.yexmp.2006.12.010; Plitas G, 2016, CANCER IMMUNOL RES, V4, P721, DOI 10.1158/2326-6066.CIR-16-0193; Ponzio Todd A, 2017, Trop Dis Travel Med Vaccines, V3, P4, DOI 10.1186/s40794-017-0047-z; Qiao YC, 2017, AUTOIMMUN REV, V16, P1058, DOI 10.1016/j.autrev.2017.08.001; Sakai A, 2008, J IMMUNOL, V181, P2898, DOI 10.4049/jimmunol.181.4.2898; Sarigul M, 2010, LUPUS, V19, P138, DOI 10.1177/0961203309348234; Shanley JD, 2005, VACCINE, V23, P996, DOI 10.1016/j.vaccine.2004.07.041; Shanley JD, 2003, VACCINE, V21, P2632, DOI 10.1016/S0264-410X(03)00037-9; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Szodoray P, 2005, CLIN IMMUNOL, V117, P168, DOI 10.1016/j.clim.2005.06.016; Tahara M, 2017, CLIN EXP IMMUNOL, V187, P213, DOI 10.1111/cei.12868; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Tang-Feldman YJ, 2006, J VIROL METHODS, V131, P122, DOI 10.1016/j.jviromet.2005.07.013; Tessmer MS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001254; Tucker SN, 2004, VACCINE, V22, P2500, DOI 10.1016/j.vaccine.2003.12.034; van Eden W, 2013, FEBS LETT, V587, P1951, DOI 10.1016/j.febslet.2013.05.024; Verma NK, 2017, J IMMUNOL, V199, P1213, DOI 10.4049/jimmunol.1700495; Wali S, 2016, CYTOKINE, V87, P9, DOI 10.1016/j.cyto.2016.06.010; Wang JJ, 2016, EUR J IMMUNOL, V46, P2444, DOI 10.1002/eji.201646300; Woyciechowski S, 2017, EUR J IMMUNOL, V47, P244, DOI 10.1002/eji.201646722; Xu DP, 2006, J IMMUNOL, V177, P739, DOI 10.4049/jimmunol.177.1.739; Zhang LW, 2018, SCAND J IMMUNOL, V87, DOI 10.1111/sji.12649; Zhao LL, 2017, RHEUMATOLOGY, V56, P303, DOI 10.1093/rheumatology/kew360; Zhu JF, 2015, CYTOKINE, V75, P14, DOI 10.1016/j.cyto.2015.05.010; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	60	0	0	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6011	6022		10.1096/fj.201801993R	http://dx.doi.org/10.1096/fj.201801993R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817215	Green Published, Bronze			2022-12-26	WOS:000466932600018
J	Gong, WW; Liu, YY; Seidl, C; Dreyer, T; Drecoll, E; Kotzsch, M; Bronger, H; Dorn, J; Magdolen, V				Gong, Weiwei; Liu, Yueyang; Seidl, Christof; Dreyer, Tobias; Drecoll, Enken; Kotzsch, Matthias; Bronger, Holger; Dorn, Julia; Magdolen, Viktor			Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients	PLOS ONE			English	Article							PROSTATE; ACTIVATION; FAMILY; CARCINOMA; VARIANTS; SURVIVAL; BREAST; GROWTH; CELLS	Overexpression of several members of the kallikrein-related peptidase (KLK) family, including KLK4, has been reported in ovarian cancer tissue, consistent with the fact that elevated levels of KLK protein are often also found in serum and in effusion fluids of ovarian cancer patients. In the present study, we quantitatively analyzed KLK4 tumor tissue mRNA expression levels in a homogeneous cohort including 138 patients of advanced high-grade serous ovarian cancer (FIGO stage III/IV). Age as well as ascites fluid volume were found to be significantly associated with KLK4 mRNA expression levels. In univariate Cox regression analysis, the clinical factors residual tumor mass and ascites fluid volume represented univariate predictors for both overall survival (OS) and progression-free survival (PFS). Furthermore, elevated KLK4 mRNA expression levels were significantly linked with reduced OS (p = 0.001), but not with PFS. The results concerning the association of KLK4 mRNA expression with OS were validated in a publicly available Affymetrix-based mRNA data set from The Cancer Genome Atlas (n = 252) applying the Kaplan-Meier Plotter tool (p = 0.047). In multivariable analyses, elevated KLK4 mRNA values turned out as an additional, independent predictive marker for shortened OS (p = 0.006), whereas residual tumor mass, but not ascites fluid volume, remained an independent indicator for both OS and PFS (p < 0.001 and p = 0.002, respectively). The results of the present study, obtained in a well-defined, homogenous cohort of patients afflicted with advanced high-grade serous ovarian cancer, are in line with previous reports describing high KLK4 levels as an unfavorable marker in ovarian cancer patients.	[Gong, Weiwei; Liu, Yueyang; Seidl, Christof; Dreyer, Tobias; Bronger, Holger; Dorn, Julia; Magdolen, Viktor] Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, Munich, Germany; [Drecoll, Enken] Tech Univ Munich, Inst Pathol, Munich, Germany; [Kotzsch, Matthias] Med Labor Ostsachsen, Dresden, Germany	Technical University of Munich; Technical University of Munich	Magdolen, V (corresponding author), Tech Univ Munich, Dept Obstet & Gynecol, Clin Res Unit, Munich, Germany.	viktor.magdolen@tum.de			Wilhelm Sander-Stiftung [2016-024.1]; Deutsche Forschungsgemeinschaft [DO 1772/1-1, BR 4733/3-1, AV 109/74-1, MA 1236/10-1]	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The present study was supported in part by grants from the the Wilhelm Sander-Stiftung, http://wilhelm-sander-stiftung.de, grant 2016-024.1 (VM) and the Deutsche Forschungsgemeinschaft, http://www.dfg.de, grants DO 1772/1-1 (JD), BR 4733/3-1 (HB), AV 109/74-1 (ED), and MA 1236/10-1 (VM), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2016, BIOL CHEM, V397, P1265, DOI 10.1515/hsz-2016-0177; Avgeris M, 2012, BIOL CHEM, V393, P301, DOI 10.1515/hsz-2011-0260; Avgeris M, 2011, PROSTATE, V71, P1780, DOI 10.1002/pros.21395; Baldwin LA, 2012, OBSTET GYNECOL, V120, P612, DOI 10.1097/AOG.0b013e318264f794; Beaufort N, 2006, BIOL CHEM, V387, P217, DOI 10.1515/BC.2006.029; Borgono CA, 2004, NAT REV CANCER, V4, P876, DOI 10.1038/nrc1474; Bustin SA, 2013, REAL-TIME PCR: ADVANCED TECHNOLOGIES AND APPLICATIONS, P51; Clements J, 2001, BIOL CHEM, V382, P5, DOI 10.1515/BC.2001.002; Davidson B, 2005, AM J CLIN PATHOL, V123, P360, DOI 10.1309/PTBB5BPCKX8K9V69; Dong Y, 2003, CLIN CANCER RES, V9, P1710; Dong Y, 2001, CLIN CANCER RES, V7, P2363; Dong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057056; Dong Y, 2010, CANCER RES, V70, P2624, DOI 10.1158/0008-5472.CAN-09-3415; Dorn J, 2013, THROMB HAEMOSTASIS, V110, P408, DOI 10.1160/TH13-03-0206; Foteinou E, 2014, BIOL CHEM, V395, P1051, DOI 10.1515/hsz-2014-0139; Geng XC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186847; Gyorffy B, 2012, ENDOCR-RELAT CANCER, V19, P197, DOI 10.1530/ERC-11-0329; Han N, 2011, ONCOL LETT, V2, P599, DOI 10.3892/ol.2011.291; Hibbs K, 2004, AM J PATHOL, V165, P397, DOI 10.1016/S0002-9440(10)63306-8; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin HH, 2006, TUMOR BIOL, V27, P274, DOI 10.1159/000094741; Kryza T, 2016, BIOCHIMIE, V122, P283, DOI 10.1016/j.biochi.2015.09.002; Lai J, 2014, BIOL CHEM, V395, P1127, DOI 10.1515/hsz-2014-0149; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; Loessner D, 2018, EXPERT OPIN THER TAR, V22, P745, DOI 10.1080/14728222.2018.1512587; Loessner D, 2013, BIOMATERIALS, V34, P7389, DOI 10.1016/j.biomaterials.2013.06.009; Loessner D, 2012, GYNECOL ONCOL, V127, P569, DOI 10.1016/j.ygyno.2012.09.001; Luo LY, 2002, BRIT J CANCER, V86, P1790, DOI 10.1038/sj.bjc.6600323; Matsumura M, 2005, PROSTATE, V62, P1, DOI 10.1002/pros.20101; Mukai S, 2008, FEBS J, V275, P1003, DOI 10.1111/j.1742-4658.2008.06265.x; Mukai S, 2015, HUM CELL, V28, P133, DOI 10.1007/s13577-015-0114-6; Obiezu CV, 2001, CLIN CANCER RES, V7, P2380; Paliouras M, 2007, CANCER LETT, V249, P61, DOI 10.1016/j.canlet.2006.12.018; Papagerakis P, 2015, ANTICANCER RES, V35, P1861; Pepin D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026075; Pfaffl MW, 2012, QUANTITATIVE REAL-TIME PCR IN APPLIED MICROBIOLOGY, P53; Polcher M, 2014, WOMENS HEALTH, V10, P179, DOI [10.2217/whe.14.4, 10.2217/WHE.14.4]; Schmitt M, 2013, RADIOL ONCOL, V47, P319, DOI 10.2478/raon-2013-0053; Shahinian H, 2014, MOL ONCOL, V8, P68, DOI 10.1016/j.molonc.2013.09.003; Shih LM, 2007, GYNECOL ONCOL, V105, P501, DOI 10.1016/j.ygyno.2007.01.018; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tan OL, 2006, BIOL CHEM, V387, P697, DOI 10.1515/BC.2006.088; Wang P, 2018, BRIT J CANCER, V119, P823, DOI 10.1038/s41416-018-0260-1; White NMA, 2009, BRIT J CANCER, V101, P1107, DOI 10.1038/sj.bjc.6605280; Xi ZJ, 2004, GYNECOL ONCOL, V94, P80, DOI 10.1016/j.ygyno.2004.03.044; Yang F, 2017, BIOL CHEM, V398, P1151, DOI 10.1515/hsz-2017-0122; Yoon H, 2009, BIOL CHEM, V390, P373, DOI 10.1515/BC.2009.026; Yousef GM, 2003, CANCER RES, V63, P2223; Yousef GM, 2003, AM J CLIN PATHOL	49	10	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212968	10.1371/journal.pone.0212968	http://dx.doi.org/10.1371/journal.pone.0212968			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811511	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400101
J	Rodriguez-Flores, CI; Ornelas, JF; Wethington, S; Arizmendi, MD				Rodriguez-Flores, Claudia I.; Francisco Ornelas, Juan; Wethington, Susan; del Coro Arizmendi, Maria			Are hummingbirds generalists or specialists? Using network analysis to explore the mechanisms influencing their interaction with nectar resources	PLOS ONE			English	Article							ANIMAL MUTUALISTIC NETWORKS; EVOLUTIONARY HISTORY; TEMPORAL DYNAMICS; COMPLEX NETWORKS; POLLINATION; PLANTS; MODULARITY; DIVERSITY; DIVERSIFICATION; BIOGEOGRAPHY	Mutualistic interactions are powerful drivers of biodiversity on Earth that can be represented as complex interaction networks that vary in connection pattern and intensity. One of the most fascinating mutualisms is the interaction between hummingbirds and the plants they visit. We conducted an exhaustive search for articles, theses, reports, and personal communications with researchers (unpublished data) documenting hummingbird visits to flowers of nectar-rewarding plants. Based on information gathered from 4532 interactions between 292 hummingbird species and 1287 plant species, we built an interaction network between nine hummingbird clades and 100 plant families used by hummingbirds as nectar resources at a continental scale. We explored the network architecture, including phylogenetic, morphological, biogeographical, and distributional information. As expected, the network between hummingbirds and their nectar plants was heterogeneous and nested, but not modular. When we incorporated ecological and historical information in the network nodes, we found a generalization gradient in hummingbird morphology and interaction patterns. The hummingbird clades that most recently diversified in North America acted as generalist nodes and visited flowers with ornithophilous, intermediate and non-ornithophilous morphologies, connecting a high diversity of plant families. This pattern was favored by intermediate morphologies (bill, wing, and body size) and by the low niche conservatism in these clades compared to the oldest clades that diversified in South America. Our work is the first effort exploring the hummingbird-plant mutualistic network at a continental scale using hummingbird clades and plant families as nodes, offering an alternative approach to exploring the ecological and evolutionary factors that explain plant-animal interactions at a large scale.	[Rodriguez-Flores, Claudia I.; del Coro Arizmendi, Maria] Univ Nacl Autonoma Mexico, Ecol Lab, Biotechnol & Prototype Unit, Iztacala Fac Higher Studies, Tlalnepantla De Baz, Estado De Mexic, Mexico; [Rodriguez-Flores, Claudia I.; del Coro Arizmendi, Maria] Univ Nacl Autonoma Mexico, Biol Sci Postgrad Program, Posgrad Unit, Mexico City, DF, Mexico; [Francisco Ornelas, Juan] Inst Ecol AC, Dept Biol Evolut, Xalapa, Veracruz, Mexico; [Wethington, Susan] Hummingbird Monitoring Network, Patagonia, AZ USA	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto de Ecologia - Mexico	Arizmendi, MD (corresponding author), Univ Nacl Autonoma Mexico, Ecol Lab, Biotechnol & Prototype Unit, Iztacala Fac Higher Studies, Tlalnepantla De Baz, Estado De Mexic, Mexico.; Arizmendi, MD (corresponding author), Univ Nacl Autonoma Mexico, Biol Sci Postgrad Program, Posgrad Unit, Mexico City, DF, Mexico.	coro@unam.mx	Rodríguez-Flores, Claudia/AFV-6025-2022; Rodríguez-Flores, Claudia/AAR-1968-2021; Arizmendi, Maria del Coro/P-6944-2014	Rodríguez-Flores, Claudia/0000-0002-6705-2118; Rodríguez-Flores, Claudia/0000-0002-6705-2118; Arizmendi, Maria del Coro/0000-0003-4838-5432	project "Develop a matrix of interactions between hummingbird species and their nectar plants" - US Forest Service International Program's Western Hummingbird Partnership; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [207196]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN210908, IN216514, IN216617]; Posgrado en Ciencias Biologicas UNAM; Department of Ecology and Evolutionary Biology of the University of Arizona; James R. Silliman Memorial Research Grant; Departamento de Biologia Evolutiva, Instituto de Ecologia, A.C. [20030/10563]; NSF [25922-N]; CONACyT [56254]	project "Develop a matrix of interactions between hummingbird species and their nectar plants" - US Forest Service International Program's Western Hummingbird Partnership; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)); Posgrado en Ciencias Biologicas UNAM(Universidad Nacional Autonoma de Mexico); Department of Ecology and Evolutionary Biology of the University of Arizona; James R. Silliman Memorial Research Grant; Departamento de Biologia Evolutiva, Instituto de Ecologia, A.C.; NSF(National Science Foundation (NSF)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Financial support was provided by the project "Develop a matrix of interactions between hummingbird species and their nectar plants" funded by the US Forest Service International Program's Western Hummingbird Partnership to MCA and CIR-F. CIR-F received a doctoral scholarship from the Consejo Nacional de Ciencia y Tecnologia (CONACyT, No. 207196). Additional research funds were provided by research grants from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT, Ref. IN210908, Ref. IN216514, Ref. IN216617) and Posgrado en Ciencias Biologicas UNAM to MCA. The Department of Ecology and Evolutionary Biology of the University of Arizona, the James R. Silliman Memorial Research Grant, the Departamento de Biologia Evolutiva, Instituto de Ecologia, A.C. (Ref. 20030/10563), a NSF grant to the University of Arizona Research Training Group (RTG) in the Analysis of Biological Diversification, and a grant (Ref. 25922-N) and a doctoral scholarship (No. 56254) from the CONACyT to JFO provided partial funding during the early stages of this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Comments by M. Fortuna and three anonymous reviewers greatly improved a previous version of this paper. We thank I. Flores and M. Quiroga for data compilation; J. Schondube, C. Lara, and R. Partida for sharing unpublished data; and J. Hernandez and L. Nunez for providing morphological information on some hummingbird species. We thank C. Soberanes-Gonzalez for sharing his photos and for figure edition. CIR-F thanks Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico, for logistic support and Consejo Nacional de Ciencia y Tecnologia (CONACyT) for her doctoral scholarship (207196). CIR-F and MCA thank the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT, Ref. IN210908, Ref. IN216514, Ref. IN216617) for research funding. We also thank G. Barrowclough (American Museum of Natural History, AMNH); P. Escalante and L. Navarijo (Coleccion Ornitologica, Instituto de Biologia, Universidad Nacional Autonoma de Mexico, UNAM); T. Huels and S. M. Russell (University of Arizona, UA); A. Navarro Siguenza (Museo de Zoologia, Facultad de Ciencias, Universidad Nacional Autonoma de Mexico, MZFC); A. T. Peterson and D. Willard (Fiel Museum of Natural History, FMNH); and F. G. Stiles (Coleccion Ornitologica, Instituto de Ciencias Naturales, Universidad Nacional de Colombia) for allowing us to examine specimens under their care. JFO thanks A. Espinosa de los Monteros and A. T. Peterson for their hospitality in New York and Chicago, respectively. This work constitutes partial fulfillment of the requirements for the Ph.D. degree of CIR-F at the Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico.	Abrahamczyk S, 2014, J ORNITHOL, P1; Abrahamczyk S, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0388-z; Achard S., 2010, BRAINWAVER BASIC WAV; Maglianesi MA, 2014, ECOLOGY, V95, P3325, DOI 10.1890/13-2261.1; Almeida-Neto M, 2008, OIKOS, V117, P1227, DOI 10.1111/j.0030-1299.2008.16644.x; [Anonymous], 2013, PLANT LIST VERSION 1; Araujo AC, 2018, J BIOGEOGR, V45, P1846, DOI 10.1111/jbi.13367; Bartomeus I, 2008, OECOLOGIA, V155, P761, DOI 10.1007/s00442-007-0946-1; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Bascompte J., 2014, MUTUALISTIC NETWORKS; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; Batagelj V, 2004, MATH VIS, P77; Bleiweiss R, 1998, BIOL J LINN SOC, V65, P77, DOI 10.1111/j.1095-8312.1998.tb00352.x; Bleiweiss R., 1990, P354; Burkle LA, 2011, AM J BOT, V98, P528, DOI 10.3732/ajb.1000391; Chesser RT, 2012, AUK, V129, P573, DOI 10.1525/auk.2012.129.3.573; Cotton PA, 1998, IBIS, V140, P647, DOI 10.1111/j.1474-919X.1998.tb04710.x; Dallas T., 2018, R PACKAGE VERSION 1; Dalsgaard B, 2017, ECOGRAPHY, V40, P1395, DOI 10.1111/ecog.02604; Dalsgaard B, 2013, ECOGRAPHY, V36, P1331, DOI 10.1111/j.1600-0587.2013.00201.x; Dalsgaard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025891; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; del Coro Arizmendi M, 2012, ORNITOLOGIA NEOTRO S, V23, P71; del Hoyo J, 2017, HDB BIRDS WORLD ALIV; Des Granges J- L, 1979, LIVING BIRD, V17, P199; Donatti CI, 2011, ECOL LETT, V14, P773, DOI 10.1111/j.1461-0248.2011.01639.x; Dormann C.F., 2008, R NEWS, V8, P8; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Elias M, 2013, CURR BIOL; FAEGRI K, 1979, P244; FEINSINGER P, 1991, ECOLOGY, V72, P1946, DOI 10.2307/1941549; Fox J., 2018, R COMPANION APPL REG, VThird; Ornelas JF, 2014, J BIOGEOGR, V41, P168, DOI 10.1111/jbi.12184; Givnish TJ, 2014, MOL PHYLOGENET EVOL, V71, P55, DOI 10.1016/j.ympev.2013.10.010; Gonzalez AMM, 2015, GLOBAL ECOL BIOGEOGR, V24, P1212, DOI 10.1111/geb.12355; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Greenewalt C.H., 1990, HUMMINGBIRDS; Gu Hao, 2015, Zoological Research, V36, P65; Guimaraes PR, 2006, ENVIRON MODELL SOFTW, V21, P1512, DOI 10.1016/j.envsoft.2006.04.002; Guimera R, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.025101; Guimera R, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/02/P02001; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; IUCN, 2012, IUCN RED LIST THREAT; James KH., 2005, CARIBBEAN J EARTH SC, V39, P69; Jaramillo C, 2006, SCIENCE, V311, P1893, DOI 10.1126/science.1121380; Jordano P, 2003, ECOL LETT, V6, P69, DOI 10.1046/j.1461-0248.2003.00403.x; Jordano Pedro, 2010, Evolution Education and Outreach, V3, P40; Kaiser L., 2015, NESTEDNESS NULL MODE; Kessler M, 2000, PLANT BIOLOGY, V2, P659, DOI 10.1055/s-2000-16642; Kirwan G., 2020, HDB BIRDS WORLD ALIV; Kress W. J., 2005, BIOL SKR, V55, P459; Lagomarsino LP, 2016, NEW PHYTOL, V210, P1430, DOI 10.1111/nph.13920; Lara C, 2006, ECOSCIENCE, V13, P23, DOI 10.2980/1195-6860(2006)13[23:TDOFUB]2.0.CO;2; Lewinsohn TM, 2006, OIKOS, V113, P174, DOI 10.1111/j.0030-1299.2006.14583.x; Licona-Vera Y, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0980-5; Marrero HJ, 2017, AGR ECOSYST ENVIRON, V239, P304, DOI 10.1016/j.agee.2017.01.027; Maruyama PK, 2016, DIVERS DISTRIB, V22, P672, DOI 10.1111/ddi.12434; Maruyama PK, 2014, BIOTROPICA, V46, P740, DOI 10.1111/btp.12170; McGuire JA, 2007, SYST BIOL, V56, P837, DOI 10.1080/10635150701656360; McGuire JA, 2014, CURR BIOL, V24, P910, DOI 10.1016/j.cub.2014.03.016; McGuire JA, 2009, J ORNITHOL, V150, P155, DOI 10.1007/s10336-008-0330-x; Medel R, 2010, EVOL ED OUTREACH, V3, P6, DOI DOI 10.1007/S12052-009-0198-0; Muchhala N, 2014, EVOLUTION, V68, P2275, DOI 10.1111/evo.12441; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Olesen JM, 2008, ECOLOGY, V89, P1573, DOI 10.1890/07-0451.1; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Ollerton J, 2012, CURR BIOL, V22, pR914, DOI 10.1016/j.cub.2012.09.023; Ollerton J, 2009, ANN BOT-LONDON, V103, P1471, DOI 10.1093/aob/mcp031; Ornelas JF, 1995, RAD GENUS AMAZILIA C; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peralta G, 2016, FUNCT ECOL, V30, P1917, DOI 10.1111/1365-2435.12669; Proctor Michael, 1996, P1; R Core Team, 2021, R LANGUAGE ENV STAT; Remsen JVJ, 2012, CLASSIFICATION BIRD; Rezende EL, 2009, ECOL LETT, V12, P779, DOI 10.1111/j.1461-0248.2009.01327.x; Rocca Marcia A., 2010, Oecologia Australis, V14, P67; Rodriguez-Flores CI, 2016, J ZOOL, V299, P262, DOI 10.1111/jzo.12360; Rodriguez-Flores Claudia Isabel, 2005, Ornitologia Colombiana, V3, P7; Rosas L, 2017, MATING SYSTEM MALE T, V154, P1297, DOI [10.1163/1568539X-00003469, DOI 10.1163/1568539X-00003469]; Rueda M, 2013, J BIOGEOGR, V40, P2215, DOI 10.1111/jbi.12214; Saavedra S, 2011, NATURE, V478, P233, DOI 10.1038/nature10433; Salazar JH, 2009, THESIS; Sandlin EA, 2000, OIKOS, V91, P18, DOI 10.1034/j.1600-0706.2000.910102.x; Schuchmann KL, HDB BIRDS WORLD, V5; Serrano- Serrano ML, 2017, GESNERIACEAE, V284; Serrano-Serrano ML, 2015, DECOUPLED EVOLUTION, V15, P247, DOI [10.1186/s12862-015-0527-6, DOI 10.1186/S12862-015-0527-6]; Skandalis DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01223-x; Smith BT, 2012, ECOL LETT, V15, P1318, DOI 10.1111/j.1461-0248.2012.01855.x; Stiles F. G., 1985, ORNITHOL MONOGR, V36, P757, DOI DOI 10.2307/40168315; Stiles FG, 2008, ORNITOL NEOTROP, V19, P511; STILES FG, 1975, ECOLOGY, V56, P285, DOI 10.2307/1934961; Stouffer DB, 2014, J ECOL, V102, P1442, DOI 10.1111/1365-2745.12310; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Taylor CM, 1997, ANN MO BOT GARD, V84, P224, DOI 10.2307/2400003; Thebault E, 2013, J BIOGEOGR, V40, P759, DOI 10.1111/jbi.12015; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Thompson John N., 2010, Evolution Education and Outreach, V3, P7; Thomson James D., 2000, Plant Species Biology, V15, P11, DOI 10.1046/j.1442-1984.2000.00026.x; Traveset A, 2014, ANNU REV ECOL EVOL S, V45, P89, DOI 10.1146/annurev-ecolsys-120213-091857; Tripp Erin, 2013, Aliso, V31, P89; Ulrich W, 2009, OIKOS, V118, P3, DOI 10.1111/j.1600-0706.2008.17053.x; Verdu M, 2008, AM NAT, V172, P751, DOI 10.1086/593003; Vitoria RS, 2018, OIKOS, V127, P561, DOI 10.1111/oik.04344; Vizentin-Bugoni J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2397; WCSP, WORLD CHECKL SEL PLA; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wester P, 2007, ANN BOT-LONDON, V100, P401, DOI 10.1093/aob/mcm036; Wester P, 2011, ANN MO BOT GARD, V98, P101, DOI 10.3417/2007035; Wethington Susan M., 2005, U S Forest Service Rocky Mountain Research Station Proceedings RMRS-P, V36, P162; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilson P, 2004, OIKOS, V104, P345, DOI 10.1111/j.0030-1299.2004.12819.x; Zanata TB, 2017, J BIOGEOGR, V44, P1891, DOI 10.1111/jbi.13045; Zuur Alain F., 2009, P1	117	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211855	10.1371/journal.pone.0211855	http://dx.doi.org/10.1371/journal.pone.0211855			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811515	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400035
J	Makondi, PT; Wei, PL; Huang, CY; Chang, YJ				Makondi, Precious Takondwa; Wei, Po-Li; Huang, Chien-Yu; Chang, Yu-Jia			Development of novel predictive miRNA/target gene pathways for colorectal cancer distance metastasis to the liver using a bioinformatic approach	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; EXTRACELLULAR VESICLES; DIAGNOSTIC BIOMARKERS; SURVIVAL; EXOSOMES; INVASION; GROWTH; HSA-MIR-619-5P; PROLIFERATION; STATISTICS	Background Liver metastases are the major cause of colorectal cancer (CRC)-related deaths. However, there is no reliable clinical predictor for CRC progression to liver metastasis. In this study, we investigated possible predictors (miRNAs and biomarkers) for clinical application. Methodology The Gene Expression Omnibus (GEO) datasets GSE49355, GSE41258 and GSE81558 for genes and GSE54088 and GSE56350 for miRNAs were used to identify common differentially expressed genes (DEGs) and miRNAs between primary CRC tissues and liver metastases. The identified miRNAs and their targets from the DEGs were verified in datasets comprising gene, miRNA and miRNA exosome profiles of CRC patients with no distant metastases (M0) and distant metastases (M1); the interaction networks and pathways were also mapped. Results There were 49 upregulated and 13 downregulated DEGs and 16 downregulated and 14 upregulated miRNAs; between the DEGs and miRNA targets, there were five upregulated and four downregulated genes. MiR-20a was strongly correlated with the status of liver metastasis. MiR-20a, miR499a, and miR-576-5p were highly correlated with the metastatic outcomes. MiR-20a was significantly highly expressed in the M1 group. In an analysis of the miRNA target genes, we found that CDH2, KNG1, and MMP2 were correlated with CRC metastasis. We demonstrated a new possible pathway for CRC metastasis: miR-576-5p/F9, miR20a/MMP2, CTSK, MMP3, and miR449a/P2RY14. The regulation of IGF transport and uptake by IGFBPs, extracellular matrix organization, signal transduction and the immune system were the enriched pathways. Conclusion This model can predict CRC to liver metastases and the pathways involved, which can be clinically applicable.	[Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan; [Makondi, Precious Takondwa; Chang, Yu-Jia] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Colorectal Surg, Taipei, Taiwan; [Wei, Po-Li; Huang, Chien-Yu] Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan; [Wei, Po-Li; Chang, Yu-Jia] Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan; [Wei, Po-Li] Taipei Med Univ, Grad Inst Canc Biol & Drug Discovery, Taipei, Taiwan; [Huang, Chien-Yu] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital	Chang, YJ (corresponding author), Taipei Med Univ, Int PhD Program Med, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Coll Med, Dept Surg, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan.; Chang, YJ (corresponding author), Taipei Med Univ, Taipei Med Univ Hosp, Dept Med Res, Translat Lab, Taipei, Taiwan.; Huang, CY (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Gen Surg, Taipei, Taiwan.	cyh@tmu.edu.tw; r5424012@tmu.edu.tw						Abba M, 2015, GENOM DATA, V6, P33, DOI 10.1016/j.gdata.2015.08.001; Akgul O, 2014, WORLD J GASTROENTERO, V20, P6113, DOI 10.3748/wjg.v20.i20.6113; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Bai ZG, 2017, CELL PHYSIOL BIOCHEM, V44, P1882, DOI 10.1159/000485877; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Borner MM, 1999, ANN ONCOL, V10, P623, DOI 10.1023/A:1008353227103; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; de Krijger I, 2011, J PATHOL, V224, P438, DOI 10.1002/path.2922; Del Rio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074599; Drusco A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096670; Engstrand J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3925-x; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Eslamizadeh S, 2018, CELL J, V20, P220, DOI 10.22074/cellj.2018.5366; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Franz M, 2018, NUCLEIC ACIDS RES, V46, pW60, DOI 10.1093/nar/gky311; Georges RB, 2011, CANCER BIOL THER, V12, P69, DOI 10.4161/cbt.12.1.15719; Giannelli F, 1996, BAILLIERE CLIN HAEM, V9, P211, DOI 10.1016/S0950-3536(96)80059-X; House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040; Jonsson K, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/568214; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kim KY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-283; Kim KY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-218; Knyazev EN, 2016, B EXP BIOL MED+, V161, P108, DOI 10.1007/s10517-016-3357-7; Lan YT, 2012, INT J COLORECTAL DIS, V27, P657, DOI 10.1007/s00384-011-1366-6; Landreau P, 2015, J GASTROEN HEPATOL, V30, P82, DOI 10.1111/jgh.12685; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li ZY, 2012, ONCOL LETT, V3, P346, DOI 10.3892/ol.2011.497; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maas SLN, 2017, TRENDS CELL BIOL, V27, P172, DOI 10.1016/j.tcb.2016.11.003; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Sayagues JM, 2016, ONCOTARGET, V7, P72908, DOI 10.18632/oncotarget.12140; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mudduluru G, 2015, CANCER RES, V75, P3010, DOI 10.1158/0008-5472.CAN-15-0997; Muhammad S, 2014, WORLD J GASTROENTERO, V20, P17011, DOI 10.3748/wjg.v20.i45.17011; Nannini M, 2009, CANCER TREAT REV, V35, P201, DOI 10.1016/j.ctrv.2008.10.006; Niki M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10500-0; Ogata-Kawata H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092921; Oshima T, 2008, ONCOL REP, V20, P359, DOI 10.3892/or_00000015; Pawlik TM, 2008, ONCOLOGIST, V13, P51, DOI 10.1634/theoncologist.2007-0142; Pawlik TM, 2007, J GASTROINTEST SURG, V11, P1057, DOI 10.1007/s11605-006-0061-3; Penna C, 2002, SURG CLIN N AM, V82, P1075, DOI 10.1016/S0039-6109(02)00051-8; Pizzini S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-589; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sempere LF, 2011, EXPERT REV MOL DIAGN, V11, P813, DOI [10.1586/ERM.11.69, 10.1586/erm.11.69]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Shkurnikov MY, 2017, B EXP BIOL MED+, V163, P475, DOI 10.1007/s10517-017-3831-x; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Simpson RJ, 2009, EXPERT REV PROTEOMIC, V6, P267, DOI [10.1586/epr.09.17, 10.1586/EPR.09.17]; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Sommer SS, 2001, MUTAT RES-DNA REPAIR, V487, P1, DOI 10.1016/S0921-8777(01)00108-2; STANGL R, 1994, LANCET, V343, P1405, DOI 10.1016/S0140-6736(94)92529-1; Taylor DD, 2008, GYNECOL ONCOL, V110, P13, DOI 10.1016/j.ygyno.2008.04.033; Tokar T, 2018, NUCLEIC ACIDS RES, V46, pD360, DOI 10.1093/nar/gkx1144; Tsalis K, 2018, J BUON, V23, P1640; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Van Cutsem E, 2006, EUR J CANCER, V42, P2212, DOI 10.1016/j.ejca.2006.04.012; Venny O.J.C., INTERACTIVE TOOL COM; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang YN, 2017, EUR J MED RES, V22, DOI 10.1186/s40001-017-0294-5; Weidle UH, 2015, CLIN EXP METASTAS, V32, P623, DOI 10.1007/s10585-015-9732-3; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu G., 2014, REACTOMEFIVIZ CYTOSC, V3, P146, DOI DOI 10.12688/F1000RESEARCH.4431.2; Xu T, 2015, EXP THER MED, V10, P683, DOI 10.3892/etm.2015.2538; Yan LK, 2017, BIOMED PHARMACOTHER, V96, P974, DOI 10.1016/j.biopha.2017.11.138; Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066; Yang LQ, 2016, CANCER MED-US, V5, P2022, DOI 10.1002/cam4.760; Yao H, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20180441; Zekri ARN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154130; Zhou BG, 2016, MOL CARCINOGEN, V55, P2260, DOI 10.1002/mc.22466; Zvibel I, 2013, CLIN EXP METASTAS, V30, P189, DOI 10.1007/s10585-012-9527-8	77	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211968	10.1371/journal.pone.0211968	http://dx.doi.org/10.1371/journal.pone.0211968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807603	gold, Green Published, Green Submitted			2022-12-26	WOS:000459712100008
J	Chen, J; He, S				Chen, Jie; He, Shan			Drug-induced sleep endoscopy-directed adenotonsillectomy in pediatric obstructive sleep apnea with small tonsils	PLOS ONE			English	Article							UPPER AIRWAY; TONSILLECTOMY; POLYSOMNOGRAPHY; DIAGNOSIS; SEDATION; PROPOFOL; AWAKE	The study aims to examine drug-induced sleep endoscopy (DISE) in the decision-making process of pediatric obstructive sleep apnea (OSA) patients with small tonsils. This was a retrospective study of children who underwent awake flexible endoscopy, DISE, and adenoidectomy with/without tonsillectomy at the Shanghai Children's Medical Center between 03/ 2015 and 12/2016. Tonsillectomy was performed for tonsillar obstruction found by DISE. Adenoidectomy was performed for all children. Cardio-pulmonary coupling (CPC) and oximetry were observed before/after surgery. The study included 126 children: 56 (44.4%) with grade 2 tonsils and 70 (55.6%) with grade 1. Mean age was 5.7 3.2 (range, 2.8-10.4) years and mean BMI of 15.7 5.5 kg/m2. Unexpectedly, DISE showed tonsillar obstruction in 57 (45.2%) children, including 44 (78.6%) with grade 2 tonsils and 13 (18.6%) with grade 1. Therefore, DISE-directed tonsillectomy was performed for 57 patients. There was an improvement in respiratory disturbance index (RDI) and oxygen saturation nadir in the DISE (P = 0.0007, P = 0.037) and control (P = 0.001, P = 0.023) groups 6 months after surgery, but RDI improvement was better in the DISE group compared with controls 1 year after surgery (P = 0.042). DISE is a good way to determine the necessity of tonsillectomy in pediatric OSA patients with small tonsils.	[Chen, Jie; He, Shan] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Otolaryngol, Shanghai, Peoples R China	Shanghai Jiao Tong University	He, S (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Otolaryngol, Shanghai, Peoples R China.	heshan@scmc.com.cn			Shenkang Three-Year Clinical Action Plan-Appropriate Technical Promotion Projects [16CR4008A]; Shanghai Jiao Tong University Medical-Engineering Cross Fund [YG2017QN32]	Shenkang Three-Year Clinical Action Plan-Appropriate Technical Promotion Projects; Shanghai Jiao Tong University Medical-Engineering Cross Fund	This study was supported by the Shenkang Three-Year Clinical Action Plan-Appropriate Technical Promotion Projects (No. 16CR4008A) and Shanghai Jiao Tong University Medical-Engineering Cross Fund (YG2017QN32).	Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; BRODSKY L, 1989, PEDIATR CLIN N AM, V36, P1551; Campanini A, 2010, ACTA OTORHINOLARYNGO, V30, P73; Cavaliere M, 2013, LARYNGOSCOPE, V123, P2315, DOI 10.1002/lary.23881; Chan DK, 2014, JAMA OTOLARYNGOL, V140, P595, DOI 10.1001/jamaoto.2014.612; CROFT CB, 1991, CLIN OTOLARYNGOL, V16, P504, DOI 10.1111/j.1365-2273.1991.tb01050.x; Dijemeni E, 2017, SLEEP BREATH, V21, P983, DOI 10.1007/s11325-017-1521-6; Edwards BA, 2011, HEAD NECK-J SCI SPEC, V33, pS37, DOI 10.1002/hed.21841; Ehsan Z, 2016, LARYNGOSCOPE, V126, P270, DOI 10.1002/lary.25399; Eikermann M, 2008, ANESTHESIOLOGY, V108, P897, DOI 10.1097/ALN.0b013e31816c8a60; Esteller E, 2016, ACTA OTORRINOLAR ESP, V67, P212, DOI 10.1016/j.otorri.2015.09.001; Guo D, 2011, SLEEP MED, V12, P384, DOI 10.1016/j.sleep.2010.09.011; Harrington J, 2013, SLEEP BREATH, V17, P1071, DOI 10.1007/s11325-013-0804-9; Huntley C, 2017, ANN OTO RHINOL LARYN, V126, P478, DOI 10.1177/0003489417703408; Koutsourelakis I, 2012, LARYNGOSCOPE, V122, P2587, DOI 10.1002/lary.23462; Krishnaswamy U, 2015, J POSTGRAD MED, V61, P223, DOI 10.4103/0022-3859.166509; Ma XX, 2012, CHINESE MED J-PEKING, V125, P869, DOI 10.3760/cma.j.issn.0366-6999.2012.05.025; Ong AA, 2016, OTOLARYNG HEAD NECK, V154, P970, DOI 10.1177/0194599816636835; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Ravesloot Madeline J L, 2017, Adv Otorhinolaryngol, V80, P22, DOI 10.1159/000470816; Roland PS, 2011, OTOLARYNG HEAD NECK, V145, pS1, DOI 10.1177/0194599811409837; Sowho M, 2014, CLIN CHEST MED, V35, P469, DOI 10.1016/j.ccm.2014.06.002; Thomas RJ, 2005, SLEEP, V28, P1151, DOI 10.1093/sleep/28.9.1151; Tunkel DE, 2012, OTOLARYNG HEAD NECK, V146, P191, DOI 10.1177/0194599811429236; Victores AJ, 2017, J CLIN SLEEP MED, V13, P169, DOI 10.5664/jcsm.6438; Villa MP, 2015, JAMA OTOLARYNGOL, V141, P990, DOI 10.1001/jamaoto.2015.2354	26	11	12	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212317	10.1371/journal.pone.0212317	http://dx.doi.org/10.1371/journal.pone.0212317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794596	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100054
J	Doulla, BE; Squire, SB; MacPherson, E; Ngadaya, ES; Mutayoba, BK; Langley, I				Doulla, Basra Esmail; Squire, Stephen Bertel; MacPherson, Eleanor; Ngadaya, Esther Stanslaus; Mutayoba, Beatrice Kemilembe; Langley, Ivor			Routine surveillance for the identification of drug resistant Tuberculosis in Tanzania: A cross-sectional study of stakeholders' perceptions	PLOS ONE			English	Article								Background Routine surveillance is required to monitor the performance of tuberculosis diagnostic programme and is essential for the rapid detection of drug resistance. The main objective of this study was to explore the effectiveness and stakeholder perception of the current routine surveillance system for previously treated tuberculosis cases in Tanzania with a view to identify interventions to improve and accelerate positive patient outcomes. Methods A study using quantitative and qualitative methods of data collection including in-depth interviews and focus group discussions with health care service providers was conducted in four regions. Quantitative data were extracted from the routine databases to assess performance. Results Quantitative findings from 2011 to 2013 showed 2,750 specimens from previously treated TB cases were received at the reference laboratory. The number increased year on year, but even in the most recent year was only 61% of that expected. The median and interquartile range of turnaround time in days from specimen reception to results reported for smear microscopy, culture and drug susceptibility testing were 1(1, 1), 61(43, 71) and 129(72, 170) respectively. Contaminated specimens were reported in 3.6% of cases. The qualitative analysis showed the system of sending specimens using postal services was seen to be efficient by participants. However, there were many challenges and significant delays in specimens reaching the reference laboratory associated with lack of funds to transfer specimens, weak form completion, inadequate training and poor supervision. These all adversely affected the implementation of the routine surveillance system. Conclusions Many issues limit the effectiveness of the routine surveillance system in Tanzania. Priority areas for strengthening are; specimen transportation, supervision and availability of commodities. A pilot study of a revised routine surveillance system that takes into account the observations from this study alongside improved access to drug susceptibility testing using Xpert MTB/RIF should be considered.	[Doulla, Basra Esmail; Mutayoba, Beatrice Kemilembe] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania; [Doulla, Basra Esmail; Mutayoba, Beatrice Kemilembe] Natl TB & Leprosy Programme, Dar Es Salaam, Tanzania; [Doulla, Basra Esmail; Squire, Stephen Bertel; MacPherson, Eleanor; Langley, Ivor] Univ Liverpool Liverpool Sch Trop Med, Ctr Appl Hlth Res & Delivery, Liverpool, Merseyside, England; [Ngadaya, Esther Stanslaus] Muhimbili Med Res Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania	Liverpool School of Tropical Medicine; National Institute of Medical Research	Doulla, BE (corresponding author), Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania.; Doulla, BE (corresponding author), Natl TB & Leprosy Programme, Dar Es Salaam, Tanzania.; Doulla, BE (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Ctr Appl Hlth Res & Delivery, Liverpool, Merseyside, England.	bedoulla@gmail.com		Langley, Ivor/0000-0002-9275-6731; MacPherson, Eleanor/0000-0002-7142-1158; Ngadaya, Esther/0000-0003-4540-5637; Squire, Stephen/0000-0001-7173-9038	Swiss Tropical and Public Health Institute, Basel, Geneva; Ministry of Health through the World Bank in Tanzania	Swiss Tropical and Public Health Institute, Basel, Geneva; Ministry of Health through the World Bank in Tanzania	The study is funded by the Swiss Tropical and Public Health Institute, Basel, Geneva and the Ministry of Health through the World Bank support in Tanzania.	Acosta CD, 2014, INT J TUBERC LUNG D, V2, P1, DOI [10.1136/bmj.h111, DOI 10.1136/BMJ.H111]; [Anonymous], 2016, AMBIENT AIR POLLUTIO; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Davies PDO, 2001, J ROY SOC MED, V94, P261, DOI 10.1177/014107680109400601; GLI, GUID PROV TECHN SUPP; Harries AD, 2004, INT J TUBERC LUNG D, V8, P204; Israel GD, 2015, NON TRADITIONAL REF, P1; Kim SJ, 2005, EUR RESPIR J, V25, P564, DOI 10.1183/09031936.05.00111304; Lewis RJ, 2003, QUALITATIVE RES PRAC; Ministry of Health and Social Services, 2013, MAN PRIS RISK HARM S, P1; Ministry of health and Social welfare, 2012, UN REP TANZ NAT TUB; MoHSW, 2012, TANZ NAT GUID MAN TU; NTLP, 2013, UN REP TANZ MIN HLTH; Park PH, 2012, TROP MED INT HEALTH, V17, P374, DOI 10.1111/j.1365-3156.2011.02933.x; Ritchie J, 2003, NON TRADITIONAL REF, P76; Royce S, 2014, INT J TUBERC LUNG D, V18, P1299, DOI 10.5588/ijtld.14.0116; Snape D., 2003, QUALITATIVE RES PRAC, DOI [10.4135/9781452230108, DOI 10.4135/9781452230108]; Store GISO, 2012, NON TRADITIONAL REF; TAHERDOOST H, 2016, SSRN ELECT J; WHO, 2014, WHO REP, P171, DOI [DOI 10.1155/2014/187842, 10.1155/2014/187842]; WHO, WHO TUB GLOB REP 201; World Health Organization, 2006, GUID PROGR MAN DRUG	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212421	10.1371/journal.pone.0212421	http://dx.doi.org/10.1371/journal.pone.0212421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794620	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000459709100065
J	Moti, N; Yu, J; Boncompain, G; Perez, F; Virshup, DM				Moti, Naushad; Yu, Jia; Boncompain, Gaelle; Perez, Franck; Virshup, David M.			Wnt traffic from endoplasmic reticulum to filopodia	PLOS ONE			English	Article							SECRETION; PROTEIN; TRANSPORT; CELLS; WINGLESS; REVEALS; SIGNALS	Wnts are a family of secreted palmitoleated glycoproteins that play key roles in cell to cell communication during development and regulate stem cell compartments in adults. Wnt receptors, downstream signaling cascades and target pathways have been extensively studied while less is known about how Wnts are secreted and move from producing cells to receiving cells. We used the synchronization system called Retention Using Selective Hook (RUSH) to study Wnt trafficking from endoplasmic reticulum to Golgi and then to plasma membrane and filopodia in real time. Inhibition of porcupine (PORCN) or knockout of Wntless (WLS) blocked Wnt exit from the ER. Wnt-containing vesicles paused at sub-cortical regions of the plasma membrane before exiting the cell. Wnt-containing vesicles were associated with filopodia extending to adjacent cells. These data visualize and confirm the role of WLS and PORCN in ER exit of Wnts and support the role of filopodia in Wnt signaling.	[Moti, Naushad; Yu, Jia; Virshup, David M.] Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore; [Boncompain, Gaelle; Perez, Franck] Sorbonne Univ, PSL Res Univ, CNRS, Inst Curie,UMR144 Cell Biol & Canc, Paris, France; [Virshup, David M.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Moti, Naushad] Univ New South Wales, Lowy Canc Res Ctr, Kensington Campus, Sydney, NSW, Australia	National University of Singapore; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Duke University; University of New South Wales Sydney	Virshup, DM (corresponding author), Duke NUS Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore.; Virshup, DM (corresponding author), Duke Univ, Dept Pediat, Durham, NC 27706 USA.	david.virshup@duke-nus.edu.sg	Virshup, David M/C-1449-2009; Boncompain, Gaelle/AAX-8374-2021	Virshup, David M/0000-0001-6976-850X; Boncompain, Gaelle/0000-0003-4274-035X; Yu, Jia/0000-0002-7004-9104; Moti, Naushad/0000-0002-8649-9919	National Medical Research Council of Singapore [NMRC/STAR/0017/2013]	National Medical Research Council of Singapore(National Medical Research Council, Singapore)	DMV was supported by Singapore NMRC/STAR/0017/2013 National Medical Research Council of Singapore, http://www.nmrc.gov.sg.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Augustin I, 2012, EMBO MOL MED, V4, P38, DOI 10.1002/emmm.201100186; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boncompain G, 2012, NAT METHODS, V9, P493, DOI [10.1038/NMETH.1928, 10.1038/nmeth.1928]; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Cretoiu D, 2017, SEMIN CELL DEV BIOL, V64, P26, DOI 10.1016/j.semcdb.2016.08.023; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Franch-Marro X, 2005, DEVELOPMENT, V132, P659, DOI 10.1242/dev.01639; Greicius G, 2018, P NATL ACAD SCI USA, V115, pE3173, DOI 10.1073/pnas.1713510115; Gross JC, 2012, NAT CELL BIOL, V14, P1036, DOI 10.1038/ncb2574; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Huang H, 2016, ELIFE, V5, DOI 10.7554/eLife.18979; Jacquemet G, 2017, J CELL BIOL, V216, P3387, DOI 10.1083/jcb.201704045; Jacquemet G, 2015, CURR OPIN CELL BIOL, V36, P23, DOI 10.1016/j.ceb.2015.06.007; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kornberg TB, 2017, CURR OPIN GENET DEV, V45, P22, DOI 10.1016/j.gde.2017.02.010; Leemhuis J, 2010, J NEUROSCI, V30, P14759, DOI 10.1523/JNEUROSCI.4036-10.2010; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; MATLIN KS, 1983, CELL, V34, P233, DOI 10.1016/0092-8674(83)90154-X; Mattes B, 2018, HISTOCHEM CELL BIOL, V150, P431, DOI 10.1007/s00418-018-1732-3; Mattes B, 2018, ELIFE, V7, DOI 10.7554/eLife.36953; Najdi R, 2012, DIFFERENTIATION, V84, P203, DOI 10.1016/j.diff.2012.06.004; Pfeiffer S, 2002, CURR BIOL, V12, P957, DOI 10.1016/S0960-9822(02)00867-9; Sagar, 2015, DEVELOPMENT, V142, P665, DOI 10.1242/dev.115964; Saha S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13096; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4; Stanganello E, 2016, J CELL SCI, V129, P665, DOI 10.1242/jcs.182469; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Vannucchi MG, 2013, J CELL MOL MED, V17, P1099, DOI 10.1111/jcmm.12134; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Yamamoto H, 2013, J CELL SCI, V126, P2931, DOI 10.1242/jcs.126052; Yu J, 2014, BIOSCIENCE REP, V34, P593, DOI 10.1042/BSR20140119; Yu J, 2014, DEV CELL, V29, P277, DOI 10.1016/j.devcel.2014.03.016; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	46	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212711	10.1371/journal.pone.0212711	http://dx.doi.org/10.1371/journal.pone.0212711			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794657	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100124
J	Turner, KME; Looker, KJ; Syred, J; Zienkiewicz, A; Baraitser, P				Turner, Katy M. E.; Looker, Katharine J.; Syred, Jonathan; Zienkiewicz, Adam; Baraitser, Paula			Online testing for sexually transmitted infections: A whole systems approach to predicting value	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS; HEALTH	Background Online testing for sexually transmitted infections has a lower unit cost than testing in clinical services and economic analysis has focused on the cost per test and cost per diagnosis in clinics and online. However, online services generate new demand for testing and shift activity between services, requiring system-level analysis to effectively predict cost-effectiveness. Methods and findings Routinely collected, anonymised, retrospective data on sexual health service activity from all specialist services (clinic and online) within an inner London sexual health economy were collated and harmonised to generate a complete dataset of individual level clinic attendances. Clinic activity and diagnoses were coded using nationally standardised codes assigned by clinicians. Costs were taken from locally or regionally agreed sexual health tariffs. The introduction of online services changed patterns of testing. In an inner London sexual health economy, online STI testing increased total number of tests, the total cost of testing and total diagnoses while slightly reducing the average cost per diagnosis. Two years after the introduction of online services 37% of tests in the were provided online and total diagnoses increased. The positivity of online services is generally lower than that in clinics but varies between contexts. Where the positivity ratio between clinic and online is less than the cost ratio, online services will reduce cost per diagnosis. In this analysis, areas with different classifications as urban and rural had different clinic/online positivity ratios changing the cost effectiveness between areas. Even after the introduction of online services, simple STI testing activity continues in clinics and providers should consider online-first options where clinically appropriate. Conclusions Online services for STI testing are not 'stand alone'. They change STI testing behaviour with impacts on all elements of the sexual health economy. Planning, development and monitoring of such services should reference the dynamic nature of these systems and the role of online services within them.	[Turner, Katy M. E.; Zienkiewicz, Adam] Univ Bristol, Sch Vet Sci, Bristol, Avon, England; [Looker, Katharine J.] Univ Bristol, Bristol Med Sch, Bristol, Avon, England; [Syred, Jonathan; Baraitser, Paula] Kings Coll London, Sch Populat Hlth & Environm Sci, London, England; [Baraitser, Paula] Kings Coll Hosp NHS Fdn Trust, Dept Sexual Hlth & HIV, London, England	University of Bristol; University of Bristol; University of London; King's College London; King's College Hospital NHS Foundation Trust	Baraitser, P (corresponding author), Kings Coll London, Sch Populat Hlth & Environm Sci, London, England.; Baraitser, P (corresponding author), Kings Coll Hosp NHS Fdn Trust, Dept Sexual Hlth & HIV, London, England.	paula.baraitser@kcl.ac.uk	Turner, Katy/R-3853-2019	Turner, Katy/0000-0002-8152-6017; Baraitser, Paula/0000-0002-3354-6494; Syred, Jonathan/0000-0002-4479-1604	'Guys and St Thomas' Charity	'Guys and St Thomas' Charity	This work was supported by a grant from 'Guys and St Thomas' Charity to PB. A mixed method evaluation of virtual sexual health services for Lambeth and Southwark. Evaluation, PI Paula Baraitser. 611,034 pound. Start date 01/01/2014 Duration 36 months. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baraitser P, 2017, SEX TRANSM INFECT, V93, pA6, DOI 10.1136/sextrans-2017-053232.17; Baraitser P, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1200-x; Barnard S, 2016, BASHH 2016 ANN C; Blake DR, 2015, SEX TRANSM DIS, V42, P13, DOI 10.1097/OLQ.0000000000000221; Department for Environment FRA, 2016, RUR URB CLASS; Emma Wilson CF, 2017, PLOS MED UNPUB   AUG; England N, NHS 5 YEAR FORW VIEW; England PH, 2016, SEX TRANSM INF CHLAM; Estcourt CS, 2017, LANCET PUBLIC HEALTH, V2, pE182, DOI 10.1016/S2468-2667(17)30034-8; Fund TKs, 2015, IMP 2015 SPEND REV H; Fund TKs, 2017, FUT NOW INN TOD POIN; Gaydos CA, 2006, SEX TRANSM DIS, V33, P451, DOI 10.1097/01.olq.0000200497.14326.fb; Gott M, 2004, FAM PRACT, V21, P528, DOI 10.1093/fampra/cmh509; Huang W, 2011, SEX TRANSM DIS, V38, P815, DOI 10.1097/OLQ.0b013e31821b0f50; Levine DK, 2005, SEX TRANSM DIS, V32, P139, DOI 10.1097/01.olq.0000149783.67826.4d; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Prevention ECfD Control, 2013, HLTH INEQ FIN CRIS I; Public Health England (PHE), 2013, GEN MED CLIN ACT DAT; Rietmeijer C. A., 2007, Sexuality Research and Social Policy, V4, P65, DOI 10.1525/srsp.2007.4.2.65; Smith KEI, 2007, INDIGEN PEOPLE POLIT, P1, DOI 10.1155/2007/62467; Voices N, SUPP SELF MAN SUMM E; World Health Organisation, 2021, SEXUALLY TRANSMITTED	22	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212420	10.1371/journal.pone.0212420	http://dx.doi.org/10.1371/journal.pone.0212420			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794589	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100064
J	Kato, S; Takahashi, A; Shindo, M; Yoshida, A; Kawamura, T; Matsumoto, K; Matsuura, B				Kato, Shinichi; Takahashi, Aoi; Shindo, Mai; Yoshida, Ayano; Kawamura, Tomoe; Matsumoto, Kenjiro; Matsuura, Bunzo			Characterization of the gastric motility response to human motilin and erythromycin in human motilin receptor-expressing transgenic mice	PLOS ONE			English	Article							GASTROINTESTINAL CONTRACTILE ACTIVITY; SMOOTH-MUSCLE; MOLECULAR CHARACTERIZATION; SUNCUS-MURINUS; HUMAN STOMACH; MOUSE MODEL; PRECURSOR; AGONIST; GASTROPARESIS; PATHWAYS	Motilin is a gastrointestinal peptide hormone that stimulates gastrointestinal motility. Motilin is produced primarily in the duodenum and jejunum. Motilin receptors (MTLRs) are G protein-coupled receptors that may represent a clinically useful pharmacological target as they can be activated by erythromycin. The functions of motilin are highly species-dependent and remain poorly understood. As a functional motilin system is absent in rodents such as rats and mice, these species are not commonly used for basic studies. In this study, we examine the usefulness of human MTLR-overexpressing transgenic (hMTLR-Tg) mice by identifying the mechanisms of the gastric motor response to human motilin and erythromycin. The distribution of hMTLR was examined immunohistochemically in male wild-type (WT) and hMTLR-Tg mice. The contractile response of gastric strips was measured isometrically in an organ bath, while gastric emptying was determined using phenol red. hMTLR expression was abundant in the gastric smooth muscle layer. Interestingly, higher levels of hMTLR expression were observed in the myenteric plexus of hMTLR-Tg mice but not WT mice. hMTLR was not co-localized with vesicular acetylcholine transporter, a marker of cholinergic neurons in the myenteric plexus. Treatment with human motilin and erythromycin caused concentration-dependent contraction of gastric strips obtained from hMTLR-Tg mice but not from WT mice. The contractile response to human motilin and erythromycin in hMTLR-Tg mice was affected by neither atropine nor tetrodotoxin and was totally absent in Ca2+-free conditions. Furthermore, intraperitoneal injection of erythromycin significantly promoted gastric emptying in hMTLR-Tg mice but not in WT mice. Human motilin and erythromycin stimulate gastric smooth muscle contraction in hMTLR-Tg mice. This action is mediated by direct contraction of smooth muscle via the influx of extracellular Ca2+. Thus, hMTLR-Tg mice may be useful for the evaluation of MTLR agonists as gastric prokinetic agents.	[Kato, Shinichi; Takahashi, Aoi; Shindo, Mai; Yoshida, Ayano; Matsumoto, Kenjiro] Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Div Pathol Sci, Yamashina Ku, Kyoto, Japan; [Kawamura, Tomoe] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon, Ehime, Japan; [Matsuura, Bunzo] Ehime Univ, Grad Sch Med, Dept Lifestylerelated Med & Endocrinol, Toon, Ehime, Japan	Kyoto Pharmaceutical University; Ehime University; Ehime University	Kato, S (corresponding author), Kyoto Pharmaceut Univ, Dept Pharmacol & Expt Therapeut, Div Pathol Sci, Yamashina Ku, Kyoto, Japan.	skato@mb.kyoto-phu.ac.jp						BANFIELD DK, 1992, BIOCHIM BIOPHYS ACTA, V1131, P341, DOI 10.1016/0167-4781(92)90038-2; Broad J, 2012, BRIT J PHARMACOL, V167, P763, DOI 10.1111/j.1476-5381.2012.02009.x; Broad J, 2013, BRIT J PHARMACOL, V168, P1859, DOI 10.1111/bph.12077; BROWN JC, 1973, CAN J BIOCHEM CELL B, V51, P533, DOI 10.1139/o73-066; Coulie B, 1998, GUT, V43, P395, DOI 10.1136/gut.43.3.395; Dass NB, 2003, BRIT J PHARMACOL, V140, P948, DOI 10.1038/sj.bjp.0705505; Dudani A, 2016, J COMP PHYSIOL B, V186, P665, DOI 10.1007/s00360-016-0985-1; Farrugia G, 1997, AM J PHYSIOL-GASTR L, V273, pG404, DOI 10.1152/ajpgi.1997.273.2.G404; Feighner SD, 1999, SCIENCE, V284, P2184, DOI 10.1126/science.284.5423.2184; Folwaczny C, 2001, EUR J ENDOCRINOL, V144, pR1, DOI 10.1530/eje.0.144R001; He J, 2010, J MOL ENDOCRINOL, V44, P37, DOI 10.1677/JME-09-0095; Huang J, 2005, AM J PHYSIOL-GASTR L, V288, pG23, DOI 10.1152/ajpgi.00305.2004; ITOH Z, 1978, AM J DIG DIS, V23, P929, DOI 10.1007/BF01072469; ITOH Z, 1984, AM J PHYSIOL, V247, pG688, DOI 10.1152/ajpgi.1984.247.6.G688; ITOH Z, 1976, SCAND J GASTROENTERO, V11, P93; James AN, 2004, AM J PHYSIOL-GASTR L, V287, pG612, DOI 10.1152/ajpgi.00431.2003; JANSSENS J, 1983, REGUL PEPTIDES, V6, P363, DOI 10.1016/0167-0115(83)90265-3; Jarvie EM, 2007, BRIT J PHARMACOL, V150, P455, DOI 10.1038/sj.bjp.0707118; KHAN N, 1990, BIOCHEMISTRY-US, V29, P5743, DOI 10.1021/bi00476a015; KITAZAWA T, 1994, BRIT J PHARMACOL, V111, P288, DOI 10.1111/j.1476-5381.1994.tb14058.x; LEE KY, 1983, AM J PHYSIOL, V245, pG547, DOI 10.1152/ajpgi.1983.245.4.G547; LUX G, 1976, SCAND J GASTROENTERO, V11, P75; Matsumoto K, 2011, NEUROSCIENCE, V172, P518, DOI 10.1016/j.neuroscience.2010.10.024; Matsumoto K, 2018, AM J PHYSIOL-GASTR L, V315, pG104, DOI 10.1152/ajpgi.00305.2017; Matsumoto K, 2008, BIOL PHARM BULL, V31, P1917, DOI 10.1248/bpb.31.1917; MATTHIJS G, 1988, REGUL PEPTIDES, V21, P321, DOI 10.1016/0167-0115(88)90015-8; Miller P, 2000, AM J PHYSIOL-GASTR L, V278, pG18, DOI 10.1152/ajpgi.2000.278.1.G18; Mondal A, 2011, NEUROGASTROENT MOTIL, V23, P1123, DOI 10.1111/j.1365-2982.2011.01801.x; Nunoi H, 2012, REGUL PEPTIDES, V176, P28, DOI 10.1016/j.regpep.2012.03.001; Ozaki K, 2009, EUR J PHARMACOL, V615, P185, DOI 10.1016/j.ejphar.2009.04.059; PEETERS T, 1989, AM J PHYSIOL, V257, pG470, DOI 10.1152/ajpgi.1989.257.3.G470; PEETERS TL, 1991, N-S ARCH PHARMACOL, V343, P202, DOI 10.1007/BF00168611; Sanger GJ, 2011, TRENDS PHARMACOL SCI, V32, P402, DOI 10.1016/j.tips.2011.03.009; SATOH M, 1994, J PHARMACOL EXP THER, V271, P574; Takeshita E, 2006, J GASTROENTEROL, V41, P223, DOI 10.1007/s00535-005-1739-0; Tanaka T, 1998, J PHARMACOL EXP THER, V287, P712; ter Beek WP, 2008, INFLAMM BOWEL DIS, V14, P612, DOI 10.1002/ibd.20364; Tsutsui C, 2009, PEPTIDES, V30, P318, DOI 10.1016/j.peptides.2008.10.006; Van Assche G, 2001, NEUROGASTROENT MOTIL, V13, P27, DOI 10.1046/j.1365-2982.2001.00237.x; VanAssche G, 1997, EUR J PHARMACOL, V337, P267, DOI 10.1016/S0014-2999(97)01317-4; Xu L, 2003, PEPTIDES, V24, P1387, DOI 10.1016/j.peptides.2003.09.005; Xu L, 2001, FEBS LETT, V490, P7, DOI 10.1016/S0014-5793(01)02125-1	42	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0205939	10.1371/journal.pone.0205939	http://dx.doi.org/10.1371/journal.pone.0205939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789939	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800004
J	Kelle, D; Kirimtay, K; Selcuk, E; Karabay, A				Kelle, Dolunay; Kirimtay, Koray; Selcuk, Ece; Karabay, Arzu			Elk1 affects katanin and spastin proteins via differential transcriptional and post-transcriptional regulations	PLOS ONE			English	Article							TERNARY COMPLEX FACTORS; ETS-DOMAIN; SIGNAL-TRANSDUCTION; ACTIVATED PROTEIN; MESSENGER-RNA; SUMO; MICROTUBULES; IDENTIFICATION; REGION; TARGETS	Microtubule severing, which is highly critical for the survival of both mitotic and post-mitotic cells, has to be precisely adjusted by regulating the expression levels of severing proteins, katanin and spastin. Even though severing mechanism is relatively well-studied, there are limited studies for the transcriptional regulation of microtubule severing proteins. In this study, we identified the main regulatory region of KATNA1 gene encoding katanin-p60 as 5' UTR, which has a key role for its expression, and showed Elk1 binding to KATNA1. Furthermore, we identified that Elk1 decreased katanin-p60 and spastin protein expressions, while mRNA levels were increased upon Elk1 overexpression. In addition, SUMOylation is a known post-translational modification regulating Elk1 activity. A previous study suggested that K230, K249, K254 amino acids in the R domain are the main SUMOylation sites; however, we identified that these amino acids are neither essential nor substantial for Elk1 SUMOylation. Also, we determined that KATNA1 methylation results in the reduction of Elk1 binding whereas SPG4 methylation does not. Together, our findings emphasizing the impacts of both transcriptional and post-transcriptional regulations of katanin-p60 and spastin suggest that Elk1 has a key role for differential expression patterns of microtubule severing proteins, thereby regulating cellular functions through alterations of microtubule organization.	[Kelle, Dolunay; Kirimtay, Koray; Selcuk, Ece; Karabay, Arzu] Istanbul Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey	Istanbul Technical University	Karabay, A (corresponding author), Istanbul Tech Univ, Dept Mol Biol & Genet, Istanbul, Turkey.	karabaya@itu.edu.tr	Kırımtay, Koray/AHB-4140-2022; Karabay, Arzu/ABB-3681-2020	Karabay, Arzu/0000-0001-5150-5349	Istanbul Technical University Scientific Research Projects-ITU-BAP [415, 38224]; Istanbul Kalkinma Ajansi [TR10/16/YNY/0130]	Istanbul Technical University Scientific Research Projects-ITU-BAP; Istanbul Kalkinma Ajansi	This study was funded by Istanbul Technical University Scientific Research Projects-ITU-BAP [Project ID: 415 #38224] to AK and Istanbul Kalkinma Ajansi [TR10/16/YNY/0130] to AK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad FJ, 1999, J CELL BIOL, V145, P305, DOI 10.1083/jcb.145.2.305; Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Baczyk D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178056; Barrett LE, 2006, NAT METHODS, V3, P455, DOI 10.1038/NMETH885; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Canbaz D, 2011, J NEUROCHEM, V117, P724, DOI 10.1111/j.1471-4159.2011.07243.x; Claudiani P, 2005, EXP CELL RES, V309, P358, DOI 10.1016/j.yexcr.2005.06.009; Connerty P, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010031; Costa MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024812; Demir O, 2009, MOL CELL NEUROSCI, V40, P111, DOI 10.1016/j.mcn.2008.10.004; Errico A, 2002, HUM MOL GENET, V11, P153, DOI 10.1093/hmg/11.2.153; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Frickey T, 2004, J STRUCT BIOL, V146, P2, DOI 10.1016/j.jsb.2003.11.020; Gille H, 1996, MOL CELL BIOL, V16, P1094; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hemberg M, 2011, NUCLEIC ACIDS RES, V39, P7092, DOI 10.1093/nar/gkr404; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Henson BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036505; Hu BQ, 2017, NUCLEIC ACIDS RES, V45, pD104, DOI 10.1093/nar/gkw888; Karabay A, 2004, J NEUROSCI, V24, P5778, DOI 10.1523/JNEUROSCI.1382-04.2004; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Lacroix B, 2010, J CELL BIOL, V189, P945, DOI 10.1083/jcb.201001024; Lee YS, 2015, NEUROBIOL LEARN MEM, V124, P28, DOI 10.1016/j.nlm.2015.08.004; Lumb JH, 2012, BBA-MOL CELL RES, V1823, P192, DOI 10.1016/j.bbamcr.2011.08.010; Mansfield KD, 2012, NUCLEIC ACIDS RES, V40, P2734, DOI 10.1093/nar/gkr1114; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally KP, 2000, J CELL SCI, V113, P1623; Meng Z, 2005, NUCLEIC ACIDS RES, V33, P2962, DOI 10.1093/nar/gki603; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Park JB, 2007, J NEUROCHEM, V100, P555, DOI 10.1111/j.1471-4159.2006.04263.x; Pastorcic M, 2003, MOL BRAIN RES, V113, P57, DOI 10.1016/S0169-328X(03)00090-1; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; Qiang L, 2006, J NEUROSCI, V26, P3120, DOI 10.1523/JNEUROSCI.5392-05.2006; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saether T, 2011, ONCOGENE, V30, P212, DOI 10.1038/onc.2010.397; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Selcuk E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069423; Sgambato V, 1998, J NEUROSCI, V18, P214; Sharma A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009002; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Sokolowski M, 1999, J VIROL, V73, P1080, DOI 10.1128/JVI.73.2.1080-1091.1999; Toyo-Oka K, 2005, HUM MOL GENET, V14, P3113, DOI 10.1093/hmg/ddi339; VALE RD, 1991, CELL, V64, P827, DOI 10.1016/0092-8674(91)90511-V; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Yang SH, 2002, MOL CELL BIOL, V22, P5036, DOI 10.1128/MCB.22.14.5036-5046.2002; Yang SH, 2001, MOL CELL BIOL, V21, P2802, DOI 10.1128/MCB.21.8.2802-2814.2001; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, MOL CELL, V12, P63, DOI 10.1016/S1097-2765(03)00265-X; Yang YF, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170167; Yang YCT, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1273-2; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036; Yu WQ, 2008, MOL BIOL CELL, V19, P1485, DOI 10.1091/mbc.E07-09-0878; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005	66	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212518	10.1371/journal.pone.0212518	http://dx.doi.org/10.1371/journal.pone.0212518			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789974	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800034
J	Shimbashi, R; Chang, B; Tanabe, Y; Takeda, H; Watanabe, H; Kubota, T; Kasahara, K; Oshima, K; Nishi, J; Maruyama, T; Kuronuma, K; Fujita, J; Ikuse, T; Kinjo, Y; Suzuki, M; Kerdsin, A; Shimada, T; Fukusumi, M; Tanaka-Taya, K; Matsui, T; Sunagawa, T; Ohnishi, M; Oishi, K; Nakano, M; Ikeda, T; Suzuki, Y; Seto, J; Yahagi, K; Kazama, K; Yamazaki, S; Kumakura, E; Hiraoka, M; Nagai, Y; Naraya, S; Tsujimoto, E; Matsumoto, M; Shigemura, H; Okamoto, F; Sera, N; Gokuden, M; Itokazu, T; Kudaka, J; Yokoyama, A; Takahashi, H; Aoyagi, T; Kaku, M; Abe, S; Tsubata, C; Saitoh, A; Ishida, M; Nakamatsu, M				Shimbashi, Reiko; Chang, Bin; Tanabe, Yoshinari; Takeda, Hiroaki; Watanabe, Hiroshi; Kubota, Tetsuya; Kasahara, Kei; Oshima, Kengo; Nishi, Junichiro; Maruyama, Takaya; Kuronuma, Koji; Fujita, Jiro; Ikuse, Tatsuki; Kinjo, Yuki; Suzuki, Motoi; Kerdsin, Anusak; Shimada, Tomoe; Fukusumi, Munehisa; Tanaka-Taya, Keiko; Matsui, Tamano; Sunagawa, Tomimasa; Ohnishi, Makoto; Oishi, Kazunori; Nakano, Michiharu; Ikeda, Tatsuya; Suzuki, Yu; Seto, Junji; Yahagi, Kazue; Kazama, Kurumi; Yamazaki, Satoru; Kumakura, Emiko; Hiraoka, Minoru; Nagai, Yuhki; Naraya, Sagako; Tsujimoto, Eri; Matsumoto, Michiaki; Shigemura, Hiroaki; Okamoto, Fuyuki; Sera, Nobuyuki; Gokuden, Mutsuyo; Itokazu, Toru; Kudaka, Jun; Yokoyama, Akihito; Takahashi, Hiroki; Aoyagi, Tetsuji; Kaku, Mitsuo; Abe, Shuichi; Tsubata, Chikako; Saitoh, Akihiko; Ishida, Masayuki; Nakamatsu, Masashi		Adult IPD Study Grp	Epidemiological and clinical features of invasive pneumococcal disease caused by serotype 12F in adults, Japan	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; POLYSACCHARIDE VACCINE; CONJUGATE VACCINE; POPULATION; RESISTANCE; CARRIAGE; OUTBREAK; CHILDREN; ENGLAND	Enhanced surveillance of invasive pneumococcal disease (IPD) in adults was conducted during April 2013-March 2018 in 10 of 47 prefectures in Japan, and a total of 1277 IPD patients were enrolled. An emergence of IPD caused by serotype 12F was identified during May 2015-March 2018 through this surveillance. 12F isolates were composed of four related sequence types. In total, 120 patients with 12F IPD were reported during this period. To characterize the clinical features of 12F IPD, the disease characteristics of these patients were compared with those of 1157 patients with non-12F IPD. Compared with the non-12F IPD patients, a significantly lower proportion of 12F IPD patients was aged 65 years or older (55% vs. 70%), vaccinated with 23-valent pneumococcal polysaccharide (4% vs. 14%), had comorbid illness (65% vs. 77%), or were immunocompromised (19% vs. 30%; all P < 0.05). No significant difference in the proportion of case fatalities was found between the two groups. The proportions of those aged 65 years or older (53% vs. 69%) and with bacteremic pneumonia (35% vs. 69%) were significantly lower in 17 patients who died from 12F IPD than in 205 patients who died from non-12F IPD (all P < 0.05). Differences in clinical features were similarly found between 12F IPD patients and patients in low-or intermediate-level invasive potential serogroups. Our data demonstrated that serotype 12F was associated with IPD in younger adults and a lower proportion of comorbid illness, including immuno-compromised conditions, in adult IPD, suggesting the high invasive potential of the serotype 12F. In addition, patients who died from 12F IPD were younger and had proportionately more bacteremia without focus. These findings may provide new insight into the pathogenesis of IPD in adults caused by 12F serotype with a high invasive potential.	[Shimbashi, Reiko] Natl Inst Infect Dis, Field Epidemiol Training Program, Tokyo, Japan; [Shimbashi, Reiko] Tohoku Univ, Grad Sch Med, Div Global Infect Dis, Dept Infect & Epidemiol, Sendai, Miyagi, Japan; [Shimbashi, Reiko; Shimada, Tomoe; Fukusumi, Munehisa; Tanaka-Taya, Keiko; Matsui, Tamano; Sunagawa, Tomimasa; Oishi, Kazunori] Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan; [Chang, Bin; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol, Tokyo, Japan; [Tanabe, Yoshinari] Niigata Prefectural Shibata Hosp, Dept Resp Med, Shibata, Japan; [Takeda, Hiroaki] Yamagata Saisei Hosp, Dept Resp Med, Yamagata, Japan; [Watanabe, Hiroshi] Kurume Univ, Sch Med, Dept Infect Control & Prevent, Kurume, Fukuoka, Japan; [Kubota, Tetsuya] Kochi Univ, Kochi Med Sch, Dept Hematol & Resp Med, Kochi, Japan; [Kasahara, Kei] Nara Med Univ, Ctr Infect Dis, Kashihara, Nara, Japan; [Oshima, Kengo] Tohoku Univ, Grad Sch Med, Dept Infect Control & Lab Diagnost, Internal Med, Sendai, Miyagi, Japan; [Nishi, Junichiro] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Microbiol, Kagoshima, Japan; [Maruyama, Takaya] Mie Hosp, Natl Hosp Org, Dept Med, Tsu, Mie, Japan; [Kuronuma, Koji] Sapporo Med Univ, Dept Resp Med & Allergol, Sch Med, Sapporo, Hokkaido, Japan; [Fujita, Jiro] Univ Ryukyus, Grad Sch Med, Dept Infect Resp & Digest Med, Nishihara, Okinawa, Japan; [Ikuse, Tatsuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat, Niigata, Japan; [Kinjo, Yuki] Natl Inst Infect Dis, Dept Bacteriol, Dept Chemotherapy & Mycoses, Tokyo, Japan; [Kinjo, Yuki] Jikei Univ, Sch Med, Tokyo, Japan; [Suzuki, Motoi] Nagasaki Univ, Inst Trop Med, Dept Clin Med, Nagasaki, Japan; [Kerdsin, Anusak] Kasetsart Univ, Fac Publ Hlth, Chalermphrakiat Sakon Nakhon Prov Campus, Sakon Nakhon, Thailand; [Nakano, Michiharu] Hokkaido Inst Publ Hlth, Sapporo, Hokkaido, Japan; Sendai City Publ Hlth Ctr, Sendai, Miyagi, Japan; [Ikeda, Tatsuya] Yamagata Prefectural Bur Publ Hlth & Welf, Yamagata, Japan; [Suzuki, Yu; Seto, Junji; Yahagi, Kazue] Yamagata Prefectural Inst Publ Hlth, Yamagata, Japan; [Kazama, Kurumi] Welf & Publ Hlth Bur Niigata Prefecture, Niigata, Japan; [Yamazaki, Satoru; Kumakura, Emiko] Hlth & Sanitat Dept Niigata City, Niigata, Japan; [Hiraoka, Minoru] Dept Hlth & Welf, Tsu, Mie, Japan; [Nagai, Yuhki; Naraya, Sagako] Mie Prefecture Hlth & Environm Res Inst, Tsu, Mie, Japan; [Tsujimoto, Eri] Dept Med Policy, Nara, Nara, Japan; [Matsumoto, Michiaki] Publ Hlth Inst Kochi Prefecture, Kochi, Japan; [Shigemura, Hiroaki; Okamoto, Fuyuki; Sera, Nobuyuki] Fukuoka Inst Hlth & Environm Sci, Dazaifu, Japan; [Gokuden, Mutsuyo] Ctr Environm & Hlth, Kagoshima, Kagoshima, Japan; [Itokazu, Toru] Welf & Publ Hlth Bur Okinawa Prefecture, Kagoshima, Japan; [Kudaka, Jun] Okinawa Prefectural Inst Hlth & Environm, Nanjo, Japan; [Yokoyama, Akihito] Kochi Univ, Kochi Med Sch, Kochi, Japan; [Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Sapporo, Hokkaido, Japan; [Aoyagi, Tetsuji; Kaku, Mitsuo] Tohoku Univ, Grad Sch Med, Sendai, Miyagi, Japan; [Abe, Shuichi] Yamagata Prefectural Cent Hosp, Yamagata, Japan; [Tsubata, Chikako; Saitoh, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Niigata, Japan; [Ishida, Masayuki] Chikamori Hosp, Kochi, Japan; [Nakamatsu, Masashi] Univ Ryukus, Nishihara, Okinawa, Japan	National Institute of Infectious Diseases (NIID); Tohoku University; National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Kurume University; Kochi University; Nara Medical University; Tohoku University; Kagoshima University; Sapporo Medical University; University of the Ryukyus; Niigata University; National Institute of Infectious Diseases (NIID); Jikei University; Nagasaki University; Kasetsart University; Kochi University; Sapporo Medical University; Tohoku University; Yamagata Prefectural Central Hospital; Niigata University; University of the Ryukyus	Oishi, K (corresponding author), Natl Inst Infect Dis, Infect Dis Surveillance Ctr, Tokyo, Japan.	oishik@nih.go.jp	Shimbashi, Reiko/ABG-6220-2021	Suzuki, Motoi/0000-0002-8340-0880; Ikuse, Tatsuki/0000-0002-0417-6797; Kerdsin, Anusak/0000-0003-1055-3656	Ministry of Health, Labour and Welfare of Japan [H28 Shinko-Gyosei-005]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by the Ministry of Health, Labour and Welfare of Japan (Grant number H28 Shinko-Gyosei-005) to KO.	Andrews NJ, 2012, VACCINE, V30, P6802, DOI 10.1016/j.vaccine.2012.09.019; [Anonymous], [No title captured]; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Brueggemann AB, 2004, J INFECT DIS, V190, P1203, DOI 10.1086/423820; Brueggemann AB, 2003, J INFECT DIS, V187, P1424, DOI 10.1086/374624; Chang B, 2015, J CLIN MICROBIOL, V53, P3318, DOI 10.1128/JCM.01222-15; CHERIAN T, 1994, JAMA-J AM MED ASSOC, V271, P695, DOI 10.1001/jama.271.9.695; Chiba N, 2010, EPIDEMIOL INFECT, V138, P61, DOI 10.1017/S0950268809990239; Deng XD, 2016, CLIN INFECT DIS, V62, P1126, DOI 10.1093/cid/ciw050; Enright MC, 1998, MICROBIOL-UK, V144, P3049, DOI 10.1099/00221287-144-11-3049; Falkenhorst G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169368; Fukusumi M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2113-y; Geno KA, 2015, CLIN MICROBIOL REV, V28, P871, DOI 10.1128/CMR.00024-15; HOGE CW, 1994, NEW ENGL J MED, V331, P643, DOI 10.1056/NEJM199409083311004; Ikuse T, 2018, EPIDEMIOL INFECT, V146, DOI 10.1017/S0950268818002133; Jansen AGSC, 2009, CLIN INFECT DIS, V49, pE23, DOI 10.1086/600045; Jorgenson G., 2005, Morbidity and Mortality Weekly Report, V54, P72; Kraicer-Melamed H, 2016, VACCINE, V34, P1540, DOI 10.1016/j.vaccine.2016.02.024; Ladhani SN, 2018, LANCET INFECT DIS, V18, P441, DOI 10.1016/S1473-3099(18)30052-5; Rakov AV, 2011, INFECT GENET EVOL, V11, P1929, DOI 10.1016/j.meegid.2011.08.016; Rokney A, 2018, EMERG INFECT DIS, V24, P453, DOI 10.3201/eid2403.170769; Sakiyama H, 2017, J AMBULATORY GEN PED, V20, P271; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Schillberg E, 2014, CLIN INFECT DIS, V59, P651, DOI 10.1093/cid/ciu366; Singleton RJ, 2007, VACCINE, V25, P2288, DOI 10.1016/j.vaccine.2006.11.065; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Torzillo PJ, 2007, VACCINE, V25, P2375, DOI 10.1016/j.vaccine.2006.09.003; Ubukata K, 2018, EMERG INFECT DIS, V24, P2010, DOI 10.3201/eid2411.180326; Ubukata K, 2015, EMERG INFECT DIS, V21, P1956, DOI 10.3201/eid2111.142029; Zulz T, 2013, J CLIN MICROBIOL, V51, P1402, DOI 10.1128/JCM.02880-12	30	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212418	10.1371/journal.pone.0212418	http://dx.doi.org/10.1371/journal.pone.0212418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789928	Green Published, gold, Green Submitted			2022-12-26	WOS:000459330800027
J	Bedini, S; Flamini, G; Cosci, F; Ascrizzi, R; Echeverria, MC; Gomez, EV; Guidi, L; Landi, M; Lucchi, A; Conti, B				Bedini, Stefano; Flamini, Guido; Cosci, Francesca; Ascrizzi, Roberta; Echeverria, Maria C.; Gomez, Evelin V.; Guidi, Lucia; Landi, Marco; Lucchi, Andrea; Conti, Barbara			Toxicity and oviposition deterrence of essential oils of Clinopodium nubigenum and Lavandula angustifolia against the myiasis-inducing blowfly Lucilia sericata	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; OREGANO ESSENTIAL OIL; ANTIMICROBIAL ACTIVITY; SALMONELLA-ENTERICA; AEDES-ALBOPICTUS; AROMATIC PLANTS; INSECT PESTS; KUNTH KUNTZE; SHEEP; DISEASE	Cutaneous myiasis is a severe worldwide medical and veterinary issue. In this trial the essential oil (EO) of the Andean medicinal plant species Clinopodium nubigenum (Kunth) Kuntze was evaluated for its bioactivity against the myiasis-inducing blowfly Lucilia sericata (Meigen) (Diptera Calliphoridae) and compared with that of the well-known medicinal plant species Lavandula angustifolia Mill. The EOs were analysed and tested in laboratory for their oviposition deterrence and toxicity against L. sericata adults. The physiology of EO toxicity was evaluated by enzymatic inhibition tests. The antibacterial and antifungal properties of the EOs were tested as well. At 0.8 mu L cm(-2), both EOs completely deterred L. sericata oviposition up to 3 hours. After 24 h, the oviposition deterrence was still 82.7% for L. angustifolia and the 89.5% for C. nubigenum. The two EOs were also toxic to eggs and adults of L. sericata. By contact/fumigation, the EOs, the LC50 values against the eggs were 0.07 and 0.48 mu L cm(-2) while, by topical application on the adults, LD50 values were 0.278 and 0.393 mu L per individual for C. nubigenum and L. angustifolia EOs, respectively. Inhibition of acetylcholine esterase of L. sericata by EOs (IC50 = 67.450 and 79.495 mg L-1 for C. nubigenum and L. angustifolia, respectively) suggested that the neural sites are targets of the EO toxicity. Finally, the observed antibacterial and antifungal properties of C. nubigenum and L. angustifolia EOs suggest that they could also help prevent secondary infections.	[Bedini, Stefano; Cosci, Francesca; Guidi, Lucia; Landi, Marco; Lucchi, Andrea; Conti, Barbara] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy; [Flamini, Guido; Ascrizzi, Roberta] Univ Pisa, Dept Pharm, Pisa, Italy; [Echeverria, Maria C.; Gomez, Evelin V.] Univ Tecn Norte, Fac Ingn Ciencias Agr & Ambientales, Ibarra, Ecuador	University of Pisa; University of Pisa	Conti, B (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.	barbara.conti@unipi.it	Bedini, Stefano/AAF-4453-2020; Ascrizzi, Roberta/J-5608-2018; Cosci, Francesca/Q-3622-2019; Flamini, Guido/A-7988-2011; Conti, Barbara/H-6373-2019	Bedini, Stefano/0000-0002-3760-9894; Ascrizzi, Roberta/0000-0003-1791-8208; Flamini, Guido/0000-0003-2418-9349; Conti, Barbara/0000-0002-7861-1536; Cosci, Francesca/0000-0003-2330-2557; Landi, Marco/0000-0003-0121-0715; Echeverria, Maria Cristina/0000-0001-8475-5432	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), BIOPIC, 2015 BABFCF	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), BIOPIC, 2015 BABFCF	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), BIOPIC, 2015 BABFCF to Prof. Barbara Conti, http://prin.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Andrade JM, 2009, PLANTAS MED SILVESTR; Anstead CA, 2017, ADV PARASIT, V98, P227, DOI 10.1016/bs.apar.2017.03.001; Bajpai VK, 2013, FOOD CONTROL, V32, P582, DOI 10.1016/j.foodcont.2013.01.032; Baker KE, 2014, AUST VET J, V92, P376, DOI 10.1111/avj.12247; Bedini S, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2006-y; Bedini S, 2015, J PEST SCI, V88, P583, DOI 10.1007/s10340-015-0647-1; Benelli G, 2012, CROP PROT, V42, P223, DOI 10.1016/j.cropro.2012.05.024; Bennett R, 2003, FINAL REPORT DEP ENV; Bisdorff B, 2006, VET REC, V158, P749, DOI 10.1136/vr.158.22.749; Bosly B., 2013, J ENTOMOL NEMATOL, V5, P50, DOI DOI 10.5897/JEN2013.0073; Bougherra HH, 2015, IND CROP PROD, V63, P249, DOI 10.1016/j.indcrop.2014.09.048; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Callander JT, 2012, VET PARASITOL, V184, P271, DOI 10.1016/j.vetpar.2011.08.017; Campolo O, 2014, PHYTOPARASITICA, V42, P223, DOI 10.1007/s12600-013-0355-4; Carson CF, 2002, ANTIMICROB AGENTS CH, V46, P1914, DOI 10.1128/AAC.46.6.1914-1920.2002; Cavanagh HMA, 2002, PHYTOTHER RES, V16, P301, DOI 10.1002/ptr.1103; Cheah SX, 2013, PARASITOL RES, V112, P3275, DOI 10.1007/s00436-013-3506-0; Chen PeterJohn., 2016, ANIMAL WELFARE AUSTR; Conti B, 2012, PARASITOL RES, V111, P291, DOI 10.1007/s00436-012-2837-6; Conti B, 2010, PARASITOL RES, V107, P1455, DOI 10.1007/s00436-010-2018-4; Cos P, 2006, J ETHNOPHARMACOL, V106, P290, DOI 10.1016/j.jep.2006.04.003; Portillo-Ruiz MC, 2012, J FOOD SCI, V77, pM441, DOI 10.1111/j.1750-3841.2012.02821.x; Daferera DJ, 2003, CROP PROT, V22, P39, DOI 10.1016/S0261-2194(02)00095-9; DAVIES NW, 1990, J CHROMATOGR, V503, P1, DOI 10.1016/S0021-9673(01)81487-4; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Gayatri Nahak, 2011, International Journal of Pharmaceutical and Biological Archives, V2, P1236; Gilardoni G, 2011, REV BRAS FARMACOGN, V21, P850, DOI 10.1590/S0102-695X2011005000139; Graczyk TK, 2001, MICROBES INFECT, V3, P231, DOI 10.1016/S1286-4579(01)01371-5; HALL M, 1995, ADV PARASIT, V35, P257, DOI 10.1016/S0065-308X(08)60073-1; Hall MJR, 2016, ANNU REV ENTOMOL, V61, P159, DOI 10.1146/annurev-ento-010715-023655; Holetz FB, 2002, MEM I OSWALDO CRUZ, V97, P1027, DOI 10.1590/S0074-02762002000700017; Ibrahim L, 2012, J ESSENT OIL RES, V24, P339, DOI 10.1080/10412905.2012.692900; Isman MB, 2000, CROP PROT, V19, P603, DOI 10.1016/S0261-2194(00)00079-X; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Junqueira ACM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16353-x; Khosravi Roya, 2013, Journal of King Saud University Science, V25, P349, DOI 10.1016/j.jksus.2013.01.002; Kwon SJ, 2017, FOOD MICROBIOL, V65, P114, DOI 10.1016/j.fm.2017.02.004; Lambert RJW, 2001, J APPL MICROBIOL, V91, P453, DOI 10.1046/j.1365-2672.2001.01428.x; Leitner N, 2016, PARASITOL RES, V115, P4417, DOI 10.1007/s00436-016-5206-z; Levot GW, 2012, AUST VET J, V90, P433, DOI 10.1111/j.1751-0813.2012.00984.x; LITTLEJOHN JW, 1991, J INST WATER ENV MAN, V5, P21; Lv F, 2011, FOOD RES INT, V44, P3057, DOI 10.1016/j.foodres.2011.07.030; Moreira MR, 2005, LWT-FOOD SCI TECHNOL, V38, P565, DOI 10.1016/j.lwt.2004.07.012; Nerio LS, 2009, J STORED PROD RES, V45, P212, DOI 10.1016/j.jspr.2009.01.002; Pascual-Villalobos M.J., 1996, Boletin de Sanidad Vegetal Plagas, V22, P411; Perricone M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00076; Rajkumar S, 2009, PARASITOL RES, V104, P337, DOI 10.1007/s00436-008-1197-8; Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554; REGNAULTROGER C, 1993, J CHEM ECOL, V19, P1233, DOI 10.1007/BF00987383; Rios M, 2007, PLANTAS UTILES ECUAD; Rose H, 2011, INT J PARASITOL, V41, P739, DOI 10.1016/j.ijpara.2011.01.012; Rothwell J, 2007, AUST VET J, V85, P94, DOI 10.1111/j.1751-0813.2007.00116.x; Ruiz S, 2010, J ESSENT OIL BEAR PL, V13, P676, DOI 10.1080/0972060X.2010.10643879; Sackett D., 2006, ASSESSING EC COST EN, V87; Sandeman RM, 2014, INT J PARASITOL, V44, P879, DOI 10.1016/j.ijpara.2014.08.009; Sartoratto A, 2004, BRAZ J MICROBIOL, V35, P275, DOI 10.1590/S1517-83822004000300001; Savelev S, 2003, PHARMACOL BIOCHEM BE, V75, P661, DOI 10.1016/S0091-3057(03)00125-4; Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586; SIKKEMA J, 1995, MICROBIOL REV, V59, P201, DOI 10.1128/MMBR.59.2.201-222.1995; Singh A, 2015, PARASITOL RES, V114, P3183, DOI 10.1007/s00436-015-4620-y; Small AH, 2018, RES VET SCI, V118, P305, DOI 10.1016/j.rvsc.2018.03.006; Sotiraki S, 2012, SMALL RUMINANT RES, V103, P75, DOI 10.1016/j.smallrumres.2011.10.021; STEPHENS R, 1995, LANCET, V345, P1135, DOI 10.1016/S0140-6736(95)90976-1; Tellam RL, 1997, INT J PARASITOL, V27, P261, DOI 10.1016/S0020-7519(96)00174-9; Tolouee M, 2010, INT J FOOD MICROBIOL, V139, P127, DOI 10.1016/j.ijfoodmicro.2010.03.032; V de la Torre L., 2008, ENCICLOPEDIA PLANTAS; Waghorn TS, 2013, NEW ZEAL VET J, V61, P274, DOI 10.1080/00480169.2012.760400; Walker JF, 2016, J FOOD SAFETY, V36, P489, DOI 10.1111/jfs.12266; Wall R, 2012, VET PARASITOL, V189, P44, DOI 10.1016/j.vetpar.2012.03.031; Yadegarinia D, 2006, PHYTOCHEMISTRY, V67, P1249, DOI 10.1016/j.phytochem.2006.04.025; Yaghoubi R., 2005, ACTA MED IRAN, V43, P155; Yazdani E, 2013, PESTIC BIOCHEM PHYS, V107, P250, DOI 10.1016/j.pestbp.2013.08.002; ZUMPT F., 1965	75	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0212576	http://dx.doi.org/10.1371/journal.pone.0212576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785945	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000072
J	Gerdes, Z; Ogonowski, M; Nybom, I; Ek, C; Adolfsson-Erici, M; Barth, A; Gorokhova, E				Gerdes, Zandra; Ogonowski, Martin; Nybom, Inna; Ek, Caroline; Adolfsson-Erici, Margaretha; Barth, Andreas; Gorokhova, Elena			Microplastic-mediated transport of PCBs? A depuration study with Daphnia magna	PLOS ONE			English	Article							HYDROPHOBIC ORGANIC-CHEMICALS; POLYCHLORINATED-BIPHENYLS; MARINE-ENVIRONMENT; POLLUTANTS; IMPACT; CONTAMINANTS; INGESTION; PLASTICS; GROWTH; BIOACCUMULATION	The role of microplastic (MP) as a carrier of persistent organic pollutants (POPs) to aquatic organisms has been a topic of debate. However, the reverse POP transport can occur if relative contaminant concentrations are higher in the organism than in the microplastic. We evaluated the effect of microplastic on the PCB removal in planktonic animals by exposing the cladoceran Daphnia magna with a high body burden of polychlorinated biphenyls (PCB 18, 40, 128 and 209) to a mixture of microplastic and algae; daphnids exposed to only algae served as the control. As the endpoints, we used PCB body burden, growth, fecundity and elemental composition (%C and %N) of the daphnids. In the daphnids fed with microplastic, PCB 209 was removed more efficiently, while there was no difference for any other congeners and Sigma PCBs between the microplastic-exposed and control animals. Also, higher size-specific egg production in the animals carrying PCB and receiving food mixed with micro-plastics was observed. However, the effects of the microplastic exposure on fecundity were of low biological significance, because the PCB body burden and the microplastic exposure concentrations were greatly exceeding environmentally relevant concentrations.	[Gerdes, Zandra; Ogonowski, Martin; Nybom, Inna; Ek, Caroline; Adolfsson-Erici, Margaretha; Gorokhova, Elena] Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden; [Ogonowski, Martin] Aquabiota Water Res AB, Stockholm, Sweden; [Ogonowski, Martin] Swedish Univ Agr Sci, Inst Freshwater Res, Dept Aquat Resources, Stockholm, Sweden; [Barth, Andreas] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden	Stockholm University; Swedish University of Agricultural Sciences; Stockholm University	Gerdes, Z (corresponding author), Stockholm Univ, Dept Environm Sci & Analyt Chem, Stockholm, Sweden.	zandra.gerdes@aces.su.se	Nybom, Inna/AAH-5314-2020; Barth, Andreas/N-8872-2013	Nybom, Inna/0000-0002-3399-1483; Gorokhova, Elena/0000-0002-4192-6956; Ogonowski, Martin/0000-0002-7082-0990; Gerdes, Zandra/0000-0003-0752-677X; Barth, Andreas/0000-0001-5784-7673	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [216-2013-1010, 2015-00932]; Swedish Institute, Isotope Ecology Network in the Baltic Sea region (NSSIA project) [12906/2013]; Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans, WEATHER-MIC project) [942-2015-1866]; Swedish Innovation Agency VINNOVA; joint Baltic Sea research and development programme (BONUS, Blue Baltic) [2017-00979]	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Institute, Isotope Ecology Network in the Baltic Sea region (NSSIA project); Joint Programming Initiative Healthy and Productive Seas and Oceans (JPI Oceans, WEATHER-MIC project); Swedish Innovation Agency VINNOVA(Vinnova); joint Baltic Sea research and development programme (BONUS, Blue Baltic)	This work was supported by Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, http://www.formas.se/en/start-page.html, (FORMAS, grant number: 216-2013-1010) - MO, EG; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning, http://www.formas.se/en/start-page.html, (FORMAS, grant number: 2015-00932) - AB, EG, MO; Swedish Institute, https://si.se/en/, Isotope Ecology Network in the Baltic Sea region (NSSIA project, grant number 12906/2013) - EG; The Joint Programming Initiative Healthy and Productive Seas and Oceans, http://jpi-oceans.eu/, (JPI Oceans, WEATHER-MIC project, grant number 942-2015-1866) - EG; The Swedish Innovation Agency VINNOVA, https://www.vinnova.se/en/, and the joint Baltic Sea research and development programme, https://www.bonusportal.org/, (BONUS, Blue Baltic) for MICROPOLL project [grant number 2017-00979] - EG.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Avio CG, 2015, ENVIRON POLLUT, V198, P211, DOI 10.1016/j.envpol.2014.12.021; Bakir A, 2016, ENVIRON POLLUT, V219, P56, DOI 10.1016/j.envpol.2016.09.046; Bejgarn S, 2015, CHEMOSPHERE, V132, P114, DOI 10.1016/j.chemosphere.2015.03.010; Bergman TU, 2011, ENVIRON SCI POLLUT R, V18, P655, DOI 10.1007/s11356-010-0413-0; Besseling E, 2017, ENVIRON SCI TECHNOL, V51, P8795, DOI 10.1021/acs.est.7b02286; Besseling E, 2014, ENVIRON SCI TECHNOL, V48, P12336, DOI 10.1021/es503001d; Boerger CM, 2010, MAR POLLUT BULL, V60, P2275, DOI 10.1016/j.marpolbul.2010.08.007; Brennecke D, 2016, ESTUAR COAST SHELF S, V178, P189, DOI 10.1016/j.ecss.2015.12.003; Browne MA, 2008, ENVIRON SCI TECHNOL, V42, P5026, DOI 10.1021/es800249a; Cedervall T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032254; Chen QQ, 2018, ENVIRON SCI TECHNOL, V52, P446, DOI 10.1021/acs.est.7b04682; Chua EM, 2014, ENVIRON SCI TECHNOL, V48, P8127, DOI 10.1021/es405717z; Cole M, 2015, ENVIRON SCI TECHNOL, V49, P1130, DOI 10.1021/es504525u; Cole M, 2013, ENVIRON SCI TECHNOL, V47, P6646, DOI 10.1021/es400663f; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Demkowicz-Dobrzanski K, 1993, SCI TOTAL ENVIRON, V134, P1151, DOI [10.1016/S0048-9697(05)80119-6, DOI 10.1016/S0048-9697(05)80119-6]; DILLON TM, 1990, ENVIRON TOXICOL CHEM, V9, P1317, DOI 10.1002/etc.5620091013; DUMONT HJ, 1975, OECOLOGIA, V19, P75, DOI 10.1007/BF00377592; Fisk AT, 2001, MAR POLLUT BULL, V43, P93, DOI 10.1016/S0025-326X(01)00038-8; Frouin H, 2013, PROG OCEANOGR, V115, P65, DOI 10.1016/j.pocean.2013.05.023; Furuhagen S, 2014, ENVIRON SCI TECHNOL, V48, P12886, DOI 10.1021/es5044722; Ge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071521; GLAZIER DS, 1991, LIMNOL OCEANOGR, V36, P354, DOI 10.4319/lo.1991.36.2.0354; Goerke H, 2001, MAR ENVIRON RES, V51, P131, DOI 10.1016/S0141-1136(00)00036-2; Gomes SIL, 2015, INT J ENV RES PUB HE, V12, P6858, DOI 10.3390/ijerph120606858; Grilo TF, 2014, ECOTOX ENVIRON SAFE, V101, P97, DOI 10.1016/j.ecoenv.2013.12.020; Hartmann NB, 2017, INTEGR ENVIRON ASSES, V13, P488, DOI 10.1002/ieam.1904; HAWKER DW, 1988, ENVIRON SCI TECHNOL, V22, P382, DOI 10.1021/es00169a004; Herzke D, 2016, ENVIRON SCI TECHNOL, V50, P1924, DOI 10.1021/acs.est.5b04663; KIRK KL, 1991, FRESHWATER BIOL, V25, P357, DOI 10.1111/j.1365-2427.1991.tb00498.x; Koelmans AA, 2015, MARINE ANTHROPOGENIC LITTER, P309, DOI 10.1007/978-3-319-16510-3_11; Koelmans AA, 2013, ENVIRON SCI TECHNOL, V47, P7812, DOI 10.1021/es401169n; Landrum PF, 2001, J GREAT LAKES RES, V27, P117, DOI 10.1016/S0380-1330(01)70627-2; Lu YF, 2016, ENVIRON SCI TECHNOL, V50, P4054, DOI 10.1021/acs.est.6b00183; MCMANUS GB, 1983, ESTUAR COAST SHELF S, V17, P421, DOI 10.1016/0272-7714(83)90127-0; Nybom I, 2016, ENVIRON SCI TECHNOL, V50, P5252, DOI 10.1021/acs.est.6b00991; OECD, 2004, TEST 202 DAPHN SP AC, DOI 10.1787/9789264069947-en; Ogonowski M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155063; Peltonen H, 2014, CHEMOSPHERE, V114, P172, DOI 10.1016/j.chemosphere.2014.04.026; Phuong NN, 2016, ENVIRON POLLUT, V211, P111, DOI 10.1016/j.envpol.2015.12.035; Rochman CM, 2014, SCI TOTAL ENVIRON, V493, P656, DOI 10.1016/j.scitotenv.2014.06.051; Rochman CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03263; Rummel CD, 2016, ENVIRON SCI-PROC IMP, V18, P788, DOI [10.1039/c6em00234j, 10.1039/C6EM00234J]; Seidensticker S, 2017, ENVIRON SCI TECHNOL, V51, P12254, DOI 10.1021/acs.est.7b02664; SIBLY RM, 1989, BIOL J LINN SOC, V37, P101, DOI 10.1111/j.1095-8312.1989.tb02007.x; Sperfeld E, 2009, J EXP BIOL, V212, P3051, DOI 10.1242/jeb.031401; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Syberg K, 2017, J TOXICOL ENV HEAL A, V80, P1369, DOI 10.1080/15287394.2017.1385046; Teuten EL, 2007, ENVIRON SCI TECHNOL, V41, P7759, DOI 10.1021/es071737s; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Tiano M, 2014, MAR POLLUT BULL, V89, P331, DOI 10.1016/j.marpolbul.2014.09.040; Velzeboer I, 2014, ENVIRON SCI TECHNOL, V48, P4869, DOI 10.1021/es405721v; Wardrop P, 2016, ENVIRON SCI TECHNOL, V50, P4037, DOI 10.1021/acs.est.5b06280; Wright SL, 2013, CURR BIOL, V23, pR1031, DOI 10.1016/j.cub.2013.10.068; Ziccardi LM, 2016, ENVIRON TOXICOL CHEM, V35, P1667, DOI 10.1002/etc.3461	56	26	28	13	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0205378	10.1371/journal.pone.0205378	http://dx.doi.org/10.1371/journal.pone.0205378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779782	gold, Green Published, Green Submitted			2022-12-26	WOS:000459062900003
J	Bond, JG; Osorio, AR; Avila, N; Gomez-Simuta, Y; Marina, CF; Fernandez-Salas, I; Liedo, P; Dor, A; Carvalho, DO; Bourtzis, K; Williams, T				Guillermo Bond, J.; Osorio, Adriana R.; Avila, Nancy; Gomez-Simuta, Yeudiel; Marina, Carlos F.; Fernandez-Salas, Ildefonso; Liedo, Pablo; Dor, Ariane; Carvalho, Danilo O.; Bourtzis, Kostas; Williams, Trevor			Optimization of irradiation dose to Aedes aegypti and Ae. albopictus in a sterile insect technique program	PLOS ONE			English	Article							GAMMA RADIATION; DISPERSAL; POPULATION; SURVIVAL; DISEASE; FUTURE	The sterile insect technique (SIT) may offer a means to control the transmission of mosquito borne diseases. SIT involves the release of male insects that have been sterilized by exposure to ionizing radiation. We determined the effects of different doses of radiation on the survival and reproductive capacity of local strains of Aedes aegypti and Ae. albopictus in southern Mexico. The survival of irradiated pupae was invariably greater than 90% and did not differ significantly in either sex for either species. Irradiation had no significant adverse effects on the flight ability (capacity to fly out of a test device) of male mosquitoes, which consistently exceeded 91% in Ae. aegypti and 96% in Ae. albopictus. The average number of eggs laid per female was significantly reduced in Ae. aegypti at doses of 15 and 30 Gy and no eggs were laid by females that had been exposed to 50 Gy. Similarly, in Ae. albopictus, egg production was reduced at doses of 15 and 25 Gy and was eliminated at 35 Gy. In Ae. aegypti, fertility in males was eliminated at 70 Gy and was eliminated at 30 Gy in females, whereas in Ae. albopictus, the fertility of males that mated with untreated females was almost zero (0.1%) in the 50 Gy treatment and female fertility was eliminated at 35 Gy. Irradiation treatments resulted in reduced ovary length and fewer follicles in both species. The adult median survival time of both species was reduced by irradiation in a dose-dependent manner. However, sterilizing doses of 35 Gy and 50 Gy resulted in little reduction in survival times of males of Ae. albopictus and Ae. aegypti, respectively, indicating that these doses should be suitable for future evaluations of SIT-based control of these species. The results of the present study will be applied to studies of male sexual competitiveness and to stepwise evaluations of the sterile insect technique for population suppression of these vectors in Mexico.	[Guillermo Bond, J.; Osorio, Adriana R.; Avila, Nancy; Marina, Carlos F.; Fernandez-Salas, Ildefonso] INSP, CRISP, Tapachula, Chiapas, Mexico; [Gomez-Simuta, Yeudiel] IICA, SAGARPA, Programa Moscas Fruta, Camino Cacaotales S-N, Metapa De Dominguez, Chiapas, Mexico; [Fernandez-Salas, Ildefonso] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Nuevo Leon, Mexico; [Liedo, Pablo; Dor, Ariane] El Colegio Frontera Sur, Tapachula, Chiapas, Mexico; [Carvalho, Danilo O.; Bourtzis, Kostas] IAEA, Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, Seibersdorf, Austria; [Williams, Trevor] Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico	Universidad Autonoma de Nuevo Leon; El Colegio de la Frontera Sur (ECOSUR); International Atomic Energy Agency; Instituto de Ecologia - Mexico	Williams, T (corresponding author), Inst Ecol AC INECOL, Xalapa, Veracruz, Mexico.	trevor.inecol@gmail.com	Dor, Ariane/A-7975-2013; Liedo, Pablo/E-9313-2010; Williams, Trevor/ABG-3961-2020; Carvalho, Danilo Oliveira/AAL-7270-2020; Williams, Trevor/F-1447-2011; Dor, Ariane/AAQ-7554-2020	Dor, Ariane/0000-0002-3483-9547; Liedo, Pablo/0000-0002-0004-1721; Carvalho, Danilo Oliveira/0000-0001-8168-4050; Williams, Trevor/0000-0003-3414-3440; Marina Fernandez, Carlos Felix/0000-0002-4804-8949	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico [FOINS-PDCAPN-2014-247673]; International Atomic Energy Agency (IAEA) [MEX5031]; Fondo de Investigacion Cientifica y Desarrollo Tecnologico project "Desarrollo de tecnologia para el manejo integral de mosquitos vectores de dengue, chikungunya y Zika en Guatemala y Mexico" of El Colegio de la Frontera Sur (ECOSUR), Mexico; Catedras CONACYT program [71314]; CONACYT, Mexico	Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico; International Atomic Energy Agency (IAEA)(International Atomic Energy Agency); Fondo de Investigacion Cientifica y Desarrollo Tecnologico project "Desarrollo de tecnologia para el manejo integral de mosquitos vectores de dengue, chikungunya y Zika en Guatemala y Mexico" of El Colegio de la Frontera Sur (ECOSUR), Mexico; Catedras CONACYT program; CONACYT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The study received financial support from the Fondo Institucional del Consejo Nacional de Ciencia y Tecnologia (CONACYT), Mexico, project FOINS-PDCAPN-2014-247673 and the International Atomic Energy Agency (IAEA) through technical cooperation project MEX5031, both awarded to JGB. ARO was funded by the Fondo de Investigacion Cientifica y Desarrollo Tecnologico project "Desarrollo de tecnologia para el manejo integral de mosquitos vectores de dengue, chikungunya y Zika en Guatemala y Mexico" of El Colegio de la Frontera Sur (ECOSUR), Mexico. AD received funding from the Catedras CONACYT program (no. 71314). NA received a Master's program scholarship from CONACYT, Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; [Anonymous], 1979, BASIC PRINCIPLES INS; Arredondo J., 2016, Proceedings of the 9th International Symposium on Fruit Flies of Economic Importance, 12-16 May 2014, Bangkok, Thailand, P355; Azizyan A, 2003, 11024R1 ARM INT AT E; Bakri A, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P233, DOI 10.1007/1-4020-4051-2_9; Bakri A, 2005, ANN ENTOMOL SOC AM, V98, P1, DOI 10.1603/0013-8746(2005)098[0001:FYORBI]2.0.CO;2; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47; Bhuyan K. B., 2016, J MOSQ RES, V6, P1; Bond JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187420; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Calkins CO, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P269, DOI 10.1007/1-4020-4051-2_10; Casas-Martinez M, 2013, J VECTOR ECOL, V38, P277, DOI 10.1111/j.1948-7134.2013.12041.x; Catteruccia F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S7; Culbert NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34469-6; Dominguez J., 2010, MOSCAS FRUTA FUNDAME; Dyck V.A., 2006, STERILE INSECT TECHN; Enkerlin WR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P651, DOI 10.1007/1-4020-4051-2_25; Equihua M, 2017, ACTA TROP, V166, P316, DOI 10.1016/j.actatropica.2016.11.014; Ernawan B, 2017, AIP CONF PROC, V1854, DOI 10.1063/1.4985401; Hernandez-Avila JE, 2018, B WORLD HEALTH ORGAN, V96, P306, DOI 10.2471/BLT.17.201004; Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015; Gaggl K, 1992, MANAGEMENT INSECT PE, P453; Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302; HALLINAN E, 1973, NATURE, V244, P368, DOI 10.1038/244368a0; Hallman GJ, 2003, J ECON ENTOMOL, V96, P1399, DOI 10.1603/0022-0493-96.5.1399; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Helinski MEH, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S6; Hendrichs J, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P563, DOI 10.1007/1-4020-4051-2_22; Huang YJS, 2017, INSECTS, V8, DOI 10.3390/insects8010021; International Atomic Energy Agency, 2004, DOS SYST SIT PROC; International Atomic Energy Agency Dosimetry for Food Irradiation, 2002, 409 INT AT EN AG, V409; Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Kuri-Morales P, 2017, MED VET ENTOMOL, V31, P240, DOI 10.1111/mve.12225; Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771; Lance DR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P69, DOI 10.1007/1-4020-4051-2_3; Lebon C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202236; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; Lopez-Martinez G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088128; Luckey T. D., 2006, Dose-Response, V4, P169, DOI 10.2203/dose-response.06-102.Luckey; Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2; Rodriguez SD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-211; Salwa M. A. B., 2011, Journal of Agricultural Biotechnology and Sustainable Development, V3, P105; SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042; Shetty V, 2017, TOXICOL IND HEALTH, V33, P930, DOI 10.1177/0748233717733599; Shetty Vinaya, 2016, Parasite Epidemiol Control, V1, P26, DOI 10.1016/j.parepi.2016.02.007; TERZIAN LA, 1958, BIOL BULL, V115, P536, DOI 10.2307/1539116; TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263; Vargas-Teran M, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P629, DOI 10.1007/1-4020-4051-2_24; WEIDHAAS D. E., 1963, Mosquito News, V23, P32; Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223; Yanez-Arenas C, 2018, J MED ENTOMOL, V55, P69, DOI 10.1093/jme/tjx185; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126	58	32	32	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212520	10.1371/journal.pone.0212520	http://dx.doi.org/10.1371/journal.pone.0212520			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779779	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000459062900062
J	Kim, AR; Choi, KW				Kim, Ah-Ram; Choi, Kwang-Wook			TRiC/CCT chaperonins are essential for organ growth by interacting with insulin/TOR signaling in Drosophila	ONCOGENE			English	Article							EUKARYOTIC CHAPERONIN; CELLULAR GROWTH; CCT CHAPERONIN; IN-VIVO; COMPLEX; PROTEINS; BIOGENESIS; ACTIVATION; EXPRESSION; AUTOPHAGY	Organ size is regulated by intercellular signaling for cell growth and proliferation. The TOR pathway mediates a key signaling mechanism for controlling cell size and number in organ growth. Chaperonin containing TCP-1 (CCT) is a complex that assists protein folding and function, but its role in animal development is largely unknown. Here we show that the CCT complex is required for organ growth by interacting with the TOR pathway in Drosophila. Reduction of CCT4 results in growth defects by affecting both cell size and proliferation. Loss of CCT4 causes preferential cell death anterior to the morphogenetic furrow in the eye disc and within wing pouch in the wing disc. Depletion of any CCT subunit in the eye disc results in headless phenotype. Overgrowth by active TOR signaling is suppressed by CCT RNAi. The CCT complex physically interacts with TOR signaling components including TOR, Rheb, and S6K. Loss of CCT leads to decreased phosphorylation of S6K and S6 while increasing phosphorylation of Akt. Insulin/TOR signaling is also necessary and sufficient for promoting CCT complex transcription. Our data provide evidence that the CCT complex regulates organ growth by directly interacting with the TOR signaling pathway.	[Kim, Ah-Ram; Choi, Kwang-Wook] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 305701, South Korea; [Kim, Ah-Ram] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA	Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Harvard Medical School	Choi, KW (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 305701, South Korea.	kchoi100@kaist.ac.kr	Choi, Kwang-Wook/C-1707-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Kim, Ah-Ram/0000-0001-9597-6759	National Research Foundation of Korea - Ministry of Education, Science & Technology, Republic of Korea [NRF-2014K1A1A2042982, NRF-2017R1A2B3007516]	National Research Foundation of Korea - Ministry of Education, Science & Technology, Republic of Korea	We are grateful to Kyungok Cho, Jongkyeong Chung, Aurelio Teleman, Gabor Juhasz, Norbert Perrimon, the Bloomington Drosophila Stock Center, the National Institute of Genetics, the the Vienna Drosophila Resource Center, the Kyoto Stock Center, the Drosophila Genomics Resource Center, and the Developmental Studies Hybridoma Bank for reagents and fly stocks. We also thank Jean Jung for commenting on the manuscript. This research was supported by grants (NRF-2014K1A1A2042982 and NRF-2017R1A2B3007516) of the National Research Foundation of Korea funded by the Ministry of Education, Science & Technology, Republic of Korea.	Abe Y, 2009, J BIOL CHEM, V284, P14939, DOI 10.1074/jbc.M900097200; Antonova SV, 2018, NAT STRUCT MOL BIOL, V25, P1119, DOI 10.1038/s41594-018-0156-z; Bassiouni R, 2016, CLIN CANCER RES, V22, P4366, DOI 10.1158/1078-0432.CCR-15-2502; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Berger J, 2018, CELL REP, V22, P313, DOI 10.1016/j.celrep.2017.12.069; Boudiaf-Benmammar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060895; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hodeify R, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau1935; Housden BE, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab3729; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu YH, 2013, G3-GENES GENOM GENET, V3, P1607, DOI 10.1534/g3.113.007021; Jaeger K, 2019, APOPTOSIS, V24, P62, DOI 10.1007/s10495-018-1505-4; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kaisari S, 2017, P NATL ACAD SCI USA, V114, P956, DOI 10.1073/pnas.1620451114; Karim FD, 1998, DEVELOPMENT, V125, P1; Kim W, 2017, DEV CELL, V42, P363, DOI 10.1016/j.devcel.2017.07.020; Kockel L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000990; Le TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11501; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Liu XQ, 2005, MOL CELL BIOL, V25, P4993, DOI 10.1128/MCB.25.12.4993-5010.2005; Liu YG, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.460; Lundin VF, 2008, DEV BIOL, V313, P320, DOI 10.1016/j.ydbio.2007.10.022; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Nagy P, 2014, AUTOPHAGY, V10, P453, DOI 10.4161/auto.27442; Noormohammadi A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13649; Pavel M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13821; Prober DA, 2000, CELL, V100, P435, DOI 10.1016/S0092-8674(00)80679-0; Raineri E, 2010, BIOINFORMATICS, V26, P1685, DOI 10.1093/bioinformatics/btq287; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Roh SH, 2015, INT J MOL SCI, V16, P26706, DOI 10.3390/ijms161125975; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Stoldt V, 1996, YEAST, V12, P523, DOI 10.1002/(SICI)1097-0061(199605)12:6<523::AID-YEA962>3.3.CO;2-3; Stowers RS, 1999, GENETICS, V152, P1631; Svanstrom A, 2016, CELL STRESS CHAPERON, V21, P55, DOI 10.1007/s12192-015-0637-5; Tang HW, 2018, CELL METAB, V27, P1040, DOI 10.1016/j.cmet.2018.02.023; Trinidad AG, 2013, MOL CELL, V50, P805, DOI 10.1016/j.molcel.2013.05.002; Tsokanos FF, 2016, EMBO J, V35, P1058, DOI 10.15252/embj.201593118; Vinayagam A, 2016, CELL REP, V16, P3062, DOI 10.1016/j.celrep.2016.08.029; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; White MF, 2003, SCIENCE, V302, P1710, DOI 10.1126/science.1092952; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	51	13	13	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 13	2019	38	24					4739	4754		10.1038/s41388-019-0754-1	http://dx.doi.org/10.1038/s41388-019-0754-1			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	IC7ND	30792539	Green Published, hybrid			2022-12-26	WOS:000471160500007
J	Jean, L; Brimijoin, S; Vaux, DJ				Jean, Letitia; Brimijoin, Stephen; Vaux, David J.			In vivo localization of human acetylcholinesterase-derived species in a -sheet conformation at the core of senile plaques in Alzheimer's disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; acetylcholinesterase (AChE); proteolysis; brain; amyloid-beta (AB); beta-sheet conformation; oligomerization domain; seeding; senile plaques; transgenic mice	BETA-AMYLOID PEPTIDES; BRAIN ACETYLCHOLINESTERASE; OLFACTORY DYSFUNCTION; PERIPHERAL SITE; MOLECULAR-FORMS; MOUSE MODEL; PROTEIN; PRECURSOR; BUTYRYLCHOLINESTERASE; AGGREGATION	Many neurodegenerative diseases are characterized by amyloid deposition. In Alzheimer's disease (AD), -amyloid (A) peptides accumulate extracellularly in senile plaques. The AD amyloid cascade hypothesis proposes that A production or reduced clearance leads to toxicity. In contrast, the cholinergic hypothesis argues for a specific pathology of brain cholinergic pathways. However, neither hypothesis in isolation explains the pattern of AD pathogenesis. Evidence suggests that a connection exists between these two scenarios: the synaptic form of human acetylcholinesterase (hAChE-S) associates with plaques in AD brains; among hAChE variants, only hAChE-S enhances A fibrillization in vitro and A deposition and toxicity in vivo. Only hAChE-S contains an amphiphilic C-terminal domain (T40, AChE(575-614)), with AChE(586-599) homologous to A and forming amyloid fibrils, which implicates T40 in AD pathology. We previously showed that the amyloid scavenger, insulin-degrading enzyme (IDE), generates T40-derived amyloidogenic species that, as a peptide mixture, seed A fibrillization. Here, we characterized 11 peptides from a T40-IDE digest for -sheet conformation, surfactant activity, fibrillization, and seeding capability. We identified residues important for amyloidogenicity and raised polyclonal antibodies against the most amyloidogenic peptide. These new antisera, alongside other specific antibodies, labeled sections from control, hAChE-S, hAPPswe, and hAChE-S/hAPPswe transgenic mice. We observed that hAChE-S -sheet species co-localized with A in mature plaque cores, surrounded by hAChE-S -helical species. This observation provides the first in vivo evidence of the conformation of hAChE-S species within plaques. Our results may explain the role of hAChE-S in A deposition and aggregation, as amyloidogenic hAChE-S -sheet species might seed A aggregation.	[Jean, Letitia; Vaux, David J.] Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England; [Brimijoin, Stephen] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	University of Oxford; Mayo Clinic	Vaux, DJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, South Parks Rd, Oxford OX1 3RE, England.	david.vaux@path.ox.ac.uk		Jean, Letitia/0000-0002-6450-7148; Vaux, David/0000-0002-4901-9795	Synaptica Ltd.	Synaptica Ltd.	Supported by a research grant from Synaptica Ltd.	Alvarez A, 1998, J NEUROSCI, V18, P3213; Alvarez A, 1997, J MOL BIOL, V272, P348, DOI 10.1006/jmbi.1997.1245; Apelt J, 2002, BRAIN RES, V953, P17, DOI 10.1016/S0006-8993(02)03262-6; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ATACK JR, 1983, NEUROSCI LETT, V40, P199, DOI 10.1016/0304-3940(83)90302-6; Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; BAKER HF, 1993, INT J EXP PATHOL, V74, P441; Beeri R, 1997, J NEUROCHEM, V69, P2441; BEERI R, 1995, CURR BIOL, V5, P1063, DOI 10.1016/S0960-9822(95)00211-9; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Berson A, 2010, RAMBAM MAIMONIDES ME, V1, DOI 10.5041/RMMJ.10014; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Brettschneider J, 2015, NAT REV NEUROSCI, V16, P109, DOI 10.1038/nrn3887; Bronfman FC, 2000, NEUROBIOL DIS, V7, P152, DOI 10.1006/nbdi.2000.0283; CARSON KA, 1991, BRAIN RES, V540, P204, DOI 10.1016/0006-8993(91)90508-S; Chi EY, 2010, BIOPHYS J, V98, P2299, DOI 10.1016/j.bpj.2010.01.056; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Christen-Zaech S, 2003, CAN J NEUROL SCI, V30, P20, DOI 10.1017/S0317167100002389; Collins-Praino LE, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0083-0; Cottingham MG, 2004, LAB INVEST, V84, P523, DOI 10.1038/labinvest.3700054; Cottingham MG, 2003, BIOCHEMISTRY-US, V42, P10863, DOI 10.1021/bi034768i; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Darvesh S, 2012, J NEUROPATH EXP NEUR, V71, P2, DOI 10.1097/NEN.0b013e31823cc7a6; Diamant S, 2006, P NATL ACAD SCI USA, V103, P8628, DOI 10.1073/pnas.0602922103; Dubois B, 2015, ALZHEIMERS DEMENT, V11, P1041, DOI 10.1016/j.jalz.2014.10.003; Dumont M, 2006, J NEURAL TRANSM, V113, P1225, DOI 10.1007/s00702-005-0373-6; Esparza TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38187; Farchi N, 2007, NEURODEGENER DIS, V4, P171, DOI 10.1159/000101842; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; FISHMAN EB, 1986, ANN NEUROL, V19, P246, DOI 10.1002/ana.410190305; Fodero LR, 2002, J NEUROCHEM, V81, P441, DOI 10.1046/j.1471-4159.2002.00902.x; Francis PT, 1999, J NEUROL NEUROSUR PS, V66, P137, DOI 10.1136/jnnp.66.2.137; Franks KH, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00234; GEULA C, 1989, BRAIN RES, V498, P185, DOI 10.1016/0006-8993(89)90419-8; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu W, 2003, J NEUROCHEM, V86, P470, DOI 10.1046/j.1471-4159.2003.01855.x; Inestrosa NC, 1996, NEURON, V16, P881, DOI 10.1016/S0896-6273(00)80108-7; Jean L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000652; Jean L, 2012, BIOPHYS J, V102, P1154, DOI 10.1016/j.bpj.2012.01.041; Jean L, 2010, FASEB J, V24, P309, DOI 10.1096/fj.09-137653; Jiang DL, 2009, J PHYS CHEM B, V113, P3160, DOI 10.1021/jp8085792; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Klimov DK, 2003, STRUCTURE, V11, P295, DOI 10.1016/S0969-2126(03)00031-5; Kolisnyk B, 2017, CEREB CORTEX, V27, P3553, DOI 10.1093/cercor/bhw177; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; LIAO J, 1994, J NEUROCHEM, V63, P1446; Lopes DHJ, 2007, BIOPHYS J, V93, P3132, DOI 10.1529/biophysj.107.110635; Madhusudan A, 2009, EUR J NEUROSCI, V30, P1064, DOI 10.1111/j.1460-9568.2009.06884.x; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; Morinaga A, 2010, BBA-PROTEINS PROTEOM, V1804, P986, DOI 10.1016/j.bbapap.2010.01.012; Morris VK, 2011, J BIOL CHEM, V286, P15955, DOI 10.1074/jbc.M110.214197; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Rees T, 2003, NEUROBIOL AGING, V24, P777, DOI 10.1016/S0197-4580(02)00230-0; Rees Tina M., 2005, Current Alzheimer Research, V2, P291, DOI 10.2174/1567205054367847; Saez-Valero J, 1999, J NEUROCHEM, V72, P1600, DOI 10.1046/j.1471-4159.1999.721600.x; Saez-Valero J, 2003, BRAIN RES, V965, P283, DOI 10.1016/S0006-8993(02)04159-8; Saxena A, 2003, BIOCHEMISTRY-US, V42, P15292, DOI 10.1021/bi030150x; Sberna G, 1998, J NEUROCHEM, V71, P723; SCHEGG KM, 1992, NEUROBIOL AGING, V13, P697, DOI 10.1016/0197-4580(92)90092-C; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; SHEN CL, 1995, BIOPHYS J, V69, P640, DOI 10.1016/S0006-3495(95)79940-4; SMITH CK, 1995, SCIENCE, V270, P980, DOI 10.1126/science.270.5238.980; SOREGHAN B, 1994, J BIOL CHEM, V269, P28551; Sormanni P, 2015, J MOL BIOL, V427, P478, DOI 10.1016/j.jmb.2014.09.026; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5; Sternfeld M, 2000, P NATL ACAD SCI USA, V97, P8647, DOI 10.1073/pnas.140004597; ULRICH J, 1990, ACTA NEUROPATHOL, V80, P624, DOI 10.1007/BF00307630; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Wesson DW, 2010, J NEUROSCI, V30, P505, DOI 10.1523/JNEUROSCI.4622-09.2010; West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211; WRIGHT CI, 1993, ANN NEUROL, V34, P373, DOI 10.1002/ana.410340312; Yoon S, 2004, PROTEIN SCI, V13, P2149, DOI 10.1110/ps.04790604; Zanuy D, 2004, PHYS BIOL, V1, P89, DOI 10.1088/1478-3967/1/2/005	85	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6253	6272		10.1074/jbc.RA118.006230	http://dx.doi.org/10.1074/jbc.RA118.006230			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30787102	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000468402000005
J	Sun, M; Kotler, JLM; Liu, SS; Street, TO				Sun, Ming; Kotler, Judy L. M.; Liu, Shanshan; Street, Timothy O.			The endoplasmic reticulum (ER) chaperones BiP and Grp94 selectively associate when BiP is in the ADP conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						heat shock protein 90 (Hsp90); chaperone; nucleotide; fluorescence resonance energy transfer (FRET); fluorescence anisotropy; nuclear magnetic resonance (NMR); allostery; BiP; Grp94; structural dynamics	SUBSTRATE TRANSFER; COOPERATIVE ACTION; HSP90; PROTEIN; HSP70; P53; COMPLEXES; REVEALS; PARALOG; DOMAIN	Hsp70 and Hsp90 chaperones are critical for protein quality control in the cytosol, whereas organelle-specific Hsp70/Hsp90 paralogs provide similar protection for mitochondria and the endoplasmic reticulum (ER). Cytosolic Hsp70/Hsp90 can operate sequentially with Hsp90 selectively associating with Hsp70 after Hsp70 is bound to a client protein. This observation has long suggested that Hsp90 could have a preference for interacting with clients at their later stages of folding. However, recent work has shown that cytosolic Hsp70/Hsp90 can directly interact even in the absence of a client, which opens up an alternative possibility that the ordered interactions of Hsp70/Hsp90 with clients could be a consequence of regulated changes in the direct interactions between Hsp70 and Hsp90. However, it is unknown how such regulation could occur mechanistically. Here, we find that the ER Hsp70/Hsp90 (BiP/Grp94) can form a direct complex in the absence of a client. Importantly, the direct interaction between BiP and Grp94 is nucleotide-specific, with BiP and Grp94 having higher affinity under ADP conditions and lower affinity under ATP conditions. We show that this nucleotide-specific association between BiP and Grp94 is largely due to the conformation of BiP. When BiP is in the ATP conformation its substrate-binding domain blocks Grp94; in contrast, Grp94 can readily associate with the ADP conformation of BiP, which represents the client-bound state of BiP. Our observations provide a mechanism for the sequential involvement of BiP and Grp94 in client folding where the conformation of BiP provides the signal for the subsequent recruitment of Grp94.	[Sun, Ming; Kotler, Judy L. M.; Liu, Shanshan; Street, Timothy O.] Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA; [Liu, Shanshan] Wuhan Univ, Inst Adv Studies, Wuhan 430072, Hubei, Peoples R China	Brandeis University; Wuhan University	Street, TO (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02453 USA.	tstreet@brandeis.edu			NIGMS, National Institutes of Health [R01 GM115356]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115356] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health Grant R01 GM115356. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvira S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6484; CARLINO A, 1992, P NATL ACAD SCI USA, V89, P2081, DOI 10.1073/pnas.89.6.2081; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Fersht A., 1999, STRUCTURE MECH PROTE, P127; FREIDEN PJ, 1992, EMBO J, V11, P63, DOI 10.1002/j.1460-2075.1992.tb05028.x; Genest O, 2015, J MOL BIOL, V427, P3877, DOI 10.1016/j.jmb.2015.10.010; Genest O, 2011, P NATL ACAD SCI USA, V108, P8206, DOI 10.1073/pnas.1104703108; Halpin JC, 2016, J BIOL CHEM, V291, P6447, DOI 10.1074/jbc.M115.702928; Huck JD, 2017, CELL REP, V20, P2800, DOI 10.1016/j.celrep.2017.08.079; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Kirschke E, 2014, CELL, V157, P1685, DOI 10.1016/j.cell.2014.04.038; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kravats AN, 2018, P NATL ACAD SCI USA, V115, pE2210, DOI 10.1073/pnas.1719969115; Kravats AN, 2017, J MOL BIOL, V429, P858, DOI 10.1016/j.jmb.2016.12.014; Liu SS, 2016, PROTEIN SCI, V25, P2209, DOI 10.1002/pro.3049; Luengo TM, 2018, MOL CELL, V70, P545, DOI 10.1016/j.molcel.2018.03.028; Marcinowski M, 2011, NAT STRUCT MOL BIOL, V18, P150, DOI 10.1038/nsmb.1970; Mayer M, 2003, J MOL BIOL, V330, P137, DOI 10.1016/S0022-2836(03)00556-4; MELNICK J, 1992, J BIOL CHEM, V267, P21303; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; Morishima Y, 2000, J BIOL CHEM, V275, P18054, DOI 10.1074/jbc.M000434200; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Nakamoto H, 2014, J BIOL CHEM, V289, P6110, DOI 10.1074/jbc.M113.524801; Park SJ, 2011, NAT STRUCT MOL BIOL, V18, P537, DOI 10.1038/nsmb.2045; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Radli M, 2018, J MOL BIOL, V430, P3029, DOI 10.1016/j.jmb.2018.05.026; Rohl A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7655; Rudiger S, 2002, P NATL ACAD SCI USA, V99, P11085, DOI 10.1073/pnas.132393699; Schmid AB, 2012, EMBO J, V31, P1506, DOI 10.1038/emboj.2011.472; Schumacher RJ, 1996, BIOCHEMISTRY-US, V35, P14889, DOI 10.1021/bi961825h; Southworth DR, 2011, MOL CELL, V42, P771, DOI 10.1016/j.molcel.2011.04.023; Sung N, 2016, ACTA CRYSTALLOGR D, V72, P904, DOI 10.1107/S2059798316009906; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; Wisniewska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008625; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012	39	15	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6387	6396		10.1074/jbc.RA118.007050	http://dx.doi.org/10.1074/jbc.RA118.007050			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30787103	Green Published, hybrid			2022-12-26	WOS:000468402000016
J	Zhang, SH; Liu, DX; Wang, L; Li, YH; Wang, YH; Zhang, H; Su, ZK; Fang, WG; Qin, XX; Shang, DS; Li, B; Han, XN; Zhao, WD; Chen, YH				Zhang, Shu-Hong; Liu, Dong-Xin; Wang, Li; Li, Yu-Hua; Wang, Yan-Hua; Zhang, Hu; Su, Zheng-Kang; Fang, Wen-Gang; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Han, Xiao-Ning; Zhao, Wei-Dong; Chen, Yu-Hua			A CASPR1-ATP1B3 protein interaction modulates plasma membrane localization of Na+/K+-ATPase in brain microvascular endothelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Na; K plus -ATPase; brain; endothelial cell; endoplasmic reticulum (ER); glutamate; ATP1B3; blood-brain barrier; contactin-associated protein 1 (CASPR1); CNS homeostasis; CNTNAP1	NA-K-ATPASE; ENDOPLASMIC-RETICULUM; PARANODAL JUNCTIONS; NA,K-ATPASE; GLUTAMATE; BARRIER; EXPRESSION; RECEPTOR; CASPR; IDENTIFICATION	Contactin-associated protein 1 (CASPR1 or CNTNAP1) was recently reported to be expressed in brain microvascular endothelial cells (BMECs), the major component of the blood-brain barrier. To investigate CASPR1's physiological role in BMECs, here we used CASPR1 as a bait in a yeast two-hybrid screen to identify CASPR1-interacting proteins and identified the 3 subunit of Na+/K+-ATPase (ATP1B3) as a CASPR1-binding protein. Using recombinant and purified CASPR1, RNAi, GST-pulldown, immunofluorescence, immunoprecipitation, and Na+/K+-ATPase activity assays, we found that ATP1B3's core proteins, but not its glycosylated forms, interact with CASPR1, which was primarily located in the endoplasmic reticulum of BMECs. CASPR1 knockdown reduced ATP1B3 glycosylation and prevented its plasma membrane localization, phenotypes that were reversed by expression of full-length CASPR1. We also found that the CASPR1 knockdown reduces the plasma membrane distribution of the 1 subunit of Na+/K+-ATPase, which is the major component assembled with ATP1B3 in the complete Na+/K+-ATPase complex. The binding of CASPR1 with ATP1B3, but not the 1 subunit, indicated that CASPR1 binds with ATP1B3 to facilitate the assembly of Na+/K+-ATPase. Furthermore, the activity of Na+/K+-ATPase was reduced in CASPR1-silenced BMECs. Interestingly, shRNA-mediated CASPR1 silencing reduced glutamate efflux through the BMECs. These results demonstrate that CASPR1 binds with ATP1B3 and thereby contributes to the regulation of Na+/K+-ATPase maturation and trafficking to the plasma membrane in BMECs. We conclude that CASPR1-mediated regulation of Na+/K+-ATPase activity is important for glutamate transport across the blood-brain barrier.	[Zhang, Shu-Hong; Liu, Dong-Xin; Wang, Li; Li, Yu-Hua; Wang, Yan-Hua; Zhang, Hu; Su, Zheng-Kang; Fang, Wen-Gang; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Han, Xiao-Ning; Zhao, Wei-Dong; Chen, Yu-Hua] China Med Univ, Minist Publ Hlth, Dept Dev Cell Biol, Key Lab Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Zhang, Shu-Hong; Liu, Dong-Xin; Wang, Li; Li, Yu-Hua; Wang, Yan-Hua; Zhang, Hu; Su, Zheng-Kang; Fang, Wen-Gang; Qin, Xiao-Xue; Shang, De-Shu; Li, Bo; Han, Xiao-Ning; Zhao, Wei-Dong; Chen, Yu-Hua] China Med Univ, Minist Educ, Key Lab Med Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China; [Zhang, Shu-Hong] Jiamusi Univ, Sch Basic Med, Dept Cell Biol, 258 Xuefu St, Jiamusi 154007, Heilongjiang, Peoples R China	China Medical University; China Medical University; Jiamusi University	Zhao, WD; Chen, YH (corresponding author), China Med Univ, Minist Publ Hlth, Dept Dev Cell Biol, Key Lab Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.; Zhao, WD; Chen, YH (corresponding author), China Med Univ, Minist Educ, Key Lab Med Cell Biol, 77 Puhe Rd, Shenyang 110122, Liaoning, Peoples R China.	wdzhao@cmu.edu.cn; yhchen@cmu.edu.cn	wangwangwang, yuanyaun/HHN-6432-2022; Wang, Yuan/HHC-1520-2022; wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; Wang, Yin/HCI-9352-2022; Wang, Yanbo/HFZ-8018-2022	li, Yuhua/0000-0002-9036-1920; Liu, Dongxin/0000-0002-0956-5142	National Natural Science Foundation of China [31771258, 31171291, 31571057, 81171537, 81201255, 31670845, 81671168]; National 1000 Plan Program; Innovation Team Program Foundation of the Ministry of Education of China [IRT13101, IRT_ 17R107]; Foundation of Liaoning Province [LT2011011, LR2012025, LS201609, LQNK201731]; Intramural Program of China Medical University [JQ20160002]; Program of Distinguished Professor of Liaoning Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 1000 Plan Program; Innovation Team Program Foundation of the Ministry of Education of China(Ministry of Education, China); Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); Intramural Program of China Medical University; Program of Distinguished Professor of Liaoning Province	This work was supported by National Natural Science Foundation of China Grants 31771258, 31171291, 31571057, 81171537, 81201255, 31670845, and 81671168; the National 1000 Plan Program; Innovation Team Program Foundation of the Ministry of Education of China Grants IRT13101 and IRT_ 17R107; the Program of Distinguished Professor of Liaoning Province; Foundation of Liaoning Province Grants LT2011011, LR2012025, LS201609, and LQNK201731; and Intramural Program of China Medical University Grant JQ20160002. The authors declare that they have no conflicts of interest with the contents of this article.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Beggah A, 1996, J BIOL CHEM, V271, P20895, DOI 10.1074/jbc.271.34.20895; Beggah AT, 1997, J BIOL CHEM, V272, P10318; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Bhat MA, 2001, NEURON, V30, P369, DOI 10.1016/S0896-6273(01)00294-X; BLANCO G, 1994, J BIOL CHEM, V269, P23420; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Chever O, 2010, J NEUROSCI, V30, P15769, DOI 10.1523/JNEUROSCI.2078-10.2010; Coman I, 2006, BRAIN, V129, P3186, DOI 10.1093/brain/awl144; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Gillessen T, 2002, ADV EXP MED BIOL, V513, P3; Gottlieb M, 2003, J NEUROCHEM, V87, P119, DOI 10.1046/j.1471-4159.2003.01972.x; Hawkins RA, 2006, J NUTR, V136, p218S, DOI 10.1093/jn/136.1.218S; Hunsberger HC, 2015, J NEUROCHEM, V132, P169, DOI 10.1111/jnc.12967; HUTCHISON HT, 1985, EXP NEUROL, V87, P260, DOI 10.1016/0014-4886(85)90216-X; Jackson JG, 2014, J NEUROSCI, V34, P1613, DOI 10.1523/JNEUROSCI.3510-13.2014; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Keaney J, 2015, FEBS J, V282, P4067, DOI 10.1111/febs.13412; Lian WN, 2006, J CELL SCI, V119, P11, DOI 10.1242/jcs.02706; Malik N, 1996, J BIOL CHEM, V271, P22754, DOI 10.1074/jbc.271.37.22754; MARKS MJ, 1978, LIFE SCI, V23, P2735, DOI 10.1016/0024-3205(78)90654-9; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Murakami S, 2016, J PHYSIOL SCI, V66, P127, DOI 10.1007/s12576-015-0404-5; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Nishitsuji H, 2016, J BIOL CHEM, V291, P4754, DOI 10.1074/jbc.M115.679357; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Riordan M, 2005, AM J PHYSIOL-RENAL, V288, pF1236, DOI 10.1152/ajprenal.00438.2004; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; Rose EM, 2009, J NEUROSCI, V29, P8143, DOI 10.1523/JNEUROSCI.1081-09.2009; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Tokbtaeva E, 2010, BIOCHEMISTRY-US, V49, P3116, DOI 10.1021/bi100115a; Tokhtaeva E, 2010, J BIOL CHEM, V285, P39289, DOI 10.1074/jbc.M110.172858; Tokhtaeva E, 2009, BIOCHEMISTRY-US, V48, P11421, DOI 10.1021/bi901438z; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; VORBRODT AW, 1988, PROG HISTOCHEM CYTOC, V18, P1; Wolswijk G, 2003, BRAIN, V126, P1638, DOI 10.1093/brain/awg151; Zhang LN, 2013, FUND CLIN PHARMACOL, V27, P96, DOI 10.1111/fcp.12000; Zhao WD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04637-3; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	44	7	7	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6375	6386		10.1074/jbc.RA118.006263	http://dx.doi.org/10.1074/jbc.RA118.006263			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30792309	hybrid, Green Published			2022-12-26	WOS:000468402000015
J	Higgins, E; Scheibling, RE; Desilets, KM; Metaxas, A				Higgins, Emily; Scheibling, Robert E.; Desilets, Kelsey M.; Metaxas, Anna			Benthic community succession on artificial and natural coral reefs in the northern Gulf of Aqaba, Red Sea	PLOS ONE			English	Article							EPIBENTHIC COMMUNITY; SURFACE ORIENTATION; HERBIVORE EXCLUSION; TEMPORAL PATTERNS; SUBTIDAL EPIBIOTA; URBAN STRUCTURES; PHASE-SHIFTS; ALGAL TURFS; RECRUITMENT; FISHES	Evaluating the efficacy of artificial structures in enhancing or sustaining biodiversity on tropical coral reefs is key to assessing their role in reef conservation or management. Here, we compare spatial and temporal patterns of colonization and succession of the benthic assemblage on settlement collectors (ceramic tiles) in a 13-mo mensurative experiment on a suspended artificial reef, a seafloor artificial reef, and two nearby natural reefs at Eilat, Gulf of Aqaba. We also conducted a concurrent 7-mo manipulative experiment on the suspended reef and one of the natural reefs, and monitored fish feeding behaviour on experimental collectors, to examine effects of large mobile consumers on these patterns. In both experiments, taxonomic composition as percent planar cover for the whole community or biomass for the invertebrate component differed between collector topsides, dominated by a filamentous algal matrix, and shaded undersides with a profuse assemblage of suspension- or filter-feeding invertebrates. In the mensurative experiment, we found differences in final community and invertebrate composition between sites, which clustered according to reef type (artificial vs. natural) for collector undersides. Invertebrate biomass was greater at both artificial reefs than at one (undersides) or both (topsides) natural reefs. In the manipulative experiment, we found similar differences in composition between sites/reef types as well as between treatments (exclusion vs. control), and the invertebrate biomass was greater on the artificial reef. Invertebrate biomass was greater in the exclusion treatment than the control on collector undersides, suggesting mobile consumers can affect community composition and abundance. Predominant fish species observed interacting with collectors differed between artificial and natural reefs, likely contributing to differences in patterns of colonization and succession between sites and reef types. Our findings suggest artificial reefs have the potential to enhance cover and biomass of certain reef-associated assemblages, particularly those occupying sheltered microhabitats.	[Higgins, Emily; Scheibling, Robert E.; Desilets, Kelsey M.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada; [Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Higgins, E (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	em557063@dal.ca			Schulich Ocean Studies Centre Initiative, Dalhousie University, Canada [PROJ-14-09]; Natural Sciences and Engineering Research Council of Canada Discovery Grants program [RGPIN-2012-34851, RGPIN-2016-04878]; 2015 Strategic Cooperative Education Incentive of the Nova Scotia Department of Labour and Advanced Education [20150137, 2016000182]; Natural Sciences and Engineering Research Council of Canada CGS Masters; Nova Scotia Research and Innovation Scholarship; Faculty of Graduate Studies at Dalhousie	Schulich Ocean Studies Centre Initiative, Dalhousie University, Canada; Natural Sciences and Engineering Research Council of Canada Discovery Grants program(Natural Sciences and Engineering Research Council of Canada (NSERC)); 2015 Strategic Cooperative Education Incentive of the Nova Scotia Department of Labour and Advanced Education; Natural Sciences and Engineering Research Council of Canada CGS Masters(Natural Sciences and Engineering Research Council of Canada (NSERC)); Nova Scotia Research and Innovation Scholarship; Faculty of Graduate Studies at Dalhousie	Funding for this study was provided by the Schulich Ocean Studies Centre Initiative, Dalhousie University, Canada (Grant number: IR& D Ref: PROJ-14-09 to AM and RES), the Natural Sciences and Engineering Research Council of Canada Discovery Grants program (RGPIN-2012-34851 to AM and RGPIN-2016-04878 to RES) and the 2015 Strategic Cooperative Education Incentive of the Nova Scotia Department of Labour and Advanced Education (project ref, #20150137 and 2016000182 to AM). EH was partially supported by scholarships from the Natural Sciences and Engineering Research Council of Canada CGS Masters, Nova Scotia Research and Innovation Scholarship, and the Faculty of Graduate Studies at Dalhousie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson A, 2006, B MAR SCI, V78, P151; Abelson A, 2005, MAR POLLUT BULL, V50, P576, DOI 10.1016/j.marpolbul.2005.02.021; Ahmed A. S. M., 2012, Journal of Environmental Protection, V3, P922; ALEVIZON WS, 1989, B MAR SCI, V44, P646; Amar KO, 2007, MAR BIOL, V151, P713, DOI 10.1007/s00227-006-0512-0; Arnold SN, 2010, MAR ECOL PROG SER, V414, P91, DOI 10.3354/meps08724; BAILEYBROCK JH, 1989, B MAR SCI, V44, P580; BAYNES TW, 1989, B MAR SCI, V44, P545; Berman T, 2000, J MARINE SYST, V26, P349, DOI 10.1016/S0924-7963(00)00045-2; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Biton E., 2011, J GEOPHYS RES OCEANS, V116; BOHNSACK JA, 1989, B MAR SCI, V44, P631; BOHNSACK JA, 1994, B MAR SCI, V55, P796; BREITBURG DL, 1985, OECOLOGIA, V65, P173, DOI 10.1007/BF00379215; BREITBURG DL, 1984, ECOLOGY, V65, P1136, DOI 10.2307/1938321; Brenner S., 2004, INT EXPERT TEAM PROJ, V6; Brown CJ, 2005, BIOFOULING, V21, P73, DOI 10.1080/08927010512331344197; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Burt J, 2009, J EXP MAR BIOL ECOL, V373, P72, DOI 10.1016/j.jembe.2009.03.009; Carr MH, 1997, FISHERIES, V22, P28, DOI 10.1577/1548-8446(1997)022<0028:ARTIOC>2.0.CO;2; Ceccarelli DM, 2001, OCEANOGR MAR BIOL, V39, P355; CHANDLER CR, 1985, B MAR SCI, V37, P129; CHUA CYY, 1994, HYDROBIOLOGIA, V285, P177, DOI 10.1007/BF00005665; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Connell SD, 1999, BIOFOULING, V14, P219, DOI 10.1080/08927019909378413; Connell SD, 2001, MAR ENVIRON RES, V52, P115, DOI 10.1016/S0141-1136(00)00266-X; Connell SD, 1999, MAR ENVIRON RES, V47, P373, DOI 10.1016/S0141-1136(98)00126-3; Davis A.R., 1989, Bioorganic Marine Chemistry, V3, P85; Diaz-Castaneda V, 1999, MAR ECOL-P S Z N I, V20, P197, DOI 10.1046/j.1439-0485.1999.2034074.x; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; DONE TJ, 1992, HYDROBIOLOGIA, V247, P121, DOI 10.1007/BF00008211; Dunlap M, 1996, MAR BIOL, V126, P117, DOI 10.1007/BF00571383; ECKMAN JE, 1989, J EXP MAR BIOL ECOL, V132, P123, DOI 10.1016/0022-0981(89)90219-0; Epstein N, 2003, AQUAT CONSERV, V13, P387, DOI 10.1002/aqc.558; Epstein N, 2001, RESTOR ECOL, V9, P432, DOI 10.1046/j.1526-100X.2001.94012.x; Ettinger-Epstein P, 2008, MAR ECOL PROG SER, V365, P103, DOI 10.3354/meps07503; Fairfull SJL, 1999, MAR FRESHWATER RES, V50, P235, DOI 10.1071/MF97267; Field SN, 2007, CORAL REEFS, V26, P279, DOI 10.1007/s00338-006-0191-9; Genin A, 2016, ISRAEL NATL MONITORI, P1; Glasby TM, 2000, J EXP MAR BIOL ECOL, V248, P177, DOI 10.1016/S0022-0981(00)00169-6; Glasby TM, 2001, MAR ECOL PROG SER, V215, P37, DOI 10.3354/meps215037; Glasby TM, 1999, J EXP MAR BIOL ECOL, V234, P275, DOI 10.1016/S0022-0981(98)00156-7; Glassom D, 2004, MAR BIOL, V144, P641, DOI 10.1007/s00227-003-1243-0; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Hanner SE, 2006, B MAR SCI, V78, P57; Hasler H, 2008, MAR POLLUT BULL, V56, P1788, DOI 10.1016/j.marpolbul.2008.06.002; Heron SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep38402; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Holloway MG, 2002, MAR ECOL PROG SER, V235, P43, DOI 10.3354/meps235043; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V546, P82, DOI 10.1038/nature22901; HUGHES TP, 1987, J EXP MAR BIOL ECOL, V113, P39, DOI 10.1016/0022-0981(87)90081-5; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; KEOUGH MJ, 1989, MAR ECOL PROG SER, V57, P163, DOI 10.3354/meps057163; Knott NA, 2004, J MAR BIOL ASSOC UK, V84, P1117, DOI 10.1017/S0025315404010550h; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Kochzius M, 2005, GENE, V347, P295, DOI 10.1016/j.gene.2004.12.032; Koplovitz G, 2016, MANAG BIOL INVASION, V7, P43, DOI 10.3391/mbi.2016.7.1.06; Korzen L, 2011, J MARINE BIOL, P2011; LEWIS SM, 1986, ECOL MONOGR, V56, P183, DOI 10.2307/2937073; Lirman D, 2001, CORAL REEFS, V19, P392, DOI 10.1007/s003380000125; Loya Y, 2004, CORAL HEALTH AND DISEASE, P1; Maldonado M, 2006, CAN J ZOOL, V84, P175, DOI 10.1139/Z05-177; McClanahan TR, 1997, J EXP MAR BIOL ECOL, V218, P77, DOI 10.1016/S0022-0981(97)00069-5; Mundy CN, 1998, J EXP MAR BIOL ECOL, V223, P235, DOI 10.1016/S0022-0981(97)00167-6; OLSON RR, 1985, ECOLOGY, V66, P30, DOI 10.2307/1941304; Osman RW, 2004, J EXP MAR BIOL ECOL, V311, P117, DOI 10.1016/j.jembe.2004.05.001; Perkol-Finkel S, 2008, ESTUAR COAST SHELF S, V77, P491, DOI 10.1016/j.ecss.2007.10.005; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Perkol-Finkel S, 2005, MAR ENVIRON RES, V59, P79, DOI 10.1016/j.marenvres.2004.03.122; Perkol-Finkel S, 2009, J EXP MAR BIOL ECOL, V369, P1, DOI 10.1016/j.jembe.2008.09.016; Plass-Johnson J, 2016, CORAL REEFS, V35, P229, DOI 10.1007/s00338-015-1369-9; Rilov G, 1998, MAR ENVIRON RES, V45, P431, DOI 10.1016/S0141-1136(98)00106-8; Rilov G, 2000, MAR BIOL, V136, P931, DOI 10.1007/s002279900250; Rinkevich B, 2005, ENVIRON SCI TECHNOL, V39, P4333, DOI 10.1021/es0482583; Rinkevich Baruch, 2006, P291, DOI 10.1201/9781420003796.ch16; Rooker JR, 1997, CORAL REEFS, V16, P83, DOI 10.1007/s003380050062; RUSS GR, 1982, OECOLOGIA, V53, P12, DOI 10.1007/BF00377130; SCHMIDT GH, 1984, MAR ECOL PROG SER, V15, P251, DOI 10.3354/meps015251; Schuhmacher H., 1988, P379; Seaman W, 2002, ICES J MAR SCI, V59, pS14, DOI 10.1006/jmsc.2002.1277; Shafir S., 2010, U MAURITIUS RES J, V16, P365; Shaish L, 2008, J EXP MAR BIOL ECOL, V358, P86, DOI 10.1016/j.jembe.2008.01.024; Shenkar N, 2008, MAR ECOL PROG SER, V367, P163, DOI 10.3354/meps07579; Steneck R.S., 1983, Symposia Series for Undersea Research, V1, P103; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; STONER DS, 1990, ECOLOGY, V71, P1682, DOI 10.2307/1937577; Svane I, 2001, MAR ECOL-P S Z N I, V22, P169, DOI 10.1046/j.1439-0485.2001.01729.x; Thacker RW, 2001, CORAL REEFS, V19, P318, DOI 10.1007/s003380000122; TODD CD, 1986, J EXP MAR BIOL ECOL, V99, P199, DOI 10.1016/0022-0981(86)90224-8; Ushiama S, 2016, BIOFOULING, V32, P1049, DOI 10.1080/08927014.2016.1224860; WATTERS DJ, 1993, TOXICON, V31, P1349, DOI 10.1016/0041-0101(93)90202-T; YOUNG CM, 1984, MAR BIOL, V81, P61, DOI 10.1007/BF00397626	95	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212842	10.1371/journal.pone.0212842	http://dx.doi.org/10.1371/journal.pone.0212842			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811459	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400091
J	Swiderski, K; Caldow, MK; Naim, T; Trieu, J; Chee, A; Koopman, R; Lynch, GS				Swiderski, Kristy; Caldow, Marissa K.; Naim, Timur; Trieu, Jennifer; Chee, Annabel; Koopman, Rene; Lynch, Gordon S.			Deletion of suppressor of cytokine signaling 3 (SOCS3) in muscle stem cells does not alter muscle regeneration in mice after injury	PLOS ONE			English	Article							PHYSIOLOGICAL NEGATIVE REGULATOR; DIFFERENTIATION; INHIBITION; ACTIVATION; MECHANISMS; MYOSTATIN; REVEALS	Muscles of older animals are more susceptible to injury and regenerate poorly, in part due to a persistent inflammatory response. The janus kinase (Jak)/signal transducer and activator of transcription (Stat) pathway mediates inflammatory signaling and is tightly regulated by the suppressor of cytokine signaling (SOCS) proteins, especially SOCS3. SOCS3 expression is altered in the muscle of aged animals and may contribute to the persistent inflammation and impaired regeneration. To test this hypothesis, we performed myotoxic injuries on mice with a tamoxifen-inducible deletion of SOCS3 specifically within the muscle stem cell compartment. Muscle stem cell-specific SOCS3 deletion reduced muscle mass at 14 days post-injury (-14%, P < 0.01), altered the myogenic transcriptional program, and reduced myogenic fusion based on the number of centrally-located nuclei per muscle fiber. Despite the delay in myogenesis, muscles with a muscle stem cell-specific deletion of SOCS3 were still able to regenerate after a single bout or multiple bouts of myotoxic injury. A reduction in SOCS3 expression in muscle stem cells is unlikely to be responsible for the incomplete muscle repair in aged animals.	[Swiderski, Kristy; Caldow, Marissa K.; Naim, Timur; Trieu, Jennifer; Chee, Annabel; Koopman, Rene; Lynch, Gordon S.] Univ Melbourne, Dept Physiol, Muscle Res Ctr, Melbourne, Vic, Australia; [Chee, Annabel] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia	University of Melbourne; Monash University	Lynch, GS (corresponding author), Univ Melbourne, Dept Physiol, Muscle Res Ctr, Melbourne, Vic, Australia.	gsl@unimelb.edu.au	Caldow, Marissa/G-5260-2011; Lynch, Gordon/G-9553-2015	Caldow, Marissa/0000-0002-4447-9020; Lynch, Gordon/0000-0001-9220-9810	Australian Research Council [ARC] [DP120101494]; Early Career Fellowship from the National Health and Medical Research Council (NH&MRC) of Australia; McKenzie Research Fellowship from The University of Melbourne	Australian Research Council [ARC](Australian Research Council); Early Career Fellowship from the National Health and Medical Research Council (NH&MRC) of Australia; McKenzie Research Fellowship from The University of Melbourne	This work was supported by the Australian Research Council [ARC; DP120101494] awarded to GSL and RK. KS was supported by an Early Career Fellowship from the National Health and Medical Research Council (NH&MRC) of Australia. MKC was supported by a McKenzie Research Fellowship from The University of Melbourne.	Boyle K, 2007, BLOOD, V110, P1466, DOI 10.1182/blood-2007-03-079178; Caldow MK, 2011, CYTOKINE, V55, P104, DOI 10.1016/j.cyto.2011.03.012; Chazaud B, 2014, CELL STEM CELL, V15, P401, DOI 10.1016/j.stem.2014.09.010; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Croker BA, 2012, IMMUNOL CELL BIOL, V90, P124, DOI 10.1038/icb.2011.29; Croker BA, 2008, SEMIN CELL DEV BIOL, V19, P414, DOI 10.1016/j.semcdb.2008.07.010; Diao YR, 2009, MOL CELL BIOL, V29, P5084, DOI 10.1128/MCB.00267-09; Emery B, 2006, P NATL ACAD SCI USA, V103, P7859, DOI 10.1073/pnas.0602574103; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Haddad F, 2006, J APPL PHYSIOL, V100, P1188, DOI 10.1152/japplphysiol.01227.2005; Kimura A, 2004, J BIOL CHEM, V279, P6905, DOI 10.1074/jbc.C300496200; Leger B, 2008, REJUV RES, V11, P163, DOI 10.1089/rej.2007.0588; Liu YH, 2009, DEV CELL, V16, P280, DOI 10.1016/j.devcel.2009.01.006; Machado L, 2017, CELL REP, V21, P1982, DOI 10.1016/j.celrep.2017.10.080; McKay BR, 2013, AM J PHYSIOL-CELL PH, V304, pC717, DOI 10.1152/ajpcell.00305.2012; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Merritt EK, 2013, J APPL PHYSIOL, V115, P937, DOI 10.1152/japplphysiol.00019.2013; Murphy KT, 2011, AM J PHYSIOL-REG I, V301, pR716, DOI 10.1152/ajpregu.00121.2011; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Ryall JG, 2015, CELL STEM CELL, V16, P171, DOI 10.1016/j.stem.2014.12.004; Sorensen JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198611; Spangenburg EE, 2005, J BIOL CHEM, V280, P10749, DOI 10.1074/jbc.M410604200; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Swiderski K, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0108-4; Tidball JG, 2017, NAT REV IMMUNOL, V17, P165, DOI 10.1038/nri.2016.150; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Trenerry MK, 2008, REJUV RES, V11, P717, DOI 10.1089/rej.2007.0643; Ushiki T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162111; van der Poel C, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-41; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; Wong PKK, 2006, J CLIN INVEST, V116, P1571, DOI 10.1172/JCI25660	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212880	10.1371/journal.pone.0212880	http://dx.doi.org/10.1371/journal.pone.0212880			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811469	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400094
J	Pillai, MR; Mihi, B; Ishiwata, K; Nakamura, K; Sakuragi, N; Finkelstein, DB; McGargill, MA; Nakayama, T; Ayabe, T; Coleman, ML; Bix, M				Pillai, Meenu R.; Mihi, Belgacem; Ishiwata, Kenji; Nakamura, Kiminori; Sakuragi, Naoya; Finkelstein, David B.; McGargill, Maureen A.; Nakayama, Toshinori; Ayabe, Tokiyoshi; Coleman, Mathew L.; Bix, Mark			Myc-induced nuclear antigen constrains a latent intestinal epithelial cell-intrinsic anthelmintic pathway	PLOS ONE			English	Article							GASTROINTESTINAL NEMATODES; ALPHA-DEFENSINS; PANETH CELLS; RESISTANCE; BETA; REDUCTION; IMMUNITY; MICE; MINA; ZINC	Expulsion of parasitic gastrointestinal nematodes requires diverse effector mechanisms coordinated by a Th2-type response. The evolutionarily conserved JmjC protein; Myc Induced Nuclear Antigen (Mina) has been shown to repress IL4, a key Th2 cytokine, suggesting Mina may negatively regulate nematode expulsion. Here we report that expulsion of the parasitic nematode Trichuris muris was indeed accelerated in Mina deficient mice. Unexpectedly, this was associated not with an elevated Th2-but rather an impaired Th1-type response. Further reciprocal bone marrow chimera and conditional KO experiments demonstrated that retarded parasite expulsion and a normal Th1-type response both required Mina in intestinal epithelial cells (IECs). Transcriptional profiling experiments in IECs revealed anti-microbial alpha-defensin peptides to be the major target of Mina-dependent retention of worms in infected mice. In vitro exposure to recombinant alpha-defensin peptides caused cytotoxic damage to whipworms. These results identify a latent IEC-intrinsic anthelmintic pathway actively constrained by Mina and point to alpha-defensins as important effectors that together with Mina may be attractive therapeutic targets for the control of nematode infection.	[Pillai, Meenu R.; Finkelstein, David B.; McGargill, Maureen A.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Mihi, Belgacem; Bix, Mark] Chiba Univ, Grad Sch Med, Dept Innovat Med, Chiba, Japan; [Mihi, Belgacem; Bix, Mark] Chiba Univ, Inst Global Prominent Res, Chiba, Japan; [Ishiwata, Kenji] Jikei Univ, Sch Med, Dept Trop Med, Tokyo, Japan; [Nakamura, Kiminori; Sakuragi, Naoya; Ayabe, Tokiyoshi] Hokkaido Univ, Grad Sch Life Sci, Dept Cell Biol Sci, Sapporo, Hokkaido, Japan; [Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Coleman, Mathew L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham, W Midlands, England	St Jude Children's Research Hospital; Chiba University; Chiba University; Jikei University; Hokkaido University; Chiba University; University of Birmingham	Pillai, MR (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.; Bix, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Innovat Med, Chiba, Japan.; Bix, M (corresponding author), Chiba Univ, Inst Global Prominent Res, Chiba, Japan.	meenu.pillai@stjude.org; mbix@alum.mit.edu	Nakamura, Kiminori/GQQ-5570-2022; Ayabe, Tokiyoshi/F-5264-2011; Coleman, Mathew L/C-1676-2014; McGargill, Maureen/N-8131-2018	Nakamura, Kiminori/0000-0002-2138-1733; Ayabe, Tokiyoshi/0000-0002-8631-5593; Coleman, Mathew L/0000-0001-6020-9023; McGargill, Maureen/0000-0002-0916-0372; Ramanatha Pillai, Meenu/0000-0002-7944-3642	ALSAC; National Institutes of Health [AI048636]; Institute for Global Prominent Research, Chiba University; Ministry of Education, Culture, Sports, Science and Technology, Japan [26221305]; Japan Agency for Medical Research and development; Japan Society for the Promotion of Science; Center of Innovation Program from Japan Science and Technology Agency; American Lebanese Syrian Associated Charities;  [26462831]; MRC [MR/N021053/1] Funding Source: UKRI	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institute for Global Prominent Research, Chiba University; Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Innovation Program from Japan Science and Technology Agency; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by ALSAC (MB); the National Institutes of Health (MB, AI048636); the Institute for Global Prominent Research, Chiba University (MB); the Ministry of Education, Culture, Sports, Science and Technology, Japan: Grants-in-Aid for Scientific Research (S, #26221305) (TN), the Practical Research Project for Allergic Diseases and Immunology (Research on Allergic Diseases and Immunology) from the Japan Agency for Medical Research and development (TN); a Grant-in-Aid for Scientific Research (C, #26462831) (KN); the Japan Society for the Promotion of Science, the Center of Innovation Program from Japan Science and Technology Agency (KN); the American Lebanese Syrian Associated Charities (MB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Chowdhury R, 2014, NATURE, V510, P422, DOI 10.1038/nature13263; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; DINSDALE D, 1984, J HISTOCHEM CYTOCHEM, V32, P139, DOI 10.1177/32.2.6693753; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eilbracht J, 2005, EUR J CELL BIOL, V84, P279, DOI 10.1016/j.ejcb.2004.12.022; ELSE KJ, 1992, PARASITE IMMUNOL, V14, P441, DOI 10.1111/j.1365-3024.1992.tb00018.x; Gasbarre LC, 2015, CAN J VET RES, V79, P296; Ge W, 2012, NAT CHEM BIOL, V8, P960, DOI [10.1038/NCHEMBIO.1093, 10.1038/nchembio.1093]; Geerts S, 2001, TROP MED INT HEALTH, V6, P915, DOI 10.1046/j.1365-3156.2001.00774.x; Geurden T, 2015, INT J PARASITOL-DRUG, V5, P163, DOI 10.1016/j.ijpddr.2015.08.001; Giblin LJ, 2006, J HISTOCHEM CYTOCHEM, V54, P311, DOI 10.1369/jhc.5A6724.2005; Gomez-Escobar N, 2000, INFECT IMMUN, V68, P6402, DOI 10.1128/IAI.68.11.6402-6410.2000; Grainger JR, 2010, J EXP MED, V207, P2331, DOI 10.1084/jem.20101074; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Grencis RK, 2014, IMMUNOL REV, V260, P183, DOI 10.1111/imr.12188; Hayes KS, 2010, SCIENCE, V328, P1391, DOI 10.1126/science.1187703; Hepworth MR, 2009, J IMMUNOL, V183, P3906, DOI 10.4049/jimmunol.0900577; Huang MY, 2017, ONCOGENE, V36, P387, DOI 10.1038/onc.2016.208; Ihler CF., 1995, ACTA VET SCAND S1, V52, pS24; Jaeger SU, 2013, MUCOSAL IMMUNOL, V6, P1179, DOI 10.1038/mi.2013.17; Klementowicz JE, 2012, SEMIN IMMUNOPATHOL, V34, P815, DOI 10.1007/s00281-012-0348-2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2011, BIOPROTOCOL, pe157, DOI [10.21769/BioProtoc.157, DOI 10.21769/BIOPROTOC.157]; Lian SL, 2018, IMMUN INFLAMM DIS, V6, P58, DOI 10.1002/iid3.191; Love S., 2011, P AUSTR SHEEP VET C; Lu YJ, 2009, CELL CYCLE, V8, P2101, DOI 10.4161/cc.8.13.8927; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; Masuda K, 2011, J INNATE IMMUN, V3, P315, DOI 10.1159/000322037; Matthews JB, 2014, INT J PARASITOL-DRUG, V4, P310, DOI 10.1016/j.ijpddr.2014.10.003; Mori T, 2013, CELL STRUCT FUNCT, V38, P155; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Okamoto M, 2009, NAT IMMUNOL, V10, P872, DOI 10.1038/ni.1747; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Playford MC, 2014, AUST VET J, V92, P464, DOI 10.1111/avj.12271; Roeber F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-153; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Shanahan MT, 2011, INFECT IMMUN, V79, P459, DOI 10.1128/IAI.00996-10; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Vercruysse J, 2011, INT J PARASITOL-DRUG, V1, P14, DOI 10.1016/j.ijpddr.2011.09.002; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; WAKELIN D, 1967, PARASITOLOGY, V57, P515, DOI 10.1017/S0031182000072395; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22875; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang YF, 2013, ACS CHEM BIOL, V8, P1907, DOI 10.1021/cb400340k	54	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0211244	10.1371/journal.pone.0211244	http://dx.doi.org/10.1371/journal.pone.0211244			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807587	Green Submitted, gold, Green Published			2022-12-26	WOS:000459712100003
J	Lebreton, L; Guillerm-Erckelboudt, AY; Gazengel, K; Linglin, J; Ourry, M; Glory, P; Sarniguet, A; Daval, S; Manzanares-Dauleux, MJ; Mougel, C				Lebreton, Lionel; Guillerm-Erckelboudt, Anne-Yvonne; Gazengel, Kevin; Linglin, Juliette; Ourry, Morgane; Glory, Pascal; Sarniguet, Alain; Daval, Stephanie; Manzanares-Dauleux, Maria J.; Mougel, Christophe			Temporal dynamics of bacterial and fungal communities during the infection of Brassica rapa roots by the protist Plasmodiophora brassicae	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; RHIZOSPHERE MICROBIOME; JASMONIC ACID; PATHOGEN; CANOLA; CLUBROOT; PACKAGE; LIFE	The temporal dynamics of rhizosphere and root microbiota composition was compared between healthy and infected Chinese cabbage plants by the pathogen Plasmodiophora brassicae. When inoculated with P. brassicae, disease was measured at five sampling dates from early root hair infection to late gall development. The first symptoms of clubroot disease appeared 14 days after inoculation (DAI) and increased drastically between 14 and 35 DAI. The structure of microbial communities associated to rhizosphere soil and root from healthy and inoculated plants was characterized through high-throughput DNA sequencing of bacterial (16S) and fungal (18S) molecular markers and compared at each sampling date. In healthy plants, Proteobacteria and Bacteroidetes bacterial phyla dominated the rhizosphere and root microbiota of Chinese cabbage. Rhizosphere bacterial communities contained higher abundances of Actinobacteria and Firmicutes compared to the roots. Moreover, a drastic shift of fungal communities of healthy plants occurred between the two last sampling dates, especially in plant roots, where most of Ascomycota fungi dominated until they were replaced by a fungus assigned to the Chytridiomycota phylum. Parasitic invasion by P. brassicae disrupted the rhizosphere and root-associated community assembly at a late step during the root secondary cortical infection stage of clubroot disease. At this stage, Flavisolibacter and Streptomyces in the rhizosphere, and Bacillus in the roots, were drastically less abundant upon parasite invasion. Rhizosphere of plants colonized by P. brassicae was significantly more invaded by the Chytridiomycota fungus, which could reflect a mutualistic relationship in this compartment between these two microorganisms.	[Lebreton, Lionel; Guillerm-Erckelboudt, Anne-Yvonne; Gazengel, Kevin; Linglin, Juliette; Ourry, Morgane; Glory, Pascal; Sarniguet, Alain; Daval, Stephanie; Manzanares-Dauleux, Maria J.; Mougel, Christophe] Univ Rennes, INRA, IGEPP, AGROCAMPUS OUEST, Le Rheu, France	INRAE; Institut Agro; Agrocampus Ouest	Lebreton, L (corresponding author), Univ Rennes, INRA, IGEPP, AGROCAMPUS OUEST, Le Rheu, France.	lionel.lebreton@inra.fr	OURRY, Morgane/AAU-7974-2020; OURRY, Morgane/AAO-4369-2021; Mougel, Christophe/D-5118-2017	OURRY, Morgane/0000-0002-8641-9114; OURRY, Morgane/0000-0002-8641-9114; GAZENGEL, Kevin/0000-0001-9054-2281; Mougel, Christophe/0000-0001-8675-3115; Manzanares-Dauleux, Maria J./0000-0002-6452-0393; DAVAL, Stephanie/0000-0001-8848-4190; lebreton, Lionel/0000-0003-1759-5269	Rennes Metropole [300 01003]; French state through the National Agency for Research under the program "Investments for the Future" [ANR-11-INBS-0001]; Regional Council of Bourgogne Franche Comte	Rennes Metropole(Region Bretagne); French state through the National Agency for Research under the program "Investments for the Future"; Regional Council of Bourgogne Franche Comte(Region Bourgogne-Franche-Comte)	This work was supported by a Scientific Installation Aid grant (no 300 01003) to CM from Rennes Metropole (https://metropole.rennes.fr/les-aides-la-recherche?idParent=13&typeParent= taxonomy_term). This work, through the involvement of Bioinformatics service of the GenoSol platform of the infrastructure ANAEE-Services, received a grant from the French state through the National Agency for Research under the program "Investments for the Future" (reference ANR-11-INBS-0001), as well as grants from the Regional Council of Bourgogne Franche Comte. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almario J, 2017, P NATL ACAD SCI USA, V114, pE9403, DOI 10.1073/pnas.1710455114; Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; [Anonymous], 1991, PLANT ROOTS HIDDEN H; Bakker PAHM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00165; Barret M, 2015, APPL ENVIRON MICROB, V81, P1257, DOI 10.1128/AEM.03722-14; Bates D. M., 2010, LME4 MIXED EFFECTS M; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berendsen RL, 2018, ISME J, V12, P1496, DOI 10.1038/s41396-018-0093-1; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Berg G, 2016, J EXP BOT, V67, P995, DOI 10.1093/jxb/erv466; Bodenhausen N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056329; Borneman J, 2000, APPL ENVIRON MICROB, V66, P4356, DOI 10.1128/AEM.66.10.4356-4360.2000; Bulgarelli D, 2015, CELL HOST MICROBE, V17, P392, DOI 10.1016/j.chom.2015.01.011; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Carvalhais LC, 2015, MOL PLANT MICROBE IN, V28, P1049, DOI 10.1094/MPMI-01-15-0016-R; Chapelle E, 2016, ISME J, V10, P265, DOI 10.1038/ismej.2015.82; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; COOK RJ, 1995, P NATL ACAD SCI USA, V92, P4197, DOI 10.1073/pnas.92.10.4197; de Souza RSC, 2016, SCI REP-UK, V6, DOI 10.1038/srep28774; de Campos SB, 2013, MICROB ECOL, V65, P593, DOI 10.1007/s00248-012-0132-9; Dombrowski N, 2017, ISME J, V11, P43, DOI 10.1038/ismej.2016.109; Edwards J, 2015, P NATL ACAD SCI USA, V112, pE911, DOI 10.1073/pnas.1414592112; Erlacher A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00175; Fahling M, 2003, J PHYTOPATHOL, V151, P425, DOI 10.1046/j.1439-0434.2003.00744.x; Gkarmiri K, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.01938-17, 10.1128/aem.01938-17]; Gransee A, 2000, J PLANT NUTR SOIL SC, V163, P381, DOI 10.1002/1522-2624(200008)163:4<381::AID-JPLN381>3.0.CO;2-7; Hacquard S, 2017, ANNU REV PHYTOPATHOL, V55, P565, DOI 10.1146/annurev-phyto-080516-035623; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; Hartmann A, 2008, PLANT SOIL, V312, P7, DOI 10.1007/s11104-007-9514-z; Hartmann A, 2009, PLANT SOIL, V321, P235, DOI 10.1007/s11104-008-9814-y; Hartwright LM, 2010, FUNGAL BIOL-UK, V114, P26, DOI 10.1016/j.mycres.2009.09.008; Hilton S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059859; Hu LF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05122-7; Hwang SF, 2012, MOL PLANT PATHOL, V13, P105, DOI 10.1111/j.1364-3703.2011.00729.x; Kageyama K, 2009, J PLANT GROWTH REGUL, V28, P203, DOI 10.1007/s00344-009-9101-z; Kim B, 2016, J MICROBIOL BIOTECHN, V26, P549, DOI 10.4014/jmb.1511.11058; Kong HG, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01314; Lahlali R, 2013, PHYTOPATHOLOGY, V103, P245, DOI 10.1094/PHYTO-06-12-0123-R; Le Van A, 2017, PEERJ, V5, DOI 10.7717/peerj.3454; Lebeis SL, 2015, SCIENCE, V349, P860, DOI 10.1126/science.aaa8764; Lemarie S, 2015, PLANT CELL PHYSIOL, V56, P2158, DOI 10.1093/pcp/pcv127; Lennon JT, 2011, NAT REV MICROBIOL, V9, P119, DOI 10.1038/nrmicro2504; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Lundberg DS, 2012, NATURE, V488, P86, DOI 10.1038/nature11237; Mahoney AK, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00132; Manzanares-Dauleux MJ, 2000, THEOR APPL GENET, V101, P885, DOI 10.1007/s001220051557; Manzanares-Dauleux MJ, 2000, EUPHYTICA, V113, P211, DOI 10.1023/A:1003997421340; Marilley L, 1999, APPL SOIL ECOL, V13, P127, DOI 10.1016/S0929-1393(99)00028-1; Mendes R, 2013, FEMS MICROBIOL REV, V37, P634, DOI 10.1111/1574-6976.12028; Monreal CM, 2018, RHIZOSPHERE-NETH, V5, P16, DOI 10.1016/j.rhisph.2017.11.004; Mougel C, 2006, NEW PHYTOL, V170, P165, DOI 10.1111/j.1469-8137.2006.01650.x; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Ourry M, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00091; Plassart P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044279; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; R Core TeamR, LANG ENV STAT COMP; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Ranjard L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2431; Rathore R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01489; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schiltz S, 2015, J APPL MICROBIOL, V119, P1467, DOI 10.1111/jam.12946; Schlaeppi K, 2014, P NATL ACAD SCI USA, V111, P585, DOI 10.1073/pnas.1321597111; Some A, 1996, PLANT PATHOL, V45, P432, DOI 10.1046/j.1365-3059.1996.d01-155.x; Sorensen J, 2009, PLANT SOIL, V321, P483, DOI 10.1007/s11104-009-9946-8; Terrat S, 2015, HEREDITY, V114, P468, DOI 10.1038/hdy.2014.91; Terrat S, 2012, MICROB BIOTECHNOL, V5, P135, DOI 10.1111/j.1751-7915.2011.00307.x; Tkacz A, 2015, ISME J, V9, P2349, DOI 10.1038/ismej.2015.41; Vacher C, 2016, ANNU REV ECOL EVOL S, V47, P1, DOI 10.1146/annurev-ecolsys-121415-032238; Vandenkoornhuyse P, 2015, NEW PHYTOL, V206, P1196, DOI 10.1111/nph.13312; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Wei Z, 2018, SOIL BIOL BIOCHEM, V118, P8, DOI 10.1016/j.soilbio.2017.11.012; Yuan J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0537-x	78	24	24	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0204195	10.1371/journal.pone.0204195	http://dx.doi.org/10.1371/journal.pone.0204195			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802246	Green Published, Green Submitted, gold			2022-12-26	WOS:000459710700001
J	Abdelrehim, A; Shaltiel, L; Zhang, L; Barenholz, Y; High, S; Harris, LK				Abdelrehim, Abbi; Shaltiel, Lior; Zhang, Ling; Barenholz, Yechezkel; High, Stephen; Harris, Lynda K.			The use of tail-anchored protein chimeras to enhance liposomal cargo delivery	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DRUG-DELIVERY; CELLULAR UPTAKE; TAT PEPTIDE; TUMOR-CELLS; MEMBRANE; TRANSLOCATION; EFFICIENT; SYSTEMS; SIZE	Background Liposomes are employed as drug delivery vehicles offering a beneficial pharmacokinetic/ distribution mechanism for in vivo therapeutics. Therapeutic liposomes can be designed to target specific cell types through the display of epitope-specific targeting peptides on their surface. The majority of peptides are currently attached by chemical modification of lipid constituents. Here we investigate an alternative and novel method of decorating liposomes with targeting ligand, using remotely and spontaneously inserting chimeric tail-anchored membrane (TA) proteins to drug loaded liposomes. Methods and results An artificial TA protein chimera containing the transmembrane domain from the spontaneously inserting TA protein cytochrome b5 (Cytb5) provided a robust membrane tether for the incorporation of three different targeting moieties into preformed liposomes. The moieties investigated were the transactivator of transcription (TAT) peptide, the EGF-receptor binding sequence GE11 and the placental and tumour homing ligand CCGKRK. In all cases, TA protein insertion neither significantly altered the size of the liposomes nor reduced drug loading. The efficacy of this novel targeted delivery system was investigated using two human cell lines, HeLa M and BeWo. Short term incubation with one ligand-modified TA chimera, incorporating the TAT peptide, significantly enhanced liposomal delivery of the encapsulated carboxyfluorescein reporter. Conclusion The Cytb5 TA was successfully employed as a membrane anchor for the incorporation of the desired peptide ligands into a liposomal drug delivery system, with minimal loss of cargo during insertion. This approach therefore provides a viable alternative to chemical conjugation and its potential to accommodate a wider range of targeting ligands may provide an opportunity for enhancing drug delivery.	[Abdelrehim, Abbi; Zhang, Ling; High, Stephen] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Shaltiel, Lior; Barenholz, Yechezkel] Lipocure Ltd, Jerusalem, Israel; [Barenholz, Yechezkel] Hebrew Univ Jerusalem, Hadassah Med Sch, Membrane & Liposome Res Lab, Jerusalem, Israel; [Harris, Lynda K.] Univ Manchester, Fac Biol Med & Hlth, Div Pharm & Optometry, Manchester, Lancs, England; [Harris, Lynda K.] Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Harris, Lynda K.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England	University of Manchester; Hebrew University of Jerusalem; University of Manchester; University of Manchester; University of Manchester	Harris, LK (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Div Pharm & Optometry, Manchester, Lancs, England.; Harris, LK (corresponding author), Univ Manchester, Inst Human Dev, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.; Harris, LK (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, St Marys Hosp, Manchester, Lancs, England.	lynda.k.harris@manchester.ac.uk	Harris, Lynda K/I-2628-2019	Harris, Lynda K/0000-0001-7709-5202; High, Stephen/0000-0002-4532-8152	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA [607072]; Lipocure Ltd.; BBSRC David Phillips Fellowship [BB/H022627/1]; Tommy's the Baby Charity; Action Medical Research Endowment Fund; Manchester NIHR Biomedical Research Centre; NIHR Greater Manchester Comprehensive Local Research Network; BBSRC [BB/H022627/1] Funding Source: UKRI	People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 under REA; Lipocure Ltd.; BBSRC David Phillips Fellowship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Tommy's the Baby Charity; Action Medical Research Endowment Fund; Manchester NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Greater Manchester Comprehensive Local Research Network; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7/2007-2013 (https://ec.europa.eu/research/mariecurieactions/) under REA grant 607072 to SH laboratory and Lipocure Ltd. The support was in the form of salaries' payment for the authors AA and LS. The specific role of each of these authors is articulated in the `author contributions' section. The BBSRC David Phillips Fellowship (https://bbsrc.ukri.org) to LKH (BB/H022627/1). The Maternal and Fetal Health Research Centre is supported by funding from Tommy's the Baby Charity (https://www.tommys.org), an Action Medical Research Endowment Fund (https://www.action.org.uk), the Manchester NIHR Biomedical Research Centre (https://www.manchesterbrc.nihr.ac.uk/) and the NIHR Greater Manchester Comprehensive Local Research Network (https://www.nihr.ac.uk/nihr-in-your-area/greater-manchester/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Agemy L, 2011, P NATL ACAD SCI USA, V108, P17450, DOI 10.1073/pnas.1114518108; Allen TM, 2013, ADV DRUG DELIVER REV, V65, P36, DOI 10.1016/j.addr.2012.09.037; ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5; Andar AU, 2014, PHARM RES-DORDR, V31, P401, DOI 10.1007/s11095-013-1171-8; Bajoria R, 1997, J PHARM PHARMACOL, V49, P675, DOI 10.1111/j.2042-7158.1997.tb06091.x; Barenholz Y, 2012, J CONTROL RELEASE, V160, P117, DOI 10.1016/j.jconrel.2012.03.020; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Borgese N, 2001, MOL BIOL CELL, V12, P2482, DOI 10.1091/mbc.12.8.2482; Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730; Brambillasca S, 2006, J CELL BIOL, V175, P767, DOI 10.1083/jcb.200608101; Byrne JD, 2008, ADV DRUG DELIVER REV, V60, P1615, DOI 10.1016/j.addr.2008.08.005; Casson J, 2017, J CELL SCI, V130, P3851, DOI 10.1242/jcs.207829; Cheng L, 2014, INT J NANOMED, V9, P921, DOI 10.2147/IJN.S53310; Cheng ZL, 2012, SCIENCE, V338, P903, DOI 10.1126/science.1226338; Deshpande PP, 2013, NANOMEDICINE-UK, V8, P1509, DOI [10.2217/NNM.13.118, 10.2217/nnm.13.118]; Dinca A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020263; Filla MS, 1997, PLACENTA, V18, P17, DOI 10.1016/S0143-4004(97)90067-9; Forssen E, 1998, ADV DRUG DELIVER REV, V29, P249, DOI 10.1016/S0169-409X(97)00083-5; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Guven A, 2009, J LIPOSOME RES, V19, P148, DOI 10.1080/08982100802674419; HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9; Hoffman JA, 2003, CANCER CELL, V4, P383, DOI 10.1016/S1535-6108(03)00273-3; Hu QY, 2013, BIOMATERIALS, V34, P9496, DOI 10.1016/j.biomaterials.2013.09.001; Jayanna PK, 2009, NANOMED-NANOTECHNOL, V5, P83, DOI 10.1016/j.nano.2008.07.006; Johnson N, 2013, BBA-MOL CELL RES, V1833, P2403, DOI 10.1016/j.bbamcr.2012.12.008; Kedmi R, 2018, NAT NANOTECHNOL, V13, P214, DOI 10.1038/s41565-017-0043-5; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; King A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600349; Leznicki P, 2010, J CELL SCI, V123, P2170, DOI 10.1242/jcs.066738; Li ZH, 2005, FASEB J, V19, P1978, DOI 10.1096/fj.05-4058com; Liguori L, 2009, METHOD ENZYMOL, V465, P209, DOI 10.1016/S0076-6879(09)65011-4; Marques-Gallego P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/129458; Matos P, 2014, MOL HUM REPROD, V20, P745, DOI 10.1093/molehr/gau039; Mickler FM, 2012, NANO LETT, V12, P3417, DOI 10.1021/nl300395q; Nomura F, 2004, P NATL ACAD SCI USA, V101, P3420, DOI 10.1073/pnas.0304660101; Pattni BS, 2015, CHEM REV, V115, P10938, DOI 10.1021/acs.chemrev.5b00046; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Ren Y, 2012, ACS NANO, V6, P8620, DOI 10.1021/nn301975s; Sakamoto Y, 2012, J BIOSCI BIOENG, V113, P322, DOI 10.1016/j.jbiosc.2011.11.004; Sarko D, 2010, MOL PHARMACEUT, V7, P2224, DOI 10.1021/mp100223d; Sawant RR, 2012, AAPS J, V14, P303, DOI 10.1208/s12248-012-9330-0; Sercombe L, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00286; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Torchilin VP, 2001, P NATL ACAD SCI USA, V98, P8786, DOI 10.1073/pnas.151247498; Tseng YL, 2002, MOL PHARMACOL, V62, P864, DOI 10.1124/mol.62.4.864; van Rooy I, 2011, J CONTROL RELEASE, V150, P30, DOI 10.1016/j.jconrel.2010.11.014; Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306; Wang T, 2010, NANOMEDICINE-UK, V5, P563, DOI [10.2217/nnm.10.30, 10.2217/NNM.10.30]; Wei XH, 2016, EUR J PHARM BIOPHARM, V104, P260, DOI 10.1016/j.ejpb.2016.04.011; Zhang FN, 2015, ANAL CHEM, V87, P9960, DOI 10.1021/acs.analchem.5b02572; Zylberberg C, 2016, DRUG DELIV, V23, P3319, DOI 10.1080/10717544.2016.1177136	54	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212701	10.1371/journal.pone.0212701	http://dx.doi.org/10.1371/journal.pone.0212701			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794671	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100121
J	Almeida, VM; Marana, SR				Almeida, Vitor M.; Marana, Sandro R.			Optimum temperature may be a misleading parameter in enzyme characterization and application	PLOS ONE			English	Article							RESIDUES	The optimum temperature is commonly determined in enzyme characterization. A search in the PubMed database for "optimum temperature" and "enzymes" yielded more than 1,700 manuscripts reporting this parameter over the last five years. Here, we show that the optimum temperature is not a constant. The catalytic activity of the mesophylic beta-glucosidase Sf beta gly was determined at different temperatures using different assay times and enzyme concentrations. We observed that the optimum temperature for Sf beta gly changed by 5 degrees C simply by modifying the assay length, and it was inversely correlated with enzyme concentration. These observations rely on the fact that close to the melting temperature, thermal denaturation continuously decreases the active enzyme concentration as the assay progresses. Thus, as the denaturation rate increases with increasing temperature, the bell-shaped curves observed in "activity versus temperature plots" occur only if the enzyme is denatured at and above the optimum temperature, which was confirmed using the thermostable beta-glucosidase bglTm. Thus, the optimum temperature hardly reflects an intrinsic enzyme property and is actually a mere consequence of the assay condition. Thus, adoption of the "optimum temperature" determined under bench conditions for large-scale uses, which differ in assay length and enzyme concentration, may result in lower yields and financial losses.	[Almeida, Vitor M.; Marana, Sandro R.] Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Marana, SR (corresponding author), Univ Sao Paulo, Inst Quim, Dept Bioquim, Sao Paulo, SP, Brazil.	srmarana@iq.usp.br	Marana, Sandro/D-3867-2012	Marana, Sandro/0000-0002-5117-1921; Almeida, Vitor Medeiros/0000-0003-4972-3341	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]; FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [16/22365-9]; CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was financed by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)-Finance code 001, FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [Grant 16/22365-9] and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida VM, 2018, PLOS ONE, V13, DOI [10.1371/Journal.pone.0191282, 10.1371/journal.pone.0191282]; [Anonymous], 2018, BCC RES MARK RES MAR; Beton D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139673; Fersht A., 1999, STRUCTURE MECH PROTE, P191; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Marana SR, 2002, EUR J BIOCHEM, V269, P3705, DOI 10.1046/j.1432-1033.2002.03061.x; Mehmood MA, 2014, PROTEIN PEPTIDE LETT, V21, P1282; Purich DL, 2010, ENZYME KINETICS: CATALYSIS & CONTROL, P1; Segel IH, 1993, ENZYME KINETICS, P926; Souza VP, 2016, FEBS J, V283, P1124, DOI 10.1111/febs.13659	10	12	12	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212977	10.1371/journal.pone.0212977	http://dx.doi.org/10.1371/journal.pone.0212977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794710	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100165
J	Bojorquez, JAZ; Jodoin, PM; Bricq, S; Walker, PM; Brunotte, F; Lalande, A				Bojorquez, Jorge Arturo Zavala; Jodoin, Pierre-Marc; Bricq, Stephanie; Walker, Paul Michael; Brunotte, Francois; Lalande, Alain			Automatic classification of tissues on pelvic MRI based on relaxation times and support vector machine	PLOS ONE			English	Article							QUANTITATIVE MRI; SEGMENTATION; T-1	Tissue segmentation and classification in MRI is a challenging task due to a lack of signal intensity standardization. MRI signal is dependent on the acquisition protocol, the coil profile, the scanner type, etc. While we can compute quantitative physical tissue properties independent of the hardware and the sequence parameters, it is still difficult to leverage these physical properties to segment and classify pelvic tissues. The proposed method integrates quantitative MRI values (T1 and T2 relaxation times and pure synthetic weighted images) and machine learning (Support Vector Machine (SVM)) to segment and classify tissues in the pelvic region, i. e.: fat, muscle, prostate, bone marrow, bladder, and air. Twenty-two men with a mean age of 30 +/- 14 years were included in this prospective study. The images were acquired with a 3 Tesla MRI scanner. An inversion recovery-prepared turbo spin echo sequence was used to obtain T1-weighted images at different inversion times with a TR of 14000 ms. A 32-echo spin echo sequence was used to obtain the T2-weighted images at different echo times with a TR of 5000 ms. T1 and T2 relaxation times, synthetic T1-and T2-weighted images and anatomical probabilistic maps were calculated and used as input features of a SVM for segmenting and classifying tissues within the pelvic region. The mean SVM classification accuracy across subjects was calculated for the different tissues: prostate (94.2%), fat (96.9%), muscle (95.8%), bone marrow (91%) and bladder (82.1%) indicating an excellent classification performance. However, the segmentation and classification for air (within the rectum) may not always be successful (mean SVM accuracy 47.5%) due to the lack of air data in the training and testing sets. Our findings suggest that SVM can reliably segment and classify tissues in the pelvic region.	[Bojorquez, Jorge Arturo Zavala; Bricq, Stephanie; Walker, Paul Michael; Brunotte, Francois; Lalande, Alain] Univ Bourgogne Franche Comte, Le2i, Dijon, France; [Jodoin, Pierre-Marc] Univ Sherbrooke, VITAL, Sherbrooke, PQ, Canada; [Walker, Paul Michael; Brunotte, Francois; Lalande, Alain] CHU Dijon, Dijon, France	Universite de Bourgogne; University of Sherbrooke; CHU Dijon Bourgogne	Lalande, A (corresponding author), Univ Bourgogne Franche Comte, Le2i, Dijon, France.; Lalande, A (corresponding author), CHU Dijon, Dijon, France.	alain.lalande@u-bourgogne.fr	Lalande, Alain/T-1050-2017	zavala bojorquez, jorge arturo/0000-0002-2527-8944	Natural Sciences and Engineering Research Council of Canada (CA) [RGPIN-2018-05401]; National Council of Science and Technology of Mexico [218612-314201]	Natural Sciences and Engineering Research Council of Canada (CA)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Council of Science and Technology of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (CA), Grant number: Discovery grant RGPIN-2018-05401 (http://www.nserc-crsng.gc.ca/index_eng.asp) to PMJ and the National Council of Science and Technology of Mexico, Grant number 218612-314201 (https://www.conacyt.gob.mx/) to JAZB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AH, 2002, J NEUROSCI METH, V122, P13, DOI 10.1016/S0165-0270(02)00273-X; Bitar R, 2006, RADIOGRAPHICS, V26, P513, DOI 10.1148/rg.262055063; Bojorquez JZ, 2017, MAGN RESON IMAGING, V35, P69, DOI 10.1016/j.mri.2016.08.021; Bojorquez JZ, 2016, MAGN RESON MATER PHY, V29, P777, DOI 10.1007/s10334-016-0562-3; Callaghan MF, 2016, NMR BIOMED, V29, P1729, DOI 10.1002/nbm.3658; Chen PF, 2009, INT CONF ACOUST SPEE, P417, DOI 10.1109/ICASSP.2009.4959609; Cho S, 1997, MAGN RESON IMAGING, V15, P1133, DOI 10.1016/S0730-725X(97)00202-6; Criminisil A, 2011, FOUND TRENDS COMPUT, V7, P81, DOI [10.1501/0000000035, 10.1561/0600000035]; de Bazelaire CMJ, 2004, RADIOLOGY, V230, P652, DOI 10.1148/radiol.2303021331; Demuth H. B., 2014, NEURAL NETWORK DESIG; Dunham M. H., 2002, DATA MINING INTRO AD; Edden RAE, 2010, J MAGN RESON IMAGING, V32, P982, DOI 10.1002/jmri.22306; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Gatidis S, 2015, NMR BIOMED, V28, P914, DOI 10.1002/nbm.3329; Iglesias JE, 2010, LECT NOTES COMPUT SC, V6363, P81; Jager F, 2009, IEEE T MED IMAGING, V28, P137, DOI 10.1109/TMI.2008.2004429; Kapur T, 1996, Med Image Anal, V1, P109, DOI 10.1016/S1361-8415(96)80008-9; Keerthi SS, 2008, P 14 ACM SIGKDD INT, P408, DOI DOI 10.1145/1401890.1401942; Kimpe T, 2007, J DIGIT IMAGING, V20, P422, DOI 10.1007/s10278-006-1052-3; Kumar R, 2012, J MAGN RESON IMAGING, V35, P300, DOI 10.1002/jmri.22831; Litjens G, 2014, MED IMAGE ANAL, V18, P359, DOI 10.1016/j.media.2013.12.002; Maji S, 2008, PROC CVPR IEEE, P2245; Noth U, 2015, NMR BIOMED, V28, P818, DOI 10.1002/nbm.3324; Pai A, 2008, MAGN RESON IMAGING, V26, P1215, DOI 10.1016/j.mri.2008.02.017; Pasquier D, 2007, INT J RADIAT ONCOL, V68, P592, DOI 10.1016/j.ijrobp.2007.02.005; Ramos-Llorden G, 2018, IEEE T MED IMAGING, P1; Ratsch G, 2001, MACH LEARN, V42, P287, DOI 10.1023/A:1007618119488; Schick F, 2016, MAGN RESON MATER PHY, V29, P89, DOI 10.1007/s10334-016-0549-0; Shinohara RT, 2014, NEUROIMAGE-CLIN, V6, P9, DOI 10.1016/j.nicl.2014.08.008; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Tofts P, 2005, QUANTITATIVE MRI BRA; Traynor CR, 2011, NEUROIMAGE, V56, P939, DOI 10.1016/j.neuroimage.2011.01.083; Wang L, 2016, MAGN RESON MATER PHY, V29, P95, DOI 10.1007/s10334-015-0520-5; West J, 2012, EUR RADIOL, V22, P998, DOI 10.1007/s00330-011-2336-7; Yakar D, 2012, J MAGN RESON IMAGING, V35, P20, DOI 10.1002/jmri.22790	36	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211944	10.1371/journal.pone.0211944	http://dx.doi.org/10.1371/journal.pone.0211944			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794559	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100027
J	Jeong, JJ; Lee, DW; Song, SY; Park, Y; Kim, JH; Kim, JI; Kim, HG; Nam, KT; Lee, WJ; Nam, KH; Lee, JH				Jeong, Jong Ju; Lee, Dong Won; Song, Seung Yong; Park, Yerin; Kim, Ji Hee; Kim, Jang Il; Kim, Hyung Goo; Nam, Ki Taek; Lee, Won Jai; Nam, Kee-Hyun; Lee, Ju Hee			Development of novel biocompatible thermosensitive anti-adhesive agents using human-derived acellular dermal matrix	PLOS ONE			English	Article							HUMAN PERITONEAL ADHESIONS; POSTOPERATIVE ADHESIONS; THYROIDECTOMY SCARS; IN-VITRO; PREVENTION; BARRIER; MEMBRANE; CHITOSAN; ACID	Postoperative adhesion is a natural phenomenon that occurs in damaged tissue cells. Several anti-adhesion agents are currently used, but there is no leading-edge product with excellent adhesion-preventive effects. The purpose of this study was to develop ideal anti-adhesive agents using human-derived acellular dermal matrix (ADM). We developed 5 new biocompatible thermosensitive anti-adhesion barriers (AABs) using micronized human-derived ADM, hyaluronic acid, and temperature-sensitive and biocompatible synthesized polymers. The biocompatibility, anti-adhesion effect, and biodegradability of these AABs were compared with those of commercial thermosensitive anti-adhesion agents. No cytotoxic effects were observed in vitro and in vivo. Animal testing of adhesion resistance confirmed that the adhesion area, strength, and grade of AAB03 were statistically superior to those of the control group. Factors related to adhesion formation, such as lymphocytes, macrophages, microvessels, and collagen fiber density, were observed using specific staining methods; the results confirmed that AAB03 group exhibited significantly lower macrophage counts, microvessel density, and collagen fiber density than the control groups. Furthermore, AAB03 was completely absorbed by 6 weeks. Thus, AAB03 has the potential to be used as a high-performance anti-adhesion agent.	[Jeong, Jong Ju; Nam, Kee-Hyun] Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; [Lee, Dong Won; Song, Seung Yong; Lee, Won Jai] Yonsei Univ, Coll Med, Inst Human Tissue Restorat, Dept Plast & Reconstruct Surg, Seoul, South Korea; [Park, Yerin; Kim, Jang Il; Kim, Hyung Goo] L&C BIO Co Ltd, R&D Ctr, Gyeonggi Do, South Korea; [Kim, Ji Hee; Lee, Ju Hee] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Ji Hee; Lee, Ju Hee] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea; [Nam, Ki Taek] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Nam, KH (corresponding author), Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea.; Lee, JH (corresponding author), Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea.	khnam@yuhs.ac; juhee@yuhs.ac		Kim, Jihee/0000-0002-0047-5941; Jeong, Jong Ju/0000-0002-4155-6035; Lee, Dongwon/0000-0003-0046-3139; Nam, Kee-Hyun/0000-0002-6852-1190; Lee, Ju Hee/0000-0002-1739-5956; won jai, lee/0000-0003-3056-0503	Technology Development Program [S2305273]; Ministry of SMEs and Startups (MSS, Korea); LC BIO Co. Ltd	Technology Development Program; Ministry of SMEs and Startups (MSS, Korea); LC BIO Co. Ltd	This work was supported by the Technology Development Program (S2305273), which is funded by the Ministry of SMEs and Startups (MSS, Korea). L&C BIO Co. Ltd provided support for this study in the form of salaries for YP, JIK, and HGK. The specific roles of these authors are articulated in the 'author contributions' section. The MSS also provided support in the form of purchasing animal study materials. The funders had no additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Musawi D, 2001, GYNAECOL ENDOSC, V10, P123, DOI 10.1046/j.1365-2508.2001.00422.x; Archana D, 2015, INT J BIOL MACROMOL, V73, P49, DOI 10.1016/j.ijbiomac.2014.10.055; Attard JAP, 2007, CAN J SURG, V50, P291; Bahadir I, 2007, DIS COLON RECTUM, V50, P2209, DOI 10.1007/s10350-007-9074-6; Binnebosel M, 2008, WORLD J SURG, V32, P296, DOI 10.1007/s00268-007-9330-x; BLAUER KL, 1988, FERTIL STERIL, V49, P144; Cheong YC, 2001, HUM REPROD UPDATE, V7, P556, DOI 10.1093/humupd/7.6.556; Ersoy E, 2008, J SURG RES, V147, P148, DOI 10.1016/j.jss.2007.09.005; Gago LA, 2006, FERTIL STERIL, V86, P1223, DOI 10.1016/j.fertnstert.2006.04.021; Gutt CN, 2004, SURG ENDOSC, V18, P898, DOI 10.1007/s00464-003-9233-3; Habara T, 2002, J BIOMED MATER RES, V61, P628, DOI 10.1002/jbm.10247; Hellebrekers BWJ, 2000, FERTIL STERIL, V74, P203, DOI 10.1016/S0015-0282(00)00656-7; Herrick SE, 2000, J PATHOL, V192, P67; Hooker GD, 1999, SURGERY, V125, P211, DOI 10.1016/S0039-6060(99)70267-9; Kim DY, 2015, DERMATOL SURG, V41, P812, DOI 10.1097/DSS.0000000000000410; Lee JH, 2015, BIOMATERIALS, V44, P195, DOI 10.1016/j.biomaterials.2014.12.004; Lee WJ, 1995, J KOREAN SURG SOC, V49, P192; Liu YC, 2007, FERTIL STERIL, V87, P940, DOI 10.1016/j.fertnstert.2006.07.1532; Luo X, 2017, J BIOMED MATER RES B, V105, P585, DOI 10.1002/jbm.b.33572; Mais V, 2011, Minerva Ginecol, V63, P47; Mirzaei-parsa MJ, 2019, CELL TISSUE RES, V375, P709, DOI 10.1007/s00441-018-2927-6; Ouaissi M, 2012, J VISC SURG, V149, pE104, DOI 10.1016/j.jviscsurg.2011.11.006; REPLOGLE RL, 1966, ANN SURG, V163, P580, DOI 10.1097/00000658-196604000-00011; Rosch R, 2011, SURG ENDOSC, V25, P3605, DOI 10.1007/s00464-011-1766-2; Rout UK, 2003, FERTIL STERIL, V79, P138, DOI 10.1016/S0015-0282(02)04569-7; Shin JU, 2015, J WOUND CARE, V24, P163, DOI 10.12968/jowc.2015.24.4.163; SIEGLER AM, 1980, FERTIL STERIL, V34, P46; STEINLEITNER A, 1991, OBSTET GYNECOL, V77, P48; Tjarnstrom J, 1999, EUR J SURG, V165, P834; URMAN B, 1991, FERTIL STERIL, V56, P563; Vlahos A, 2001, AM SURGEON, V67, P15; Yang HY, 1997, J KOREAN SURG SOC, V52, P335; 오애경, 2013, [Biomaterials Research, 생체재료학회지], V17, P138; 이윤기, 2008, [Annals of Surgical Treatment and Research, 대한외과학회지], V74, P399	34	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212583	10.1371/journal.pone.0212583	http://dx.doi.org/10.1371/journal.pone.0212583			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794612	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100091
J	Porobic, J; Fulton, EA; Parada, C; Frusher, S; Ernst, B; Manriquez, P				Porobic, Javier; Fulton, Elizabeth A.; Parada, Carolina; Frusher, Stewart; Ernst, Billy; Manriquez, Pablo			The impact of fishing on a highly vulnerable ecosystem, the case of Juan Fernandez Ridge ecosystem	PLOS ONE			English	Article							LOBSTER JASUS-EDWARDSII; CRAB CHACEON-CHILENSIS; ROBINSON-CRUSOE ISLAND; SEA SEAMOUNT FISHERIES; ROCK LOBSTER; HOPLOSTETHUS-ATLANTICUS; MARINE ECOSYSTEMS; SPINY LOBSTER; ORANGE ROUGHY; ARCHIPELAGO	The Juan Fernandez Ridge (JFRE) is a vulnerable marine ecosystem (VME) located off the coast of central Chile formed by the Juan Fernandez Archipelago and a group of seamounts. This ecosystem has unique biological and oceanographic features, characterized by: small geographical units, high degree of endemism with a high degree of connectivity within the system. Two fleets have historically operated in this system: a long term coastal artisanal fishery associated with the Islands, focused mainly on lobster, and a mainland based industrial demersal finfish fishery operating on the seamounts which is currently considered overexploited. The management of these fisheries has been based on a classical single-species approach to determine output controls (industrial fleet) and a mixed management system with formal and informal components (artisanal fleet). There has been growing interest in increasing the exploitation of fisheries, and modernization of the fishing fleet already operating in the JFRE. Under this scenario of increased levels of fishing exploitation and the high level of interrelation of species it might be necessary to understand the impact of these fisheries from a holistic perspective based on a ecosystem-based modeling approach. To address these challenges we developed an Atlantis end-to-end model was configured for this ecosystem. The implemented model has a high degree of skill in representing the observed trends and fluctuations of the JFRE. The model shows that the industrial fishing has a localized impact and the artisanal fisheries have a relatively low impact on the ecosystem, mainly via the lobster fishery. The model indicates that the depletion of large sized lobster has leads to an increase in the population of sea urchins. Although this increase is not sufficient, as yet, to cause substantial flow-on effects to other groups, caution is advised in case extra pressure leads the ecosystem towards a regime shift.	[Porobic, Javier] Inst Marine & Antarctic Studies, Quantitat Marine Sci Program, Hobart, Tas, Australia; [Porobic, Javier; Fulton, Elizabeth A.] CSIRO Oceans & Atmosphere, Hobart, Tas, Australia; [Porobic, Javier] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Fulton, Elizabeth A.; Frusher, Stewart] Univ Tasmania, Ctr Marine Socioecol, Hobart, Tas, Australia; [Parada, Carolina] Univ Concepcion, Dept Geofis, Concepcion, Chile; [Parada, Carolina] Univ Concepcion, Inst Milenio Oceanog, Concepcion, Chile; [Parada, Carolina; Ernst, Billy] Univ CatoIica Norte, Dept Biol Marina, Millennium Nucleus Ecol & Sustainable Management, Coquimbo, Chile; [Ernst, Billy; Manriquez, Pablo] Univ Concepcion, Dept Oceanog, Concepcion, Chile	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; University of Tasmania; Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion	Porobic, J (corresponding author), CSIRO Oceans & Atmosphere, Hobart, Tas, Australia.; Porobic, J (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	javier.porobicgarate@csiro.au	Fulton, Beth/A-2871-2008; Porobic, Javier/ABE-7495-2021	Fulton, Beth/0000-0002-5904-7917; Porobic, Javier/0000-0001-5642-5372	Commonwealth Scientific and Industrial Research Organization; Institute for Marine and Antarctic Studies, University of Tasmania; University of Tasmania	Commonwealth Scientific and Industrial Research Organization; Institute for Marine and Antarctic Studies, University of Tasmania; University of Tasmania	This work was supported by The Commonwealth Scientific and Industrial Research Organization and the Institute for Marine and Antarctic Studies, University of Tasmania. The author Javier Porobic received a PhD scholarship, part of the Quantitative Marine Science program from the University of Tasmania and The Commonwealth Scientific and Industrial Research Organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada M, 2009, LAT AM J AQUAT RES, V37, P285, DOI 10.3856/vol37-issue3-fulltext-2; Althaus F, 2009, MAR ECOL PROG SER, V397, P279, DOI 10.3354/meps08248; Anderson OF, 2003, MAR FRESHWATER RES, V54, P643, DOI 10.1071/MF02163; Andrade I, 2014, LAT AM J AQUAT RES, V42, P888, DOI 10.3856/vol42-issue4-fulltext-14; [Anonymous], 2009, ADAPTIVE ENV MANAGEM, DOI DOI 10.1007/978-1-4020-9632-7_13; Arana P, 2012, PROPUESTA INDICACION; Arana P, 1983, ANALISIS PESQUERIAS, P77; Arana P., 2000, INVEST MAR, V28, P39; Arana P.M., 1987, ISLAS OCEANICAS CHIL, P321; Arana PM, 2000, INVEST MAR VALPARAIS, V28, P219, DOI 10.4067/S0717-71782000002800016; Arana PM, 1985, INVEST MAR, P126; Ardron JA, 2014, MAR POLICY, V49, P146, DOI 10.1016/j.marpol.2013.11.017; Audzijonyte A., 2017, ATLANTIS USERS GUI 2; Audzijonyte A., 2017, ATLANTIS USERS GUI 1; Audzijonyte A, 2018, METHODS ECOLOGY EVOL; Auster PJ, 2011, ICES J MAR SCI, V68, P254, DOI 10.1093/icesjms/fsq074; Clark MR, 2012, ENVIRON CONSERV, V39, P204, DOI 10.1017/S0376892912000021; Clark MR, 2010, ANNU REV MAR SCI, V2, P253, DOI 10.1146/annurev-marine-120308-081109; Clark Malcolm R., 2007, Fish and Aquatic Resources Series, V12, P413; Clark MR, 2009, LAT AM J AQUAT RES, V37, P501, DOI 10.3856/vol37-issue3-fulltext-17; Directorate General of Civil Aeronautics of Chile, CLIM YB; Dunn MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026704; Ernst B, 2017, INFORME FINAL; Ernst B., 2016, EVALUACION DIRECTA B; Ernst B, 2014, INFORME FINAL PROGRA; Ernst B., 2010, B MAR SCI, V86, P1; Ernst B, 2015, FINAL REPORT ESTUDIO; Ernst B, 2012, 472849LE11 U CONC; Ernst B, 2013, GLOBAL ENVIRON CHANG, V23, P1381, DOI 10.1016/j.gloenvcha.2013.08.002; Francis J, 1998, MAR MAMMAL SCI, V14, P552, DOI 10.1111/j.1748-7692.1998.tb00742.x; Free Software Foundation Inc, 2016, GNU COMP COLL; Friedlander AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145059; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Goes CA, 2009, BRAZ J BIOL, V69, P143, DOI 10.1590/S1519-69842009000100018; Goni R, 1998, OCEAN COAST MANAGE, V40, P37, DOI 10.1016/S0964-5691(98)00037-4; Grabowski JH, 2009, NEW ZEAL J MAR FRESH, V43, P185, DOI 10.1080/00288330909509992; Guerrero A, 2009, LAT AM J AQUAT RES, V37, P347, DOI 10.3856/vol37-issue3-fulltext-6; Guest MA, 2009, MAR ECOL PROG SER, V388, P169, DOI 10.3354/meps08096; Halpern BS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8615; Heino M, 2015, ANNU REV ECOL EVOL S, V46, P461, DOI 10.1146/annurev-ecolsys-112414-054339; Hormazabal S, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001956; Horn PL, 2010, J FISH BIOL, V76, P2382, DOI 10.1111/j.1095-8649.2010.02630.x; Huvenne VAI, 2016, BIOL CONSERV, V200, P60, DOI 10.1016/j.biocon.2016.05.030; Ilustre Municipalidad de Juan Fernandez, 2015, ACT PLAN DES COM 2 1; Institute de Recherche pour le Developpement, 2018, ICHTH SIM ICHTH DYN; Johnson P, 2011, CHILD SOC, V25, P394, DOI 10.1111/j.1099-0860.2009.00288.x; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Komoroske LM, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00083; Kramer-Schadt S, 2007, ECOL MODEL, V204, P553, DOI 10.1016/j.ecolmodel.2007.01.018; Kruse G.H., 1993, BIOL PERSPECTIVES CR; Labbe F. Johnny, 2001, Revista de Biologia Marina y Oceanografia, V36, P75; Lett C, 2008, ENVIRON MODELL SOFTW, V23, P1210, DOI 10.1016/j.envsoft.2008.02.005; Levin PS, 2009, PLOS BIOL, V7, P23, DOI 10.1371/journal.pbio.1000014; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Liakath-Ali K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4540; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Linnane A, 2014, ICES J MAR SCI, V71, P528, DOI 10.1093/icesjms/fst176; Loh TL, 2015, PEERJ, V3, P16; MACE PM, 1990, NEW ZEAL J MAR FRESH, V24, P105, DOI 10.1080/00288330.1990.9516406; Manriquez  Pablo, 2016, CRECIMIENTO SOMATICO; Masumoto Y., 2004, J EARTH SIMULATOR, V1, P35; Mayorga E, 2010, ENVIRON MODELL SOFTW, V25, P837, DOI 10.1016/j.envsoft.2010.01.007; Medel C, 2018, PROG OCEANOGR, V162, P98, DOI 10.1016/j.pocean.2018.02.017; Niklitschek E, 2005, ESTIMACION BIOMASA R; Niklitschek E, 2007, INFORME FINAL EVALUA; Niklitschek EJ, 2010, MAR ECOL-EVOL PERSP, V31, P168, DOI 10.1111/j.1439-0485.2010.00372.x; Norse EA, 2012, MAR POLICY, V36, P307, DOI 10.1016/j.marpol.2011.06.008; Olsen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146467; Parada C, 2017, ICES J MAR SCI, V74, P2398, DOI 10.1093/icesjms/fsx065; Paya I, 2013, 2 INFORME CONVENIO E; Paya I, 2003, DEEP SEA 2003 C GO 2, V1, P97; Pequeno R. German, 2000, Investigaciones Marinas Universidad Catolica de Valparaiso, V28, P27; Perez-Matus A, 2014, LAT AM J AQUAT RES, V42, P814, DOI 10.3856/vol42-issue4-fulltext-9; Pitcher TJ, 2010, OCEANOGRAPHY, V23, P134, DOI 10.5670/oceanog.2010.66; Plaganyi E.E., 2007, MODELS ECOSYSTEM APP, V477; Plaganyi EE, 2014, FISH FISH, V15, P1, DOI 10.1111/j.1467-2979.2012.00488.x; Porobic J, 2013, ESTUDIO CONECTIVIDAD; Porobic J, 2013, J HERED, V104, P223, DOI 10.1093/jhered/ess141; Porobic J, 2012, LAT AM J AQUAT RES, V40, P613, DOI 10.3856/vol40-issue3-fulltext-11; Preciado I, 2017, DEEP-SEA RES PT II, V137, P56, DOI 10.1016/j.dsr2.2016.07.013; R Core Team, 2013, R LANG ENV STAT COMP; Rivara P, 2013, ESTUDIO BIOL REPROD; Rodrigo C, 2014, LAT AM J AQUAT RES, V42, P907, DOI 10.3856/vol42-issue4-fulltext-15; Rodriguez-Ruiz MC, 2014, LAT AM J AQUAT RES, V42, P918, DOI 10.3856/vol42-issue4-fulltext-16; Sasaki H, 2008, HIGH RESOLUTION NUMERICAL MODELLING OF THE ATMOSPHERE AND OCEAN, P157, DOI 10.1007/978-0-387-49791-4_10; Smith ADM, 2007, ICES J MAR SCI, V64, P633, DOI 10.1093/icesjms/fsm041; Steneck RS, 2006, J CRUSTACEAN BIOL, V26, P628, DOI 10.1651/S-2753.1; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Vargas R, 2011, BOSQUE, V32, P155, DOI 10.4067/S0717-92002011000200006; Waddington KI, 2009, FISH RES, V99, P1, DOI 10.1016/j.fishres.2009.04.002; White M, 2007, FISH AQUATIC RESOURC, P65; Wiff R, 2013, 2 INFORME CONVENIO E; Worm B, 2009, SCIENCE, V325, P578, DOI 10.1126/science.1173146; Yanez E, 2008, BIODIVERSIDAD MONTES; YANEZ E, 1996, INVEST MAR, V24, P131; Yanez E, 2009, LAT AM J AQUAT RES, V37, P555, DOI 10.3856/vol37-issue3-fulltext-20	97	9	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212485	10.1371/journal.pone.0212485	http://dx.doi.org/10.1371/journal.pone.0212485			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794609	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000459709100076
J	Miszczuk, GS; Banales, JM; Zucchetti, AE; Pisani, GB; Boaglio, AC; Saez, E; Medina, JF; Roma, MG; Crocenzi, FA				Miszczuk, Gisel S.; Banales, Jesus M.; Zucchetti, Andres E.; Pisani, Gerardo B.; Boaglio, Andrea C.; Saez, Elena; Medina, Juan F.; Roma, Marcelo G.; Crocenzi, Fernando A.			Adaptive downregulation of Cl-/HCO3- exchange activity in rat hepatocytes under experimental obstructive cholestasis	PLOS ONE			English	Article							MULTIDRUG-RESISTANCE PROTEIN-2; AQUAPORIN-8 WATER CHANNELS; PLASMA-MEMBRANE INSERTION; NITRIC-OXIDE PRODUCTION; SALT EXPORT PUMP; TRANSPORTER EXPRESSION; URSODEOXYCHOLIC ACID; BILE-ACIDS; INTRACELLULAR PH; LIVER	In obstructive cholestasis, there is an integral adaptive response aimed to diminish the bile flow and minimize the injury of bile ducts caused by increased intraluminal pressure and harmful levels of bile salts and bilirrubin. Canalicular bicarbonate secretion, driven by the anion exchanger 2 (AE2), is an influential determinant of the canalicular bile salt-independent bile flow. In this work, we ascertained whether AE2 expression and/or activity is reduced in hepatocytes from rats with common bile duct ligation (BDL), as part of the adaptive response to cholestasis. After 4 days of BDL, we found that neither AE2 mRNA expression (measured by quantitative real-time PCR) nor total levels of AE2 protein (assessed by western blot) were modified in freshly isolated hepatocytes. However, BDL led to a decrease in the expression of AE2 protein in plasma membrane fraction as compared with SHAM control. Additionally, AE2 activity (J(OH)-, mmol/L/min), measured in primary cultured hepatocytes from BDL and SHAM rats, was decreased in the BDL group versus the control group (1.9 +/- 0.3 vs. 3.1 +/- 0.2, p<0.005). cAMP-stimulated AE2 activity, however, was not different between SHAM and BDL groups (3.7 +/- 0.3 vs. 3.5 +/- 0.3), suggesting that cAMP stimulated insertion into the canalicular membrane of AE2-containing intracellular vesicles, that had remained abnormally internalized after BDL. In conclusion, our results point to the existence of a novel adaptive mechanism in cholestasis aimed to reduce biliary pressure, in which AE2 internalization in hepatocytes might result in decreased canalicular HCO3- output and decreased bile flow.	[Miszczuk, Gisel S.; Zucchetti, Andres E.; Boaglio, Andrea C.; Roma, Marcelo G.; Crocenzi, Fernando A.] Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Fisiol Expt IFISE, Rosario, Santa Fe, Argentina; [Banales, Jesus M.; Saez, Elena; Medina, Juan F.; Crocenzi, Fernando A.] Univ Navarra, CIMA, Div Gene Therapy & Hepatol, Pamplona, Spain; [Banales, Jesus M.] Univ Basque Country, Dept Liver & Gastrointestinal Dis, Biodonostia Res Inst, Donostia Univ Hosp,CIBERehd,Ikerbasque, Donostia San Sebastian, Spain; [Pisani, Gerardo B.] Univ Nacl Rosario, Area Morfol, Fac Ciencias Bioquim & Farmaceut, Rosario, Santa Fe, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; University of Navarra; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University Hospital Donostia; University of Basque Country; National University of Rosario	Crocenzi, FA (corresponding author), Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Fisiol Expt IFISE, Rosario, Santa Fe, Argentina.	crocenzi@ifise-conicet.gov.ar	Banales, Jesus M/R-9739-2019; Crocenzi, Fernando/P-7522-2018	Crocenzi, Fernando/0000-0001-6893-916X; Banales, Jesus/0000-0002-5224-2373; Saez De Blas, Elena/0000-0002-6494-9739; Zucchetti, Andres Ernesto/0000-0001-7067-1182	Spanish Carlos III Health Institute (ISCIII) - Fondo Europeo de Desarrollo Regional [FIS PI15/01132, PI18/01075, CON14/00129]; "Instituto de Salud Carlos III" [CIBERehd], Spain; BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia) [2017111010]; Department of Health of the Basque Country [2017111010]; Euskadi RIS3 [2016222001, 2017222014, 2018222029]; "Fundacion Cientifica de la Asociacion Espanola Contra el Cancer" (AECC Scientific Foundation); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina	Spanish Carlos III Health Institute (ISCIII) - Fondo Europeo de Desarrollo Regional; "Instituto de Salud Carlos III" [CIBERehd], Spain(Instituto de Salud Carlos III); BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia); Department of Health of the Basque Country(Basque Government); Euskadi RIS3; "Fundacion Cientifica de la Asociacion Espanola Contra el Cancer" (AECC Scientific Foundation); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Spanish Carlos III Health Institute (ISCIII) [J. M. Banales (FIS PI15/01132, PI18/01075 and Miguel Servet Program CON14/00129) cofinanced by "Fondo Europeo de Desarrollo Regional" (FEDER); "Instituto de Salud Carlos III" [CIBERehd: J. M. Banales], Spain; BIOEF (Basque Foundation for Innovation and Health Research: EiTB Maratoia BIO15/CA/016/BD to J. M. Banales), Department of Health of the Basque Country (J. M. Banales: 2017111010) and Euskadi RIS3 (J. M. Banales: 2016222001, 2017222014, 2018222029). "Fundacion Cientifica de la Asociacion Espanola Contra el Cancer" (AECC Scientific Foundation, to J. M. Banales). F. A. Crocenzi was recipient of a Young Investigator Scholarship from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVARO D, 1995, J CLIN INVEST, V96, P665, DOI 10.1172/JCI118109; Arenas F, 2008, J CLIN INVEST, V118, P695, DOI 10.1172/JCI33156; BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; Banales JM, 2006, WORLD J GASTROENTERO, V12, P3496, DOI 10.3748/wjg.v12.i22.3496; BENEDETTI A, 1994, P NATL ACAD SCI USA, V91, P792, DOI 10.1073/pnas.91.2.792; BENEDETTI A, 1991, AM J PHYSIOL, V261, pG512, DOI 10.1152/ajpgi.1991.261.3.G512; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; BOUSCAREL B, 1995, AM J PHYSIOL-GASTR L, V268, pG300, DOI 10.1152/ajpgi.1995.268.2.G300; Boyer JL, 2007, J HEPATOL, V46, P365, DOI 10.1016/j.jhep.2006.12.001; Boyer JL, 2006, AM J PHYSIOL-GASTR L, V290, pG1124, DOI 10.1152/ajpgi.00539.2005; BOYER JL, 1971, AM J PHYSIOL, V221, P1156, DOI 10.1152/ajplegacy.1971.221.4.1156; Carreras FI, 2003, HEPATOLOGY, V37, P1026, DOI 10.1053/jhep.2003.50170; Carreras FI, 2007, AM J PHYSIOL-GASTR L, V292, pG905, DOI 10.1152/ajpgi.00386.2006; CHAILLET JR, 1986, P NATL ACAD SCI USA, V83, P522, DOI 10.1073/pnas.83.2.522; Crocenzi FA, 2008, HEPATOLOGY, V48, P1885, DOI 10.1002/hep.22532; Desmet V., 1979, PATHOLOGY LIVER, P272; Donner MG, 2007, AM J PHYSIOL-GASTR L, V293, pG1134, DOI 10.1152/ajpgi.00079.2007; Esteller A, 2008, WORLD J GASTROENTERO, V14, P5641, DOI 10.3748/wjg.14.5641; Fernandez-Martinez E, 2006, EXP TOXICOL PATHOL, V58, P49, DOI 10.1016/j.etp.2006.03.002; Fickert P, 2002, GASTROENTEROLOGY, V123, P1238, DOI 10.1053/gast.2002.35948; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Geier A, 2007, BBA-MOL CELL RES, V1773, P283, DOI 10.1016/J.BBAMCR.2006.04.014; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gradilone SA, 2003, HEPATOLOGY, V37, P1435, DOI 10.1053/jhep.2003.50241; Gradilone Sergio A, 2005, BMC Physiol, V5, P13, DOI 10.1186/1472-6793-5-13; Hamazaki K, VIVO, V9, P109; Huebert RC, 2002, J BIOL CHEM, V277, P22710, DOI 10.1074/jbc.M202394200; KLOPPEL TM, 1987, AM J PHYSIOL, V253, pG232, DOI 10.1152/ajpgi.1987.253.2.G232; Kubitz R, 1999, GASTROENTEROLOGY, V116, P401, DOI 10.1016/S0016-5085(99)70138-1; Lee JM, 2000, GASTROENTEROLOGY, V118, P163, DOI 10.1016/S0016-5085(00)70425-2; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsuzaki Y, 1997, AM J PHYSIOL-GASTR L, V273, pG164, DOI 10.1152/ajpgi.1997.273.1.G164; Meier PJ, 2000, NEWS PHYSIOL SCI, V15, P89; Miszczuk GS, 2018, BBA-MOL BASIS DIS, V1864, P1072, DOI 10.1016/j.bbadis.2018.01.015; NATHANSON MH, 1991, HEPATOLOGY, V14, P551, DOI 10.1002/hep.1840140324; Paulusma CC, 2000, HEPATOLOGY, V31, P684, DOI 10.1002/hep.510310319; Rao YP, 1997, J LIPID RES, V38, P2446; Slitt AL, 2007, BBA-BIOMEMBRANES, V1768, P637, DOI 10.1016/j.bbamem.2006.10.008; Spirli C, 2003, GASTROENTEROLOGY, V124, P737, DOI 10.1053/gast.2003.50100; Storrie Brian, 1996, Bioessays, V18, P895, DOI 10.1002/bies.950181108; Tietz P, 2005, J LIPID RES, V46, P1426, DOI 10.1194/jlr.M400412-JLR200; Trauner M, 2003, PHYSIOL REV, V83, P633, DOI 10.1152/physrev.00027.2002; Tu W, 2002, J SURG RES, V106, P31, DOI 10.1006/jsre.2002.6436; Wagner M, 2003, GASTROENTEROLOGY, V125, P825, DOI 10.1016/S0016-5085(03)01068-0; Zollner G, 2003, J HEPATOL, V38, P717, DOI 10.1016/S0168-8278(03)00096-5; Zollner G, 2006, MOL PHARMACEUT, V3, P231, DOI 10.1021/mp060010s	46	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212215	10.1371/journal.pone.0212215	http://dx.doi.org/10.1371/journal.pone.0212215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789925	Green Submitted, Green Published, gold			2022-12-26	WOS:000459330800020
J	Hirano, D; Urabe, Y; Tanaka, S; Nakamura, K; Ninomiya, Y; Yuge, R; Hayashi, R; Oka, S; Kitadai, Y; Shimamoto, F; Arihiro, K; Chayama, K				Hirano, Daiki; Urabe, Yuji; Tanaka, Shinji; Nakamura, Koki; Ninomiya, Yuki; Yuge, Ryo; Hayashi, Ryohei; Oka, Shiro; Kitadai, Yasuhiko; Shimamoto, Fumio; Arihiro, Koji; Chayama, Kazuaki			Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes	PLOS ONE			English	Article							COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CHROMOSOMAL INSTABILITY; CDX2 EXPRESSION; POOR-PROGNOSIS; COLON-CANCER; FEATURES; BRAF; ADENOMA; DIFFERENTIATION	Serrated adenocarcinoma (SAC) is considered the end stage of the serrated neoplasia pathway. Although SAC prognosis is not widely recognized, the serrated pathway-associated subtype consistently exhibits unfavorable prognosis in genetic studies. Herein, we classified molecularly distinct subtypes of serrated adenocarcinomas and clarified their associated clinicopathological characteristics and genetic changes. We examined 38 early-stage colorectal SACs. Of these, 24 were classified into three molecularly distinct groups by colon cancer subtyping (CCS). The clinicopathological characteristics, Ki 67 labeling index (LI), and SAC epithelial serration were assessed. The DNA from carcinomas and normal tissue/adenoma was extracted by laser microdissection and sequenced by next-generation sequencing, and mutation numbers and patterns of a 15-oncogene panel were determined. The CCS groups included CCS1 (CDX2+, HTR2B-, FRMD6-, ZEB1-, and microsatellite instable-low [MSI-L]/microsatellite stable [MSS]; 14 cases), CCS2 (microsatellite instable-high [MSI-H], 5 cases), and CCS3 (CDX2-, HTR2B+, FRMD6+, ZEB1+, and MSI-L/MSS; 5 cases). Invasive cancer was significantly more frequent in CCS3 than in CCS1 (5/5 versus 3/14, respectively). Ki67 LI and epithelial serration were higher in CCS3 than in CCS1 (83.0 +/- 5.8 versus 65.4 +/- 4.0 and 5/5 versus 3/14, respectively; p=0.031 and 0.0048). CCS2 showed the highest mutation number, whereas KRAS and BRAF mutation numbers were higher in CCS3 than in CCS1. Early-stage SACs were classified into three molecularly distinct subtypes with different clinicopathological and genetic characteristics.	[Hirano, Daiki; Nakamura, Koki; Oka, Shiro; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Grad Sch Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Urabe, Yuji] Hiroshima Univ Hosp, Dept Regenerat & Med, Med Ctr Translat & Clin Res, Hiroshima, Japan; [Tanaka, Shinji; Ninomiya, Yuki; Yuge, Ryo; Hayashi, Ryohei] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Kitadai, Yasuhiko] Prefectural Univ Hiroshima, Dept Fac Human Culture & Sci, Hiroshima, Japan; [Shimamoto, Fumio] Hiroshima Shudo Univ Hiroshima, Fac Humanities & Human Sci, Hiroshima, Japan; [Arihiro, Koji] Hiroshima Univ Hosp, Dept Anat Pathol, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University; Hiroshima University	Urabe, Y (corresponding author), Hiroshima Univ Hosp, Dept Regenerat & Med, Med Ctr Translat & Clin Res, Hiroshima, Japan.	beyan13@hiroshima-u.ac.jp	Oka, Shiro/AAZ-8368-2021; Kitadai, Yasuhiko/AAG-4389-2021; 北台, 靖彦/AAH-1678-2021	北台, 靖彦/0000-0002-8743-3815; Chayama, Kazuaki/0000-0002-5530-5341; Urabe, Yuji/0000-0003-0942-1541	JSPS KAKENHI [17K09476]; Tuchiya Memorial Medical Promotion Fund; Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Tuchiya Memorial Medical Promotion Fund; Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University; Nagasaki University; Fukushima Medical University	Y.U. have financial relationships to disclose. Next-generation sequencing was carried out at the Analysis Center of Life Science, Hiroshima University (https://www.hiroshima-u.ac.jp). Reagents for a portion of targeted enrichment and next-generation sequencing were provided by Illumina (https://jp.illumina.com/?gclid=EAIaIQobChMIrsDXhrfp3AIVkLaWCh3UxggfEAAYASAAEgJY-vD_BwE). This work was supported by JSPS KAKENHI (grant no. 17K09476), (https://www.jsps.go.jp/english/e-grants/index.html) and Tuchiya Memorial Medical Promotion Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The MSI analysis was supported by the Program of the Network-Type Joint Usage/Research Center for Radiation Disaster Medical Science of Hiroshima University, Nagasaki University, and Fukushima Medical University. Next-generation sequencing was carried out at the Analysis Center of Life Science, Hiroshima University.	Ali M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15617; Aoki K, 2003, NAT GENET, V35, P323, DOI 10.1038/ng1265; Baba Y, 2009, CLIN CANCER RES, V15, P4665, DOI 10.1158/1078-0432.CCR-09-0401; Bae JM, 2015, WORLD J GASTROENTERO, V21, P1457, DOI 10.3748/wjg.v21.i5.1457; Banerjea A, 2003, ANAL BIOCHEM, V322, P130, DOI 10.1016/j.ab.2003.07.006; Boland CR, 1998, CANCER RES, V58, P5248; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Dalerba P, 2016, NEW ENGL J MED, V374, P211, DOI 10.1056/NEJMoa1506597; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao N, 2009, DEV CELL, V16, P588, DOI 10.1016/j.devcel.2009.02.010; Garcia-Solano J, 2010, HUM PATHOL, V41, P1359, DOI 10.1016/j.humpath.2010.04.002; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Guo RJ, 2004, CANCER BIOL THER, V3, P593, DOI 10.4161/cbt.3.7.913; Gurzu S, 2012, PATHOL RES PRACT, V208, P163, DOI 10.1016/j.prp.2012.01.003; Hirano D, 2017, BMC GASTROENTEROL, V17, DOI 10.1186/s12876-017-0702-x; JASS JR, 1992, PATHOLOGY, V24, P233, DOI 10.3109/00313029209068874; Kaimaktchiev V, 2004, MODERN PATHOL, V17, P1392, DOI 10.1038/modpathol.3800205; Laiho P, 2007, ONCOGENE, V26, P312, DOI 10.1038/sj.onc.1209778; Lee CT, 2017, ONCOTARGET, V8, P35165, DOI 10.18632/oncotarget.16815; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Lugli A, 2008, MODERN PATHOL, V21, P1403, DOI 10.1038/modpathol.2008.117; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; Makinen MJ, 2001, J PATHOL, V193, P286, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH800>3.0.CO;2-2; Michael-Robinson JM, 2001, GUT, V48, P360, DOI 10.1136/gut.48.3.360; Moran A, 2010, WORLD J GASTRO ONCOL, V2, P151, DOI 10.4251/wjgo.v2.i3.151; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Oka S, 2004, GASTROINTEST ENDOSC, V59, P213, DOI 10.1016/S0016-5107(03)02693-2; Pilati C, 2017, ANN ONCOL, V28, P1032, DOI 10.1093/annonc/mdx066; Pino MS, 2010, GASTROENTEROLOGY, V138, P2059, DOI 10.1053/j.gastro.2009.12.065; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Shida Y, 2012, PATHOBIOLOGY, V79, P169, DOI 10.1159/000334837; Silberg DG, 2000, GASTROENTEROLOGY, V119, P961, DOI 10.1053/gast.2000.18142; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Stefanius K, 2011, HISTOPATHOLOGY, V58, P679, DOI 10.1111/j.1365-2559.2011.03821.x; Sugihara K, 2009, JAP CLASS COL CARC, P1; Urabe Y, 2013, J HEPATOL, V58, P875, DOI 10.1016/j.jhep.2012.12.024; Vilar E, 2010, NAT REV CLIN ONCOL, V7, P153, DOI 10.1038/nrclinonc.2009.237; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Yao T, 2000, J PATHOL, V190, P444, DOI 10.1002/(SICI)1096-9896(200003)190:4<444::AID-PATH520>3.0.CO;2-O; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042	42	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211477	10.1371/journal.pone.0211477	http://dx.doi.org/10.1371/journal.pone.0211477			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785889	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000027
J	Wasir, R; Irawati, S; Makady, A; Postma, M; Goettsch, W; Buskens, E; Feenstra, T				Wasir, Riswandy; Irawati, Sylvi; Makady, Amr; Postma, Maarten; Goettsch, Wim; Buskens, Erik; Feenstra, Talitha			Use of medicine pricing and reimbursement policies for universal health coverage in Indonesia	PLOS ONE			English	Article							QUALITATIVE RESEARCH; PERFORMANCE; FOCUS; CARE; PAY	Objectives This study aimed to define the problems of the current use of the e-Catalogue and the national formulary (NF)-two elements of medicine pricing and reimbursement policies in Indonesia for achieving universal health coverage (UHC)-by examining the knowledge and attitudes of stakeholders. Specifically, to investigate (1) the perceived challenges involved in the further implementation of the e-Catalogue and the NF, (2) reasons of prescribing medicines not listed in the NF, and (3) possible improvements in the acceptance and use of the e-Catalogue and the NF. Methods Semi-structured interviews were conducted with stakeholders (policymakers, healthcare providers, a pharmaceutical industry representative, and experienced patients) to collect the qualitative data. The data was analysed using directed content analysis, following the guidelines of the COnsolidated criteria for REporting Qualitative studies (COREQ) in reporting the findings. Results Interestingly, 20 of 45 participants decided to withdraw from the interview due to their lack of knowledge of the e-Catalogue and the NF. All 25 stakeholders who fully participated in this research were in favor of the e-Catalogue and the NF. However, interviewees identified a range of challenges. A major challenge was the lack of harmonization between the lists of medicines in the e-Catalogue and the NF. Several system and personal reasons for prescribing medicines not listed in the NF were identified. Important reasons were a lack of incentives for physicians as well as a lack of transparent and evidence-based methods of selection for the medicines to be listed in the NF. Conclusions The e-Catalogue and the NF have not been fully utilized for achieving UHC in Indonesia. Some possible improvements suggested were harmonization of medicines listed in the e-Catalogue and the NF, restructuring incentive programs for prescribing NF medicines, and increasing the transparency and evidence-based approach for selection of medicines listed in the e-Catalogue and the NF.	[Wasir, Riswandy; Buskens, Erik; Feenstra, Talitha] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wasir, Riswandy] Sekolah Tinggi Ilmu Farmasi Makassar, Makassar, Indonesia; [Wasir, Riswandy; Irawati, Sylvi; Postma, Maarten] Univ Groningen, Groningen Res Inst Pharm PharmacoTherapy Epidemio, Groningen, Netherlands; [Irawati, Sylvi] Univ Surabaya, Ctr Med Informat & Pharmaceut Care, Fac Pharm, Surabaya, Indonesia; [Irawati, Sylvi] Univ Surabaya, Dept Clin & Community Pharm, Fac Pharm, Surabaya, Indonesia; [Makady, Amr; Goettsch, Wim] Natl Hlth Care Inst, Diemen, Netherlands; [Makady, Amr; Goettsch, Wim] Univ Utrecht, Dept Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Postma, Maarten] Univ Groningen, Dept Hlth Sci, Groningen, Netherlands; [Postma, Maarten] Univ Groningen, Dept Econ Econometr & Finance, Fac Econ & Business, Groningen, Netherlands; [Postma, Maarten] Univ Airlangga, Dept Pharmacol & Therapy, Fac Med, Surabaya, Indonesia; [Buskens, Erik] Univ Groningen, Fac Econ & Business, Dept Operat, Groningen, Netherlands; [Feenstra, Talitha] Dutch Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands	University of Groningen; University of Groningen; Universitas Surabaya (UBAYA); Universitas Surabaya (UBAYA); Utrecht University; University of Groningen; University of Groningen; Airlangga University; University of Groningen	Wasir, R (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.; Wasir, R (corresponding author), Sekolah Tinggi Ilmu Farmasi Makassar, Makassar, Indonesia.; Wasir, R (corresponding author), Univ Groningen, Groningen Res Inst Pharm PharmacoTherapy Epidemio, Groningen, Netherlands.	r.wasir@umcg.nl	Feenstra, Talitha/AAM-3234-2020; Irawati, Sylvi/GLQ-9438-2022	Feenstra, Talitha/0000-0002-5788-0454; Irawati, Sylvi/0000-0001-6278-9017; buskens, erik/0000-0002-6463-1106; Wasir, Riswandy/0000-0001-6184-925X; Postma, Maarten/0000-0002-6306-3653	DIKTI scholarship from the Ministry of Research, Technology and Higher Education; LPDP scholarship from the Ministry of Finance of the Republic Indonesia	DIKTI scholarship from the Ministry of Research, Technology and Higher Education(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); LPDP scholarship from the Ministry of Finance of the Republic Indonesia	This work was financially supported by DIKTI (to RW) and LPDP (to SI) scholarships from the Ministry of Research, Technology and Higher Education, and the Ministry of Finance of the Republic Indonesia, respectively. The DIKTI and LPDP had no direct role in research design, data collection, analysis and interpretation, or manuscript writing and publication.	Angelis A, 2018, EUR J HEALTH ECON, V19, P123, DOI 10.1007/s10198-017-0871-0; [Anonymous], 2013, MALAYSIA HEAL SYST R, V3, P103; [Anonymous], 2010, WOR HEALT REP; Ariati N., 2017, INTEGRITAS, V3, P231; Babar Z, 2017, PHARM POLICY COUNTRI; Bigdeli M, 2015, MED UNIVERSAL HLTH C; BPJS Kesehatan, 2014, PAND PRAKT PROL PROG; Cameron A, 2009, LANCET, V373, P240, DOI 10.1016/S0140-6736(08)61762-6; Chalkidou K, 2013, LANCET, V382, pE48, DOI 10.1016/S0140-6736(13)62559-3; Diack A, 2010, ASSESSMENT GOVERNANC; Dirjen Binfar dan Alkes Kemenkes RI, 2015, IMPL FORM NAS DAL PE; Doran T, 2006, NEW ENGL J MED, V355, P375, DOI 10.1056/NEJMsa055505; Fahamnuaypol P., 2015, KINGDOM THAILAND HLT; Godman B, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00106; Gustafsson LL, 2011, BASIC CLIN PHARMACOL, V108, P224, DOI 10.1111/j.1742-7843.2011.00682.x; Hawkins L., 2011, WHO HAI PROJECT MED; Hidayat B, 2015, OUT POCKET PAYMENTS; Holloway KA., 2011, MISSION REPORT, P30; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Kemetrian Kesehatan Republik Indonesia, 2015, PED PEN FORM NAS; Kibuule D, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12918; Leach M, 2012, BRIT J GEN PRACT, V62, P293, DOI 10.3399/bjgp12X649061; Lembaga Kebijakan Pengadaan Barang dan Jasa Pemerintah (LKPP), 2018, KAT PROD OB 2018; Mashalla Y. J., 2016, Journal of Public Health and Epidemiology, V8, P127; MAYS N, 1995, BRIT MED J, V311, P182, DOI 10.1136/bmj.311.6998.182; Menteri Kesehatan Republik Indonesia, 2014, PER MENT KES REP IND, DOI [10.3389/fphar.2014.00106, DOI 10.3389/FPHAR.2014.00106]; Menteri Kesehatan Republik Indonesia, 2015, PED PEN FORM NAS; Ministry of Health Malaysia, 2012, MAL NAT MED POL; Nguyen TA, 2017, PHARM POLICY COUNTRI, P75; Rickwood S, 2013, IMS I HEALTHCARE INF, P5; Soonman Kwon, 2014, PHARM POLICY FINANCI; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Nguyen TA, 2015, HEALTH POLICY PLANN, V30, P267, DOI 10.1093/heapol/czt105; Wettermark B, 2009, APPL HEALTH ECON HEA, V7, P137, DOI 0.2165/11314810-000000000-00000; WHO, 2016, WORLD HLTH STAT 2016; WHO, GLOB HLTH EXP DAT; Whyte P, 2013, ROLE HLTH TECHNOLOGY; Wirtz VJ, 2017, LANCET, V389, P403, DOI 10.1016/S0140-6736(16)31599-9; World Health Organization, 2015, WHO GUID COUNTR PHAR; World Health Organization, WHO DEF EB 134 30	41	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212328	10.1371/journal.pone.0212328	http://dx.doi.org/10.1371/journal.pone.0212328			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779809	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000459062900047
J	Mascaro, C; Ortega, A; Carceller, E; Rodriguez, RR; Ciceri, F; Lunardi, S; Yu, L; Hilbert, M; Maes, T				Mascaro, Cristina; Ortega, Alberto; Carceller, Elena; Ruiz Rodriguez, Raquel; Ciceri, Filippo; Lunardi, Serena; Yu, Li; Hilbert, Manuel; Maes, Tamara			Chemoprobe-based assays of histone lysine demethylase 1A target occupation enable in vivo pharmacokinetics and pharmacodynamics studies of KDM1A inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						epigenetics; enzyme inactivation; pharmacokinetics; protein-drug interaction; drug development; chemoprobe; chemoproteomics; lysine demethylase; histone demethylase; FAD; translational studies; target engagement; chromatin modification; histone lysine demethylase (KDM)	ACTIVITY-BASED PROBES; FAMILY; POTENT	Screening of cellular activity for inhibitors of histone lysine modifiers is most frequently performed indirectly by analyzing changes in the total levels of histone marks targeted by lysine methylases/demethylases. However, inhibition of histone lysine modifiers often leads to local rather than total changes in histone marks. Also, because histone modifications can be modulated by more than one cellular enzyme, it is not always clear whether changes in histone marks are a direct or indirect consequence of the inhibitor treatment applied. Direct assessment of target occupation can provide a useful tool to quantify the fraction of an epigenetic modifier that is bound to a pharmacological inhibitor (target engagement). Here, we developed and used a novel chemoprobe-based immunoassay to quantify target engagement in cells. Quantification of the fraction of free KDM1A was made possible, in an immune-based assay, by coupling a biotinylated chemoprobe to a warhead capable of selectively and irreversibly binding to the free active form of KDM1A. The results obtained confirmed that this approach is able to determine the degree of target engagement in a dose-dependent manner. Furthermore, the assay can be also used on tissue extracts to analyze the in vivo pharmacokinetics and pharmacodynamics relationship of KDM1A inhibitors, as has been exemplified with ORY-1001 (iadademstat), a potent and irreversible inhibitor of KDM1A. The principle of this assay may be applied to other targets, and the KDM1A probe may be employed in chemoproteomic analyses.	[Mascaro, Cristina; Ortega, Alberto; Carceller, Elena; Ruiz Rodriguez, Raquel; Ciceri, Filippo; Lunardi, Serena; Maes, Tamara] Oryzon Genom SA, Carrer St Ferran 74, Barcelona 08940, Spain; [Yu, Li] Roche Innovat Ctr New York, New York, NY 10016 USA; [Hilbert, Manuel] Roche Innovat Ctr Basel, Grenzacherstr 124, CH-4070 Basel, Switzerland	Oryzon Genomics, SA; Roche Holding	Maes, T (corresponding author), Oryzon Genom SA, Carrer St Ferran 74, Barcelona 08940, Spain.	tmaes@oryzon.com		Maes, Tamara/0000-0001-5104-6867				Bantscheff M, 2011, NAT BIOTECHNOL, V29, P255, DOI 10.1038/nbt.1759; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Becher I, 2014, ACS CHEM BIOL, V9, P1736, DOI 10.1021/cb500235n; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Cervelli M, 2003, J BIOL CHEM, V278, P5271, DOI 10.1074/jbc.M207888200; Fiskus W, 2014, LEUKEMIA, V28, P2155, DOI 10.1038/leu.2014.119; Forneris F, 2005, J BIOL CHEM, V280, P41360, DOI 10.1074/jbc.M509549200; Gonzales E.C., 2017, Patent, Patent No. [WO2017158136, 2017158136]; Harris WJ, 2012, CANCER CELL, V21, P473, DOI 10.1016/j.ccr.2012.03.014; Hitchin JR, 2013, MEDCHEMCOMM, V4, P1513, DOI 10.1039/c3md00226h; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Maes T, 2017, ALZHEIMERS DEMENT, V13; Maes T, 2018, CANCER CELL, V33, P495, DOI 10.1016/j.ccell.2018.02.002; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Ortega Munoz A, 2013, (Hetero)Aryl Cyclopropylamine Compounds as LSD1 Inhibitors, Patent No. [WO2013/057320, 2013057320]; Ourailidou ME, 2017, BIOORGAN MED CHEM, V25, P847, DOI 10.1016/j.bmc.2016.11.043; Pollock JA, 2012, ACS CHEM BIOL, V7, P1221, DOI 10.1021/cb300108c; Rasmussen PB, 2014, EPIGENOMICS-UK, V6, P277, DOI [10.2217/epi.14.14, 10.2217/EPI.14.14]; Salisbury CM, 2007, P NATL ACAD SCI USA, V104, P1171, DOI 10.1073/pnas.0608659104; Schenk T, 2012, NAT MED, V18, P605, DOI 10.1038/nm.2661; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Sorna V, 2013, J MED CHEM, V56, P9496, DOI 10.1021/jm400870h; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Xu CP, 2009, CHEM BIOL, V16, P980, DOI 10.1016/j.chembiol.2009.07.010; Yang MJ, 2007, BIOCHEMISTRY-US, V46, P8058, DOI 10.1021/bi700664y; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294	26	11	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 17	2019	294	20					8311	8322		10.1074/jbc.RA118.006980	http://dx.doi.org/10.1074/jbc.RA118.006980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	IC0NH	30804215	hybrid, Green Published			2022-12-26	WOS:000470656500028
J	Lay, FT; Ryan, GF; Caria, S; Phan, TK; Veneer, PK; White, JA; Kvansakul, M; Hulett, MD				Lay, Fung T.; Ryan, Gemma F.; Caria, Sofia; Thanh Kha Phan; Veneer, Prem K.; White, Julie A.; Kvansakul, Marc; Hulett, Mark D.			Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis	FASEB JOURNAL			English	Article						antimicrobial peptide; cell permeabilization; X-ray crystallography; anticancer; innate immunity	CATIONIC ANTIMICROBIAL PEPTIDES; PLANT DEFENSIN; BELL PEPPER; INHIBITION; EXPRESSION; SEQUENCE; SYSTEM; FAMILY; GENE; NAD1	Defensins are an extensive family of host defense peptides found ubiquitously across plant and animal species. In addition to protecting against infection by pathogenic microorganisms, some defensins are selectively cytotoxic toward tumor cells. As such, defensins have attracted interest as potential antimicrobial and anticancer therapeutics. The mechanism of defensin action against microbes and tumor cells appears to be conserved and involves the targeting and disruption of cellular membranes. This has been best defined for plant defensins, which upon binding specific phospholipids, such as phosphatidylinositol 4,5-bisphosphate (PIP2) and phosphatidic acid, form defensin-lipid oligomeric complexes that destabilize membranes, leading to cell lysis. In this study, to further define the anticancer and therapeutic properties of plant defensins, we have characterized a novel plant defensin, Nicotiana occidentalis defensin 173 (NoD173), from N. occidentalis. NoD173 at low micromolar concentrations selectively killed a panel of tumor cell lines over normal primary cells. To improve the anticancer activity of NoD173, we explored increasing cationicity by mutation, with NoD173 with the substitution of Q22 with lysine [NoD173(Q22K)], increasing the antitumor cell activity by 2-fold. NoD173 and the NoD173(Q22K) mutant exhibited only low levels of hemolytic activity, and both maintained activity against tumor cells in serum. The ability of NoD173 to inhibit solid tumor growth in vivo was tested in a mouse B16-F1 model, whereby injection of NoD173 into established subcutaneous tumors significantly inhibited tumor growth. Finally, we showed that NoD173 specifically targets PIP2 and determined by X-ray crystallography that a high-resolution structure of NoD173, which forms a conserved family-defining cysteine-stabilized- motif with a dimeric lipid-binding conformation, configured into an arch-shaped oligomer of 4 dimers. These data provide insights into the mechanism of how defensins target membranes to kill tumor cells and provide proof of concept that defensins are able to inhibit tumor growth in vivo.Lay, F. T., Ryan, G. F., Caria, S., Phan, T. K., Veneer, P. K., White, J. A., Kvansakul, M., Hulett M. D. Structural and functional characterization of the membrane-permeabilizing activity of Nicotiana occidentalis defensin NoD173 and protein engineering to enhance oncolysis.	[Lay, Fung T.; Ryan, Gemma F.; Caria, Sofia; Thanh Kha Phan; Veneer, Prem K.; White, Julie A.; Kvansakul, Marc; Hulett, Mark D.] La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, LIMS1 Rm 518, Melbourne, Vic 3086, Australia	La Trobe University	Kvansakul, M; Hulett, MD (corresponding author), La Trobe Univ, Dept Biochem & Genet, La Trobe Inst Mol Sci, LIMS1 Rm 518, Melbourne, Vic 3086, Australia.	m.kvansakul@latrobe.edu.au; m.hulett@latrobe.edu.au	Phan, Thanh Kha/AAD-4969-2019; Kvansakul, Marc/AAF-2453-2019; Lay, Fung T./A-9043-2010	Kvansakul, Marc/0000-0003-2639-2498; Caria, Sofia/0000-0001-7289-2093; Hulett, Mark/0000-0003-2072-5968; Lay, Fung T./0000-0002-3101-3782; Phan, Thanh Kha/0000-0001-5802-1603	Hexima; Australian Research Council [FT130101349]; Balmoral Proprietary	Hexima; Australian Research Council(Australian Research Council); Balmoral Proprietary	The authors thank the MX2 Beamline staff at the Australian Synchrotron (Clayton, VIC, Australia) for help with X-ray data collection and Janet Newman and Shane Seabrook at the Commonwealth Scientific and Industrial Research Organisation Collaborative Crystallisation Centre (Parkville, VIC, Australia) for assistance with crystallization. The authors thank Christopher Adda (La Trobe University) for the Nicotiana occidentalis defensin 173 antibody and staff at the Comprehensive Proteomic Platform (La Trobe Institute for Molecular Science, La Trobe University) for assistance with mass spectrometry analyses. The authors acknowledge funding from Hexima and Balmoral Proprietary. This work was supported, in part, by the Australian Research Council (Fellowship FT130101349 to M.K.). The authors declare no conflicts of interest.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baxter AA, 2017, CELL MOL LIFE SCI, V74, P3809, DOI 10.1007/s00018-017-2604-z; Baxter AA, 2015, MOL CELL BIOL, V35, P1964, DOI 10.1128/MCB.00282-15; Beck T, 2008, ACTA CRYSTALLOGR D, V64, P1179, DOI 10.1107/S0907444908030266; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chu HT, 2012, SCIENCE, V337, P477, DOI 10.1126/science.1218831; COLILLA FJ, 1990, FEBS LETT, V270, P191, DOI 10.1016/0014-5793(90)81265-P; Cools TL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02051; Dracatos PM, 2014, MOL PLANT PATHOL, V15, P67, DOI 10.1111/mpp.12066; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gaspar D., 2016, HOST DEFENSE PEPTIDE, P95; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hancock REW, 2000, TRENDS MICROBIOL, V8, P402, DOI 10.1016/S0966-842X(00)01823-0; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Houlne G, 1998, MOL GEN GENET, V259, P504, DOI 10.1007/s004380050841; Islam KT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16508-w; Jarva M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0979; Jarva M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04434-y; Jarva M, 2017, FEBS LETT, V591, P2482, DOI 10.1002/1873-3468.12761; KARUNANANDAA B, 1994, PLANT MOL BIOL, V26, P459, DOI 10.1007/BF00039555; Komori T., 1997, PLANT PHYSIOL, V115, P314; Kushmerick C, 1998, FEBS LETT, V440, P302, DOI 10.1016/S0014-5793(98)01480-X; Kvansakul M, 2016, P NATL ACAD SCI USA, V113, P11202, DOI 10.1073/pnas.1607855113; Lay F. T, 2003, THESIS; Lay FT, 2005, CURR PROTEIN PEPT SC, V6, P85, DOI 10.2174/1389203053027575; Lay FT, 2003, PLANT PHYSIOL, V131, P1283, DOI 10.1104/pp.102.016626; Lay FT, 2003, J MOL BIOL, V325, P175, DOI 10.1016/S0022-2836(02)01103-8; Lay FT, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-41; Lay FT, 2012, J BIOL CHEM, V287, P19961, DOI 10.1074/jbc.M111.331009; Lay FT, 2012, ACTA CRYSTALLOGR F, V68, P314, DOI 10.1107/S1744309112001510; Mader JS, 2006, EXPERT OPIN INV DRUG, V15, P933, DOI 10.1517/13543784.15.8.933; Mahlapuu M, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00194; Mendez E, 1996, EUR J BIOCHEM, V239, P67, DOI 10.1111/j.1432-1033.1996.0067u.x; MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x; Meyer B, 1996, PLANT PHYSIOL, V112, P615, DOI 10.1104/pp.112.2.615; Meyer PA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10882; Mirouze M, 2006, PLANT J, V47, P329, DOI 10.1111/j.1365-313X.2006.02788.x; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Parisi K, 2019, SEMIN CELL DEV BIOL, V88, P107, DOI 10.1016/j.semcdb.2018.02.004; Phan TK, 2016, ONCOTARGET, V7, P2054, DOI 10.18632/oncotarget.6520; POON I, 2014, WHITE, V3, DOI DOI 10.7554/ELIFE.01808; Raschig J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006261; Riedl S, 2011, CHEM PHYS LIPIDS, V164, P766, DOI 10.1016/j.chemphyslip.2011.09.004; Sagaram US, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018550; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Shafee TMA, 2017, CELL MOL LIFE SCI, V74, P663, DOI 10.1007/s00018-016-2344-5; Shafee TMA, 2016, MOL BIOL EVOL, V33, P2345, DOI 10.1093/molbev/msw106; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; Phan TK, 2018, IMMUNOL CELL BIOL, V96, P54, DOI 10.1111/imcb.1017; van der Weerden NL, 2008, J BIOL CHEM, V283, P14445, DOI 10.1074/jbc.M709867200; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Vriens K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32121; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Yamada S., 1997, PLANT PHYSIOL, V115, P314	58	14	15	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6470	6482		10.1096/fj.201802540R	http://dx.doi.org/10.1096/fj.201802540R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794440	Bronze			2022-12-26	WOS:000466932600052
J	Mahajan, N; Hoover, B; Rajendram, M; Shi, HY; Kawasak, K; Weibel, DB; Zhang, M				Mahajan, Nitin; Hoover, Brandon; Rajendram, Manohary; Shi, Heidi Y.; Kawasak, Kiyoshi; Weibel, Douglas B.; Zhang, Ming			Maspin binds to cardiolipin in mitochondria and triggers apoptosis	FASEB JOURNAL			English	Article						diphosphatidylglycerol; cytochrome c; mitochondrial membranes; anionic phospholipids	CYTOCHROME-C RELEASE; TUMOR-CELL APOPTOSIS; PHOSPHATIDYLSERINE; PHAGOCYTOSIS; RECOGNITION; LYMPHOCYTES; MECHANISMS; EXPRESSION; EXPOSURE; PROTEIN	A central question in cell biology is how cells respond to stress signals and biochemically regulate apoptosis. One critical pathway involves the change of mitochondrial function and release of cytochrome c to initiate apoptosis. In response to apoptotic stimuli, we found that maspina noninhibitory member of the serine protease inhibitor superfamilytranslocates from the cytosol to mitochondria and binds to cardiolipin in the inner mitochondrial membrane. Biolayer interferometry assay revealed that recombinant maspin binds cardiolipin with an apparent K-d,of approximate to 15.8 M and competes with cytochrome c (apparent K-d of approximate to 1.31 M) for binding to cardiolipin-enriched membranes. A hydrophobic, lysine-rich domain in maspin consists of 27 aa, is located at position 268-294, and is responsible for the interaction of this protein with cardiolipin. Depletion of cardiolipin in cells significantly prevents maspin binding to the inner mitochondrial membrane and decreases cytochrome c release and apoptosis. Alteration to maspin's cardiolipin binding domain changes its ability to bind cardiolipin, and tumor cells expressing this mutant have a low frequency of apoptosis. We propose a model of apoptosis in which maspin binds to cardiolipin, displaces cytochrome c from the membrane, and facilitates its release to the cytoplasm.Mahajan, N., Hoover, B., Rajendram, M., Shi, H. Y., Kawasaki, K., Weibel, D. B., Zhang, M. Maspin binds to cardiolipin in mitochondria and triggers apoptosis.	[Mahajan, Nitin; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Dept Biochem & Mol Genet, Feinberg Sch Med, Chicago, IL 60611 USA; [Mahajan, Nitin; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Olson 8-452,710 N Fairbanks Ct, Chicago, IL 60611 USA; [Hoover, Brandon; Rajendram, Manohary; Weibel, Douglas B.] Univ Wisconsin, Dept Biochem, 440 Henry Mall, Madison, WI 53706 USA; [Weibel, Douglas B.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Kawasak, Kiyoshi] Doshisha Womens Univ, Fac Pharmaceut Sci, Kyoto, Japan	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, M (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Feinberg Sch Med, Olson 8-452,710 N Fairbanks Ct, Chicago, IL 60611 USA.; Weibel, DB (corresponding author), Univ Wisconsin, Dept Biochem, 440 Henry Mall, Madison, WI 53706 USA.	douglas.weibel@wisc.edu; m-zhang@northwestern.edu			U.S. National Institutes of Health (NIH) National Cancer Institute [CA079736]; NIH Office of the Director [1DP2OD008735-01]; U.S. National Science Foundation [DMR-1121288]; NIH Molecular Biophysics Predoctoral Traineeship [T32 GM08293]; Northwestern University Zell Foundation; Dr. James Chieh-Hsia Mao Wisconsin Distinguished Graduate Fellowship	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Science Foundation(National Science Foundation (NSF)); NIH Molecular Biophysics Predoctoral Traineeship; Northwestern University Zell Foundation; Dr. James Chieh-Hsia Mao Wisconsin Distinguished Graduate Fellowship	The authors thank Dr. M. Geiger (Medical University of Vienna, Vienna, Austria) for stimulating discussions and for providing the protein-lipid overlay assay protocol. This work was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute (Grant CA079736 to M.Z.), NIH Office of the Director (Grant 1DP2OD008735-01 to D.B.W.) and the U.S. National Science Foundation (Grant DMR-1121288; University of Wisconsin-Madison). M.R. was supported by the Dr. James Chieh-Hsia Mao Wisconsin Distinguished Graduate Fellowship, B.H. by an NIH Molecular Biophysics Predoctoral Traineeship (T32 GM08293), and H.Y.S by the Northwestern University Zell Foundation. The authors declare no conflicts of interest.	ARNOLD M, 1995, BBA-BIOMEMBRANES, V1233, P198, DOI 10.1016/0005-2736(94)00251-J; Ashman RF, 1995, IMMUNOL LETT, V48, P159, DOI 10.1016/0165-2478(95)02471-9; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Callahan MK, 2000, CELL DEATH DIFFER, V7, P645, DOI 10.1038/sj.cdd.4400690; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; DAUM G, 1985, BIOCHIM BIOPHYS ACTA, V822, P1, DOI 10.1016/0304-4157(85)90002-4; de Bruin EC, 2008, CANCER TREAT REV, V34, P737, DOI 10.1016/j.ctrv.2008.07.001; Deak M, 1999, FEBS LETT, V451, P220, DOI 10.1016/S0014-5793(99)00556-6; Dennison SM, 2014, J VIROL, V88, P9406, DOI 10.1128/JVI.01031-14; Domanov YA, 2005, BBA-BIOMEMBRANES, V1716, P49, DOI 10.1016/j.bbamem.2005.09.002; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Esposti MD, 2003, CELL DEATH DIFFER, V10, P1300, DOI 10.1038/sj.cdd.4401306; Estaquier J, 2012, ADV EXP MED BIOL, V942, P157, DOI 10.1007/978-94-007-2869-1_7; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; FADOK VA, 1992, J IMMUNOL, V148, P2207; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Galluzzi L, 2012, NAT REV MOL CELL BIO, V13, P780, DOI 10.1038/nrm3479; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Gonzalvez F, 2007, APOPTOSIS, V12, P877, DOI 10.1007/s10495-007-0718-8; Hong YN, 2012, J AM CHEM SOC, V134, P18713, DOI 10.1021/ja307426k; Jiang N, 2002, ONCOGENE, V21, P4089, DOI 10.1038/sj.onc.1205507; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Kawasaki K, 1999, J BIOL CHEM, V274, P1828, DOI 10.1074/jbc.274.3.1828; KERTESZ Z, 1995, BIOCHEM J, V310, P315, DOI 10.1042/bj3100315; Khalifat N, 2008, BIOPHYS J, V95, P4924, DOI 10.1529/biophysj.108.136077; Krahling S, 1999, CELL DEATH DIFFER, V6, P183, DOI 10.1038/sj.cdd.4400473; Latha K, 2005, MOL CELL BIOL, V25, P1737, DOI 10.1128/MCB.25.5.1737-1748.2005; Li CH, 2010, NEOPLASIA, V12, P150, DOI 10.1593/neo.91500; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Li JJ, 1998, CARCINOGENESIS, V19, P833, DOI 10.1093/carcin/19.5.833; Liu JY, 2004, CANCER RES, V64, P1703, DOI 10.1158/0008-5472.CAN-03-2568; Lutter M, 2000, NAT CELL BIOL, V2, P754, DOI 10.1038/35036395; Mahajan N, 2013, J BIOL CHEM, V288, P11611, DOI 10.1074/jbc.M112.410852; Merrick BA, 1996, BBA-PROTEIN STRUCT M, V1297, P57; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; NICHOLLS P, 1974, BIOCHIM BIOPHYS ACTA, V346, P261, DOI 10.1016/0304-4173(74)90003-2; O'Brien ES, 2015, J BIOL CHEM, V290, P30879, DOI 10.1074/jbc.M115.689406; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Ott M, 2002, P NATL ACAD SCI USA, V99, P1259, DOI 10.1073/pnas.241655498; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Ravenhill L, 2010, J BIOL CHEM, V285, P36285, DOI 10.1074/jbc.M110.177253; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Schlegel RA, 1996, ADV EXP MED BIOL, V406, P21; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Sheng SJ, 2006, J CELL PHYSIOL, V209, P631, DOI 10.1002/jcp.20786; Shi HY, 2001, CANCER RES, V61, P6945; Stepanov G, 2009, FEBS LETT, V583, P97, DOI 10.1016/j.febslet.2008.11.029; Talmard C, 2007, CHEMBIOCHEM, V8, P163, DOI 10.1002/cbic.200600319; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; VERHOVEN B, 1995, J EXP MED, V182, P1597, DOI 10.1084/jem.182.5.1597; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Zhang G, 1998, APOPTOSIS, V3, P27, DOI 10.1023/A:1009655018726; Zhang WG, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-50; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	58	7	7	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6354	6364		10.1096/fj.201802182R	http://dx.doi.org/10.1096/fj.201802182R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30786218	Green Published, Bronze			2022-12-26	WOS:000466932600043
J	Nahar, A; Fu, XY; Polovin, G; Orth, JD; Park, S				Nahar, Asrafun; Fu, Xinyi; Polovin, George; Orth, James D.; Park, Soyeon			Two alternative mechanisms regulate the onset of chaperone-mediated assembly of the proteasomal ATPases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases associated with diverse cellular activities (AAA); chaperone; proteasome; protein assembly; protein complex	26S PROTEASOME; TRANSCRIPTIONAL REGULATOR; 20S PROTEASOME; S PROTEASOME; PARTICLE; PATHWAY; PROTEIN; YEAST; SUBUNITS; CORE	The proteasome holoenzyme is a molecular machine that degrades most proteins in eukaryotes. In the holoenzyme, its heterohexameric ATPase injects protein substrates into the proteolytic core particle, where degradation occurs. The heterohexameric ATPase, referred to as 'Rpt ring', assembles through six ATPase subunits (Rpt1-Rpt6) individually binding to specific chaperones (Rpn14, Nas6, Nas2, and Hsm3). Here, our findings suggest that the onset of Rpt ring assembly can be regulated by two alternative mechanisms. Excess Rpt subunits relative to their chaperones are sequestered into multiple puncta specifically during early-stage Rpt ring assembly. Sequestration occurs during stressed conditions, for example heat, which transcriptionally induce Rpt subunits. When the free Rpt pool is limited experimentally, Rpt subunits are competent for proteasome assembly even without their cognate chaperones. These data suggest that sequestration may regulate amounts of individual Rpt subunits relative to their chaperones, allowing for proper onset of Rpt ring assembly. Indeed, Rpt subunits in the puncta can later resume their assembly into the proteasome. Intriguingly, when proteasome assembly resumes in stressed cells or is ongoing in unstressed cells, excess Rpt subunits are recognized by an alternative mechanismdegradation by the proteasome holoenzyme itself. Rpt subunits undergo proteasome assembly until the holoenzyme complex is generated at a sufficient level. The fully-formed holoenzyme can then degrade any remaining excess Rpt subunits, thereby regulating its own Rpt ring assembly. These two alternative mechanisms, degradation and sequestration of Rpt subunits, may help control the onset of chaperone-mediated Rpt ring assembly, thereby promoting proper proteasome holoenzyme formation.	[Nahar, Asrafun; Fu, Xinyi; Polovin, George; Orth, James D.; Park, Soyeon] Univ Colorado Boulder, Dept Mol Cellular & Dev Biol, 1945 Colorado Ave, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Park, S (corresponding author), Univ Colorado Boulder, Dept Mol Cellular & Dev Biol, 1945 Colorado Ave, Boulder, CO 80309 USA.	soyeon.park-1@colorado.edu		Fu, Xinyi/0000-0002-7928-8697	Boettcher Webb-Waring Biomedical Research Award; University of Colorado Start-up fund; National Institutes of Health [1R01GM127688-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM127688] Funding Source: NIH RePORTER	Boettcher Webb-Waring Biomedical Research Award; University of Colorado Start-up fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Boettcher Webb-Waring Biomedical Research Award, a University of Colorado Start-up fund, and National Institutes of Health Grant 1R01GM127688-01A1 (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BALZI E, 1994, J BIOL CHEM, V269, P2206; Barrault MB, 2012, P NATL ACAD SCI USA, V109, pE1001, DOI 10.1073/pnas.1116538109; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; ECKER DJ, 1987, J BIOL CHEM, V262, P3524; Elsasser S, 2005, METHOD ENZYMOL, V398, P353, DOI 10.1016/S0076-6879(05)98029-4; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Estrin E, 2013, STRUCTURE, V21, P1624, DOI 10.1016/j.str.2013.06.023; Fehlker M, 2003, EMBO REP, V4, P959, DOI 10.1038/sj.embor.embor938; FINLEY D, 1987, CELL, V48, P1035, DOI 10.1016/0092-8674(87)90711-2; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Forster F, 2009, BIOCHEM BIOPH RES CO, V388, P228, DOI 10.1016/j.bbrc.2009.07.145; Fukunaga K, 2010, BIOCHEM BIOPH RES CO, V396, P1048, DOI 10.1016/j.bbrc.2010.05.061; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Gerlinger UM, 1997, MOL BIOL CELL, V8, P2487, DOI 10.1091/mbc.8.12.2487; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GHISLAIN M, 1993, NATURE, V366, P358, DOI 10.1038/366358a0; Glickman MH, 1998, CELL, V94, P615, DOI 10.1016/S0092-8674(00)81603-7; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hahn JS, 2006, MOL MICROBIOL, V60, P240, DOI 10.1111/j.1365-2958.2006.05097.x; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Isono E, 2007, MOL BIOL CELL, V18, P569, DOI 10.1091/mbc.E06-07-0635; Ju DH, 2004, J BIOL CHEM, V279, P23851, DOI 10.1074/jbc.C400111200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443; Li F, 2017, P NATL ACAD SCI USA, V114, P1548, DOI 10.1073/pnas.1612922114; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Marshall RS, 2016, CELL REP, V16, P1717, DOI 10.1016/j.celrep.2016.07.015; Marshall RS, 2015, MOL CELL, V58, P1053, DOI 10.1016/j.molcel.2015.04.023; Park S, 2013, NATURE, V497, P512, DOI 10.1038/nature12123; Park S, 2011, J BIOL CHEM, V286, P36652, DOI 10.1074/jbc.M111.285924; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Park Y, 2005, MOL CELL BIOL, V25, P3842, DOI 10.1128/MCB.25.9.3842-3853.2005; Preissler S, 2015, EMBO J, V34, P1905, DOI 10.15252/embj.201490194; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Satoh T, 2014, STRUCTURE, V22, P731, DOI 10.1016/j.str.2014.02.014; Shim SM, 2012, CELL REP, V2, P603, DOI 10.1016/j.celrep.2012.07.013; Shirozu R, 2015, FEBS LETT, V589, P933, DOI 10.1016/j.febslet.2015.02.025; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Sokolova V, 2015, SCI REP-UK, V5, DOI 10.1038/srep14909; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; TANAKA K, 1989, BIOCHEM BIOPH RES CO, V159, P1309, DOI 10.1016/0006-291X(89)92253-5; Thompson D, 2009, J BIOL CHEM, V284, P24891, DOI 10.1074/jbc.M109.023218; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Tsvetkov P, 2017, P NATL ACAD SCI USA, V114, P382, DOI 10.1073/pnas.1619067114; Waite KA, 2016, J BIOL CHEM, V291, P3239, DOI 10.1074/jbc.M115.699124; Wendler P, 2004, J BIOL CHEM, V279, P37751, DOI 10.1074/jbc.M403551200; WOOLFORD CA, 1986, MOL CELL BIOL, V6, P2500, DOI 10.1128/MCB.6.7.2500; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026	61	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6562	6577		10.1074/jbc.RA118.006298	http://dx.doi.org/10.1074/jbc.RA118.006298			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814255	Green Published, hybrid			2022-12-26	WOS:000468402000030
J	Steingruber, M; Keller, L; Socher, E; Ferre, S; Hesse, AM; Coute, Y; Hahn, F; Buscher, N; Plachter, B; Sticht, H; Marschall, M				Steingruber, Mirjam; Keller, Lena; Socher, Eileen; Ferre, Sabrina; Hesse, Anne-Marie; Coute, Yohann; Hahn, Friedrich; Buescher, Nicole; Plachter, Bodo; Sticht, Heinrich; Marschall, Manfred			Cyclins B1, T1, and H differ in their molecular mode of interaction with cytomegalovirus protein kinase pUL97	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						viral replication; cyclin; protein kinase; protein assembly; phosphorylation; reprogramming; cyclins B1; T1; and H; human cytomegalovirus; protein phosphorylation; regulatory interaction; viral kinase pUL97-cyclin complexes	NUCLEAR EGRESS COMPLEX; INTRANUCLEAR LOCALIZATION; RETINOBLASTOMA PROTEIN; UL97 PHOSPHORYLATES; DEPENDENT KINASES; VIRAL PROTEIN; IN-VITRO; INFECTION; PUL69; REPLICATION	Human cytomegalovirus (HCMV) is a common -herpesvirus causing life-long latent infections. HCMV replication interferes with cell cycle regulation in host cells because the HCMV-encoded cyclin-dependent kinase (CDK) ortholog pUL97 extensively phosphorylates the checkpoint regulator retinoblastoma protein. pUL97 also interacts with cyclins B1, T1, and H, and recent findings have strongly suggested that these interactions influence pUL97 substrate recognition. Interestingly, here we detected profound mechanistic differences among these pUL97-cyclin interactions. Our study revealed the following. (i) pUL97 interacts with cyclins B1 and H in a manner dependent on pUL97 activity and HCMV-specific cyclin modulation, respectively. (ii) The phosphorylated state of both proteins is an important determinant of the pUL97-cyclin B1 interaction. (iii) Activated phospho-Thr-315 cyclin H is up-regulated during HCMV replication. (iv) Thr-315 phosphorylation is independent of intracellular pUL97 or CDK7 activity. (v) pUL97-mediated in vitro phosphorylation is detectable for cyclin B1 but not H. (vi) Mutual transphosphorylation between pUL97 and CDK7 is not detectable, and an MS-based phosphosite analysis indicated that pUL97 might unexpectedly not be phosphorylated in its T-loop. (vii) The binary complexes pUL97-cyclin H and CDK7-cyclin H as well as the ternary complex pUL97-cyclin-H-CDK7 are detectable in an assembly-based CoIP approach. (viii) pUL97 self-interaction can be bridged by the transcriptional cyclins T1 or H but not by the classical cell cycle-regulating B1 cyclin. Combined, our findings unravel a number of cyclin type-specific differences in pUL97 interactions and suggest a multifaceted regulatory impact of cyclins on HCMV replication.	[Steingruber, Mirjam; Keller, Lena; Hahn, Friedrich; Marschall, Manfred] Friedrich Alexander Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Socher, Eileen; Sticht, Heinrich] Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Div Bioinformat, D-91054 Erlangen, Germany; [Ferre, Sabrina; Hesse, Anne-Marie; Coute, Yohann] Univ Grenoble Alpes, CEA, INSERM, BIG BGE, F-38000 Grenoble, France; [Buescher, Nicole; Plachter, Bodo] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Virol, D-55131 Mainz, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; CEA; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Johannes Gutenberg University of Mainz	Steingruber, M; Marschall, M (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.; Sticht, H (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Inst Biochem, Div Bioinformat, D-91054 Erlangen, Germany.	mirjam.steingruber@uk-erlangen.de; heinrich.sticht@fau.de; manfred.marschall@fau.de	Couté, Yohann/G-2695-2015	Couté, Yohann/0000-0003-3896-6196; Hesse, Anne-Marie/0000-0001-6110-0636; Socher, Eileen/0000-0002-6239-3749; Ferre, Sabrina/0000-0002-1379-3025; Hahn, Friedrich/0000-0003-3011-8416	Deutsche Forschungsgemeinschaft [MA1289/8-1, STI155/5-1, PL236/7-1, ANR-10-INBS-08-01]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants MA1289/8-1, STI155/5-1, and PL236/7-1) and the proteomic experiments were supported in part by the ProFl Grant ANR-10-INBS-08-01. The authors declare that they have no conflicts of interest with the contents of this article.	[Anonymous], [No title captured]; Baek MC, 2004, VIROLOGY, V324, P184, DOI 10.1016/j.virol.2004.03.015; Baek MC, 2002, J VIROL, V76, P11943, DOI 10.1128/JVI.76.23.11943-11952.2002; Becke S, 2010, J GEN VIROL, V91, P2531, DOI 10.1099/vir.0.022293-0; Bigley TM, 2015, J VIROL, V89, P10230, DOI 10.1128/JVI.00986-15; Buxmann H, 2017, DTSCH ARZTEBL INT, V114, P45, DOI 10.3238/arztebl.2017.0045; Chou SW, 2008, REV MED VIROL, V18, P233, DOI 10.1002/rmv.574; Dell'Oste V, 2014, J VIROL, V88, P6970, DOI 10.1128/JVI.00384-14; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; Graf L, 2016, J GEN VIROL, V97, P144, DOI 10.1099/jgv.0.000337; Graf L, 2013, VIRUSES-BASEL, V5, P3213, DOI 10.3390/v5123213; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Hume AJ, 2008, SCIENCE, V320, P797, DOI 10.1126/science.1152095; Hume AJ, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-1; Hutterer C, 2015, ANTIMICROB AGENTS CH, V59, P2062, DOI 10.1128/AAC.04534-14; Iwahori S, 2017, J BIOL CHEM, V292, P6583, DOI 10.1074/jbc.M116.773150; Iwahori S, 2015, J BIOL CHEM, V290, P19666, DOI 10.1074/jbc.M115.660043; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Kawaguchi Y, 1999, J VIROL, V73, P4456, DOI 10.1128/JVI.73.5.4456-4460.1999; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; Kochin V, 2014, J CELL SCI, V127, P2683, DOI 10.1242/jcs.141820; Konig P, 2017, J GEN VIROL, V98, P2850, DOI 10.1099/jgv.0.000939; Kuny CV, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001092; Malumbres M, 2014, GENOME BIOL, V15, DOI 10.1186/gb4184; Marschall M, 2005, J BIOL CHEM, V280, P33357, DOI 10.1074/jbc.M502672200; Marschall M, 2000, ANTIMICROB AGENTS CH, V44, P1588, DOI 10.1128/AAC.44.6.1588-1597.2000; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Marschall M, 2002, J GEN VIROL, V83, P1013, DOI 10.1099/0022-1317-83-5-1013; Marschall M, 2001, J GEN VIROL, V82, P1439, DOI 10.1099/0022-1317-82-6-1439; Marschall M, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1934; Marschall M, 2011, ADV VIRUS RES, V80, P69, DOI 10.1016/B978-0-12-385987-7.00004-X; Milbradt J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005825; Milbradt J, 2014, MOL CELL PROTEOMICS, V13, P2132, DOI 10.1074/mcp.M113.035782; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; Milbradt J, 2009, J GEN VIROL, V90, P579, DOI 10.1099/vir.0.005231-0; Mocarski Jr E, 2013, FIELDS VIROLOGY, V2, P1960; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Oberstein A, 2015, PROTEOMICS, V15, P2006, DOI 10.1002/pmic.201400607; Rechter S, 2009, J BIOL CHEM, V284, P8942, DOI 10.1074/jbc.M805693200; Reyda S, 2014, VIRUSES-BASEL, V6, P172, DOI 10.3390/v6010172; Romaker D, 2006, J MED CHEM, V49, P7044, DOI 10.1021/jm060696s; ROWE WP, 1956, P SOC EXP BIOL MED, V92, P418, DOI 10.3181/00379727-92-22497; Ruiz-Carrascoso G, 2013, J MED VIROL, V85, P1250, DOI 10.1002/jmv.23570; Schregel V, 2007, J GEN VIROL, V88, P395, DOI 10.1099/vir.0.82393-0; Sharma M, 2015, J VIROL, V89, P523, DOI 10.1128/JVI.02426-14; Sonntag E, 2017, J GEN VIROL, V98, P2569, DOI 10.1099/jgv.0.000931; Sonntag E, 2016, J GEN VIROL, V97, P1676, DOI 10.1099/jgv.0.000495; Steingruber M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080219; Steingruber M, 2015, VIRUSES-BASEL, V7, P4582, DOI 10.3390/v7082834; Thomas M, 2009, J GEN VIROL, V90, P567, DOI 10.1099/vir.0.005827-0; Tsutsui Yoshihiro, 2009, Congenital Anomalies, V49, P47, DOI 10.1111/j.1741-4520.2009.00222.x; Webel R, 2014, J VIROL, V88, P4776, DOI 10.1128/JVI.00192-14; Webel R, 2012, J GEN VIROL, V93, P1756, DOI 10.1099/vir.0.040592-0; Webel R, 2011, J GEN VIROL, V92, P638, DOI 10.1099/vir.0.026799-0	56	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 12	2019	294	15					6188	6203		10.1074/jbc.RA118.007049	http://dx.doi.org/10.1074/jbc.RA118.007049			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HU2CA	30782840	hybrid, Green Published			2022-12-26	WOS:000465077500045
J	Rosato, M; Leavey, G; Cooper, J; De Cock, P; Devine, P				Rosato, Michael; Leavey, Gerard; Cooper, Janine; De Cock, Paul; Devine, Paula			Factors associated with public knowledge of and attitudes to dementia: A cross-sectional study	PLOS ONE			English	Article							NORTHERN-IRELAND; NATIONAL-SURVEY; STIGMA; DISEASE; PEOPLE	Introduction Dementia is a major public health concern but one that continues to be stigmatised. We examine lay knowledge of dementia and attitudes to people with dementia as potential precursors of public anxiety, focusing on the social characteristics associated with (a) the formation of these attitudes, and (b) the perception of the need for restriction and control for people with dementia. Methods Analysis of the 2014 Northern Ireland Life and Times survey, which included questions on knowledge of, attitudes to and personal experience with dementia. We used (a) latent class analysis and (b) logistic regression to examine factors associated with respondent attitudes towards dementia. Results Respondents (n = 1211) had relatively good general knowledge of dementia, but limited knowledge of specific risk factors. Negative perceptions of dementia were mitigated somewhat by personal contact. A high proportion of respondents felt that high levels of control were appropriate for people diagnosed with dementia, even at early stages of the disease. Conclusion Personal antipathy to dementia was highly prevalent despite ongoing public campaigns to increase public awareness of developments in its prevention, treatment and consequent care pathways and hampering efforts to widen social inclusion. Fresh thinking and more resources may be needed to challenge persisting common misapprehension of the condition and the formation of entrenched stigma.	[Rosato, Michael; Leavey, Gerard; Cooper, Janine; De Cock, Paul] Ulster Univ, Sch Psychol, Bamford Ctr Mental Hlth & Wellbeing, Coleraine, Londonderry, North Ireland; [Devine, Paula] Queens Univ Belfast, Sch Social Sci Educ & Social Work, Belfast, Antrim, North Ireland	Ulster University; Queens University Belfast	Rosato, M (corresponding author), Ulster Univ, Sch Psychol, Bamford Ctr Mental Hlth & Wellbeing, Coleraine, Londonderry, North Ireland.	mg.rosato@ulster.ac.uk	Leavey, Gerard/AAU-2912-2020	Leavey, Gerard/0000-0001-8411-8919; de Cock, Paul/0000-0002-7485-4039; Rosato, Michael/0000-0002-4787-734X				[Anonymous], 2008, MPLUS USERS GUIDE; Bamford S., 2014, NEW PERSPECTIVES APP; Behuniak SM, 2011, AGEING SOC, V31, P70, DOI 10.1017/S0144686X10000693; Bharucha AJ, 2009, AM J GERIAT PSYCHIAT, V17, P88, DOI 10.1097/JGP.0b013e318187dde5; Burke D, 2007, BRIT J PSYCHIAT, V190, P371, DOI 10.1192/bjp.bp.106.033407; Cahill S, 2015, ALZHEIMERS DIS ASS D, V29; Cipriani G, 2014, PSYCHOGERIATRICS, V14, P135, DOI 10.1111/psyg.12044; Devine P, 2016, PUBLIC ATTITUDES KNO; Elwood P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081877; Glynn RW, 2017, AGE AGEING, V46, P865, DOI 10.1093/ageing/afx082; Goffman E, 1963, STIGMA NOTES MANAGEM, P1; Halek M, 2012, SCAND J CARING SCI, V26, P404, DOI 10.1111/j.1471-6712.2011.00932.x; Handley M, 2015, SYSTEMATIC REV, V4, P18; Herrmann LK, 2018, AM J GERIAT PSYCHIAT, V26, P316, DOI 10.1016/j.jagp.2017.09.006; Hillman A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002274; Hoe J, 2017, BJPSYCH OPEN, V3, P34, DOI 10.1192/bjpo.bp.116.004069; Kitwood T., 1997, DEMENTIA RECONSIDERE; Kivipelto M, 2017, SCI AM           APR; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; Liu D, 2008, J CROSS-CULT GERONTO, V23, P283, DOI 10.1007/s10823-008-9075-5; Livingston G., 2012, AGING HLTH, V8, P377, DOI [DOI 10.2217/AHE.12.42, 10.2217/ahe.12.42]; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; McParland P, 2012, INT PSYCHOGERIATR, V24, P1600, DOI 10.1017/S1041610212000658; Nganda T, 2015, LANCET, V385; [NILT Northern Ireland Life and Times Survey], 2014, NILT TECHN NOT; O'Reilly D, 2012, INT J EPIDEMIOL, V41, P634, DOI 10.1093/ije/dyq271; Prince M, 2017, LANCET, V390, pE51, DOI 10.1016/S0140-6736(17)31757-9; Rasmussen J, 2014, NEW PERSPECTIVES APP; Rusch N, 2005, EUR PSYCHIAT, V20, P529, DOI 10.1016/j.eurpsy.2005.04.004; Scambler G, 1998, LANCET, V352, P1054, DOI 10.1016/S0140-6736(98)08068-4; Smith BJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-661; StataCorp, 2013, STATA STAT SOFTW REL; Ward R, 2018, INT PSYCHOGERIATR, V30, P867, DOI 10.1017/S1041610217000631; Welsh S, 2003, AGING MENT HEALTH, V7, P372, DOI 10.1080/1360786031000150658; Werner P, 2012, GERONTOLOGIST, V52, P89, DOI 10.1093/geront/gnr117; World Health Organization, 2017, GLOBAL ACTION PLAN P	37	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0210543	10.1371/journal.pone.0210543	http://dx.doi.org/10.1371/journal.pone.0210543			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817791	gold, Green Published, Green Submitted			2022-12-26	WOS:000460371500007
J	Korenromp, EL; Rowley, J; Alonso, M; Mello, MB; Wijesooriya, NS; Mahiane, SG; Ishikawa, N; Le, LV; Newman-Owiredu, M; Nagelkerke, N; Newman, L; Kamb, M; Broutet, N; Taylor, MM				Korenromp, Eline L.; Rowley, Jane; Alonso, Monica; Mello, Maeve B.; Wijesooriya, N. Saman; Mahiane, S. Guy; Ishikawa, Naoko; Linh-Vi Le; Newman-Owiredu, Morkor; Nagelkerke, Nico; Newman, Lori; Kamb, Mary; Broutet, Nathalie; Taylor, Melanie M.			Global burden of maternal and congenital syphilis and associated adverse birth outcomes-Estimates for 2016 and progress since 2012	PLOS ONE			English	Article							BLOOD-DONORS; HIV; SEROPREVALENCE; INFECTIONS; PREVALENCE; SERVICE; HEALTH; HCV	Background In 2007 the World Health Organization (WHO) launched the global initiative to eliminate mother-to-child transmission of syphilis (congenital syphilis, or CS). To assess progress towards the goal of <50 CS cases per 100,000 live births, we generated regional and global estimates of maternal and congenital syphilis for 2016 and updated the 2012 estimates. Methods Maternal syphilis estimates were generated using the Spectrum-STI model, fitted to sentinel surveys and routine testing of pregnant women during antenatal care (ANC) and other representative population data. Global and regional estimates of CS used the same approach as previous WHO estimates. Results The estimated global maternal syphilis prevalence in 2016 was 0.69% (95% confidence interval: 0.57-0.81%) resulting in a global CS rate of 473 (385-561) per 100,000 live births and 661,000 (538,000-784,000) total CS cases, including 355,000 (290,000-419,000) adverse birth outcomes (ABO) and 306,000 (249,000-363,000) non-clinical CS cases (infants without clinical signs born to un-treated mothers). The ABOs included 143,000 early fetal deaths and stillbirths, 61,000 neonatal deaths, 41,000 preterm or low-birth weight births, and 109,000 infants with clinical CS. Of these ABOs-203,000 (57%) occurred in pregnant women attending ANC but not screened for syphilis; 74,000 (21%) in mothers not enrolled in ANC, 55,000 (16%) in mothers screened but not treated, and 23,000 (6%) in mothers enrolled, screened and treated. The revised 2012 estimates were 0.70% (95% CI: 0.63-0.77%) maternal prevalence, and 748,000 CS cases (539 per 100,000 live births) including 397,000 (361,000-432,000) ABOs. The estimated decrease in CS case rates between 2012 and 2016 reflected increased access to ANC and to syphilis screening and treatment. Conclusions Congenital syphilis decreased worldwide between 2012 and 2016, although maternal prevalence was stable. Achieving global CS elimination, however, will require improving access to early syphilis screening and treatment in ANC, clinically monitoring all women diagnosed with syphilis and their infants, improving partner management, and reducing syphilis prevalence in the general population by expanding testing, treatment and partner referral beyond ANC.	[Korenromp, Eline L.] Avenir Hlth, Geneva, Switzerland; [Alonso, Monica; Mello, Maeve B.] Panamer Hlth Org, Dept Communicable Dis & Environm Determinants Hlt, Washington, DC USA; [Mahiane, S. Guy] Avenir Hlth, Glastonbury, CT USA; [Ishikawa, Naoko; Linh-Vi Le] WHO, Reg Off Western Pacific, Manila, Philippines; [Newman-Owiredu, Morkor] WHO, Subsaharan Africa Off, Brazzaville, Rep Congo; [Newman, Lori; Kamb, Mary] Ctr Dis Control & Prevent, Cambodia Country Off, Phnom Penh, Cambodia; [Broutet, Nathalie; Taylor, Melanie M.] USA Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Taylor, Melanie M.] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland	WHO Western Pacific Regional Office; World Health Organization; World Health Organization; World Health Organization	Korenromp, EL (corresponding author), Avenir Hlth, Geneva, Switzerland.	ekorenromp@avenirhealth.org		Wijesooriya, Nalinka Saman/0000-0003-3447-0222; Ishikawa, Naoko/0000-0002-2701-6892	World Health Organization, Department of Reproductive Health and Research/Human Reproduction Programme; U.S. Centers for Disease Control and Prevention; Department of International Development (DfID) of the United Kingdom	World Health Organization, Department of Reproductive Health and Research/Human Reproduction Programme; U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Department of International Development (DfID) of the United Kingdom	The project was funded by the World Health Organization, Department of Reproductive Health and Research/Human Reproduction Programme. The analysis was furthermore supported by a cooperative agreement from the U.S. Centers for Disease Control and Prevention in support of prevention of mother-to-child transmission of syphilis, and by the Department of International Development (DfID) of the United Kingdom. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the World Health Organization, or the U.S. Centers for Disease Control and Prevention.	Amin TT, 2014, INT PUBLIC HLTH FORU, V1, P6; Ansbro EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127728; Arshad Aisha, 2016, BMC Hematol, V16, P27; Attaullah S, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-20; Avenir Health World Health Organization Reproductive Health and Research department, 2017, GUID COUNTR DAT NEED; Blencowe H, 2016, LANCET GLOB HEALTH, V4, pE98, DOI 10.1016/S2214-109X(15)00275-2; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Changalucha J, 2011, SEX TRANSM INFECT, V87, pA1, DOI 10.1136/sextrans-2011-050102.5; Darville T, 1999, Pediatr Rev, V20, P160, DOI 10.1542/pir.20-5-160; Dayan S, 2013, J INFECT DEV COUNTR, V7, P665, DOI 10.3855/jidc.2835; Demirel Y, 2004, SAUDI MED J, V25, P2037; Enkhbat E, 2017, CONGENITAL SYPHILIS; Ensari T, 2015, J INFECT DEV COUNTR, V9, P1011, DOI 10.3855/jidc.6064; Garcia PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066905; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Gottlieb SL, 2008, SEX TRANSM DIS, V35, P507, DOI 10.1097/OLQ.0b013e3181644bae; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Hawkes SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056713; Kahn JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087510; Korenromp EL, 2018, PAN AM J PUBLIC HLTH, V42, pe118, DOI DOI 10.26633/RPSP.2018.118; Korenromp EL, 2017, SEX TRANSM INFECT; Korenromp EL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29805-9; Lawn JE, 2016, LANCET, V387, P587, DOI 10.1016/S0140-6736(15)00837-5; Mohammadali F, 2014, ARCH IRAN MED, V17, P613, DOI 0141709/AIM.006; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Munkhuu B, 2009, SEX TRANSM DIS, V36, P714, DOI 10.1097/OLQ.0b013e3181bc0960; Nazir S, 2013, ADVAN LIFE SCI, V1, P27; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Nurse-Findlay S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002473; Owusu-Edusei K, 2014, SEX TRANSM DIS, V41, P103, DOI 10.1097/OLQ.0000000000000085; Pan-American Health Organization UNICEF, 2016, ELIM MOTH TO CHILD T; Qadeer MI, 2013, SEX TRANSM INFECT S1, V89; Qin JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102203; Rowley J, 2017, PILOT APPL SPECTRUM; Rowley J., 2017, SPECTRUM STI MODULE; Smolak A., 2017, CLIN INFECT DIS; UNICEF East Asia and Pacific Regional Office World Health Organization Western Pacific regional office UNAIDS, 2016, EL PAR TO CHILD TRAN; Waheed U., 2012, ANN PAK I MED SCI, V8, P236; WHO, 2020, WHO INF NOT US DUAL; WHO Regional Office for the Western Pacific, 2017, TRIPL EL MOTH TO CHI; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organisation, 2017, 2016 GLOB STAT REP B; World Health Organization, 2016, 1609 WHORHR; World Health Organization, GUID US WHO TOOL EST; World Health Organization, 2014, GLOB GUID CRIT PROC; World Health Organization, 2016, WHO GUIDELINES TREAT; World Health Organization, 2018, WHO VAL EL MOTH TO C; World Health Organization, 2017, GLOB GUID CRIT PROC, V2nd	49	127	137	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211720	10.1371/journal.pone.0211720	http://dx.doi.org/10.1371/journal.pone.0211720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811406	gold, Green Submitted, Green Published			2022-12-26	WOS:000459806400030
J	Yang, XD; Wang, J; Xu, MS; Ali, A; Xu, YL; Lamb, D; Duan, LC; Yan, KH; Yang, ST				Yang, Xiao-Dong; Wang, Juan; Xu, Ming-Shan; Ali, Arshad; Xu, Yilu; Lamb, Dane; Duan, Lu-Chun; Yan, Kai-Hong; Yang, Sheng-Tian			Effects of the ephemeral stream on plant species diversity and distribution in an alluvial fan of arid desert region: An application of a low altitude UAV	PLOS ONE			English	Article							MOJAVE DESERT; WATER; VEGETATION; MORTALITY	Biodiversity conservation, plant growth and spatial distribution of plant species are the central issues in contemporary community ecology. Ephemeral stream may influence soil properties, which in turn may determine biodiversity and function of an ecosystem in alluvial fan of arid desert region. Ephemeral stream is one of the most common natural disturbances, yet the effects of the ephemeral stream on plant communities in terms of species diversity and plant species distribution remain poorly studied. In this study, the information of species distribution, ephemeral stream beds ('washes'), and the characteristics of plant growth, i.e. height, crown area, were interpreted at different heights using the images of low altitude unmanned aerial vehicle (UAV). After that, soil properties such as soil texture (sand, silt and clay), soil water content, pH, soil organic matter, soil electric conductivity, soil bulk density and the percentage of gravel content, and their relationships with UAV data were assessed in order to explore the influences of ephemeral stream on species diversity, plant growth characteristics and species distribution in an alluvial fan of arid desert region. The results showed that deep-rooted plants were only distributed in washes whereas shallow-rooted plants were distributed in both washes and the outside of washes ('non-washes'). Species richness was significantly higher in washes than that in non-washes whereas the opposite pattern was true for abundance. Soil properties, plant height and crown area were higher in washes than that in non-washes. Plant height, crown area and the total number of individual plants increased with increasing wash width and per unit length of stream flow. This study highlights that the coupling factors of ephemeral stream, such as soil erosion, particle transport and sedimentation, can dramatically cause changes in soil properties and total number of individual plants, and hence, can influence species diversity, plant growth characteristics and spatial distribution of plant species in an alluvial fan of arid desert regions.	[Yang, Xiao-Dong] Xinjiang Univ, Inst Resources & Environm Sci, Urumqi, Peoples R China; [Yang, Xiao-Dong] Key Lab Oasis Ecol, Urumqi, Peoples R China; [Yang, Xiao-Dong; Xu, Yilu; Lamb, Dane; Duan, Lu-Chun; Yan, Kai-Hong] Univ Newcastle UON, GCER, Newcastle, NSW, Australia; [Wang, Juan; Yang, Sheng-Tian] Beijing Normal Univ, Coll Water Sci, Beijing, Peoples R China; [Wang, Juan; Yang, Sheng-Tian] Beijing Normal Univ, Fac Geog Sci, Beijing, Peoples R China; [Xu, Ming-Shan] East China Normal Univ, Coll Ecol & Environm Sci, Shanghai, Peoples R China; [Ali, Arshad] South China Normal Univ, Sch Life Sci, Spatial Ecol Lab, Guangzhou, Guangdong, Peoples R China	Xinjiang University; University of Newcastle; Beijing Normal University; Beijing Normal University; East China Normal University; South China Normal University	Yang, XD (corresponding author), Xinjiang Univ, Inst Resources & Environm Sci, Urumqi, Peoples R China.; Yang, XD (corresponding author), Key Lab Oasis Ecol, Urumqi, Peoples R China.; Yang, XD (corresponding author), Univ Newcastle UON, GCER, Newcastle, NSW, Australia.	xjyangxd@sina.com	xu, mingshan/HDN-6139-2022; Ali, Arshad/G-3988-2014; Lamb, Dane/A-7243-2017	Ali, Arshad/0000-0001-9966-2917; Lamb, Dane/0000-0003-2303-5460; Yang, Xiao-Dong/0000-0002-3553-2125	National Natural Science Foundation of China [31860111, 41871031, U1603241, 31500343]; Natural Science Foundation of Xinjiang Uygur Autonomous Region [2017D01C080]; Research Fund for the Doctoral Program of Xinjiang University [BS160235]; China Postdoctoral Science Foundation [2018M643117]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Xinjiang Uygur Autonomous Region; Research Fund for the Doctoral Program of Xinjiang University; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31860111, 41871031, U1603241 and 31500343), Natural Science Foundation of Xinjiang Uygur Autonomous Region (Grant No. 2017D01C080), Research Fund for the Doctoral Program of Xinjiang University (Grant No. BS160235) and China Postdoctoral Science Foundation (Grant No. 2018M643117). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Anderson K, 2013, FRONT ECOL ENVIRON, V11, P138, DOI 10.1890/120150; [Anonymous], 2016, ECOLOGICAL METHODS; Armas C, 2005, J ECOL, V93, P978, DOI 10.1111/j.1365-2745.2005.01033.x; Bhardwaj A, 2016, REMOTE SENS ENVIRON, V175, P196, DOI 10.1016/j.rse.2015.12.029; Blair TC, 1994, ALLUVIAL FAN PROCESS; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Bull WB., 1977, PROGR PHYSICAL GEOGR, V1, P222, DOI [10.1177/030913337700100202, DOI 10.1177/030913337700100202]; Crandall RM, 2003, COMMUNITY ECOL, V4, P225, DOI 10.1556/ComEc.4.2003.2.9; Dorn RI, 2015, GEOMORPHOLOGY DESERT; Faye E, 2016, METHODS ECOL EVOL, V7, P437, DOI 10.1111/2041-210X.12488; Fischer FM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0276; Fossati J, 1999, J ARID ENVIRON, V43, P63, DOI 10.1006/jare.1999.0526; Franklin SE, 2017, PHOTOGRAMM ENG REM S, V83, P501, DOI 10.14358/PERS.83.7.501; Hamerlynck EP, 2010, J ARID ENVIRON, V74, P1569, DOI 10.1016/j.jaridenv.2010.06.001; Hamerlynck ER, 2008, J ARID ENVIRON, V72, P1793, DOI 10.1016/j.jaridenv.2008.05.002; Hamerlynck EP, 2002, ECOLOGY, V83, P768, DOI 10.1890/0012-9658(2002)083[0768:EROTMD]2.0.CO;2; HOOKE RLB, 1967, J GEOL, V75, P438, DOI 10.1086/627271; Huang TM, 2017, HYDROGEOL J, V25, P743, DOI 10.1007/s10040-017-1534-z; Jin XL, 2017, REMOTE SENS ENVIRON, V198, P105, DOI 10.1016/j.rse.2017.06.007; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Kunstler G, 2016, NATURE, V529, P204, DOI 10.1038/nature16476; Lahiri P., 2013, SMALL AREA ESTIMATIO; Lu B, 2018, INT J REMOTE SENS, V39, P5265, DOI 10.1080/01431161.2017.1363441; [马辉英 Ma Huiying], 2017, [生态学报, Acta Ecologica Sinica], V37, P829; McAuliffe JR, 2010, J ARID ENVIRON, V74, P885, DOI 10.1016/j.jaridenv.2010.01.001; Neugirg F, 2014, P S HELD NEW ORL LOU, P51, DOI [10.5194/piahs-367-51-2015, DOI 10.5194/PIAHS-367-51-2015]; Pekarova P, 2013, J HYDROL HYDROMECH, V61, P326, DOI 10.2478/johh-2013-0041; RICKLEFS RE, 1977, AM NAT, V111, P376, DOI 10.1086/283169; Ruzgiene B, 2015, MEASUREMENT, V73, P619, DOI 10.1016/j.measurement.2015.04.018; Saint-Laurent D, 2016, WATER-SUI, V8, DOI 10.3390/w8050208; Sankey T, 2017, REMOTE SENS ENVIRON, V195, P30, DOI 10.1016/j.rse.2017.04.007; Schwinning S, 2011, ECOHYDROLOGY, V4, P12, DOI 10.1002/eco.116; Tarafdar JC, 2006, HAND BOOK SOIL ANAL; Turner D, 2014, IEEE T GEOSCI REMOTE, V52, P2738, DOI 10.1109/TGRS.2013.2265295; Wilkinson DM, 1999, OIKOS, V84, P145, DOI 10.2307/3546874; Yang XD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109071; Yang Xiao-dong, 2010, Journal of Plant Resources and Environment, V19, P37; Zhang XJ, 2017, RNA BIOL, V14, P1705, DOI 10.1080/15476286.2017.1358347	38	4	4	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212057	10.1371/journal.pone.0212057	http://dx.doi.org/10.1371/journal.pone.0212057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811442	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400049
J	Wu, J; Niu, P; Zhao, YQ; Cheng, YY; Chen, WP; Lin, L; Lu, JM; Cheng, X; Xu, ZL				Wu, Juan; Niu, Ping; Zhao, Yueqiang; Cheng, Yanyang; Chen, Weiping; Lin, Lan; Lu, Jingmei; Cheng, Xue; Xu, Zhiliang			Impact of miR-223-3p and miR-2909 on inflammatory factors IL-6, IL-1 beta, and TNF-alpha, and the TLR4/TLR2/NF-kappa B/STAT3 signaling pathway induced by lipopolysaccharide in human adipose stem cells	PLOS ONE			English	Article							STROMAL CELLS; EXPRESSION; MACROPHAGES; RESPONSES; INJURY	MicroRNAs (miRNAs) are small non-coding RNA molecules that play an important role in the regulation of gene expression related to inflammatory responses. Human adipose stem cells are characterized by pluripotent differentiation potential and isolated from adipose tissues. These cells regulate inflammation mainly by interacting with immune cells and affecting the secretion of immune factors; details of this interaction are currently unknown. In the current study, we successfully established an acute inflammation model and a chronic inflammation model involving adipose stem cells. We used high-throughput miRNA microarray analysis to identify miRNAs that were significantly (p < 0.05) differentially expressed during both acute and chronic inflammation. Lipopolysaccharide (LPS) significantly (p < 0.05) reduced the expression of miR-223-3P and miR-2909, while promoting the production of pro-inflammatory cytokines, interleukin (IL) 6, IL-1 beta, and tumor necrosis factor (TNF)-alpha via the Toll-like receptor (TLR) 4/TLR2/nuclear factor (NF)-kappa B/signal transducer and activator of transcription (STAT) 3 signaling pathway in human adipose stem cells. Further, miR-2233P expression was significantly (p < 0.05) reduced in human adipose stem cells during activation by IL-6 stimulation. The inducible down-regulation of miR-223-3P resulted in the activation of STAT3, which was directly targeted by miR-223-3P. STAT3 directly targeted TLR4 and TLR2, promoting the production of the pro-inflammatory cytokine, IL-6, and formed a positive feedback loop to regulate IL-6 levels. Similarly, TNF-alpha significantly (p < 0.05) increased the expression of miR-223-3p, with LPS and TLR4/TLR2/NF-kappa B/STAT3 forming a negative feedback loop to regulate TNF-alpha levels. In addition, miR-2909, which depends on NF-kappa B, targeted Krueppel-like factor (KLF) 4 to regulate the levels of pro-inflammatory cytokines, IL-6, IL-1 beta, and TNF-alpha. We conclude that miR-223-3p and miR-2909 form a complex regulatory network with pro-inflammatory factors and signaling pathways in adipose stem cells stimulated by LPS. These findings will inform the development of therapies against autoimmune and inflammatory diseases.	[Wu, Juan; Niu, Ping; Zhao, Yueqiang; Cheng, Yanyang; Chen, Weiping; Lin, Lan; Lu, Jingmei; Cheng, Xue; Xu, Zhiliang] Wuhan Univ, Ren Min Hosp, Dept Pediat, Wuhan, Hubei, Peoples R China	Wuhan University	Xu, ZL (corresponding author), Wuhan Univ, Ren Min Hosp, Dept Pediat, Wuhan, Hubei, Peoples R China.	zlxu-rm@163.com	Chen, Wei/GZK-7348-2022		Wuhan Applied Basic Research Program [2015061701011643]	Wuhan Applied Basic Research Program	This work was supported by grants from the Wuhan Applied Basic Research Program (2015061701011643), which is a government organisation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora M, 2014, MOL CELL BIOCHEM, V392, P49, DOI 10.1007/s11010-014-2017-3; Baloh RH, 2018, CURR OPIN NEUROL, V31, P655, DOI 10.1097/WCO.0000000000000598; Berenstein R, 2016, MOL CARCINOGEN, V55, P1927, DOI 10.1002/mc.22440; Chavarria-Velazquez CO, 2017, IMMUNOBIOLOGY, V223, P38, DOI 10.1016/j.imbio.2017.10.016; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Chen T, 2018, CELL MOL LIFE SCI, V75, P4079, DOI 10.1007/s00018-018-2859-z; Choi H, 2011, BLOOD, V118, P330, DOI 10.1182/blood-2010-12-327353; Dorhoi A, 2013, J CLIN INVEST, V123, P4836, DOI 10.1172/JCI67604; Engin AB, 2017, ADV EXP MED BIOL, V960, P327, DOI 10.1007/978-3-319-48382-5_14; Garibotto G, 2017, J NEPHROL, V30, P719, DOI 10.1007/s40620-017-0432-8; Ha TZ, 2010, CARDIOVASC RES, V87, P694, DOI 10.1093/cvr/cvq116; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Melief SM, 2013, STEM CELLS, V31, P1980, DOI 10.1002/stem.1432; Moqadam FA, 2014, LEUKEMIA, V28, P1008, DOI 10.1038/leu.2013.308; Moriya N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169702; Niu GC, 2018, BMC GASTROENTEROL, V18, DOI 10.1186/s12876-018-0850-7; Nojehdehi S, 2018, J CELL BIOCHEM, V119, P9433, DOI 10.1002/jcb.27260; Paeng SH, 2015, INT J MOL MED, V36, P808, DOI 10.3892/ijmm.2015.2266; Pan GF, 2017, INT IMMUNOPHARMACOL, V52, P119, DOI 10.1016/j.intimp.2017.08.030; Peng SC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-308; Perlee D, 2018, STEM CELLS, V36, P1778, DOI 10.1002/stem.2891; Poon KS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09709-w; Rahimifard M, 2017, AGEING RES REV, V36, P11, DOI 10.1016/j.arr.2017.02.004; Raicevic G, 2010, HUM IMMUNOL, V71, P235, DOI 10.1016/j.humimm.2009.12.005; Sharma M, 2013, GENE, V522, P60, DOI 10.1016/j.gene.2013.03.058; Slomiany BL, 2017, INFLAMMOPHARMACOLOGY, V25, P415, DOI 10.1007/s10787-017-0360-1; Sun KY, 2017, CYTOKINE, V92, P1, DOI 10.1016/j.cyto.2017.01.003; Ulbrich F, 2016, J NEUROCHEM, V138, P859, DOI 10.1111/jnc.13662; Wang JJ, 2016, AM J TRANSL RES, V8, P615; Wang J, 2015, INT J MOL SCI, V16, P24965, DOI 10.3390/ijms161024965; Wang XH, 2014, BBA-MOL BASIS DIS, V1842, P701, DOI 10.1016/j.bbadis.2014.01.012; Xu LL, 2016, MOL MED REP, V13, P5005, DOI 10.3892/mmr.2016.5168; Yan L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01658; Yoon S, 2010, AUTOPHAGY, V6, P1125, DOI 10.4161/auto.6.8.13547; Zhang M, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15028297; Zhang NJ, 2017, MOL IMMUNOL, V91, P42, DOI 10.1016/j.molimm.2017.08.026; Zhu JP, 2016, PHARM BIOL, V54, P347, DOI 10.3109/13880209.2015.1042981; Zulueta A, 2018, CELL SIGNAL, V51, P110, DOI 10.1016/j.cellsig.2018.07.015	38	44	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212063	10.1371/journal.pone.0212063	http://dx.doi.org/10.1371/journal.pone.0212063			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807577	Green Submitted, gold, Green Published			2022-12-26	WOS:000459712100011
J	Artzner, T; Clere-Jehl, R; Schenck, M; Greget, M; Merdji, H; De Marini, P; Tuzin, N; Helms, J; Meziani, F				Artzner, Thierry; Clere-Jehl, Raphael; Schenck, Malika; Greget, Michel; Merdji, Hamid; De Marini, Pierre; Tuzin, Nicolas; Helms, Julie; Meziani, Ferhat			Spontaneous ilio-psoas hematomas complicating intensive care unit hospitalizations	PLOS ONE			English	Article							DISSEMINATED INTRAVASCULAR COAGULATION; SEPTIC SHOCK; MULTICENTER; PREVALENCE; HEMORRHAGE	Background Ilio-psoas hematoma is a potentially lethal condition that can arise during hospital stay. However, neither the incidence nor the prognosis of patients whose stay in intensive care units (ICU) is complicated by a iatrogenic ilio-psoas hematoma is known. Methods A bicentric retrospective study was conducted to compile the patients who developed an ilio-psoas hematoma while they were hospitalized in ICU between January 2009 and December 2016. Their biometric characteristics, pre-existing conditions, the circumstances in which the hematoma was diagnosed, the treatments they received and their prognosis were recorded. Results Forty patients were diagnosed with an ilio-psoas hematoma during their ICU stay. The incidence of this complication was 3.8 cases for 1000 admissions, taking into account only patients who stayed more than three days in ICU. The median age of patients was 74 years old and the median time between admission and the diagnosis of ilio-psoas hematoma was 12.6 days. A large proportion of them was obese (42.5%) and/or under dialysis (50%) prior to developing their hematoma. Ninety-five percent of the patients had heparin at prophylactic or therapeutic doses. Only 10% of them were above the therapeutic range of anticoagulation. The ICU mortality rate was of 50% following this complication (versus a general mortality rate of 22% for the patients without IPH over the same period of time). Patients with IPH that were complicated by disseminated intravascular coagulopathy had a significantly higher mortality rate than those with IPH and no disseminated intravascular coagulopathy (OR 6.91, 95% CI [1.28; 58.8], p = 0.04). Conclusion Age, anticoagulation, a high body mass index and dialysis seem to be risk factors of developing an ilio-psoas hematoma in ICU. Iatrogenic ilio-psoas hematomas complicated by disseminated intravascular coagulopathies are more at risk of leading to death. It is noteworthy that activated partial thromboplastin time above the therapeutic range was not a good predictor of developing a hematoma for patients who received unfractioned heparin therapy.	[Artzner, Thierry; Clere-Jehl, Raphael; Merdji, Hamid; Helms, Julie; Meziani, Ferhat] Univ Strasbourg UNISTRA, Fac Med, Hop Univ Strasbourg, Serv Reanim Med,Nouvel Hop Civil, Strasbourg, France; [Clere-Jehl, Raphael; Helms, Julie] Univ Strasbourg, ImmunoRhumatol Mol, INSERM,Fac Med,Federat Hosp Univ FHU OMICARE,FMTS, UMR S1109,LabEx TRANSPLANTEX,Ctr Rech Immunol & H, Strasbourg, France; [Schenck, Malika] Hop Univ Strasbourg, Hop Hautepierre, Serv Reanimat Med, Strasbourg, France; [Greget, Michel; De Marini, Pierre] Hop Univ Strasbourg, Serv Imagerie Intervent, Strasbourg, France; [Merdji, Hamid; Meziani, Ferhat] French Natl Inst Hlth & Med Res, INSERM, UMR 1260, Regenerat Nanomed RNM,FMTS, Strasbourg, France; [Tuzin, Nicolas] Hop Univ Strasbourg, Lab Biostat & Informat Med, ICube UMR 7357, Fac Med, Strasbourg, France; [Tuzin, Nicolas] Hop Univ Strasbourg, Grp Methode Rech Clin, Serv Sante Publ, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Meziani, F (corresponding author), Univ Strasbourg UNISTRA, Fac Med, Hop Univ Strasbourg, Serv Reanim Med,Nouvel Hop Civil, Strasbourg, France.; Meziani, F (corresponding author), French Natl Inst Hlth & Med Res, INSERM, UMR 1260, Regenerat Nanomed RNM,FMTS, Strasbourg, France.	ferhat.meziani@chru-strasbourg.fr	merdji, hamid/GXF-7656-2022; DE MARINI, Pierre/P-5110-2019	merdji, hamid/0000-0002-4670-1596; DE MARINI, Pierre/0000-0002-3760-1526				Bajaj SP, 1999, SEMIN THROMB HEMOST, V25, P407, DOI 10.1055/s-2007-994943; Boccardo P, 2004, SEMIN THROMB HEMOST, V30, P579, DOI 10.1055/s-2004-835678; Chan YC, 2008, INT J CLIN PRACT, V62, P1604, DOI 10.1111/j.1742-1241.2007.01494.x; De Waele JJ, 2003, INTENS CARE MED, V29, P332, DOI 10.1007/s00134-002-1578-x; Delabranche X, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0339-5; Delabranche X, 2016, CRIT CARE MED, V44, pE930, DOI 10.1097/CCM.0000000000001836; Delabranche X, 2013, INTENS CARE MED, V39, P1695, DOI 10.1007/s00134-013-2993-x; Gando S, 2006, CRIT CARE MED, V34, P625, DOI 10.1097/01.CCM.0000202209.42491.38; Goldhill DR, 1998, CRIT CARE MED, V26, P1337, DOI 10.1097/00003246-199808000-00017; Gonzalez C, 2003, MEDICINE, V82, P257, DOI 10.1097/00005792-200307000-00004; Guivarc'h M, 1997, J CHIR-PARIS, V134, P382; Hauguel M, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002161; HEIM M, 1982, ARCH ORTHOP TRAUM SU, V99, P195, DOI 10.1007/BF00379208; Kim HY, 2013, PLATELETS, V24, P213, DOI 10.3109/09537104.2012.684733; Llitjos JF, 2016, ANN INTENSIVE CARE, P6; Pezzini A, 2013, STROKE, V44, P1584, DOI 10.1161/STROKEAHA.111.000069; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Sakr Y, 2015, CRIT CARE MED, V43, P519, DOI 10.1097/CCM.0000000000000754; Sunga Kharmene L, 2012, J Emerg Med, V43, pe157, DOI 10.1016/j.jemermed.2011.06.006; Takemoto CM, 2013, AM J CLIN PATHOL, V139, P450, DOI 10.1309/AJCPS6OW6DYNOGNH	20	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211680	10.1371/journal.pone.0211680	http://dx.doi.org/10.1371/journal.pone.0211680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794573	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100022
J	Ligita, T; Wicking, K; Francis, K; Harvey, N; Nurjannah, I				Ligita, Titan; Wicking, Kristin; Francis, Karen; Harvey, Nichole; Nurjannah, Intansari			How people living with diabetes in Indonesia learn about their disease: A grounded theory study	PLOS ONE			English	Article							SELF-MANAGEMENT EDUCATION; HEALTH; MELLITUS; CARE; COMMUNICATION; INDIVIDUALS; EMPOWERMENT; EXPERIENCES; PREVALENCE; OUTCOMES	Background Diabetes education has been found to impact positively on self-management by people with diabetes although little is known about the process by which they assimilate information. The aim of this study was to generate a theory explaining the process by which people with diabetes learn about their disease in Indonesia. Methods This study employed a grounded theory methodology influenced by constructivism and symbolic interactionism. A total of twenty-eight face-to-face or telephone interviews with participants from Indonesia that included people with diabetes, healthcare professionals, health service providers and families of people with diabetes were conducted in both Indonesia and Australia. Results This study discloses a core category of Learning, choosing, and acting: self-management of diabetes in Indonesia as the basic social process of how people learn about their diabetes. The process includes five distinctive major categories. People with diabetes acted after they had received recommendations that they considered to be trustworthy. Factors that influenced their choice of recommendations to adopt are also identified. Conclusions Awareness of the complexity involved in their decision making will assist healthcare professionals to engage effectively with people living with diabetes.	[Ligita, Titan; Wicking, Kristin; Francis, Karen; Nurjannah, Intansari] James Cook Univ, Coll Healthcare Sci, Nursing Midwifery & Nutr, Townsville, Qld, Australia; [Ligita, Titan] Univ Tanjungpura, Sch Nursing, Pontianak, Indonesia; [Francis, Karen] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Launceston, Tas, Australia; [Harvey, Nichole] James Cook Univ, Coll Med & Dent, Med, Townsville, Qld, Australia; [Nurjannah, Intansari] Univ Gadjahmada, Sch Nursing, Yogyakarta, Indonesia	James Cook University; Universitas Tanjungpura; University of Tasmania; James Cook University; Gadjah Mada University	Ligita, T (corresponding author), James Cook Univ, Coll Healthcare Sci, Nursing Midwifery & Nutr, Townsville, Qld, Australia.; Ligita, T (corresponding author), Univ Tanjungpura, Sch Nursing, Pontianak, Indonesia.	titan.ligita@my.jcu.edu.au	Nurjannah, Intansari/GNH-2409-2022; Francis, Karen/AAC-6291-2019; Francis, Karen/N-9318-2016	Francis, Karen/0000-0003-3578-2498; Wicking, Kristin/0000-0002-5996-6518	Department of Foreign Affairs and Trade, Australian Government; Australia Awards Scholarship [13/3377]	Department of Foreign Affairs and Trade, Australian Government; Australia Awards Scholarship	Department of Foreign Affairs and Trade, Australian Government provides the Australia Awards Scholarship funding for Titan Ligita's Doctor of Philosophy study at James Cook University. The Australia Awards Scholarship grant number 13/3377. www.australiaawardsindonesia.org/.; This paper is part of a doctoral degree program. The authors acknowledge the Department of Foreign Affairs and Trade, Australian Government, for the funding provided for Titan Ligita's Doctor of Philosophy study at James Cook University, Australia. The authors would like to thank the participants for their contributions to this study and appreciate the access to study settings for participant recruitment.	AlQarni ZA, 2016, J INFECT PUBLIC HEAL, V9, P708, DOI 10.1016/j.jiph.2016.08.015; [Anonymous], 2018, REGIONAL PROVINCE MI; [Anonymous], 2014, NATL STATEMENT HLTH; Arksey H., 2005, INT J SOC RES METHOD, V8, P19, DOI [10.1080/1364557032000119616, DOI 10.1080/1364557032000119616]; Birks M., 2015, GROUNDED THEORY PRAC; Blumer H., 1969, SYMB INTERACT; Bockwoldt D, 2017, J TRANSCULT NURS, V28, P363, DOI 10.1177/1043659616651674; Boels AM, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016180; Brunisholz KD, 2014, J MULTIDISCIP HEALTH, V7, P533, DOI 10.2147/JMDH.S69000; Burt RS, 2005, BROKERAGE CLOSURE IN; Charmaz Kathy, 2014, INTRO QUALITATIVE ME, V2nd; Corbin J., 2007, BASICS QUALITATIVE R, V3rd, DOI DOI 10.4135/9781452230153.N8; Creswell J. W., 2013, QUALITATIVE INQUIRY; Edwards DJ, 2018, J CHILD HEALTH CARE, V22, P382, DOI 10.1177/1367493518760734; Eyuboglu E, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010186; Funnell MM, 2010, DIABETES CARE, V33, pS89, DOI 10.2337/dc10-S089; Glaser B.G., 1968, DISCOV GROUNDED THEO; Grant MJ, 2009, HEALTH INFO LIBR J, V26, P91, DOI 10.1111/j.1471-1842.2009.00848.x; Greenhalgh T, 2005, BRIT MED J, V330, P628, DOI 10.1136/bmj.330.7492.628; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Hartayu TS, 2012, J PHARM HEALTH SERV, V3, P95, DOI 10.1111/j.1759-8893.2012.00088.x; Hartayu Titien Siwi, 2012, BMC Res Notes, V5, P315, DOI 10.1186/1756-0500-5-315; Herlitz A, 2016, HEALTH COMMUN, V31, P964, DOI 10.1080/10410236.2015.1025332; Hjelm K, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-11; Horigan G, 2017, DIABETIC MED, V34, P14, DOI 10.1111/dme.13120; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Klein HA, 2013, NURS RES PRACT, V2013, DOI 10.1155/2013/581012; Lee YK, 2015, INT J NURS PRACT, V21, P125, DOI 10.1111/ijn.12355; Ligita T, 2018, INT NURSING REV; Mahdalena M, 2016, KESMAS NATL PUBLIC H, V11; Malini H, 2017, COLLEGIAN, V24, P183, DOI 10.1016/j.colegn.2015.11.002; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Mendenhall E, 2016, ANTHROPOL MED, V23, P295, DOI 10.1080/13648470.2016.1184010; Moffatt A., 2012, INDONESIAN CULTURE P; Murray CM, 2016, PRIM CARE DIABETES, V10, P179, DOI 10.1016/j.pcd.2015.10.007; Naccashian Z, 2014, DIABETES EDUCATOR, V40, P638, DOI 10.1177/0145721714535993; National Institute for Health Research and Development, 2013, RIS KES DAS; National Institute for Health Research and Development, 2008, RIS KES DAS; Nutbeam D, 1998, HEALTH PROMOT INT, V13, P349, DOI 10.1093/heapro/13.4.349; Peng W, 2016, TELEMED E-HEALTH, V22, P733, DOI 10.1089/tmj.2015.0180; Pitaloka D, 2015, QUAL HEALTH RES, V25, P1155, DOI 10.1177/1049732315577607; Powers MA, 2017, DIABETES EDUCATOR, V43, P40, DOI 10.1177/0145721716689694; Pramono LA, 2015, MED J INDONES, V24, P67, DOI 10.13181/mji.v24i2.1260; QSR International Pty Ltd, 2016, NVIVO QUAL DAT ANL S; Quandt SA, 2013, J APPL GERONTOL, V32, P783, DOI 10.1177/0733464811435506; Rehackova L, 2017, DIABETIC MED, V34, P1554, DOI 10.1111/dme.13426; Rudijanto A., 2011, J ASEAN FED ENDOCR S, V26, P17; Saldana J, 2013, CODING MANUAL QUALIT; Sja'bani Mohammad, 2005, Acta Med Indones, V37, P199; Soebardi Suharko, 2009, Acta Med Indones, V41, P186; Soegondo S, 2009, MED J INDONES, V18, P124; Soewondo P, 2010, MED J INDONES, V19, P235; Soewondo P, 2013, DIABETES RES CLIN PR, V100, pS47, DOI 10.1016/S0168-8227(13)70010-X; Sutanegara D, 2000, DIABETES RES CLIN PR, V50, pS9, DOI 10.1016/S0168-8227(00)00173-X; Tanto A, 2017, AS AC SOC INT C P KH; Wan CR, 2012, PATIENT EDUC COUNS, V87, P402, DOI 10.1016/j.pec.2011.09.010; Webster E, 2017, AUST NZ J PUBL HEAL, V41, P27, DOI 10.1111/1753-6405.12605; White RO, 2016, J HEALTH COMMUN, V21, P127, DOI 10.1080/10810730.2016.1207116; White RO, 2015, PATIENT EDUC COUNS, V98, P144, DOI 10.1016/j.pec.2014.10.019; World Health Organization, 2016, IND DIAB COUNTR PROF; Youngson A, 2015, BRIT J OCCUP THER, V78, P24, DOI 10.1177/0308022614561240	62	24	24	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212019	10.1371/journal.pone.0212019	http://dx.doi.org/10.1371/journal.pone.0212019			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794570	Green Published, Green Accepted, gold			2022-12-26	WOS:000459709100031
J	Rodriguez, AE; Bogart, C; Gilbert, CM; McCullers, JA; Smith, AM; Kanneganti, TD; Lupfer, CR				Rodriguez, Angeline E.; Bogart, Christopher; Gilbert, Christopher M.; McCullers, Jonathan A.; Smith, Amber M.; Kanneganti, Thirumala-Devi; Lupfer, Christopher R.			Enhanced IL-1 beta production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae	PLOS ONE			English	Article							ALVEOLAR MACROPHAGE PHAGOCYTOSIS; PNEUMOCOCCAL PNEUMONIA; BACTERIAL PNEUMONIA; INFLAMMATORY CASPASES; PANDEMIC INFLUENZA; MOUSE MODEL; GASDERMIN D; ACTIVATION; INFECTIONS; SUSCEPTIBILITY	Viral-bacterial coinfections, such as with influenza A virus and Streptococcus pneumoniae (S.p.), are known to cause severe pneumonia. It is well known that the host response has an important role in disease. Interleukin-1 beta (IL-1 beta) is an important immune signaling cytokine responsible for inflammation and has been previously shown to contribute to disease severity in numerous infections. Other studies in mice indicate that IL-1 beta levels are dramatically elevated during IAV-S.p. coinfection. However, the regulation of IL-1 beta during coinfection is unknown. Here, we report the NLRP3 inflammasome is the major inflammasome regulating IL-1 beta activation during coinfection. Furthermore, elevated IL-1 beta mRNA expression is due to enhanced TLR2-MYD88 signaling, which increases the amount of pro-IL-1 beta substrate for the inflammasome to process. Finally, NLRP3 and high IL-1 beta levels were associated with increased bacterial load in the brain. Our results show the NLRP3 inflammasome is not protective during IAV-S.p. coinfection.	[Rodriguez, Angeline E.; Bogart, Christopher; Lupfer, Christopher R.] Missouri State Univ, Dept Biol, Springfield, MO 65897 USA; [Gilbert, Christopher M.] Cox Med Ctr South, Dept Pathol, Springfield, MO USA; [McCullers, Jonathan A.; Smith, Amber M.] Univ Tennessee, Dept Pediat, Hlth Sci Ctr, Memphis, TN USA; [Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Rodriguez, Angeline E.] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA	Missouri State University; University of Tennessee System; University of Tennessee Health Science Center; St Jude Children's Research Hospital; University of Arkansas System; University of Arkansas Fayetteville	Lupfer, CR (corresponding author), Missouri State Univ, Dept Biol, Springfield, MO 65897 USA.	ChristopherLupfer@missouristate.edu	Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Smith, Amber/0000-0002-7092-6904	National Institutes of Health [R56 AI125324, K25 AI00946]; American Lebanese Syrian Associated Charities; Missouri State University Grant [F07314]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K25AI100946, R56AI125324, R01AI139088] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Missouri State University Grant; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R56 AI125324 (AMS) and K25 AI00946 (AMS), the American Lebanese Syrian Associated Charities (JAM and TDK) and Missouri State University Grant F07314 (CRL). AMS received salary support from the National Institutes of Health grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The results publish here do not necessarily reflect the views of the funding agencies.	Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bansal S, 2018, J IMMUNOL, V200, P1425, DOI 10.4049/jimmunol.1700210; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Califano D, 2018, J IMMUNOL, V201, P134, DOI 10.4049/jimmunol.1701406; Casalino E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182191; Colamussi ML, 1999, BLOOD, V93, P2395, DOI 10.1182/blood.V93.7.2395.407a22_2395_2403; Dawood FS, 2014, J INFECT DIS, V209, P686, DOI 10.1093/infdis/jit473; Engelich G, 2001, J LEUKOCYTE BIOL, V69, P50; Fang RD, 2014, INFECT IMMUN, V82, P2310, DOI 10.1128/IAI.01572-14; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Ghoneim HE, 2014, J INFECT DIS, V209, P1459, DOI 10.1093/infdis/jit653; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Han K, 2011, CLIN INFECT DIS, V53, P326, DOI 10.1093/cid/cir398; HARTSHORN KL, 1995, J IMMUNOL, V154, P3952; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; JAKAB GJ, 1982, AM REV RESPIR DIS, V126, P778; Karunanithi K, 2017, UNIVERSAL J MED SCI, DOI [10.13189/ujmsj.2015.030401, DOI 10.13189/UJMSJ.2015.030401]; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lee B, 2015, AM J PHYSIOL-LUNG C, V309, pL158, DOI 10.1152/ajplung.00338.2014; Lupfer C, 2008, ARCH VIROL, V153, P929, DOI 10.1007/s00705-008-0067-0; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Lynnelle A, 2006, INFECT INFECT IMMUNI, V74, P6707, DOI [10.1128/IAI.00789-06, DOI 10.1128/IAI.00789-06]; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; McCullers JA, 2002, J INFECT DIS, V186, P341, DOI 10.1086/341462; McCullers JA, 2014, NAT REV MICROBIOL, V12, P252, DOI 10.1038/nrmicro3231; McGuire LW, 1918, AM J PUBLIC HEALTH, V8, P741, DOI 10.2105/AJPH.8.10.741; Metzger DW, 2013, J IMMUNOL, V191, P2047, DOI 10.4049/jimmunol.1301152; Mina MJ, 2015, J INTERF CYTOK RES, V35, P474, DOI 10.1089/jir.2014.0087; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nakamura S, 2011, J CLIN INVEST, V121, P3657, DOI 10.1172/JCI57762; Nedel Wagner Luis, 2016, World J Crit Care Med, V5, P89, DOI 10.5492/wjccm.v5.i1.89; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; Peltola VT, 2004, PEDIATR INFECT DIS J, V23, pS87, DOI 10.1097/01.inf.0000108197.81270.35; Pittet LA, 2010, AM J RESP CELL MOL, V42, P450, DOI 10.1165/rcmb.2007-0417OC; Robinson KM, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97470; Robinson KM, 2015, CURR OPIN IMMUNOL, V34, P59, DOI 10.1016/j.coi.2015.02.002; Robinson KM, 2013, J IMMUNOL, V191, P5153, DOI 10.4049/jimmunol.1301237; Rudd Jennifer M, 2016, J Infect Pulm Dis, V2, DOI 10.16966/2470-3176.114; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; Seki M, 2004, EUR RESPIR J, V24, P143, DOI 10.1183/09031936.04.00126103; Seki M, 2007, INTERNAL MED, V46, P953, DOI 10.2169/internalmedicine.46.6364; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Smith AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38703; Smith AM, 2014, CURR TOP MICROBIOL, V385, P327, DOI 10.1007/82_2014_394; Smith AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003238; Smith MW, 2007, COMPARATIVE MED, V57, P82; Soper GA, 1918, SCIENCE, V48, P451, DOI 10.1126/science.48.1245.451; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; van der Sluijs KF, 2004, J IMMUNOL, V172, P7603, DOI 10.4049/jimmunol.172.12.7603; van Lieshout MHP, 2018, EUR J IMMUNOL, V48, P66, DOI 10.1002/eji.201646554; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	58	22	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212236	10.1371/journal.pone.0212236	http://dx.doi.org/10.1371/journal.pone.0212236			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794604	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100048
J	Sung, SH; Lee, CW; Wang, PN; Lee, HY; Chen, CH; Chung, CP				Sung, Shih-Hsien; Lee, Ching-Wei; Wang, Pei-Ning; Lee, Hsiang-Ying; Chen, Chen-Huan; Chung, Chih-Ping			Cognitive functions and jugular venous reflux in severe mitral regurgitation: A pilot study	PLOS ONE			English	Article							WHITE-MATTER CHANGES; DEMENTIA; IMPAIRMENT; DISEASE; SYSTEM	Cardiac diseases with elevated central venous pressure have higher frequency of jugular venous reflux (JVR), which is associated with decreased cerebral blood flow and white matter hyperintensities. Whether patients with severe mitral-regurgitation (SMR) have poorer cognitive functions and whether JVR is involved were determined in this pilot study. Patients with SMR and age/sex-matched controls were prospectively recruited. Neuropsychological tests such as global cognitive (Mini-Mental State Examination, MMSE), verbal memory, executive, and visuospatial domains were performed. Cardiac parameters by cardiac catheterisation and echocardiography, and the frequency of JVR by colour-coded duplex ultrasonography were obtained. Forty patients with SMR and 40 controls (71.1 +/- 12.2, 38-89 years; 75% men) were included. Compared with the controls, patients with SMR had lower scores in all neuropsychological tests but only MMSE and visuospatial test scores were statistically significant after adjusting for age, sex, and educational level. We further adjusted for cardiovascular risk factors; the significance remained in the visuospatial test but diminished in MMSE. Multivariate linear regression analyses adjusted for age, sex, and educational level showed that JVR combined with high right-atrial-pressure (RAP > 50th-percentile, 12 mmHg) was significantly associated with poorer performances in both MMSE [right JVR: B coefficient(95% confidence interval, p) = -2.83(-5.46-0.20, 0.036); left JVR: -2.77(-5.52-0.02, 0.048)] and visuospatial test [right JVR: -4.52(-8.89-0.16, 0.043); left JVR: -4.56 (-8.81-0.30, 0.037)], with significances that remained after further adjusting for cardiovascular risk factors. Our pilot results suggest that retrogradely-transmitted venous pressure might be involved in the mechanisms mediating the relationship between cardiac diseases and brain functions.	[Sung, Shih-Hsien; Lee, Ching-Wei; Chen, Chen-Huan] Taipei Vet Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan; [Sung, Shih-Hsien; Lee, Ching-Wei; Chen, Chen-Huan] Natl Yang Ming Univ, Cardiovasc Res Ctr, Taipei, Taiwan; [Sung, Shih-Hsien; Chen, Chen-Huan] Natl Yang Ming Univ, Inst Publ Hlth, Taipei, Taiwan; [Sung, Shih-Hsien; Lee, Ching-Wei; Wang, Pei-Ning; Chen, Chen-Huan; Chung, Chih-Ping] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan; [Wang, Pei-Ning; Lee, Hsiang-Ying; Chung, Chih-Ping] Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan; [Wang, Pei-Ning] Natl Yang Ming Univ, Brain Res Ctr, Taipei, Taiwan; [Chen, Chen-Huan] Taipei Vet Gen Hosp, Dept Med Educ, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Chung, CP (corresponding author), Natl Yang Ming Univ, Sch Med, Taipei, Taiwan.; Chung, CP (corresponding author), Taipei Vet Gen Hosp, Neurol Inst, Dept Neurol, Taipei, Taiwan.	pin324pin324@gmail.com	Chen, Chen-Huan/AAE-4036-2022	Chung, Chih-Ping/0000-0001-9419-9070	Ministry of Science and Technology; Taipei Veterans General Hospital, Taiwan [VGH V105C-055, MOST 104-2314-B-075-MY3]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	The authors received grants from Ministry of Science and Technology and Taipei Veterans General Hospital, Taiwan (Chung: VGH V105C-055; MOST 104-2314-B-075-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Asgar AW, 2015, J AM COLL CARDIOL, V65, P1231, DOI 10.1016/j.jacc.2015.02.009; Cannon JA, 2017, J CARD FAIL, V23, P464, DOI 10.1016/j.cardfail.2017.04.007; Chang CC, 2010, J INT NEUROPSYCH SOC, V16, P244, DOI 10.1017/S1355617709991184; Chung CP, 2011, ANN NEUROL, V69, P553, DOI 10.1002/ana.22276; Chung CP, 2010, ULTRASOUND MED BIOL, V36, P1776, DOI 10.1016/j.ultrasmedbio.2010.07.006; Chung CP, 2010, CEREBROVASC DIS, V29, P122, DOI 10.1159/000262307; Chung CP, 2008, J MED ULTRASOUND, V16, P210, DOI 10.1016/S0929-6441(08)60050-8; DRESSER LP, 1987, AM J SURG, V154, P220, DOI 10.1016/0002-9610(87)90185-1; FISHER J, 1982, CIRCULATION, V65, P188, DOI 10.1161/01.CIR.65.1.188; Harb SC, 2017, CURR CARDIOL REP, V19, DOI 10.1007/s11886-017-0883-5; Hester RL, 2004, J INT NEUROPSYCH SOC, V10, P475, DOI 10.1017/S1355617704104037; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Jones DW, 2004, HYPERTENSION, V43, P1, DOI 10.1161/01.HYP.0000110061.06674.ca; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Lee WJ, 2018, JAMA NEUROL, V75, P80, DOI 10.1001/jamaneurol.2017.2853; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; LIU HC, 1995, J AM GERIATR SOC, V43, P144, DOI 10.1111/j.1532-5415.1995.tb06379.x; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Nikendei C, 2016, PSYCHOSOM MED, V78, P432, DOI 10.1097/PSY.0000000000000284; Nishimura RA, 2017, J AM COLL CARDIOL, V70, P252, DOI 10.1016/j.jacc.2017.03.011; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; Schaller B, 2004, BRAIN RES REV, V46, P243, DOI 10.1016/j.brainresrev.2004.04.005; Schaller B, 2004, CEREBROVASC DIS, V18, P179, DOI 10.1159/000079939; Waragai M, 2006, EUR J NEUROL, V13, P754, DOI 10.1111/j.1468-1331.2006.01318.x; Wu I-Hui, 2011, Acta Neurol Taiwan, V20, P15; Yamakami I, 2001, J CLIN NEUROSCI, V8, P471, DOI 10.1054/jocn.2000.0796; ZEIDMAN SM, 1995, AM J NEURORADIOL, V16, P1080	28	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207832	10.1371/journal.pone.0207832	http://dx.doi.org/10.1371/journal.pone.0207832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794544	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100004
J	Teletcheaid, S; Santuz, H; Leonard, S; Etchebest, C				Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.			Repository of Enriched Structures of Proteins Involved in the Red Blood Cell Environment (RESPIRE)	PLOS ONE			English	Article							STRUCTURE PREDICTION; SECONDARY STRUCTURE; PROTEOMIC ANALYSIS; GENE ONTOLOGY; I-TASSER; MEMBRANE; SEQUENCE; DATABASE; IDENTIFICATION; GENERATION	The Red Blood Cell (RBC) is a metabolically-driven cell vital for processes such a gas transport and homeostasis. RBC possesses at its surface exposing antigens proteins that are critical in blood transfusion. Due to their importance, numerous studies address the cell function as a whole but more and more details of RBC structure and protein content are now studied using massive state-of-the art characterisation techniques. Yet, the resulting information is frequently scattered in many scientific articles, in many databases and specialized web servers. To provide a more compendious view of erythrocytes and of their protein content, we developed a dedicated database called RESPIRE that aims at gathering a comprehensive and coherent ensemble of information and data about proteins in RBC. This cell-driven database lists proteins found in erythrocytes. For a given protein entry, initial data are processed from external portals and enriched by using state-of-the-art bioinformatics methods. As structural information is extremely useful to understand protein function and predict the impact of mutations, a strong effort has been put on the prediction of protein structures with a special treatment for membrane proteins. Browsing the database is available through text search for reference gene names or protein identifiers, through pre-defined queries or via hyperlinks. The RESPIRE database provides valuable information and unique annotations that should be useful to a wide audience of biologists, clinicians and structural biologists.	[Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] Inst Natl Transfus Sanguine, Paris, France; [Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] INSERM, UMR S 1134, Paris, France; [Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France; [Teletcheaid, S.; Santuz, H.; Leonard, S.; Etchebest, C.] Lab Excellence GR Ex, Paris, France; [Teletcheaid, S.] Univ Nantes, CNRS, UMR 6286, UFIP, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Nantes Universite	Etchebest, C (corresponding author), Inst Natl Transfus Sanguine, Paris, France.; Etchebest, C (corresponding author), INSERM, UMR S 1134, Paris, France.; Etchebest, C (corresponding author), Univ Paris Diderot, Sorbonne Paris Cite, Paris, France.; Etchebest, C (corresponding author), Lab Excellence GR Ex, Paris, France.	catherine.etchebest@inserm.fr	etchebest, catherine/O-2485-2019; Téletchéa, Stéphane/N-8897-2019; Téletchéa, Stéphane/B-1082-2009	etchebest, catherine/0000-0002-5871-2372; Téletchéa, Stéphane/0000-0002-2402-028X; Téletchéa, Stéphane/0000-0002-2402-028X; Santuz, Hubert/0000-0001-6149-9480	Institut National de la Sante et la Recherche Medicale; Universite Paris Diderot, Sorbonne Paris Cite; Institut National de la Transfusion Sanguine; Conseil Regional Ile de France (SESAME 2009); French National Research Agency [ANR-11-IDEX-0005-02, ANR-11-LABX-0051]; University La Reunion	Institut National de la Sante et la Recherche Medicale; Universite Paris Diderot, Sorbonne Paris Cite; Institut National de la Transfusion Sanguine; Conseil Regional Ile de France (SESAME 2009); French National Research Agency(French National Research Agency (ANR)); University La Reunion	This work was funded by: Institut National de la Sante et la Recherche Medicale, Recurrent funding; Universite Paris Diderot, Sorbonne Paris Cite, Recurrent funding; Institut National de la Transfusion Sanguine, Recurrent funding; Conseil Regional Ile de France (SESAME 2009); French National Research Agency [ANR-11-IDEX-0005-02], Program "Investissements d'avenir"for the Laboratory of Excellence GR-Ex who granted S. Teletchea [ANR-11-LABX-0051]; and University La Reunion, Recurrent funding.	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An XL, 2015, CURR OPIN HEMATOL, V22, P206, DOI 10.1097/MOH.0000000000000134; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Arnaud L, 2009, TRANSFUSION, V49, P479, DOI 10.1111/j.1537-2995.2008.02003.x; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bagger FO, 2016, NUCLEIC ACIDS RES, V44, pD917, DOI 10.1093/nar/gkv1101; Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Ballif BA, 2013, EMBO MOL MED, V5, P751, DOI 10.1002/emmm.201302466; Barneaud-Rocca D, 2013, J BIOL CHEM, V288, P26372, DOI 10.1074/jbc.M113.465989; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bell AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060300; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Bryk AH, 2017, J PROTEOME RES, V16, P2752, DOI 10.1021/acs.jproteome.7b00025; Chaar V, 2010, HAEMATOL-HEMATOL J, V95, P1841, DOI 10.3324/haematol.2010.026294; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chu TTT, 2018, BRIT J HAEMATOL, V180, P118, DOI 10.1111/bjh.14976; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; D'Alessandro A, 2017, EXPERT REV PROTEOMIC, V14, P243, DOI 10.1080/14789450.2017.1291347; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daniels G, 2011, ISBT SCI SERIES, V6, P257, DOI DOI 10.1111/J.1751-2824.2011.01497.X; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; de Brevern AG, 2005, BBA-GEN SUBJECTS, V1724, P288, DOI 10.1016/j.bbagen.2005.05.016; de Brevern Alexandre G., 2009, Infectious Disorders - Drug Targets, V9, P289; De Palma A, 2010, J CHROMATOGR A, V1217, P5328, DOI 10.1016/j.chroma.2010.06.045; Edgar RC, 2004, 2004 IEEE COMPUTATIONAL SYSTEMS BIOINFORMATICS CONFERENCE, PROCEEDINGS, P728; Esque J, 2015, AMINO ACIDS, V47, P2303, DOI 10.1007/s00726-015-2010-5; Gautier EF, 2016, CELL REP, V16, P1470, DOI 10.1016/j.celrep.2016.06.085; Gomez J, 2013, BIOINFORMATICS, V29, P1103, DOI 10.1093/bioinformatics/btt100; Goodman SR, 2013, EXP BIOL MED, V238, P509, DOI 10.1177/1535370213488474; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Hanson RM, 2013, ISR J CHEM, V53, P207, DOI 10.1002/ijch.201300024; Hegedus T, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav056; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kajan L, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-85; Kelm S, 2010, BIOINFORMATICS, V26, P2833, DOI 10.1093/bioinformatics/btq554; Khor BY, 2015, THEOR BIOL MED MODEL, V12, DOI 10.1186/s12976-015-0014-1; Lange PF, 2014, J PROTEOME RES, V13, P2028, DOI 10.1021/pr401191w; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin Andrew C R, 2014, F1000Res, V3, P249, DOI 10.12688/f1000research.5486.1; McGrath KE, 2017, METHODS, V112, P68, DOI 10.1016/j.ymeth.2016.08.012; Moras M, 2017, FRONT PHYSIOL, V8, DOI [10.3389/FPHYS.2017.01076, 10.3389/fphys.2017.01076]; Mungall CJ, 2011, J BIOMED INFORM, V44, P80, DOI 10.1016/j.jbi.2010.02.002; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Olivella M, 2013, BIOINFORMATICS, V29, P1589, DOI 10.1093/bioinformatics/btt249; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Palis J, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00003; Pallotta V, 2013, J PROTEOME RES, V12, P3529, DOI 10.1021/pr400431b; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pasini EM, 2010, J PROTEOMICS, V73, P403, DOI 10.1016/j.jprot.2009.06.005; Pasini EM, 2010, J PROTEOMICS, V73, P421, DOI 10.1016/j.jprot.2009.07.004; Patrinos GP, 2004, NUCLEIC ACIDS RES, V32, pD537, DOI 10.1093/nar/gkh006; Postic G, 2015, BIOCHIMIE, V115, P155, DOI 10.1016/j.biochi.2015.05.018; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Roux-Dalvai F, 2008, MOL CELL PROTEOMICS, V7, P2254, DOI 10.1074/mcp.M800037-MCP200; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; van Gestel RA, 2010, J PROTEOMICS, V73, P456, DOI 10.1016/j.jprot.2009.08.010; Wagner FF, 2014, TRANSFUS MED HEMOTH, V41, P357, DOI 10.1159/000366176; Wilson MC, 2016, MOL CELL PROTEOMICS, V15, P1938, DOI 10.1074/mcp.M115.057315; Yang JY, 2016, PROTEINS, V84, P233, DOI 10.1002/prot.24918; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	72	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211043	10.1371/journal.pone.0211043	http://dx.doi.org/10.1371/journal.pone.0211043			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794542	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100012
J	Caillaud, M; Guillard, J; Richard, D; Milin, S; Chassaing, D; Paccalin, M; Page, G; Bilan, AR				Caillaud, Martial; Guillard, Jerome; Richard, Damien; Milin, Serge; Chassaing, Damien; Paccalin, Marc; Page, Guylene; Bilan, Agnes Rioux			Trans epsilon viniferin decreases amyloid deposits and inflammation in a mouse transgenic Alzheimer model	PLOS ONE			English	Article							A-BETA; DISEASE; RESVERATROL; MICE; MEMORY; BRAIN	As Alzheimer's disease (AD) induces several cellular and molecular damages, it could be interesting to use multi-target molecules for therapeutics. We previously published that trans E-viniferin induced the disaggregation of A beta(42) peptide and inhibited the inflammatory response in primary cellular model of AD. Here, effects of this stilbenoid were evaluated in transgenic APPswePS1dE9 mice. We report that trans epsilon-viniferin could go through the blood brain barrier, reduces size and density of amyloid deposits and decreases reactivity of astrocytes and microglia, after a weekly intraperitoneal injection at 10 mg/kg from 3 to 6 months of age.	[Caillaud, Martial; Milin, Serge; Chassaing, Damien; Paccalin, Marc; Page, Guylene; Bilan, Agnes Rioux] Univ Poitiers, Neurovasc Unit, EA3808, Poitiers, France; [Caillaud, Martial; Milin, Serge; Chassaing, Damien; Paccalin, Marc; Page, Guylene; Bilan, Agnes Rioux] Univ Poitiers, Pole Biol Sante, Cognit Disorders, Poitiers, France; [Guillard, Jerome] Univ Poitiers, Inst Chem Poitiers Mat & Nat Resources, UMR CNRS 7285, Poitiers, France; [Richard, Damien] UMR INSERM 1107, Dept Pharmacol & Biol Toxicol, Clermont Ferrand, France; [Milin, Serge] Univ Poitiers Hosp, Dept Pathol, Poitiers, France; [Paccalin, Marc] Univ Poitiers Hosp, Dept Geriatr, Poitiers, France; [Paccalin, Marc] Univ Poitiers Hosp, CMRR, Poitiers, France	Universite de Poitiers; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Bilan, AR (corresponding author), Univ Poitiers, Neurovasc Unit, EA3808, Poitiers, France.; Bilan, AR (corresponding author), Univ Poitiers, Pole Biol Sante, Cognit Disorders, Poitiers, France.	agnes.rioux-bilan@univ-poitiers.fr	Caillaud, Martial/AAW-5733-2021	Caillaud, Martial/0000-0002-7874-1664	French Ministry of Education and Research and Technology [EA3808]	French Ministry of Education and Research and Technology	This work was not supported by any research grant. Financial support came only from the EA3808 dotation from the French Ministry of Education and Research and Technology.	Allain H, 2003, FUND CLIN PHARMACOL, V17, P419, DOI 10.1046/j.1472-8206.2003.00153.x; Anand R, 2014, NEUROPHARMACOLOGY, V76, P27, DOI 10.1016/j.neuropharm.2013.07.004; Capiralla H, 2012, J NEUROCHEM, V120, P461, DOI 10.1111/j.1471-4159.2011.07594.x; Couturier J, 2012, CURR ALZHEIMER RES, V9, P344, DOI 10.2174/156720512800107582; Cuello AC, 2017, TRENDS PHARMACOL SCI, V38, P956, DOI 10.1016/j.tips.2017.07.005; Damjanac M, 2007, BRAIN RES, V1128, P40, DOI 10.1016/j.brainres.2006.05.050; Francois A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0139-x; Garcia-Alloza M, 2006, NEUROBIOL DIS, V24, P516, DOI 10.1016/j.nbd.2006.08.017; Houille B, 2014, J NAT PROD, V77, P1658, DOI 10.1021/np5002576; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Ladiwala ARA, 2010, J BIOL CHEM, V285, P24228, DOI 10.1074/jbc.M110.133108; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marutle A, 2002, NEUROSCI LETT, V328, P269, DOI 10.1016/S0304-3940(02)00546-3; Pedros I, 2014, BBA-MOL BASIS DIS, V1842, P1556, DOI 10.1016/j.bbadis.2014.05.025; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Richard T, 2013, BBA-GEN SUBJECTS, V1830, P5068, DOI 10.1016/j.bbagen.2013.06.031; Richard T, 2011, BIOORGAN MED CHEM, V19, P3152, DOI 10.1016/j.bmc.2011.04.001; Riviere C, 2010, BIOORG MED CHEM LETT, V20, P3441, DOI 10.1016/j.bmcl.2009.09.074; Ruan LF, 2009, CURR ALZHEIMER RES, V6, P531, DOI 10.2174/156720509790147070; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Serriere S, 2015, NEUROBIOL AGING, V36, P1639, DOI 10.1016/j.neurobiolaging.2014.11.023; Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035; Vion E, 2018, MOL CELL NEUROSCI, V88, P1, DOI 10.1016/j.mcn.2017.12.003; Worthley G, 1965, TECHNICAL REPORT; Xu PX, 2014, BEHAV BRAIN RES, V264, P173, DOI 10.1016/j.bbr.2014.02.002; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081203	27	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212663	10.1371/journal.pone.0212663	http://dx.doi.org/10.1371/journal.pone.0212663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785960	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000082
J	Grant, MKO; Seelig, DM; Sharkey, LC; Choi, WSV; Abdelgawad, IY; Zordoky, BN				Grant, Marianne K. O.; Seelig, Davis M.; Sharkey, Leslie C.; Choi, Wan S. V.; Abdelgawad, Ibrahim Y.; Zordoky, Beshay N.			Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C5761/6 mice	PLOS ONE			English	Article							SOLUBLE EPOXIDE HYDROLASE; ADRIAMYCIN-INDUCED NEPHROPATHY; INDUCED TESTICULAR TOXICITY; ALTERS CYTOCHROME-P450 EXPRESSION; ARACHIDONIC-ACID METABOLISM; ACUTE-RENAL-FAILURE; OXIDATIVE STRESS; IN-VIVO; KIDNEY; LIVER	Doxorubicin (DOX) is a chemotherapeutic agent that has been reported to cause nephrotoxicity in rodent models and to a lesser degree in cancer patients. Female rodents have been shown to be protected against several features of DOX-induced nephrotoxicity. Nevertheless, the underlying mechanisms of this sexual dimorphism are not fully elucidated. Therefore, in the current study, we investigated the sex and time-dependent changes in pathological lesions as well as apoptotic and fibrotic markers in response to acute DOX-induced nephrotoxicity. We also determined the effect of acute DOX treatment on the renal expression of the sexually dimorphic enzyme, soluble epoxide hydrolase (sEH), since inhibition of sEH has been shown to protect against DOX-induced nephrotoxicity. Acute DOX-induced nephrotoxicity was induced by a single intra-peritoneal injection of 20 mg/kg DOX to male and female adult C57BI/6 mice. The kidneys were isolated 1, 3 and 6 days after DOX administration. Histopathology assessment, gene expression of the apoptotic marker, BAX, protein expression of the fibrotic marker, transforming growth factor-beta (TGF-beta), and gene and protein expression of sEH were assessed. DOX administration caused more severe pathological lesions as well as higher induction of the apoptotic and fibrotic markers in kidneys of male than in female mice. Intriguingly, DOX inhibited sEH protein expression in kidneys of male mice sacrificed at 3 and 6 days following administration, suggesting that induction of sEH is not necessary for acute DOX-induced nephrotoxicity. However, DOX-induced inhibition of renal sEH in male mice may protect the kidney from further DOX-induced injury in a negative feedback mechanism. We also observed lower constitutive expressions of TGF-beta and sEH in the kidney of female mice which may contribute, at least in part, to sexual dimorphism of DOX-induced nephrotoxicity.	[Grant, Marianne K. O.; Choi, Wan S. V.; Abdelgawad, Ibrahim Y.; Zordoky, Beshay N.] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA; [Seelig, Davis M.; Sharkey, Leslie C.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Zordoky, BN (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	zordo001@umn.edu	Zordoky, Beshay/AAB-4390-2020; Grant, Marianne/AAL-1396-2020	Zordoky, Beshay/0000-0002-9358-4185; Grant, Marianne/0000-0002-2963-4686	Masonic Cancer Center, a comprehensive cancer center; Rally Foundation [582420]	Masonic Cancer Center, a comprehensive cancer center; Rally Foundation	B.N.Z. is a Masonic Cancer Center Women's Health Scholar, sponsored by the Masonic Cancer Center, a comprehensive cancer center designated by the National Cancer Institute, and administered by the University of Minnesota Women's Health Research Program. B.N.Z. was also supported by Rally Foundation grant 582420. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhamid G, 2015, FREE RADICAL BIO MED, V82, P1, DOI 10.1016/j.freeradbiomed.2015.01.005; Anwar-Mohamed A, 2013, XENOBIOTICA, V43, P719, DOI 10.3109/00498254.2012.754113; Bettaieb A, 2017, BBA-GEN SUBJECTS, V1861, P2758, DOI 10.1016/j.bbagen.2017.07.021; Carlson A, 2017, VET COMP ONCOL, DOI [10.1111/vco.2 PMID: 30157941; PubMed Central PMCID: PMCPMC6114275, DOI 10.1111/VCO.2]; Carron PL, 2014, HEMODIAL INT, V18, P846, DOI 10.1111/hdi.12196; Deng BQ, 2017, P NATL ACAD SCI USA, V114, P12608, DOI 10.1073/pnas.1705615114; Fouad AA, 2015, Z NATURFORSCH C, V70, P175, DOI 10.1515/znc-2015-5031; Grant MKO, 2017, BIOL SEX DIFFER, V8, DOI 10.1186/s13293-016-0124-4; Gupta NC, 2012, ARTERIOSCL THROM VAS, V32, P1936, DOI 10.1161/ATVBAHA.112.251520; Hagiuda J, 2015, J ASSIST REPROD GEN, V32, P917, DOI 10.1007/s10815-015-0472-8; Hashimoto T, 2015, J TOXICOL SCI, V40, P451, DOI 10.2131/jts.40.451; INOUE N, 1993, BIOL PHARM BULL, V16, P1004; Kabel AM, 2018, BIOMED PHARMACOTHER, V97, P439, DOI 10.1016/j.biopha.2017.10.144; Kandhi S, 2015, AM J PHYSIOL-LUNG C, V309, pL1478, DOI 10.1152/ajplung.00208.2015; Kienesberger PC, 2012, MOL CELL BIOL, V32, P740, DOI 10.1128/MCB.06470-11; Kim J, 2015, AM J PHYSIOL-RENAL, V308, pF131, DOI 10.1152/ajprenal.00531.2014; Korashy HM, 2016, BASIC CLIN PHARMACOL, V119, P173, DOI 10.1111/bcpt.12555; Lahoti TS, 2012, CURR NEUROVASC RES, V9, P282; Levi M, 2015, REPRODUCTION, V150, P357, DOI 10.1530/REP-15-0129; Liang YX, 2015, BIOCHEM BIOPH RES CO, V463, P70, DOI 10.1016/j.bbrc.2015.05.020; Liu LL, 2007, TOXICOLOGY, V231, P81, DOI 10.1016/j.tox.2006.11.067; Liu SS, 2013, AM J PHYSIOL-RENAL, V305, pF1533, DOI 10.1152/ajprenal.00656.2012; Meiners B, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0198-2; Mohamed N, 2013, AM J KIDNEY DIS, V61, P778, DOI 10.1053/j.ajkd.2012.08.048; PINOT F, 1995, BIOCHEM PHARMACOL, V50, P501, DOI 10.1016/0006-2952(95)00167-X; Pokrzywinski KL, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0183-9; Qin J, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12838; Qin J, 2015, AM J PHYSIOL-HEART C, V309, pH1860, DOI 10.1152/ajpheart.00568.2015; Reddy KP, 2016, FOOD CHEM TOXICOL, V91, P65, DOI 10.1016/j.fct.2016.02.017; Rizk SM, 2014, FOOD CHEM TOXICOL, V67, P176, DOI 10.1016/j.fct.2014.02.031; Sakemi T, 1996, AM J NEPHROL, V16, P540, DOI 10.1159/000169057; Sherif IO, 2014, J BIOCHEM MOL TOXIC, V28, P515, DOI 10.1002/jbt.21593; Si H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004802; Su ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18314; Szalay CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127090; Takahashi H, 2011, J TOXICOL SCI, V36, P559; Takiue K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-14; Wang Q, 2018, AM J PHYSIOL-RENAL, V315, pF915, DOI 10.1152/ajprenal.00534.2017; Wang Q, 2013, AM J PHYSIOL-RENAL, V304, pF168, DOI 10.1152/ajprenal.00129.2012; Wang Yuan Min, 2015, Curr Protoc Immunol, V108, DOI 10.1002/0471142735.im1528s108; Xiao S, 2017, TOXICOL SCI, V157, P320, DOI 10.1093/toxsci/kfx047; Yang WN, 2012, CYTOKINE, V59, P370, DOI 10.1016/j.cyto.2012.04.014; Yang YM, 2018, P NATL ACAD SCI USA, V115, P613, DOI 10.1073/pnas.1716016115; Yu ZG, 2000, CIRC RES, V87, P992, DOI 10.1161/01.RES.87.11.992; Zhang J, 2014, TOXICOL PATHOL, V42, P361, DOI 10.1177/0192623313482778; Zordoky Beshay N, 2016, Cardiooncology, V2, P4, DOI 10.1186/s40959-016-0013-3; Zordoky BNM, 2011, DRUG METAB DISPOS, V39, P1440, DOI 10.1124/dmd.111.039123	47	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212486	10.1371/journal.pone.0212486	http://dx.doi.org/10.1371/journal.pone.0212486			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785938	gold, Green Submitted, Green Published			2022-12-26	WOS:000459307000065
J	Simon, V; Hyacinthe, C; Retaux, S				Simon, Victor; Hyacinthe, Carole; Retaux, Sylvie			Breeding behavior in the blind Mexican cavefish and its river-dwelling conspecific	PLOS ONE			English	Article							ASTYANAX-MEXICANUS; MATING PREFERENCES; FISH; EVOLUTION; COURTSHIP; GENETICS; MALES	Fish reproductive patterns are very diverse in terms of breeding frequency, mating system, sexual dimorphisms and selection, mate choice, spawning site choice, courtship patterns, spawning behaviors and parental care. Here we have compared the breeding behavior of the surface-dwelling and cave-dwelling morphs of the characiform A. mexicanus, with the goals of documenting the spawning behavior in this emerging model organism, its possible evolution after cave colonization, and the sensory modalities involved. Using infrared video recordings, we showed that cave and surface Astyanax spawning behavior is identical, occurs in the dark, and can be divided into 5 rapid phases repeated many times, about once per minute, during spawning sessions which last about one hour and involve one female and several males. Such features may constitute "pre-adaptive traits" which have facilitated fish survival after cave colonization, and may also explain how the two morphs can hybridize in the wild and in the laboratory. Accordingly, cross-breeding experiments involving females of one morphotype and males of the other morphotype showed the same behavior including the same five phases. However, breeding between cavefish females and surface fish males was more frequent than the reverse. Finally, cavefish female pheromonal solution was able to trigger strong behavioral responses in cavefish males-but not on surface fish males. Lastly, egg production seemed higher in surface fish females than in cavefish females. These results are discussed with regards to the sensory modalities involved in triggering reproductive behavior in the two morphs, as well as its possible ongoing evolution.	[Simon, Victor; Hyacinthe, Carole; Retaux, Sylvie] Univ Paris Saclay, Univ Paris Sud, CNRS UMR9197, Paris Saclay Inst Neurosci, Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay	Retaux, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS UMR9197, Paris Saclay Inst Neurosci, Gif Sur Yvette, France.	retaux@inaf.cnrs-gif.fr		RETAUX, Sylvie/0000-0003-0981-1478; SIMON, Victor/0000-0003-1723-8472	Equipe FRM grant from Fondation pour le Recherche Medicale [DEQ20150331745RETAUX]; CNRS (Centre Nationale de la Recherche Scientifique)	Equipe FRM grant from Fondation pour le Recherche Medicale; CNRS (Centre Nationale de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	Work supported by an Equipe FRM grant DEQ20150331745RETAUX from Fondation pour le Recherche Medicale and CNRS (Centre Nationale de la Recherche Scientifique) to SR; https://www.frm.org/chercheurs; http://www.cnrs.fr/fr/page-daccueil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2010, J EXP BIOL, V213, P2997, DOI 10.1242/jeb.044586; Amorim MCP, 2004, J FISH BIOL, V65, P1358, DOI 10.1111/j.0022-1112.2004.00535.x; Azevedo MA, 2010, IHERINGIA SER ZOOL, V100, P469, DOI 10.1590/S0073-47212010000400020; Bibliowicz J, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-25; Borowsky R, 2008, CSH PROTOCOLS, V2008; Borowsky R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079903; Casane D, 2016, ADV GENET, V95, P117, DOI 10.1016/bs.adgen.2016.03.001; Darrow KO, 2004, ZEBRAFISH, V1, P40, DOI 10.1089/154585404774101662; Elipot Y, 2014, ZEBRAFISH, V11, P291, DOI 10.1089/zeb.2014.1005; Elipot Y, 2013, CURR BIOL, V23, P1, DOI 10.1016/j.cub.2012.10.044; Elliott W. R., 2018, BULLETIN, V26; Espinasa L, 2017, SUBTERR BIOL, V21, P1, DOI DOI 10.3897/subtbiol.21.11046; Espinasa L, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-35; Feng NY, 2016, CURR BIOL, V26, P2681, DOI 10.1016/j.cub.2016.07.079; Fumey J, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1156-7; Gross JB, 2008, P NATL ACAD SCI USA, V105, P20106, DOI 10.1073/pnas.0806238105; Helfman G., 2009, DIVERSITY FISH BIOL; Herman A, 2018, MOL ECOL, V27, P4397, DOI 10.1111/mec.14877; Hinaux H, 2016, DEVELOPMENT, V143, P4521, DOI 10.1242/dev.141291; Hinaux H, 2011, ZEBRAFISH, V8, P155, DOI 10.1089/zeb.2011.0713; Huppop K., 1987, International Journal of Speleology, V16, P59; Huppop KaW, 1991, Z ZOOL SYST EVOLUT, V29, P280; Hutchins M, 2003, GRZIMEKS ANIMAL LIFE, V4- 5; Kihslinger RL, 2002, J COMP PSYCHOL, V116, P210, DOI 10.1037//0735-7036.116.2.210; LILEY NR, 1982, CAN J FISH AQUAT SCI, V39, P22, DOI 10.1139/f82-005; Ma L, 2018, DEV BIOL, V441, P209, DOI 10.1016/j.ydbio.2018.07.014; Manica A, 2002, BIOL REV, V77, P261, DOI 10.1017/S1464793101005905; Maruska KP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037612; McGaugh S.E, 2016, BIOL EVOLUTION MEXIC; MITCHELL RW, 1977, SPEC PUBL MUS TEXAS, V12, P1; Miyagi R, 2013, GENES GENET SYST, V88, P145, DOI 10.1266/ggs.88.145; Niemiller ML, 2010, BIOLOGY OF SUBTERRANEAN FISHES, P169, DOI 10.1201/EBK1578086702-c7; Park Jae-Min, 2014, Dev Reprod, V18, P241, DOI 10.12717/devrep.2014.18.4.241; PARTRIDGE BL, 1976, ANIM BEHAV, V24, P291, DOI 10.1016/S0003-3472(76)80037-1; Plath M, 2006, NATURWISSENSCHAFTEN, V93, P103, DOI 10.1007/s00114-005-0072-z; Plath M, 2006, BEHAVIOUR, V143, P15, DOI 10.1163/156853906775133560; Protas ME, 2006, NAT GENET, V38, P107, DOI 10.1038/ng1700; Protas M, 2008, EVOL DEV, V10, P196, DOI 10.1111/j.1525-142X.2008.00227.x; Riesch R, 2010, ECOLOGY, V91, P1494, DOI 10.1890/09-1008.1; SCHEMMEL C, 1980, Z TIERPSYCHOL, V53, P9; Stacey NE, 2015, FISH PHEROMONES RELA; Stacey Norm, 2002, P375; Torres-Paz J, 2018, EVOLUTION GASTRULATI; WILKENS H, 1988, EVOL BIOL, V23, P271; WILKENS H., 1971, ZOOL ANZ, V188, P1	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212591	10.1371/journal.pone.0212591	http://dx.doi.org/10.1371/journal.pone.0212591			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785948	Green Submitted, gold, Green Published			2022-12-26	WOS:000459307000074
J	Mandeng, SE; Awono-Ambene, HP; Bigoga, JD; Ekoko, WE; Binyang, J; Piameu, M; Mbakop, LR; Fesuh, BN; Mvondo, N; Tabue, R; Nwane, P; Mimpfoundi, R; Toto, JC; Kleinschmidt, I; Knox, TB; Mnzava, AP; Donnelly, MJ; Fondjo, E; Etang, J				Mandeng, Stanislas Elysee; Awono-Ambene, Herman Parfait; Bigoga, Jude D.; Ekoko, Wolfgang Eyisap; Binyang, Jerome; Piameu, Michael; Mbakop, Lili Ranaise; Fesuh, Betrand Nono; Mvondo, Narcisse; Tabue, Raymond; Nwane, Philippe; Mimpfoundi, Remy; Toto, Jean Claude; Kleinschmidt, Immo; Knox, Tessa Bellamy; Mnzava, Abraham Peter; Donnelly, Martin James; Fondjo, Etienne; Etang, Josiane			Spatial and temporal development of deltamethrin resistance in malaria vectors of the Anopheles gambiae complex from North Cameroon	PLOS ONE			English	Article							SODIUM-CHANNEL GENE; INSECTICIDE RESISTANCE; MOLECULAR-FORMS; POPULATIONS; S.L.; DDT; IDENTIFICATION; CULICIDAE; MOSQUITOS; FUNESTUS	The effectiveness of insecticide-based malaria vector control interventions in Africa is threatened by the spread and intensification of pyrethroid resistance in targeted mosquito populations. The present study aimed at investigating the temporal and spatial dynamics of deltamethrin resistance in An. gambiae s. l. populations from North Cameroon. Mosquito larvae were collected from 24 settings of the Garoua, Pitoa and Mayo Oulo Health Districts (HDs) from 2011 to 2015. Two to five days old female An. gambiae s. l. emerging from larval collections were tested for deltamethrin resistance using the World Health Organization's (WHO) standard protocol. Sub samples of test mosquitoes were identified to species using PCR-RFLP and genotyped for knockdown resistance alleles (Kdr 1014F and 1014S) using Hot Ligation Oligonucleotide Assay (HOLA). All the tested mosquitoes were identified as belonging to the An. gambiae complex, including 3 sibling species mostly represented by Anopheles arabiensis (67.6%), followed by Anopheles coluzzii (25.4%) and Anopheles gambiae (7%). Deltamethrin resistance frequencies increased significantly between 2011 and 2015, with mosquito mortality rates declining from 70-85% to 49-73% in the three HDs (Jonckheere-Terstra test statistic (JT) = 5638, P< 0.001), although a temporary increase of mortality rates (91-97%) was seen in the Pitoa and Mayo Oulo HDs in 2012. Overall, confirmed resistance emerged in 10 An. gambiae s. l. populations over the 24 field populations monitored during the study period, from 2011 to 2015. Phenotypic resistance was mostly found in urban settings compared with semi-urban and rural settings (JT = 5282, P< 0.0001), with a spatial autocorrelation between neighboring localities. The Kdr 1014F allelic frequencies in study HDs increased from 0-30% in 2011 to 18-61% in 2014-2015 (JT = 620, P < 0.001), especially in An. coluzzii samples. The overall frequency of the Kdr 1014S allele was 0.1%. This study revealed a rapid increase and widespread deltamethrin resistance frequency as well as Kdr 1014F allelic frequencies in An. gambiae s. l. populations over time, emphasizing the urgent need for vector surveillance and insecticide resistance management strategies in Cameroon.	[Mandeng, Stanislas Elysee; Awono-Ambene, Herman Parfait; Ekoko, Wolfgang Eyisap; Piameu, Michael; Mbakop, Lili Ranaise; Nwane, Philippe; Toto, Jean Claude; Etang, Josiane] OCEAC, IRY, Yaounde, Cameroon; [Mandeng, Stanislas Elysee; Binyang, Jerome; Mbakop, Lili Ranaise; Mvondo, Narcisse; Mimpfoundi, Remy] Univ Yaounde I, Lab Gen Biol, Yaounde, Cameroon; [Bigoga, Jude D.; Tabue, Raymond] Nkolbisson Univ Yaounde I, Biotechnol Ctr, Natl Reference Unit Vector Control, Lab Vector Biol & Control, Yaounde, Cameroon; [Ekoko, Wolfgang Eyisap] Univ Douala, Fac Sci, Lab Anim Biol & Physiol, Douala, Cameroon; [Piameu, Michael] Univ Catholique Afrique Cent, Ecole Sci Sante, Yaounde, Cameroon; [Fesuh, Betrand Nono] Univ Yaounde I, Natl Adv Sch Engn, Yaounde, Cameroon; [Tabue, Raymond; Fondjo, Etienne] Natl Malaria Control Programme, Minist Publ Hlth, Yaounde, Cameroon; [Kleinschmidt, Immo] London Sch Trop Med & Hyg, MRC Trop Epidemiol Grp, Dept Infect Dis Epidemiol, London, England; [Kleinschmidt, Immo] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Knox, Tessa Bellamy] WHO, Global Malaria Programme, Geneva, Switzerland; [Mnzava, Abraham Peter] ALMA, Dar Es Salaam, Tanzania; [Donnelly, Martin James] Univ Liverpool Liverpool Sch Trop Med, Dept Vector Biol, Liverpool, Merseyside, England; [Etang, Josiane] Univ Douala, Fac Med & Pharmaceut Sci, Dept Biol Sci, Douala, Cameroon; [Etang, Josiane] Justus Liebig Univ Giessen, Inst Insect Biotechnol, Heinrich Buff Ring, Germany	University of Yaounde I; University of Yaounde I; University of London; London School of Hygiene & Tropical Medicine; University of Witwatersrand; World Health Organization; Liverpool School of Tropical Medicine; Justus Liebig University Giessen	Etang, J (corresponding author), OCEAC, IRY, Yaounde, Cameroon.; Etang, J (corresponding author), Univ Douala, Fac Med & Pharmaceut Sci, Dept Biol Sci, Douala, Cameroon.; Etang, J (corresponding author), Justus Liebig Univ Giessen, Inst Insect Biotechnol, Heinrich Buff Ring, Germany.	josyet2@gmail.com		PIAMEU, Michael/0000-0001-7409-3359; Donnelly, Martin/0000-0001-5218-1497; BINYANG, Jerome Achille/0000-0002-2361-0659; Bigoga, Jude/0000-0001-7206-3308	Bill and Melinda Gates Foundation [484991.01]; MRC [MR/R010161/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding was provided by the Bill and Melinda Gates Foundation (Grant Number: 484991.01). This research forms part of a multi-country study coordinated by the Global Malaria Programme of the World Health Organization. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Antonio-Nkondjio C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2417-9; Antonio-Nkondjio C, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0675-6; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-232; Busula AO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0635-1; Chareonviriyaphap T, 2002, J VECTOR ECOL, V27, P222; Chouaibou M, 2008, TROP MED INT HEALTH, V13, P476, DOI 10.1111/j.1365-3156.2008.02025.x; Chouaibou M, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-77; Cisse MBM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0847-4; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117; Czeher C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-189; Dabire KR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-188; Diabate A, 2007, J MED ENTOMOL, V44, P60, DOI 10.1603/0022-2585(2007)44[60:ETEOPI]2.0.CO;2; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Etang J, 2003, J MED ENTOMOL, V40, P491, DOI 10.1603/0022-2585-40.4.491; Etang J, 2007, J VECTOR ECOL, V32, P123, DOI 10.3376/1081-1710(2007)32[123:SOMRTD]2.0.CO;2; Etang J, 2006, AM J TROP MED HYG, V74, P795, DOI 10.4269/ajtmh.2006.74.795; Etang J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1420-x; Etang J, 2009, MOL ECOL, V18, P3076, DOI 10.1111/j.1365-294X.2009.04256.x; Fanello C, 2003, INSECT MOL BIOL, V12, P241, DOI 10.1046/j.1365-2583.2003.00407.x; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Finney D.J., 1971, PROBIT ANAL; Fossog BT, 2015, EVOL APPL, V8, P326, DOI 10.1111/eva.12242; Fossog BT, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-1; Foster GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155746; Gillies M, 1987, PUBL S AFRI CAN I ME, V55, P1; Gillies M. T., 1968, PUBL S AFR I MED RES, V54, P343; Gimonneau G, 2010, BEHAV ECOL, V21, P1087, DOI 10.1093/beheco/arq114; Glunt KD, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0807-z; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Kleinschmidt I, 2018, LANCET INFECT DIS, V18, P640, DOI 10.1016/S1473-3099(18)30172-5; Lynd A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-16; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Mbida Arthur Mbida, 2016, Journal of Entomology and Zoology Studies, V4, P105; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Ndiath MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031943; Ndjemai HNM, 2009, T ROY SOC TROP MED H, V103, P1127, DOI 10.1016/j.trstmh.2008.11.018; Nwane P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-41; Nwane Philippe, 2011, BMC Res Notes, V4, P463, DOI 10.1186/1756-0500-4-463; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Organization WH, 2015, WHO GLOB MAL PROGR; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Raymond M, 1998, PHILOS T R SOC B, V353, P1707, DOI 10.1098/rstb.1998.0322; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Rooker S, 1996, HEREDITY, V77, P555; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Same-Ekobo A, 2005, J CAM ACADSCI, V5, P3; *SERV MW, 1993, MOSQ EC FIELD SAMPL; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Strode C, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001619; Tabue RN, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1933-3; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; Weill M, 2002, P ROY SOC B-BIOL SCI, V269, P2007, DOI 10.1098/rspb.2002.2122; WHO, 2012, GLOB PLAN INS RES MA; WHO, 2017, WHO GLOB MAL PROGR; WHO, PREQ VECT CONTR; WHO (World Health Organization), WHO PREQ IND RES SPR; Wondji C, 2005, J MED ENTOMOL, V42, P998, DOI 10.1603/0022-2585(2005)042[0998:SAPOTA]2.0.CO;2; World Health Organization, 2016, TAX SUG DRINKS, P2; Yahouedo GA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1661-8	64	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212024	10.1371/journal.pone.0212024	http://dx.doi.org/10.1371/journal.pone.0212024			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779799	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900024
J	Meelab, S; Bunupuradah, I; Suttiruang, J; Sakulrojanawong, S; Thongkua, N; Chantawiboonchai, C; Chirabandhu, P; Lertthanaporn, S; Suwanthip, K; Songsaengthum, C; Keattisaksri, B; Trakulsuk, P; Pittapun, A; Nata, N; Rangsin, R; Sakboonyarat, B				Meelab, Suprawee; Bunupuradah, Itsara; Suttiruang, Jitrada; Sakulrojanawong, Salisa; Thongkua, Nisanat; Chantawiboonchai, Chattarin; Chirabandhu, Prim; Lertthanaporn, Sasanpin; Suwanthip, Krissada; Songsaengthum, Chindanai; Keattisaksri, Boonyagorn; Trakulsuk, Peeranut; Pittapun, Apichat; Nata, Naowanit; Rangsin, Ram; Sakboonyarat, Boonsub			Prevalence and associated factors of uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand: A cross-sectional study	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; SEDENTARY BEHAVIORS; NECK CIRCUMFERENCE; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; FATTY-ACIDS; RISK; POPULATION; OBESITY; PREDICTORS	Introduction Hypertension is a common cardiovascular disease at present. Uncontrolled blood pressure leads to further complications including heart attack, stroke and chronic kidney disease. In Thailand, most of the information related to this issue is collected by hospitals or hospital-based organizations rather than at the community level. The objectives of this study were to determine the prevalence of uncontrolled hypertension and to assess the relationship between patient characteristics (socio-behavioral and clinical) and uncontrolled blood pressure among hypertensive patients in the rural communities in the central areas in Thailand. Materials and methods This was a cross-sectional study conducted in Na-Yao and Phra-Pleong rural communities of Thailand in 2018 using the total design method. In all, 406 individuals aged >= 18 years were interviewed using structured questionnaires related to demographic information, higher risk behavior, comorbidities and arthrometric measurement. Blood pressure was assessed for all participants. Uncontrolled hypertension was defined as BP >= 140/90 mmHg. Results The prevalence of uncontrolled hypertension was 54.4% (males: 59.8%; females: 52.4%). Uncontrolled blood pressure was associated with neck circumference more than 35.75 cm for males and 32.75 cm. for females (adjusted odds ratio; 1.66, 95% confidence interval; 1.03-2.68), sedentary behavior more than 5 hours a day (adjusted odds ratio; 2.03, 95% confidence interval; 1.28-3.23) and missed doctor appointments (adjusted odds ratio; 3.29, 95% confidence interval; 1.09-9.94). Conclusion Approximately one half of hypertensive patients in these rural communities had uncontrolled blood pressure. The Ministry of Public Health and health care providers should provide further strategies to prevent uncontrolled blood pressure's complications.	[Meelab, Suprawee; Bunupuradah, Itsara; Suttiruang, Jitrada; Sakulrojanawong, Salisa; Thongkua, Nisanat; Chantawiboonchai, Chattarin; Chirabandhu, Prim; Lertthanaporn, Sasanpin; Suwanthip, Krissada; Songsaengthum, Chindanai; Keattisaksri, Boonyagorn; Trakulsuk, Peeranut; Pittapun, Apichat] Phramongkutklao Coll Med, Bangkok, Thailand; [Nata, Naowanit] Phramongkutklao Coll Med, Dept Internal Med, Bangkok, Thailand; [Rangsin, Ram; Sakboonyarat, Boonsub] Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand	Phramongkutklao College of Medicine; Phramongkutklao College of Medicine; Phramongkutklao College of Medicine	Sakboonyarat, B (corresponding author), Phramongkutklao Coll Med, Dept Mil & Community Med, Bangkok, Thailand.	boonsub1991@pcm.ac.th	Rangsin, Ram/AAW-9527-2020; Rangsin, Ram/AAR-9082-2021	Rangsin, Ram/0000-0002-7175-0963; Sakboonyarat, Boonsub/0000-0003-0577-0699	Department of Military and Community Medicine, Phramongkutklao College of Medicine	Department of Military and Community Medicine, Phramongkutklao College of Medicine	The authors express their grateful thanks to all participants of the survey, to the health care providers and officers of Na-Yao and Phra-Pleong Primary Healthcare Units. The authors wish to thank the entire staff members of the Department of Military and Community Medicine, Phramongkutklao College of Medicine, for their support in completing this study. The authors wish to thank Mrs. Kornkanok Supawaropas for proof reading the manuscripts.	Aekplakorn W, 2012, J HYPERTENS, V30, P1734, DOI 10.1097/HJH.0b013e3283568158; Ben-Noun LL, 2004, AM J HYPERTENS, V17, P409, DOI 10.1016/j.amjhyper.2004.02.005; Bertrais S, 2005, OBES RES, V13, P936, DOI 10.1038/oby.2005.108; Beunza JJ, 2007, AM J HYPERTENS, V20, P1156, DOI 10.1016/j.amjhyper.2007.06.007; Cardiovascular risk factor levels in urban and rural Thailand-The International Collaborative Study of Cardiovascular Disease in Asia (InterASIA), 2003, EUROPEAN J CARDIOVAS, V10, P249; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Dave GJ, 2013, J CLIN HYPERTENS, V15, P562, DOI 10.1111/jch.12122; Desa U. N, 2014, WORLD URBANIZATION P; Fan SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02879-7; Federation ID, 2005, MED PRAKT, P1; Freet CS, 2013, AUTON NEUROSCI-BASIC, V174, P8, DOI 10.1016/j.autneu.2012.12.005; Gerage AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146078; Hall JE, 2000, BRAZ J MED BIOL RES, V33, P605, DOI 10.1590/S0100-879X2000000600001; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Hsu CY, 2005, ARCH INTERN MED, V165, P923, DOI 10.1001/archinte.165.8.923; Iyer AS, 2010, J AM SOC HYPERTENS, V4, P22, DOI 10.1016/j.jash.2010.02.002; Jafar TH, 2018, AM J HYPERTENS, V31, P1205, DOI 10.1093/ajh/hpy071; Jakes RW, 2003, EUR J CLIN NUTR, V57, P1089, DOI 10.1038/sj.ejcn.1601648; Knight EL, 2001, HYPERTENSION, V38, P809, DOI 10.1161/hy0901.091681; Konecny T, 2014, HYPERTENSION, V63, P203, DOI 10.1161/HYPERTENSIONAHA.113.00613; Kuciene R, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0444-2; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Masuo K, 2000, HYPERTENSION, V35, P1135, DOI 10.1161/01.HYP.35.5.1135; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Onat A, 2009, CLIN NUTR, V28, P46, DOI 10.1016/j.clnu.2008.10.006; Parati G, 2013, EUR RESP SOC; Piro S, 2008, NUTR METAB CARDIOVAS, V18, P96, DOI 10.1016/j.numecd.2007.01.009; Stojiljkovic MP, 2002, J HYPERTENS, V20, P1215, DOI 10.1097/00004872-200206000-00036; Tangjatuporn Warakarn, 2012, J Med Assoc Thai, V95 Suppl 5, pS48; Thrift AG, 1996, STROKE, V27, P2020, DOI 10.1161/01.STR.27.11.2020; Vatcheva K.P, 2016, EPIDEMIOLOGY, V6; Wang Z, 2018, CIRCULATION; WHO, 1988, MEAS OB CLASS DESCR; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Yoon Sung Sug Sarah, 2015, NCHS Data Brief, P1; Zhou JY, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-76	38	14	14	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212572	10.1371/journal.pone.0212572	http://dx.doi.org/10.1371/journal.pone.0212572			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779818	gold, Green Published, Green Submitted			2022-12-26	WOS:000459062900065
J	Hernandez, S; Fried, DE; Grubisic, V; McClain, JL; Gulbransen, BD				Hernandez, Siomara; Fried, David E.; Grubisic, Vladimir; McClain, Jonathon L.; Gulbransen, Brian D.			Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness	FASEB JOURNAL			English	Article						pyridostigmine bromide; cholinergic signaling; enteric nervous system	NICOTINIC ACETYLCHOLINE-RECEPTOR; ENTERIC NERVOUS-SYSTEM; CELL-PROLIFERATION; HEALTH-STATUS; VAGUS NERVE; VETERANS; GLIA; MOTILITY; NEURONS; ACTIVATION	Gulf War illness (GWI) is a chronic multisymptom disorder that is prominent in Gulf War veterans. Major unexplained symptoms of GWI include functional gastrointestinal disorders and undiagnosed illnesses, including neurologic disorders. Exposure to the antinerve gas drug pyridostigmine bromide (PB) is linked to the development of GWI, but the exact mechanisms remain unclear. Here, we tested the hypothesis that PB alters gut function by disrupting the neural and immune systems of the intestine. We exposed male and female mice to physiologically comparable amounts of PB that match the dose, route, and time frame of exposure experienced by Gulf War veterans and assessed the acute and chronic impacts on gastrointestinal functions, the functional architecture of the enteric nervous system, and immune responses in the gut and brain. Exposure to PB drove acute alterations to colonic motility and structure in both male and female mice that transitioned to chronic changes in gut functions. PB drove acute alterations to enteric neural and glial activity, glial reactivity, and neuron survival with glial reactivity persisting into the chronic phase in male mice. Despite having no effect on colonic permeability, exposure to PB caused major shifts in the expression of proinflammatory cytokines and chemokines in the colon and brain that suggest immunosuppressive effects. Interestingly, immune disruption was still evident in the colon and brain in female animals at 1 mo following exposure to PB. Together, our results show that the paradigm of PB exposure experienced by veterans of the Persian Gulf War contributes to long-lasting pathophysiology by driving enteric neuroinflammation, promoting immunosuppression, and altering functional anatomy of the colon in a sex-dependent manner.Hernandez, S., Fried, D. E., Grubii, V., McClain, J. L., Gulbransen, B. D. Gastrointestinal neuroimmune disruption in a mouse model of Gulf War illness.	[Hernandez, Siomara; Fried, David E.; Grubisic, Vladimir; McClain, Jonathon L.; Gulbransen, Brian D.] Michigan State Univ, Dept Physiol, 567 Wilson Rd, E Lansing, MI 48824 USA; [Gulbransen, Brian D.] Michigan State Univ, Neurosci Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Gulbransen, BD (corresponding author), Michigan State Univ, Dept Physiol, 567 Wilson Rd, E Lansing, MI 48824 USA.	gulbrans@msu.edu		Grubisic, Vladimir/0000-0003-1429-2844	Department of Defense-Congressionally Directed Medical Research Programs (DOD - CDMRP) [W81XWH1610631]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK103723]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103723] Funding Source: NIH RePORTER	Department of Defense-Congressionally Directed Medical Research Programs (DOD - CDMRP); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This project was supported by grants from the Department of Defense-Congressionally Directed Medical Research Programs (DOD - CDMRP; W81XWH1610631, to B.D.G.) and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (R01DK103723, to B.D.G.). The authors declare no conflicts of interest.	Alhasson F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172914; Baez-Pagan CA, 2015, J NEUROIMMUNE PHARM, V10, P468, DOI 10.1007/s11481-015-9601-5; Belkind-Gerson J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02890-y; Berthoud TK, 2009, J IMMUNOL METHODS, V340, P33, DOI 10.1016/j.jim.2008.09.021; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bradley JS, 1997, CELL TISSUE RES, V289, P455, DOI 10.1007/s004410050891; Brierley SM, 2014, NAT REV GASTRO HEPAT, V11, P611, DOI 10.1038/nrgastro.2014.103; Brown IAM, 2016, CELL MOL GASTROENTER, V2, P77, DOI 10.1016/j.jcmgh.2015.08.007; Browning KN, 2017, GASTROENTEROLOGY, V152, P730, DOI 10.1053/j.gastro.2016.10.046; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Caligioni CS, 2009, CURR PROTOC NEUROSCI, V4, p4I, DOI DOI 10.1002/0471142301.NSA04IS48; Camp AJ, 2009, INT J BIOCHEM CELL B, V41, P2118, DOI 10.1016/j.biocel.2009.05.007; Chiari A, 1999, ANESTHESIOLOGY, V91, P1447, DOI 10.1097/00000542-199911000-00038; Costantini TW, 2012, AM J PATHOL, V181, P478, DOI 10.1016/j.ajpath.2012.04.005; Coughlin S.S., 2017, J ENV HLTH SCI, V3; Coughlin SS, 2013, J MIL VETERANS HEALT, V21, P4; De Giorgio R, 2016, ADV EXP MED BIOL, V891, P123, DOI 10.1007/978-3-319-27592-5_12; Degen LP, 1996, GUT, V39, P299, DOI 10.1136/gut.39.2.299; Delvalle NM, 2018, AM J PHYSIOL-GASTR L, V315, pG473, DOI 10.1152/ajpgi.00155.2018; Dunphy RC, 2003, PAIN, V102, P79, DOI 10.1016/S0304-3959(02)00342-1; Duque GA, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00491; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; France M, 2012, NEUROGASTROENT MOTIL, V24, pe450, DOI 10.1111/j.1365-2982.2012.01981.x; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Fried DE, 2017, AM J PHYSIOL-GASTR L, V313, pG570, DOI 10.1152/ajpgi.00154.2017; Fujii T, 2017, J PHARMACOL SCI, V134, P1, DOI 10.1016/j.jphs.2017.05.002; Fulco C. E., 2000, GULF WAR HLTH, V1; Furness JB, 2008, NEUROGASTROENT MOTIL, V20, P32, DOI 10.1111/j.1365-2982.2008.01094.x; Furness JB, 2012, NAT REV GASTRO HEPAT, V9, P286, DOI 10.1038/nrgastro.2012.32; GABELLA G, 1984, J NEUROCYTOL, V13, P73, DOI 10.1007/BF01148319; GIOIA A, 1958, BRIT J PHARM CHEMOTH, V13, P467, DOI 10.1111/j.1476-5381.1958.tb00239.x; Golomb BA, 2008, P NATL ACAD SCI USA, V105, P4295, DOI 10.1073/pnas.0711986105; Goswami R, 2011, J IMMUNOL, V186, P3283, DOI 10.4049/jimmunol.1003049; Goverse G, 2016, J PHYSIOL-LONDON, V594, P5771, DOI 10.1113/JP271537; Graves J. C., 2008, GULF WAR ILLNESS HLT; Grubisic V, 2017, J PHYSIOL-LONDON, V595, P3409, DOI 10.1113/JP273492; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Hancock A, 1998, AM J RESP CELL MOL, V18, P60, DOI 10.1165/ajrcmb.18.1.2627; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; HEATON KW, 1992, GUT, V33, P818, DOI 10.1136/gut.33.6.818; JOINER PD, 1973, J PHARMACOL EXP THER, V186, P552; Kosmidis C, 2018, J CANCER, V9, P232, DOI 10.7150/jca.22962; Lalo U, 2004, BRIT J PHARMACOL, V142, P1227, DOI 10.1038/sj.bjp.0705878; Liu ML, 2011, CYTOKINE GROWTH F R, V22, P121, DOI 10.1016/j.cytogfr.2011.06.001; LOEWENSTEINLICHTENSTEIN Y, 1995, NAT MED, V1, P1082, DOI 10.1038/nm1095-1082; Matos JF, 2016, WORLD J GASTROENTERO, V22, P5761, DOI 10.3748/wjg.v22.i25.5761; McClain JL, 2015, CELL MOL GASTROENTER, V1, P631, DOI 10.1016/j.jcmgh.2015.08.004; McClain JL, 2014, GASTROENTEROLOGY, V146, P497, DOI 10.1053/j.gastro.2013.10.061; MCCONALOGUE K, 1994, BAILLIERE CLIN ENDOC, V8, P51, DOI 10.1016/S0950-351X(05)80226-5; Michaelson MD, 1996, DEV BIOL, V179, P251, DOI 10.1006/dbio.1996.0255; Morris KT, 2014, BRIT J CANCER, V110, P1211, DOI 10.1038/bjc.2013.822; Murphy FM, 1999, MIL MED, V164, P327, DOI 10.1093/milmed/164.5.327; Nasser Y, 2006, AM J PHYSIOL-GASTR L, V291, pG912, DOI 10.1152/ajpgi.00067.2006; National Cancer Institute-NIH, 2018, INT 2; Nouri-Shirazi M, 2007, IMMUNOL LETT, V109, P155, DOI 10.1016/j.imlet.2007.02.005; O'Grady NP, 1999, J INFECT DIS, V179, P136, DOI 10.1086/314559; Ogden Cynthia L, 2004, Adv Data, P1; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Razani-Boroujerdi S, 2008, J NEUROIMMUNOL, V194, P83, DOI 10.1016/j.jneuroim.2007.11.019; Rosenblum JM, 2010, J IMMUNOL, V184, P3450, DOI 10.4049/jimmunol.0903831; Schumm WR, 2002, PSYCHOL REP, V90, P707, DOI 10.2466/PR0.90.3.707-721; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Sostek MB, 1996, AM J GASTROENTEROL, V91, P2494; Steele L, 2000, AM J EPIDEMIOL, V152, P992, DOI 10.1093/aje/152.10.992; Thacker M, 2011, NEUROGASTROENT MOTIL, V23, pE500, DOI 10.1111/j.1365-2982.2011.01696.x; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; von Boyen GBT, 2004, GUT, V53, P222, DOI 10.1136/gut.2003.012625; Wang DW, 2009, CHIN J TRAUMATOL, V12, P355, DOI 10.3760/cma.j.issn.1008-1275.2009.06.007; Wang H, 2004, NAT MED, V10, P1216, DOI 10.1038/nm1124; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang L, 2007, AM J PHYSIOL-GASTR L, V292, pG419, DOI 10.1152/ajpgi.00289.2006; White RF, 2016, CORTEX, V74, P449, DOI 10.1016/j.cortex.2015.08.022; Wolfe J, 2002, J OCCUP ENVIRON MED, V44, P271, DOI 10.1097/00043764-200203000-00015; Zdanowski R, 2015, CENT EUR J IMMUNOL, V40, P373, DOI 10.5114/ceji.2015.54602; Zhou QQ, 2018, CLIN J PAIN, V34, P944, DOI 10.1097/AJP.0000000000000611	76	17	18	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6168	6184		10.1096/fj.201802572R	http://dx.doi.org/10.1096/fj.201802572R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30789759	Green Published, Bronze			2022-12-26	WOS:000466932600030
J	Zhao, LX; Ge, YH; Li, JB; Xiong, CH; Law, PY; Xu, JR; Qiu, Y; Chen, HZ				Zhao, Lan-Xue; Ge, Yan-Hui; Li, Jia-Bing; Xiong, Cai-Hong; Law, Ping-Yee; Xu, Jian-Rong; Qiu, Yu; Chen, Hong-Zhuan			M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt	FASEB JOURNAL			English	Article						mTOR; signal transduction; GluA1 Ser845; GluA1 trafficking	LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTOR; IN-VIVO; ACTIVATION; KINASE; MTOR; TRAFFICKING; MATURATION; INTERNALIZATION; MODULATION	M1 muscarinic acetylcholine receptors are highly expressed in key areas that control cognition, such as the cortex and hippocampus, representing one potential therapeutic target for cognitive dysfunctions of Alzheimer's disease and schizophrenia. We have reported that M1 receptors facilitate cognition by promoting membrane insertion of -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor AMPA receptor subunit 1 (GluA1) through phosphorylation at Ser845. However, the signaling pathway is still unclear. Here we showed that adenylyl cyclase inhibitor 2',5'-dideoxyadenosine and PKA inhibitor KT5720 inhibited enhancement of phosphorylation of Ser845 and membrane insertion of GluA1 induced by M1 receptor activation. Furthermore, PI3K inhibitor LY294002 and protein kinase B (Akt) inhibitor IV blocked the effects of M1 receptors as well. Remarkably, the increase of the activity of PI3K-Akt signaling induced by M1 receptor activation could be abolished by cAMP-PKA inhibitors. Moreover, inhibiting the mammalian target of rapamycin (mTOR) complex 1, an important downstream effector of PI3K-Akt, by short-term application of rapamycin attenuated the effects of M1 receptors on GluA1. Furthermore, such effect was unrelated to possible protein synthesis promoted by mTOR. Taken together, these data demonstrate that M1 receptor activation induces membrane insertion of GluA1 via a signaling linking cAMP-PKA and PI3K-Akt-mTOR pathways but is irrelevant to protein synthesis.Zhao, L.-X., Ge, Y.-H., Li, J.-B., Xiong, C.-H., Law, P.-Y., Xu, J.-R., Qiu, Y., Chen, H.-Z. M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP-PKA and PI3K-Akt.	[Zhao, Lan-Xue; Ge, Yan-Hui; Li, Jia-Bing; Xiong, Cai-Hong; Xu, Jian-Rong; Qiu, Yu] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Law, Ping-Yee] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA; [Chen, Hong-Zhuan] Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201210, Peoples R China	Shanghai Jiao Tong University; University of Minnesota System; University of Minnesota Twin Cities; Shanghai University of Traditional Chinese Medicine	Qiu, Y (corresponding author), Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China.; Chen, HZ (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Interdisciplinary Integrat Biomed Res, 1200 Cailun Rd, Shanghai 201210, Peoples R China.	qiuy@shsmu.edu.cn; yaoli@shsmu.edu.cn		Qiu, Yu/0000-0002-1236-1941	National Natural Science Foundation of China [81473217, 81573415, 81872841, 81872840]; Shanghai Jiao Tong University Medical-Engineering Cross Fund [YG2017ZD14]; General Financial Grant from the China Postdoctoral Science Foundation [2016M601619]; International Science and Technology Cooperation Program of China [2011DFA33180]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Jiao Tong University Medical-Engineering Cross Fund; General Financial Grant from the China Postdoctoral Science Foundation; International Science and Technology Cooperation Program of China	The authors thank Ying-Hui Yan (Children's Hospital of Soochow University, Jiangsu, Suzhou, China) for scientific suggestions. This work was supported by the National Natural Science Foundation of China (81473217, 81573415, 81872841, 81872840), Shanghai Jiao Tong University Medical-Engineering Cross Fund (YG2017ZD14), the General Financial Grant from the China Postdoctoral Science Foundation (2016M601619), and the International Science and Technology Cooperation Program of China (2011DFA33180). The authors declare no conflicts of interest.	Arendt KL, 2010, NAT NEUROSCI, V13, P36, DOI 10.1038/nn.2462; Bassani S, 2013, CELL MOL LIFE SCI, V70, P4411, DOI 10.1007/s00018-013-1309-1; Blancquaert S, 2010, MOL ENDOCRINOL, V24, P1453, DOI 10.1210/me.2010-0087; Borroto-Escuela DO, 2018, PHARMACOL REP, V70, P936, DOI 10.1016/j.pharep.2018.04.002; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Bymaster FP, 2003, EUR J NEUROSCI, V17, P1403, DOI 10.1046/j.1460-9568.2003.02588.x; Carruthers SP, 2015, NEUROSCI BIOBEHAV R, V55, P393, DOI 10.1016/j.neubiorev.2015.05.011; Chen Y, 2017, NEURON, V96, P1070, DOI 10.1016/j.neuron.2017.10.023; Ciullo I, 2001, ONCOGENE, V20, P1186, DOI 10.1038/sj.onc.1204219; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; de Joussineau C, 2014, HUM MOL GENET, V23, P5418, DOI 10.1093/hmg/ddu265; Deng H, 2010, AM J RESP CELL MOL, V42, P744, DOI 10.1165/rcmb.2009-0037OC; Dennis SH, 2016, CEREB CORTEX, V26, P414, DOI 10.1093/cercor/bhv227; Dickinson BA, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-18; Digby GJ, 2012, J NEUROSCI, V32, P8532, DOI 10.1523/JNEUROSCI.0337-12.2012; Dong JY, 2018, J AFFECT DISORDERS, V227, P633, DOI 10.1016/j.jad.2017.11.041; Felder CC, 2018, NEUROPHARMACOLOGY, V136, P449, DOI 10.1016/j.neuropharm.2018.01.028; de Sevilla DF, 2010, J NEUROSCI, V30, P11032, DOI 10.1523/JNEUROSCI.1848-10.2010; Ghoshal A, 2016, NEUROPSYCHOPHARMACOL, V41, P598, DOI 10.1038/npp.2015.189; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Gururajan A, 2014, J NEUROCHEM, V129, P377, DOI 10.1111/jnc.12622; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; Hell JW, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf7067; Henley Jeremy M, 2013, Dialogues Clin Neurosci, V15, P11; Henley JM, 2011, TRENDS NEUROSCI, V34, P258, DOI 10.1016/j.tins.2011.02.004; Jahromi LP, 2018, MED HYPOTHESES, V110, P120, DOI 10.1016/j.mehy.2017.12.007; Jiang ST, 2014, NEUROSCI BULL, V30, P295, DOI 10.1007/s12264-013-1406-z; Kam AYF, 2010, J NEUROSCI, V30, P15304, DOI 10.1523/JNEUROSCI.4255-10.2010; Keshwani MM, 2012, P NATL ACAD SCI USA, V109, pE1221, DOI 10.1073/pnas.1202741109; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kibaly C, 2016, BIOL PSYCHIAT, V79, P906, DOI 10.1016/j.biopsych.2015.04.019; Koles L, 2016, PURINERG SIGNAL, V12, P1, DOI 10.1007/s11302-015-9480-5; Lebois EP, 2018, NEUROPHARMACOLOGY, V136, P362, DOI 10.1016/j.neuropharm.2017.11.018; Lee K, 2016, ADV PROTEIN CHEM STR, V103, P203, DOI 10.1016/bs.apcsb.2015.10.004; Lipton JO, 2014, NEURON, V84, P275, DOI 10.1016/j.neuron.2014.09.034; Ma L, 2011, AM J PHYSIOL-LUNG C, V300, pL701, DOI 10.1152/ajplung.00119.2009; Marlo JE, 2009, MOL PHARMACOL, V75, P577, DOI 10.1124/mol.108.052886; Melancon BJ, 2013, DRUG DISCOV TODAY, V18, P1185, DOI 10.1016/j.drudis.2013.09.005; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Moran SP, 2018, NEUROPSYCHOPHARMACOL, V43, P1763, DOI 10.1038/s41386-018-0033-9; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Nathanson NM, 2000, P NATL ACAD SCI USA, V97, P6245, DOI 10.1073/pnas.97.12.6245; Park P, 2016, J NEUROSCI, V36, P622, DOI 10.1523/JNEUROSCI.3625-15.2016; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Seol GH, 2007, NEURON, V55, P919, DOI 10.1016/j.neuron.2007.08.013; Serulle Y, 2008, CHANNELS, V2, P230, DOI 10.4161/chan.2.4.6391; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sun CY, 2014, MOL CELL ENDOCRINOL, V382, P835, DOI 10.1016/j.mce.2013.10.017; Tillo SE, 2017, CELL REP, V19, P617, DOI 10.1016/j.celrep.2017.03.070; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wang C, 2014, MOL NEUROBIOL, V49, P120, DOI 10.1007/s12035-013-8505-8; Xu JT, 2014, J CLIN INVEST, V124, P592, DOI 10.1172/JCI70236; Yan YH, 2014, NEUROSCI LETT, V566, P231, DOI 10.1016/j.neulet.2014.02.059; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhang B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03680-2; Zhao LX, 2018, FASEB J, V32, P4247, DOI 10.1096/fj.201800029R	61	13	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6622	6631		10.1096/fj.201802351R	http://dx.doi.org/10.1096/fj.201802351R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794430				2022-12-26	WOS:000466932600064
J	Villar, LM; Geloneze, B; Vasques, ACJ; Pires, MLE; Miguel, JC; da Silva, EF; Marques, VA; Scalioni, LD; Lampe, E				Villar, Livia Melo; Geloneze, Bruno; Junqueira Vasques, Ana Carolina; Elias Pires, Maria Lucia; Miguel, Juliana Custodio; da Silva, Elisangela Ferreira; Marques, Vanessa Alves; Scalioni, Leticia de Paula; Lampe, Elisabeth			Prevalence of hepatitis B and hepatitis C among diabetes mellitus type 2 individuals	PLOS ONE			English	Article							VIRUS-INFECTION; RISK-FACTORS; SEROPREVALENCE; ASSOCIATION; POPULATION	Diabetes mellitus type 2 (DM2) patients have higher risk to be infected with parenterally transmitted viruses, like hepatitis B or C virus. This study aims to determine HBV and HCV infection prevalence in DM2 patients from Northeast and Southeast Brazil. A total of 537 DM2 patients were included, 194 (36.12%) males and 343 (63.87%) females, with mean age of 57.13 +/- 11.49 years. HBV and HCV markers were determined using serological and molecular analysis, and risk factors were evaluated in a subgroup from Southeast (n = 84). Two HBV acute (HBsAg+/anti-HBc-) and one HBV chronic case (HBsAg+/anti-HBc+) were found. Six individuals (1.1%) were isolated anti-HBc, 37 (6.9%) had HBV infection resolved (anti-HBc+/anti-HBs+), 40 (7.4%) were considered HBV vaccinated (anti-HBc-/anti-HBs+). Thirteen patients (2.42%) had anti-HCV and 7 of them were HCV RNA+. In the subgroup, anti-HBc positivity was associated to age and anti-HCV positivity was associated to age, time of diabetes diagnosis, total bilirubin, indirect bilirubin, alkaline phosphatase at bivariate analysis, but none of them was statistically significant at multivariate analysis. As conclusion, low prevalence of HBV and high prevalence HCV was found in DM2 patients.	[Villar, Livia Melo; Miguel, Juliana Custodio; da Silva, Elisangela Ferreira; Marques, Vanessa Alves; Scalioni, Leticia de Paula; Lampe, Elisabeth] Fiocruz MS, Inst Oswaldo Cruz, Lab Viral Hepatitis, Rio De Janeiro, RJ, Brazil; [Geloneze, Bruno; Junqueira Vasques, Ana Carolina] Univ Campinas UNICAMP, Gastroctr, Lab Invest Metab & Diabet LIMED, Sao Paulo, Brazil; [Junqueira Vasques, Ana Carolina] Univ Estadual Campinas, Sch Appl Sci, Sao Paulo, Brazil; [Elias Pires, Maria Lucia] Fed Univ State Rio de Janeiro UNIRIO, Dept Clin Med Surg, Rio De Janeiro, RJ, Brazil; [Elias Pires, Maria Lucia] Fed Univ State Rio de Janeiro UNIRIO, Sch Med, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal do Estado do Rio de Janeiro; Universidade Federal do Estado do Rio de Janeiro	Villar, LM (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Viral Hepatitis, Rio De Janeiro, RJ, Brazil.	lvillar@ioc.fiocruz.br	Geloneze, Bruno/F-4231-2010; VILLAR, LIVIA M/F-7811-2012	Geloneze, Bruno/0000-0002-0557-4578; VILLAR, LIVIA M/0000-0001-7644-8969; Vasques, Ana Carolina Junqueira/0000-0001-9222-1107	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Brazilian National Counsel of Technological and Scientific Development (CNPq); Coordination of Improvement of Higher Level Personnel; Oswaldo Cruz Foundation (FIOCRUZ)	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination of Improvement of Higher Level Personnel; Oswaldo Cruz Foundation (FIOCRUZ)	This research was supported by the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Brazilian National Counsel of Technological and Scientific Development (CNPq), Coordination of Improvement of Higher Level Personnel, and the Oswaldo Cruz Foundation (FIOCRUZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrelias CCA, 2016, REV ESC ENFERM USP, V50, P253, DOI 10.1590/S0080-623420160000200011; Ba-Essa EM, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1578-0; Barbosa JR, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14070793; Cadranel JF, 2008, EUR J GASTROEN HEPAT, V20, P829, DOI 10.1097/MEG.0b013e3282fc73a1; Cai CX, 2015, EXP THER MED, V10, P693, DOI 10.3892/etm.2015.2537; Chehadeh Wassim, 2011, J Infect Public Health, V4, P200, DOI 10.1016/j.jiph.2011.05.004; Chen Hua-Fen, 2006, J Chin Med Assoc, V69, P146; Cortes VF, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759047, 10.1590/s1678-9946201759047]; Cruz MS, 2013, INT J DRUG POLICY, V24, P432, DOI 10.1016/j.drugpo.2013.03.012; Ephraim RKD, 2014, ANN MED HEALTH SCI R, V4, P719, DOI 10.4103/2141-9248.141529; Flores GL, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13030314; da Costa LMFC, 2008, BRAZ J INFECT DIS, V12, P24, DOI 10.1590/S1413-86702008000100007; Garcia-Compean D, 2009, WORLD J GASTROENTERO, V15, P280, DOI 10.3748/wjg.15.280; Greca LF, 2012, BRAZ J MED BIOL RES, V45, P284, DOI 10.1590/S0100-879X2012007500013; Gulcan A, 2008, J INVEST MED, V56, P858, DOI 10.2310/JIM.0b013e3181788d28; Hirakauva EY, 2002, TRANSPLANT P, V34, P3220, DOI 10.1016/S0041-1345(02)03657-6; International Diabetes Federation IDF, 2017, DIABETES ATLAS; Korkmaz H, 2015, J INVEST MED, V63, P251, DOI 10.1097/JIM.0000000000000126; Lu JY, 2017, J DIABETES INVEST, V8, P115, DOI 10.1111/jdi.12546; Mekonnen D, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.40.2465; Naing C, 2012, WORLD J GASTROENTERO, V18, P1642, DOI 10.3748/wjg.v18.i14.1642; Nascimento CD, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1956-2; Ocak S, 2006, INT J CLIN PRACT, V60, P670, DOI 10.1111/j.1368-5031.2006.00738.x; Parolin Mônica Beatriz, 2006, Arq. Gastroenterol., V43, P77, DOI 10.1590/S0004-28032006000200003; Pereira LMMB, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-60; Pereira LMMB, 2009, AM J TROP MED HYG, V81, P240; Shiffman ML, 2017, LIVER INT, V37, P13, DOI 10.1111/liv.13282; Sotiropoulos A, 1999, DIABETIC MED, V16, P250, DOI 10.1046/j.1464-5491.1999.00009.x; Thompson Nicola D, 2009, J Diabetes Sci Technol, V3, P283; Villar LM, 2014, J MED VIROL, V86, P1515, DOI 10.1002/jmv.23993; World Health Organization, HEP B; World Health Organization (WHO), HEP C	32	8	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0211193	10.1371/journal.pone.0211193	http://dx.doi.org/10.1371/journal.pone.0211193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817756	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500011
J	Benoit, G; Warma, A; Lussier, JG; Ndiaye, K				Benoit, Gabriel; Warma, Aly; Lussier, Jacques G.; Ndiaye, Kalidou			Gonadotropin regulation of ankyrin-repeat and SOCS-box protein 9 (ASB9) in ovarian follicles and identification of binding partners	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; FACTOR-STIMULATED GENE-6; BOVINE GRANULOSA-CELLS; NECROSIS-FACTOR-ALPHA; CREATINE-KINASE; EXTRACELLULAR-MATRIX; LH SURGE; TSG-6; EXPRESSION; OVULATION	Ankyrin-repeat and SOCS-box protein 9 (ASB9) is a member of the large SOCS-box containing proteins family and acts as the specific substrate recognition component of E3 ubiquitin ligases in the process of ubiquitination and proteasomal degradation. We previously identified ASB9 as a differentially expressed gene in granulosa cells (GC) of bovine ovulatory follicles. This study aimed to further investigate ASB9 mRNA and protein regulation, identify binding partners in GC of bovine ovulatory follicles, and study its function. GC were obtained from small follicles (SF: 2-4 mm), dominant follicles at day 5 of the estrous cycle (DF), and ovulatory follicles, 24 hours following hCG injection (OF). Analyses by RTPCR showed a 104-fold greater expression of ASB9 in GC of OF than in DF. Steady-state levels of ASB9 in follicular walls (granulosa and theca cells) analyzed at 0, 6, 12, 18 and 24 hours after hCG injection showed a significant induction of ASB9 expression at 12 and 18 hours, reaching a maximum induction of 10.2-fold at 24 hours post-hCG as compared to 0 hour. These results were confirmed in western blot analysis showing strongest ASB9 protein amounts in OF. Yeast two-hybrid screening of OF-cDNAs library resulted in the identification of 10 potential ASB9 binding partners in GC but no interaction was found between ASB9 and creatine kinase B (CKB) in these GC. Functional studies using CRISPR-Cas9 approach revealed that ASB9 inhibition led to increased GC proliferation and modulation of target genes expression. Overall, these results support a physiologically relevant role of ASB9 in the ovulatory follicle by targeting specific proteins likely for degradation, contributing to reduced GC proliferation, and could be involved in the final GC differentiation into luteal cells.	[Benoit, Gabriel; Warma, Aly; Lussier, Jacques G.; Ndiaye, Kalidou] Univ Montreal, Fac Med Vet, Dept Biomed Vet, CRRF, St Hyacinthe, PQ, Canada	Universite de Montreal	Ndiaye, K (corresponding author), Univ Montreal, Fac Med Vet, Dept Biomed Vet, CRRF, St Hyacinthe, PQ, Canada.	k.ndiaye@umontreal.ca			Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2018-04516]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a Discovery Grant (#RGPIN-2018-04516) from Natural Sciences and Engineering Research Council of Canada (NSERC) to KN. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam H, 2009, ENDOCRINOLOGY, V150, P915, DOI 10.1210/en.2008-0850; Andresen CA, 2014, J BIOL CHEM, V289, P2043, DOI 10.1074/jbc.M113.534602; Balasubramaniam D, 2015, BIOCHEMISTRY-US, V54, P1673, DOI 10.1021/bi501420n; Bayliss MT, 2001, OSTEOARTHR CARTILAGE, V9, P42, DOI 10.1053/joca.2000.0348; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; Debrincat MA, 2007, J BIOL CHEM, V282, P4728, DOI 10.1074/jbc.M609164200; Eppig JJ, 2002, P NATL ACAD SCI USA, V99, P2890, DOI 10.1073/pnas.052658699; Espey LL, 2002, BIOL REPROD, V67, P1662, DOI 10.1095/biolreprod.102.005173; ESPEY LL, 1980, BIOL REPROD, V22, P73, DOI 10.1095/biolreprod22.1.73; Fei XW, 2012, PROTEIN J, V31, P275, DOI 10.1007/s10930-012-9401-1; Filion F, 2001, J BIOL CHEM, V276, P34323, DOI 10.1074/jbc.M103709200; Fulop C, 1997, GENE, V202, P95, DOI 10.1016/S0378-1119(97)00459-9; Fulop C, 2003, DEVELOPMENT, V130, P2253, DOI 10.1242/dev.00422; Gilbert I, 2011, REPRODUCTION, V141, P193, DOI 10.1530/REP-10-0381; Huang Y, 2008, CELL RES, V18, P780, DOI 10.1038/cr.2008.70; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kile BT, 2001, MOL CELL BIOL, V21, P6189, DOI 10.1128/MCB.21.18.6189-6197.2001; Kim J, 2009, ENDOCRINOLOGY, V150, P3392, DOI 10.1210/en.2008-0948; KLAMPFER L, 1994, MOL CELL BIOL, V14, P6561, DOI 10.1128/MCB.14.10.6561; Knight PG, 2001, REPRODUCTION, V121, P503, DOI 10.1530/reprod/121.4.503; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Lee MR, 2008, MOL CELLS, V26, P621; LEE TH, 1993, J BIOL CHEM, V268, P6154; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lesley J, 2004, J BIOL CHEM, V279, P25745, DOI 10.1074/jbc.M313319200; Linossi EM, 2012, IUBMB LIFE, V64, P316, DOI 10.1002/iub.1011; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lussier JG, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0306-x; Lussier JG LV, 2016, GENE EXPRESSION PROF; Mahajan VB, 2000, P NATL ACAD SCI USA, V97, P12062, DOI 10.1073/pnas.97.22.12062; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Milner CM, 2003, J CELL SCI, V116, P1863, DOI 10.1242/jcs.00407; Mukhopadhyay D, 2001, ARCH BIOCHEM BIOPHYS, V394, P173, DOI 10.1006/abbi.2001.2552; Muniz JRC, 2013, J MOL BIOL, V425, P3166, DOI 10.1016/j.jmb.2013.06.015; Nagyeri G, 2011, J BIOL CHEM, V286, P23559, DOI 10.1074/jbc.M111.222026; NAUMOFF PA, 1985, INT J BIOCHEM, V17, P1363, DOI 10.1016/0020-711X(85)90061-8; Ndiaye K, 2005, BIOL REPROD, V73, P324, DOI 10.1095/biolreprod.104.038026; Ndiaye K, 2016, J OVARIAN RES, V9, DOI 10.1186/s13048-016-0280-5; Ndiaye K, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0148-0; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; Richards JS, 2018, TRENDS ENDOCRIN MET, V29, P313, DOI 10.1016/j.tem.2018.02.012; Rosenfeld CS, 2001, REPRODUCTION, V122, P215, DOI 10.1530/rep.0.1220215; Salustri A, 1999, HUM REPROD UPDATE, V5, P293, DOI 10.1093/humupd/5.4.293; Sayasith K, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111849; Sayasith K, 2008, ENDOCRINOLOGY, V149, P6213, DOI 10.1210/en.2008-0459; Sayasith K, 2007, REPRODUCTION, V133, P135, DOI 10.1530/rep.1.01200; Schiffer JM, 2016, STRUCTURE, V24, P1248, DOI 10.1016/j.str.2016.05.016; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; Sirois J, 2004, HUM REPROD UPDATE, V10, P373, DOI 10.1093/humupd/dmh032; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Thomas JC, 2013, BIOCHEMISTRY-US, V52, P5236, DOI 10.1021/bi400758h; Tokuoka M, 2010, INT J ONCOL, V37, P1105, DOI 10.3892/ijo_00000762; Uranbileg B, 2014, INT J CANCER, V134, P2189, DOI 10.1002/ijc.28547; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wisniewski HG, 1996, J IMMUNOL, V156, P1609; Yoshioka S, 2000, ENDOCRINOLOGY, V141, P4114, DOI 10.1210/en.141.11.4114; Zhong L, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2091; Zhou JL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.371; Zhuo LS, 2001, CELL STRUCT FUNCT, V26, P189, DOI 10.1247/csf.26.189	65	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212571	10.1371/journal.pone.0212571	http://dx.doi.org/10.1371/journal.pone.0212571			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811458	Green Published, gold			2022-12-26	WOS:000459806400077
J	Grimm, R; Pettinato, M; Gillis, S; Daelemans, W				Grimm, Robert; Pettinato, Michele; Gillis, Steven; Daelemans, Walter			Simulating speech processing with cochlear implants: How does channel interaction affect learning in neural networks?	PLOS ONE			English	Article							VOCAL-TRACT LENGTH; NORMAL-HEARING; RECOGNITION; DISCRIMINATION; PERCEPTION; CHILDREN; NOISE	We introduce a novel machine learning approach for investigating speech processing with cochlear implants (CIs)-prostheses used to replace a damaged inner ear. Concretely, we use a simple perceptron and a deep convolutional network to classify speech spectrograms that are modified to approximate CI-delivered speech. Implant-delivered signals suffer from reduced spectral resolution, chiefly due to a small number of frequency channels and a phenomenon called channel interaction. The latter involves the spread of information from neighboring channels to similar populations of neurons and can be modeled by linearly combining adjacent channels. We find that early during training, this input modification degrades performance if the networks are first pre-trained on high-resolution speech-with a larger number of channels, and without added channel interaction. This suggests that the spectral degradation caused by channel interaction alters the signal to conflict with perceptual expectations acquired from high-resolution speech. We thus predict that a reduction of channel interaction will accelerate learning in CI users who are implanted after having adapted to high-resolution speech during normal hearing. (The code for replicating our experiments is available online: https://github.com/clips/SimulatingCochlearImplants).	[Grimm, Robert; Pettinato, Michele; Gillis, Steven; Daelemans, Walter] Univ Antwerp, Dept Linguist, Computat Linguist & Psycholinguist Res Ctr, Antwerp, Belgium; [Grimm, Robert] Univ Antwerp, Computat Linguist & Psycholinguist Res Ctr, Antwerp, Belgium	University of Antwerp; University of Antwerp	Grimm, R (corresponding author), Univ Antwerp, Dept Linguist, Computat Linguist & Psycholinguist Res Ctr, Antwerp, Belgium.; Grimm, R (corresponding author), Univ Antwerp, Computat Linguist & Psycholinguist Res Ctr, Antwerp, Belgium.	robert.grimm@protonmail.com	Daelemans, Walter/N-5785-2014; Gillis, Steven/S-3914-2019	Gillis, Steven/0000-0002-2067-0576; Daelemans, Walter/0000-0002-9832-7890	BOF/TOP grant of the Research Council of the University of Antwerp [29072]	BOF/TOP grant of the Research Council of the University of Antwerp	The present research was supported by a BOF/TOP grant (ID 29072) of the Research Council of the University of Antwerp to SG and WD in order to support the work of RG. The University of Antwerp (www.uantwerpen.be) provided support in the role of salaries for SG, WD, and RG. A commercial company, Third Space Learning (www.thirdspacelearning.com), provided support in the form of salaries for MP. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bizley JK, 2013, NAT REV NEUROSCI, V14, P693, DOI 10.1038/nrn3565; Chatterjee M, 2018, P INT S AUD AUD RES, V6, P117; Chatterjee M, 2015, HEARING RES, V322, P151, DOI 10.1016/j.heares.2014.10.003; Coath M, 2007, BIOSYSTEMS, V89, P182, DOI 10.1016/j.biosystems.2006.04.016; Cullington HE, 2008, J ACOUST SOC AM, V123, P450, DOI 10.1121/1.2805617; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Garofolo J. S., 1993, LINGUISTIC DATA CONS; Gaudrain E, 2018, EAR HEARING, V39, P226, DOI 10.1097/AUD.0000000000000480; Gaudrain E, 2015, J ACOUST SOC AM, V137, P1298, DOI 10.1121/1.4908235; Harrison RV, 2005, DEV PSYCHOBIOL, V46, P252, DOI 10.1002/dev.20052; Ioffe S, 2015, ARXIV 1502 03167, V32, P448; Jones GL, 2013, J ACOUST SOC AM, V133, P425, DOI 10.1121/1.4768881; Landsberger DM, 2009, HEARING RES, V254, P34, DOI 10.1016/j.heares.2009.04.007; LeCun Y, 1995, HDB BRAIN BRAIN SCI, P225; Mao YT, 2017, INT J AUDIOL, V56, pS23, DOI 10.1080/14992027.2016.1219073; McDermott JH, 2011, NEURON, V71, P926, DOI 10.1016/j.neuron.2011.06.032; Moberly AC, 2014, J SPEECH LANG HEAR R, V57, P566, DOI 10.1044/2014_JSLHR-H-12-0323; Noreen E. W., 1989, COMPUTER INTENSIVE M; Oh SH, 2003, ACTA OTO-LARYNGOL, V123, P148, DOI 10.1080/0036554021000028111; Rouger J, 2007, P NATL ACAD SCI USA, V104, P7295, DOI 10.1073/pnas.0609419104; SHANNON RV, 1983, HEARING RES, V12, P1, DOI 10.1016/0378-5955(83)90115-6; Shera CA, 2002, P NATL ACAD SCI USA, V99, P3318, DOI 10.1073/pnas.032675099; Stickney GS, 2006, HEARING RES, V211, P33, DOI 10.1016/j.heares.2005.08.008; Stickney GS, 2004, J ACOUST SOC AM, V116, P1081, DOI 10.1121/1.1772399; Tang Q, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/046029; Yamins DLK, 2016, NAT NEUROSCI, V19, P356, DOI 10.1038/nn.4244; Yeh A., 2000, P 18 C COMPUTATIONAL, P947, DOI [10.3115/992730.992783, DOI 10.3115/992730.992783]; Zeiler M. D, 2012, ARXIV12125701	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212134	10.1371/journal.pone.0212134	http://dx.doi.org/10.1371/journal.pone.0212134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811448	gold, Green Submitted, Green Published			2022-12-26	WOS:000459806400055
J	Wertheim, BM; Lin, YD; Zhang, YY; Samokhin, AO; Alba, GA; Arons, E; Yu, PB; Maron, BA				Wertheim, Bradley M.; Lin, Yi-Dong; Zhang, Ying-Yi; Samokhin, Andriy O.; Alba, George A.; Arons, Elena; Yu, Paul B.; Maron, Bradley A.			Isolating pulmonary microvascular endothelial cells ex vivo: Implications for pulmonary arterial hypertension, and a caution on the use of commercial biomaterials	PLOS ONE			English	Article							GRIFFONIA-SIMPLICIFOLIA; CULTURE; HEART; LYMPHANGIOGENESIS; EXPRESSION; RNA	Transcriptomic analysis of pulmonary microvascular endothelial cells from experimental models offers insight into pulmonary arterial hypertension (PAH) pathobiology. However, culturing may alter the molecular profile of endothelial cells prior to analysis, limiting the translational relevance of results. Here we present a novel and validated method for isolating RNA from pulmonary microvascular endothelial cells (PMVECs) ex vivo that does not require cell culturing. Initially, presumed rat PMVECs were isolated from rat peripheral lung tissue using tissue dissociation and enzymatic digestion, and cells were cultured until confluence to assess endothelial marker expression. Anti-CD31, anti-von Willebrand Factor, and anti-alpha-smooth muscle actin immunocytochemistry/immunofluorescence signal was detected in presumed rat PMVECs, but also in non-endothelial cell type controls. By contrast, flow cytometry using an anti-CD31 antibody and isolectin 1-B-4 (from Griffonia simplicifolia) was highly specific for rat PMVECs. We next developed a strategy in which the addition of an immunomagnetic selection step for CD31+ cells permitted culture-free isolation of rat PMVECs ex vivo for RNA isolation and transcriptomic analysis using fluorescence-activated cell sorting. Heterogeneity in the validity and reproducibility of results using commercial antibodies against endothelial surface markers corresponded to a substantial burden on laboratory time, labor, and scientific budget. We demonstrate a novel protocol for the culture-free isolation and transcriptomic analysis of rat PMVECs with translational relevance to PAH. In doing so, we highlight wide variability in the quality of commonly used biological reagents, which emphasizes the importance of investigator-initiated validation of commercial biomaterials.	[Wertheim, Bradley M.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Lin, Yi-Dong; Zhang, Ying-Yi; Samokhin, Andriy O.; Arons, Elena; Yu, Paul B.; Maron, Bradley A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Alba, George A.] Massachusetts Gen Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Maron, BA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	bmaron@bwh.harvard.edu	Yu, Paul B./J-7540-2019	Yu, Paul B./0000-0003-2145-4944; Wertheim, Bradley/0000-0002-1414-4692	NIH [5T32HL007633-32, 1F32HL139019-01, R56HL131787, 1R01HL139613-01]; NIH/NHLBI [HL131910-, HL132742]; National Scleroderma Foundation; Cardiovascular Medicine Educational Research Foundation [CMREF]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL139613, F32HL139019, T32HL007633] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Scleroderma Foundation; Cardiovascular Medicine Educational Research Foundation [CMREF]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by B.M.W. (NIH 5T32HL007633-32, Pulmonary Vascular Research Institute Basic Research Fellowship), G.A.A. (NIH 1F32HL139019-01), P.B.Y. (NIH/NHLBI HL131910- and HL132742), and B.A.M. (NIH R56HL131787, 1R01HL139613-01, National Scleroderma Foundation, Cardiovascular Medicine Educational Research Foundation [CMREF]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya Poulomi, 2017, F1000Res, V6, P851, DOI 10.12688/f1000research.11774.1; Alphonse RS, 2015, NAT PROTOC, V10, P1697, DOI 10.1038/nprot.2015.107; Baluk P, 2008, ANN NY ACAD SCI, V1131, P1, DOI 10.1196/annals.1413.001; Benza RL, 2016, PULM CIRC, V6, P551, DOI 10.1086/688774; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Comhair SAA, 2012, AM J RESP CELL MOL, V46, P723, DOI 10.1165/rcmb.2011-0416TE; ESSER C, 1995, CYTOMETRY, V21, P382, DOI 10.1002/cyto.990210411; Fehrenbach ML, 2009, AM J PHYSIOL-LUNG C, V296, pL1096, DOI 10.1152/ajplung.90613.2008; Gaskill C, 2017, PULM CIRC, V7, P108, DOI 10.1177/2045893217702346; HANSENSMITH FM, 1988, MICROVASC RES, V36, P199, DOI 10.1016/0026-2862(88)90022-2; Helenius MH, 2015, AM J PHYSIOL-LUNG C, V308, pL1046, DOI 10.1152/ajplung.00340.2014; Jin YX, 2012, METHODS MOL BIOL, V843, P147, DOI 10.1007/978-1-61779-523-7_14; Kim J, 2013, NAT MED, V19, P74, DOI 10.1038/nm.3040; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Kosmidou C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17634-1; Lauer M., 2016, NIH EXTRAMURAL NEXUS; Liu L, 2017, BIOL PROCED ONLINE, V19, DOI 10.1186/s12575-017-0065-2; Lu HW, 2012, MOL CELL BIOCHEM, V363, P217, DOI 10.1007/s11010-011-1173-y; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; MAGEE JC, 1994, AM J PHYSIOL-LUNG C, V267, pL433, DOI 10.1152/ajplung.1994.267.4.L433; Mitchell JB, 2006, STEM CELLS, V24, P376, DOI 10.1634/stemcells.2005-0234; Moldobaeva A, 2017, ANGIOGENESIS, V20, P73, DOI 10.1007/s10456-016-9529-2; Nilsson H, 2014, J BIOTECHNOL, V192, P62, DOI 10.1016/j.jbiotec.2014.09.016; Pollett JB, 2013, J HEART LUNG TRANSPL, V32, P746, DOI 10.1016/j.healun.2013.04.013; Provencher S, 2018, CIRC RES, V122, P1021, DOI 10.1161/CIRCRESAHA.117.312579; Ranchoux B, 2018, PULM CIRC, V8, DOI 10.1177/2045893217752912; RYAN US, 1982, TISSUE CELL, V14, P597, DOI 10.1016/0040-8166(82)90050-7; SAHAGUN G, 1989, AM J PATHOL, V134, P1227; Samokhin AO, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap7294; SILVERMAN JD, 1990, J NEUROCYTOL, V19, P789, DOI 10.1007/BF01188046; Sobczak Magdalena, 2010, J Vis Exp, DOI 10.3791/2316; Suresh K, 2018, AM J PHYSIOL-LUNG C, V314, pL893, DOI 10.1152/ajplung.00430.2017; Szulcek R, 2016, AM J RESP CRIT CARE, V193, P1410, DOI 10.1164/rccm.201506-1231OC; Tamosiuniene R, 2011, CIRC RES, V109, P867, DOI 10.1161/CIRCRESAHA.110.236927; Townsley MI, 2012, COMPR PHYSIOL, V2, P675, DOI 10.1002/cphy.c100081; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Voskuil Jan L A, 2017, F1000Res, V6, P161, DOI 10.12688/f1000research.10851.1; WATT SM, 1993, BLOOD, V82, P2649; Weber SC, 2011, PEDIATR RES, V70, P236, DOI 10.1203/PDR.0b013e318225f748; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	42	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211909	10.1371/journal.pone.0211909	http://dx.doi.org/10.1371/journal.pone.0211909			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811450	gold, Green Submitted, Green Published			2022-12-26	WOS:000459806400039
J	Dent, J; Gaspar, N; Njeuhmeli, E; Kripke, K				Dent, Juan; Gaspar, Nuno; Njeuhmeli, Emmanuel; Kripke, Katharine			Age targeting and scale-up of voluntary medical male circumcision in Mozambique	PLOS ONE			English	Article							ADOLESCENTS; PREVENTION; HIV	Background The voluntary medical male circumcision (VMMC) program in Mozambique aimed to increase male circumcision (MC) coverage to 80 percent among males ages 10 to 49 by 2018. Given the difficulty in attracting adult men over age 20 for circumcision, Mozambique became interested in assessing its age-targeting strategy and progress at the provincial level to inform program planning. Methods We examined the impact and cost-effectiveness of circumcising different age groups of men using the Decision Makers' Program Planning Toolkit, Version 2.1 (DMPPT 2). We also applied the model to assess the scale-up efforts through the end of September 2017 and project their impact on HIV incidence through 2030. The DMPPT 2 is a compartmental Excel-based model that analyzes the effects of age at circumcision on program impact and cost-effectiveness. The model tracks changes in age-specific MC coverage due to VMMC program circumcisions. Baseline MC prevalence was based on data from the 2011 Demographic and Health Survey. The DMPPT 2 was populated with HIV incidence projections from Spectrum/Goals under an assumption that Mozambique would reach its national targets for HIV treatment and prevention by 2022. Results We estimate the VMMC program increased MC coverage among males ages 10 to 49 from 27 percent in 2009 to 48 percent by end of September 2017. Coverage increased primarily in males ages 10 to 29. VMMCs conducted in the national program through the end of September 2017 are projected to avert 67,076 HIV infections from 2010 to 2030. Scaling up circumcisions in males ages 20 to 29 will have the most immediate impact on HIV incidence, while the greatest impact over a 15-year period is obtained by circumcising males ages 15 to 24 in the majority of priority provinces. Circumcising 80 percent of males ages 10 to 29 can achieve 77 percent of the impact through 2030 compared with circumcising 80 percent of males ages 10 to 49. Conclusion The VMMC program in Mozambique has made great strides in increasing MC coverage, particularly for males ages 10 to 29. Scaling up and maintaining MC coverage in this age group offers an attainable and cost-effective target for VMMC in Mozambique.	[Dent, Juan] Palladium Grp, Washington, DC USA; [Gaspar, Nuno] USAID Mozambique, Maputo, Mozambique; [Njeuhmeli, Emmanuel] USAID Eswatini, Mbabane, Eswatini, South Africa; [Kripke, Katharine] Avenir Hlth, Washington, DC 20012 USA	United States Agency for International Development (USAID)	Kripke, K (corresponding author), Avenir Hlth, Washington, DC 20012 USA.	KKripke@avenirhealth.org			U.S. President's Emergency Plan for AIDS Relief (PEPFAR); U.S. Agency for International Development (USAID) under the Cooperative Agreement Project SOAR (Supporting Operational AIDS Research) [OAA-A-14-00060]; USAID; PEPFAR	U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Agency for International Development (USAID) under the Cooperative Agreement Project SOAR (Supporting Operational AIDS Research)(United States Agency for International Development (USAID)); USAID(United States Agency for International Development (USAID)); PEPFAR	This manuscript is made possible by the generous support of the American people through the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) with the U.S. Agency for International Development (USAID) under the Cooperative Agreement Project SOAR (Supporting Operational AIDS Research), number OAA-A-14-00060. Juan Dent was employed by The Palladium Group at the time of writing. The Palladium Group provided support in the form of salary for author JD but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Katharine Kripke is employed by Avenir Health. Avenir Health provided support in the form of salary for author KK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The information provided does not necessarily reflect the views of USAID or the United States Government, and the contents of this article are the sole responsibility of Projects SOAR, the Population Council, and the authors.; John Stover of Avenir Health developed the DMPPT 2.0 model at the request of USAID, under the USAID- and PEPFAR-funded Health Policy Project. The authors gratefully acknowledge Jotamo Come, the VMMC Program Director of the Mozambican Ministry of Health, and Nathaniel Lohman of USAID for providing the data for this analysis. We thank Steven Forsythe for helpful comments on the draft. The authors are also grateful to Sherry Hutchinson for her help with editing and formatting the manuscript. Finally, we thank Marcos Canda and the staff of Jhpiego, FHI 360, and Columbia University's ICAP whose tireless efforts to implement VMMC in Mozambique form the basis for this manuscript.	BAUTISTAARREDONDO, 2018, PLOS ONE, V13, DOI DOI 10.1371/JOURNAL.PONE.0203121; Direccao Nacional da Assistencia Medica, 2012, PLAN ESTR EXP CIRC M; Forsythe S, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-S1-S4; Galarraga O, 2018, AIDS RES THER, V15, DOI 10.1186/s12981-018-0207-x; Instituto Nacional de Estatistica, 2013, MO AMBIQUE INQU RITO; Instituto Nacional de Estatsitica [Internet], 1996, MAP MOZ REC GER POP; Instituto Nacional de Saude (INS) Instituto Nacional de Estatistica (INE) e ICF Macro, 2010, NON TRADITIONAL REF; Korenromp EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142908; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164144; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158693; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156776; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157071; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156909; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153363; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156521; Kripke K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158767; Mutabazi V, 2012, JAIDS-J ACQ IMM DEF, V61, P49, DOI 10.1097/QAI.0b013e3182631d69; Njeuhmeli E, 2018, CLIN INFECT DIS, V66, pS166, DOI 10.1093/cid/cix969; Njeuhmeli E, 2014, JAIDS-J ACQ IMM DEF, V66, pS193, DOI 10.1097/QAI.0000000000000179; Njeuhmeli E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001132; Tchuenche M, 2018, VOLUNTARY MED MALE C; Torres-Rueda S, 2018, JAIDS-J ACQ IMM DEF, V78, P291, DOI 10.1097/QAI.0000000000001682; World Health Organization and UNAIDS, 2007, P WHO UNAIDS TECHN C; World Health Organization (WHO), 2017, VOL MED MAL CIRC HIV	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211958	10.1371/journal.pone.0211958	http://dx.doi.org/10.1371/journal.pone.0211958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794561	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100028
J	Nguyen, DT; Ryu, S; Qureshi, MNI; Choi, M; Lee, KH; Lee, B				Duc Thanh Nguyen; Ryu, Seungjun; Qureshi, Muhammad Naveed Iqbal; Choi, Min; Lee, Kun Ho; Lee, Boreom			Hybrid multivariate pattern analysis combined with extreme learning machine for Alzheimer's dementia diagnosis using multi-measure rs-fMRI spatial patterns	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; RESTING-STATE FMRI; LOW-FREQUENCY FLUCTUATIONS; FEATURE-SELECTION; FUNCTIONAL CONNECTIVITY; FEATURE-RANKING; GENE SELECTION; CLASSIFICATION; DISEASE; PREDICTION	Background Early diagnosis of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI) is essential for timely treatment. Machine learning and multivariate pattern analysis (MVPA) for the diagnosis of brain disorders are explicitly attracting attention in the neuroimaging community. In this paper, we propose a voxel-wise discriminative framework applied to multi-measure resting-state fMRI (rs-fMRI) that integrates hybrid MVPA and extreme learning machine (ELM) for the automated discrimination of AD and MCI from the cognitive normal (CN) state. Materials and methods We used two rs-fMRI cohorts: the public Alzheimer's disease Neuroimaging Initiative database (ADNI2) and an in-house Alzheimer's disease cohort from South Korea, both including individuals with AD, MCI, and normal controls. After extracting three-dimensional (3-D) patterns measuring regional coherence and functional connectivity during the resting state, we performed univariate statistical t-tests to generate a 3-D mask that retained only voxels showing significant changes. Given the initial univariate features, to enhance discriminative patterns, we implemented MVPA feature reduction using support vector machine-recursive feature elimination (SVM-RFE), and least absolute shrinkage and selection operator (LASSO), in combination with the univariate t-test. Classifications were performed by an ELM, and its efficiency was compared to linear and nonlinear (radial basis function) SVMs. Results The maximal accuracies achieved by the method in the ADNI2 cohort were 98.86% (p<0.001) and 98.57% (p<0.001) for AD and MCI vs. CN, respectively. In the in-house cohort, the same accuracies were 98.70% (p<0.001) and 94.16% (p<0.001). Conclusion From a clinical perspective, combining extreme learning machine and hybrid MVPA applied on concatenations of multiple rs-fMRI biomarkers can potentially assist the clinicians in AD and MCI diagnosis.	[Duc Thanh Nguyen; Ryu, Seungjun; Choi, Min; Lee, Boreom] GIST, IIT, Dept Biomed Sci & Engn BMSE, Gwangju, South Korea; [Qureshi, Muhammad Naveed Iqbal] McGill Univ, Res Ctr Studies Aging MCSA, Translat Neuroimaging Lab, Montreal, PQ, Canada; [Qureshi, Muhammad Naveed Iqbal] McGill Univ, Douglas Mental Hlth Univ Inst, Alzheimers Dis Res Unit, Montreal, PQ, Canada; [Qureshi, Muhammad Naveed Iqbal] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Qureshi, Muhammad Naveed Iqbal] Montreal Neurol Hosp & Inst, Montreal, PQ, Canada; [Lee, Kun Ho] Chosun Univ, Natl Res Ctr Dementia, Gwangju, South Korea; [Lee, Kun Ho] Chosun Univ, Dept Biomed Sci, Gwangju, South Korea	Gwangju Institute of Science & Technology (GIST); McGill University; McGill University; McGill University; McGill University; Chosun University; Chosun University	Lee, B (corresponding author), GIST, IIT, Dept Biomed Sci & Engn BMSE, Gwangju, South Korea.	leebr@gist.ac.kr	ryu, seungjun/AAD-2474-2021		Bio & Medical Technology Development Program of the NRF - Korean government, MSIT [NRF-2016M3A9E9941946]	Bio & Medical Technology Development Program of the NRF - Korean government, MSIT	This work was supported by the Bio & Medical Technology Development Program of the NRF funded by the Korean government, MSIT (NRF-2016M3A9E9941946). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbabshirani MR, 2017, NEUROIMAGE, V145, P137, DOI 10.1016/j.neuroimage.2016.02.079; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Beheshti I, 2017, COMPUT BIOL MED, V83, P109, DOI 10.1016/j.compbiomed.2017.02.011; Beheshti I, 2016, MAGN RESON IMAGING, V34, P252, DOI 10.1016/j.mri.2015.11.009; Beltrachini L, 2015, CURR ALZHEIMER RES, V12, P592, DOI 10.2174/156720501206150716120332; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Calhoun Vince D, 2016, Biol Psychiatry Cogn Neurosci Neuroimaging, V1, P230; Casanova Ramon, 2011, Front Neuroinform, V5, P22, DOI 10.3389/fninf.2011.00022; Challis E, 2015, NEUROIMAGE, V112, P232, DOI 10.1016/j.neuroimage.2015.02.037; Chaves R, 2009, NEUROSCI LETT, V461, P293, DOI 10.1016/j.neulet.2009.06.052; Chu C, 2012, NEUROIMAGE, V60, P59, DOI 10.1016/j.neuroimage.2011.11.066; Dai D, 2013, MACH VISION APPL, V24, P1445, DOI 10.1007/s00138-012-0462-0; Dai D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00063; Dai ZJ, 2015, CEREB CORTEX, V25, P3723, DOI 10.1093/cercor/bhu246; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; de Vos F, 2018, NEUROIMAGE, V167, P62, DOI 10.1016/j.neuroimage.2017.11.025; Eavani Harini, 2013, Inf Process Med Imaging, V23, P426, DOI 10.1007/978-3-642-38868-2_36; Falahati F, 2014, J ALZHEIMERS DIS, V41, P685, DOI 10.3233/JAD-131928; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Guo ZW, 2017, CLIN NEUROPHYSIOL, V128, P1344, DOI 10.1016/j.clinph.2017.05.003; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hidalgo-Munoz AR, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00020; Jie B, 2014, IEEE T BIO-MED ENG, V61, P576, DOI 10.1109/TBME.2013.2284195; Kendall M., 1990, CORRELATION METHODS; Khazaee A, 2017, BEHAV BRAIN RES, V322, P339, DOI 10.1016/j.bbr.2016.06.043; Khazaee A, 2015, CLIN NEUROPHYSIOL, V126, P2132, DOI 10.1016/j.clinph.2015.02.060; Kim J, 2018, HUM BRAIN MAPP, V39, P3728, DOI 10.1002/hbm.24207; Leonardi N, 2013, NEUROIMAGE, V83, P937, DOI 10.1016/j.neuroimage.2013.07.019; Li XB, 2012, BIOCHEM BIOPH RES CO, V419, P148, DOI 10.1016/j.bbrc.2012.01.087; Li YX, 2017, J ALZHEIMERS DIS, V58, P1175, DOI 10.3233/JAD-161282; Li YX, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4680972; Lin Q, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00094; Lopez M, 2011, NEUROCOMPUTING, V74, P1260, DOI 10.1016/j.neucom.2010.06.025; Mahmoudi A, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/961257; Mishra S., 2015, KARBALA INT J MOD SC, V1, P86, DOI DOI 10.1016/J.KIJOMS.2015.10.002; Mwangi B, 2014, NEUROINFORMATICS, V12, P229, DOI 10.1007/s12021-013-9204-3; Mwangi B, 2012, BRAIN, V135, P1508, DOI 10.1093/brain/aws084; Duc NT, 2019, J NEURAL ENG, V16, DOI 10.1088/1741-2552/ab0169; Ota K, 2015, J NEUROSCI METH, V256, P168, DOI 10.1016/j.jneumeth.2015.08.020; Qureshi MNI, 2017, FRONT NEUROINFORM, V11, DOI 10.3389/fninf.2017.00059; Qureshi MNI, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00157; Qureshi MNI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160697; Rathore S, 2017, NEUROIMAGE, V155, P530, DOI 10.1016/j.neuroimage.2017.03.057; Retico A, 2015, J NEUROIMAGING, V25, P552, DOI 10.1111/jon.12163; Salvatore C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00307; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Suk HI, 2016, NEUROIMAGE, V129, P292, DOI 10.1016/j.neuroimage.2016.01.005; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wee CY, 2014, HUM BRAIN MAPP, V35, P3414, DOI 10.1002/hbm.22411; Wee CY, 2014, BRAIN STRUCT FUNCT, V219, P641, DOI 10.1007/s00429-013-0524-8; Wee CY, 2013, HUM BRAIN MAPP, V34, P3411, DOI 10.1002/hbm.22156; Wee CY, 2012, NEUROIMAGE, V59, P2045, DOI 10.1016/j.neuroimage.2011.10.015; Wu TT, 2009, BIOINFORMATICS, V25, P714, DOI 10.1093/bioinformatics/btp041; Wu X, 2013, IEEE ACM T COMPUT BI, V10, P173, DOI 10.1109/TCBB.2012.141; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yan K, 2015, SENSOR ACTUAT B-CHEM, V212, P353, DOI 10.1016/j.snb.2015.02.025; Yang Z, 2012, NEUROSCI BULL, V28, P399, DOI 10.1007/s12264-012-1253-3; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhan ZW, 2018, CNS NEUROSCI THER, V24, P897, DOI 10.1111/cns.12838; Zhang DQ, 2011, NEUROIMAGE, V55, P856, DOI 10.1016/j.neuroimage.2011.01.008; Zheng WH, 2018, BIOL PSYCHIAT-COGN N, V3, P887, DOI 10.1016/j.bpsc.2018.06.004; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhou Y, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00200; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	70	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212582	10.1371/journal.pone.0212582	http://dx.doi.org/10.1371/journal.pone.0212582			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794629	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100090
J	Garcia, PK; Annamalai, T; Wang, WJ; Bell, RS; Le, D; Pancorbo, PM; Sikandar, S; Seddek, A; Yu, XF; Sun, DQ; Uhlemann, AC; Tiwari, PB; Leng, FF; Tse-Dinh, YC				Garcia, Pamela K.; Annamalai, Thirunavukkarasu; Wang, Wenjie; Bell, Raven S.; Le, Duc; Pancorbo, Paula Martin; Sikandar, Sabah; Seddek, Ahmed; Yu, Xufen; Sun, Dianqing; Uhlemann, Anne-Catrin; Tiwari, Purushottam B.; Leng, Fenfei; Tse-Dinh, Yuk-Ching			Mechanism and resistance for antimycobacterial activity of a fluoroquinophenoxazine compound	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; DNA TOPOISOMERASE-I; MEMBRANE-PROTEINS; CELL-WALL; TUBERCULOSIS; PORIN; ABSCESSUS; GROWTH; GENE; SUSCEPTIBILITY	We have previously reported the inhibition of bacterial topoisomerase I activity by a fluoroquinophenoxazine compound (FP-11g) with a 6-bipiperidinyl lipophilic side chain that exhibited promising antituberculosis activity (MIC = 2.5 mu M against Mycobacterium tuberculosis, SI = 9.8). Here, we found that the compound is bactericidal towards Mycobacterium smegmatis, resulting in greater than 5 Log(10) reduction in colony-forming units [cfu]/mL following a 10 h incubation at 1.25 mu M (4X MIC) concentration. Growth inhibition (MIC = 50 mu M) and reduction in cfu could also be observed against a clinical isolate of Mycobacterium abscessus. Stepwise isolation of resistant mutants of M. smegmatis was conducted to explore the mechanism of resistance. Mutations in the resistant isolates were identified by direct comparison of whole-genome sequencing data from mutant and wild-type isolates. These include mutations in genes likely to affect the entry and retention of the compound. FP-11g inhibits Mtb topoisomerase I and Mtb gyrase with IC50 of 0.24 and 27 mu M, respectively. Biophysical analysis showed that FP-11g binds DNA as an intercalator but the IC50 for inhibition of Mtb topoisomerase I activity is >10 fold lower than the compound concentrations required for producing negatively supercoiled DNA during ligation of nicked circular DNA. Thus, the DNA-binding property of FP-11g may contribute to its antimycobacterial mechanism, but that alone cannot account for the observed inhibition of Mtb topoisomerase I.	[Garcia, Pamela K.; Annamalai, Thirunavukkarasu; Wang, Wenjie; Pancorbo, Paula Martin; Sikandar, Sabah; Seddek, Ahmed; Leng, Fenfei; Tse-Dinh, Yuk-Ching] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Garcia, Pamela K.] Florida Int Univ, Biochem PhD Program, Miami, FL 33199 USA; [Annamalai, Thirunavukkarasu; Wang, Wenjie; Bell, Raven S.; Le, Duc; Seddek, Ahmed; Leng, Fenfei; Tse-Dinh, Yuk-Ching] Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA; [Yu, Xufen; Sun, Dianqing] Univ Hawaii, Daniel K Inouye Coll Pharm, Dept Pharmaceut Sci, Hilo, HI 96720 USA; [Uhlemann, Anne-Catrin] Columbia Univ, Med Ctr, Div Infect Dis, New York, NY USA; [Tiwari, Purushottam B.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol,Sch Med, Washington, DC 20007 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of Hawaii System; University Hawaii Hilo; Columbia University; Georgetown University	Tse-Dinh, YC (corresponding author), Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA.; Tse-Dinh, YC (corresponding author), Florida Int Univ, Dept Chem & Biochem, Miami, FL 33199 USA.	ytsedinh@fiu.edu	Seddek, Ahmed/ABF-6140-2021; YU, XUFEN/AAB-9838-2020	YU, XUFEN/0000-0001-7794-7890	NIH [P30CA51008, R01 AI069313]; FIU Technology Fee Initiative [16-162]; NSF-REU Site Grant [CHE1560375]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FIU Technology Fee Initiative; NSF-REU Site Grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH grant R01 AI069313 (to Yuk-Ching Tse-Dinh). Next-Gen sequencing was supported by FIU Technology Fee Initiative, Proposal #16-162. Experimental SPR sensorgrams were measured using Biacore T200 SPR instrument available in Biacore Molecular Interaction Shared Resource (BMISR) facility at Georgetown University. The BMISR is supported by NIH grant P30CA51008. REU participant RB was supported by the NSF-REU Site Grant CHE1560375 to FIU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R, 2012, EUR J CELL BIOL, V91, P326, DOI 10.1016/j.ejcb.2011.06.003; Ahmed W, 2015, MICROBIOL-SGM, V161, P341, DOI 10.1099/mic.0.000014; Ahmed W, 2014, FEMS MICROBIOL LETT, V353, P116, DOI 10.1111/1574-6968.12412; Akerman KJ, 2014, J AM CHEM SOC, V136, P5670, DOI 10.1021/ja412350f; Annamalai T, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-18; Cao N, 2018, NUCLEIC ACIDS RES, V46, P7296, DOI 10.1093/nar/gky492; Cavalli Z, 2017, J CYST FIBROS, V16, P579, DOI 10.1016/j.jcf.2017.01.017; Corbett KD, 2004, ANNU REV BIOPH BIOM, V33, P95, DOI 10.1146/annurev.biophys.33.110502.140357; Danilchanka O, 2008, ANTIMICROB AGENTS CH, V52, P3127, DOI 10.1128/AAC.00239-08; Delmar JA, 2015, J BIOL CHEM, V290, P28559, DOI 10.1074/jbc.M115.683797; Ding C, 2012, J PROTEOMICS, V77, P321, DOI 10.1016/j.jprot.2012.09.006; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Falkinham JO, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01613; Forterre P, 2009, NUCLEIC ACIDS RES, V37, P679, DOI 10.1093/nar/gkp032; Fujimoto-Nakamura M, 2005, ANTIMICROB AGENTS CH, V49, P3810, DOI 10.1128/AAC.49.9.3810-3815.2005; Gu M, 2016, SCI REP-UK, V6, DOI 10.1038/srep36006; Hayoz S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185359; He ZG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-121; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Ishiekwene C, 2017, RESPIR MED CASE REP, V20, P123, DOI 10.1016/j.rmcr.2017.01.011; Kartmann B, 1999, J BACTERIOL, V181, P6543, DOI 10.1128/JB.181.20.6543-6546.1999; Korepanova A, 2005, PROTEIN SCI, V14, P148, DOI 10.1110/ps.041022305; Mailaender C, 2004, MICROBIOL-SGM, V150, P853, DOI 10.1099/mic.0.26902-0; Marais BJ, 2016, ADV DRUG DELIVER REV, V102, P3, DOI 10.1016/j.addr.2016.01.021; Martinez-Garcia B, 2018, METHODS MOL BIOL, V1805, P291, DOI 10.1007/978-1-4939-8556-2_15; Mattenberger Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124309; Nagaraja V, 2017, DRUG DISCOV TODAY, V22, P510, DOI 10.1016/j.drudis.2016.11.006; Nessar R, 2012, J ANTIMICROB CHEMOTH, V67, P810, DOI 10.1093/jac/dkr578; Niederweis M, 1999, MOL MICROBIOL, V33, P933, DOI 10.1046/j.1365-2958.1999.01472.x; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pacheco SA, 2013, J BIOL CHEM, V288, P24213, DOI 10.1074/jbc.M113.473371; Purdy GE, 2009, MOL MICROBIOL, V73, P844, DOI 10.1111/j.1365-2958.2009.06801.x; Ravishankar S, 2015, TUBERCULOSIS, V95, P589, DOI 10.1016/j.tube.2015.05.004; Ren JS, 1999, BIOCHEMISTRY-US, V38, P16067, DOI 10.1021/bi992070s; Sandhu P, 2015, INT J MED MICROBIOL, V305, P413, DOI 10.1016/j.ijmm.2015.03.005; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Sharbati S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-31; Sohn Sungmin, 2017, Korean J Thorac Cardiovasc Surg, V50, P50, DOI 10.5090/kjtcs.2017.50.1.50; Soni I, 2016, J MED MICROBIOL, V65, P1, DOI 10.1099/jmm.0.000198; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Stephan J, 2005, MOL MICROBIOL, V58, P714, DOI 10.1111/j.1365-2958.2005.04878.x; Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004; Strnad L, 2018, SEMIN RESP CRIT CARE, V39, P362, DOI 10.1055/s-0038-1651494; Svetlikova Z, 2009, ANTIMICROB AGENTS CH, V53, P4015, DOI 10.1128/AAC.00590-09; Taneja NK, 2007, J ANTIMICROB CHEMOTH, V60, P288, DOI 10.1093/jac/dkm207; Walker SS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180965; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Yu XF, 2017, EUR J MED CHEM, V125, P515, DOI 10.1016/j.ejmech.2016.09.053	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0207733	10.1371/journal.pone.0207733	http://dx.doi.org/10.1371/journal.pone.0207733			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794538	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100003
J	Lim, HJ; Park, JH; Jo, C; Yoon, K; Koh, YH				Lim, Hyun Joung; Park, Jung Hyun; Jo, Chulman; Yoon, Keejung; Koh, Young Ho			Cigarette smoke extracts and cadmium induce COX-2 expression through gamma-secretase-mediated p38 MAPK activation in C6 astroglia cells	PLOS ONE			English	Article							SIGNALING PATHWAY; GENE-EXPRESSION; PROTEIN-KINASE; EP2 RECEPTORS; ASTROCYTES; BRAIN; DEATH; CREB; TRANSCRIPTION; APOPTOSIS	Exposure to cigarette smoke has been implicated in the progression of cerebrovascular and neurological disorders like stroke through inflammation and blood-brain barrier disruption. In this study, we investigated the signaling cascade activated by cigarette smoke extracts (CSE) and cadmium (Cd) resulting in the COX-2 induction in C6 rat astroglia cells. CSE or Cd induced Notch1 cleavage and activated p38 MAPK and CREB signaling pathways in C6 astroglia cells. Knockdown of nicastrin using siRNA or gamma-secretase inhibitors, DAPT and L-685,486, reduced Notch1 cleavage and phosphorylation of p38 MAPK and CREB, while phosphorylation of ERK and JNK remained unaffected. Additionally, the blockage of gamma-secretase activity did not show any effect on the phosphorylation of AKT, another upstream activator of CREB, indicating that gamma-secretase-mediated CREB activation occurs via p38 MAPK. gamma-secretase inhibitor also inhibited the CSE and Cd-mediated increase in the expression of COX-2. Furthermore, recombinant overexpression of Notch1 intracellular domain resulted in an increase in the expression of COX-2. Notch signaling induced by CSE and Cd induced apoptosis in C6 cells. Our results demonstrate that CSE exposure activated the p38 MAPK and CREB-mediated induction in COX-2 expression in astrocytes via gamma-secretase-mediated Notch1 signaling. Our data provides novel insights into the potential mechanism of pro-inflammatory response activated by exposure to cigarette smoke.	[Lim, Hyun Joung; Park, Jung Hyun; Jo, Chulman; Koh, Young Ho] Korea Natl Inst Hlth, Ctr Biomed Sci, Div Brain Dis, Cheongju, Chungcheongbuk, South Korea; [Yoon, Keejung] Sungkyunkwan Univ, Coll Biotechnol & Bioengn, Suwon, Gyeonggi Do, South Korea	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Biomedical Science; Sungkyunkwan University (SKKU)	Koh, YH (corresponding author), Korea Natl Inst Hlth, Ctr Biomed Sci, Div Brain Dis, Cheongju, Chungcheongbuk, South Korea.	kohyoungho122@gmail.com			Research of Korea Centers for Disease Control and Prevention [2017-NI62002-00]	Research of Korea Centers for Disease Control and Prevention	This study was supported by funds (2017-NI62002-00) from Research of Korea Centers for Disease Control and Prevention to Dr. YHK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad AS, 2008, NEUROTOX RES, V14, P343, DOI 10.1007/BF03033858; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Borne Y, 2017, J AM HEART ASS, V6; Cakmak S, 2014, ENVIRON POLLUT, V189, P208, DOI 10.1016/j.envpol.2014.03.004; Cheng YL, 2014, BRAIN RES, V1586, P193, DOI 10.1016/j.brainres.2014.08.054; Cho SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18042-1; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Gentle ME, 2012, J IMMUNOL, V189, P1274, DOI 10.4049/jimmunol.1103102; Gordon GRJ, 2007, GLIA, V55, P1214, DOI 10.1002/glia.20543; Gu W, 2015, SCI REP-UK, V5, DOI 10.1038/srep08733; Guo SZ, 2009, STROKE, V40, pS4, DOI 10.1161/STROKEAHA.108.534388; Huang RY, 2011, BBA-REV CANCER, V1815, P158, DOI 10.1016/j.bbcan.2010.11.005; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kim SD, 2005, BIOCHEM BIOPH RES CO, V328, P326, DOI 10.1016/j.bbrc.2004.11.173; Konishi H, 1997, FEBS LETT, V410, P493, DOI 10.1016/S0014-5793(97)00541-3; Ladecola C, 2001, P NATL ACAD SCI USA, V98, P1294, DOI 10.1073/pnas.98.3.1294; Lee SM, 2002, FREE RADICAL BIO MED, V32, P1185, DOI 10.1016/S0891-5849(02)00815-8; Lenz B, 2010, INT J NEUROPSYCHOPH, V13, P207, DOI 10.1017/S1461145709991052; Liu YP, 2008, J NEUROCHEM, V105, P137, DOI 10.1111/j.1471-4159.2007.05118.x; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; MARLOWE M, 1985, J ABNORM CHILD PSYCH, V13, P185, DOI 10.1007/BF00910641; Meng M, 2017, CELL SIGNAL, V31, P15, DOI 10.1016/j.cellsig.2016.12.006; Miyagishi H, 2013, J PHARMACOL SCI, V121, P347, DOI 10.1254/jphs.12274SC; Miyahara T, 2004, TOXICOLOGY, V200, P159, DOI 10.1016/j.tox.2004.03.014; MOON C, 1985, J LEARN DISABIL, V18, P217, DOI 10.1177/002221948501800407; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Nogawa S, 1997, J NEUROSCI, V17, P2746; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Park CS, 2008, TOXICOL SCI, V106, P413, DOI 10.1093/toxsci/kfn197; Park SY, 2015, J TOXICOL SCI, V40, P151, DOI 10.2131/jts.40.151; Peters JL, 2010, ENVIRON RES, V110, P199, DOI 10.1016/j.envres.2009.12.004; Piao CS, 2002, MOL BRAIN RES, V107, P137, DOI 10.1016/S0169-328X(02)00456-4; Rockwell P, 2004, CELL SIGNAL, V16, P343, DOI 10.1016/j.cellsig.2003.08.006; Sawe N, 2008, J NEUROSCI RES, V86, P1659, DOI 10.1002/jnr.21604; Takadera T, 2004, NEUROCHEM INT, V45, P713, DOI 10.1016/j.neuint.2004.02.005; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Tang QB, 2001, ONCOGENE, V20, P5164, DOI 10.1038/sj.onc.1204667; Tellez-Plaza M, 2013, EPIDEMIOLOGY, V24, P421, DOI 10.1097/EDE.0b013e31828b0631; World Health Organisation, 2011, WHO REP GLOC TOB EP; Zhao YX, 2010, NEUROTHERAPEUTICS, V7, P439, DOI 10.1016/j.nurt.2010.07.004	44	12	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212749	10.1371/journal.pone.0212749	http://dx.doi.org/10.1371/journal.pone.0212749			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794693	Green Submitted, gold, Green Published			2022-12-26	WOS:000459709100129
J	Nunez-Valdez, ME; Lanois, A; Pages, S; Duvic, B; Gaudriault, S				Nunez-Valdez, Maria Eugenia; Lanois, Anne; Pages, Sylvie; Duvic, Bernard; Gaudriault, Sophie			Inhibition of Spodoptera frugiperda phenoloxidase activity by the products of the Xenorhabdus rhabduscin gene cluster	PLOS ONE			English	Article							SUPPRESSES HOST DEFENSES; PHOTORHABDUS-LUMINESCENS; BACTERIAL SYMBIONT; INSECT; NEMATOPHILA; PROTEIN; METABOLITES; EVOLUTION; VIRULENCE; VECTOR	We evaluated the impact of bacterial rhabduscin synthesis on bacterial virulence and phenoloxidase inhibition in a Spodoptera model. We first showed that the rhabduscin cluster of the entomopathogenic bacterium Xenorhabdus nematophila was not necessary for virulence in the larvae of Spodoptera littoralis and Spodoptera frugiperda. Bacteria with mutations affecting the rhabduscin synthesis cluster (Delta isnAB and Delta GT mutants) were as virulent as the wild-type strain. We then developed an assay for measuring phenoloxidase activity in S. frugiperda and assessed the ability of bacterial culture supernatants to inhibit the insect phenoloxidase. Our findings confirm that the X. nematophila rhabduscin cluster is required for the inhibition of S. frugiperda phenoloxidase activity. The X. nematophila Delta isnAB mutant was unable to inhibit phenoloxidase, whereas Delta GT mutants displayed intermediate levels of phenoloxidase inhibition relative to the wild-type strain. The culture supernatants of Escherichia coli and of two entomopathogenic bacteria, Serratia entomophila and Xenorhabdus poinarii, were unable to inhibit S. frugiperda phenoloxidase activity. Heterologous expression of the X. nematophila rhabduscin cluster in these three strains was sufficient to restore inhibition. Interestingly, we observed pseudogenization of the X. poinarii rhabduscin gene cluster via the insertion of a 120 bp element into the isnA promoter. The inhibition of phenoloxidase activity by X. poinarii culture supernatants was restored by expression of the X. poinarii rhabduscin cluster under the control of an inducible P-tet promoter, consistent with recent pseudogenization. This study paves the way for advances in our understanding of the virulence of several entomopathogenic bacteria in non-model insects, such as the new invasive S. frugiperda species in Africa.	[Nunez-Valdez, Maria Eugenia] Univ Autonoma Estado Morelos, Cuernavaca, Morelos, Mexico; [Lanois, Anne; Pages, Sylvie; Duvic, Bernard; Gaudriault, Sophie] Univ Montpellier, INRA, DGIMI, Montpellier, France	Universidad Autonoma del Estado de Morelos; INRAE; Universite de Montpellier	Nunez-Valdez, ME (corresponding author), Univ Autonoma Estado Morelos, Cuernavaca, Morelos, Mexico.; Gaudriault, S (corresponding author), Univ Montpellier, INRA, DGIMI, Montpellier, France.	eugenia@uaem.mx; sophie.gaudriault@umontpellier.fr	Duvic, Bernard/ABG-5094-2020; , Gaudriault/AAK-9152-2021	, Gaudriault/0000-0003-2789-4959; Duvic, Bernard/0000-0002-7618-7719; Nunez-Valdez, Maria Eugenia/0000-0003-4729-9954	INRA [SPE 2010-1133-01]; CONACYT [CB2014-243027]; INRA	INRA; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); INRA	This study was supported by INRA (grant SPE 2010-1133-01, "Genomique comparative et evolutive de nouveaux facteurs d'adaptation de la bacterie entomopathogene Xenorhadus a ses hotes insectes"). MEN-V was the recipient of a travel grant in the DGIMI laboratory from INRA. The support of CONACYT, project CB2014-243027 is acknowledged.	AKHURST RJ, 1986, SYST APPL MICROBIOL, V8, P142, DOI 10.1016/S0723-2020(86)80162-X; Asgari S, 2003, INSECT BIOCHEM MOLEC, V33, P1017, DOI 10.1016/S0965-1748(03)00116-4; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Bisch G, 2016, GENOME BIOL EVOL, V8, P148, DOI 10.1093/gbe/evv248; Bisch G, 2015, J INVERTEBR PATHOL, V124, P15, DOI 10.1016/j.jip.2014.10.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Cerenius L, 2010, TRENDS BIOCHEM SCI, V35, P575, DOI 10.1016/j.tibs.2010.04.006; Chaston JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027909; Ciche TA, 2003, APPL ENVIRON MICROB, V69, P1890, DOI 10.1128/AEM.69.4.1890-1897.2003; Colinet D, 2009, DEV COMP IMMUNOL, V33, P681, DOI 10.1016/j.dci.2008.11.013; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Crawford JM, 2012, P NATL ACAD SCI USA, V109, P10821, DOI 10.1073/pnas.1201160109; Crawford JM, 2010, CURR BIOL, V20, P69, DOI 10.1016/j.cub.2009.10.059; Dowd PF, 1999, NAT TOXINS, V7, P337, DOI 10.1002/1522-7189(199911/12)7:6<337::AID-NT69>3.0.CO;2-O; Duvic B, 2012, J INSECT PHYSIOL, V58, P881, DOI 10.1016/j.jinsphys.2012.04.001; Eleftherianos I, 2007, P NATL ACAD SCI USA, V104, P2419, DOI 10.1073/pnas.0610525104; Eleftherianos I, 2011, J INNATE IMMUN, V3, P28, DOI 10.1159/000321931; Nunez-Valdez ME, 2008, APPL ENVIRON MICROB, V74, P802, DOI 10.1128/AEM.01074-07; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Goergen G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165632; Gonzalez-Santoyo I, 2012, ENTOMOL EXP APPL, V142, P1, DOI 10.1111/j.1570-7458.2011.01187.x; GRIMONT PAD, 1988, INT J SYST BACTERIOL, V38, P1, DOI 10.1099/00207713-38-1-1; Herbert EE, 2007, NAT REV MICROBIOL, V5, P634, DOI 10.1038/nrmicro1706; Jubelin G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003915; Kim IH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4311-4; Kim Y, 2005, J INVERTEBR PATHOL, V89, P258, DOI 10.1016/j.jip.2005.05.001; Kuo CH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001050; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li XY, 2009, MOL BIOCHEM PARASIT, V165, P162, DOI 10.1016/j.molbiopara.2009.02.001; Lim FY, 2018, MBIO, V9, DOI [10.1128/mBio.00785-18, 10.1128/mbio.00785-18]; Lu Z, 2008, J BIOL CHEM, V283, P21325, DOI 10.1074/jbc.M801593200; Lu ZQ, 2010, INSECT BIOCHEM MOLEC, V40, P497, DOI 10.1016/j.ibmb.2010.04.009; McMullen JG, 2017, MICROBIOL-SGM, V163, P510, DOI 10.1099/mic.0.000449; Mikonranta L, 2017, J INVERTEBR PATHOL, V144, P88, DOI 10.1016/j.jip.2017.01.012; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Mouammine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110060; Mulley G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144937; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Thuan NH, 2013, J IND MICROBIOL BIOT, V40, P1329, DOI 10.1007/s10295-013-1332-0; Nielsen-LeRoux C, 2012, CURR OPIN MICROBIOL, V15, P220, DOI 10.1016/j.mib.2012.04.006; Ogier JC, 2014, GENOME BIOL EVOL, V6, P1495, DOI 10.1093/gbe/evu119; Paulick A, 2009, MOL MICROBIOL, V71, P836, DOI 10.1111/j.1365-2958.2008.06570.x; POINAR GO, 1967, J INVERTEBR PATHOL, V9, P510, DOI 10.1016/0022-2011(67)90131-0; POITOUT S, 1970, Annales de Zoologie Ecologie Animale, V2, P79; Sicard M, 2004, APPL ENVIRON MICROB, V70, P6473, DOI 10.1128/AEM.70.11.6473-6480.2004; Snyder H, 2007, APPL ENVIRON MICROB, V73, P5338, DOI 10.1128/AEM.02947-06; Song CJ, 2011, J MICROBIOL BIOTECHN, V21, P317, DOI 10.4014/jmb.1010.10034; Ullah I, 2015, J MICROBIOL, V53, P127, DOI 10.1007/s12275-015-4632-4; Ullah I, 2014, MOLECULES, V19, P20913, DOI 10.3390/molecules191220913; van Sambeek J, 1999, J INVERTEBR PATHOL, V73, P154, DOI 10.1006/jipa.1998.4823; Vigneux F, 2007, J BIOL CHEM, V282, P9571, DOI 10.1074/jbc.M604301200; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507	54	3	3	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212809	10.1371/journal.pone.0212809	http://dx.doi.org/10.1371/journal.pone.0212809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794697	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100144
J	Shin, GT; Lee, HJ; Park, JE				Shin, Gyu-Tae; Lee, Hwa Joung; Park, Ji Eun			Growth arrest and DNA damage 45 gamma is required for caspase-dependent renal tubular cell apoptosis	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; IN-VITRO; GADD45-GAMMA; INVOLVEMENT; ACTIVATION; EXPRESSION; PATHWAYS; STRESS; KINASE; ALPHA	Background Growth Arrest and DNA Damage 45 gamma (GADD45 gamma) is a member of the DNA damage-inducible gene family which responds to environmental stresses. Apoptosis is a critical mode of renal tubular cell death in nephrotoxin-induced acute kidney injury. In this study, we investigated the role of GADD45 gamma in renal tubular cell apoptosis induced by nephrotoxic drugs. Methods Primary human renal tubular epithelial (HRE) cells were used in this study. To derive stable cell lines in which GADD45 gamma expression was silenced, HRE cells were transduced with a plasmid encoding GADD45 gamma-specific shRNA. The recombinant adenovirus containing the GADD45 gamma gene was synthesized to overexpress GADD45 gamma protein. Cell death was induced by cisplatin and cyclosporine A (CsA). To prevent apoptotic cell death, pan-caspase inhibitor ZVAD-FMK was used. To prevent non-apoptotic cell death, necrostatin-1 and ferrostatin-1 were used. The degree of apoptosis and necrosis of cultured cells were evaluated by flow cytometry. Results Expression of the GADD45 gamma gene was significantly upregulated in response to treatment with CsA and cisplatin. Apoptosis and necrosis induced by these drugs were significantly reduced by silencing of GADD45 gamma, and significantly augmented by the overexpression of GADD45 gamma. The activation of caspase-3 and caspase-7 as well as caspase-9 induced by cisplatin or CsA was reduced by silencing of GADD45 gamma, and was augmented by the overexpression of GADD45 gamma, indicating that caspase activation is dependent on the expression of GADD45 gamma. ZVAD-FMK significantly inhibited apoptosis induced by cisplatin or CsA, indicating a role of caspases in mediating apoptotic cell death. ZVAD-FMK was effective to prevent necrosis as well, indicating that the observed necrosis was a secondary event following apoptosis at least in part. Conclusions To our knowledge, this is the first study to show that GADD45 gamma is required for the caspase-dependent apoptosis of renal tubular cells induced by nephrotoxic drugs.	[Shin, Gyu-Tae; Lee, Hwa Joung; Park, Ji Eun] Ajou Univ, Sch Med, Dept Nephrol, Suwon, South Korea	Ajou University	Shin, GT (corresponding author), Ajou Univ, Sch Med, Dept Nephrol, Suwon, South Korea.	gtshin@ajou.ac.kr						Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Burdmann EA, 2003, SEMIN NEPHROL, V23, P465, DOI 10.1016/S0270-9295(03)00090-1; Daemen MARC, 1999, J CLIN INVEST, V104, P541, DOI 10.1172/JCI6974; El Mouedden M, 2000, TOXICOL SCI, V56, P229, DOI 10.1093/toxsci/56.1.229; Havasi A, 2011, KIDNEY INT, V80, P29, DOI 10.1038/ki.2011.120; Hizoh I, 1998, NEPHROL DIAL TRANSPL, V13, P911, DOI 10.1093/ndt/13.4.911; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Justo P, 2003, J AM SOC NEPHROL, V14, P3072, DOI 10.1097/01.ASN.0000099383.57934.0E; Kelly KJ, 2001, J CLIN INVEST, V108, P1291, DOI 10.1172/JCI13018; KOPP JB, 1990, J AM SOC NEPHROL, V1, P162; Lau AH, 1999, KIDNEY INT, V56, P1295, DOI 10.1046/j.1523-1755.1999.00687.x; Lerolle N, 2010, INTENS CARE MED, V36, P471, DOI 10.1007/s00134-009-1723-x; Lieberthal W, 1996, AM J PHYSIOL-RENAL, V270, pF700, DOI 10.1152/ajprenal.1996.270.4.F700; Lin H, 2007, MOL PHARMACOL, V72, P1238, DOI 10.1124/mol.107.037523; Linkermann A, 2013, P NATL ACAD SCI USA, V110, P12024, DOI 10.1073/pnas.1305538110; Lu BF, 2001, IMMUNITY, V14, P583, DOI 10.1016/S1074-7613(01)00141-8; Lucas A, 2015, CARDIOVASC RES, V108, P254, DOI 10.1093/cvr/cvv219; Ohse T, 2006, KIDNEY INT, V70, P1447, DOI 10.1038/sj.ki.5001704; Ortiz A, 1998, KIDNEY INT, V54, pS25, DOI 10.1046/j.1523-1755.1998.06808.x; Sachet M, 2017, APOPTOSIS, V22, P1189, DOI 10.1007/s10495-017-1413-z; Schelling JR, 1999, KIDNEY INT, V56, P1313, DOI 10.1046/j.1523-1755.1999.00684.x; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Sheikh-Hamad D, 2001, J AM SOC NEPHROL, V12, P2732, DOI 10.1681/ASN.V12122732; Shihab FS, 1999, KIDNEY INT, V56, P2147, DOI 10.1046/j.1523-1755.1999.00794.x; Shin GT, 2008, KIDNEY INT, V73, P1251, DOI 10.1038/ki.2008.93; SMITH ML, 1994, SCIENCE, V266, P1376, DOI 10.1126/science.7973727; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Thomas SE, 1998, KIDNEY INT, V53, P897, DOI 10.1046/j.1523-1755.1998.00835.x; Tsuruya K, 2008, LIFE SCI, V83, P550, DOI 10.1016/j.lfs.2008.08.002; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Verzola D, 2007, KIDNEY INT, V72, P1262, DOI 10.1038/sj.ki.5002531; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Yu F, 2007, AM J PHYSIOL-RENAL, V293, pF52, DOI 10.1152/ajprenal.00119.2007; Yu S, 2009, AM J NEPHROL, V30, P135, DOI 10.1159/000209317; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101	37	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212818	10.1371/journal.pone.0212818	http://dx.doi.org/10.1371/journal.pone.0212818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794682	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100146
J	Comstock, JP; Sherpa, SR; Ferguson, R; Bailey, S; Beem-Miller, JP; Lin, F; Lehmann, J; Wolfe, DW				Comstock, Jonathan P.; Sherpa, Sonam R.; Ferguson, Richard; Bailey, Scarlett; Beem-Miller, Jeffrey P.; Lin, Feng; Lehmann, Johannes; Wolfe, David W.			Carbonate determination in soils by mid-IR spectroscopy with regional and continental scale models	PLOS ONE			English	Article							DIFFUSE-REFLECTANCE SPECTROSCOPY; PARTIAL LEAST-SQUARES; ORGANIC-MATTER; PREDICTION; SEQUESTRATION; NIR	A Partial Least Squares (PLS) carbonate (CO3) prediction model was developed for soils throughout the contiguous United States using mid-infrared (MIR) spectroscopy. Excellent performance was achieved over an extensive geographic and chemical diversity of soils. A single model for all soil types performed very well with a root mean square error of prediction (RMSEP) of 12.6 g kg(-1) and was further improved if Histosols were excluded (RMSEP 11.1 g kg(-1)). Exclusion of Histosols was particularly beneficial for accurate prediction of CO3 values when the national model was applied to an independent regional dataset. Little advantage was found in further narrowing the taxonomic breadth of the calibration dataset, but higher precision was obtained by running models for a restricted range of CO3. A model calibrated using only on the independent regional dataset, was unable to accurately predict CO3 content for the more chemically diverse national dataset. Ten absorbance peaks enabling CO3 prediction by mid-infrared (MIR) spectroscopy were identified and evaluated for individual and combined predictive power. A single-band model derived from an absorbance peak centered at 1796 cm(-) yielded the lowest RMSEP of 13.5 g kg(-1) for carbonate prediction compared to other single-band models. This predictive power is attributed to the strength and sharpness of the peak, and an apparent minimal overlap with confounding co-occurring spectral features of other soil components. Drawing from the 10 identified bands, multiple combinations of 3 or 4 peaks were able to predict CO3 content as well as the full-spectrum national models. Soil CO3 is an excellent example of a soil parameter that can be predicted with great effectiveness and generality, and MIR models could replace direct laboratory measurement as a lower cost, high quality alternative.	[Comstock, Jonathan P.; Beem-Miller, Jeffrey P.; Wolfe, David W.] Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14850 USA; [Comstock, Jonathan P.; Sherpa, Sonam R.; Ferguson, Richard; Bailey, Scarlett] Nat Resources Conservat Serv, Kellogg Soil Survey Lab, Lincoln, NE USA; [Sherpa, Sonam R.; Lehmann, Johannes] Cornell Univ, Sch Integrat Plant Sci, Soil & Crop Sci Sect, Ithaca, NY USA; [Lin, Feng] Nanjing Agr Univ, Jiangsu Key Lab Low Carbon Agr & GHGs Mitigat, Nanjing, Jiangsu, Peoples R China; [Lehmann, Johannes; Wolfe, David W.] Cornell Univ, Atkinson Ctr Sustainable Future, Ithaca, NY USA	Cornell University; Cornell University; Nanjing Agricultural University; Cornell University	Comstock, JP (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Hort Sect, Ithaca, NY 14850 USA.; Comstock, JP (corresponding author), Nat Resources Conservat Serv, Kellogg Soil Survey Lab, Lincoln, NE USA.	jpc8@cornell.edu	Lehmann, Johannes/H-2682-2014	Lehmann, Johannes/0000-0002-4701-2936; Beem-Miller, Jeffrey/0000-0003-0955-6622	United States Department of Agriculture, National Institute of Food and Agriculture Agriculture, and Food Research Initiative [2011-67003-3025]	United States Department of Agriculture, National Institute of Food and Agriculture Agriculture, and Food Research Initiative(United States Department of Agriculture (USDA))	Funded by grant#2011-67003-3025 United States Department of Agriculture, National Institute of Food and Agriculture Agriculture, and Food Research Initiative. https://nifa.usda.gov/program/agriculture-and-food-research-initiativeafri. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON LE, 1965, METHODS SOIL ANAL 2, P1346; Bellon-Maurel V, 2011, SOIL BIOL BIOCHEM, V43, P1398, DOI 10.1016/j.soilbio.2011.02.019; Bellon-Maurel V, 2010, TRAC-TREND ANAL CHEM, V29, P1073, DOI 10.1016/j.trac.2010.05.006; BENDOR E, 1990, APPL SPECTROSC, V44, P1064, DOI 10.1366/0003702904086821; Bornemann L, 2010, SOIL SCI SOC AM J, V74, P1147, DOI 10.2136/sssaj2009.0195; Brown DJ, 2006, GEODERMA, V132, P273, DOI 10.1016/j.geoderma.2005.04.025; Bughio MA, 2016, GEODERMA, V262, P12, DOI 10.1016/j.geoderma.2015.08.003; Burt R, 2014, 42 USDA; Calderon FJ, 2011, SOIL SCI SOC AM J, V75, P568, DOI 10.2136/sssaj2009.0375; Chatterjee A, 2009, CRIT REV PLANT SCI, V28, P164, DOI 10.1080/07352680902776556; Gillet P, 1996, GEOCHIM COSMOCHIM AC, V60, P3471, DOI 10.1016/0016-7037(96)00178-0; Grinand C, 2012, EUR J SOIL SCI, V63, P141, DOI 10.1111/j.1365-2389.2012.01429.x; HAALAND DM, 1988, ANAL CHEM, V60, P1193, DOI 10.1021/ac00162a020; Hartemink AE, 2014, PROGR SOIL SCI, P483, DOI 10.1007/978-3-319-04084-4_48; Horvath B, 2005, SOIL SCI SOC AM J, V69, P1066, DOI 10.2136/sssaj2004.0010; JANIK LJ, 1995, AUST J SOIL RES, V33, P621, DOI 10.1071/SR9950621; Lal R., 2000, GLOBAL CLIMATE CHANG; Loeppert R. H., 1996, SSSA BOOK SERIES, V3, P53711, DOI DOI 10.2136/sssabookser5.3.c15; McCarty GW, 2006, SOIL SCI, V171, P94, DOI 10.1097/01.ss.0000187377.84391.54; McCarty GW, 2002, SOIL SCI SOC AM J, V66, P640, DOI 10.2136/sssaj2002.0640; NGUYEN TT, 1991, AUST J SOIL RES, V29, P49, DOI 10.1071/SR9910049; RABENHORST MC, 1988, SOIL SCI SOC AM J, V52, P965, DOI 10.2136/sssaj1988.03615995005200040012x; Reeves JB, 2010, GEODERMA, V158, P3, DOI 10.1016/j.geoderma.2009.04.005; Reeves JB, 2009, APPL GEOCHEM, V24, P1472, DOI 10.1016/j.apgeochem.2009.04.017; Rossel RAV, 2012, EUR J SOIL SCI, V63, P848, DOI 10.1111/j.1365-2389.2012.01495.x; Rossel RAV, 2006, GEODERMA, V131, P59, DOI 10.1016/j.geoderma.2005.03.007; Sanderman J, 2012, AGR ECOSYST ENVIRON, V155, P70, DOI 10.1016/j.agee.2012.04.015; Sherrod LA, 2002, SOIL SCI SOC AM J, V66, P299, DOI 10.2136/sssaj2002.0299; Singh BP, SOIL HLTH CLIMATE CH; Singh K, 2012, SOIL RES, V50, P672, DOI 10.1071/SR12119; Soriano-Disla JM, 2014, APPL SPECTROSC REV, V49, P139, DOI 10.1080/05704928.2013.811081; Stetson SJ, 2015, COMMUN SOIL SCI PLAN, V46, P2162, DOI 10.1080/00103624.2015.1069316; Stumpe B, 2011, EUR J SOIL SCI, V62, P849, DOI 10.1111/j.1365-2389.2011.01401.x; Van der Marel H.W., 1976, ATLAS INFRARED SPECT; White W.B, 1974, INFRARED SPECTRA MIN; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145	36	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0210235	10.1371/journal.pone.0210235	http://dx.doi.org/10.1371/journal.pone.0210235			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789918	Green Published, gold			2022-12-26	WOS:000459330800008
J	Thorsted, A; Bouchene, S; Tano, E; Castegren, M; Lipcsey, M; Sjolin, J; Karlsson, MO; Friberg, LE; Nielsen, EI				Thorsted, Anders; Bouchene, Salim; Tano, Eva; Castegren, Markus; Lipcsey, Miklos; Sjolin, Jan; Karlsson, Mats O.; Friberg, Lena E.; Nielsen, Elisabet I.			A non-linear mixed effect model for innate immune response: In vivo kinetics of endotoxin and its induction of the cytokines tumor necrosis factor alpha and interleukin-6	PLOS ONE			English	Article							ESCHERICHIA-COLI; PHARMACOKINETICS; PATHOGENESIS; INFLAMMATION; TOBRAMYCIN; CEFUROXIME; ACTIVATION; REDUCTION; RELEASE; SEPSIS	Endotoxin, a component of the outer membrane of Gram-negative bacteria, has been extensively studied as a stimulator of the innate immune response. However, the temporal aspects and exposure-response relationship of endotoxin and resulting cytokine induction and tolerance development is less well defined. The aim of this work was to establish an in silico model that simultaneously captures and connects the in vivo time-courses of endotoxin, tumor necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6), and associated tolerance development. Data from six studies of porcine endotoxemia in anesthetized piglets (n = 116) were combined and used in the analysis, with purified endotoxin (Escherichia coli O111: B4) being infused intravenously for 1-30 h in rates of 0.063-16.0 mu g/kg/h across studies. All data were modelled simultaneously by means of importance sampling in the non-linear mixed effects modelling software NONMEM. The infused endotoxin followed one-compartment disposition and non-linear elimination, and stimulated the production of TNF-alpha to describe the rapid increase in plasma concentration. Tolerance development, observed as declining TNF-alpha concentration with continued infusion of endotoxin, was also driven by endotoxin as a concentration-dependent increase in the potency parameter related to TNF-alpha production (EC50). Production of IL-6 was stimulated by both endotoxin and TNF-a, and four consecutive transit compartments described delayed increase in plasma IL-6. A model which simultaneously account for the time-courses of endotoxin and two immune response markers, the cytokines TNF-alpha and IL-6, as well as the development of endotoxin tolerance, was successfully established. This model-based approach is unique in its description of the time-courses and their interrelation and may be applied within research on immune response to bacterial endotoxin, or in pre-clinical pharmaceutical research when dealing with study design or translational aspects.	[Thorsted, Anders; Bouchene, Salim; Karlsson, Mats O.; Friberg, Lena E.; Nielsen, Elisabet I.] Uppsala Univ, Dept Pharmaceut Biosci, Pharmacometr Res Grp, Uppsala, Sweden; [Tano, Eva] Uppsala Univ Hosp, Sect Clin Microbiol & Infect Med, Dept Med Sci, Uppsala, Sweden; [Castegren, Markus; Sjolin, Jan] Uppsala Univ Hosp, Infect Dis Sect, Dept Med Sci, Uppsala, Sweden; [Castegren, Markus] Karolinska Univ Hosp, Div Perioperat Med & Intens Care, Stockholm, Sweden; [Castegren, Markus] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Lipcsey, Miklos] Uppsala Univ Hosp, Dept Surg Sci, Sect Anesthesiol & Intens Care, Hedenstierna Lab, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Uppsala University Hospital	Thorsted, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Pharmacometr Res Grp, Uppsala, Sweden.	anders.thorsted@farmbio.uu.se	Friberg, Lena/AAW-5888-2021; Nielsen, Elisabet/X-3368-2019; Nielsen, Elisabet I/GSM-6795-2022; Thorsted, Anders/AAA-6475-2021; Castegren, Markus/AAF-2620-2019; Lipcsey, Miklos/K-4308-2012	Friberg, Lena/0000-0002-2979-679X; Thorsted, Anders/0000-0003-1804-2703; Bouchene, Salim/0000-0003-1078-6708; Lipcsey, Miklos/0000-0002-1976-4129; Castegren, Markus/0000-0002-9292-0298; Nielsen, Elisabet/0000-0003-0725-214X	Swedish Foundation for Strategic Research (SSF)	Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research)	This project was sponsored by the Swedish Foundation for Strategic Research (SSF, https://strategiska.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arefian H, 2017, J INFECTION, V74, P107, DOI 10.1016/j.jinf.2016.11.006; Beal S, 2018, NONMEM 7 4 2 USERS G; Beal SL, 2001, J PHARMACOKINET PHAR, V28, P481, DOI 10.1023/A:1012299115260; Bergstrand M, 2011, AAPS J, V13, P143, DOI 10.1208/s12248-011-9255-z; Biesmans S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/716920; BRAUDE AI, 1955, J CLIN INVEST, V34, P858, DOI 10.1172/JCI103141; Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Carlsson M, 2009, CRIT CARE MED, V37, P1031, DOI 10.1097/CCM.0b013e31819b5683; Castegren M, 2012, SHOCK, V37, P501, DOI 10.1097/SHK.0b013e318249bb0d; Deng MH, 2013, J IMMUNOL, V190, P5152, DOI 10.4049/jimmunol.1300496; Diep JK, 2018, CPT-PHARMACOMET SYST, V7, P507, DOI 10.1002/psp4.12312; ELIN RJ, 1976, ANNU REV MED, V27, P127, DOI 10.1146/annurev.me.27.020176.001015; Gardmark M, 1999, CLIN PHARMACOKINET, V36, P145; Gnauck A, 2016, CRIT REV CL LAB SCI, V53, P197, DOI 10.3109/10408363.2015.1123215; Gonzalez D, 2011, CURR PHARM BIOTECHNO, V12, P2030, DOI 10.2174/138920111798808211; Goscinski G, 2007, J ANTIMICROB CHEMOTH, V60, P328, DOI 10.1093/jac/dkm190; Goscinski G, 2004, CRIT CARE, V8, pR35, DOI 10.1186/cc2415; Henderson JC, 2016, ANNU REV MICROBIOL, V70, P255, DOI 10.1146/annurev-micro-102215-095308; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4; Keizer RJ, 2013, CPT-PHARMACOMET SYST, V2, DOI 10.1038/psp.2013.24; LINDSAY GK, 1989, J CLIN MICROBIOL, V27, P947, DOI 10.1128/JCM.27.5.947-951.1989; Lipcsey M, 2006, J ENDOTOXIN RES, V12, P99, DOI 10.1179/096805106X89053; Lipcsey M, 2008, SHOCK, V29, P173, DOI 10.1097/SHK.0b013e318067dfbc; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; MATHISON JC, 1979, J IMMUNOL, V123, P2133; Matsuno H, 2002, RHEUMATOLOGY, V41, P329, DOI 10.1093/rheumatology/41.3.329; Mould DR, 2012, CPT-PHARMACOMET SYST, V1, DOI 10.1038/psp.2012.4; MULLEN PG, 1995, J SURG RES, V58, P124, DOI 10.1006/jsre.1995.1020; Nielsen EI, 2013, PHARMACOL REV, V65, P1053, DOI 10.1124/pr.111.005769; Nieman G, 2012, CRIT CARE MED, V40, P1052, DOI 10.1097/CCM.0b013e31823e986a; Pasin L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082775; PREMARATNE S, 1995, J SURG RES, V59, P428, DOI 10.1006/jsre.1995.1186; R Core Team, 2018, R LANG ENV STAT COMP; REDL H, 1993, IMMUNOBIOLOGY, V187, P330, DOI 10.1016/S0171-2985(11)80348-7; Roberts JA, 2012, INT J ANTIMICROB AG, V39, P187, DOI 10.1016/j.ijantimicag.2011.11.002; Schirm S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156047; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sjolin J, 2000, CLIN MICROBIOL INFEC, V6, P74, DOI 10.1046/j.1469-0691.2000.00025.x; Skorup P, 2018, CRIT CARE MED, V46, pE634, DOI 10.1097/CCM.0000000000003139; Skorup P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090441; Smith AM, 2011, J THEOR BIOL, V276, P106, DOI 10.1016/j.jtbi.2011.01.052; Stearns-Kurosawa DJ, 2011, ANNU REV PATHOL-MECH, V6, P19, DOI 10.1146/annurev-pathol-011110-130327; Suffredini AF, 1999, J INFECT DIS, V179, P1278, DOI 10.1086/314717; Taccone Fabio Silvio, 2011, Curr Infect Dis Rep, V13, P406, DOI 10.1007/s11908-011-0203-y; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; von Seth M, 2015, SHOCK, V43, P604, DOI 10.1097/SHK.0000000000000351; Wickham H, 2017, TIDYR EASILY TIDY DA; Wickham H., 2009, MEDIA, V35, P10, DOI 10.1007/978-0-387-98141-3; Zhang LP, 2003, J PHARMACOKINET PHAR, V30, P387, DOI 10.1023/B:JOPA.0000012998.04442.1f	52	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0211981	10.1371/journal.pone.0211981	http://dx.doi.org/10.1371/journal.pone.0211981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789941	Green Published, gold			2022-12-26	WOS:000459330800014
J	Engeli, KM; Baumann, S; Rolle-Kampczyk, U; Schiller, J; von Bergen, M; Grunewald, S				Engeli, Kathrin M.; Baumann, Sven; Rolle-Kampczyk, Ulrike; Schiller, Juergen; von Bergen, Martin; Grunewald, Sonja			Metabolomic profiling reveals correlations between spermiogram parameters and the metabolites present in human spermatozoa and seminal plasma	PLOS ONE			English	Article							TOF MASS-SPECTROMETRY; ANDROGEN RECEPTOR; CREATINE-KINASE; SPERM MOTILITY; SEMEN QUALITY; L-CARNITINE; MEN; IDENTIFICATION; CHROMATOGRAPHY; SPECTROSCOPY	In 50% of all infertility cases, the male is subfertile or infertile, however, the underlying mechanisms are often unknown. Even when assisted reproductive procedures such as in vitro fertilization and intracytoplasmic sperm injection are performed, the causes of male factor infertility frequently remain elusive. Since the overall activity of cells is closely linked to their metabolic capacity, we analyzed a panel of 180 metabolites in human sperm and seminal plasma and elucidated their associations with spermiogram parameters. Therefore, metabolites from a group of 20 healthy donors were investigated using a targeted LC-MS/MS approach. The correlation analyses of the amino acids, biogenic amines, acylcarnitines, lysophosphatidylcholines, phosphatidylcholines, sphingomyelins and sugars from sperm and seminal plasma with standard spermiogram parameters revealed that metabolites in sperm are closely related to sperm motility, whereas those in seminal plasma are closely related to sperm concentration and morphology. This study provides essential insights into the metabolome of human sperm and seminal plasma and its associations with sperm functions. This metabolomics technique could be a promising screening tool to detect the factors of male infertility in cases where the cause of infertility is unclear.	[Engeli, Kathrin M.; Grunewald, Sonja] Univ Hosp Leipzig, Training Ctr European Acad Androl EAA, Dermatol Venerol & Allergol Clin, Leipzig, Germany; [Engeli, Kathrin M.; Schiller, Juergen] Univ Leipzig, Inst Med Phys & Biophys, Fac Med, Leipzig, Germany; [Baumann, Sven; Rolle-Kampczyk, Ulrike; von Bergen, Martin] UFZ Helmholtz Ctr Environm Res, Dept Mol Syst Biol, Leipzig, Germany; [von Bergen, Martin] Univ Leipzig, Inst Biochem, Fac Life Sci, Leipzig, Germany; [Baumann, Sven] Umweltbundesamt UBA, Dessau Rosslau, Germany	Leipzig University; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Leipzig University	Grunewald, S (corresponding author), Univ Hosp Leipzig, Training Ctr European Acad Androl EAA, Dermatol Venerol & Allergol Clin, Leipzig, Germany.	sonja.grunewald@medizin.uni-leipzig.de	Baumann, Sven/M-2177-2013; Rolle-Kampczyk, Ulrike E./D-4786-2015	Baumann, Sven/0000-0002-3453-5308; Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; Schiller, Jurgen/0000-0002-4328-8652	German Research Council (Deutsche Forschungsgemeinschaft) [DFG GR 2075/7-1, DFG Schi 476/12-2]	German Research Council (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	The study was funded by grants for SG and JS of the German Research Council (Deutsche Forschungsgemeinschaft, http://www.dfg.de/, grant numbers DFG GR 2075/7-1 and DFG Schi 476/12-2). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliabadi E, 2012, IRAN J REPROD MED, V10, P77; Amaral A, 2014, J PROTEOME RES, V13, P5670, DOI 10.1021/pr500652y; Andersen JM, 2016, ANDROLOGY-US, V4, P857, DOI 10.1111/andr.12227; [Anonymous], [No title captured]; Baker MA, 2011, ASIAN J ANDROL, V13, P6, DOI 10.1038/aja.2010.62; Bhattacharjee R, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124495; Bottrel M, 2018, ANIM REPROD SCI, V189, P128, DOI 10.1016/j.anireprosci.2017.12.021; Breier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089728; Brosnan JT, 2003, J NUTR, V133, p2068S, DOI 10.1093/jn/133.6.2068S; Busetto GM, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12927; CALDAMONE AA, 1980, J UROLOGY, V123, P683, DOI 10.1016/S0022-5347(17)56091-7; Courant F, 2013, J PROTEOME RES, V12, P2914, DOI 10.1021/pr400204q; Dudiki T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141961; EDWARDS K. D. G., 1959, AUSTRALASIAN ANN MED, V8, P218; Ellerbrock RE, 2018, THERIOGENOLOGY, V117, P1, DOI 10.1016/j.theriogenology.2018.05.010; Engel KM, 2017, LIPIDS, V52, P857, DOI 10.1007/s11745-017-4283-9; Esteves SC, 2011, CLINICS, V66, P691, DOI 10.1590/S1807-59322011000400026; Fuchs B, 2012, MINI-REV MED CHEM, V12, P74, DOI 10.2174/138955712798868931; Glander HJ, 2002, ANDROLOGIA, V34, P360, DOI 10.1046/j.1439-0272.2002.00508.x; GONZALES GF, 1992, ANDROLOGIA, V24, P95; Grunewald S, 2005, ANDROLOGIA, V37, P69, DOI 10.1111/j.1439-0272.2005.00656.x; Grunewald S, 2013, J DTSCH DERMATOL GES, V11, P799, DOI 10.1111/ddg.12177; Guo D, 2017, ONCOTARGET, V8, P48619, DOI 10.18632/oncotarget.14950; Hallak J, 2001, UROLOGY, V58, P446, DOI 10.1016/S0090-4295(01)01224-9; Henriksen JR, 2010, BIOPHYS J, V98, P2199, DOI 10.1016/j.bpj.2010.01.037; Holt Jr LE, 1944, T ASSOC AM PHYSICIAN, V58, P143; Ijiri Takashi W, 2012, J Signal Transduct, V2012, P181560, DOI 10.1155/2012/181560; Johnson GD, 2011, MOL HUM REPROD, V17, P721, DOI 10.1093/molehr/gar054; Kenez A, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1112-8; KOHENGKUL S, 1977, FERTIL STERIL, V28, P1333; Lessig J, 2004, COMP BIOCHEM PHYS B, V137, P265, DOI 10.1016/j.cbpc.2003.12.001; Longo N, 2016, BBA-MOL CELL RES, V1863, P2422, DOI 10.1016/j.bbamcr.2016.01.023; Lu JC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146304; Mahony MC, 1999, BIOL REPROD, V60, P1239, DOI 10.1095/biolreprod60.5.1239; MANN T, 1974, J REPROD FERTIL, V37, P179, DOI 10.1530/jrf.0.0370179; Nimptsch A, 2014, LIPIDS, V49, P287, DOI 10.1007/s11745-013-3870-7; Paiva C, 2015, ANDROLOGY-US, V3, P496, DOI 10.1111/andr.12027; Partyka A, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/7279341; Pearson BL, 2018, EPIGENOMICS-UK, V10, P689, DOI 10.2217/epi-2018-0015; Pereira R, 2017, ASIAN J ANDROL, V19, P5, DOI 10.4103/1008-682X.167716; Pyttel S, 2014, THERIOGENOLOGY, V82, P396, DOI 10.1016/j.theriogenology.2014.04.017; Pyttel S, 2012, CHEM PHYS LIPIDS, V165, P861, DOI 10.1016/j.chemphyslip.2012.11.001; Qiao SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181115; RUBINSTEIN S, 1991, BIOCHEM J, V278, P25, DOI 10.1042/bj2780025; Schiller J, 2000, CHEM PHYS LIPIDS, V106, P145, DOI 10.1016/S0009-3084(00)00148-1; Schmidt JA, 2016, EUR J CLIN NUTR, V70, P306, DOI 10.1038/ejcn.2015.144; SHETTLES LB, 1960, FERTIL STERIL, V11, P88; Sidhu RS, 1998, INT J FERTIL WOMEN M, V43, P192; SILVESTRONI L, 1979, ARCH ANDROLOGY, V2, P257, DOI 10.3109/01485017908987322; TANIMURA J, 1967, Bulletin of the Osaka Medical School, V13, P84; Tanrikut C, 2010, FERTIL STERIL, V94, P1021, DOI 10.1016/j.fertnstert.2009.04.039; Tanrikut C, 2007, UROLOGY, V69, DOI 10.1016/j.urology.2006.10.034; Teuber K, 2011, ANIM REPROD SCI, V123, P270, DOI 10.1016/j.anireprosci.2011.01.009; Tut TG, 1997, J CLIN ENDOCR METAB, V82, P3777, DOI 10.1210/jc.82.11.3777; Vanella A, 1978, Acta Eur Fertil, V9, P99; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu GY, 2009, AMINO ACIDS, V37, P153, DOI 10.1007/s00726-008-0210-y; Zhang XL, 2015, CLIN CHIM ACTA, V450, P254, DOI 10.1016/j.cca.2015.09.001; Zhao K, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8327506; Zitzmann M, 2003, INT J ANDROL, V26, P76, DOI 10.1046/j.1365-2605.2003.00393.x; Zopfgen A, 2000, HUM REPROD, V15, P840, DOI 10.1093/humrep/15.4.840	61	36	36	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211679	10.1371/journal.pone.0211679	http://dx.doi.org/10.1371/journal.pone.0211679			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785892	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000035
J	Ghazal, S; Sauthier, M; Brossier, D; Bouachir, W; Jouvet, PA; Noumeir, R				Ghazal, Sam; Sauthier, Michael; Brossier, David; Bouachir, Wassim; Jouvet, Philippe A.; Noumeir, Rita			Using machine learning models to predict oxygen saturation following ventilator support adjustment in critically ill children: A single center pilot study	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; MECHANICAL VENTILATION; EQUILIBRATION	Background In an intensive care units, experts in mechanical ventilation are not continuously at patient's bedside to adjust ventilation settings and to analyze the impact of these adjustments on gas exchange. The development of clinical decision support systems analyzing patients' data in real time offers an opportunity to fill this gap. Objective The objective of this study was to determine whether a machine learning predictive model could be trained on a set of clinical data and used to predict transcutaneous hemoglobin oxygen saturation 5 min ((5min) SpO(2)) after a ventilator setting change. Data sources Data of mechanically ventilated children admitted between May 2015 and April 2017 were included and extracted from a high-resolution research database. More than 776,727 data rows were obtained from 610 patients, discretized into 3 class labels (< 84%, 85% to 91% and c92% to 100%). Performance metrics of predictive models Due to data imbalance, four different data balancing processes were applied. Then, two machine learning models (artificial neural network and Bootstrap aggregation of complex decision trees) were trained and tested on these four different balanced datasets. The best model predicted SpO(2) with area under the curves < 0.75. Conclusion This single center pilot study using machine learning predictive model resulted in an algorithm with poor accuracy. The comparison of machine learning models showed that bagged complex trees was a promising approach. However, there is a need to improve these models before incorporating them into a clinical decision support systems. One potentially solution for improving predictive model, would be to increase the amount of data available to limit over-fitting that is potentially one of the cause for poor classification performances for 2 of the three class labels.	[Ghazal, Sam; Noumeir, Rita] ETS, Dept Hlth Informat Anal, Montreal, PQ, Canada; [Sauthier, Michael; Brossier, David; Jouvet, Philippe A.] St Justine Hosp, Dept Pediat, Montreal, PQ, Canada; [Bouachir, Wassim] TELUQ Univ, LICEF Res Ctr, Montreal, PQ, Canada	University of Quebec; Ecole de Technologie Superieure - Canada; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Quebec; Universite TELUQ	Jouvet, PA (corresponding author), St Justine Hosp, Dept Pediat, Montreal, PQ, Canada.	philippe.jouvet@umontreal.ca	Jouvet, Philippe A/H-3293-2018	Jouvet, Philippe A/0000-0001-5684-3398; brossier, david/0000-0002-2059-9888	Natural Sciences and Engineering Research Council of Canada (NSERC); Institut de Valorisation des Donnees (IVADO); Fonds de Recherche du Quebec Sante (FRQS); Quebec Ministry of Health; Sainte Justine Hospital	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Institut de Valorisation des Donnees (IVADO); Fonds de Recherche du Quebec Sante (FRQS); Quebec Ministry of Health; Sainte Justine Hospital	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) to RN, by the Institut de Valorisation des Donnees (IVADO) to PAJ, by grants from the "Fonds de Recherche du Quebec Sante (FRQS)", the Quebec Ministry of Health and Sainte Justine Hospital to PAJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Mr. Redha Eltaani for his support in all tasks related to data access at Ste-Justine Hospital. This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC), by the Institut de Valorisation des Donnees (IVADO), by grants from the "Fonds de Recherche du Quebec-Sante (FRQS)", the Quebec Ministry of Health and Sainte Justine Hospital.	[Anonymous], 2000, REANIM URGENCES, V9, P407; Breiman Leo, 1994, BAGGING PREDICTORS, P421; Brossier D, 2018, PEDIATR CRIT CARE ME, V19, pE189, DOI 10.1097/PCC.0000000000001460; Cakar N, 2001, INTENS CARE MED, V27, P655, DOI 10.1007/s001340100900; Chandler JR, 2012, J CLIN MONIT COMPUT, V26, P145, DOI 10.1007/s10877-012-9347-z; Chawla N. V., 2004, P OCEAN DRILLING PRO, V6, P1, DOI [DOI 10.2973/ODP.PROC.IR.207.2004, DOI 10.1145/1007730.1007733]; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Elhassan T., 2016, GLOBAL J TECHNOL OPT, V1; Fildissis G, 2010, HEART LUNG, V39, P147, DOI 10.1016/j.hrtlng.2009.06.009; Flechelles O, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/943281; Fouzas S, 2011, PEDIATRICS, V128, P740, DOI 10.1542/peds.2011-0271; Girardis M, 2016, JAMA-J AM MED ASSOC, V316, P1583, DOI 10.1001/jama.2016.11993; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Johnson AEW, 2016, P IEEE, V104, P444, DOI 10.1109/JPROC.2015.2501978; Jouvet P, 2015, PEDIATR CRIT CARE ME, V16, P428, DOI 10.1097/PCC.0000000000000350; Jouvet P, 2012, CRIT CARE, V16, DOI 10.1186/cc11343; Jouvet P, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-51; Pannu SR, 2016, AM J RESP CRIT CARE, V193, P4, DOI 10.1164/rccm.201509-1810ED; Payen V, 2012, PEDIATR CRIT CARE ME, V13, P152, DOI 10.1097/PCC.0b013e3182257a24; Rose L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0755-6; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Salyer John W, 2003, Respir Care, V48, P386; Sheela KG, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/425740; Smallwood CD, 2018, CRIT CARE MED, V46, pE375, DOI 10.1097/CCM.0000000000003001; Sokolova M, 2009, INFORM PROCESS MANAG, V45, P427, DOI 10.1016/j.ipm.2009.03.002; Tugrul S, 2005, CRIT CARE MED, V33, P995, DOI 10.1097/01.CCM.0000163402.29767.7B	26	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0198921	10.1371/journal.pone.0198921	http://dx.doi.org/10.1371/journal.pone.0198921			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785881	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000459307000001
J	Oliveira, MM; Aragon, DC; Bomfim, VS; Trevilato, TMB; Alves, LG; Heck, AR; Martinez, FE; Camelo, JS				Oliveira, Mariana M.; Aragon, Davi C.; Bomfim, Vanessa S.; Trevilato, Tania M. B.; Alves, Larissa G.; Heck, Analia R.; Martinez, Francisco E.; Camelo, Jose S., Jr.			Development of a human milk concentrate with human milk lyophilizate for feeding very low birth weight preterm infants: A preclinical experimental study	PLOS ONE			English	Article							RAW HUMAN-MILK; NECROTIZING ENTEROCOLITIS; BREAST-MILK; TARGET FORTIFICATION; PREMATURE-INFANTS; VLBW INFANTS; NUTRITION; PROTEIN; OUTCOMES; ZINC	Breast milk is considered the gold standard nutritional resource for very low birth weight (VLBW) infants in terms of nutrients and protective factors. If mother's milk is not available, the second choice is donated and fortified human milk (HM) from the Human Milk Bank (HMB). This study hypothesized that HM could be lyophilized and used as an additive to increase the levels of macronutrients and micronutrients available to VLBW infants. This study aimed to constitute a lyophilized HM concentrate and determine the osmolality and the concentration of macronutrients and micronutrients in HM samples at "baseline" and in "HM concentrates", analyzed immediately (HMCI), and after 3 (HMC3m) and 6 (HMC6m) months of freezing. Osmolality was verified using the freezing point osmometric method. Macronutrient quantification was performed using the MIRIS Human Milk Analyzer. Micro nutrients were determined by Flame Atomic Absorption Spectrophotometry and by the automated colorimetric method. Bayesian linear mixed effect models were adjusted using OpenBUGS to estimate mean differences and 95% credibility intervals (Crl) of osmolality and of macro- and micronutrients between the types of HM samples. A comparison of dosage values showed a significant increase between HM baseline and HMCI, HMC3m, and HMC6m. Comparing HM baseline and HMCI highlighted the increase in energy content and the concentration of carbohydrates and total lipids. The Ca and P contents increased and the levels of energy, total lipids, and Cu were reduced in HMC3m compared to HMCI. Ca, Mg, K, Zn, and P increased and the levels of energy, total lipids, and Cu were reduced in HMC6m, compared to HMCI. The present study confirms the possibility of formulation and utilization of the immediate concentrate. Partial stability of HM concentrates generated from freeze-drying of donated milk do not recommend storage.	[Oliveira, Mariana M.; Aragon, Davi C.; Bomfim, Vanessa S.] Univ Sao Paulo, Ribeirao Preto Med Sch, Childrens Hosp, Dept Pediat, Ribeirao Preto, SP, Brazil; [Trevilato, Tania M. B.] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Hosp Ribeirao Preto, Pediat Lab, Ribeirao Preto, SP, Brazil; [Alves, Larissa G.; Heck, Analia R.] Clin Hosp Ribeirao Preto, Human Milk Bank, Ribeirao Preto, SP, Brazil; [Martinez, Francisco E.; Camelo, Jose S., Jr.] Univ Sao Paulo, Ribeirao Preto Med Sch, Childrens Hosp, Dept Pediat,Neonatol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Camelo, JS (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Childrens Hosp, Dept Pediat,Neonatol, Ribeirao Preto, SP, Brazil.	jscamelo@fmrp.usp.br	Aragon, Davi C/R-6604-2016; Camelo, José/AAL-4716-2020; Camelo, Jose S/G-3169-2012; Martinez, Francisco E/H-1194-2014	Aragon, Davi C/0000-0003-1019-3654; Martinez, Francisco E/0000-0002-6269-9182; Moraes de Oliveira, Mariana/0000-0001-7260-7299; Trevilato, Tania Maria Beltramini/0000-0003-1078-1237	Bill and Melinda Gates Foundation (Grand Challenges Brazil) [OPP1107597]; CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil [401612/2013-9]; Ministry of Health / Department of Science and Technology, Brazil	Bill and Melinda Gates Foundation (Grand Challenges Brazil); CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health / Department of Science and Technology, Brazil	The present study was supported by Bill and Melinda Gates Foundation (Grand Challenges Brazil), Grant #OPP1107597 to JSC Jr., CNPq-Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil, Grant #401612/2013-9 to JSC Jr., and Ministry of Health / Department of Science and Technology, Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiramalatha T, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012413.pub2; Abrams SA, 2014, BREASTFEED MED, V9, P281, DOI 10.1089/bfm.2014.0024; Agostoni C, 2010, J PEDIATR GASTR NUTR, V50, P85, DOI 10.1097/MPG.0b013e3181adaee0; Ahrabi AF, 2016, J PEDIATR-US, V177, P140, DOI 10.1016/j.jpeds.2016.06.024; Andreas NJ, 2015, EARLY HUM DEV, V91, P629, DOI 10.1016/j.earlhumdev.2015.08.013; Assad M, 2016, J PERINATOL, V36, P216, DOI 10.1038/jp.2015.168; Bertino E, 2013, EARLY HUM DEV, V89, pS3, DOI 10.1016/j.earlhumdev.2013.07.008; Bhatia J, 2013, J PEDIATR-US, V162, pS48, DOI 10.1016/j.jpeds.2012.11.053; Grazziotin MCB, 2016, J HUM LACT, V32, P446, DOI 10.1177/0890334416647710; Brown JVE, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000343.pub3; Carroll K, 2013, BREASTFEED MED, V8, P286, DOI 10.1089/bfm.2012.0068; Choi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148941; Colaizy TT, 2016, J PEDIATR-US, V175, P100, DOI 10.1016/j.jpeds.2016.03.040; Colaizy TT, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-124; Cortez J, 2018, J PERINATOL, V38, P71, DOI 10.1038/jp.2017.149; de Halleux V, 2013, AM J CLIN NUTR, V98, p529S, DOI 10.3945/ajcn.112.042689; Denning TW, 2017, SEMIN PERINATOL, V41, P15, DOI 10.1053/j.semperi.2016.09.014; Dritsakou K, 2016, J MATERN-FETAL NEO M, V29, P1131, DOI 10.3109/14767058.2015.1038232; Dutta S, 2015, NUTRIENTS, V7, P423, DOI 10.3390/nu7010423; Einloft PR, 2015, OSTEOPOROSIS INT, V26, P2265, DOI 10.1007/s00198-015-3144-8; Escuder-Vieco D, 2016, J HUM LACT, V32, pNP73, DOI 10.1177/0890334415591338; Fumeaux CJF, 2018, NEONATOLOGY, V113, P131, DOI 10.1159/000480535; Ganapathy V, 2012, BREASTFEED MED, V7, P29, DOI 10.1089/bfm.2011.0002; Gidrewicz DA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-216; Grance Thayana Regina de Souza, 2015, Rev. paul. pediatr., V33, P28, DOI 10.1016/j.rpped.2014.07.001; Haiden N, 2016, ANN NUTR METAB, V69, P8, DOI 10.1159/000452821; Hair AB, 2016, BREASTFEED MED, V11, P133, DOI 10.1089/bfm.2015.0166; Hair AB, 2016, BREASTFEED MED, V11, P70, DOI 10.1089/bfm.2015.0134; Hair AB, 2014, J PEDIATR-US, V165, P915, DOI 10.1016/j.jpeds.2014.07.005; Harding JE, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003310.pub2; Harding JE, 2017, LANCET, V389, P1660, DOI 10.1016/S0140-6736(17)30552-4; Hiltunen H, 2018, NEONATOLOGY, V113, P100, DOI 10.1159/000480633; Isemann B, 2016, JPEN-PARENTER ENTER, V40, P342, DOI 10.1177/0148607114558303; Kojima C, 2017, PEDIATR INT, V59, P1165, DOI 10.1111/ped.13409; Koletzko B, 2017, CLIN PERINATOL, V44, P85, DOI 10.1016/j.clp.2016.11.002; Koo W, 2018, JPEN-PARENTER ENTER, V42, P813, DOI 10.1177/0148607117713202; Kornmann MN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121318; Kreissl A, 2013, J PEDIATR GASTR NUTR, V57, P432, DOI 10.1097/MPG.0b013e3182a208c7; Kumar RK, 2017, FRONT NUTR, V4, DOI 10.3389/fnut.2017.00020; Lava SAG, 2015, PEDIATR NEPHROL, V30, P1389, DOI 10.1007/s00467-014-2931-3; Lewis ED, 2017, CLIN PERINATOL, V44, P23, DOI 10.1016/j.clp.2016.11.008; Lonnerdal B, 2017, CLIN PERINATOL, V44, P179, DOI 10.1016/j.clp.2016.11.013; Lozano B, 2014, INT J FOOD SCI NUTR, V65, P703, DOI 10.3109/09637486.2014.917154; Marquardt ML, 2012, PEDIATRICS, V130, pE695, DOI 10.1542/peds.2011-1295; McNelis K, 2017, CLIN PERINATOL, V44, P395, DOI 10.1016/j.clp.2017.01.012; Mohd-Taufek N, 2016, J PERINATOL, V36, P897, DOI 10.1038/jp.2016.88; Morlacchi L, 2018, AM J CLIN NUTR, V107, P195, DOI 10.1093/ajcn/nqx001; Patra K, 2017, NEONATOLOGY, V112, P330, DOI 10.1159/000475834; Peila C, 2017, J PEDIATR GASTR NUTR, V64, P353, DOI 10.1097/MPG.0000000000001435; Peila C, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080477; Perrella SL, 2015, J PEDIATR GASTR NUTR, V60, P264, DOI 10.1097/MPG.0000000000000596; Picaud JC, 2017, CLIN PERINATOL, V44, P95, DOI 10.1016/j.clp.2016.11.003; Raiten DJ, 2016, AM J CLIN NUTR, V103, p599S, DOI 10.3945/ajcn.115.124222; Rigo J, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101125; Rochow N, 2015, NUTRIENTS, V7, P2297, DOI 10.3390/nu7042297; Rochow N, 2013, J PEDIATR-US, V163, P1001, DOI 10.1016/j.jpeds.2013.04.052; Rosas R, 2016, ACTA PAEDIATR, V105, pE555, DOI 10.1111/apa.13522; Sammallahti S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185632; Schneider J, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-2169; Senterre T, 2015, J PEDIATR GASTR NUTR, V61, P491, DOI 10.1097/MPG.0000000000000854; Shulhan J, 2017, ADV NUTR, V8, P80, DOI 10.3945/an.116.013193; Sousa SG, 2014, FOOD CHEM, V151, P79, DOI 10.1016/j.foodchem.2013.11.024; Spiegler J, 2016, J PEDIATR-US, V169, P76, DOI 10.1016/j.jpeds.2015.10.080; Stephens BE, 2009, PEDIATRICS, V123, P1337, DOI 10.1542/peds.2008-0211; Sullivan S, 2010, J PEDIATR-US, V156, P562, DOI 10.1016/j.jpeds.2009.10.040; Terrin G, 2015, NUTRIENTS, V7, P10427, DOI 10.3390/nu7125542; Terrin G, 2013, AM J CLIN NUTR, V98, P1468, DOI 10.3945/ajcn.112.054478; Thomaz DMC, 2012, J PEDIAT-BRAZIL, V88, P119, DOI 10.2223/JPED.2166; Tudehope D, 2013, J PEDIATR-US, V162, pS72, DOI 10.1016/j.jpeds.2012.11.056; Cortez MV, 2016, BREASTFEED MED, V11, P551, DOI 10.1089/bfm.2016.0102; Valentine CJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030302; Walker A, 2010, J PEDIATR-US, V156, pS3, DOI 10.1016/j.jpeds.2009.11.021; Watson L, 2018, J PAEDIATR CHILD H, V54, P319, DOI 10.1111/jpc.13780; Westin V, 2018, CLIN NUTR ESPEN, V23, P245, DOI 10.1016/j.clnesp.2017.09.004	74	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210999	10.1371/journal.pone.0210999	http://dx.doi.org/10.1371/journal.pone.0210999			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785913	Green Submitted, gold, Green Published			2022-12-26	WOS:000459307000017
J	van Leeuwen, N; Walgaard, C; van Doorn, PA; Jacobs, BC; Steyerberg, EW; Lingsma, HF				van Leeuwen, Nikki; Walgaard, Christa; van Doorn, Pieter A.; Jacobs, Bart C.; Steyerberg, Ewout W.; Lingsma, Hester F.			Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barre syndrome	PLOS ONE			English	Article							COVARIATE ADJUSTMENT; BASE-LINE; LOGISTIC-REGRESSION; STATISTICAL POWER; SUBGROUP ANALYSIS; CLINICAL-TRIALS; OUTCOMES	Background Randomized controlled trials (RCTs) pose specific challenges in rare and heterogeneous neurological diseases due to the small numbers of patients and heterogeneity in disease course. Two analytical approaches have been proposed to optimally handle these issues in RCTs: covariate adjustment and ordinal analysis. We investigated the potential gain in efficiency of these approaches in rare and heterogeneous neurological diseases, using Guillain-Barre syndrome (GBS) as an example. Methods We analyzed two published GBS trials with primary outcome 'at least one grade improvement' on the GBS disability scale. We estimated the treatment effect using logistic regression models with and without adjustment for prognostic factors. The difference between the unadjusted and adjusted estimates was disentangled in imbalance (random differences in baseline covariates between treatment arms) and stratification (change of the estimate due to covariate adjustment). Second, we applied proportional odds regression, which exploits the ordinal nature of the GBS disability score. The standard error of the estimated treatment effect indicated the statistical efficiency. Results Both trials were slightly imbalanced with respect to baseline characteristics, which was corrected in the adjusted analysis. Covariate adjustment increased the estimated treatment effect in the two trials by 8% and 18% respectively. Proportional odds analysis resulted in lower standard errors indicating more statistical power. Conclusion Covariate adjustment and proportional odds analysis most efficiently use the available data and ensure balance between the treatment arms to obtain reliable and valid treatment effect estimates. These approaches merit application in future trials in rare and heterogeneous neurological diseases like GBS.	[van Leeuwen, Nikki; Steyerberg, Ewout W.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands; [Walgaard, Christa; van Doorn, Pieter A.; Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands; [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Steyerberg, Ewout W.] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van Leeuwen, N (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands.	n.vanleeuwen.1@erasmusmc.nl	Jacobs, Bart/ABE-2210-2021		Netherlands Organization for Health Research and Development; Prinses Beatrix Spierfonds; GBS-CIDP Foundation International; Grifols; Erasmus MC; Baxalta; CSLBehring; Annexon; Janivo Stichting; Sanquin Plasma Pharmaceuticals	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Prinses Beatrix Spierfonds; GBS-CIDP Foundation International; Grifols; Erasmus MC; Baxalta; CSLBehring; Annexon; Janivo Stichting; Sanquin Plasma Pharmaceuticals	BJ received unrestricted research support from the Netherlands Organization for Health Research and Development, Erasmus MC, Prinses Beatrix Spierfonds, GBS-CIDP Foundation International, Baxalta, CSLBehring, Grifols, and Annexon. PvD received unrestricted research support from the Prinses Beatrix Spierfonds, Janivo Stichting, Baxalta, Grifols, and Sanquin Plasma Pharmaceuticals. No other disclosures were reported.	Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Bath P, 2009, STROKE, V40, P888, DOI 10.1161/STROKEAHA.108.519207; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; BLAND JM, 1994, BRIT MED J, V309, P780, DOI 10.1136/bmj.309.6957.780; BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499; Garssen MPJ, 2007, J NEUROL NEUROSUR PS, V78, P1012, DOI 10.1136/jnnp.2006.102731; HAUCK WW, 1991, J CLIN EPIDEMIOL, V44, P77, DOI 10.1016/0895-4356(91)90203-L; Hernandez AV, 2006, J NEUROTRAUM, V23, P1295, DOI 10.1089/neu.2006.23.1295; Hernandez AV, 2004, J CLIN EPIDEMIOL, V57, P454, DOI 10.1016/j.jclinepi.2003.09.014; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; ROBINSON LD, 1991, INT STAT REV, V59, P227, DOI 10.2307/1403444; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Roozenbeek B, 2009, CRIT CARE MED, V37, P2683, DOI 10.1097/CCM.0b013e3181ab85ec; Saver JL, 2007, STROKE, V38, P3055, DOI 10.1161/STROKEAHA.107.488536; SENN S, 1993, STAT MED, V12, P2147, DOI 10.1002/sim.4780122208; Steyerberg EW, 2000, AM HEART J, V139, P745, DOI 10.1016/S0002-8703(00)90001-2; Thompson DD, 2015, J CLIN EPIDEMIOL, V68, P1068, DOI 10.1016/j.jclinepi.2014.11.001; Turner EL, 2012, J CLIN EPIDEMIOL, V65, P474, DOI 10.1016/j.jclinepi.2011.08.012; Valenta Z, 2006, STAT MED, V25, P4227, DOI 10.1002/sim.2678; van Koningsveld R, 2004, LANCET, V363, P192, DOI 10.1016/S0140-6736(03)15324-X; van Koningsveld R, 2007, LANCET NEUROL, V6, P589, DOI 10.1016/S1474-4422(07)70130-8; VANDERMECHE FGA, 1992, NEW ENGL J MED, V326, P1123, DOI 10.1056/NEJM199204233261705; Vickers AJ, 2001, BMJ-BRIT MED J, V323, P1123, DOI 10.1136/bmj.323.7321.1123; Walgaard C, 2011, NEUROLOGY, V76, P968, DOI 10.1212/WNL.0b013e3182104407	28	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211404	10.1371/journal.pone.0211404	http://dx.doi.org/10.1371/journal.pone.0211404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785890	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000024
J	Vitali, M; Sirri, R; Zappaterra, M; Zambonelli, P; Giannini, G; Lo Fiego, DP; Davoli, R				Vitali, Marika; Sirri, Rubina; Zappaterra, Martina; Zambonelli, Paolo; Giannini, Giulia; Lo Fiego, Domenico Pietro; Davoli, Roberta			Functional analysis finds differences on the muscle transcriptome of pigs fed an n-3 PUFA-enriched diet with or without antioxidant supplementations	PLOS ONE			English	Article							LONGISSIMUS-DORSI MUSCLE; RICH PLANT-PRODUCTS; GRAPE SEED EXTRACT; MEAT QUALITY; GENE-EXPRESSION; VITAMIN-E; GROWTH-PERFORMANCE; FATTY-ACIDS; OXIDATIVE STABILITY; RESVERATROL	Supplementing pig diets with n-3 polyunsaturated fatty acids (n-3 PUFA) may produce meat products with an increased n-3 fatty acid content, and the combined antioxidants addition could prevent lipid oxidation in the feed. However, to date, the effects of these bioactive compounds at the molecular level in porcine skeletal muscle are mostly unknown. This study aimed to analyse changes in the Longissimus thoracis transcriptome of 35 pigs fed three diets supplemented with: linseed (L); linseed, vitamin E and Selenium (LES) or linseed and plant-derived polyphenols (LPE). Pigs were reared from 80.8 +/- 5.6 kg to 151.8 +/- 9.9 kg. After slaughter, RNA-Seq was performed and 1182 differentially expressed genes (DEGs) were submitted to functional analysis. The L vs LES comparison did not show differences, while L vs LPE showed 1102 DEGs and LES vs LPE 80 DEGs. LPE compared to the other groups showed the highest number of up-regulated genes involved in preserving muscle metabolism and structure. Results enlighten that the combined supplementation of bioactive lipids (n-3 PUFA from linseed) with plant extracts as a source of polyphenols increases, compared to the only addition of linseed, the expression of genes involved in mRNA metabolic processes and transcriptional regulation, glucose uptake and, finally, in supporting muscle development and physiology. These results improve the knowledge of the biological effect of bioactive compounds in Longissimus thoracis muscle, and sustain the growing interest over their use in pig production.	[Vitali, Marika; Sirri, Rubina; Zambonelli, Paolo; Davoli, Roberta] Univ Bologna, Interdept Ctr Ind Agrifood Res CIRI AGRO, Cesena, Italy; [Zappaterra, Martina; Zambonelli, Paolo; Giannini, Giulia; Davoli, Roberta] Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy; [Lo Fiego, Domenico Pietro] Univ Modena & Reggio Emilia, Dept Life Sci, Reggio Emilia, Italy; [Lo Fiego, Domenico Pietro] Univ Modena & Reggio Emilia, Interdept Res Ctr Agri Food Biol Resources Improv, Reggio Emilia, Italy	University of Bologna; University of Bologna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia	Davoli, R (corresponding author), Univ Bologna, Interdept Ctr Ind Agrifood Res CIRI AGRO, Cesena, Italy.; Davoli, R (corresponding author), Univ Bologna, Dept Agr & Food Sci DISTAL, Bologna, Italy.	roberta.davoli@unibo.it	Vitali, Marika/P-5927-2019; Sirri, Rubina/O-3903-2019; Zambonelli, Paolo/N-3084-2014; Lo Fiego, Domenico Pietro/H-4811-2013	Vitali, Marika/0000-0002-8373-0898; Zambonelli, Paolo/0000-0002-2532-5528; Lo Fiego, Domenico Pietro/0000-0002-9154-9888; Sirri, Rubina/0000-0002-8603-8418; Zappaterra, Martina/0000-0001-5085-4811; DAVOLI, ROBERTA/0000-0003-4600-8326	Regione Emilia-Romagna POR-FESR [PG/2015/730542]	Regione Emilia-Romagna POR-FESR(Regione Emilia Romagna)	This research was funded by Regione Emilia-Romagna POR-FESR 2014-2020 (URL: https://fesr.regione.emilia-romagna.it/) "Innovare la filiera suina mediante la valorizzazione di sottoprodotti vegetali e l'impiego di avanzate tecnologie "omiche" e di processo, per la produzione sostenibile di carne e salumi ad impatto positivo sulla salute"- Green Charcuterie grant n. PG/2015/730542. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding was received by RD.	Ahmetov II, 2015, ADV CLIN CHEM, V70, P247, DOI 10.1016/bs.acc.2015.03.003; Andersen HJ, 2005, MEAT SCI, V70, P543, DOI 10.1016/j.meatsci.2004.07.015; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Azorin-Ortuno M, 2012, J NUTR BIOCHEM, V23, P829, DOI 10.1016/j.jnutbio.2011.04.007; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; BUCKLEY DJ, 1995, J ANIM SCI, V73, P3122; Calder PC, 2018, P NUTR SOC, V77, P52, DOI [10.1017/S0029665117003950, 10.1017/s0029665117003950]; Calviello G, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/743171; Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003; Cimmino R, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1513-1; Collins JF, 2004, PFLUG ARCH EUR J PHY, V447, P647, DOI 10.1007/s00424-003-1088-x; Corino C, 2008, J ANIM SCI, V86, P1850, DOI 10.2527/jas.2007-0155; Daleprane JB, 2012, J NUTR, V142, P441, DOI 10.3945/jn.111.150706; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; De Groote D, 2012, ANN NUTR METAB, V61, P15, DOI 10.1159/000338634; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dugdale HF, 2018, MOL CELL BIOCHEM, V444, P109, DOI 10.1007/s11010-017-3236-1; Duriez C, 2002, GENE, V282, P207, DOI 10.1016/S0378-1119(01)00825-3; El Akoum S., 2014, ENDOCRINOL METAB SYN, V3, P2161, DOI [10.4172/2161-1017.1000126, DOI 10.4172/2161-1017.1000126]; Fiesel A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0196-5; Fletcher LM, 2000, BIOCHEM J, V352, P267, DOI 10.1042/0264-6021:3520267; Gessner DK, 2017, J ANIM PHYSIOL AN N, V101, pe185, DOI 10.1111/jpn.12586; Guo B, 2017, WOODHEAD PUBL FOOD S, P259, DOI 10.1016/B978-0-08-100593-4.00012-6; Gutierrez-Salmean G, 2014, J NUTR BIOCHEM, V25, P91, DOI 10.1016/j.jnutbio.2013.09.007; Han XZ, 2007, INT J MOL SCI, V8, P950, DOI 10.3390/i8090950; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Huang L, 2007, GENESIS, V45, P487, DOI 10.1002/dvg.20319; Huguet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003043; Hussain T, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/7432797; Jakobek L, 2015, FOOD CHEM, V175, P556, DOI 10.1016/j.foodchem.2014.12.013; Jeromson S, 2015, MAR DRUGS, V13, P6977, DOI 10.3390/md13116977; JIANG H, 2010, DIETARY POLYPHENOLS, P325, DOI DOI 10.1007/978-1-4419-0410-2_16; Juang H-H, 2013, EUR UROL SUPPL, V12, pe148; Kaminski J, 2012, J FOOD DRUG ANAL, V20, P398; Kashani Arash, 2015, Journal of Animal Science and Technology, V57, P8, DOI 10.1186/s40781-015-0047-3; Kawabata S, 2015, FEBS LETT, V589, P3679, DOI 10.1016/j.febslet.2015.10.013; Kawecka M, 2013, ACTA AGR SCAND A-AN, V63, P194, DOI 10.1080/09064702.2014.922607; Kim Y., 2016, NUTRIENTS, P8; Lahucky R, 2005, CZECH J ANIM SCI, V50, P175, DOI 10.17221/4012-CJAS; Lamy S, 2012, EXP CELL RES, V318, P1586, DOI 10.1016/j.yexcr.2012.04.004; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lipinski K, 2017, ANN ANIM SCI, V17, P41, DOI 10.1515/aoas-2016-0042; Liu F, 2016, EXP PHYSIOL, V101, P801, DOI 10.1113/EP085746; Lo Fiego DP, 2010, ITAL J ANIM SCI, V9, P200, DOI 10.4081/ijas.2010.e39; Lu JM, 2009, CARCINOGENESIS, V30, P636, DOI 10.1093/carcin/bgp009; Ma XY, 2016, CRIT REV FOOD SCI, V56, P858, DOI 10.1080/10408398.2013.850059; Mapiye C, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-54; Markus MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028926; Marouli E, 2016, NUTR METAB CARDIOVAS, V26, P201, DOI 10.1016/j.numecd.2015.10.003; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mika D, 2014, J CELL SCI, V127, P1033, DOI 10.1242/jcs.140251; Mo XY, 2011, MOL BIOL REP, V38, P4389, DOI 10.1007/s11033-010-0566-4; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Morel PCH, 2013, MEAT SCI, V95, P151, DOI 10.1016/j.meatsci.2013.04.047; Niculita Petru, 2007, Polish Journal of Food and Nutrition Sciences, V57, P125; Oczkowicz M, 2016, ANN ANIM SCI, V16, P1073, DOI 10.1515/aoas-2016-0033; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Park JC, 2012, ASIAN AUSTRAL J ANIM, V25, P1759, DOI 10.5713/ajas.2012.12416; Peoples GE, 2014, BRIT J NUTR, V111, P996, DOI 10.1017/S0007114513003449; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Pieszka M, 2017, MEAT SCI, V126, P1, DOI 10.1016/j.meatsci.2016.11.016; Qiu HF, 2010, MOL BIOL REP, V37, P629, DOI 10.1007/s11033-009-9882-y; Ramayo-Caldas Y, 2018, SCI REP, V8, P1, DOI [10.1038/241598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Ravi S, 2015, J NUTR, V145, P841, DOI 10.3945/jn.114.203216; Robichon C, 2006, BBA-MOL CELL BIOL L, V1761, P1107, DOI 10.1016/j.bbalip.2006.07.007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rossi R, 2014, FOOD RES INT, V65, P88, DOI 10.1016/j.foodres.2014.03.062; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sayem AM, 2018, MOLECULES, V23, DOI 10.3390/molecules23020258; Smith GI, 2015, AM J CLIN NUTR, V102, P115, DOI 10.3945/ajcn.114.105833; Stankus T, 2009, J AGRIC FOOD INF, V10, P37, DOI 10.1080/10496500802690544; Supruniuk E, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00923; Surai P.F., 2016, J ANIM RES NUTR, V1, P8, DOI [10.21767/2572-5459.100008, DOI 10.21767/2572-5459.100008]; Szostak A, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0517-4; Taipale M, 2014, CELL, V158, P434, DOI 10.1016/j.cell.2014.05.039; Tarazona S, 2015, NUCLEIC ACIDS RES, V43, P1; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Vlavcheski F, 2017, MOLECULES, V22, DOI 10.3390/molecules22101669; Walsh TG, 2015, PLATELETS, V26, P199, DOI 10.3109/09537104.2014.909022; Wang Y, 2012, FOOD RES INT, V46, P460, DOI 10.1016/j.foodres.2011.08.019; Wood JD, 2004, MEAT SCI, V66, P21, DOI 10.1016/S0309-1740(03)00022-6; Zappaterra M, 2016, MEAT SCI, V121, P27, DOI 10.1016/j.meatsci.2016.05.007; Zhang C, 2015, MEAT SCI, V102, P15, DOI 10.1016/j.meatsci.2014.11.014; 2003, DIET NUTR PREV REP J, V916, P1	88	5	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212449	10.1371/journal.pone.0212449	http://dx.doi.org/10.1371/journal.pone.0212449			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785965	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000062
J	Gasmi, S; Ogden, NH; Ripoche, M; Leighton, PA; Lindsay, RL; Nelder, MP; Rees, E; Bouchard, C; Vrbova, L; Rusk, R; Russell, C; Pelcat, Y; Mechai, S; Kotchi, SO; Koffi, JK				Gasmi, Salima; Ogden, Nicholas H.; Ripoche, Marion; Leighton, Patrick A.; Lindsay, Robbin L.; Nelder, Mark P.; Rees, Erin; Bouchard, Catherine; Vrbova, Linda; Rusk, Richard; Russell, Curtis; Pelcat, Yann; Mechai, Samir; Kotchi, Serge-Olivier; Koffi, Jules K.			Detection of municipalities at-risk of Lyme disease using passive surveillance of Ixodes scapularis as an early signal: A province-specific indicator in Canada	PLOS ONE			English	Article							BORRELIA-BURGDORFERI; GEOGRAPHIC-DISTRIBUTION; TICKS; AGENT; SOUTHEASTERN; ABUNDANCE; DENSITY; HABITAT; NYMPHS; ACARI	Lyme disease, the most commonly reported vector-borne disease in North America, is caused by the spirochete Borrelia burgdorferi sensu stricto, which is transmitted by Ixodes scapularis in eastern Canada and Ixodes pacificus in western Canada. Recently, the northward range expansion of I. scapularis ticks, in south-eastern Canada, has resulted in a dramatic increase in the incidence of human Lyme disease. Detecting emerging areas of Lyme disease risk allows public health to target disease prevention efforts. We analysed passive tick surveillance data from Ontario and Manitoba to i) assess the relationship between the total numbers of I. scapularis submissions in passive surveillance from humans, and the number of human Lyme disease cases, and ii) develop province-specific acarological indicators of risk that can be used to generate surveillance-based risk maps. We also assessed associations between numbers of nymphal I. scapularis tick submissions only and Lyme disease case incidence. Using General Estimating Equation regression, the relationship between I. scapularis submissions (total numbers and numbers of nymphs only) in each census sub-division (CSD) and the number of reported Lyme disease cases was positively correlated and highly significant in the two provinces (P <= 0.001). The numbers of I. scapularis submissions over five years discriminated CSDs with >= 3 Lyme disease cases from those with < 3 cases with high accuracy when using total numbers of tick submission (Receiver Operating Characteristics area under the curve [AUC] = 0.89) and moderate accuracy (AUC = 0.78) when using nymphal tick submissions only. In Ontario the optimal cut-off point was a total 12 tick submissions from a CSD over five years (Sensitivity = 0.82, Specificity = 0.84), while in Manitoba the cut-off point was five ticks (Sensitivity = 0.71, Specificity = 0.79) suggesting regional variability of the risk of acquiring Lyme disease from an I. scapularis bite. The performances of the acarological indicators developed in this study for Ontario and Manitoba support the ability of passive tick surveillance to provide an early signal of the existence Lyme disease risk areas in regions where ticks and the pathogens they transmit are expanding their range.	[Gasmi, Salima; Koffi, Jules K.] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Policy Integrat & Zoonoses Div, St Hyacinthe, PQ, Canada; [Gasmi, Salima; Ogden, Nicholas H.; Ripoche, Marion; Leighton, Patrick A.; Rees, Erin; Bouchard, Catherine; Pelcat, Yann; Mechai, Samir; Kotchi, Serge-Olivier; Koffi, Jules K.] Univ Montreal, Fac Vet Med, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada; [Ogden, Nicholas H.; Bouchard, Catherine; Pelcat, Yann; Mechai, Samir; Kotchi, Serge-Olivier] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, St Hyacinthe, PQ, Canada; [Ripoche, Marion; Leighton, Patrick A.; Rees, Erin] Univ Montreal, Fac Vet Med, Dept Pathol & Microbiol, St Hyacinthe, PQ, Canada; [Lindsay, Robbin L.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens Div, Winnipeg, MB, Canada; [Nelder, Mark P.; Russell, Curtis] Publ Hlth Ontario, Communicable Dis Emergency Preparedness & Respons, Enter Zoonot & Vector Borne Dis, Toronto, ON, Canada; [Vrbova, Linda] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Toronto, ON, Canada; [Rusk, Richard] Manitoba Hlth Seniors & Act Living, Act Living Indigenous Relat Populat & Publ Hlth D, Communicable Dis Control Branch, Winnipeg, MB, Canada	Public Health Agency of Canada; Universite de Montreal; Public Health Agency of Canada; Universite de Montreal; Public Health Agency of Canada; Public Health Agency of Canada	Gasmi, S (corresponding author), Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Policy Integrat & Zoonoses Div, St Hyacinthe, PQ, Canada.; Gasmi, S (corresponding author), Univ Montreal, Fac Vet Med, Grp Rech Epidemiol Zoonoses & Sante Publ, St Hyacinthe, PQ, Canada.	salima.gasmi@canada.ca	Kotchi, Serge Olivier/R-2237-2019	Kotchi, Serge Olivier/0000-0002-4931-1489; Mechai, Sam/0000-0001-9979-5525	Public Health Agency of Canada	Public Health Agency of Canada	This study was funded by Public Health Agency of Canada.	Adam-Poupart A, 2016, SURVEILLANCE MALADIE; Aenishaenslin C, 2017, TICKS TICK-BORNE DIS, V8, P112, DOI 10.1016/j.ttbdis.2016.10.006; [Anonymous], 2009, CAS DEF COMM DIS NAT; [Anonymous], 2018, EST RISK AR; [Anonymous], 2018, RISK LYM DIS CAN; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Bouchard C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-195; Brownstein JS, 2005, OECOLOGIA, V146, P469, DOI 10.1007/s00442-005-0251-9; Caraguel CGB, 2011, J VET DIAGN INVEST, V23, P2, DOI 10.1177/104063871102300102; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P590; Clow KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189393; Cull B, 2018, TICKS TICK-BORNE DIS, V9, P605, DOI 10.1016/j.ttbdis.2018.01.011; Dibernardo A, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-183; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Diuk-Wasser MA, 2012, AM J TROP MED HYG, V86, P320, DOI 10.4269/ajtmh.2012.11-0395; Diuk-Wasser MA, 2010, GLOBAL ECOL BIOGEOGR, V19, P504, DOI 10.1111/j.1466-8238.2010.00526.x; Dohoo I., 2009, VET EPIDEMIOLOGIC RE; Ebi KL, 2018, ENVIRON RES LETT, V13, DOI 10.1088/1748-9326/aac4bd; Eisen L, 2016, J MED ENTOMOL, V53, P1050, DOI 10.1093/jme/tjw092; Falco RC, 1996, AM J EPIDEMIOL, V143, P187, DOI 10.1093/oxfordjournals.aje.a008728; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gabriele-Rivet V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131282; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Gasmi S, 2017, Can Commun Dis Rep, V43, P194, DOI 10.14745/ccdr.v43i10a01; Gasmi S, 2016, TICKS TICK-BORNE DIS, V7, P1075, DOI 10.1016/j.ttbdis.2016.09.006; Hanincova K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073066; Hardin J.W., 2005, ENCY STAT BEHAV SCI, DOI 10.1002/0470013192.bsa250; Institut national de sante publique du Quebec, 2018, RAPPORT SURVEILLANCE; Johnson JL, 2004, VECTOR-BORNE ZOONOT, V4, P137, DOI 10.1089/1530366041210710; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; Leighton PA, 2012, J APPL ECOL, V49, P457, DOI 10.1111/j.1365-2664.2012.02112.x; Lindsay LR, 1999, J MED ENTOMOL, V36, P243, DOI 10.1093/jmedent/36.3.243; Mather TN, 1996, AM J EPIDEMIOL, V144, P1066, DOI 10.1093/oxfordjournals.aje.a008879; Mechai S, 2015, APPL ENVIRON MICROB, V81, P1309, DOI 10.1128/AEM.03730-14; Naleway AL, 2002, AM J EPIDEMIOL, V155, P1120, DOI 10.1093/aje/155.12.1120; Nelder MP, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1529-y; Nelder MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105358; Ogden NH, 2006, J MED ENTOMOL, V43, P600, DOI 10.1603/0022-2585(2006)43[600:ISTCBP]2.0.CO;2; Ogden N H, 2014, Can Commun Dis Rep, V40, P74; Ogden NH, 2006, J MED ENTOMOL, V43, P403, DOI 10.1603/0022-2585(2006)043[0403:IOGLAR]2.0.CO;2; Ogden NH, 2018, J MED ENTOMOL, V55, P1386, DOI 10.1093/jme/tjy104; Ogden NH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171731; Ogden NH, 2013, J APPL ECOL, V50, P510, DOI [10.1111/1365-2664.12050, 10.1111/]; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2017, VECT BORN DIS 2016 S; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2015, VECT BORN DIS 2014 S; Pepin KM, 2012, AM J TROP MED HYG, V86, P1062, DOI 10.4269/ajtmh.2012.11-0630; Rand PW, 2007, J MED ENTOMOL, V44, P1118, DOI 10.1603/0022-2585(2007)44[1118:PSIMAA]2.0.CO;2; Reichenheim ME, 2002, STATA J, V2, P351, DOI 10.1177/1536867X0200200402; Ripoche M, 2018, J MED ENTOMOL, V55, P1016, DOI 10.1093/jme/tjy030; Simon JA, 2014, EVOL APPL, V7, P750, DOI 10.1111/eva.12165; Stafford KC, 1998, J CLIN MICROBIOL, V36, P1240, DOI 10.1128/JCM.36.5.1240-1244.1998; STEVENS JP, 1984, PSYCHOL BULL, V95, P334, DOI 10.1037/0033-2909.95.2.334; Tack W, 2011, EXP APPL ACAROL, V54, P285, DOI 10.1007/s10493-011-9444-6; Walker ED, 1998, J MED ENTOMOL, V35, P872, DOI 10.1093/jmedent/35.5.872; Walter KS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0834; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Xu G, 2016, VECTOR-BORNE ZOONOT, V16, P520, DOI 10.1089/vbz.2015.1912	59	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212637	10.1371/journal.pone.0212637	http://dx.doi.org/10.1371/journal.pone.0212637			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779789	gold, Green Published, Green Submitted			2022-12-26	WOS:000459062900068
J	Ohwada, T; Sakamoto, T; Kanno, Y; Yokokawa, S; Amami, K; Nakazato, K; Takeishi, Y; Watanabe, K				Ohwada, Takayuki; Sakamoto, Takayuki; Kanno, Yuki; Yokokawa, Sayoko; Amami, Kazuaki; Nakazato, Kazuhiko; Takeishi, Yasuchika; Watanabe, Kenichi			Apolipoprotein B correlates with intra-plaque necrotic core volume in stable coronary artery disease	PLOS ONE			English	Article							C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; VIRTUAL HISTOLOGY; INTRAVASCULAR ULTRASOUND; ANGINA-PECTORIS; 52 COUNTRIES; A-I; LIPOPROTEINS; CHOLESTEROL; INTERHEART	Objective To determine the relationship between plaque composition and low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), apolipoprotein B (Apo-B), and Apo-A1 using virtual-histology intravascular ultrasound (VH-IVUS). Methods We assessed plaque composition in patients with stable coronary artery disease (SCD) admitted to our hospital for percutaneous coronary intervention (PCI) between November 1, 2012, and March 10, 2015. Before PCI, fibrous (FI), fibrofatty (FF), necrotic core (NC), and dense calcium (DC) regions were evaluated using VH-IVUS, and the contributions of each to the culprit lesion volume were recorded. Plasma LDL-C, HDL-C, Apo-B, and Apo-A1 levels were assessed before PCI. The relationship between the regions on VH-IVUS and plasma lipid levels was assessed. Patients were categorized into low Apo-B (LAB) and high Apo-B (HAB) groups, based on the overall cohort median Apo-B level. Results We enrolled 115 patients (median Apo-B, 91 mg/dL, male n = 88) with 57 and 58 patients in the LAB (Apo-B <= 90 mg/dL) and HAB (Apo-B >= 91 mg/dL) groups, respectively. Vessel, plaque, and %NC volumes were significantly greater in the HAB group than in the LAB group. The %FI, %FF, and %DC volumes were similar in both groups. In all 115 patients, the %NC volume correlated with LDL-C (r = 0.2353, P = 0.0114) and Apo-B (r = 0.2487, P = 0.0074) but not with HDL-C and Apo A-1. The high-sensitivity C-reactive protein level tended to be higher in the HAB group than in the LAB group. Multiple regression analysis showed that being male, Apo-A1, and Apo-B were significant predictors of %NC volume extent. Conclusions Elevated Apo-B level was related to the %NC in target coronary artery lesions in SCD patients, suggesting a role of Apo-B as a biomarker of unstable plaque in this population.	[Ohwada, Takayuki; Sakamoto, Takayuki; Watanabe, Kenichi] Fukushima Red Cross Hosp, Dept Cardiol, Fukushima, Japan; [Kanno, Yuki; Yokokawa, Sayoko; Amami, Kazuaki; Nakazato, Kazuhiko; Takeishi, Yasuchika] Fukushima Med Univ, Dept Cardiol, Fukushima, Japan	Fukushima Medical University	Ohwada, T (corresponding author), Fukushima Red Cross Hosp, Dept Cardiol, Fukushima, Japan.	ikyoku18@fukushima-med-jrc.jp		Ohwada, Takayuki/0000-0003-1515-6377				Campos CM, 2015, EUR HEART J-CARD IMG, V16, P1112, DOI 10.1093/ehjci/jev039; Cheng JM, 2014, AM J CARDIOL, V114, P1497, DOI 10.1016/j.amjcard.2014.08.013; Contois JH, 2009, CLIN CHEM, V55, P407, DOI 10.1373/clinchem.2008.118356; Fuchs M, 2017, J CARDIOVASC SURG, V58, P55, DOI 10.23736/S0021-9509.16.07655-2; Fujiwara H, 2013, CIRC J, V77, P1590, DOI 10.1253/circj.CJ-66-0065; Garcia-Garcia HM, 2011, INT J CARDIOVAS IMAG, V27, P215, DOI 10.1007/s10554-010-9789-7; Golshahi Jafar, 2014, Adv Biomed Res, V3, P192, DOI 10.4103/2277-9175.140624; Hiruta N, 2013, INT HEART J, V54, P68, DOI 10.1536/ihj.54.68; Ko YG, 2012, YONSEI MED J, V53, P508, DOI 10.3349/ymj.2012.53.3.508; Koskinas KC, 2016, ATHEROSCLEROSIS, V247, P154, DOI 10.1016/j.atherosclerosis.2016.02.015; Kubo T, 2009, CORONARY ARTERY DIS, V20, P531, DOI 10.1097/MCA.0b013e328332a6b0; MCGILL DA, 1993, CORONARY ARTERY DIS, V4, P261, DOI 10.1097/00019501-199303000-00006; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Moss AJ, 1999, CIRCULATION, V99, P2517, DOI 10.1161/01.CIR.99.19.2517; Nair Anuja, 2007, EuroIntervention, V3, P113; Park JP, 2010, CIRC J, V74, P332, DOI 10.1253/circj.CJ-09-0570; Puri R, 2014, EUR HEART J-CARD IMG, V15, P380, DOI 10.1093/ehjci/jet251; Raber L, 2015, EUR HEART J, V36, P490, DOI 10.1093/eurheartj/ehu373; Ramjee V, 2011, J AM COLL CARDIOL, V58, P457, DOI 10.1016/j.jacc.2011.05.009; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Ruotolo G, 1998, J AM COLL CARDIOL, V32, P1648, DOI 10.1016/S0735-1097(98)00442-2; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Walldius G, 2001, LANCET, V358, P2026, DOI 10.1016/S0140-6736(01)07098-2; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212539	10.1371/journal.pone.0212539	http://dx.doi.org/10.1371/journal.pone.0212539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779793	Green Published, Green Submitted, gold			2022-12-26	WOS:000459062900064
J	Takeuchi, F; Ikeda, S; Tsukamoto, Y; Iwasawa, Y; Chen, QH; Otakaki, Y; Ryota, O; Yao, WL; Narita, R; Makoto, H; Watashi, K; Wakita, T; Takeuchi, K; Chayama, K; Kogure, A; Kato, H; Fujita, T				Takeuchi, Fumihiko; Ikeda, Sotaro; Tsukamoto, Yuta; Iwasawa, Yoshikazu; Chen Qihao; Otakaki, Yukie; Ryota, Ouda; Yao, Wan-Ling; Narita, Ryo; Makoto, Hijikata; Watashi, Koichi; Wakita, Takaji; Takeuchi, Koh; Chayama, Kazuaki; Kogure, Amane; Kato, Hiroki; Fujita, Takashi			Screening for inhibitor of episomal DNA identified dicumarol as a hepatitis B virus inhibitor	PLOS ONE			English	Article							CLOSED CIRCULAR DNA; HBV; ANTIGEN; REPLICATION; EXPRESSION; PREVENTION; THERAPY; ANALOGS; CCCDNA; CELLS	Currently, there is no available therapy to eradicate hepatitis B virus (HBV) in chronically infected individuals. This is due to the difficulty in eliminating viral covalently closed circular (ccc) DNA, which is central to the gene expression and replication of HBV. We developed an assay system for nuclear circular DNA using an integration-deficient lentiviral vector. This vector produced non-integrated circular DNA in nuclei of infected cells. We engineered this vector to encode firefly luciferase to monitor the lentiviral episome DNA. We screened 3,840 chemicals by this assay for luciferase-reducing activity and identified dicumarol, which is known to have anticoagulation activity. We confirmed that dicumarol reduced lentiviral episome DNA. Furthermore, dicumarol inhibited HBV replication in cell culture using NTCP-expressing HepG2 and primary human hepatocytes. Dicumarol reduced intracellular HBV RNA, DNA, supernatant HBV antigens and DNA. We also found that dicumarol reduced the cccDNA level in HBV infected cells, but did not affect HBV adsorption/entry. This is a novel assay system for screening inhibitors targeting nuclear cccDNA and is useful for finding new antiviral substances for HBV.	[Takeuchi, Fumihiko; Ikeda, Sotaro; Iwasawa, Yoshikazu; Chen Qihao; Otakaki, Yukie; Yao, Wan-Ling; Makoto, Hijikata; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan; [Takeuchi, Fumihiko; Ikeda, Sotaro; Tsukamoto, Yuta; Iwasawa, Yoshikazu; Chen Qihao; Otakaki, Yukie; Ryota, Ouda; Yao, Wan-Ling; Narita, Ryo; Makoto, Hijikata; Kogure, Amane; Kato, Hiroki; Fujita, Takashi] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Kyoto, Japan; [Tsukamoto, Yuta; Kato, Hiroki] Univ Hosp Bonn, Inst Cardiovasc Immunol, Bonn, Germany; [Ryota, Ouda] Hokkaido Univ, Fac Med, Dept Immunol, Sapporo, Hokkaido, Japan; [Ryota, Ouda] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Narita, Ryo] Aarhus Univ, Dept Mol Biol & Genet, Ctr Struct Biol, Aarhus, Denmark; [Watashi, Koichi; Wakita, Takaji] Natl Inst Infect Dis, Dept Virol 2, Tokyo, Japan; [Watashi, Koichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba, Japan; [Watashi, Koichi] Japan Sci & Technol Agcy JST, CREST, Saitama, Japan; [Takeuchi, Koh] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo, Japan; [Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan	Kyoto University; Kyoto University; University of Bonn; Hokkaido University; Hokkaido University; Aarhus University; National Institute of Infectious Diseases (NIID); Tokyo University of Science; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University	Fujita, T (corresponding author), Kyoto Univ, Grad Sch Biostudies, Kyoto, Japan.; Fujita, T (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Kyoto, Japan.	tfujita@infront.kyoto-u.ac.jp	Ouda, Ryota/P-9681-2019; Takeuchi, Koh/B-4971-2010	Takeuchi, Koh/0000-0002-6227-4627; YAO, WAN-LING/0000-0001-6193-9247; Chayama, Kazuaki/0000-0002-5530-5341; TSUKAMOTO, Yuta/0000-0002-0773-7190	Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) for Program on the Innovative Development and the Application of New Drugs for Hepatitis B [JP18fk0310107h0002, JP18fk0310109h0002]	Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) for Program on the Innovative Development and the Application of New Drugs for Hepatitis B(Japan Agency for Medical Research and Development (AMED))	The work was supported by The Ministry of Health, Labour and Welfare/Japan Agency for Medical Research and Development (AMED) for Program on the Innovative Development and the Application of New Drugs for Hepatitis B, Grant number: JP18fk0310107h0002 to TF and JP18fk0310109h0002 to KC and HK (URL: https://www.amed.go.jp/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baran B, 2015, WORLD J HEPATOL, V7, P1742, DOI 10.4254/wjh.v7.i13.1742; BEASLEY RP, 1983, LANCET, V2, P1099; BROWN PO, 1987, CELL, V49, P347, DOI 10.1016/0092-8674(87)90287-X; BUKRINSKY MI, 1991, SCIENCE, V254, P423, DOI 10.1126/science.1925601; Cai DW, 2012, ANTIMICROB AGENTS CH, V56, P4277, DOI 10.1128/AAC.00473-12; DANE DS, 1970, LANCET, V1, P695; Durantel D, 2016, J HEPATOL, V64, pS117, DOI 10.1016/j.jhep.2016.02.016; Faure-Dupuy S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050095; Guo H, 2017, METHODS MOL BIOL, V1540, P1, DOI 10.1007/978-1-4939-6700-1; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Honda M, 2016, J INFECT DIS, V213, P1096, DOI 10.1093/infdis/jiv572; Ishida Y, 2015, AM J PATHOL, V185, P1275, DOI 10.1016/j.ajpath.2015.01.028; Kramvis A, 2008, J MED VIROL, V80, P27, DOI 10.1002/jmv.21049; Kumar R, 2016, LIVER INT, V36, P72, DOI 10.1111/liv.13001; Ladner SK, 1997, ANTIMICROB AGENTS CH, V41, P1715, DOI 10.1128/AAC.41.8.1715; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Levrero M, 2016, CURR OPIN VIROL, V18, P135, DOI 10.1016/j.coviro.2016.06.003; Lucifora J, 2016, J HEPATOL, V64, pS41, DOI 10.1016/j.jhep.2016.02.009; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Madari H, 2003, CANCER RES, V63, P1214; Norder H, 2004, INTERVIROLOGY, V47, P289, DOI 10.1159/000080872; Ogura N, 2014, BIOCHEM BIOPH RES CO, V452, P315, DOI 10.1016/j.bbrc.2014.08.029; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Tie JK, 2011, BLOOD, V117, P2967, DOI 10.1182/blood-2010-08-304303; Tsukamoto Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197664; Urban S, 2014, GASTROENTEROLOGY, V147, P48, DOI 10.1053/j.gastro.2014.04.030; Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892; WHO, 2015, HEP B; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yao WL, 2017, INT IMMUNOL, V29, P109, DOI 10.1093/intimm/dxx012; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhang EJ, 2015, ANTIVIR RES, V123, P193, DOI 10.1016/j.antiviral.2015.10.009; Zhou TL, 2006, ANTIVIR RES, V72, P116, DOI 10.1016/j.antiviral.2006.05.006; Zoulim F, 2004, ANTIVIR RES, V64, P1, DOI [10.1016/j.antiviral.2004.07.003, 10.1016/S0166-3542(04)00162-7]	34	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212233	10.1371/journal.pone.0212233	http://dx.doi.org/10.1371/journal.pone.0212233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779774	Green Published, Green Submitted, gold			2022-12-26	WOS:000459062900036
J	Shao, S; Fang, H; Zhang, JL; Jiang, M; Xue, K; Ma, JY; Zhang, JY; Lei, J; Zhang, YY; Li, B; Yuan, X; Dang, EL; Wang, G				Shao, Shuai; Fang, Hui; Zhang, Jingliang; Jiang, Man; Xue, Ke; Ma, Jingyi; Zhang, Jieyu; Lei, Jie; Zhang, Yangyang; Li, Bing; Yuan, Xu; Dang, Erle; Wang, Gang			Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes	FASEB JOURNAL			English	Article						GPP; autoimmune; neutrophils; vesicles; OLFM4	MONOCYTE ADSORPTION APHERESIS; IL-36; MATRIX-METALLOPROTEINASE-9; PROLIFERATION; GRANULOCYTE; MECHANISM; MICROVESICLES; INFILTRATION; AUTOIMMUNE; CYTOKINES	Generalized pustular psoriasis (GPP) is a rare and severe inflammatory skin disease that can be life-threatening. Gene mutations are found in some cases, but its immune pathogenesis is largely unknown. Here, we observed that the neutrophil:lymphocyte ratio in patients with GPP was higher than that in healthy controls and decreased after effective treatment. Neutrophils isolated from patients with GPP induced higher expressions of inflammatory genes including IL-1 beta, IL-36G, IL-18, TNF-alpha, and C-X-C motif chemokine ligands in keratinocytes than normal neutrophils did. Moreover, neutrophils from patients with GPP secreted more exosomes than controls, which were then rapidly internalized by keratinocytes, increasing the expression of these inflammatory molecules via activating NF-kappa B and MAPK signaling pathways. The proteomic profiles in neutrophil exosomes further characterized functional proteins and identified olfactomedin 4 as the critical differentially expressed protein that mediates the autoimmune inflammatory responses of GPP. These results demonstrate that neutrophil exosomes have an immune-regulatory effect on keratinocytes, which modulates immune cell migration and autoinflammation in GPP.-Shao, S., Fang, H., Zhang, J., Jiang, M., Xue, K., Ma, J., Zhang, J., Lei, J., Zhang, Y., Li, B., Yuan, X., Dang, E., Wang, G. Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes.	[Shao, Shuai; Fang, Hui; Zhang, Jingliang; Jiang, Man; Xue, Ke; Ma, Jingyi; Zhang, Jieyu; Lei, Jie; Zhang, Yangyang; Li, Bing; Yuan, Xu; Dang, Erle; Wang, Gang] Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Dang, EL; Wang, G (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Dermatol, 127 Changlexi Rd, Xian 710032, Shaanxi, Peoples R China.	dangerle@fmmu.edu.cn; xjwgang@fmrnu.edu.cn	Wang, Gang/H-6710-2019; zhang, yangyang/GZG-7467-2022	Dang, Erle/0000-0003-4761-6673; Wang, Gang/0000-0002-5842-8080; Li, Bing/0000-0002-8080-9883	National Natural Science Foundation of China [81430073, 81673051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank the psoriasis patients and healthy donors for their participation in this study. This study was supported by the National Natural Science Foundation of China (81430073 and 81673051). The authors declare no conflicts of interest.	Alder MN, 2017, CRIT CARE MED, V45, pE426, DOI 10.1097/CCM.0000000000002102; Almutairi D, 2018, J CUTAN MED SURG, V22, P507, DOI 10.1177/1203475418758986; Nicolas-Avila JA, 2017, IMMUNITY, V46, P15, DOI 10.1016/j.immuni.2016.12.012; Ataseven Arzu, 2014, Mater Sociomed, V26, P231, DOI 10.5455/msm.2014.231-233; Bachelez H, 2018, BRIT J DERMATOL, V178, P614, DOI 10.1111/bjd.16232; Balato A, 2016, J INVEST DERMATOL, V136, P1520, DOI 10.1016/j.jid.2016.03.020; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Bridgewood C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00200; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Cheung KL, 2016, J EXP MED, V213, P2399, DOI 10.1084/jem.20160258; Clancy DM, 2018, CELL REP, V22, P2937, DOI 10.1016/j.celrep.2018.02.062; Clark HL, 2016, J IMMUNOL, V196, P336, DOI 10.4049/jimmunol.1502037; Clemmensen SN, 2012, J LEUKOCYTE BIOL, V91, P495, DOI 10.1189/jlb.0811417; Cymbaluk-Ploska A, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/6589262; D'Amico F, 2018, INFLAMM RES, V67, P609, DOI 10.1007/s00011-018-1147-6; Duvallet E, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1198865; Eken C, 2008, J IMMUNOL, V180, P817, DOI 10.4049/jimmunol.180.2.817; Fang H, 2018, J PATHOL, V245, P114, DOI 10.1002/path.5061; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Fujii A, 2018, THER APHER DIAL, V22, P92, DOI 10.1111/1744-9987.12596; Fujisawa T, 2015, THER APHER DIAL, V19, P336, DOI 10.1111/1744-9987.12342; Henry CM, 2016, CELL REP, V14, P708, DOI 10.1016/j.celrep.2015.12.072; Jin H, 2015, J DERMATOL, V42, P674, DOI 10.1111/1346-8138.12863; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Kanda N, 2007, EUR J IMMUNOL, V37, P338, DOI 10.1002/eji.200636420; Khandpur R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005580; Koike Y, 2017, BRIT J DERMATOL, V177, P1732, DOI 10.1111/bjd.15509; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kormelink TG, 2018, SEMIN IMMUNOPATHOL, V40, P439, DOI 10.1007/s00281-018-0681-1; Lee YS, 2018, ACS NANO, V12, P2531, DOI 10.1021/acsnano.7b08297; Liang Y, 2017, CURR OPIN IMMUNOL, V49, P1, DOI 10.1016/j.coi.2017.07.007; Liu WL, 2018, AM J PHYSIOL-CELL PH, V315, pC494, DOI 10.1152/ajpcell.00336.2017; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Macleod T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24880; Mahil SK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2514; Majumdar R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002336; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Mayadas TN, 2014, ANNU REV PATHOL-MECH, V9, P181, DOI 10.1146/annurev-pathol-020712-164023; McBride JD, 2017, J INVEST DERMATOL, V137, P1622, DOI 10.1016/j.jid.2017.04.021; Morelli AE, 2004, BLOOD, V104, P3257, DOI 10.1182/blood-2004-03-0824; Nicolas E, 2011, LEUKEMIA, V25, P57, DOI 10.1038/leu.2010.251; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Papadaki G, 2016, EUR J IMMUNOL, V46, P2542, DOI 10.1002/eji.201646542; Prieto D, 2017, BLOOD, V130, P777, DOI 10.1182/blood-2017-02-769851; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Riani M, 2017, J ALLERGY CLIN IMMUN, V139, P863, DOI 10.1016/j.jaci.2016.08.012; Rogalski C, 2002, J INVEST DERMATOL, V118, P49, DOI 10.1046/j.0022-202x.2001.01650.x; Rood KM, 2016, AM J REPROD IMMUNOL, V76, P108, DOI 10.1111/aji.12523; Sabbione F, 2017, J INNATE IMMUN, V9, P387, DOI 10.1159/000460293; Saikaly SK, 2016, CUREUS, V8, DOI 10.7759/cureus.652; Setta-Kaffetzi N, 2014, AM J HUM GENET, V94, P790, DOI 10.1016/j.ajhg.2014.04.005; Shao S, 2016, J INVEST DERMATOL, V136, P1418, DOI 10.1016/j.jid.2016.03.002; Shen GF, 2017, EUR J IMMUNOL, V47, P900, DOI 10.1002/eji.201546203; Slater TW, 2017, J IMMUNOL, V198, P2886, DOI 10.4049/jimmunol.1601810; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tonello S, 2017, J DERMATOL SCI, V88, P110, DOI 10.1016/j.jdermsci.2017.05.010; Twelves S, 2019, J ALLERGY CLIN IMMUN, V143, P1021, DOI 10.1016/j.jaci.2018.06.038; Umezawa Y, 2003, ARCH DERMATOL RES, V295, pS43, DOI 10.1007/s00403-002-0371-6; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vandooren J, 2013, CRIT REV BIOCHEM MOL, V48, P222, DOI 10.3109/10409238.2013.770819; Vargas A, 2016, AM J RESP CELL MOL, V55, P450, DOI 10.1165/rcmb.2016-0033OC; Walz W, 2017, NEUROCHEM RES, V42, P2560, DOI 10.1007/s11064-017-2265-1; Wang L, 2018, J STRATEGY MANAG, V11, P52, DOI 10.1108/JSMA-11-2016-0083; Wang SW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01298; Warnatsch A, 2015, SCIENCE, V349, P316, DOI 10.1126/science.aaa8064; Welin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069575; Wu Xiaoqi, 2017, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V42, P173, DOI 10.11817/j.issn.1672-7347.2017.02.009; Yamamoto M, 2013, DIS MARKERS, V34, P153, DOI [10.1155/2013/702763, 10.3233/DMA-120958]; Zhang L, 2017, J EUR ACAD DERMATOL, V31, pE491, DOI 10.1111/jdv.14334; Zhang WG, 2017, J PATHOL, V241, P392, DOI 10.1002/path.4848	71	38	39	3	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6813	6828		10.1096/fj.201802090RR	http://dx.doi.org/10.1096/fj.201802090RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811955				2022-12-26	WOS:000476114200012
J	Wang, YR; Ren, YH; Pan, JM				Wang, Yingrui; Ren, Yahui; Pan, Junmin			Regulation of flagellar assembly and length in Chlamydomonas by LF4, a MAPK-related kinase	FASEB JOURNAL			English	Article						cilia assembly; length control; intraflagellar transport; phosphorylation; kinesin	INTRAFLAGELLAR TRANSPORT; CILIARY LENGTH; PROTEIN-KINASE; ORGANELLE SIZE; REINHARDTII; PHOSPHORYLATION; KINESIN; IFT; CILIOGENESIS; MODEL	Members of the MAPK superfamily are known as key regulators of ciliogenesis. Long flagellar (LF) 4, a MAPK-related kinase in Chlamydomonas, is the first kinase that was implicated in ciliary assembly and length. However, little is known about its cellular properties, regulation, and molecular functions. LF4 is localized both in the flagella and cell body with enrichment at the 2 basal bodies, shown by super-resolution microscopy. LF4 is constitutively phosphorylated at T159 at the kinase activation loop and remains at the basal bodies during flagellar assembly. Gene mutations that affect the kinase activity or T159 phosphorylation alter the localization of LF4 at the basal bodies, and the mutants fail to rescue lf4-3, a null mutant. LF4 does not affect the velocities of intraflagellar transport (IFT). However, LF4 null mutation induces accumulation of IFT proteins in the flagellum and reduces the phosphorylation of the kinesin-II subunit FLA8/KIF3B, indicating that LF4 negatively regulates IFT entry. Furthermore, LF2, a cell cycle-related kinase, and LF3, a novel protein, are required for LF4 phosphorylation. Our study demonstrates that LF4 is likely a constitutively active kinase that is regulated by LF2 and regulates IFT entry at the basal bodies to control flagellar assembly and length.Wang, Y., Ren, Y., Pan, J. Regulation of flagellar assembly and length in Chlamydomonas by LF4, a MAPK-related kinase.	[Wang, Yingrui; Ren, Yahui; Pan, Junmin] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Key Lab Prot Sci, MOE,Sch Life Sci, 1 Qinghuayuan,Renhuanlou 413, Beijing 100084, Peoples R China; [Pan, Junmin] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Shandong, Peoples R China	Tsinghua University; Qingdao National Laboratory for Marine Science & Technology	Pan, JM (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Key Lab Prot Sci, MOE,Sch Life Sci, 1 Qinghuayuan,Renhuanlou 413, Beijing 100084, Peoples R China.	panjunmin@tsinghua.edu.cn	Wang, Yingrui/H-2073-2016	Wang, Yingrui/0000-0001-5532-3454	National Natural Science Foundation of China [31330044, 31671387]; National Key Research and Development Program of China [2017YFA0503500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	The authors thank Dr. Pete Lefebvre (University of Minnesota, Minneapolis, MN, USA) for discussion. The authors are also grateful to Drs. Joel Rosenbaum (Yale University, New Haven, CT, USA), Robert Bloodgood (University of Virginia, Charlottesville, VA, USA), Kaiyao Huang (Institute of Hydrobiology, Wuhan, China), and Karl Lechtreck (University of Georgia, Athens, GA, USA) for providing antibodies and plasmids. The authors also thank the Core Facility of the Center for Biomedical Analysis (Tsinghua University) for assistance with cell imaging analysis. This work was supported by the National Natural Science Foundation of China (31330044, 31671387) and the National Key Research and Development Program of China (2017YFA0503500) (to J.P.). The authors declare no conflicts of interest.	Asleson CM, 1998, GENETICS, V148, P693; Bengs F, 2005, MOL MICROBIOL, V55, P1606, DOI 10.1111/j.1365-2958.2005.04498.x; Berman SA, 2003, CURR BIOL, V13, P1145, DOI 10.1016/S0960-9822(03)00415-9; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; BLOODGOOD RA, 1994, J CELL BIOL, V127, P803, DOI 10.1083/jcb.127.3.803; Broekhuis JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108470; Burghoorn J, 2007, P NATL ACAD SCI USA, V104, P7157, DOI 10.1073/pnas.0606974104; Cao MQ, 2013, P NATL ACAD SCI USA, V110, P12337, DOI 10.1073/pnas.1302364110; Chan YHM, 2012, SCIENCE, V337, P1186, DOI 10.1126/science.1223539; Chaya T, 2014, EMBO J, V33, P1227, DOI 10.1002/embj.201488175; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Engel BD, 2009, J CELL BIOL, V187, P81, DOI 10.1083/jcb.200812084; Fu Z., 2012, PROTEIN KINASES, P229; Geimer S, 2005, EUKARYOT CELL, V4, P1253, DOI 10.1128/EC.4.7.1253-1263.2005; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hilton LK, 2013, CURR BIOL, V23, P2208, DOI 10.1016/j.cub.2013.09.038; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Ko HW, 2010, DEV CELL, V18, P237, DOI 10.1016/j.devcel.2009.12.014; Lechtreck KF, 2009, CELL MOTIL CYTOSKEL, V66, P469, DOI 10.1002/cm.20369; Liang YW, 2018, CURR BIOL, V28, P2429, DOI 10.1016/j.cub.2018.05.069; Liang YW, 2014, DEV CELL, V30, P585, DOI 10.1016/j.devcel.2014.07.019; Liang YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069902; Lin HW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005508; Ludington WB, 2013, P NATL ACAD SCI USA, V110, P3925, DOI 10.1073/pnas.1217354110; Luo MN, 2011, CURR BIOL, V21, P586, DOI 10.1016/j.cub.2011.02.046; Lv B, 2017, J CELL SCI, V130, P1662, DOI 10.1242/jcs.200758; Marshall WF, 2005, MOL BIOL CELL, V16, P270, DOI 10.1091/mbc.E04-07-0586; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; McCooke JK, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-393; Meng D, 2016, MOL BIOL CELL, V27, P838, DOI 10.1091/mbc.E15-10-0707; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Moon H, 2014, P NATL ACAD SCI USA, V111, P8541, DOI 10.1073/pnas.1323161111; Nguyen RL, 2005, GENETICS, V169, P1415, DOI 10.1534/genetics.104.027615; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Omori Y, 2010, P NATL ACAD SCI USA, V107, P22671, DOI 10.1073/pnas.1009437108; Ou Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048773; Pan JM, 2014, CURR BIOL, V24, pR75, DOI 10.1016/j.cub.2013.11.043; Phirke P, 2011, DEV BIOL, V357, P235, DOI 10.1016/j.ydbio.2011.06.028; Reiter JF, 2017, NAT REV MOL CELL BIO, V18, P533, DOI 10.1038/nrm.2017.60; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; ROSENBAU.JL, 1969, J CELL BIOL, V41, P600, DOI 10.1083/jcb.41.2.600; SANDERS MA, 1989, J CELL BIOL, V108, P1751, DOI 10.1083/jcb.108.5.1751; Shalom O, 2008, FEBS LETT, V582, P1465, DOI 10.1016/j.febslet.2008.03.036; Smith LA, 2006, J AM SOC NEPHROL, V17, P2821, DOI 10.1681/ASN.2006020136; Tam LW, 2007, J CELL BIOL, V176, P819, DOI 10.1083/jcb.200610022; Tam LW, 2013, MOL BIOL CELL, V24, P588, DOI 10.1091/mbc.E12-10-0718; Tam LW, 2003, J CELL BIOL, V163, P597, DOI 10.1083/jcb.200307143; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Wu Q, 2018, FASEB J, V32, P3689, DOI 10.1096/fj.201701396RR; Yang Y, 2013, EMBO REP, V14, P741, DOI 10.1038/embor.2013.80; Yi PS, 2018, TRAFFIC, V19, P522, DOI 10.1111/tra.12572; Zheng XD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11874; Zhu B, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006627; Zhu X, 2017, CELL MOL LIFE SCI, V74, P3425, DOI 10.1007/s00018-017-2525-x	57	11	11	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6431	6441		10.1096/fj.201802375RR	http://dx.doi.org/10.1096/fj.201802375RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30794426				2022-12-26	WOS:000466932600049
J	Seo, J; Lee, JW; Kang, Y; Lee, E; Ahn, JM; Kim, DH; Kang, HS				Seo, Jiwoon; Lee, Joon Woo; Kang, Yusuhn; Lee, Eugene; Ahn, Joong Mo; Kim, Dong Hyun; Kang, Heung Sik			Evaluation of the responsiveness of outcome measures after spine injection: A retrospective study	PLOS ONE			English	Article							LOW-BACK-PAIN; EPIDURAL STEROID INJECTION; RATING-SCALE; SCORES; REDUCTION; AGREEMENT	Discrepancies in patients' responses to various outcome measures challenge clinicians' evaluation of treatment outcomes. Therefore, we aimed to 1) evaluate the concordance of outcome measures after spine injection, 2) determine the patient variables that lead to discordant responses, and 3) suggest practical outcome measure for spine injections with good responsiveness. From October 2014 to November 2014, 164 patients with neck or low back pain who visited our outpatient clinics and had spine injections on the previous visit were enrolled. We asked patients to report changes in their symptom in the form of outcome measures: numeric rating scale, Oswestry disability index, neck disability index, residual symptom percentage and global perceived effect. The responses were categorized into three groups according to the degree of change; not improved, minimally improved, and significantly improved. The concordances of these categorized answers were evaluated. When "significantly improved" was considered as true improvement, 46 (28%) of the 164 patients had discordant responses to the four measures. There was no significant patients' variable that affects discordance in the outcome measures. Good agreement was shown between the global perceived effect and residual symptom percentage, while the Oswestry disability index had poor agreement with the other measurements. The calculated numeric rating scale and residual symptom percentage also had low levels of agreement. However, patients with severe pre-treatment pain tended to have better agreement. In conclusion, this result suggest that the residual symptom percentage may be a more practical for clinicians and better represent patients' improvements after spine injection.	[Seo, Jiwoon; Lee, Joon Woo; Kang, Yusuhn; Lee, Eugene; Ahn, Joong Mo; Kang, Heung Sik] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea; [Kim, Dong Hyun] Seoul Natl Univ, Boramae Med Ctr, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, JW (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam Si, Gyeonggi Do, South Korea.	joonwoo2@gmail.com	Kang, Yusuhn/AAE-3405-2019	Kang, Yusuhn/0000-0003-1838-2564; Kim, Dong Hyun/0000-0002-3871-7002; Lee, Joon Woo/0000-0002-7106-5229	National Research Foundation of Korea [NRF-2016R1A2B4010992]; Seoul National University Bundang Hospital [02-2013-092]; NRF - Korea government (MSIP) [NRF-2016R1A2B4010992]; SNUBH Research Fund [02-2013-092]	National Research Foundation of Korea(National Research Foundation of Korea); Seoul National University Bundang Hospital; NRF - Korea government (MSIP); SNUBH Research Fund	Funded by National Research Foundation of Korea NRF-2016R1A2B4010992. Dr Joonwoo Lee. Seoul National University Bundang Hospital 02-2013-092. Dr Joonwoo Lee.; This work was supported by Mid-career Researcher Program through NRF grant funded by the Korea government (MSIP) (No. NRF-2016R1A2B4010992); the SNUBH Research Fund (grant no. 02-2013-092).	Cepeda MS, 2003, PAIN, V106, P439, DOI 10.1016/j.pain.2003.09.006; Chapman JR, 2011, SPINE, V36, pS54, DOI 10.1097/BRS.0b013e31822ef74d; Childs JD, 2005, SPINE, V30, P1331, DOI 10.1097/01.brs.0000164099.92112.29; Cohen SP, 2015, MAYO CLIN PROC, V90, P284, DOI 10.1016/j.mayocp.2014.09.008; Cormier S, 2016, PAIN, V157, P329, DOI 10.1097/j.pain.0000000000000379; Cushman D, 2015, PAIN MED, V16, P870, DOI 10.1111/pme.12669; Guyatt GH, 2002, J CLIN EPIDEMIOL, V55, P900, DOI 10.1016/S0895-4356(02)00435-3; Hooten WM, 2015, MAYO CLIN PROC, V90, P1699, DOI 10.1016/j.mayocp.2015.10.009; Kamper SJ, 2010, J CLIN EPIDEMIOL, V63, P760, DOI 10.1016/j.jclinepi.2009.09.009; Kim HJ, 2014, PAIN PRACT, V14, P405, DOI 10.1111/papr.12084; Ostelo RWJG, 2008, SPINE, V33, P90, DOI 10.1097/BRS.0b013e31815e3a10; Costa LOP, 2008, SPINE, V33, P2459, DOI 10.1097/BRS.0b013e3181849dbe; Shahgholi L, 2015, AM J NEURORADIOL, V36, P594, DOI 10.3174/ajnr.A4150; Theodore BR, 2012, PAIN MED, V13, P1131, DOI 10.1111/j.1526-4637.2012.01442.x; Tomkins-Lane CC, 2012, ARCH PHYS MED REHAB, V93, P2008, DOI 10.1016/j.apmr.2012.05.014	15	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211763	10.1371/journal.pone.0211763	http://dx.doi.org/10.1371/journal.pone.0211763			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811428	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400032
J	Harichund, C; Kunene, P; Simelane, S; Karim, QA; Moshabela, M				Harichund, Charlene; Kunene, Pinky; Simelane, Sinenhlanhla; Karim, Quarraisha Abdool; Moshabela, Mosa			Repeat HIV testing practices in the era of HIV self-testing among adults in KwaZulu-Natal, South Africa	PLOS ONE			English	Article							ACCEPTABILITY; POPULATION; PREVENTION	Repeat HIV testing is important in high HIV burden communities to enable sustainability of prevention initiatives; however, an understanding of repeat testing practices is limited. Additional HIV testing approaches may be required to increase testing. HIV self-testing is an additional testing approach, but knowledge on its potential for repeat testing is limited. This study explored repeat HIV testing practices and uptake of HIV self-testing among repeat testers, following exposure to HIV self-testing. HIV testing practices were explored at two time points. During Phase 1, eighty in-depth interviews were conducted among 40 consenting adults, and 30 telephonic contacts were completed during Phase 2. Framework analysis was used to analyse the transcripts from the in-depth interviews. The practice of repeat HIV testing is primarily influenced by HIV status awareness and risk exposure. Thirteen regular testers and one HIV na ve tester at baseline had undergone repeat testing through the use of a traditional testing approach such as HIV counselling and testing as reported in Phase 2. HIV self-testing has a role among repeat testers, but affordability and access are barriers.	[Harichund, Charlene; Kunene, Pinky; Simelane, Sinenhlanhla; Karim, Quarraisha Abdool] Ctr AIDS Programme Res South Africa, Durban, South Africa; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, New York, NY USA; [Karim, Quarraisha Abdool; Moshabela, Mosa] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Durban, South Africa; [Moshabela, Mosa] Africa Hlth Res Inst, Kwa Zulu, South Africa	Columbia University; University of Kwazulu Natal; Africa Health Research Institute	Harichund, C (corresponding author), Ctr AIDS Programme Res South Africa, Durban, South Africa.	Charlene.Harichund@caprisa.org	Abdool Karim, Quarraisha/GVS-1160-2022; Moshabela, Mosa/AAK-4418-2021	Abdool Karim, Quarraisha/0000-0002-0985-477X; Moshabela, Mosa/0000-0002-9438-7095; Harichund, Charlene/0000-0003-4641-1924	University of KwaZulu-Natal	University of KwaZulu-Natal	The research was supported by a scholarship grant from the University of KwaZulu-Natal. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asante A, 2007, B WORLD HEALTH ORGAN, V85, P644, DOI 10.2471/BLT.06.037671; Brown W, 2016, AIDS BEHAV, V20, P2000, DOI 10.1007/s10461-016-1309-x; Burke VM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183280; Cambiano V, 2014, AIDS BEHAV, V18, pS450, DOI 10.1007/s10461-014-0824-x; Harichund C, 2018, AIDS BEHAV, V22, P560, DOI 10.1007/s10461-017-1848-9; Hensen B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2259-3; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21594; Kalichman SC, 2008, J CLIN PSYCHOL MED S, V15, P127, DOI 10.1007/s10880-008-9116-9; Kelvin EA, 2018, AIDS CARE, V30, P47, DOI 10.1080/09540121.2017.1360997; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; MUSHEKE M, 2013, BIOMED CENTRAL PUBLI, V13, DOI DOI 10.1186/1471-2458-13-220; Orne-Gliemann J, 2016, AIDS CARE, V28, P14, DOI 10.1080/09540121.2016.1164805; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Perkins JM, 2018, AIDS BEHAV, V22, P616, DOI 10.1007/s10461-017-1691-z; Rabiee F, 2004, P NUTR SOC, V63, P655, DOI 10.1079/PNS2004399; Ryder K, 2005, AIDS BEHAV, V9, P459, DOI 10.1007/s10461-005-9032-z; Siegler AJ, 2015, AIDS CARE, V27, P229, DOI 10.1080/09540121.2014.947914	17	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212343	10.1371/journal.pone.0212343	http://dx.doi.org/10.1371/journal.pone.0212343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794580	Green Submitted, gold, Green Published			2022-12-26	WOS:000459709100055
J	Sato, T; Morishita, S; Horie, T; Fukumoto, M; Kida, T; Oku, H; Nakamura, K; Takai, S; Jin, D; Ikeda, T				Sato, Takaki; Morishita, Seita; Horie, Taeko; Fukumoto, Masanori; Kida, Teruyo; Oku, Hidehiro; Nakamura, Kimitoshi; Takai, Shinji; Jin, Denan; Ikeda, Tsunehiko			Involvement of premacular mast cells in the pathogenesis of macular diseases	PLOS ONE			English	Article							PRECORTICAL VITREOUS POCKET; ENDOTHELIAL GROWTH-FACTOR; ANGIOTENSIN-CONVERTING ENZYME; TNF-ALPHA; VITREOMACULAR TRACTION; FACTOR-1 CXCL12; LYMPH-NODES; STEM-CELLS; IN-VIVO; FIBROBLASTS	We previously reported on the elevated intravitreal activities of tryptase and chymase in association with idiopathic epiretinal membrane (ERM) and idiopathic macular hole (MH). In this present study, we investigated the potential intraocular production of these serine proteases, and measured and compared tryptase and chymase activities in the vitreous body and serum in ERM, MH, proliferative diabetic retinopathy (PDR), and rhegmatogenous retinal detachment (RRD) patients. In addition, nuclear staining with hematoxylin and eosin (H&E) and mast-cell staining with toluidine blue were performed on samples of the vitreous core and bursa premacularis (BPM) of MH. We also performed immunostaining on the above two regions of vitreous samples for MH with anti-tryptase antibody, anti-chymase antibody, anti-podoplanin antibody, anti-lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) antibody, and anti-fibroblast antibody. Moreover, we performed immunostaining with anti-tryptase antibody and anti-chymase antibody on ERMs collected intraoperatively. Tryptase activity in the vitreous body was significantly higher in ERM and MH than in PDR. However, no significant differences were observed in the tryptase activity in the serum among these four diseases. Chymase activity in the vitreous body was significantly higher in MH than in the other three diseases, yet chymase activity in the serum was below detection limit in any of the diseases. Nuclear staining with H&E revealed an abundance of nuclei in the BPM region, but few in the surrounding area. Mast-cell staining with toluidine blue revealed that the BPM showed metachromatic staining. In immunostaining with anti-fibroblasts antibody, anti-tryptase antibody, anti-chymase antibody, anti-podoplanin antibody, and anti-LYVE-1 antibody, the BPM stained more strongly than the vitreous core. Tryptase and chymase-positive cells were also observed in ERM. These findings revealed that the presence of mast cells in the BPM potentially represent the source of these serine proteases. Moreover, the BPM, as a lymphatic tissue, may play an important role in the pathogenesis of macular disease.	[Sato, Takaki; Morishita, Seita; Horie, Taeko; Fukumoto, Masanori; Kida, Teruyo; Oku, Hidehiro; Ikeda, Tsunehiko] Osaka Med Coll, Dept Ophthalmol, Takatsuki, Osaka, Japan; [Nakamura, Kimitoshi] Nakamura Eye Clin, Matsumoto, Nagano, Japan; [Takai, Shinji; Jin, Denan] Osaka Med Coll, Grad Sch Med, Dept Innovat Med, Takatsuki, Osaka, Japan	Osaka Medical College; Osaka Medical College	Ikeda, T (corresponding author), Osaka Med Coll, Dept Ophthalmol, Takatsuki, Osaka, Japan.	tikeda@osaka-med.ac.jp	Oku, Hidehiro/AAD-5029-2019	Oku, Hidehiro/0000-0003-4359-4219; Takai, Shinji/0000-0003-3963-3983				Alam F, 2008, AM J ROENTGENOL, V191, P604, DOI 10.2214/AJR.07.3401; Antila S, 2017, J EXP MED, V214, P3645, DOI 10.1084/jem.20170391; ATKINS FM, 1985, INT ARCH ALLER A IMM, V77, P96, DOI 10.1159/000233760; Au SR, 2007, J CELL BIOCHEM, V100, P1170, DOI 10.1002/jcb.21107; Belot MP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1410, DOI 10.1152/ajpendo.00286.2006; Bhatia B, 2009, EXP EYE RES, V89, P373, DOI 10.1016/j.exer.2009.04.005; Bischoff SC, 1999, INT ARCH ALLERGY IMM, V118, P104, DOI 10.1159/000024041; Butler JM, 2005, J CLIN INVEST, V115, P86, DOI 10.1172/JCI200522869; Chang S, 2006, AM J OPHTHALMOL, V141, P1033, DOI 10.1016/j.ajo.2006.02.014; Duker JS, 2013, OPHTHALMOLOGY, V120, P2611, DOI 10.1016/j.ophtha.2013.07.042; Ebihara N, 2005, CURR EYE RES, V30, P429, DOI 10.1080/02713680590959367; EISNER G, 1975, A GRAEF ARCH KLIN EX, V193, P33, DOI 10.1007/BF00410525; Fine HF, 2006, ARCH OPHTHALMOL-CHIC, V124, P1663, DOI 10.1001/archopht.124.11.1663; Friend DS, 1996, J CELL BIOL, V135, P279, DOI 10.1083/jcb.135.1.279; Fukumoto M, 2008, CURR EYE RES, V33, P885, DOI 10.1080/02713680802389851; FURITSU T, 1989, P NATL ACAD SCI USA, V86, P10039, DOI 10.1073/pnas.86.24.10039; GARTNER J, 1971, AM J OPHTHALMOL, V71, P1317; Gruber BL, 1997, J IMMUNOL, V158, P2310; Hata Y, 2011, BRIT J OPHTHALMOL, V95, P261, DOI 10.1136/bjo.2010.190322; Hitchon C, 2002, ARTHRITIS RHEUM, V46, P2587, DOI 10.1002/art.10520; Hjertson M, 1996, EXP HEMATOL, V24, P748; Iddamalgoda A, 2008, ARCH DERMATOL RES, V300, pS69, DOI 10.1007/s00403-007-0806-1; Ikeda T, 2015, CLIN OPHTHALMOL, V9, P1181, DOI 10.2147/OPTH.S82015; Ishizaki E, 2006, AM J OPHTHALMOL, V141, P129, DOI 10.1016/j.ajo.2005.08.066; JONGEBLOED WL, 1986, DOC OPHTHALMOL, V64, P117, DOI 10.1007/BF00166693; Kakehashi Akihiro, 1995, Nippon Ganka Gakkai Zasshi, V99, P323; Kim KW, 2007, ARTHRITIS RHEUM-US, V56, P1076, DOI 10.1002/art.22439; KISHI S, 1990, ARCH OPHTHALMOL-CHIC, V108, P979, DOI 10.1001/archopht.1990.01070090081044; Kishi S, 2016, JPN J OPHTHALMOL, V60, P239, DOI 10.1007/s10384-016-0447-z; KITAMURA Y, 1993, AM J MED SCI, V306, P185, DOI 10.1097/00000441-199309000-00011; KOCHEVAR IE, 1994, J INVEST DERMATOL, V103, P797, DOI 10.1111/1523-1747.ep12413286; LAZARUS HS, 1994, ARCH OPHTHALMOL-CHIC, V112, P1356, DOI 10.1001/archopht.1994.01090220106031; Leskinen M, 2001, ARTERIOSCL THROM VAS, V21, P516, DOI 10.1161/01.ATV.21.4.516; Li JC, 1996, ANN ANAT, V178, P259, DOI 10.1016/S0940-9602(96)80059-8; Li Liang, 2010, Zhonghua Yan Ke Za Zhi, V46, P317; LINENBERGER ML, 1995, EXP HEMATOL, V23, P1104; Liu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102950; Lobov GI, 2011, B EXP BIOL MED+, V151, P5, DOI 10.1007/s10517-011-1246-7; Los LI, 2008, EYE, V22, P1223, DOI 10.1038/eye.2008.39; Majji AB, 2006, EYE, V20, P46, DOI 10.1038/sj.eye.6701788; Maruichi M, 2004, CURR EYE RES, V29, P321, DOI 10.1080/02713680490516161; May CA, 1999, HISTOCHEM CELL BIOL, V112, P381, DOI 10.1007/s004180050420; Mekori YA, 2000, HEMATOL ONCOL CLIN N, V14, P569, DOI 10.1016/S0889-8588(05)70297-5; Mughal M A, 1988, J Pak Med Assoc, V38, P78; Nguyen M, 2005, J IMMUNOL, V175, P5701, DOI 10.4049/jimmunol.175.9.5701; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Polak BCP, 2012, ACTA OPHTHALMOL, V90, pe652, DOI 10.1111/j.1755-3768.2012.02539.x; Rossi T, 2018, EXP EYE RES, V175, P159, DOI 10.1016/j.exer.2018.06.022; SAINTEMARIE G, 1990, CELL TISSUE RES, V261, P1, DOI 10.1007/BF00329433; Sandler C, 2007, INFLAMM RES, V56, P230, DOI 10.1007/s00011-007-6135-1; Santiago B, 2011, CYTOKINE, V53, P184, DOI 10.1016/j.cyto.2010.06.006; Sato T, 2013, OPHTHALMOLOGICA, V230, P76, DOI 10.1159/000351655; SEBAG J, 1989, INVEST OPHTH VIS SCI, V30, P1867; Shanas U, 1998, J NEUROIMMUNOL, V90, P207, DOI 10.1016/S0165-5728(98)00137-4; Shim YJ, 2012, BIOCHEM BIOPH RES CO, V422, P200, DOI 10.1016/j.bbrc.2012.04.162; Shimada H, 2009, EUR J OPHTHALMOL, V19, P1102, DOI 10.1177/112067210901900638; Shinohara Harumichi, 2003, Okajimas Folia Anatomica Japonica, V79, P175, DOI 10.2535/ofaj.79.175; Sommer F, 2009, EXP EYE RES, V88, P995, DOI 10.1016/j.exer.2008.11.026; Song KF, 1999, JPN J PHARMACOL, V79, P131, DOI 10.1254/jjp.79.131; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P481, DOI 10.1097/00006982-200308000-00006; Stalmans P, 2012, NEW ENGL J MED, V367, P606, DOI 10.1056/NEJMoa1110823; Stanga PE, 2014, AM J OPHTHALMOL, V157, P397, DOI 10.1016/j.ajo.2013.10.008; Sugiyama T, 2006, OPHTHALMIC RES, V38, P201, DOI 10.1159/000093072; Takai S, 1999, CIRCULATION, V100, P654, DOI 10.1161/01.CIR.100.6.654; Tokuda N, 2010, HISTOCHEM CELL BIOL, V134, P445, DOI 10.1007/s00418-010-0754-2; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; VANVLIET E, 1986, J HISTOCHEM CYTOCHEM, V34, P883, DOI 10.1177/34.7.3519751; Worst J, 1978, J Am Intraocul Implant Soc, V4, P7; WORST J G F, 1976, P275; Worst JG., 1995, CISTERNAL ANATOMY VI; WORST JGF, 1977, T OPHTHAL SOC UK, V97, P550; WORST JGF, 1992, DOC OPHTHALMOL, V82, P169, DOI 10.1007/BF00157007; Yamaba H, 2016, EXP DERMATOL, V25, P45, DOI 10.1111/exd.13084; Zhang H, 2010, INVEST OPHTH VIS SCI, V51, P6157, DOI 10.1167/iovs.10-5205	74	7	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211438	10.1371/journal.pone.0211438	http://dx.doi.org/10.1371/journal.pone.0211438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794552	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100017
J	Buma, B; Thompson, T				Buma, Brian; Thompson, Thomas			Long-term exposure to more frequent disturbances increases baseline carbon in some ecosystems: Mapping and quantifying the disturbance frequency-ecosystem C relationship	PLOS ONE			English	Article							TEMPERATE RAIN-FOREST; WINDTHROW DISTURBANCE; YELLOW-CEDAR; DYNAMICS; LANDSLIDES; DECLINE; CLIMATE; DIVERSITY; IMPACTS; BIOMASS	Disturbance regimes have a major influence on the baseline carbon that characterizes any particular ecosystem. Often regimes result in lower average regional baseline C (compared to those same systems if the disturbance processes were lessened/removed). However, in infrequently disturbed systems the role of disturbance as a "background" process that influences broad-scale, baseline C levels is often neglected. Long-term chronosequences suggest disturbances in these systems may serve to increase regional biomass C stocks by maintaining productivity. However, that inference has not been tested spatially. Here, the large forested system of southeast Alaska, USA, is utilized to 1) estimate baseline regional C stocks, 2) test the fundamental disturbance-ecosystem C relationship, 3) estimate the cumulative impact of disturbances on baseline C. Using 1491 ground points with carbon measurements and a novel way of mapping disturbance regimes, the relationship between total biomass C, disturbance exposure, and climate was analyzed statistically. A spatial model was created to determine regional C and compare different disturbance scenarios. In this infrequently disturbed ecosystem, higher disturbance exposure is correlated with higher biomass C, supporting the hypothesis that disturbances maintain productivity at broad scales. The region is estimated to potentially contain a baseline 1.21-1.52 Pg biomass C (when unmanaged). Removal of wind and landslides from the model resulted in lower net C stocks (-2 to -19% reduction), though the effect was heterogeneous on finer scales. There removal of landslides alone had a larger effect then landslide and wind combined removal. The relationship between higher disturbance exposure and higher biomass within the broad ecosystem (which, on average, has a very low disturbance frequency) suggest that disturbances can serve maintain higher levels of productivity in infrequently disturbed but very C dense ecosystems. Carbon research in other systems, especially those where disturbances are infrequent relative to successional processes, should consider the role of disturbances in maintaining baseline ecosystem productivity.	[Buma, Brian] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Thompson, Thomas] US Forest Serv, USDA, Resource Monitoring & Assessment Program, PNW Res Stn, Anchorage, AK USA	University of Colorado System; University of Colorado Denver; United States Department of Agriculture (USDA); United States Forest Service	Buma, B (corresponding author), Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA.	brian.buma@ucdenver.edu			National Science Foundation [1711974, 1557186]	National Science Foundation(National Science Foundation (NSF))	Support was provided through National Science Foundation grants to BB, #1711974 and #1557186. The sponsors played no role in study design, analysis, preparation, or publishing.	ADAMS PW, 1987, FOREST ECOL MANAG, V18, P93, DOI 10.1016/0378-1127(87)90136-8; Ager AA, 2012, FOREST ECOL MANAG, V267, P271, DOI 10.1016/j.foreco.2011.11.021; Amiro BD, 2010, J GEOPHYS RES-BIOGEO, V115, DOI 10.1029/2010JG001390; [Anonymous], 2017, SCENARIOS NETWORK AR; Baichtal JF, 2008, AAA ANN M POST SESS; BINKLEY D, 1995, CAN J FOREST RES, V25, P621, DOI 10.1139/x95-069; Bisbing SM, 2018, CAN J FOREST RES, V48, P180, DOI 10.1139/cjfr-2017-0178; Bisbing SM, 2016, ECOHYDROLOGY, V9, P354, DOI 10.1002/eco.1640; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Boose ER, 2001, ECOL MONOGR, V71, P27, DOI 10.1890/0012-9615(2001)071[0027:LARIOH]2.0.CO;2; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buma B, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00058.1; Buma B, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6364-x; Buma B, 2017, GLOBAL CHANGE BIOL, V23, P2903, DOI 10.1111/gcb.13555; Buma B, 2016, CAN J FOREST RES, V46, P844, DOI 10.1139/cjfr-2016-0041; Buma B, 2015, GLOBAL CHANGE BIOL, V21, P3445, DOI 10.1111/gcb.12915; Buma B, 2015, GEOMORPHOLOGY, V228, P504, DOI 10.1016/j.geomorph.2014.10.014; Dantas VD, 2016, ECOL LETT, V19, P12, DOI 10.1111/ele.12537; Diaz-Yanez O, 2017, FOREST ECOL MANAG, P401; Geertsema M, 2007, GEOMORPHOLOGY, V89, P55, DOI 10.1016/j.geomorph.2006.07.019; Hard JS, 1974, PNWGTR013 USDA FOR S; Harris AS, 1999, PNWGTR244 USDA FS, P63; Hennon PE, 2012, BIOSCIENCE, V62, P147, DOI 10.1525/bio.2012.62.2.8; Hobbie SE, 2002, PLANT SOIL, V242, P163, DOI 10.1023/A:1019670731128; Hoffman KM, 2018, FOREST ECOL MANAG, V424, P11, DOI 10.1016/j.foreco.2018.04.020; Houghton JT, 1997, REVISED 1996 INTERGO; Hudiburg T, 2009, ECOL APPL, V19, P163, DOI 10.1890/07-2006.1; Hudiburg TW, 2017, BIOGEOSCIENCES, V14, P3873, DOI 10.5194/bg-14-3873-2017; Keith H, 2009, P NATL ACAD SCI USA, V106, P11635, DOI 10.1073/pnas.0901970106; KLINGER LF, 1990, HOLARCTIC ECOL, V13, P72; Kobayashi Y, 2017, ENVIRON MANAGE, V59, P807, DOI 10.1007/s00267-017-0820-9; Kramer MG, 2004, ECOLOGY, V85, P2230, DOI 10.1890/02-4098; Kramer MG, 2001, ECOLOGY, V82, P2749, DOI 10.1890/0012-9658(2001)082[2749:ACOLTW]2.0.CO;2; Kranabetter JM, 2016, ECOSYSTEMS, V19, P387, DOI 10.1007/s10021-015-9934-1; Leighty WW, 2006, ECOSYSTEMS, V9, P1051, DOI 10.1007/s10021-005-0028-3; Lutz JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082784; MATSON PA, 1984, ECOLOGY, V65, P1511, DOI 10.2307/1939130; Mclauchlan KK, 2014, BIOSCIENCE, V64, P105, DOI 10.1093/biosci/bit017; MCNICOL G, 2019, ENV RES LETT, V0014; MILES DWR, 1984, SOIL SCI SOC AM J, V48, P667, DOI 10.2136/sssaj1984.03615995004800030040x; Moisen GG, 2002, ECOL MODEL, V157, P209, DOI 10.1016/S0304-3800(02)00197-7; Morris JL, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0057-0; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Parfitt RL, 2005, BIOGEOCHEMISTRY, V75, P305, DOI 10.1007/s10533-004-7790-8; Peltzer DA, 2010, ECOL MONOGR, V80, P509, DOI 10.1890/09-1552.1; Perakis SS, 2015, ECOSYSTEMS, V18, P573, DOI 10.1007/s10021-015-9847-z; Perakis SS, 2011, OECOLOGIA, V167, P793, DOI 10.1007/s00442-011-2016-y; PICKETT STA, 1989, OIKOS, V54, P129, DOI 10.2307/3565258; Rejou-Mechain M, 2014, BIOGEOSCIENCES DISCU, V11, P5711, DOI DOI 10.5194/BGD-11-5711-2014; Rhemtulla JM, 2009, P NATL ACAD SCI USA, V106, P6082, DOI 10.1073/pnas.0810076106; Running SW, 2008, SCIENCE, V321, P652, DOI 10.1126/science.1159607; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Simard M, 2007, ECOL APPL, V17, P1619, DOI 10.1890/06-1795.1; Smithwick EAH, 2002, ECOL APPL, V12, P1303, DOI 10.1890/1051-0761(2002)012[1303:PUBOCS]2.0.CO;2; Swanston DN, 1974, PNWGTR017 USDA FOR S, P17; Thom D, 2016, BIOL REV, V91, P760, DOI 10.1111/brv.12193; Turner M.G., 2015, LANDSCAPE ECOLOGY TH, P175, DOI 10.1007/978-1-4939-2794-4_4; UGOLINI FC, 1979, NATURE, V281, P366, DOI 10.1038/281366a0; USFS, 2018, FOR INV AN DAT DAT D; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White PS, 2001, PROG BOT, V62, P399; Wilcke W, 2003, CATENA, V53, P79, DOI 10.1016/S0341-8162(02)00196-0; Zhang GY, 2012, J APPL STAT, V39, P151, DOI 10.1080/02664763.2011.578621	64	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212526	10.1371/journal.pone.0212526	http://dx.doi.org/10.1371/journal.pone.0212526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789951	gold, Green Published			2022-12-26	WOS:000459330800035
J	Micic, D; Gaetano, JN; Nigam, N; Peller, M; Rao, VL; Semrad, C; Stein, AC; Kupfer, SS				Micic, Dejan; Gaetano, John N.; Nigam, Neha; Peller, Matthew; Rao, Vijaya L.; Semrad, Carol; Stein, Adam C.; Kupfer, Sonia S.			Risk factors for small bowel bleeding in an overt gastrointestinal bleeding presentation after negative upper and lower endoscopy	PLOS ONE			English	Article							VIDEO CAPSULE ENDOSCOPY; DIAGNOSIS; MANAGEMENT; ICD-9-CM	Introduction A small bowel source is suspected when evaluation of overt gastrointestinal (GI) bleeding with upper and lower endoscopy is negative. Video capsule endoscopy (VCE) is the recommended next diagnostic test for small bowel bleeding sources. However, clinical or endoscopic predictive factors for small bowel bleeding in the setting of an overt bleeding presentation are unknown. We aimed to define predictive factors for positive VCE among individuals presenting with overt bleeding and a suspected small bowel source. Methods We included consecutive inpatient VCE performed between September 1, 2012 to September 1, 2015 for melena or hematochezia at two tertiary centers. All patients had EGD and colonoscopy performed prior to VCE. Patient demographics, medication use, and endoscopic findings were retrospectively recorded. VCE findings were graded based on the PO-P2 grading system. The primary outcome of interest was a positive (P2) VCE. The secondary outcome of interest was the performance of a therapeutic intervention. Data were analyzed with the Fisher exact test for dichotomous variables and logistic regression. Results Two hundred forty-three VCE were reviewed, and 117 were included in the final analysis. A positive VCE (P2) was identified in 35 (29.9%) cases. In univariate analysis, a positive VCE was inversely associated with presence of diverticula on preceding colonoscopy (OR: 0.44, 95% CI: 0.2-0.99), while identification of blood on terminal ileal examination was associated with a positive VCE (OR: 5.18, 95% CI: 1.51-17.76). In multivariate analysis, only blood identified on terminal ileal examination remained a significant risk factor for positive VCE (OR: 6.13, 95% CI: 1.57-23.81). Blood on terminal ileal examination was also predictive of therapeutic intervention in both univariate (OR: 4.46, 95% CI: 1.3-15.2) and multivariate analysis (OR: 5.04, 95% CI: 1.25-20.32). Conclusion Among patients presenting with overt bleeding but negative upper and lower endoscopy, the presence of blood on examination of the terminal ileum is strongly associated with a small bowel bleeding source as well as with small bowel therapeutic intervention. Presence of diverticula on colonoscopy is inversely associated with a positive VCE and therapeutic intervention in univariate analysis.	[Micic, Dejan; Gaetano, John N.; Nigam, Neha; Rao, Vijaya L.; Semrad, Carol; Kupfer, Sonia S.] Univ Chicago Med, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA; [Peller, Matthew] Northwestern Med, Dept Internal Med, Chicago, IL USA; [Stein, Adam C.] Northwestern Med, Dept Internal Med, Div Gastroenterol & Hepatol, Chicago, IL USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Micic, D (corresponding author), Univ Chicago Med, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA.	dmicic@medicine.bsd.uchicago.edu	Kupfer, Sonia S/ABD-9416-2021					DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Gerson LB, 2015, AM J GASTROENTEROL, V110, P1265, DOI 10.1038/ajg.2015.246; Gerson LB, 2013, CLIN GASTROENTEROL H, V11, P1224, DOI 10.1016/j.cgh.2013.03.010; Jensen DM, 2000, NEW ENGL J MED, V342, P78, DOI 10.1056/NEJM200001133420202; Katsinelos P, 2016, HIPPOKRATIA, V20, P127; Lepileur L, 2012, CLIN GASTROENTEROL H, V10, P1376, DOI 10.1016/j.cgh.2012.05.024; Longstreth GF, 1997, AM J GASTROENTEROL, V92, P419; Pennazio M, 2004, GASTROENTEROLOGY, V126, P643, DOI 10.1053/j.gastro.2003.11.057; Prakash C, 2003, GASTROINTEST ENDOSC, V58, P330, DOI 10.1067/S0016-5107(03)00003-8; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rastogi A, 2004, GASTROINTEST ENDOSC, V60, P959, DOI 10.1016/S0016-5107(04)02226-6; Robinson CA, 2011, GASTROINTEST ENDOSC, V74, P1061, DOI 10.1016/j.gie.2011.07.019; Saurin JC, 2003, ENDOSCOPY, V35, P576; Scaglione G, 2011, DIGEST DIS SCI, V56, P1188, DOI 10.1007/s10620-010-1419-7; Schlag C, 2015, GASTROINTEST ENDOSC, V81, P889, DOI 10.1016/j.gie.2014.09.035; Singh A, 2013, GASTROINTEST ENDOSC, V77, P761, DOI 10.1016/j.gie.2012.11.041; Strate LL, 2016, AM J GASTROENTEROL, V111, P459, DOI 10.1038/ajg.2016.41; Zuckerman GR, 1999, GASTROINTEST ENDOSC, V49, P228, DOI 10.1016/S0016-5107(99)70491-8	18	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212509	10.1371/journal.pone.0212509	http://dx.doi.org/10.1371/journal.pone.0212509			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785946	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000066
J	Qiu, Y; Wang, SC; Huang, BX; Zhong, HX; Pan, ZH; Zhuang, QY; Peng, C; Hou, GY; Wang, KC				Qiu, Yuan; Wang, Suchun; Huang, Baoxu; Zhong, Huanxiang; Pan, Zihao; Zhuang, Qingye; Peng, Cheng; Hou, Guangyu; Wang, Kaicheng			Viral infection detection using metagenomics technology in six poultry farms of eastern China	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; UNIVERSAL PRIMER SET; PHYLOGENETIC ANALYSIS; GENOME SEQUENCE; RNA VIRUSES; IDENTIFICATION; CLEAVAGE; AMPLIFICATION; GENOTYPE	With rapidly increasing animal pathogen surveillance requirements, new technologies are needed for a comprehensive understanding of the roles of pathogens in the occurrence and development of animal diseases. We applied metagenomic technology to avian virus surveillance to study the main viruses infecting six poultry farms in two provinces in eastern China. Cloacal/throat double swabs were collected from 60 birds at each farm according to a random sampling method. The results showed that the method could simultaneously detect major viruses infecting farms, including avian influenza virus, infectious bronchitis virus, Newcastle disease virus, rotavirus G, duck hepatitis B virus, and avian leukemia virus subgroup J in several farms. The test results were consistent with the results from traditional polymerase chain reaction (PCR) or reverse transcription-PCR analyses. Five H9N2 and one H3N8 avian influenza viruses were detected at the farms and were identified as low pathogenic avian influenza viruses according to HA cleavage sites analysis. One detected Newcastle disease virus was classified as Class II genotype I and avirulent type according to F0 cleavage sites analysis. Three avian infectious bronchitis viruses were identified as 4/91, CK/CH/LSC/99I and TC07-2 genotypes by phylogenetic analysis of S1 genes. The viral infection surveillance method using metagenomics technology enables the monitoring of multiple viral infections, which allows the detection of main infectious viruses.	[Qiu, Yuan; Wang, Suchun; Huang, Baoxu; Zhuang, Qingye; Peng, Cheng; Hou, Guangyu; Wang, Kaicheng] China Anim Hlth & Epidemiol Ctr, Qingdao, Shandong, Peoples R China; [Qiu, Yuan] Guangdong Inst Appl Biol Resources, Guangzhou, Guangdong, Peoples R China; [Zhong, Huanxiang; Pan, Zihao] Nanjing Agr Univ, Coll Vet Med, Nanjing, Jiangsu, Peoples R China	China Animal Health & Epidemiology Center; Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; Nanjing Agricultural University	Wang, KC (corresponding author), China Anim Hlth & Epidemiol Ctr, Qingdao, Shandong, Peoples R China.	wangkaicheng@cahec.cn			National Key Research and Development Program of China [2017YFC120050]; China Animal Health and Epidemiology Center Innovation Fund [2015IF-0004FF]	National Key Research and Development Program of China; China Animal Health and Epidemiology Center Innovation Fund	This research was funded by the National Key Research and Development Program of China (2017YFC120050), China Animal Health and Epidemiology Center Innovation Fund (2015IF-0004FF).	Belongia EA, 2016, LANCET INFECT DIS, V16, P942, DOI 10.1016/S1473-3099(16)00129-8; Chen GQ, 2018, VIRUS GENES, V54, P536, DOI 10.1007/s11262-018-1568-x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gall A, 2008, J CLIN MICROBIOL, V46, P2561, DOI 10.1128/JCM.00466-08; Ge FF, 2009, J CLIN MICROBIOL, V47, P3294, DOI 10.1128/JCM.00355-09; Gong YN, 2017, ARCH VIROL, V162, P2013, DOI 10.1007/s00705-017-3406-1; Guan HZ, 2016, J NEUROVIROL, V22, P240, DOI 10.1007/s13365-015-0390-7; Haas L, 1997, J VET MED B, V44, P257, DOI 10.1111/j.1439-0450.1997.tb00972.x; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Horiba K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22133-y; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Jenkins AO, 2011, VET MICROBIOL, V151, P139, DOI 10.1016/j.vetmic.2011.02.037; Jing Chen, 2008, CHINESE J VIROLIGY, V24; Kim SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074022; Li LL, 2010, VET MICROBIOL, V143, P145, DOI 10.1016/j.vetmic.2009.11.022; Lin SY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102030; Liu HL, 2008, RES VET SCI, V85, P612, DOI 10.1016/j.rvsc.2008.02.013; Luo HB, 2012, VIRUS GENES, V44, P19, DOI 10.1007/s11262-011-0657-x; Masembe C, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-218; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Merriman B, 2012, ELECTROPHORESIS, V33, P3397, DOI 10.1002/elps.201200424; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Parson W, 2013, FORENSIC SCI INT-GEN, V7, P543, DOI 10.1016/j.fsigen.2013.06.003; Qingye Zhuang, 2016, CHINA ANIMAL HLTH IN, V33; Qiu Y, 2017, VIRUS RES, V237, P22, DOI 10.1016/j.virusres.2017.05.003; Roossinck MJ, 2015, PHYTOPATHOLOGY, V105, P716, DOI 10.1094/PHYTO-12-14-0356-RVW; Roussan DA, 2012, POL J VET SCI, V15, P337, DOI 10.2478/v10181-012-0052-0; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Umali DV, 2014, VIRUS GENES, V49, P89, DOI 10.1007/s11262-014-1075-7; Wang CYJ, 2002, J CLIN MICROBIOL, V40, P2584, DOI 10.1128/JCM.40.7.2584-2590.2002; Wang JY, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0351-z; Wang KC, 2017, VIRUS RES, V233, P1, DOI 10.1016/j.virusres.2017.03.007; Wang YH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183923; Wu W, 2015, INFECT GENET EVOL, V32, P34, DOI 10.1016/j.meegid.2015.02.016; Xu C, 2018, POULTRY SCI, V97, P3023, DOI 10.3382/ps/pey154; Xu CP, 2007, VET MICROBIOL, V122, P61, DOI 10.1016/j.vetmic.2007.01.006; Xu LW, 2018, INFECT GENET EVOL, V66, P82, DOI 10.1016/j.meegid.2018.09.018; Zelin Wang, 2010, CHINESE J VET SCI, V30; Zeng XW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094980; Zengqi Yang, 2015, ACTA AGR BOREALI OCC, V24; Zhao G, 2013, AVIAN DIS, V57, P155, DOI 10.1637/10293-062812-Case.1; Zhaoqiang Xu, 2011, CHINA ANIMAL HLTH, V8; Zhu J, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0211-2; Zou NL, 2010, VIRUS GENES, V41, P202, DOI 10.1007/s11262-010-0500-9; Zou XH, 2017, SCI CHINA LIFE SCI, V60, P279, DOI 10.1007/s11427-016-0244-8	47	4	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211553	10.1371/journal.pone.0211553	http://dx.doi.org/10.1371/journal.pone.0211553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785912	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000031
J	Habermann, E; San Martin, JAB; Contin, DR; Bossan, VP; Barboza, A; Braga, MR; Groppo, M; Martinez, CA				Habermann, Eduardo; Barrera San Martin, Juca Abramo; Contin, Daniele Ribeiro; Bossan, Vitor Potenza; Barboza, Anelize; Braga, Marcia Regina; Groppo, Milton; Martinez, Carlos Alberto			Increasing atmospheric CO2 and canopy temperature induces anatomical and physiological changes in leaves of the C-4 forage species Panicum maximum	PLOS ONE			English	Article							INFRARED HEATER ARRAYS; WATER-USE EFFICIENCY; ELEVATED CO2; STOMATAL CONDUCTANCE; GENETIC MANIPULATION; PLANT-GROWTH; PHOTOSYNTHESIS; EVOLUTION; RESPONSES; CARBON	Changes in leaf anatomy and ultrastructure are associated with physiological performance in the context of plant adaptations to climate change. In this study, we investigated the isolated and combined effects of elevated atmospheric CO2 concentration ([CO2]) up to 600 mu mol mol(-1) (eC) and elevated temperature (eT) to 2 degrees C more than the ambient canopy temperature on the ultrastructure, leaf anatomy, and physiology of Panicum maximum Jacq. grown under field conditions using combined free-air carbon dioxide enrichment (FACE) and temperature free-air controlled enhancement (T-FACE) systems. Plants grown under eC showed reduced stomatal density, stomatal index, stomatal conductance (g(s)), and leaf transpiration rate (E), increased soil-water content (SWC) conservation and adaxial epidermis thickness were also observed. The net photosynthesis rate (A) and intrinsic water-use efficiency (iWUE) were enhanced by 25% and 71%, respectively, with a concomitant increase in the size of starch grains in bundle sheath cells. Under air warming, we observed an increase in the thickness of the adaxial cuticle and a decrease in the leaf thickness, size of vascular bundles and bulliform cells, and starch content. Under eCeT, air warming offset the eC effects on SWC and E, and no interactions between [CO2] and temperature for leaf anatomy were observed. Elevated [CO2] exerted more effects on external characteristics, such as the epidermis anatomy and leaf gas exchange, while air warming affected mainly the leaf structure. We conclude that differential anatomical and physiological adjustments contributed to the acclimation of P. maximum growing under elevated [CO2] and air warming, improving the leaf biomass production under these conditions.	[Habermann, Eduardo; Barrera San Martin, Juca Abramo; Contin, Daniele Ribeiro; Bossan, Vitor Potenza; Barboza, Anelize; Groppo, Milton; Martinez, Carlos Alberto] Univ Sao Paulo, FFCLRP, Dept Biol, Ribeirao Preto, SP, Brazil; [Braga, Marcia Regina] Inst Bot, Dept Plant Physiol & Biochem, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Instituto de Botanica - Sao Paulo	Martinez, CA (corresponding author), Univ Sao Paulo, FFCLRP, Dept Biol, Ribeirao Preto, SP, Brazil.	carlosamh@ffclrp.usp.br	Habermann, Eduardo/E-1222-2016; Groppo, Milton/G-2175-2012; Martinez, Carlos/B-8222-2011	Habermann, Eduardo/0000-0003-3371-7684; Groppo, Milton/0000-0003-2932-7798; Martinez, Carlos/0000-0002-0246-9481; San Martin, Juca/0000-0001-8827-4118	CNPq/ANA/MCTI [446357/2015-4]; Sao Paulo Research Foundation -FAPESP [2008/58075-8]; FAPESP [14/26821-3]	CNPq/ANA/MCTI; Sao Paulo Research Foundation -FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the CNPq/ANA/MCTI (Grant 446357/2015-4) to C.A.M. and the Sao Paulo Research Foundation -FAPESP (Grant 2008/58075-8) to C.A.M., and FAPESP Grant (14/26821-3) to E.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElgawad H, 2015, PLANT SCI, V231, P1, DOI 10.1016/j.plantsci.2014.11.001; Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Asner GP, 2004, ANNU REV ENV RESOUR, V29, P261, DOI 10.1146/annurev.energy.29.062403.102142; Bernacchi CJ, 2007, PLANT PHYSIOL, V143, P134, DOI 10.1104/pp.106.089557; BOWES G, 1993, ANNU REV PLANT PHYS, V44, P309, DOI 10.1146/annurev.pp.44.060193.001521; Prado CHBD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149620; Carnevalli RA, 2006, TROP GRASSLANDS, V40, P165; Chandra S, 2004, J AGRON CROP SCI, V190, P13, DOI 10.1046/j.0931-2250.2003.00064.x; Chartzoulakis K, 2002, SCI HORTIC-AMSTERDAM, V95, P39, DOI 10.1016/S0304-4238(02)00016-X; Correa LDA, 2003, MANEJO UTILIZACAO PL; da Silva SC, 2015, AGRICULTURE-BASEL, V5, P598, DOI 10.3390/agriculture5030598; De Souza AP, 2008, PLANT CELL ENVIRON, V31, P1116, DOI 10.1111/j.1365-3040.2008.01822.x; DELUCIA EH, 1984, CAN J BOT, V62, P2423, DOI 10.1139/b84-331; DELUCIA EH, 1985, PHOTOSYNTH RES, V7, P175, DOI 10.1007/BF00037008; Doheny-Adams T, 2012, PHILOS T R SOC B, V367, P547, DOI 10.1098/rstb.2011.0272; Driscoll SP, 2006, J EXP BOT, V57, P381, DOI 10.1093/jxb/erj030; EMBRAPA, 2014, REL AV IMP TECN GER, P1; Engineer CB, 2014, NATURE, V513, P246, DOI 10.1038/nature13452; Flugge UI, 2000, TRENDS PLANT SCI, V5, P135, DOI 10.1016/S1360-1385(00)01578-8; FRANKLIN GL, 1945, NATURE, V155, P51, DOI 10.1038/155051a0; Franks PJ, 2015, NEW PHYTOL, V207, P188, DOI 10.1111/nph.13347; Fu G, 2015, J PLANT GROWTH REGUL, V34, P57, DOI 10.1007/s00344-014-9442-0; GRABBER JH, 1992, GRASS FORAGE SCI, V47, P400, DOI 10.1111/j.1365-2494.1992.tb02286.x; Gray JE, 2000, NATURE, V408, P713, DOI 10.1038/35047071; Guan M, 2016, INT J PHYTOREMEDIAT, V18, P368, DOI 10.1080/15226514.2015.1109591; Han M, 2007, FRONT BIOL BEIJING, V2, P333, DOI DOI 10.1007/; Han X, 2013, J EXP BOT, V64, P4589, DOI 10.1093/jxb/ert262; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Johansen DA, 1941, PLANT MICROTECHNIQUE; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Kim HK, 2014, J EXP BOT, V65, P1895, DOI 10.1093/jxb/eru075; Kimball BA, 2008, GLOBAL CHANGE BIOL, V14, P309, DOI 10.1111/j.1365-2486.2007.01486.x; Kimball BA, 2012, THEOR APPL CLIMATOL, V108, P247, DOI 10.1007/s00704-011-0518-5; Kirkham MB, 2011, ELEVATED CARBON DIOX; Kosma DK, 2009, PLANT PHYSIOL, V151, P1918, DOI 10.1104/pp.109.141911; Leakey ADB, 2009, J EXP BOT, V60, P2859, DOI 10.1093/jxb/erp096; Marin FR, 2013, CLIMATIC CHANGE, V117, P227, DOI 10.1007/s10584-012-0561-y; Martinez CA, 2014, ENVIRON EXP BOT, V102, P58, DOI 10.1016/j.envexpbot.2014.02.001; Masle J, 2000, PLANT PHYSIOL, V122, P1399, DOI 10.1104/pp.122.4.1399; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Metcalfe CR, 1960, ANATOMY MONOCOTYLEDO; Miglietta F, 1999, ENVIRON MONIT ASSESS, V66, P107; Morgan JA, 2011, NATURE, V476, P202, DOI 10.1038/nature10274; OBRIEN TP, 1964, PROTOPLASMA, V59, P368, DOI 10.1007/BF01248568; OERTLI JJ, 1990, ACTA OECOL, V11, P281; Pachauri R.K., 2014, CONTRIBUTION WORKING, P151, DOI DOI 10.1016/S0022-0248(00)00575-3; Pezzopane JRM, 2017, GRASS FORAGE SCI, V72, P104, DOI 10.1111/gfs.12229; R Core Team, 2021, R LANGUAGE ENV STAT; Ranasinghe S, 1996, J EXP BOT, V47, P349, DOI 10.1093/jxb/47.3.349; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Sack L, 2013, NEW PHYTOL, V198, P983, DOI 10.1111/nph.12253; Sage RF, 2007, PLANT CELL ENVIRON, V30, P1086, DOI 10.1111/j.1365-3040.2007.01682.x; Samuels L, 2008, ANNU REV PLANT BIOL, V59, P683, DOI 10.1146/annurev.arplant.59.103006.093219; Smith RA, 2012, FUNCT PLANT BIOL, V39, P285, DOI 10.1071/FP11238; Terashima I, 2011, PLANT PHYSIOL, V155, P108, DOI 10.1104/pp.110.165472; Thalmann M, 2017, NEW PHYTOL, V214, P943, DOI 10.1111/nph.14491; Tipping C, 1999, INT J PLANT SCI, V160, P1063, DOI 10.1086/314201; Amaral Lourdes Isabel Velho do, 2007, Hoehnea, V34, P425; Walz H., 2009, IMAGING PAM M SERIES; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; WATSON ML, 1958, J BIOPHYS BIOCHEM CY, V4, P475, DOI 10.1083/jcb.4.4.475; Webb NP, 2012, CLIMATIC CHANGE, V112, P925, DOI 10.1007/s10584-011-0236-0; Werner, 1997, RECOMENDACOES ADUBAC; Wullschleger SD, 2002, PLANT CELL ENVIRON, V25, P319, DOI 10.1046/j.1365-3040.2002.00796.x; Xu CY, 2012, J EXP BOT, V63, P5829, DOI 10.1093/jxb/ers231; Xu ZZ, 2013, J PLANT GROWTH REGUL, V32, P692, DOI 10.1007/s00344-013-9337-5; Yamane K, 2008, PLANT PROD SCI, V11, P139, DOI 10.1626/pps.11.139; Zeeman SC, 2010, ANNU REV PLANT BIOL, V61, P209, DOI 10.1146/annurev-arplant-042809-112301; Zhang FF, 2012, SCI WORLD J, P1, DOI 10.1100/2012/601263; Zhang JJ, 2015, PLANT BIOLOGY, V17, P437, DOI 10.1111/plb.12255; Zheng YP, 2013, ACTA PHYSIOL PLANT, V35, P2891, DOI 10.1007/s11738-013-1320-z	73	31	32	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212506	10.1371/journal.pone.0212506	http://dx.doi.org/10.1371/journal.pone.0212506			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779815	gold, Green Published			2022-12-26	WOS:000459062900060
J	Chhabra, Y; Nelson, CN; Plescher, M; Barclay, JL; Smith, AG; Andrikopoulos, S; Mangiafico, S; Waxman, DJ; Brooks, AJ; Waters, MJ				Chhabra, Yash; Nelson, Caroline N.; Plescher, Monika; Barclay, Johanna L.; Smith, Aaron G.; Andrikopoulos, Sof; Mangiafico, Salvatore; Waxman, David J.; Brooks, Andrew J.; Waters, Michael J.			Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity	FASEB JOURNAL			English	Article						metabolism; gluconeogenesis; hepatic glucose output	SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; GENE-EXPRESSION; NEGATIVE REGULATOR; RECEPTOR SUBSTRATE-1; TARGETED DISRUPTION; GLUCOSE-PRODUCTION; DIABETES-MELLITUS; LARON SYNDROME; FATTY LIVER	Growth hormone (GH) has an important function as an insulin antagonist with elevated insulin sensitivity evident in humans and mice lacking a functional GH receptor (GHR). We sought the molecular basis for this sensitivity by utilizing a panel of mice possessing specific deletions of GHR signaling pathways. Metabolic clamps and glucose homeostasis tests were undertaken in these obese adult C57BL/6 male mice, which indicated impaired hepatic gluconeogenesis. Insulin sensitivity and glucose disappearance rate were enhanced in muscle and adipose of mice lacking the ability to activate the signal transducer and activator of transcription (STAT)5 via the GHR (Ghr-391(-/-)) as for GHR-null (GHR(-/-)) mice. These changes were associated with a striking inhibition of hepatic glucose output associated with altered glycogen metabolism and elevated hepatic glycogen content during unfed state. The enhanced hepatic insulin sensitivity was associated with increased insulin receptor and insulin receptor substrate 1 activation along with activated downstream protein kinase B signaling cascades. Although phosphoenolpyruvate carboxykinase (Pck)-1 expression was unchanged, its inhibitory acetylation was elevated because of decreased sirtuin-2 expression, thereby promoting loss of PCK1. Loss of STAT5 signaling to defined chromatin immunoprecipitation targets would further increase lipogenesis, supporting hepatosteatosis while lowering glucose output. Finally, up-regulation of IL-15 expression in muscle, with increased secretion of adiponectin and fibroblast growth factor 1 from adipose tissue, is expected to promote insulin sensitivity.Chhabra, Y., Nelson, C. N., Plescher, M., Barclay, J. L., Smith, A. G., Andrikopoulos, S., Mangiafico, S., Waxman, D. J., Brooks, A. J., Waters, M. J. Loss of growth hormone-mediated signal transducer and activator of transcription 5 (STAT5) signaling in mice results in insulin sensitivity with obesity.	[Chhabra, Yash; Brooks, Andrew J.] Univ Queensland, Diamantina Inst, Translat Res Inst, 37 Kent St, Brisbane, Qld 4102, Australia; [Barclay, Johanna L.] Univ Queensland, Mater Res Inst, Translat Res Inst, Brisbane, Qld, Australia; [Smith, Aaron G.] Univ Queensland, Sch Biomed Sci, Translat Res Inst, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Chhabra, Yash; Nelson, Caroline N.; Plescher, Monika; Barclay, Johanna L.; Brooks, Andrew J.; Waters, Michael J.] Univ Queensland, Inst Mol Biosci, 306 Carmody Rd, Brisbane, Qld 4072, Australia; [Plescher, Monika] Univ Bonn, Med Fac, Inst Cellular Neurosci, Bonn, Germany; [Andrikopoulos, Sof; Mangiafico, Salvatore] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [Waxman, David J.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA	University of Queensland; Mater Research; University of Queensland; Queensland University of Technology (QUT); University of Queensland; University of Queensland; University of Bonn; University of Melbourne; Boston University	Chhabra, Y (corresponding author), Univ Queensland, Diamantina Inst, Translat Res Inst, 37 Kent St, Brisbane, Qld 4102, Australia.; Waters, MJ (corresponding author), Univ Queensland, Inst Mol Biosci, 306 Carmody Rd, Brisbane, Qld 4072, Australia.	y.chhabra1@uq.edu.au; m.waters@uq.edu.au	Brooks, Andrew/A-9969-2011; Barclay, Johanna/G-6293-2012	Brooks, Andrew/0000-0002-2691-1668; Barclay, Johanna/0000-0001-5737-1775; Plescher, Monika/0000-0002-3515-9789; Chhabra, Yash/0000-0003-2883-4675	National Health and Medical Research Council [1083612, 1124026, 401668]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK033765]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK033765, R01DK033765] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank The University of Queensland Institute for Molecular Biosciences Animal House Facility for animal husbandry services. The research was supported by National Health and Medical Research Council grants 1083612 (to A.G.S.), 1124026 (to A.J.B.), and 401668 (to M.J.W.). D.J.W. was supported, in part, by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK033765. The authors declare no conflicts of interest.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Barbour LA, 2005, J BIOL CHEM, V280, P37489, DOI 10.1074/jbc.M506967200; Barclay JL, 2011, ENDOCRINOLOGY, V152, P181, DOI 10.1210/en.2010-0537; Berryman DE, 2004, GROWTH HORM IGF RES, V14, P309, DOI 10.1016/j.ghir.2004.02.005; Bonkowski MS, 2006, P NATL ACAD SCI USA, V103, P7901, DOI 10.1073/pnas.0600161103; BOUGNERES PF, 1985, J CLIN ENDOCR METAB, V61, P1152, DOI 10.1210/jcem-61-6-1152; Boutant M, 2014, MOL METAB, V3, P5, DOI 10.1016/j.molmet.2013.10.006; Busquets S, 2006, BBA-GEN SUBJECTS, V1760, P1613, DOI 10.1016/j.bbagen.2006.09.001; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Caton PW, 2010, J ENDOCRINOL, V205, P97, DOI 10.1677/JOE-09-0345; Chhabra Y, 2018, ONCOGENE, V37, P489, DOI 10.1038/onc.2017.352; Chhabra Y, 2011, EXPERT REV ENDOCRINO, V6, P71, DOI [10.1586/eem.10.73, 10.1586/EEM.10.73]; Corbit KC, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91001; COTES PM, 1949, NATURE, V164, P209, DOI 10.1038/164209a0; Cutfield WS, 2000, LANCET, V355, P610, DOI 10.1016/S0140-6736(99)04055-6; da Rocha AF, 2013, MOL CELL BIOCHEM, V375, P89, DOI 10.1007/s11010-012-1531-4; Dominici FP, 2002, EXP BIOL MED, V227, P149, DOI 10.1177/153537020222700301; Dominici FP, 1999, AM J PHYSIOL-ENDOC M, V277, pE447, DOI 10.1152/ajpendo.1999.277.3.E447; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Frara S, 2016, TRENDS ENDOCRIN MET, V27, P470, DOI 10.1016/j.tem.2016.04.014; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068105; Geering B, 2007, BIOCHEM SOC T, V35, P199, DOI 10.1042/BST0350199; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; Hoybye C, 2008, HORM METAB RES, V40, P498, DOI 10.1055/s-2008-1065322; Husbands S, 2001, CLIN ENDOCRINOL, V55, P87, DOI 10.1046/j.1365-2265.2001.01298.x; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2013, DIABETES, V62, P3404, DOI 10.2337/db12-1650; Kanety H, 2009, EUR J ENDOCRINOL, V161, P837, DOI 10.1530/EJE-09-0419; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Kim YD, 2012, DIABETES, V61, P2484, DOI 10.2337/db11-1665; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Ling GY, 2010, MOL CELL BIOL, V30, P5531, DOI 10.1128/MCB.00601-10; List EO, 2014, ENDOCRINOLOGY, V155, P1793, DOI 10.1210/en.2013-2086; List EO, 2013, MOL ENDOCRINOL, V27, P524, DOI 10.1210/me.2012-1330; Longo KA, 2010, GROWTH HORM IGF RES, V20, P73, DOI 10.1016/j.ghir.2009.08.002; Mangiafico SP, 2011, J ENDOCRINOL, V210, P335, DOI 10.1530/JOE-11-0126; Mavalli MD, 2010, J CLIN INVEST, V120, P4007, DOI 10.1172/JCI42447; Mejhert N, 2010, J CLIN ENDOCR METAB, V95, P2451, DOI 10.1210/jc.2009-2049; Meyer RD, 2009, MOL ENDOCRINOL, V23, P1914, DOI 10.1210/me.2009-0242; Miller RA, 2011, J CLIN INVEST, V121, P2518, DOI 10.1172/JCI45942; MOLLER N, 1990, J CLIN ENDOCR METAB, V70, P1179, DOI 10.1210/jcem-70-4-1179; MOLLER N, 1990, AM J PHYSIOL, V258, pE86, DOI 10.1152/ajpendo.1990.258.1.E86; Nellemann B, 2014, ACTA PHYSIOL, V210, P392, DOI 10.1111/apha.12183; Nelson CN, 2018, GROWTH HORM IGF RES, V42-43, P40, DOI 10.1016/j.ghir.2018.08.004; NG SF, 1990, METABOLISM, V39, P264, DOI 10.1016/0026-0495(90)90045-E; Nordstrom SM, 2013, MOL ENDOCRINOL, V27, P1333, DOI 10.1210/me.2013-1110; Panasyuk G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1667; Panici JA, 2009, J GERONTOL A-BIOL, V64, P1126, DOI 10.1093/gerona/glp111; Prattali RR, 2005, FEBS LETT, V579, P3152, DOI 10.1016/j.febslet.2005.04.075; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rowland JE, 2005, MOL CELL BIOL, V25, P66, DOI 10.1128/MCB.25.1.66-77.2005; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasca D, 2014, BLOOD, V124, P121, DOI 10.1182/blood-2013-11-538819; Schirra HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002764; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Taniguchi CM, 2006, P NATL ACAD SCI USA, V103, P12093, DOI 10.1073/pnas.0604628103; Turei D, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/737591; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Vijayakumar A, 2012, DIABETES, V61, P94, DOI 10.2337/db11-0814; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Wang Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/925350; Wei D, 2011, AM J PHYSIOL-ENDOC M, V300, pE312, DOI 10.1152/ajpendo.00524.2010; Weigert C, 2008, MOL ENDOCRINOL, V22, P2729, DOI 10.1210/me.2008-0102; White UA, 2007, DIABETES, V56, P1623, DOI 10.2337/db06-1286; Yakar S, 2004, J CLIN INVEST, V113, P96, DOI 10.1172/JCI200417763; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan JG, 1996, P NATL ACAD SCI USA, V93, P4953, DOI 10.1073/pnas.93.10.4953; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	77	16	17	2	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6412	6430		10.1096/fj.201802328R	http://dx.doi.org/10.1096/fj.201802328R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30779881	Bronze, Green Published			2022-12-26	WOS:000466932600048
J	Michno, W; Nystrom, S; Wehrli, P; Lashley, T; Brinkmalm, G; Guerard, L; Syvanen, S; Sehlin, D; Kaya, I; Brinet, D; Nilsson, KPR; Hammarstrom, P; Blennow, K; Zetterberg, H; Hanrieder, J				Michno, Wojciech; Nystrom, Sofie; Wehrli, Patrick; Lashley, Tammaryn; Brinkmalm, Gunnar; Guerard, Laurent; Syvanen, Stina; Sehlin, Dag; Kaya, Ibrahim; Brinet, Dimitri; Nilsson, K. Peter R.; Hammarstrom, Per; Blennow, Kaj; Zetterberg, Henrik; Hanrieder, Jorg			Pyroglutamation of amyloid-x-42 (Ax-42) followed by A1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amyloid-beta (A); Alzheimer disease; mass spectrometry (MS); imaging; protein aggregation; neurodegeneration; pyroglutamation; plaque polymorphism; hyperspectral imaging; transgenic mice; pyroglutamic acid	HEREDITARY CEREBRAL-HEMORRHAGE; A-BETA-DEPOSITION; PRECURSOR PROTEIN; CEREBROSPINAL-FLUID; TRANSGENIC MOUSE; MASS-SPECTROMETRY; AGGREGATION PATHWAYS; SENILE PLAQUES; IN-VITRO; PEPTIDE	Amyloid- (A) pathology in Alzheimer's disease (AD) is characterized by the formation of polymorphic deposits comprising diffuse and cored plaques. Because diffuse plaques are predominantly observed in cognitively unaffected, amyloid-positive (CU-AP) individuals, pathogenic conversion into cored plaques appears to be critical to AD pathogenesis. Herein, we identified the distinct A species associated with amyloid polymorphism in brain tissue from individuals with sporadic AD (s-AD) and CU-AP. To this end, we interrogated A polymorphism with amyloid conformation-sensitive dyes and a novel in situ MS paradigm for chemical characterization of hyperspectrally delineated plaque morphotypes. We found that maturation of diffuse into cored plaques correlated with increased A1-40 deposition. Using spatial in situ delineation with imaging MS (IMS), we show that A1-40 aggregates at the core structure of mature plaques, whereas A1-42 localizes to diffuse amyloid aggregates. Moreover, we observed that diffuse plaques have increased pyroglutamated Ax-42 levels in s-AD but not CU-AP, suggesting an AD pathology-related, hydrophobic functionalization of diffuse plaques facilitating A1-40 deposition. Experiments in tgAPP(Swe) mice verified that, similar to what has been observed in human brain pathology, diffuse deposits display higher levels of A1-42 and that A plaque maturation over time is associated with increases in A1-40. Finally, we found that A1-40 deposition is characteristic for cerebral amyloid angiopathy deposition and maturation in both humans and mice. These results indicate that N-terminal Ax-42 pyroglutamation and A1-40 deposition are critical events in priming and maturation of pathogenic A from diffuse into cored plaques, underlying neurotoxic plaque development in AD.	[Michno, Wojciech; Wehrli, Patrick; Brinkmalm, Gunnar; Kaya, Ibrahim; Brinet, Dimitri; Blennow, Kaj; Zetterberg, Henrik; Hanrieder, Jorg] Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, S-43180 Molndal, Sweden; [Nystrom, Sofie; Nilsson, K. Peter R.; Hammarstrom, Per] Linkoping Univ, Dept Phys Chem & Biol, S-58183 Linkoping, Sweden; [Lashley, Tammaryn; Zetterberg, Henrik; Hanrieder, Jorg] UCL, Dept Neurodegenerat Dis, UCL Queen Sq Inst Neurol, London WC1N 3BG, England; [Syvanen, Stina; Sehlin, Dag] Uppsala Univ, Dept Publ Hlth & Caring Sci, S-75236 Uppsala, Sweden; [Blennow, Kaj; Zetterberg, Henrik] Sahlgrens Univ Hosp, Clin Neurochem Lab, S-43180 Molndal, Sweden; [Zetterberg, Henrik] UCL, UK Dementia Res Inst, London WC1E 6BT, England; [Guerard, Laurent] Univ Gothenburg, Sahlgrenska Acad, Ctr Cellular Imaging, S-41390 Gothenburg, Sweden	University of Gothenburg; Linkoping University; University of London; University College London; Uppsala University; Sahlgrenska University Hospital; University of London; University College London; University of Gothenburg	Hanrieder, J (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Psychiat & Neurochem, Molndal Hosp, House V, S-43180 Molndal, Sweden.	jh@gu.se	Brinkmalm, Gunnar/AAH-3914-2021; Michno, Wojciech/C-2599-2019	Michno, Wojciech/0000-0002-3096-3604; Sehlin, Dag/0000-0002-9430-3859; Kaya, Ibrahim/0000-0003-3345-5602; Hammarstrom, Per/0000-0001-5827-3587; Lashley, Tammaryn/0000-0001-7389-0348; Syvanen, Stina/0000-0002-8196-4041; Guerard, Laurent/0000-0002-5166-8524; Nystrom, Sofie/0000-0002-4303-4783; Hanrieder, Jorg/0000-0001-6059-198X	Leonard Wolfson Centre for Experimental Neurology; Reta Lila Weston Institute for Neurological Studies; Medical Research Council	Leonard Wolfson Centre for Experimental Neurology; Reta Lila Weston Institute for Neurological Studies; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the staff at the Centre for Cellular Imaging (CCI), Core Facilities, Sahlgrenska Academy at the University of Gothenburg and the National Microscopy Infrastructure, NMI (VR-RFI 2016-00968), for help with development of hyperspectral imaging paradigm and microscopy expertise. TL acknowledges the Leonard Wolfson Centre for Experimental Neurology for financial support. The Queen Square Brain Bank is supported by the Reta Lila Weston Institute for Neurological Studies and the Medical Research Council.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Blennow K, 2010, NAT REV NEUROL, V6, P131, DOI 10.1038/nrneurol.2010.4; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brinkmalm G, 2012, J MASS SPECTROM, V47, P591, DOI 10.1002/jms.2987; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Condello C, 2018, P NATL ACAD SCI USA, V115, pE782, DOI 10.1073/pnas.1714966115; Cummings DM, 2015, BRAIN, V138, P1992, DOI 10.1093/brain/awv127; D'Arrigo C, 2009, BIOPOLYMERS, V91, P861, DOI 10.1002/bip.21271; DICKSON DW, 1992, NEUROBIOL AGING, V13, P179, DOI 10.1016/0197-4580(92)90027-U; Dickson TC, 2001, NEUROSCIENCE, V105, P99, DOI 10.1016/S0306-4522(01)00169-5; Dong MY, 2016, CHEMPHYSCHEM, V17, P2558, DOI 10.1002/cphc.201600256; Ellingsen PG, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.10.101313; Esbjorner EK, 2014, CHEM BIOL, V21, P732, DOI 10.1016/j.chembiol.2014.03.014; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fukumoto H, 1996, NEURODEGENERATION, V5, P13, DOI 10.1006/neur.1996.0002; GIBBONS GH, 1994, NEW ENGL J MED, V330, P1431; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Gu L, 2013, J NEUROCHEM, V126, P305, DOI 10.1111/jnc.12202; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Hanrieder J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009308; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Heilbronner G, 2013, EMBO REP, V14, P1017, DOI 10.1038/embor.2013.137; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang THJ, 2000, J BIOL CHEM, V275, P36436, DOI 10.1074/jbc.M005698200; IKEDA S, 1989, LAB INVEST, V60, P113; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jack CR, 2018, ALZHEIMERS DEMENT, V14, P535, DOI 10.1016/j.jalz.2018.02.018; Jiang DL, 2012, LANGMUIR, V28, P12711, DOI 10.1021/la3021436; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kaya I, 2017, ACS CHEM NEUROSCI, V8, P2778, DOI 10.1021/acschemneuro.7b00314; Klingstedt T, 2013, CHEMBIOCHEM, V14, P607, DOI 10.1002/cbic.201200731; Kumar-Singh S, 2008, GENES BRAIN BEHAV, V7, P67, DOI 10.1111/j.1601-183X.2007.00380.x; Kumar-Singh S, 2005, AM J PATHOL, V167, P527, DOI 10.1016/S0002-9440(10)62995-1; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 2001, MOL MED, V7, P609, DOI 10.1007/BF03401867; Lendel C, 2014, ANGEW CHEM INT EDIT, V53, P12756, DOI 10.1002/anie.201406357; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Lord A, 2006, NEUROBIOL AGING, V27, P67, DOI 10.1016/j.neurobiolaging.2004.12.007; Lord A, 2011, AM J PATHOL, V178, P2286, DOI 10.1016/j.ajpath.2011.01.052; Mann DMA, 1996, AM J PATHOL, V148, P1257; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORI H, 1992, J BIOL CHEM, V267, P17082; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nilsson KPR, 2007, ACS CHEM BIOL, V2, P553, DOI 10.1021/cb700116u; Nystrom S, 2013, ACS CHEM BIOL, V8, P1128, DOI 10.1021/cb4000376; Pannee J, 2016, J NEUROCHEM, V139, P651, DOI 10.1111/jnc.13838; Philipson O, 2009, NEUROBIOL AGING, V30, P1393, DOI 10.1016/j.neurobiolaging.2007.11.022; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2007, J PROTEOME RES, V6, P4433, DOI 10.1021/pr0703627; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Psonka-Antonczyk KM, 2016, FRONT CHEM, V4, DOI 10.33839/fchem.2016.00044; Rasmussen J, 2017, P NATL ACAD SCI USA, V114, P13018, DOI 10.1073/pnas.1713215114; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schmidt M, 2009, P NATL ACAD SCI USA, V106, P19813, DOI 10.1073/pnas.0905007106; Shin RW, 1997, J NEUROSCI, V17, P8187; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; Terai K, 2001, BRAIN RES, V900, P48, DOI 10.1016/S0006-8993(01)02202-8; Thal Dietmar R, 2006, Sci Aging Knowledge Environ, V2006, pre1, DOI 10.1126/sageke.2006.6.re1; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Verbeek MM, 2009, ANN NEUROL, V66, P245, DOI 10.1002/ana.21694; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Watts JC, 2014, P NATL ACAD SCI USA, V111, P10323, DOI 10.1073/pnas.1408900111; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Westermark GT, 1999, METHOD ENZYMOL, V309, P3; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V76, P541, DOI 10.1007/BF00689591; Yang JH, 2011, ANAL CHEM, V83, P5728, DOI 10.1021/ac200998a	76	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6719	6732		10.1074/jbc.RA118.006604	http://dx.doi.org/10.1074/jbc.RA118.006604			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30814252	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000467394700011
J	Malak, OA; Gluhov, GS; Grizel, AV; Kudryashova, KS; Sokolova, OS; Loussouarn, G				Malak, Olfat A.; Gluhov, Grigory S.; Grizel, Anastasia V.; Kudryashova, Kseniya S.; Sokolova, Olga S.; Loussouarn, Gildas			Voltage-dependent activation in EAG channels follows a ligand-receptor rather than a mechanical-lever mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ion channel; electrophysiology; peptides; physiology; biophysics; allosteric regulation; EAG channel; Kv 10; 2 channel; S4-S5 linker; S6 C-terminus; voltage dependence	AMINO-TERMINAL DOMAIN; CRYO-EM STRUCTURE; S4-S5 LINKER; POTASSIUM CHANNELS; GATING MECHANISM; N-TERMINUS; HERG; SENSOR; REVEALS; DEACTIVATION	Ether-a-go-go family (EAG) channels play a major role in many physiological processes in humans, including cardiac repolarization and cell proliferation. Cryo-EM structures of two of them, K(V)10.1 and human ether-a-go-go-related gene (hERG or K(V)11.1), have revealed an original nondomain-swapped structure, suggesting that the mechanism of voltage-dependent gating of these two channels is quite different from the classical mechanical-lever model. Molecular aspects of hERG voltage-gating have been extensively studied, indicating that the S4-S5 linker (S4-S5(L)) acts as a ligand binding to the S6 gate (S6 C-terminal part, S6(T)) and stabilizes it in a closed state. Moreover, the N-terminal extremity of the channel, called N-Cap, has been suggested to interact with S4-S5(L) to modulate channel voltage-dependent gating, as N-Cap deletion drastically accelerates hERG channel deactivation. In this study, using COS-7 cells, site-directed mutagenesis, electrophysiological measurements, and immunofluorescence confocal microscopy, we addressed whether these two major mechanisms of voltage-dependent gating are conserved in K(V)10.2 channels. Using cysteine bridges and S4-S5(L)-mimicking peptides, we show that the ligand/receptor model is conserved in K(V)10.2, suggesting that this model is a hallmark of EAG channels. Truncation of the N-Cap domain, Per-Arnt-Sim (PAS) domain, or both in K(V)10.2 abolished the current and altered channel trafficking to the membrane, unlike for the hERG channel in which N-Cap and PAS domain truncations mainly affected channel deactivation. Our results suggest that EAG channels function via a conserved ligand/receptor model of voltage gating, but that the N-Cap and PAS domains have different roles in these channels.	[Malak, Olfat A.; Loussouarn, Gildas] Univ Nantes, Inst Thorax, CNRS, INSERM, F-44007 Nantes, France; [Gluhov, Grigory S.; Kudryashova, Kseniya S.; Sokolova, Olga S.] Moscow MV Lomonosov State Univ, Moscow 119234, Russia; [Grizel, Anastasia V.] St Petersburg State Univ, St Petersburg 199034, Russia; [Kudryashova, Kseniya S.] Russian Acad Sci, Inst Bioorgan Chem, Shemyakin Ovchinnikov Inst, Moscow 117997, Russia	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; Lomonosov Moscow State University; Saint Petersburg State University; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Loussouarn, G (corresponding author), UN, IRS, Inst Thorax, INSERM,UMR 1087,CNRS,UMR 6291, 8 Quai Moncousu BP 70721, F-44007 Nantes 1, France.	gildas.loussouarn@inserm.fr	Sokolova, Olga/AAM-8289-2020; Sokolova, Olga S/G-7794-2016; Loussouarn, Gildas/D-3590-2015; Loussouarn, Gildas/ABH-6043-2020; Glukhov, Grigoriy/E-7262-2018; Kudryashova, Ksenia S/A-9510-2014; Grizel, Anastasia V/A-4415-2015	Sokolova, Olga/0000-0003-4678-232X; Loussouarn, Gildas/0000-0001-8007-5931; Loussouarn, Gildas/0000-0001-8007-5931; Grizel, Anastasia V/0000-0003-4875-8171; Kudryashova, Ksenia/0000-0002-6937-3193	Moscow Lomonosov State University Program of Development	Moscow Lomonosov State University Program of Development	We thank Isabelle Baro for careful reading of the manuscript. We thank the MicroPiCell facility of SFR Sante F. Bonamy for confocal microscopy experiments (Nantes). O. A. M. personally thanks Line Pomaret for her generous support. The LSM710-Confocor3 microscope was supported by the Moscow Lomonosov State University Program of Development.	Barros F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020248; Beekwilder JP, 2003, J PHARMACOL EXP THER, V304, P531, DOI 10.1124/jpet.102.042135; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; Charpentier F, 2010, J MOL CELL CARDIOL, V48, P37, DOI 10.1016/j.yjmcc.2009.08.005; Choveau FS, 2011, J BIOL CHEM, V286, P707, DOI 10.1074/jbc.M110.146324; de la Pea P, 2018, PFLUG ARCH EUR J PHY, V470, P517, DOI 10.1007/s00424-017-2093-9; de la Pena P, 2013, BIOCHEM J, V451, P463, DOI 10.1042/BJ20121717; de la Pena P, 2011, J BIOL CHEM, V286, P19065, DOI 10.1074/jbc.M111.238899; Fernandez-Trillo J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024674; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Gilchrist Annette, 2002, Sci STKE, V2002, ppl1, DOI 10.1126/stke.2002.118.pl1; Goodchild SJ, 2014, CHANNELS, V8, P84, DOI 10.4161/chan.26775; Horton RM, 2013, BIOTECHNIQUES, V54, P129; Jimenez-Perez L, 2016, J BIOL CHEM, V291, P3569, DOI 10.1074/jbc.M115.678995; Jouni M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002159; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Judge SI, 2006, PHARMACOL THERAPEUT, V111, P224, DOI 10.1016/j.pharmthera.2005.10.006; Ke Y, 2014, J BIOL CHEM, V289, P13782, DOI 10.1074/jbc.M113.531277; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ma LJ, 2011, BIOPHYS J, V100, P885, DOI 10.1016/j.bpj.2010.12.3726; Malak OA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00155-2; Ng CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016191; Osteen JD, 2012, P NATL ACAD SCI USA, V109, P7103, DOI 10.1073/pnas.1201582109; Pal S, 2003, J NEUROSCI, V23, P4798; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Piron J, 2010, J PHYSIOL-LONDON, V588, P3471, DOI 10.1113/jphysiol.2010.195313; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; Shen HZ, 2017, SCIENCE, V355, DOI 10.1126/science.aal4326; Silva J, 2005, CIRCULATION, V112, P1384, DOI 10.1161/CIRCULATIONAHA.105.543306; Sokolova O S, 2012, Bioorg Khim, V38, P177; Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019; Thouta S, 2014, BIOPHYS J, V106, P1057, DOI 10.1016/j.bpj.2014.01.035; Tomczak AP, 2017, J GEN PHYSIOL, V149, P577, DOI 10.1085/jgp.201611742; Tristani-Firouzi M, 2002, J BIOL CHEM, V277, P18994, DOI 10.1074/jbc.M200410200; Vardanyan V, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00145; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JL, 2000, J GEN PHYSIOL, V115, P749, DOI 10.1085/jgp.115.6.749; Wang WW, 2017, CELL, V169, P422, DOI 10.1016/j.cell.2017.03.048; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Yang Y, 2013, J NEUROSCI, V33, P16586, DOI 10.1523/JNEUROSCI.2307-13.2013; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978	44	10	10	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6506	6521		10.1074/jbc.RA119.007626	http://dx.doi.org/10.1074/jbc.RA119.007626			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30808709	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000468402000026
J	de Melo, MG; Varella, I; Gorbach, PM; Sprinz, E; Santos, B; Rocha, TD; Simon, M; Almeida, M; Lira, R; Chaves, MC; Baker, Z; Kerin, T; Nielsen-Saines, K				de Melo, Marineide Goncalves; Varella, Ivana; Gorbach, Pamina M.; Sprinz, Eduardo; Santos, Breno; Rocha, Taui de Melo; Simon, Mariana; Almeida, Marcelo; Lira, Rita; Chaves, Maria Cristina; Baker, Zoe; Kerin, Tara; Nielsen-Saines, Karin			Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil	PLOS ONE			English	Article							SEXUAL TRANSMISSION; DISOPROXIL FUMARATE; CONDOM USE; THERAPY; RNA; WOMEN; RISK; BEHAVIOR; BELIEFS; ADULTS	Background An undetectable serum HIV-1 load is key to effectiveness of antiretroviral (ARV) therapy, which depends on adherence to treatment. We evaluated factors possibly associated with ARV adherence and virologic response in HIV-infected heterosexual individuals. Methods A cross-sectional study was conducted in 200 HIV-1 serodiscordant couples and 100 unpartnered individuals receiving ARV treatment at a tertiary hospital in southern Brazil. All subjects provided written informed consent, answered demographic/behavioral questionnaires through audio computer-assisted self-interviews (ACASI), and collected blood and vaginal samples for biological markers and assessment of sexually transmitted infections (STIs). HIV-negative partners were counseled and tested for HIV-1. Results The study population mean age was 39.9 years, 53.6% were female, 62.5% were Caucasian, 52.6% had incomplete or complete elementary education, 63.1% resided in Porto Alegre. Demographic, behavioral and biological marker characteristics were similar between couples and single individuals. There was an association between adherence reported on ACASI and an undetectable serum viral load (P<0.0001). Logistic regression analysis demonstrated that single-tablet ARV-regimens were independently associated with adherence (OR = 2.3; 95CI%: 1.2-4.4; P = 0.011) after controlling for age, gender, education, marital status, personal income, ARV regimen, and median time of ARV use. A positive correlation between genital secretion PCR results and serum viral load was significant in the presence of STIs (r = 0.359; P = 0.017). Although HIV PCR detection in vaginal secretions was more frequent in women with detectable viremia (9/51, 17.6%), it was also present in 7 of 157 women with undetectable serum viral loads (4.5%), p = 0.005. Conclusions ARV single tablet regimens are associated with adherence. Detectable HIV-1 may be present in the genital secretions of women with undetectable viremia which means there is potential for HIV transmission in adherent individuals with serologic suppression.	[de Melo, Marineide Goncalves; Varella, Ivana; Santos, Breno; Rocha, Taui de Melo; Simon, Mariana; Almeida, Marcelo; Lira, Rita; Chaves, Maria Cristina] Hosp Nossa Senhora Conceicao, Porto Alegre, RS, Brazil; [Gorbach, Pamina M.; Baker, Zoe] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Sprinz, Eduardo] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil; [Kerin, Tara; Nielsen-Saines, Karin] David Geffen UCLA Sch Med, Dept Pediat, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Universidade Federal do Rio Grande do Sul; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Nielsen-Saines, K (corresponding author), David Geffen UCLA Sch Med, Dept Pediat, Los Angeles, CA 90095 USA.	KNiesen@mednet.ucla.edu	sprinz, eduardo/V-7961-2019	sprinz, eduardo/0000-0003-4343-8304; SANTOS, BRENO/0000-0002-2888-2573	UCLA AIDS Institute; UCLA Center for AIDS Research (CFAR); National Institute of Allergy and Infections Diseases (NIAID) [AI28697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069424] Funding Source: NIH RePORTER	UCLA AIDS Institute; UCLA Center for AIDS Research (CFAR); National Institute of Allergy and Infections Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the UCLA AIDS Institute (http://aidsinstitute.ucla.edu) and the UCLA Center for AIDS Research (CFAR; http://aidsinstitute.ucla.edu/cfar), National Institute of Allergy and Infections Diseases (NIAID; https://www.niaid.nih.gov/) AI28697.	[Anonymous], 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003255, DOI 10.1002/14651858.CD003255]; [Anonymous], 2012, GUIDANCE COUPLES HIV; Aye WL, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4309-5; Behrens G, 2014, AIDS PATIENT CARE ST, V28, P168, DOI 10.1089/apc.2013.0310; Chen YY, 2013, CURR HIV-AIDS REP, V10, P79, DOI 10.1007/s11904-012-0144-6; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Cotte L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170661; daBrasil S.M., 2016, B EPIDEMIOLOGICO DST, P1; DeJesus E, ELVITEGRAVIR COBICIS; Fiscus SA, 2013, CLIN INFECT DIS, V57, P290, DOI 10.1093/cid/cit195; Griffith DC, 2019, HIV MED, V20, P169, DOI 10.1111/hiv.12695; Hanif H, 2014, AIDS BEHAV, V18, P1945, DOI 10.1007/s10461-014-0711-5; Hasse B, 2010, CLIN INFECT DIS, V51, P1314, DOI 10.1086/656809; Hemmige V, 2018, AIDS CARE, V30, P1017, DOI 10.1080/09540121.2018.1442554; Hinkin CH, 2004, AIDS, V18, pS19, DOI 10.1097/00002030-200418001-00004; Joint United Nations Programme on HIV/AIDS (UNAIDS), GLOB AIDS UPD; Kouyos RD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv077; Launay O, 2011, ANTIVIR THER, V16, P843, DOI 10.3851/IMP1856; Marschner IC, 1998, J INFECT DIS, V177, P40, DOI 10.1086/513823; Melo MG, 2008, SEX TRANSM DIS, V35, P912, DOI 10.1097/OLQ.0b013e31817e2491; Murray JS, 1999, AIDS, V13, P797, DOI 10.1097/00002030-199905070-00008; Patterson S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0969-x; Rodger AJ, 2016, JAMA-J AM MED ASSOC, V316, P171, DOI 10.1001/jama.2016.5148; Safren SA, 2015, JAIDS-J ACQ IMM DEF, V69, P234, DOI 10.1097/QAI.0000000000000593; SAUDE BdSMD, 2013, PROT CLIN DIR BRAZ; Sax PE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031591; Suzan-Monti M, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20095; UNAIDS, END AIDS PROGR 90 90; Venkatesh KK, 2011, AIDS, V25, P1939, DOI 10.1097/QAD.0b013e32834b4ced; Vernazza P, 2008, B MED SUISSES, V89, P165; Vernazza Pietro L., 2009, HIV Therapy, V3, P113, DOI 10.2217/17584310.3.2.113; Wilkins EL, 2016, AIDS CARE, V28, P401, DOI 10.1080/09540121.2015.1096890; Wilson TE, 2001, J ACQ IMMUN DEF SYND, V27, P289, DOI 10.1097/00126334-200107010-00012; Wilson TE, 2007, AIDS EDUC PREV, V19, P151, DOI 10.1521/aeap.2007.19.2.151	34	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212744	10.1371/journal.pone.0212744	http://dx.doi.org/10.1371/journal.pone.0212744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811480	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400087
J	Kuupiel, D; Tlou, B; Bawontuo, V; Drain, PK; Mashamba-Thompson, TP				Kuupiel, Desmond; Tlou, Boikhutso; Bawontuo, Vitalis; Drain, Paul K.; Mashamba-Thompson, Tivani P.			Poor supply chain management and stock-outs of point-of-care diagnostic tests in Upper East Region's primary healthcare clinics, Ghana	PLOS ONE			English	Article							CHALLENGES; IMPLEMENTATION; QUALITY; HIV	Introduction Several supply chain components are important to sustain point-of-care (POC) testing services in rural settings. To evaluate the availability of POC diagnostic tests in rural Ghana's primary healthcare (PHC) clinics, we conducted an audit of the supply chain management for POC diagnostic services in rural Upper East Region's (UER) PHC clinics, Ghana to determine the reasons/causes of POC tests deficiencies. Material and methods We conducted a review of accessible POC diagnostics in 100 PHC clinics in UER, Ghana from February to March 2018. We used a monitoring audit tool adopted from the World Health Organization and Management Science for Health guidelines for supply chain management of diagnostics for compliance. We determined a clinic's compliance with the stipulated guidelines, and a composite compliant score was defined as a percentage rating of 90 to 100%. We used univariate logistic regression analysis in Stata 14 to determine the level of association between supply chain management and the audit variables. Results Overall, the composite compliant score of supply chain management for existing POC tests was at 81% (95% CI: 79%-82%). The mean compliance with distribution guidelines was at 93.8% (95% CI: 91.9%-95.6%) the highest score, whilst inventory management scored the lowest, at 53.5% (95% CI: 49.5%-57.5%) compliance. Of the 13 districts in the region, the results showed complete stock-out of blood glucose test in all selected PHC clinics in seven (53.8%) districts, haemoglobin and hepatitis B virus test in three (23.1%), and urine protein test in two (15.4%) districts. Based on our univariate logistics regression models, stock-out of tests at the Regional Medical and District Health Directorates stores in the region, high clinic attendance, lack of documentation of expiry date/expired tests, poor documentation of inventory level, poor monitoring of monthly consumption level, and failure to document unexplained losses of the various POC tests were significant predictors of complete test stock-out in most of the clinics in the Upper East Region. Discussion There is poor supply chain management of POC diagnostic tests in UER's PHC clinics. Improvement in inventory management and human resource capacity for POC testing is critical to ensure accessibility and sustainability of POC diagnostic services in resource-limited settings PHC clinics.	[Kuupiel, Desmond; Tlou, Boikhutso; Mashamba-Thompson, Tivani P.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth Med, Durban, South Africa; [Bawontuo, Vitalis] Catholic Univ Coll Ghana, Fac Hlth & Allied Sci, Fiapre, Sunyani, Ghana; [Drain, Paul K.] Univ Washington, Dept Global Hlth, Int Clin Res Ctr, Seattle, WA 98195 USA; [Drain, Paul K.] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA USA; [Drain, Paul K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Kwazulu Natal; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Kuupiel, D (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Dept Publ Hlth Med, Durban, South Africa.	desmondkuupiel98@hotmail.com	TLOU, BOIKHUTSO/AEA-3161-2022; Mashamba-Thompson, Tivani/GRO-3709-2022; Kuupiel, Desmond/V-8883-2019	Mashamba-Thompson, Tivani/0000-0002-4193-2416; Kuupiel, Desmond/0000-0001-7780-1955; Bawontuo, Vitalis/0000-0001-8440-0172; Drain, Paul/0000-0002-9569-4097	University of KwaZulu-Natal, College of Health Sciences Research Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI108293] Funding Source: NIH RePORTER	University of KwaZulu-Natal, College of Health Sciences Research Scholarship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by University of KwaZulu-Natal, College of Health Sciences Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonawitz Rachael E, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS58, DOI 10.1016/j.ijgo.2015.04.015; Dassah ET, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-2935-y; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Embrey MA, 2012, HLTH MSF MDS 3 MANAG; Engel N, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000132; Fonjungo PN, 2016, CLIN INFECT DIS, V62, P369, DOI 10.1093/cid/civ866; Ghana Statistical Service, 2012, MAL POP HOUS CENS 19; Hasselback L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-295; Hawkes S, 2011, LANCET INFECT DIS, V11, P684, DOI 10.1016/S1473-3099(11)70104-9; Jani IV, 2013, NEW ENGL J MED, V368, P2319, DOI 10.1056/NEJMsb1214197; Jaya Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183044; Kuupiel D, 2018, ACCESSIBILITY POINT; Kuupiel D, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7040058; Kyabayinze DJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-695; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Majors CE, 2017, LAB CHIP, V17, P3351, DOI 10.1039/c7lc00374a; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Palamountain KM, 2012, J INFECT DIS, V205, pS181, DOI 10.1093/infdis/jis203; Peeling R, 2015, EXPERT REV MOL DIAGN, V15, P1107, DOI 10.1586/14737159.2015.1081802; Peeling RW, 2006, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro1569; Peeling RW, 2015, INT HEALTH, V7, P384, DOI 10.1093/inthealth/ihv062; Peeling RW, 2009, FUTURE MICROBIOL, V4, P1271, DOI 10.2217/FMB.09.100; Pinna R, 2015, APPL CONT MANAGEMENT; Schito M, 2012, J INFECT DIS, V205, pS169, DOI 10.1093/infdis/jis044; Sharma S, 2016, STRATEGIES OVERCOMIN; Smith Adriana, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS70, DOI 10.1016/j.ijgo.2015.04.009; Thairu L, 2011, AIDS CARE, V23, P814, DOI 10.1080/09540121.2010.541416; UNAIDS, 2011, COUNTD ZERO GLOB PLA; World Health Organization, 2013, MAN PROC DIAGN REL L; World Health Organssatioas, 2018, WHO MOD LIST ESS IN	30	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211498	10.1371/journal.pone.0211498	http://dx.doi.org/10.1371/journal.pone.0211498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811407	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400020
J	Marushka, L; Kenny, TA; Batal, M; Cheung, WWL; Fediuk, K; Golden, CD; Salomon, AK; Sadik, T; Weatherdon, LV; Chan, HM				Marushka, Lesya; Kenny, Tiff-Annie; Batal, Malek; Cheung, William W. L.; Fediuk, Karen; Golden, Christopher D.; Salomon, Anne K.; Sadik, Tonio; Weatherdon, Lauren V.; Chan, Hing Man			Potential impacts of climate-related decline of seafood harvest on nutritional status of coastal First Nations in British Columbia, Canada	PLOS ONE			English	Article							NORTHWEST COAST; FOOD INSECURITY; DIET QUALITY; GLOBAL OCEAN; MARINE; FISHERIES; ADAPTATION; HEALTH; SHELLFISH; INUIT	Background Traditional food systems are under pressure from various stressors, including climate change which is projected to negatively alter the abundance of marine species harvested by coastal First Nations (FNs) in British Columbia (BC). Objective To model the potential impacts of the climate-related declines in seafood production on the nutritional status of coastal BC FNs. In addition, we projected potential changes in nutrient intakes, under different scenarios of substitution where traditional seafood is replaced with alternative non-traditional foods. Methods The study design is a mixed-method approach that combines two datasets: projected scenarios of climate-related change on seafood catch potential for coastal BC FNs and data derived from the cross-sectional First Nations Food, Nutrition, and Environment Study. The consumption of seafood was estimated using a food frequency questionnaire among 356 FNs. The contribution of seafood consumption to protein, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), vitamins (A, B12, D, niacin), and minerals (zinc, selenium and iron) requirements was assessed using Dietary Reference Intakes (DRIs). Results Traditional seafood consumption provided daily recommendations of EPA+DHA (74-184%) and vitamin B12 (84-152%) and substantial levels of niacin (28-55%), selenium (29-55%), vitamin D (15-30%) and protein (14-30%). Projected climate change was estimated to reduce the intakes of essential nutrients by 21% and 31% under 'strong mitigation' (Representative Concentration Pathway, RCP2.6) and 'business-as-usual' (RCP8.5) climate change scenarios, respectively, by the year 2050 relative to 2000. The hypothetical substitution of seafood with selected alternative non-traditional foods does not provide adequate amounts of nutrients. Conclusion Traditionally-harvested seafood remains fundamental to the contemporary diet and health of coastal BC FNs. Potential dietary shifts aggravated by climate-related declines in seafood consumption may have significant nutritional and health implications for BC FN. Strategies to improve access to seafood harvest potential in coastal communities are needed to ensure nutritional health and overall well-being and to promote food security and food sovereignty in coastal FNs.	[Marushka, Lesya; Kenny, Tiff-Annie; Chan, Hing Man] Univ Ottawa, Dept Biol, Ottawa, ON, Canada; [Batal, Malek] Univ Montreal, Fac Med, Dept Nutr, Pavillon Liliane de Stewart, Montreal, PQ, Canada; [Cheung, William W. L.] Univ British Columbia, Changing Ocean Res Unit, Inst Oceans & Fisheries, Vancouver, BC, Canada; [Cheung, William W. L.] Univ British Columbia, Inst Oceans & Fisheries, Nippon Fdn, UBC Nereus Program, Vancouver, BC, Canada; [Golden, Christopher D.] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Golden, Christopher D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Salomon, Anne K.] Simon Fraser Univ, Sch Resource & Environm Management, Burnaby, BC, Canada; [Sadik, Tonio] Assembly First Nations, Ottawa, ON, Canada; [Weatherdon, Lauren V.] UN Environm World Conservat Monitoring Ctr, Cambridge, England	University of Ottawa; Universite de Montreal; University of British Columbia; University of British Columbia; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Simon Fraser University	Chan, HM (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON, Canada.	laurie.chan@uottawa.ca		Kenny, Tiff-Annie/0000-0001-9688-6149; Marushka, Lesya/0000-0001-8040-1004; Chan, Laurie/0000-0003-4351-7483; Weatherdon, Lauren V./0000-0002-3989-027X	Health Canada; Canadian Institute of Health Research; Canada Research Chair; Welcome Trust Our Planet, Our Health program [106864MA]; National Socio-Environmental Synthesis Center (SESYNC) from National Science Foundation [DBI-1052875]	Health Canada; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Welcome Trust Our Planet, Our Health program; National Socio-Environmental Synthesis Center (SESYNC) from National Science Foundation(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by: 1. Health Canada, https://www.canada.ca/en/health-canada.html, funding to HMC, MB and TS, Funder has no role on the research; 2. Canadian Institute of Health Research, http://www.cihr-irsc.gc.ca/e/193.html, funding to HMC, Funder has no role in the study; 3. Canada Research Chair, http://www.chairs-chaires.gc.ca/home-accueil-eng.aspx, funding to HMC, Funder has no role in the study; 4. Welcome Trust Our Planet, Our Health program [Grant number: 106864MA], https://wellcome.ac.uk/home, funding to CDG, Funder has no role in the study; 5. the National Socio-Environmental Synthesis Center (SESYNC) under funding received from the National Science Foundation DBI-1052875, https://www.sesync.org/, funding to CDG, Funder has no role in the study.	Academy FTHE, 2014, POS AC NUTR DIET DIE; ADA & Journal of the American Dietetic Association, 2007, J AM DIET ASSOC, V107, P2151; Adelson N, 2005, CAN J PUBLIC HEALTH, V96, pS45, DOI 10.1007/BF03403702; AFN, 2017, ASS 1 NAT; Anderson TJ, 2016, CAN J CARDIOL, V32, P1263, DOI 10.1016/j.cjca.2016.07.510; Austin SE, 2015, INT J ENV RES PUB HE, V12, P623, DOI 10.3390/ijerph120100623; Batal M, 2017, QUANTIFYING ASS DIET, P1; Baum J.K., 2016, CANADAS MARINE FISHE; BC AFN, 2017, BRIT COL ASS 1 NAT; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Bennett M., 1971, INDIAN FISHING ITS C; Brian Morton, VANCOUVER SUN NEWS; Brown F, 2009, STAYING COURSE STAYI, P1; Butler VL, 2004, J WORLD PREHIST, V18, P327, DOI 10.1007/s10963-004-5622-3; Chan L, 2011, 1 NATIONS FOOD NUTR; Chan LH, 1 NATIONS FOOD NUTR; Charlton KE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2953-9; Cheung WWL, 2016, SCIENCE, V354, P1591, DOI 10.1126/science.aag2331; Cheung WWL, 2016, ICES J MAR SCI, V73, P1283, DOI 10.1093/icesjms/fsv250; Cheung WWL, 2016, ECOL MODEL, V325, P57, DOI 10.1016/j.ecolmodel.2015.12.018; Cheung WWL, 2013, NAT CLIM CHANGE, V3, P254, DOI 10.1038/NCLIMATE1691; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; CHISHOLM BS, 1983, CURR ANTHROPOL, V24, P396, DOI 10.1086/203018; Cisneros-Montemayor AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166681; Colin G., 2017, DIVERSITY HUNTER GAT; DEUR D, 2005, TRADITIONS PLANT USE; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Egeland GM, 2011, J NUTR, V141, P1746, DOI 10.3945/jn.111.139006; Fang R, 2010, SUMMARY REPORT HLTH, P1; FNIGC, 2012, 1 NAT REG HLTH SURV, P1; Fong LC, SQUAMISH 1 NATION CO; Ford JD, 2014, AM J PUBLIC HEALTH, V104, pE9, DOI 10.2105/AJPH.2013.301724; Ford JD, 2010, GLOBAL ENVIRON CHANG, V20, P668, DOI 10.1016/j.gloenvcha.2010.05.003; Furgal C, 2006, ENVIRON HEALTH PERSP, V114, P1964, DOI 10.1289/ehp.8433; Garibaldi A, 2004, ECOL SOC, V9; Golden C, 2016, NATURE, V534, P317, DOI 10.1038/534317a; Government of Canada, AB FISH STRAT; Groesbeck AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091235; Harris D., 2010, ARCTIC REV LAW POLIT, V1, P82; Health Canada, 2008, STAT PROFL HLTH 1 NA; Health Canada, 2015, CAN NUTR FIL CNF 201; Health Canada, 2014, STAT PROF HLTH 1 NAT; Health Canada, 2012, HOUS FOOD SEC SURV M; HLPE, 2014, REP HIGH LEV PAN EXP; Huet C, 2012, J NUTR, V142, P541, DOI 10.3945/jn.111.149278; Institute of Medicine, 2003, MEDICINE, P237; Jackley J, 2016, ECOL SOC, V21, DOI 10.5751/ES-08747-210420; Johannes M, 2007, PACIFIC SALMON RESOU, P69; Kawarazuka, 2010, 2106 WORLDFISH; Krebs-smith SM, 1989, MEAN PROPORTION POPU, V5; Kuhnlein H., 2013, LLEGACY NUXALK FOOD, P159; Kuhnlein H. V., 2013, Indigenous peoples' food systems and well-being: interventions and policies for healthy communities, P3; Kuhnlein H. V., 2013, Indigenous peoples' food systems and well-being: interventions and policies for healthy communities, P237; Kuhnlein HV, 2007, J NUTR, V137, P1110, DOI 10.1093/jn/137.4.1110; Kuhnlein HV, 1996, ANNU REV NUTR, V16, P417, DOI 10.1146/annurev.nu.16.070196.002221; KUHNLEIN HV, 1989, J CAN DIET ASSOC, V50, P102; Lam VWY, 2016, SCI REP-UK, V6, DOI 10.1038/srep32607; Lawn J, 2004, NUTR FOOD SECURITY F; Lehn Don, 2018, FRASER VALLEY 1 NATI; Lepofsky D, 2015, AM ANTIQUITY, V80, P236, DOI 10.7183/0002-7316.80.2.236; McKechnie I, 2014, P NATL ACAD SCI USA, V111, pE807, DOI 10.1073/pnas.1316072111; Mos L, 2004, J TOXICOL ENV HEAL A, V67, P791, DOI 10.1080/15287390490428224a; MOSS ML, 1993, AM ANTHROPOL, V95, P631, DOI 10.1525/aa.1993.95.3.02a00050; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Nancarrow TL, 2010, RURAL REMOTE HEALTH, V10; Nesbitt HK, 2016, J APPL ECOL, V53, P1489, DOI 10.1111/1365-2664.12717; Nord M., 2010, HOUSEHOLD FOOD SECUR; Office of the Provincial Health Officer, 2015, 1 NAT HLTH WELL BEIN; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Otten Jennifer, 2006, DIETARY DRI REFERENC; Pauly D, 2018, GLOBAL CHANGE BIOL, V24, pE15, DOI 10.1111/gcb.13831; Quinn S. B. C., 2018, 1 NATIONS GET CLARIT; Reading C. L., 2009, HLTH INEQUALITIES SO, P1; Reid MG, 2014, J ETHNOBIOL, V34, P401, DOI 10.2993/0278-0771-34.3.401; Rosol R, 2016, INT J CIRCUMPOL HEAL, V75, DOI 10.3402/ijch.v75.31127; Ross AC, 2011, Dietary Reference Intakes for Calcium and Vitamin D, P1; Sheehy T, 2015, J HUM NUTR DIET, V28, P262, DOI 10.1111/jhn.12243; Socha T., 2012, Journal of Aboriginal Health, V8, P5; State Pharmacopoeia Commission, 2015, POPULATION WELFARE, P1; Statistics Canada, 2009, OV OB AD SELF REP; Statistics Canada, 2010, HOUS FOO INS CAN 200; Statistics Canada, 2010, SMOK 2009; Statistics Canada, 2009, LAB MARK REV 2009; Statistics Canada, 2017, AB PEOPL CAN KEY RES; Sturtevant William C., 1978, HDB N AM INDIANS; Turner NJ, 2009, GLOBAL ENVIRON CHANG, V19, P180, DOI 10.1016/j.gloenvcha.2009.01.005; UN-OCHA, 2017, SUST DEV GOALS REP, P1, DOI DOI 10.18356/3405D09F-EN; Weatherdon L V, 2016, PLOS ONE, V11, P1, DOI DOI 10.1371/J0URNAL.P0NE.0145285; Weatherdon LV, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00048; Whaley SE, 2003, J NUTR, V133, p3965S, DOI 10.1093/jn/133.11.3965S; Williams T, 2013, CLIMATIC CHANGE, V120, P531, DOI 10.1007/s10584-013-0850-0; Willows N, 2011, HEAL REPORTS STAT CA, V22; Willows ND, 2005, CAN J PUBLIC HEALTH, V96, pS32, DOI 10.1007/BF03405199	93	16	16	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211473	10.1371/journal.pone.0211473	http://dx.doi.org/10.1371/journal.pone.0211473			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811408	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400019
J	Merida-Garcia, R; Liu, GZ; He, S; Gonzalez-Dugo, V; Dorado, G; Galvez, S; Solis, I; Zarco-Tejada, PJ; Reif, JC; Hernandez, P				Merida-Garcia, Rosa; Liu, Guozheng; He, Sang; Gonzalez-Dugo, Victoria; Dorado, Gabriel; Galvez, Sergio; Solis, Ignacio; Zarco-Tejada, Pablo J.; Reif, Jochen C.; Hernandez, Pilar			Genetic dissection of agronomic and quality traits based on association mapping and genomic selection approaches in durum wheat grown in Southern Spain	PLOS ONE			English	Article							GRAIN PROTEIN-CONTENT; QUANTITATIVE TRAITS; WIDE ASSOCIATION; GLUTEN STRENGTH; MEDITERRANEAN CONDITIONS; LINKAGE DISEQUILIBRIUM; BREADMAKING QUALITY; DROUGHT RESISTANCE; YIELD; QTLS	Climatic conditions affect the growth, development and final crop production. As wheat is of paramount importance as a staple crop in the human diet, there is a growing need to study its abiotic stress adaptation through the performance of key breeding traits. New and complementary approaches, such as genome-wide association studies (GWAS) and genomic selection (GS), are used for the dissection of different agronomic traits. The present study focused on the dissection of agronomic and quality traits of interest (initial agronomic score, yield, gluten index, sedimentation index, specific weight, whole grain protein and yellow colour) assessed in a panel of 179 durum wheat lines (Triticum durum Desf.), grown under rainfed conditions in different Mediterranean environments in Southern Spain (Andalusia). The findings show a total of 37 marker-trait associations (MTAs) which affect phenotype expression for three quality traits (specific weight, gluten and sedimentation indexes). MTAs could be mapped on the A and B durum wheat subgenomes (on chromosomes 1A, 1B, 2A, 2B and 3A) through the recently available bread wheat reference assembly (IWGSC RefSeqv1). Two of the MTAs found for quality traits (gluten index and SDS) corresponded to the known Glu-B1 and Glu-A1 loci, for which candidate genes corresponding to high molecular weight glutenin subunits could be located. The GS prediction ability values obtained from the breeding materials analyzed showed promising results for traits as grain protein content, sedimentation and gluten indexes, which can be used in plant breeding programs.	[Merida-Garcia, Rosa; Gonzalez-Dugo, Victoria; Zarco-Tejada, Pablo J.; Hernandez, Pilar] CSIC, IAS, Alameda Obispo S-N, Cordoba, Spain; [Liu, Guozheng; He, Sang; Reif, Jochen C.] Leibniz Inst Plant Genet & Crop Plant Res IPK Gat, Dept Breeding Res, Corrensstr 3, Stadt Seeland, Germany; [Dorado, Gabriel] Univ Cordoba, Dept Bioquim & Biol Mol, Campus Rabanales C6-1-E17, Cordoba, Spain; [Galvez, Sergio] Univ Malaga, Andalucia Tech, ETSI Informat, Campus Teatinos S-N, Malaga, Spain; [Solis, Ignacio] Univ Seville, ETSIA, Ctra Utrera Km1, Seville, Spain; [Liu, Guozheng] BASF Agr Solut Seed GmbH, OT Gatersleben, Schwabeplan 8, Gatersleben, Germany; [He, Sang] Agr Victoria, AgriBio, Ctr AgriBiosci, Bundoora, Vic, Australia	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Agricultura Sostenible (IAS); Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung; Universidad de Cordoba; Universidad de Malaga; University of Sevilla; La Trobe University	Hernandez, P (corresponding author), CSIC, IAS, Alameda Obispo S-N, Cordoba, Spain.	phernandez@ias.csic.es	Zarco-Tejada, Pablo J./A-6874-2012; Hernandez, Pilar/B-5996-2016; Rojas, Sergio Gálvez/K-7733-2014; Mérida-García, Rosa/AAA-5540-2020; Zarco-Tejada, Pablo J./AAZ-3704-2020	Zarco-Tejada, Pablo J./0000-0003-1433-6165; Hernandez, Pilar/0000-0001-5166-4454; Rojas, Sergio Gálvez/0000-0003-4743-2807; Mérida-García, Rosa/0000-0002-3169-2471; Reif, Jochen/0000-0002-6742-265X; He, Sang/0000-0003-0832-3472	Junta de Andalucia (Andalusian Regional Government), Spain - (FEDER) [P12-AGR-0482]; MINECO (Spanish Ministry of Economy, Industry and Competitiveness) [AGL2016-77149-C2-1-P]	Junta de Andalucia (Andalusian Regional Government), Spain - (FEDER); MINECO (Spanish Ministry of Economy, Industry and Competitiveness)	This work was funded by project P12-AGR-0482 to PH from Junta de Andalucia (Andalusian Regional Government), Spain (Co-funded by FEDER). PH is supported by project AGL2016-77149-C2-1-P from MINECO (Spanish Ministry of Economy, Industry and Competitiveness). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Galindo MA, 2015, CROP SCI, V55, P477, DOI 10.2135/cropsci2013.11.0793; [Anonymous], 2001, NEAR INFRARED TECHNO; ANSCOMBE FJ, 1963, TECHNOMETRICS, V5, P141, DOI 10.2307/1266059; Appels R, 2018, SCIENCE, V361, P661, DOI 10.1126/science.aar7191; Araus JL, 1998, AUST J PLANT PHYSIOL, V25, P835, DOI 10.1071/PP98071; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Araus JL, 1998, FIELD CROP RES, V55, P209, DOI 10.1016/S0378-4290(97)00079-8; AXFORD DWE, 1978, CEREAL FOOD WORLD, V23, P477; Battenfield SD, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0005; Belaid A., 2000, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P35; Beleggia R, 2011, CEREAL CHEM, V88, P504, DOI 10.1094/CCHEM-02-11-0013; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentley AR, 2014, THEOR APPL GENET, V127, P2619, DOI 10.1007/s00122-014-2403-y; Bernardo R, 2009, CROP SCI, V49, P419, DOI 10.2135/cropsci2008.08.0452; BIDINGER FR, 1987, AUST J AGR RES, V38, P37, DOI 10.1071/AR9870037; Blanco A, 2006, THEOR APPL GENET, V112, P1195, DOI 10.1007/s00122-006-0221-6; Blanco A, 2012, MOL BREEDING, V30, P79, DOI 10.1007/s11032-011-9600-z; Blanco A, 2002, PLANT MOL BIOL, V48, P615, DOI 10.1023/A:1014864230933; BLUM A, 1990, AUST J AGR RES, V41, P799, DOI 10.1071/AR9900799; Borghi B, 1997, EUR J AGRON, V6, P145, DOI 10.1016/S1161-0301(96)02040-0; Breseghello F, 2006, GENETICS, V172, P1165, DOI 10.1534/genetics.105.044586; Burgueno J, 2012, CROP SCI, V52, P707, DOI 10.2135/cropsci2011.06.0299; CARRILLO JM, 1990, THEOR APPL GENET, V79, P321, DOI 10.1007/BF01186074; Clarke FR, 2010, CAN J PLANT SCI, V90, P1, DOI 10.4141/CJPS09035; Conti V, 2011, J APPL GENET, V52, P287, DOI 10.1007/s13353-011-0045-1; Crossa J, 2014, HEREDITY, V112, P48, DOI 10.1038/hdy.2013.16; Crossa J, 2017, TRENDS PLANT SCI, V22, P961, DOI 10.1016/j.tplants.2017.08.011; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; CUBADDA R, 1992, CEREAL FOOD WORLD, V37, P866; D'Ovidio R, 2004, J CEREAL SCI, V39, P321, DOI 10.1016/j.jcs.2003.12.002; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; De Vita P, 2007, EUR J AGRON, V26, P39, DOI 10.1016/j.eja.2006.08.009; Elouafi I., 2000, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P505; FEILLET P, 1996, PASTA NOODLE TECHNOL, P9511; Fernando RL, 2007, ACTA AGR SCAND A-AN, V57, P192, DOI 10.1080/09064700801959395; Fiedler JD, 2017, PLANT GENOME-US, V10, DOI 10.3835/plantgenome2017.05.0038; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Galvez S, 2019, FUNCT INTEGR GENOMIC, V19, P295, DOI 10.1007/s10142-018-0639-3; Garcia del Moral LF, 2003, AGRON J, V95, P266, DOI 10.2134/agronj2003.0266; Garrido-Lestache E, 2005, EUR J AGRON, V23, P265, DOI 10.1016/j.eja.2004.12.001; Giraldo P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166577; Gonzalez-Ribot G, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01781; Groos C, 2003, THEOR APPL GENET, V106, P1032, DOI 10.1007/s00122-002-1111-1; Haile JK, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0818-x; He S, 2017, THEOR APPL GENET, V130, P635, DOI 10.1007/s00122-016-2840-x; Hentschel V, 2002, J AGR FOOD CHEM, V50, P6663, DOI 10.1021/jf025701p; Huang XQ, 2006, THEOR APPL GENET, V113, P753, DOI 10.1007/s00122-006-0346-7; Kaan F., 1993, Journal of Genetics and Breeding, V47, P151; Kabbaj H, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01277; Kollers S, 2014, MOL BREEDING, V34, P363, DOI 10.1007/s11032-014-0039-x; KRAMER T, 1979, EUPHYTICA, V28, P209, DOI 10.1007/BF00056577; Kristensen PS, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00069; Kumar A, 2013, J CEREAL SCI, V57, P21, DOI 10.1016/j.jcs.2012.09.006; Li YF, 2013, J CEREAL SCI, V57, P398, DOI 10.1016/j.jcs.2013.01.005; Liu ZS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0511-8; LOSS SP, 1994, ADV AGRON, V52, P229, DOI 10.1016/S0065-2113(08)60625-2; Maccaferri M, 2008, GENETICS, V178, P489, DOI 10.1534/genetics.107.077297; Maccaferri M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-873; Maccaferri M, 2011, J EXP BOT, V62, P409, DOI 10.1093/jxb/erq287; Martinez CS, 2010, INT J FOOD PROP, V15, DOI [10.1080/10942912.2010, DOI 10.1080/10942912.2010]; McCartney CA, 2006, PLANT BREEDING, V125, P565, DOI 10.1111/j.1439-0523.2006.01256.x; Mengistu DK, 2016, PLANT BIOTECHNOL J, V14, P1800, DOI 10.1111/pbi.12538; Meuwissen THE, 2001, GENETICS, V157, P1819; MOONEN JHE, 1982, EUPHYTICA, V31, P677, DOI 10.1007/BF00039206; Neumann K, 2011, MOL BREEDING, V27, P37, DOI 10.1007/s11032-010-9411-7; Pagnotta MA, 2009, GENET RESOUR CROP EV, V56, P299, DOI 10.1007/s10722-008-9364-4; Papadakis J, 1980, PENINSULA IBE RICA E; Patil RM, 2013, EUPHYTICA, V190, P117, DOI 10.1007/s10681-012-0785-y; Patil RM, 2009, J CEREAL SCI, V49, P378, DOI 10.1016/j.jcs.2009.01.001; PENA RJ, 1990, J CEREAL SCI, V12, P105, DOI 10.1016/S0733-5210(09)80092-1; Piepho HP, 2000, HEREDITY, V84, P437, DOI 10.1046/j.1365-2540.2000.00678.x; POGNA NE, 1990, J CEREAL SCI, V11, P15, DOI 10.1016/S0733-5210(09)80178-1; Poland J, 2012, PLANT GENOME-US, V5, P103, DOI 10.3835/plantgenome2012.06.0006; Rajaram S, 1992, WHEAT SPECIAL REPORT, V9, P14; Rapp M, 2018, THEOR APPL GENET, V131, P1315, DOI 10.1007/s00122-018-3080-z; Reif JC, 2005, CROP SCI, V45, P1, DOI 10.2135/cropsci2005.0001; Reynolds MP, 2012, PHYSL BREEDING, pix; Rharrabti Y, 2003, FIELD CROP RES, V80, P133, DOI 10.1016/S0378-4290(02)00177-6; Rharrabti Y, 2001, PLANT BREEDING, V120, P381, DOI 10.1046/j.1439-0523.2001.00628.x; Rosello M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01512; RUIZ M, 1993, THEOR APPL GENET, V87, P353, DOI 10.1007/BF01184923; Seabourn BW, 2012, CROP SCI, V52, P1306, DOI 10.2135/cropsci2011.04.0210; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Steiner B, 2019, THEOR APPL GENET, V132, P969, DOI 10.1007/s00122-018-3253-9; Stich B., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105039; Sukumaran S, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.12.0112; Sukumaran S, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00081; Sun CW, 2017, PLANT BIOTECHNOL J, V15, P953, DOI 10.1111/pbi.12690; Zhang JL, 2018, THEOR APPL GENET, V131, P1741, DOI 10.1007/s00122-018-3111-9; Zhao Y, 2014, HEREDITY, V112, P638, DOI 10.1038/hdy.2014.1; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	91	17	18	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211718	10.1371/journal.pone.0211718	http://dx.doi.org/10.1371/journal.pone.0211718			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811415	Green Published, gold			2022-12-26	WOS:000459806400029
J	Sodre, V; Araujo, JN; Goncalves, TA; Vilela, N; Braz, ASK; Franco, TT; Neto, MD; Damasio, ARD; Garcia, W; Squina, FM				Sodre, Victoria; Araujo, Juscemacia Nascimento; Goncalves, Thiago Augusto; Vilela, Nathalia; Kimus Braz, Antonio Sergio; Franco, Telma Teixeira; Neto, Mario de Oliveira; de Lima Damasio, Andre Ricardo; Garcia, Wanius; Squina, Fabio Marcio			An alkaline active feruloyl-CoA synthetase from soil metagenome as a potential key enzyme for lignin valorization strategies	PLOS ONE			English	Article							PEDIOCOCCUS-ACIDILACTICI BD16; CATABOLIC GENES; TRANSCRIPTIONAL REGULATOR; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; ACID; PROTEIN; VANILLIN; STRAIN; DEGRADATION	Ferulic acid (FA), a low-molecular weight aromatic compound derived from lignin, represents a high-value molecule, used for applications in the cosmetic and pharmaceutical industries. FA can be further enzymatically converted in other commercially interesting molecules, such as vanillin and bioplastics. In several organisms, these transformations often start with a common step of FA activation via CoA-thioesterification, catalyzed by feruloyl-CoA synthetases (Fcs). In this context, these enzymes are of biotechnological interest for conversion of lignin-derived FA into high value chemicals. In this study, we describe the first structural characterization of a prokaryotic Fcs, named FCS1, isolated from a lignin-degrading microbial consortium. The FCS1 optimum pH and temperature were 9 and 37 degrees C, respectively, with Km of 0.12 mM and Vmax of 36.82 U/mg. The circular dichroism spectra indicated a notable secondary structure stability at alkaline pH values and high temperatures. This secondary structure stability corroborates the activity data, which remains high until pH 9. The Small Angle X-Ray Scattering analyses resulted on the tertiary/quaternary structure and the low-resolution envelope in solution of FCS1, which was modeled as a homodimer using the hyperthermophilic nucleoside diphosphate-forming acetyl-CoA synthetase from Candidatus Korachaeum cryptofilum. This study contributes to the field of research by establishing the first biophysical and structural characterization for Fcs, and our data may be used for comparison against novel enzymes of this class that to be studied in the future.	[Sodre, Victoria; Franco, Telma Teixeira; Squina, Fabio Marcio] Univ Campinas UNICAMP, Fac Chem Engn, Campinas, SP, Brazil; [Sodre, Victoria; Goncalves, Thiago Augusto; Vilela, Nathalia; de Lima Damasio, Andre Ricardo] Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, SP, Brazil; [Araujo, Juscemacia Nascimento; Kimus Braz, Antonio Sergio; Garcia, Wanius] Univ Fed ABC UFABC, Ctr Ciencias Nat & Humanas, Santo Andre, SP, Brazil; [Goncalves, Thiago Augusto; Vilela, Nathalia; Squina, Fabio Marcio] Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil; [Neto, Mario de Oliveira] Univ Estadual Paulista UNESP, Inst Biociencias, Dept Fis & Biofis, Botucatu, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal do ABC (UFABC); Universidade de Sorocaba; Universidade Estadual Paulista	Squina, FM (corresponding author), Univ Campinas UNICAMP, Fac Chem Engn, Campinas, SP, Brazil.; Squina, FM (corresponding author), Univ Sorocaba UNISO, Programa Proc Tecnol & Ambientais, Sorocaba, SP, Brazil.	fabio.squina@prof.uniso.br	Silva, Wanius J. G./L-3948-2016; Franco, Telma Teixeira/A-2397-2013; Damasio, André RL/H-1162-2016; Neto, Mario Oliveira/F-2717-2013; Franco, Telma Teixeira/AAP-6842-2021; Araujo, Juscemácia Nascimento/N-2245-2017; Squina, Fabio/J-8130-2012; Araujo, Juscemácia/AAQ-7299-2020	Franco, Telma Teixeira/0000-0002-9611-4541; Damasio, André RL/0000-0001-9304-3998; Franco, Telma Teixeira/0000-0002-9611-4541; Araujo, Juscemácia Nascimento/0000-0001-9034-1463; Squina, Fabio/0000-0002-8154-7459; Araujo, Juscemácia/0000-0001-9034-1463; Goncalves, Thiago Augusto/0000-0001-6526-905X; Vilela, Nathalia/0000-0002-1072-0568; Sodre, Victoria/0000-0002-2240-9128; Garcia, Wanius/0000-0003-3712-3488	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/50590-4, 15/50612-8, 17/17275-3, 17/22669-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305748/2017-3, 305740/2017-2, 304816/2017-5]; CAPES/PROEX; FAPESP [2018/18101-1, 2017/05901-7, 17/16089-1, 2017/16976-8, 17/08166-6]; CAPES	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PROEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was financially supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; 15/50590-4, 15/50612-8, 17/17275-3 and 17/22669-0) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; 305748/2017-3, 305740/2017-2 and 304816/2017-5). TAG and JNA were supported by FAPESP fellowship (17/16089-1 and 2017/16976-8 respectively). VS was supported by CAPES/PROEXFellowship and FAPESP fellowships (2018/18101-1 and 2017/05901-7). NV was supported by CAPES and FAPESP fellowship (17/08166-6).	Achterholt S, 2000, APPL MICROBIOL BIOT, V54, P799, DOI 10.1007/s002530000431; Alper H, 2009, NAT REV MICROBIOL, V7, P715, DOI 10.1038/nrmicro2186; Balan Venkatesh, 2014, ISRN Biotechnol, V2014, P463074, DOI 10.1155/2014/463074; Banci L, 1999, BIOCHEMISTRY-US, V38, P3205, DOI 10.1021/bi982139g; Barberousse H, 2008, J SCI FOOD AGR, V88, P1494, DOI 10.1002/jsfa.3242; Beckham GT, 2016, CURR OPIN BIOTECH, V42, P40, DOI 10.1016/j.copbio.2016.02.030; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brasen C, 2008, J BIOL CHEM, V283, P15409, DOI 10.1074/jbc.M710218200; Brenelli LB, 2016, IND CROP PROD, V83, P94, DOI 10.1016/j.indcrop.2015.12.013; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Calisti C, 2008, APPL MICROBIOL BIOT, V80, P475, DOI 10.1007/s00253-008-1557-4; Chakraborty D, 2017, APPL MICROBIOL BIOT, V101, P5615, DOI 10.1007/s00253-017-8283-8; Chakraborty D, 2016, PROTEIN EXPRES PURIF, V128, P123, DOI 10.1016/j.pep.2016.08.015; Cortes-Tolalpa L, 2018, APPL MICROBIOL BIOT, V102, P2913, DOI 10.1007/s00253-017-8714-6; Davis KM, 2016, ENERGIES, V9, DOI 10.3390/en9100808; de Oliveira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118225; Dellomonaco C, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-3; Engel C, 1996, CURR OPIN STRUC BIOL, V6, P790, DOI 10.1016/S0959-440X(96)80009-1; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fleige C, 2016, APPL ENVIRON MICROB, V82, P3410, DOI 10.1128/AEM.00802-16; Friedman M, 2000, J AGR FOOD CHEM, V48, P2101, DOI 10.1021/jf990489j; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Ghosh S, 2007, J IND MICROBIOL BIOT, V34, P131, DOI 10.1007/s10295-006-0177-1; Gomez LD, 2008, NEW PHYTOL, V178, P473, DOI 10.1111/j.1469-8137.2008.02422.x; Graf N, 2014, APPL MICROBIOL BIOT, V98, P137, DOI 10.1007/s00253-013-5303-1; GROSS GG, 1966, Z NATURFORSCH PT B, VB 21, P683; Grossman A, 2019, CURR OPIN BIOTECH, V56, P112, DOI 10.1016/j.copbio.2018.10.009; Hammersley A. P., 1997, ESRF97HA02T; HEIJNE GV, 1978, ORIGINS LIFE EVOL B, V9, P27, DOI 10.1007/BF00929711; Hirakawa H, 2012, J BACTERIOL, V194, P1960, DOI 10.1128/JB.06817-11; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Jachimska B, 2008, LANGMUIR, V24, P6866, DOI 10.1021/la800548p; Kasai D, 2012, FEMS MICROBIOL LETT, V332, P68, DOI 10.1111/j.1574-6968.2012.02576.x; Kaur B, 2014, APPL MICROBIOL BIOT, V98, P8539, DOI 10.1007/s00253-014-5950-x; Kaur B, 2013, APPL BIOCHEM BIOTECH, V169, P1353, DOI 10.1007/s12010-012-0066-1; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klumpp S, 2002, EUR J BIOCHEM, V269, P1067, DOI 10.1046/j.1432-1033.2002.02755.x; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Linger JG, 2014, P NATL ACAD SCI USA, V111, P12013, DOI 10.1073/pnas.1410657111; LOFTY S, 1994, PHYTOCHEMISTRY, V35, P1419, DOI 10.1016/S0031-9422(00)86867-3; Madden TL, 1996, METHOD ENZYMOL, V266, P131; Martinez AT, 2005, INT MICROBIOL, V8, P195; Masai E, 2002, APPL ENVIRON MICROB, V68, P4416, DOI 10.1128/AEM.68.9.4416-4424.2002; Mathew S, 2006, CRIT REV MICROBIOL, V32, P115, DOI 10.1080/10408410600709628; Mitra A, 1999, ARCH BIOCHEM BIOPHYS, V365, P10, DOI 10.1006/abbi.1999.1140; Mohr A, 2013, ENERG POLICY, V63, P114, DOI 10.1016/j.enpol.2013.08.033; Moraes EC, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1073-4; Narbad A, 1998, MICROBIOL-SGM, V144, P1397, DOI 10.1099/00221287-144-5-1397; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otani H, 2016, NUCLEIC ACIDS RES, V44, P595, DOI 10.1093/nar/gkv955; Otani H, 2014, J BACTERIOL, V196, P4293, DOI 10.1128/JB.02247-14; Overhage J, 1999, APPL ENVIRON MICROB, V65, P4837; Parke D, 2003, APPL ENVIRON MICROB, V69, P5398, DOI 10.1128/AEM.69.9.5398-5409.2003; Plaggenborg R, 2006, APPL MICROBIOL BIOT, V72, P745, DOI 10.1007/s00253-005-0302-5; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rosazza JPN, 1995, J IND MICROBIOL, V15, P457, DOI 10.1007/BF01570016; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Sainsbury PD, 2013, ACS CHEM BIOL, V8, P2151, DOI 10.1021/cb400505a; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Salvachua D, 2015, GREEN CHEM, V17, P4951, DOI [10.1039/C5GC01165E, 10.1039/c5gc01165e]; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teramoto M, 2010, J BIOSCI BIOENG, V110, P48, DOI 10.1016/j.jbiosc.2009.12.008; Varanasi P, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-14; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Weisse RHJ, 2016, P NATL ACAD SCI USA, V113, pE519, DOI 10.1073/pnas.1518614113; WOLODKO WT, 1994, J BIOL CHEM, V269, P10883; Wu ML, 2017, ENVIRON POLLUT, V223, P657, DOI 10.1016/j.envpol.2017.01.079; Yang WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067339; ZENK MH, 1980, ANAL BIOCHEM, V101, P182, DOI 10.1016/0003-2697(80)90058-5; ZIMMERMANN W, 1990, J BIOTECHNOL, V13, P119, DOI 10.1016/0168-1656(90)90098-V	78	5	5	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212629	10.1371/journal.pone.0212629	http://dx.doi.org/10.1371/journal.pone.0212629			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802241	Green Published, Green Submitted, gold			2022-12-26	WOS:000459710700015
J	Gutreuter, S; Igumbor, E; Wabiri, N; Desai, M; Durand, L				Gutreuter, Steve; Igumbor, Ehimario; Wabiri, Njeri; Desai, Mitesh; Durand, Lizette			Improving estimates of district HIV prevalence and burden in South Africa using small area estimation techniques	PLOS ONE			English	Article							POPULATION-BASED SURVEYS; GENERALIZED EPIDEMICS; SURVEILLANCE; PEOPLE; PLACES; CENSUS; TRENDS; LEVEL	Many countries, including South Africa, have implemented population-based household surveys to estimate HIV prevalence and the burden of HIV infection. Most household HIV surveys are designed to provide reliable estimates down to only the first subnational geopolitical level which, in South Africa, is composed of nine provinces. However HIV prevalence estimates are needed down to at least the second subnational level in order to better target the delivery of HIV care, treatment and prevention services. The second subnational level in South Africa is composed of 52 districts. Achieving adequate precision at the second subnational level therefore requires either a substantial increase in survey sample size or use of model-based estimation capable of incorporating other pre-existing data. Our purpose is demonstration of the efficacy of relatively simple small-area estimation of HIV prevalence in the 52 districts of South Africa using data from the South African National HIV Prevalence, Incidence and Behavior Survey, 2012, district-level HIV prevalence estimates obtained from testing of pregnant women who attended antenatal care (ANC) clinics in 2012, and 2012 demographic data. The best-fitting model included only ANC prevalence and dependency ratio as out-of-survey predictors. Our key finding is that ANC prevalence was the superior auxiliary covariate, and provided substantially improved precision in many district-level estimates of HIV prevalence in the general population. Inclusion of a district-level spatial simultaneously autoregressive covariance structure did not result in improved estimation.	[Gutreuter, Steve; Desai, Mitesh; Durand, Lizette] US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA; [Igumbor, Ehimario] US Ctr Dis Control & Prevent, Div Global HIV & TB, Pretoria, South Africa; [Igumbor, Ehimario] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa; [Wabiri, Njeri] Human Sci Res Council, Div Epidemiol & Strateg Informat, Pretoria, South Africa; [Desai, Mitesh] US Ctr Dis Control & Prevent, Div Global HIV & TB, Yangon, Myanmar; [Durand, Lizette] US Dept HHS, Off Global Affairs, Camp Hm Smith, HI USA	Centers for Disease Control & Prevention - USA; University of the Western Cape; Human Sciences Research Council-South Africa	Gutreuter, S (corresponding author), US Ctr Dis Control & Prevent, Div Global HIV & TB, Atlanta, GA 30333 USA.	sgutreuter@cdc.gov	Gutreuter, Steve/ABC-7980-2020; Igumbor, Ehimario U/B-2652-2012	Gutreuter, Steve/0000-0002-0733-2900; Igumbor, Ehimario U/0000-0002-6313-6031	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC)	This work was supported by the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) through the U.S. Centers for Disease Control and Prevention (CDC). The findings and conclusions reported in this manuscript are those of the authors and do not represent the views of the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SJ, 2014, LANCET, V384, P249, DOI 10.1016/S0140-6736(14)61053-9; [Anonymous], 2017, UNAIDS DAT 2017; [Anonymous], 2013, 2012 NAT ANT SENT HI; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cochran WG., 1963, SAMPLING TECHNIQUES; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; FAY RE, 1979, J AM STAT ASSOC, V74, P269, DOI 10.1080/01621459.1979.10482505; Garcia-Calleja JM, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010298; Gething PW, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000724; GHOSH M, 1994, STAT SCI, V9, P55, DOI 10.1214/ss/1177010647; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Hedt BL, 2011, STAT MED, V30, P560, DOI 10.1002/sim.3920; Johnson FA, 2010, J OFF STAT, V26, P341; Johnson LF, 2017, S AFR J HIV MED, V18, DOI 10.4102/sajhivmed.v18i1.695; Kandala NB, 2011, AIDS, V25, P95, DOI 10.1097/QAD.0b013e328340fe0f; Kleinschmidt I, 2007, AM J TROP MED HYG, V77, P1163, DOI 10.4269/ajtmh.2007.77.1163; Kondlo L, 2012, P 58 WORLD STAT C, P5002; Larmarange J, 2014, AIDS, V28, pS469, DOI 10.1097/QAD.0000000000000480; Mahy M, 2012, SEX TRANSM INFECT, V88, pI65, DOI 10.1136/sextrans-2012-050789; Marhuenda Y, 2013, COMPUT STAT DATA AN, V58, P308, DOI 10.1016/j.csda.2012.09.002; Massyn N., 2014, DURBAN HLTH SYSTEMS; Molina I, 2015, R J, V7, P81; Montana LS, 2008, SEX TRANSM INFECT, V84, pI78, DOI 10.1136/sti.2008.030106; Ngesa O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103299; Niragire F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119944; Office of the US Global AIDS Coordinator, 2014, PEPFAR 3 0 CONTR EP; R Core Team, 2018, R LANG ENV STAT COMP; Rao J., 2015, WILEY SERIES SURVEY; South African National AIDS Council, 2017, LET OUR ACT COUNT S; Stanton MC, 2013, ENVIRONMETRICS, V24, P158, DOI 10.1002/env.2205; Statistics South Africa, 2011, 2011 MUN FACT SHEET; UNAIDS, 2014, END AIDS EP 2030; Working Group on Global HIV/ AIDS UW, 2003, GUID COND HIV SENT S; You Y., 2006, SURV METHODOL, V32, P97	34	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212445	10.1371/journal.pone.0212445	http://dx.doi.org/10.1371/journal.pone.0212445			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794619	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100068
J	Tavares, AS; Morcatty, TQ; Zuanon, J; Magnusson, WE				Tavares, Aline S.; Morcatty, Thais Queiroz; Zuanon, Jansen; Magnusson, William E.			Influence of body size, topography, food availability and tree-fall gaps on space use by yellow-footed tortoises (Chelonoidis denticulatus) in Central Amazonia	PLOS ONE			English	Article							MESOSCALE DISTRIBUTION PATTERNS; GEOCHELONE-DENTICULATA; DESERT TORTOISES; SEED DISPERSAL; HOME-RANGE; MOVEMENT PATTERNS; GOPHER TORTOISES; SOIL; CARBONARIA; FOREST	Habitat selection and extension of the area used by a given species may vary during different phases of its life and are often determined by the distribution and availability of resources throughout the landscape, such as food, breeding sites, and shelters. In this study, we assessed the influence of body size on the areas used by 21 individuals of the yellow-footed tortoises (Chelonoidis denticulatus) from January to June 2017 in a dense rain forest area in Central Amazonia. We also investigated whether individuals selected different ranges of terrain slope, elevation, areas with high food availability, or areas with treefall gaps that could be used for shelter or thermoregulation. We monitored tortoise movements using thread-bobbins, and sampled terrain characteristics, availability of potential food resources and forest gaps along the routes used by the tortoises. We also measured the same variables in plots distributed systematically throughout the study area to evaluate resource availability. Tortoises used an average area of 1.56 ha (SD = 1.51, min = 0.03, max = 6.44). The size of the area used was positively associated with the individual body size, but did not vary between sexes. Small individuals selected higher and flatter areas where the availability of fallen flowers was higher, whereas the area used by larger individuals did not differ from the natural availability of topographic traits and food in the region. Although tortoises did not select areas according to availability of tree-fall gaps, most larger tortoises were found sheltered under fallen trees (85%). Conversely, small individuals were mainly found hidden under litter (66%). Body size determined the patterns of landscape use by tortoises; larger individuals were mainly generalists, but small individuals occupied high and flat areas. The yellow-footed tortoise is endangered by hunting, illegal collection for the pet trade, habitat destruction and effects of climate change. Size-related differences in habitat selection should be taken into account in species-distribution models for the identification of suitable areas for reintroduction and the development of management plans in protected areas.	[Tavares, Aline S.; Morcatty, Thais Queiroz] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad & Ecol, Manaus, AM, Brazil; [Morcatty, Thais Queiroz] Oxford Brookes Univ, Oxford Wildlife Trade Res Grp, Dept Social Sci, Oxford, England; [Zuanon, Jansen; Magnusson, William E.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Biodiversidade, Manaus, AM, Brazil	Institute Nacional de Pesquisas da Amazonia; Oxford Brookes University; Institute Nacional de Pesquisas da Amazonia	Tavares, AS (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad & Ecol, Manaus, AM, Brazil.	tavaressantos.aline@gmail.com	Morcatty, Thais Queiroz/AAU-7435-2020; Zuanon, Jansen A. S./E-5791-2013	Morcatty, Thais Queiroz/0000-0002-3095-7052; Zuanon, Jansen A. S./0000-0001-8354-2750; Tavares, Aline/0000-0002-5413-9070	Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM) [573721/2008-4]; National Council for Scientific and Technological Development (CNPq) [313183/2014-7, 300627/2008-4]; National Council for Scientific and Technological Development (CNPq); WCS Graduate Scholarship Program; Wildlife Conservation Society; Christensen Conservation Leaders Scholarship; Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award	Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); WCS Graduate Scholarship Program; Wildlife Conservation Society; Christensen Conservation Leaders Scholarship; Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award	This study received financial and logistic support from the Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM; processo: 573721/2008-4). JZ and WEM received productivity grants from National Council for Scientific and Technological Development (CNPq; 313183/2014-7 and 300627/2008-4). ATS thanks the National Council for Scientific and Technological Development (CNPq) for financial support. TQM is supported by the WCS Graduate Scholarship Program, a program of the Wildlife Conservation Society, the Christensen Conservation Leaders Scholarship, and by the Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award.; We thank the logistics teams of CENBAM and the Ducke Reserve for supporting our field activities, Cleide, Jabson, Wallace, Celio and especially Joao and Zelao for participating in the data collection. We also thank Jonas Goncalves, Hani El Bizri and Rafael Rabelo for valuable suggestions and assistance in statistical analyses. This study received financial and logistic support from the Centro de Estudos Integrados da Biodiversidade Amazonica (CENBAM; processo: 573721/2008-4). JZ and WEM received productivity grants from National Council for Scientific and Technological Development (CNPq; 313183/2014-7 and 300627/2008-4). ATS thanks the National Council for Scientific and Technological Development (CNPq) for financial support. T. Q. M. is supported by the WCS Graduate Scholarship Program, a program of the Wildlife Conservation Society, and the Christensen Conservation Leaders Scholarship, and by the Wildlife Conservation Network Scholarship Program through the Sidney Byers Scholarship award.	[Anonymous], 1996, RED LIST THREATENED; Brown GP, 2004, ECOLOGY, V85, P1627, DOI 10.1890/03-0107; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Butler JA, 1996, J HERPETOL, V30, P455, DOI 10.2307/1565195; Capaverde UD, 2018, BIOTROPICA, P1; Castano Mora O.V., 1981, Cespedesia, V10, P55; CHAUVEL A, 1987, EXPERIENTIA, V43, P234, DOI 10.1007/BF01945546; Cintra R, 2012, INT J ECOLOGY, V2012, P25; Costa FRC, 2009, J VEG SCI, V20, P69, DOI 10.1111/j.1654-1103.2009.05314.x; Costa FRC, 2005, J ECOL, V93, P863, DOI 10.1111/j.1365-2745.2005.01020.x; de Castilho CV, 2006, FOREST ECOL MANAG, V234, P85, DOI 10.1016/j.foreco.2006.06.024; De Souza-Mazurek RR, 2000, BIODIVERS CONSERV, V9, P579, DOI 10.1023/A:1008999201747; de Toledo JJ, 2011, FOREST ECOL MANAG, V262, P331, DOI 10.1016/j.foreco.2011.03.039; EMMONS LH, 1989, J HERPETOL, V23, P311, DOI 10.2307/1564460; Epperson DM, 2003, J HERPETOL, V37, P315, DOI 10.1670/0022-1511(2003)037[0315:NAHEOG]2.0.CO;2; Eubanks JO, 2003, HERPETOLOGICA, V59, P311, DOI 10.1655/01-105.1; Ferrara C.R., 2017, QUELONIOS AMAZONICOS, V1st; Ferreira Júnior Paulo Dias, 2009, Acta Amaz., V39, P139, DOI 10.1590/S0044-59672009000100014; Guzman A, 2008, AMPHIBIA-REPTILIA, V29, P463, DOI 10.1163/156853808786230442; Harless ML, 2010, HERPETOL CONSERV BIO, V5, P374; Harless ML, 2009, COPEIA, P378, DOI 10.1643/CE-07-226; Hofmeyr M, 2012, AMPHIBIA-REPTILIA, V33, P185, DOI 10.1163/156853812X634071; ICMBIO - Instituto Chico Mendes de Conservacao da Biodiversidade, 2016, LIVR VERM FAUN BRAS; Jerozolimski A, 2005, THESIS, P1; Jerozolimski A, 2009, OECOLOGIA, V161, P517, DOI 10.1007/s00442-009-1396-8; Jimenez-Munoz JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33130; Kinupp VF, 2005, J TROP ECOL, V21, P363, DOI 10.1017/S0266467405002440; Lagarde F, 2012, ENVIRON CONSERV, V39, P172, DOI 10.1017/S0376892911000634; Laurance WF, 1999, FOREST ECOL MANAG, V118, P127, DOI 10.1016/S0378-1127(98)00494-0; Legler J. M., 1960, MUS NAT HIST, V11, P527; Lovich JE, 2014, CALIF FISH GAME, V100, P404; Magnusson William E., 2005, Biota Neotrop., V5, P19, DOI 10.1590/S1676-06032005000300002; Marques-Filho AO, 1982, ACTA AMAZON, V11, P759; McIntyre NE, 1999, LANDSCAPE ECOL, V14, P437, DOI 10.1023/A:1008074407036; McMaster MK, 2009, J HERPETOL, V43, P561, DOI 10.1670/07-078.1; MCRAE WA, 1981, AM MIDL NAT, V106, P165, DOI 10.2307/2425146; Menin M, 2007, J TROP ECOL, V23, P539, DOI 10.1017/S0266467407004269; Morcatty TQ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07701-200303; Morcatty TQ, 2015, ORYX, V49, P577, DOI 10.1017/S003060531500071X; Morcatty TQ, 2013, ECOL RES, V28, P935, DOI 10.1007/s11284-013-1076-3; Moskovits D., 1985, BEHAV ECOLOGY 2 AMAZ; Moskovits DK, 1987, FUNCT ECOL, V1, P203, DOI 10.2307/2389422; MOSKOVITS DK, 1990, HERPETOLOGICA, V46, P207; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Peres CA, 2006, BIODIVERS CONSERV, V15, P2627, DOI 10.1007/s10531-005-5406-9; Riedle JD, 2008, COPEIA, P414, DOI 10.1643/CH-06-010; Rodrigues LF, 2014, J TROP ECOL, V30, P565, DOI 10.1017/S0266467414000431; Rojas-Ahumada DP, 2012, AUSTRAL ECOL, V37, P865, DOI 10.1111/j.1442-9993.2011.02330.x; Rozylowicz L, 2013, EUR J WILDLIFE RES, V59, P47, DOI 10.1007/s10344-012-0646-y; Rueda-Almonacid JV, 2007, SERIE GUIAS TROPICAL, V6; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Sobral-Souza T, 2017, PERSPECT ECOL CONSER, V15, P300, DOI 10.1016/j.pecon.2017.08.005; Stevenson PR, 2007, AMPHIBIA-REPTILIA, V28, P217, DOI 10.1163/156853807780202459; Strong JN, 2006, BIOTROPICA, V38, P683, DOI 10.1111/j.1744-7429.2006.00185.x; Valenzuela N, 2004, COPEIA, P735, DOI 10.1643/CH-03-248R1; van Dijk PP, 2012, CHELON RES MONOGR, V5, DOI [DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014, 10.3854/crm.5.000]; Vasconcelos HL, 2003, STUD NEOTROP FAUNA E, V38, P115, DOI 10.1076/snfe.38.2.115.15923; Wilson DS, 1998, ECOLOGY, V79, P1884, DOI 10.2307/176696	58	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211869	10.1371/journal.pone.0211869	http://dx.doi.org/10.1371/journal.pone.0211869			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794558	Green Published, gold			2022-12-26	WOS:000459709100025
J	Yabe, T; Sekimoto, Y; Tsubouchi, K; Ikemoto, S				Yabe, Takahiro; Sekimoto, Yoshihide; Tsubouchi, Kota; Ikemoto, Satoshi			Cross-comparative analysis of evacuation behavior after earthquakes using mobile phone data	PLOS ONE			English	Article							SYSTEM; GPS	Despite the importance of predicting evacuation mobility dynamics after large scale disasters for effective first response and disaster relief, our general understanding of evacuation behavior remains limited because of the lack of empirical evidence on the evacuation movement of individuals across multiple disaster instances. Here we investigate the GPS trajectories of a total of more than 1 million anonymized mobile phone users whose positions were tracked for a period of 2 months before and after four of the major earthquakes that occurred in Japan. Through a cross comparative analysis between the four disaster instances, we find that in contrast to the assumed complexity of evacuation decision making mechanisms in crisis situations, an individual's evacuation probability is strongly dependent on the seismic intensity that they experience. In fact, we show that the evacuation probabilities in all earthquakes collapse into a similar pattern, with a critical threshold at around seismic intensity 5.5. This indicates that despite the diversity in the earthquakes profiles and urban characteristics, evacuation behavior is similarly dependent on seismic intensity. Moreover, we found that probability density functions of the distances that individuals evacuate are not dependent on seismic intensities that individuals experience. These insights from empirical analysis on evacuation from multiple earthquake instances using large scale mobility data contributes to a deeper understanding of how people react to earthquakes, and can potentially assist decision makers to simulate and predict the number of evacuees in urban areas with little computational time and cost. This can be achieved by utilizing only the information on population density distribution and seismic intensity distribution, which can be observed instantaneously after the shock.	[Yabe, Takahiro; Sekimoto, Yoshihide] Univ Tokyo, Dept Civil Engn, Tokyo, Japan; [Sekimoto, Yoshihide] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Tsubouchi, Kota] Yahoo Japan Corp, Tokyo, Japan; [Ikemoto, Satoshi] Zenrin DataCom Corp, Tokyo, Japan; [Yabe, Takahiro] Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA	University of Tokyo; University of Tokyo; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Yabe, T (corresponding author), Univ Tokyo, Dept Civil Engn, Tokyo, Japan.; Yabe, T (corresponding author), Purdue Univ, Lyles Sch Civil Engn, W Lafayette, IN 47907 USA.	tyabe@purdue.edu		Yabe, Takahiro/0000-0001-8967-1967	Yahoo Japan Corporation; Zenrin DataCom Corporation;  [17J09460]	Yahoo Japan Corporation; Zenrin DataCom Corporation; 	TY was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Research Fellow 17J09460. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders (Yahoo Japan Corporation and Zenrin DataCom Corporation) provided support in the form of salaries for authors KT and SI, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; We thank Dr. Naoya Fujiwara of Tohoku University and Dr. Akihito Sudo of Shizuoka University for many fruitful discussions. Takahiro Yabe was supported by Grant-in-Aid for Japan Society for the Promotion of Science (JSPS) Research Fellow 17J09460.	[Anonymous], 2016, MAINICHI NEWSPAPER; Ashbrook D, 2003, PERS UBIQUIT COMPUT, V7, P275, DOI 10.1007/s00779-003-0240-0; Bagrow JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017680; Baker JW, 2015, EARTHQ SPECTRA, V31, P579, DOI 10.1193/021113EQS025M; Bengtsson L, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001083; Chiaro G, 2017, RECONNISSANCE REPORT; de Montjoye YA, 2013, SCI REP-UK, V3, DOI 10.1038/srep01376; Demissie MG, 2013, TRANSPORT RES C-EMER, V32, P76, DOI 10.1016/j.trc.2013.03.010; Deville P, 2014, P NATL ACAD SCI USA, V111, P15888, DOI 10.1073/pnas.1408439111; Gething PW, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001085; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Heath R., 1995, DISASTER PREVENTION, V4, P11, DOI DOI 10.1108/09653569510100965; Hirose F, 2011, EARTH PLANETS SPACE, V63, P513, DOI 10.5047/eps.2011.05.019; Horanont T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081153; Horanont T, 2013, IEEE INTELL SYST, V28, P26, DOI 10.1109/MIS.2013.3; Iqbal MS, 2014, TRANSPORT RES C-EMER, V40, P63, DOI 10.1016/j.trc.2014.01.002; Jiang S, 2016, P NATL ACAD SCI USA, V113, pE5370, DOI 10.1073/pnas.1524261113; Kagawa T, 2017, EARTH PLANETS SPACE, V69, DOI 10.1186/s40623-017-0689-0; Kanasugi H, 2013, INT CONF PERVAS COMP, P267; Koshimura S, 2009, COAST ENG J, V51, P243, DOI 10.1142/S0578563409002004; Kryvasheyeu Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500779; Kryvasheyeu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117288; Lin AM, 2015, TECTONOPHYSICS, V656, P142, DOI 10.1016/j.tecto.2015.06.018; Lu X, 2012, P NATL ACAD SCI USA, V109, P11576, DOI 10.1073/pnas.1203882109; Mimura N, 2011, MITIG ADAPT STRAT GL, V16, P803, DOI 10.1007/s11027-011-9297-7; Nishi Kentaro, 2014, P 22 ACM SIGSPATIAL, P281; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; OpenStreetMap contributors, 2017, PLAN DUMP; Phithakkitnukoon S, 2015, PERVASIVE MOB COMPUT, V18, P18, DOI 10.1016/j.pmcj.2014.07.003; Phithakkitnukoon S, 2010, LECT NOTES COMPUT SC, V6219, P14, DOI 10.1007/978-3-642-14715-9_3; Sekimoto Y, 2011, IEEE PERVAS COMPUT, V10, P27, DOI 10.1109/MPRV.2011.43; Shimosaka M, 2015, PROCEEDINGS OF THE 2015 ACM INTERNATIONAL JOINT CONFERENCE ON PERVASIVE AND UBIQUITOUS COMPUTING (UBICOMP 2015), P535, DOI 10.1145/2750858.2807527; Shirahama Y, 2016, EARTH PLANETS SPACE, V68, DOI 10.1186/s40623-016-0559-1; Song X, 2013, IEEE INTELL SYST, V28, P35, DOI 10.1109/MIS.2013.35; Tokyo Metropolitan Government, 2012, REP DAM EST TOK DUE; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Wang P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01001; Wang Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112608; Wang Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154547; Wardrop NA, 2018, P NATL ACAD SCI USA, V115, P3529, DOI 10.1073/pnas.1715305115; Wilson Robin, 2016, PLoS Curr, V8, DOI 10.1371/currents.dis.d073fbece328e4c39087bc086d694b5c; Yabe T, 2016, P 24 ACM SIGSPATIAL; Yabe T., 2016, P 5 INT WORKSH URB C, V81, P1; Yun NY, 2015, EARTHQ SPECTRA, V31, P1237, DOI 10.1193/082013EQS234M	46	25	25	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211375	10.1371/journal.pone.0211375	http://dx.doi.org/10.1371/journal.pone.0211375			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785908	Green Published, gold, Green Submitted			2022-12-26	WOS:000459307000022
J	Nguyen, HL; Duviau, MP; Cocaign-Bousquet, M; Nouaille, S; Girbal, L				Huong Le Nguyen; Duviau, Marie-Pierre; Cocaign-Bousquet, Muriel; Nouaille, Sebastien; Girbal, Laurence			Multiplexing polysome profiling experiments to study translation in Escherichia coli	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; GENE-EXPRESSION; LACTOCOCCUS-LACTIS; HIGH SALINITY; REVEALS; STRESS; STABILITY; RESPONSES; TRANSCRIPTION; ADAPTATION	Polysome profiling is a widely used method to monitor the translation status of mRNAs. Although it is theoretically a simple technique, it is labor intensive. Repetitive polysome fractionation rapidly generates a large number of samples to be handled in the downstream processes of protein elimination, RNA extraction and quantification. Here, we propose a multiplex polysome profiling experiment in which distinct cellular extracts are pooled before loading on the sucrose gradient for fractionation. We used the multiplexing method to study translation in E. coli. Multiplexing polysome profiling experiments provided similar mRNA translation status to that obtained with the non-multiplex method with comparable distribution of mRNA copies between the polysome profiling fractions, similar ribosome occupancy and ribosome density. The multiplexing method was used for parallel characterization of gene translational responses to changing mRNA levels. When the mRNA level of two native genes, cysZ and lacZ was increased by transcription induction, their global translational response was similar, with a higher ribosome load leading to increased ribosome occupancy and ribosome densities. However the pattern and the magnitude of the translational response were gene specific. By reducing the number of polysome profiling experiments, the multiplexing method saved time and effort and reduced cost and technical bias. This method would be useful to study the translational effect of mRNA sequence-dependent parameters that often require testing multiple samples and conditions in parallel.	[Huong Le Nguyen; Duviau, Marie-Pierre; Cocaign-Bousquet, Muriel; Nouaille, Sebastien; Girbal, Laurence] Univ Toulouse, LISBP, CNRS, INRA,INSA, Toulouse, France	INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS)	Cocaign-Bousquet, M; Girbal, L (corresponding author), Univ Toulouse, LISBP, CNRS, INRA,INSA, Toulouse, France.	cocaign@insa-toulouse.fr; girbal@insa-toulouse.fr		GIRBAL, Laurence/0000-0002-8773-4829	INRA (french national institute for agricultural research)	INRA (french national institute for agricultural research)	HLN was supported by a pre-doctoral fellowship from INRA (french national institute for agricultural research). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ah-Seng Y, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003956; Alves LR, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0436-2; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Artieri CG, 2014, GENOME RES, V24, P411, DOI 10.1101/gr.165522.113; Chasse H, 2018, NUCLEIC ACIDS RES, V46, P4607, DOI 10.1093/nar/gky258; Chasse H, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw907; Duval M, 2015, BIOCHIMIE, V114, P18, DOI 10.1016/j.biochi.2015.03.007; Esquerre T, 2014, NUCLEIC ACIDS RES, V42, P2460, DOI 10.1093/nar/gkt1150; Evfratov SA, 2017, NUCLEIC ACIDS RES, V45, P3487, DOI 10.1093/nar/gkw1141; Fisunov GY, 2017, BIOCHIMIE, V132, P66, DOI 10.1016/j.biochi.2016.10.015; Giuliodori AM, 2010, MOL CELL, V37, P21, DOI 10.1016/j.molcel.2009.11.033; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; King HA, 2016, BRIEF FUNCT GENOMICS, V15, P22, DOI 10.1093/bfgp/elu045; Lange C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-415; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Maligoy M, 2008, APPL ENVIRON MICROB, V74, P485, DOI 10.1128/AEM.01531-07; Matsuura H, 2013, PLANT CELL PHYSIOL, V54, P474, DOI 10.1093/pcp/pcs189; Matsuura H, 2010, PLANT CELL PHYSIOL, V51, P448, DOI 10.1093/pcp/pcq010; Melamed D, 2008, RNA, V14, P1337, DOI 10.1261/rna.864908; Morin M, 2017, MBIO, V8, DOI 10.1128/mBio.01628-17; Nouaille S, 2017, NUCLEIC ACIDS RES, V45, P11711, DOI 10.1093/nar/gkx781; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Picard F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-588; Picard F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-528; Potts AH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01613-1; Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029; Pytharopoulou S, 2011, AQUAT TOXICOL, V105, P157, DOI 10.1016/j.aquatox.2011.06.007; Redon E, 2005, J BIOL CHEM, V280, P36380, DOI 10.1074/jbc.M506006200; SAGLIOCCO FA, 1993, J BIOL CHEM, V268, P26522; Smirnova JB, 2005, MOL CELL BIOL, V25, P9340, DOI 10.1128/MCB.25.21.9340-9349.2005; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Z, 2015, GENOME BIOL EVOL, V7, P1155, DOI 10.1093/gbe/evv059; Wu YH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163256; Xiang R, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.00501-18, 10.1128/AAC.02356-17, 10.1128/aac.00501-18]; Yamasaki S, 2015, PLANT CELL PHYSL, V56; Yu CH, 2015, MOL CELL, V59, P744, DOI 10.1016/j.molcel.2015.07.018; Zhang L, 2014, BBA-BIOMEMBRANES, V1838, P1809, DOI 10.1016/j.bbamem.2014.03.003	38	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212297	10.1371/journal.pone.0212297	http://dx.doi.org/10.1371/journal.pone.0212297			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779773	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900042
J	Zhang, YF; Chen, Y; Cai, YT; Cui, ZY; Zhang, JJ; Wang, XH; Shen, LR				Zhang, Yifan; Chen, Yong; Cai, Yiting; Cui, Zongyan; Zhang, Jinjie; Wang, Xiaohou; Shen, Lirong			Novel polyclonal antibody-based rapid gold sandwich immunochromatographic strip for detecting the major royal jelly protein 1 (MRJP1) in honey	PLOS ONE			English	Article							CARBON-ISOTOPE RATIO; INFRARED SPECTROSCOPY; MONOCLONAL-ANTIBODY; APALBUMIN 1; ADULTERATION; SYRUPS; ELISA; AUTHENTICATION; IDENTIFICATION; STANDARD	Honey adulteration is becoming increasingly alarming incidents in food safety. Monitoring and detecting adulteration face greater challenges. Honey contains the major royal jelly proteins (MRJP) secreted by bee workers. To detect honey adulteration fast and accurately, a rapid gold sandwich immunochromatographic strip (GSIS) was developed based on two specific polyclonal antibodies (PoAbs) against the MRJP1, the most abundant protein of all MRJPs. We determined the best of pH value (pH 8.6) and PoAb SP-1 amount (5 mu g/mL) in conjunction with colloidal. The cut-off value (sensitivity) of GSIS in detecting MRJP1 is 2.0 mu g/mL in solution. Validation analysis with RJ, milk vetch honey, acacia honey and honey adulteration containing rice syrup and corn syrup with different ratios demonstrated that the GSIS could show consistent Test line (T line) when the test samples contain more than 30% pure honey or MRJP1 0.4 mg/g. The validation results by isotope ratio mass spectrometry on the same pure and all adulteration milk vetch honey samples showed the same information of GSIS test. The qualitative assay GSIS provided a valuable new way for honey authenticity and laid the foundation for the future application of GSIS with monoclonal antibodies in honey authentication.	[Zhang, Yifan; Chen, Yong; Cai, Yiting; Wang, Xiaohou; Shen, Lirong] Zhejiang Univ, Dept Food Sci & Nutr, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China; [Cui, Zongyan; Zhang, Jinjie] Qinhuangdao Entry Exit Inspect & Quarantine Bur, Qinhuangdao, Hebei, Peoples R China	Zhejiang University	Shen, LR (corresponding author), Zhejiang Univ, Dept Food Sci & Nutr, Zhejiang Key Lab Agrofood Proc, Hangzhou, Zhejiang, Peoples R China.	shenlirong@zju.edu.cn	Chen, Yong/ABH-8664-2020	Chen, Yong/0000-0001-8240-1286; Shen, Lirong/0000-0002-3197-9245; Cui, Zongyan/0000-0003-0786-8323	Science and Technology Project of Zhejiang Province [2017C32033]; National Key Research and Development Program of China [2017YFC1601700]	Science and Technology Project of Zhejiang Province; National Key Research and Development Program of China	This work was supported by the Science and Technology Project of Zhejiang Province (No. 2017C32033) and the National Key Research and Development Program of China (No. 2017YFC1601700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anuracpreeda P, 2014, ACTA TROP, V136, P1, DOI 10.1016/j.actatropica.2014.04.012; *AOAC, 2005, 99812 AOAC, P27; Bertelli D, 2010, J AGR FOOD CHEM, V58, P8495, DOI 10.1021/jf101460t; Bilikova K, 2010, J AGR FOOD CHEM, V58, P8776, DOI 10.1021/jf101583s; Bougrini M, 2016, FOOD ANAL METHOD, V9, P2161, DOI 10.1007/s12161-015-0393-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chua LS, 2015, ANAL LETT, V48, P697, DOI 10.1080/00032719.2014.952374; Dong H, 2016, J AGR FOOD CHEM, V64, P3258, DOI 10.1021/acs.jafc.6b00691; Gui WJ, 2008, ANAL BIOCHEM, V377, P202, DOI 10.1016/j.ab.2008.03.013; Guler A, 2014, FOOD CHEM, V155, P155, DOI 10.1016/j.foodchem.2014.01.033; Guo LL, 2015, BIOMED CHROMATOGR, V29, P1432, DOI 10.1002/bmc.3442; Guo YR, 2009, ANAL BIOCHEM, V389, P32, DOI 10.1016/j.ab.2009.03.020; Hawkins J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134735; Kato Y, 2014, J AGR FOOD CHEM, V62, P10672, DOI 10.1021/jf503464a; Lenhardt L, 2015, FOOD CHEM, V175, P284, DOI [10.1016/j.foodchem.2014.11.162, 10.1016/j.fo]; Li SF, 2012, J FOOD COMPOS ANAL, V28, P69, DOI 10.1016/j.jfca.2012.07.006; LUTIER PM, 1993, REV PALAEOBOT PALYNO, V78, P129, DOI 10.1016/0034-6667(93)90019-Q; Pang GF, 2006, J SCI FOOD AGR, V86, P315, DOI 10.1002/jsfa.2328; Rios-Corripio MA, 2012, CYTA-J FOOD, V10, P119, DOI 10.1080/19476337.2011.596576; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Ruiz-Matute AI, 2007, J AGR FOOD CHEM, V55, P7264, DOI 10.1021/jf070559j; Salazar-Olivo LA, 2005, TOXICOL IN VITRO, V19, P645, DOI 10.1016/j.tiv.2005.03.001; Shen LR, 2015, J ZHEJIANG UNIV-SC B, V16, P155, DOI 10.1631/jzus.B1400223; Shim WB, 2006, J AGR FOOD CHEM, V54, P9728, DOI 10.1021/jf0620057; Sivakesava S, 2001, J FOOD SCI, V66, P787, DOI 10.1111/j.1365-2621.2001.tb15173.x; Soares S, 2017, COMPR REV FOOD SCI F, V16, P1072, DOI 10.1111/1541-4337.12278; Trifkovic J, 2017, J AOAC INT, V100, P827, DOI 10.5740/jaoacint.17-0142; Wang JM, 2014, FOOD ANAL METHOD, V7, P2003, DOI 10.1007/s12161-014-9833-7; Wang SQ, 2015, FOOD CHEM, V172, P669, DOI 10.1016/j.foodchem.2014.09.044; WHITE JW, 1989, J ASSOC OFF ANA CHEM, V72, P907; Won SR, 2008, FOOD RES INT, V41, P952, DOI 10.1016/j.foodres.2008.07.014; Wu XL, 2015, ANAL METHODS-UK, V7, P6190, DOI 10.1039/c5ay01166c; Zhu XR, 2010, J FOOD ENG, V101, P92, DOI 10.1016/j.jfoodeng.2010.06.014	33	2	2	5	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212335	10.1371/journal.pone.0212335	http://dx.doi.org/10.1371/journal.pone.0212335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779780	gold, Green Published, Green Submitted			2022-12-26	WOS:000459062900048
J	Gau, D; Veon, W; Shroff, SG; Roy, P				Gau, David; Veon, William; Shroff, Sanjeev G.; Roy, Partha			The VASP-profilin1 (Pfn1) interaction is critical for efficient cell migration and is regulated by cell-substrate adhesion in a PKA-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						profilin; PKA; cell adhesion; cell motility; phosphorylation; cytoskeleton; kinase signaling; Mena; vasodilator-stimulated phosphoprotein (VASP)	MICROFILAMENT PROTEIN VASP; F-ACTIN BINDING; ENA/VASP PROTEINS; FOCAL ADHESION; LEADING-EDGE; KINASE-A; PHOSPHORYLATION; PROFILIN; MOTILITY; POLYMERIZATION	Dynamic regulation of the actin cytoskeleton is an essential feature of cell motility. Action of Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP), a family of conserved actin-elongating proteins, is an important aspect of regulation of the actin cytoskeletal architecture at the leading edge that controls membrane protrusion and cell motility. In this study, we performed mutagenesis experiments in overexpression and knockdown-rescue settings to provide, for the first time, direct evidence of the role of the actin-binding protein profilin1 (Pfn1) in VASP-mediated regulation of cell motility. We found that VASP's interaction with Pfn1 is promoted by cell-substrate adhesion and requires down-regulation of PKA activity. Our experimental data further suggest that PKA-mediated Ser(137) phosphorylation of Pfn1 potentially negatively regulates the Pfn1-VASP interaction. Finally, Pfn1's ability to be phosphorylated on Ser(137) was partly responsible for the anti-migratory action elicited by exposing cells to a cAMP/PKA agonist. On the basis of these findings, we propose a mechanism of adhesion-protrusion coupling in cell motility that involves dynamic regulation of Pfn1 by PKA activity.	[Gau, David; Veon, William; Shroff, Sanjeev G.; Roy, Partha] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Roy, Partha] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Roy, P (corresponding author), Univ Pittsburgh, 306 CNBIO,300 Technol Dr, Pittsburgh, PA 15219 USA.	par19@pitt.edu		Roy, Partha/0000-0002-4946-8531	NCI, National Institutes of Health [2R01CA108607]; National Science Foundation Predoctoral Fellowship [2012139050]; NHLBI, National Institutes of Health [2T32HL076124]; NATIONAL CANCER INSTITUTE [R01CA108607] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076124] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Predoctoral Fellowship(National Science Foundation (NSF)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NCI, National Institutes of Health Grant 2R01CA108607 (to P. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Science Foundation Predoctoral Fellowship 2012139050 and NHLBI, National Institutes of Health Grant 2T32HL076124.; Supported by NHLBI, National Institutes of Health Grant 2T32HL076124.	Alasbahi RH, 2012, PHARMAZIE, V67, P5, DOI 10.1691/ph.2012.1642; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549; Bae YH, 2009, J CELL PHYSIOL, V219, P354, DOI 10.1002/jcp.21677; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2009, J CELL SCI, V122, P1947, DOI 10.1242/jcs.038125; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Carmona G, 2016, ONCOGENE, V35, P5155, DOI 10.1038/onc.2016.47; Chen L, 2008, J BIOL CHEM, V283, P13799, DOI 10.1074/jbc.M800555200; Chen XJ, 2014, DEV CELL, V30, P569, DOI 10.1016/j.devcel.2014.08.001; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; Ding ZJ, 2009, EXP CELL RES, V315, P2963, DOI 10.1016/j.yexcr.2009.07.004; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Ferron F, 2007, EMBO J, V26, P4597, DOI 10.1038/sj.emboj.7601874; Forrester WC, 1997, DEVELOPMENT, V124, P1831; Gau D, 2011, CELL MOL BIOENG, V4, P1, DOI 10.1007/s12195-010-0133-z; Gau D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156313; Geese M, 2002, MOL BIOL CELL, V13, P2383, DOI 10.1091/mbc.E02-01-0058; Gertler FB, 1996, CELL, V87, P227, DOI 10.1016/S0092-8674(00)81341-0; Goh KL, 2002, CURR BIOL, V12, P565, DOI 10.1016/S0960-9822(02)00725-X; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Howe AK, 2002, J BIOL CHEM, V277, P38121, DOI 10.1074/jbc.M205379200; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Lacayo CI, 2007, PLOS BIOL, V5, P2035, DOI 10.1371/journal.pbio.0050233; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; Li Y, 2008, EUR J CELL BIOL, V87, P893, DOI 10.1016/j.ejcb.2008.06.003; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lindsay SL, 2007, J CELL SCI, V120, P3011, DOI 10.1242/jcs.003061; Loureiro JJ, 2002, MOL BIOL CELL, V13, P2533, DOI 10.1091/mbc.E01-10-0102; Mouneimne G, 2012, CANCER CELL, V22, P615, DOI 10.1016/j.ccr.2012.09.027; Padilla-Rodriguez M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05367-2; Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; REINHARD M, 1995, P NATL ACAD SCI USA, V92, P7956, DOI 10.1073/pnas.92.17.7956; REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Sathish K, 2004, CELL SIGNAL, V16, P589, DOI 10.1016/j.cellsig.2003.10.001; Schweinhuber SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117244; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Sheetz Michael P., 1999, P233; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Tian YH, 2018, ONCOL LETT, V16, P2151, DOI 10.3892/ol.2018.8930; Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2; Zou L, 2007, BRIT J CANCER, V97, P1361, DOI 10.1038/sj.bjc.6604038	53	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6972	6985		10.1074/jbc.RA118.005255	http://dx.doi.org/10.1074/jbc.RA118.005255			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30814249	Green Published, hybrid			2022-12-26	WOS:000467394700030
J	Sueyoshi, K; Ledderose, C; Shen, Y; Lee, AH; Shapiro, NI; Junger, WG				Sueyoshi, Koichiro; Ledderose, Carola; Shen, Yong; Lee, Albert H.; Shapiro, Nathan I.; Junger, Wolfgang G.			Lipopolysaccharide suppresses T cells by generating extracellular ATP that impairs their mitochondrial function via P2Y11 receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						T cell; lipopolysaccharide (LPS); monocyte; purinergic receptor; sepsis; adaptive immunity; ATP release; immune dysregulation; purinergic signaling; T cell suppression	IMPROVES SURVIVAL; SEPTIC SHOCK; SEPSIS; ACTIVATION; MONOCYTES; NUCLEOTIDES; RELEASE; IMMUNOPATHOLOGY; DYSFUNCTION; IL-1-BETA	T cell suppression contributes to immune dysfunction in sepsis. However, the underlying mechanisms are not well-defined. Here, we show that exposure of human peripheral blood mononuclear cells to bacterial lipopolysaccharide (LPS) can rapidly and dose-dependently suppress interleukin-2 (IL-2) production and T cell proliferation. We also report that these effects depend on monocytes. LPS did not prevent the interaction of monocytes with T cells, nor did it induce programmed cell death protein 1 (PD-1) signaling that causes T cell suppression. Instead, we found that LPS stimulation of monocytes led to the accumulation of extracellular ATP that impaired mitochondrial function, cell migration, IL-2 production, and T cell proliferation. Mechanistically, LPS-induced ATP accumulation exerted these suppressive effects on T cells by activating the purinergic receptor P2Y11 on the cell surface of T cells. T cell functions could be partially restored by enzymatic removal of extracellular ATP or pharmacological blocking of P2Y11 receptors. Plasma samples obtained from sepsis patients had similar suppressive effects on T cells from healthy subjects. Our findings suggest that LPS and ATP accumulation in the circulation of sepsis patients suppresses T cells by promoting inappropriate P2Y11 receptor stimulation that impairs T cell metabolism and functions. We conclude that inhibition of LPS-induced ATP release, removal of excessive extracellular ATP, or P2Y11 receptor antagonists may be potential therapeutic strategies to prevent T cell suppression and restore host immune function in sepsis.	[Sueyoshi, Koichiro; Ledderose, Carola; Shen, Yong; Lee, Albert H.; Junger, Wolfgang G.] Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA; [Shapiro, Nathan I.] Harvard Med Sch, Dept Emergency Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Junger, Wolfgang G.] Ludwig Boltzmann Inst Traumatol, A-1200 Vienna, Austria	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Ludwig Boltzmann Institute	Ledderose, C; Junger, WG (corresponding author), Harvard Med Sch, Dept Surg, Beth Israel Deaconess Med Ctr, 330 Brookline Ave, Boston, MA 02215 USA.	cleddero@bidmc.harvard.edu; wjunger@bidmc.harvard.edu	Junger, Wolfgang G/I-1932-2013	Junger, Wolfgang G/0000-0003-3350-8452; Shen, Yong/0000-0002-4866-838X	NIAID, National Institutes of Health [AI-080582]; NIGMS, National Institutes of Health [GM-51477, GM-60475, GM-116162, T32 GM-103702]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051477, T32GM103702, R01GM060475, R01GM116162] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIAID, National Institutes of Health, Grant AI-080582 and NIGMS, National Institutes of Health, Grants GM-51477, GM-60475, GM-116162, and T32 GM-103702. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Bryn T, 2008, INT IMMUNOL, V20, P235, DOI 10.1093/intimm/dxm134; Burnstock G, 2014, PURINERG SIGNAL, V10, P103, DOI 10.1007/s11302-013-9395-y; Carson WF, 2010, EUR J IMMUNOL, V40, P998, DOI 10.1002/eji.200939739; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Communi D, 1999, BRIT J PHARMACOL, V128, P1199, DOI 10.1038/sj.bjp.0702909; Csoka B, 2015, FASEB J, V29, P25, DOI 10.1096/fj.14-253567; De Ita M, 2016, LIFE SCI, V145, P85, DOI 10.1016/j.lfs.2015.12.013; Delano MJ, 2016, J CLIN INVEST, V126, P23, DOI 10.1172/JCI82224; Dreisig K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01159; Dreisig K, 2016, PURINERG SIGNAL, V12, P427, DOI 10.1007/s11302-016-9514-7; Duhant X, 2002, J IMMUNOL, V169, P15, DOI 10.4049/jimmunol.169.1.15; Fallon EA, 2018, J LEUKOCYTE BIOL, V103, P1151, DOI 10.1002/JLB.2MIR0917-377R; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Hawkins RB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01511; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Jensen IJ, 2018, J IMMUNOL, V200, P1543, DOI 10.4049/jimmunol.1701618; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Kornum BR, 2011, NAT GENET, V43, P66, DOI 10.1038/ng.734; Kurishita Y, 2012, J AM CHEM SOC, V134, P18779, DOI 10.1021/ja308754g; Lachmandas E, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.246; Landelle C, 2010, INTENS CARE MED, V36, P1859, DOI 10.1007/s00134-010-1962-x; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Ledderose C, 2018, J CLIN INVEST, V128, P3583, DOI 10.1172/JCI120972; Ledderose C, 2016, J INFECT DIS, V213, P456, DOI 10.1093/infdis/jiv373; Ledderose C, 2014, J BIOL CHEM, V289, P25936, DOI 10.1074/jbc.M114.575308; Lee AH, 2018, CRIT CARE MED, V46, pE1183, DOI 10.1097/CCM.0000000000003446; Li Xiaoou, 2017, Crit Care Med, V45, pe97; Mayr FB, 2014, VIRULENCE, V5, P4, DOI 10.4161/viru.27372; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Poujol F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144375; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Shindo Y, 2017, J SURG RES, V208, P33, DOI 10.1016/j.jss.2016.08.099; Shinohara Y, 2018, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00986; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sumi Y, 2014, SHOCK, V42, P142, DOI 10.1097/SHK.0000000000000180; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Venet F, 2018, NAT REV NEPHROL, V14, P121, DOI 10.1038/nrneph.2017.165; Vitiello L, 2012, BLOOD, V120, P511, DOI 10.1182/blood-2012-01-406496; von Andrian UH, 2000, NEW ENGL J MED, V343, P1020, DOI 10.1056/NEJM200010053431407; Wang CM, 2014, EMBO J, V33, P1354, DOI 10.15252/embj.201386666; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Weiler M, 2016, EXP CELL RES, V349, P1, DOI 10.1016/j.yexcr.2016.05.017; Wenzel RP, 2012, NEW ENGL J MED, V366, P2122, DOI 10.1056/NEJMe1203412; Woehrle T, 2010, BLOOD, V116, P3475, DOI 10.1182/blood-2010-04-277707; Wolk K, 2000, BLOOD, V96, P218, DOI 10.1182/blood.V96.1.218.013k04_218_223; Wu JH, 2013, ACS CHEM NEUROSCI, V4, P963, DOI 10.1021/cn400012b; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yegutkin GG, 2014, CRIT REV BIOCHEM MOL, V49, P473, DOI 10.3109/10409238.2014.953627; Zanin-Zhorov A, 2007, J IMMUNOL, V179, P41, DOI 10.4049/jimmunol.179.1.41	58	17	18	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6283	6293		10.1074/jbc.RA118.007188	http://dx.doi.org/10.1074/jbc.RA118.007188			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30787105	Green Published, hybrid			2022-12-26	WOS:000468402000007
J	Kim, HJ; Jeong, HE; Bae, JH; Baek, YH; Shin, JY				Kim, Hye-Jun; Jeong, Han Eol; Bae, Ji-Hwan; Baek, Yeon-Hee; Shin, Ju-Young			Characteristics and trends of spontaneous reporting of therapeutic ineffectiveness in South Korea from 2000 to 2016	PLOS ONE			English	Article							DRUG; ADHERENCE; EVENTS	Therapeutic ineffectiveness involves drug-related therapeutic failure, inefficacy or resistance and has not been sufficiently studied. Objective of our study was to evaluate reporting trends in therapeutic ineffectiveness by year and describe factors affecting therapeutic ineffectiveness using the Korea Adverse Event Reporting System. Proportion of therapeutic ineffectiveness reports was based on total submitted reports between 2000 and 2016. Utilizing 2016 alone, we compared the characteristics of therapeutic ineffectiveness with age group and gender matching by random extraction. We conducted a logistic regression analysis to estimate reporting odds ratios (ROR) and its 95% confidence intervals (CI) for reports by type of reporters, e.g., doctors, pharmacists, or consumers. We presented most frequent reports by the anatomical main groups and therapeutic subgroups according to the Anatomical Therapeutic Chemical (ATC) classification system. For the 17-years, the proportion of therapeutic ineffectiveness adverse drug reactions reporting ranged from 0.0% to 3.7% between 2000 and 2016. Of 228,939 reports, 2,797 (1.2%) were submitted in 2016. Consumers accounted for 6.92% of reports and doctors accounted for 45.49%, in which, consumers were more likely to report therapeutic ineffectiveness than doctors (adjusted ROR 3.98; 95% CI, 2.92 to 5.41). According to the ATC classification system, "nervous system" was the most frequently reported anatomical group (18.7%) and "parathyroid hormones and analogues" was reported most frequently in the pharmacological subgroup (23.7%). Teriparatide, a drug used to treat osteoporosis, had the most reports (11.0%). Therapeutic ineffectiveness reports may be used as a scientific tool for the reevaluation of respective drugs in order to confirm of its therapeutic effects.	[Kim, Hye-Jun; Jeong, Han Eol; Bae, Ji-Hwan; Baek, Yeon-Hee; Shin, Ju-Young] Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU)	Shin, JY (corresponding author), Sungkyunkwan Univ, Sch Pharm, Suwon, Gyeonggi Do, South Korea.	shin.jy@skku.edu		Jeong, Han Eol/0000-0001-6678-0941; Baek, Yeon-Hee/0000-0001-9597-6310	Basic Science Research Program through the National Research Foundation, South Korea; South Korean government (Ministry of Science and ICT) [2017K1A3A1A12073341]; Health Fellowship Foundation	Basic Science Research Program through the National Research Foundation, South Korea; South Korean government (Ministry of Science and ICT); Health Fellowship Foundation	The authors gratefully acknowledge funding from the Basic Science Research Program through the National Research Foundation, South Korea, by the South Korean government (Ministry of Science and ICT, Grant no: 2017K1A3A1A12073341) and the Health Fellowship Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 2011, BRIT J CLIN PHARMACO, V72, P806, DOI 10.1111/j.1365-2125.2011.03990.x; Bate R, 2011, J HEALTH ECON, V30, P1150, DOI 10.1016/j.jhealeco.2011.08.006; Blenkinsopp A, 2007, BRIT J CLIN PHARMACO, V63, P148, DOI 10.1111/j.1365-2125.2006.02746.x; Britten N, 2009, BRIT J CLIN PHARMACO, V67, P646, DOI 10.1111/j.1365-2125.2009.03421.x; Cipriani A, 2018, LANCET, V391, P1357, DOI 10.1016/S0140-6736(17)32802-7; Cramer J, 2003, VALUE HEALTH, V6, P566, DOI 10.1046/j.1524-4733.2003.65269.x; EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Figueras A, 2002, DRUG SAFETY, V25, P485, DOI 10.2165/00002018-200225070-00002; Hartigan-Go KY, 2000, SIDE EFFECT, V23, pXXVII; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Howell AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144107; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Kim S, 2017, PSYCHIAT RES, V256, P237, DOI 10.1016/j.psychres.2017.06.038; Meyboom RHB, 2000, DRUG SAFETY, V22, P415, DOI 10.2165/00002018-200022060-00001; Min J, 2018, DRUG SAFETY, V41, P313, DOI 10.1007/s40264-017-0611-5; Misu Takashi, 2018, Drugs Real World Outcomes, V5, P91, DOI 10.1007/s40801-018-0131-3; Nebeker JR, 2006, J AM COLL CARDIOL, V47, P175, DOI 10.1016/j.jacc.2005.07.071; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Papaioannou A, 2007, DRUG AGING, V24, P37, DOI 10.2165/00002512-200724010-00003; Shin EG, 2018, COMP ANAL PHARMACOVI; Gonzalez CPV, 2013, PHARMACOEPIDEM DR S, V22, P199, DOI 10.1002/pds.3355; WHO Uppsala Monitoring Centre, 1988, ADV REACT TERM; Woo Y, 2015, J KOREAN MED SCI, V30, P371, DOI 10.3346/jkms.2015.30.4.371	24	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212905	10.1371/journal.pone.0212905	http://dx.doi.org/10.1371/journal.pone.0212905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817781	Green Submitted, Green Published, gold			2022-12-26	WOS:000460371500054
J	Lindskou, TA; Pilgaard, L; Sovso, MB; Klojgard, TA; Larsen, TM; Jensen, FB; Weinrich, UM; Christensen, EF				Lindskou, Tim Alex; Pilgaard, Laura; Sovso, Morten Breinholt; Klojgard, Torben Anders; Larsen, Thomas Mulvad; Jensen, Flemming Bogh; Weinrich, Ulla Moller; Christensen, Erika Frischknecht			Symptom, diagnosis and mortality among respiratory emergency medical service patients	PLOS ONE			English	Article							QUALITY; DYSPNEA	Objective Breathing difficulties and respiratory diseases have been under-reported in Emergency Medical Services research, despite these conditions being prevalent with substantial mortality. Our aim was two-fold; 1) to investigate the diagnostic pattern and mortality among EMS patients to whom an ambulance was dispatched due to difficulty breathing, and 2) to investigate the initial symptoms and mortality for EMS patients diagnosed with respiratory diseases in hospital. Methods Population-based historic cohort study in the North Denmark Region 2012-2015. We included two patient groups; 1) patients calling the emergency number with breathing difficulty as main symptom, and 2) patients diagnosed with respiratory diseases in hospital following an emergency call. Main outcome was estimated 1- and 30-day mortality rates. Results There were 3803 patients with the symptom breathing difficulty, nearly half were diagnosed with respiratory diseases 47.3%, followed by circulatory diseases 13.4%, and symptoms and signs 12.0%. The 1-day mortality rate was highest for circulatory diseases, then respiratory diseases and other factors. Over-all 30-day mortality was 13.2%, and the highest rate was for circulatory diseases (17.7%) then respiratory diseases and other factors. A total of 4014 patients were diagnosed with respiratory diseases, 44.8% had the symptom breathing difficulty, 13.4% unclear problems and 11.3%. chest pain/heart disease. 1-day mortality rates were highest for decreased consciousness, then breathing difficulties and unclear problem. Over-all 30-day mortality rates were 12.5%, the highest with symptoms of decreased consciousness (19.1%), then unclear problem and breathing difficulty. There was an overlap of 1797 patients between the two groups. Conclusions The over-all mortality rates alongside the distribution of symptoms and diagnoses, suggest the breathing difficulty patient group is complex and has severe health problems. These findings may be able to raise awareness towards the patient group, and thereby increase focus on diagnostics and treatment to improve the patient outcome.	[Lindskou, Tim Alex; Pilgaard, Laura; Sovso, Morten Breinholt; Klojgard, Torben Anders; Larsen, Thomas Mulvad; Christensen, Erika Frischknecht] Aalborg Univ, Dept Clin Med, Ctr Prehosp & Emergency Res, Aalborg, Denmark; [Larsen, Thomas Mulvad] North Denmark Reg, Unit Business Intelligence, Aalborg, Denmark; [Jensen, Flemming Bogh; Christensen, Erika Frischknecht] North Denmark Reg, Emergency Med Serv, Aalborg, Denmark; [Weinrich, Ulla Moller] Aalborg Univ Hosp, Dept Resp Dis, Aalborg, Denmark; [Weinrich, Ulla Moller] Aalborg Univ Hosp, Pulm Res Ctr, Aalborg, Denmark; [Christensen, Erika Frischknecht] Aalborg Univ Hosp, Clin Internal & Emergency Med, Aalborg, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital	Lindskou, TA (corresponding author), Aalborg Univ, Dept Clin Med, Ctr Prehosp & Emergency Res, Aalborg, Denmark.	tim.l@rn.dk	Christensen, Erika Frischknecht/H-8753-2017; Weinreich, Ulla M/L-9069-2013; Søvsø, Morten Breinholt/AAV-1547-2020; Lindskou, Tim Alex/AAU-3762-2020; Lindskou, Tim Alex/O-5281-2015	Christensen, Erika Frischknecht/0000-0003-3673-9694; Weinreich, Ulla M/0000-0003-1975-3654; Søvsø, Morten Breinholt/0000-0002-3156-5595; Lindskou, Tim Alex/0000-0002-9607-7859; 	philanthropic fund of the TRYG foundation	philanthropic fund of the TRYG foundation	The professorship of EFC is supported by a grant given from the philanthropic fund of the TRYG foundation to Aalborg University. The grant does not restrict any scientific research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MS, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-53; [Anonymous], 2016, DANSK INDEKS AKUTHJA; Botker MT, 2017, ANN EMERG MED, V70, P366, DOI 10.1016/j.annemergmed.2016.12.017; Hansen KM, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2156-9; Hayen A, 2013, MATURITAS, V76, P45, DOI 10.1016/j.maturitas.2013.06.005; Kelly AM, 2017, ACAD EMERG MED, V24, P328, DOI 10.1111/acem.13118; Kelly AM, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0305-5; Krafft T, 2003, EUR J PUBLIC HEALTH, V13, P85, DOI 10.1093/eurpub/13.suppl_1.85; Mockel M, 2013, EUR J EMERG MED, V20, P103, DOI 10.1097/MEJ.0b013e328351e609; Osteras O, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0442-5; Parshall MB, 2012, AM J RESP CRIT CARE, V185, P435, DOI 10.1164/rccm.201111-2042ST; Persson Kristina Brand, 2003, Health Inf Manag, V31, P8, DOI 10.1177/183335830303100104; Pines JM, 2013, J AM GERIATR SOC, V61, P12, DOI 10.1111/jgs.12072; Pittet V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-380; Prekker ME, 2014, ACAD EMERG MED, V21, P543, DOI 10.1111/acem.12380; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Sovso MB, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3361-x; Vest-Hansen Betina, 2013, Clin Epidemiol, V5, P129, DOI 10.2147/CLEP.S41905	18	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0213145	10.1371/journal.pone.0213145	http://dx.doi.org/10.1371/journal.pone.0213145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817792	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500085
J	Chen-Sankey, JC; Kong, G; Choi, K				Chen-Sankey, Julia Cen; Kong, Grace; Choi, Kelvin			Perceived ease of flavored e-cigarette use and e-cigarette use progression among youth never tobacco users	PLOS ONE			English	Article							HIGH-SCHOOL-STUDENTS; PRODUCT USE; UNITED-STATES; SUBSTANCE USE; ADOLESCENTS; MIDDLE; REASONS; PREFERENCES; EXPOSURE; SMOKING	Background There is an increased need to understand how e-cigarette flavors may contribute to e-cigarette uptake and use among youth. We examined the relationship between perceived ease of flavored e-cigarette use and e-cigarette use susceptibility and progression among a nationally representative sample of U.S. youth never tobacco users. Methods The wave 1 (2013-2014) and wave 2 (2014-2015) surveys of PATH Study were used. Youth never tobacco users (ages 12-17) who reported whether flavored e-cigarettes were easier to use than unflavored e-cigarettes at wave 1 (n = 6,983) were included in the study. Multivariable logistic regressions were used to examine the associations between perceived ease of using flavored e-cigarettes (wave 1) and e-cigarette use outcomes including e-cigarette use susceptibility (wave 1) and e-cigarette initiation and past-30-day use (wave 2). Results Overall, 21.2% of the sample perceived flavored e-cigarettes easier to use than unflavored e-cigarettes; and 28.9% of the sample were susceptible to using e-cigarettes at wave 1, and 7.5% and 2.0% initiated e-cigarettes and used e-cigarettes in the past 30 days at wave 2, respectively. Among those who perceived flavored e-cigarettes easier to use, 41.0% were susceptible to using e-cigarettes at wave 1, and 10.6% and 3.4% initiated and used e-cigarettes in the past 30 days at wave 2, respectively. Perceiving flavored e-cigarettes as easier to use than unflavored e-cigarettes at wave 1 was positively associated with e-cigarette use susceptibility at wave 1 (AOR = 1.43, CI = 1.21, 1.69), and e-cigarette initiation (AOR = 1.32, CI = 1.12, 1.67) and past-30-day use (AOR = 1.25, CI = 1.10, 2.47) at wave 2. Conclusions Perceiving flavored e-cigarettes as easier to use than unflavored e-cigarettes may lead to e-cigarette use progression among youth never tobacco users. Determining the factors (including e-cigarette marketing and specific e-cigarette flavors) that lead to perceived ease of using flavored e-cigarettes would inform efforts to prevent and curb youth e-cigarette use.	[Chen-Sankey, Julia Cen; Choi, Kelvin] Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Bethesda, MD 20892 USA; [Kong, Grace] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA	National Institutes of Health (NIH) - USA; NIH National Institute on Minority Health & Health Disparities (NIMHD); Yale University	Chen-Sankey, JC (corresponding author), Natl Inst Minor Hlth & Hlth Dispar, Div Intramural Res, Bethesda, MD 20892 USA.	Julia.Chen@nih.gov	Choi, Kelvin/U-1806-2019	Chen-Sankey, Julia/0000-0002-1797-5248	National Institute on Minority Health and Health Disparities Division of Intramural Research; Yale Tobacco Center of Regulatory Science [TCORS: P50DA036151]; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA036151] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [ZIAMD000006] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities Division of Intramural Research; Yale Tobacco Center of Regulatory Science; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	JCC and KC's efforts were supported by the National Institute on Minority Health and Health Disparities Division of Intramural Research. GK's efforts were partly supported by Yale Tobacco Center of Regulatory Science (TCORS: P50DA036151). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose BK, 2015, JAMA-J AM MED ASSOC, V314, P1871, DOI 10.1001/jama.2015.13802; Avena NM, 2008, NEUROSCI BIOBEHAV R, V32, P20, DOI 10.1016/j.neubiorev.2007.04.019; Bedoya L., 2008, GLOBAL APPRAISAL IND; Bold KW, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-1832; Chen JC, 2018, TOB REGUL SCI, V4, P32, DOI 10.18001/TRS.4.4.4; Chen Julia Cen, 2017, Tob Regul Sci, V3, P68, DOI 10.18001/TRS.3.1.7; Conway KP, 2018, ADDICT BEHAV, V76, P208, DOI 10.1016/j.addbeh.2017.08.009; Cooper Maria, 2016, Tob Regul Sci, V2, P278; Courtemanche CJ, 2017, AM J PREV MED, V52, pE139, DOI 10.1016/j.amepre.2016.11.019; Dennis Matthew, 2006, AM INDIAN RHETORICS, P15; DESOR JA, 1987, PHYSIOL BEHAV, V39, P639, DOI 10.1016/0031-9384(87)90166-1; Fendrich M, 2003, DRUG ALCOHOL DEPEN, V70, P241, DOI 10.1016/S0376-8716(03)00010-3; Flay BR, 1999, NICOTINE TOB RES, P1; Garrison KA, 2018, DRUG ALCOHOL DEPEN, V186, P233, DOI 10.1016/j.drugalcdep.2018.01.026; Harrell M B, 2017, Prev Med Rep, V5, P33; Hoffman AC, 2016, TOB CONTROL, V25, pii32, DOI 10.1136/tobaccocontrol-2016-053192; Hoyle RH, 2002, PERS INDIV DIFFER, V32, P401, DOI 10.1016/S0191-8869(01)00032-0; Huh J, 2016, AM J PREV MED, V51, P513, DOI 10.1016/j.amepre.2016.04.004; Hyland A, 2017, TOB CONTROL, V26, P371, DOI 10.1136/tobaccocontrol-2016-052934; Jamal A, 2017, MMWR-MORBID MORTAL W, V66, P597, DOI 10.15585/mmwr.mm6623a1; Kim H, 2016, TOB CONTROL, V2016; Kong Grace, 2017, Tob Regul Sci, V3, P10, DOI 10.18001/TRS.3.1.2; Kong G, 2015, NICOTINE TOB RES, V17, P847, DOI 10.1093/ntr/ntu257; Krishnan-Sarin S, 2015, NICOTINE TOB RES, V17, P810, DOI 10.1093/ntr/ntu243; Kuiper NM, 2018, PREV CHRONIC DIS, V15, DOI 10.5888/pcd15.170576; Mantey DS, 2016, J ADOLESCENT HEALTH, V58, P686, DOI 10.1016/j.jadohealth.2016.03.003; Marynak K, 2018, MMWR-MORBID MORTAL W, V67, P294, DOI 10.15585/mmwr.mm6710a3; Morean ME, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189015; Office of the Commissioner C for TP, PRESS ANN STAT FDA C; Pepper JK, 2017, J ADOLESCENT HEALTH, V61, P599, DOI 10.1016/j.jadohealth.2017.05.010; Pepper JK, 2014, INT J ENV RES PUB HE, V11, P10345, DOI 10.3390/ijerph111010345; Percy A, 2005, ADDICTION, V100, P189, DOI 10.1111/j.1360-0443.2004.00943.x; Pierce JP, 1996, HEALTH PSYCHOL, V15, P355, DOI 10.1037/0278-6133.15.5.355; Pisinger C, 2014, PREV MED, V69, P248, DOI 10.1016/j.ypmed.2014.10.009; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Soneji S, 2017, JAMA PEDIATR, V171, P788, DOI 10.1001/jamapediatrics.2017.1488; Stanton CA, 2016, TOB CONTROL, V25, pii1, DOI 10.1136/tobaccocontrol-2016-053486; Substance Abuse and Mental Health Services Administration (US) and Office of the Surgeon General (US), 2020, SMOK CESS REP SURG G; The U. S. Food and Drug Administration. Press Announcements- FDA, FTC TAKE ACTION CO M; Tsai J, 2018, MMWR-MORBID MORTAL W, V67, P196, DOI 10.15585/mmwr.mm6706a5; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO; US Food and Drug Administration, 2018, STAT FDA COMM S GOTT; Villanti AC, 2017, AM J PREV MED, V53, P139, DOI 10.1016/j.amepre.2017.01.026; Warner KE, 2016, AM J PREV MED, V51, P179, DOI 10.1016/j.amepre.2015.12.004; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	46	20	21	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212353	10.1371/journal.pone.0212353	http://dx.doi.org/10.1371/journal.pone.0212353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM9LQ	30811486	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400070
J	Arias, MF; Mazarico, E; Gonzalez, A; Muniesa, M; Molinet, C; Almeida, L; Roig, MDG				Fernandez Arias, M.; Mazarico, E.; Gonzalez, A.; Muniesa, M.; Molinet, C.; Almeida, L.; Gomez Roig, M. D.			Genetic risk assessment of thrombophilia in patients with adverse obstetric outcomes	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; V-LEIDEN MUTATION; INHERITED THROMBOPHILIA; PREGNANCY OUTCOMES; RECURRENCE RATE; WOMEN; PREECLAMPSIA; COMPLICATIONS; DISORDERS	Objectives To investigate the incidence of inherited thrombophilias in patients with adverse obstetric outcomes and to compare detection rates of thrombophilias between standard blood tests and a novel genetic test. Methods This is a case-control prospective study performed in Hospital Sant Joan de Deu in Barcelona, Spain. Cases had a history of intrauterine growth restriction requiring delivery before 34 weeks gestation, placental abruption before 34 weeks gestation, or severe preeclampsia. Controls had at least two normal, spontaneously conceived pregnancies at term, without complications or no underlying medical disease. At least 3 months after delivery, all case and control women underwent blood collection for standard blood tests for thrombophilias and saliva collection for the genetic test, which enables the diagnosis of 12 hereditary thrombophilias by analyzing genetic variants affecting different points of the blood coagulation cascade. Results The study included 33 cases and 41 controls. There were no statistically significant differences between cases and controls in the standard blood tests for thrombophilias in plasma or the TiC test for genetic variables. One clinical-genetic model was generated using variables with the lowest P values: ABO, body mass index, C_rs5985, C_rs6025, and protein S. This model exhibited good prediction capacity, with an area under the curve of almost 0.7 (P <0.05), sensitivity of almost 67%, and specificity of 70%. Conclusion Although some association may exist between hypercoagulability and pregnancy outcomes, no significant direct correlation was observed between adverse obstetric outcomes and inherited thrombophilias when analyzed using either standard blood tests or the genetic test. Future studies with a larger sample size are required to create a clinical-genetic model that better discriminates women with a history of adverse pregnancy outcomes and an increased risk of poor outcomes in subsequent pregnancies.	[Fernandez Arias, M.; Mazarico, E.; Gonzalez, A.; Muniesa, M.; Molinet, C.; Almeida, L.; Gomez Roig, M. D.] Hosp St Joan de Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain; [Fernandez Arias, M.; Mazarico, E.; Gonzalez, A.; Muniesa, M.; Molinet, C.; Almeida, L.; Gomez Roig, M. D.] Hosp Clin Barcelona, Barcelona, Spain; [Mazarico, E.; Almeida, L.; Gomez Roig, M. D.] ISCIII, Subdirectorate Gen Res Assessment & Promot, Maternal & Child Hlth & Dev Network SAMID 2 2, Madrid, Spain; [Mazarico, E.; Almeida, L.; Gomez Roig, M. D.] ERDF, Madrid, Spain; [Mazarico, E.; Almeida, L.; Gomez Roig, M. D.] IR SJD, Barcelona, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Instituto de Salud Carlos III	Mazarico, E (corresponding author), Hosp St Joan de Deu, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain.; Mazarico, E (corresponding author), Hosp Clin Barcelona, Barcelona, Spain.; Mazarico, E (corresponding author), ISCIII, Subdirectorate Gen Res Assessment & Promot, Maternal & Child Hlth & Dev Network SAMID 2 2, Madrid, Spain.; Mazarico, E (corresponding author), ERDF, Madrid, Spain.; Mazarico, E (corresponding author), IR SJD, Barcelona, Spain.	emazarico@sjdhospitalbarcelona.org		Molinet Coll, Cristina/0000-0002-1775-4509	PN I+D + I 2008-2011 (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF) [RD12/0026]; Fund for Health Research of the Spanish Social Security Service [PI11/02613]	PN I+D + I 2008-2011 (Spain); ISCIII-Sub-Directorate General for Research Assessment and Promotion; European Regional Development Fund (ERDF)(European Commission); Fund for Health Research of the Spanish Social Security Service	We thank the Gynecology and Obstetrics Service at the Sant Joan de Deu University Hospital in Barcelona and the RETICS, funded by the PN I+D + I 2008-2011 (Spain), the ISCIII-Sub-Directorate General for Research Assessment and Promotion, the European Regional Development Fund (ERDF, ref. RD12/0026), and the Fund for Health Research of the Spanish Social Security Service, for financial support of this project (Exp. PI11/02613).	Alfirevic Z, 2002, EUR J OBSTET GYN R B, V101, P6, DOI 10.1016/S0301-2115(01)00496-1; Aracic N, 2015, J MATERN-FETAL NEO M, V28, P306, DOI 10.3109/14767058.2014.916268; ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165; Baschat AA, 2003, ULTRASOUND OBST GYN, V21, P124, DOI 10.1002/uog.20; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bates SM, 2013, EXPERT REV HEMATOL, V6, P287, DOI [10.1586/EHM.13.18, 10.1586/ehm.13.18]; Branch DW, 2010, OBSTET GYNECOL, V115, P2, DOI 10.1097/AOG.0b013e3181c879ca; Brenner B, 2007, CLIN PERINATOL, V34, P527, DOI 10.1016/j.clp.2007.09.002; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Davenport WB, 2014, OBSTET GYN CLIN N AM, V41, P133, DOI 10.1016/j.ogc.2013.10.005; De Vries JIP, 2012, J THROMB HAEMOST, V10, P64, DOI 10.1111/j.1538-7836.2011.04553.x; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; DizonTomson DS, 1997, AM J OBSTET GYNECOL, V177, P402, DOI 10.1016/S0002-9378(97)70205-9; Facchinetti F, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.032; Grandone E, 2008, BLOOD COAGUL FIBRIN, V19, P226, DOI 10.1097/MBC.0b013e3282f54545; Grandone MD., 2009, SEMINARS THROMBOSIS, V35; Kahn SR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.023; Kalk JJ, 2004, NETH J MED, V62, P83; Kist WJ, 2008, THROMB HAEMOSTASIS, V99, P77, DOI 10.1160/TH07-05-0373; Kosar A, 2011, BLOOD COAGUL FIBRIN, V22, P14, DOI 10.1097/MBC.0b013e32834013f2; Kupferminc MJ, 2011, J MATERN-FETAL NEO M, V24, P1042, DOI 10.3109/14767058.2010.545911; Lykke JA, 2012, J THROMB HAEMOST, V10, P1320, DOI 10.1111/j.1538-7836.2012.04773.x; Mello G, 2005, HYPERTENSION, V45, P86, DOI 10.1161/01.HYP.0000149950.05182.a3; Redline R., 2006, CLIN OBSTET GYNECOLO, V46; Rey E, 2003, LANCET, V361, P901, DOI 10.1016/S0140-6736(03)12771-7; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; ROBINSON HP, 1975, BRIT J OBSTET GYNAEC, V82, P702, DOI 10.1111/j.1471-0528.1975.tb00710.x; Rodger MA, 2008, OBSTET GYNECOL, V112, P320, DOI 10.1097/AOG.0b013e31817e8acc; Said JM, 2012, ACTA OBSTET GYN SCAN, V91, P250, DOI 10.1111/j.1600-0412.2011.01293.x; Silver RM, 2010, OBSTET GYNECOL, V115, P14, DOI 10.1097/AOG.0b013e3181c88918; The American College of Obstetricians and Gynecologists, 2013, INH THROMB PREGN PRA, V22; Woodham PC, 2011, AM J PERINAT, V28, P495, DOI 10.1055/s-0031-1272964	32	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211114	10.1371/journal.pone.0211114	http://dx.doi.org/10.1371/journal.pone.0211114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811416	Green Submitted, gold, Green Published			2022-12-26	WOS:000459806400014
J	Midway, SR; Wagner, T; Burgess, GH				Midway, Stephen R.; Wagner, Tyler; Burgess, George H.			Trends in global shark attacks	PLOS ONE			English	Article							ECOLOGICAL ROLE; PELAGIC SHARKS; CONSERVATION; POPULATIONS; COLLAPSE	Shark attacks are a global phenomenon that attracts widespread attention and publicity, often with negative outcomes for shark populations. Despite the widespread perceptions of shark attacks, trends in human water activities and shark populations are both dynamic, resulting in variable rates of shark attacks over space and time. Understanding variable trends in shark attacks may contribute to a better understanding of risk, and a more tempered response in the wake of an attack. We found that global shark attack rates are low, yet variable across global regions and over decades. Countries with low populations were found to have the highest rates of attack, while countries with high populations (U.S.A., Australia, South Africa) tended to have overall low attack rates, but also much more interannual variability. From the 1960s to the present, those countries with the highest populations also tended to be the places where attack rates have increased. Ultimately, shark attack risk is also driven by local conditions (e.g., time of day, species present); however, a global scale understanding of attack rates helps place risk into perspective and may contribute to a more scientifically-grounded discussion of sharks, and their management and conservation.	[Midway, Stephen R.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Wagner, Tyler] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Burgess, George H.] Univ Florida, Int Shark Attack File, Gainesville, FL USA	Louisiana State University System; Louisiana State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; State University System of Florida; University of Florida	Midway, SR (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	smidway@lsu.edu		Midway, Stephen/0000-0003-0162-1995				Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Bethea DM, 2015, ENVIRON BIOL FISH, V98, P1233, DOI 10.1007/s10641-014-0355-3; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Chapman BK, 2016, OCEAN COAST MANAGE, V133, P72, DOI 10.1016/j.ocecoaman.2016.09.010; Clarke SC, 2006, ECOL LETT, V9, P1115, DOI 10.1111/j.1461-0248.2006.00968.x; Dulvy NK, 2008, AQUAT CONSERV, V18, P459, DOI 10.1002/aqc.975; Ferretti F, 2015, FRONT ECOL ENVIRON, V13, P412, DOI 10.1890/150109; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; ISAF, 2016, INT SHARK ATT FIL; Karl SA, 2011, CONSERV GENET, V12, P371, DOI 10.1007/s10592-010-0145-1; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McPhee D, 2014, COAST MANAGE, V42, P478, DOI 10.1080/08920753.2014.942046; Muter BA, 2013, CONSERV BIOL, V27, P187, DOI 10.1111/j.1523-1739.2012.01952.x; R Team, 2014, R PROJECT STAT COMPU; Roff G, 2016, TRENDS ECOL EVOL, V31, P395, DOI 10.1016/j.tree.2016.02.014; Simpfendorfer CA, 2017, CURR BIOL, V27, pR97, DOI 10.1016/j.cub.2016.12.017; United States Census Bureau, 2016, POPULATION; WINEMILLER KO, 1992, CAN J FISH AQUAT SCI, V49, P2196, DOI 10.1139/f92-242; World Bank, 2016, WORLD BANK POP DAT	20	30	31	4	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211049	10.1371/journal.pone.0211049	http://dx.doi.org/10.1371/journal.pone.0211049			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811398	gold, Green Submitted, Green Published			2022-12-26	WOS:000459806400013
J	Raitskin, O; Schudoma, C; West, A; Patron, NJ				Raitskin, Oleg; Schudoma, Christian; West, Anthony; Patron, Nicola J.			Comparison of efficiency and specificity of CRISPR-associated (Cas) nucleases in plants: An expanded toolkit for precision genome engineering	PLOS ONE			English	Article							RNA-GUIDED ENDONUCLEASE; TARGETED MUTAGENESIS; DNA REPLICONS; SYSTEM; ARABIDOPSIS; MULTIPLEX; DETERMINANTS; MECHANISMS; EXPRESSION; DESIGN	Molecular tools adapted from bacterial CRISPR (Clustered Regulatory Interspaced Short Palindromic Repeats) systems for adaptive immunity have become widely used for plant genome engineering, both to investigate gene functions and to engineer desirable traits. A number of different Cas (CRISPR-associated) nucleases are now used but, as most studies performed to date have engineered different targets using a variety of plant species and molecular tools, it has been difficult to draw conclusions about the comparative performance of different nucleases. Due to the time and effort required to regenerate engineered plants, efficiency is critical. In addition, there have been several reports of mutations at sequences with less than perfect identity to the target. While in some plant species it is possible to remove these so-called 'off-targets' by backcrossing to a parental line, the specificity of genome engineering tools is important when targeting specific members of closely-related gene families, especially when recent paralogues are co-located in the genome and unlikely to segregate. Specificity is also important for species that take years to reach sexual maturity or that are clonally propagated. Here, we directly compare the efficiency and specificity of Cas nucleases from different bacterial species together with engineered variants of Cas9. We find that the nucleotide content of the target correlates with efficiency and that Cas9 from Staphylococcus aureus (SaCas9) is comparatively most efficient at inducing mutations. We also demonstrate that 'high-fidelity' variants of Cas9 can reduce off-target mutations in plants. We present these molecular tools as standardised DNA parts to facilitate their re-use.	[Raitskin, Oleg; Schudoma, Christian; West, Anthony; Patron, Nicola J.] Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England; [West, Anthony] Isogenica Ltd, Chesterford Res Pk, Saffron Walden, Saffron Walden, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Earlham Institute; Isogenica Limited	Patron, NJ (corresponding author), Earlham Inst, Norwich Res Pk, Norwich, Norfolk, England.	nicola.patron@earlham.ac.uk	Patron, Nicola J/D-8778-2014	Patron, Nicola J/0000-0002-8389-1851; Schudoma, Christian/0000-0003-1157-1354	UK Biotechnological and Biological Sciences Research Council (BBSRC); Engineering and Physics Research Council (EPSRC) Synthetic Biology for Growth program [BB/L014130/1]; BBSRC National Capability in Genomics at the Earlham Institute [BB/CCG1720/1]; BBSRC [BB/CCG1720/1, BBS/E/T/000PR9816]; BBSRC [BB/L014130/1] Funding Source: UKRI	UK Biotechnological and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physics Research Council (EPSRC) Synthetic Biology for Growth program(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC National Capability in Genomics at the Earlham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Biotechnological and Biological Sciences Research Council (BBSRC) and Engineering and Physics Research Council (EPSRC) Synthetic Biology for Growth program [OpenPlant Synthetic Biology Research Centre; BB/L014130/1]. Next-generation sequencing and library construction and automated DNA assembly was delivered via the BBSRC National Capability in Genomics at the Earlham Institute [BB/CCG1720/1]. CS was supported by BBSRC strategic funding, Core Capability Grant [BB/CCG1720/1, BBS/E/T/000PR9816]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltes NJ, 2014, PLANT CELL, V26, P151, DOI 10.1105/tpc.113.119792; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Begemann MB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11760-6; Brooks C, 2014, PLANT PHYSIOL, V166, P1292, DOI 10.1104/pp.114.247577; Cermak T, 2017, PLANT CELL, DOI [10.1111/TPJ.13446, DOI 10.1111/TPJ.13446]; Cermak T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0796-9; Char SN, 2017, PLANT BIOTECHNOL J, V15, P257, DOI 10.1111/pbi.12611; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Engler C, 2014, ACS SYNTH BIOL, V3, P839, DOI 10.1021/sb4001504; Friedland AE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0817-8; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao CX, 2018, NAT REV MOL CELL BIO, V19, P275, DOI 10.1038/nrm.2018.2; Gil-Humanes J, 2017, PLANT J, V89, P1251, DOI 10.1111/tpj.13446; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.19760; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Hu ZB, 2016, ANNU REV PLANT BIOL, V67, P439, DOI 10.1146/annurev-arplant-043015-111902; Kaya H, 2016, SCI REP-UK, V6, DOI 10.1038/srep26871; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koster J, 2012, BIOINFORMATICS, V28, P2520, DOI 10.1093/bioinformatics/bts480; Kohli A, 2006, PLANT SIGNAL BEHAV, V1, P185, DOI 10.4161/psb.1.4.3195; Lawrenson T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0826-7; Lee K, 2018, PLANT SIGNAL BEHAV, V13, DOI 10.1080/15592324.2018.1449543; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Li ZS, 2015, PLANT PHYSIOL, V169, P960, DOI 10.1104/pp.15.00783; Liang Z, 2018, NAT PROTOC, V13, P413, DOI 10.1038/nprot.2017.145; Liu MJ, 2015, GENOME RES, V25, P1182, DOI 10.1101/gr.188680.114; Ma XL, 2015, MOL PLANT, V8, P1274, DOI 10.1016/j.molp.2015.04.007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Moreno-Mateos MA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01836-2; Patron N, 2015, NEW PHYTOL, V208, P13, DOI 10.1111/nph.13532; PHILLIPS RL, 1994, P NATL ACAD SCI USA, V91, P5222, DOI 10.1073/pnas.91.12.5222; Pinello L, 2016, NAT BIOTECHNOL, V34, P695, DOI 10.1038/nbt.3583; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ricroch A, 2017, EMERG TOP LIFE SCI, V1, P168; Schiml S, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0103-0; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Slaymaker IM, 2015, SCIENCE, V10, P1126; Steinert J, 2015, PLANT J, V84, P1295, DOI 10.1111/tpj.13078; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Tang X, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.18; Vazquez-Vilar M, 2016, PLANT METHODS, V12, DOI 10.1186/s13007-016-0101-2; Wang YM, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1445-x; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Werner S, 2012, BIOENGINEERED, V3, P38, DOI [10.4161/bbug.3.1.18223, 10.1371/journal.pone.0016765]; Wu JC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093806, 10.1371/journal.pone.0090528]; Xie HH, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700561; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Xu H, 2015, GENOME RES, V25, P1147, DOI 10.1101/gr.191452.115; XU P, 2018, FRONT PLANT SCI, V9, P1, DOI DOI 10.3389/fpls.2018.01528; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yamano T, 2017, MOL CELL, V67, P633, DOI 10.1016/j.molcel.2017.06.035; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang D, 2014, PLOS ONE, V9, P5, DOI DOI 10.1371/J0URNAL.P0NE.0096132><PMID:24788396>; Zhang DB, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1325-9; Zhang Q, 2018, PLANT MOL BIOL, V96, P445, DOI 10.1007/s11103-018-0709-x; Zhou JH, 2018, PLANT BIOTECHNOL J, V16, P1868, DOI 10.1111/pbi.12922	68	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211598	10.1371/journal.pone.0211598	http://dx.doi.org/10.1371/journal.pone.0211598			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811422	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400024
J	Moshynets, OV; Babenko, LM; Rogalsky, SP; Iungin, OS; Foster, J; Kosakivska, IV; Potters, G; Spiers, AJ				Moshynets, Olena V.; Babenko, Lidia M.; Rogalsky, Sergiy P.; Iungin, Olga S.; Foster, Jessica; Kosakivska, Iryna V.; Potters, Geert; Spiers, Andrew J.			Priming winter wheat seeds with the bacterial quorum sensing signal N-hexanoyl-L-homoserine lactone (C6-HSL) shows potential to improve plant growth and seed yield	PLOS ONE			English	Article							ACYL-L-HOMOSERINE; DEFENSE RESPONSES; STRESS; COMMUNICATION; RESISTANCE; FERTILIZER; PATHOGENS; DISEASES; TOMATO; SIZE	Several model plants are known to respond to bacterial quorum sensing molecules with altered root growth and gene expression patterns and induced resistance to plant pathogens. These compounds may represent novel elicitors that could be applied as seed primers to enhance cereal crop resistance to pathogens and abiotic stress and to improve yields. We investigated whether the acyl-homoserine lactone N-hexanoyl-L-homoserine lactone (C6-HSL) impacted winter wheat (Triticum aestivum L.) seed germination, plant development and productivity, using two Ukrainian varieties, Volodarka and Yatran 60, in both in vitro experiments and field trials. In vitro germination experiments indicated that C6-HSL seed priming had a small but significant positive impact on germination levels (1.2x increase, p < 0.0001), coleoptile and radicle development (1.4x increase, p < 0.0001). Field trials over two growing seasons (2015-16 and 2016-17) also demonstrated significant improvements in biomass at the tillering stage (1.4x increase, p < 0.0001), and crop structure and productivity at maturity including grain yield (1.4-1.5x increase, p < 0.0007) and quality (1.3x increase in good grain, p < 0.0001). In some cases variety effects were observed (p <= 0.05) suggesting that the effect of C6-HSL seed priming might depend on plant genetics, and some benefits of priming were also evident in F1 plants grown from seeds collected the previous season (p <= 0.05). These field-scale findings suggest that bacterial acyl-homoserine lactones such as C6-HSL could be used to improve cereal crop growth and yield and reduce reliance on fungicides and fertilisers to combat pathogens and stress.	[Moshynets, Olena V.] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine; [Babenko, Lidia M.; Kosakivska, Iryna V.] Natl Acad Sci Ukraine, MG Kholodny Inst Bot, Kiev, Ukraine; [Rogalsky, Sergiy P.] Natl Acad Sci Ukraine, VP Kukhar Inst Bioorgan Chem & Petrochem, Kiev, Ukraine; [Iungin, Olga S.] Natl Acad Sci Ukraine, DK Zabolotny Inst Microbiol & Virol, Kiev, Ukraine; [Foster, Jessica; Spiers, Andrew J.] Abertay Univ, Sch Sci Engn & Technol, Dundee, Scotland; [Potters, Geert] Antwerp Maritime Acad, Antwerp, Belgium; [Potters, Geert] Univ Antwerp, Dept Biosci Engn, Antwerp, Belgium	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; National Academy of Sciences Ukraine; M.G. Kholodny Institute of Botany, NAS of Ukraine; National Academy of Sciences Ukraine; V. P. Kukhar Institute of Bioorganic Chemistry & Petrochemistry of the National Academy of Sciences of Ukraine; National Academy of Sciences Ukraine; Zabolotny Institute of Microbiology & Virology of NASU; University of Abertay Dundee; University of Antwerp	Moshynets, OV (corresponding author), Natl Acad Sci Ukraine, Inst Mol Biol & Genet, Kiev, Ukraine.; Spiers, AJ (corresponding author), Abertay Univ, Sch Sci Engn & Technol, Dundee, Scotland.	moshynets@gmail.com; a.spiers@abertay.ac.uk	Potters, Geert/HDM-3489-2022; Spiers, Andrew/I-3535-2012; Moshynets, Olena/O-8840-2015; Iungin, Olga/AAZ-8970-2021; Kosakivska, Iryna/AAB-7752-2020; Babenko, Lidia/AAC-6216-2020; Rogalsky, Sergiy/AAG-6119-2020; Moshynets, Olena/N-4256-2019	Potters, Geert/0000-0002-8924-3169; Spiers, Andrew/0000-0003-0463-8629; Moshynets, Olena/0000-0002-2209-8681; Iungin, Olga/0000-0001-8876-6075; Babenko, Lidia/0000-0001-5391-9203; Rogalsky, Sergiy/0000-0002-5200-5247; Moshynets, Olena/0000-0002-2209-8681; Kosakivska, Iryna/0000-0002-2173-8341	National Multidisciplinary NASU Research Program "Molecular and Cellular Biotechnology for Medicine, Industry and Agrarian Sciences" [0115U004178]; IMBG; Abertay University	National Multidisciplinary NASU Research Program "Molecular and Cellular Biotechnology for Medicine, Industry and Agrarian Sciences"; IMBG; Abertay University	The project was partially supported by a grant to L.M. Babenko and O.V. Moshynets (0115U004178; Development of wheat priming biotechnology based on N-Acyl Homoserine Lactones for increasing resistance and productivity, 2015-2019) provided under the National Multidisciplinary NASU Research Program "Molecular and Cellular Biotechnology for Medicine, Industry and Agrarian Sciences". Further internal support to O.V. Moshynets and A.J. Spiers was provided by IMBG and Abertay University. There was no additional external funding received for this study.	[Anonymous], 2016, APPROACHES STRATEGIE; [Anonymous], 1989, TISSUE CULTURE TECHN; Bebber DP, 2014, GLOBAL ECOL BIOGEOGR, V23, P1398, DOI 10.1111/geb.12214; Becker-Reshef I, 2010, REMOTE SENS ENVIRON, V114, P1312, DOI 10.1016/j.rse.2010.01.010; BRODFUHRER U, 1955, PLANTA, V45, P1, DOI 10.1007/BF01937677; Chakraborty S, 2013, GLOBAL CHANGE BIOL, V19, P1985, DOI 10.1111/gcb.12205; Cheng FF, 2018, MOL PLANT PATHOL, V19, P104, DOI 10.1111/mpp.12502; Chhabra SR, 2003, J MED CHEM, V46, P97, DOI 10.1021/jm020909n; DEHORITY BA, 1989, APPL ENVIRON MICROB, V55, P2789, DOI 10.1128/AEM.55.11.2789-2792.1989; Ding LN, 2016, PHYSIOL PLANTARUM, V158, P414, DOI 10.1111/ppl.12476; Egorov NS., 1995, GUIDE PRACTICAL TRAI; Elasri M, 2001, APPL ENVIRON MICROB, V67, P1198, DOI 10.1128/AEM.67.3.1198-1209.2001; Figueroa M, 2018, MOL PLANT PATHOL, V19, P1523, DOI 10.1111/mpp.12618; Floryszak-Wieczorek J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00844; Guberac V, 1999, BODENKULTUR, V50, P39; Gutzat R, 2012, CURR OPIN PLANT BIOL, V15, P568, DOI 10.1016/j.pbi.2012.08.007; Hawkesford MJ, 2014, J CEREAL SCI, V59, P276, DOI 10.1016/j.jcs.2013.12.001; Jansen MAK, 2017, UV-B RADIATION AND PLANT LIFE: MOLECULAR BIOLOGY TO ECOLOGY, P58, DOI 10.1079/9781780648590.0058; Jin GP, 2012, BIOCHEM BIOPH RES CO, V417, P991, DOI 10.1016/j.bbrc.2011.12.066; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Khalid A, 2004, J APPL MICROBIOL, V96, P473, DOI 10.1046/j.1365-2672.2003.02161.x; Kizilkaya R, 2008, ECOL ENG, V33, P150, DOI 10.1016/j.ecoleng.2008.02.011; Klein I, 2009, PLANT SIGNAL BEHAV, V4, P50, DOI 10.4161/psb.4.1.7300; Kogan F, 2013, INT J APPL EARTH OBS, V23, P192, DOI 10.1016/j.jag.2013.01.002; Kumar S, 2018, EPIGENOMES, V2, DOI 10.3390/epigenomes2010006; Lamke J, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1263-6; Lareen A, 2016, PLANT MOL BIOL, V90, P575, DOI 10.1007/s11103-015-0417-8; Laue RE, 2000, MICROBIOL-UK, V146, P2469, DOI 10.1099/00221287-146-10-2469; Licciardello G, 2007, FEMS MICROBIOL ECOL, V61, P222, DOI 10.1111/j.1574-6941.2007.00338.x; Liu F, 2012, MOL PLANT MICROBE IN, V25, P677, DOI 10.1094/MPMI-10-11-0274; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Macholdt J, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7030045; Maksimov I. V., 2014, American Journal of Plant Sciences, V5, P1745, DOI 10.4236/ajps.2014.512189; Mathesius U, 2003, P NATL ACAD SCI USA, V100, P1444, DOI 10.1073/pnas.262672599; Miao CJ, 2012, BIOCHEM BIOPH RES CO, V427, P293, DOI 10.1016/j.bbrc.2012.09.044; Moshynets OV, 2010, B NAT KHARKOV AGRARI, V2, P19; Moshynets OV, 2010, B NAT KHARKOV AGRARI, V3, P6; NATELSON S, 1989, MICROCHEM J, V40, P226, DOI 10.1016/0026-265X(89)90074-X; NAYLOR REL, 1993, ANN APPL BIOL, V123, P379, DOI 10.1111/j.1744-7348.1993.tb04100.x; Ortiz-Castro R, 2008, PLANT CELL ENVIRON, V31, P1497, DOI 10.1111/j.1365-3040.2008.01863.x; Palmer AG, 2014, ACS CHEM BIOL, V9, P1834, DOI 10.1021/cb500191a; Papenfort K, 2016, NAT REV MICROBIOL, V14, P576, DOI 10.1038/nrmicro.2016.89; Paradikovic N, 2013, AGR FOOD SCI, V22, P307, DOI 10.23986/afsci.7354; Pierson EA, 1998, MOL PLANT MICROBE IN, V11, P1078, DOI 10.1094/MPMI.1998.11.11.1078; Potters G, 2007, TRENDS PLANT SCI, V12, P98, DOI 10.1016/j.tplants.2007.01.004; ROSENBLATT JE, 1973, APPL MICROBIOL, V25, P77, DOI 10.1128/AEM.25.1.77-85.1973; Schenk ST, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00784; Schenk ST, 2014, PLANT CELL, V26, P2708, DOI 10.1105/tpc.114.126763; Schikora A, 2016, PLANT MOL BIOL, V90, P605, DOI 10.1007/s11103-016-0457-8; Schuhegger R, 2006, PLANT CELL ENVIRON, V29, P909, DOI 10.1111/j.1365-3040.2005.01471.x; Shaharoona B, 2008, APPL MICROBIOL BIOT, V79, P147, DOI 10.1007/s00253-008-1419-0; Sjofjan O, 2011, WORLDS POULT SCI J, V10, P411, DOI [10.3923/ ijps.2011.411.415, DOI 10.3923/IJPS.2011.411.415]; Stella M., 2010, Journal of Tropical Agriculture and Food Science, V38, P211; Torres K.C., 1989, TISSUE CULTURE TECHN, P26; Tsygankova V, 2016, EUR J BIOTECHNOL BIO, V4, P41; Wegulo SN, 2011, CROP PROT, V30, P685, DOI 10.1016/j.cropro.2011.02.002; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Whiteley M, 2017, NATURE, V551, P313, DOI 10.1038/nature24624; Wiik L, 2010, CROP PROT, V29, P11, DOI 10.1016/j.cropro.2009.09.008; Woomer P.L., 1994, METHODS SOIL ANAL 2, P59	60	18	19	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0209460	10.1371/journal.pone.0209460	http://dx.doi.org/10.1371/journal.pone.0209460			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802259	Green Published, gold, Green Submitted			2022-12-26	WOS:000459710700004
J	Dabagh, M; Randles, A				Dabagh, Mahsa; Randles, Amanda			Role of deformable cancer cells on wall shear stress-associated-VEGF secretion by endothelium in microvasculature	PLOS ONE			English	Article							FINITE-ELEMENT; GROWTH-FACTOR; TUMOR-CELLS; ADHESION; SELECTIN; MOTION; FLOW; SIMULATIONS; RECEPTOR-2; ACTIVATION	Endothelial surface layer (glycocalyx) is the major physiological regulator of tumor cell adhesion to endothelium. Cancer cells express vascular endothelial growth factor (VEGF) which increases the permeability of a microvessel wall by degrading glycocalyx. Endothelial cells lining large arteries have also been reported, in vitro and in vivo, to mediate VEGF expression significantly under exposure to high wall shear stress (WSS) > 0.6 Pa. The objective of the present study is to explore whether local hemodynamic conditions in the vicinity of a migrating deformable cancer cell can influence the function of endothelial cells to express VEGF within the microvasculature. A three-dimensional model of deformable cancer cells (DCCs) migrating within a capillary is developed by applying a massively parallel hemodynamics application to simulate the fluid-structure interaction between the DCC and fluid surrounding the DCC. We study how dynamic interactions between the DCC and its local microenvironment affect WSS exposed on endothelium, under physiological conditions of capillaries with different diameters and flow conditions. Moreover, we quantify the area of endothelium affected by the DCC. Our results show that the DCC alters local hemodynamics in its vicinity up to an area as large as 40 times the cancer cell lateral surface. In this area, endothelium experiences high WSS values in the range of 0.6-12 Pa. Endothelial cells exposed to this range of WSS have been reported to express VEGF. Furthermore, we demonstrate that stiffer cancer cells expose higher WSS on the endothelium. A strong impact of cell stiffness on its local microenvironment is observed in capillaries with diameters <16 mu m. WSS-induced-VEGF by endothelium represents an important potential mechanism for cancer cell adhesion and metastasis in the microvasculature. This work serves as an important first step in understanding the mechanisms driving VEGF-expression by endothelium and identifying the underlying mechanisms of glycocalyx degradation by endothelium in micro-vasculature. The identification of angiogenesis factors involved in early stages of cancer cell-endothelium interactions and understanding their regulation will help, first to develop anti-angiogenic strategies applied to diagnostic studies and therapeutic interventions, second to predict accurately where different cancer cell types most likely adhere in microvasculature, and third to establish accurate criteria predisposing the cancer metastasis.	[Dabagh, Mahsa; Randles, Amanda] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Randles, A (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	amanda.randles@duke.edu		Dabagh, Mahsa/0000-0003-1540-7420	NIH [DP5OD091876]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	AR and MD received funding from the NIH DP5OD091876. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artoli AM, 2007, J BIOMECH, V40, P3493, DOI 10.1016/j.jbiomech.2007.05.031; Cai B, 2012, J APPL PHYSIOL, V113, P1141, DOI 10.1152/japplphysiol.00479.2012; Chang KC, 2000, P NATL ACAD SCI USA, V97, P11262, DOI 10.1073/pnas.200240897; Dabagh M, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0185; Dabagh M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0431; Daddi-Moussa-Ider A, 2017, PHYS FLUIDS, V29, DOI 10.1063/1.5002192; Fai TG, 2013, SIAM J SCI COMPUT, V35, pB1132, DOI 10.1137/120903038; Fan J, 2016, ANN BIOMED ENG, V44, P2189, DOI 10.1007/s10439-015-1517-y; Fan J, 2011, ANN BIOMED ENG, V39, P2223, DOI 10.1007/s10439-011-0321-6; GELLER AS, 1986, J FLUID MECH, V169, P27, DOI 10.1017/S0022112086000538; Gounley J., 2017, ELS P COMP SCI, V108; Gounley J, 2015, COMMUN COMPUT PHYS, V17, P1073, DOI 10.4208/cicp.2014.m355; Guo P, 2014, BIOMECH MODEL MECHAN, V13, P537, DOI 10.1007/s10237-013-0515-y; Hong D, 2006, AM J PHYSIOL-HEART C, V290, pH2498, DOI 10.1152/ajpheart.00828.2005; Howard B, 1958, J FLU, V4, P195; Jadhav S, 2005, BIOPHYS J, V88, P96, DOI 10.1529/biophysj.104.051029; Khismatullin DB, 2012, BIOPHYS J, V102, P1757, DOI 10.1016/j.bpj.2012.03.018; Khismatullin DB, 2005, PHYS FLUIDS, V17, DOI 10.1063/1.1862635; Kruger T, 2011, COMPUT MATH APPL, V61, P3485, DOI 10.1016/j.camwa.2010.03.057; Lefebvre Y, 2007, J FLUID MECH, V589, P157, DOI 10.1017/S0022112007007586; Li J, 2005, BIOPHYS J, V88, P3707, DOI 10.1529/biophysj.104.047332; Liang S, 2005, EXP CELL RES, V310, P282, DOI 10.1016/j.yexcr.2005.07.028; Luo ZY, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4965251; Luo ZY, 2015, J FLUID MECH, V775, P77, DOI 10.1017/jfm.2015.286; Matyka M, 2013, COMPUT FLUIDS, V73, P115, DOI 10.1016/j.compfluid.2012.12.018; Paz NG, 2011, J CELL SCI, V125, P831; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; PRASAD ARS, 1993, CIRC RES, V72, P827, DOI 10.1161/01.RES.72.4.827; Rai S, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0223-9; Randles A, 2015, INT C HIGH PERF COMP; Randles A, 2015, J COMPUT SCI-NETH, V9, P70, DOI 10.1016/j.jocs.2015.04.003; Randles AP, 2013, INT PARALL DISTRIB P, P1063, DOI 10.1109/IPDPS.2013.109; Rinker KD, 2001, BIOPHYS J, V80, P1722, DOI 10.1016/S0006-3495(01)76143-7; Secomb TW, 2001, AM J PHYSIOL-HEART C, V281, pH629, DOI 10.1152/ajpheart.2001.281.2.H629; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; SHRIVASTAVA S, 1993, J STRAIN ANAL ENG, V28, P31, DOI 10.1243/03093247V281031; Smith MJ, 1999, BIOPHYS J, V77, P3371, DOI 10.1016/S0006-3495(99)77169-9; Stroka KM, 2014, AM J PHYSIOL-CELL PH, V306, pC98, DOI 10.1152/ajpcell.00289.2013; Takeishi N, 2016, AM J PHYSIOL-HEART C, V311, pH395, DOI 10.1152/ajpheart.00241.2016; TOZEREN A, 1992, BIOPHYS J, V63, P700, DOI 10.1016/S0006-3495(92)81660-0; Urbich C, 2003, FEBS LETT, V535, P87, DOI 10.1016/S0014-5793(02)03879-6; Walter J, 2010, INT J NUMER METH ENG, V83, P829, DOI 10.1002/nme.2859; Wang DG, 1999, CANCER RES, V59, P1464; White SJ, 2011, J CELL PHYSIOL, V226, P2841, DOI 10.1002/jcp.22629; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Xu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0022900; Zhang Y, 2002, BIOPHYS J, V83, P1934, DOI 10.1016/S0006-3495(02)73956-8; Zhang Z, 2017, BIOMECH MOD MECHANOB; ZHELEV DV, 1994, BIOPHYS J, V67, P696, DOI 10.1016/S0006-3495(94)80529-6; ZHONGCAN OY, 1989, PHYS REV A, V39, P5280, DOI 10.1103/PhysRevA.39.5280	50	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211418	10.1371/journal.pone.0211418	http://dx.doi.org/10.1371/journal.pone.0211418			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794550	Green Submitted, Green Published, gold			2022-12-26	WOS:000459709100015
J	Mondragon, R; Sanchez, D; Cabello, R; Llopis, R; Julia, JE				Mondragon, Rosa; Sanchez, Daniel; Cabello, Ramon; Llopis, Rodrigo; Enrique Julia, J.			Flat plate solar collector performance using alumina nanofluids: Experimental characterization and efficiency tests	PLOS ONE			English	Article							HEAT-TRANSFER; THERMAL PERFORMANCE; CONDUCTIVITY; FLOW	Solar energy has become an important renewable energy source for reducing the use of fossil fuels and to mitigate global warming, for which solar collectors constitute a technology that is to be promoted. The use of nanofluids can increase the efficiency of solar into thermal energy conversion in solar collectors. Experimental values for the specific heat, thermal conductivity and viscosity of alumina/water nanofluids are needed to evaluate the influence of the solid content (from 0.25 to 5 v%) and the flow rate on the Reynolds, Nusselt and the heat transfer coefficient. In the laminar flow regime, thermal conductivity enhancement over specific heat decrement is key parameter, and a 2.34% increase in the heat transfer coefficient is theoretically obtained for 1 v% alumina nanofluid. To corroborate the results, experimental tests were run in a flat plate solar collector. A reduction in efficiency from 47% to 41.5% and a decrease in the heat removal factor were obtained using the nanofluid due to the formation of a nanoparticle deposition layer adding an addition thermal resistance to heat transfer. Nanofluids are recommended only if the nanoparticle concentration is high enough to enhance thermal conductivity, but no so high so as to avoid wall deposition.	[Mondragon, Rosa; Sanchez, Daniel; Cabello, Ramon; Llopis, Rodrigo; Enrique Julia, J.] Univ Jaume 1, Dept Ingn Mecan & Construcc, Castellon De La Plana, Spain	Universitat Jaume I	Mondragon, R (corresponding author), Univ Jaume 1, Dept Ingn Mecan & Construcc, Castellon De La Plana, Spain.	mondragn@uji.es	García-Vacas, Daniel Sánchez/L-3764-2014; Llopis, R./H-7184-2019; Cabello-Lopez, Ramon/R-1056-2018	García-Vacas, Daniel Sánchez/0000-0003-4924-1254; Llopis, R./0000-0003-0866-1009; Cabello-Lopez, Ramon/0000-0002-1916-5142; Mondragon, Rosa/0000-0002-9353-0275	Spanish Ministry of Science and Innovation [CTQ2010-21321-C02-01, CTQ2010-21321-C02-02]; Spanish Ministry of Economy and Competitiveness [ENE2014-53760-R, ENE2016-77694-R]; University Jaume I of Castellon [P11B2015-66, UJI-B2016-47]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government); University Jaume I of Castellon	The authors gratefully acknowledge the financial support from the Spanish Ministry of Science and Innovation (CTQ2010-21321-C02-01 and CTQ2010-21321-C02-02), the Spanish Ministry of Economy and Competitiveness (ENE2014-53760-R and ENE2016-77694-R), and the University Jaume I of Castellon (P11B2015-66 and UJI-B2016-47).	[Anonymous], 2001, PERRYS CHEM ENG HDB; Bazdidi-Tehrani F, 2018, RENEW ENERG, V122, P406, DOI 10.1016/j.renene.2018.01.056; Choi SUS., 1993, ASME INT MECH ENG C; Farajzadeh E, 2018, RENEW ENERG, V118, P122, DOI 10.1016/j.renene.2017.10.102; Ganvir RB, 2017, RENEW SUST ENERG REV, V75, P451, DOI 10.1016/j.rser.2016.11.010; Genc AM, 2018, APPL THERM ENG, V130, P395, DOI 10.1016/j.applthermaleng.2017.10.166; Hawwash AA, 2018, APPL THERM ENG, V130, P363, DOI 10.1016/j.applthermaleng.2017.11.027; Hemmat Esfe M, 2014, J THERM ANAL CALORIM, V117, P675, DOI 10.1007/s10973-014-3771-x; Kaya H, 2018, RENEW ENERG, V122, P329, DOI 10.1016/j.renene.2018.01.115; Kherbeet AS, 2015, EXP THERM FLUID SCI, V65, P13, DOI 10.1016/j.expthermflusci.2015.02.023; Kim H, 2017, ENERGY, V118, P1304, DOI 10.1016/j.energy.2016.11.009; KITANO T, 1981, RHEOL ACTA, V20, P207, DOI 10.1007/BF01513064; Mahbubul IM, 2018, RENEW ENERG, V121, P36, DOI 10.1016/j.renene.2018.01.006; Mahian O, 2013, INT J HEAT MASS TRAN, V57, P582, DOI 10.1016/j.ijheatmasstransfer.2012.10.037; Martinez-Cuenca R, 2016, APPL THERM ENG, V98, P841, DOI 10.1016/j.applthermaleng.2015.11.050; Mehrali M, 2015, J NANOPART RES, V17, DOI 10.1007/s11051-015-3062-x; Mirzaei M, 2018, APPL THERM ENG, V134, P68, DOI 10.1016/j.applthermaleng.2018.01.104; Mondragon R, 2013, POWDER TECHNOL, V249, P516, DOI 10.1016/j.powtec.2013.08.035; Purohit N, 2018, RENEW ENERG, V120, P14, DOI 10.1016/j.renene.2017.12.066; Raj P, 2018, RENEW SUST ENERG REV, V84, P54, DOI 10.1016/j.rser.2017.10.012; Sharafeldin MA, 2018, ENERG CONVERS MANAGE, V155, P32, DOI 10.1016/j.enconman.2017.10.070; Sharafeldin MA, 2017, ENERGY, V141, P2436, DOI 10.1016/j.energy.2017.11.068; Stalin PMJ, 2017, J THERMAL ANAL CALOR, P1; Yin ZQ, 2018, J EXP NANOSCI, V13, P82, DOI 10.1080/17458080.2017.1413599; Yousefi T, 2012, SOL ENERGY, V86, P771, DOI 10.1016/j.solener.2011.12.003; Yousefi T, 2012, EXP THERM FLUID SCI, V39, P207, DOI 10.1016/j.expthermflusci.2012.01.025; Yousefi T, 2012, RENEW ENERG, V39, P293, DOI 10.1016/j.renene.2011.08.056	27	22	22	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212260	10.1371/journal.pone.0212260	http://dx.doi.org/10.1371/journal.pone.0212260			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794583	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100050
J	Rodelo-Haad, C; Aguera, ML; Carmona, A; Navarro, MD; Carracedo, J; Rodriguez-Benot, A; Aljama, P				Rodelo-Haad, Cristian; Luisa Aguera, Maria; Carmona, Andres; Dolores Navarro, Maria; Carracedo, Julia; Rodriguez-Benot, Alberto; Aljama, Pedro			Pancreatic autoantibodies and CD14(+)CD16(+) monocytes subset are associated with the impairment of beta-cell function after simultaneous pancreas-kidney transplantation	PLOS ONE			English	Article							ISLET AUTOANTIBODIES; T-CELLS; TYPE-1; MACROPHAGES; RECURRENCE; DIAGNOSIS; CHILDREN; INSULIN; DISEASE; MARKERS	Pancreatic autoantibodies (AAb) has been associated with a worse pancreas graft survival after simultaneous pancreas-kidney transplantation (SPK). However, due to the variable time for AAb to become positive and the lack of early biomarkers suggesting such autoimmune activation, the mechanisms leading beta-cell destruction remain uncertain. The present study aimed to evaluate the association between post-transplant AAb and the functional impairment of the pancreatic beta-cell and also the association of such AAb with inflammation after SPK. In a longitudinal study, we analyzed the impact of post-transplant glutamic acid decarboxylase (GAD-65) and the insulinoma-associated autoantigen 2 (IA-2) AAb on pancreas graft function. Serum Hb1Ac and C-peptide (C-pep) were longitudinally compared between a group with positive posttransplant AAb (AAb+; n = 40) and another matched group with negative AAb (AAb-; n = 40) until the fifth year following seroconversion. In the cross-sectional analysis, we further evaluated the systemic signatures of inflammation by measuring pro-inflammatory CD14(+)CD16(+) monocytes by flow-cytometry and interleukin 17-A serum levels in 38 SPK recipients and ten healthy controls. In the longitudinal study, patients with AAb+ showed higher levels of Hb1Ac (p<0.001) and lower C-pep levels (p<0.001) compared to those who remained AAb-throughout the follow-up. In the cross-sectional study, AAb+ patients showed a higher percentage of CD14(+)CD16(+) monocytes compared with those with AAb- and the healthy controls (6.70 +/- 4.19% versus 4.0 +/- 1.84% and 3.44 +/- 0.93%; p = 0.026 and 0.009 respectively). Also, CD14(+)CD16(+) monocytes correlated with Hb1Ac and C-pep serum levels. Multivariate logistic regression showed that posttransplant AAb+ was independently associated with a higher percentage of pro-inflammatory monocytes (adjusted-OR 1.59, 95% CI 1.05-2.40, p = 0.027). The group of patients with positive AAb also showed higher levels of IL17A as compared with the other groups (either healthy control or the negative AAb subjects). In conclusion, pancreatic AAb+ after SPK were not only associated with higher Hb1Ac and lower c-peptide serum levels but also with an increased percentage of CD14(+) CD16(+) monocytes and higher levels of circulating IL17-A.	[Rodelo-Haad, Cristian; Luisa Aguera, Maria; Dolores Navarro, Maria; Rodriguez-Benot, Alberto; Aljama, Pedro] Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain; [Rodelo-Haad, Cristian; Luisa Aguera, Maria; Carmona, Andres; Dolores Navarro, Maria; Rodriguez-Benot, Alberto; Aljama, Pedro] Reina Sofia Univ Hosp, Nephrol Unit, Cordoba, Spain; [Rodelo-Haad, Cristian; Luisa Aguera, Maria; Carmona, Andres; Dolores Navarro, Maria; Carracedo, Julia; Rodriguez-Benot, Alberto; Aljama, Pedro] Inst Salud Carlos III, RETICs Red Renal, Madrid, Spain; [Carracedo, Julia] Univ Complutense Madrid, Inst Invest Sanitaria Hosp 12 Octubre imas12, Fac Biol, Dept Genet Fisiol & Microbiol, Madrid, Spain	Universidad de Cordoba; Hospital Universitario Reina Sofia - Cordoba; Instituto de Salud Carlos III; Complutense University of Madrid	Rodelo-Haad, C (corresponding author), Univ Cordoba, Reina Sofia Univ Hosp, Maimonides Biomed Res Inst Cordoba IMIBIC, Cordoba, Spain.; Rodelo-Haad, C (corresponding author), Reina Sofia Univ Hosp, Nephrol Unit, Cordoba, Spain.; Rodelo-Haad, C (corresponding author), Inst Salud Carlos III, RETICs Red Renal, Madrid, Spain.	crisroha@yahoo.com	Carracedo, Julia/ABG-2464-2020; Carracedo, Julia/L-2012-2015	Carracedo, Julia/0000-0002-8422-812X; Carracedo, Julia/0000-0002-8422-812X; Rodriguez Benot, Alberto/0000-0003-1385-4526; Carmona, Andres/0000-0002-1830-2096; Aguera Morales, Maria Luisa/0000-0002-7736-908X; Rodelo-Haad, Cristian/0000-0002-8139-3840	Plan Nacional de I+D+i Proyectos de Investigacion en Salud of Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion, Fondos de Desarrollo Regional (FEDER) [PI12/01489]	Plan Nacional de I+D+i Proyectos de Investigacion en Salud of Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion, Fondos de Desarrollo Regional (FEDER)	This work was supported by Plan Nacional de I+D+i Proyectos de Investigacion en Salud of Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion, Fondos de Desarrollo Regional (FEDER) (PI12/01489). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; [Anonymous], 2015, DIABETES CARE, V38, pS8, DOI 10.2337/dc15-S005; Bluestone JA, 2010, NATURE, V464, P1293, DOI 10.1038/nature08933; Bradshaw EM, 2009, J IMMUNOL, V183, P4432, DOI 10.4049/jimmunol.0900576; Carmona A, 2017, AM J PHYSIOL-RENAL, V312, pF673, DOI 10.1152/ajprenal.00013.2016; Choi JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186827; Dieterle CD, 2005, TRANSPL INT, V18, P1361, DOI 10.1111/j.1432-2277.2005.00223.x; Emamaullee JA, 2009, DIABETES, V58, P1302, DOI 10.2337/db08-1113; Erbel C, 2014, J IMMUNOL, V193, P4344, DOI 10.4049/jimmunol.1400181; Evans HG, 2007, P NATL ACAD SCI USA, V104, P17034, DOI 10.1073/pnas.0708426104; Ge S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098019; Gruessner RWG, 2013, NAT REV ENDOCRINOL, V9, P555, DOI 10.1038/nrendo.2013.138; Han BY, 2005, J CLIN INVEST, V115, P1879, DOI 10.1172/JCI24219; Helminen O, 2015, DIABETES, V64, P1719, DOI 10.2337/db14-0497; Israni AK, 2014, AM J TRANSPLANT, V14, P45, DOI 10.1111/ajt.12580; Koskinen MK, 2016, EUR J ENDOCRINOL, V174, P251, DOI 10.1530/EJE-15-0674; Marwaha AK, 2010, J IMMUNOL, V185, P3814, DOI 10.4049/jimmunol.1001860; Merino A, 2012, NEPHROL DIAL TRANSPL, V27, P2907, DOI 10.1093/ndt/gfr767; Merino A, 2011, J IMMUNOL, V186, P1809, DOI 10.4049/jimmunol.1001866; Morgan NG, 2017, DIABETIC MED, V34, P879, DOI 10.1111/dme.13365; Orban T, 2009, DIABETES CARE, V32, P2269, DOI 10.2337/dc09-0934; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Qiao YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176157; Reinert-Hartwall L, 2015, J IMMUNOL, V194, P68, DOI 10.4049/jimmunol.1401653; Rodelo-Haad C, 2015, TRANSPL P, V47, P107, DOI 10.1016/j.transproceed.2014.11.011; Schmidt M, 2001, J IMMUNOL; Schuster C, 2018, EUR J IMMUNOL, V48, P1211, DOI 10.1002/eji.201847498; Steck AK, 2011, DIABETES CARE, V34, P1397, DOI 10.2337/dc10-2088; SUTHERLAND DER, 1989, DIABETES, V38, P85, DOI 10.2337/diab.38.1.S85; Thivolet C, 2000, TRANSPLANTATION, V69, P99, DOI 10.1097/00007890-200001150-00018; Ulrich C, 2008, AM J TRANSPLANT, V8, P103, DOI 10.1111/j.1600-6143.2007.02035.x; Uno S, 2007, DIABETOLOGIA, V50, P596, DOI 10.1007/s00125-006-0569-9; Van Belle TL, 2011, PHYSIOL REV, V91, P79, DOI 10.1152/physrev.00003.2010; Vendrame F, 2016, AM J TRANSPLANT, V16, P235, DOI 10.1111/ajt.13426; Vendrame F, 2010, DIABETES, V59, P947, DOI 10.2337/db09-0498; Waugh K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174840; Yu H, 2018, IMMUNOLOGY, V153, P161, DOI 10.1111/imm.12867; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Zizzo G, 2013, J IMMUNOL, V190, P5237, DOI 10.4049/jimmunol.1203017	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212547	10.1371/journal.pone.0212547	http://dx.doi.org/10.1371/journal.pone.0212547			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794611	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100087
J	Couto, CMV; Cumming, GS; Lacorte, GA; Congrains, C; Izbicki, R; Braga, EM; Rocha, CD; Moralez-Silva, E; Henry, DAW; Manu, SA; Abalaka, J; Regalla, A; da Silva, AS; Diop, MS; Del Lama, SN				Villar Couto, Cynthia M.; Cumming, Graeme S.; Lacorte, Gustavo A.; Congrains, Carlos; Izbicki, Rafael; Braga, Erika Martins; Rocha, Cristiano D.; Moralez-Silva, Emmanuel; Henry, Dominic A. W.; Manu, Shiiwua A.; Abalaka, Jacinta; Regalla, Aissa; da Silva, Alfredo Simao; Diop, Moussa S.; Del Lama, Silvia N.			Avian haemosporidians in the cattle egret (Bubulcus ibis) from central-western and southern Africa: High diversity and prevalence	PLOS ONE			English	Article							MALARIA PARASITES; MOLECULAR CHARACTERIZATION; MOSQUITO ABUNDANCE; BLOOD PARASITES; DYNAMICS; TEMPERATURE; PLASMODIUM; LEUCOCYTOZOON; EXPANSION; NETWORKS	We described the geographic distribution of 82 haemosporidian lineages (Plasmodium, Haemoproteus, and Leucocytozoon) in the cattle egret sampled in five countries in central-western and southern Africa. Seventy-three lineages have not previously been reported. We determined the prevalence of three haemosporidians in the samples. We investigated the influence of the internal environment of the host and environmental variables on the Plasmodium diversity and whether environmental variables may explain spatial variations in the prevalence of Plasmodium. We screened DNA from 509 blood samples from nestlings in 15 African colonies for infection by sequencing the cytochrome b gene of parasites. The molecular phylogenetic analysis was performed using Bayesian methods and including sequences from the MalAvi and GeneBank databases. We found 62 new Plasmodium lineages in a clade with MYCAME02, which is a lineage described in waterbirds and recently identified in birds of prey as Plasmodium paranucleophilum. Two Haemoproteus lineages identified in cattle egret formed a distinct group with Haemoproteus catharti and MYCAMH1 (Haemoproteus spp.). Seven Leucocytozoon lineages found in the cattle egret clustered with Leucocytozoon californicus. We found different Plasmodium diversities among the colonies sampled, demonstrating that the internal environment of the host is not the primary determinant of diversity. A linear mixed-effects multivariate model showed that precipitation was positively associated with Plasmodium diversity when controlling for the effects of temperature, colony composition (mixed and non-mixed species) and country. Moreover, a generalized mixed model showed that temperature was positively associated with the prevalence of Plasmodium when controlling for precipitation, elevation and country. We conclude that the cattle egret is a good model for future haemosporidian studies, as we found a significant number of new lineages in this host, which occupies regions with different climate characteristics where environmental variables exert an influence on the diversity and prevalence of Plasmodium.	[Villar Couto, Cynthia M.; Congrains, Carlos; Rocha, Cristiano D.; Moralez-Silva, Emmanuel; Del Lama, Silvia N.] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, SP, Brazil; [Cumming, Graeme S.; Henry, Dominic A. W.] Univ Cape Town, DST NRF Ctr Excellence, Percy FitzPatrick Inst, Cape Town, South Africa; [Lacorte, Gustavo A.] Inst Fed Minas Gerais, Dept Ciencias & Linguagens, Bambui, MG, Brazil; [Izbicki, Rafael] Univ Fed Sao Carlos, Ctr Ciencias Exatas & Tecnol, Dept Estat, Sao Carlos, SP, Brazil; [Braga, Erika Martins] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Manu, Shiiwua A.; Abalaka, Jacinta] AP Leventis Ornithol Res Inst, Jos, Nigeria; [Regalla, Aissa; da Silva, Alfredo Simao] IBAP, Bissau, Guinea Bissau; [Diop, Moussa S.] AfriWet Consultants, Dakar, Thiaroye, Senegal; [Cumming, Graeme S.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld, Australia; [da Silva, Alfredo Simao] Programme UICN Guinee Bissau, Bissau, Guinea Bissau	Universidade Federal de Sao Carlos; National Research Foundation - South Africa; University of Cape Town; Instituto Federal de Educacao, Ciencia e Tecnologia de Minas Gerais (IFMG); Universidade Federal de Sao Carlos; Universidade Federal de Minas Gerais; James Cook University	Del Lama, SN (corresponding author), Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, Sao Carlos, SP, Brazil.	dsdl@ufscar.br	Braga, Erika Martins/A-6776-2008; Lacorte, Gustavo Augusto/AAS-1968-2021; Congrains, Carlos/E-5709-2017; G.A., Lacorte/T-8904-2017; Cumming, Graeme S./B-6551-2008	Braga, Erika Martins/0000-0001-5550-7157; Lacorte, Gustavo Augusto/0000-0002-6866-348X; Congrains, Carlos/0000-0001-7506-6133; G.A., Lacorte/0000-0002-6866-348X; Cumming, Graeme S./0000-0002-3678-1326; Izbicki, Rafael/0000-0003-0379-9690; Regalla de Barros, Aissa/0000-0003-1522-8211	Brazilian fostering agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [State of Sao Paulo Research Assistance Foundation]) through Research Grants [2010/50406-5, 2016/01673-7, 2017/03363-8]	Brazilian fostering agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [State of Sao Paulo Research Assistance Foundation]) through Research Grants(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was primarily funded by governmental institutions from Brazil. This work was supported by the Brazilian fostering agency Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP [State of Sao Paulo Research Assistance Foundation]) through Research Grants awarded to SN Del Lama (2010/50406-5, 2016/01673-7) and awarded to R Izbicki (2017/03363-8). AfriWet Consultants provided support in the form of salaries for authors MD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; BROWDER JA, 1973, BIRD BANDING, V44, P158, DOI 10.2307/4511956; Brown L.H., 1982, BIRDS AFRICA, V1; Illera JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184587; Chahad-Ehlers S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2847-z; Congrains C, 2016, J AVIAN BIOL, V47, P846, DOI 10.1111/jav.00972; CROSBY GT, 1972, BIRD BANDING, V43, P205, DOI 10.2307/4511880; Cumming GS, 2013, PARASITOLOGY, V140, P193, DOI 10.1017/S0031182012001461; Dawson A, 2004, TECH ECOL CONSERVAT, P211; del Hoyo J., 1992, P1; Durrant KL, 2006, ORNITHOL MONOGR, P98; Ferraguti M, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-208; Galen SC, 2014, J AVIAN BIOL, V45, P374, DOI 10.1111/jav.00375; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2011, J WILDLIFE DIS, V47, P849, DOI 10.7589/0090-3558-47.4.849; HUDSON JW, 1974, COMP BIOCHEM PHYSIOL, V49, P717, DOI 10.1016/0300-9629(74)90900-1; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ishtiaq F, 2017, ECOL EVOL, V7, P8040, DOI 10.1002/ece3.3319; Jones MR, 2013, J PARASITOL, V99, P903, DOI 10.1645/12-147.1; Kim KS, 2010, MOL ECOL, V19, P5545, DOI 10.1111/j.1365-294X.2010.04897.x; Krone O, 2001, ACTA PROTOZOOL, V40, P281; Kushlan J.A., 2005, HERONS; Lacorte GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057770; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MADDOCK M, 1994, OSTRICH, V65, P191, DOI 10.1080/00306525.1994.9639682; Martin AP, 1997, ATLAS SO AFRICAN BIR, V1; Moens MAJ, 2016, INT J PARASITOL, V46, P41, DOI 10.1016/j.ijpara.2015.08.001; Nylander J.A.A., 2004, MRMODELTEST V2 PROGR; Okanga S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086382; Okanga S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-370; Outlaw DC, 2017, PARASITOLOGY, V144, P394, DOI 10.1017/S0031182016001979; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Padilla DP, 2017, INT J PARASITOL, V47, P225, DOI 10.1016/j.ijpara.2016.11.008; Perez-Rodriguez A, 2013, GLOBAL CHANGE BIOL, V19, P3245, DOI 10.1111/gcb.12226; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; R Development Core Team, 2015, R LANG ENV STAT COMP; Ricklefs RE, 2017, J BIOGEOGR, V44, P1113, DOI 10.1111/jbi.12928; Sambrook J., 2001, MOL CLONING LAB MANU; Samraoui F, 2007, OSTRICH, V78, P481, DOI 10.2989/OSTRICH.2007.78.2.58.172; Sehgal RNM, 2011, P ROY SOC B-BIOL SCI, V278, P1025, DOI 10.1098/rspb.2010.1720; Sehgal RNM, 2015, INT J PARASITOL-PAR, V4, P421, DOI 10.1016/j.ijppaw.2015.09.001; Shurulinkov P, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2179-7; Stroup W.W., 2016, GEN LINEAR MIXED MOD; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Tostes R, 2017, PARASITOL RES, V116, P1887, DOI 10.1007/s00436-017-5465-3; Valki<umacron>nas G, 2005, AVIAN MALARIA PARASI; Valkiunas G, 2014, PARASITOL RES, V113, P2251, DOI 10.1007/s00436-014-3880-2; van Rooyen J, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-139; Villar CM, 2013, J PARASITOL, V99, P522, DOI 10.1645/12-73.1; Walther E, 2016, PARASITOL RES, V115, P1853, DOI 10.1007/s00436-016-4925-5; Yabsley MJ, 2018, MALARIA J, V17, DOI 10.1186/s12936-017-2165-5; Zehtindjiev P, 2008, EXP PARASITOL, V119, P99, DOI 10.1016/j.exppara.2007.12.018	60	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212425	10.1371/journal.pone.0212425	http://dx.doi.org/10.1371/journal.pone.0212425			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794584	Green Published, Green Accepted, gold			2022-12-26	WOS:000459709100066
J	Hasnain, Z; Mason, J; Gill, K; Miranda, G; Gill, IS; Kuhn, P; Newton, PK				Hasnain, Zaki; Mason, Jeremy; Gill, Karanvir; Miranda, Gus; Gill, Inderbir S.; Kuhn, Peter; Newton, Paul K.			Machine learning models for predicting post-cystectomy recurrence and survival in bladder cancer patients	PLOS ONE			English	Article							RADICAL CYSTECTOMY; PROGNOSIS	Currently in patients with bladder cancer, various clinical evaluations (imaging, operative findings at transurethral resection and radical cystectomy, pathology) are collectively used to determine disease status and prognosis, and recommend neoadjuvant, definitive and adjuvant treatments. We analyze the predictive power of these measurements in forecasting two key long-term outcomes following radical cystectomy, i.e., cancer recurrence and survival. Information theory and machine learning algorithms are employed to create predictive models using a large prospective, continuously collected, temporally resolved, primary bladder cancer dataset comprised of 3503 patients (1971-2016). Patient recurrence and survival one, three, and five years after cystectomy can be predicted with greater than 70% sensitivity and specificity. Such predictions may inform patient monitoring schedules and post-cystectomy treatments. The machine learning models provide a benchmark for predicting oncologic outcomes in patients undergoing radical cystectomy and highlight opportunities for improving care using optimal preoperative and operative data collection.	[Hasnain, Zaki; Kuhn, Peter; Newton, Paul K.] Univ Southern Calif, Viterbi Sch Engn, Dept Aerosp & Mech Engn, Univ Pk Campus, Los Angeles, CA 90007 USA; [Mason, Jeremy; Gill, Karanvir; Kuhn, Peter] Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Univ Pk Campus, Los Angeles, CA 90007 USA; [Miranda, Gus; Gill, Inderbir S.; Kuhn, Peter] Univ Southern Calif, Keck Sch Med, USC Inst Urol, Hlth Sci Campus, Los Angeles, CA 90007 USA; [Kuhn, Peter] Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Univ Pk Campus, Los Angeles, CA 90007 USA; [Kuhn, Peter; Newton, Paul K.] Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Hlth Sci Campus, Los Angeles, CA 90007 USA; [Newton, Paul K.] Univ Southern Calif, Dept Math, Univ Pk Campus, Los Angeles, CA USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Kuhn, P (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Aerosp & Mech Engn, Univ Pk Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Univ Pk Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Keck Sch Med, USC Inst Urol, Hlth Sci Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Viterbi Sch Engn, Dept Biomed Engn, Univ Pk Campus, Los Angeles, CA 90007 USA.; Kuhn, P (corresponding author), Univ Southern Calif, Keck Sch Med, Norris Comprehens Canc Ctr, Hlth Sci Campus, Los Angeles, CA 90007 USA.	pkuhn@usc.edu		Miranda, Gus/0000-0001-6110-9024; Kuhn, Peter/0000-0003-2629-4505	Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services [HHSN261201500003B]; Seven Bridges Genomics, Inc.	Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services; Seven Bridges Genomics, Inc.	This work was supported by Federal funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN261201500003B; Seven Bridges Genomics, Inc.; as well as institutional support from the University of Southern California Institute of Urology and the University of Southern California Michelson Center for Convergent Biosciences.	Akritas AG, 2004, MATH COMPUT SIMULAT, V67, P15, DOI 10.1016/j.matcom.2004.05.005; American Cancer Society, 2018, CANC FACTS FIG 2018; [Anonymous], 2018, AGE STANDARDS SURVIV; Bader P, 2003, J UROLOGY, V169, P849, DOI 10.1097/01.ju.0000049032.38743.c7; Bochner BH, 2006, J CLIN ONCOL, V24, P3967, DOI 10.1200/JCO.2005.05.3884; Butte A J, 2000, Pac Symp Biocomput, P418; Cheng L, 2014, CRIT REV ONCOL HEMAT, V89, P73, DOI 10.1016/j.critrevonc.2013.08.008; Cruz JA, 2006, CANCER INFORM, V2, P59; Dobruch J, 2016, EUR UROL, V69, P300, DOI 10.1016/j.eururo.2015.08.037; Herr HW, 2004, J CLIN ONCOL, V22, P2781, DOI 10.1200/JCO.2004.11.024; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Kourou K, 2015, COMPUT STRUCT BIOTEC, V13, P8, DOI 10.1016/j.csbj.2014.11.005; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Moriyama M, 2003, MOL CANCER THER, V2, P199; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Quek ML, 2005, J UROLOGY, V174, P103, DOI 10.1097/01.ju.0000163267.93769.d8; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Stenzl A, 2011, EUR UROL, V59, P1009, DOI 10.1016/j.eururo.2011.03.023; Svatek RS, 2011, BJU INT, V107, P898, DOI 10.1111/j.1464-410X.2010.09628.x; Talukder AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29647; Vickers AJ, 2009, CANCER-AM CANCER SOC, V115, P5460, DOI 10.1002/cncr.24615	22	29	30	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0210976	10.1371/journal.pone.0210976	http://dx.doi.org/10.1371/journal.pone.0210976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785915	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000016
J	Uhlenbusch, N; Lowe, B; Harter, M; Schramm, C; Weiler-Normann, C; Depping, MK				Uhlenbusch, Natalie; Loewe, Bernd; Haerter, Martin; Schramm, Christoph; Weiler-Normann, Christina; Depping, Miriam K.			Depression and anxiety in patients with different rare chronic diseases: A cross-sectional study	PLOS ONE			English	Article							PRIMARY-CARE; RISK-FACTOR; HEALTH; DISORDERS; VALIDITY; PHQ-9; COMORBIDITY; SEVERITY; STANDARDIZATION; PREVALENCE	Objective Empirical evidence on depression and anxiety in patients with rare diseases is scarce but can help improve comprehensive treatment. The objectives of this study were to investigate the frequency of depression and anxiety in this heterogeneous population and to examine aspects associated with increased psychopathology. Methods N = 300 patients with 79 different rare diseases (female:80%, age:M = 44.3(12.8), range:16-74 years) participated in a cross-sectional online study. We determined the percentages of patients reporting elevated depression (PHQ-9) and anxiety (GAD-7) scores. We calculated two linear regressions with depression and anxiety as outcomes. Predictor variables were diagnosis-related aspects (diagnosis assigned to ICD-10 chapter, visibility of symptoms, time since diagnosis, comorbid diseases), perceived somatic-symptom-severity (PHQ-15), illness-perceptions (consequences, control, identity, concern, understanding and treatment control; B-IPQ-R), coping mechanisms (constructive attitudes, active engagement in life) and social support (heiQ). We controlled for gender, age and depression or anxiety depending on the outcome. Results 42% of the patients (95%CI [36.41%,47.59%]) reported depression scores indicating moderately or severely elevated symptom levels. Regarding anxiety, this applies to 23% (95%CI [18.54%,28.06%]). Variables significantly associated with depression were higher perceived somatic-symptom-severity (B = 0.41,p <.001), less control (B =.17,p <.05), lower levels of concern (B =-0.32,p <.01) and less constructive attitudes (B =-1.40,p <.001). No diagnosis-related variables were associated with depression. Variables significantly associated with anxiety were diseases of the circulatory system compared to congenital malformations (B = 1.88,p <.05), less consequences (B =-0.32,p <.05) and more concern (B =-0.32,p <.01). Conclusion The data reveal first insights into depression and anxiety in patients with different rare diseases. High percentages of patients showed clinically relevant symptom burden. No diagnosis-related differences were found in depression while anxiety seems to be particularly frequent in patients with rare diseases of the circulatory system. Besides perceived somatic symptom severity, cognitive appraisal seems to be linked to depression. Supporting patients in coping with their disease may help reduce psychopathology and therefore improve overall health.	[Uhlenbusch, Natalie; Loewe, Bernd; Depping, Miriam K.] Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Haerter, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Schramm, Christoph; Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Dept Med 1, Hamburg, Germany; [Schramm, Christoph; Weiler-Normann, Christina] Univ Med Ctr Hamburg Eppendorf, Martin Zeitz Ctr Rare Dis, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Uhlenbusch, N (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.	n.uhlenbusch@uke.de	Löwe, Bernd/AAG-4038-2020	Uhlenbusch, Natalie/0000-0002-4031-9839; Lowe, Bernd/0000-0003-4220-3378	Robert Bosch Stiftung; ACHSE e.V.; Martin Zeitz Center for Rare Diseases	Robert Bosch Stiftung; ACHSE e.V.; Martin Zeitz Center for Rare Diseases	The Robert Bosch Stiftung provided funding for this study in the form of salaries for authors [NU] but did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The foundation only provided financial support in the form of authors' salaries and research materials.; This study is part of the research project 'Patients for Patients: Qualified Peer Counselling and Self-Management for Patients with Rare Chronic Diseases' (PI: Prof. Dr. Bernd Lowe). We would like to thank our partners ACHSE e.V. and the Martin Zeitz Center for Rare Diseases for their cooperation and support. We are grateful to all physicians, centres for rare diseases, patient organizations and self-help groups for supporting us in the recruitment process as well as to all patients who supported us by participating in the study. We would further like to thank our research assistant Anne Marie-Wassmuth for supporting data preparation and Dr. Marco Lehmann for statistical advice.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Barry MJ, 2012, NEW ENGL J MED, V366, P780, DOI 10.1056/NEJMp1109283; Bloss S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172532; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; Ciribassi RM, 2016, SOC SCI MED, V148, P131, DOI 10.1016/j.socscimed.2015.11.033; Clarke DM, 2009, MED J AUSTRALIA, V190, pS54; Cohen JS, 2010, AM J MED GENET A, V152A, P1136, DOI 10.1002/ajmg.a.33380; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; El-Gabalawy R, 2011, GEN HOSP PSYCHIAT, V33, P556, DOI 10.1016/j.genhosppsych.2011.07.005; EURORDIS, 2009, VOIC 12000 PAT EXP E; Eurordis, 2017, WHAT IS RAR DIS EUR; Eurordis, 2005, RAR DIS UND THIS PUB; Field A., 2013, DISCOVERING STAT USI; Grafe K, 2004, DIAGNOSTICA, V50, P171, DOI 10.1026/0012-1924.50.4.171; Heath J, 2016, ALLERGY ASTHMA PROC, V37, P409, DOI 10.2500/aap.2016.37.3977; Helgeson VS, 2017, ANNU REV PSYCHOL, V68, P545, DOI 10.1146/annurev-psych-010416-044014; Institut fur Qualitat und Wirtschaftlichkeit im Gesundheitswesen (IQWiG), 2014, BEW AUSW STUD BEI SE; Katon W, 2007, GEN HOSP PSYCHIAT, V29, P147, DOI 10.1016/j.genhosppsych.2006.11.005; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Kohlmann S, 2016, J PSYCHOSOM RES, V90, P51, DOI 10.1016/j.jpsychores.2016.09.004; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Lowe B, 2008, GEN HOSP PSYCHIAT, V30, P191, DOI 10.1016/j.genhosppsych.2008.01.001; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Lowe B, 2017, BRIT J PSYCHIAT, V210, P132, DOI 10.1192/bjp.bp.116.184168; Lowe B, 2004, PSYCHOTHER PSYCHOSOM, V73, P386, DOI 10.1159/000080393; Lowe B, 2004, J AFFECT DISORDERS, V78, P131, DOI 10.1016/S0165-0327(02)00237-9; Martin A, 2006, GEN HOSP PSYCHIAT, V28, P71, DOI 10.1016/j.genhosppsych.2005.07.003; Moller-Leimkuhler AM, 2002, J AFFECT DISORDERS, V71, P1, DOI 10.1016/S0165-0327(01)00379-2; Olney M.F., 2005, J POSTSECOND EDUC DI, V18, P80; Osborne RH, 2007, PATIENT EDUC COUNS, V66, P192, DOI 10.1016/j.pec.2006.12.002; Petrie KJ, 2007, CURR OPIN PSYCHIATR, V20, P163, DOI 10.1097/YCO.0b013e328014a871; POLISSAR L, 1982, MED CARE, V20, P959, DOI 10.1097/00005650-198209000-00008; Roest AM, 2010, J AM COLL CARDIOL, V56, P38, DOI 10.1016/j.jacc.2010.03.034; Sareen J, 2005, DEPRESS ANXIETY, V21, P193, DOI 10.1002/da.20072; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Shire Human Genetic Therapies, 2013, RAR DIS IMP REP INS; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stafford L, 2009, J PSYCHOSOM RES, V66, P211, DOI 10.1016/j.jpsychores.2008.09.005; Stanton AL, 2007, ANNU REV PSYCHOL, V58, P565, DOI 10.1146/annurev.psych.58.110405.085615; Stewart DE, 2011, PSYCHOSOMATICS, V52, P199, DOI 10.1016/j.psym.2011.01.036; Sumpton D, 2017, ARTHRIT CARE RES, V69, P1733, DOI 10.1002/acr.23207; Talwar A, 2015, J EXERC REHABIL, V11, P259, DOI 10.12965/jer.150230; Velvin G, 2015, CLIN GENET, V87, P109, DOI 10.1111/cge.12422; von der Lippe C, 2017, MOL GENET GENOM MED, V5, P758, DOI 10.1002/mgg3.315; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068	51	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0211343	10.1371/journal.pone.0211343	http://dx.doi.org/10.1371/journal.pone.0211343			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM2OT	30785907	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000021
J	Marcek, T; Hamow, KA; Vegh, B; Janda, T; Darko, E				Marcek, Tihana; Hamow, Kamiran Aron; Vegh, Balazs; Janda, Tibor; Darko, Eva			Metabolic response to drought in six winter wheat genotypes	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION NETWORK; OSMOTIC-STRESS; WATER-STRESS; TRANSPIRATION RATE; GALACTURONIC ACID; ENZYME-ACTIVITIES; GLYCINE BETAINE; GENE-EXPRESSION; ABIOTIC STRESS; PHOTOSYNTHESIS	Wheat is one of the most important cereals, whose growth and development is strongly limited by drought. This study investigated the physiological and metabolic response of six winter wheat cultivars to drought with the emphasis on the induction of dominant metabolites affected by the treatment and genotypes or both. The plants were exposed to a moderate (non-lethal) drought stress, which was induced by withholding watering for six days under controlled greenhouse conditions. A decline in CO2 assimilation (Pn) and transpiration rate, stomata closure, a decrease in relative water content (RWC) and increase of malondialdehyde content were observed in drought-treated plants of all cultivars. These changes were most pronounced in Ellvis, while Soissons was able to retain the higher RWC and Pn. Among the studied metabolites, sugars (sucrose, glucose, fructose, several disaccharides), organic acids (malic acid, oxalic acids), amino acids (proline, threonine, gamma-aminobutyric acid (GABA), glutamine) and sugar alcohols such as myo-inositol accumulated to higher levels in the plants exposed to drought stress in comparison with the control. The accumulation of several metabolites in response to drought differed between the genotypes. Drought induced the production of sucrose, malic acid and oxalic acid, unknown organic acid 1, unknown disaccharide 1, 2 and 3, GABA, L-threonine, glutamic acid in four (Soissons, Zitarka, Antonija or Toborzo) out of six genotypes. In addition, Soissons, which was the most drought tolerant genotype, accumulated the highest amount of unknown disaccharide 5, galactonic and phosphoric acids. The two most drought sensitive cultivars, Srpanjka and Ellvis, demonstrated different metabolic adjustment in response to the stress treatment. Srpanjka responded to drought by increasing the amount of glucose and fructose originated from hydrolyses of sucrose and accumulating unidentified sugar alcohols 1 and 2. In Ellvis, drought caused inhibition of photosynthetic carbon metabolism, as evidence by the decreased Pn, gs, RWC and accumulation levels of sugar metabolites (sucrose, glucose and fructose). The results revealed the differences in metabolic response to drought among the genotypes, which drew attention on metabolites related with general response and on those metabolites which are part of specific response that may play an important role in drought tolerance.	[Marcek, Tihana] Josip Juraj Strossmayer Univ Osijek, Fac Food Technol, Dept Food & Nutr Res, Osijek, Croatia; [Hamow, Kamiran Aron] Hungarian Acad Sci, Ctr Agr Res, Plant Protect Inst, Dept Zool, Budapest, Hungary; [Hamow, Kamiran Aron; Vegh, Balazs; Janda, Tibor; Darko, Eva] Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Dept Plant Physiol, Martonvasar, Hungary	University of JJ Strossmayer Osijek; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Darko, E (corresponding author), Hungarian Acad Sci, Ctr Agr Res, Agr Inst, Dept Plant Physiol, Martonvasar, Hungary.	darko.eva@agrar.mta.hu	Darkó, Éva/AAR-8167-2021; , Tihana/AAE-8603-2019	, Tihana/0000-0002-8617-5009; Hamow, Kamiran Aron/0000-0002-7089-1078	European Regional Development Fund; Hungarian Government [GINOP-2.3.2-15-2016-00029]	European Regional Development Fund(European Commission); Hungarian Government	This work was supported by the European Regional Development Fund and the Hungarian Government (GINOP-2.3.2-15-2016-00029).	Abid M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21441-7; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Akram NA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00613; Allahverdiyev T., 2015, Journal of Stress Physiology & Biochemistry, V11, P29; ARAKAWA T, 1982, BIOCHEMISTRY-US, V21, P6536, DOI 10.1021/bi00268a033; Araujo WL, 2011, PLANT SIGNAL BEHAV, V6, P1305, DOI 10.4161/psb.6.9.16425; Arve LE, 2013, PLANT CELL ENVIRON, V36, P382, DOI 10.1111/j.1365-3040.2012.02580.x; Atkinson RRL, 2012, NEW PHYTOL, V196, P200, DOI 10.1111/j.1469-8137.2012.04274.x; Azevedo RA, 2006, AMINO ACIDS, V30, P143, DOI 10.1007/s00726-005-0245-2; Bajji M, 2001, PLANT SCI, V160, P669, DOI 10.1016/S0168-9452(00)00443-X; Bates GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049641; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Batish DR, 2006, PLANT PHYSIOL BIOCH, V44, P819, DOI 10.1016/j.plaphy.2006.10.014; Bogdan J, 2006, PLANT PHYSIOL BIOCH, V44, P787, DOI 10.1016/j.plaphy.2006.10.028; Bown AW, 2016, TRENDS PLANT SCI, V21, P811, DOI 10.1016/j.tplants.2016.08.001; Bowne JB, 2012, MOL PLANT, V5, P418, DOI 10.1093/mp/ssr114; Budak H, 2013, SCI WORLD J, DOI 10.1155/2013/548246; Bundy JG, 2009, METABOLOMICS, V5, P3, DOI 10.1007/s11306-008-0152-0; Cevik S, 2014, J PLANT PHYSIOL, V171, P807, DOI 10.1016/j.jplph.2014.01.010; Choluj D, 2008, ACTA PHYSIOL PLANT, V30, P679, DOI 10.1007/s11738-008-0166-2; Darko E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174170; Darko E, 2015, EUPHYTICA, V203, P491, DOI 10.1007/s10681-014-1245-7; Daryanto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156362; Das A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6020021; Dichio B, 2006, TREE PHYSIOL, V26, P179, DOI 10.1093/treephys/26.2.179; Du HM, 2012, J AM SOC HORTIC SCI, V137, P411, DOI 10.21273/JASHS.137.6.411; Ergen NZ, 2009, FUNCT INTEGR GENOMIC, V9, P377, DOI 10.1007/s10142-009-0123-1; Ergen NZ, 2009, PLANT CELL ENVIRON, V32, P220, DOI 10.1111/j.1365-3040.2008.01915.x; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fang YJ, 2015, CELL MOL LIFE SCI, V72, P673, DOI 10.1007/s00018-014-1767-0; Fernie AR, 2009, PHYTOCHEMISTRY, V70, P828, DOI 10.1016/j.phytochem.2009.04.023; Flexas J, 2006, PHYSIOL PLANTARUM, V127, P343, DOI 10.1111/j.1399-3054.2006.00621.x; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Foyer CH, 2000, NEW PHYTOL, V146, P359, DOI 10.1046/j.1469-8137.2000.00667.x; Gigon A, 2004, ANN BOT-LONDON, V94, P345, DOI 10.1093/aob/mch150; Giri J, 2011, PLANT SIGNAL BEHAV, V6, P1746, DOI 10.4161/psb.6.11.17801; Goggin DE, 2004, FUNCT PLANT BIOL, V31, P11, DOI 10.1071/FP03123; GRIEVE CM, 1983, PLANT SOIL, V70, P303, DOI 10.1007/BF02374789; Gu XG, 2004, PLANT PHYSIOL, V136, P4256, DOI 10.1104/pp.104.052365; Guo R, 2018, AOB PLANTS, V10, DOI 10.1093/aobpla/ply016; Hannah MA, 2006, J EXP BOT, V57, P3801, DOI 10.1093/jxb/erl152; Ho SL, 2001, PLANT PHYSIOL, V125, P877, DOI 10.1104/pp.125.2.877; Hou JF, 2018, J PLANT PHYSIOL, V231, P182, DOI 10.1016/j.jplph.2018.09.017; Jain M, 2010, PLANT SOIL ENVIRON, V56, P263, DOI 10.17221/233/2009-PSE; Jin R, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01123; Juhasz Z, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0363-7; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Konno H, 2008, J PLANT PHYSIOL, V165, P745, DOI 10.1016/j.jplph.2007.07.007; Krasensky J, 2012, J EXP BOT, V63, P1593, DOI 10.1093/jxb/err460; Larbi A., 2004, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P193; Li YP, 2017, CROP J, V5, P231, DOI 10.1016/j.cj.2017.01.001; Liu CW, 2003, SCI TOTAL ENVIRON, V313, P77, DOI 10.1016/S0048-9697(02)00683-6; Liu HS, 2005, PLANT GROWTH REGUL, V46, P233, DOI 10.1007/s10725-005-8806-7; Liu SW, 2018, GENET MOL BIOL, V41, P624, DOI [10.1590/1678-4685-GMB-2017-0229, 10.1590/1678-4685-gmb-2017-0229]; Lopez-Bucio J, 2000, PLANT SCI, V160, P1, DOI 10.1016/S0168-9452(00)00347-2; Maggio A, 2002, PLANT J, V31, P699, DOI 10.1046/j.1365-313X.2002.01389.x; Mechri B, 2015, J CHROMATOGR SCI, V53, P1631, DOI 10.1093/chromsci/bmv066; Merewitz EB, 2012, J EXP BOT, V63, P1315, DOI 10.1093/jxb/err372; Mibei EK, 2018, J SCI FOOD AGR, V98, P205, DOI 10.1002/jsfa.8458; Michaletti A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24012-y; Misra BB, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00334; Moharramnejad S., 2015, Journal of BioScience and Biotechnology, V4, P313; Munnik T, 2010, PLANT CELL ENVIRON, V33, P655, DOI 10.1111/j.1365-3040.2009.02097.x; Obata T, 2015, PLANT PHYSIOL, V169, P2665, DOI 10.1104/pp.15.01164; Outlaw WH, 2001, PLANT PHYSIOL, V126, P1716, DOI 10.1104/pp.126.4.1716; Pena-Bautista RJ, 2017, CEREAL FOOD WORLD, V62, P231, DOI 10.1094/CFW-62-5-0231; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Piro G, 2003, PLANT SCI, V165, P559, DOI 10.1016/S0168-9452(03)00215-2; Raza MAS, 2014, J SOIL SCI PLANT NUT, V14, P346; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Roberts Lee D, 2012, Curr Protoc Mol Biol, VChapter 30, DOI 10.1002/0471142727.mb3002s98; Rodriguez-Calcerrada J, 2011, FUNCT PLANT BIOL, V38, P1004, DOI 10.1071/FP11135; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosa M, 2009, PLANT SIGNAL BEHAV, V4, P388, DOI 10.4161/psb.4.5.8294; Saeidi M, 2017, ARID LAND RES MANAG, V31, P204, DOI 10.1080/15324982.2016.1260073; Saibo NJM, 2009, ANN BOT-LONDON, V103, P609, DOI 10.1093/aob/mcn227; Saxena SN, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2522-6; Schauer N, 2005, J EXP BOT, V56, P297, DOI 10.1093/jxb/eri057; Signarbieux C, 2012, J PLANT RES, V125, P251, DOI 10.1007/s10265-011-0427-9; Singh M, 2015, REV ENVIRON SCI BIO, V14, P407, DOI 10.1007/s11157-015-9372-8; Szegletes Z, 2000, CEREAL RES COMMUN, V28, P403; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Tezara W, 1999, NATURE, V401, P914, DOI 10.1038/44842; Toumi I, 2008, BIOL PLANTARUM, V52, P161, DOI 10.1007/s10535-008-0035-2; Tran LSP, 2007, METHOD ENZYMOL, V428, P109, DOI 10.1016/S0076-6879(07)28006-1; Ullah N, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4321-2; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Vavasseur A, 2005, NEW PHYTOL, V165, P665, DOI 10.1111/j.1469-8137.2004.01276.x; Wang GP, 2010, PHOTOSYNTHETICA, V48, P117, DOI 10.1007/s11099-010-0016-5; Wardlaw IF, 2000, NEW PHYTOL, V148, P413, DOI 10.1046/j.1469-8137.2000.00777.x; Williamson JD, 2002, J AM SOC HORTIC SCI, V127, P467, DOI 10.21273/JASHS.127.4.467; Wu GQ, 2016, PLANT SOIL ENVIRON, V62, P189, DOI 10.17221/101/2016-PSE; Xu ZZ, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00657; ZADOKS JC, 1974, WEED RES, V14, P415, DOI 10.1111/j.1365-3180.1974.tb01084.x; Zandalinas SI, 2018, PHYSIOL PLANTARUM, V162, P2, DOI 10.1111/ppl.12540; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	96	59	59	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212411	10.1371/journal.pone.0212411	http://dx.doi.org/10.1371/journal.pone.0212411			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779775	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000459062900053
J	Santos, CS; Pie, MR; da Rocha, TC; Navarro-Silva, MA				Santos, Camila Silva; Pie, Marcio Roberto; da Rocha, Tatiana Carneiro; Navarro-Silva, Mario Antonio			Molecular identification of blood meals in mosquitoes (Diptera, Culicidae) in urban and forested habitats in southern Brazil	PLOS ONE			English	Article							RIO-DE-JANEIRO; CHAIN-REACTION PCR; SAO-PAULO STATE; FEEDING PATTERNS; ATLANTIC FOREST; RIBEIRA VALLEY; HUMAN DNA; AMPLIFICATION; PREFERENCES; MALARIA	The study of host associations of mosquitoes (Diptera, Culicidae) provides valuable information to assist in our understanding of a variety of related issues, from their life-history to the entomological surveillance of pathogens. In this study, we identified and characterized mosquito blood meals from both urban and forested areas in the city of Paranagua, state of Parana, Brazil, by analyzing the amplification of host DNA ingested by mosquitoes under different storage conditions and digestion levels. Host DNA preservation was evaluated in fresh blood meals according to storage duration (30 to 180 days) and temperature (-20 degrees C / -80 degrees C) and, in digested blood, according the degree of digestion classified on the Sella scale. Molecular analysis of blood meals was based on DNA extraction and amplification of a fragment of the mitochondrial COI gene. We determined that, up to 180 days of storage, the evaluated temperatures did not influence the preservation of fresh blood meals DNA, whereas the amplification success was increasingly reduced over the course of the digestion process. The species Anopheles cruzii, Aedes fluviatilis, Aedes scapularis, Psorophora ferox, Culex quinquefasciatus, Culex mollis, and Culex intrincatus, together with specimens representing four subgenera and one genus of Culicidae [Ae. (Ochlerotatus), Cx. (Culex), Cx. (Melanoconion), Cx. (Microculex), and Limatus, respectively] had their blood meals identified. Their diverse host use was evidenced by the identification of 19 species of vertebrate host, namely two amphibians, three mammals and 14 birds. Birds were the most commonly identified host in blood meals. These results not only show the diversity of mosquito hosts, but also underscore the challenges involved in monitoring arboviruses of public health importance, given potential combinations of host use for each mosquito species.	[Santos, Camila Silva; Navarro-Silva, Mario Antonio] Univ Fed Parana, Dept Zool, Lab Morfol & Fisiol Culicidae & Chironomidae, Curitiba, Parana, Brazil; [Pie, Marcio Roberto] Univ Fed Parana, Dept Zool, Lab Dinam Evolut & Sistemas Complexos, Curitiba, Parana, Brazil; [da Rocha, Tatiana Carneiro] Univ Fed Parana, Dept Farm, Lab Saude Publ & Ambiental, Curitiba, Parana, Brazil	Universidade Federal do Parana; Universidade Federal do Parana; Universidade Federal do Parana	Santos, CS; Navarro-Silva, MA (corresponding author), Univ Fed Parana, Dept Zool, Lab Morfol & Fisiol Culicidae & Chironomidae, Curitiba, Parana, Brazil.	camilatri@hotmail.com; mnavarro@ufpr.br	Santos, Camila Silva/R-2137-2019; da Silva, Mario Antonio Navarro/C-5287-2013; S. Santos, Camila/F-3380-2018	S. Santos, Camila/0000-0002-8733-2627; Navarro da Silva, Mario Antonio/0000-0002-9762-632X	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [132609/2016-9, 301636/2016-8, 307916/2016-2, 440385/2016-4]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) [88887.130791/2016.00, 14/2016 Zika]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) under process numbers 132609/2016-9 (CS Santos); 301636/2016-8 (MR Pie); 307916/2016-2; 440385/2016-4 (MA Navarro-Silva) and by CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) under process number 88887.130791/2016.00 Notice 14/2016 Zika (MA Navarro-Silva). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANE A, 1994, J FORENSIC SCI, V39, P362; Alcaide M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007092; Alencar J, 2015, J MED ENTOMOL, V52, P783, DOI 10.1093/jme/tjv098; Alencar J, 2012, J MED ENTOMOL, V49, P952, DOI 10.1603/ME11270; Ali Oshaghi M, 2006, EXP PARASITOL, V112, P232, DOI 10.1016/j.exppara.2005.11.008; AlRokayan SAH., 2000, PAKISTAN J BIOL SCI, V3, P392, DOI [DOI 10.3923/PJBS.2000.392.394, 10.3923/pjbs.2000.392.394]; [Anonymous], 1962, WHO MONOGRAPHIES SER; [Anonymous], GRAD EST 2010; [Anonymous], 2002, CULICIDOLOGIA MED; Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9; Brugman VA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2098-4; Carrano E, 2006, THESIS; Consoli R. A. G. B., 1994, PRINCIPAIS MOSQUITOS; COULSON RMR, 1990, MED VET ENTOMOL, V4, P357, DOI 10.1111/j.1365-2915.1990.tb00452.x; Dalla Bona AC, 2012, ZOOLOGIA-CURITIBA, V29, P540; de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x; dos Santos EB, 2016, EXP APPL ACAROL, V69, P323, DOI 10.1007/s10493-016-0045-2; Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FORATTINI OP, 1989, REV SAUDE PUBL, V23, P9, DOI 10.1590/S0034-89101989000100003; FORATTINI OP, 1987, REV SAUDE PUBL, V21, P171, DOI 10.1590/S0034-89101987000300002; Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201; Gomes AC, 2003, J VECTOR ECOL, V28, P74; Gomes LAM, 2001, MEM I OSWALDO CRUZ, V96, P693, DOI 10.1590/S0074-02762001000500020; Gomez-Diaz E, 2010, TRENDS PARASITOL, V26, P470, DOI 10.1016/j.pt.2010.06.007; Guimaraes Rubio Marcelo Burigo, 2014, Chiroptera Neotropical, V20, P1255; HALL T., 2013, BIOEDIT VERSION 7 2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hara M, 2015, FORENS SCI INT-GEN S, V5, pE39, DOI 10.1016/j.fsigss.2015.09.016; Harbach RE, 2007, ZOOTAXA, P591; Hernandez-Triana LM, 2017, ZOOTAXA, V4250, P67, DOI 10.11646/zootaxa.4250.1.5; Kenney JL, 2014, ADV VIRUS RES, V89, P39, DOI 10.1016/B978-0-12-800172-1.00002-1; Kent RJ, 2009, MOL ECOL RESOUR, V9, P4, DOI 10.1111/j.1755-0998.2008.02469.x; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kirchgatter K, 2014, REV INST MED TROP SP, V56, P403, DOI 10.1590/S0036-46652014000500006; Lane J., NEOTROPICAL CULICIDA, VII; Lane J., NEOTROPICAL CULICIDA, VI; Laurito M, 2013, MEM I OSWALDO CRUZ, V108, P110, DOI 10.1590/0074-0276130457; Leivas PT., 2014, THESIS; Silva JBL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181678; Lorosa ES, 2010, J AM MOSQUITO CONTR, V26, P18, DOI 10.2987/09-5914.1; Lourenco-de-Oliveira R., 1986, Memorias do Instituto Oswaldo Cruz, V81, P15; Lutz A., 1939, Ann Acad Sci Brasil, V11, P250; Lyimo IN, 2012, J EVOLUTION BIOL, V25, P452, DOI 10.1111/j.1420-9101.2011.02442.x; Mestre LAM, 2007, BRAZ ARCH BIOL TECHN, V50, P75, DOI 10.1590/S1516-89132007000100009; Martinez-de la Puente J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-109; Moreno M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005337; Mucci LF, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0005-z; Mukabana WR, 2002, B ENTOMOL RES, V92, P233, DOI 10.1079/BER2002164; Mukabana WR, 2002, TRENDS PARASITOL, V18, P505, DOI 10.1016/S1471-4922(02)02364-4; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Neves A, 2013, ACTA TROP, V125, P102, DOI 10.1016/j.actatropica.2012.08.014; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; Passos FC, 2007, PRIMATOLOGIA BRASIL, V10, P119; Phasomkusolsil S, 2015, ACTA TROP, V152, P220, DOI 10.1016/j.actatropica.2015.09.021; R Core Team, 2013, R LANG ENV STAT COMP; Reeves LE, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0096-5; Reeves LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1791-z; Regis L, 2009, AN ACAD BRAS CIENC, V81, P655, DOI 10.1590/S0001-37652009000400004; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Silva JD, 2012, J VECTOR ECOL, V37, P342, DOI 10.1111/j.1948-7134.2012.00237.x; Sotomayor-Bonilla J, 2017, J WILDLIFE DIS, V53, P657, DOI 10.7589/2016-11-249; Stein M, 2013, MEM I OSWALDO CRUZ, V108, P563, DOI 10.1590/S0074-02762013000500005; Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216; Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toma T, 2014, J AM MOSQUITO CONTR, V30, P215, DOI 10.2987/14-6398R.1; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tuten HC, 2012, MED VET ENTOMOL, V26, P407, DOI 10.1111/j.1365-2915.2012.01012.x; Vanhoni F., 2008, REV BRASILEIRA CLIMA, V3, P49, DOI [10.5380/abclima.v3i0.25423, DOI 10.5380/ABCLIMA.V3I0.25423]; Wang Gang, 2012, PLoS ONE, V7, pe47051, DOI 10.1371/journal.pone.0047051	72	20	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212517	10.1371/journal.pone.0212517	http://dx.doi.org/10.1371/journal.pone.0212517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779816	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900061
J	Lu, H; Cherepanova, NA; Gilmore, R; Contessa, JN; Lehrman, MA				Lu, Hua; Cherepanova, Natalia A.; Gilmore, Reid; Contessa, Joseph N.; Lehrman, Mark A.			Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction	FASEB JOURNAL			English	Article						glycobiology; glycosylation; glycoprotein; herpesvirus; lipid-linked oligosaccharide	ASPARAGINE-LINKED OLIGOSACCHARIDES; MEMBRANE-PROTEINS; N-GLYCOSYLATION; GLYCOPROTEIN-D; OLIGOSACCHARYLTRANSFERASE; 2-DEOXY-D-GLUCOSE; POLYPEPTIDES; FIBROBLASTS; INFECTIVITY; INHIBITION	Herpes simplex virus 1 (HSV-1) is a contagious neurotropic herpesvirus responsible for oral lesions and herpesviral encephalitis. The HSV-1 envelope contains N-glycosylated proteins involved in infection and that are candidate drug targets. NGI-1 is a small-molecule inhibitor of oligosaccharyltransferase (OST) complexes STT3A-OST and STT3B-OST, which catalyze cotranslational and post-translational N-glycosylation, respectively. Because host OSTs attach HSV-1 glycans, NGI-1 might have anti-HSV-1 activity. We evaluated HSV-1 function using NGI-1 and human embryonic kidney 293 knockout lines for OST isoform-specific catalytic and accessory subunits. N-glycosylation of 2 representative envelope proteins (gC and gD) was primarily dependent upon STT3A-OST, but to a large extent replaceable by STT3B-OST. Knockouts impairing STT3A- or STT3B-OST activity, by themselves, did not appreciably affect HSV-1 function (plaque-forming units, normalized to viral particles measured by unglycosylated capsid protein VP5 content). However, with cells lacking STT3B-OST activity (missing the catalytic subunit STT3B or the oxidoreductase subunits magnesium transporter 1/tumor suppressor candidate 3) and thus solely dependent upon STT3A-OST for N-glycosylation, NGI-1 treatment resulted in HSV-1 having cell type-dependent dysfunction (affecting infectivity with Vero cells much more than with the 293 lines). Ablation of post-translational N-glycosylation can therefore make HSV-1 infectivity, and possibly masking of immunogenic peptide epitopes by glycans, highly sensitive to pharmacological inhibition of cotranslational N-glycosylation.-Lu, H., Cherepanova, N. A., Gilmore, R., Contessa, J. N., Lehrman, M. A. Targeting STT3A-oligosaccharyltransferase with NGI-1 causes herpes simplex virus 1 dysfunction.	[Lu, Hua; Lehrman, Mark A.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd,Room ND9-300D, Dallas, TX 75390 USA; [Cherepanova, Natalia A.; Gilmore, Reid] Univ Massachusetts, Sch Med, Dept Biochem, Worcester, MA 01655 USA; [Contessa, Joseph N.] Yale Sch Med, Dept Therapeut Radiol, New Haven, CT USA; [Contessa, Joseph N.] Yale Sch Med, Dept Pharmacol, New Haven, CT USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Massachusetts System; University of Massachusetts Worcester; Yale University; Yale University	Lehrman, MA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd,Room ND9-300D, Dallas, TX 75390 USA.	mark.lehrman@utsouthwestern.edu			U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01-GM038545, R01-GM043768, R01-GM127383]; NIH National Cancer Institute [R01-CA172391]; NATIONAL CANCER INSTITUTE [R01CA172391] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043768, R01GM127383, R01GM038545] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants R01-GM038545 (to M.A.L.), R01-GM043768 (to R.G.), R01-GM127383 (to J.N.C.), and NIH National Cancer Institute Grant R01-CA172391 (to J.N.C.). Experiments with HSV-1 were performed with the oversight of the University of Texas Southwestern Medical Center Office of Safety and Business Continuity. J.N.C. has ownership interest (including stock, patents, etc.) in NGI-1. The remaining authors declare no other conflicts of interest.	Anand M, 2001, MOL BIOL CELL, V12, P487, DOI 10.1091/mbc.12.2.487; Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021; Bagdonaite I, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004784; Braunger K, 2018, SCIENCE, V360, P215, DOI 10.1126/science.aar7899; CAMPADELLIFIUME G, 1982, J VIROL, V43, P1061, DOI 10.1128/JVI.43.3.1061-1071.1982; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; COHEN GH, 1980, J VIROL, V36, P429, DOI 10.1128/JVI.36.2.429-439.1980; COMPTON T, 1984, J VIROL, V52, P630, DOI 10.1128/JVI.52.2.630-637.1984; COURTNEY RJ, 1973, VIROLOGY, V52, P447, DOI 10.1016/0042-6822(73)90340-1; Doores KJ, 2015, FEBS J, V282, P4679, DOI 10.1111/febs.13530; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Gao NG, 2013, GLYCOBIOLOGY, V23, P1111, DOI 10.1093/glycob/cwt067; Gao NG, 2011, MOL BIOL CELL, V22, P2994, DOI 10.1091/mbc.E11-04-0286; Gay A, 2015, BIOPHYS J, V108, P1459, DOI 10.1016/j.bpj.2015.02.008; JOHNSON DC, 1983, CELL, V32, P987, DOI 10.1016/0092-8674(83)90083-1; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; KNOWLES RW, 1976, J VIROL, V18, P644, DOI 10.1128/JVI.18.2.644-651.1976; KUHN JE, 1988, J GEN VIROL, V69, P2847, DOI 10.1099/0022-1317-69-11-2847; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lavie M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00910; LEHRMAN M A, 1991, Glycobiology, V1, P553, DOI 10.1093/glycob/1.6.553; Lin DL, 2017, MBIO, V8, DOI [10.1128/mbio.00939-17, 10.1128/mBio.00939-17]; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Lu H, 2018, P NATL ACAD SCI USA, V115, P9557, DOI 10.1073/pnas.1806034115; Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Merchan JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013699; Ng BG, 2018, TRENDS GENET, V34, P466, DOI 10.1016/j.tig.2018.03.002; PATTERSON SI, 1994, J CELL BIOL, V124, P521, DOI 10.1083/jcb.124.4.521; POUYSSEGUR J, 1977, CELL, V11, P941, DOI 10.1016/0092-8674(77)90305-1; Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054; Rider PJF, 2017, J VIROL, V91, DOI 10.1128/JVI.00873-17; Rinis N, 2018, CELL CHEM BIOL, V25, P1231, DOI 10.1016/j.chembiol.2018.07.005; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; SHIU RPC, 1977, P NATL ACAD SCI USA, V74, P3840, DOI 10.1073/pnas.74.9.3840; Shrimal S, 2017, J CELL BIOL, V216, P3625, DOI 10.1083/jcb.201702159; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; SODORA DL, 1991, J VIROL, V65, P4424, DOI 10.1128/JVI.65.8.4424-4431.1991; SODORA DL, 1989, J VIROL, V63, P5184, DOI 10.1128/JVI.63.12.5184-5193.1989; SODORA DL, 1991, J VIROL, V65, P4432, DOI 10.1128/JVI.65.8.4432-4441.1991; SPEAR PG, 1976, J VIROL, V17, P991, DOI 10.1128/JVI.17.3.991-1008.1976; TALSINGER R, 1994, VIROLOGY, V202, P1050, DOI 10.1006/viro.1994.1437; TALSINGER R, 1995, J VIROL, V69, P4471, DOI 10.1128/JVI.69.7.4471-4483.1995; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; ZHU XY, 1992, J BIOL CHEM, V267, P8895	46	7	7	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6801	6812		10.1096/fj.201802044RR	http://dx.doi.org/10.1096/fj.201802044RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811219	Bronze, Green Published			2022-12-26	WOS:000476114200011
J	Cazzaniga, A; Locatelli, L; Castiglioni, S; Maier, JAM				Cazzaniga, Alessandra; Locatelli, Laura; Castiglioni, Sara; Maier, Jeanette A. M.			The dynamic adaptation of primary human endothelial cells to simulated microgravity	FASEB JOURNAL			English	Article						HUVEC; RWV; stress response	THIOREDOXIN-INTERACTING PROTEIN; OXIDATIVE STRESS; NITRIC-OXIDE; GENE-EXPRESSION; CYTOSKELETON; IMPACT; GROWTH; EXPOSURE	Culture of human endothelial cells for 10 d in real microgravity onboard the International Space Station modulated more than 1000 genes, some of which are involved in stress response. On Earth, 24 h after exposure to simulated microgravity, endothelial cells up-regulate heat shock protein (HSP) 70. To capture a broad view of endothelial stress response to gravitational unloading, we cultured primary human endothelial cells for 4 and 10 d in the rotating wall vessel, a U.S. National Aeronautics and Space Administration-developed surrogate system for benchtop microgravity research on Earth. We highlight the crucial role of the early increase of HSP70 because its silencing markedly impairs cell survival. Once HSP70 up-regulation fades away after 4 d of simulated microgravity, a complex and articulated increase of various stress proteins (sirtuin 2, paraoxonase 2, superoxide dismutase 2, p21, HSP27, and phosphorylated HSP27, all endowed with cytoprotective properties) occurs and counterbalances the up-regulation of the pro-oxidant thioredoxin interacting protein (TXNIP). Interestingly, TXNIP was the most overexpressed transcript in endothelial cells after spaceflight. We conclude that HSP70 up-regulation sustains the initial adaptive response of endothelial cells to mechanical unloading and drives them toward the acquisition of a novel phenotype that maintains cell viability and function through the sequential involvement of different stress proteins.Cazzaniga, A., Locatelli, L., Castiglioni, S., Maier, J. A. M. The dynamic adaptation of primary human endothelial cells to simulated microgravity.	[Cazzaniga, Alessandra; Locatelli, Laura; Castiglioni, Sara; Maier, Jeanette A. M.] Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Via GB Grassi 74, I-20157 Milan, Italy	University of Milan	Maier, JAM (corresponding author), Univ Milan, Dipartimento Sci Biomed & Clin L Sacco, Via GB Grassi 74, I-20157 Milan, Italy.	jeanette.maier@unimi.it	LOCATELLI, LAURA/AAP-4110-2021; castiglioni, sara/H-9289-2012	LOCATELLI, LAURA/0000-0002-4568-7825; Cazzaniga, Alessandra/0000-0001-7153-2256; castiglioni, sara/0000-0002-8785-9891	Italian Space Agency	Italian Space Agency(Agenzia Spaziale Italiana (ASI))	This work was supported, in part, by the Italian Space Agency [Coculture of Endothelial Cells and Osteoblast in Space: Effects on Osteoblast Activity (ENDOSTEO) Project]. The authors declare no conflict of interest.	Afolayan AJ, 2014, AM J PHYSIOL-LUNG C, V306, pL351, DOI 10.1152/ajplung.00264.2013; Altenhofer S, 2010, J BIOL CHEM, V285, P24398, DOI 10.1074/jbc.M110.118604; Aubert AE, 2005, ACTA CARDIOL, V60, P129, DOI 10.2143/AC.60.2.2005024; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Baratchi S, 2017, TRENDS MOL MED, V23, P850, DOI 10.1016/j.molmed.2017.07.007; Beck M, 2014, INT J MOL MED, V34, P606, DOI 10.3892/ijmm.2014.1785; Carlsson SIM, 2003, BBA-MOL CELL RES, V1642, P173, DOI 10.1016/j.bbamcr.2003.08.003; Castiglioni S, 2017, NANOMATERIALS-BASEL, V7, DOI 10.3390/nano7060124; Castiglioni S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16538; Cazzaniga A, 2016, BIOCHEM BIOPH RES CO, V473, P181, DOI 10.1016/j.bbrc.2016.03.075; Cmielova J, 2011, J CELL BIOCHEM, V112, P3502, DOI 10.1002/jcb.23296; Cotrupi S, 2005, BBA-MOL CELL RES, V1746, P163, DOI 10.1016/j.bbamcr.2005.10.002; DeBalsi KL, 2014, J BIOL CHEM, V289, P8106, DOI 10.1074/jbc.M113.511535; Dejeans N, 2010, GENES NUTR, V5, P263, DOI 10.1007/s12263-010-0166-x; Demontis GC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00547; Grenon SM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01494; Griffoni C, 2011, J CELL BIOCHEM, V112, P265, DOI 10.1002/jcb.22921; Han SH, 2003, ONCOGENE, V22, P4035, DOI 10.1038/sj.onc.1206610; Hatton JP, 1999, FASEB J, V13, pS23, DOI 10.1096/fasebj.13.9001.s23; Horke S, 2007, CIRCULATION, V115, P2055, DOI 10.1161/CIRCULATIONAHA.106.681700; Janmaleki M, 2016, SCI REP-UK, V6, DOI 10.1038/srep32418; Kapitonova M Y, 2012, Malays J Pathol, V34, P103; Kapitonova MY, 2013, B EXP BIOL MED+, V154, P796, DOI 10.1007/s10517-013-2059-7; Lane T, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00050; Leidi M, 2010, EUR J CELL BIOL, V89, P654, DOI 10.1016/j.ejcb.2010.05.001; Liu JN, 2013, INT J MOL SCI, V14, P5633, DOI 10.3390/ijms14035633; Liu Yongqing, 2008, Genomics Proteomics & Bioinformatics, V6, P29, DOI 10.1016/S1672-0229(08)60018-2; Maier JAM, 2006, INT J IMMUNOPATH PH, V19, P279, DOI 10.1177/039463200601900205; Maier JAM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434803; Mariotti M, 2009, MICROGRAVITY SCI TEC, V21, P141, DOI 10.1007/s12217-008-9066-8; Mariotti M, 2008, J CELL BIOCHEM, V104, P129, DOI 10.1002/jcb.21605; Najrana T, 2016, FRONT PEDIATR, V4, DOI 10.3389/fped.2016.00140; Quinta HR, 2011, CELL SIGNAL, V23, P1907, DOI 10.1016/j.cellsig.2011.07.023; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Risso A, 2005, PROTEOMICS, V5, P1827, DOI 10.1002/pmic.200401082; Spindel ON, 2014, CIRC RES, V114, P1125, DOI 10.1161/CIRCRESAHA.114.301315; Spindel ON, 2012, ARTERIOSCL THROM VAS, V32, P1264, DOI 10.1161/ATVBAHA.111.244681; Sun HB, 2015, BIOCHEM BIOPH RES CO, V463, P377, DOI 10.1016/j.bbrc.2015.04.152; Tousoulis D, 2012, CURR VASC PHARMACOL, V10, P4, DOI 10.2174/157016112798829760; Versari S, 2007, BBA-MOL CELL RES, V1773, P1645, DOI 10.1016/j.bbamcr.2007.05.014; Versari S, 2013, FASEB J, V27, P4466, DOI 10.1096/fj.13-229195; Vidyasagar A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-7; Wang JH, 2009, NEUROCHEM INT, V55, P710, DOI 10.1016/j.neuint.2009.07.002; Yee A, 2008, ANN BIOMED ENG, V36, P571, DOI 10.1007/s10439-008-9452-9	44	19	20	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					5957	5966		10.1096/fj.201801586RR	http://dx.doi.org/10.1096/fj.201801586RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30817172	Green Submitted, Bronze			2022-12-26	WOS:000466932600013
J	Andrade, H; Lin, WL; Zhang, YX				Andrade, Helena; Lin, Weilin; Zhang, Yixin			Specificity from nonspecific interaction: regulation of tumor necrosis factor- activity by DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						tumor necrosis factor (TNF); DNA-protein interaction; circular dichroism (CD); allosteric regulation; protein-nucleic acid interaction; activity regulation; biolayer interferometry; homoquenching; nonspecific interaction; photo-switchable protein	T-CELL REPERTOIRE; TNF-ALPHA; SERUM-LEVELS; CANCER; DEOLIGOMERIZATION; IDENTIFICATION; AUTOIMMUNITY; SELECTION; PLASMA; IL-6	As anionic biopolymers, oligonucleotides can have biological functions independent from their roles as the medium for the storage and flow of genetic information. In this paper, we investigated the interaction between DNA and the pro-inflammatory cytokine tumor necrosis factor- (TNF). Although various forms of DNA bind to TNF with low m dissociation constants, the interaction stabilizes the trimeric form of TNF and enhances its cytotoxic effect. Based on this mechanism, a photoswitchable TNF (TNF-2-nitroveratryloxycarbonyl) has been designed whose sensitivity to DNA-mediated up-regulation of TNF activity can be tuned by light irradiation. The mechanism described in this study represents a general model to understand the involvement of nonspecific interactions among biomolecules in regulating their biological functions. Because the interaction is not DNA sequence-specific, the resulting effect should be considered for oligonucleotide-based therapeutics in general.	[Andrade, Helena; Lin, Weilin; Zhang, Yixin] Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01307 Dresden, Germany; [Andrade, Helena] Swiss Fed Inst Technol, Inst Biogeochem & Pollutant Dynam IBP, CH-8092 Zurich, Switzerland	Technische Universitat Dresden; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zhang, YX (corresponding author), Tech Univ Dresden, B CUBE Ctr Mol Bioengn, D-01307 Dresden, Germany.	yixin.zhang1@tu-dresden.de		Andrade, Helena/0000-0003-4127-8087; Lin, Weilin/0000-0002-2262-5859; Zhang, Yixin/0000-0002-6669-4995	Bundesministerium fur Bildung und Forschung [03Z2EN12, 03Z2E511]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by Bundesministerium fur Bildung und Forschung Grants 03Z2EN12 and 03Z2E511. The authors declare that they have no conflicts of interest with the contents of this article.	ALZANI R, 1993, J BIOL CHEM, V268, P12526; ALZANI R, 1995, BIOCHEMISTRY-US, V34, P6344, DOI 10.1021/bi00019a012; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Bazzoni F, 1996, NEW ENGL J MED, V334, P1717, DOI 10.1056/NEJM199606273342607; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chatterjee S, 2012, NANOSCALE, V4, P1568, DOI 10.1039/c2nr12039a; Cheng C, 2009, CANCER SCI, V100, P303, DOI 10.1111/j.1349-7006.2008.01021.x; CORTI A, 1992, BIOCHEM J, V284, P905, DOI 10.1042/bj2840905; ECK MJ, 1989, J BIOL CHEM, V264, P17595; Fulda S, 2014, SEMIN CELL DEV BIOL, V35, P51, DOI 10.1016/j.semcdb.2014.07.002; Haugbro K, 2004, ANN RHEUM DIS, V63, P386, DOI 10.1136/ard.2003.016303; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Hoffmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031298; Humphreys DT, 1999, CYTOKINE, V11, P773, DOI 10.1006/cyto.1998.0492; Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H; Intiso D, 2004, NEUROL SCI, V24, P390, DOI 10.1007/s10072-003-0194-z; Ishihara J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04525-w; Kenig M, 2008, J CHROMATOGR B, V867, P119, DOI 10.1016/j.jchromb.2008.03.023; Kimoto M, 2016, NUCLEIC ACIDS RES, V44, P7487, DOI 10.1093/nar/gkw619; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Kosmrlj A, 2008, P NATL ACAD SCI USA, V105, P16671, DOI 10.1073/pnas.0808081105; Ledford H, 2018, NATURE, V560, P291, DOI 10.1038/d41586-018-05867-7; Li P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00460; Li SP, 2018, NAT BIOTECHNOL, V36, P258, DOI 10.1038/nbt.4071; Mannocci L, 2008, P NATL ACAD SCI USA, V105, P17670, DOI 10.1073/pnas.0805130105; Measey TJ, 2012, LANGMUIR, V28, P12588, DOI 10.1021/la302626d; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Organick L, 2018, NAT BIOTECHNOL, V36, P242, DOI 10.1038/nbt.4079; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; SMITH RA, 1987, J BIOL CHEM, V262, P6951; Stull R A, 1993, Antisense Res Dev, V3, P295; Su KY, 2009, SCAND J IMMUNOL, V70, P175, DOI 10.1111/j.1365-3083.2009.02300.x; Szpechcinski A, 2015, BRIT J CANCER, V113, P476, DOI 10.1038/bjc.2015.225; Tamkovich SN, 2005, CLIN CHEM, V51, P1317, DOI 10.1373/clinchem.2004.045062; Vanlangenakker N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.111; Vrisekoop N, 2014, IMMUNITY, V41, P181, DOI 10.1016/j.immuni.2014.07.007; Zeraati M, 2018, NAT CHEM, V10, P631, DOI 10.1038/s41557-018-0046-3; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199	41	4	4	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6397	6404		10.1074/jbc.RA119.007586	http://dx.doi.org/10.1074/jbc.RA119.007586			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30814250	hybrid, Green Published			2022-12-26	WOS:000468402000017
J	Zhang, ZL; Zhan, XM; Kim, B; Wu, J				Zhang, Zilai; Zhan, Xiaoming; Kim, Bongwoo; Wu, Jiang			A proteomic approach identifies SAFB-like transcription modulator (SLTM) as a bidirectional regulator of GLI family zinc finger transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Sonic hedgehog (SHH); gene transcription; signaling; mouse genetics; chromatin; proteomics; GLI transcription factors; SAFB-like transcription modulator (SLTM); GLI family zinc finger; transcription activation; transcription repression; epigenetics; cell differentiation	SONIC HEDGEHOG; OSTEOBLAST DIFFERENTIATION; SUFU; SHH; SPECIFICATION; SUPPRESSOR; PROTEINS; GENE; PHOSPHORYLATION; ASSOCIATION	In Sonic hedgehog (SHH) signaling, GLI family zinc finger (GLI)-mediated diverse gene transcription outcomes are strictly regulated and are important for SHH function in both development and disease. However, how the GLI factors differentially regulate transcription in response to variable SHH activities is incompletely understood. Here, using a newly generated, tagged Gli3 knock-in mouse (Gli3(TAP)), we performed proteomic analyses and identified the chromatin-associated SAFB-like transcription modulator (SLTM) as a GLI-interacting protein that context-dependently regulates GLI activities. Using immunoprecipitation and immunoblotting, RT-quantitative PCR, and ChIP assays, we show that SLTM interacts with all three GLI proteins and that its cellular levels are regulated by SHH. We also found that SLTM enhances GLI3 binding to chromatin and increases GLI3 repressor (GLI3R) form protein levels. In a GLI3-dependent manner, SLTM promoted the formation of a repressive chromatin environment and functioned as a GLI3 co-repressor. In the absence of GLI3 or in the presence of low GLI3 levels, SLTM co-activated GLI activator (GLIA)-mediated target gene activation and cell differentiation. Moreover, in vivo Sltm deletion generated through CRISPR/Cas9-mediated gene editing caused perinatal lethality and SHH-related abnormal ventral neural tube phenotypes. We conclude that SLTM regulates GLI factor binding to chromatin and contributes to the transcriptional outcomes of SHH signaling via a novel molecular mechanism.	[Zhang, Zilai; Zhan, Xiaoming; Kim, Bongwoo; Wu, Jiang] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Zhan, Xiaoming] Univ Texas Southwestern Med Ctr Dallas, Ctr Genet Host Def, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Wu, J (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	jiang9.wu@utsouthwestern.edu			March of Dimes Foundation; Welch Foundation [I-1940-20170325]; National Institutes of Health [R01NS09606, R21NS104596]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS104596, R01NS096068] Funding Source: NIH RePORTER	March of Dimes Foundation(March of Dimes); Welch Foundation(The Welch Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funds from the March of Dimes Foundation, Welch Foundation Grant I-1940-20170325 (to J. W.), and National Institutes of Health Grants R01NS09606 and R21NS104596 (to J. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Cao Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4127; Chan CW, 2007, BIOCHEM J, V407, P355, DOI 10.1042/BJ20070170; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Ding Q, 1998, DEVELOPMENT, V125, P2533; Endoh-Yamagami S, 2009, CURR BIOL, V19, P1320, DOI 10.1016/j.cub.2009.06.046; Falkenstein KN, 2014, SEMIN CELL DEV BIOL, V33, P73, DOI 10.1016/j.semcdb.2014.05.010; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Garee JP, 2010, J CELL BIOCHEM, V109, P312, DOI 10.1002/jcb.22420; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Han YH, 2015, P NATL ACAD SCI USA, V112, P6383, DOI 10.1073/pnas.1421628112; Hojo H, 2012, J BIOL CHEM, V287, P17860, DOI 10.1074/jbc.M112.347716; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; Ingham PW, 2006, NAT REV GENET, V7, P841, DOI 10.1038/nrg1969; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jagani Z, 2010, NAT MED, V16, P1429, DOI 10.1038/nm.2251; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Lin CW, 2014, GENE DEV, V28, P2547, DOI 10.1101/gad.249425.114; Lipinski RJ, 2006, EXP CELL RES, V312, P1925, DOI 10.1016/j.yexcr.2006.02.019; Lopez-Rios J, 2014, NATURE, V511, P46, DOI 10.1038/nature13289; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Niewiadomski P, 2014, CELL REP, V6, P168, DOI 10.1016/j.celrep.2013.12.003; Norman M, 2016, BIOCHEM J, V473, P4271, DOI 10.1042/BCJ20160649; Oosterveen T, 2012, DEV CELL, V23, P1006, DOI 10.1016/j.devcel.2012.09.015; PAVLETICH NP, 1993, SCIENCE, V261, P1701, DOI 10.1126/science.8378770; Peterson KA, 2012, GENE DEV, V26, P2802, DOI 10.1101/gad.207142.112; Rallu M, 2002, DEVELOPMENT, V129, P4963; Shi XM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6425; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tukachinsky H, 2010, J CELL BIOL, V191, P415, DOI 10.1083/jcb.201004108; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Yuasa T, 2002, J CELL PHYSIOL, V193, P225, DOI 10.1002/jcp.10166; Zhan XM, 2011, P NATL ACAD SCI USA, V108, P12758, DOI 10.1073/pnas.1018510108; Zhang Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3608	52	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 5	2019	294	14					5549	5561		10.1074/jbc.RA118.007018	http://dx.doi.org/10.1074/jbc.RA118.007018			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HT4EU	30782847	hybrid, Green Published			2022-12-26	WOS:000464517500025
J	Balzamino, BO; Esposito, G; Marino, R; Keller, F; Micera, A				Balzamino, Bijorn Omar; Esposito, Graziana; Marino, Ramona; Keller, Flavio; Micera, Alessandra			Changes in vitreal protein profile and retina mRNAs in Reeler mice: NGF, IL33 and Muller cell activation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; AQUEOUS-HUMOR; GLIA CELLS; RECEPTOR; IL-33; EXPRESSION; DEGENERATION; INFLAMMATION; BIOMARKERS; ROLES	A possible link between Nerve Growth Factor (NGF) and Reelin might take place during impaired retinal development occurring in the Reelin deficient mouse model (Reeler). To better characterize NGF and retina impairments at the Reeler retina, vitreous and retina were investigated by means of protein expression and glial cell activation. Reeler (n = 9; RELN-/-) and WT (n = 9; wild-type RELN+/+, B6C3Fe) mice were analyzed at 14, 21 and 28 postnatal days (p). Retinas and vitreous were subjected to confocal analysis and protein array, followed by conventional analysis. A significant increase of NGF, IL33 and TIMP1, a trend to a decrease of IL12 and IL6, as well as a significant decrease of NT3 were detected in Reeler vitreous, particularly at p28 (p<0.05). MIP3 beta mRNA was decreased while IL33mRNA was significantly upregulated in Reeler retina. Increased number of GFAP(+) and Nestin(+) cells as well as upregulation of Glutamine Synthetase and Nestin mRNAs were observed in Reeler retinas (p<0.05). These findings extend our previous studies on Reeler retina showing a selective Muller cell activation. NGF and IL33 release into vitreous would suggest a local activation of Muller cells, in addition to retinal ganglion and accessory cells. Overall, the data from this experimental study would strength the potential neuroprotective role played by activated Muller cells through NGF release.	[Balzamino, Bijorn Omar; Esposito, Graziana; Micera, Alessandra] IRCCS Fdn Bietti, Res Labs Ophthalmol, Rome, Italy; [Marino, Ramona; Keller, Flavio] Univ Campus Biomed, Lab Dev Neurosci & Neural Plast, Rome, Italy	IRCCS - Fondazione "G.B. Bietti" per lo Studio e la Ricerca in Oftalmologia; University Campus Bio-Medico - Rome Italy	Micera, A (corresponding author), IRCCS Fdn Bietti, Res Labs Ophthalmol, Rome, Italy.	amicera@gmail.com	Micera, Alessandra/J-3373-2013; balzamino, bijorn omar/A-4433-2013; micera, alessandra/AAY-4696-2020	balzamino, bijorn omar/0000-0002-2254-1647; micera, alessandra/0000-0002-9375-6071; Keller, Flavio/0000-0002-6449-6960	Italian Ministry of Health [RC2635302]; Italian Ministry of Education [PRIN 2009P9CE2R]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of Education	This work was supported by: BOB, GE and AM: Italian Ministry of Health acc. number: RC2635302; RM and FK: Italian Ministry of Education acc. number: PRIN 2009P9CE2R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloe L, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0395-y; Balzamino BO, 2015, NEUROMOL MED, V17, P314, DOI 10.1007/s12017-015-8360-z; Balzamino Bijorn Omar, 2014, Int J Cell Biol, V2014, P725928, DOI 10.1155/2014/725928; Berardi N, 1999, J NEUROBIOL, V41, P119, DOI 10.1002/(SICI)1097-4695(199910)41:1<119::AID-NEU15>3.0.CO;2-N; BIGNAMI A, 1984, BRAIN RES, V300, P175, DOI 10.1016/0006-8993(84)91355-6; Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Brunne B, 2013, GLIA, V61, P1347, DOI 10.1002/glia.22519; Cacciamani A, 2016, CURR EYE RES, V41, P971, DOI 10.3109/02713683.2015.1080282; Campbell DJ, 2003, SEMIN IMMUNOL, V15, P277, DOI 10.1016/j.smim.2003.08.005; CARMIGNOTO G, 1989, J NEUROSCI, V9, P1263; CARMIGNOTO G, 1991, EXP NEUROL, V111, P302, DOI 10.1016/0014-4886(91)90097-V; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; D'Arcangelo G, 2006, EPILEPSY BEHAV, V8, P81, DOI 10.1016/j.yebeh.2005.09.005; Davuluri G, 2009, ARCH OPHTHALMOL-CHIC, V127, P613, DOI 10.1001/archophthalmol.2009.88; EHLERS MRW, 1991, BIOCHEMISTRY-US, V30, P10065, DOI 10.1021/bi00106a001; Gadani SP, 2016, J EXP MED, V213, P141, DOI 10.1084/jem.2132insight2; Garcia TB, 2014, J NEUROCHEM, V131, P303, DOI 10.1111/jnc.12822; Johnsen EO, 2018, CURR EYE RES, V43, P340, DOI 10.1080/02713683.2017.1403630; Kim SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106861; Koss MJ, 2012, ACTA OPHTHALMOL, V90, pe98, DOI 10.1111/j.1755-3768.2011.02292.x; Le AP, 2012, J NEUROSCI, V32, P703, DOI 10.1523/JNEUROSCI.4128-11.2012; LIMB G A, 1991, Eye (London), V5, P686; Lin M, 2011, DIABETOLOGIA, V54, P1554, DOI 10.1007/s00125-011-2081-0; Liu XC, 2012, INFLAMMATION, V35, P776, DOI 10.1007/s10753-011-9379-4; Micera A, 2016, CURR MOL MED, V16, P620, DOI 10.2174/1566524016666160805115044; Micera A, 2018, INVEST OPHTH VIS SCI, V59, P2024, DOI 10.1167/iovs.17-23358; Micera A, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9672082; Oderfeld-Nowak B, 2001, NEUROSCI LETT, V308, P165, DOI 10.1016/S0304-3940(01)02001-8; OKADA M, 1990, GRAEF ARCH CLIN EXP, V228, P467, DOI 10.1007/BF00927264; Oubaha M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9440; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pulido JS, 2007, GRAEF ARCH CLIN EXP, V245, P889, DOI 10.1007/s00417-006-0458-4; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rocco ML, 2018, GRAEF ARCH CLIN EXP, V256, P729, DOI 10.1007/s00417-018-3931-y; Rocco ML, 2017, GRAEF ARCH CLIN EXP, V255, P567, DOI 10.1007/s00417-016-3567-8; Rocco ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124810; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; SMITH T, 1994, NEUROPATH APPL NEURO, V20, P413, DOI 10.1111/j.1365-2990.1994.tb00991.x; Vecino E, 2016, PROG RETIN EYE RES, V51, P1, DOI 10.1016/j.preteyeres.2015.06.003; Villarreal DO, 2014, CURR OPIN IMMUNOL, V28, P102, DOI 10.1016/j.coi.2014.03.004; Vujosevic S, 2016, ACTA OPHTHALMOL, V94, P56, DOI 10.1111/aos.12812; Vujosevic S, 2015, INVEST OPHTH VIS SCI, V56, P3913, DOI 10.1167/iovs.15-16554; Wang Xiaoli, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P231; Wang YH, 2017, CELL PHYSIOL BIOCHEM, V44, P479, DOI 10.1159/000485085; Willbold E, 1998, HISTOL HISTOPATHOL, V13, P531, DOI 10.14670/HH-13.531; Wright JW, 2009, BEHAV BRAIN RES, V203, P27, DOI 10.1016/j.bbr.2009.04.014; Xi HK, 2016, J EXP MED, V213, P189, DOI 10.1084/jem.20150894; Xie W, 2009, NEUROSCIENCE, V160, P847, DOI 10.1016/j.neuroscience.2009.03.016; Xue LP, 2010, CAN J NEUROL SCI, V37, P643, DOI 10.1017/S0317167100010830; Yoshimura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008158; Zimmermann J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057307	52	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212732	10.1371/journal.pone.0212732	http://dx.doi.org/10.1371/journal.pone.0212732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811468	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400086
J	Liu, SQ; Kim, ED; Wu, AZ; Meyerid, ML; Cheng, S; Hoogeveen, RC; Ballantyne, CM; Tanaka, H; Heiss, G; Selvin, E; Matsushita, K				Liu, Shuiqing; Kim, Esther D.; Wu, Aozhou; Meyerid, Michelle L.; Cheng, Susan; Hoogeveen, Ron C.; Ballantyne, Christie M.; Tanaka, Hirofumi; Heiss, Gerardo; Selvin, Elizabeth; Matsushita, Kunihiro			Central and peripheral pulse wave velocity and subclinical myocardial stress and damage in older adults	PLOS ONE			English	Article							HEART-FAILURE RISK; ARTERIAL STIFFNESS; ATHEROSCLEROSIS RISK; NATRIURETIC PEPTIDE; TROPONIN-T; BLOOD-PRESSURE; RECOMMENDATIONS; ASSOCIATION; MECHANISMS; STATEMENT	Background Arterial stiffness independently predicts cardiovascular disease. However, few studies have evaluated the associations of central and peripheral pulse wave velocity (PWV) with bio-markers of both myocardial stress (natriuretic peptide [NT-proBNP]) and damage (high-sensitivity cardiac troponin-T [hs-cTnT]) among persons without cardiac disease. Methods We examined 3,348 participants (67-90 years) without prevalent cardiac disease in the Atherosclerosis Risk in Communities (ARIC) Study (2011-13). The cross-sectional associations of PWV quartiles for central arterial segments (carotid-femoral, heart-carotid, heart-femoral) and peripheral artery (femoral-ankle) with NT-proBNP and hs-cTnT were evaluated accounting for potential confounders. Results Most PWV measures demonstrated J- or U-shaped associations with the two cardiac bio-markers. The highest (Q4) vs. second lowest (Q2) quartile of central PWV measures (carotid-femoral, heart-carotid, heart-femoral PWV) were associated with higher levels of NT-proBNP independently of demographic characteristics. The associations were less evident for hs-cTnT. These associations were attenuated after adjusting for traditional cardiovascular risk factors, but the heart-carotid PWV-NT-proBNP relationship remained borderline significant (difference in log-NT-proBNP = 0.08 [-0.01, 0.17] in Q4 vs. Q2, p = 0.07). Peripheral PWV demonstrated inverse associations. Higher values of NT-proBNP were seen in the lowest vs. second lowest quartile of all PWV measures. Conclusions Central stiffness measures showed stronger associations with cardiac biomarkers (particularly NT-proBNP) than peripheral measures among older adults without cardiac disease. Our findings are consistent with the concept of ventricular-vascular coupling and suggest that central rather than peripheral arterial hemodynamics are more closely related to myocardial stress rather than damage.	[Liu, Shuiqing; Kim, Esther D.; Wu, Aozhou; Selvin, Elizabeth; Matsushita, Kunihiro] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Meyerid, Michelle L.; Heiss, Gerardo] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Cheng, Susan] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Hoogeveen, Ron C.; Ballantyne, Christie M.] Baylor Coll Med, Houston, TX 77030 USA; [Tanaka, Hirofumi] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Baylor College of Medicine; University of Texas System; University of Texas Austin	Matsushita, K (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	kuni.matsushita@jhu.edu	Matsushita, Kunihiro/AAJ-5817-2020; Ballantyne, Christie/A-6599-2008	Matsushita, Kunihiro/0000-0002-7179-718X; Meyer, Michelle/0000-0001-7085-3154; Cheng, Susan/0000-0002-4977-036X; Tanaka, Hirofumi/0000-0002-1780-7471; Ballantyne, Christie/0000-0002-6432-1730	National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL134320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK106414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG053938] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Atherosclerosis Risk in Communities study has been funded in whole or in part with Federal funds from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services, under Contract nos. (HHSN268201700001I, HHSN268201700002I, HHSN268201700003I, HHSN268201700005I, HHSN268201700004I). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston-Coldea Lucia, 2008, Rom J Intern Med, V46, P313; Al-Mohammad A, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4130; AlGhatrif M, 2013, HYPERTENSION, V62, P934, DOI 10.1161/HYPERTENSIONAHA.113.01445; [Anonymous], 2015, ARIC VISIT 5 NCS ANA; Bai YY, 2011, ATHEROSCLEROSIS, V218, P493, DOI 10.1016/j.atherosclerosis.2011.06.035; Bay M, 2003, HEART, V89, P150, DOI 10.1136/heart.89.2.150; Booth J, 2010, CLIN J AM SOC NEPHRO, V5, P1036, DOI 10.2215/CJN.09001209; Caliskan Y, 2012, KIDNEY BLOOD PRESS R, V35, P340, DOI 10.1159/000332084; Chatzis D, 2010, INT J CARDIOL, V141, P291, DOI 10.1016/j.ijcard.2008.12.018; Forouhi NG, 2006, DIABETOLOGIA, V49, P822, DOI 10.1007/s00125-006-0189-4; Gupta DK, 2014, JACC-HEART FAIL, V2, P447, DOI 10.1016/j.jchf.2014.05.008; Hashimoto J, 2014, J HYPERTENS, V32, P1665, DOI 10.1097/HJH.0000000000000242; Ilter A, 2016, CLIN RHEUMATOL, V35, P2663, DOI 10.1007/s10067-015-3163-z; Izzo JL, HYPERTENSION PRIMER; Kannel WB, 2004, AM J CARDIOL, V94, P380, DOI 10.1016/j.amjcard.2004.04.043; Kato A, 2012, THER APHER DIAL, V16, P232, DOI 10.1111/j.1744-9987.2012.01058.x; Kavsak PA, 2011, CLIN BIOCHEM, V44, P1021, DOI 10.1016/j.clinbiochem.2011.05.017; Kimura K, 2015, J CARDIOL, V66, P135, DOI 10.1016/j.jjcc.2014.10.008; Kociol RD, 2010, J AM COLL CARDIOL, V56, P1071, DOI 10.1016/j.jacc.2010.06.016; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levy D, 2007, CIRCULATION, V115, P3079, DOI 10.1161/CIRCULATIONAHA.106.652842; Lopez-Giacoman Salvador, 2015, World J Nephrol, V4, P57, DOI 10.5527/wjn.v4.i1.57; Meyer ML, 2016, AM J HYPERTENS, V29, P470, DOI 10.1093/ajh/hpv127; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Otaki Y, 2015, BBA CLIN, V4, P35, DOI 10.1016/j.bbacli.2015.06.003; Roman MJ, 2000, HYPERTENSION, V36, P489, DOI 10.1161/01.HYP.36.4.489; See R, 2007, J AM COLL CARDIOL, V50, P752, DOI 10.1016/j.jacc.2007.04.066; Shah AM, 2014, CIRC-CARDIOVASC IMAG, V7, P173, DOI 10.1161/CIRCIMAGING.113.000736; Tanaka H, 2009, J HYPERTENS, V27, P2022, DOI 10.1097/HJH.0b013e32832e94e7; Townsend RR, 2015, HYPERTENSION, V66, P698, DOI 10.1161/HYP.0000000000000033; Tsuchikura S, 2010, ATHEROSCLEROSIS, V211, P480, DOI 10.1016/j.atherosclerosis.2010.03.037; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; Wilkins LW, MED SURG NURSING MAD; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Yin ZX, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0193-6; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	39	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212892	10.1371/journal.pone.0212892	http://dx.doi.org/10.1371/journal.pone.0212892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811490	Green Submitted, gold, Green Published			2022-12-26	WOS:000459806400096
J	Sheehan, K; Lee, J; Chong, J; Zavala, K; Sharma, M; Philipsen, S; Maruyama, T; Xu, ZY; Guan, ZH; Eilers, H; Kawamata, T; Schumacher, M				Sheehan, Kayla; Lee, Jessica; Chong, Jillian; Zavala, Kathryn; Sharma, Manohar; Philipsen, Sjaak; Maruyama, Tomoyuki; Xu, Zheyun; Guan, Zhonghui; Eilers, Helge; Kawamata, Tomoyuki; Schumacher, Mark			Transcription factor Sp4 is required for hyperalgesic state persistence	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PRIMARY SENSORY NEURONS; CHEMOTHERAPY-INDUCED NEUROPATHY; DORSAL-ROOT; VANILLOID RECEPTOR; PERIPHERAL INFLAMMATION; COLD HYPERSENSITIVITY; PAINFUL NEUROPATHY; TRPV1 EXPRESSION; ANIMAL-MODEL	Understanding how painful hypersensitive states develop and persist beyond the initial hours to days is critically important in the effort to devise strategies to prevent and/or reverse chronic painful states. Changes in nociceptor transcription can alter the abundance of nociceptive signaling elements, resulting in longer-term change in nociceptor phenotype. As a result, sensitized nociceptive signaling can be further amplified and nocifensive behaviors sustained for weeks to months. Building on our previous finding that transcription factor Sp4 positively regulates the expression of the pain transducing channel TRPV1 in Dorsal Root Ganglion (DRG) neurons, we sought to determine if Sp4 serves a broader role in the development and persistence of hypersensitive states in mice. We observed that more than 90% of Sp4 staining DRG neurons were small to medium sized, primarily unmyelinated (NF200 neg) and the majority co-expressed nociceptor markers TRPV1 and/or isolectin B4 (IB4). Genetically modified mice (Sp4+/-) with a 50% reduction of Sp4 showed a reduction in DRG TRPV1 mRNA and neuronal responses to the TRPV1 agonist-capsaicin. Importantly, Sp4 +/- mice failed to develop persistent inflammatory thermal hyperalgesia, showing a reversal to control values after 6 hours. Despite a reversal of inflammatory thermal hyperalgesia, there was no difference in CFA-induced hindpaw swelling between CFA Sp4+/- and CFA wild type mice. Similarly, Sp4+/- mice failed to develop persistent mechanical hypersensitivity to hind-paw injection of NGF. Although Sp4+/- mice developed hypersensitivity to traumatic nerve injury, Sp4+/- mice failed to develop persistent cold or mechanical hypersensitivity to the platinum-based chemotherapeutic agent oxaliplatin, a non-traumatic model of neuropathic pain. Overall, Sp4+/- mice displayed a remarkable ability to reverse the development of multiple models of persistent inflammatory and neuropathic hypersensitivity. This suggests that Sp4 functions as a critical control point for a network of genes that conspire in the persistence of painful hypersensitive states.	[Sheehan, Kayla; Lee, Jessica; Chong, Jillian; Zavala, Kathryn; Sharma, Manohar; Xu, Zheyun; Guan, Zhonghui; Eilers, Helge; Schumacher, Mark] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Philipsen, Sjaak] Erasmus Univ, Med Ctr, Dept Cell Biol, Rotterdam, Netherlands; [Maruyama, Tomoyuki; Kawamata, Tomoyuki] Wakayama Med Univ, Dept Anesthesiol, Wakayama, Japan	University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; Wakayama Medical University	Schumacher, M (corresponding author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA.	Mark.Schumacher@ucsf.edu	Kawamata, Tomoyuki/AAY-6918-2020	Sheehan, Kayla/0000-0003-3944-1666; Xu, Zheyun/0000-0002-1101-7014	Department of Anesthesia and Perioperative Care; University of California, San Francisco (UCSF); National Institutes of Health (NIH) [NS38737]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS100801] Funding Source: NIH RePORTER	Department of Anesthesia and Perioperative Care; University of California, San Francisco (UCSF)(University of California System); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by: MS: Department of Anesthesia and Perioperative Care. University of California, San Francisco (UCSF), with additional support at the projects inception from the National Institutes of Health (NIH) NS38737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers JW, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005228.pub3; Alloui A, 2006, EMBO J, V25, P2368, DOI 10.1038/sj.emboj.7601116; Amann R, 1996, PAIN, V64, P323, DOI 10.1016/0304-3959(95)00120-4; Amaya F, 2004, EUR J NEUROSCI, V20, P2303, DOI 10.1111/j.1460-9568.2004.03701.x; Amaya F, 2003, BRAIN RES, V963, P190, DOI 10.1016/S0006-8993(02)03972-0; Anderson EO, 2018, CELL REP, V23, P701, DOI 10.1016/j.celrep.2018.03.094; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Attal N, 2009, PAIN, V144, P245, DOI 10.1016/j.pain.2009.03.024; Baiou D, 2007, J COMP NEUROL, V503, P334, DOI 10.1002/cne.21389; Barabas ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047988; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Blackshaw LA, 2014, BRIT J PHARMACOL, V171, P2528, DOI 10.1111/bph.12641; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Breese NM, 2005, PAIN, V115, P37, DOI 10.1016/j.pain.2005.02.010; Brierley SM, 2011, J PHYSIOL-LONDON, V589, P3575, DOI 10.1113/jphysiol.2011.206789; Brouwers Elke E M, 2008, BMC Clin Pharmacol, V8, P7, DOI 10.1186/1472-6904-8-7; Capsoni S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017321; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chang WC, 2005, BIOCHEM BIOPH RES CO, V338, P117, DOI 10.1016/j.bbrc.2005.08.014; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Cheng YR, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0448-y; Chu C, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-44; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Crow M, 2015, FASEB J, V29, P3370, DOI 10.1096/fj.14-264440; Daemen MARC, 1998, NEUROL RES, V20, P41; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; De Felice M, 2011, PAIN, V152, P2701, DOI 10.1016/j.pain.2011.06.008; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Descoeur J, 2011, EMBO MOL MED, V3, P266, DOI 10.1002/emmm.201100134; Diogenes A, 2007, J DENT RES, V86, P550, DOI 10.1177/154405910708600612; Eskander MA, 2015, J NEUROSCI, V35, P8593, DOI 10.1523/JNEUROSCI.3993-14.2015; Gauchan P, 2009, NEUROSCI LETT, V458, P93, DOI 10.1016/j.neulet.2009.04.029; Geber C, 2013, PAIN, V154, P2877, DOI 10.1016/j.pain.2013.08.028; Gereau RW, 2014, J PAIN, V15, P1203, DOI 10.1016/j.jpain.2014.09.004; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; Gollner H, 2001, MECH DEVELOP, V106, P77, DOI 10.1016/S0925-4773(01)00420-8; Gollner H, 2001, GENES CELLS, V6, P689, DOI 10.1046/j.1365-2443.2001.00455.x; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Gregus AM, 2012, P NATL ACAD SCI USA, V109, P6721, DOI 10.1073/pnas.1110460109; Guan Zhonghui, 2016, F1000Res, V5; Guan ZH, 2016, NAT NEUROSCI, V19, P94, DOI 10.1038/nn.4189; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heurteaux C, 2004, EMBO J, V23, P2684, DOI 10.1038/sj.emboj.7600234; Hong GS, 2016, NEURON, V91, P708, DOI 10.1016/j.neuron.2016.07.019; Indo Y, 2001, HUM MUTAT, V18, P462, DOI 10.1002/humu.1224; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Johar K, 2014, EUR J NEUROSCI, V39, P566, DOI 10.1111/ejn.12415; Johar K, 2013, J NEUROCHEM, V127, P496, DOI 10.1111/jnc.12433; Joseph EK, 2008, J PAIN, V9, P463, DOI 10.1016/j.jpain.2008.01.335; Kato Y, 2014, ANTI-CANCER DRUG, V25, P39, DOI 10.1097/CAD.0000000000000022; Kays J, 2018, NEUROSCIENCE, V371, P420, DOI 10.1016/j.neuroscience.2017.12.030; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Kwon HS, 1999, J BIOL CHEM, P274; Lawton SK, 2017, J IMMUNOL, V199, P1465, DOI 10.4049/jimmunol.1602151; Lennertz RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043597; Leonard GD, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-116; Lerner LE, 2002, J BIOL CHEM, V277, P25877, DOI 10.1074/jbc.M201407200; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Li L, 2004, BIOCHEM CELL BIOL, V82, P460, DOI 10.1139/O04-045; Liedtke W, 2005, J PHYSIOL-LONDON, V567, P53, DOI 10.1113/jphysiol.2005.088963; Lin T, 2007, J NEUROIMMUNOL, V192, P40, DOI 10.1016/j.jneuroim.2007.09.003; Ling B, 2007, TOXICOLOGY, V234, P176, DOI 10.1016/j.tox.2007.02.013; Ling B, 2007, PAIN, V128, P225, DOI 10.1016/j.pain.2006.09.016; Malik-Hall M, 2005, EUR J NEUROSCI, V21, P3387, DOI 10.1111/j.1460-9568.2005.04173.x; McMahon SB, 1996, PHILOS T R SOC B, V351, P431, DOI 10.1098/rstb.1996.0039; Michael GJ, 1999, J NEUROSCI, V19, P1844; Mills CD, 2013, EUR J PAIN, V17, P469, DOI 10.1002/j.1532-2149.2012.00202.x; Miltenburg NC, 2014, CANCER TREAT REV, V40, P872, DOI 10.1016/j.ctrv.2014.04.004; Mizuno K, 2014, J PHARMACOL SCI, V125, P91, DOI 10.1254/jphs.13244FP; Nair B, 2016, BBA-MOL CELL RES, V1863, P1, DOI 10.1016/j.bbamcr.2015.10.005; Nassini R, 2011, PAIN, V152, P1621, DOI 10.1016/j.pain.2011.02.051; Niiyama Y, 2007, NEUROSCIENCE, V148, P560, DOI 10.1016/j.neuroscience.2007.05.049; Pachman DR, 2014, J CLIN INVEST, V124, P72, DOI 10.1172/JCI73908; Pasetto LM, 2006, CRIT REV ONCOL HEMAT, V59, P159, DOI 10.1016/j.critrevonc.2006.01.001; Petruska JC, 2004, NEUROSCI LETT, V361, P168, DOI 10.1016/j.neulet.2003.12.012; Pinacho R, 2011, BIPOLAR DISORD, V13, P474, DOI 10.1111/j.1399-5618.2011.00941.x; Piomelli D, 2014, NAT NEUROSCI, V17, P164, DOI 10.1038/nn.3612; Priya A, 2014, BBA-MOL CELL RES, V1843, P1196, DOI 10.1016/j.bbamcr.2014.02.008; Qiu ZH, 2006, J BIOL CHEM, V281, P16672, DOI 10.1074/jbc.M511648200; Ramos B, 2007, P NATL ACAD SCI USA, V104, P9882, DOI 10.1073/pnas.0701946104; Ramos B, 2009, MOL CELL NEUROSCI, V42, P152, DOI 10.1016/j.mcn.2009.06.008; Ranade SS, 2014, NATURE, V516, P121, DOI 10.1038/nature13980; Reichling DB, 2013, PAIN, V154, pS2, DOI 10.1016/j.pain.2013.05.037; Reichling DB, 2009, TRENDS NEUROSCI, V32, P611, DOI 10.1016/j.tins.2009.07.007; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; Ren Ke, 1999, ILAR J, V40, P111; Rukwied R, 2010, PAIN, V148, P407, DOI 10.1016/j.pain.2009.11.022; Saia G, 2014, J NEUROCHEM, V129, P743, DOI 10.1111/jnc.12657; Sakai K, 2016, PAIN, V157, P2536, DOI 10.1097/j.pain.0000000000000674; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schuhmacher LN, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0279-2; Schumacher MA, 2010, PAIN PRACT, V16, DOI [10.1111/J.1471-4159.2006.04363.X, DOI 10.1111/J.1471-4159.2006.04363.X]; Sexton JE, 2014, HANDB EXP PHARMACOL, V223, P873, DOI 10.1007/978-3-319-05161-1_6; Shi J, 2011, MOL PSYCHIATR, V16, P193, DOI 10.1038/mp.2009.124; Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Shu XQ, 1999, P NATL ACAD SCI USA, V96, P7693, DOI 10.1073/pnas.96.14.7693; Sisignano M, 2014, NAT REV NEUROL, V10, P694, DOI 10.1038/nrneurol.2014.211; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Sugimoto A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18089-0; Sun XX, 2015, DEV NEUROBIOL, V75, P93, DOI 10.1002/dneu.22212; Sung KJ, 2018, J NEUROSCI, V38, P3394, DOI 10.1523/JNEUROSCI.1686-17.2018; Supp DM, 1996, DEV BIOL, V176, P284, DOI 10.1006/dbio.1996.0134; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Ta LE, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-15; Ugarte GD, 2013, J CELL PHYSIOL, V228, P860, DOI 10.1002/jcp.24236; WOOLF CJ, 1994, NEUROSCIENCE, V62, P327, DOI 10.1016/0306-4522(94)90366-2; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030; Xue Q, 2001, GENOMICS, V76, P14, DOI 10.1006/geno.2001.6582; Xue Q, 2007, J NEUROCHEM, V101, P212, DOI 10.1111/j.1471-4159.2006.04363.x; Yamamoto K, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0072-8; Yan F, 2015, J NEUROCHEM, V135, P1099, DOI 10.1111/jnc.13355; Yu L, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-61; Zappia KJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0069-16.2017; Zavala K, 2014, NEUROSCI LETT, V578, P211, DOI 10.1016/j.neulet.2014.01.021; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhao CT, 2006, BIOCHEM BIOPH RES CO, V342, P214, DOI 10.1016/j.bbrc.2006.01.134; Zhou X, 2007, GENES BRAIN BEHAV, V6, P269, DOI 10.1111/j.1601-183X.2006.00256.x; Zhou X, 2005, MOL PSYCHIATR, V10, P393, DOI 10.1038/sj.mp.4001621; Zhou XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005196; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Zwick M, 2002, J NEUROSCI, V22, P4057, DOI 10.1523/JNEUROSCI.22-10-04057.2002	128	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0211349	10.1371/journal.pone.0211349	http://dx.doi.org/10.1371/journal.pone.0211349			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811405	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400016
J	Westerdijk, K; Simons, KS; Zegers, M; Wever, PC; Pickkers, P; de Jager, CPC				Westerdijk, Kim; Simons, Koen S.; Zegers, Marissa; Wever, Peter C.; Pickkers, Peter; de Jager, Cornelis P. C.			The value of the neutrophil-lymphocyte count ratio in the diagnosis of sepsis in patients admitted to the Intensive Care Unit: A retrospective cohort study	PLOS ONE			English	Article							INTERNATIONAL CONSENSUS DEFINITIONS; CRITICALLY-ILL PATIENTS; C-REACTIVE PROTEIN; ORGAN FAILURE; SEPTIC SHOCK; PROCALCITONIN; DISEASE; TRAUMA	Background Early diagnosis and treatment has proven to be of utmost importance in the outcome of sepsis patients. We compared the accuracy of the neutrophil-lymphocyte count ratio (NLCR) to conventional inflammatory markers in patients admitted to the Intensive Care Unit (ICU). Methods We performed a retrospective cohort study consisting of 276 ICU patients with sepsis and 388 ICU patients without sepsis. We compared the NLCR as well as C-reactive protein (CRP) level, procalcitonin (PCT) level, white blood cell (WBC) count, neutrophil count and lymphocyte count on ICU admission between sepsis and non-sepsis ICU patients. To evaluate the sensitivity and specificity, we constructed receiver operating characteristics (ROC) curves. Results Significant differences in NLCR values were observed between sepsis and non-sepsis patients (15.3 [10.8-38.2] (median [interquartile range] vs. 9.3 [6.2-14.5]; P<0.001), as well as for CRP level, PCT level and lymphocyte count. The area under the ROC curve (AUROC) of the NLCR was 0.66 (95% CI = 0.62-0.71). AUROC was significantly higher for CRP and PCT level with AUROC's of 0.89 (95% CI 0.87-0.92) and 0.88 (95% CI 0.86-0.91) respectively. Conclusions The NLCR is less suitable than conventional inflammatory markers CRP and PCT to detect the presence of sepsis in ICU patients.	[Westerdijk, Kim; Simons, Koen S.; Zegers, Marissa; de Jager, Cornelis P. C.] Jeroen Bosch Hosp, Dept Intens Care Med, Shertogenbosch, Netherlands; [Wever, Peter C.] Jeroen Bosch Hosp, Dept Med Microbiol & Infect Control, Shertogenbosch, Netherlands; [Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands	Jeroen Bosch Ziekenhuis; Jeroen Bosch Ziekenhuis; Radboud University Nijmegen	Westerdijk, K (corresponding author), Jeroen Bosch Hosp, Dept Intens Care Med, Shertogenbosch, Netherlands.	kim.westerdijk@radboudumc.nl	Westerdijk, Kim/F-1357-2019; Simons, Koen/W-4896-2019; Pickkers, P./H-8080-2014	Westerdijk, Kim/0000-0003-3512-4671; Pickkers, P./0000-0002-1104-4303				Adib-Conquy M, 2009, THROMB HAEMOSTASIS, V101, P36, DOI 10.1160/TH08-07-0421; Akilli NB, 2014, AM J EMERG MED, V32, P1476, DOI 10.1016/j.ajem.2014.09.001; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Clyne B, 1999, J EMERG MED, V17, P1019, DOI 10.1016/S0736-4679(99)00135-3; de Jager CPC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046561; de Jager CPC, 2010, CRIT CARE, V14, DOI 10.1186/cc9309; Dell'Anna AM, 2014, RESUSCITATION, V85, P932, DOI 10.1016/j.resuscitation.2014.04.003; Furutate R, 2016, INTERNAL MED, V55, P223, DOI 10.2169/internalmedicine.55.5772; Garnacho-Montero J, 2014, CRIT CARE, V18, DOI 10.1186/cc13908; Gunay E, 2014, INFLAMMATION, V37, P374, DOI 10.1007/s10753-013-9749-1; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Kim SY, 2015, ANN CLIN BIOCHEM, V52, P654, DOI 10.1177/0004563214568685; Laukemann S, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002264; Loonen AJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087315; Lowsby R, 2015, EMERG MED J, V32, P531, DOI 10.1136/emermed-2014-204071; Luan YY, 2014, J INTERF CYTOK RES, V34, P2, DOI 10.1089/jir.2013.0042; Luzzani A, 2003, CRIT CARE MED, V31, P1737, DOI 10.1097/01.CCM.0000063440.19188.ED; OMAHONY JB, 1984, J TRAUMA, V24, P869, DOI 10.1097/00005373-198410000-00001; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Riche F, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1144-x; Ristagno G, 2015, CLIN CHEM LAB MED, V53, P1847, DOI 10.1515/cclm-2014-1271; Salciccioli JD, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0731-6; Shankar-Hari M, 2016, JAMA-J AM MED ASSOC, V315, P775, DOI 10.1001/jama.2016.0289; Simons KS, 2016, LANCET RESP MED, V4, P194, DOI 10.1016/S2213-2600(16)00025-4; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Summers C, 2010, TRENDS IMMUNOL, V31, P318, DOI 10.1016/j.it.2010.05.006; Tabuchi Y, 1989, J Anesth, V3, P123, DOI 10.1007/s0054090030123; Tang BMP, 2007, LANCET INFECT DIS, V7, P210, DOI 10.1016/S1473-3099(07)70052-X; Uzzan B, 2006, CRIT CARE MED, V34, P1996, DOI 10.1097/01.CCM.0000226413.54364.36; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wacker C, 2013, LANCET INFECT DIS, V13, P426, DOI 10.1016/S1473-3099(12)70323-7; Zahorec R, 2001, Bratisl Lek Listy, V102, P5	33	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212861	10.1371/journal.pone.0212861	http://dx.doi.org/10.1371/journal.pone.0212861			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811475	Green Published, Green Submitted, gold			2022-12-26	WOS:000459806400093
J	van Dammen, L; Wekker, V; de Rooij, SR; Mol, BJ; Groen, H; Hoek, A; Roseboom, TJ				van Dammen, Lotte; Wekker, Vincent; de Rooij, Susanne R.; Mol, Ben Willem J.; Groen, Henk; Hoek, Annemieke; Roseboom, Tessa J.			The effects of a pre-conception lifestyle intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep and quality of life	PLOS ONE			English	Article							DEPRESSION SCALE HADS; HEALTH SURVEY SF-36; HOSPITAL ANXIETY; WEIGHT-LOSS; ILL PATIENTS; VERSION; ADULTS; VALIDATION; VALIDITY; OUTCOMES	Background Obesity is an increasing problem worldwide and is associated with serious health risks. Obesity not only reduces physical health, but can also negatively affect levels of perceived stress, mood symptoms, sleep quality and quality of life (QoL), which may lead to further weight gain. We have previously shown that a pre-conception lifestyle intervention reduced weight and improved physical QoL in the short term. In the current study, we assessed the effects of this intervention in women with obesity and infertility on perceived stress, mood symptoms, sleep quality and QoL five years after randomization. Methods and findings We followed women who participated in the LIFEstyle study. This is a multi-center randomized controlled trial comparing a six-month lifestyle intervention to improve diet and increase physical activity followed by infertility treatment, versus prompt infertility treatment. Participants were 577 women with infertility between 18 and 39 years of age with a body mass index (BMI). 29 kg/m(2). For the current study we measured perceived stress, mood symptoms, sleep quality and QoL in 178 women five years after randomization. T-tests and linear regression models were used to assess differences between the intervention and control groups. Five years after randomization, no differences were observed for perceived stress, mood symptoms, sleep quality and QoL between the intervention (n = 84) and control groups (n = 94). There was selective participation: women who did not participate in the follow-up had lower baseline mental QoL, and benefitted more from the intervention in terms of improved physical QoL during the original LIFEstyle intervention. Conclusions We found no evidence that a pre-conception lifestyle intervention improved female wellbeing five years after randomization.	[van Dammen, Lotte; Hoek, Annemieke] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands; [van Dammen, Lotte; Groen, Henk] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wekker, Vincent; Roseboom, Tessa J.] Univ Amsterdam, Amsterdam UMC, Dept Obstet & Gynecol, Amsterdam, Netherlands; [Wekker, Vincent; de Rooij, Susanne R.; Roseboom, Tessa J.] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Wekker, Vincent; Roseboom, Tessa J.] Amsterdam UMC, Amsterdam Reprod & Dev Res Inst, Amsterdam, Netherlands; [Wekker, Vincent; Roseboom, Tessa J.] Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Amsterdam, Netherlands; [Mol, Ben Willem J.] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic, Australia	University of Groningen; University of Groningen; University of Amsterdam; University of Amsterdam; University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Monash University	van Dammen, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands.; van Dammen, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	l.van.dammen@umcg.nl	Groen, Henk/B-2163-2013	Groen, Henk/0000-0002-6629-318X; Mol, Ben Willem/0000-0001-8337-550X; de Rooij, Susanne Rosalie/0000-0001-7382-5749; Roseboom, Tessa/0000-0003-0564-5994	Netherlands Organization for Health Research and Development [50-50110-96-518]; Dutch Heart Foundation [2013T085]; European Commission (Horizon2020 project 'DynaHealth') [633595]	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Dutch Heart Foundation(Netherlands Heart Foundation); European Commission (Horizon2020 project 'DynaHealth')(European CommissionEuropean Commission Joint Research Centre)	This research was supported by The Netherlands Organization for Health Research and Development (50-50110-96-518), the Dutch Heart Foundation (Grant number: 2013T085), and the European Commission (Horizon2020 project 'DynaHealth', 633595). The department of obstetrics and gynaecology from the UMCG receives an unrestricted educational grant from Ferring Pharmaceutical BV the Netherlands, unrelated to the present study.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Augner C, 2011, CENT EUR J PUBL HEAL, V19, P115, DOI 10.21101/cejph.a3647; Barnes RD, 2015, OBES REV, V16, P304, DOI 10.1111/obr.12264; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Butler AC, 2006, CLIN PSYCHOL REV, V26, P17, DOI 10.1016/j.cpr.2005.07.003; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chair SY, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0436-5; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dag ZO, 2017, GYNECOL ENDOCRINOL, V33, P250, DOI 10.1080/09513590.2016.1254610; Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2; Ford M Allison, 2017, Int J Health Sci (Qassim), V11, P13; Gadie A, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014920; Gaudry S, 2017, ANN INTENSIVE CARE, V7, DOI 10.1186/s13613-017-0243-z; Hinz A, 2011, J PSYCHOSOM RES, V71, P74, DOI 10.1016/j.jpsychores.2011.01.005; Hopman WM, 2006, QUAL LIFE RES, V15, P527, DOI 10.1007/s11136-005-2096-4; Knufinke M, 2018, J SLEEP RES, V27, P78, DOI 10.1111/jsr.12509; Kolotkin R L, 2001, Obes Rev, V2, P219, DOI 10.1046/j.1467-789X.2001.00040.x; Korten NCM, 2017, INT J GERIATR PSYCH, V32, P439, DOI 10.1002/gps.4486; Lee M, 2009, J NUTR HEALTH AGING, V13, P576, DOI 10.1007/s12603-009-0110-1; Lucas AR, 2017, INTEGR CANCER THER, V16, P263, DOI 10.1177/1534735416668257; Marik PE, 2000, CHEST, V118, P569, DOI 10.1378/chest.118.3.569; Markowitz S, 2008, CLIN PSYCHOL-SCI PR, V15, P1, DOI 10.1111/j.1468-2850.2008.00106.x; Marques A, 2018, EUR J PUBLIC HEALTH, V28, P295, DOI 10.1093/eurpub/ckx143; McBride CM, 2003, HEALTH EDUC RES, V18, P156, DOI 10.1093/her/18.2.156; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Moore CJ, 2012, J ACAD NUTR DIET, V112, P518, DOI 10.1016/j.jand.2011.12.001; Mutsaerts MAQ, 2016, NEW ENGL J MED, V374, P1942, DOI 10.1056/NEJMoa1505297; Mutsaerts MAQ, 2010, BMC WOMENS HEALTH, V10, DOI 10.1186/1472-6874-10-22; Nordin M, 2013, SCAND J PSYCHOL, V54, P502, DOI 10.1111/sjop.12071; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Ross KM, 2016, J BEHAV MED, V39, P465, DOI 10.1007/s10865-015-9704-8; Scott KM, 2008, INT J OBESITY, V32, P192, DOI 10.1038/sj.ijo.0803701; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Szentkiralyi Andras, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P49, DOI 10.1586/14737167.9.1.49; van Dammen L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190662; van de Beek C, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-016579; van der Steeg JW, 2008, HUM REPROD, V23, P324, DOI 10.1093/humrep/dem371; Wadden TA, 2014, DIABETES CARE, V37, P1544, DOI 10.2337/dc13-1928; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; Ware JE, 1996, JAMA-J AM MED ASSOC, V276, P1039, DOI 10.1001/jama.1996.03540130037027; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Wu T, 2009, OBES REV, V10, P313, DOI 10.1111/j.1467-789X.2008.00547.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	45	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0212914	10.1371/journal.pone.0212914	http://dx.doi.org/10.1371/journal.pone.0212914			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8EH	30802271	Green Published, gold, Green Submitted			2022-12-26	WOS:000459710700025
J	Cadenas, O; Megson, GM				Cadenas, Oswaldo; Megson, Graham M.			Preprocessing 2D data for fast convex hull computations	PLOS ONE			English	Article								This paper presents a method to reduce a set of n 2D points to a smaller set of s 2D points with the property that the convex hull on the smaller set is the same as the convex hull of the original bigger set. The paper shows, experimentally, that such reduction accelerates computations; the time it takes to reduce from n down to s points plus the time of computing the convex hull on the s points is less than the time to compute the convex hull on the original set of n points. The method accepts 2D points expressed as real numbers and thus extends our previous method that required points as integers. The method achieves a percentage of reduction of points of over 90% in a collections of four datasets. This amount of reduction provides speedup factors of at least two for various common convex hull algorithms. Theoretically, the reduction method executes in time within O(n) and thus is suitable for preprocessing 2D data before computing the convex hull by any known algorithm.	[Cadenas, Oswaldo] London South Bank Univ, Sch Engn, London, England; [Megson, Graham M.] Univ Westminster, Sch Elect & Comp Sci, London, England	London South Bank University; University of Westminster	Cadenas, O (corresponding author), London South Bank Univ, Sch Engn, London, England.	cadenaso@lsbu.ac.uk		Cadenas, Oswaldo/0000-0003-4152-6458				AKL SG, 1978, INFORM PROCESS LETT, V7, P219, DOI 10.1016/0020-0190(78)90003-0; Brassey CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091691; Cadenas JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149860; Chan TM, 1996, DISCRETE COMPUT GEOM, V16, P361, DOI 10.1007/BF02712873; Chazelle B., 1986, ALGORITHMICA, V1; Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194; Knuth KH, 2013, ARXIVPHYSICS0605197; MELKMAN AA, 1987, INFORM PROCESS LETT, V25, P11, DOI 10.1016/0020-0190(87)90086-X; Nodenskjold R, 2013, NEUROIMAGE, V83, P355, DOI [10.1016/j.neuroimage.2013.06.068, DOI 10.1016/J.NEUROIMAGE.2013.06.068]; Patterson, 2019, COMPUTER ARCHITECTUR; PERL Y, 1978, COMMUN ACM, V21, P550, DOI 10.1145/359545.359557; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Skiena S. S., 2010, ALGORITHM DESIGN MAN; Zheng W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134835	14	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212189	10.1371/journal.pone.0212189	http://dx.doi.org/10.1371/journal.pone.0212189			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794575	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000459709100044
J	Xiong, XW; Yu, JH; Fan, R; Zhang, CC; Xu, L; Sun, XP; Huang, YM; Wang, QZ; Ruan, HB; Qian, XL				Xiong, Xiwen; Yu, Jiahui; Fan, Rui; Zhang, Cuicui; Xu, Lin; Sun, Xupeng; Huang, Yanmei; Wang, Qingzhi; Ruan, Hai-Bin; Qian, Xinlai			NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice	PLOS ONE			English	Article							FATTY LIVER-DISEASE; SIRT1; METABOLISM; PROTECTS; MECHANISMS; INHIBITION; INSIGHTS; DELETION; ETHANOL; HEALTH	Nicotinamide phosphoribosyltransferase (NAMPT) is a rate-limiting enzyme in mammalian nicotinamide adenine dinucleotide (NAD)(+) biosynthesis. Through its NAD(+)-biosynthetic activity, NAMPT influences the activity of NAD(+)-dependent enzymes, such as sirtuins. NAMPT is able to modulate processes involved in the pathogenesis of non-alcohol induced fatty liver disease (NAFLD), but the roles NAMPT plays in development of alcoholic liver disease (ALD) still remain unknown. Here, we show that ethanol treatment suppresses the expression of Nampt in hepatocytes. Consistently, chronic ethanol administration also reduces Nampt expression in the mouse liver. We next demonstrate that hepatocytes infected with Ad-NAMPT adenovirus exhibit significantly elevated intracellular NAD(+) levels and decreased ethanol-induced triglyceride (TG) accumulation. Similarly, adenovirus-mediated overexpression of NAMPT in mice ameliorates ethanol induced hepatic steatosis. Moreover, we demonstrate that SIRT1 is required to mediate the effects of NAMPT on reduction of hepatic TG accumulation and serum ALT, AST levels in ethanol-fed mice. Our results provide important insights in targeting NAMPT for treating alcoholic fatty liver disease.	[Xiong, Xiwen; Yu, Jiahui; Sun, Xupeng; Huang, Yanmei; Wang, Qingzhi; Ruan, Hai-Bin; Qian, Xinlai] Xinxiang Med Univ, Sch Forens Med, Xinxiang, Henan, Peoples R China; [Xiong, Xiwen; Yu, Jiahui; Ruan, Hai-Bin] Xinxiang Med Univ, Xinxiang Key Lab Metab & Integrat Physiol, Xinxiang, Henan, Peoples R China; [Fan, Rui; Zhang, Cuicui] Xinxiang Med Univ, Sch Basic Med Sci, Xinxiang, Henan, Peoples R China; [Xu, Lin] Huazhong Univ Sci & Technol, Sch Basic Med, Tongji Med Coll, Dept Med Genet, Wuhan, Hubei, Peoples R China; [Ruan, Hai-Bin] Univ Minnesota, Sch Med, Dept Integrat Biol & Physiol, Minneapolis, MN 55455 USA	Xinxiang Medical University; Xinxiang Medical University; Xinxiang Medical University; Huazhong University of Science & Technology; University of Minnesota System; University of Minnesota Twin Cities	Xiong, XW; Qian, XL (corresponding author), Xinxiang Med Univ, Sch Forens Med, Xinxiang, Henan, Peoples R China.; Xiong, XW (corresponding author), Xinxiang Med Univ, Xinxiang Key Lab Metab & Integrat Physiol, Xinxiang, Henan, Peoples R China.	xiongxw@yahoo.com; qxlfssws@163.com	huang, yan/GWM-4747-2022; Xiong, Xiwen/GSN-0686-2022; Ruan, Hai-Bin/AAN-7777-2021	Ruan, Hai-Bin/0000-0002-3858-1272	Key Science and Technology Project of Xinxiang [CXGG17007]; National Natural and Science Foundation of China [81670526]; Key Science and Technology Project of Henan [182102310107]; Key Scientific Research Project of Universities in Henan [19A180005]	Key Science and Technology Project of Xinxiang; National Natural and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Science and Technology Project of Henan; Key Scientific Research Project of Universities in Henan	The present work was supported by grants from the Key Science and Technology Project of Xinxiang (CXGG17007, to X.X), National Natural and Science Foundation of China (81670526, to X.X), the Key Science and Technology Project of Henan (182102310107, to X.X), and the Key Scientific Research Project of Universities in Henan (19A180005, to X.X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bertola A, 2013, NAT PROTOC, V8, P627, DOI 10.1038/nprot.2013.032; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Celli R, 2014, J CLIN TRANSL HEPATO, V2, P103, DOI 10.14218/JCTH.2014.00010; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Choi SE, 2013, AGING CELL, V12, P1062, DOI 10.1111/acel.12135; Dahl TB, 2010, J CLIN ENDOCR METAB, V95, P3039, DOI 10.1210/jc.2009-2148; Dong X Charlie, 2012, Diabetes Manag (Lond), V2, P243; Elhassan YS, 2017, J ENDOCR SOC, V1, P816, DOI 10.1210/js.2017-00092; Etchegaray JP, 2013, CURR TOP MED CHEM, V13, P2991, DOI 10.2174/15680266113136660213; Fan R, 2018, BIOCHEM BIOPH RES CO, V500, P476, DOI 10.1016/j.bbrc.2018.04.107; Gariani K, 2017, J HEPATOL, V66, P132, DOI 10.1016/j.jhep.2016.08.024; Garten A, 2015, NAT REV ENDOCRINOL, V11, P535, DOI 10.1038/nrendo.2015.117; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang SS, 2018, J PHARMACOL EXP THER, V364, P452, DOI 10.1124/jpet.117.243105; Imai S, 2013, DIABETES OBES METAB, V15, P26, DOI 10.1111/dom.12171; Li Q, 2014, ALCOHOL CLIN EXP RES, V38, P1982, DOI 10.1111/acer.12396; Li SB, 2016, SCI REP-UK, V6, DOI 10.1038/srep26746; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V373, P246, DOI 10.1016/j.bbrc.2008.06.006; Liu JY, 2014, WORLD J GASTROENTERO, V20, P14672, DOI 10.3748/wjg.v20.i40.14672; Louvet A, 2015, NAT REV GASTRO HEPAT, V12, P231, DOI 10.1038/nrgastro.2015.35; Mukhopadhyay P, 2017, J HEPATOL, V66, P589, DOI 10.1016/j.jhep.2016.10.023; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Orman ES, 2013, J GASTROEN HEPATOL, V28, P77, DOI 10.1111/jgh.12030; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Purohit V, 2009, ALCOHOL CLIN EXP RES, V33, P191, DOI 10.1111/j.1530-0277.2008.00827.x; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rowell Rachel J, 2015, Clin Med (Lond), V15 Suppl 6, ps77, DOI 10.7861/clinmedicine.15-6-s77; Tao RY, 2011, J BIOL CHEM, V286, P14681, DOI 10.1074/jbc.M110.201061; Travelli C, 2018, PHARMACOL RES, V135, P25, DOI 10.1016/j.phrs.2018.06.022; Wang LF, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0464-z; Wang SF, 2018, REDOX BIOL, V17, P89, DOI 10.1016/j.redox.2018.04.006; Warren KR, 2013, J GASTROEN HEPATOL, V28, P4, DOI 10.1111/jgh.12246; Xiong XW, 2012, J BIOL CHEM, V287, P39107, DOI 10.1074/jbc.M112.412569; Yin HQ, 2014, GASTROENTEROLOGY, V146, P801, DOI 10.1053/j.gastro.2013.11.008; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; You M, 2015, HEPATOBIL SURG NUTR, V4, P88, DOI 10.3978/j.issn.2304-3881.2014.12.06; Zhang DQ, 2018, HEPATOLOGY, V68, P883, DOI 10.1002/hep.29878; Zhang LQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.132; Zhou CC, 2016, BRIT J PHARMACOL, V173, P2352, DOI 10.1111/bph.13513	43	8	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212523	10.1371/journal.pone.0212523	http://dx.doi.org/10.1371/journal.pone.0212523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794635	gold, Green Published, Green Submitted			2022-12-26	WOS:000459709100080
J	Blazquez, E; Rodriguez, C; Rodenas, J; Navarro, N; Riquelme, C; Rosell, R; Campbell, J; Crenshaw, J; Segales, J; Pujols, J; Polo, J				Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Navarro, Nuria; Riquelme, Cristina; Rosell, Rosa; Campbell, Joy; Crenshaw, Joe; Segales, Joaquim; Pujols, Joan; Polo, Javier			Evaluation of the effectiveness of the SurePure Turbulator ultraviolet-C irradiation equipment on inactivation of different enveloped and non-enveloped viruses inoculated in commercially collected liquid animal plasma	PLOS ONE			English	Article							PORCINE CIRCOVIRUS TYPE-2; LABILE BLOOD DERIVATIVES; EPIDEMIC DIARRHEA VIRUS; MICROBIAL INACTIVATION; EXPERIMENTAL-INFECTION; NONTHERMAL TREATMENT; UVC IRRADIATION; WEANLING PIGS; RADIATION; LIGHT	The objective of this study was to evaluate the effectiveness of the SurePure Turbulator ultraviolet-C (UV-C, 254 nm wavelength) irradiation equipment on inactivation of different enveloped and non-enveloped viruses in commercially collected liquid animal plasma. Specifically, Pseudorabies virus (PRV), Porcine reproductive and respiratory syndrome virus (PRRSV), Porcine epidemic diarrhea virus (PEDV), Bovine viral diarrhea virus (BVDV), Classical swine fever virus (CSFV), Swine influenza virus (SIV) as enveloped viruses and Porcine parvovirus (PPV), Swine vesicular disease virus (SVDV), Porcine circovirus type 2 (PCV-2) and Senecavirus A (SVA) as non-enveloped viruses, were inoculated in bovine or porcine plasma and subjected to different UV-C irradiation doses (0, 750, 1500, 3000, 6000 and 9000 J/L) using an UV-C device developed for opaque liquid working under turbulent flow. The enveloped viruses tested were inactivated at < 3000 J/L of UV-C, being the dose needed to inactivate 4 log TCID50 (4D) of 1612 J/L for PRV, 1004 J/L for PRRSV, 1953 J/L for PEDV, 1639 J/L for SIV, 1641 J/L for CSFV and 1943 J/L for BVDV. The non-enveloped viruses tended to have higher 4D values: 2161 J/L for PPV, 3223 J/L for SVA and 3708 J/L for SVDV. Because the initial viral concentration was < 4.0 Log for PCV-2, it was not possible to calculate the 4D value for this virus. In conclusion, these results demonstrated that the SurePure Turbulator UV-C treatment system is capable of inactivating significant levels of swine viruses inoculated in commercially collected porcine or bovine plasma. It was concluded that irradiation with UV-C can provide an additional redundant biosafety feature in the manufacturing process of spray-dried animal plasma.	[Blazquez, Elena; Rodriguez, Carmen; Rodenas, Jesus; Polo, Javier] SLU Pol Ind El Congost, APC EUROPE, Granollers, Spain; [Blazquez, Elena; Navarro, Nuria; Riquelme, Cristina; Segales, Joaquim; Pujols, Joan] UAB, IRTA, CReSA, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Rosell, Rosa] Generalitat Catalunya, Dept Agr Ramaderia Pesca & Alimentacio DARP, Campus Univ Autonoma Barcelona, Barcelona, Spain; [Campbell, Joy; Crenshaw, Joe; Polo, Javier] APC Inc, Ankeny, IA 50021 USA; [Segales, Joaquim] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, Barcelona, Spain	Autonomous University of Barcelona; IRTA; Autonomous University of Barcelona; Autonomous University of Barcelona	Polo, J (corresponding author), SLU Pol Ind El Congost, APC EUROPE, Granollers, Spain.; Polo, J (corresponding author), APC Inc, Ankeny, IA 50021 USA.	Javier.polo@apc-europe.com	Pujols, Joan/AAV-6427-2020; Segalés, Joaquim/A-4933-2011; Segalés, Joaquim/AAB-4815-2020	Pujols, Joan/0000-0002-6940-1529; Segalés, Joaquim/0000-0002-1539-7261; Segalés, Joaquim/0000-0002-1539-7261; Rosell, Rosa/0000-0002-8294-1159; Crenshaw, Joe/0000-0002-6704-9373; Blazquez Salvador, Elena/0000-0001-8115-3225	Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya [2014 DI 066]; APC EUROPE	Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya; APC EUROPE	This study was partly supported by Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya. Author who received the award: EB. Grant number: 2014 DI 066. Full name of funder: Secretaria de Universitats i Recerca del Departament d'Economia i Coneixement of the Generalitat de Catalunya. URL funder website: universitatsirecerca. gencat. cat/ca/inici. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. APC EUROPE provided support in the form of salaries for authors EB, CR, JR and JPolo retrospectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini F, 2015, J FOOD ENG, V162, P63, DOI 10.1016/j.jfoodeng.2015.04.009; Albert I, 2005, INT J FOOD MICROBIOL, V100, P197, DOI 10.1016/j.ijfoodmicro.2004.10.016; Baratelli M, 2014, RES VET SCI, V96, P380, DOI 10.1016/j.rvsc.2013.12.006; Blazquez E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175289; Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x; Campbell JM, 2006, J APPL POULTRY RES, V15, P584, DOI 10.1093/japr/15.4.584; Campbell JM, 2004, J APPL POULTRY RES, V13, P388, DOI 10.1093/japr/13.3.388; CERF O, 1977, J APPL BACTERIOL, V42, P1, DOI 10.1111/j.1365-2672.1977.tb00665.x; Chan HL, 2006, FEBS LETT, V580, P3229, DOI 10.1016/j.febslet.2006.05.002; Cottingim KM, 2017, J ANIM SCI, V95, P3120, DOI 10.2527/jas.2017.1486; Crook JA, 2015, FOODBORNE PATHOG DIS, V12, P506, DOI 10.1089/fpd.2014.1843; Cutler T, 2011, J APPL MICROBIOL, V111, P389, DOI 10.1111/j.1365-2672.2011.05046.x; DEBOUCK P, 1980, AM J VET RES, V41, P219; Dee S, 2011, VET MICROBIOL, V150, P96, DOI 10.1016/j.vetmic.2011.01.014; Diaz I, 2005, J GEN VIROL, V86, P1943, DOI 10.1099/vir.0.80959-0; Donaghy J, 2009, LETT APPL MICROBIOL, V49, P217, DOI 10.1111/j.1472-765X.2009.02644.x; Fort M, 2010, VET IMMUNOL IMMUNOP, V137, P226, DOI 10.1016/j.vetimm.2010.05.013; Fredericks IN, 2011, FOOD MICROBIOL, V28, P510, DOI 10.1016/j.fm.2010.10.018; FREEMAN AG, 1987, MUTAT RES, V184, P187, DOI 10.1016/0167-8817(87)90016-2; Geeraerd AH, 2000, INT J FOOD MICROBIOL, V59, P185, DOI 10.1016/S0168-1605(00)00362-7; Geeraerd AH, 2005, INT J FOOD MICROBIOL, V102, P95, DOI 10.1016/j.ijfoodmicro.2004.11.038; Gerber PF, 2014, VET MICROBIOL, V174, P86, DOI 10.1016/j.vetmic.2014.09.008; Groenewald WH, 2013, J NEW GENER SCI, V11, P19; Guerrero-Beltran JA, 2004, FOOD SCI TECHNOL INT, V10, P137, DOI 10.1177/1082013204044359; Hijnen WAM, 2006, WATER RES, V40, P3, DOI 10.1016/j.watres.2005.10.030; HOROWITZ B, 1985, TRANSFUSION, V25, P516, DOI 10.1046/j.1537-2995.1985.25686071422.x; HOROWITZ B, 1988, VOX SANG, V54, P14, DOI 10.1111/j.1423-0410.1988.tb01606.x; Jagger J., 1967, INTRO RES ULTRAVIOLE; KASZA L, 1972, RES VET SCI, V13, P46; Keil SD, 2015, TRANSFUSION, V55, P1736, DOI 10.1111/trf.13030; Keyser M, 2008, INNOV FOOD SCI EMERG, V9, P348, DOI 10.1016/j.ifset.2007.09.002; Korneyeva M, 2002, BIOLOGICALS, V30, P153, DOI 10.1006/biol.2002.0334; Koutchma T, 2009, FOOD BIOPROCESS TECH, V2, P138, DOI 10.1007/s11947-008-0178-3; Lin CH, 2012, J HAZARD MATER, V209, P348, DOI 10.1016/j.jhazmat.2012.01.029; LUNDBLAD JL, 1991, VOX SANG, V60, P75, DOI 10.1111/j.1423-0410.1991.tb00878.x; LYTLE CD, 1972, INT J RADIAT BIOL RE, V22, P159, DOI 10.1080/716100000; Lytle CD, 2005, J VIROL, V79, P14244, DOI 10.1128/JVI.79.22.14244-14252.2005; Mafart P, 2002, INT J FOOD MICROBIOL, V72, P107, DOI 10.1016/S0168-1605(01)00624-9; MCFERRAN JB, 1979, COMP IMMUNOL MICROB, V2, P327, DOI 10.1016/0147-9571(79)90020-1; Meunier SM, 2017, J IND MICROBIOL BIOT, V44, P893, DOI 10.1007/s10295-017-1917-0; Opriessnig T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104766; Orlowska M, 2015, FOOD CONTROL, V47, P647, DOI 10.1016/j.foodcont.2014.08.004; Perez-Bosque A, 2016, PORCINE HEALTH MANAG, V2, DOI 10.1186/s40813-016-0034-1; Phukan T, 2018, ECOTOX ENVIRON SAFE, V155, P171, DOI 10.1016/j.ecoenv.2018.02.066; Polo J, 2005, J ANIM SCI, V83, P1933; Polo J, 2002, BACTERICIDAL EFFECT, V1; Polo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133008; Pujols J, 2008, VET REC, V163, P536, DOI 10.1136/vr.163.18.536; Pujols J, 2007, AM ASS SWINE VET, P281; Pujols J, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0232-x; Pujols J, 2014, VET MICROBIOL, V174, P427, DOI 10.1016/j.vetmic.2014.10.021; Pujols Joan, 2011, Vet J, V190, pe16, DOI 10.1016/j.tvjl.2011.02.021; RAUTH AM, 1965, BIOPHYS J, V5, P257, DOI 10.1016/S0006-3495(65)86715-7; Rodriguez-Arrioja GM, 2002, AM J VET RES, V63, P354, DOI 10.2460/ajvr.2002.63.354; Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Simmons MJH, 2012, INNOV FOOD SCI EMERG, V14, P122, DOI 10.1016/j.ifset.2011.11.006; Srinivasan V, 2001, J VIROL, V75, P1681, DOI 10.1128/JVI.75.4.1681-1688.2001; Torrallardona D, 2010, ASIAN AUSTRAL J ANIM, V23, P131; W.H. Organization, 2004, WHO TECHNICAL REPORT, V924, P150; Wang J, 2004, VOX SANG, V86, P230, DOI 10.1111/j.0042-9007.2004.00485.x	61	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212332	10.1371/journal.pone.0212332	http://dx.doi.org/10.1371/journal.pone.0212332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789926	Green Published, Green Submitted, gold			2022-12-26	WOS:000459330800024
J	Lang, SN; Germerodt, S; Glock, C; Skerka, C; Zipfel, PF; Schuster, S				Lang, Stefan N.; Germerodt, Sebastian; Glock, Christina; Skerka, Christine; Zipfel, Peter F.; Schuster, Stefan			Molecular crypsis by pathogenic fungi using human factor H. A numerical model	PLOS ONE			English	Article							CANDIDA-ALBICANS; COMPLEMENT REGULATORS; BORRELIA-BURGDORFERI; IMMUNE EVASION; MIMICRY; HOST; PARASITE; SYSTEM; CONSEQUENCES; COEVOLUTION	Molecular mimicry is the formation of specific molecules by microbial pathogens to avoid recognition and attack by the immune system of the host. Several pathogenic Ascomycota and Zygomycota show such a behaviour by utilizing human complement factor H to hide in the blood stream. We call this type of mimicry molecular crypsis. Such a crypsis can reach a point where the immune system can no longer clearly distinguish between self and non-self cells. Thus, a trade-off between attacking disguised pathogens and erroneously attacking host cells has to be made. Based on signalling theory and protein-interaction modelling, we here present a mathematical model of molecular crypsis of pathogenic fungi using the example of Candida albicans. We tackle the question whether perfect crypsis is feasible, which would imply that protection of human cells by complement factors would be useless. The model identifies pathogen abundance relative to host cell abundance as the predominant factor influencing successful or unsuccessful molecular crypsis. If pathogen cells gain a (locally) quantitative advantage over host cells, even autoreactivity may occur. Our new model enables insights into the mechanisms of candidiasis-induced sepsis and complement-associated autoimmune diseases.	[Lang, Stefan N.; Germerodt, Sebastian; Glock, Christina; Schuster, Stefan] Friedrich Schiller Univ Jena, Dept Bioinformat, Jena, Germany; [Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Jena, Germany; [Zipfel, Peter F.] Friedrich Schiller Univ Jena, Inst Microbiol, Jena, Germany	Friedrich Schiller University of Jena; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Schuster, S (corresponding author), Friedrich Schiller Univ Jena, Dept Bioinformat, Jena, Germany.	stefan.schu@uni-jena.de			German Research Foundation (DFG) within the Jena School for Microbial Communication [DFG-GSC 214/2]; German Research Foundation (DFG) [Transregio 124]	German Research Foundation (DFG) within the Jena School for Microbial Communication; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the Jena School for Microbial Communication (grant no. DFG-GSC 214/2) and the Transregio 124 (FungiNet, projects B1, C4 and C6).; Financial support by the German Research Foundation (DFG) within the Jena School for Microbial Communication (grant no. DFG-GSC 214/2) and the Transregio 124 (FungiNet, projects B1, C4 and C6) is gratefully acknowledged.	ANDERSON RM, 1982, PARASITOLOGY, V85, P411, DOI 10.1017/S0031182000055360; Arnold DV, 2002, IEEE T EVOLUT COMPUT, V6, P30, DOI [10.1109/4235.985690, 10.1023/A:1015059928466]; Becker DJ, 2018, J ANIM ECOL, V87, P511, DOI 10.1111/1365-2656.12765; Blank M, 2007, CLIN REV ALLERG IMMU, V32, P111; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Brockhurst MA, 2013, TRENDS ECOL EVOL, V28, P367, DOI 10.1016/j.tree.2013.02.009; *CDCP, 2001, NAT HLTH NUTR EX SUR; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8293-8, 10.1007/s12016-011-8294-7]; DAMIAN RT, 1989, CURR TOP MICROBIOL, V145, P101; DAMIAN RT, 1964, AM NAT, V98, P129, DOI 10.1086/282313; DITTRICH W, 1993, P ROY SOC B-BIOL SCI, V251, P195, DOI 10.1098/rspb.1993.0029; Duhring S, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0095; Duhring S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00625; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haupt K, 2007, J INFECT DIS, V196, P124, DOI 10.1086/518509; Hellwage J, 2001, J BIOL CHEM, V276, P8427, DOI 10.1074/jbc.M007994200; Holen OH, 2006, AM NAT, V167, P377, DOI 10.1086/499567; Holen OH, 2004, AM NAT, V164, P598, DOI 10.1086/424972; Hoops S, 2006, BIOINFORMATICS, V22, P3067, DOI 10.1093/bioinformatics/btl485; HUHEEY J E, 1988, American Naturalist, V131, pS22, DOI 10.1086/284765; HUHEEY JE, 1976, EVOLUTION, V30, P86, DOI 10.1111/j.1558-5646.1976.tb00884.x; Hummert S, 2017, PLAYING HIDE AND SEE; Hummert S, 2014, MOL BIOSYST, V10, P3044, DOI 10.1039/c3mb70602h; Jacob A, 2010, J NEUROIMMUNOL, V221, P46, DOI 10.1016/j.jneuroim.2010.02.011; Korotaevskiy AA, 2009, MATH BIOSCI, V222, P127, DOI 10.1016/j.mbs.2009.10.003; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lan CY, 2002, P NATL ACAD SCI USA, V99, P14907, DOI 10.1073/pnas.232566499; Liu B, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001059; Lively CM, 2000, NATURE, V405, P679, DOI 10.1038/35015069; Markiewski MM, 2008, J CELL MOL MED, V12, P2245, DOI 10.1111/j.1582-4934.2008.00504.x; Meri T, 2002, INFECT IMMUN, V70, P5185, DOI 10.1128/IAI.70.9.5185-5192.2002; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; PANGBURN MK, 1984, SPRINGER SEMIN IMMUN, V7, P163, DOI 10.1007/BF01893019; PASTEUR G, 1982, ANNU REV ECOL SYST, V13, P169, DOI 10.1146/annurev.es.13.110182.001125; Perkins SJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00126; PRIES AR, 1992, AM J PHYSIOL, V263, pH1770, DOI 10.1152/ajpheart.1992.263.6.H1770; Sasse C, 2013, EUKARYOT CELL, V12, P50, DOI 10.1128/EC.00266-12; Schaller M, 2003, INFECT IMMUN, V71, P3227, DOI 10.1128/IAI.71.6.3227-3234.2003; Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407; SIM RB, 1981, BIOCHEM J, V193, P115, DOI 10.1042/bj1930115; SLUTSKY B, 1987, J BACTERIOL, V169, P189, DOI 10.1128/JB.169.1.189-197.1987; Soll DR, 2009, FEMS YEAST RES, V9, P973, DOI 10.1111/j.1567-1364.2009.00562.x; Soloviev DA, 2011, INFECT IMMUN, V79, P1546, DOI 10.1128/IAI.00650-10; Speed MP, 2010, AM NAT, V176, pE1, DOI 10.1086/652990; SPEED MP, 1993, ANIM BEHAV, V45, P571, DOI 10.1006/anbe.1993.1067; Spellberg B, 2005, J INFECT DIS, V192, P336, DOI 10.1086/430952; STONE HH, 1974, ANN SURG, V179, P697, DOI 10.1097/00000658-197405000-00024; Tsonis PA, 2008, BBA-MOL CELL RES, V1783, P177, DOI 10.1016/j.bbamcr.2007.11.001; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; VANEWRIGHT RI, 1976, BIOL J LINN SOC, V8, P25, DOI 10.1111/j.1095-8312.1976.tb00240.x; Wiley R. Haven, 1994, P157; Wooster DG, 2006, IMMUNOLOGY, V117, P482, DOI 10.1111/j.1365-2567.2006.02323.x; Yanes RE, 2017, SEMIN HEMATOL, V54, P33, DOI 10.1053/j.seminhematol.2016.10.003; ZABKA H, 1986, BEHAV PROCESS, V13, P159, DOI 10.1016/0376-6357(86)90023-9; Zewde N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152337; Zipfel PF, 2013, MOL IMMUNOL, V56, P152, DOI 10.1016/j.molimm.2013.05.222; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2015, COMPLEMENT ALTERNATI; Zuckmayer C, 1932, CAPTAIN KOPENICK MOD	62	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0212187	10.1371/journal.pone.0212187	http://dx.doi.org/10.1371/journal.pone.0212187			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779817	Green Submitted, Green Published, gold			2022-12-26	WOS:000459062900031
J	Wang, ZQ; Cai, M; Wei, L; Tay, R; Zhang, F; Wu, P; Huynh, A; Cao, XM; Di Paolo, G; Peng, JM; Milewicz, DM; Du, GW				Wang, Ziqing; Cai, Ming; Wei, Li; Tay, Rachel; Zhang, Feng; Wu, Ping; Huynh, Anh; Cao, Xiumei; Di Paolo, Gilbert; Peng, Junmin; Milewicz, Dianna M.; Du, Guangwei			Phosphatidic acid generated by PLD2 promotes the plasma membrane recruitment of IQGAP1 and neointima formation	FASEB JOURNAL			English	Article						phospholipase D; PA; VSMC; migration	MUSCLE-CELL-MIGRATION; PHOSPHOLIPASE-D; GROWTH-FACTOR; BINDING; ACTIVATION; ATHEROSCLEROSIS; MECHANISMS; SIGNAL; RHO; PHOSPHORYLATION	Very little is known about how lipid signaling regulates intima hyperplasia after vascular injury. Herein, we report that deletion and pharmacological inhibition of phospholipase D (PLD)2, which generates the signaling lipid phosphatidic acid (PA), reduced neointimal formation in the mouse carotid artery ligation model. PLD2 deficiency inhibits migration of vascular smooth muscle cells (VSMCs) into the intima in mice as well as migration and formation of membrane ruffles in primary VSMCs. PA specifically binds to the IQ motif-containing guanosine triphosphatase-activating protein 1 (IQGAP1) scaffold protein. The binding between PA and IQGAP is required for the plasma membrane recruitment of IQGAP1. Similar to PLD2 inhibition, knockdown of IQGAP1 blocks ruffle formation and migration in VSMCs, which are rescued by expression of the exogenous IQGAP1 but not the PA binding-deficient mutant. These data reveal that the PLD2-PA-IQGAP1 pathway plays an important role in VSMC migration and injury-induced vascular remodeling, and implicate PLD2 as a candidate target for therapeutic interventions.-Wang, Z., Cai, M., Tay, L. W. R., Zhang, F., Wu, P., Huynh, A., Cao, X., Di Paolo, G., Peng, J., Milewicz, D. M., Du, G. Phosphatidic acid generated by PLD2 promotes the plasma membrane recruitment of IQGAP1 and neointima formation.	[Wang, Ziqing; Cai, Ming; Wei, Li; Tay, Rachel; Zhang, Feng; Wu, Ping; Huynh, Anh; Cao, Xiumei; Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA; [Milewicz, Dianna M.] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; [Cai, Ming] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Gastrointestinal Surg, Union Hosp, Wuhan, Hubei, Peoples R China; [Di Paolo, Gilbert] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Peng, Junmin] St Jude Childrens Res Hosp, Ctr Prote & Metabol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Zhang, Feng] Quzhou Peoples Hosp, Quzhou, Peoples R China; [Di Paolo, Gilbert] Denali Therapeut, San Francisco, CA USA	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Huazhong University of Science & Technology; Columbia University; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Du, GW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	guangwei.du@uth.tmc.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Du, Guangwei/0000-0003-4193-6975	U.S. National Institutes of Health (NIH) National Heath, Lung, and Blood Institute [R01HL119478]; NIH, National Institute of General Medical Sciences [R01GM114260]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119478] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114260] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heath, Lung, and Blood Institute; NIH, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for IQ motif-containing guanosine triphosphatase (GTPase)-activating protein 1 (IQGAP1) constructs from Drs. Kozo Kabuchi (Nagoya University, Nagoya, Japan [glutathione S-transferase (GST)-N, M, Ras GTPase-activating protein related domain, C, and green fluorescent protein-tagged IQGAP1), Richard A. Anderson (University of Wisconsin-Madison, Madison, WI, USA) (His-C2), and Ruth Kroschewski (ETH Zurich, Zurich, Switzerland) (GST-C1). The authors also thank Dr. Suyoung Choi (University of Wisconsin-Madison) for advice on purifying GST-C1. Confocal microscopy was performed at the Center for Advanced Microscopy, Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston (UTHealth). This work was supported by grants from the U.S. National Institutes of Health (NIH) National Heath, Lung, and Blood Institute (R01HL119478, to G.D.) and the NIH, National Institute of General Medical Sciences (R01GM114260, to J.P.). The authors declare no conflicts of interest.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENDECK MP, 1994, CIRC RES, V75, P539, DOI 10.1161/01.RES.75.3.539; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; BURSTEN SL, 1992, AM J PHYSIOL, V262, pC328, DOI 10.1152/ajpcell.1992.262.2.C328; Chen Q, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003257; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Choi Suyong, 2015, Advances in Biological Regulation, V60, P29, DOI 10.1016/j.jbior.2015.10.004; Choi S, 2013, EMBO J, V32, P2617, DOI 10.1038/emboj.2013.191; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Du GW, 2000, MOL BIOL CELL, V11, P4359, DOI 10.1091/mbc.11.12.4359; Gerthoffer WT, 2007, CIRC RES, V100, P607, DOI 10.1161/01.RES.0000258492.96097.47; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Goicoechea S, 2006, J CELL SCI, V119, P3316, DOI 10.1242/jcs.03076; Golovina VA, 2006, NAT PROTOC, V1, P2681, DOI 10.1038/nprot.2006.425; Gomez-Cambronero J, 2014, J BIOL CHEM, V289, P22557, DOI 10.1074/jbc.R114.574152; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; He JQ, 2017, FASEB J, V31, P2893, DOI 10.1096/fj.201601353R; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Henkels KM, 2013, ONCOGENE, V32, P5551, DOI 10.1038/onc.2013.207; Hoon JL, 2012, MOL CELL BIOL, V32, P4246, DOI 10.1128/MCB.00551-12; INUI H, 1994, J BIOL CHEM, V269, P30546; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jiang W, 2015, SCI REP-UK, V5, DOI 10.1038/srep13875; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Kohno T, 2013, AM J PHYSIOL-CELL PH, V305, pC591, DOI 10.1152/ajpcell.00011.2013; Ktistakis NT, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3151pe46; Kuhel DG, 2002, ARTERIOSCL THROM VAS, V22, P955, DOI 10.1161/01.ATV.0000017994.77066.75; Langenickel TH, 2008, J CLIN INVEST, V118, P3848, DOI 10.1172/JCI33206; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Mahankali M, 2011, P NATL ACAD SCI USA, V108, P19617, DOI 10.1073/pnas.1114692108; Monovich L, 2007, BIOORG MED CHEM LETT, V17, P2310, DOI 10.1016/j.bmcl.2007.01.059; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Oliveira TG, 2010, J NEUROSCI, V30, P16419, DOI 10.1523/JNEUROSCI.3317-10.2010; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.bi.59.070190.001021; Raghu P, 2009, BBA-MOL CELL BIOL L, V1791, P889, DOI 10.1016/j.bbalip.2009.03.013; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Schwartz SM, 1997, J CLIN INVEST, V99, P2814, DOI 10.1172/JCI119472; Sciorra VA, 1999, EMBO J, V18, P5911, DOI 10.1093/emboj/18.21.5911; Scott SA, 2009, NAT CHEM BIOL, V5, P108, DOI 10.1038/nchembio.140; Selvy PE, 2011, CHEM REV, V111, P6064, DOI 10.1021/cr200296t; Shome K, 2000, ENDOCRINOLOGY, V141, P2200, DOI 10.1210/en.141.6.2200; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Tang ZH, 2008, CIRCULATION, V118, P764, DOI 10.1161/CIRCULATIONAHA.107.761932; Tay LWR, 2017, METHOD ENZYMOL, V583, P359, DOI 10.1016/bs.mie.2016.09.043; Touyz RM, 1999, HYPERTENSION, V34, P976, DOI 10.1161/01.HYP.34.4.976; Wang ZQ, 2017, DEV CELL, V43, P186, DOI 10.1016/j.devcel.2017.09.012; Watanabe T, 2015, CELL STRUCT FUNCT, V40, DOI 10.1247/csf.15003; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13; Zhang LN, 2008, CURR VASC PHARMACOL, V6, P37, DOI 10.2174/157016108783331321; Zhang YQ, 2009, BBA-MOL CELL BIOL L, V1791, P850, DOI 10.1016/j.bbalip.2009.05.013	58	6	6	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2019	33	6					6713	6725		10.1096/fj.201800390RR	http://dx.doi.org/10.1096/fj.201800390RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	IJ7YD	30811216	Bronze, Green Published			2022-12-26	WOS:000476114200004
J	Li, LS; Baxter, SS; Zhao, P; Gu, N; Zhan, X				Li, Lushen; Baxter, Shaneen S.; Zhao, Peng; Gu, Ning; Zhan, Xi			Differential interactions of missing in metastasis and insulin receptor tyrosine kinase substrate with RAB proteins in the endocytosis of CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endocytosis; Rab; chemotaxis; chemokine; C-X-C chemokine receptor type 4 (CXCR-4); cell signaling; endosome; insulin receptor tyrosine kinase substrate (IRTKS); missing in metastasis (MIM); RAB11; RAB7; SH3	IN-METASTASIS; BAR DOMAINS; MEMBRANE; IRTKS; MIM; IRSP53; TRAFFICKING; EXPRESSION; ENDOSOMES; CELLS	Missing in metastasis (MIM), an inverse Bin-Amphiphysin-Rvs (I-BAR) domain protein, promotes endocytosis of C-X-C chemokine receptor 4 (CXCR4) in mammalian cells. In response to the CXCR4 ligand stromal cell-derived factor 1 (SDF-1 or CXCL12), MIM associates with RAS-related GTP-binding protein 7 (RAB7) 30 min after stimulation. However, RAB7's role in MIM function remains undefined. Here we show that RNAi-mediated suppression of RAB7 expression in human HeLa cells has little effect on the binding of MIM to RAB5 and on the recruitment of CXCR4 to early endosomes but effectively abolishes MIM-mediated CXCR4 degradation, chemotactic response, and sorting into late endosomes and lysosomes. To determine whether I-BAR domain proteins interact with RAB7, we examined cells expressing insulin receptor tyrosine kinase substrate (IRTKS), an I-BAR domain protein bearing an Src homology 3 (SH3) domain. We observed that both MIM and IRTKS interact with RAB5 at an early response to SDF-1 and that IRTKS binds poorly to RAB7 but strongly to RAB11 at a later time point. Moreover, IRTKS overexpression reduced CXCR4 internalization and enhanced the chemotactic response to SDF-1. Interestingly, deletion of the SH3 domain in IRTKS abolished the IRTKS-RAB11 interaction and promoted CXCR4 degradation. Furthermore, the SH3 domain was required for selective targeting of MIM-IRTKS fusion proteins by both RAB7 and RAB11. Hence, to the best of our knowledge, our results provide first evidence that the SH3 domain is critical in the regulation of specific endocytic pathways by I-BAR domain proteins.	[Li, Lushen; Baxter, Shaneen S.; Zhan, Xi] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Zhan, Xi] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhan, Xi] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Zhao, Peng; Gu, Ning] Southeast Univ, Sch Biol Sci & Med Engn, Jiangsu Key Lab Biomat & Devices, State Key Lab Bioelect, Nanjing 210096, Jiangsu, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Southeast University - China	Zhan, X (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.; Zhan, X (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Zhan, X (corresponding author), Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA.	xzhan@som.umaryland.edu		Li, lushen/0000-0002-6701-7937	NCI, National Institutes of Health [R01 CA113809]; National Natural Science Foundation of China [61420106012]; NATIONAL CANCER INSTITUTE [R01CA113809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055036] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NCI, National Institutes of Health Grant R01 CA113809 (to X.Z.) and National Natural Science Foundation of China for Key Project of International Cooperation Grant 61420106012 (to N.G). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Brown AS, 2018, P NATL ACAD SCI USA, V115, pE12407, DOI 10.1073/pnas.1816177115; Chou AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40485; Dawson JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031141; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Duleh SN, 2010, CYTOSKELETON, V67, P193, DOI 10.1002/cm.20437; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Goh WI, 2011, J BIOL CHEM, V286, P13681, DOI 10.1074/jbc.M110.182683; Itoh Y, 2016, CELL STRUCT FUNCT, V41, P1, DOI 10.1247/csf.15014; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; Lazar T, 2002, EUR J CELL BIOL, V81, P635, DOI 10.1078/0171-9335-00290; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Li LS, 2017, J CELL SCI, V130, P1475, DOI 10.1242/jcs.198937; Li LS, 2016, BIOCHEM BIOPH RES CO, V479, P787, DOI 10.1016/j.bbrc.2016.09.131; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Numrich J, 2015, J CELL SCI, V128, P2278, DOI 10.1242/jcs.164905; Oikawa Tsukasa, 2012, Commun Integr Biol, V5, P511, DOI 10.4161/cib.21252; Oikawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060528; Patel A, 2012, EUR J CELL BIOL, V91, P171, DOI 10.1016/j.ejcb.2011.11.006; Quinones GA, 2010, J CELL BIOL, V189, P353, DOI 10.1083/jcb.200910136; Saarikangas J, 2015, DEV CELL, V33, P644, DOI 10.1016/j.devcel.2015.04.014; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Sakaguchi Aisa, 2016, Commun Integr Biol, V9, pe1208325, DOI 10.1080/19420889.2016.1208325; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Sudhaharan T, 2016, J CELL SCI, V129, P2829, DOI 10.1242/jcs.179655; Vanlandingham PA, 2009, J BIOL CHEM, V284, P12110, DOI 10.1074/jbc.M809277200; Veltman DM, 2011, BIOCHEM J, V436, P45, DOI 10.1042/BJ20101684; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Wild PS, 2017, J CLIN INVEST, V127, P1798, DOI 10.1172/JCI84840; Xia S, 2010, DEVELOPMENT, V137, P1075, DOI 10.1242/dev.049437; Yu D, 2012, ONCOGENE, V31, P3561, DOI 10.1038/onc.2011.509; Zhan T, 2016, LEUKEMIA, V30, P1327, DOI 10.1038/leu.2016.39; Zhao HX, 2011, CURR OPIN CELL BIOL, V23, P14, DOI 10.1016/j.ceb.2010.10.005; Zheng DT, 2010, BIOCHEM BIOPH RES CO, V401, P527, DOI 10.1016/j.bbrc.2010.09.087; Zhi D., 2012, Frontiers in Genetics, V3, P92, DOI 10.3389/fgene.2012.00092; Zimmerberg J, 2004, CURR BIOL, V14, pR250, DOI 10.1016/j.cub.2004.02.060	40	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6494	6505		10.1074/jbc.RA118.006071	http://dx.doi.org/10.1074/jbc.RA118.006071			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30808710	Green Published, hybrid			2022-12-26	WOS:000468402000025
J	Douma, LN; Uiters, E; Timmermans, DRM				Douma, Linda N.; Uiters, Ellen; Timmermans, Danielle R. M.			Do people with a different goal-orientation or specific focus make different decisions about colorectal cancer-screening participation?	PLOS ONE			English	Article							REGULATORY FOCUS; SELF-REGULATION; BOWEL-CANCER; SINGLE-ITEM; VALUES; ADULTS; BEHAVIORS; KNOWLEDGE; ATTITUDES; BELIEFS	Objective Previous studies have shown that having promotion-oriented goals (e.g. wanting to become healthy) or prevention-oriented goals (e.g. wanting to avoid getting ill) can affect people's health-related decisions and behaviour by emphasising aspects and information that seem relevant in light of what they want to achieve. However, this issue has not yet been researched regarding colorectal cancer (CRC) screening. With our study, we aimed to examine the relationship between people's goal-orientation or focus on advantages or disadvantages and their CRC screening participation, as this could provide insights for supporting people in making this complex decision. Methods An online survey was carried out among a sample of first-time CRC screening invitees (1282 respondents, response rate 49%). We assessed people's goal-orientation (i.e. promotion-orientation and prevention-orientation), focus on the advantages or disadvantages of CRC screening, screening participation and main considerations (e.g. cancer is a serious illness) concerning their screening decision. Results Generally, CRC screening participants scored higher on both promotion-orientation and prevention-orientation than non-participants. Both CRC screening participation and non-participation were not associated with a dominant goal-orientation. CRC screening participants did show a dominant focus on the advantages of CRC screening. Mediation analysis showed support for our premise that the relationship between people's goal-orientation or focus on advantages or disadvantages and their screening participation could be (partially) mediated by people's main considerations concerning CRC screening. Conclusion CRC screening participants and non-participants differed in their goal-orientation and focus on advantages or disadvantages. CRC screening participation appears to be associated with a focus on the advantages of CRC screening, which could impede the making of an informed decision. CRC screening non-participation appears not to be associated with any clear goal-orientation or focus, or we have not yet managed to capture this, which could be either beneficial or problematic for making an informed decision.	[Douma, Linda N.; Timmermans, Danielle R. M.] Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Boechorststr 7, Amsterdam, Netherlands; [Douma, Linda N.; Uiters, Ellen; Timmermans, Danielle R. M.] Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Netherlands National Institute for Public Health & the Environment	Douma, LN (corresponding author), Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Boechorststr 7, Amsterdam, Netherlands.; Douma, LN (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands.	l.douma@vumc.nl			Strategic Programme of the National Institute for Public Health and the Environment (RIVM)	Strategic Programme of the National Institute for Public Health and the Environment (RIVM)	This research was funded by the Strategic Programme of the National Institute for Public Health and the Environment (RIVM).	Allport F. H, 1955, THEORIES PERCEPTION; Avraham R, 2016, PSYCHOL HEALTH MED, V21, P696, DOI 10.1080/13548506.2015.1112413; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bergvik S, 2010, J HEALTH PSYCHOL, V15, P915, DOI 10.1177/1359105309359542; Beydoun HA, 2008, CANCER CAUSE CONTROL, V19, P339, DOI 10.1007/s10552-007-9100-y; Brodscholl JC, 2007, EUR J SOC PSYCHOL, V37, P628, DOI 10.1002/ejsp.380; Denters M. J., 2013, HLTH EXPECTATIONS, V18, P839, DOI DOI 10.1111/HEX.12056; Diamantopoulos A, 2012, J ACAD MARKET SCI, V40, P434, DOI 10.1007/s11747-011-0300-3; Eccles JS, 2002, ANNU REV PSYCHOL, V53, P109, DOI 10.1146/annurev.psych.53.100901.135153; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Fuglestad PT, 2015, AM J HEALTH BEHAV, V39, P709, DOI 10.5993/AJHB.39.5.12; Hall NJ, 2015, HEALTH EXPECT, V18, P1645, DOI 10.1111/hex.12157; Higgins ET, 2000, AM PSYCHOL, V55, P1217, DOI 10.1037/0003-066X.55.11.1217; Higgins ET, 1997, AM PSYCHOL, V52, P1280, DOI 10.1037/0003-066X.52.12.1280; Higgins ET, 2002, J CONSUM PSYCHOL, V12, P177, DOI 10.1207/S15327663JCP1203_01; Hoeppner BB, 2011, J SUBST ABUSE TREAT, V41, P305, DOI 10.1016/j.jsat.2011.04.005; Hoffman RM, 2016, PATIENT EDUC COUNS, V99, P624, DOI 10.1016/j.pec.2015.11.001; Irwig L, 2006, BMJ-BRIT MED J, V332, P1148, DOI 10.1136/bmj.332.7550.1148; Jepson RG, 2007, SOC SCI MED, V65, P890, DOI 10.1016/j.socscimed.2007.04.009; Johansson M, 2015, LANCET, V385, P1597, DOI 10.1016/S0140-6736(15)60258-6; Kim YJ, 2006, J ADVERTISING, V35, P143, DOI 10.2753/JOA0091-3367350109; Kunda Z., 1999, SOCIAL COGNITION MAK; Leder S, 2015, PSYCHOL HEALTH, V30, P165, DOI 10.1080/08870446.2014.954574; Lee AY, 2004, J PERS SOC PSYCHOL, V86, P205, DOI 10.1037/0022-3514.86.2.205; Leerdam MEv, 2016, LANDELIJKE MONITORIN; Lockwood P, 2002, J PERS SOC PSYCHOL, V83, P854, DOI 10.1037//0022-3514.83.4.854; MacKinnon DP, 2007, ANNU REV PSYCHOL, V58, P593, DOI 10.1146/annurev.psych.58.110405.085542; Marteau T M, 2001, Health Expect, V4, P99, DOI 10.1046/j.1369-6513.2001.00140.x; McCaffery K, 2003, PREV MED, V36, P525, DOI 10.1016/S0091-7435(03)00016-1; McCaffery K, 2001, SOC SCI MED, V53, P679, DOI 10.1016/S0277-9536(00)00375-0; Miller SM, 1996, PSYCHOL BULL, V119, P70, DOI 10.1037/0033-2909.119.1.70; O'Connor A., 1989, NURSING DIAGNOSIS IN, P486; Pardo A, REFLECTIONS BARON KE; Peters E, 2010, MARKET CONSUM PSYCH, P75; Pfattheicher S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01314; Pitts SBJ, 2013, J RURAL HEALTH, V29, P78, DOI 10.1111/j.1748-0361.2012.00424.x; Rimer BK, 2004, CANCER-AM CANCER SOC, V101, P1214, DOI 10.1002/cncr.20512; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Smith SK, 2014, MED DECIS MAKING, V34, P756, DOI 10.1177/0272989X13518976; Smith-McLallen Aaron, 2008, Psychol Health Med, V13, P389, DOI 10.1080/13548500701842933; Summerville A, 2008, J RES PERS, V42, P247, DOI 10.1016/j.jrp.2007.05.005; Twisk, 2017, INLEIDING TOEGEPASTE; Weber EU, 2009, ANNU REV PSYCHOL, V60, P53, DOI 10.1146/annurev.psych.60.110707.163633; Wools A, 2016, EUR J PUBLIC HEALTH, V26, P158, DOI 10.1093/eurpub/ckv148; Zhao X, RECONSIDERING BARON	45	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0213003	10.1371/journal.pone.0213003	http://dx.doi.org/10.1371/journal.pone.0213003			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HN7LS	30817788	Green Published, Green Submitted, gold			2022-12-26	WOS:000460371500066
J	Tobe, RG; Islam, MT; Yoshimura, Y; Hossain, J				Tobe, Ruoyan Gai; Islam, Mohammad Tajul; Yoshimura, Yukie; Hossain, Jahangir			Strengthening the community support group to improve maternal and neonatal health seeking behaviors: A cluster-randomized controlled trial in Satkhira District, Bangladesh	PLOS ONE			English	Article							EMERGENCY OBSTETRIC CARE; RURAL BANGLADESH; NEWBORN HEALTH; SERVICES; INTERVENTIONS; STRATEGIES; FACILITIES; MORTALITY; SETTINGS; DELIVERY	Background Although achieved development goals on maternal and child health, in the era of Sustainable Development Goals (SDGs), Bangladesh still needs to promote skilled attendance at birth as well as a continuum of care for mothers and babies. How to implement effective interventions by strengthening the community health system also remains as a crucial policy issue. The objective of the proposed study is to evaluate the impact of a community-based intervention as part of a bilateral development aid project on utilization of maternal and neonatal care provided by skilled providers and qualified facilities. Methods A cluster randomized trial was conducted in Kalaroa Upazila of Satkhira District. Community Clinics (CCs) in the study setting were randomly allocated to either intervention or control. We recruited all eligible women covered by CC catchment areas who gave a birth during the past 12 months of data collection at the baseline and end-line surveys. In the intervention areas, three Community Support Groups (CSGs) were developed in each of the CC areas. The members of CSG were trained to identify pregnant women, educate community people on pregnancy related danger signs, and encourage them for utilization of skilled services in the community and health facilities. The primary outcomes were the utilization of services for antenatal care, delivery, postnatal care and sick newborns. Difference-in-Difference (DID) analysis was performed to identify the changes by the intervention with adjustment of cluster effects by generalized mixed effects regression models. Result The major indicators of the utilization of maternal and neonatal care among pregnant women with different wealth status showed significant improvement after the intervention. The impacts of the intervention were in particular significant among the women of 2nd and 3rd quintiles of household wealth status. The use of CCs increased after the intervention and private hospitals / clinics served as the major health providers. The study also identified increased practices of cesarean section. Conclusion The success of the intervention suggests a potential of the government efforts to strengthen the community support system for promotion of safe motherhood. The intervention helps to identify and remove existing and emerging barriers that lie between women and healthcare providers for safe motherhood and continuum of care.	[Tobe, Ruoyan Gai] Natl Ctr Child Hlth & Dev, Dept Hlth Policy, Tokyo, Japan; [Islam, Mohammad Tajul] Save Children Int, MaMoni HSS Project, Dhaka, Bangladesh; [Yoshimura, Yukie] JICA Bangladesh, SHASTO Project, Dhaka, Bangladesh; [Hossain, Jahangir] CARE Bangladesh, Dhaka, Bangladesh	National Center for Child Health & Development - Japan; Save the Children	Yoshimura, Y (corresponding author), JICA Bangladesh, SHASTO Project, Dhaka, Bangladesh.	yoshiboubd@gmail.com	Hossain, Jahangir/AAD-5492-2020	Hossain, Jahangir/0000-0001-7602-3581	Japan International Cooperation Agency; Japan International Cooperation Agency (JICA)	Japan International Cooperation Agency; Japan International Cooperation Agency (JICA)	This entire study was conducted with the financial support of Japan International Cooperation Agency.; Japan International Cooperation Agency (JICA) provided financial and technical supports to the field study.	Alam B, 2015, INT J GYNECOL OBSTET, V131, P63, DOI 10.1016/j.ijgo.2015.04.041; Anwar I, 2009, J HEALTH POPUL NUTR, V27, P139, DOI 10.3329/jhpn.v27i2.3327; Basu S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001244; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chowdhury S, 2011, BJOG-INT J OBSTET GY, V118, P36, DOI 10.1111/j.1471-0528.2011.03111.x; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Das S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1069-7; Directorate General of Health Services, 2015, MAN IMPL 5S HOSP SET; El Arifeen S, 2014, LANCET, V384, P1366, DOI 10.1016/S0140-6736(14)60955-7; General Economics Division Planning Commission of Government of the People's Republic of Bangladesh, 2016, MAPP MIN TARG IMPL S; General Economics Division Planning Commission of Government of the People's Republic of Bangladesh UNDP Bangladesh, 2014, MILL DEV GOALS BANGL; Haider MR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181408; Hotchkiss DR, 2014, HEALTH POLICY PLANN, V29, pI12, DOI 10.1093/heapol/czt062; Hoxha I, 2017, BMJ OPEN, V7, DOI [10.1136/bmjopen-2016-013670, 10.1136/bmjopen-2017-016600]; Huq NL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0520-5; Islam MT, 2015, RES REP NEONATOL, V5, P65, DOI 10.2147/RRN.S87122; Islam N, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-86; Japan International Cooperation Agency Bangladesh, 2012, NARS BANGL SAV LIV M; Kamiya Y, 2013, SOC SCI MED, V83, P34, DOI 10.1016/j.socscimed.2013.01.035; Karim RM, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1461-z; Khan MN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177579; Kibria Gulam Muhammed Al, 2017, Matern Health Neonatol Perinatol, V3, P7, DOI 10.1186/s40748-017-0046-0; Lassi ZS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007754.pub3; Mbuagbaw L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010994.pub2; National Institute of population research training (Bangladesh) Mitra and associates (firm) macro international. Institute for resource development, 2011, BANGL DEM HLTH SURV; Neuman M, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005982; Prost A, 2013, LANCET, V381, P1736, DOI 10.1016/S0140-6736(13)60685-6; Pulok MH, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0970-4; Rahman M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161647; Roy L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187238; Sarker BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146161; Sarker Mohammad Abul Bashar, 2015, BMC Res Notes, V8, P590, DOI 10.1186/s13104-015-1374-7; Seward N, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002467; Shahjahan M, 2017, MIDWIFERY, V52, P42, DOI 10.1016/j.midw.2017.05.011; Sikder SS, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1405-2; Sustainable Development Goals, GOAL 3 ENS HLTH LIV; Taleb F, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0501-8; Tango T, 2016, BIOSTATISTICS, V17, P334, DOI 10.1093/biostatistics/kxv047; Tripathy P, 2016, LANCET GLOB HEALTH, V4, pE119, DOI 10.1016/S2214-109X(15)00287-9; Twisk J, 2018, CONT CLIN TRIAL COMM, V10, P80, DOI 10.1016/j.conctc.2018.03.008; Vieira C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047946; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187303; Yaya S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171573	46	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212847	10.1371/journal.pone.0212847	http://dx.doi.org/10.1371/journal.pone.0212847			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817784	Green Published, Green Submitted, gold			2022-12-26	WOS:000460371500046
J	Khani, M; Lawrence, BJ; Sass, LR; Gibbs, CP; Pluid, JJ; Oshinski, JN; Stewart, GR; Zeller, JR; Martin, BA				Khani, Mohammadreza; Lawrence, Braden J.; Sass, Lucas R.; Gibbs, Christina P.; Pluid, Joshua J.; Oshinski, John N.; Stewart, Gregory R.; Zeller, Jillynne R.; Martin, Bryn A.			Characterization of intrathecal cerebrospinal fluid geometry and dynamics in cynomolgus monkeys (macaca fascicularis) by magnetic resonance imaging	PLOS ONE			English	Article							DRUG DISTRIBUTION; DELIVERY; FLOW; PHYSIOLOGY; PRESSURE; ARTERIAL; MODEL; RESPIRATION; MOTION	Recent advancements have been made toward understanding the diagnostic and therapeutic potential of cerebrospinal fluid (CSF) and related hydrodynamics. Increased understanding of CSF dynamics may lead to improved detection of central nervous system (CNS) diseases and optimized delivery of CSF based CNS therapeutics, with many proposed therapeutics hoping to successfully treat or cure debilitating neurological conditions. Before significant strides can be made toward the research and development of interventions designed for human use, additional research must be carried out with representative subjects such as non-human primates (NHP). This study presents a geometric and hydrodynamic characterization of CSF in eight cynomolgus monkeys (Macaca fascicularis) at baseline and two-week follow-up. Results showed that CSF flow along the entire spine was laminar with a Reynolds number ranging up to 80 and average Womersley number ranging from 4.1-7.7. Maximum CSF flow rate occurred similar to 25 mm caudal to the foramen magnum. Peak CSF flow rate ranged from 0.3-0.6 ml/s at the C3-C4 level. Geometric analysis indicated that average intrathecal CSF volume below the foramen magnum was 7.4 ml. The average surface area of the spinal cord and dura was 44.7 and 66.7 cm(2) respectively. Subarachnoid space cross-sectional area and hydraulic diameter ranged from 7-75 mm(2) and 2-3.7 mm, respectively. Stroke volume had the greatest value of 0.14 ml at an axial location corresponding to C3-C4.	[Khani, Mohammadreza; Lawrence, Braden J.; Sass, Lucas R.; Gibbs, Christina P.; Pluid, Joshua J.; Martin, Bryn A.] Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA; [Lawrence, Braden J.] Univ Washington, Sch Med, Seattle, WA USA; [Oshinski, John N.] Emory Univ, Dept Radiol, Atlanta, GA 30322 USA; [Stewart, Gregory R.] Axovant, New York, NY USA; [Stewart, Gregory R.] Voyager Therapeut, Cambridge, MA USA; [Zeller, Jillynne R.] Northern Biomed Res, Spring Lake, MI USA	Idaho; University of Idaho; University of Washington; University of Washington Seattle; Emory University	Martin, BA (corresponding author), Univ Idaho, Dept Biol Engn, Moscow, ID 83843 USA.	brynm@uidaho.edu	Martin, Bryn A./N-6640-2016	Martin, Bryn A./0000-0003-1234-7880; Lawrence, Braden/0000-0002-1936-3122	Voyager Therapeutics; National Institutes of Health; National Institute of General Medical Sciences [P20GM103408, 4U54GM104944-04]; University of Idaho, Vandal Ideas Project; University of Idaho Open Access Publishing Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103408, U54GM104944] Funding Source: NIH RePORTER	Voyager Therapeutics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Idaho, Vandal Ideas Project; University of Idaho Open Access Publishing Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Voyager Therapeutics, National Institutes of Health, National Institute of General Medical Sciences grant P20GM103408 and 4U54GM104944-04 and the University of Idaho, Vandal Ideas Project. Publication of this article was funded by the University of Idaho Open Access Publishing Fund. The funders had no role in study data collection and analysis, decision to publish, or preparation of the manuscript. Voyager Therapeutics had a role in the study design. Author GRS is employed by Axovant and was employed by Voyager Therapeutics during the course of this study. Axovant provided support in the form of salary for author GRS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Voyager Therapeutics provided support in the form of salary for author GRS. Author JRZ is employed by Northern Biomedical Research. Northern Biomedical Research provided support in the form of salary for author JRZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section; Publication of this article was funded by the University of Idaho Open Access Publishing Fund	Bert RJ, 2017, ANESTH ANALG, V124, P1403, DOI 10.1213/ANE.0000000000002071; Bertram CD, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001165; Bilston LE, 2010, J NEUROSURG, V112, P808, DOI 10.3171/2009.5.JNS08945; BRADLEY WG, 1986, RADIOLOGY, V159, P611, DOI 10.1148/radiology.159.3.3704142; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Bunck AC, 2012, EUR RADIOL, V22, P1860, DOI 10.1007/s00330-012-2457-7; Chazen JL, 2017, CLIN IMAG, V43, P132, DOI 10.1016/j.clinimag.2017.02.007; Chen BKK, 2015, TRANSFUSION, V55, P1013, DOI 10.1111/trf.12938; Cirovic S, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1410-7; Cirovic S, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4005853; Claborn MK, 2019, ANN PHARMACOTHER, V53, P61, DOI 10.1177/1060028018789956; Deepa P, 2011, J NEURAL TRANSM, V118, P531, DOI 10.1007/s00702-010-0520-6; Elliott NSJ, 2013, J FLUID STRUCT, V40, P1, DOI 10.1016/j.jfluidstructs.2013.01.010; ENZMANN DR, 1991, RADIOLOGY, V178, P467, DOI 10.1148/radiology.178.2.1987610; Gray SJ, 2013, GENE THER, V20, P450, DOI 10.1038/gt.2012.101; Greitz D, 1996, AM J NEURORADIOL, V17, P431; Hall J. E., 2011, GUYTON HALL TXB MED, V12e, pxix; Hemley SJ, 2013, J NEUROTRAUM, V30, P1457, DOI 10.1089/neu.2012.2614; Jain K, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2853; Kalata W, 2009, IEEE T BIOMED ENG; Katz N, 2018, HUM GENE THER METHOD; Khani M, 2018, J BIOMECHANICAL ENG; Khani M, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4040401; Khani M, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4036608; Lawrence BJ, 2018, WORLD NEUROSURG, V116, pE298, DOI 10.1016/j.wneu.2018.04.191; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Lu CT, 2014, INT J NANOMED, V9, P2241, DOI 10.2147/IJN.S61288; Martin BA, 2016, ANN BIOMEDICAL ENG; Martin BA, 2016, ANN BIOMED ENG, V44, P1524, DOI 10.1007/s10439-015-1449-6; Martin BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075335; Martin BA, 2012, AM J PHYSIOL-HEART C, V302, pH1492, DOI 10.1152/ajpheart.00658.2011; Martin BA, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000089; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; O'Donnell John, 2015, Curr Sleep Med Rep, V1, P1; Ordia JI, 1996, J NEUROSURG, V85, P452, DOI 10.3171/jns.1996.85.3.0452; Papisov MI, 2013, MOL PHARMACEUT, V10, P1522, DOI 10.1021/mp300474m; Patel T, 2012, ADV DRUG DELIVER REV, V64, P701, DOI 10.1016/j.addr.2011.12.006; Pizzichelli G, 2017, COMPUT METHOD BIOMEC, P1; Puy V, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00154; Reymond P, 2012, J BIOMECH, V45, P2499, DOI 10.1016/j.jbiomech.2012.07.020; Sass LR, 2017, FLUIDS BARRIERS CNS, V14, DOI 10.1186/s12987-017-0085-y; SCHROTH G, 1992, NEURORADIOLOGY, V35, P10, DOI 10.1007/BF00588271; Sweetman B, 2011, ANN BIOMED ENG, V39, P484, DOI 10.1007/s10439-010-0141-0; Tangen K., 2016, ANN BIOMED ENG; Tangen KM, 2017, ANESTH ANALG, V124, P1686, DOI 10.1213/ANE.0000000000002011; Vardoulis O, 2011, EUR J VASC ENDOVASC, V42, P704, DOI 10.1016/j.ejvs.2011.08.006; Watanabe Y, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.28; WILLIAMS B, 1981, ACTA NEUROCHIR, V58, P167, DOI 10.1007/BF01407124; Wostyn Peter, 2009, Cerebrospinal Fluid Res, V6, P14, DOI 10.1186/1743-8454-6-14; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yeo J, 2017, AJNR AM J NEURORADIO; Yiallourou TI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052284; Yildiz S, 2017, J MAGN RESON IMAGING, V46, P431, DOI 10.1002/jmri.25591; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	54	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212239	10.1371/journal.pone.0212239	http://dx.doi.org/10.1371/journal.pone.0212239			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811449	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400063
J	Li, QY; Shi, RM; Liang, FM				Li, Qianyun; Shi, Runmin; Liang, Faming			Drug sensitivity prediction with high-dimensional mixture regression	PLOS ONE			English	Article							VARIABLE SELECTION; CANCER; LIKELIHOOD; INHIBITOR; ALGORITHM	This paper proposes a mixture regression model-based method for drug sensitivity prediction. The proposed method explicitly addresses two fundamental issues in drug sensitivity prediction, namely, population heterogeneity and feature selection pertaining to each of the subpopulations. The mixture regression model is estimated using the imputation-conditional consistency algorithm, and the resulting estimator is consistent. This paper also proposes an average-BIC criterion for determining the number of components for the mixture regression model. The proposed method is applied to the CCLE dataset, and the numerical results indicate that the proposed method can make a drastic improvement over the existing ones, such as random forest, support vector regression, and regularized linear regression, in both drug sensitivity prediction and feature selection. The p-values for the comparisons in drug sensitivity prediction can reach the order O(10(-8)) or lower for the drugs with heterogeneous populations.	[Li, Qianyun] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA; [Shi, Runmin] Univ Florida, Dept Stat, Gainesville, FL 32611 USA; [Liang, Faming] Purdue Univ, Dept Stat, W Lafayette, IN 47906 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Liang, FM (corresponding author), Purdue Univ, Dept Stat, W Lafayette, IN 47906 USA.	fmliang@purdue.edu			NIGMS [DMS-1818674, R01-GM126089, R01-GM117597, DMS/NIGMS R01-GM117597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117597, R01GM126089] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Faming Liang's research was supported in part by the grants DMS-1818674 (https://www.nsf.gov/div/index.jsp?div=DMS), R01-GM126089 and R01-GM117597 (https://www.nigms.nih.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Liang's research was supported in part by the grants DMS-1818674, DMS/NIGMS R01-GM117597, and NIGMS R01-GM126089.	Abu-Jamous B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056432; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Celeux G., 1986, COMPUT STAT Q, V2, P73; Chen JH, 2008, BIOMETRIKA, V95, P759, DOI 10.1093/biomet/asn034; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; De Niz C, 2016, ALGORITHMS, V9, DOI 10.3390/a9040077; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dong ZL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1492-6; Fan JQ, 2008, J R STAT SOC B, V70, P849, DOI 10.1111/j.1467-9868.2008.00674.x; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fong CW, 2006, CANCER RES, V66, P2048, DOI 10.1158/0008-5472.CAN-05-1072; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Haider S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144490; Hejase HA, 2015, CPT-PHARMACOMET SYST, V4, P98, DOI 10.1002/psp4.2; Holt SV, 2012, CANCER RES, V72, P1804, DOI 10.1158/0008-5472.CAN-11-1780; Jang IS, 2014, BIOCOMPUT-PAC SYM, P63; Khalili A, 2007, J AM STAT ASSOC, V102, P1025, DOI 10.1198/016214507000000590; Lee HJ, 2016, NEURO-ONCOLOGY, V18, P486, DOI 10.1093/neuonc/now037; Liang FM, 2018, J R STAT SOC B, V80, P899, DOI 10.1111/rssb.12279; Liang FM, 2013, J AM STAT ASSOC, V108, P589, DOI 10.1080/01621459.2012.761942; Liang FM, 2008, JP J BIOSTAT, V2, P57; MAUNG K, 2004, CLIN BREAST CANCER, V4, P398, DOI DOI 10.1016/S1526-8209(11)70826-6; Medina PJ, 2008, CLIN THER, V30, P1426, DOI 10.1016/j.clinthera.2008.08.008; Nielsen SF, 2000, BERNOULLI, V6, P457, DOI 10.2307/3318671; Ospina JD, 2014, INT J RADIAT ONCOL, V89, P1024, DOI 10.1016/j.ijrobp.2014.04.027; Riddick G, 2011, BIOINFORMATICS, V27, P220, DOI 10.1093/bioinformatics/btq628; Shi R., 2018, BLOCKWISE CONSISTENC; Shokoohi F., 2016, PACKAGE FMRS VARIABL; Song QF, 2015, J AM STAT ASSOC, V110, P1607, DOI 10.1080/01621459.2014.984812; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vega-Pons S, 2011, INT J PATTERN RECOGN, V25, P337, DOI 10.1142/S0218001411008683; Wan Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101183; Xue JN, 2017, J COMPUT GRAPH STAT, V26, P803, DOI 10.1080/10618600.2017.1328364; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zoppoli G, 2012, P NATL ACAD SCI USA, V109, P15030, DOI 10.1073/pnas.1205943109; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	37	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212108	10.1371/journal.pone.0212108	http://dx.doi.org/10.1371/journal.pone.0212108			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811440	Green Submitted, Green Published, gold			2022-12-26	WOS:000459806400054
J	Billong, SC; Nguefack-Tsague, G; Fokam, J; Emmanuel, F; Isac, S; Fodjo, RAT; Ngoufack, MN; Kwedi, S; Moukam, LV; Tchetmi, T; Tapka, VK; Ndjolo, A; Shubber, Z; Cheikh, N; Blanchard, J; Elat, JBN; Mziray, EN				Billong, Serge C.; Nguefack-Tsague, Georges; Fokam, Joseph; Emmanuel, Faran; Isac, Shajy; Fodjo, Raoul A. T.; Ngoufack, Marie Nicole; Kwedi, Sylvie; Moukam, Laure Vartan; Tchetmi, Thomas; Tapka, Vincent K.; Ndjolo, Alexis; Shubber, Zara; Cheikh, Nejma; Blanchard, James; Elat, Jean-Bosco N.; Mziray, Elizabeth N.			Mapping and size estimates of female sex workers in Cameroon: Toward informed policy for design and implementation in the national HIV program	PLOS ONE			English	Article							POPULATIONS; HIDDEN	Background Due to high HIV prevalence among Female Sex Workers (FSWs) in Cameroon (36.5%), this population is especially vulnerable to HIV acquisition and transmission nationwide. Though being prioritized in the national HIV response, it would be relevant to generate statistics on the number of FSWs in order to guide HIV interventions among FSWs. Our objective was to estimate the size of FSWs within hotspots of Cameroon. Methods A cross-sectional study was conducted from September-November 2015 in selected cities in Cameroon: Bafoussam, Bamenda, Bertoua, Buea, Douala, Kribi, Limbe, and Yaounde. A programmatic mapping was used, consisting of interviews with secondary key informants (KI) to identify hotspots of FSWs and their respective estimated numbers. Validation of size estimates was done by interviews with FSW at each hotspot. Size estimations in the councils mapped were extended to others not mapped using a Poisson regression model. Results A total of 2,194 hotspots were identified: Douala (760), Yaounde (622), Bamenda (263), Bafoussam (194), Kribi (154), Bertoua (140), Limbe (35), and Buea (26). The estimated total number (range) of FSWs was 21,124 (16,079-26,170), distributed per city as follows: Douala 7,557 (5,550-9,364), Yaounde ' 6,596 (4,712-8,480), Bafoussam 2,458 (1,994-2,923), Bamenda 1,975 (1,605-2,345), Kribi 1,121 (832-1,408), Bertoua 1,044 (8911,198), Buea 225 (185-266), and Limbe ' 148 (110-148). The variability of estimates among cities was also observed within the councils of each city. The national predicted estimate of FSW population was 112,580 (103,436-121,723), covering all councils of Cameroon. An estimate of 1.91% (112,580/5,881,526; 0.47%-3.36%) adult female population in Cameroon could be sex workers. Conclusion There are considerable numbers of FSW in major cities in Cameroon. There is a need to prioritize interventions for HIV prevention toward this population in order to limit the burden of HIV sexual transmission nationwide.	[Billong, Serge C.; Fodjo, Raoul A. T.; Elat, Jean-Bosco N.] Natl AIDS Control Comm, Cent Tech Grp, Yaounde, Cameroon; [Billong, Serge C.; Nguefack-Tsague, Georges; Fokam, Joseph; Kwedi, Sylvie; Ndjolo, Alexis] Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon; [Billong, Serge C.; Fokam, Joseph; Elat, Jean-Bosco N.] Minist Publ Hlth, Natl HIV Drug Resistance Working Grp, Yaounde, Cameroon; [Billong, Serge C.; Nguefack-Tsague, Georges] Minist Publ Hlth, Natl Key Populat Working Grp, Yaounde, Cameroon; [Fokam, Joseph; Ngoufack, Marie Nicole; Ndjolo, Alexis] Chantal BIYA Int Reference Ctr Res HIV AIDS Preve, Yaounde, Cameroon; [Emmanuel, Faran; Isac, Shajy; Blanchard, James] Univ Manitoba, Winnipeg, MB, Canada; [Ngoufack, Marie Nicole] Univ Yaounde I, Fac Sci, Yaounde, Cameroon; [Moukam, Laure Vartan] Assoc Camerounaise Mkt Social, Yaounde, Cameroon; [Tchetmi, Thomas; Tapka, Vincent K.] Country Off, United Nations Joint Programme HIV AIDS, Yaounde, Cameroon; [Shubber, Zara; Cheikh, Nejma; Mziray, Elizabeth N.] World Bank Grp, Hlth Nutr & Populat, Washington, DC USA	University of Yaounde I; University of Manitoba; University of Yaounde I; The World Bank	Nguefack-Tsague, G (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Yaounde, Cameroon.; Nguefack-Tsague, G (corresponding author), Minist Publ Hlth, Natl Key Populat Working Grp, Yaounde, Cameroon.	nguefacktsague@gmail.com	Nguefack-Tsague, Georges/N-3277-2019	Nguefack-Tsague, Georges/0000-0002-3847-3490; Blanchard, James/0000-0002-4701-590X; Fokam, Joseph/0000-0002-1501-2763	World Bank Group	World Bank Group	This study was conducted through the financial support of the World Bank Group. The founder had no role in designing, implementing, analysing and in the decision for publication.	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; [Anonymous], 2017, CAMEROON COUNTRY OPE; [Anonymous], 2018, CAMEROON COUNTRY OPE; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; BUCREP, 2015, PROJ POP 2015; CAMPHIA, 2018, CAM POP BAS HIV IMP; Emmanuel F, 2013, SEX TRANSM INFECT, V89, P29, DOI 10.1136/sextrans-2013-051062; Emmanuel F, 2013, EXPERT REV ANTI-INFE, V11, P451, DOI [10.1586/ERI.13.33, 10.1586/eri.13.33]; Emmanuel F, 2010, AIDS, V24, pS77, DOI 10.1097/01.aids.0000386737.25296.c4; Global Fund, 2010, US PROGR MAPP IMPR P; Handcock MS, 2014, ELECTRON J STAT, V8, P1491, DOI 10.1214/14-EJS923; Ikpeazu A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103619; Jing LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095601; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; NAAC, 2015, NAT HIV AIDS STRAT P; Odek WO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089180; Papworth E, 2014, EXAMINING RISK FACTO; Pisani E., 2003, ESTIMATING SIZE POPU; Pruss-Ustun A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063476; Royston P, 2005, STATA J, V5, P405; Sabin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155150; Scheibe A, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0164-z; Tamoufe U, 2009, SEROEPIDEMIOLOGICAL; UNAIDS/WHO, 2013, UNAIDS REP GLOB AIDS; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2011, GUID EST SIZ POP MOS; Weir SS, 2002, SEX TRANSM INFECT, V78, pI106, DOI 10.1136/sti.78.suppl_1.i106; World Health Organization, 2013, IMPL COMPR HIV STI P; Yu D, 2014, W PACIFIC SURVEILLAN, V5	28	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212315	10.1371/journal.pone.0212315	http://dx.doi.org/10.1371/journal.pone.0212315			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807616	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100014
J	Willow, J; Silva, A; Veromann, E; Smagghe, G				Willow, Jonathan; Silva, Ana; Veromann, Eve; Smagghe, Guy			Acute effect of low-dose thiacloprid exposure synergised by tebuconazole in a parasitoid wasp	PLOS ONE			English	Article							ERETMOCERUS-MUNDUS; BIOLOGICAL-CONTROL; HYMENOPTERA; INSECTICIDES; PESTICIDES; DELTAMETHRIN; LEPIDOPTERA; POPULATIONS; EULOPHIDAE; FUNGICIDES	Agricultural practices often involve tank-mixing and co-application of insecticides with fungicides to control crop pests. However, natural methods relying on biological control agents such as hymenopteran parasitoids have been shown to be highly effective in suppressing crop pest populations. The current body of insecticide risk assessment data accounting for fungicide co-application is very small, the present study being the first to examine this in a parasitoid wasp. Through low-dose exposure to dry residues of the neonicotinoid insecticide thiacloprid, we examined its mortal and knockdown effect on Aphelinus abdominalis when co-applied with increasing doses of the fungicide tebuconazole. Both of these acute effects of thiacloprid were synergised (toxicity increased to a greater-than-additive effect) by tebuconazole, resulting in significant mortality from low-dose co-applications of tebuconazole, and significant knockdown even without co-applied tebuconazole, the effect increasing as tebuconazole concentration increased. We show the highly toxic effect that a low dose of thiacloprid imposes on A. abdominalis populations, and a synergistic toxicity when co-applied with low doses of tebuconazole. Our work suggests a need for updating pesticide risk assessment methods, accounting for pesticide mixtures, in order to make these risk assessments more field relevant.	[Willow, Jonathan; Smagghe, Guy] Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Lab Agrozool, Ghent, Belgium; [Willow, Jonathan; Veromann, Eve] Estonian Univ Life Sci, Inst Agr & Environm Sci, Chair Plant Hlth, Tartu, Estonia; [Silva, Ana] Cardiff Univ, Sch Psychol, CUBRIC, Cardiff, S Glam, Wales	Ghent University; Estonian University of Life Sciences; Cardiff University	Willow, J (corresponding author), Univ Ghent, Fac Biosci Engn, Dept Plants & Crops, Lab Agrozool, Ghent, Belgium.; Willow, J (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Chair Plant Hlth, Tartu, Estonia.	jonathan.willow@student.emu.ee	Veromann, Eve/I-3095-2016; Silva, Ana Isabel/AAG-5265-2019; Smagghe, Guy/AAE-8914-2019; Willow, Jonathan/AAG-5864-2019; Willow, Jonathan/AAE-1337-2020	Veromann, Eve/0000-0002-0977-5270; Silva, Ana Isabel/0000-0002-1184-4909; Smagghe, Guy/0000-0001-8334-3313; Willow, Jonathan/0000-0003-2377-4917	European ERA-NET C-IPM project [33: IPM4Meligethes]; Estonian Research Council [IUT36-2]; Research Foundation-Flanders (FWO-Vlaanderen); European Social Fund; Internalisation Programme DoRa by Archimedes Foundation	European ERA-NET C-IPM project; Estonian Research Council; Research Foundation-Flanders (FWO-Vlaanderen)(FWO); European Social Fund(European Social Fund (ESF)); Internalisation Programme DoRa by Archimedes Foundation	This study was partially funded by European ERA-NET C-IPM project no 33: IPM4Meligethes, the Institutional Research Funding project no IUT36-2 of Estonian Research Council, and Research Foundation-Flanders (FWO-Vlaanderen). JW received a PhD grant from European Social Fund Doctoral Students, as well as the Internalisation Programme DoRa (carried out by Archimedes Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2018, R R PROJECT STAT COM; Barmentlo SH, 2018, SCI TOTAL ENVIRON, V631-632, P341, DOI 10.1016/j.scitotenv.2018.03.021; Biondi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076548; Cook N, 2016, ECOL ENTOMOL, V41, P693, DOI 10.1111/een.12344; Delpuech JM, 2013, SCI TOTAL ENVIRON, V447, P274, DOI 10.1016/j.scitotenv.2012.12.096; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Drobnjakovic T, 2018, BIOCONTROL SCI TECHN, V28, P1, DOI 10.1080/09583157.2017.1409336; Francesena N, 2017, ENVIRON SCI POLLUT R, V24, P17719, DOI 10.1007/s11356-017-9400-z; Garcia-Mari F, 2004, BIOL CONTROL, V29, P215, DOI 10.1016/S1049-9644(03)00155-5; Giorio C, 2021, ENVIRON SCI POLLUT R, V28, P11716, DOI 10.1007/s11356-017-0394-3; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Khan MA, 2017, PEST MANAG SCI, V73, P2465, DOI 10.1002/ps.4639; Kovacs G, 2019, PEST MANAG SCI, V75, P658, DOI 10.1002/ps.5161; Kovacs G, 2017, BIOCONTROL, V62, P29, DOI 10.1007/s10526-016-9765-9; Kruess A, 2000, OECOLOGIA, V122, P129, DOI 10.1007/PL00008829; LASHOMB J, 1987, J ECON ENTOMOL, V80, P65, DOI 10.1093/jee/80.1.65; Noyes JS, 2018, UNIVERSAL CHALCIDOID; Pisa L, 2021, ENVIRON SCI POLLUT R, V28, P11749, DOI 10.1007/s11356-017-0341-3; POLLUMAJANDUSAMET PMAIS Avalik Vaade, 2017, PMAIS AV VAADE; Raimets R, 2018, PEST MANAG SCI, V74, P541, DOI 10.1002/ps.4756; Schneider MI, 2003, J ECON ENTOMOL, V96, P1054, DOI 10.1603/0022-0493-96.4.1054; Schowalter TD, 2018, BASIC APPL ECOL, V26, P1, DOI 10.1016/j.baae.2017.09.011; Sgolastra F, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0887; Sgolastra F, 2017, PEST MANAG SCI, V73, P1236, DOI 10.1002/ps.4449; Simmonds MSJ, 2002, ENTOMOL EXP APPL, V102, P39, DOI 10.1023/A:1015255411612; Sugiyama K, 2011, APPL ENTOMOL ZOOL, V46, P311, DOI 10.1007/s13355-011-0044-z; Tappert L, 2017, SCI REP-UK, V7, DOI 10.1038/srep42756; Teder T, 2019, CHEMOSPHERE, V214, P371, DOI 10.1016/j.chemosphere.2018.09.132; Thies C, 1999, SCIENCE, V285, P893, DOI 10.1126/science.285.5429.893; Thompson H.M., 2012, EFSA SUPPORT PUBL; Thompson HM, 2014, APIDOLOGIE, V45, P545, DOI 10.1007/s13592-014-0273-6; Vandame R, 1998, NEUROSCI LETT, V251, P57, DOI 10.1016/S0304-3940(98)00494-7; vandeVeire M, 1996, ENTOMOPHAGA, V41, P235, DOI 10.1007/BF02764249; Veromann E, 2011, INT J PEST MANAGE, V57, P85, DOI 10.1080/09670874.2010.539714; Wang DS, 2018, J PEST SCI, V91, P65, DOI 10.1007/s10340-017-0864-x; Whitehorn PR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0389; ZHAO JZ, 1992, GREAT LAKES ENTOMOL, V25, P253; Zhu WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0077547; Zhu YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176837; Zumoffen L, 2018, APPL ENTOMOL ZOOL, V53, P1, DOI 10.1007/s13355-017-0520-1	40	13	13	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212456	10.1371/journal.pone.0212456	http://dx.doi.org/10.1371/journal.pone.0212456			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794624	gold, Green Submitted, Green Published			2022-12-26	WOS:000459709100070
J	Nonomura, T; Shibata, H; Takaki, R				Nonomura, Taku; Shibata, Hisaichi; Takaki, Ryoji			Extended-Kalman-filter-based dynamic mode decomposition for simultaneous system identification and denoising	PLOS ONE			English	Article							FLOWS	A new dynamic mode decomposition (DMD) method is introduced for simultaneous system identification and denoising in conjunction with the adoption of an extended Kalman filter algorithm. The present paper explains the extended-Kalman-filter-based DMD (EKFDMD) algorithm which is an online algorithm for dataset for a small number of degree of freedom (DoF). It also illustrates that EKFDMD requires significant numerical resources for many-degree-of-freedom (many-DoF) problems and that the combination with truncated proper orthogonal decomposition (trPOD) helps us to apply the EKFDMD algorithm to many-DoF problems, though it prevents the algorithm from being fully online. The numerical experiments of a noisy dataset with a small number of DoFs illustrate that EKFDMD can estimate eigenvalues better than or as well as the existing algorithms, whereas EKFDMD can also denoise the original dataset online. In particular, EKFDMD performs better than existing algorithms for the case in which system noise is present. The EKFDMD with trPOD, which unfortunately is not fully online, can be successfully applied to many-DoF problems, including a fluid-problem example, and the results reveal the superior performance of system identification and denoising.	[Nonomura, Taku] Tohoku Univ, Grad Sch Engn, Dept Aerosp Engn, Sendai, Miyagi, Japan; [Nonomura, Taku] JST, Presto, Sendai, Miyagi, Japan; [Shibata, Hisaichi; Takaki, Ryoji] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan	Tohoku University; Japan Science & Technology Agency (JST); Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS)	Nonomura, T (corresponding author), Tohoku Univ, Grad Sch Engn, Dept Aerosp Engn, Sendai, Miyagi, Japan.; Nonomura, T (corresponding author), JST, Presto, Sendai, Miyagi, Japan.	nonomura@aero.mech.tohoku.ac.jp	Shibata, Hisaichi/GPX-7331-2022; Nonomura, Taku/AAC-4303-2019	Nonomura, Taku/0000-0001-7739-7104; Shibata, Hisaichi/0000-0003-3187-8871	PREST, JST [JPMJPR1678]	PREST, JST(Japan Science & Technology Agency (JST))	This work was supported by PREST, JST (JPMJPR1678). URL: https://www.jst.go.jp/kisoken/presto/en/index.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askham T, 2018, SIAM J APPL DYN SYST, V17, P380, DOI 10.1137/M1124176; BERKOOZ G, 1993, ANNU REV FLUID MECH, V25, P539, DOI 10.1146/annurev.fl.25.010193.002543; Dawson STM, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-016-2127-7; Fujii K, 1999, AIAA J, V37, P125, DOI 10.2514/2.676; Fujii K., 1990, HIGH PERFORMANCE COM, P139; Hemati M., 2016, P 54 AIAA AER SCI M; Hemati M. S., 2017, THEORETICAL COMPUTAT, P1, DOI [10.1007/s00162-017-0432-2,1502.03854, DOI 10.1007/S00162-017-0432-2,1502.03854]; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kutz JN, 2016, DYNAMIC MODE DECOMPO, V149; LELE SK, 1992, J COMPUT PHYS, V103, P16, DOI 10.1016/0021-9991(92)90324-R; Moarref R, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4876195; Nishida H, 2009, J COMPUT PHYS, V228, P3182, DOI 10.1016/j.jcp.2009.01.032; Nonomura T, 2018, AIP ADV, V8, DOI 10.1063/1.5031816; Ohmichi Y, 2016, INT J NUMER METH FL, V80, P614, DOI 10.1002/fld.4166; Ohmichi Y, 2017, AIP ADV, V7, DOI 10.1063/1.4996024; Ohnishi N, 2015, PHYS FLUIDS, V27, DOI 10.1063/1.4922086; Priebe S, 2016, J FLUID MECH, V807, P441, DOI 10.1017/jfm.2016.557; Rowley CW, 2004, PHYSICA D, V189, P115, DOI 10.1016/j.physd.2003.03.001; Rowley CW., 2017, LIB TOOLS COMPUTING; Schmid PJ, 2010, J FLUID MECH, V656, P5, DOI 10.1017/S0022112010001217; Shibata H, 2015, PLASMA SOURCES SCI T, V24, DOI 10.1088/0963-0252/24/5/055014; Surana A., 2017, 56 IEEE C DEC CONTR, P94; Surana A, 2016, IFAC PAPERSONLINE, V49, P716, DOI 10.1016/j.ifacol.2016.10.250; Taira K, 2017, AIAA J, V55, P4013, DOI 10.2514/1.J056060; Theofilis V, 2011, ANNU REV FLUID MECH, V43, P319, DOI 10.1146/annurev-fluid-122109-160705; Tu J.H., 2014, J COMPUT DYN, V1, P391, DOI [10.3934/jcd.2014.1.391, DOI 10.3934/JCD.2014.1.391]; Wang L, 2019, ACCIDENT ANAL PREV, V122, P378, DOI 10.1016/j.aap.2017.06.003; Zhang H, 2017, PREPRINT	28	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0209836	10.1371/journal.pone.0209836	http://dx.doi.org/10.1371/journal.pone.0209836			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789916	Green Published, gold, Green Submitted			2022-12-26	WOS:000459330800007
J	Kwon, AY; Park, HY; Hyeon, J; Nam, SJ; Kim, SW; Lee, JE; Yu, JH; Lee, SK; Cho, SY; Cho, EY				Kwon, Ah-Young; Park, Ha Young; Hyeon, Jiyeon; Nam, Seok Jin; Kim, Seok Won; Lee, Jeong Eon; Yu, Jong-Han; Lee, Se Kyung; Cho, Soo Youn; Cho, Eun Yoon			Practical approaches to automated digital image analysis of Ki-67 labeling index in 997 breast carcinomas and causes of discordance with visual assessment	PLOS ONE			English	Article							NEUROENDOCRINE TUMORS; PROLIFERATIVE INDEX; KI67 INDEX; CANCER; REPRODUCIBILITY; QUANTIFICATION; METAANALYSIS; PROGNOSIS; SURVIVAL; MARKER	The Ki-67 labeling index (LI) is an important prognostic factor in breast carcinoma. The Ki-67 LI is traditionally calculated via unaided microscopic estimation; however, inter-observer and intra-observer variability and low reproducibility are problems with this visual assessment (VA) method. For more accurate assessment and better reproducibility with Ki-67 LI, digital image analysis was introduced recently. We used both VA and automated digital image analysis (ADIA) (Ventana Virtuoso image management software) to estimate Ki-67 LI for 997 cases of breast carcinoma, and compared VA and ADIA results. VA and ADIA were highly correlated (intraclass correlation coefficient 0.982, and Spearman's correlation coefficient 0.966, p<0.05). We retrospectively analyzed cases with a greater than 5% difference between VA and ADIA results. The cause of these differences was: (1) tumor heterogeneity (98 cases, 56.0%), (2) VA interpretation error (32 cases, 18.3%), (3) misidentification of tumor cells (26 cases, 14.9%), (4) poor immunostaining or slide quality (16 cases, 9.1%), and (5) Estimation of non-tumor cells (3 cases, 1.7%). There were more discrepancies between VA and ADIA results in the group with a VA value of 10-20% compared to groups with <10% and >= 20%. Although ADIA is more accurate than VA, there are some limitations. Therefore, ADIA findings require confirmation by a pathologist.	[Kwon, Ah-Young] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Pathol, Seongnam, Gyeonggi Do, South Korea; [Park, Ha Young] Inje Univ, Coll Med, Busan Paik Hosp, Dept Pathol, Busan, South Korea; [Hyeon, Jiyeon] Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Dept Pathol, Seoul, South Korea; [Nam, Seok Jin; Kim, Seok Won; Lee, Jeong Eon; Yu, Jong-Han; Lee, Se Kyung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; [Cho, Soo Youn; Cho, Eun Yoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea	Pochon Cha University; Inje University; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Cho, SY; Cho, EY (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea.	sooyoun.cho@samsung.com; eunyoon.cho@samsung.com		Hyeon, Jiyeon/0000-0003-3074-4142				Abubakar M, 2016, J PATHOL CLIN RES, V2, P138, DOI 10.1002/cjp2.42; Bigras G, 2017, APPL IMMUNOHISTO M M, V25, P687, DOI 10.1097/PAI.0000000000000371; BOUZUBAR N, 1989, BRIT J CANCER, V59, P943, DOI 10.1038/bjc.1989.200; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Christgen M, 2015, HUM PATHOL, V46, P1341, DOI 10.1016/j.humpath.2015.05.016; Chung YR, 2016, J PATHOL TRANSL MED, V50, P129, DOI 10.4132/jptm.2015.12.24; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Demichelis F, 2002, VIRCHOWS ARCH, V441, P159, DOI 10.1007/s00428-001-0561-1; Desmeules P, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0294-0; Domagala W, 1996, CLIN CANCER RES, V2, P147; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Fulawka L, 2017, INDIAN J PATHOL MICR, V60, P177, DOI 10.4103/IJPM.IJPM_732_15; Fulawka L, 2016, ANTICANCER RES, V36, P3965; Gnant M, 2011, BREAST CARE, V6, P136, DOI 10.1159/000328054; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Harvey J, 2015, PATHOLOGY, V47, P13, DOI 10.1097/PAT.0000000000000192; Hida AI, 2015, J CLIN PATHOL, V68, P356, DOI 10.1136/jclinpath-2014-202695; Koopman T, 2018, BREAST CANCER RES TR, V169, P33, DOI 10.1007/s10549-018-4669-2; Laurinavicius A, 2016, VIRCHOWS ARCH, V468, P493, DOI 10.1007/s00428-016-1907-z; Laurinavicius A, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3639; Maeda I, 2016, BREAST CANCER-TOKYO, V23, P745, DOI 10.1007/s12282-015-0634-7; Mikami Y, 2013, CANCER SCI, V104, P1539, DOI 10.1111/cas.12245; Mohammed ZMA, 2012, BRIT J CANCER, V106, P383, DOI 10.1038/bjc.2011.569; Plancoulaine B, 2015, VIRCHOWS ARCH, V467, P711, DOI 10.1007/s00428-015-1865-x; Reid MD, 2015, MODERN PATHOL, V28, P686, DOI 10.1038/modpathol.2014.156; Roge R, 2016, BREAST CANCER RES TR, V158, P11, DOI 10.1007/s10549-016-3852-6; Romero Q, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-118; Shui RH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125131; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Voros A, 2014, PATHOL ONCOL RES, V20, P391, DOI 10.1007/s12253-013-9708-z; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Zhong FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150505	35	11	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212309	10.1371/journal.pone.0212309	http://dx.doi.org/10.1371/journal.pone.0212309			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785924	gold, Green Published, Green Submitted			2022-12-26	WOS:000459307000055
J	Chen, YY; Fang, WH; Wang, CC; Kao, TW; Chang, YW; Wu, CJ; Zhou, YC; Sun, YS; Chen, WL				Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang			Helicobacter pylori infection increases risk of incident metabolic syndrome and diabetes: A cohort study	PLOS ONE			English	Article							17-BETA-ESTRADIOL; INTERLEUKIN-8; ASSOCIATION; SECRETION; FOCUS; VACA	Emerging studies have shed light on the association between Helicobacter pylori (HP) infection and cardiometabolic risk. However, there is no evidence to support a causal link for the relationship in the general population. Our aim was to determine whether HP infection is associated with the risks of incident type II diabetes mellitus (DM) in a population-based cohort consisting of adults from the general population. A total of 69235 adults enrolled in the study obtained health examinations at the Tri-Service General Hospital in Taiwan from 2010 to 2016. HP infection detection was performed by rapid urease tests (RUTs), and endoscopic examinations were used to diagnose gastroesophageal reflux disease (GERD), gastric ulcers (GUs) and duodenal ulcers (DUs). Cross-sectional and longitudinal analyses were performed to examine the association between HP infection and cardiometabolic diseases using logistic regression and Cox regression in a large population-based study. HP infection was significantly associated with the presence of metabolic syndrome (MetS) (OR = 1.26, 95%CI: 1.00-1.57) and DM (OR = 1.59, 95%CI: 1.17-2.17) only in male subjects, and abnormal endoscopic findings were also correlated with cardiometabolic diseases. Our findings demonstrated that participants with HP infection had an elevated risk of developing incident DM (HR = 1.54, 95%CI: 1.11-2.13). In addition, endoscopic findings of a DU (HR = 1.63, 95%CI: 1.02-2.63), rather than GERD or a GU, were also predictive of incident DM. In this cohort, HP infection was a statistically significant predictor of incident DM among male population.	[Chen, Yuan-Yuei] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Songshan Branch, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chen, Yuan-Yuei; Fang, Wen-Hui; Wang, Chung-Ching; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Zhou, Yi-Chao; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Div Family Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Fang, Wen-Hui; Kao, Tung-Wei; Chang, Yaw-Wen; Wu, Chen-Jung; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Div Geriatr Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Fang, Wen-Hui; Kao, Tung-Wei; Chang, Yaw-Wen; Sun, Yu-Shan; Chen, Wei-Liang] Natl Def Med Ctr, Hlth Management Ctr, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan; [Wu, Chen-Jung] Taoyuan Armed Forces Gen Hosp, Dept Community Med, Div Family Med, Taoyuan, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Chen, WL (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Div Family Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Div Geriatr Med, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan.; Chen, WL (corresponding author), Natl Def Med Ctr, Hlth Management Ctr, Dept Family & Community Med, Triserv Gen Hosp, Taipei, Taiwan.	weiliang0508@gmail.com	Chang, Yaw-Wen/AAF-2630-2020	Chang, Yaw-Wen/0000-0002-8436-0518				Bagheri N, 2015, MICROB PATHOGENESIS, V81, P33, DOI 10.1016/j.micpath.2015.03.010; Bajaj Sarita, 2014, Indian J Endocrinol Metab, V18, P694, DOI 10.4103/2230-8210.139235; Calvet X, 2009, CLIN INFECT DIS, V48, P1385, DOI 10.1086/598198; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; CRABTREE JE, 1995, J CLIN PATHOL, V48, P967, DOI 10.1136/jcp.48.10.967; Eeskandarian R, 2012, CARDIOVASC J AFR, V23, P131, DOI 10.5830/CVJA-2011-016; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Gasbarrini A, 1998, EUR J GASTROEN HEPAT, V10, P469, DOI 10.1097/00042737-199806000-00006; Herman WH, 2016, DIABETES CARE, V39, pS3, DOI 10.2337/dc16-S002; Jeffery PL, 2011, WORLD J GASTROENTERO, V17, P1249, DOI 10.3748/wjg.v17.i10.1249; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Kato S, 2004, ALIMENT PHARM THERAP, V20, P17, DOI 10.1111/j.1365-2036.2004.01985.x; Kayar Y, 2015, RELATIONSHIP HELICOB, P1; Kohlgruber A, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0670-x; KUIPERS EJ, 1995, ALIMENT PHARM THERAP, V9, P59; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Mishra RR, 2013, INDIAN J GASTROENTER, V32, P232, DOI 10.1007/s12664-013-0321-6; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Ohtani M, 2007, CARCINOGENESIS, V28, P2597, DOI 10.1093/carcin/bgm150; Ohtani M, 2011, CARCINOGENESIS, V32, P1244, DOI 10.1093/carcin/bgr072; Perna F, 2005, Minerva Gastroenterol Dietol, V51, P247; Qi L, 2008, CURR MOL MED, V8, P519, DOI 10.2174/156652408785747915; SIMON L, 1989, Orvosi Hetilap, V130, P1325; Sundrud MS, 2004, P NATL ACAD SCI USA, V101, P7727, DOI 10.1073/pnas.0401528101; Uotani T, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.04; Wang YK, 2015, WORLD J GASTROENTERO, V21, P11221, DOI 10.3748/wjg.v21.i40.11221; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; White JR, 2015, J INFLAMM RES, V8, P137, DOI 10.2147/JIR.S64888; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; WOTHERSPOON AC, 1991, LANCET, V338, P1175, DOI 10.1016/0140-6736(91)92035-Z; Zhou MG, 2018, DIABETOLOGIA, V61, P300, DOI 10.1007/s00125-017-4465-2	32	12	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0208913	10.1371/journal.pone.0208913	http://dx.doi.org/10.1371/journal.pone.0208913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HL9KY	30779804	Green Published, Green Submitted, gold			2022-12-26	WOS:000459062900006
J	Yu, SH; Zhang, YL; Wu, YY; Yang, HY; Chen, Y; Yang, YB; Zhang, Z				Yu, Shuhui; Zhang, Yali; Wu, Yuyun; Yang, Hongying; Chen, Yang; Yang, Yingbin; Zhang, Ze			Subcellular localization of mutated -catenins with different incidences of cis-peptide bonds at the Xaa246-P247 site in HepG2 cells	FASEB JOURNAL			English	Article						missense mutations; ICPB; interaction; APC; E-cadherin	BETA-CATENIN; PROLINE ISOMERIZATION; TRANS ISOMERIZATION; E-CADHERIN; CONFORMATION; PROTEIN; STABILIZATION; SPECIFICITY; ADHESION	Mutations may ultimately change the local conformation of proteins; however, little attention has been paid to alterations in protein function caused by the incidence of cis-peptide bonds (ICPB) in mammalian cells. In this study, a statistical approach, coimmunoprecipitation, and immunofluorescence staining have been used to confirm that S246Y and S246W missense mutations, which help increase the ICPB in Xaa246-P247 (Xaa is any amino acid) in human -catenin, can reduce the interactions between -catenin and adenomatous polyposis coli (APC) and between -catenin and Ca2(+)-dependent cell adhesion molecule family in epithelial tissue (E-cadherin), eventually leading to increased nuclear migration of -catenin in the HepG2 cell line (an immortalized cell line consisting of human liver carcinoma cells). Conversely, S246L and S246M missense mutations, which reduce the ICPB in Xaa246-P247 in human -catenin, can enhance interactions between -catenin and APC and between -catenin and E-cadherin, leading to decreased nuclear migration of -catenin. These results not only indicate that a change in the ICPB may be an important cause of functional protein changes but also provide a new basis for the study of genetic disease prediction, gene diagnosis, individualized treatment, and protein modification at the gene level for clinicians and other professionals.Yu, S., Zhang, Y., Wu, Y., Yang, H., Chen, Y., Yang, Y., Zhang, Z. Subcellular localization of mutated -catenins with different incidences of cis-peptide bonds at the Xaa246-P247 site in HepG2 cells.	[Yu, Shuhui; Zhang, Ze] Chongqing Univ, Sch Life Sci, Chongqing, Peoples R China; [Yu, Shuhui] Southwest Univ, Informat Inst, Chongqing, Peoples R China; [Zhang, Yali; Wu, Yuyun; Yang, Hongying; Chen, Yang; Yang, Yingbin] Southwest Univ, Sch Life Sci, 2 Tiansheng Rd, Chongqing 400716, Peoples R China; [Zhang, Yali] Army Mil Med Univ, Affiliated Hosp 1, Dept Hematol, Chongqing, Peoples R China	Chongqing University; Southwest University - China; Southwest University - China	Yang, YB (corresponding author), Southwest Univ, Sch Life Sci, 2 Tiansheng Rd, Chongqing 400716, Peoples R China.; Zhang, Z (corresponding author), Univ Chongqing, Sch Life Sci, Daxuecheng South Rd 55, Chongqing 401331, Peoples R China.	yybin@swu.edu.cn; zezhang@cqu.edu.cn			National Natural Science Foundation of China (NSFC) [31501100]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (NSFC; Grant 31501100). The authors declare no conflicts of interest.	[Anonymous], 1970, Biochemistry, V9, P3471; Dar MS, 2016, BBA-MOL CELL RES, V1863, P2345, DOI 10.1016/j.bbamcr.2016.06.010; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Evans TC, 1996, BIOCHEMISTRY-US, V35, P8210, DOI 10.1021/bi9606354; Exarchos KP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-113; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Follis AV, 2015, MOL CELL, V59, P677, DOI 10.1016/j.molcel.2015.06.029; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Hamelberg D, 2009, J AM CHEM SOC, V131, P147, DOI 10.1021/ja806146g; Huang TS, 2015, STEM CELLS, V33, P1419, DOI 10.1002/stem.1944; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Joseph AP, 2012, AMINO ACIDS, V43, P1369, DOI 10.1007/s00726-011-1211-9; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Maguire PB, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700419; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Pahlke D, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-8; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Perera L, 1998, BIOCHEMISTRY-US, V37, P10920, DOI 10.1021/bi980263u; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sarkar P, 2011, NAT CHEM BIOL, V7, P51, DOI 10.1038/NCHEMBIO.494; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Suizu F, 2006, MOL CELL BIOL, V26, P1463, DOI 10.1128/MCB.26.4.1463-1479.2006; Truckses DM, 1996, PROTEIN SCI, V5, P1907, DOI 10.1002/pro.5560050917; Tsuge H, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv094; Verstak B, 2013, J IMMUNOL, V191, P6101, DOI 10.4049/jimmunol.1300849; Wu WJ, 1998, BIOPOLYMERS, V45, P381, DOI 10.1002/(SICI)1097-0282(19980415)45:5<381::AID-BIP6>3.0.CO;2-H; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yang YB, 2010, EXP CELL RES, V316, P3329, DOI 10.1016/j.yexcr.2010.02.014; Yu ST, 2010, CANCER RES, V70, P2585, DOI 10.1158/0008-5472.CAN-09-3841	33	2	2	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2019	33	5					6574	6583		10.1096/fj.201801937RR	http://dx.doi.org/10.1096/fj.201801937RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	HW8IK	30807699	Green Published, hybrid			2022-12-26	WOS:000466932600060
J	DeLalio, LJ; Billaud, M; Ruddiman, CA; Johnstone, SR; Butcher, JT; Wolpe, AG; Jin, XY; Keller, TCS; Keller, AS; Riviere, T; Good, ME; Best, AK; Lohman, AW; Swayne, LA; Penuela, S; Thompson, RJ; Lampe, PD; Yeager, M; Isakson, BE				DeLalio, Leon J.; Billaud, Marie; Ruddiman, Claire A.; Johnstone, Scott R.; Butcher, Joshua T.; Wolpe, Abigail G.; Jin, Xueyao; Keller, T. C. Stevenson; Keller, Alexander S.; Riviere, Thibaud; Good, Miranda E.; Best, Angela K.; Lohman, Alexander W.; Swayne, Leigh Anne; Penuela, Silvia; Thompson, Roger J.; Lampe, Paul D.; Yeager, Mark; Isakson, Brant E.			Constitutive SRC-mediated phosphorylation of pannexin 1 at tyrosine 198 occurs at the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						pannexin 1 (PANX1); SRC; smooth muscle; ATP; ATP release; vascular biology; adrenergic receptor; hypertension; vasoconstriction; SRC family kinase (SFK); kinase signaling; muscle contraction; membrane channel	FOCAL ADHESION KINASE; SMOOTH-MUSCLE; ATP RELEASE; ANGIOTENSIN-II; GROWTH-FACTOR; RECEPTOR ACTIVATION; INDUCED CONTRACTION; CA2+ SENSITIVITY; FAMILY KINASES; G-PROTEINS	Pannexin 1 (PANX1)-mediated ATP release in vascular smooth muscle coordinates 1-adrenergic receptor (1-AR) vasoconstriction and blood pressure homeostasis. We recently identified amino acids 198-200 (YLK) on the PANX1 intracellular loop that are critical for 1-AR-mediated vasoconstriction and PANX1 channel function. We report herein that the YLK motif is contained within an SRC homology 2 domain and is directly phosphorylated by SRC proto-oncogene, nonreceptor tyrosine kinase (SRC) at Tyr(198). We demonstrate that PANX1-mediated ATP release occurs independently of intracellular calcium but is sensitive to SRC family kinase (SFK) inhibition, suggestive of channel regulation by tyrosine phosphorylation. Using a PANX1 Tyr(198)-specific antibody, SFK inhibitors, SRC knockdown, temperature-dependent SRC cells, and kinase assays, we found that PANX1-mediated ATP release and vasoconstriction involves constitutive phosphorylation of PANX1 Tyr(198) by SRC. We specifically detected SRC-mediated Tyr(198) phosphorylation at the plasma membrane and observed that it is not enhanced or induced by 1-AR activation. Last, we show that PANX1 immunostaining is enriched in the smooth muscle layer of arteries from hypertensive humans and that Tyr(198) phosphorylation is detectable in these samples, indicative of a role for membrane-associated PANX1 in small arteries of hypertensive humans. Our discovery adds insight into the regulation of PANX1 by post-translational modifications and connects a significant purinergic vasoconstriction pathway with a previously identified, yet unexplored, tyrosine kinase-based 1-AR constriction mechanism. This work implicates SRC-mediated PANX1 function in normal vascular hemodynamics and suggests that Tyr(198)-phosphorylated PANX1 is involved in hypertensive vascular pathology.	[DeLalio, Leon J.; Ruddiman, Claire A.; Johnstone, Scott R.; Wolpe, Abigail G.; Keller, T. C. Stevenson; Keller, Alexander S.; Good, Miranda E.; Best, Angela K.; Isakson, Brant E.] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA; [DeLalio, Leon J.; Ruddiman, Claire A.; Keller, Alexander S.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Wolpe, Abigail G.] Univ Virginia, Sch Med, Dept Cell Biol, Charlottesville, VA 22908 USA; [Jin, Xueyao; Keller, T. C. Stevenson; Yeager, Mark; Isakson, Brant E.] Univ Virginia, Sch Med, Dept Mol Physiol & Biophys, Charlottesville, VA 22908 USA; [Billaud, Marie] Univ Pittsburgh, Sch Med, Dept Cardiothorac Surg, Pittsburgh, PA 15213 USA; [Butcher, Joshua T.] Augusta Univ, Dept Physiol, Augusta, GA 30912 USA; [Riviere, Thibaud] Univ Bordeaux, Dept Life & Hlth Sci, F-33000 Bordeaux, France; [Lohman, Alexander W.; Thompson, Roger J.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB T2N 4N1, Canada; [Lohman, Alexander W.; Thompson, Roger J.] Univ Calgary, Dept Cell Biol & Anat, Calgary, AB T2N 4N1, Canada; [Swayne, Leigh Anne] Univ Victoria, Ctr Biomed Res, Div Med Sci, Victoria, BC V8P 5C2, Canada; [Penuela, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Dept Anat, London, ON N6A 3K7, Canada; [Penuela, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Dept Cell Biol, London, ON N6A 3K7, Canada; [Penuela, Silvia] Univ Western Ontario, Schulich Sch Med & Dent, Dept Oncol, London, ON N6A 3K7, Canada; [Lampe, Paul D.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Georgia; Augusta University; UDICE-French Research Universities; Universite de Bordeaux; University of Calgary; University of Calgary; University of Victoria; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Fred Hutchinson Cancer Center	Isakson, BE (corresponding author), Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, POB 801394, Charlottesville, VA 22908 USA.	brant@virginia.edu	Johnstone, Scott R/E-5032-2013; Penuela, Silvia/A-6961-2010; Billaud, Marie/N-7609-2017; Butcher, Joshua/ABH-7212-2022	Johnstone, Scott R/0000-0003-1920-5033; Penuela, Silvia/0000-0003-4829-5517; Billaud, Marie/0000-0002-7591-0362; Wolpe, Abigail/0000-0002-4169-3697; Butcher, Joshua/0000-0002-7341-1949; Good, Miranda/0000-0001-7775-1863; DeLalio, Leon/0000-0002-9251-0109	NIGMS, National Institutes of Health [F31 HL137270]; National Institutes of Health [T32 GM00813]; NHLBI, National Institutes of Health [P01 HL120840]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL137270, P01HL120840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIGMS, National Institutes of Health, Grant F31 HL137270 (to L. J. D.), National Institutes of Health Grant T32 GM00813 (to L. J. D.), and NHLBI, National Institutes of Health, Grant P01 HL120840 (to B. E. I.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABEBE W, 1995, J CARDIOVASC PHARM, V26, P153, DOI 10.1097/00005344-199507000-00024; Angus JA, 2016, EUR J PHARMACOL, V791, P179, DOI 10.1016/j.ejphar.2016.08.035; ATKINSON MM, 1981, J CELL BIOL, V91, P573, DOI 10.1083/jcb.91.2.573; Bargiotas P, 2011, P NATL ACAD SCI USA, V108, P20772, DOI 10.1073/pnas.1018262108; Billaud M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005824; Billaud M, 2012, MICROCIRCULATION, V19, P360, DOI 10.1111/j.1549-8719.2012.00172.x; Billaud M, 2011, CIRC RES, V109, P80, DOI 10.1161/CIRCRESAHA.110.237594; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; Bolen JB, 1997, ANNU REV IMMUNOL, V15, P371, DOI 10.1146/annurev.immunol.15.1.371; Bolos V, 2010, ONCOTARGETS THER, V3, P83; Bond SR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00058; Boyce AKJ, 2017, BIOCHEM J, V474, P2133, DOI 10.1042/BCJ20170257; Burnstock G, 2010, BRIT J PHARMACOL, V161, P527, DOI 10.1111/j.1476-5381.2010.00937.x; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Chekeni FB, 2010, NATURE, V467, P863, DOI 10.1038/nature09413; Chiu YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14324; DeLalio LJ, 2018, ARTERIOSCL THROM VAS, V38, P2065, DOI 10.1161/ATVBAHA.118.311290; Dinkel H, 2016, NUCLEIC ACIDS RES, V44, pD294, DOI 10.1093/nar/gkv1291; DISALVO J, 1993, ARCH BIOCHEM BIOPHYS, V304, P386, DOI 10.1006/abbi.1993.1366; DISALVO J, 1993, BIOCHEM BIOPH RES CO, V190, P968, DOI 10.1006/bbrc.1993.1144; DISALVO J, 1989, J BIOL CHEM, V264, P10773; DISALVO J, 1994, CAN J PHYSIOL PHARM, V72, P1434; Fisher SA, 2010, PHYSIOL GENOMICS, V42A, P169, DOI 10.1152/physiolgenomics.00111.2010; Godecke S, 2012, AM J PHYSIOL-CELL PH, V302, pC915, DOI 10.1152/ajpcell.00283.2010; Gomez GI, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040957; Gottlieb-Abraham E, 2013, MOL BIOL CELL, V24, P3881, DOI 10.1091/mbc.E13-03-0163; Grassi G, 2015, CIRC RES, V116, P976, DOI 10.1161/CIRCRESAHA.116.303604; Grassi G, 2009, HYPERTENSION, V54, P690, DOI 10.1161/HYPERTENSIONAHA.108.119883; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Han C, 2008, J CELL PHYSIOL, V216, P486, DOI 10.1002/jcp.21420; Hughes AD, 1998, ACTA PHYSIOL SCAND, V164, P457; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Jackson WF, 2008, BRIT J PHARMACOL, V155, P514, DOI 10.1038/bjp.2008.276; Jin N, 1996, AM J PHYSIOL-HEART C, V271, pH1348, DOI 10.1152/ajpheart.1996.271.4.H1348; Li L, 2010, PEPTIDES, V31, P1159, DOI 10.1016/j.peptides.2010.03.014; Li SW, 1996, J BIOL CHEM, V271, P29182, DOI 10.1074/jbc.271.46.29182; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Lohman AW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8965; Lohman AW, 2012, J VASC RES, V49, P405, DOI 10.1159/000338758; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Luttrell DK, 2004, ONCOGENE, V23, P7969, DOI 10.1038/sj.onc.1208162; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; McGarrigle Deirdre, 2007, Sci STKE, V2007, ppe35, DOI 10.1126/stke.3922007pe35; Min JH, 2012, J CELL PHYSIOL, V227, P3585, DOI 10.1002/jcp.24062; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Murali S, 2017, J PHYSIOL-LONDON, V595, P4261, DOI 10.1113/JP273473; Murali S, 2014, J PHYSIOL-LONDON, V592, P4747, DOI 10.1113/jphysiol.2014.279299; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nyberg M, 2018, HYPERTENSION, V71, P151, DOI 10.1161/HYPERTENSIONAHA.117.10251; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Patwardhan P, 2010, MOL CELL BIOL, V30, P4094, DOI 10.1128/MCB.00246-10; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2014, BIOCHEM J, V461, P371, DOI 10.1042/BJ20140447; Penuela S, 2014, CHANNELS, V8, P124, DOI 10.4161/chan.27422; Penuela S, 2014, FEBS LETT, V588, P1411, DOI 10.1016/j.febslet.2014.01.028; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; Pinheiro AR, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-70; Pinheiro AR, 2013, J BIOL CHEM, V288, P27571, DOI 10.1074/jbc.M113.460865; Poornima V, 2015, NITRIC OXIDE-BIOL CH, V47, P77, DOI 10.1016/j.niox.2015.04.005; POSTE G, 1979, CELL, V17, P789, DOI 10.1016/0092-8674(79)90319-2; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; Riquelme MA, 2013, NEUROPHARMACOLOGY, V75, P594, DOI 10.1016/j.neuropharm.2013.03.022; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Sandilos JK, 2012, J BIOL CHEM, V287, P11303, DOI 10.1074/jbc.M111.323378; Seminario-Vidal L, 2009, J BIOL CHEM, V284, P20638, DOI 10.1074/jbc.M109.004762; Shah BH, 2002, MOL PHARMACOL, V61, P343, DOI 10.1124/mol.61.2.343; Shao Q, 2016, J BIOL CHEM, V291, P12432, DOI 10.1074/jbc.M116.717934; Shvartsman DE, 2007, J CELL BIOL, V178, P675, DOI 10.1083/jcb.200701133; Solan JL, 2008, CELL COMMUN ADHES, V15, P75, DOI 10.1080/15419060802014016; Somlyo AP, 1998, ACTA PHYSIOL SCAND, V164, P437; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Sumi Y, 2010, AM J PHYSIOL-CELL PH, V299, pC1118, DOI 10.1152/ajpcell.00122.2010; Tanoue A, 2002, J CLIN INVEST, V109, P765, DOI 10.1172/JCI200214001; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Ward D, 2002, J VASC RES, V39, P1, DOI 10.1159/000048988; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; Weilinger NL, 2012, J NEUROSCI, V32, P12579, DOI 10.1523/JNEUROSCI.1267-12.2012; Weng YI, 2002, BBA-MOL CELL RES, V1589, P285, DOI 10.1016/S0167-4889(02)00189-1; XING Z, 1994, MOL BIOL CELL, V5, P413, DOI 10.1091/mbc.5.4.413; YU HT, 1992, SCIENCE, V258, P1665, DOI 10.1126/science.1280858; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200; Zhang M, 2012, J PHYSIOL-LONDON, V590, P4335, DOI 10.1113/jphysiol.2012.236265	88	28	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 26	2019	294	17					6940	6956		10.1074/jbc.RA118.006982	http://dx.doi.org/10.1074/jbc.RA118.006982			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HX4TZ	30814251	hybrid, Green Published			2022-12-26	WOS:000467394700028
J	Denu, RA; Sass, MM; Johnson, JM; Potts, GK; Choudhary, A; Coon, JJ; Burkard, ME				Denu, Ryan A.; Sass, Madilyn M.; Johnson, James M.; Potts, Gregory K.; Choudhary, Alka; Coon, Joshua J.; Burkard, Mark E.			Polo-like kinase 4 maintains centriolar satellite integrity by phosphorylation of centrosomal protein 131 (CEP131)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						centrosome; centriole; microtubule; phosphoproteomics; mass spectrometry (MS); chemical biology; cell division; centriole duplication; chemical genetics; chromosome segregation; PLK4; CEP131; centriolar satellite	PLK4; DUPLICATION; PROMOTES; CILIOGENESIS; INSTABILITY; RECRUITMENT; BIOGENESIS; REGULATORS; OVERDUPLICATION; CYTOKINESIS	The centrosome, consisting of two centrioles surrounded by a dense network of proteins, is the microtubule-organizing center of animal cells. Polo-like kinase 4 (PLK4) is a Ser/Thr protein kinase and the master regulator of centriole duplication, but it may play additional roles in centrosome function. To identify additional proteins regulated by PLK4, we generated an RPE-1 human cell line with a genetically engineered analog-sensitive PLK4(AS), which genetically encodes chemical sensitivity to competitive inhibition via a bulky ATP analog. We used this transgenic line in an unbiased multiplex phosphoproteomic screen. Several hits were identified and validated as direct PLK4 substrates by in vitro kinase assays. Among them, we confirmed Ser-78 in centrosomal protein 131 (CEP131, also known as AZI1) as a direct substrate of PLK4. Using immunofluorescence microscopy, we observed that although PLK4-mediated phosphorylation of Ser-78 is dispensable for CEP131 localization, ciliogenesis, and centriole duplication, it is essential for maintaining the integrity of centriolar satellites. We also found that PLK4 inhibition or use of a nonphosphorylatable CEP131 variant results in dispersed centriolar satellites. Moreover, replacement of endogenous WT CEP131 with an S78D phosphomimetic variant promoted aggregation of centriolar satellites. We conclude that PLK4 phosphorylates CEP131 at Ser-78 to maintain centriolar satellite integrity.	[Denu, Ryan A.] Univ Wisconsin, Med Scientist Training Program, Madison, WI 53705 USA; [Denu, Ryan A.; Sass, Madilyn M.; Johnson, James M.; Choudhary, Alka; Burkard, Mark E.] Univ Wisconsin, Dept Med, Div Hematol Oncol, Madison, WI 53705 USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Dept Chem, Madison, WI 53705 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53705 USA; [Potts, Gregory K.; Coon, Joshua J.] Univ Wisconsin, Genome Ctr, Madison, WI 53705 USA; [Denu, Ryan A.; Sass, Madilyn M.; Johnson, James M.; Choudhary, Alka; Burkard, Mark E.] Univ Wisconsin, Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burkard, ME (corresponding author), 6059 WIMR,1111 Highland Ave, Madison, WI 53705 USA.	meburkard@medicine.wisc.edu		Sass, Madilyn/0000-0002-3084-1084; Burkard, Mark/0000-0002-4215-7722; Denu, Ryan/0000-0001-9698-9201	National Institutes of Health (NIH) [R01 GM097245, F30CA203271]; National Center for Quantitative Biology of Complex Systems (NIH) [P41 GM108538]; University of Wisconsin Carbone Cancer Center [P30 CA014520]; Abbvie; Genentech; Loxo Oncology; Puma; NATIONAL CANCER INSTITUTE [F30CA203271, P30CA014520] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427, TL1TR000429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008692, P41GM108538] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Quantitative Biology of Complex Systems (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Carbone Cancer Center; Abbvie(AbbVie); Genentech(Roche HoldingGenentech); Loxo Oncology; Puma; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by National Institutes of Health (NIH) Grants R01 GM097245 (to M. E. B.), F30CA203271 (to R. A. D.), the National Center for Quantitative Biology of Complex Systems (NIH Grant P41 GM108538 to J. J. C.), and University of Wisconsin Carbone Cancer Center Support Grant P30 CA014520. M. E. B. is on the medical advisory board of Strata Oncology and receives research funding from Abbvie, Genentech, Puma, and Loxo Oncology. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ai RN, 2016, CANCER BIOL THER, V17, P943, DOI 10.1080/15384047.2016.1210734; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Bahtz R, 2012, J CELL SCI, V125, P486, DOI 10.1242/jcs.093930; Balczon R, 1999, CELL MOTIL CYTOSKEL, V42, P60, DOI 10.1002/(SICI)1097-0169(1999)42:1<60::AID-CM6>3.0.CO;2-7; BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Bedard P. L., 2016, CANCER RES, DOI [10.1158/1538-7445, 10.1158/1538-7445.AM2016-CT066, DOI 10.1158/1538-7445]; Berdougo E, 2009, METHODS MOL BIOL, V545, P21, DOI 10.1007/978-1-60327-993-2_2; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bonni S, 2008, CELL CYCLE, V7, P545, DOI 10.4161/cc.7.4.5387; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Chang J, 2010, EMBO J, V29, P2395, DOI 10.1038/emboj.2010.118; Cunha-Ferreira I, 2013, CURR BIOL, V23, P2245, DOI 10.1016/j.cub.2013.09.037; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Denu RA, 2018, MOL CANCER RES, V16, P517, DOI 10.1158/1541-7786.MCR-17-0197; Denu RA, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2083-x; Dzhindzhev NS, 2014, CURR BIOL, V24, P2526, DOI 10.1016/j.cub.2014.08.061; Firat-Karalar EN, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0460; Firat-Karalar EN, 2014, CURR BIOL, V24, P664, DOI 10.1016/j.cub.2014.01.067; Flanagan AM, 2017, MOL BIOL CELL, V28, P736, DOI 10.1091/mbc.E16-05-0325; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Galletta BJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12476; Godinho SA, 2014, NATURE, V510, P167, DOI 10.1038/nature13277; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Guderian G, 2010, J CELL SCI, V123, P2163, DOI 10.1242/jcs.068502; Hall EA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003928; Hatch EM, 2010, J CELL BIOL, V191, P721, DOI 10.1083/jcb.201006049; Hoang-Minh LB, 2016, TRANSL ONCOL, V9, P392, DOI 10.1016/j.tranon.2016.08.006; Holland AJ, 2012, GENE DEV, V26, P2684, DOI 10.1101/gad.207027.112; Holland AJ, 2012, MOL BIOL CELL, V23, P1838, DOI 10.1091/mbc.E11-12-1043; Holland AJ, 2010, J CELL BIOL, V188, P191, DOI 10.1083/jcb.200911102; Hori A, 2017, CELL MOL LIFE SCI, V74, P213, DOI 10.1007/s00018-016-2315-x; Hori A, 2016, EMBO REP, V17, P326, DOI 10.15252/embr.201541432; Kazazian K, 2017, CANCER RES, V77, P434, DOI 10.1158/0008-5472.CAN-16-2060; Kim TS, 2013, P NATL ACAD SCI USA, V110, pE4849, DOI 10.1073/pnas.1319656110; Kitagawa D, 2011, CELL, V144, P364, DOI 10.1016/j.cell.2011.01.008; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Klebba JE, 2013, CURR BIOL, V23, P2255, DOI 10.1016/j.cub.2013.09.019; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kodani A, 2015, ELIFE, V4, DOI 10.7554/eLife.07519; Korzeniewski N, 2010, MOL BIOL CELL, V21, P3942, DOI 10.1091/mbc.E09-12-1049; Kratz AS, 2015, BIOL OPEN, V4, P370, DOI 10.1242/bio.201411023; Kubo A, 1999, J CELL BIOL, V147, P969, DOI 10.1083/jcb.147.5.969; Lambrus BG, 2015, J CELL BIOL, V210, P63, DOI 10.1083/jcb.201502089; Lasek AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150225; Lee M, 2017, CELL CYCLE, V16, P1225, DOI 10.1080/15384101.2017.1325555; Lera RF, 2012, J BIOL CHEM, V287, P42812, DOI 10.1074/jbc.M112.412544; Leung GC, 2007, FEBS LETT, V581, P77, DOI 10.1016/j.febslet.2006.11.080; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14866; Liu XH, 2017, INT J BIOCHEM CELL B, V90, P1, DOI 10.1016/j.biocel.2017.07.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopes CAM, 2011, J CELL SCI, V124, P600, DOI 10.1242/jcs.077156; Mahjoub MR, 2013, ORGANOGENESIS, V9, P61, DOI 10.4161/org.25144; Martin CA, 2014, NAT GENET, V46, P1283, DOI 10.1038/ng.3122; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; Mason JM, 2014, CANCER CELL, V26, P163, DOI 10.1016/j.ccr.2014.05.006; McLamarrah TA, 2018, J CELL BIOL, V217, P1217, DOI 10.1083/jcb.201605106; Merrill AE, 2013, CURR OPIN CHEM BIOL, V17, P779, DOI 10.1016/j.cbpa.2013.06.011; Mori Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140968; Moyer TC, 2015, J CELL BIOL, V209, P863, DOI 10.1083/jcb.201502088; Petrinac S, 2009, CELL CYCLE, V8, P327, DOI 10.4161/cc.8.2.7355; Pihan GA, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00277; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Richards AL, 2015, CURR OPIN CHEM BIOL, V24, P11, DOI 10.1016/j.cbpa.2014.10.017; Riley NM, 2016, CELL SYST, V2, P142, DOI 10.1016/j.cels.2016.03.002; Riley NM, 2016, ANAL CHEM, V88, P74, DOI 10.1021/acs.analchem.5b04123; Rosario CO, 2010, P NATL ACAD SCI USA, V107, P6888, DOI 10.1073/pnas.0910941107; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sillibourne JE, 2010, MOL BIOL CELL, V21, P547, DOI 10.1091/mbc.E09-06-0505; Sir JH, 2013, J CELL BIOL, V203, P747, DOI 10.1083/jcb.201309038; Sonnen KF, 2013, J CELL SCI, V126, P3223, DOI 10.1242/jcs.129502; Staples CJ, 2012, J CELL SCI, V125, P4770, DOI 10.1242/jcs.104059; Tanaka T, 2004, J CELL BIOL, V165, P709, DOI 10.1083/jcb.200309025; Taus T, 2011, J PROTEOME RES, V10, P5354, DOI 10.1021/pr200611n; Tollenaere MAX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10075; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Villumsen BH, 2013, EMBO J, V32, P3029, DOI 10.1038/emboj.2013.223; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Wheway G, 2015, NAT CELL BIOL, V17, P1074, DOI 10.1038/ncb3201; Wong YL, 2015, SCIENCE, V348, P1155, DOI 10.1126/science.aaa5111	82	13	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 19	2019	294	16					6531	6549		10.1074/jbc.RA118.004867	http://dx.doi.org/10.1074/jbc.RA118.004867			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	HY8PK	30804208	hybrid, Green Published			2022-12-26	WOS:000468402000028
J	Fard, N; Schlemmer, HP; Raue, F; Jobke, B				Fard, Nassim; Schlemmer, Heinz-Peter; Raue, Friedhelm; Jobke, Bjoern			CT- and ultrasound-characteristics of hepatic lesions in patients with multiple endocrine neoplasia syndrome. A retrospective image review of 25 cases	PLOS ONE			English	Review							PANCREATIC NEUROENDOCRINE TUMORS; MEDULLARY-THYROID CARCINOMA; LONG-TERM-FOLLOW; LIVER METASTASES; HEMANGIOMAS; DIAGNOSIS; DIFFERENTIATION; GUIDELINES; MANAGEMENT; TYPE-1	Introduction Liver metastases from neuroendocrine tumors in multiple endocrine neoplasia syndrome are common (75%) and significantly impairs the prognosis. Characterisation of liver lesions in these patients is challenging, as liver metastases are difficult to differentiate from benign liver lesions such as haemangioma. Methods In this study we aimed to characterize the radiological findings of hepatic metastases in MEN patients. The findings of contrast-enhanced CT were considered for the main diagnosis. We retrospectively evaluated 25 patients with MEN-syndrome (10 MEN1/15 MEN2) including 11 men and 14 women between 28-62 years of age. Results Liver metastases (48%, 12/25) and hemangioma (40%, 10/25) were the most common liver lesions among our patients. The most common primary tumors in our MEN1 and MEN2 patients with liver metastases were of pancreatic neuroendocrine tumor (70%, 7/10) und medullary thyroid carcinoma (100%, 15/15) origin, respectively. CT-characteristics were grouped into three main categories, depending on contrast dynamics. The majority of hepatic metastases (75%, 14/25) are presented as multiple lesions with a slow growth in an average 5 years of follow-up-period. We were able to find a common CT pattern and categorise these for each MEN-syndrome. Hepatic metastases in MEN1 presented commonly a blurred arterial enhancement with a low portal venous enhancement and less frequently a prominent enhancement in the arterial phase, which mimics the classical haemangioma. In MEN2 the liver metastases exhibited disseminated mixed hyper-and hypo-enhanced lesions in CT-scans. Moreover, lesion calcifications are pathognomonic in MEN2. The main limitation of this study is the missing histopathological confirmation in the majority of cases. Conclusions In this retrospective imaging study, we were able to categorise and find a common CT pattern for hepatic lesions in patients with MEN-syndrome. In order to differentiate these lesions sufficiently, a combination of a 3-phasic CT-scan with US is required. Other liver specific imaging modalities (MRI, CEUS, SMS-PET/CT) should complement the diagnosis in individual cases.	[Fard, Nassim; Schlemmer, Heinz-Peter; Jobke, Bjoern] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany; [Raue, Friedhelm] Endocrine Practice Heidelberg, Heidelberg, Germany; [Jobke, Bjoern] Telemed Clin Unilabs, Barcelona, Spain	Helmholtz Association; German Cancer Research Center (DKFZ)	Jobke, B (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.; Jobke, B (corresponding author), Telemed Clin Unilabs, Barcelona, Spain.	bjobke@msk-radpath.net	Raue, Friedhelm/ABD-6150-2021; Raue, Friedhelm/AAC-4405-2020	Raue, Friedhelm/0000-0002-7700-1648; 				Ball DW, 2007, ENDOCRIN METAB CLIN, V36, P823, DOI 10.1016/j.ecl.2007.04.001; BANKOFF MS, 1987, J COMPUT ASSIST TOMO, V11, P1102, DOI 10.1097/00004728-198711000-00045; Belousova E, 2017, CLIN RADIOL, V72, P150, DOI 10.1016/j.crad.2016.10.021; Berger JF, 1996, J COMPUT ASSIST TOMO, V20, P349, DOI 10.1097/00004728-199605000-00003; Bodei L, 2018, EUR J NUCL MED MOL I, V45, P1155, DOI 10.1007/s00259-018-3967-6; Brandi ML, 2001, J CLIN ENDOCR METAB, V86, P5658, DOI 10.1210/jc.86.12.5658; BUETOW PC, 1995, AM J ROENTGENOL, V165, P1175, DOI 10.2214/ajr.165.5.7572498; Capdevila J, 2018, NEUROENDOCRINOLOGY, V28; Castroneves LA, 2018, J CLIN ENDOCR METAB, V103, P3250, DOI 10.1210/jc.2018-00193; Chiti A, 1998, EUR J NUCL MED, V25, P1396, DOI 10.1007/s002590050314; Corrias G, 2018, CLIN IMAG, V51, P59, DOI 10.1016/j.clinimag.2018.02.004; D'Souza SL, 2014, J CLIN GASTROENTEROL, V48, P458, DOI 10.1097/MCG.0000000000000062; DOPPMAN JL, 1985, SEMIN ROENTGENOL, V20, P7, DOI 10.1016/0037-198X(85)90019-7; Fidler JL, 2001, J GASTROINTEST CANC, V30, P73, DOI 10.1385/IJGC:30:1-2:073; Fromigue J, 2006, J CLIN ENDOCR METAB, V91, P2496, DOI 10.1210/jc.2005-2401; Ganeshan D, 2013, AM J ROENTGENOL, V201, pW867, DOI 10.2214/AJR.12.10370; Giraudet AL, 2007, J CLIN ENDOCR METAB, V92, P4185, DOI 10.1210/jc.2007-1211; Giraudet AL, 2017, ANN ENDOCRINOL-PARIS, V78, P38, DOI 10.1016/j.ando.2016.10.002; Harman M, 2014, ABDOMINAL IMAGING; Harring TR, 2011, INT J HEPATOL, V2011, DOI 10.4061/2011/154541; Heshmati HM, 1997, EUR J ENDOCRINOL, V137, P572, DOI 10.1530/eje.0.1370572; Hofman MS, 2015, RADIOGRAPHICS, V35, P500, DOI 10.1148/rg.352140164; Imperiale A, 2010, CLIN NUCL MED, V35, P434, DOI 10.1097/RLU.0b013e3181db4e45; Ito T, 2013, MEDICINE, V92, P135, DOI 10.1097/MD.0b013e3182954af1; Jimenez C, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00277; Klotz T, 2013, Diagn Interv Imaging, V94, P849, DOI 10.1016/j.diii.2013.04.008; MCDONNELL CH, 1986, J COMPUT ASSIST TOMO, V10, P976, DOI 10.1097/00004728-198611000-00015; Nose VG, 2013, DIAGNOSTIC PATHOLOGY; Raue F, 2015, RECENT RESULTS CANC, V204, P207, DOI 10.1007/978-3-319-22542-5_10; Raue F, 2010, FAM CANCER, V9, P449, DOI 10.1007/s10689-010-9320-2; Scarsbrook AF, 2006, RADIOGRAPHICS, V26, P433, DOI 10.1148/rg.262055073; Schlumberger M, 2012, EUR J ENDOCRINOL, V166, P5, DOI 10.1530/EJE-11-0631; SOYER P, 1995, AM J ROENTGENOL, V165, P1407, DOI 10.2214/ajr.165.6.7484575; Sundin A, 2009, NEUROENDOCRINOLOGY, V90, P167, DOI 10.1159/000184855; Szavcsur P, 2005, EJSO-EUR J SURG ONC, V31, P183, DOI 10.1016/j.ejso.2004.06.011; Tamm EP, 2007, HEMATOL ONCOL CLIN N, V21, P409, DOI 10.1016/j.hoc.2007.04.006; Termanini B, 1997, RADIOLOGY, V202, P151, DOI 10.1148/radiology.202.1.8988205; Thakker R V, 2012, Indian J Endocrinol Metab, V16, pS272, DOI 10.4103/2230-8210.104058; Thakker RV, 1998, J CLIN ENDOCR METAB, V83, P2617, DOI 10.1210/jc.83.8.2617; WEBER HC, 1995, GASTROENTEROLOGY, V108, P1637, DOI 10.1016/0016-5085(95)90124-8; Wells SA, 2015, THYROID, V25, P567, DOI 10.1089/thy.2014.0335	41	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212865	10.1371/journal.pone.0212865	http://dx.doi.org/10.1371/journal.pone.0212865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817772	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500047
J	Noori, R; Tian, FQ; Berndtsson, R; Abbasi, MR; Naseh, MV; Modabberi, A; Soltani, A; Klove, B				Noori, Roohollah; Tian, Fuqiang; Berndtsson, Ronny; Abbasi, Mahmud Reza; Naseh, Mohammadreza Vesali; Modabberi, Anahita; Soltani, Ali; Klove, Bjorn			Recent and future trends in sea surface temperature across the Persian Gulf and Gulf of Oman	PLOS ONE			English	Article							PROPER ORTHOGONAL DECOMPOSITION; CLIMATE-CHANGE; NORTH-ATLANTIC; INDIAN-OCEAN; VARIABILITY; MODEL; PRECIPITATION; CIRCULATION; SIMULATION; SCENARIOS	Climate change's effect on sea surface temperature (SST) at the regional scale vary due to driving forces that include potential changes in ocean circulation and internal climate variability, ice cover, thermal stability, and ocean mixing layer depth. For a better understanding of future effects, it is important to analyze historical changes in SST at regional scales and test prediction techniques. In this study, the variation in SST across the Persian Gulf and Gulf of Oman (PG&GO) during the past four decades was analyzed and predicted to the end of 21 st century using a proper orthogonal decomposition (POD) model. As input, daily optimum interpolation SST anomaly (DOISSTA) data, available from the National Oceanic and Atmospheric Administration of the United States, were used. Descriptive analyses and POD results demonstrated a gradually increasing trend in DOISSTA in the PG&GO over the past four decades. The spatial distribution of DOISSTA indicated: (1) that shallow parts of the Persian Gulf have experienced minimum and maximum values of DOISSTA and (2) high variability in DOISSTA in shallow parts of the Persian Gulf, including some parts of southern and northwestern coasts. Prediction of future SST using the POD model revealed the highest warming during summer in the entire PG&GO by 2100 and the lowest warming during fall and winter in the Persian Gulf and Gulf of Oman, respectively. The model indicated that monthly SST in the Persian Gulf may increase by up to 4.3 degrees C in August by the turn of the century. Similarly, mean annual changes in SST across the PG&GO may increase by about 2.2 degrees C by 2100.	[Noori, Roohollah; Modabberi, Anahita; Soltani, Ali] Univ Tehran, Sch Environm, Coll Engn, Tehran, Iran; [Noori, Roohollah; Tian, Fuqiang] Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing, Peoples R China; [Berndtsson, Ronny] Lund Univ, Dept Water Resources Engn, Lund, Sweden; [Berndtsson, Ronny] Lund Univ, Ctr Middle Eastern Studies, Lund, Sweden; [Abbasi, Mahmud Reza] Natl Inst Oceanog & Atmospher Sci, Tehran, Iran; [Naseh, Mohammadreza Vesali] Arak Univ, Dept Civil Engn, Fac Engn, Arak, Iran; [Klove, Bjorn] Univ Oulu, Fac Technol, Water Resources & Environm Engn Res Unit, Oulu, Finland	University of Tehran; Tsinghua University; Lund University; Lund University; Arak University; University of Oulu	Noori, R (corresponding author), Univ Tehran, Sch Environm, Coll Engn, Tehran, Iran.; Noori, R (corresponding author), Tsinghua Univ, Dept Hydraul Engn, State Key Lab Hydrosci & Engn, Beijing, Peoples R China.	noor@ut.ac.ir	Soltani, Ali/AFL-8549-2022; Vesalinaseh, Mohammadreza/GOJ-7795-2022; Tian, Fuqiang/M-9958-2013; Berndtsson, Ronny/C-7449-2015	Soltani, Ali/0000-0001-8042-410X; Tian, Fuqiang/0000-0001-9414-7019; Berndtsson, Ronny/0000-0003-1473-0138; Modabberi, Anahita/0000-0003-0552-6119; Vesali Naseh, Mohammad Reza/0000-0001-7556-3850				Ahlman D, 2002, NUMER HEAT TR B-FUND, V42, P285, DOI 10.1080/10407790190053950; Ainsworth TD, 2016, SCIENCE, V352, P338, DOI 10.1126/science.aac7125; Ajai, 2013, INT J OCEANOGR, V2013, DOI [10.1155/2013/501602, DOI 10.1155/2013/501602]; Al Senafi F, 2015, INT J CLIMATOL, V35, P4509, DOI 10.1002/joc.4302; Al-Rashidi TB, 2009, NAT HAZARDS, V50, P73, DOI 10.1007/s11069-008-9320-9; Alexander MA, 2018, ELEMENTA-SCI ANTHROP, V6, DOI 10.1525/elementa.191; AlMuzaini S, 1996, ENVIRON INT, V22, P369, DOI 10.1016/0160-4120(96)00023-2; Aral MM, 2016, WATER-SUI, V8, DOI 10.3390/w8110519; Ashrafi K, 2012, ATMOS ENVIRON, V47, P468, DOI 10.1016/j.atmosenv.2011.10.016; Ateweberhan M, 2010, MAR POLLUT BULL, V60, P964, DOI 10.1016/j.marpolbul.2010.03.033; Ban N, 2015, GEOPHYS RES LETT, V42, P1165, DOI 10.1002/2014GL062588; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Berg N, 2015, J CLIMATE, V28, P6324, DOI 10.1175/JCLI-D-14-00624.1; BERKOOZ G, 1993, ANNU REV FLUID MECH, V25, P539, DOI 10.1146/annurev.fl.25.010193.002543; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Brander KM, 2007, P NATL ACAD SCI USA, V104, P19709, DOI 10.1073/pnas.0702059104; Cane MA, 1997, SCIENCE, V275, P957, DOI 10.1126/science.275.5302.957; Chang B, 2015, J HYDROL ENG, V20, DOI 10.1061/(ASCE)HE.1943-5584.0000860; Chatterjee A, 2000, CURR SCI INDIA, V78, P808; Chen H, 2014, EXP THERM FLUID SCI, V58, P48, DOI 10.1016/j.expthermflusci.2014.06.017; Chen H, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1703-y; Chen H, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/8/085302; Chust G, 2014, GLOBAL CHANGE BIOL, V20, P2124, DOI 10.1111/gcb.12562; Deser C, 2010, ANNU REV MAR SCI, V2, P115, DOI 10.1146/annurev-marine-120408-151453; Donat MG, 2014, INT J CLIMATOL, V34, P581, DOI 10.1002/joc.3707; Esfahanian V, 2009, J FLUID ENG-T ASME, V131, DOI 10.1115/1.3153368; Falvey M, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010519; Gobler CJ, 2017, P NATL ACAD SCI USA, V114, P4975, DOI 10.1073/pnas.1619575114; Guan JB, 2013, CLIM RES, V58, P55, DOI 10.3354/cr01189; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hassanzadeh S, 2012, OCEANOL HYDROBIOL ST, V41, P85, DOI 10.2478/s13545-012-0010-6; Hausfather Z, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601207; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; Kampf J, 2006, OCEAN SCI, V2, P27; Karhunen K., 1946, ANN ACAD SCI FENN-M, V34; Khan AH, 2013, ICES J MAR SCI, V70, P915, DOI 10.1093/icesjms/fst002; Kheirabadi H, 2018, J HYDROINFORM, V20, P1419, DOI 10.2166/hydro.2018.149; Kosambi DD, 1943, J INDIAN MATH SOC, V7, P76, DOI [DOI 10.1007/978-81-322-3676-4_15, 10.18311/jims/1943/17156, DOI 10.18311/JIMS/1943/17156, 10.1007/978-81-322-3676-4_15]; L'Heveder B, 2017, INT J CLIMATOL, V37, P2831, DOI 10.1002/joc.4882; Levine RC, 2013, CLIM DYNAM, V41, P155, DOI 10.1007/s00382-012-1656-x; Liang YC, 2002, J SOUND VIB, V252, P527, DOI 10.1006/jsvi.2001.4041; Lluch-Cota SE, 2013, ATMOSFERA, V26, P537, DOI 10.1016/S0187-6236(13)71094-4; Loeve M., 1946, REV SCI, P195; Loschnigg J, 2003, J CLIMATE, V16, P1617, DOI 10.1175/1520-0442(2003)016<1617:TAMTTB>2.0.CO;2; Medhaug I, 2017, NATURE, V545, P41, DOI 10.1038/nature22315; Meehl G.A., 2007, GLOBAL CLIMATE PROJE; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Moradi M, 2015, MAR POLLUT BULL, V98, P14, DOI 10.1016/j.marpolbul.2015.07.018; Nixon SW, 2003, WARMING NARRAGANSETT, V2, P19; Noori R, 2019, J HYDRAUL RES, V57, P561, DOI 10.1080/00221686.2018.1499052; Noori R, 2017, ESTUAR COAST SHELF S, V197, P236, DOI 10.1016/j.ecss.2017.08.022; Noori R, 2015, J HYDROL, V530, P645, DOI 10.1016/j.jhydrol.2015.10.022; Obukhov AM., 1954, T GEOPHYS INT AKAD N, V24, P3; Pal JS, 2016, NAT CLIM CHANGE, V6, P197, DOI [10.1038/NCLIMATE2833, 10.1038/nclimate2833]; Parry M, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P1; Piontkovski Sergey A., 2012, Open Marine Biology Journal, V6, P38; Poloczanska E, 2012, 2012 REPORT CARD; Pougachev V.S., 1953, IZV AKAD NAUK SSSR M, V17, P401; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Purkis SJ, 2005, MAR ECOL PROG SER, V287, P99, DOI 10.3354/meps287099; Reynolds RW, 2007, J CLIMATE, V20, P5473, DOI 10.1175/2007JCLI1824.1; Riegl B, 2002, MAR BIOL, V140, P29, DOI 10.1007/s002270100676; Rogelj J, 2012, NAT CLIM CHANGE, V2, P248, DOI [10.1038/NCLIMATE1385, 10.1038/nclimate1385]; Sadrinasab M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020425; Sandeep S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06403; Sanford T, 2014, NAT CLIM CHANGE, V4, P164, DOI 10.1038/nclimate2148; Scannell HA, 2016, GEOPHYS RES LETT, V43, P2069, DOI 10.1002/2015GL067308; Schiedek D, 2007, MAR POLLUT BULL, V54, P1845, DOI 10.1016/j.marpolbul.2007.09.020; Shaltout M, 2014, OCEANOLOGIA, V56, P411, DOI 10.5697/oc.56-3.411; Shearman RK, 2010, J PHYS OCEANOGR, V40, P1004, DOI 10.1175/2009JPO4300.1; Sheppard C, 2010, MAR POLLUT BULL, V60, P13, DOI 10.1016/j.marpolbul.2009.10.017; Shinoda T, 2004, DEEP-SEA RES PT I, V51, P619, DOI 10.1016/j.dsr.2004.01.005; Shirvani A, 2017, THEOR APPL CLIMATOL, V127, P123, DOI 10.1007/s00704-015-1625-5; Shirvani A, 2015, ARAB J GEOSCI, V8, P2121, DOI 10.1007/s12517-014-1278-1; Somot S, 2006, CLIM DYNAM, V27, P851, DOI 10.1007/s00382-006-0167-z; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stocker TF, 2007, CLIMATE CHANGE 2013; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Trenberth KE, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P235; Trenberth KE, 2014, NAT CLIM CHANGE, V4, P17, DOI 10.1038/NCLIMATE2067; Turner RE, 2003, INTEGRATED ASSESSMEN, P85; Willcox K, 2006, COMPUT FLUIDS, V35, P208, DOI 10.1016/j.compfluid.2004.11.006; Xue PF, 2015, J CLIMATE, V28, P5041, DOI 10.1175/JCLI-D-14-00189.1	84	41	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2019	14	2							e0212790	10.1371/journal.pone.0212790	http://dx.doi.org/10.1371/journal.pone.0212790			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HN7LS	30817766	Green Published, gold, Green Submitted			2022-12-26	WOS:000460371500039
J	Burkes, RM; Astemborski, J; Lambert, AA; Brown, TT; Wise, RA; Kirk, GD; Drummond, MB				Burkes, Robert M.; Astemborski, Jacquie; Lambert, Allison A.; Brown, Todd T.; Wise, Robert A.; Kirk, Gregory D.; Drummond, M. Bradley			Plasma cathelicidin and longitudinal lung function in current and former smokers	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; DIRECT ANTIVIRAL ACTIVITY; AIRWAY EPITHELIAL-CELLS; RECEPTOR-LIKE 1; VITAMIN-D; ANTIMICROBIAL PEPTIDE; LL-37; ASTHMA; ASSOCIATION; IMPACT	Introduction Cathelicidin (also known as LL-37 in humans) is an antimicrobial peptide secreted by epithelial and immune cells and regulated by vitamin D. The immunological roles of cathelicidin make it a putative biomarker to identify individuals at risk for reduced lung function. The objective of this study is to determine potential independent associations between low plasma cathelicidin and longitudinal lung function in current or former smokers without COPD. Methods In a nested analysis of 308 participants from an observational cohort study, plasma cathelicidin and serum 25-hydroxy-vitamin D measurements were obtained at baseline, years three and five. The independent association between lowest quartile cathelicidin (<35 ng/ml) and forced-expiratory-volume-in-1-second (FEV1) at baseline, six and 18 months from each cathelicidin measurement was assessed with generalized estimating equations after adjusting for age, sex, race, smoking status and intensity. The long-term stability of cathelicidin and relationship with vitamin D was evaluated. Results The cohort was 91% African-American, mean age 48.6 years, 32% female, and 81% current smokers. Participants with low cathelicidin were more likely to be female and have lower FEV1. Low cathelicidin was not independently associated with baseline FEV1. There was an independent association between low cathelicidin and reduced FEV1 at six months [-72 ml (95% CI, -140 to -8ml); p = 0.027] and 18 months [-103 ml (95% CI, -180 to -27 ml); p = 0.007]. Cathelicidin was stable over time and not correlated with vitamin D level. Conclusion In current and former smokers with preserved lung function, low cathelicidin is associated with sustained lung function reductions at six and 18 months, suggesting that cathelicidin may be an informative biomarker to predict persistent lung function disparities among at-risk individuals.	[Burkes, Robert M.; Drummond, M. Bradley] Univ N Carolina, Dept Med, Div Pulm Dis & Crit Care Med, Chapel Hill, NC 27515 USA; [Astemborski, Jacquie; Brown, Todd T.; Kirk, Gregory D.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Lambert, Allison A.] Univ Washington, Div Pulm & Crit Care, Spokane, WA USA; [Brown, Todd T.] Johns Hopkins Univ, Dept Med, Div Endocrinol & Metab, Baltimore, MD USA; [Wise, Robert A.] Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Kirk, Gregory D.] Johns Hopkins Univ, Dept Med, Div Infect Dis, Baltimore, MD USA	University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; University of Washington; Washington State University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Burkes, RM (corresponding author), Univ N Carolina, Dept Med, Div Pulm Dis & Crit Care Med, Chapel Hill, NC 27515 USA.	Robert.Burkes@unchealth.unc.edu		Kirk, Gregory/0000-0002-7829-1405; Burkes, Robert/0000-0002-9718-9115; Wise, Robert/0000-0002-8353-2349; Drummond, Michael/0000-0002-6968-4610	National Institutes of Health [R01HL125432, R01DA04334, R01HL90483]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL121814, R01HL125432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U01DA036297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants through the National Institutes of Health R01HL125432 (MBD), R01DA04334 (GDK), and R01HL90483 (GDK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allinson JP, 2017, AM J RESP CRIT CARE, V196, P1021, DOI 10.1164/rccm.201703-0506OC; Amatngalim GD, 2017, J INNATE IMMUN, V9, P359, DOI 10.1159/000455193; Arikoglu T, 2015, ALLERGY ASTHMA PROC, V36, pE51, DOI 10.2500/aap.2015.36.3848; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bhatt SP, 2016, AM J RESP CRIT CARE, V194, P178, DOI 10.1164/rccm.201511-2219OC; Bui DS, 2017, AM J RESP CRIT CARE, V196, P39, DOI [10.1164/rccm.201606-1272oc, 10.1164/rccm.201606-1272OC]; Buonfiglio LGV, 2017, BMJ OPEN RESPIR RES, V4, DOI 10.1136/bmjresp-2017-000211; Cantorna MT, 2008, MOL ASPECTS MED, V29, P369, DOI 10.1016/j.mam.2008.04.004; Cazzola M, 2008, EUR RESPIR J, V31, P416, DOI 10.1183/09031936.00099306; Coffelt SB, 2008, INT J CANCER, V122, P1030, DOI 10.1002/ijc.23186; Currie SM, 2016, J IMMUNOL, V196, P2699, DOI 10.4049/jimmunol.1502478; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; Frew L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103434; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Gupta N, 2018, J ANTIMICROB CHEMOTH, V73, P1586, DOI 10.1093/jac/dky033; Hacihamdioglu DO, 2016, J CLIN RES PEDIATR E, V8, P325, DOI 10.4274/jcrpe.2563; Han JE, 2017, NUTRITION, V38, P102, DOI 10.1016/j.nut.2017.02.002; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hertting O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015580; Heulens N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160482; JEDRYCHOWSKI W, 1990, EUR J EPIDEMIOL, V6, P20, DOI 10.1007/BF00155544; Jiang YY, 2012, RESP MED, V106, P1680, DOI 10.1016/j.rmed.2012.08.018; Kalhan R, 2018, AM J RESP CRIT CARE, V197, P1616, DOI 10.1164/rccm.201710-2108OC; Kalhan R, 2010, AM J MED, V123, DOI 10.1016/j.amjmed.2009.07.037; Larsen JM, 2015, IMMUNOLOGY, V144, P333, DOI 10.1111/imm.12376; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Majewski K, 2017, CLIN INVEST MED, V40, pE34; Mallia P, 2012, AM J RESP CRIT CARE, V186, P1117, DOI 10.1164/rccm.201205-0806OC; Martinez FD, 2016, NEW ENGL J MED, V375, P871, DOI 10.1056/NEJMra1603287; Martinez FJ, 2018, AM J RESP CRIT CARE, V197, P1540, DOI 10.1164/rccm.201710-2028PP; Matsunawa M, 2009, TOXICOL SCI, V109, P50, DOI 10.1093/toxsci/kfp044; McGeachie MJ, 2016, NEW ENGL J MED, V374, P1842, DOI 10.1056/NEJMoa1513737; Nagaoka I, 2006, J IMMUNOL, V176, P3044, DOI 10.4049/jimmunol.176.5.3044; Nielsen KL, 2014, INFECT IMMUN, V82, P1572, DOI 10.1128/IAI.01393-13; Olmos-Ortiz A, 2016, J STEROID BIOCHEM, V163, P173, DOI 10.1016/j.jsbmb.2016.05.017; Pouwels SD, 2015, EUR RESPIR J, V45, P1482, DOI 10.1183/09031936.00158414; Prietl B, 2013, NUTRIENTS, V5, P2502, DOI 10.3390/nu5072502; Quraishi SA, 2015, CRIT CARE MED, V43, P1928, DOI 10.1097/CCM.0000000000001148; Reinholz M, 2012, ANN DERMATOL, V24, P126, DOI 10.5021/ad.2012.24.2.126; Rennard SI, 2015, LANCET, V385, P1778, DOI 10.1016/S0140-6736(15)60647-X; Reyfman PA, 2018, AM J RESP CRIT CARE, V198, P440, DOI 10.1164/rccm.201801-0120PP; Rigo I, 2012, INNATE IMMUN-LONDON, V18, P250, DOI 10.1177/1753425911399796; Samuel S, 2008, NUTR REV, V66, pS116, DOI 10.1111/j.1753-4887.2008.00094.x; Savran O, 2018, INT J CHRONIC OBSTR, V13, P683, DOI 10.2147/COPD.S153555; Schrumpf JA, 2017, AM J RESP CELL MOL, V56, P749, DOI 10.1165/rcmb.2016-0289OC; Seiler F, 2013, J IMMUNOL, V190, P1603, DOI 10.4049/jimmunol.1200596; Sharifi A, 2016, SAUDI J GASTROENTERO, V22, P316, DOI 10.4103/1319-3767.187606; Sousa FH, 2017, PEPTIDES, V95, P76, DOI 10.1016/j.peptides.2017.07.013; Sun CC, 2014, LAB INVEST, V94, P991, DOI 10.1038/labinvest.2014.86; Szulcek R, 2018, BIOCHEM BIOPH RES CO, V496, P887, DOI 10.1016/j.bbrc.2018.01.130; Tagiyeva N, 2016, AM J RESP CRIT CARE, V193, P23, DOI 10.1164/rccm.201505-0870OC; Torres A, 2015, THORAX, V70, P984, DOI 10.1136/thoraxjnl-2015-206780; Van de Moortele T, 2019, CLIN BIOMECH, V66, P60, DOI 10.1016/j.clinbiomech.2017.11.005; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Whyteside AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083260; Wnorowska U, 2015, ANTIMICROB AGENTS CH, V59, P3808, DOI 10.1128/AAC.00421-15; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zemans RL, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0597-7; Zhang YF, 2012, J IMMUNOL, V189, P3914, DOI 10.4049/jimmunol.1201604; Zhu M, 2016, INT J CHRONIC OBSTR, V11, DOI 10.2147/COPD.S101382	63	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212628	10.1371/journal.pone.0212628	http://dx.doi.org/10.1371/journal.pone.0212628			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811465	gold, Green Published, Green Submitted			2022-12-26	WOS:000459806400080
J	Ontiveros, ES; Hughes, S; Penedo, MCT; Grahn, RA; Stern, JA				Ontiveros, Eric S.; Hughes, Shayne; Penedo, Maria Cecilia T.; Grahn, Robert A.; Stern, Joshua A.			Genetic heterogeneity and diversity of North American golden retrievers using a low density STR marker panel	PLOS ONE			English	Article							DOGS; BREED; DNA; RELATEDNESS; ASSOCIATION; HAPLOTYPE; DISEASE	Thirty-three autosomal short tandem repeat (STR) markers were used to evaluate genetic heterogeneity and diversity in 525 golden retrievers (GRs). This breed was selected because of its popularity and artificial selection for conformation vs. performance phenotypes. Seven additional STRs were used to evaluate the highly polymorphic dog leukocyte antigen (DLA) class I and class II regions. From 3 to 13 alleles were found at each of the 33 loci (mean 7) and the average effective alleles (Ne) was 3.34. The observed heterozygosity was 0.65 and the expected heterozygosity was 0.68. The resulting fixation index was 0.035 indicating that the population was randomly breeding. We found that modern GRs retain 46% of genomic diversity present in all canids and 21/175 (12%) and 20/90 (22%) of the known DLA class I and class II haplotypes, respectively. Selection for performance or conformation led to a narrowing of genomic and DLA diversity with conformation having a greater effect than performance. A comparison was made between coefficient of inbreeding (COI) determined from 10 or 12 generation pedigrees and DNA based internal relatedness values. A weak but significant correlation was observed between IR score and 10 or 12 generation COI (r = 0.38, p<0.0001 and r = 0.40, p<0.0001, respectively). IR values were higher in conformation than performance lines but only significant at p = 0.17. This was supported by 10 and 12 generation COI values that were significantly (p<0.0001) higher in conformation than performance lines. We demonstrate herein that a low density of STR markers can be utilized to study the genetic makeup of GRs.	[Ontiveros, Eric S.; Stern, Joshua A.] Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA; [Hughes, Shayne; Penedo, Maria Cecilia T.; Grahn, Robert A.] Univ Calif Davis, Vet Genet Lab, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Stern, JA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Med & Epidemiol, Davis, CA 95616 USA.	jstern@ucdavis.edu	Fiumefreddo, Andrea/T-2977-2019	Stern, Joshua/0000-0001-5611-5745	American Kennel Club Canine Health Foundation; Golden Retriever Foundation [02228-MOU]	American Kennel Club Canine Health Foundation; Golden Retriever Foundation	Funding came from the American Kennel Club Canine Health Foundation and Golden Retriever Foundation, Grant No: 02228-MOU; and the University of California Davis Center for Companion and Animal Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2010, P NATL ACAD SCI USA, V107, P1160, DOI 10.1073/pnas.0909918107; Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; [Anonymous], 2013, GEN DIV TEST STAND P; [Anonymous], 2008, ENCY GENETICS GENOMI, P985; Ballou J., 1983, GENETICS CONSERVATIO, V509, P520; Bellumori TP, 2013, JAVMA-J AM VET MED A, V242, P1549, DOI 10.2460/javma.242.11.1549; Butler John M, 2007, Forensic Sci Med Pathol, V3, P200, DOI 10.1007/s12024-007-0018-1; Glazewska I, 2008, LIVEST SCI, V113, P296, DOI 10.1016/j.livsci.2007.06.012; HaasRochholz H, 1997, INT J LEGAL MED, V110, P312, DOI 10.1007/s004140050094; Hayward JJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10460; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Jobling MA, 2004, NAT REV GENET, V5, P739, DOI 10.1038/nrg1455; Keijser S F A, 2018, Canine Genet Epidemiol, V5, P12, DOI 10.1186/s40575-018-0068-6; Kennedy LJ, 2006, TISSUE ANTIGENS, V68, P502, DOI 10.1111/j.1399-0039.2006.00715.x; Kennedy LJ, 2006, TISSUE ANTIGENS, V67, P53, DOI 10.1111/j.1399-0039.2005.00518.x; Leroy G, 2006, J ANIM BREED GENET, V123, P1, DOI 10.1111/j.1439-0388.2006.00565.x; Leroy G, 2009, ANIM GENET, V40, P323, DOI 10.1111/j.1365-2052.2008.01842.x; Leroy G, 2015, VET J, V203, P74, DOI 10.1016/j.tvjl.2014.11.008; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pedersen N, 2013, J ANIM BREED GENET, V130, P236, DOI 10.1111/jbg.12017; Pedersen Niels C, 2016, Canine Genet Epidemiol, V3, P6, DOI 10.1186/s40575-016-0036-y; Pedersen Niels C, 2015, Canine Genet Epidemiol, V2, P14, DOI 10.1186/s40575-015-0026-5; Pedersen NC, 2012, VET IMMUNOL IMMUNOP, V145, P264, DOI 10.1016/j.vetimm.2011.11.015; Ross CT, 2014, AM J PRIMATOL, V76, P313, DOI 10.1002/ajp.22235; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; The International Society of Animal Genetics (ISAG), 2005, CAN PAN PAR VER; Vilas A, 2015, MOL ECOL, V24, P4419, DOI 10.1111/mec.13334; Wade CM, 2011, VET J, V189, P183, DOI 10.1016/j.tvjl.2011.06.017; Wictum E, 2013, FORENSIC SCI INT-GEN, V7, P82, DOI 10.1016/j.fsigen.2012.07.001; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872	32	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2019	14	2							e0212171	10.1371/journal.pone.0212171	http://dx.doi.org/10.1371/journal.pone.0212171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM9LQ	30811441	Green Published, gold, Green Submitted			2022-12-26	WOS:000459806400057
J	Brunet, J; Zhao, Y; Clayton, MK				Brunet, Johanne; Zhao, Yang; Clayton, Murray K.			Linking the foraging behavior of three bee species to pollen dispersal and gene flow	PLOS ONE			English	Article							SEED DISPERSAL; ALFALFA; POLLINATION; EASE; CONSEQUENCES	Foraging behaviors that impact gene flow can guide the design of pollinator strategies to mitigate gene flow. Reduced gene flow is expected to minimize the impact of genetically engineered (GE) crops on feral and natural populations and to facilitate the coexistence of different agricultural markets. The goal of this study is to link foraging behavior to gene flow and identify behaviors that can help predict gene flow for different bee species. To reach this goal, we first examined and compared the foraging behaviors of three distinct bee species, the European honey bee, Apis mellifera L., the common eastern bumble bee, Bombus impatiens Cr., and the alfalfa leafcutting bee, Megachile rotundata F., foraging on Medicago sativa flowers. Each foraging behavior investigated differed among bee species. Both social bees exhibited directionality of movement and had similar residence, in contrast to the random movement and shorter residence of the solitary bee. Tripping rate and net distance traveled differed among the three bee species. We ranked each behavior among bee species and used the relative ranking as gene flow predictor before testing the predictions against empirical gene flow data. Tripping rate and net distance traveled, but not residence, predicted relative gene dispersal among bee species. Linking specific behaviors to gene flow provides mechanisms to explain differences in gene flow among bee species and guides the development of management practices to reduce gene flow. Although developed in one system, the approach developed here can be generalized to different plant/pollinator systems.	[Brunet, Johanne] Univ Wisconsin, USDA ARS, VCRU, Dept Entomol, Madison, WI 53706 USA; [Zhao, Yang; Clayton, Murray K.] Univ Wisconsin, Dept Stat, Madison, WI 53706 USA; [Zhao, Yang] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA	United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Gilead Sciences	Brunet, J (corresponding author), Univ Wisconsin, USDA ARS, VCRU, Dept Entomol, Madison, WI 53706 USA.	Johanne.Brunet@ars.usda.gov	Brunet, Johanne/ABB-6499-2021	Brunet, Johanne/0000-0003-4555-7411	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture [2013-33522-20999]; Graduate School at UW Madison Fall competition; United States Department of Agriculture, Agricultural Research Service	Biotechnology Risk Assessment Grant Program from the USDA National Institute of Food and Agriculture; Graduate School at UW Madison Fall competition; United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by a Biotechnology Risk Assessment Grant Program, competitive grant no. 2013-33522-20999 from the USDA National Institute of Food and Agriculture to J. Brunet and M. K. Clayton, from funds from the Graduate School at UW Madison Fall competition to J. B. and M. K. C. and from funds from the United States Department of Agriculture, Agricultural Research Service to J. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AA, 2017, AM J BOT, V104, P772, DOI 10.3732/ajb.1600405; BOHART GE, 1957, ANNU REV ENTOMOL, V2, P355, DOI 10.1146/annurev.en.02.010157.002035; Breazeale D, 2008, J CENT EUR AGRIC, V9, P107; Brunet J, 2010, PSYCHE; Brunet J, P 2018 WINT SEED SCH, P63; Brunet J, 2009, MOL ECOL, V18, P3745, DOI 10.1111/j.1365-294X.2009.04304.x; Cane JH, 2002, J ECON ENTOMOL, V95, P22, DOI 10.1603/0022-0493-95.1.22; Cecen S, 2008, ACTA AGR SCAND B-S P, V58, P77, DOI 10.1080/09064710701214627; Collevatti R. G., 2000, Revista Brasileira de Biologia, V60, P29, DOI 10.1590/S0034-71082000000100005; Cresswell JE, 2002, OIKOS, V98, P375, DOI 10.1034/j.1600-0706.2002.980302.x; Cresswell JE, 2004, J APPL ECOL, V41, P539, DOI 10.1111/j.0021-8901.2004.00912.x; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Fitzpatrick S, 2008, GENE FLOW ALFALFA BI, V28; Fitzpatrick S., 2003, CENTR ALF IMPR C VIR; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Greene SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143296; Harder LD, 1998, ECOLOGY, V79, P2789, DOI 10.1890/0012-9658(1998)079[2789:TCOHTC]2.0.CO;2; HARDER LD, 1990, ECOLOGY, V71, P1110, DOI 10.2307/1937379; Hoyle M, 2007, ECOL APPL, V17, P1234, DOI 10.1890/06-0569; Kershen D., 2005, ADVENTITIOUS PRESENC; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; KNAPP EE, 1993, CROP SCI, V33, P1176, DOI 10.2135/cropsci1993.0011183X003300060014x; KNAPP EE, 1994, CROP SCI, V34, P323, DOI 10.2135/cropsci1994.0011183X003400020001x; Levey DJ, 2005, SCIENCE, V309, P146, DOI 10.1126/science.1111479; Levey DJ, 2008, J ECOL, V96, P599, DOI 10.1111/j.1365-2745.2008.01401.x; LEVIN DA, 1971, EVOLUTION, V25, P113, DOI 10.1111/j.1558-5646.1971.tb01864.x; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; Putnam DH, 2004, PUB, V8153; RASMUSSEN IR, 1992, OECOLOGIA, V89, P277, DOI 10.1007/BF00317228; SMITH KF, 2016, AGRONOMY-BASEL, V6, DOI DOI 10.3390/AGRONOMY6040059; TEUBER LR, 1988, CROP SCI, V28, P558, DOI 10.2135/cropsci1988.0011183X002800030027x; Teuber LR, 2004, JOINT M 39 N AM ALF; Upton GJG, SPATIAL DATA ANAL EX, V2; Van Deynze A., 2007, P GEN FLOW S N CENTR; WADDINGTON KD, 1980, OECOLOGIA, V44, P199, DOI 10.1007/BF00572680; WASER NM, 1982, OECOLOGIA, V55, P251, DOI 10.1007/BF00384496; WATSON GS, 1967, J GEOPHYS RES, V72, P5655, DOI 10.1029/JZ072i022p05655	38	19	19	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 26	2019	14	2							e0212561	10.1371/journal.pone.0212561	http://dx.doi.org/10.1371/journal.pone.0212561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EU	30807591	Green Published, gold, Green Submitted			2022-12-26	WOS:000459712100018
J	Coussement, J; Lebeaux, D; El Bizri, N; Claes, V; Kohnen, M; Steensels, D; Etienne, I; Salord, H; Bergeron, E; Rodriguez-Nava, V				Coussement, Julien; Lebeaux, David; El Bizri, Najla; Claes, Vincent; Kohnen, Michel; Steensels, Deborah; Etienne, Isabelle; Salord, Helene; Bergeron, Emmanuelle; Rodriguez-Nava, Veronica			Nocardia polymerase chain reaction (PCR)-based assay performed on bronchoalveolar lavage fluid after lung transplantation: A prospective pilot study	PLOS ONE			English	Article							SOLID-ORGAN; INFECTIONS; SPP.; IDENTIFICATION; RECIPIENTS	Background Transplant recipients are at risk of pulmonary nocardiosis, a life-threatening opportunistic infection caused by Nocardia species. Given the limitations of conventional diagnostic techniques (i.e., microscopy and culture), a polymerase chain reaction (PCR)-based assay was developed to detect Nocardia spp. on clinical samples. While this test is increasingly being used by transplant physicians, its performance characteristics are not well documented. We evaluated the performance characteristics of this test on bronchoalveolar lavage (BAL) fluid samples from lung transplant recipients (LTRs). Methods We prospectively included all BAL samples from LTRs undergoing bronchoscopy at our institution between December 2016 and June 2017 (either surveillance or clinically-indicated bronchoscopies). Presence of microbial pathogens was assessed using techniques available locally (including microscopy and 10-day culture for Nocardia). BAL samples were also sent to the French Nocardiosis Observatory (Lyon, France) for the Nocardia PCR-based assay. Transplant physicians and patients were blinded to the Nocardia PCR results. Results We included 29 BAL samples from 21 patients (18 surveillance and 11 clinically-indicated bronchoscopies). Nocardiosis was not diagnosed in any of these patients by conventional techniques. However, Nocardia PCR was positive in five BAL samples from five of the patients (24%, 95% confidence interval: 11-45%); four were asymptomatic and undergoing surveillance bronchoscopy, and one was symptomatic and was later diagnosed with influenza virus infection. None of the five PCR-positive patients died or were diagnosed with nocardiosis during the median follow-up of 21 months after the index bronchoscopy (range: 20-23 months). Conclusions In this prospective study, Nocardia PCR was positive on BAL fluid from one fourth of the LTRs. Nocardia PCR-based assays should be used with caution on respiratory samples from LTRs because of the possible detection of airway colonization using this technique. Larger studies are required to determine the usefulness of the Nocardia PCR-based assay in transplant recipients.	[Coussement, Julien] Univ Libre Bruxelles, CUB Hop Erasme, Dept Infect Dis, Brussels, Belgium; [Coussement, Julien; El Bizri, Najla; Claes, Vincent; Kohnen, Michel; Steensels, Deborah] Univ Libre Bruxelles, CUB Hop Erasme, Dept Microbiol, Brussels, Belgium; [Lebeaux, David] Univ Paris 05, Sorbonne Paris Cite, Hop Europeen Georges Pompidou, AP HP,Serv Microbiol,Unite Mobile Microbiol Clin, Paris, France; [Etienne, Isabelle] Univ Libre Bruxelles, CUB Hop Erasme, Lung Transplantat Unit, Brussels, Belgium; [Salord, Helene] Hop Croix Rousse, Lab Bacteriol, Lyon, France; [Bergeron, Emmanuelle; Rodriguez-Nava, Veronica] Univ Lyon 1, Res Grp Bacterial Opportunist Pathogens & Environ, Observatoire Francais Nocardioses,Hosp Civils Lyo, CNRS,UMR 5557,INRA1418 Ecol Microbienne,VetAgro S, Lyon, France	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Libre de Bruxelles; CHU Lyon; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup	Coussement, J (corresponding author), Univ Libre Bruxelles, CUB Hop Erasme, Dept Infect Dis, Brussels, Belgium.; Coussement, J (corresponding author), Univ Libre Bruxelles, CUB Hop Erasme, Dept Microbiol, Brussels, Belgium.	jcoussem@ulb.ac.be	Lebeaux, David/ABB-2704-2020	Coussement, Julien/0000-0002-4302-6599; Claes, Vincent/0000-0001-6398-4009	"Fonds Erasme pour la Recherche Medicale" (Belgium)	"Fonds Erasme pour la Recherche Medicale" (Belgium)	Julien COUSSEMENT is supported by a research grant from the "Fonds Erasme pour la Recherche Medicale" (Belgium).	Ambrosioni J, 2010, INFECTION, V38, P89, DOI 10.1007/s15010-009-9193-9; Bhaskaran A, 2013, SEMIN RESP CRIT CARE, V34, P371, DOI 10.1055/s-0033-1348475; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Clark NM, 2013, AM J TRANSPLANT, V13, P83, DOI 10.1111/ajt.12102; Couble A, 2005, J CLIN MICROBIOL, V43, P1921, DOI 10.1128/JCM.43.4.1921-1924.2005; Coussement J, 2017, CURR OPIN INFECT DIS, V30, P545, DOI [10.1097/qco.0000000000000404, 10.1097/QCO.0000000000000404]; Coussement J, 2016, CLIN INFECT DIS, V63, P338, DOI 10.1093/cid/ciw241; Ekrami A, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.12495; Ferrer A, 2005, ENFERM INFEC MICR CL, V23, P62, DOI 10.1157/13071607; Lumb R, 2002, EUR J CLIN MICROBIOL, V21, P230, DOI 10.1007/s10096-001-0687-8; Martin SI, 2013, AM J TRANSPLANT, V13, P272, DOI 10.1111/ajt.12119; Peleg AY, 2007, CLIN INFECT DIS, V44, P1307, DOI 10.1086/514340; Rodriguez-Nava V, 2006, J CLIN MICROBIOL, V44, P536, DOI 10.1128/JCM.44.2.536-546.2006; Rodriguez-Nava V, 2015, MED MICROBIOL IMMUN, V204, P493, DOI 10.1007/s00430-014-0360-3; Rouzaud C, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.00002-18; Saubolle MA, 2003, J CLIN MICROBIOL, V41, P4497, DOI 10.1128/JCM.41.10.4497-4501.2003; Steensels D, 2015, J CLIN VIROL, V72, P36, DOI 10.1016/j.jcv.2015.08.022; TELENTI A, 1993, J CLIN MICROBIOL, V31, P175, DOI 10.1128/JCM.31.2.175-178.1993; Minero MV, 2009, MEDICINE, V88, P250, DOI 10.1097/MD.0b013e3181afa1c8; vanBurik JA, 1997, CLIN INFECT DIS, V24, P1154, DOI 10.1086/513654; Vetor R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1651-7	21	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 25	2019	14	2							e0211989	10.1371/journal.pone.0211989	http://dx.doi.org/10.1371/journal.pone.0211989			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8EH	30802260	Green Published, gold, Green Submitted			2022-12-26	WOS:000459710700008
J	Baldovin, M; Puglisi, A; Vulpiani, A				Baldovin, Marco; Puglisi, Andrea; Vulpiani, Angelo			Langevin equations from experimental data: The case of rotational diffusion in granular media	PLOS ONE			English	Article							MODEL	A model has two main aims: predicting the behavior of a physical system and understanding its nature, that is how it works, at some desired level of abstraction. A promising recent approach to model building consists in deriving a Langevin-type stochastic equation from a time series of empirical data. Even if the protocol is based upon the introduction of drift and diffusion terms in stochastic differential equations, its implementation involves subtle conceptual problems and, most importantly, requires some prior theoretical knowledge about the system. Here we apply this approach to the data obtained in a rotational granular diffusion experiment, showing the power of this method and the theoretical issues behind its limits. A crucial point emerged in the dense liquid regime, where the data reveal a complex multiscale scenario with at least one fast and one slow variable. Identifying the latter is a major problem within the Langevin derivation procedure and led us to introduce innovative ideas for its solution.	[Baldovin, Marco; Puglisi, Andrea; Vulpiani, Angelo] Sapienza Univ Roma, Dipartimento Fis, Ple A Moro 2, I-00185 Rome, Italy; [Puglisi, Andrea] CNR, ISC, Ple A Moro 2, I-00185 Rome, Italy; [Vulpiani, Angelo] Accademia Lincei, Ctr Linceo Interdisciplinare B Segre, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto dei Sistemi Complessi (ISC-CNR)	Baldovin, M (corresponding author), Sapienza Univ Roma, Dipartimento Fis, Ple A Moro 2, I-00185 Rome, Italy.	marco.baldovin@roma1.infn.it	BALDOVIN, MARCO/AAJ-3582-2021; Puglisi, Andrea/C-5566-2008	BALDOVIN, MARCO/0000-0003-3559-4032; Puglisi, Andrea/0000-0002-7229-9457				Andersen KH, 2000, EUR PHYS J B, V18, P447, DOI 10.1007/s100510070032; ANDREOTTI B., 2013, GRANULAR MEDIA FLUID; Baldassarri A, 2015, CR PHYS, V16, P291, DOI 10.1016/j.crhy.2015.03.017; Baldovin M, 2018, ENTROPY-SWITZ, V20, DOI 10.3390/e20100807; Baldovin M, 2018, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/aab687; Cavagna A, 2009, PHYS REP, V476, P51, DOI 10.1016/j.physrep.2009.03.003; Cecconi F, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/12/P12001; Coffey W. T., 1996, LANGEVIN EQUATION AP; D'Anna G, 2003, NATURE, V424, P909, DOI 10.1038/nature01867; Dyre JC, 2006, REV MOD PHYS, V78, P953, DOI 10.1103/RevModPhys.78.953; Fiege A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.098001; Flyvbjerg H, 1998, LECT NOTES PHYS, V501, P88; Friedrich R, 2011, PHYS REP, V506, P87, DOI 10.1016/j.physrep.2011.05.003; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Gnoli A, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/14002; Heussinger C, 2010, EPL-EUROPHYS LETT, V90, DOI 10.1209/0295-5075/90/20005; Jaeger HM, 1996, PHYS TODAY, V49, P32, DOI 10.1063/1.881494; Kantz H., 2004, NONLINEAR TIME SERIE, V7; Khain E, 2018, PHYS REV E, V98, DOI 10.1103/PhysRevE.98.012903; Klafter J., 2012, FRACTIONAL DYNAMICS; Klages R, 2008, ANOMALOUS TRANSPORT; Lasanta A, 2015, J CHEM PHYS, V143, DOI 10.1063/1.4928456; Lechenault F, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/46003; Leibovich N, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.052130; Luding S, 2009, NONLINEARITY, V22, pR101, DOI 10.1088/0951-7715/22/12/R01; Ma S. K., 1985, STAT MECH; Mao XG, 2018, CHAOS, V28, DOI 10.1063/1.5038758; Marty G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.015701; ONSAGER L, 1953, PHYS REV, V91, P1505, DOI 10.1103/PhysRev.91.1505; Pons A, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.020201; Radjai F, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.064302; RAHMAN A, 1964, PHYS REV, V136, pA405, DOI 10.1103/PhysRev.136.A405; Reis PM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.188301; Risken H., 1989, FOKKER PLANCK EQUATI, DOI DOI 10.1007/978-3-642-61544-3; Rodriguez MA, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042122; RUBIN RJ, 1960, J MATH PHYS, V1, P309, DOI 10.1063/1.1703664; Sarracino A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/34001; Sarracino A, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/04/P04013; SAUER T, 1991, J STAT PHYS, V65, P579, DOI 10.1007/BF01053745; Scalliet C, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.198001; SEARS VF, 1965, P PHYS SOC LOND, V86, P953, DOI 10.1088/0370-1328/86/5/306; Siegert S, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.041107; Utter B, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.031308; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P1; VOLLMER HD, 1979, Z PHYS B CON MAT, V33, P103, DOI 10.1007/BF01325818; Vulpiani A., 2014, LARGE DEVIATIONS PHY; Wortel GH, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012202; Zwanzig R., 2001, NONEQUILIBRIUM STAT	48	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212135	10.1371/journal.pone.0212135	http://dx.doi.org/10.1371/journal.pone.0212135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794586	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100039
J	Chattopadhyay, S; Smyth, EM; Kulkarni, P; Babik, KR; Reid, M; Hittle, LE; Clark, PI; Mongodin, EF; Sapkota, AR				Chattopadhyay, Suhana; Smyth, Eoghan M.; Kulkarni, Prachi; Babik, Kelsey R.; Reid, Molly; Hittle, Lauren E.; Clark, Pamela I.; Mongodin, Emmanuel F.; Sapkota, Amy R.			Little cigars and cigarillos harbor diverse bacterial communities that differ between the tobacco and the wrapper	PLOS ONE			English	Article							STAPHYLOCOCCUS-SCIURI; CIGARETTES; SMOKING; RISK; PRODUCTS; CANCER; PRICE	Despite their potential importance with regard to infectious and chronic diseases among tobacco users, microbial constituents of tobacco products lack characterization. Specifically, to our knowledge, there are no data describing the bacterial diversity of little cigars or cigarillos. To address this knowledge gap, we tested four brands of little cigars and cigarillos. Tobacco and wrapper subsamples (n = 132) were separately subjected to DNA extraction, followed by PCR amplification of the V3V4 hypervariable region of the 16S rRNA gene, and sequencing using Illumina HiSeq. Sequences were analyzed using QIIME and Phyloseq implemented in R. We identified 2,681 operational taxonomic units across all products. Significant differences in alpha and beta diversity were observed between Swisher Sweets and Cheyenne products. Alpha and beta diversity was also significantly different between tobacco and wrapper subsamples within the same product. Beta diversity analyses of only tobacco samples identified no significant differences in the bacterial microbiota of different lots of the same products; however, the microbiota in the wrapper differed significantly across lots for all brands. Overall, Firmicutes were found to dominate in the wrapper, whereas Proteobacteria were most abundant in the tobacco. At the genus level, Bacillus and Lactobacillus dominated in the wrappers, and Staphylococcus and Pseudomonas dominated in the tobacco. Our findings suggest that the bacterial microbiota of little cigars and cigarillos is diverse and differs significantly between the tobacco and the wrapper, and across brands. Future work is necessary to evaluate the potential public health implications of these findings.	[Chattopadhyay, Suhana; Smyth, Eoghan M.; Kulkarni, Prachi; Babik, Kelsey R.; Reid, Molly; Sapkota, Amy R.] Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA; [Smyth, Eoghan M.; Hittle, Lauren E.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Smyth, Eoghan M.; Hittle, Lauren E.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Clark, Pamela I.] Univ Maryland, Sch Publ Hlth, Dept Behav & Community Hlth, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Sapkota, AR (corresponding author), Univ Maryland, Sch Publ Hlth, Maryland Inst Appl Environm Hlth, College Pk, MD 20742 USA.	ars@umd.edu	Babik, Kelsey/GYU-8346-2022; Mongodin, Emmanuel/AAF-1850-2020; Chattopadhyay, Suhana/HHC-2870-2022	Mongodin, Emmanuel/0000-0003-3833-7437; Babik, Kelsey/0000-0002-8084-6449	National Cancer Institute [P50CA180523]; Food and Drug Administration, Center for Tobacco Products; NATIONAL CANCER INSTITUTE [P50CA180523] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Food and Drug Administration, Center for Tobacco Products; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by grant number P50CA180523 from the National Cancer Institute and the Food and Drug Administration, Center for Tobacco Products awarded to the University of Maryland to authors PIC, EFM, and ARS, https://www.cancer.gov/about-nci/budget/fact-book/extramural-programs. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JG, 2015, ENV HLTH PERSPECT, V124; Baker F, 2000, JAMA-J AM MED ASSOC, V284, P735, DOI 10.1001/jama.284.6.735; Baker RR, 2006, PROG ENERG COMBUST, V32, P373, DOI 10.1016/j.pecs.2006.01.001; Barrington-Trimis JL, 2014, JAMA-J AM MED ASSOC, V312, P2493, DOI 10.1001/jama.2014.14830; Bati A., 1997, CIGAR COMPANION CONN, V3rd; Berendsen EM, 2015, APPL ENVIRON MICROB, V81, P7791, DOI 10.1128/AEM.01993-15; Boffetta P, 1999, JNCI-J NATL CANCER I, V91, P697, DOI 10.1093/jnci/91.8.697; Cantrell J, 2013, AM J PUBLIC HEALTH, V103, P1902, DOI 10.2105/AJPH.2013.301362; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chopyk J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00358; Chopyk J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0235-0; Cruz AT, 2007, J CLIN MICROBIOL, V45, P1989, DOI 10.1128/JCM.00632-07; Cullen J, 2011, AM J PUBLIC HEALTH, V101, P1955, DOI 10.2105/AJPH.2011.300209; Delnevo CD, 2004, ADDICT BEHAV, V29, P1799, DOI 10.1016/j.addbeh.2004.04.024; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Gammon DG, 2016, TOB CONTROL, V25, P538, DOI 10.1136/tobaccocontrol-2015-052343; Garten S, 2004, PREV MED, V38, P793, DOI 10.1016/j.ypmed.2004.01.019; GILARDI GL, 1972, ANN INTERN MED, V77, P211, DOI 10.7326/0003-4819-77-2-211; Hage JE, 2013, PERITON DIALYSIS INT, V33, P223, DOI 10.3747/pdi.2012.00112; Henningfield J E, 1999, Nicotine Tob Res, V1, P163, DOI 10.1080/14622299050011271; Holt Hanne M., 1997, Clin Microbiol Infect, V3, P329, DOI 10.1111/j.1469-0691.1997.tb00622.x; Horii T, 2001, SCAND J INFECT DIS, V33, P930, DOI 10.1080/00365540110076750; Hsueh PR, 2000, J CLIN MICROBIOL, V38, P2450; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; Jackson HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095414; Kappstein I, 2000, J HOSP INFECT, V44, P27, DOI 10.1053/jhin.1999.0648; Kostygina G, 2016, TOB CONTROL, V25, pi75, DOI 10.1136/tobaccocontrol-2016-053094; Kreiss K, 2002, NEW ENGL J MED, V347, P330, DOI 10.1056/NEJMoa020300; Larsson L, 2008, TOB INDUC DIS, V4, DOI [10.1007/s12026-009-8117-6, DOI 10.1007/S12026-009-8117-6]; Love MI, 2014, MODERATED ESTIMATION; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Milam AI, 2012, PROG COMM HLTH PARTN, V6, P205, DOI 10.1353/cpr.2012.0027; Nemec A, 2001, INT J SYST EVOL MICR, V51, P1891, DOI 10.1099/00207713-51-5-1891; O'Connor RJ, 2012, TOB CONTROL, V21, P181, DOI 10.1136/tobaccocontrol-2011-050281; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Pauly JL, 2010, IMMUNOL RES, V46, P127, DOI 10.1007/s12026-009-8117-6; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Richardson A, 2013, NICOTINE TOB RES, V15, P1729, DOI 10.1093/ntr/ntt053; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sapkota AR, 2010, ENVIRON HEALTH PERSP, V118, P351, DOI 10.1289/ehp.0901201; Schuster RM, 2013, NICOTINE TOB RES, V15, P925, DOI 10.1093/ntr/nts222; Shannon TR, 2004, BIOPHYS J, V87, P3351, DOI 10.1529/biophysj.104.047449; Shapiro JA, 2000, JNCI-J NATL CANCER I, V92, P333, DOI 10.1093/jnci/92.4.333; Shittu A, 2004, J MED MICROBIOL, V53, P51, DOI 10.1099/jmm.0.05294-0; SIDNEY S, 1995, ARCH INTERN MED, V155, P727, DOI 10.1001/archinte.155.7.727; Smyth EM, 2017, APPL MICROBIOL BIOT, V101, P5391, DOI 10.1007/s00253-017-8282-9; Stepanovic S, 2005, INT J STD AIDS, V16, P452, DOI 10.1258/0956462054093999; Stepanovic S, 2003, J CLIN MICROBIOL, V41, P5262, DOI 10.1128/JCM.41.11.5262-5264.2003; Touey GP, 1957, TOBACCO SCI, V1, P33; Tyx RE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146939; Wang HK, 2017, J MICROBIOL IMMUNOL, V50, P923, DOI 10.1016/j.jmii.2016.06.001; Wang TW, 2018, NICOTINE TOB RES, V20, P1401, DOI 10.1093/ntr/ntx249; Wayne GF, 2004, NICOTINE TOB RES, V6, P927, DOI 10.1080/14622200412331324839; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	56	8	8	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211705	10.1371/journal.pone.0211705	http://dx.doi.org/10.1371/journal.pone.0211705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794551	Green Published, gold, Green Submitted			2022-12-26	WOS:000459709100023
J	Dolan, CB; BenYishay, A; Grepin, KA; Tanner, JC; Kimmel, AD; Wheeler, DC; McCord, GC				Dolan, Carrie B.; BenYishay, Ariel; Grepin, Karen A.; Tanner, Jeffery C.; Kimmel, April D.; Wheeler, David C.; McCord, Gordon C.			The impact of an insecticide treated bednet campaign on all-cause child mortality: A geospatial impact evaluation from the Democratic Republic of Congo	PLOS ONE			English	Article							MALARIA CONTROL; INFANT-MORTALITY; PLASMODIUM-FALCIPARUM; AFRICA; ERADICATION; STRATEGIES; EFFICACY; PROGRESS; ECOLOGY; HEALTH	Objective To test the impact of a nationwide Long-Lasting Insecticidal Nets [LLINs] distribution program in the Democratic Republic of Congo [DRC] on all-cause under-five child mortality exploiting subnational variation in malaria endemicity and the timing in the scale-up of the program across provinces. Design Geospatial Impact Evaluation using a difference-in-differences approach. Setting Democratic Republic of the Congo. Participants 52,656 children sampled in the 2007 and 2013/2014 DRC Demographic and Health Surveys. Interventions The analysis provides plausibly causal estimates of both average treatment effects of the LLIN distribution campaign and geospatial heterogeneity in these effects based on malaria endemicity. It compares the under-five, all-cause mortality for children pre- and post-LLIN campaign relative to children in those areas that had not yet been exposed to the campaign using a difference-in-differences model and controlling for year- and province-fixed effects, and province-level trends in mortality. Results We find that the campaign led to a 41% decline [3.7 percentage points, 95% CI 1.3 to 6.0] in under-5 mortality risk among children living in rural areas with malaria ecology above the sample median. Results were robust to controlling for household assets and the presence of other health aid programs. No effect was detected in children living in areas with malaria ecology below the median. Conclusion The findings of this paper make important contributions to the evidence base for the effectiveness of large scale-national LLIN campaigns against malaria. We found that the program was effective in areas of the DRC with the highest underlying risk of malaria. Targeting bed-nets to areas with greatest underlying risk for malaria may help to increase the efficiency of increasingly limited malaria resources but should be balanced against other malaria control concerns.	[Dolan, Carrie B.] William & Mary, Dept Kinesiol & Hlth Sci, Williamsburg, VA 23185 USA; [BenYishay, Ariel] William & Mary, Dept Econ, Williamsburg, VA USA; [Grepin, Karen A.] Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON, Canada; [Tanner, Jeffery C.] World Bank, Independent Evaluat Grp, 1818 H St NW, Washington, DC 20433 USA; [Kimmel, April D.] Virginia Commonwealth Univ, Hlth Behav & Policy, Richmond, VA USA; [Wheeler, David C.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA; [McCord, Gordon C.] Univ Calif San Diego, Sch Global Policy & Strategy, San Diego, CA 92103 USA	Wilfrid Laurier University; The World Bank; Virginia Commonwealth University; Virginia Commonwealth University; University of California System; University of California San Diego	Dolan, CB (corresponding author), William & Mary, Dept Kinesiol & Hlth Sci, Williamsburg, VA 23185 USA.	cbdolan@wm.edu	Grepin, Karen Ann/P-1248-2018	Grepin, Karen Ann/0000-0003-4368-0045; McCord, Gordon/0000-0001-5042-9225; Dolan, Carrie/0000-0002-4445-7075	government of Japan through a Policy and Human Resources Development Grant	government of Japan through a Policy and Human Resources Development Grant	This work was partially funded through a generous grant from the government of Japan through a Policy and Human Resources Development Grant, for which the team is grateful. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Akachi Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021309; [Anonymous], PLOS ONE; Aregawi MW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-46; BenYishay A, 2015, J HUM RESOUR, V50, P516, DOI 10.3368/jhr.50.2.516; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bleakley H, 2010, AM ECON J-APPL ECON, V2, P1, DOI 10.1257/app.2.2.1; Coghlan B, 2006, LANCET, V367, P44, DOI 10.1016/S0140-6736(06)67923-3; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Coulibaly D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-374; Cutler D, 2010, AM ECON J-APPL ECON, V2, P72, DOI 10.1257/app.2.2.72; Demombynes G, 2016, ECON HUM BIOL, V21, P17, DOI 10.1016/j.ehb.2015.11.004; Deuchert E, 2010, EVALUATING NATIONWID; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Flaxman AD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000328; Gething PW, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-39; Giardina F, 2014, LANCET GLOB HEALTH, V2, pe615; Girond F, 2018, ECLINICALMEDICINE, V1, P62, DOI 10.1016/j.eclinm.2018.07.003; Grepin KA, 2012, HEALTH AFFAIR, V31, P1406, DOI 10.1377/hlthaff.2012.0279; International Diabetes Federation, 2013, DIABETES ATLAS, P13; Ishida K, 2011, POP STUD-J DEMOG, V65, P57, DOI 10.1080/00324728.2010.544323; Jagannathan P, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-435; Jakubowski A, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002319; Kiszewski A, 2004, AM J TROP MED HYG, V70, P486, DOI 10.4269/ajtmh.2004.70.486; Kleinschmidt I, 2009, AM J TROP MED HYG, V80, P882, DOI 10.4269/ajtmh.2009.80.882; Kyu HH, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-14; Landoh ED, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-389; Lengeler C., 2004, INSECTICIDE TREATED; Lewin S, 2009, HEALTH RES POLICY SY, V7, DOI 10.1186/1478-4505-7-S1-S8; Lim SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001091; Louis VR, 2015, B WORLD HEALTH ORGAN, V93, P750, DOI 10.2471/BLT.14.147702; Lucas AM, 2010, AM ECON J-APPL ECON, V2, P46, DOI 10.1257/app.2.2.46; Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3; Mayer JD, 2000, SOC SCI MED, V50, P937, DOI 10.1016/S0277-9536(99)00346-9; McCord GC, 2017, AM J TROP MED HYG, V96, P616, DOI 10.4269/ajtmh.16-0602; Mukonka VM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-153; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Njau JD, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-245; Noor AM, 2014, LANCET, V383, P1739, DOI 10.1016/S0140-6736(13)62566-0; Noor AM, 2009, LANCET, V373, P58, DOI 10.1016/S0140-6736(08)61596-2; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Okiro EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062214; Okiro Emelda A, 2009, BMC Med, V7, P75, DOI 10.1186/1741-7015-7-75; Pathania V, 2014, ECON DEV CULT CHANGE, V62, P459, DOI 10.1086/675382; Pigott DM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-246; Pongou R, 2013, DEMOGRAPHY, V50, P421, DOI 10.1007/s13524-012-0161-5; President's MI, 2014, MAL OP PLAN FY2014; Rajaratnam JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000253; Simon C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-458; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; The WB, 2005, PROJ APPR DOC PROP G; USAID, 2017, GLOB HLTH DEM REP CO; WHO, 2015, WORLD MAL REP 2015; World Health Organization, 2017, DEPRESSION; Zelman B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115714; 2012, WORLD MAL REP 2012, P1	57	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212890	10.1371/journal.pone.0212890	http://dx.doi.org/10.1371/journal.pone.0212890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794694	Green Published, gold			2022-12-26	WOS:000459709100156
J	Eschenfeldt, PC; Hur, C				Eschenfeldt, Patrick C.; Hur, Chin			A quantitative exploration of gastrointestinal bleeding in intensive care unit patients	PLOS ONE			English	Article							BLOOD UREA NITROGEN; HYPOVOLEMIC SHOCK; CLASSIFICATION	Background Quantitative assessments of the severity of bleeding in patients with bleeds within the gastrointestinal tract (GIB) are generally limited to blood tests like the hematocrit. The varied and irregular nature of the data collected during such observations makes it difficult in retrospective data analysis to characterize the complete course of bleeding. We intend to quantify the rate of blood loss over the course of an ICU stay, facilitating more precise analysis of retrospective data, and to use this quantification to examine questions about the effects of GIB. Methods and findings A population of 2,445 intensive care admissions across 2,266 patients with a diagnosis of GIB was studied. Using statistical techniques for smoothing data and accepted medical approaches for calculating blood loss, we are able to convert collections of individual laboratory readings that are difficult to understand into a simple, interpretable overview of the patient's bleeding status over time. To demonstrate this method, we compare patients' standard vital signs while bleeding heavily to times when they are not bleeding, finding a 3.0 +/- 0.5% increase in heart rate, a 1.3 +/- 0.4% decrease in systolic blood pressure and a 0.9 +/- 0.5% decrease in diastolic blood pressure. After considering the effect of bleeding on standard vital signs, we demonstrate that patients with upper GIB have significantly elevated blood urea nitrogen levels while bleeding heavily, with a mean increase of 11.7 +/- 7.2%, while patients with lower GIB do not, with a mean increase of 4.2 +/- 6.6%. Conclusions This study introduces a novel method of processing retrospective laboratory data to characterize the course of bleeds within the gastrointestinal tract. This method is used to examine the direct effects of bleeding on a patient and can be deployed in future studies of bleeding using retrospective data.	[Eschenfeldt, Patrick C.] Massachusetts Gen Hosp, Inst Technol Assessment, Boston, MA 02114 USA; [Eschenfeldt, Patrick C.] Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Eschenfeldt, Patrick C.] Harvard Med Sch, Boston, MA 02115 USA; [Hur, Chin] Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University	Hur, C (corresponding author), Columbia Univ, Med Ctr, Dept Med, New York, NY 10027 USA.	Ch447@cumc.columbia.edu						Al-Naamani K, 2008, CAN J GASTROENTEROL, V22, P399, DOI 10.1155/2008/207850; American College of Surgeons Committee on Trauma, 2008, ADV TRAUM LIF SUPP D; BOURKE DL, 1974, ANESTHESIOLOGY, V41, P609, DOI 10.1097/00000542-197412000-00015; Brecher ME, 1997, TRANSFUSION, V37, P1070, DOI 10.1046/j.1537-2995.1997.371098016448.x; DIERCKX P, 1982, SIAM J NUMER ANAL, V19, P1286, DOI 10.1137/0719093; Dierckx P., 1993, CURVE SURFACE FITTIN; Dierckx P., 1975, J COMPUT APPL MATH, V1, P165, DOI [DOI 10.1016/0771-050X(75)90034-0, 10.1016/0771-050X(75)90034-0]; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; GROSS JB, 1983, ANESTHESIOLOGY, V58, P277, DOI 10.1097/00000542-198303000-00016; Hunt BJ, 2015, BRIT J HAEMATOL, V170, P788, DOI 10.1111/bjh.13580; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Jones E., 2001, SCIPY OPEN SOURCE SC; Kumar S, 2017, FRONTLINE GASTROENTE, V8, P167, DOI 10.1136/flgastro-2016-100722; Mutschler M, 2014, INJURY, V45, pS35, DOI 10.1016/j.injury.2014.08.015; Mutschler M, 2013, RESUSCITATION, V84, P309, DOI 10.1016/j.resuscitation.2012.07.012; Mutschler M, 2013, CRIT CARE, V17, DOI 10.1186/cc12555; NADLER SB, 1962, SURGERY, V51, P224; Rossum G., 1995, PYTHON REFERENCE MAN; TEASDALE G, 1974, LANCET, V2, P81; Thomas I, 2004, BMJ-BRIT MED J, V328, P451, DOI 10.1136/bmj.328.7437.451; Tomizawa M, 2015, WORLD J GASTROENTERO, V21, P7500, DOI 10.3748/wjg.v21.i24.7500; Tomizawa M, 2014, WORLD J GASTROENTERO, V20, P1311, DOI 10.3748/wjg.v20.i5.1311	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0212040	10.1371/journal.pone.0212040	http://dx.doi.org/10.1371/journal.pone.0212040			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM8DR	30794554	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100035
J	Yoshitake, N; Omori, M; Sugawara, M; Akishinonomiya, K; Shimada, S				Yoshitake, Naomi; Omori, Mika; Sugawara, Masumi; Akishinonomiya, Kiko; Shimada, Sachiko			Do health beliefs, personality traits, and interpersonal concerns predict TB prevention behavior among Japanese adults?	PLOS ONE			English	Article							SELF-REGULATION; MODEL; RISK	Despite public health measures and health-promotion efforts, the decline in tuberculosis (TB) morbidity in Japan has been slow, with a higher TB incidence rate relative to those observed in most developed countries. Because health behavior depends on multiple factors and is formulated within a social context, a theory-driven model would be necessary to increase TB prevention behavior. Based upon the Health Belief Model, this study examined the effects of health beliefs, personality traits, and social factors on TB prevention behavior among Japanese adults. A cross-sectional survey was carried out with a nationally representative sample (N = 911; 50.9% women; mean age 49.5, SD = 14.1). Path analyses gave empirical support for the hypothesized model, suggesting that TB prevention behaviors are influenced by not only perceived susceptibility to the illness but also social factors such as cues to action and one's concern to benefit others. The findings have implications for research examining health communication tailored to individual differences in personality and interpersonal concern.	[Yoshitake, Naomi] Juntendo Univ, Fac Int Liberal Arts, Tokyo, Japan; [Omori, Mika; Sugawara, Masumi; Akishinonomiya, Kiko; Shimada, Sachiko] Ochanomizu Univ, Dept Psychol, Tokyo, Japan	Juntendo University; Ochanomizu University	Yoshitake, N (corresponding author), Juntendo Univ, Fac Int Liberal Arts, Tokyo, Japan.	n-yoshitake@juntendo.ac.jp			Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was funded by a research grant to K.A. from the Japan Society for the Promotion of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akishinonomiya K., 2013, KEKKAKU, V88, P525; BECKER MH, 1975, MED CARE, V13, P10, DOI 10.1097/00005650-197501000-00002; Champion V, 2005, RES NURS HEALTH, V28, P329, DOI 10.1002/nur.20088; Chang Li-Chun, 2007, J Nurs Res, V15, P78; Cornelis I, 2013, J APPL SOC PSYCHOL, V43, P456, DOI 10.1111/j.1559-1816.2013.01029.x; Costa P.T., 2008, SAGE HDB PERSONALITY, P179, DOI [10.4135/9781849200479.n9, DOI 10.4135/9781849200479.N9, 10.4135/9781849200479.N9]; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Karasz A, 2005, SOC SCI MED, V60, P1625, DOI 10.1016/j.socscimed.2004.08.011; Legler J, 2002, CANCER EPIDEM BIOMAR, V11, P59; LEVENTHAL H, 1983, HEALTH EDUC QUART, V10, P3, DOI 10.1177/109019818301000101; Li M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159780; Li ZT, 2015, PUBLIC HEALTH, V129, P907, DOI 10.1016/j.puhe.2015.04.008; Mattson M, 1999, COMMUN MONOGR, V66, P240, DOI 10.1080/03637759909376476; Nagafusa Noriyuki, 2012, Shinrigaku Kenkyu, V83, P470; Poss J E, 2001, ANS Adv Nurs Sci, V23, P1; Rimer BK, 2001, HEALTH EDUC BEHAV, V28, P231, DOI 10.1177/109019810102800208; Rodriguez-Reimann Dolores I, 2004, J Immigr Health, V6, P51, DOI 10.1023/B:JOIH.0000019165.09266.71; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Saito K., 1999, B AICHI SHUKUTOKU U, V24, P67; Shimonaka Y., 1998, JAPANESE J PERSONAL, V6, P138, DOI [10.2132/jjpjspp.6.2_138, DOI 10.2132/JJPJSPP.6.2_138]; Sirois FM, 2015, PERS INDIV DIFFER, V87, P59, DOI 10.1016/j.paid.2015.07.031; Smith TW, 2006, ANNU REV CLIN PSYCHO, V2, P435, DOI 10.1146/annurev.clinpsy.2.022305.095257; Smith TW, 2006, CURR DIR PSYCHOL SCI, V15, P227, DOI 10.1111/j.1467-8721.2006.00441.x; Triandis H. C., 1990, NEBRASKA S MOTIVATIO, P41; Tuberculosis Surveillance Center, 2016, TUB JAP ANN REP; Weber K, 2015, AGING MENT HEALTH, V19, P151, DOI 10.1080/13607863.2014.920295; Wyss LL, 2007, ONLINE J ISSUES NURS, V12, P7, DOI DOI 10.3912/0JIN.V0L12N01PPT01	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 22	2019	14	2							e0211728	10.1371/journal.pone.0211728	http://dx.doi.org/10.1371/journal.pone.0211728			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HM8DR	30794563	Green Published, Green Submitted, gold			2022-12-26	WOS:000459709100024
J	Liao, DQ; Zhu, J; Zhang, MH; Li, XE; Sun, P; Wei, JH; Qi, JJ				Liao, Dengqun; Zhu, Juan; Zhang, Menghuan; Li, Xian'en; Sun, Peng; Wei, Jianhe; Qi, Jianjun			Comparative transcriptomic analysis reveals genes regulating the germination of morphophysiologically dormant Paris polyphylla seeds during a warm stratification	PLOS ONE			English	Article							ABSCISIC-ACID; ARABIDOPSIS; HOMEOSTASIS; BIOSYNTHESIS; ACCUMULATION; GIBBERELLINS; MATURATION; ETHYLENE; MUTANTS; GROWTH	We previously analyzed the expression of genes associated with Paris polyphylla var. yunna-nensis seed maturation and dormancy release; however, we were unable to clarify the relationship between gene expression levels and these processes. To reveal the molecular mechanisms underlying P. polyphylla var. yunnanensis seed dormancy release during a warm stratification, the transcriptomes of dormant and germinating P. polyphylla var. yunna-nensis seeds were separately analyzed by RNA sequencing and were also compared with the transcriptomes of stem-leaf and root tissues harvested during the seed maturation stage. The RNA sequencing of five tissues generated 234,331 unigenes, of which 10,137 (4.33%) were differentially expressed among the analyzed tissues. The 6,619 unigenes whose expression varied among mature dormant, sprouted, and germinated seeds included 95 metabolic and 62 signaling genes related to abscisic acid, gibberellin, auxin, brassinosteroid, cytokinin, ethylene, jasmonic acid and salicylic acid. Additionally, 243 differentially expressed genes were annotated as known seed dormancy/germination-related genes. Among these genes, 109 were regulated by hormones or involved in hormone signal transduction. Finally, 310 transcription factor unigenes, including 71 homologs of known seed dormancy/germination-related genes, were observed to be differentially expressed during a warm stratification. These results confirm that multiple hormones and transcription factors influence P. polyphylla var. yunnanensis seed dormancy release and germination during a warm stratification. This study identified candidate genes (e.g., ABI5) that should be cloned and functionally characterized regarding their effects on the release of P. polyphylla var. yunnanensis seed morphophysiological dormancy.	[Liao, Dengqun; Zhu, Juan; Zhang, Menghuan; Li, Xian'en; Sun, Peng; Wei, Jianhe; Qi, Jianjun] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China; [Liao, Dengqun; Zhu, Juan; Zhang, Menghuan; Li, Xian'en; Sun, Peng; Wei, Jianhe; Qi, Jianjun] Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Qi, JJ (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing, Peoples R China.	jjqi@implad.ac.cn			National Natural Science Foundation of China [31471575, 31171623]; CAMS Initiative for Innovative Medicine [2016-I2M-2-003, 2017-I2M-3-013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Initiative for Innovative Medicine	This work was supported by the National Natural Science Foundation of China (31471575, and 31171623 to JQ) and the CAMS Initiative for Innovative Medicine (2016-I2M-2-003 to JQ, 2017-I2M-3-013 to XL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Antoni R, 2012, PLANT PHYSIOL, V158, P970, DOI 10.1104/pp.111.188623; Ariizumi T, 2007, PLANT CELL, V19, P791, DOI 10.1105/tpc.106.048009; Barrero JM, 2009, PLANT PHYSIOL, V150, P1006, DOI 10.1104/pp.109.137901; Bi C, 2017, PLANT MOL BIOL, V94, P197, DOI 10.1007/s11103-017-0603-y; Chen ShuYing, 2011, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V42, P793; Chen W, 2011, HUBEI AGR SCI, V50, P972; Chen Wei, 2015, Southwest China Journal of Agricultural Sciences, V28, P783; Chitnis VR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087543; Chung HY, 2010, PLANT CELL REP, V29, P397, DOI 10.1007/s00299-010-0830-z; Corbineau F, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00539; Dong T, 2014, PLANT PHYSIOL, V165, P277, DOI 10.1104/pp.114.239210; Dong XY, 2015, MODERN AGR SCI TECHN, V3, P78; Gao WX, 2006, FOREST INVENTORY PLA, V1, P100; Gillespie LM, 2017, ANN BOT-LONDON, V119, P311, DOI 10.1093/aob/mcw264; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Han C, 2015, PROTEOMICS, V15, P1671, DOI 10.1002/pmic.201400375; Hauvermale AL, 2015, PLANT CELL PHYSIOL, V56, P1773, DOI 10.1093/pcp/pcv084; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Huang W, 2008, CHINESE AGR SCI B, V24, P242; Kim HJ, 2016, CURR OPIN PLANT BIOL, V33, P48, DOI 10.1016/j.pbi.2016.06.002; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Ma, 2015, Journal of Yunnan Agricultural University, V30, P766; Li ShaoPing, 2008, Southwest China Journal of Agricultural Sciences, V21, P956; Li XJ, 2016, PLANT BIOTECHNOL J, V14, P1021, DOI 10.1111/pbi.12474; Li Zhao-ling, 2015, Zhongguo Zhong Yao Za Zhi, V40, P629; Ling LZ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010219; Linkies A, 2012, PLANT CELL REP, V31, P253, DOI 10.1007/s00299-011-1180-1; Liu AH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056536, 10.1371/journal.pone.0057359, 10.1371/journal.pone.0056570, 10.1371/journal.pone.0054001]; Liu ZH, 2015, MOL PLANT, V8, P1751, DOI 10.1016/j.molp.2015.09.002; Nonogaki H, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00233; Oh E, 2009, PLANT CELL, V21, P403, DOI 10.1105/tpc.108.064691; Pu Mei, 2016, Forest Research, V29, P268; Qi JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-358; Riefler M, 2006, PLANT CELL, V18, P40, DOI 10.1105/tpc.105.037796; Sandhu KS, 2012, G3-GENES GENOM GENET, V2, P1585, DOI 10.1534/g3.112.004580; Shang XL, 2016, J INTEGR PLANT BIOL, V58, P627, DOI 10.1111/jipb.12444; Shim D, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.59; Shu K, 2016, MOL PLANT, V9, P34, DOI 10.1016/j.molp.2015.08.010; Skubacz A, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01884; Stotz HU, 2013, J EXP BOT, V64, P963, DOI 10.1093/jxb/ers389; Szostkiewicz I, 2010, PLANT J, V61, P25, DOI 10.1111/j.1365-313X.2009.04025.x; Tang L, 2015, J YUNNAN U TRADITION, V5, P37; To JPC, 2008, TRENDS PLANT SCI, V13, P85, DOI 10.1016/j.tplants.2007.11.005; Varbanova M, 2007, PLANT CELL, V19, P32, DOI 10.1105/tpc.106.044602; Verhoef N, 2013, J EXP BOT, V64, P2435, DOI 10.1093/jxb/ert102; Wang YF, 2012, J YUNNAN U TRADITION, V35, P28; Wu Z, 2017, J NAT MED-TOKYO, V71, P139, DOI 10.1007/s11418-016-1043-8; Xu W, 2013, THESIS; Yang YG, 2017, BIOMED CHROMATOGR, V31, DOI 10.1002/bmc.3913; Yoneyama K, 1998, BIOSCI BIOTECH BIOCH, V62, P1448, DOI 10.1271/bbb.62.1448; [袁理春 Yuan Lichun], 2003, [种子, Seed], V0, P33; Zander M, 2010, PLANT J, V61, P200, DOI 10.1111/j.1365-313X.2009.04044.x; Zeng QY, 2016, CENTRAL S PHARM, V12, P1328; Zhang L, 2013, CHINESE PHARM J, V48, P1917; [张绍山 Zhang Shaoshan], 2017, [中草药, Chinese Traditional and Herbal Drugs], V48, P2111; Zhao J, 2014, J YUNNAN U TRADITION, V37, P28; Zhao TZ., 2014, CHIN WILD PLANT RES, V33, P61, DOI [10.3969/j.issn.1006-9690.2014.05.017, DOI 10.3969/J.ISSN.1006-9690.2014.05.017]	61	5	8	4	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212514	10.1371/journal.pone.0212514	http://dx.doi.org/10.1371/journal.pone.0212514			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789936	Green Submitted, Green Published, gold			2022-12-26	WOS:000459330800033
J	Zeppelini, D; Queiroz, GC; Lopes, NP; Mendonca, FJB				Zeppelini, Douglas; Queiroz, Gabriel C.; Lopes, Norberto P.; Mendonca-Junior, Francisco J. B.			Chemical analysis of Brasilimeria Stach, 1949 (Hexapoda, Collembola, Neanuridae) hemolymphatic secretion, and description of a new species	PLOS ONE			English	Article							VOLATILE CONSTITUENTS; MASS-SPECTROMETRY; LEAVES	Though Collembola is a widespread hexapod its use of chemical compounds for defense has been reported for only a few European species. Chemical composition analyses of the hemolymphatic secretion of Neotropical Collembola using Gas Chromatography with Mass Spectrometry (GC-MS) has been performed for the first time. The GC-MS analysis revealed 32 constituents, such as aliphatic and aromatic hydrocarbons, esters, alcohols, a phenol, an aldehyde and a ketone. Benzyl benzoate, the main component (at 46.98%), is a compound with known acaricide and insecticide properties. This is the first report on chemical constituents produced by Neotropical Pseudachorutinae, genus Brasilimeria, and will permit future secretion comparisons for Collembola. The taxonomic description of the species producing the secretion analyzed is provided; Brasilimeria assu sp. nov. (Collembola, Neanuridae, Pseudachorutinae) is the third known species of the genus; an updated diagnosis of the genus, an identification key, and further remarks on the species Brasilimeria Stach, 1949 are provided.	[Zeppelini, Douglas] State Univ Paraiba, Dept Biol Sci, Lab Sistemat Colembolla & Conservacao, Joao Pessoa, PB, Brazil; [Queiroz, Gabriel C.] Univ Fed Rio de Janeiro, Nacl Museum, Dept Entomol, Setor Apterygota, Rio De Janeiro, RJ, Brazil; [Lopes, Norberto P.] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Chem & Phys, Nucleo Pesquisa Prod Nat & Sintet, Ribeirao Preto, SP, Brazil; [Mendonca-Junior, Francisco J. B.] State Univ Paraiba, Dept Biol Sci, Lab Sintese & Vetorizacao Mol, Joao Pessoa, PB, Brazil	Universidade Estadual da Paraiba; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Estadual da Paraiba	Zeppelini, D (corresponding author), State Univ Paraiba, Dept Biol Sci, Lab Sistemat Colembolla & Conservacao, Joao Pessoa, PB, Brazil.	zeppelini@daad-alumni.de	QUEIROZ, GABRIEL COSTA/D-7413-2015; JUNIOR, FRANCISCO JAIME BEZERRA MENDONÇA/J-2926-2015; Lopes, Norberto P/C-7148-2012	QUEIROZ, GABRIEL COSTA/0000-0001-9917-1755; JUNIOR, FRANCISCO JAIME BEZERRA MENDONÇA/0000-0003-3588-833X; Lopes, Norberto P/0000-0002-8159-3658; zeppelini, douglas/0000-0002-9026-1129	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ [302673/2015-6, 308590/2017-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PDJ [150451/2015-6, 451149/2016-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PDJ; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by: D. Zeppelini, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ #302673/2015-6; Francisco J. B. Mendonca-Junior, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) PQ #308590/2017-1; Gabriel C. Queiroz, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)-PDJ #150451/2015-6 and #451149/2016-5, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) -Finance Code 001.	Aksenov AA, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0054; [Anonymous], 1981, CHEM DEFENSES ARTHRO; ARLE R., 1939, BOL BIOL [SAO PAULO], V4, P67; Bastos IVGA, 2017, AN ACAD BRAS CIENC, V89, P991, DOI 10.1590/0001-3765201720160586; Bellinger P.F., CHECKLIST COLLEMBOLA; BELLINGER PETER F., 1960, ENT NEWS, V71, P254; Botre F, 2008, EXPERT REV PROTEOMIC, V5, P535, DOI 10.1586/14789450.5.4.535; Brunetti AE, 2018, ACS OMEGA, V3, P5426, DOI 10.1021/acsomega.7b02029; Burns DA, 2010, ROOKS TXB DERMATOLOG, P38; Cassagnau P, 1962, COLLEMBOLES AM SUD P, V1, P139; Cassagnau P, 1989, 3 INT SEM APT SIEN, P171; D'Haese C, 2003, EUROPEAN J ENTOMOLOG, V101, P385, DOI [10.14411/eje.2003.060, DOI 10.14411/EJE.2003.060]; De Lima W, 2015, NAT PROD COMMUN, V10, P1321; Deharveng L, 2004, PEDOBIOLOGIA, V48, P415, DOI 10.1016/j.pedobi.2004.08.001; Dettner K, 1996, J CHEM ECOL, V22, P1051, DOI 10.1007/BF02029954; Essien EE, 2019, NAT PROD RES, V33, P1637, DOI 10.1080/14786419.2018.1425842; Faddeeva A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130600; GOHLKE RS, 1993, J AM SOC MASS SPECTR, V4, P367, DOI 10.1016/1044-0305(93)85001-E; Gurevich A, 2018, NAT MICROBIOL, V3, P319, DOI 10.1038/s41564-017-0094-2; Hayes Jr WJ, 1990, HDB PESTICIDE TOXICO, P1505; Hopkin S.P., 1997, BIOL SPRINGTAILS INS; Jannetto PJ, 2016, CLIN CHEM, V62, P92, DOI 10.1373/clinchem.2015.248146; Kildgaard S, 2014, MAR DRUGS, V12, P3681, DOI 10.3390/md12063681; KULAKKATTOLICKAL AT, 1989, AQUACULTURE, V78, P293, DOI 10.1016/0044-8486(89)90107-5; Laurent P, 2005, TOP CURR CHEM, V240, P167; Martinez LC, 2018, B ENTOMOL RES, V108, P716, DOI 10.1017/S0007485317001262; Massoud Z, BIOL AM AUSTRALE, V3; Messer C, 1999, PEDOBIOLOGIA, V43, P174; Messer C, 2000, PEDOBIOLOGIA, V44, P210, DOI 10.1078/S0031-4056(04)70041-4; Oliveira Elisiana, 1994, Bulletin de la Societe Entomologique de France, V99, P389; Pang GF, 2018, J AOAC INT, V101, P1156, DOI 10.5740/jaoacint.17-0125; Pico Y, 2015, ADV MASS SPECTROMETR, V68; Plata-Rueda A, 2018, ECOTOX ENVIRON SAFE, V156, P263, DOI 10.1016/j.ecoenv.2018.03.033; Queiroz GC, 2017, ZOOL ANZ, V269, P127, DOI 10.1016/j.jcz.2017.08.005; Queiroz Gabriel Costa, 2014, Soil Organisms, V86, P169; Satyal P, 2015, NAT PROD COMMUN, V10, P361; Schulz S, 1997, TETRAHEDRON LETT, V38, P2077, DOI 10.1016/S0040-4039(97)00341-9; Shaikh J., 2005, ENCY TOXICOLOGY, V1, P264; Stach J., 1949, ACTA MONOGRAPHICA MU; Stranska-Zachariasova M, 2016, J CHROMATOGR B, V1015, P22, DOI 10.1016/j.jchromb.2016.01.050; WHO, 2009, MOD FORM 2008, P311; Yang KeDi, 2009, Guangxi Zhiwu / Guihaia, V29, P424; Zhang N, 2016, PHYTOMEDICINE, V23, P1727, DOI 10.1016/j.phymed.2016.10.017	43	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 21	2019	14	2							e0212451	10.1371/journal.pone.0212451	http://dx.doi.org/10.1371/journal.pone.0212451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2WC	30789930	Green Submitted, gold, Green Published			2022-12-26	WOS:000459330800029
J	Sagami, S; Kobayashi, T; Kikkawa, N; Umeda, S; Nakano, M; Toyonaga, T; Okabayashi, S; Ozaki, R; Hibi, T				Sagami, Shintaro; Kobayashi, Taku; Kikkawa, Nao; Umeda, Satoko; Nakano, Masaru; Toyonaga, Takahiko; Okabayashi, Shinji; Ozaki, Ryo; Hibi, Toshifumi			Combination of colonoscopy and magnetic resonance enterography is more useful for clinical decision making than colonoscopy alone in patients with complicated Crohn's disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; EVIDENCE-BASED CONSENSUS; SMALL-INTESTINE; CAPSULE ENDOSCOPY; MANAGEMENT; VALIDATION; BIOMARKERS; DIAGNOSIS; SEVERITY; ACCURACY	Background/aims The small bowel is affected in more than half of patients with Crohn's disease (CD) at the time of diagnosis, and small bowel involvement has a negative impact on the long-term outcome. Many patients reportedly have active lesions in the small intestine even in patients in clinical remission. This study was performed to compare findings of magnetic resonance enterography (MRE) and ileocolonoscopy. Methods A single-center retrospective study was conducted in 50 patients (60 imaging series) with CD, for whom MRE was additionally performed during the bowel preparation for subsequent ileocolonoscopy. Endoscopic remission was defined as a Simple Endoscopic Score for CD (SES-CD) of <5. MRE remission was defined as a Magnetic Resonance Index of Activity (MaRIA) score of <50. The time to treatment escalation was assessed by the log-rank test. Results Importantly, 7 of 29 patients (24.1%) with endoscopic remission had a MaRIA score of >= 50. Both SES-CD and MaRIA correlated with the need for treatment escalation (P = 0.025, P = 0.009, respectively). MRE predicted the need for treatment escalation even in patients with endoscopic remission. Although no correlation was present between SES-CD and MaRIA score in patients with structuring/penetrating disease, or insufficient ileal insertion (<10cm), a high MaRIA score still correlated with the need for treatment escalation in stricturing or penetrating disease (P=0.0306). Conclusions The MaRIA score predicts the need for treatment escalation even in patients with endoscopic remission, indicating that addition of MRE to conventional ileocolonoscopy alone can be a useful, noninvasive tool for monitoring CD especially in stricturing or penetrating disease.	[Sagami, Shintaro; Kobayashi, Taku; Nakano, Masaru; Toyonaga, Takahiko; Okabayashi, Shinji; Ozaki, Ryo; Hibi, Toshifumi] Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Minato Ku, Tokyo, Japan; [Kikkawa, Nao] Kitasato Univ, Kitasato Inst Hosp, Dept Radiol, Minato Ku, Tokyo, Japan; [Umeda, Satoko] Keio Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol,Shinjuku Ku, Tokyo, Japan; [Nakano, Masaru; Toyonaga, Takahiko; Ozaki, Ryo] Kitasato Univ, Kitasato Inst Hosp, Dept Gastroenterol & Hepatol, Minato Ku, Tokyo, Japan	Kitasato University; Kitasato University; Keio University; Kitasato University	Kobayashi, T (corresponding author), Kitasato Univ, Kitasato Inst Hosp, Ctr Adv IBD Res & Treatment, Minato Ku, Tokyo, Japan.	kobataku@insti.kitasato-u.ac.jp	Sagami, Shintaro/ABB-4369-2020; Kobayashi, Taku/AAO-6437-2020; Sagami, Shintaro/AAU-4476-2021	Kobayashi, Taku/0000-0002-2073-4234; Sagami, Shintaro/0000-0002-1202-8161; Okabayashi, Shinji/0000-0003-2683-9018				Annese V, 2013, J CROHNS COLITIS, V7, P982, DOI 10.1016/j.crohns.2013.09.016; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Colombel JF, 2017, LANCET, V390, P2779, DOI 10.1016/S0140-6736(17)32641-7; COREMANS G, 1984, GASTROINTEST ENDOSC, V30, P167, DOI 10.1016/S0016-5107(84)72358-3; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; De Cruz P, 2013, INFLAMM BOWEL DIS, V19, P429, DOI 10.1002/ibd.22977; Florie J, 2005, CLIN GASTROENTEROL H, V3, P1221, DOI 10.1016/S1542-3565(05)00853-0; Florin THJ, 2006, SCAND J GASTROENTERO, V41, P306, DOI 10.1080/00365520500217118; Garcia-Bosch O, 2016, J CROHNS COLITIS, V10, P663, DOI 10.1093/ecco-jcc/jjw015; Gauss A, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003477; Gomollon F, 2017, J CROHNS COLITIS, V11, P3, DOI 10.1093/ecco-jcc/jjw168; Hanauer SB, 2001, AM J GASTROENTEROL, V96, P635; HARVEY RF, 1980, LANCET, V1, P514; Henriksen M, 2007, SCAND J GASTROENTERO, V42, P602, DOI 10.1080/00365520601076124; Jones J, 2008, CLIN GASTROENTEROL H, V6, P1218, DOI 10.1016/j.cgh.2008.06.010; Khanna R, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010642.pub2; Kopylov U, 2015, INFLAMM BOWEL DIS, V21, P2726, DOI 10.1097/MIB.0000000000000497; Kopylov U, 2015, AM J GASTROENTEROL, V110, P1316, DOI 10.1038/ajg.2015.221; Lakatos PL, 2005, HEPATO-GASTROENTEROL, V52, P817; Louis E, 2001, GUT, V49, P777, DOI 10.1136/gut.49.6.777; Manser CN, 2014, INFLAMM BOWEL DIS, V20, P1548, DOI 10.1097/MIB.0000000000000123; Mendoza JL, 2012, REV ESP ENFERM DIG, V104, P578, DOI 10.4321/S1130-01082012001100005; Naganuma M, 2017, ABDOM RADIOL, V42, P141, DOI 10.1007/s00261-016-0878-5; Ordas I, 2014, GASTROENTEROLOGY, V146, P374, DOI 10.1053/j.gastro.2013.10.055; Ordas I, 2012, CURR DRUG TARGETS, V13, P1252, DOI 10.2174/138945012802429714; Rezvan PH, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0022-1; Rimola J, 2009, GUT, V58, P1113, DOI 10.1136/gut.2008.167957; Rimola J, 2011, INFLAMM BOWEL DIS, V17, P1759, DOI 10.1002/ibd.21551; Sato H, 2015, J GASTROEN HEPATOL, V30, P667, DOI 10.1111/jgh.12851; Steward MJ, 2012, EUR J RADIOL, V81, P2080, DOI 10.1016/j.ejrad.2011.07.013; Takenaka K, 2017, AM J GASTROENTEROLOG; Takenaka K, 2015, INFLAMM BOWEL DIS, V21, P1832, DOI 10.1097/MIB.0000000000000449; Takenaka K, 2014, GASTROENTEROLOGY, V147, P334, DOI 10.1053/j.gastro.2014.04.008; Taylor SA, 2018, LANCET GASTROENTEROL, V3, P548, DOI 10.1016/S2468-1253(18)30161-4; van der Heijden GJMG, 2006, J CLIN EPIDEMIOL, V59, P1102, DOI 10.1016/j.jclinepi.2006.01.015; Yoon HM, 2017, JAMA PEDIATR, V171, P1208, DOI 10.1001/jamapediatrics.2017.3400	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212404	10.1371/journal.pone.0212404	http://dx.doi.org/10.1371/journal.pone.0212404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785943	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000060
J	Shimshoni, JA; Sperling, R; Massarwa, M; Chen, Y; Bommuraj, V; Borisover, M; Barel, S				Shimshoni, Jakob A.; Sperling, Roy; Massarwa, Muhammad; Chen, Yaira; Bommuraj, Vijayakumar; Borisover, Mikhail; Barel, Shimon			Pesticide distribution and depletion kinetic determination in honey and beeswax: Model for pesticide occurrence and distribution in beehive products	PLOS ONE			English	Article							MULTIRESIDUE METHOD; RESIDUES; POLLEN; DEGRADATION; HIVE; NEONICOTINOIDS; STABILITY; EXPOSURE	Beehive products such as honey, beeswax and recently pollen have been regarded for many years as appropriate sentinels for environmental pesticide pollutions. However, despite yearly application of hundreds of approved pesticides in agricultural fields, only a minor fraction of these organic compounds were actually detected in honey and beeswax samples. This observation has led us to question the general suitability of beehive products as a sentinel for synthetic organic pesticides applied in the field. The aim of the present study was to experimentally determine the distribution (logarithmic ratio of beeswax to honey pesticide concentration, LogD) and depletion kinetics (half-life) of selected pesticides in honey and beeswax as a measure of the latter matrixes to serve as a pesticide sentinel. The obtained parameters were used to extrapolate to pesticide burden in honey and beeswax samples collected from German and Israeli apiaries. In addition, we aimed to establish a mathematical model, enabling us to predict distribution of selected pesticides between honey to beeswax, by utilizing simple substance descriptors, namely, octanol/water partitioning coefficient, molar weight and Henry coefficient. Based on the present results, it appears that pesticides with LogD values > 1 and half-life in beeswax > 1 day, were likely to accumulate and detected in beeswax samples, and less likely to be found in honey. On the other hand, pesticides with negative LogD values were highly likely to be found in honey and less so in beeswax samples. Finally, pesticides with LogD values between 0-1 were expected to be found in both matrixes. The developed model was successfully applied to predict LogD values, thereby identifying octanol/water partitioning and molar weight as the most prominent substance descriptors, which affect pesticide distribution between honey and beeswax.	[Shimshoni, Jakob A.; Chen, Yaira; Bommuraj, Vijayakumar] Agr Res Org, Volcani Ctr, Dept Food Qual & Safety, Inst Postharvest & Food Sci, Rishon Leziyyon, Israel; [Sperling, Roy] Bilacon GMbH, Dept Instrumental Analyt, Berlin, Germany; [Massarwa, Muhammad] Minist Agr, Inst Plant Protect & Inspect Serv, Dept Feed Qual Lab, Rishon Leziyyon, Israel; [Borisover, Mikhail] Agr Res Org, Dept Soil Chem Plant Nutr & Microbiol, Inst Soil Water & Environm Sci, Volcani Ctr, Rishon Leziyyon, Israel; [Barel, Shimon] Kimron Vet Inst, Dept Toxicol, Bet Dagan, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Kimron Veterinary Institute	Shimshoni, JA (corresponding author), Agr Res Org, Volcani Ctr, Dept Food Qual & Safety, Inst Postharvest & Food Sci, Rishon Leziyyon, Israel.	jakobshimshoni@gmail.com	Borisover, Mikhail/AAE-5577-2020	Bommuraj, Vijayakumar/0000-0003-3947-0117	Bilacon GMbH	Bilacon GMbH	Dr. Jakob Shimshoni is a young PI, who joined the Volcani Institute as a young researcher in May 2017. Every young scientist receives from the Volcani Institute seed money for two years. This latter budget was used for financing the analytical services provided by Bilacon GMbH. Otherwise no additional financial support was provided. Dr. Jakob Shimshoni, whose budget was used for financing the analytical services provided by Bilacon GMbH, receives regardless of the present project, salary from the Volcani Institute, Israel. Bilacon GMbH provided support in the form of salaries for author RS, but did not have any additional role in the study design, data collection and decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Aichholz R, 1999, J CHROMATOGR A, V855, P601, DOI 10.1016/S0021-9673(99)00725-6; Al-Alam J, 2017, ANAL BIOANAL CHEM, V409, P5157, DOI 10.1007/s00216-017-0463-y; Amulen DR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178546; Anastassiades M, 2003, J AOAC INT, V86, P412; Anderson KE, 2014, MOL ECOL, V23, P5904, DOI 10.1111/mec.12966; Arnot JA, 2004, ENVIRON TOXICOL CHEM, V23, P2343, DOI 10.1897/03-438; Boi M, 2016, PEST MANAG SCI, V72, P1366, DOI 10.1002/ps.4161; Calatayud-Vernich P, 2017, SCI TOTAL ENVIRON, V605, P745, DOI 10.1016/j.scitotenv.2017.06.174; Chauzat MP, 2011, ENVIRON TOXICOL CHEM, V30, P103, DOI 10.1002/etc.361; Chiesa LM, 2018, FOOD ADDIT CONTAM A, V35, P1340, DOI 10.1080/19440049.2018.1451660; COATS JR, 1991, ACS SYM SER, V459, P10; da Silva PM, 2016, FOOD CHEM, V196, P309, DOI 10.1016/j.foodchem.2015.09.051; de Oliveira RC, 2016, CHEMOSPHERE, V163, P525, DOI 10.1016/j.chemosphere.2016.08.022; European Commission, 2013, SUMM REP STAND COMM; Farha W, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5709-1; Finizio A, 1997, CHEMOSPHERE, V34, P131, DOI 10.1016/S0045-6535(96)00355-4; Gibaldi M, 1982, PHARMACOKINETICS; Goss KU, 2001, ENVIRON SCI TECHNOL, V35, P1, DOI 10.1021/es000996d; Iyer M, 2002, PHARMACEUT RES, V19, P1611, DOI 10.1023/A:1020792909928; JAN J, 1993, B ENVIRON CONTAM TOX, V51, P640, DOI 10.1007/BF00201639; Jin XC, 2017, ENVIRON SCI-PROC IMP, V19, P300, DOI 10.1039/c6em00626d; Kah M, 2007, J AGR FOOD CHEM, V55, P4487, DOI 10.1021/jf0635356; Kochansky J, 2001, APIDOLOGIE, V32, P119, DOI 10.1051/apido:2001117; Korta E, 2001, J AGR FOOD CHEM, V49, P5835, DOI 10.1021/jf010787s; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Laidler KJ., 1982, PHYS CHEM, P18; Majewski MS, 1995, PESTICIDES ATMOSPHER, P94; Mitchell EAD, 2017, SCIENCE, V358, P109, DOI 10.1126/science.aan3684; Nazzi F, 2014, TRENDS PARASITOL, V30, P556, DOI 10.1016/j.pt.2014.09.006; Niell S, 2015, J AGR FOOD CHEM, V63, P4484, DOI 10.1021/acs.jafc.5b00795; OECD, 1995, TEST NO 107 PARTITIO, DOI 10.1787/9789264069626-en; Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x; Perugini M, 2018, SCI TOTAL ENVIRON, V625, P470, DOI 10.1016/j.scitotenv.2017.12.321; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sharma AK, 2014, J AGR FOOD CHEM, V62, P6577, DOI 10.1021/jf5017175; Silvina N, 2017, SCI TOTAL ENVIRON, V581, P25, DOI 10.1016/j.scitotenv.2017.01.011; Tosi S, 2018, SCI TOTAL ENVIRON, V615, P208, DOI 10.1016/j.scitotenv.2017.09.226; Tulp HC, 2008, ENVIRON SCI TECHNOL, V42, P2034, DOI 10.1021/es702473f; Valdovinos-Flores C, 2017, J APICULT RES, V56, P667, DOI 10.1080/00218839.2017.1340798; Wilmart O, 2016, J AGR FOOD CHEM, V64, P8425, DOI 10.1021/acs.jafc.6b02813; Wolt JD, 2001, REV ENVIRON CONTAM T, V169, P123	42	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2								10.1371/journal.pone.0212631	http://dx.doi.org/10.1371/journal.pone.0212631			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785931	Green Published, Green Submitted, gold			2022-12-26	WOS:000459307000076
J	Ventura, M; Belleudi, V; Sciattella, P; Di Domenicantonio, R; Di Martino, M; Agabiti, N; Davoli, M; Fusco, D				Ventura, Martina; Belleudi, Valeria; Sciattella, Paolo; Di Domenicantonio, Riccardo; Di Martino, Mirko; Agabiti, Nera; Davoli, Marina; Fusco, Danilo			High quality process of care increases one-year survival after acute myocardial infarction (AM I): A cohort study in Italy	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; TO-BALLOON TIME; ACUTE CORONARY SYNDROMES; LONG-TERM SURVIVAL; OBSTRUCTIVE PULMONARY-DISEASE; PRIMARY ANGIOPLASTY; MEDICAL THERAPY; SECONDARY PREVENTION; HOSPITAL MORTALITY; TASK-FORCE	Background The relationship between guideline adherence and outcomes in patients with acute myocardial infarction (AMI) has been widely investigated considering the emergency, acute, post acute phases separately, but the effectiveness of the whole care process is not known. Aim The study aim was to evaluate the effect of the multicomponent continuum of care on 1-year survival after AMI. Methods We conducted a cohort study selecting all incident cases of AMI from health information systems during 2011-2014 in the Lazio region. Patients' clinical history was defined by retrieving previous hospitalizations and drugs prescriptions. For each subject the probability to reach the hospital and the conditional probabilities to survive to 30 days from admission and to 31-365 days post discharge were estimated through multivariate logistic models. The 1-year survival probability was calculated as the product of the three probabilities. Quality of care indicators were identified in terms of emergency timeliness (time between residence and the nearest hospital), hospital performance in treatment of acute phase (number/timeliness of PCI on STEMI) and drug therapy in post-acute phase (number of drugs among anti platelet, (beta-blockers, ACE inhibitors/ARBs, statins). The 1-year survival Probability Ratio (PR) and its Bootstrap Confidence Intervals (BCI) between who were exposed to the highest level of quality of care (timeliness<10', hospitalization in high performance hospital, complete drug therapy) and who exposed to the worst (timeliness >= 10', hospitalization in low performance hospital, suboptimal drug therapy) were calculated fora mean-severity patient and varying gender and age. PRs for patients with diabetes and COPD were also evaluated. Results We identified 38,517 incident cases of AMI. The out-of-hospital mortality was 27.6%. Among the people arrived in hospital, 42.9% had a hospitalization for STEMI with 11.1% of mortality in acute phase and 5.4% in post-acute phase. For a mean-severity patient the PR was 1.19 (BCI 1.14-1.24). The ratio did not change by gender, while it moved from 1.06 (BCI 1.05-1.08) for age<65 years to 1.62 (BCI 1.45-1.80) for age >85 years. For patients with diabetes and COPD a slight increase in PRs was also observed. Conclusions The 1-year survival probability post AMI depends strongly on the quality of the whole multi component continuum of care. Improving the performance in the different phases, taking into account the relationship among these, can lead to considerable saving of lives, in particular for the elderly and for subjects with chronic diseases.	[Ventura, Martina; Belleudi, Valeria; Di Domenicantonio, Riccardo; Di Martino, Mirko; Agabiti, Nera; Davoli, Marina; Fusco, Danilo] Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy; [Sciattella, Paolo] Sapienza Univ Rome, Dept Stat Sci, Rome, Italy	Sapienza University Rome	Agabiti, N (corresponding author), Lazio Reg Hlth Serv, Dept Epidemiol, Rome, Italy.	n.agabiti@deplazio.it	Di Domenicantonio, Riccardo/HII-5605-2022; Belleudi, Valeria/J-9070-2016; belleudi, valeria/AAR-4553-2021; Fusco, Danilo/AAB-8646-2019; Di Domenicantonio, Riccardo/H-7867-2018; Agabiti, Nera/K-1053-2016	Belleudi, Valeria/0000-0002-8286-443X; belleudi, valeria/0000-0002-8286-443X; Fusco, Danilo/0000-0003-1759-5621; Di Domenicantonio, Riccardo/0000-0002-9726-0786; Agabiti, Nera/0000-0003-3385-1197; SCIATTELLA, PAOLO/0000-0002-8364-1895				Agarwal M, 2017, AM J CARDIOL, V119, P1555, DOI 10.1016/j.amjcard.2017.02.024; Kirchberger I, 2014, AM J CARDIOL, V114, P329, DOI 10.1016/j.amjcard.2014.04.046; Amann U, 2014, CLIN RES CARDIOL, V103, P655, DOI 10.1007/s00392-014-0688-0; [Anonymous], 2017, TECHNICAL REPORT; [Anonymous], 2017, LAZIO REGIONAL OUTCO; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Bates ER, 2013, NEW ENGL J MED, V369, P889, DOI 10.1056/NEJMp1308772; Belleudi V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3019-8; Belleudi V, 2012, EPIDEMIOL PREV, V36, P162; Belleudi V, 2011, PHARMACOEPIDEM DR S, V20, P169, DOI 10.1002/pds.2079; Briffa T, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b36; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; De Luca G, 2004, CIRCULATION, V109, P1223, DOI 10.1161/01.CIR.0000121424.76486.20; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; De Luca L, 2017, EUR HEART J SUPPL, V19, pD130, DOI 10.1093/eurheartj/sux013; Denktas AE, 2011, JACC-CARDIOVASC INTE, V4, P599, DOI 10.1016/j.jcin.2011.02.012; Di Domenicantonio R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158336; Di Martino M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010926; Estevez-Loureiro R, 2014, WORLD J CARDIOL, V6, P424, DOI 10.4330/wjc.v6.i6.424; Faustini A, 2012, COPD, V9, P184, DOI 10.3109/15412555.2011.654014; Fusco D, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-25; Gouya G, 2007, EUR J EPIDEMIOL, V22, P145, DOI 10.1007/s10654-006-9087-9; Henriksson C, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2014-000051; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Iezzoni LI, 1997, ANN INTERN MED, V127, P666, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00048; Jager B, 2017, EUR HEART J-ACUTE CA, V6, P254, DOI 10.1177/2048872616633882; Juliard JM, 2003, AM J CARDIOL, V91, P1401, DOI 10.1016/S0002-9149(03)00388-6; Kim HL, 2013, J KOREAN MED SCI, V28, P1749, DOI 10.3346/jkms.2013.28.12.1749; Kirchmayer U, 2013, PHARMACOEPIDEM DR S, V22, P649, DOI 10.1002/pds.3430; Koek HL, 2007, EUR J EPIDEMIOL, V22, P883, DOI 10.1007/s10654-007-9191-5; Lawesson SS, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020211; Lee JH, 2010, AM HEART J, V159, P1012, DOI 10.1016/j.ahj.2010.03.009; Lee Min Goo, 2009, Korean Circ J, V39, P243, DOI 10.4070/kcj.2009.39.6.243; Lenzi J, 2015, EUR J CLIN PHARMACOL, V71, P243, DOI 10.1007/s00228-014-1793-8; Lundberg V, 1997, J INTERN MED, V241, P485; Magid DJ, 2005, JAMA-J AM MED ASSOC, V294, P803, DOI 10.1001/jama.294.7.803; Marzolini S, 2015, CIRC-CARDIOVASC QUAL, V8, P608, DOI 10.1161/CIRCOUTCOMES.115.001751; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Mehta RH, 2002, JAMA-J AM MED ASSOC, V287, P1269, DOI 10.1001/jama.287.10.1269; Milonas C, 2010, AM J CARDIOL, V105, P1229, DOI 10.1016/j.amjcard.2009.12.032; Mukherjee D, 2004, CIRCULATION, V109, P745, DOI 10.1161/01.CIR.0000112577.69066.CB; National Clinical Guideline Centre (UK), 2013, MI SEC PREV SEC PREV; Newby LK, 1996, J AM COLL CARDIOL, V27, P1646; Nguyen HL, 2010, CIRC-CARDIOVASC QUAL, V3, P82, DOI 10.1161/CIRCOUTCOMES.109.884361; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; OECD/EU, 2016, HLTH GLANC EUR 2016, DOI [10.1787/health_glance_eur-2016-41-en, DOI 10.1787/HEALTH_GLANCE_EUR-2016-41-EN]; Piepoli MF, 2016, EUR J PREV CARDIOL, V23, P1994, DOI 10.1177/2047487316663873; Pilgrim T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137047; Rathore SS, 2009, AM J CARDIOL, V104, P1198, DOI 10.1016/j.amjcard.2009.06.034; Renzi C, 2014, INT J QUAL HEALTH C, V26, P223, DOI 10.1093/intqhc/mzu041; Ribas N, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0493-6; Rothnie KJ, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007824; Rothnie KJ, 2015, HEART, V101, P1103, DOI 10.1136/heartjnl-2014-307251; Saberi F, 2014, NURS MIDWIFERY STUD, V3, DOI 10.17795/nmsjournal24238; Smith SC, 2011, CIRCULATION, V124, P2458, DOI 10.1161/CIR.0b013e318235eb4d; Sorita A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7393; SPRAFKA JM, 1991, DIABETES CARE, V14, P537, DOI 10.2337/diacare.14.7.537; Stefan MS, 2012, CHEST, V141, P1441, DOI 10.1378/chest.11-2032; Sullivan AL, 2014, CIRC-CARDIOVASC QUAL, V7, P86, DOI 10.1161/CIRCOUTCOMES.113.000396; Terkelsen CJ, 2010, JAMA-J AM MED ASSOC, V304, P763, DOI 10.1001/jama.2010.1139; Timmer JR, 2004, EUR HEART J, V25, P926, DOI 10.1016/j.ehj.2004.04.001; Wei L, 2008, HEART, V94, P1141, DOI 10.1136/hrt.2007.123612; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Yan AT, 2007, AM HEART J, V154, P1108, DOI 10.1016/j.ahj.2007.07.040; Yan AT, 2004, AM J CARDIOL, V94, P25, DOI 10.1016/j.amjcard.2004.03.024; Yudi MB, 2016, INT J CARDIOL, V224, P72, DOI 10.1016/j.ijcard.2016.09.003	66	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 20	2019	14	2							e0212398	10.1371/journal.pone.0212398	http://dx.doi.org/10.1371/journal.pone.0212398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HM2OT	30785928	Green Submitted, Green Published, gold			2022-12-26	WOS:000459307000058
J	Carson, NJ; Mullin, B; Sanchez, MJ; Lu, F; Yang, K; Menezes, M; Le Cook, B				Carson, Nicholas J.; Mullin, Brian; Sanchez, Maria Jose; Lu, Frederick; Yang, Kelly; Menezes, Michelle; Le Cook, Benjamin			Identification of suicidal behavior among psychiatrically hospitalized adolescents using natural language processing and machine learning of electronic health records	PLOS ONE			English	Article							RISK-FACTORS; IDEATION; RESILIENCE; PREDICTION; DIAGNOSES; VALIDITY; SUPPORT; TIME; CARE; AGE	Objective The rapid proliferation of machine learning research using electronic health records to classify healthcare outcomes offers an opportunity to address the pressing public health problem of adolescent suicidal behavior. We describe the development and evaluation of a machine learning algorithm using natural language processing of electronic health records to identify suicidal behavior among psychiatrically hospitalized adolescents. Methods Adolescents hospitalized on a psychiatric inpatient unit in a community health system in the northeastern United States were surveyed for history of suicide attempt in the past 12 months. A total of 73 respondents had electronic health records available prior to the index psychiatric admission. Unstructured clinical notes were downloaded from the year preceding the index inpatient admission. Natural language processing identified phrases from the notes associated with the suicide attempt outcome. We enriched this group of phrases with a clinically focused list of terms representing known risk and protective factors for suicide attempt in adolescents. We then applied the random forest machine learning algorithm to develop a classification model. The model performance was evaluated using sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy. Results The final model had a sensitivity of 0.83, specificity of 0.22, AUC of 0.68, a PPV of 0.42, NPV of 0.67, and an accuracy of 0.47. The terms mostly highly associated with suicide attempt clustered around terms related to suicide, family members, psychiatric disorders, and psychotropic medications. Conclusion This analysis demonstrates modest success of a natural language processing and machine learning approach to identifying suicide attempt among a small sample of hospitalized adolescents in a psychiatric setting.	[Carson, Nicholas J.; Mullin, Brian; Sanchez, Maria Jose; Lu, Frederick; Yang, Kelly; Menezes, Michelle; Le Cook, Benjamin] Cambridge Hlth Alliance, Hlth Equ Res Lab, Cambridge, MA 02139 USA; [Carson, Nicholas J.; Le Cook, Benjamin] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Sanchez, Maria Jose] George Washington Univ, Prevent & Community Hlth Dept, Milken Sch Publ Hlth, Washington, DC USA; [Yang, Kelly] Albert Einstein Coll Med, Dept Psychiat, Bronx, NY USA; [Menezes, Michelle] Univ Virginia, Charlottesville, VA USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School; George Washington University; Yeshiva University; Albert Einstein College of Medicine; University of Virginia	Carson, NJ (corresponding author), Cambridge Hlth Alliance, Hlth Equ Res Lab, Cambridge, MA 02139 USA.; Carson, NJ (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.	ncarson@cha.harvard.edu	Cook, Benjamin/AAA-3543-2022	Lu, Frederick/0000-0002-9884-8231; Sanchez R., Maria Jose/0000-0001-8551-1368	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, National Institutes of Health) [UL1 TR001102]; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER	Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources, National Institutes of Health); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health); Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was conducted with support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award UL1 TR001102) and financial contributions from Harvard University and its affiliated academic healthcare centers. The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic healthcare centers, or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HD, 2015, J AM BOARD FAM MED, V28, P65, DOI 10.3122/jabfm.2015.01.140181; [Anonymous], 2017, R LANG ENV STAT COMP; [Anonymous], 2016, DULCANS TXB CHILD AD; [Anonymous], 2017, INVENIO; Association AP, TEEN SUIC IS PREV 20; Babeva K, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0738-6; Bae SM, 2015, NEUROPSYCH DIS TREAT, V11, P2367, DOI 10.2147/NDT.S91111; Barak-Corren Y, 2017, AM J PSYCHIAT, V174, P154, DOI 10.1176/appi.ajp.2016.16010077; Beam AL, 2018, JAMA-J AM MED ASSOC, V319, P1317, DOI 10.1001/jama.2017.18391; Becker DF, 2007, CAN J PSYCHIAT, V52, P572, DOI 10.1177/070674370705200905; Borowsky IW, 2001, PEDIATRICS, V107, P485, DOI 10.1542/peds.107.3.485; Brady TM, 2015, CLIN PEDIATR, V54, P667, DOI 10.1177/0009922814559379; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; Bridge JA, 2006, J CHILD PSYCHOL PSYC, V47, P372, DOI 10.1111/j.1469-7610.2006.01615.x; Busch KA, 2003, J CLIN PSYCHIAT, V64, P14, DOI 10.4088/JCP.v64n0105; Cabitza F, 2017, JAMA-J AM MED ASSOC, V318, P517, DOI 10.1001/jama.2017.7797; Canty A.J., 2002, R NEWS, V2, P2, DOI DOI 10.1159/000323281; Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613; Center for Disease and Control Prevention, SUIC RISK PROT FACT; Centers for Disease Control and Prevention, 2018, YOUTH RISK BEH SURV; Centers for Disease Control and Prevention, 2017, MMWR MORBIDITY MORTA, DOI 10.15585/mmwr.mm6609a5; Colpe LJ, 2014, AM J PREV MED, V47, pS130, DOI 10.1016/j.amepre.2014.05.024; Connor JJ, 2006, J FAM PSYCHOL, V20, P143, DOI 10.1037/0893-3200.20.1.143; Cook BL, 2016, COMPUT MATH METHOD M, V2016, DOI 10.1155/2016/8708434; Czyz EK, 2015, J CLIN CHILD ADOLESC, V44, P181, DOI 10.1080/15374416.2013.836454; D'Eramo KS, 2004, CHILD PSYCHIAT HUM D, V35, P21, DOI 10.1023/B:CHUD.0000039318.72868.a2; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Downs Johnny, 2017, AMIA Annu Symp Proc, V2017, P641; Fernandes AC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25773-2; Goldston DB, 2009, J CONSULT CLIN PSYCH, V77, P281, DOI 10.1037/a0014732; Goldston DB, 1999, J AM ACAD CHILD PSY, V38, P660, DOI 10.1097/00004583-199906000-00012; Haerian K, 2012, AMIA Annu Symp Proc, V2012, P1244; Harwich E, 2018, THINKING ITS OWN NHS; Hunt IM, 2009, PSYCHOL MED, V39, P443, DOI 10.1017/S0033291708003644; Huth-Bocks AC, 2007, J AM ACAD CHILD PSY, V46, P387, DOI 10.1097/chi.0b013e31802b9535; Jeste DV, 2013, AM J PSYCHIAT, V170, P188, DOI 10.1176/appi.ajp.2012.12030386; Kaslow N, 2018, TEEN SUICIDES WHAT A; Kessler RC, 2015, JAMA PSYCHIAT, V72, P49, DOI 10.1001/jamapsychiatry.2014.1754; Khalilia M, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-51; King CA, 2006, J CONSULT CLIN PSYCH, V74, P199, DOI 10.1037/0022-006X.74.1.199; King CA, 2014, J ABNORM CHILD PSYCH, V42, P467, DOI 10.1007/s10802-013-9794-0; Lachal J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127359; Lacson R, 2011, J AM COLL RADIOL, V8, P436, DOI 10.1016/j.jacr.2011.04.020; Lindberg C, 1990, J Am Med Rec Assoc, V61, P40; Linehan MM, 2006, PSYCHOL ASSESSMENT, V18, P303, DOI 10.1037/1040-3590.18.3.303; Lipschitz JM, 2012, PSYCHIAT RES, V200, P400, DOI 10.1016/j.psychres.2012.07.051; Longhurst CA, 2014, HEALTH AFFAIR, V33, P1229, DOI 10.1377/hlthaff.2014.0099; Luo W, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5870; Mars B, 2016, ARCH SUICIDE RES, V20, P113, DOI 10.1080/13811118.2015.1033121; Millner AJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141606; Monuteaux MC, J AM ACAD CHILD ADOL, V55, P835, DOI [10.1016/j.jaac.2016.07.87084340, DOI 10.1016/J.JAAC.2016.07.87084340]; Ougrin D, 2013, J ADOLESCENCE, V36, P221, DOI 10.1016/j.adolescence.2012.09.006; Passos IC, 2016, J AFFECT DISORDERS, V193, P109, DOI 10.1016/j.jad.2015.12.066; Pons E, 2016, RADIOLOGY, V279, P329, DOI 10.1148/radiol.16142770; Poulin C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085733; Qin P, 2005, ARCH GEN PSYCHIAT, V62, P427, DOI 10.1001/archpsyc.62.4.427; Rodriguez JJ, 2006, IEEE T PATTERN ANAL, V28, P1619, DOI 10.1109/TPAMI.2006.211; Safer D J, 1997, Ann Clin Psychiatry, V9, P263, DOI 10.1023/A:1022364629060; Savova GK, 2010, J AM MED INFORM ASSN, V17, P507, DOI 10.1136/jamia.2009.001560; Stewart Christine, 2017, Psychiatr Serv, V68, P215, DOI 10.1176/appi.ps.201600450; Walsh CG, 2018, J CHILD PSYCHOL PSYC, V59, P1261, DOI 10.1111/jcpp.12916; Walsh CG, 2017, CLIN PSYCHOL SCI, V5, P457, DOI 10.1177/2167702617691560; Wisdom JP, 2006, ADM POLICY MENT HLTH, V33, P133, DOI 10.1007/s10488-006-0036-4; Wolff JC, 2018, J ABNORM CHILD PSYCH, V46, P355, DOI 10.1007/s10802-017-0293-6; Yen S, 2013, PSYCHOL MED, V43, P983, DOI 10.1017/S0033291712001912	65	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 19	2019	14	2							e0211116	10.1371/journal.pone.0211116	http://dx.doi.org/10.1371/journal.pone.0211116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HL9KY	30779800	Green Published, gold, Green Submitted			2022-12-26	WOS:000459062900011
